PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Tachi, T; Yokoi, T; Goto, C; Umeda, M; Noguchi, Y; Yasuda, M; Minamitani, M; Mizui, T; Tsuchiya, T; Teramachi, H				Tachi, T.; Yokoi, T.; Goto, C.; Umeda, M.; Noguchi, Y.; Yasuda, M.; Minamitani, M.; Mizui, T.; Tsuchiya, T.; Teramachi, H.			Hyponatremia and hypokalemia as risk factors for falls	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article							HOSPITALIZED-PATIENTS; ELDERLY-PEOPLE; POPULATION; FRACTURE; SYSTEM; CARE; MEDICATIONS; INJURIES; DRUGS; WOMEN	BACKGROUND/OBJECTIVES: Fall accidents may reduce an individual's quality of life and ability to perform the activities of daily life, and may delay recovery from illness. Consequently, medical institutions need to take measures to prevent falls. There are various risk factors for falls, including advanced age, illness and medication effects. Although hyponatremia and hypokalemia have been reported to increase the rate of falls, how they affect falls is not fully understood. SUBJECTS/METHODS: We retrospectively examined 2948 patients,. 18 years old who had been hospitalized for. 3 days at Gifu (Japan) Municipal Hospital between May 2012 and April 2013 to determine the effects of hyponatremia and hypokalemia on the risk of falls. After the patients had been divided into fall and non-fall groups, their data were subjected to univariate and multiple regression analysis to identify significant differences. RESULTS: The univariate analysis results revealed significant differences between the groups in terms of age (. 65 years); the presence of hyponatremia, hypokalemia, central nervous system disease, cardiovascular disease and/or peripheral nerve/muscular disease; intake of medications that increase the risk of falls; and increased sedative dosage. The multivariate analysis results revealed significant differences between the groups in terms of the presence of hyponatremia (odds ratio (OR), 1.751; 95% confidence interval (CI), 1.020-3.005), hypokalemia (OR, 2.209; 95% CI, 1.280-3.813), central nervous system disease (OR, 2.492; 95% CI, 1.629-3.814) and/or age. 65 years (OR, 2.180; 95% CI, 1.242-3.826). CONCLUSIONS: The results indicated that the presence of hyponatremia or hypokalemia increases the risk of falls.	[Tachi, T.; Yokoi, T.; Noguchi, Y.; Teramachi, H.] Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu 5011196, Japan; [Tachi, T.; Goto, C.; Umeda, M.; Yasuda, M.; Mizui, T.] Gifu Municipal Hosp, Dept Pharm, Gifu, Japan; [Minamitani, M.] Gifu Municipal Hosp, Dept Nursing, Gifu, Japan; [Tsuchiya, T.] Community Hlth Support & Res Ctr, Gifu, Japan	Tachi, T (reprint author), Gifu Pharmaceut Univ, Lab Clin Pharm, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	tachi@gifu-pu.ac.jp					Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; Vestergaard P, 2007, CALCIFIED TISSUE INT, V81, P153, DOI 10.1007/s00223-007-9065-6; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Leipzig RM, 1999, J AM GERIATR SOC, V47, P40; Janicic N, 2003, ENDOCRIN METAB CLIN, V32, P459, DOI 10.1016/S0889-8529(03)00004-5; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; ROBBINS AS, 1989, ARCH INTERN MED, V149, P1628, DOI 10.1001/archinte.149.7.1628; Liu B, 1998, LANCET, V351, P1303, DOI 10.1016/S0140-6736(97)09528-7; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342; Gribbin J, 2010, AGE AGEING, V39, P592, DOI 10.1093/ageing/afq092; Decaux G, 2006, AM J MED, V119, pS79, DOI 10.1016/j.amjmed.2006.05.013; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; MILLER M, 1995, J AM GERIATR SOC, V43, P1410; Shuto H, 2010, BRIT J CLIN PHARMACO, V69, P535, DOI 10.1111/j.1365-2125.2010.03613.x; PAICE BJ, 1986, POSTGRAD MED J, V62, P187; ARIEFF AI, 1984, CLIN ENDOCRINOL META, V13, P269, DOI 10.1016/S0300-595X(84)80022-5; Ash K L, 1998, J Gerontol Nurs, V24, P7; Cashin Richard P, 2011, Can J Hosp Pharm, V64, P321; Coutinho Evandro S F, 2008, BMC Geriatr, V8, P21, DOI 10.1186/1471-2318-8-21; Davis JW, 1999, J AM GERIATR SOC, V47, P792; Echt MA, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-19; Gennari FJ, 1998, NEW ENGL J MED, V339, P451, DOI 10.1056/NEJM199808133390707; Ishikawa S, 2008, B SOC SEA WATER SCI, V62, P9; Janicic N, 2003, ENDOCRIN METAB CLIN, V32, pvii; Kakuda W, 2008, TOKYO JIKEIKAI MED J, V123, P347; Krauss MJ, 2007, INFECT CONT HOSP EP, V28, P544, DOI 10.1086/513725; Liamis G, 2007, INTERNAL MED, V46, P685, DOI 10.2169/internalmedicine.46.6223; Obayashi Kyoko, 2013, Drugs R D, V13, P159, DOI 10.1007/s40268-013-0019-3; Renneboog B, 2006, AM J MED, V119, pe1; SUTTON JC, 1994, BRIT J CLIN PRACT, V48, P63; Suzuki M, 1993, J JPN ACAD NURS SCI, V13, P10; Suzuki T, 2003, JAPANESE J GERIATRIC, V40, P85; Takahashi K, 2011, JPN J PHARMACOEPIDEM, V16, P11; Tanaka M., 2010, PHARM B FUKUOKA U, V10, P47; Tsunoda M, 2009, JPN J PHARM HLTH CAR, V35, P281; Uchida S, 2002, JPN J NEPHROL, V44, P18	36	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0954-3007	1476-5640		EUR J CLIN NUTR	Eur. J. Clin. Nutr.	FEB	2015	69	2					205	210		10.1038/ejcn.2014.195		6	Nutrition & Dietetics	Nutrition & Dietetics	CB2CH	WOS:000349433800011		
J	Yauchi, Y; Ide, M; Shiogai, R; Chikugo, T; Iwasawa, T				Yauchi, Yuta; Ide, Masataka; Shiogai, Ryo; Chikugo, Takuya; Iwasawa, Tetsuo			Regio- and Stereoselective Synthesis of Vicinal (Z)-Dihaloalkenylsilanes from Silyl Ethynylarenes	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Alkenes; Stereoselectivity; Vinyl halides; Halogens; Silanes	CROSS-COUPLING REACTIONS; IODINE MONOCHLORIDE; TETRASUBSTITUTED OLEFINS; AROMATIC HALOGENATION; ARYLBORONIC ACIDS; VINYL HALIDES; ALKYNES; SILICON; CHLORINATION; ACETYLENES	The direct access to (Z)-(1-bromo-2-chloro-2-arylvinyl)triisopropylsilane through formal addition of BrCl to triisopropylsilyl ethynylarene was explored. BrCl was generated in situ from commercially available TMSCl and N-bromosuccinimide. This simple protocol enabled highly efficient regio- and stereoselective bromochlorination, bis-bromination, and bis-chlorination of the triple bond on a gram scale in the syn mode. It thus provided a potentially diverse scaffold for adaptable preparation of differently all-carbon tetrasubstituted olefins.	[Yauchi, Yuta; Ide, Masataka; Shiogai, Ryo; Chikugo, Takuya; Iwasawa, Tetsuo] Ryukoku Univ, Fac Sci & Technol, Dept Chem Mat, Otsu, Shiga 5202194, Japan	Iwasawa, T (reprint author), Ryukoku Univ, Fac Sci & Technol, Dept Chem Mat, Otsu, Shiga 5202194, Japan.	iwasawa@rins.ryukoku.ac.jp					Littke AF, 2000, J AM CHEM SOC, V122, P4020, DOI 10.1021/ja0002058; NEUMANN H, 1978, CHEM BER-RECL, V111, P2785, DOI 10.1002/cber.19781110807; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Denmark SE, 2010, ANGEW CHEM INT EDIT, V49, P2978, DOI 10.1002/anie.200905657; EVANS DA, 1976, J ORG CHEM, V41, P3947, DOI 10.1021/jo00887a003; Ma DW, 2008, ACCOUNTS CHEM RES, V41, P1450, DOI 10.1021/ar8000298; Maibunkaew T, 2014, SYNLETT, V25, P1769, DOI 10.1055/s-0034-1378225; Fleming I, 1997, CHEM REV, V97, P2063, DOI 10.1021/cr941074u; Ruan JW, 2011, ACCOUNTS CHEM RES, V44, P614, DOI 10.1021/ar200053d; Bortolini O, 2002, GREEN CHEM, V4, P621, DOI 10.1039/b209436n; Okamoto N, 2013, ORG LETT, V15, P2571, DOI 10.1021/ol401311h; Ide M, 2014, EUR J ORG CHEM, V2014, P3262, DOI 10.1002/ejoc.201402057; Ide M, 2014, TETRAHEDRON, V70, P8532, DOI 10.1016/j.tet.2014.09.075; Flynn AB, 2007, CHEM REV, V107, P4698, DOI 10.1021/cr050051k; Nakao Y, 2011, CHEM SOC REV, V40, P4893, DOI 10.1039/c1cs15122c; Lemay AB, 2006, J ORG CHEM, V71, P3615, DOI 10.1021/jo060144h; Sato AH, 2013, TETRAHEDRON LETT, V54, P1309, DOI 10.1016/j.tetlet.2012.12.101; Sato AH, 2011, TETRAHEDRON LETT, V52, P6284, DOI 10.1016/j.tetlet.2011.09.089; BEARPARK M, 1990, J AM CHEM SOC, V112, P1732, DOI 10.1021/ja00161a012; Bellina F, 2003, J ORG CHEM, V68, P10175, DOI 10.1021/jo035372f; Brandsma L., 1990, PREPARATIVE POLAR OR, V2; Brandsma L., 1987, PREPARATIVE POLAR OR, V1; Brook M. A., 2000, SILICON ORGANIC ORGA; BUTLER IR, 1991, CAN J CHEM, V69, P1117, DOI 10.1139/v91-165; Colvin E. W., 1981, SILICON ORGANIC SYNT; Colvin E. W., 1988, SILICON REAGENTS ORG; Denmark S. E., 2010, ANGEW CHEM, V122, P3040; DeVito SC, 1996, CHEMTECH, V26, P34; Dondoni A, 2014, EUR J ORG CHEM, P3955, DOI 10.1002/ejoc.201301879; Fischer J., 1979, ANGEW CHEM, V91, P168, DOI 10.1002/ange.19790910219; FISCHER J, 1979, ANGEW CHEM INT EDIT, V18, P167, DOI 10.1002/anie.197901671; Fleming I., 2004, ORG REACTIONS, P57; Gangolli S., 1999, DICT SUBSTANCES THEI, P676; Heasley VL, 2002, J ORG CHEM, V67, P2183, DOI 10.1021/jo011031v; Ho ML, 2007, J ORG CHEM, V72, P977, DOI 10.1021/jo062188w; HUBIG SM, 1994, J ORG CHEM, V59, P6233, DOI 10.1021/jo00100a025; Mitani M, 2004, SYNLETT, P1227, DOI 10.1055/s-2004-825579; Miyaura N, 1998, ADV MET ORG, V6, P187; Moatamedi O., 2008, HETEROCYCL COMMUN, V14, P307; Pawluc P, 2010, EUR J ORG CHEM, P219, DOI 10.1002/ejoc.200900883; Sato AH, 2012, TETRAHEDRON LETT, V53, P3585, DOI 10.1016/j.tetlet.2012.05.004; Schlosser M., 2002, ORGANOMETALLICS SYNT, P1; SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467; TENDIL J, 1974, TETRAHEDRON, V30, P579, DOI 10.1016/S0040-4020(01)97005-X; UEMURA S, 1977, J CHEM SOC PERK T 1, P676, DOI 10.1039/p19770000676; Wakefield B. J., 1988, ORGANOLITHIUM METHOD; Weber W. P., 1983, SILICON REAGENTS ORG; Ye XL, 2007, J CHEM RES-S, P319, DOI 10.3184/030823407X218039	48	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	FEB	2015		5					938	943		10.1002/ejoc.201403450		6	Chemistry, Organic	Chemistry	CB1ML	WOS:000349391700003		
J	Kashima, K; Ishii, M; Tanaka, K				Kashima, Kenichi; Ishii, Masahiro; Tanaka, Ken			Synthesis of Pyridylphosphonates by Rhodium-Catalyzed [2+2+2] Cycloaddition of 1,6-and 1,7-Diynes with Diethyl Phosphorocyanidate	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Homogeneous catalysis; Cycloaddition; Cyclization; Nitrogen heterocycles; Alkynes; Rhodium	GASEOUS ALKYNE EQUIVALENTS; CARBON BOND FORMATION; LIQUID ENOL ETHERS; ENANTIOSELECTIVE SYNTHESIS; PHOTOPHYSICAL PROPERTIES; CYCLOTRIMERIZATION REACTIONS; UNACTIVATED NITRILES; ASYMMETRIC-SYNTHESIS; OLEFIN COMPLEXES; PYRIDINES	The convenient and atom-economical synthesis of substituted bicyclic pyridylphosphonates has been achieved by the cationic rhodium(I)/H8-binap-complex-catalyzed [2+2+2] cycloaddition of 1,6- and 1,7-diynes with diethyl phosphorocyanidate. These reactions may proceed via an azarhodacyclopentadiene intermediate in addition to the rhodacyclopentadiene intermediate.	[Kashima, Kenichi; Ishii, Masahiro; Tanaka, Ken] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Appl Chem, Koganei, Tokyo 1848588, Japan; [Tanaka, Ken] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, Meguro Ku, Tokyo 1528550, Japan; [Tanaka, Ken] Japan Sci & Technol Agcy JST, ACT C, Kawaguchi, Saitama 3320012, Japan	Tanaka, K (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Appl Chem, Koganei, Tokyo 1848588, Japan.	ktanaka@apc.titech.ac.jp			ACT-C, Japan Science and Technology Agency (JST, Japan)	This work was supported partly by ACT-C, Japan Science and Technology Agency (JST, Japan). The authors are grateful to the Takasago International Corporation for a gift of H<INF>8</INF>-binap, Umicore for generous support in supplying the rhodium complex, and Dr. Yu Shibata for assistance in preparing the manuscript.	Agenet N., 2007, ORG REACTIONS, V68, P1; Heller B, 2007, CHEM SOC REV, V36, P1085, DOI 10.1039/b607877j; Dominguez G, 2011, CHEM SOC REV, V40, P3430, DOI 10.1039/c1cs15029d; Gutmann B, 2010, CHEM-EUR J, V16, P12182, DOI 10.1002/chem.201001703; Wilking M, 2013, J AM CHEM SOC, V135, P8133, DOI 10.1021/ja402910d; Nissen F, 2011, CHEM COMMUN, V47, P6656, DOI 10.1039/c1cc11298h; Nishida G, 2007, ANGEW CHEM INT EDIT, V46, P3951, DOI 10.1002/anie.200700064; Weding N, 2011, CHEM SOC REV, V40, P4525, DOI 10.1039/c0cs00189a; Komine Y, 2009, ORG LETT, V11, P2361, DOI 10.1021/ol900802d; Varela JA, 2003, J ORG CHEM, V68, P8595, DOI 10.1021/jo035050b; Sawada Y, 2012, J AM CHEM SOC, V134, P4080, DOI 10.1021/ja300278e; Hapke M, 2010, ORGANOMETALLICS, V29, P4298, DOI 10.1021/om100692K; Stolley RM, 2013, ORGANOMETALLICS, V32, P4952, DOI 10.1021/om400666k; Hapke M, 2010, J ORG CHEM, V75, P3993, DOI 10.1021/jo100122d; Fukawa N, 2010, ORG LETT, V12, P1324, DOI 10.1021/ol100227k; Wang CX, 2011, ANGEW CHEM INT EDIT, V50, P7162, DOI 10.1002/anie.201102001; Yamashita K, 2012, J AM CHEM SOC, V134, P7660, DOI 10.1021/ja302868s; Xu F, 2015, GREEN CHEM, V17, P799, DOI 10.1039/c4gc01756k; Yamamoto Y, 2005, ADV SYNTH CATAL, V347, P1913, DOI 10.1002/adsc.200505193; STAAB HA, 1972, CHEM BER-RECL, V105, P2310, DOI 10.1002/cber.19721050724; Sakiyama N, 2011, CHEM-EUR J, V17, P1428, DOI 10.1002/chem.201003134; Yamamoto Y, 2003, CHEM-EUR J, V9, P2469, DOI 10.1002/chem.200204540; Beesley RM, 1915, J CHEM SOC, V107, P1080, DOI 10.1039/ct9150701080; Zou Y, 2008, ORG LETT, V10, P4661, DOI 10.1021/ol8019549; Moura-Letts G, 2011, P NATL ACAD SCI USA, V108, P6745, DOI 10.1073/pnas.1015268108; McCormick MM, 2005, J AM CHEM SOC, V127, P5030, DOI 10.1021/ja0508931; Garcia P, 2012, CHEM-EUR J, V18, P4337, DOI 10.1002/chem.201103906; Wang CX, 2013, J ORG CHEM, V78, P3065, DOI 10.1021/jo400057t; Mori F, 2011, ORG LETT, V13, P362, DOI 10.1021/ol102927y; Okamoto S, 2012, HETEROCYCLES, V85, P1579, DOI 10.3987/REV-12-737; Xiang CB, 2012, J ORG CHEM, V77, P7706, DOI 10.1021/jo301108g; Kase K, 2007, ORG LETT, V9, P931, DOI 10.1021/ol070037p; Xu F, 2013, CHEM-EUR J, V19, P2252, DOI 10.1002/chem.201203909; Okamoto S, 2013, SYNLETT, V24, P1044, DOI 10.1055/s-0032-1316913; Richard V, 2014, CHEM COMMUN, V50, P593, DOI 10.1039/c3cc47700b; Shibata Y, 2012, SYNTHESIS-STUTTGART, V44, P323, DOI 10.1055/s-0031-1289665; Chopade PR, 2006, ADV SYNTH CATAL, V348, P2307, DOI 10.1002/adsc.200600325; Konno T, 2010, ORG BIOMOL CHEM, V8, P1718, DOI 10.1039/b926192c; Chauvin AS, 2009, INORG CHEM, V48, P10687, DOI 10.1021/ic901424w; Kalek M, 2009, ADV SYNTH CATAL, V351, P3207, DOI 10.1002/adsc.200900590; Lane TK, 2012, J ORG CHEM, V77, P7555, DOI 10.1021/jo3012418; Garcia P, 2011, ORG LETT, V13, P2030, DOI 10.1021/ol200417p; Zou Y, 2011, ORG LETT, V13, P4352, DOI 10.1021/ol201682k; Comby S, 2004, INORG CHEM, V43, P7369, DOI 10.1021/ic049118x; Belabassi Y, 2008, J ORGANOMET CHEM, V693, P3171, DOI 10.1016/j.jorganchem.2008.07.020; Nishida G, 2008, ORG LETT, V10, P2849, DOI 10.1021/ol801013v; Tanaka K, 2006, ORG LETT, V8, P907, DOI 10.1021/ol053044r; Nishida G, 2008, ANGEW CHEM INT EDIT, V47, P3410, DOI 10.1002/anie.200800144; Onodera G, 2012, J AM CHEM SOC, V134, P10515, DOI 10.1021/ja3028394; Yamamoto Y, 2001, J AM CHEM SOC, V123, P6189, DOI 10.1021/ja003890r; Kumar P, 2011, ANGEW CHEM INT EDIT, V50, P10694, DOI 10.1002/anie.201104475; Stolley RM, 2012, J AM CHEM SOC, V134, P15154, DOI 10.1021/ja3075924; Yamamoto Y, 2006, ORG LETT, V8, P3565, DOI 10.1021/ol061350e; Tanaka K, 2012, HETEROCYCLES, V85, P1017, DOI 10.3987/REV-12-729; Hara H, 2008, ORG LETT, V10, P2537, DOI 10.1021/ol800813g; Thiel I, 2013, CHEM-EUR J, V19, P2548, DOI 10.1002/chem.201202946; Yamamoto Y, 2006, CHEM-EUR J, V12, P5618, DOI 10.1002/chem.200600176; Amatore M, 2013, J AM CHEM SOC, V135, P4576, DOI 10.1021/ja309301n; Schafer G, 2013, ANGEW CHEM INT EDIT, V52, P12187, DOI 10.1002/anie.201304686; Berger O, 2013, ADV SYNTH CATAL, V355, P1361, DOI 10.1002/adsc.201300069; Geny A, 2009, ANGEW CHEM INT EDIT, V48, P1810, DOI 10.1002/anie.200806001; Nishida G, 2006, ORG LETT, V8, P3489, DOI 10.1021/ol0611550; Bauer RA, 2010, ORG LETT, V12, P2084, DOI 10.1021/ol100574y; Basu C, 2007, EUR J ORG CHEM, P136, DOI 10.1002/ejoc.200600675; Bessmertnykh A, 2008, SYNTHESIS-STUTTGART, P1575, DOI 10.1055/s-2008-1072570; Bonaga L. V. R., 2005, J AM CHEM SOC, V127, P3473; Broere DLJ, 2012, SYNTHESIS-STUTTGART, V44, P2639, DOI 10.1055/s-0032-1316757; Charbonniere LJ, 2007, CHEM-EUR J, V13, P346, DOI 10.1002/chem.200600915; Dallinger D, 2010, J ORG CHEM, V75, P5278, DOI 10.1021/jo1011703; Dassonneville B, 2011, EUR J ORG CHEM, P2836, DOI 10.1002/ejoc.201100121; Geny A., 2009, ANGEW CHEM, V121, P1842; Goswami A, 2008, ADV SYNTH CATAL, V350, P143, DOI 10.1002/adsc.200700380; Gray BL, 2008, ORG LETT, V10, P2621, DOI 10.1021/ol8004936; Gutnov A, 2004, ANGEW CHEM INT EDIT, V43, P3795, DOI 10.1002/anie.200454164; Gutnov A., 2004, ANGEW CHEM, V116, P3883, DOI 10.1002/ange.200454164; Hara H, 2009, TETRAHEDRON, V65, P5093, DOI 10.1016/j.tet.2009.02.047; Hartley F. H., 1996, THE CHEMISTRY OF ORG; Hrdina R, 2007, ADV SYNTH CATAL, V349, P822, DOI 10.1002/adsc.200600400; Ishii M, 2014, CHEM-EUR J, V20, P2169, DOI 10.1002/chem.201304623; Johansson T, 2001, CHEM COMMUN, P2564, DOI 10.1039/b108857m; Kumar P., 2011, ANGEW CHEM, V123, P10882; Ligtenbarg AGJ, 1998, J CHEM SOC DALTON, P263, DOI 10.1039/a704170e; Liu C, 2002, ORGANOMETALLICS, V21, P5666, DOI 10.1021/om020643i; Mameri S, 2007, TETRAHEDRON LETT, V48, P9132, DOI 10.1016/j.tetlet.2007.10.121; McIver A, 2008, CHEM COMMUN, P4750, DOI 10.1039/b811068a; McIver AL, 2010, ORG LETT, V12, P1288, DOI 10.1021/ol100177u; Mitrofanov A, 2012, SYNTHESIS-STUTTGART, V44, P3805, DOI 10.1055/s-0032-1317517; Mori F, 2012, HETEROCYCLES, V86, P139, DOI 10.3987/COM-12-S(N)30; Murayama K, 2013, J ORG CHEM, V78, P6202, DOI 10.1021/jo4008892; Nishida G., 2008, ANGEW CHEM, V120, P3458, DOI 10.1002/ange.200800144; Nishida G., 2007, ANGEW CHEM, V119, P4025, DOI 10.1002/ange.200700064; Nissen F, 2011, EUR J ORG CHEM, P2845, DOI 10.1002/ejoc.201100131; Perekalin D. S., 2013, EUR J INORG CHEM, P481; Pozharskii A. F., 1997, HETEROCYCLES IN LIFE; Schafer G., 2013, ANGEW CHEM, V125, P12409; Severa L, 2009, TETRAHEDRON LETT, V50, P4526, DOI 10.1016/j.tetlet.2009.05.079; Shibata T, 2002, TETRAHEDRON, V58, P8661, DOI 10.1016/S0040-4020(02)01122-5; Stolley RM, 2011, EUR J ORG CHEM, P3815, DOI 10.1002/ejoc.201100428; Takavec T. N., 2006, J ORG CHEM, V71, P5834; Tanaka K, 2007, ORG LETT, V9, P1907, DOI 10.1021/ol070456m; Tanaka K., 2009, CHEM-ASIAN J, V4, P508; Tanaka K, 2007, SYNLETT, P1977, DOI 10.1055/s-2007-984541; Tanaka K, 2008, SYNLETT, P2017, DOI 10.1055/s-2008-1077968; Tanaka K, 2006, EUR J ORG CHEM, P3917, DOI 10.1002/ejoc.20060034; Tanaka K., 2013, TRANSITION METAL MED; Thiel I, 2013, ORGANOMETALLICS, V32, P3415, DOI 10.1021/om400330x; Turek P, 2008, EUR J ORG CHEM, P3335, DOI 10.1002/ejoc.200800205; Varela JA, 2008, SYNLETT, P2571, DOI 10.1055/s-2008-1078275; Wang C., 2011, ANGEW CHEM, V123, P7300; Weding N, 2011, ADV SYNTH CATAL, V353, P3423, DOI 10.1002/adsc.201100489; Weding N, 2012, ORGANOMETALLICS, V31, P5660, DOI 10.1021/om300503y; Yamamoto Y, 2001, CHEM COMMUN, P1102, DOI 10.1039/b102588k; Yamamoto Y, 2007, CHEM-ASIAN J, V2, P1388, DOI 10.1002/asia.200700077; Yamamoto Y, 2005, J AM CHEM SOC, V127, P605, DOI 10.1021/ja045694g; Young D. D., 2007, ANGEW CHEM INT EDIT, V46, P5187; Young D. D., 2007, ANGEW CHEM, V119, P5279, DOI 10.1002/ange.200700802; Ziessel RF, 2005, J ORG CHEM, V70, P9835, DOI 10.1021/jo051586g	117	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	FEB	2015		5					1092	1099		10.1002/ejoc.201403452		8	Chemistry, Organic	Chemistry	CB1ML	WOS:000349391700022		
J	Suzuki, S; Das, A				Suzuki, Sei; Das, Arnab			Quantum annealing: The fastest route to quantum computation?	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Editorial Material									[Suzuki, Sei] Saitama Med Univ, Dept Liberal Arts, Moroyama, Saitama 3500495, Japan; [Das, Arnab] Indian Assoc Cultivat Sci, Dept Theoret Phys, Kolkata 700032, India	Suzuki, S (reprint author), Saitama Med Univ, Dept Liberal Arts, 38 Moro Hongo, Moroyama, Saitama 3500495, Japan.	sei01@saitama-med.ac.jp; arnab.das.physics@gmail.com						0	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355	1951-6401		EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	FEB	2015	224	1					1	4		10.1140/epjst/e2015-02336-2		4	Physics, Multidisciplinary	Physics	CB2GZ	WOS:000349446400001		
J	Das, A; Suzuki, S				Das, Arnab; Suzuki, Sei			Quo Vadis quantum annealing?	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Review							ADIABATIC EVOLUTION; OPTIMIZATION; SIMULATIONS; MECHANICS; MODEL	In this article we sketch a broad outline of quantum annealing as a framework for realizing analog quantum computation. We provide a short review of the basic ideas and discuss some issues relevant to the current scenario of condensed matter physics and quantum computation.	[Das, Arnab] Indian Assoc Cultivat Sci, Dept Theoret Phys, Kolkata 700032, India; [Suzuki, Sei] Saitama Med Univ, Dept Liberal Arts, Moroyama, Saitama 3500495, Japan	Das, A (reprint author), Indian Assoc Cultivat Sci, Dept Theoret Phys, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, India.	arnab.das.physics@gmail.com; sei01@saitama-med.ac.jp					Altshuler B., 2010, P NATL ACAD SCI USA, V107, P28; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; Das A, 2008, REV MOD PHYS, V80, P1061, DOI 10.1103/RevModPhys.80.1061; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Santoro GE, 2002, SCIENCE, V295, P2427, DOI 10.1126/science.1068774; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Brooke J, 1999, SCIENCE, V284, P779, DOI 10.1126/science.284.5415.779; FINNILA AB, 1994, CHEM PHYS LETT, V219, P343, DOI 10.1016/0009-2614(94)00117-0; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Sarandy MS, 2004, QUANTUM INF PROCESS, V3, P331, DOI 10.1007/s11128-004-7712-7; Santoro GE, 2006, J PHYS A-MATH GEN, V39, pR393, DOI 10.1088/0305-4470/39/36/R01; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; AMARA P, 1993, J PHYS CHEM-US, V97, P6715, DOI 10.1021/j100127a023; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; RAY P, 1989, PHYS REV B, V39, P11828, DOI 10.1103/PhysRevB.39.11828; Laumann CR, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.030502; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; De Grandi C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.224303; APOLLONI B, 1989, STOCH PROC APPL, V33, P233, DOI 10.1016/0304-4149(89)90040-9; Balents L., 2010, NATURE, V464, P119; Breuer H-P, 2002, THEORY OPEN QUANTUM; Caneva T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144427; Chuang IL, 2010, QUANTUM COMPUTATION; Das A, 2009, J PHYS CONF SER, V143, DOI 10.1088/1742-6596/143/1/012001; Das A., 2005, LECT NOTES PHYS, V679; Das A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061121; Farhi E., 2000, ARXIVQUANTPH0001106; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Henelius P, 2000, PHYS REV B, V62, P1102, DOI 10.1103/PhysRevB.62.1102; Johnston H., 2014, PHYS WORLD NEWS; Lauchli AM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.212401; Roland J, 2002, PHYS REV A, V65, DOI [10.1103/PhysRevA.65.042308, 10.1103/PhysRevB.65.042308]; Sachdev S., 2011, QUANTUM PHASE TRANSI; Schiff L. I., 1968, QUANTUM MECH; Suzuki S., 2013, LECT NOTES PHYS, V862; Tsuda J, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.114004	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355	1951-6401		EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	FEB	2015	224	1					5	13		10.1140/epjst/e2015-02337-1		9	Physics, Multidisciplinary	Physics	CB2GZ	WOS:000349446400002		
J	Nishimori, H				Nishimori, H.			Comparison of quantum annealing and simulated annealing	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Review							ADIABATIC EVOLUTION; OPTIMIZATION; QUBITS	A brief description is given on the present status of the theory of quantum annealing from author's perspective. An emphasis is given on comparison of quantum annealing and simulated annealing.	Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan	Nishimori, H (reprint author), Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan.						Aarts E., 1989, SIMULATED ANNEALING; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; Lanting T, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021041; Das A, 2008, REV MOD PHYS, V80, P1061, DOI 10.1103/RevModPhys.80.1061; Bian ZB, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130505; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Morita S, 2008, J MATH PHYS, V49, DOI 10.1063/1.2995837; [Anonymous], 2014, 3 INT WORKSH AD QUAN; Santoro GE, 2006, J PHYS A-MATH GEN, V39, pR393, DOI 10.1088/0305-4470/39/36/R01; Katzgraber HG, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021008; Boixo S, 2014, NAT PHYS, V10, P218, DOI [10.1038/nphys2900, 10.1038/NPHYS2900]; Morita S, 2006, J PHYS A-MATH GEN, V39, P13903, DOI 10.1088/0305-4470/39/45/004; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; Boixo S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3067; Dickson NG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2920; Johnson JW, 2011, NATURE, V473, P194; Kadowaki T, 1998, ARXIVQUANTPH0205020; Morita S, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.064002; Morita S, 2008, THESIS TOKYO I TECHN; Perdomo-Ortiz A., 2001, ARXIV14067601; Perdomo-Ortiz A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00571; Pudenz KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4243; Ronnow T. F., 2014, SCI EXPR, V19; Suzuki S, 2013, QUANTUM ISING PHASES; Venturelli D., 1953, ARXIV14067553; Vinci W., 1928, ARXIV14034228	26	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355	1951-6401		EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	FEB	2015	224	1					15	16		10.1140/epjst/e2015-02338-0		2	Physics, Multidisciplinary	Physics	CB2GZ	WOS:000349446400003		
J	Suzuki, S				Suzuki, S.			Performance of quantum annealing in solving optimization problems: A review	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Review							ISING SPIN-GLASS; COMPUTATIONAL-COMPLEXITY; MODEL; ALGORITHM; RELAXATION	Quantum annealing is one of the optimization method for generic optimization problems. It uses quantum mechanics and is implemented by a quantum computer ideally. At the earlier stage, several numerical experiments using conventional computers have provided results showing that quantum annealing produces an answer faster than simulated annealing, a classical counterpart of quantum annealing. Later, theoretical and numerical studies have shown that there are drawbacks in quantum annealing. The power of quantum annealing is still an open problem. What makes quantum annealing a hot topic now is that a quantum computer based on quantum annealing is manufactured and commercialized by a Canadian company named D-Wave Systems. In the present article, we review the study of quantum annealing, focusing mainly on its power.	Saitama Med Univ, Dept Liberal Arts, Moroyama, Saitama 3500495, Japan	Suzuki, S (reprint author), Saitama Med Univ, Dept Liberal Arts, Moroyama, Saitama 3500495, Japan.	sei01@saitama-med.ac.jp					Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; EDWARDS SF, 1975, J PHYS F MET PHYS, V5, P965, DOI 10.1088/0305-4608/5/5/017; Das A, 2008, REV MOD PHYS, V80, P1061, DOI 10.1103/RevModPhys.80.1061; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; von Neumann J, 1929, PHYS Z, V30, P467; Santoro GE, 2002, SCIENCE, V295, P2427, DOI 10.1126/science.1068774; Battaglia DA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066707; Young AP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.020502; Morita S, 2008, J MATH PHYS, V49, DOI 10.1063/1.2995837; White SR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.076401; Altshuler B, 2010, P NATL ACAD SCI USA, V107, P12446, DOI 10.1073/pnas.1002116107; Dziarmaga J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.064416; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; Albash T, 2015, EUR PHYS J-SPEC TOP, V224, P111, DOI 10.1140/epjst/e2015-02346-0; Morita S, 2006, J PHYS A-MATH GEN, V39, P13903, DOI 10.1088/0305-4470/39/45/004; Jorg T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.147204; Monasson R, 1999, NATURE, V400, P133; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; RAY P, 1989, PHYS REV B, V39, P11828, DOI 10.1103/PhysRevB.39.11828; Laumann CR, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.030502; KATO T, 1950, J PHYS SOC JPN, V5, P435; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721; Farhi E, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.052334; BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; Caneva T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144427; Daley AJ, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/04/P04005; Das A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026701; Farhi E., 2000, ARXIVQUANTPH0001106; Garey M.R., 1979, COMPUTERS INTRACTABI; Hen I, 2015, EUR PHYS J-SPEC TOP, V224, P63, DOI 10.1140/epjst/e2015-02343-3; Jorg T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.207206; Laumann CR, 2015, EUR PHYS J-SPEC TOP, V224, P75, DOI 10.1140/epjst/e2015-02344-2; Martonak R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.057701; Messiah A., 1962, QUANTUM MECH, V2; Mezard M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056126; Mezard M., 1987, SPIN GLASS THEORY; Monasson R, 1997, PHYS REV E, V56, P1357, DOI 10.1103/PhysRevE.56.1357; Morita S, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.064002; Nakamura T, 2003, J PHYS SOC JPN, V72, P2405, DOI [10.1143/JPSJ.72.2405, 10.1143/JPS.72.2405]; Rieger H, 1999, EUR PHYS J B, V9, P233, DOI 10.1007/s100510050761; Seki Y, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051112; Shankar R, 1994, PRINCIPLES QUANTUM M; Shor P, 1994, P 35 ANN S FDN COMP, P124, DOI DOI 10.1109/SFCS.1994.365700; SUZUKI M, 1971, PROG THEOR PHYS, V46, P1337, DOI 10.1143/PTP.46.1337; Suzuki S., 2013, LECT NOTES PHYS, V862; Suzuki S, 2009, J PHYS CONF SER, V143, DOI 10.1088/1742-6596/143/1/012002; Suzuki S, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03032; Tsuda J, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.114004; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287	49	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355	1951-6401		EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	FEB	2015	224	1					51	61		10.1140/epjst/e2015-02342-4		11	Physics, Multidisciplinary	Physics	CB2GZ	WOS:000349446400007		
J	Inoue, J				Inoue, J.			Infinite-range transverse field Ising models and quantum computation	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Review							REPLICA-SYMMETRY-BREAKING; ERROR-CORRECTING CODES; SPIN-GLASS MODEL; NEURAL-NETWORKS; STATISTICAL-MECHANICS; SOLVABLE MODEL; EVOLUTION	We present a brief review on information processing, computing and inference via quantum fluctuation, and clarify the relationship between the probabilistic information processing and theory of quantum spin glasses through the analysis of the infinite-range model. We also argue several issues to be solved for the future direction in the research field.	Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, Sapporo, Hokkaido 0640814, Japan	Inoue, J (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, N14-W9, Sapporo, Hokkaido 0640814, Japan.	j_inoue@complex.ist.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) [2533027803, 26282089, 2512001313]	The author gratefully acknowledges his friends and colleagues Y. Otsubo, K. Nagata, M. Okada, S. Suzuki, Y. Saika, A. Das, A. Chandra, S. Dasgupta, P. Sen, A. Dutta, S. Sharma and B. K. Chakrabarti for collaboration on this research topic. This study was financially supported by Grant-in-Aid for Scientific Research (C) of Japan Society for the Promotion of Science (JSPS) No. 2533027803, Grant-in-Aid for Scientific Research (B) No. 26282089, and Grant-in-Aid for Scientific Research on Innovative Area No. 2512001313.	Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; Harris R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.177001; Heyl M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135704; SOURLAS N, 1989, NATURE, V339, P693, DOI 10.1038/339693a0; GOLDSCHMIDT YY, 1990, PHYS REV LETT, V64, P2467, DOI 10.1103/PhysRevLett.64.2467; MEZARD M, 1986, J PHYS-PARIS, V47, P1285, DOI 10.1051/jphys:019860047080128500; Tanaka K, 2002, J PHYS A-MATH GEN, V35, pR81, DOI 10.1088/0305-4470/35/37/201; Nishimori H, 1996, J PHYS SOC JPN, V65, P3780, DOI 10.1143/JPSJ.65.3780; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; SHERRINGTON D, 1975, PHYS REV LETT, V35, P1792, DOI 10.1103/PhysRevLett.35.1792; Chandran A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.064304; Young AP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.170503; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; DEALMEIDA JRL, 1978, J PHYS A-MATH GEN, V11, P983, DOI 10.1088/0305-4470/11/5/028; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; RAY P, 1989, PHYS REV B, V39, P11828, DOI 10.1103/PhysRevB.39.11828; Bapst V, 2013, J PHYS CONF SER, V473, DOI 10.1088/1742-6596/473/1/012011; Boixo S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3067; Chakrabarti BK, 2006, EUR PHYS J B, V51, P321, DOI 10.1140/epjb/e2006-00226-6; Chandra AK, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021101; Cohen E., 2013, IEEE C P INT S BROAD, P1; Cohen E, 2014, PROC SPIE, V9217, DOI 10.1117/12.2061278; COOLEN ACC, 1988, PHYS REV A, V38, P4253, DOI 10.1103/PhysRevA.38.4253; GOLDSCHMIDT YY, 1990, PHYS REV B, V41, P4858, DOI 10.1103/PhysRevB.41.4858; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Inoue J, 2001, PHYS REV E, V63; Inoue J, 2010, J PHYS CONF SER, V233, DOI 10.1088/1742-6596/233/1/012010; Inoue J, 2009, J PHYS CONF SER, V143, DOI 10.1088/1742-6596/143/1/012019; Inoue J., 2012, LECT NOTES PHYS, V862; Inoue JI, 2005, LECT NOTES PHYS, V679, P259; Kabashima Y., 1999, EPL-EUROPHYS LETT, V45, P98; Mezard M., 1987, SPIN GLASS THEORY; Nishimori H, 1999, PHYS REV E, V60, P132, DOI 10.1103/PhysRevE.60.132; Nishimori H, 2001, STAT PHYS SPIN GLASS; Obuchi T, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.054002; Otsubo Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051138; Otsubo Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012126; Santoro G.E., 2002, SCIENCE, V295, P5564; Suzuki M., 1976, PROG THEOR PHYS, V56, P2454; Tanaka T, 2001, EUROPHYS LETT, V54, P540, DOI 10.1209/epl/i2001-00306-3; THIRUMALAI D, 1989, J PHYS A-MATH GEN, V22, P3339, DOI 10.1088/0305-4470/22/16/023; Uesaka Y., 1993, MATH FDN NEURAL COMP; VANNIMENUS J, 1984, J PHYS LETT-PARIS, V45, P1145, DOI 10.1051/jphyslet:0198400450240114500	43	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355	1951-6401		EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	FEB	2015	224	1					149	161		10.1140/epjst/e2015-02348-x		13	Physics, Multidisciplinary	Physics	CB2GZ	WOS:000349446400013		
J	Das, A; Suzuki, S				Das, A.; Suzuki, S.			Debate and discussion: Quo Vadis quantum annealing?	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Editorial Material							COMPUTATION		[Das, A.] Indian Assoc Cultivat Sci, Dept Theoret Phys, Kolkata 700032, India; [Suzuki, S.] Saitama Med Univ, Dept Liberal Arts, Moroyama, Saitama 3500495, Japan	Das, A (reprint author), Indian Assoc Cultivat Sci, Dept Theoret Phys, 2A & 2B,Raja SC Mullick Rd, Kolkata 700032, India.	arnab.das.physics@gmail.com; sei01@saitama-med.ac.jp					Amin MHS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.022107; Sarandy MS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.250503; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; Yucesoy B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012104; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Preskill J, 2013, QUANTUM INF COMPUT, V13, P181; Knill E, 1998, SCIENCE, V279, P342, DOI 10.1126/science.279.5349.342; Childs A. M., 2002, Physical Review A (Atomic, Molecular, and Optical Physics), V65, DOI 10.1103/PhysRevA.65.012322; DAS A, REV MOD PHYS, V80, P1061; Dickson NG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2920; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Somma RD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.030603; Stern M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.123601	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355	1951-6401		EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	FEB	2015	224	1					205	212		10.1140/epjst/e2015-02351-3		8	Physics, Multidisciplinary	Physics	CB2GZ	WOS:000349446400016		
J	Harari, S; Lau, EMT; Tamura, Y; Cottin, V; Simonneau, G; Humbert, M				Harari, Sergio; Lau, Edmund M. T.; Tamura, Yuichi; Cottin, Vincent; Simonneau, Gerald; Humbert, Marc			Rare (pulmonary) disease day: "feeding the breath, energy for life!"	EUROPEAN RESPIRATORY JOURNAL			English	Editorial Material							ARTERIAL-HYPERTENSION; FIBROSIS; LYMPHANGIOLEIOMYOMATOSIS; EFFICACY; BRONCHIOLITIS; PIRFENIDONE; REGISTRY; THERAPY; SAFETY; TRIAL	(1)U0 Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Eisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe - MultiMedica, Milan, Italy. (2)Dept of Respiratory Medicine, Royal Prince Alfred Hospital, University of Sydney, Camperdown, Australia. (3)Faculte de Medecine, Universite Paris-Sud, Le Kremlin Bicetre, France. (4)Service de Pneumologie, DHU Thorax Innovation, Hopital Bicetre, Assistance Publigue Hepitaux de Paris, Le Kremlin-Bicetre, France. (5)Inserm UMR_S 999, LabExLERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. (6)Dept of Cardiology, Keio University School of Medicine, Tokyo, Japan. (7)Centre national de reference des maladies pulmonaires rares, Service de pneumologie, Hopital Louis-Pradel, Hopitaux de Lyon, UMR 754, Universite Claude-Bernard Lyon 1, Lyon, France.	[Harari, Sergio] Osped San Giuseppe MultiMed, Serv Fisiopatol & Resp Emodinam Polmonare, UO Pneumol & Terapia Semi Intensiva Resp, Milan, Italy; [Lau, Edmund M. T.] Univ Sydney, Royal Prince Alfred Hosp, Dept Resp Med, Camperdown, NSW, Australia; [Lau, Edmund M. T.; Tamura, Yuichi; Simonneau, Gerald; Humbert, Marc] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Lau, Edmund M. T.; Tamura, Yuichi; Simonneau, Gerald; Humbert, Marc] Hop Bicetre, AP HP, DHU Thorax Innovat, Serv Pneumol, Le Kremlin Bicetre, France; [Lau, Edmund M. T.; Tamura, Yuichi; Simonneau, Gerald; Humbert, Marc] Ctr Chirurg Marie Lannelongue, Inserm UMR S 999, LabExLERMIT, Le Plessis Robinson, France; [Tamura, Yuichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Cottin, Vincent] Univ Lyon 1, Hop Lyon, Ctr Natl Reference Malad Pulmonaires Rares, Serv Pneumol,Hop Louis Pradel,UMR 754, F-69365 Lyon, France	Harari, S (reprint author), Osped San Giuseppe MultiMed, Serv Fisiopatol & Resp Emodinam Polmonare, UO Pneumol & Terapia Semi Intensiva Resp, Milan, Italy.	sharari@ilpolmone.it					Chang WYC, 2014, EUR RESPIR J, V43, P1114, DOI 10.1183/09031936.00167413; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Piras B, 2013, EUR RESPIR J, V42, P54, DOI 10.1183/09031936.00104712; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Ortega H, 2014, EUR RESPIR J, V44, P239, DOI 10.1183/09031936.00220413; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Pepke-Zaba J, 2013, EUR RESPIR J, V41, P985, DOI 10.1183/09031936.00201612; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313; Bonella F, 2012, EUR RESPIR J, V40, P1468, DOI 10.1183/09031936.00017612; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Jenkins DP, 2013, EUR RESPIR J, V41, P735, DOI 10.1183/09031936.00058112; Simonneau G, 2012, EUR RESPIR J, V40, P874, DOI 10.1183/09031936.00137511; Humbert M, 2014, CIRCULATION, V130, P2189, DOI 10.1161/CIRCULATIONAHA.114.006974; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Cordier JF, 2013, PRESSE MED, V42, P507, DOI 10.1016/j.lpm.2013.02.308; Bode R, 2011, EUR RESPIR REV, V20, P98; Caminati Antonella, 2013, Eur Respir Rev, V22, P292, DOI 10.1183/09059180.00002713; Caminati Antonella, 2012, Eur Respir Rev, V21, P207, DOI 10.1183/09059180.00003112; Cordier JF, 2013, EUR RESPIR J, V41, P1126, DOI 10.1183/09031936.00099812; Cordier JF, 2011, EUR RESPIR MONOGR, V54; Cottin V, 2014, EUR RESPIR J, V43, P966, DOI 10.1183/09031936.00025314; Cottin V, 2012, EUR RESPIR J, V40, P630, DOI 10.1183/09031936.00093111; Epaud R, 2015, EUR RESPIR J, V45, P831, DOI 10.1183/09031936.00146114; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Harari Sergio, 2013, Eur Respir Rev, V22, P199, DOI 10.1183/09059180.00004613; Harari Sergio, 2012, Eur Respir Rev, V21, P171, DOI 10.1183/09059180.00004112; Hoeper MM, 2014, EUR RESPIR J, V43, P1230, DOI 10.1183/09031936.00037114; Meyer KC, 2014, EUR RESPIR J, V44, P1479, DOI 10.1183/09031936.00107514; Orphanet, 2012, ABOUT RARE DISEASES; Poletti V, 2013, EUR RESPIR J, V41, P1012, DOI 10.1183/09031936.00041813; Rare Disease Day, 2014, WHAT IS RARE DISEASE; Simonneau G, 2014, EUR RESPIR J IN PRES, DOI [10.1183/09031936.00087114, DOI 10.1183/09031936.00087114]; Spagnolo P, 2013, LANCET RESP MED, V1, P479, DOI 10.1016/S2213-2600(13)70085-7; Taboada D, 2014, EUR RESPIR J, V44, P1635, DOI 10.1183/09031936.00050114; Wei P, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000141	38	0	0	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	FEB	2015	45	2					297	300		10.1183/09031936.00221914		4	Respiratory System	Respiratory System	CB3DZ	WOS:000349509700001		
J	Gomez-Arroyo, J; Sakagami, M; Syed, AA; Farkas, L; Van Tassell, B; Kraskauskas, D; Mizuno, S; Abbate, A; Bogaard, HJ; Byron, PR; Voelkel, NF				Gomez-Arroyo, Jose; Sakagami, Masahiro; Syed, Aamer A.; Farkas, Laszlo; Van Tassell, Benjamin; Kraskauskas, Donatas; Mizuno, Shiro; Abbate, Antonio; Bogaard, Harm J.; Byron, Peter R.; Voelkel, Norbert F.			Iloprost reverses established fibrosis in experimental right ventricular failure	EUROPEAN RESPIRATORY JOURNAL			English	Article							PULMONARY ARTERIAL-HYPERTENSION; TISSUE GROWTH-FACTOR; SMOOTH-MUSCLE PROLIFERATION; INHALED ILOPROST; PROSTACYCLIN ANALOGS; HEART; RECEPTOR; THERAPY; DYSFUNCTION; FIBROBLASTS	Prostacyclin and its analogues improve cardiac output and functional capacity in patients with pulmonary arterial hypertension (PAH); however, the underlying mechanism is not fully understood. We hypothesised that prostanoids have load-independent beneficial effects on the right ventricle (RV). Angio-obliterative PAH and RV failure were induced in rats with a single injection of SU5416 followed by 4 weeks of exposure to hypoxia. Upon confirmation of RV dysfunction and PAH, rats were randomised to 0.1 mu g.kg(-1) nebulised iloprost or drug-free vehicle, three times daily for 2 weeks. RV function and treadmill running time were evaluated pre- and post-iloprost/vehicle treatment. Pulmonary artery banded rats were treated 8 weeks after surgery to allow for significant RV hypertrophy. Inhaled iloprost significantly improved tricuspid annulus plane systolic excursion and increased exercise capacity, while mean pulmonary artery pressure and the percentage of occluded pulmonary vessels remained unchanged. Rats treated with iloprost had a striking reduction in RV collagen deposition, procollagen mRNA levels and connective tissue growth factor expression in both SU5416/hypoxia and pulmonary artery banded rats. In vitro, cardiac fibroblasts treated with iloprost showed a reduction in transforming growth factor (TGF)-beta 1-induced connective tissue growth factor expression, in a protein kinase A-dependent manner. Iloprost decreased TGF-beta 1-induced procollagen mRNA expression as well as cardiac fibroblast activation and migration. Iloprost significantly induced metalloproteinase-9 gene expression and activity and increased the expression of autophagy genes associated with collagen degradation. Inhaled iloprost improves RV function and reverses established RV fibrosis partially by preventing collagen synthesis and by increasing collagen turnover.	[Gomez-Arroyo, Jose; Syed, Aamer A.; Farkas, Laszlo; Van Tassell, Benjamin; Kraskauskas, Donatas; Abbate, Antonio; Voelkel, Norbert F.] Virginia Commonwealth Univ, Victoria Johnson Ctr Lung Obstruct Dis Res, Richmond, VA USA; [Sakagami, Masahiro; Byron, Peter R.] Virginia Commonwealth Univ, Dept Pharmaceut, Sch Pharm, Richmond, VA USA; [Van Tassell, Benjamin; Abbate, Antonio] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA; [Mizuno, Shiro] Kanazawa Med Univ, Div Resp Dis, Uchinada, Ishikawa, Japan; [Bogaard, Harm J.] Vrije Univ Amsterdam Med Ctr, Dept Pulm Med, Amsterdam, Netherlands	Gomez-Arroyo, J (reprint author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, 720 Rutland Ave,Ross 361, Baltimore, MD 21224 USA.	jgomeza1@jhmi.edu			Actelion; VCU's Medical College of Virginia Foundation; VCU's CTSA Grant from the National Center for Advancing Translational Sciences [UL1TR00058]; NIH-CI Cancer Center Support Grant [P30 CA016059]	This work was partly funded by a grant from Actelion, supplemented by funds from the VCU's Medical College of Virginia Foundation. P.R. Byron and M. Sakagami received support from VCU's CTSA Grant (UL1TR00058) from the National Center for Advancing Translational Sciences. The VCU Nucleic Acids Research Facility core laboratory is funded by a NIH-CI Cancer Center Support Grant (P30 CA016059). Ventavis was provided by Actelion Pharmaceuticals (Allschwil, Switzerland) free of charge.	Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; EGHBALI M, 1992, BASIC RES CARDIOL, V87, P183; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; VOELKEL NF, 1981, CIRC RES, V48, P207; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Clapp LH, 2002, AM J RESP CELL MOL, V26, P194; Stratton R, 2001, J CLIN INVEST, V108, P241, DOI 10.1172/JCI12020; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Rain S, 2013, CIRCULATION, V128, P2016, DOI 10.1161/CIRCULATIONAHA.113.001873; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC; Falcetti E, 2010, AM J RESP CRIT CARE, V182, P1161, DOI 10.1164/rccm.201001-0011OC; Hara A, 2005, CIRCULATION, V112, P84, DOI 10.1161/CIRCULATIONAHA.104.527077; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; Hoper MM, 1997, AM J RESP CELL MOL, V17, P748; Pogoriler JE, 2012, HISTOPATHOLOGY, V61, P597, DOI 10.1111/j.1365-2559.2012.04246.x; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Drake JI, 2011, AM J RESP CELL MOL, V45, P1239, DOI 10.1165/rcmb.2010-0412OC; Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, pL401, DOI 10.1152/ajplung.00114.2010; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Hoeper MM, 2000, NEW ENGL J MED, V342, P1866, DOI 10.1056/NEJM200006223422503; Ogo T, 2013, AM J RESP CELL MOL, V48, P733, DOI 10.1165/rcmb.2012-0049OC; Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC; Francois H, 2005, CELL METAB, V2, P201, DOI 10.1016/j.cmet.2005.08.005; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Rich S, 2010, CHEST, V138, P1234, DOI 10.1378/chest.09-2815; Shi-Wen X, 2000, EXP CELL RES, V259, P213, DOI 10.1006/excr.2000.4972; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Gomez-Arroyo J, 2012, AM J PHYSIOL-LUNG C, V302, pL977, DOI 10.1152/ajplung.00362.2011; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Arndt S, 2011, AM J PATHOL, V178, P2622, DOI 10.1016/j.ajpath.2011.02.009; Delcroix M, 2009, Eur Respir Rev, V18, P253, DOI 10.1183/09059180.00003109; Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127; Fontana M, 2007, BRIT J PHARMACOL, V151, P779, DOI 10.1038/sj.bjp.0707300; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Olschewski H, 2010, RESP MED, V104, P731, DOI 10.1016/j.rmed.2010.01.008; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Rex S, 2008, CRIT CARE, V12, DOI 10.1186/cc7005; Stratton R, 2002, FASEB J, V16, P1949, DOI 10.1096/fj.02-0204fje; Syed A, 2012, AM J RESP CRIT CARE, V185, pA3415; Voelkel NF, 1996, ANN NY ACAD SCI, V796, P186, DOI 10.1111/j.1749-6632.1996.tb32580.x	52	1	1	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	FEB	2015	45	2					449	462		10.1183/09031936.00188013		14	Respiratory System	Respiratory System	CB3DZ	WOS:000349509700022		
J	Tagami, T; Matsui, H; Horiguchi, H; Fushimi, K; Yasunaga, H				Tagami, Takashi; Matsui, Hiroki; Horiguchi, Hiromasa; Fushimi, Kiyohide; Yasunaga, Hideo			Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients	EUROPEAN RESPIRATORY JOURNAL			English	Article							RESPIRATORY-DISTRESS-SYNDROME; SEVERE SEPSIS; SEPTIC SHOCK; PROPENSITY SCORE; CONTROLLED-TRIAL; CLINICAL-COURSE; MANAGEMENT; METAANALYSIS; OUTCOMES; IMPACT	The relationship between low-dose corticosteroid use and mortality in patients with severe community-acquired pneumonia (CAP) remains unclear. 6925 patients with severe CAP who received mechanical ventilation with or without shock (defined as use of catecholamines) at 983 hospitals were identified using a Japanese nationwide administrative database. The main outcome measure was 28-day mortality. 2524 patients with severe CAP who received catecholamines were divided into corticosteroid (n=631) and control (n=1893) groups. The 28-day mortality was significantly different between corticosteroid and control groups (unmatched: 24.6% versus 36.3%, p<0.001; propensity score-matched: 25.3% versus 32.6%, p=0.01; inverse probability-weighted: 27.5% versus 34.2%, p<0.001). 4401 patients with severe CAP who did not receive catecholamines were also divided into corticosteroid (n=1112) and control (n=3289) groups. The 28-day mortality was not significantly different between corticosteroid and control groups in propensity score-matched analyses (unmatched: 16.0% versus 19.4%, p=0.01; propensity score-matched: 17.7% versus 15.6%, p=0.22; inverse probability-weighted: 18.8% versus 18.2%, p=0.44). Low-dose corticosteroid use may be associated with reduced 28-day mortality in patients with septic shock complicating CAP.	[Tagami, Takashi; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Grad Sch Med, Tokyo 1138555, Japan; [Tagami, Takashi] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Dept Clin Data Management & Res, Clin Res Ctr, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Informat & Policy, Tokyo, Japan	Tagami, T (reprint author), Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Grad Sch Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138555, Japan.	t-tagami@nms.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare of Japan (Research on Policy Planning and Evaluation) [H25-Policy-010]	H. Horiguchi, K. Fushimi and H. Yasunaga received grant support from the Ministry of Health, Labour and Welfare of Japan (Research on Policy Planning and Evaluation, grant no. H25-Policy-010). The funders had no role in the execution of this study or the interpretation of the results.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI 10.1056/NEJMra1208623; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Chon GR, 2011, J INFECT CHEMOTHER, V17, P449, DOI 10.1007/s10156-010-0196-8; Park DW, 2012, CRIT CARE MED, V40, P3140, DOI 10.1097/CCM.0b013e3182657b75; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; MARIK P, 1993, CHEST, V104, P389, DOI 10.1378/chest.104.2.389; Salluh JIF, 2008, CHEST, V134, P947, DOI 10.1378/chest.08-1382; Kim SH, 2011, AM J RESP CRIT CARE, V183, P1207, DOI 10.1164/rccm.201101-0110OC; Salluh JIF, 2011, J CRIT CARE, V26, P193, DOI 10.1016/j.jcrc.2010.07.014; Mikami K, 2007, LUNG, V185, P249, DOI 10.1007/s00408-007-9020-3; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Garcia-Vidal C, 2007, EUR RESPIR J, V30, P951, DOI 10.1183/09031936,00027607; Wilson BZ, 2012, CRIT CARE MED, V40, P2310, DOI 10.1097/CCM.0b013e31825151a8; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002; Adrie C, 2013, CRIT CARE, V17, DOI 10.1186/cc13095; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Meduri GU, 2008, INTENS CARE MED, V34, P61, DOI 10.1007/s00134-007-0933-3; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; Briel M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006150; Cheng M, 2014, RESP CARE, V59, P557, DOI 10.4187/respcare.02758; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Messika J, 2014, J CRIT CARE, V29, P733, DOI 10.1016/j.jcrc.2014.05.021; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; PUREN AJ, 1995, CHEST, V107, P1342, DOI 10.1378/chest.107.5.1342; Salluh JI, 2010, J CRIT CARE, V25, P541; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Ugajin Motoi, 2013, Int J Gen Med, V6, P693, DOI 10.2147/IJGM.S49275; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869	40	10	10	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	FEB	2015	45	2					463	472		10.1183/09031936.00081514		10	Respiratory System	Respiratory System	CB3DZ	WOS:000349509700023		
J	Tanishima, S; Fukada, S; Ishii, H; Dokai, T; Morio, Y; Nagashima, H				Tanishima, Shinji; Fukada, Satoru; Ishii, Hiroyuki; Dokai, Toshiyuki; Morio, Yasuo; Nagashima, Hideki			Comparison between walking test and treadmill test for intermittent claudication associated with lumbar spinal canal stenosis	EUROPEAN SPINE JOURNAL			English	Article						Neurogenic intermittent claudication; Walking test; Treadmill test; Lumbar spinal canal stenosis	CAUDA-EQUINA; NEUROGENIC CLAUDICATION; COMPRESSION	To clarify the priorities of the walking test and the treadmill test for intermittent claudication of lumbar canal stenosis. The study population comprised 45 subjects, with a mean age of 72.6 years. An investigator walked with the subjects during the walking test or watched the subjects walking on the treadmill machine in the treadmill test. The pain scales became significantly worse after the walking test. Ten patients who were diagnosed as root symptom type or cauda equine symptoms were subsequently diagnosed as mixed type by the walking test. The numbers of patients who experienced muscle weakness that was not revealed at rest were eight with the walking test and seven with the treadmill test. The numbers of patients who experienced sensory disturbance that was not observed at rest were seven with the walking test and two with the treadmill test. The walking test detected significantly more symptoms that were not detected at rest than the treadmill test.	[Tanishima, Shinji; Fukada, Satoru; Ishii, Hiroyuki; Morio, Yasuo] Misasa Onsen Hosp, Fac Orthoped Surg, Misasa, Tottori 6820197, Japan; [Dokai, Toshiyuki] Yonago Med Ctr, Dept Orthoped Surg, Yonago, Tottori 6830006, Japan; [Nagashima, Hideki] Tottori Univ, Dept Orthoped Surg, Fac Med, Yonago, Tottori 6388504, Japan	Tanishima, S (reprint author), Misasa Onsen Hosp, Fac Orthoped Surg, 690 Yamada, Misasa, Tottori 6820197, Japan.	shinji@sanmedia.or.jp					Rainville J, 2012, SPINE J, V12, P101, DOI 10.1016/j.spinee.2011.12.006; White SC, 1998, MED SCI SPORT EXER, V30, P1537, DOI 10.1097/00005768-199810000-00011; Tomkins CC, 2007, SPINE, V32, P1896, DOI 10.1097/BRS.0b013e31811328eb; Takahashi K, 1995, SPINE, V20, P2746, DOI 10.1097/00007632-199512150-00017; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403; Stolze H, 1997, ELECTROMYOGR MOTOR C, V105, P490, DOI 10.1016/S0924-980X(97)00055-6; AMUNDSEN T, 1995, SPINE, V20, P1178, DOI 10.1097/00007632-199505150-00013; BLAU JN, 1978, BRAIN, V101, P211, DOI 10.1093/brain/101.2.211; CIRICILLO SF, 1993, WESTERN J MED, V158, P171; Deen HG, 1998, SPINE, V23, P244, DOI 10.1097/00007632-199801150-00019; DONG G, 1989, SPINE, V14, P965, DOI 10.1097/00007632-198909000-00009; DYCK P, 1979, Spine, V4, P89, DOI 10.1097/00007632-197901000-00014; DYCK P, 1977, J NEUROSURG, V46, P667, DOI 10.3171/jns.1977.46.5.0667; EPSTEIN JA, 1973, J NEUROSURG, V39, P362, DOI 10.3171/jns.1973.39.3.0362; Jellinger K, 1972, HDB CLIN NEUROLOGY 2, P507; KIKUCHI S, 1985, Orthopaedic Transactions, V9, P514; Kim Youn-Soo, 2009, Asian Spine J, V3, P96, DOI 10.4184/asj.2009.3.2.96; Konno S, 2000, SPINE, V25, P1533, DOI 10.1097/00007632-200006150-00012; NELSON RC, 1972, MED SCI SPORT EXER, V4, P233, DOI 10.1249/00005768-197200440-00029; Padmanabhan G, 2011, J Man Manip Ther, V19, P35, DOI 10.1179/2042618610Y.0000000002; Porter RW, 1996, SPINE, V21, P2046, DOI 10.1097/00007632-199609010-00024; PORTER RW, 1992, SPINE, V17, P9, DOI 10.1097/00007632-199201000-00002; Sato K, 1997, SPINE, V22, P1898, DOI 10.1097/00007632-199708150-00018; WILSON CB, 1969, J NEUROSURG, V31, P499, DOI 10.3171/jns.1969.31.5.0499	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	FEB	2015	24	2					327	332		10.1007/s00586-014-3511-8		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CB2DP	WOS:000349437200018		
J	Yamada, K; Aota, Y; Higashi, T; Ishida, K; Niimura, T; Konno, T; Saito, T				Yamada, Katsutaka; Aota, Yoichi; Higashi, Takayuki; Ishida, Ko; Niimura, Takanori; Konno, Tomoyuki; Saito, Tomoyuki			Roentgenographic and computed tomographic findings in symptomatic lumbar foraminal stenosis	EUROPEAN SPINE JOURNAL			English	Article						Lumbar foraminal stenosis; Symptomatic foraminal stenosis; Spinal canal stenosis; Segmental range of motion in sagittal plane; Posterior instability	DORSAL-ROOT GANGLIA; INTERVERTEBRAL FORAMEN; FLEXION-EXTENSION; NERVE ROOTS; ENTRAPMENT; ANATOMY; MYELOGRAPHY; DIAGNOSIS; CANALS; SPINE	To determine the static and dynamic radiological findings characteristic of symptomatic foraminal stenosis. Between 2006 and 2011, a total of 114 patients with unilateral leg pain due to L5 nerve root compression were screened to investigate the characteristic radiological findings of symptomatic foraminal stenosis. Static findings on sagittal CT images and dynamic findings on X-rays were compared between 39 surgically treated L5-S1 foraminal stenosis patients (FS group) and 75 surgically treated L4-5 intra-spinal canal stenosis patients (CS group). There was no significant difference between the FS and CS groups in all demographic data and radiologic findings, except for the segmental range of motion in sagittal plane on functional X-rays and posterior translation on extension. The segmental range of motion in sagittal plane at L5-S1 was significantly larger in the FS group (13.4 +/- A 3.1 vs. 4.2 +/- A 2.0; p = 0.03) compared to the CS group. The prevalence of 3 mm or more posterior translation at L5 was significantly higher in the FS group (38 vs. 3 %; p = 0.04) compared to the CS group, and the average posterior translation of L5 was significantly greater in the FS group (3.1 +/- A 1.6 mm) than that in the CS group (0.3 +/- A 0.6 mm) (p = 0.02). A large segmental range of motion in sagittal plane of L5-S1 and posterior instability of L5 are risk factors for symptomatic L5-S1 foraminal stenosis. These dynamic radiological findings support the diagnosis of symptomatic foraminal stenosis.	[Yamada, Katsutaka; Aota, Yoichi; Higashi, Takayuki; Ishida, Ko; Niimura, Takanori; Konno, Tomoyuki; Saito, Tomoyuki] Yokohama City Univ, Dept Orthopaed Surg, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Yamada, K (reprint author), Yokohama City Univ, Dept Orthopaed Surg, Kanazawa Ku, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan.	katsutaka@af.em-net.ne.jp					Jenis LG, 2000, SPINE, V25, P389, DOI 10.1097/00007632-200002010-00022; PORTER RW, 1984, SPINE, V9, P418, DOI 10.1097/00007632-198405000-00017; KUNOGI J, 1991, SPINE, V16, P1312, DOI 10.1097/00007632-199111000-00012; AOTA Y, 1995, J SPINAL DISORD, V8, P464, DOI 10.1097/00024720-199512000-00006; Inufusa A, 1996, SPINE, V21, P2412, DOI 10.1097/00007632-199611010-00002; Aota Y, 2007, SPINE, V32, P896, DOI 10.1097/01.brs.0000259809.75760.d5; Nowicki BH, 1996, AM J NEURORADIOL, V17, P1605; VANDERLINDEN RG, 1984, SPINE, V9, P19, DOI 10.1097/00007632-198401000-00006; LEE CK, 1988, SPINE, V13, P313, DOI 10.1097/00007632-198803000-00015; Fujiwara A, 2003, SPINE, V28, P1601, DOI 10.1097/00007632-200307150-00023; HASEGAWA T, 1995, J BONE JOINT SURG AM, V77A, P32; MACNAB I, 1971, J BONE JOINT SURG AM, VA 53, P891; BOSE K, 1984, SPINE, V9, P16, DOI 10.1097/00007632-198401000-00005; Burton K, 1981, CLIN ORTHOP RELAT R, V157, P191; COHEN MS, 1990, SPINE, V15, P1248, DOI 10.1097/00007632-199012000-00003; CROCK HV, 1981, J BONE JOINT SURG BR, V63, P487; Fujiwara A, 2001, SPINE, V26, P876, DOI 10.1097/00007632-200104150-00010; Hasegawa T, 1996, SPINE, V21, P1005, DOI 10.1097/00007632-199605010-00001; KIRKALDYWILLIS WH, 1982, CLIN ORTHOP RELAT R, P171; KRUDY AG, 1992, AM J ROENTGENOL, V159, P1315; LIYANG D, 1989, Spine, V14, P523, DOI 10.1097/00007632-198905000-00009; Milette PC, 1999, SPINE, V24, P44, DOI 10.1097/00007632-199901010-00011; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; White A.A, 1990, CLIN BIOMECHANICS SP	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	FEB	2015	24	2					333	338		10.1007/s00586-014-3683-2		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CB2DP	WOS:000349437200019		
J	Aizawa, T; Ozawa, H; Kusakabe, T; Tanaka, Y; Sekiguchi, A; Hashimoto, K; Kanno, H; Morozumi, N; Ishii, Y; Sato, T; Takahashi, E; Kokubun, S; Itoi, E				Aizawa, Toshimi; Ozawa, Hiroshi; Kusakabe, Takashi; Tanaka, Yasuhisa; Sekiguchi, Akira; Hashimoto, Ko; Kanno, Haruo; Morozumi, Naoki; Ishii, Yushin; Sato, Tetsuro; Takahashi, Eiji; Kokubun, Shoichi; Itoi, Eiji			Reoperation rates after fenestration for lumbar spinal canal stenosis: a 20-year period survival function method analysis	EUROPEAN SPINE JOURNAL			English	Article						Lumbar spinal canal stenosis; Fenestration; Reoperation; Survival function method	THORACIC MYELOPATHY; SURGICAL-TREATMENT; SURGERY; SPONDYLOLISTHESIS; OPERATIONS	Fenestration is the gold standard surgery for lumbar spinal canal stenosis in Japan. Several previous studies have analyzed the reoperation rates in large numbers of patients undergoing several surgical procedures such as laminectomy with or without instrumented spinal fusion; however, there have been few studies focusing solely on fenestration. The purpose of this study was to calculate the reoperation rates after fenestration using the survival function method. Form 1988-2007, 6,998 surgeries for lumbar spinal canal stenosis occurred in Miyagi prefecture, Japan, and these patients were enrolled by the spinal surgery registration system of the Department of Orthopaedic Surgery, Tohoku University. Among these, 5,835 surgeries involved fenestration as a primary surgery and for those who underwent a parts per thousand yen2 lumbar surgeries we analyzed the reoperation rates using the Kaplan-Meier method. Among the 5,835 patients undergoing primary fenestration, 215 patients underwent 221 revisions; 112 included the same spinal levels and 103 were revised only at other levels as primary fenestration. The overall reoperation rates were 0.8 % at 1 year, 2.9 % at 5 years, 5.2 % at 10 years, 7.5 % at 15 years and 8.6 % at > 17.7 years. Reoperation rates for those at the same spinal levels were 0.6 % at 1 year, 1.7 % at 5 years, 2.7 % at 10 years, 3.8 % at 15 years, and 4.1 % at > 17.0 years. Fenestration can be performed at low cost using standard spinal surgery equipments. The reoperation rates of this procedure were lower than previously reported for several other surgical procedures.	[Aizawa, Toshimi; Ozawa, Hiroshi; Hashimoto, Ko; Kanno, Haruo; Itoi, Eiji] Tohoku Univ Sch Med, Dept Orthopaed Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kusakabe, Takashi; Sekiguchi, Akira] Tohoku Rosai Hosp, Dept Orthopaed Surg, Sendai, Miyagi, Japan; [Tanaka, Yasuhisa] Tohoku Cent Hosp, Dept Orthopaed Surg, Yamagata, Japan; [Morozumi, Naoki; Ishii, Yushin; Kokubun, Shoichi] Sendai Nishitaga Natl Hosp, Dept Orthopaed Surg, Sendai, Miyagi, Japan; [Sato, Tetsuro; Takahashi, Eiji] Sendai Orthopaed Hosp, Dept Orthopaed Surg, Sendai, Miyagi, Japan	Aizawa, T (reprint author), Tohoku Univ Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	toshi-7@ra2.so-net.ne.jp					Adachi Ko, 2003, Spine J, V3, P471, DOI 10.1016/S1529-9430(03)00149-9; Aizawa T, 2012, J ORTHOP SCI, V17, P107, DOI 10.1007/s00776-011-0184-6; Martin BI, 2007, SPINE, V32, P2119, DOI 10.1097/BRS.0b013e318145a56a; Kim CH, 2013, SPINE J, V13, P1230, DOI 10.1016/j.spinee.2013.06.069; SHARMA M, 1995, SPINE, V20, P887; Aizawa T, 2006, J NEUROSURG-SPINE, V5, P514, DOI 10.3171/spi.2006.5.6.514; Aizawa T, 2006, TOHOKU J EXP MED, V210, P199, DOI 10.1620/tjem.210.199; Deyo RA, 2011, J BONE JOINT SURG AM, V93A, P1979, DOI 10.2106/JBJS.J.01292; Jansson KA, 2005, EUR SPINE J, V14, P659, DOI 10.1007/s00586-004-0851-9; Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46; [Anonymous], 1996, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-199602000-00018; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; NAKAI O, 1991, J BONE JOINT SURG AM, V73A, P1184; Papagelopoulos PJ, 1997, SPINE, V22, P442, DOI 10.1097/00007632-199702150-00019; Aykac B, 2011, ACTA ORTHOP TRAUMATO, V45, P47, DOI 10.3944/AOTT.2011.2387; Aizawa T, 2007, J NEUROSURG-SPINE, V7, P13, DOI 10.3171/SPI-07/07/013; Brodke DS, 2013, SPINE, V38, P2287, DOI 10.1097/BRS.0000000000000068; GETTY CJM, 1981, J BONE JOINT SURG BR, V63, P330; Kida H, 1980, J JPN ORTHOP ASSOC, V54, P1142; Koyanagi E, 1998, ORTHOP TRAUMATOL, V47, P64; Matsumoto T, 2002, ORTHOP TRAUMATOL, V51, P524; Nath R, 2013, INDIAN J ORTHOP, V46, P285; Otani K, 2010, J SPINAL RES, V1, P1248; Patel CK, 2011, ROTHMAN SIMEONE SPIN, P1064; Sato T, 1997, TOHOKU J EXP MED, V184, P1; Sato T, 2005, KANTO J ORTHOP TRAUM, V36, P99; Su BW, 2011, ROTHMAN SIMEONE SPIN, P1083; Sugawara A, 2012, SPINAL SURG, V26, P205; Tanaka Y, 2003, ORTHOP SURG TRAUMATO, V46, P391; Tominaga A, 2011, CTR JPN J ORTHOP TRA, V54, P815; Yamazaki K, 2009, ORTHOP SURG, V60, P407; Yoshida M, 2005, MINIMALLY INVASIVE S, P15	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	FEB	2015	24	2					381	387		10.1007/s00586-014-3479-4		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CB2DP	WOS:000349437200024		
J	Minamide, A; Yoshida, M; Yamada, H; Nakagawa, Y; Hashizume, H; Iwasaki, H; Tsutsui, S				Minamide, Akihito; Yoshida, Munehito; Yamada, Hiroshi; Nakagawa, Yukihiro; Hashizume, Hiroshi; Iwasaki, Hiroshi; Tsutsui, Shunji			Clinical outcomes after microendoscopic laminotomy for lumbar spinal stenosis: a 5-year follow-up study	EUROPEAN SPINE JOURNAL			English	Article						Clinical outcome; Degenerative spondylolisthesis; Endoscopic surgery; Lumbar spinal stenosis; Minimally invasive surgery	DEGENERATIVE SPONDYLOLISTHESIS; SURGICAL-MANAGEMENT; FUSION; DECOMPRESSION; INSTABILITY; VALIDATION; STABILITY	To prospectively investigate the long-term clinical outcomes of microendoscopic laminotomy (MEL) in patients with lumbar spinal stenosis (LSS) with and without degenerative spondylolisthesis (DS). In total, 159 patients (mean age, 68 years) who had undergone MEL for single-level LSS at L4/5 at our institute were recruited and followed-up for 5 years. Patients with and without DS were assigned to the DS (n = 71) and control (n = 88) groups, respectively. In addition to slippage rate, Japanese orthopedic association (JOA), recovery rate, short-form 36 (SF-36), and Roland-Morris disability questionnaire (RDQ) values were evaluated preoperatively and 5 years postoperatively. All parameters were analyzed by Student's t test, with p < 0.05 considered statistically significant. Of 159 patients, 12 were lost to follow-up (follow-up rate, 92.5 %); moreover, 15 patients were excluded because of death, cerebral infarction, dementia, or terminal cancer. Thus, 132 patients (DS group: 61, control group: 71) were finally examined. No significant differences were found in preoperative JOA, JOA recovery rate, RDQ, and SF-36 values between groups. The slippage rate in the DS group was 18.1 % preoperatively and 16.8 % at 5 years postoperatively (p > 0.05). There was no significant increase in instability in those with DS following MEL. Progressive spinal instability was noted in six patients (9.8 %) and five patients (7.0 %) in the DS and control groups, respectively (p > 0.05). Moreover, the success rate of MEL was good/excellent in 70 %, fair in 20 %, and poor in 10 % of patients in both groups. MEL showed similar outcomes in patients with DS and in those without DS.	[Minamide, Akihito; Yoshida, Munehito; Yamada, Hiroshi; Nakagawa, Yukihiro; Hashizume, Hiroshi; Iwasaki, Hiroshi; Tsutsui, Shunji] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama 6418510, Japan	Minamide, A (reprint author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418510, Japan.	minamide@wakayama-med.ac.jp					Aebi M, 2005, EUR SPINE J, V14, P925, DOI 10.1007/s00586-005-1053-9; Nakamura M, 2003, SPINE, V28, P2414, DOI 10.1097/01.BRS.0000085425.90995.09; ABUMI K, 1990, SPINE, V15, P1142, DOI 10.1097/00007632-199011010-00011; Athiviraham A, 2007, CLIN ORTHOP RELAT R, P90, DOI 10.1097/BLO.0b013e31803799a9; Kornblum MB, 2004, SPINE, V29, P726, DOI 10.1097/01.BRS.0000119398.22620.92; BRIDWELL KH, 1993, J SPINAL DISORD, V6, P461; MATSUNAGA S, 1990, SPINE, V15, P1204, DOI 10.1097/00007632-199011010-00021; Matsunaga S, 2000, J NEUROSURG, V93, P194, DOI 10.3171/spi.2000.93.2.0194; Martin CR, 2007, SPINE, V32, P1791, DOI 10.1097/BRS.0b013e3180bc219e; Minamide A, 2013, J NEUROSURG-SPINE, V19, P664, DOI 10.3171/2013.8.SPINE13125; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Khoo LT, 2002, NEUROSURGERY, V51, pS146, DOI 10.1227/01.NEU.0000031220.75770.29; HAHER TR, 1994, SPINE, V19, P2667, DOI 10.1097/00007632-199412010-00012; Park P, 2004, SPINE, V29, P1938, DOI 10.1097/01.brs.0000137069.88904.03; HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802; Pao JL, 2009, EUR SPINE J, V18, P672, DOI 10.1007/s00586-009-0903-2; Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; Ghiselli G, 2004, J BONE JOINT SURG AM, V86A, P1497; Bolesta M J, 1989, Instr Course Lect, V38, P157; JOHNSSON KE, 1989, SPINE, V14, P591, DOI 10.1097/00007632-198906000-00008; Kauppila LI, 1998, SPINE, V23, P1868, DOI 10.1097/00007632-199809010-00014; KIRKALDYWILLIS WH, 1982, CLIN ORTHOP RELAT R, P110; NEWMAN PH, 1976, CLIN ORTHOP RELAT R, P116; Perez-Cruet MJ, 2002, NEUROSURGERY, V51, pS129, DOI 10.1227/01.NEU.0000031004.69814.2D; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	FEB	2015	24	2					396	403		10.1007/s00586-014-3599-x		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CB2DP	WOS:000349437200026		
J	Kase, S; Shinohara, T; Kase, M				Kase, Satoru; Shinohara, Toshiya; Kase, Manabu			Histological observation of goblet cells following topical rebamipide treatment of the human ocular surface: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						rebamipide; goblet cells; mucin-like substance; humans; histopathology	DRY EYE; OPC-12759	The topical administration of rebamipide (Mucosta (R)), an antiulcer agent, clinically increases the mucin level of tear film. The aim of this study was to report the histological changes of goblet cells following the topical administration of rebamipide to a patient with nevus of the lacrimal caruncle. A 62-year-old male exhibited a pigmented nodule located in the lacrimal caruncle in the left eye. An excisional biopsy and subsequent surgical resection were conducted at the caruncle, prior to and three months after topical rebamipide administration. Histologically, a biopsy specimen revealed a pigmented nevus beneath the caruncle epithelium containing a few goblet cells [4 cells/high power field (HPF)]. A few nevus cells were present at the surgical margin. By contrast, the secondary resected specimen obtained three months after the initiation of topical rebamipide treatment revealed the epithelium and nevus, where numerous goblet cells were present (28 cells/HPF), and mucin-like substances were markedly secreted from the goblet cells. Topical rebamipide markedly increased the number of goblet cells and stimulated the secretion of mucin-like substances in the caruncular tissue of a human patient. These results suggest that topical rebamipide is useful in patients following surgery and/or biopsy to support tissue repair of the ocular surface.	[Kase, Satoru; Kase, Manabu] Teine Keijinkai Hosp, Dept Ophthalmol, Sapporo, Hokkaido 0060811, Japan; [Shinohara, Toshiya] Teine Keijinkai Hosp, Dept Surg Pathol, Sapporo, Hokkaido 0060811, Japan	Kase, S (reprint author), Teine Keijinkai Hosp, Dept Ophthalmol, Teine Ku, Maeda 1-12, Sapporo, Hokkaido 0060811, Japan.	kaseron@keijinkai.or.jp					Le QH, 2010, INVEST OPHTH VIS SCI, V51, P1397, DOI 10.1167/iovs.09-3886; Kinoshita S, 2012, OPHTHALMOLOGY, V119, P2471, DOI 10.1016/j.ophtha.2012.06.052; Urashima H, 2012, J OCUL PHARMACOL TH, V28, P264, DOI 10.1089/jop.2011.0147; Rios JD, 2006, CORNEA, V25, P573; Rios JD, 2008, EXP EYE RES, V86, P629, DOI 10.1016/j.exer.2008.01.007; Itakura Hirotaka, 2013, Clin Ophthalmol, V7, P2137, DOI 10.2147/OPTH.S5451; Kase S, 2014, JAMA OPHTHALMOL, V132, P1021, DOI 10.1001/jamaophthalmol.2014.431; Kashima Tomoyuki, 2012, Clin Ophthalmol, V6, P1403, DOI 10.2147/OPTH.S35122; Koh S, 2013, CORNEA, V32, P1219, DOI 10.1097/ICO.0b013e318294f97e; Ohguchi T, 2013, INVEST OPHTH VIS SCI, V54, P7793, DOI 10.1167/iovs.13-13128	10	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	FEB	2015	9	2					456	458		10.3892/etm.2014.2108		3	Medicine, Research & Experimental	Research & Experimental Medicine	CB3CX	WOS:000349506900029		
J	Makihara, N; Arimura, K; Ago, T; Tachibana, M; Nishimura, A; Nakamura, K; Matsuo, R; Wakisaka, Y; Kuroda, J; Sugimori, H; Kamouchi, M; Kitazono, T				Makihara, Noriko; Arimura, Koichi; Ago, Tetsuro; Tachibana, Masaki; Nishimura, Ataru; Nakamura, Kuniyuki; Matsuo, Ryu; Wakisaka, Yoshinobu; Kuroda, Junya; Sugimori, Hiroshi; Kamouchi, Masahiro; Kitazono, Takanari			Involvement of platelet-derived growth factor receptor beta in fibrosis through extracellular matrix protein production after ischemic stroke	EXPERIMENTAL NEUROLOGY			English	Article						Collagen; Extracellular matrix; Fibroblast; Fibronectin; Fibrosis; Ischemic stroke; Pericyte; Platelet-derived growth factor receptor beta	BLOOD-BRAIN-BARRIER; MESENCHYMAL STEM-CELLS; PERIVASCULAR FIBROBLASTS; CEREBRAL-ARTERY; TISSUE-REPAIR; BONE-MARROW; PERICYTES; INJURY; SCAR; RECRUITMENT	Fibrosis is concomitant with repair processes following injuries in the central nervous system (CNS). Pericytes are considered as an origin of fibrosis-forming cells in the CNS. Here, we examined whether platelet-derived growth factor receptor beta(PDGFR beta), a well-known indispensable molecule for migration, proliferation, and survival of pericytes, was involved in the production of extracellular matrix proteins, fibronectin and collagen type I, which is crucial for fibrosis after ischemic stroke. Immunohistochemistry demonstrated induction of PDGFR beta expression in vascular cells of pen-infarct areas at 3-7 days in a mouse stroke model. The PDGFR beta-expressing cells extended from pen-infarct areas toward the ischemic core after day 7 while expressing fibronectin and collagen type I in the infarct areas. In contrast, desmin and alpha-smooth muscle actin, markers of pericytes, were only expressed in vascular cells. In PDGFR beta heterozygous knockout mice, the expression of fibronectin and collagen type I was attenuated at both mRNA and protein levels with an enlargement of the infarct volume after ischemic stroke compared with that in wild-type littermates. In cultured brain pericytes, the expression of PDGF-B, PDGFR beta, fibronectin, and collagen type I, but not desmin, was significantly increased by serum depletion (SD). The SD-induced upregulation of fibronectin and collagen type I was suppressed by SU11652, an inhibitor of PDGFR beta, while PDGF-B further increased the SD-induced upregulation. In conclusion, the expression level of PDGFR beta may be a crucial determinant of fibrosis after ischemic stroke. Moreover, PDGFR beta signaling participates in the production of fibronectin and collagen type I after ischemic stroke. (C) 2014 Elsevier Inc. All rights reserved.	[Makihara, Noriko; Arimura, Koichi; Ago, Tetsuro; Tachibana, Masaki; Nishimura, Ataru; Nakamura, Kuniyuki; Matsuo, Ryu; Wakisaka, Yoshinobu; Kuroda, Junya; Sugimori, Hiroshi; Kamouchi, Masahiro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Arimura, Koichi; Nishimura, Ataru] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 8128582, Japan; [Matsuo, Ryu; Kamouchi, Masahiro] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 8128582, Japan	Ago, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	agou@intmed2.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26461145, 26462163, 25461134]; Takeda Science Foundation, Japan; Innovation Center for Medical Redox Navigation	The work was supported in part by a Grant-in-Aid for Scientific Research (C) (26461145) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T.A.), the Takeda Science Foundation, Japan (to TA.), the Innovation Center for Medical Redox Navigation (to T.A.), a Grant-in-Aid for Scientific Research (C) (25461134) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to J.K.), and a Grant-in-Aid for Scientific Research (C) (26462163) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to Y.W.).	Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Peng Y, 2013, EUR J CLIN INVEST, V43, P358, DOI 10.1111/eci.12053; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sugimori H, 2004, BRAIN RES PROTOC, V13, P189, DOI 10.1016/j.brainresprot.2004.06.001; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Renner Oliver, 2003, Brain Res Mol Brain Res, V113, P44; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Kamouchi M, 2011, CELL MOL NEUROBIOL, V31, P175, DOI 10.1007/s10571-010-9605-x; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Asashima T, 2002, EUR J CELL BIOL, V81, P145, DOI 10.1078/0171-9335-00227; Jung KH, 2011, NEUROBIOL DIS, V41, P489, DOI 10.1016/j.nbd.2010.10.020; Terasaki T, 2003, DRUG DISCOV TODAY, V8, P944, DOI 10.1016/S1359-6446(03)02858-7; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32	35	3	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2015	264						127	134		10.1016/j.expneurol.2014.12.007		8	Neurosciences	Neurosciences & Neurology	CB4IC	WOS:000349590400014		
J	Komatsu, M; Sato, Y; Negami, T; Terada, T; Sasaki, O; Yasuda, J; Arakawa, A; Yoshida, C; Takahashi, H; Malau-Aduli, AEO; Suzuki, K; Shimizu, K				Komatsu, Masanori; Sato, Yoichi; Negami, Tatsuki; Terada, Tohru; Sasaki, Osamu; Yasuda, Jumpei; Arakawa, Aisaku; Yoshida, Chikara; Takahashi, Hideaki; Malau-Aduli, Aduli E. O.; Suzuki, Keiichi; Shimizu, Kentaro			Overdominance Effect of the Bovine Ghrelin Receptor (GHSR1a)-DelR242 Locus on Growth in Japanese Shorthorn Weaner Bulls: Heterozygote Advantage in Bull Selection and Molecular Mechanisms	G3-GENES GENOMES GENETICS			English	Article						overdominance; growth; ghrelin receptor (GHSR1a); DelR242; cattle	HORMONE SECRETAGOGUE RECEPTOR; GENOME-WIDE ASSOCIATION; BEEF-CATTLE; FEED-EFFICIENCY; HETEROSIS; TRAITS; VISUALIZATION; HYPOTHALAMUS; EXPRESSION; RELEASE	Ghrelin and the ghrelin receptor (GHSR1a) are involved in growth hormone secretion, food intake, and several other important functions. Ghrelin acts on GHSR1a and induces signal transduction via the G alpha q subunit. In our previous study, we identified the DelR242 (3R) allele, a truncated 3-arginine residue (3R) [major type: 4 arginine residues (4R)] of the third intracellular loop of GHSR1a, with a high frequency in Japanese Shorthorn bulls (0.43) but with a low frequency in other cattle breeds (0.00-0.09). To further investigate the reasons for the higher frequency of the 3R allele, we performed several experiments. In this study, we found a significant sex difference in the frequency of the 3R allele. Statistical analysis revealed a significant overdominance effect of the DelR242 locus on growth in Japanese Shorthorn weaner bulls. However, additive/dominance/overdominance effects of the 3R allele on carcass traits in adult steers and dams were not significant. The mode of the overdominance effect was estimated to be solely controlled by the single DelR242 locus without any other linked loci using linkage disequilibrium analysis in GHSR1a. These results indicated that 4R/3R heterozygotes had a selective advantage in weaner bulls because of their higher average daily gain than homozygotes. We discussed possible molecular mechanisms involved in the overdominance effect of the DelR242 locus on these traits in weaner bulls using a structural model of the complex consisting of a GHSR1a dimer and G alpha q.	[Komatsu, Masanori; Sasaki, Osamu; Takahashi, Hideaki] Natl Agr & Food Res Org NARO, NARO Inst Livestock & Grassland Sci, Anim Breeding Res Grp, Tsukuba, Ibaraki 3050901, Japan; [Negami, Tatsuki; Terada, Tohru; Shimizu, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo 1138657, Japan; [Terada, Tohru; Shimizu, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo 1138657, Japan; [Sato, Yoichi; Yasuda, Jumpei; Yoshida, Chikara] IARC, Anim Ind Res Inst, Takizawa, Iwate 0200173, Japan; [Malau-Aduli, Aduli E. O.] Univ Tasmania, Fac Sci Engn & Technol, Sch Land & Food, Tasmanian Inst Agr, Hobart, Tas 7001, Australia; [Malau-Aduli, Aduli E. O.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia; [Arakawa, Aisaku] Natl Inst Agrobiol Sci, Anim Res Grp, Tsukuba, Ibaraki 3050901, Japan; [Suzuki, Keiichi] Tohoku Univ, Grad Sch Agr, Sendai, Miyagi 9818555, Japan	Komatsu, M (reprint author), Natl Agr & Food Res Org NARO, NARO Inst Livestock & Grassland Sci, 2 Ikenodai, Tsukuba, Ibaraki 3050901, Japan.	mkomatsu@affrc.go.jp			NARO [212-j-01-001]; NIAS (National Institute of Agrobiological Sciences) Gene Bank Project; NILGS; Animal Industry Research Institute, IARC, in Japan; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by a NARO grant (No. 212-j-01-001), the NIAS (National Institute of Agrobiological Sciences) Gene Bank Project, and the collaborative research projects between NILGS and the Animal Industry Research Institute, IARC, in Japan. Support was also provided by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Albarran-Zeckler RG, 2011, PEPTIDES, V32, P2229, DOI 10.1016/j.peptides.2011.07.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Perez-Enciso M, 2004, BIOINFORMATICS, V20, P2792, DOI 10.1093/bioinformatics/bth331; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; East EM, 1936, GENETICS, V21, P375; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Cruz CRY, 2008, VITAM HORM, V77, P47, DOI 10.1016/S0083-6729(06)77004-2; Inoue H, 2011, J CLIN ENDOCR METAB, V96, pE373, DOI 10.1210/jc.2010-1570; Lu D, 2013, J ANIM SCI, V91, P3612, DOI 10.2527/jas.2012-5716; Bruce A. B., 1910, Science New York N S, V32, DOI 10.1126/science.32.827.627-a; Connor EE, 1999, J ANIM SCI, V77, P2736; Gemmell NJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000125; Goff SA, 2013, CURR OPIN PLANT BIOL, V16, P221, DOI 10.1016/j.pbi.2013.03.009; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Itoh F, 2005, DOMEST ANIM ENDOCRIN, V28, P34, DOI 10.1016/j.domaniend.2004.06.001; Japan Meat Grading Association (JMGA), 1988, NEW BEEF CARC GRAD S; Japanese Shorthorn Registry Association (JSRA), 1980, JAP SHORTH CATTL; Komatsu M, 2011, ANIM SCI J, V82, P396, DOI 10.1111/j.1740-0929.2010.00852.x; Komatsu M, 2012, DOMEST ANIM ENDOCRIN, V42, P83, DOI 10.1016/j.domaniend.2011.09.006; Komatsu M, 2010, ANIM SCI J, V81, P530, DOI 10.1111/j.1740-0929.2010.00797.x; Lall S, 2004, ENDOCRINOLOGY, V145, P1602, DOI 10.1210/en.2003-1509; Lindholm-Perry A. K., 2011, ANIM GENET, V43, P112; Mackay T. F. C., 1996, INTRO QUANTITATIVE G; Mano-Otagiri A, 2006, ENDOCRINOLOGY, V147, P4093, DOI 10.1210/en.2005-1619; Pantel J, 2009, J CLIN ENDOCR METAB, V94, P4334, DOI 10.1210/jc.2009-1327; Rolf M. M., 2011, ANIM GENET, V43, P367; Saatchi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1004; [SAS] Statistical Analysis System, 2004, SAS STAT 9 1 US GUID; Mizuma Y., 1974, Japanese Journal of Zootechnical Science, V45, P262; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Stuber C. W., 1992, GENETICS, V132, P832; STUBER CW, 1973, CROP SCI, V13, P195; URICK JJ, 1968, J ANIM SCI, V27, P323	37	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	FEB 1	2015	5	2					271	279		10.1534/g3.114.016105		9	Genetics & Heredity	Genetics & Heredity	CB2IV	WOS:000349451500012		
J	Nakama, T; Yoshida, S; Ishikawa, K; Kobayashi, Y; Zhou, Y; Nakao, S; Sassa, Y; Oshima, Y; Takao, K; Shimahara, A; Yoshikawa, K; Hamasaki, T; Ohgi, T; Hayashi, H; Matsuda, A; Kudo, A; Nozaki, M; Ogura, Y; Kuroda, M; Ishibashi, T				Nakama, T.; Yoshida, S.; Ishikawa, K.; Kobayashi, Y.; Zhou, Y.; Nakao, S.; Sassa, Y.; Oshima, Y.; Takao, K.; Shimahara, A.; Yoshikawa, K.; Hamasaki, T.; Ohgi, T.; Hayashi, H.; Matsuda, A.; Kudo, A.; Nozaki, M.; Ogura, Y.; Kuroda, M.; Ishibashi, T.			Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin	GENE THERAPY			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; SUBRETINAL NEOVASCULAR MEMBRANES; DEGENERATION TREATMENTS TRIALS; OXYGEN-INDUCED RETINOPATHY; PIGMENT EPITHELIAL-CELLS; TOLL-LIKE RECEPTOR-3; MACULAR DEGENERATION; GROWTH-FACTOR; GEOGRAPHIC ATROPHY; MOUSE MODEL	Age-related macular degeneration (AMD) is a vision-threatening disease characterized by choroidal fibrovascular membrane (FVM) formation, choroidal neovascularization (CNV) and choroidal fibrosis. No safe and effective therapeutic method has been developed for the choroidal fibrosis, although anti-vascular endothelial growth factor therapy can partially shrink the CNV. We recently reported that periostin (POSTN), which is produced by retinal pigment epithelial cells, has an important role in the formation of preretinal FVMs, but its role in choroidal FVMs has not been determined. In this study, we used Postn knockout mice to investigate the role played by POSTN in choroidal FVM formation. In addition, we used a new class of RNA interference (RNAi) agent (NK0144) that targets POSTN and determined its effect on choroidal FVM development. Genetic ablation of Postn had an inhibitory effect not only on CNV formation but also on choroidal fibrosis in a mouse CNV model. NK0144 also had a greater inhibitory effect on both the CNV and choroidal fibrosis than control RNAi with no apparent adverse effects. These findings suggest a causal relationship between POSTN and choroidal FVM formation, and also a potential therapeutic role of intravitreal NK0144 for AMD.	[Nakama, T.; Yoshida, S.; Ishikawa, K.; Kobayashi, Y.; Zhou, Y.; Nakao, S.; Sassa, Y.; Oshima, Y.; Ishibashi, T.] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Sassa, Y.] Fukuoka Univ, Chikushi Hosp, Dept Ophthalmol, Fukuoka 81401, Japan; [Takao, K.; Shimahara, A.; Yoshikawa, K.] AQUA Therapeut Co Ltd, Kobe, Hyogo, Japan; [Hamasaki, T.; Ohgi, T.; Hayashi, H.] BIO Factory, BONAC Corp, Strateg Headquarters Res & Dev, Fukuoka, Japan; [Matsuda, A.] Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; [Kudo, A.] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Nozaki, M.; Ogura, Y.] Nagoya City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kuroda, M.] Tokyo Med Univ, Dept Mol Pathol, Tokyo 1608402, Japan	Yoshida, S (reprint author), Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 8128582, Japan.	yosida@eye.med.kyushu-u.ac.jp	Kudo, Akira/C-7340-2015; Matsuda, Akira/A-9981-2010	Kudo, Akira/0000-0001-6289-3391; Matsuda, Akira/0000-0002-0792-3663	JSPS KAKENHI grant [24249083, 23592574, 26293374, 26670757]; Takeda Science Foundation; Adaptable and Seamless Technology Transfer Program through Target-driven R&D from the Japan Science and Technology Agency; Japan Society for the Promotion of Science	We thank the staff of the Research Support Center (Graduate School of Medical Sciences, Kyushu University) for technical support and Masayo Eto, Kinuko Sasada and Hiroko Miura for their excellent technical assistance. This work was supported in part by JSPS KAKENHI grant numbers 24249083, 23592574, 26293374, 26670757, Takeda Science Foundation, and Adaptable and Seamless Technology Transfer Program through Target-driven R&D from the Japan Science and Technology Agency. T Nakama is supported by a fellowship from the Japan Society for the Promotion of Science for Young Scientists.	Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Ishikawa K, 2012, LAB INVEST, V92, P91, DOI 10.1038/labinvest.2011.141; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; LOPEZ PF, 1991, AM J OPHTHALMOL, V112, P647; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Yamaji Y, 2008, INVEST OPHTH VIS SCI, V49, P3151, DOI 10.1167/iovs.07-1249; Ishikawa K, 2010, INVEST OPHTH VIS SCI, V51, P4307, DOI 10.1167/iovs.09-4605; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.0.CO;2-#; Bloch SB, 2013, AM J OPHTHALMOL, V156, P116, DOI 10.1016/j.ajo.2013.02.012; Ontsuka K, 2012, EXP DERMATOL, V21, P331, DOI 10.1111/j.1600-0625.2012.01454.x; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Nakata I, 2013, AM J OPHTHALMOL, V156, P1002, DOI 10.1016/j.ajo.2013.06.007; Kariko K, 2004, J IMMUNOL, V172, P6545; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Grunwald JE, 2014, OPHTHALMOLOGY, V121, P150, DOI 10.1016/j.ophtha.2013.08.015; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Stewart MW, 2008, BRIT J OPHTHALMOL, V92, P667, DOI 10.1136/bjo.2007.134874; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Nagineni CN, 2003, J CELL PHYSIOL, V197, P453, DOI 10.1002/jcp.10378; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Ishikawa K, 2014, FASEB J, V28, P131, DOI 10.1096/fj.13-229740; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; GROSSNIKLAUS HE, 1992, AM J OPHTHALMOL, V114, P464; Tanimoto N, 2009, FRONT BIOSCI, V14, P2730, DOI 10.2741/4009; Arima M, 2012, INVEST OPHTH VIS SCI, V53, P6495, DOI 10.1167/iovs.12-9684; Asato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054191; CHANDRA SR, 1974, AM J OPHTHALMOL, V78, P579; Cho WG, 2009, P NATL ACAD SCI USA, V106, P7137, DOI 10.1073/pnas.0812317106; Daniel E, 2014, OPHTHALMOLOGY, V121, P656, DOI 10.1016/j.ophtha.2013.10.019; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Fujita Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03325; Hamasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042655; Hogg R, 2003, BRIT J OPHTHALMOL, V87, P609, DOI 10.1136/bjo.87.5.609; Hwang JC, 2011, OPHTHAL SURG LAS IM, V42, DOI 10.3928/15428877-20100924-01; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; Recalde S, 2011, INVEST OPHTH VIS SCI, V52, P7090, DOI 10.1167/iovs.11-7300; Watanabe D, 2005, RETINA-J RET VIT DIS, V25, P911, DOI 10.1097/00006982-200510000-00015; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yoshida S, 2011, INVEST OPHTH VIS SCI, V52, P5670, DOI 10.1167/iovs.10-6625; Yoshida S, 2010, BRIT J OPHTHALMOL, V94, P795, DOI 10.1136/bjo.2009.167072	50	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	FEB	2015	22	2					127	137		10.1038/gt.2014.112		11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CB2CK	WOS:000349434100003		
J	Shimazu, Y; Kurozumi, K; Ichikawa, T; Fujii, K; Onishi, M; Ishida, J; Oka, T; Watanabe, M; Nasu, Y; Kumon, H; Date, I				Shimazu, Y.; Kurozumi, K.; Ichikawa, T.; Fujii, K.; Onishi, M.; Ishida, J.; Oka, T.; Watanabe, M.; Nasu, Y.; Kumon, H.; Date, I.			Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma	GENE THERAPY			English	Article							ONCOLYTIC VIRUS; BETA-CATENIN; CILENGITIDE; APOPTOSIS; CANCER; ALPHA(V)BETA(3); GLIOBLASTOMA; ANGIOGENESIS; CARCINOMA; EFFICACY	Reduced expression in immortalized cells/Dickkopf-3 (REIC/Dkk-3) was identified as a gene whose expression is reduced in many human cancers. REIC/Dkk-3 expression is also downregulated in malignant glioma and regulates cell growth through caspase-dependent apoptosis. cRGD (EMD121974), an antagonist of integrins, has demonstrated preclinical efficacy against malignant glioma. In this study, we investigated the antiglioma effect of combination therapy using an adenovirus vector carrying REIC/Dkk-3 (Ad-REIC) and cRGD. Quantitative real-time reverse-transcription PCR revealed the reduction of REIC/Dkk-3 mRNA levels in malignant glioma cell lines. The reduction of REIC/Dkk-3 protein expression in malignant glioma cell lines was also confirmed with western blot analysis. After treatment with Ad-REIC and cRGD, the proliferative rate of malignant glioma cells was significantly reduced in a time-dependent manner. In vivo, there was a statistically significant increase in the survival of mice treated with Ad-REIC and cRGD combination therapy compared with Ad-REIC monotherapy. We identified an apoptotic effect following monotherapy with Ad-REIC. Moreover, cRGD augmented the antiglioma efficacy of Ad-REIC. These results may lead to a promising new approach for the treatment of malignant glioma.	[Shimazu, Y.; Kurozumi, K.; Ichikawa, T.; Fujii, K.; Onishi, M.; Ishida, J.; Oka, T.; Date, I.] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Kumon, H.] Okayama Univ, Dept Urol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Watanabe, M.; Nasu, Y.] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan	Kurozumi, K (reprint author), Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kkuro@md.okayama-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [19591675, 22591611, 20890133, 21791364]; Okayama University	We thank M Arao and N Uemori for their technical assistance. This study was supported by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology to TI (Nos. 19591675 and 22591611) and KK (Nos. 20890133 and 21791364). A part of the present study was supported by the Grant in aids for strategic research promotion by Okayama University.	Abdollahi A, 2005, CLIN CANCER RES, V11, P6270, DOI 10.1158/1078-0432.CCR-04-1223; Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; Kurozumi K, 2007, J NATL CANCER I, V99, P1768, DOI 10.1093/jnci/djm229; Burke PA, 2002, CANCER RES, V62, P4263; VARNER JA, 1995, MOL BIOL CELL, V6, P725; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; Kashiwakura Y, 2008, CANCER RES, V68, P8333, DOI 10.1158/0008-5472.CAN-08-0080; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Mizobuchi Y, 2008, NEURO-ONCOLOGY, V10, P244, DOI 10.1215/15228517-2008-016; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Fujii K, 2013, CANCER GENE THER, V20, P437, DOI 10.1038/cgt.2013.38; Matsuzaki T, 2009, CANCER SCI, V100, P2402, DOI 10.1111/j.1349-7006.2009.01315.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Hodivala-Dilke KM, 2003, CELL TISSUE RES, V314, P131, DOI 10.1007/s00441-003-0774-5; Kurozumi K, 2012, NEUROL MED-CHIR, V52, P539; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Chatterjee S, 2000, J NEURO-ONCOL, V46, P135, DOI 10.1023/A:1006444300504; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Howard JC, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-16; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; Mikkelsen T, 2009, INT J CANCER, V124, P2719, DOI 10.1002/ijc.24240; Onishi M, 2013, NEUROPATHOLOGY, V33, P162, DOI 10.1111/j.1440-1789.2012.01344.x; Onishi M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-160; Penas-Prodo M, 2007, EXPERT REV ANTICANC, V7, P641, DOI 10.1586/14737140.7.5.641; Tentori L, 2008, ONCOL REP, V19, P1039; Than SS, 2011, ONCOL REP, V25, P989, DOI 10.3892/or.2011.1149; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; Varner Judith A., 1996, P69; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503	34	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	FEB	2015	22	2					146	154		10.1038/gt.2014.100		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CB2CK	WOS:000349434100005		
J	Tsukahara, T; Iwase, N; Kawakami, K; Iwasaki, M; Yamamoto, C; Ohmine, K; Uchibori, R; Teruya, T; Ido, H; Saga, Y; Urabe, M; Mizukami, H; Kume, A; Nakamura, M; Brentjens, R; Ozawa, K				Tsukahara, T.; Iwase, N.; Kawakami, K.; Iwasaki, M.; Yamamoto, C.; Ohmine, K.; Uchibori, R.; Teruya, T.; Ido, H.; Saga, Y.; Urabe, M.; Mizukami, H.; Kume, A.; Nakamura, M.; Brentjens, R.; Ozawa, K.			The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies	GENE THERAPY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SLEEPING-BEAUTY SYSTEM; LINEAGE MALIGNANCIES; BAC TRANSGENESIS; VIRUS; INTEGRATION; LYMPHOCYTES; ELEMENT; MICE; CD19	Engineered T-cell therapy using a CD19-specific chimeric antigen receptor ( CD19-CAR) is a promising strategy for the treatment of advanced B-cell malignancies. Gene transfer of CARs to T-cells has widely relied on retroviral vectors, but transposon-based gene transfer has recently emerged as a suitable nonviral method to mediate stable transgene expression. The advantages of transposon vectors compared with viral vectors include their simplicity and cost-effectiveness. We used the Tol2 transposon system to stably transfer CD19-CAR into human T-cells. Normal human peripheral blood lymphocytes were co-nucleofected with the Tol2 transposon donor plasmid carrying CD19-CAR and the transposase expression plasmid and were selectively propagated on NIH3T3 cells expressing human CD19. Expanded CD3+ T-cells with stable and high-level transgene expression (similar to 95%) produced interferon. gamma upon stimulation with CD19 and specifically lysed Raji cells, a CD19(+) human B-cell lymphoma cell line. Adoptive transfer of these T-cells suppressed tumor progression in Raji tumor-bearing Rag2(-/-)gamma c(-/-) immunodeficient mice compared with control mice. These results demonstrate that the Tol2 transposon system could be used to express CD19-CAR in genetically engineered T-cells for the treatment of refractory B-cell malignancies.	[Tsukahara, T.; Iwase, N.; Yamamoto, C.; Uchibori, R.; Saga, Y.; Urabe, M.; Mizukami, H.; Kume, A.; Ozawa, K.] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi 3290498, Japan; [Tsukahara, T.; Ohmine, K.; Uchibori, R.; Teruya, T.; Ido, H.; Ozawa, K.] Jichi Med Univ, Div Immunogene & Cell Therapy Takara Bio, Shimotsuke, Tochigi 3290498, Japan; [Kawakami, K.; Iwasaki, M.] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 411, Japan; [Yamamoto, C.; Ohmine, K.; Ozawa, K.] Jichi Med Univ, Dept Med, Div Hematol, Shimotsuke, Tochigi 3290498, Japan; [Saga, Y.] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan; [Nakamura, M.] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, Tokyo, Japan; [Brentjens, R.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Tsukahara, T (reprint author), Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ttsukahara@jichi.ac.jp	Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X	MEXT-Supported Program [22700923, 24390247]	We thank Miyoko Mitsu and Satomi Fujiwara for the AAV preparations. This work was supported in part by a Grant-in-Aid for Scientific Research (Nos. 22700923 and 24390247), a JMU Graduate Student Start-Up Grant for Young Investigators to N Iwase and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017. We thank Dr M Ito (Central Institute for Experimental Animals) for providing Balb/c Rag2<SUP>-/-</SUP>gamma c<SUP>-/-</SUP> mice. We also thank JMU Core Center of Research Apparatus for assistance with flow cytometry. This publication was subsidized by JKA through its promotion funds from KEIRIN RACE.	Maiti SN, 2013, J IMMUNOTHER, V36, P112, DOI 10.1097/CJI.0b013e3182811ce9; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Saito S, 2014, CYTOTHERAPY, V16, P1257, DOI 10.1016/j.jcyt.2014.05.022; Latouche JB, 2000, NAT BIOTECHNOL, V18, P405; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Ohbo K, 1996, BLOOD, V87, P956; Ammar I, 2012, NUCLEIC ACIDS RES, V40, P6693, DOI 10.1093/nar/gks317; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Jin Z, 2011, GENE THER, V18, P849, DOI 10.1038/gt.2011.40; Manuri PVR, 2010, HUM GENE THER, V21, P427, DOI 10.1089/hum.2009.114; Peng PD, 2009, GENE THER, V16, P1042, DOI 10.1038/gt.2009.54; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Davila ML, 2012, ONCOIMMUNOLOGY, V1, P1577, DOI 10.4161/onci.22524; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Tsukahara T, 2013, BIOCHEM BIOPH RES CO, V438, P84, DOI 10.1016/j.bbrc.2013.07.030; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Kebriaei P, 2012, HUM GENE THER, V23, P444, DOI 10.1089/hum.2011.167; Xin KQ, 2001, HUM GENE THER, V12, P1047, DOI 10.1089/104303401750214276; Ohteki T, 1999, J EXP MED, V189, P1981, DOI 10.1084/jem.189.12.1981; Suster ML, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-477; Wang C, 2013, J CLIN INVEST, V123, P1677, DOI 10.1172/JCI66204; KANNAGI M, 1983, J IMMUNOL, V130, P2942; Kawakami K., 2007, GENOME BIOL, V1, P57; Kogure K, 2001, INT J HEMATOL, V73, P469, DOI 10.1007/BF02994009; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Tsukahara T, 2006, BIOCHEM BIOPH RES CO, V345, P1099, DOI 10.1016/j.bbrc.2006.05.007; Yagi H, 2011, J GENE MED, V13, P114, DOI 10.1002/jgm.1543; Yagita K, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-3	38	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	FEB	2015	22	2					209	215		10.1038/gt.2014.104		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CB2CK	WOS:000349434100013		
J	Cho, SY; Asharani, PV; Kim, OH; Iida, A; Miyake, N; Matsumoto, N; Nishimura, G; Ki, CS; Hong, G; Kim, SJ; Sohn, YB; Park, SW; Lee, J; Kwun, Y; Carney, TJ; Huh, R; Ikegawa, S; Jin, DK				Cho, Sung Yoon; Asharani, P. V.; Kim, Ok-Hwa; Iida, Aritoshi; Miyake, Noriko; Matsumoto, Naomichi; Nishimura, Gen; Ki, Chang-Seok; Hong, Geehay; Kim, Su Jin; Sohn, Young Bae; Park, Sung Won; Lee, Jieun; Kwun, Younghee; Carney, Thomas J.; Huh, Rimm; Ikegawa, Shiro; Jin, Dong-Kyu			Identification and In Vivo Functional Characterization of Novel Compound Heterozygous BMP1 Variants in Osteogenesis Imperfecta	HUMAN MUTATION			English	Article						osteogenesis imperfecta; BMP1; zebrafish; whole-exome sequencing; mutation	MUTATION; PROTEIN; METALLOPROTEINASES; DEFICIENCY; ZEBRAFISH; PATIENT; 5'-UTR	Osteogenesis imperfecta (OI) comprises a heterogeneous group of disorders that are characterized by susceptibility to bone fractures, and range in severity from a subtle increase in fracture frequency to death in the perinatal period. Most patients have defects in type I collagen biosynthesis with autosomal-dominant inheritance, but many autosomal-recessive genes have been reported. We applied whole-exome sequencing to identify mutations in a Korean OI patient who had an umbilical hernia, frequent fractures, a markedly short stature, delayed motor development, scoliosis, and dislocation of the radial head, with a bowed radius and ulna. We identified two novel variants in the BMP1 gene: c.808A>G and c.1297G>T. The former variant caused a missense change p.(Met270Val) and the latter variant caused the skipping of exon 10. The hypofunctional nature of the two variants was demonstrated in a zebrafish assay.	[Cho, Sung Yoon; Lee, Jieun; Kwun, Younghee; Huh, Rimm; Jin, Dong-Kyu] Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Asharani, P. V.; Carney, Thomas J.] Proteos, Inst Mol & Cell Biol, Singapore, Singapore; [Kim, Ok-Hwa] Gachon Univ, Gil Med Ctr, Dept Radiol, Inchon, South Korea; [Iida, Aritoshi; Ikegawa, Shiro] RIKEN Ctr Integrated Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Fuchu, Tokyo, Japan; [Ki, Chang-Seok; Hong, Geehay] Sungkyunkwan Univ, Sch Med, Dept Lab Med & Genet, Seoul, South Korea; [Kim, Su Jin] Kwandong Univ, Coll Med, Myongji Hosp, Dept Pediat, Goyang, South Korea; [Sohn, Young Bae] Ajou Univ, Sch Med, Ajou Univ Hosp, Dept Med Genet, Suwon 441749, South Korea; [Park, Sung Won] Kwandong Univ, Coll Med, Cheil Gen Hosp, Dept Pediat, Seoul, South Korea; [Park, Sung Won] Womans Hlth Care Ctr, Seoul, South Korea; [Carney, Thomas J.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Ikegawa, S (reprint author), RIKEN Ctr Integrated Med Sci, Lab Bone & Joint Dis, Tokyo, Japan.	sikegawa@ims.u-tokyo.ac.jp; jindk@skku.edu	Carney, Tom/H-4389-2011; ASTAR, IMCB/E-2320-2012; ki, cs/O-5931-2014		Samsung Medical Center [GFO 1140061]; Samsung Bio Research Institute [SMO1131471];  [H26-Itaku (Nanbyo)-Ippan-083]	Contract grant sponsors: Samsung Medical Center (grant #GFO 1140061); Samsung Bio Research Institute (SMO1131471]; H26-Itaku (Nanbyo)-Ippan-083.	Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Puig-Hervas MT, 2012, HUM MUTAT, V33, P1444, DOI 10.1002/humu.22133; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200605194; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; Van Dijk FS, 2014, AM J MED GENET A, V164, P1470, DOI 10.1002/ajmg.a.36545; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; Fahiminiya S, 2014, HUM MOL GENET; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Imagawa E, 2014, HUM GENET, V133, P225, DOI 10.1007/s00439-013-1372-6; Symoens Sofie, 2013, Orphanet J Rare Dis, V8, P154, DOI 10.1186/1750-1172-8-154; Valencia M, 2014, AM J MED GENET A, V164, P1143, DOI 10.1002/ajmg.a.36427	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	FEB	2015	36	2					191	195		10.1002/humu.22731		5	Genetics & Heredity	Genetics & Heredity	CB1OL	WOS:000349397300006		
J	Sakai, C; Yamaguchi, S; Sasaki, M; Miyamoto, Y; Matsushima, Y; Goto, Y				Sakai, Chika; Yamaguchi, Seiji; Sasaki, Masayuki; Miyamoto, Yusaku; Matsushima, Yuichi; Goto, Yu-ichi			ECHS1 Mutations Cause Combined Respiratory Chain Deficiency Resulting in Leigh Syndrome	HUMAN MUTATION			English	Article						combined respiratory chain deficiency; Leigh syndrome; ECHS1; fatty acid -oxidation disorder	COMPLEX-I DEFICIENCY; FATTY-ACID OXIDATION; ACYL-COA DEHYDROGENASES; RAT-LIVER MITOCHONDRIA; BETA-OXIDATION; TRIFUNCTIONAL PROTEIN; COENZYME; EXPRESSION; MECHANISM; FEATURES	The human ECHS1 gene encodes the short-chain enoyl coenzyme A hydratase, the enzyme that catalyzes the second step of -oxidation of fatty acids in the mitochondrial matrix. We report on a boy with ECHS1 deficiency who was diagnosed with Leigh syndrome at 21 months of age. The patient presented with hypotonia, metabolic acidosis, and developmental delay. A combined respiratory chain deficiency was also observed. Targeted exome sequencing of 776 mitochondria-associated genes encoded by nuclear DNA identified compound heterozygous mutations in ECHS1. ECHS1 protein expression was severely depleted in the patient's skeletal muscle and patient-derived myoblasts; a marked decrease in enzyme activity was also evident in patient-derived myoblasts. Immortalized patient-derived myoblasts that expressed exogenous wild-type ECHS1 exhibited the recovery of the ECHS1 activity, indicating that the gene defect was pathogenic. Mitochondrial respiratory complex activity was also mostly restored in these cells, suggesting that there was an unidentified link between deficiency of ECHS1 and respiratory chain. Here, we describe the patient with ECHS1 deficiency; these findings will advance our understanding not only the pathology of mitochondrial fatty acid -oxidation disorders, but also the regulation of mitochondrial metabolism.	[Sakai, Chika; Matsushima, Yuichi; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo 1878502, Japan; [Yamaguchi, Seiji] Shimane Univ, Dept Pediat, Izumo, Shimane, Japan; [Sasaki, Masayuki] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan; [Miyamoto, Yusaku] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan; [Matsushima, Yuichi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 812, Japan	Goto, Y (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo 1878502, Japan.	matsush5@cclm.med.kyushu-u.ac.jp; goto@ncnp.go.jp			Ministry of Health, Labor and welfare of Japan; National Center of Neurology and Psychiatry [21A-6, 24-8]; JSPS KAKENHI [25670275]	Contract grant sponsor(s): Grants-in-Aid for Research on Intractable Diseases (Mitochondrial Disease) from the Ministry of Health, Labor and welfare of Japan; Research Grant for Nervous and Mental Disorders from the National Center of Neurology and Psychiatry (21A-6, 24-8) and JSPS KAKENHI (25670275).	Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Spiekerkoetter U, 2004, PEDIATR RES, V55, P190, DOI 10.1203/01.PDR.0000103931.80055.06; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; WHITEHOU.S, 1974, BIOCHEM J, V141, P761; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; Xiao CX, 2013, CANCER LETT, V330, P67, DOI 10.1016/j.canlet.2012.11.030; Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; HOCHSTRASSER DF, 1992, ELECTROPHORESIS, V13, P992, DOI 10.1002/elps.11501301201; Kompare M, 2008, SEMIN PEDIATR NEUROL, V15, P140, DOI 10.1016/j.spen.2008.05.008; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Chang Y, 2013, FEBS LETT, V587, P607, DOI 10.1016/j.febslet.2013.02.005; Chen JS, 2003, CURR CANCER DRUG TAR, V3, P219, DOI 10.2174/1568009033481994; Corydon MJ, 1996, PEDIATR RES, V39, P1059, DOI 10.1203/00006450-199606000-00021; Enns GM, 2000, J PEDIATR-US, V136, P251, DOI 10.1016/S0022-3476(00)70111-9; IKEDA Y, 1985, BIOCHEMISTRY-US, V24, P7192, DOI 10.1021/bi00346a027; IKEDA Y, 1985, J BIOL CHEM, V260, P1326; IKEDA Y, 1983, J BIOL CHEM, V258, P1066; Jethva R, 2008, MOL GENET METAB, V95, P195, DOI 10.1016/j.ymgme.2008.09.007; KAMIJO T, 1993, J BIOL CHEM, V268, P26452; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; LUCAS M, 1975, BIOCHIMIE, V57, P637, DOI 10.1016/S0300-9084(75)80145-3; Matsunaga T, 2005, ANN OTO RHINOL LARYN, V114, P153; Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194; Narayan SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035048; Peters H, 2014, BRAIN, V137, P2903, DOI 10.1093/brain/awu216; Shimazaki H, 2012, J MED GENET, V49, P777, DOI 10.1136/jmedgenet-2012-101212; Steinman H M, 1975, Methods Enzymol, V35, P136, DOI 10.1016/0076-6879(75)35149-5; Zhang J, 2012, J GEN PHYSIOL, V139, P395, DOI 10.1085/jgp.201210797	33	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	FEB	2015	36	2					232	239		10.1002/humu.22730		8	Genetics & Heredity	Genetics & Heredity	CB1OL	WOS:000349397300011		
J	Asayama, K; Wei, FF; Liu, YP; Hara, A; Gu, YM; Schutte, R; Li, Y; Thijs, L; Staessen, JA				Asayama, Kei; Wei, Fang-Fei; Liu, Yan-Ping; Hara, Azusa; Gu, Yu-Mei; Schutte, Rudolph; Li, Yan; Thijs, Lutgarde; Staessen, Jan A.			Does blood pressure variability contribute to risk stratification? Methodological issues and a review of outcome studies based on home blood pressure	HYPERTENSION RESEARCH			English	Review						average real variability; beat-to-beat blood pressure; blood pressure variability; home blood pressure; variability independent of the mean index	TO-VISIT VARIABILITY; CHRONIC KIDNEY-DISEASE; BY-DAY VARIABILITY; PROGNOSTIC VALUE; ESSENTIAL-HYPERTENSION; HEART-RATE; FINN-HOME; CARDIOVASCULAR RISK; MORNING SURGE; ORGAN DAMAGE	This review addresses methodological issues in the assessment of blood pressure variability and the predictive value of blood pressure variability derived from blood pressure readings obtained in the relaxed home environment. Preference should be given to indexes of blood pressure variability that are independent of the mean because we should evaluate the impact of blood pressure variability by eliminating the effect of blood pressure levels. Beat-to-beat blood pressure recordings outperform home blood pressure measurement in the assessment of blood pressure variability in longitudinal Belgian and Japanese population studies, whereas blood pressure variability did not incrementally predict outcome beyond blood pressure level and other cardiovascular risk factors. In conclusion, clinicians should focus on blood pressure level, given that it is the predominant risk factor and is manageable by lifestyle modifications and adequate antihypertensive drug treatment. Blood pressure variability remains a research tool that requires further prospective studies with hard end points to define its potential application, as it may be potentially useful in daily clinical practice.	[Asayama, Kei; Wei, Fang-Fei; Liu, Yan-Ping; Hara, Azusa; Gu, Yu-Mei; Schutte, Rudolph; Thijs, Lutgarde; Staessen, Jan A.] Univ Leuven, KU Leuven, Studies Coordinating Ctr, Dept Cardiovasc Sci,Res Unit Hypertens & Cardiova, B-3000 Louvain, Belgium; [Asayama, Kei] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Wei, Fang-Fei; Li, Yan] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai 200030, Peoples R China; [Wei, Fang-Fei; Li, Yan] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Ctr Vasc Evaluat,Shanghai Key Lab Hypertens,Shang, Shanghai 200030, Peoples R China; [Schutte, Rudolph] North West Univ, HART, Potchefstroom, South Africa; [Staessen, Jan A.] Maastricht Univ, VitaK Res & Dev, NL-6200 MD Maastricht, Netherlands	Asayama, K (reprint author), Univ Leuven, KU Leuven, Studies Coordinating Ctr, Dept Cardiovasc Sci,Res Unit Hypertens & Cardiova, B-3000 Louvain, Belgium.	kei@asayama.org	Staessen, Jan/A-1065-2011	Staessen, Jan/0000-0002-3026-1637			Acharya DU, 1996, AM J HYPERTENS, V9, P943, DOI 10.1016/0895-7061(96)00177-X; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Johansson JK, 2012, HYPERTENSION, V59, P212, DOI 10.1161/HYPERTENSIONAHA.111.178657; Asayama K, 2012, HYPERTENS RES, V35, P1102, DOI 10.1038/hr.2012.125; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Wei FF, 2014, HYPERTENSION, V63, P790, DOI 10.1161/HYPERTENSIONAHA.113.02681; Asayama K, 2013, HYPERTENSION, V61, P61, DOI 10.1161/HYPERTENSIONAHA.111.00138; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Okada T, 2012, BLOOD PRESS MONIT, V17, P1, DOI 10.1097/MBP.0b013e32834f7125; PENAZ J, 1992, PHYSIOL RES, V41, P5; Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273; Schutte R, 2012, HYPERTENSION, V60, P1138, DOI 10.1161/HYPERTENSIONAHA.112.202143; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Nishimura M, 2013, HYPERTENS RES, V36, P705, DOI 10.1038/hr.2013.22; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Asayama K, 2005, EUR HEART J, V26, P2026, DOI 10.1093/eurheartj/ehi330; Fan HQ, 2010, J HYPERTENS, V28, P2036, DOI 10.1097/HJH.0b013e32833b49fe; Asayama K, 2006, HYPERTENSION, V48, P737, DOI 10.1161/01.HYP.0000240332.01877.11; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Kato T, 2010, AM J HYPERTENS, V23, P980, DOI 10.1038/ajh.2010.94; Niiranen TJ, 2010, HYPERTENSION, V55, P1346, DOI 10.1161/HYPERTENSIONAHA.109.149336; Veerman DP, 1996, AM J HYPERTENS, V9, P455, DOI 10.1016/0895-7061(95)00437-8; Little P, 2002, BRIT MED J, V325, P258, DOI 10.1136/bmj.325.7358.258; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Johansson JK, 2010, J HYPERTENS, V28, P1836, DOI 10.1097/HJH.0b013e32833b6c8a; BAUMGART P, 1989, J HYPERTENS, V7, P331; CLEMENT DL, 1979, CLIN SCI, V57, pS217; Cox D. R., 1989, ANAL BINARY DATA; Fukui M, 2013, HYPERTENS RES, V36, P219, DOI 10.1038/hr.2012.177; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI 10.1161/HYPERTENSIONAHA.109.140798; Imai Y, 1992, ANN REV NEPHROL, V1991, P55; Khattar RS, 1999, CIRCULATION, V100, P1071; Levitan EB, 2013, J HUM HYPERTENS, V27, P589, DOI 10.1038/jhh.2013.19; MANCIA G, 1983, CHEST, V83, P317, DOI 10.1378/chest.83.2.317; Muntner P, 2013, HYPERTENS RES, V36, P940, DOI 10.1038/hr.2013.58; PARATI G, 1987, J HYPERTENS, V5, P93, DOI 10.1097/00004872-198702000-00013; Parati G, 2005, J HYPERTENS, V23, P483, DOI 10.1097/01.hjh.0000160200.51158.9a; Romero MJ, 2013, HYPERTENS RES, V36, P673, DOI 10.1038/hr.2013.53; STAESSEN J, 1985, J CHRON DIS, V38, P397, DOI 10.1016/0021-9681(85)90135-3; Ushigome E, 2011, HYPERTENS RES, V34, P1271, DOI 10.1038/hr.2011.128	43	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	FEB	2015	38	2					97	101		10.1038/hr.2014.153		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB2NJ	WOS:000349464200001		
J	Kohagura, K; Ohya, Y				Kohagura, Kentaro; Ohya, Yusuke			Renal tubulointerstitial damage and salt-sensitive hypertension in chronic kidney disease: is the tubulointerstitium relevant beyond the glomerulus?	HYPERTENSION RESEARCH			English	Editorial Material							OXIDATIVE STRESS; RATS; INJURY		[Kohagura, Kentaro; Ohya, Yusuke] Univ Ryukyus, Ryukyus Sch Med, Dept Cardiovasc Med Nephrol & Neurol, Nishihara, Okinawa 90301, Japan	Kohagura, K (reprint author), Univ Ryukyus, Ryukyus Sch Med, Dept Cardiovasc Med Nephrol & Neurol, 207 Uehara, Nishihara, Okinawa 90301, Japan.	kohagura@med.u-ryukyu.ac.jp					Cowley AW, 2008, HYPERTENSION, V52, P777, DOI 10.1161/HYPERTENSIONAHA.107.092858; Minutolo R, 2011, ARCH INTERN MED, V171, P1090, DOI 10.1001/archinternmed.2011.230; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Herrera J, 2006, J AM SOC NEPHROL, V17, pS218, DOI 10.1681/ASN.2006080918; BERKMAN J, 1973, Metabolism Clinical and Experimental, V22, P715, DOI 10.1016/0026-0495(73)90243-6; Chen QZ, 2013, HYPERTENS RES, V36, P306, DOI 10.1038/hr.2012.170; Haruhara K, 2015, HYPERTENS RES, V38, P116, DOI 10.1038/hr.2014.140; Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078; Rodriguez-Iturbe B, 2010, HYPERTENS RES, V33, P975, DOI 10.1038/hr.2010.148; Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003; Sanchez-Lozada LG, 2003, KIDNEY INT S, V86, pS9; Sugama I, 2014, J HYPERTENS, V32, P534, DOI 10.1097/HJH.0000000000000064; Wenzel UO, 2002, KIDNEY INT, V61, P2119, DOI 10.1046/j.1523-1755.2002.00354.x	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	FEB	2015	38	2					102	103		10.1038/hr.2014.167		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB2NJ	WOS:000349464200002		
J	Umemoto, S				Umemoto, Seiji			Safety and clinical outcome in combination therapy for high-risk elderly hypertensive patients	HYPERTENSION RESEARCH			English	Editorial Material							CALCIUM-CHANNEL BLOCKER; CARDIOVASCULAR EVENTS; CONTROLLED-TRIAL; ADHERENCE; JAPANESE; DISEASE		Yamaguchi Univ, Clin Res Ctr, Ube, Yamaguchi 7558505, Japan	Umemoto, S (reprint author), Yamaguchi Univ, Clin Res Ctr, Ube, Yamaguchi 7558505, Japan.	umemoto@yamaguchi-u.ac.jp					Ogawa H, 2012, AM J MED, V125, P981, DOI 10.1016/j.amjmed.2011.12.010; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Ogihara T, 2014, J HYPERTENS, V32, P2054, DOI 10.1097/HJH.0000000000000281; Shin S, 2013, HYPERTENS RES, V36, P1000, DOI 10.1038/hr.2013.85; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Ogihara T, 2012, HYPERTENS RES, V35, P441, DOI 10.1038/hr.2011.216; Katsuya T, 2003, HYPERTENS RES, V26, P521, DOI 10.1291/hypres.26.521; Granger BB, 2005, LANCET, V366, P2005, DOI 10.1016/S0140-6736(05)67760-4; Kohro T, 2013, HYPERTENS RES, V36, P559, DOI 10.1038/hr.2012.216; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Matsuzaki M, 2011, J HYPERTENS, V29, P1649, DOI 10.1097/HJH.0b013e328348345d; Saruta T, 2015, HYPERTENS RES, V38, P132, DOI 10.1038/hr.2014.141; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Takabayashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075027	15	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	FEB	2015	38	2					104	105		10.1038/hr.2014.166		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB2NJ	WOS:000349464200003		
J	Haruhara, K; Tsuboi, N; Koike, K; Fukui, A; Miyazaki, Y; Kawamura, T; Ogura, M; Yokoo, T				Haruhara, Kotaro; Tsuboi, Nobuo; Koike, Kentaro; Fukui, Akira; Miyazaki, Yoichi; Kawamura, Tetsuya; Ogura, Makoto; Yokoo, Takashi			Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients	HYPERTENSION RESEARCH			English	Article						ambulatory blood pressure monitoring; chronic kidney disease; interstitial fibrosis/tubular atrophy; nocturnal hypertension; renal biopsy	SALT-SENSITIVE HYPERTENSION; DEPENDENT HYPERTENSION; OXFORD CLASSIFICATION; NEPHROPATHY; ASSOCIATION; PROTEINURIA; PROGRESSION; POPULATION; ATHEROSCLEROSIS; HYPERURICEMIA	Recent studies have demonstrated that ambulatory blood pressure monitoring is useful for predicting the long-term renal prognosis and future cardiovascular events in chronic kidney disease patients. Currently, however, information is limited regarding the relationships between individual renal histopathological findings and abnormalities in ambulatory blood pressure. This retrospective cross-sectional study included a total of 138 patients, in whom both renal biopsies and ambulatory blood pressure monitoring were performed during the same admission period. Renal histopathological findings, including global glomerulosclerosis, interstitial fibrosis/tubular atrophy and the presence of arterial lesions and arteriole lesions, were scored and analyzed in relation to the ambulatory blood pressure values. Among these histopathological characteristics, only the severity of interstitial fibrosis/tubular atrophy exhibited a significant association with an increased mean value of daytime and nighttime blood pressure. However, the remaining histopathological features showed only trends or weak relationships with these values. In addition, a moderately advanced grade of interstitial fibrosis/tubular atrophy was found to be significantly associated with both daytime and nighttime hypertension, independent of the kidney function, overt proteinuria and the use of antihypertensive medications, according to multivariate analyses. Furthermore, the night-to-day ratio of the mean blood pressure displayed a significant increasing trend according to the grade of interstitial fibrosis/tubular atrophy. These results suggest that interstitial fibrosis/tubular atrophy is the most relevant renal histopathological parameter associated with abnormalities in ambulatory blood pressure, including nocturnal hypertension, in this population.	[Haruhara, Kotaro; Tsuboi, Nobuo; Koike, Kentaro; Fukui, Akira; Miyazaki, Yoichi; Kawamura, Tetsuya; Ogura, Makoto; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo 1058461, Japan	Tsuboi, N (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	tsuboi-n@jikei.ac.jp					Agarwal R, 2006, KIDNEY INT, V69, P1175, DOI 10.1038/sj.ki.5000247; Alvarez V, 2002, AM J PHYSIOL-RENAL, V283, pF1132, DOI 10.1152/ajprenal.00199.2002; Andoh TF, 2001, AM J TRANSPLANT, V1, P222, DOI 10.1046/j.1600-6135.ajt10305.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kohan DE, 2013, AM J PHYSIOL-REG I, V305, pR659, DOI 10.1152/ajpregu.00345.2013; Malan NT, 2012, J HYPERTENS, V30, P2387, DOI 10.1097/HJH.0b013e3283599bb5; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Rule AD, 2011, MAYO CLIN PROC, V86, P282, DOI 10.4065/mcp.2010.0821; Kawai T, 2011, NEPHROL DIAL TRANSPL, V26, P3256, DOI 10.1093/ndt/gfr054; Johnson RJ, 1997, KIDNEY INT, V52, P1169, DOI 10.1038/ki.1997.442; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Baylis C, 2005, EXP GERONTOL, V40, P271, DOI 10.1016/j.exger.2005.01.008; Minutolo R, 2011, ARCH INTERN MED, V171, P1090, DOI 10.1001/archinternmed.2011.230; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Oppermann M, 2010, J AM SOC NEPHROL, V21, P468, DOI 10.1681/ASN.2009060658; Wakui H, 2013, HYPERTENSION, V61, P1203, DOI 10.1161/HYPERTENSIONAHA.111.00572; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319; Evans M, 2005, AM J KIDNEY DIS, V46, P863, DOI 10.1053/j.ajkd.2005.07.040; Davidson MB, 2006, ARCH INTERN MED, V166, P846, DOI 10.1001/archinte.166.8.846; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; Castleman B, 1943, JAMA-J AM MED ASSOC, V121, P1256; Farmer CKT, 1997, NEPHROL DIAL TRANSPL, V12, P2301, DOI 10.1093/ndt/12.11.2301; Forte P, 1998, HYPERTENSION, V32, P730; Fukuda M, 2008, HYPERTENSION, V52, P1155, DOI 10.1161/HYPERTENSIONAHA.108.115329; Hermida RC, 2011, CHRONOBIOL INT, V28, P509, DOI 10.3109/07420528.2011.580871; Jonhson RJ, 1997, KIDNEY INT, V52, P1169; Kawai T, 2013, HYPERTENS RES, V36, P232, DOI 10.1038/hr.2012.162; Kimura G., 2001, CLIN EXP NEPHROL, V5, P13, DOI 10.1007/PL00012172; KORBMACHER C, 1993, AM J PHYSIOL, V265, pC349; Okada T, 2012, NEPHROLOGY, V17, P68, DOI 10.1111/j.1440-1797.2011.01525.x; PERERA G A, 1955, J Chronic Dis, V1, P33, DOI 10.1016/0021-9681(55)90019-9; Schmidt MI, 1996, METABOLISM, V45, P699, DOI 10.1016/S0026-0495(96)90134-1; Vanegas V, 2005, KIDNEY INT, V68, P1161, DOI 10.1111/j.1523-1755.2005.00508.x; Weir MR, 2005, AM J KIDNEY DIS, V45, P176, DOI 10.1053/j.ajkd.2004.08.041; Wu Q, 2001, AM J KIDNEY DIS, V37, P380, DOI 10.1053/ajkd.2001.21319; Yanagi M, 2013, HYPERTENS RES, V36, P262, DOI 10.1038/hr.2012.184	41	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	FEB	2015	38	2					116	122		10.1038/hr.2014.140		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB2NJ	WOS:000349464200005		
J	Saruta, T; Ogihara, T; Saito, I; Rakugi, H; Shimamoto, K; Matsuoka, H; Teramukai, S; Higaki, J; Ito, S; Shimada, K				Saruta, Takao; Ogihara, Toshio; Saito, Ikuo; Rakugi, Hiromi; Shimamoto, Kazuaki; Matsuoka, Hiroaki; Teramukai, Satoshi; Higaki, Jitsuo; Ito, Sadayoshi; Shimada, Kazuyuki		COLM Investigators	Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability	HYPERTENSION RESEARCH			English	Article						adverse event; combination therapy; discontinuation; elderly hypertensive patient; olmesartan	DOSE COMBINATION THERAPY; SERUM URIC-ACID; CARDIOVASCULAR EVENTS; CONTROLLED-TRIAL; BLOOD-PRESSURE; SYSTOLIC HYPERTENSION; DOUBLE-BLIND; HYDROCHLOROTHIAZIDE; RISK; AMLODIPINE	The cardiovascular effects of combined therapy with the angiotensin receptor blocker (olmesartan) and a dihydropyridine calcium channel blocker (CCB) or a diuretic were compared in high-risk elderly Japanese hypertensive patients by performing a randomized, open label, blinded-endpoint study of morbidity and mortality (the COLM study). Here we report the results obtained with respect to safety and tolerability. High-risk hypertensive patients aged 65-84 years were enrolled and were randomized to receive olmesartan combined with either a CCB (amlodipine or azelnidipine) or a low-dose diuretic for at least 3 years. The primary endpoint was a composite of fatal and non fatal cardiovascular events, whereas adverse events (AEs) and the percentage of patients who discontinued the allocated treatment were evaluated as secondary endpoints. A total of 5141 patients were randomized. Both combination regimens achieved a similar reduction of cardiovascular morbidity and mortality. The incidences of AEs, serious AEs, drug-related serious AEs and discontinuation due to serious AEs were lower in the olmesartan plus CCB group than in the olmesartan plus diuretic group. Serum levels of uric acid and creatinine were significantly higher in the olmesartan plus diuretic group than in the olmesartan plus CCB group. Olmesartan combined with a CCB was significantly superior to olmesartan plus a diuretic with regard to the frequency of AEs and discontinuation of treatment.	[Saruta, Takao; Saito, Ikuo] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Ogihara, Toshio] Morinomiya Univ Med Sci, Osaka, Japan; [Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Osaka, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan; [Matsuoka, Hiroaki] Dokkyo Med Univ, Dept Hypertens & Cardiorenal Med, Mibu, Tochigi, Japan; [Teramukai, Satoshi] Kyoto Univ, Grad Sch Med, Translat Res Ctr, Dept Clin Trial Design & Management, Shitsukawa, Ehime, Japan; [Higaki, Jitsuo] Ehime Univ, Grad Sch Med, Dept Integrated Med & Informat, Div Cardiol, Sendai, Miyagi, Japan; [Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Dept Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Shimada, Kazuyuki] Shin Oyama City Hosp, Dept Cardiol, Oyama, Japan	Saruta, T (reprint author), 1003 Koie Bldg,6-7 Samon Cho,Sinjuku Ku, Tokyo 1600017, Japan.	takao_saruta@ybb.ne.jp			Japan Heart Foundation	We thank the collaborators and members of the COLM study group. The present study was funded by Japan Heart Foundation. This study was endorsed by the Japanese Society of Hypertension. The COLM study was funded by a grant from the Japan Heart Foundation.	Agarwal R, 2013, J HYPERTENS, V31, P1692, DOI 10.1097/HJH.0b013e32836157be; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; LaCroix AZ, 2000, ANN INTERN MED, V133, P516; Ito S, 2012, HYPERTENS RES, V35, P867, DOI 10.1038/hr.2012.59; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Ogihara T, 2014, J HYPERTENS, V32, P2054, DOI 10.1097/HJH.0000000000000281; NAKASHIMA M, 1992, EUR J CLIN PHARMACOL, V42, P333; Ogihara T, 2012, HYPERTENS RES, V35, P441, DOI 10.1038/hr.2011.216; Franse LV, 2000, J HYPERTENS, V18, P1149, DOI 10.1097/00004872-200018080-00021; Gradman AH, 2010, J AM SOC HYPERTENS, V4, P42, DOI 10.1016/j.jash.2010.02.005; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Holeggens A, 2004, KIDNEY INT, V65, P1041; Kuramoto K, 1999, HYPERTENSION, V34, P1129; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Matsuzaki M, 2011, J HYPERTENS, V29, P1649, DOI 10.1097/HJH.0b013e328348345d; Ogihara T, 2009, HYPERTENS RES, V32, P163, DOI 10.1038/hr.2008.31; Ohishi M, 2013, HYPERTENS RES, V36, P620, DOI 10.1038/hr.2013.10; Saruta T, 2007, HYPERTENS RES, V30, P729, DOI 10.1291/hypres.30.729; SOFFER BA, 1995, HYPERTENSION, V26, P112; Wang JG, 2001, HYPERTENSION, V37, P1069	20	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	FEB	2015	38	2					132	136		10.1038/hr.2014.141		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB2NJ	WOS:000349464200007		
J	Yasutake, K; Horita, N; Murata, Y; Koyama, S; Enjoji, M; Tsuchihashi, T				Yasutake, Kenichiro; Horita, Noriko; Murata, Yusuke; Koyama, Susumu; Enjoji, Munechika; Tsuchihashi, Takuya			Estimated urinary salt excretion by a self-monitoring device is applicable to education of salt restriction	HYPERTENSION RESEARCH			English	Article						blood pressure; salt intake; salt restriction; self-monitoring device	JAPANESE CARDIOLOGY OUTPATIENTS; BLOOD-PRESSURE CONTROL; LONG-TERM COMPLIANCE; HYPERTENSIVE PATIENTS; POTASSIUM EXCRETION; DIETARY SALT; SODIUM; REDUCTION; ADULTS; PREDICTORS	The objective was to investigate the validity of a self-monitoring device that estimates 24-h urinary salt excretion from overnight urine samples as a tool for education regarding salt restriction. Twenty healthy volunteers consumed test meals for 14 days, with salt content as follows: 10 g (days 1-5); 5 g (days 6-8, 12 and 14); and 13 g (days 9-11 and 13). On days 2-15, urinary salt excretion was estimated from overnight urine samples by a self-monitoring device. Twenty-four-hour urine samples were collected on days 5 and 8 to measure salt excretion directly. Blood pressure was measured in the morning and during sleep on days 1-15. Estimated urinary salt excretion measured by the device showed a correlation with salt intake, and the ratio of estimated urinary salt excretion to salt intake was 0.84 +/- 0.10 (days 2-6), 1.27 +/- 0.28 (days 7-9), 0.70 +/- 0.11 (days 10-12), 1.37 +/- 0.22 (day 13), 0.68 +/- 0.13 (day 14) and 1.33 +/- 0.19 (day 15). The correlation between estimated urinary salt excretion measured by a device and directly measured 24-h urinary salt excretion was significant (r = 0.65, P < 0.05) during the period of 10 g salt intake, but not during 5 g salt intake. Blood pressure in the morning was not influenced by the change in salt intake, but systolic pressure during sleep showed a significant increase or decrease according to the levels of salt intake. In conclusion, a self-monitoring device, which can estimate 24-h urinary salt excretion from overnight urine samples, is considered to be a practical tool for education regarding salt restriction, although a similar future investigation is needed in older and/or hypertensive subjects.	[Yasutake, Kenichiro] Nakamura Gakuen Univ, Fac Nutr Sci, Dept Nutr Sci, Jonan Ku, Fukuoka 8140198, Japan; [Horita, Noriko] Nishikyushu Univ, Fac Hlth & Nutr Sci, Dept Hlth & Nutr Sci, Saga, Japan; [Murata, Yusuke; Koyama, Susumu; Enjoji, Munechika] Fukuoka Univ, Hlth Care Ctr, Fukuoka 81401, Japan; [Tsuchihashi, Takuya] Steel Mem Yawata Hosp, Hypertens Ctr, Kitakyushu, Fukuoka, Japan	Yasutake, K (reprint author), Nakamura Gakuen Univ, Fac Nutr Sci, Dept Nutr Sci, Jonan Ku, 5-7-1 Befu, Fukuoka 8140198, Japan.	yasutake@nakamura-u.ac.jp			JSPS KAKENHI [25750067]	We would like to thank the kind volunteers in the Department of Health and Nutrition Sciences, Faculty of Health and Social Welfare Sciences, Nishikyushu University, for their enrollment in this study. This work was supported by JSPS KAKENHI Grant Number 25750067.	Uzu T, 1997, CIRCULATION, V96, P1859; Ohta Y, 2013, HYPERTENS RES, V36, P172, DOI 10.1038/hr.2012.155; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; Obarzanek E, 2003, HYPERTENSION, V42, P459, DOI 10.1161/01.HYP.0000091267.39066.72; Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262; ANTONIOS TFT, 1995, J HUM HYPERTENS, V9, P511; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj/jhh/1001307; du Cailar G, 2002, AM J HYPERTENS, V15, P222, DOI 10.1016/S0895-7061(01)02287-7; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; Espeland MA, 1999, ARCH FAM MED, V8, P228, DOI 10.1001/archfami.8.3.228; FORSTER JL, 1990, AM J CLIN NUTR, V51, P253; Hirota S, 2012, HYPERTENS RES, V35, P1069, DOI 10.1038/hr.2012.98; Hirota S, 2013, HYPERTENS RES, V36, P1096, DOI 10.1038/hr.2013.138; Intersalt Cooperative Research Group, 1988, BMJ-BRIT MED J, V297, P319, DOI DOI 10.1136/BMJ.297.66; Kawano Y, 2007, HYPERTENS RES, V30, P887, DOI 10.1291/hypres.30.887; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Ohta Y, 2004, HYPERTENS RES, V27, P243, DOI 10.1291/hypres.27.243; Ohta Y, 2004, J HUM HYPERTENS, V18, P273, DOI 10.1038/sj.jhh.1001666; Ohta Y, 2010, CLIN EXP HYPERTENS, V32, P234, DOI 10.3109/10641963.2010.491888; Ohta Y, 2009, CLIN EXP HYPERTENS, V31, P690, DOI 10.3109/10641960903407058; Okubo H, 2006, PUBLIC HEALTH NUTR, V9, P651, DOI 10.1079/PHN2005894; TOCHIKUBO O, 1983, HYPERTENSION, V5, P270; Yamasue K, 2006, J HUM HYPERTENS, V20, P593, DOI 10.1038/sj.jhh.1002049; YAMORI Y, 1982, JPN CIRC J, V46, P939; Yasutake K, 2013, ASIA PAC J CLIN NUTR, V22, P25, DOI 10.6133/apjcn.2013.22.1.03; Yasutake K, 2011, EXP THER MED, V2, P615, DOI 10.3892/etm.2011.265	27	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	FEB	2015	38	2					143	148		10.1038/hr.2014.155		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB2NJ	WOS:000349464200009		
J	Toda, A; Ishizaka, Y; Tani, M; Yamakado, M				Toda, Akiko; Ishizaka, Yuko; Tani, Mizuki; Yamakado, Minoru			Current dietary salt intake of Japanese individuals assessed during health check-up	HYPERTENSION RESEARCH			English	Article						lifestyle; prevention & control; salt	BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; REDUCTION COMMITTEE; SODIUM-INTAKE; HYPERTENSION; MANAGEMENT; SOCIETY; METAANALYSIS; RESTRICTION; POPULATIONS	Excess salt intake is a risk factor for increased blood pressure (BP) and hypertension. To prevent hypertension, the reduction of salt intake is promoted in many countries. For people with hypertension or cardiovascular disease (CVD), a more severe restriction of salt intake is indispensable. Japanese individuals consume high quantities of salt, and it is thus important to determine the degree to which the salt intake of these individuals has been restricted. Here, we investigated the current level of salt consumption of Japanese individuals using data obtained during annual health check-ups. A total of 10 762 individuals were assessed who underwent annual health check-ups at our institution in 2011. The estimated daily salt intake (EDSI) was calculated using spot urine samples. The average EDSI was 7.83 +/- 2.02 g per day. BP increased in proportion to the EDSI, and multivariate logistic regression analysis showed that the EDSI was a significant and independent risk factor for hypertension. The average EDSI of the subjects with hypertension or a history of CVD was higher than that of the subjects without these diseases. The subjects who drank more heavily showed higher EDSIs. This study demonstrated that the average EDSI of the subjects needing to restrict their salt intake because of past or present illnesses was high. To achieve adherence to the recommended reduction of salt intake, more efforts are required.	[Toda, Akiko; Ishizaka, Yuko; Tani, Mizuki; Yamakado, Minoru] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo 1018643, Japan	Toda, A (reprint author), Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Chiyoda Ku, 1 Kandaizumicho, Tokyo 1018643, Japan.	toda-tky@umin.ac.jp					Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Bolinder G, 1998, AM J HYPERTENS, V11, P1153, DOI 10.1016/S0895-7061(98)00137-X; Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; Tsuchihashi T, 2013, HYPERTENS RES, V36, P1026, DOI 10.1038/hr.2013.103; Umesawa M, 2008, AM J CLIN NUTR, V88, P195; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; Elliott P, 1996, BRIT MED J, V312, P1249; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; MARMOT MG, 1994, BRIT MED J, V308, P1263; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; Minami J, 1999, HYPERTENSION, V33, P586; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Tada N, 2011, J ATHEROSCLER THROMB, V18, P723; du Cailar G, 2002, AM J HYPERTENS, V15, P222, DOI 10.1016/S0895-7061(01)02287-7; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Hasegawa H, 2013, HYPERTENS RES, V36, P776, DOI 10.1038/hr.2013.41; Hirota S, 2012, HYPERTENS RES, V35, P1069, DOI 10.1038/hr.2012.98; ELLIOTT P, 1988, BRIT MED J, V297, P319; Kawamura M, 2012, HYPERTENS RES, V35, P611, DOI 10.1038/hr.2012.6; Kawano Y, 2007, HYPERTENS RES, V30, P879, DOI 10.1291/hypres.30.879; Miura K, 2013, HYPERTENS RES, V36, P1020, DOI 10.1038/hr.2013.105; Miyaki K, 2013, INT J ENV RES PUB HE, V10, P980, DOI 10.3390/ijerph10030980; Strazzullo P, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4567; Teramoto T, 2012, HYPERTENS RES, V35, P1136, DOI 10.1038/hr.2012.93; Vennegoor MA, 2009, J RENAL NUTR, V19, P63, DOI 10.1053/j.jrn.2008.10.019; Wrobel MJ, 2011, J AM SOC HYPERTENS, V5, P208, DOI 10.1016/j.jash.2011.05.003	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	FEB	2015	38	2					163	168		10.1038/hr.2014.154		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB2NJ	WOS:000349464200012		
J	Kawasaki, H; Ohta, M; Yamashita, K				Kawasaki, Hikaru; Ohta, Masaya; Yamashita, Katsumi			Extension of N-Continuous OFDM Precoder Matrix for Improving Error Rate	IEEE COMMUNICATIONS LETTERS			English	Article						OFDM; precoding; sidelobe suppression	SIDELOBE SUPPRESSION; SYSTEMS	The modulation technique of N-continuous orthogonal frequency division multiplexing (OFDM) has lower sidelobes than those of the original OFDM as a result of the continuous connection with higher-order derivatives between the OFDM symbols. Compared with the other sidelobe suppression schemes, for example, cancellation carrier insertion, and windowing, N-continuous OFDM does not require an extended guard interval nor the insertion of a wide guard band or cancellation carriers. However, N-continuous OFDM requires an iterative algorithm to remove the correction symbols from received symbols at the receiver and the large power of the correction symbols in the high-frequency area results in unavailable bandwidth. Here, we propose an extension of the N-continuous OFDM precoder matrix that flattens the bias power caused by the correction symbols in all frequency areas. Numerical experiments show that the proposed method improves the error rate performance without degrading the sidelobe suppression performance. The proposed method can also reduce the unavailable bandwidth.	[Kawasaki, Hikaru; Ohta, Masaya; Yamashita, Katsumi] Osaka Prefecture Univ, Grad Sch Engn, Dept Elect & Informat Syst, Osaka 5998531, Japan	Kawasaki, H (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Elect & Informat Syst, Osaka 5998531, Japan.	ota@eis.osakafu-u.ac.jp					Brandes S, 2006, IEEE COMMUN LETT, V10, P420, DOI [10.1109/LCOMM.2006.1638602, 10.1109/LCOMM.2006.06027]; Mahmoud HA, 2008, IEEE COMMUN LETT, V12, P133, DOI 10.1109/LCOMM.2008.071729; van de Beek J, 2009, IEEE COMMUN LETT, V13, P1, DOI 10.1109/LCOMM.2009.081446; Cosovic I, 2006, IEEE COMMUN LETT, V10, P444, DOI [10.1109/LCOMM.2006.1638610, 10.1109/LCOMM.2006.06001]; Ohta M, 2010, IEICE ELECTRON EXPR, V7, P1354, DOI 10.1587/elex.7.1354; Ohta M., 2011, P IEEE GLOBECOM, P1; Weiss T, 2004, P IEEE VEH TECHN C V, P1873; Zheng YM, 2012, IEEE COMMUN LETT, V16, P1937, DOI 10.1109/LCOMM.2012.102612.122168	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1089-7798	1558-2558		IEEE COMMUN LETT	IEEE Commun. Lett.	FEB	2015	19	2					283	286		10.1109/LCOMM.2014.2379643		4	Telecommunications	Telecommunications	CB3OJ	WOS:000349537500043		
J	Cho, K; Miyano, T				Cho, Kenichiro; Miyano, Takaya			Chaotic Cryptography Using Augmented Lorenz Equations Aided by Quantum Key Distribution	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						Augmented lorenz equations; chaotic cryptography; quantum key distribution	SYNCHRONIZATION; COMMUNICATION; CRYPTOSYSTEMS; SYSTEMS; MODEL; CRYPTANALYSIS; ENCRYPTION; MODULATION; ALGORITHMS; SECURITY	We have recently developed a chaotic gas turbine whose rotational motion might simulate turbulent Rayleigh-Benard convection. The nondimensionalized equations of motion of our turbine are expressed as a star network of Lorenz subsystems, referred to as augmented Lorenz equations. Here, we propose an application of the augmented Lorenz equations to chaotic cryptography, as a type of symmetric secret-key cryptographic method, wherein message encryption is performed by superimposing the chaotic signal generated from the equations on a plaintext in much the same way as in one-time pad cryptography. The ciphertext is decrypted by unmasking the chaotic signal precisely reproduced with a secret key consisting of (e.g., N = 101) real numbers that specify the augmented Lorenz equations. The transmitter and receiver are assumed to be connected via both a quantum communication channel on which the secret key is distributed using a quantum key distribution protocol and a classical data communication channel on which the ciphertext is transmitted. We discuss the security and feasibility of our cryptographic method.	[Cho, Kenichiro; Miyano, Takaya] Ritsumeikan Univ, Dept Mech Engn, Shiga 5258577, Japan	Cho, K (reprint author), Ritsumeikan Univ, Dept Mech Engn, Shiga 5258577, Japan.	tmiyano@se.rit-sumei.ac.jp					EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; CUOMO KM, 1993, PHYS REV LETT, V71, P65, DOI 10.1103/PhysRevLett.71.65; Argyris A, 2005, NATURE, V438, P343, DOI 10.1038/nature04275; Frohlich B, 2013, NATURE, V501, P69, DOI 10.1038/nature12493; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI 10.1137/S0097539795293172; Sasaki T, 2014, NATURE, V509, P475, DOI 10.1038/nature13303; PECORA LM, 1991, PHYS REV A, V44, P2374, DOI 10.1103/PhysRevA.44.2374; DEDIEU H, 1993, IEEE T CIRCUITS-II, V40, P634, DOI 10.1109/82.246164; Ekert A, 2014, NATURE, V507, P443, DOI 10.1038/nature13132; ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; HAYES S, 1994, PHYS REV LETT, V73, P1781, DOI 10.1103/PhysRevLett.73.1781; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; Hwang WY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057901; DIEKS D, 1982, PHYS LETT A, V92, P271, DOI 10.1016/0375-9601(82)90084-6; Niemela JJ, 2000, NATURE, V404, P837, DOI 10.1038/35009036; CUOMO KM, 1993, IEEE T CIRCUITS-II, V40, P626, DOI 10.1109/82.246163; Masuda N, 2006, IEEE T CIRCUITS-I, V53, P1341, DOI [10.1109/TCSI.2006.874182, 10.1109/TCSI.2006.874186]; Wang XB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230503; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Miyano T, 2012, PROC IUTAM, V5, P99, DOI 10.1016/j.piutam.2012.06.013; Patel KA, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041010; Scarani V, 2009, REV MOD PHYS, V81, P1301, DOI 10.1103/RevModPhys.81.1301; Sreenivasan KR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056306; CLAUSER JF, 1969, PHYS REV LETT, V23, P880, DOI 10.1103/PhysRevLett.23.880; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Alvarez G, 2006, INT J BIFURCAT CHAOS, V16, P2129, DOI 10.1142/S0218127406015970; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI 10.1145/359340.359342; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Jiang GP, 2003, CHAOS SOLITON FRACT, V15, P925, DOI 10.1016/S0960-0779(02)00214-X; Kocarev L, 2004, CHAOS, V14, P1078, DOI 10.1063/1.1821671; Anstett F, 2006, IEEE T CIRCUITS-I, V53, P2673, DOI 10.1109/TCSI.2006.885979; Araujo FF, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.084502; Arroyo D, 2009, INT J MOD PHYS B, V23, P651, DOI 10.1142/S0217979209049966; Barrio R, 2009, PHYSICA D, V238, P1615, DOI 10.1016/j.physd.2009.04.019; Barrio R, 2007, PHYSICA D, V229, P43, DOI 10.1016/j.physd.2007.03.013; Bennett C. H., 1984, P IEEE INT C COMP SY, P175; Bershadskii A., 2010, CHAOS, V20; Bohm D., 1951, QUANTUM THEORY; Camargo S, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036207; Cho K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036308; DIFFIE W, 1976, IEEE T INFORM THEORY, V22, P644, DOI 10.1109/TIT.1976.1055638; Kish LB, 2014, QUANTUM INF PROCESS, V13, P2213, DOI 10.1007/s11128-014-0729-7; Kish LB, 2006, PHYS LETT A, V352, P178, DOI 10.1016/j.physleta.2005.11.062; KOLAR M, 1992, PHYS REV A, V45, P626, DOI 10.1103/PhysRevA.45.626; Kurtsiefer C, 2002, NATURE, V419, P450, DOI 10.1038/419450a; Lai YC, 1999, PHYS LETT A, V255, P75, DOI 10.1016/S0375-9601(99)00175-9; Lo H.-K., 2005, PHYS REV LETT, V94; Miyano T, 2011, IEICE T FUND ELECTR, VE94A, P282, DOI 10.1587/transfun.E94.A.282; Muthukumar P., 2014, CHAOS, V24; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Porfiri M, 2008, P AMER CONTR CONF, P511, DOI 10.1109/ACC.2008.4586542; Strogatz S. H., 1994, NONLINEAR DYNAMICS C, P9; Tenny R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047903; Tenny R, 2005, IEEE T CIRCUITS-I, V52, P672, DOI 10.1109/TCSI.2004.842870; Xu WK, 2014, IEEE T CIRCUITS-I, V61, P2624, DOI 10.1109/TCSI.2014.2312477; Yoshimoto K., 2013, IEICE NONLINEAR THEO, V4, P341	57	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	FEB	2015	62	2					478	487		10.1109/TCSI.2014.2365767		10	Engineering, Electrical & Electronic	Engineering	CB1PJ	WOS:000349399800016		
J	Samra, S; El-Mahdy, A; Wada, Y				Samra, Sameh; El-Mahdy, Ahmed; Wada, Yasutaka			A Linear Time and Space Algorithm for Optimal Traffic-Signal Duration at an Intersection	IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS			English	Article						Dynamic programming; optimization; traffic-signal control	OPTIMIZATION; SYSTEMS; LIGHTS	Finding an optimal solution for traffic-signal control duration is a computationally intensive task. It is typically O(T-3) in time and O(T-2) in space, where T is the length of the control interval in discrete-time steps. In this paper, we propose a linear time and space algorithm for the traffic-signal control problem. The algorithm provides an efficient dynamic programming formulation of the state space that prunes nonoptimal states early on. This paper proves the correctness of the algorithm and provides an initial experimental validation. This paper also conducts a simulation study comparing with other typical control methods. The results show significant improvement in the average waiting time metric with respect to all other methods.	[Samra, Sameh] E JUST, Smart City Facil, Alexandria 21934, Egypt; [Samra, Sameh; El-Mahdy, Ahmed] E JUST, Sch Elect Commun & Comp, Dept Comp Sci & Engn, Alexandria 21934, Egypt; [El-Mahdy, Ahmed] E JUST, Smart City Facil, Parallel Comp Lab, Alexandria 21934, Egypt; [Wada, Yasutaka] Univ Electrocommun, Grad Sch Informat Syst, Tokyo 1828585, Japan	Samra, S (reprint author), E JUST, Smart City Facil, Alexandria 21934, Egypt.	sameh.abosamra@ejust.edu.eg; ahmed.elmahdy@ejust.edu.eg; wada@is.uec.ac.jp			IBM Ph.D. Fellowship Award	This work was supported in part by an IBM Ph.D. Fellowship Award. The Associate Editor for this paper was Z.-H. Mao. The Associate Editor for this paper was Z.-H. Mao.	Ceylan H, 2004, TRANSPORT RES B-METH, V38, P329, DOI 10.1016/S0191-2615(03)00015-8; Mirchandani P, 2001, TRANSPORT RES C-EMER, V9, P415, DOI 10.1016/S0968-090X(00)00047-4; Papageorgiou M, 2003, P IEEE, V91, P2043, DOI 10.1109/JPROC.2003.819610; Sen S, 1997, TRANSPORT SCI, V31, P5, DOI 10.1287/trsc.31.1.5; Chen B, 2010, IEEE T INTELL TRANSP, V11, P485, DOI 10.1109/TITS.2010.2048313; Trabia MB, 1999, TRANSPORT RES C-EMER, V7, P353, DOI 10.1016/S0968-090X(99)00026-1; Asthana R., 2012, INT J SCI ENG RES, V3, P1; Ben-Akiva M., 1998, P DACCORS SHORT TERM; Cai C, 2010, POW EN ENG C APPEEC, P1; Cools SB, 2008, ADV INFORM KNOWL PRO, P41, DOI 10.1007/978-1-84628-982-8_3; Cormen T. H., 2001, INTRO ALGORITHMS; Fang F., 2004, THESIS PENNSYLVANIA; Head L., 1995, TRANSPORT RES REC, V510, P45; Huang YS, 2008, J INF SCI ENG, V24, P875; Kim CO, 2005, LECT NOTES COMPUT SC, V3483, P148; Li T, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, P286; Liu C., 2014, P ASCE, V10, P1126; Porche I., 1999, J INTELL TRANSP SYST, V4, P260, DOI 10.1080/10248079908903752; Saito M., 2000, COMPUT-AIDED CIV INF, V15, P293, DOI DOI 10.1111/0885-9507.00192; Samra S, 2011, LECT NOTES COMPUT SC, V7916, P270, DOI 10.1007/978-3-642-24650-0_23; Smith B. L., 1994, P IEEE INT C SYST MA, V2, P1706, DOI 10.1109/ICSMC.1994.400094; Wiering M., 2004, P IEEE INT VEH S, P453; Wiering M., 2004, UUCS2004029; Zhanquan Sun, 2014, INT J INTELL TRANSP, V12, P20	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1524-9050	1558-0016		IEEE T INTELL TRANSP	IEEE Trans. Intell. Transp. Syst.	FEB	2015	16	1					387	395		10.1109/TITS.2014.2336657		9	Engineering, Civil; Engineering, Electrical & Electronic; Transportation Science & Technology	Engineering; Transportation	CB1MG	WOS:000349391200033		
J	Skibbe, H; Reisert, M; Maeda, S; Koyama, M; Oba, S; Ito, K; Ishii, S				Skibbe, Henrik; Reisert, Marco; Maeda, Shin-ichi; Koyama, Masanori; Oba, Shigeyuki; Ito, Kei; Ishii, Shin			Efficient Monte Carlo Image Analysis for the Location of Vascular Entity	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Angiography; Monte Carlo methods; neuronal networks; tubular network; vessel detection	ARTERY CENTERLINE EXTRACTION; CEREBRAL VASCULATURE; TUBULAR STRUCTURES; POINT-PROCESSES; CT ANGIOGRAPHY; ROBUST; 3D; SEGMENTATION; TRACKING; MODEL	Tubular shaped networks appear not only in medical images like X-ray-, time-of-flight MRI- or CT-angiograms but also in microscopic images of neuronal networks. We present EMILOVE (Efficient Monte-carlo Image-analysis for the Location Of Vascular Entity), a novel modeling algorithm for tubular networks in biomedical images. The model is constructed using tablet shaped particles and edges connecting them. The particles encode the intrinsic information of tubular structure, including position, scale and orientation. The edges connecting the particles determine the topology of the networks. For simulated data, EMILOVE was able to accurately extract the tubular network. EMILOVE showed high performance in real data as well; it successfully modeled vascular networks in real cerebral X-ray and time-of-flight MRI angiograms. We also show some promising, preliminary results on microscopic images of neurons.	[Skibbe, Henrik; Maeda, Shin-ichi; Koyama, Masanori; Oba, Shigeyuki; Ishii, Shin] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Ishii Lab, Kyoto 6068501, Japan; [Reisert, Marco] Univ Med Ctr Freiburg, Dept Radiol, D-79098 Freiburg, Germany; [Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan	Skibbe, H (reprint author), Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Ishii Lab, Kyoto 6068501, Japan.	skibbe-h@sys.i.kyoto-u.ac.jp; marco.reisert@uniklinik-freiburg.de; ichi@sys.i.kyoto-u.ac.jp; koyama-m@sys.i.kyoto-u.ac.jp; oba@i.kyoto-u.ac.jp; itokei@iam.u-tokyo.ac.jp; ishii@i.kyoto-u.ac.jp			Bioinformatics for Brain Sciences under the Strategic Research Program for Brain Sciences, MEXT (Japan); Deutsche Forschungsgemeinschaft (DFG) [RE 3286/2-1]	This work was supported by Bioinformatics for Brain Sciences under the Strategic Research Program for Brain Sciences, MEXT (Japan). The work of M. Reisert is supported by the Deutsche Forschungsgemeinschaft (DFG) under Grant RE 3286/2-1. Asterisk indicates corresponding author.	Turetken E, 2011, NEUROINFORMATICS, V9, P279, DOI 10.1007/s12021-011-9122-1; Chai DF, 2013, PROC CVPR IEEE, P1894, DOI 10.1109/CVPR.2013.247; Krissian K, 2000, COMPUT VIS IMAGE UND, V80, P130, DOI 10.1006/cviu.2000.0866; Worz S, 2007, IEEE T IMAGE PROCESS, V16, P1994, DOI 10.1109/TIP.2007.901204; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Zheng YF, 2013, LECT NOTES COMPUT SC, V8151, P74; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.1093/biomet/82.4.711; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Manniesing R, 2006, MED IMAGE ANAL, V10, P200, DOI 10.1016/j.media.2005.09.001; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130; Yang GY, 2012, INT J CARDIOVAS IMAG, V28, P921, DOI 10.1007/s10554-011-9894-2; Tyrrell JA, 2007, IEEE T MED IMAGING, V26, P223, DOI 10.1109/TMI.2006.889722; Schaap M, 2009, MED IMAGE ANAL, V13, P701, DOI 10.1016/j.media.2009.06.003; Brown KM, 2011, NEUROINFORMATICS, V9, P143, DOI 10.1007/s12021-010-9095-5; Aylward SR, 2002, IEEE T MED IMAGING, V21, P61, DOI 10.1109/42.993126; Lacoste C, 2005, IEEE T PATTERN ANAL, V27, P1568, DOI 10.1109/TPAMI.2005.206; Hamarneh G, 2010, COMPUT MED IMAG GRAP, V34, P605, DOI 10.1016/j.compmedimag.2010.06.002; Behrens T, 2003, IEEE T SYST MAN CY B, V33, P554, DOI 10.1109/TSMCB.2003.814305; Piccinelli M, 2009, IEEE T MED IMAGING, V28, P1141, DOI 10.1109/TMI.2009.2021652; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; Bouix S, 2005, MED IMAGE ANAL, V9, P209, DOI 10.1016/j.media.2004.06.026; Friman O, 2010, MED IMAGE ANAL, V14, P160, DOI 10.1016/j.media.2009.12.003; Aylward E. B. D. E. S., 1996, P IEEE WORKSH MATH M; Basu S, 2013, LECT NOTES COMPUT SC, V8149, P396, DOI 10.1007/978-3-642-40811-3_50; Bauer C., 2008, INSIGHT J; Bauer C., 2009, INT WORKSH PULM IM A, P191; Bauer C, 2008, LECT NOTES COMPUT SC, V5096, P163, DOI 10.1007/978-3-540-69321-5_17; Bhalerao A., 2001, P MED IM COMP COMP A, P820; Bogunovic H, 2011, MED PHYS, V38, P210, DOI 10.1118/1.3515749; Bogunovic H., 2008, P SOC PHOTO-OPT INS, p691 419; Bogunovic H, 2012, MED IMAGE ANAL, V16, P889, DOI 10.1016/j.media.2012.01.006; Cetin S., 2011, MICCAI WORKSH COMP V, P81; Goch C J, 2011, BILDVERARBEITUNG FUR, P104; Gulsun MA, 2008, LECT NOTES COMPUT SC, V5241, P602, DOI 10.1007/978-3-540-85988-8_72; Jiang Y., 2010, CVPRW, P178; Kitamura Y., 2012, P 9 IEEE INT S BIOM, P234; Lara DSD, 2009, SIBGRAPI, P194, DOI 10.1109/SIBGRAPI.2009.41; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Metz C, 2007, I S BIOMED IMAGING, P856, DOI 10.1109/ISBI.2007.356987; Pock T., 2005, P COMP VIS WINT WORK, P93; Reisert M, 2009, LECT NOTES COMPUT SC, V5748, P131; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Shikata H., 2009, J BIOMED IMAGING, V2009, P24; Sun KQ, 2007, LECT NOTES COMPUT SC, V4679, P467; Xu ZY, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P796; Zambal S., 2008, INSIGHT J, V4; Zhao F, 2011, I S BIOMED IMAGING, P2066; Zhao F, 2010, I S BIOMED IMAGING, P41	49	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	FEB	2015	34	2					628	643		10.1109/TMI.2014.2364404		16	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	CB0TA	WOS:000349338900024		
J	Watanabe, S; Takayama, Y; Ishikawa, R; Honjo, K				Watanabe, Shintaro; Takayama, Yoichiro; Ishikawa, Ryo; Honjo, Kazuhiko			A Miniature Broadband Doherty Power Amplifier With a Series-Connected Load	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Balun; broadband; Doherty power amplifier (PDA); GaN HEMT; microwave; power amplifier (PA); series connected load type	WIDE-BAND; ARCHITECTURE	A microwave Doherty power amplifier (DPA) consists of a carrier amplifier (CA), a peaking amplifier (PA), and an impedance inverting network. In this paper, a novel DPA topology with neither the impedance inverting network nor offset lines is proposed. This topology enables the enhancement of amplifier bandwidth and achieves a more compact amplifier size. To remove the impedance inverting network and to realize high efficiency at large back-off power level, the output-matching network of the CA is designed to realize high performance both at a low signal power level in the off-state of the PA and at the saturated signal power level. A 1.9-GHz series-connected load Doherty power amplifier without an impedance inverting network is designed and fabricated using GaN HEMTs. The amplifier achieves a power-added efficiency (PAE) of 50% under a 6-dB output back-off from a 34-dBm saturated output power with a PAE of 59%. A maximum PAE higher than 44% is obtained over a frequency range of 1.63-1.98 GHz.	[Watanabe, Shintaro; Takayama, Yoichiro; Ishikawa, Ryo; Honjo, Kazuhiko] Univ Electrocommun, Dept Commun Engn & Informat, Chofu, Tokyo 1828585, Japan	Watanabe, S (reprint author), Univ Electrocommun, Dept Commun Engn & Informat, Chofu, Tokyo 1828585, Japan.	y.takayama@uec.ac.jp; r.ishikawa@uec.ac.jp; honjou@uec.ac.jp			Ministry of Internal Affairs and Communications, Japan	This work was supported in part by the Ministry of Internal Affairs and Communications, Japan, for the 2013 SCOPE programme.	Doherty WH, 1936, P IRE, V24, P1163, DOI 10.1109/JRPROC.1936.228468; Piazzon L, 2013, IEEE MICROW WIREL CO, V23, P626, DOI 10.1109/LMWC.2013.2281413; Qureshi JH, 2010, IEEE MTT S INT MICR, P1504, DOI 10.1109/MWSYM.2010.5517561; Wu DYT, 2012, IEEE T MICROW THEORY, V60, P3201, DOI 10.1109/TMTT.2012.2209446; Kang D, 2011, IEEE T MICROW THEORY, V59, P3474, DOI 10.1109/TMTT.2011.2171042; Sun GL, 2012, IEEE T MICROW THEORY, V60, P99, DOI 10.1109/TMTT.2011.2175237; Rubio JM, 2012, IEEE T MICROW THEORY, V60, P2543, DOI 10.1109/TMTT.2012.2201745; Gustafsson D, 2013, IEEE T MICROW THEORY, V61, P922, DOI 10.1109/TMTT.2012.2231421; Giofre R, 2013, IEEE T MICROW THEORY, V61, P3308, DOI 10.1109/TMTT.2013.2274432; Watanabe S, 2012, 2012 ASIA-PACIFIC MICROWAVE CONFERENCE (APMC 2012), P361, DOI 10.1109/APMC.2012.6421598; Akbarpour M, 2012, IEEE T MICROW THEORY, V60, P2863, DOI 10.1109/TMTT.2012.2206050; Grebennikov A, 2012, IEEE T MICROW THEORY, V60, P3214, DOI 10.1109/TMTT.2012.2210906; Bathich K, 2011, IEEE Transactions on Microwave Theory and Techniques, V59, DOI 10.1109/TMTT.2010.2098040; Kawai S, 2009, APMC: 2009 ASIA PACIFIC MICROWAVE CONFERENCE, VOLS 1-5, P325; Kawai S, 2012, IEEE T MICROW THEORY, V60, P352, DOI 10.1109/TMTT.2011.2176505; Takayama Y., 2012, P IEICE GEN C MAR	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	FEB	2015	63	2	2		SI		572	579		10.1109/TMTT.2014.2377725		8	Engineering, Electrical & Electronic	Engineering	CB4UN	WOS:000349623800003		
J	Hu, S; Kousai, S; Wang, H				Hu, Song; Kousai, Shouhei; Wang, Hua			Antenna Impedance Variation Compensation by Exploiting a Digital Doherty Power Amplifier Architecture	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Antenna mismatch; CMOS integrated circuits; digital; Doherty; impedance variation; power amplifiers (PAs)	MATCHING NETWORK; CMOS; EFFICIENCY; MISMATCH; METHODOLOGY; PROTECTION	This paper presents a comprehensive theoretical study on Doherty power amplifiers (PAs) under antenna impedance mismatch. It is demonstrated for the first time that by varying the relative gain and phase of the carrier and peaking amplifiers, the PA performance degradation caused by the antenna impedance mismatch can be largely compensated. Such a compensation effect is discussed extensively for different antenna impedance conditions. Four types of Doherty PAs, i.e., three digital Doherty PAs with different degrees of flexibility and the classical analog Doherty PA, are covered in the complete theoretical analysis. To intuitively show the proposed concept, this paper presents numerical simulation results based on the theoretical analysis. In addition, measurement results on a fully integrated digital Doherty PA implemented in 65-nm bulk CMOS are demonstrated to verify our theoretical study.	[Hu, Song; Wang, Hua] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30308 USA; [Kousai, Shouhei] Toshiba Co Ltd, Ctr Semicond R&D, Saiwai Ku, Kawasaki, Kanagawa 2128520, Japan	Hu, S (reprint author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30308 USA.	husong@gatech.edu; shouhei.kousai@toshiba.co.jp; hua.wang@ece.gatech.edu					Nam J, 2007, IEEE T MICROW THEORY, V55, P633, DOI 10.1109/TMTT.2007.892800; Darraji R, 2011, IEEE T MICROW THEORY, V59, P2898, DOI 10.1109/TMTT.2011.2166122; Darraji R, 2012, IEEE T CIRCUITS-II, V59, P219, DOI 10.1109/TCSII.2012.2188455; Nemati HM, 2009, IEEE T MICROW THEORY, V57, P1110, DOI 10.1109/TMTT.2009.2017257; Doherty WH, 1936, P IRE, V24, P1163, DOI 10.1109/JRPROC.1936.228468; Scuderi A, 2005, IEEE J SOLID-ST CIRC, V40, P611, DOI 10.1109/JSSC.2005.843634; Neo WCE, 2006, IEEE J SOLID-ST CIRC, V41, P2166, DOI 10.1109/JSSC.2006.880586; Kim J, 2011, IEEE T MICROW THEORY, V59, P425, DOI 10.1109/TMTT.2010.2086466; Kim J, 2005, IEEE T MICROW THEORY, V53, P1802, DOI 10.1109/TMTT.2005.847073; Darraji R, 2011, IEEE T MICROW THEORY, V59, P1284, DOI 10.1109/TMTT.2011.2106137; Grebennikov A, 2012, P IEEE, V100, P3190, DOI 10.1109/JPROC.2012.2211091; [Anonymous], 2014, P IEEE RF INT CIRC S; Kaymaksut E, 2012, IEEE J SOLID-ST CIRC, V47, P1659, DOI 10.1109/JSSC.2012.2191334; Jeon H, 2012, IEEE J SOLID-ST CIRC, V47, P2019, DOI 10.1109/JSSC.2012.2193510; Darraji R, 2012, IEEE T MICROW THEORY, V60, P2875, DOI 10.1109/TMTT.2012.2207910; Chang CW, 2011, IEEE MICROW WIREL CO, V21, P571, DOI 10.1109/LMWC.2011.2165535; Balanis C. A., 2005, ANTENNA THEORY ANAL; Carrara F, 2008, IEEE J SOLID-ST CIRC, V43, P2057, DOI 10.1109/JSSC.2008.2001894; Carrara F, 2009, IEEE T MICROW THEORY, V57, P2122, DOI 10.1109/TMTT.2009.2027078; Cripps S., 2006, RF POWER AMPLIFIERS; Elmala M, 2006, IEEE J SOLID-ST CIRC, V41, P1323, DOI [10.1109/JSSC.2006.874284, 10.1109/JSSC.2006.874294]; Gaber W. M., 2012, P ESSCIRC, P341; Gonzalez G., 1996, MICROWAVE TRANSISTOR; Hammi O, 2006, IEEE T MICROW THEORY, V54, P3246, DOI 10.1109/TMTT.2006.877810; Ji D., 2013, P IEEE RFIC S, P341; Kousai S., 2014, IEEE INT SOL STAT CI, P58; Onizuka K., 2012, IEEE S VLSI CIRC, P78; Onizuka Kohei, 2012, Proceedings of the 2012 IEEE Asian Solid State Circuits Conference (A-SSCC); Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; Qiao DJ, 2005, IEEE T MICROW THEORY, V53, P1089, DOI 10.1109/TMTT.2005.843495; van Bezooijen A, 2007, IEEE J SOLID-ST CIRC, V42, P1834, DOI 10.1109/JSSC.2007.900783; van Bezooijen A, 2008, IEEE J SOLID-ST CIRC, V43, P2259, DOI 10.1109/JSSC.2008.2004334; van Bezooijen A, 2005, IEEE T CIRCUITS-I, V52, P2101, DOI [10.1109/TCSI.2005.853254, 10.1109/TSCI.2005.853254]; Wongkomet N, 2006, IEEE J SOLID-ST CIRC, V41, P2852, DOI 10.1109/JSSC.2006.884832; Yoon Y, 2014, IEEE J SOLID-ST CIRC, V49, P608, DOI 10.1109/JSSC.2013.2297414	35	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	FEB	2015	63	2	2		SI		580	597		10.1109/TMTT.2014.2385860		18	Engineering, Electrical & Electronic	Engineering	CB4UN	WOS:000349623800004		
J	Chung, S; Ma, R; Shinjo, S; Nakamizo, H; Parsons, K; Teo, KH				Chung, SungWon; Ma, Rui; Shinjo, Shintaro; Nakamizo, Hideyuki; Parsons, Kieran; Teo, Koon Hoo			Concurrent Multiband Digital Outphasing Transmitter Architecture Using Multidimensional Power Coding	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Class-S power amplifier; concurrent dual-band transmitter; interband carrier aggregation; multiband delta-sigma modulator; outphasing; power coding	PULSE-MODULATION; RF TRANSMITTERS; AMPLIFIER; EFFICIENCY; DESIGN; CMOS; OPTIMIZATION; 2.4-GHZ; SIGNAL	All-digital outphasing transmitter architecture using multidimensional power coding (MDPC) is proposed for noncontiguous concurrent multiband transmission with a high power efficiency. MDPC transforms multiband digital baseband signals into multibit low-resolution digital signals that drive switching-mode PAs. A prototype digital outphasing transmitter consists of two 1-GHz bandwidth GaN Class-D PAs and a Chireix power combiner. The two GaN PAs are driven by bipolar radio frequency (RF) pulse-width modulation (PWM) signals, which are transformed from a concurrent dual-band LTE signal by MDPC. The dual-band LTE signal with 15-MHz aggregate channel bandwidth at 240 and 500 MHz frequency band is transmitted with 30 and 37 dBc out-of-band emissions, respectively. Digital outphasing achieves more than two times higher coding efficiency than conventional concurrent dual-band digital transmitters with the same PAs in Class-S operation. Measured power coding efficiencies of 35.4% and 47.1% are observed with outphasing bipolar and 3-level RF PWM signals respectively, which are encoded from the dual-band LTE signal.	[Chung, SungWon] Mitsubishi Elect Res Labs, Cambridge, MA 02139 USA; [Chung, SungWon] MIT, MTL, Cambridge, MA 02139 USA; [Shinjo, Shintaro; Nakamizo, Hideyuki] Mitsubishi Electr Corp, Informat Technol R&D Ctr, Kamakura, Kanagawa 2478501, Japan; [Ma, Rui; Parsons, Kieran; Teo, Koon Hoo] Mitsubishi Elect Res Labs, Cambridge, MA 02139 USA	Chung, S (reprint author), Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA.	rma@merl.com					Ravi A, 2012, IEEE J SOLID-ST CIRC, V47, P3184, DOI 10.1109/JSSC.2012.2216671; Chen WH, 2011, IEEE T MICROW THEORY, V59, P2537, DOI 10.1109/TMTT.2011.2164089; Beltran R, 2009, IEEE MTT-S, P757, DOI 10.1109/MWSYM.2009.5165807; Helaoui M, 2008, IEEE T CIRCUITS-II, V55, P1129, DOI 10.1109/TCSII.2008.2003345; Yao J, 2006, IEEE T CIRCUITS-II, V53, P763, DOI 10.1109/TCSII.2006.876384; Johnson T, 2008, IEEE T CIRCUITS-I, V55, P3763, DOI 10.1109/TCSI.2008.927219; Saad P, 2012, IEEE T MICROW THEORY, V60, P1840, DOI 10.1109/TMTT.2012.2189120; Barton TW, 2013, IEEE MICROW WIREL CO, V23, P28, DOI 10.1109/LMWC.2012.2236084; Zhang YP, 2006, IEEE T MICROW THEORY, V54, P3779, DOI 10.1109/TMTT.2006.882895; Silva NV, 2013, IEEE T MICROW THEORY, V61, P625, DOI 10.1109/TMTT.2012.2228669; Birafane A, 2004, IEEE T MICROW THEORY, V52, P1702, DOI 10.1109/TMTT.2004.830485; Nielsen M, 2008, IEEE T MICROW THEORY, V56, P300, DOI 10.1109/TMTT.2007.913375; Ebrahimi MM, 2013, IEEE MICROW MAG, V14, P68, DOI 10.1109/MMM.2012.2226541; Chung SW, 2010, IEEE MTT S INT MICR, P264; Grebennikov A, 2012, IEEE T MICROW THEORY, V60, P3214, DOI 10.1109/TMTT.2012.2210906; Qureshi JH, 2009, IEEE T MICROW THEORY, V57, P1925, DOI 10.1109/TMTT.2009.2025430; Xu HT, 2011, IEEE J SOLID-ST CIRC, V46, P1596, DOI 10.1109/JSSC.2011.2143930; Godoy PA, 2012, IEEE J SOLID-ST CIRC, V47, P2372, DOI 10.1109/JSSC.2012.2202810; Hung TP, 2007, IEEE T MICROW THEORY, V55, P2845, DOI 10.1109/TMTT.2007.909881; Asmar M. E., 2012, IEEE T MICROW THEORY, V60, P1886; Blocher T, 2009, MIDWEST SYMP CIRCUIT, P276, DOI 10.1109/MWSCAS.2009.5236098; Chen JH, 2010, IEEE MICROW WIREL CO, V20, P684, DOI 10.1109/LMWC.2010.2079923; Chi SL, 2013, IEEE T CIRCUITS-I, V60, P1901, DOI 10.1109/TCSI.2012.2226487; Choi J, 2007, IEEE T MICROW THEORY, V55, P2679, DOI 10.1109/TMTT.2007.907137; Chung S., 2015, IEEE RAD WIR S SAN D; Ebrahimi M. M., 2012, P IEEE RAD WIR S JAN, P411; Hezar R., 2014, P IEEE RAD FREQ INT, P217; Interband Carrier Aggregation, 2013, TR36850V1110 3GPP; Kitayabu Toru, 2010, Proceedings 2010 IEEE Radio and Wireless Symposium (RWS 2010), DOI 10.1109/RWS.2010.5434135; Leberer R, 2008, IEEE MTT-S, P85, DOI 10.1109/MWSYM.2008.4633109; Maehata T, 2013, EUR MICROW CONF, P1523; Markert D., 2014, P EUR MICR INT CIRC, P420; Nakamizo H., 2015, IEEE RADIO IN PRESS; Ozen M., 2012, P IEEE EUR MICR S NO; Park JC, 2013, IEEE T MICROW THEORY, V61, P4168, DOI 10.1109/TMTT.2013.2288084; RAAB FH, 1973, IEEE T COMMUN, VCO21, P958, DOI 10.1109/TCOM.1973.1091763; Raab FH, 2010, IEEE MTT S INT MICR, P924, DOI 10.1109/MWSYM.2010.5516001; Schreier R., 2005, UNDERSTANDING DELTA; Wentzel A, 2010, IEEE MTT S INT MICR, P812, DOI 10.1109/MWSYM.2010.5517402; Ye Z., 2007, P IEEE WORKSH SIGN P, P1, DOI 10.1109/DATE.2007.364561; Zhu Q., 2014, P IEEE MTT S INT MIC, P1	41	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	FEB	2015	63	2	2		SI		598	613		10.1109/TMTT.2014.2387845		16	Engineering, Electrical & Electronic	Engineering	CB4UN	WOS:000349623800005		
J	Yoshioka, K; Shikata, A; Sekimoto, R; Kuroda, T; Ishikuro, H				Yoshioka, Kentaro; Shikata, Akira; Sekimoto, Ryota; Kuroda, Tadahiro; Ishikuro, Hiroki			An 8 bit 0.3-0.8 V 0.2-40 MS/s 2-bit/Step SAR ADC With Successively Activated Threshold Configuring Comparators in 40 nm CMOS	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						2-bit/step; extremely low voltage; low power; SAR ADC; threshold configuring comparator	DIGITAL CMOS; MU-W	A 0.3-0.8 V low-power 2-bit/step asynchronous successive approximation register analog-to-digital converter (ADC) is presented. A low-power 2-bit/step operation technique is proposed which uses dynamic threshold configuring comparator instead of multiple digital-to-analog converters (DACs). Power and area overhead is minimized by successively activated comparators. The comparator threshold is configured by simple V-cm biased current source, which keep the ADC free from power supply variations over 10%. Simple digital calibration is enabled by generating the reference internally. The prototype ADC fabricated in a 40 nm CMOS achieved a 44.3 dB signal-to-noise-plus-distortion ratio (SNDR) with 6.14 MS/s at a single supply voltage of 0.5 V. The ADC achieved a peak FoM of 4.8 fJ/conv-step at 0.4 V and operates down to 0.3 V.	[Yoshioka, Kentaro; Ishikuro, Hiroki] Keio Univ, Ishikuro Lab, Yokohama, Kanagawa 2238522, Japan; [Sekimoto, Ryota] Canon Inc, Tokyo 1468501, Japan; [Shikata, Akira] Analog Devices Inc, Japan Design Ctr, Tokyo 1056891, Japan; [Kuroda, Tadahiro] Keio Univ, Keio Kuroda Lab, Yokohama, Kanagawa 2238522, Japan	Yoshioka, K (reprint author), Keio Univ, Ishikuro Lab, Yokohama, Kanagawa 2238522, Japan.	yoshioka@iskr.elec.keio.ac.jp; akira.shikata@analog.com; sekimoto@iskr.elec.keio.ac.jp; kuroda@elec.keio.ac.jp; ishikuro@elec.keio.ac.jp			METI; NEDO	This work was supported in part by METI and in part by NEDO, carried out as a part of the Extremely Low Power Project.	van Elzakker M, 2010, IEEE J SOLID-ST CIRC, V45, P1007, DOI 10.1109/JSSC.2010.2043893; Verbruggen B, 2009, IEEE J SOLID-ST CIRC, V44, P874, DOI 10.1109/JSSC.2009.2012449; Miyahara M, 2008, IEEE ASIAN SOLID STA, P269, DOI 10.1109/ASSCC.2008.4708780; Lee S, 2012, IEEE J SOLID-ST CIRC, V47, P1603, DOI 10.1109/JSSC.2012.2191184; Shikata A, 2012, IEEE J SOLID-ST CIRC, V47, P1022, DOI 10.1109/JSSC.2012.2185352; Nuzzo P, 2008, IEEE T CIRCUITS-I, V55, P1441, DOI 10.1109/TCSI.2008.917991; Cao ZH, 2009, IEEE J SOLID-ST CIRC, V44, P862, DOI 10.1109/JSSC.2008.2012329; El-Chammas M, 2011, IEEE J SOLID-ST CIRC, V46, P838, DOI 10.1109/JSSC.2011.2108125; Liu CC, 2010, IEEE J SOLID-ST CIRC, V45, P731, DOI 10.1109/JSSC.2010.2042254; Goll B., 2009, ISSCC, P328; Harpe P., 2013, IEEE ISSCC, P270; Harpe P., 2012, IEEE ISSCC, P472; Hong H. P., 2012, P IEEE CICC SEP, P1; Lien Y.-C., 2012, IEEE S VLSI CIRC, P88; Nakamura Y. ., 2012, P 12 IEEE INT WORKSH, V26768, P1; Nomura M., 2013, IEEE S VLSI CIRC JUN, P36; Nuzzo P, 2009, 2009 SYMPOSIUM ON VLSI CIRCUITS, DIGEST OF TECHNICAL PAPERS, P238; Rabaey J., 2011, IEEE S VLSI CIRC JUN, P6; Razavi B., 2001, DESIGN ANALOG CMOS I; Sekimoto R., 2011, P ESSCIRC SEP, P471; Shikata A, 2013, IEICE T FUND ELECTR, VE96A, P443, DOI 10.1587/transfun.E96.A.443; Shu Y.-S., 2012, IEEE S VLSI CIRC JUN, P26; Stepanovic D., 2012, IEEE S VLSI CIRC, P84; Tai H.-Y., 2012, IEEE S VLSI CIRC, P92; Van der Plas G., 2006, ICANN 2006 ATH GREEC, P31; Van der Plas G, 2008, IEEE J SOLID-ST CIRC, V43, P2631, DOI 10.1109/JSSC.2008.2006315; Verbruggen B., 2011, IEEE J SOLID-ST CIRC, V45, P2080; Wei H., 2011, IEEE ISSCC, P188, DOI DOI 10.1109/ISSCC.2011.5746276; Yip M., 2011, IEEE INT SOL STAT CI, P190; Yoshioka K., 2012, P IEEE ESSCIRC SEP, P381; Yoshioka M., 2010, IEEE ISSCC, P384	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	FEB	2015	23	2					356	368		10.1109/TVLSI.2014.2304733		13	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CB1XD	WOS:000349420400012		
J	Shimizu, N; Sato, N; Kikuchi, T; Ishizaki, T; Kobayashi, K; Kita, K; Takimoto, K				Shimizu, Nobuhiro; Sato, Natsumi; Kikuchi, Teppei; Ishizaki, Takuro; Kobayashi, Kazuto; Kita, Kaori; Takimoto, Koichi			A sustained increase in the intracellular Ca2+ concentration induces proteolytic cleavage of EAG2 channel	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Potassium channel; Ca2+; Proteolysis; Cancer; Cell volume	GO POTASSIUM CHANNELS; FUNCTIONAL EXPRESSION; CARDIAC-ARRHYTHMIA; TERMINAL REGION; KCNH-CHANNEL; K+ CHANNELS; HUMAN ETHER; C-TERMINUS; CALPAIN; HERG	Voltage-gated EAG2 channel is abundant in the brain and enhances cancer cell growth by controlling cell volume. The channel contains a cyclic nucleotide-binding homology (CNBH) domain and multiple calmodulin-binding motifs. Here we show that a raised intracellular Ca2+ concentration causes proteolytic digestion of heterologously expressed and native EAG2 channels. A treatment of EAG2-expressing cells with the Ca2+ ionophore A23187 for 1 h reduces the full-length protein by similar to 80% with a concomitant appearance of 30-35-kDa peptides. Similarly, a treatment with the Ca2+-ATPase inhibitor thapsigargin for 3 h removes 30-35-kDa peptides from similar to 1/3 of the channel protein. Moreover, an incubation of the isolated rat brain membrane with CaCl2 leads to the generation of fragments with similar sizes. This Ca2+-induced digestion is not seen with EAG1. Mutations in a C-terminal calmodulin-binding motif alter the degrees and positions of the cleavage. Truncated channels that mimic the digested proteins exhibit a reduced current density and altered channel gating. In particular, these shorter channels lack a rapid activation typical in EAG channels with more than 20-mV positive shifts in voltage dependence of activation. The truncation also eliminates the ability of EAG2 channel to reduce cell volume. These results suggest that a sustained increase in the intracellular Ca2+ concentration leads to proteolytic cleavage at the C-terminal cytosolic region following the CNBH domain by altering its interaction with calmodulin. The observed Ca2+-induced proteolytic cleavage of EAG2 channel may act as an adaptive response under physiological and/or pathological conditions. (C) 2014 Elsevier Ltd. All rights ruerveth	[Shimizu, Nobuhiro; Sato, Natsumi; Kikuchi, Teppei; Ishizaki, Takuro; Kobayashi, Kazuto; Takimoto, Koichi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Kita, Kaori; Takimoto, Koichi] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Takimoto, K (reprint author), Nagaoka Univ Technol, Dept Bioengn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	koichi@vos.nagaokaut.ac.jp					Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Pedrozo Z, 2010, BBA-MOL BASIS DIS, V1802, P356, DOI 10.1016/j.bbadis.2009.12.005; VANSEVENTER GA, 1992, J IMMUNOL, V149, P3872; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dennis AT, 2011, J BIOL CHEM, V286, P34413, DOI 10.1074/jbc.M111.254367; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Friedrich P, 2005, BIOL CHEM, V386, P609, DOI 10.1515/BC.2005.071; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI [10.1016/j.jmb.2012.06.025, 10.1016/jmb.2012.06.025]; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; LUDWIG J, 1994, EMBO J, V13, P4451; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Stuhmer W, 2006, FEBS LETT, V580, P2850, DOI 10.1016/j.febslet.2006.03.062; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Kopil CM, 2011, J BIOL CHEM, V286, P35998, DOI 10.1074/jbc.M111.254177; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; Carrillo E, 2004, J MEMBRANE BIOL, V199, P155, DOI 10.1007/s00232-004-0683-x; DEJONGH KS, 1994, J NEUROCHEM, V63, P1558; DILIBERTO PA, 1992, J BIOL CHEM, V267, P11888; Fu Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175307; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Goncalves JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010873; Henrich M, 2008, J NEUROPHYSIOL, V100, P456, DOI 10.1152/jn.01380.2007; Pattni K, 2003, BIOCHEM J, V375, P643, DOI 10.1042/BJ20030505; Rodriguez-Rasgado JA, 2012, SENSORS-BASEL, V12, P5986, DOI 10.3390/s120505986; Saganich MJ, 1999, J NEUROSCI, V19, P10789; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; Shabala L, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-30; Sorimachi H, 2012, BIOL CHEM, V393, P853, DOI 10.1515/hsz-2012-0143; Tiago T, 2011, CELL CALCIUM, V49, P174, DOI 10.1016/j.ceca.2011.01.009; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	FEB	2015	59						126	134		10.1016/j.bioce1.2014.12.007		9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CB1YV	WOS:000349424800014		
J	Georgieva, M; Staneva, D; Uzunova, K; Efremov, T; Balashev, K; Harata, M; Miloshev, G				Georgieva, Milena; Staneva, Dessislava; Uzunova, Katya; Efremov, Toni; Balashev, Konstantin; Harata, Masahiko; Miloshev, George			The linker histone in Saccharomyces cerevisiae interacts with actin-related protein 4 and both regulate chromatin structure and cellular morphology	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Hho1p; Actin-related protein 4 (Arp4p); Chromatin higher-order chromatin structure; Chromatin remodeling	HUMAN SWI/SNF; TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; GLOBULAR DOMAINS; COMET ASSAY; YEAST; DNA; HHO1P; CELLS; H1	Chromatin structure promotes important epigenetic mechanisms that regulate cellular fate by organizing, preserving and controlling the way by which the genetic information works. Our understanding of chromatin and its functions is sparse and not yet well defined. The uncertainty comes from the complexity of chromatin and is induced by the existence of a large number of nuclear proteins that influence it. The intricate interaction among all these structural and functional nuclear proteins has been under extensive study in the recent years. Here, we show that Saccharomyces cerevisiae linker histone physically interacts with Arp4p (actin-related protein 4) which is a key subunit of three chromatin modifying complexes INO80, SWR1 and NuA4. A single - point mutation in the actin - fold domain of Arp4p together with the knock-out of the gene for the linker histone in S. cerevisiae severely abrogates cellular and nuclear morphology and leads to complete disorganizing of the higher levels of chromatin organization. (C) 2014 Elsevier Ltd. All rights reserved.	[Georgieva, Milena; Staneva, Dessislava; Uzunova, Katya; Efremov, Toni; Miloshev, George] Bulgarian Acad Sci, Yeast Mol Genet Lab, Inst Mol Biol R Tsanev, BU-1113 Sofia, Bulgaria; [Balashev, Konstantin] Sofia Univ St Kliment Ohridski, Fac Chem & Pharm, Dept Phys Chem, Biophys Chem Lab, Sofia 1164, Bulgaria; [Harata, Masahiko] Tohoku Univ, Mol Biol Lab, Dept Mol & Cell Biol, Div Life Sci,Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan	Miloshev, G (reprint author), Bulgarian Acad Sci, Yeast Mol Genet Lab, Inst Mol Biol R Tsanev, BU-1113 Sofia, Bulgaria.	gmlab@chromatinepigenetics.com		Georgieva, Milena/0000-0002-2371-7544	Bulgarian Science Fund [DMU 02/8, DID 02/35]	This work was supported by the Bulgarian Science Fund [DMU 02/8 to M.G. and T.E., DID 02/35 to M.G., D.S. and G.M.].	Agatep R, 1998, TRANSFORMATION SACCH; Ali T, 2004, J MOL BIOL, V337, P1123, DOI 10.1016/j.jmb.2004.02.029; Ali T, 2004, J MOL BIOL, V338, P139, DOI 10.1016/j.jmb.2004.02.046; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Bryant JM, 2012, MOL CELL BIOL, V32, P2771, DOI 10.1128/MCB.00282-12; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Hellauer K, 2001, J BIOL CHEM, V276, P13587; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Georgieva M, 2008, J CELL BIOCHEM, V104, P59, DOI 10.1002/jcb.21600; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; SONI R, 1993, CURR GENET, V24, P455, DOI 10.1007/BF00351857; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Tark-Dame M, 2011, J CELL SCI, V124, P839, DOI 10.1242/jcs.077628; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Harata M, 2002, NUCLEIC ACIDS RES, V30, P1743, DOI 10.1093/nar/30.8.1743; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; James P, 1996, GENETICS, V144, P1425; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Benton K, 1993, EMBO J, V12, P5267; Choi EY, 2001, EXP CELL RES, V271, P180, DOI 10.1006/excr.2001.5355; Dion V, 2010, CURR OPIN CELL BIOL, V22, P1; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Georgieva M, 2012, BBA-GENE REGUL MECH, V1819, P366, DOI 10.1016/j.bbagrm.2011.12.003; Gorzer I, 2003, MOL MICROBIOL, V50, P1155, DOI 10.1046/j.1365-2958.2003.03759.x; Gregory T, 2005, GENOME SIZE EVOLUTIO, P4; Harata M, 1999, MOL BIOL CELL, V10, P2595; Harata M, 2000, J BIOCHEM, V128, P665; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; JACKSON DA, 1990, EMBO J, V9, P567; Levy A, 2008, P NATL ACAD SCI USA, V105, P11703, DOI 10.1073/pnas.0709403105; Maier VK, 2008, BIOL CHEM, V389, P345, DOI 10.1515/BC.2008.040; Maier VK, 2007, EMBO J, V27, P817; Miller J. H., 1972, EXPT MOL GENETICS; OLIVE PL, 1993, MUTAT RES, V294, P275, DOI 10.1016/0921-8777(93)90010-E; Peycheva E, 2009, BIOTECHNOL BIOTEC EQ, V23, P1090; Philimonenko AA, 2004, J STRUCT BIOL, V148, P279, DOI 10.1016/j.jsb.2004.08.001; Pollard KJ, 1998, BIOESSAYS, V20, P771, DOI 10.1002/(SICI)1521-1878(199809)20:9<771::AID-BIES10>3.0.CO;2-V; Ramachandran A, 2003, J BIOL CHEM, V278, P48590, DOI 10.1074/jbc.M309033200; Sambrook J., 1989, MOL CLONING LAB MANU; Schafer G, 2005, BIOCHEMISTRY-US, V44, P16766, DOI 10.1021/bi0511787; Schafer G, 2008, P NATL ACAD SCI USA, V105, P14838, DOI 10.1073/pnas.0806337105; VARGAWEISZ PD, 1995, EMBO J, V14, P2209; Varga-Weisz PD, 2006, CURR OPIN GENET DEV, V16, P151, DOI 10.1016/j.gde.2006.02.006; Veron M, 2006, GENETICS, V173, P579, DOI 10.1534/genetics.105.050195; Wach A, 1998, METHOD MICROBIOL, V26, P67; WEBER V, 1995, MOL BIOL CELL, V6, P1263; Yu Q, 2009, J BIOL CHEM, V284, P740, DOI 10.1074/jbc.M806274200	63	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	FEB	2015	59						182	192		10.1016/j.bioce1.2014.12.006		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CB1YV	WOS:000349424800019		
J	Murata, A; Okamoto, K; Mayumi, T; Muramatsu, K; Matsuda, S				Murata, Atsuhiko; Okamoto, Kohji; Mayumi, Toshihiko; Muramatsu, Keiji; Matsuda, Shinya			Observational study to compare antithrombin and thrombomodulin for disseminated intravascular coagulation	INTERNATIONAL JOURNAL OF CLINICAL PHARMACY			English	Article						Antithrombin; Database; Disseminated intravascular coagulation; Healthcare costs; Length of stay; Mortality; Thrombomodulin	HUMAN SOLUBLE THROMBOMODULIN; NATIONAL ADMINISTRATIVE DATABASE; ENDOSCOPIC SUBMUCOSAL DISSECTION; SEVERE SEPSIS; GASTRIC-CANCER; HOSPITAL VOLUME; DOUBLE-BLIND; TIME TREND; EFFICACY; OUTCOMES	Background There have been no studies comparing the effects of antithrombin (AT-III) and recombinant human soluble thrombomodulin (rhs-TM) on outcomes in patients with disseminated intravascular coagulation (DIC) associated with infectious diseases. Objective The aim of this observational study is to compare AT-III and rhs-TM in terms of outcomes such as mortality, length of hospitalization, and medical costs in patients with DIC associated with infectious diseases based on a Japanese administrative database. Setting A total of 7,535 patients with DIC associated with infectious diseases in 886 hospitals from 2010 to 2012 in Japan. Methods We collected patients' data from the administrative database to compare clinical and medical economic outcomes of patients with DIC. Patients were divided into two groups according to treatment of DIC: AT-III (n = 3,601) and rhs-TM (n = 3,934). Main outcomes measure In-hospital mortality (within 14 days, within 28 days, and overall mortality), length of stay (LOS), and medical costs during hospitalization. Results Multilevel logistic regression analysis showed that there were no significant differences with regard to in-hospital mortality between AT-III and rhs-TM within 14 days (odds ratio (OR) of rhs-TM 0.97, 95 % confidence interval (CI) 0.85-1.11, p = 0.744), within 28 days (OR 1.00, 95 % CI 0.89-1.13, p = 0.919), and overall (OR 0.95, 95 % CI 0.85-1.07, p = 0.470). However, multilevel linear regression analysis revealed that use of rhs-TM significantly decreased LOS and medical costs during hospitalization. The coefficient for LOS was -2.92 days (95 % CI -4.79 to -1.04 days; p = 0.002) whereas that for medical costs during hospitalization was -798.3 Euro (95 % CI -1,515.7 to -81.0 Euro; p = 0.029). Conclusion This study demonstrated no significant difference in in-hospital mortality between AT-III and rhs-TM. However, use of rhs-TM was significantly associated with decreased LOS and medical costs during hospitalization in patients with DIC associated with infectious diseases.	[Murata, Atsuhiko; Muramatsu, Keiji; Matsuda, Shinya] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Okamoto, Kohji] Yahata Municipal Hosp, Dept Surg, Kitakyushu, Fukuoka, Japan; [Mayumi, Toshihiko] Univ Occupat & Environm Hlth, Dept Emergency Med, Kitakyushu, Fukuoka 8078555, Japan	Murata, A (reprint author), Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Sch Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	amurata@med.uoeh-u.ac.jp					Gogos CA, 2003, J INFECTION, V47, P300, DOI 10.1016/S0163-4453(03)00101-4; Murata A, 2014, SURG ENDOSC, V28, P1298, DOI 10.1007/s00464-013-3326-4; Murata A, 2014, J THROMB THROMBOLYS, V38, P364, DOI 10.1007/s11239-014-1068-3; Cartin-Ceba R, 2011, CHEST, V140, P1447, DOI 10.1378/chest.11-1197; Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03; Murata A, 2014, J SURG RES, V186, P157, DOI 10.1016/j.jss.2013.09.015; Nishiyama T, 2000, CRIT CARE MED, V28, P1419, DOI 10.1097/00003246-200005000-00027; Iba T, 2012, THROMB RES, V130, pE129, DOI 10.1016/j.thromres.2012.03.021; Bick RL, 2002, CLIN APPL THROMB-HEM, V8, P1, DOI 10.1177/107602960200800103; Murata A, 2011, J HEPATO-BIL-PAN SCI, V18, P678, DOI 10.1007/s00534-011-0375-8; Murata A, 2014, GASTRIC CANCER, V17, P294, DOI 10.1007/s10120-013-0282-6; Wada H, 2010, THROMB RES, V125, P6, DOI 10.1016/j.thromres.2009.08.017; Levi M, 2010, SEMIN THROMB HEMOST, V36, P367, DOI 10.1055/s-0030-1254046; Murata A, 2013, J PUBLIC HEALTH MAN, V19, pE23, DOI 10.1097/PHH.0b013e31828b7150; Levi M, 2013, INTERN EMERG MED, V8, P23, DOI 10.1007/s11739-012-0859-9; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Yamakawa K, 2013, INTENS CARE MED, V39, P644, DOI 10.1007/s00134-013-2822-2; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8; Ogawa Y, 2012, J TRAUMA ACUTE CARE, V72, P1150, DOI 10.1097/TA.0b013e3182516ab5; Fukuda T, 2013, RESUSCITATION, V84, P964, DOI 10.1016/j.resuscitation.2013.02.019; Kato Takahiro, 2013, Thromb J, V11, P3, DOI 10.1186/1477-9560-11-3; Mimuro J, 2013, THROMB RES, V131, P436, DOI 10.1016/j.thromres.2013.03.008; Ministry of Health Welfare and Labor of Japan, STAT; Murata A, 2013, GERIATR GERONTOL INT, V13, P731, DOI 10.1111/j.1447-0594.2012.00938.x; Murata A, 2014, J DIGEST DIS, V15, P62, DOI 10.1111/1751-2980.12106; Nakagawa M, 1999, Rinsho Ketsueki, V40, P362; Okamoto K, 2013, J HEPATO-BIL-PAN SCI, V20, P55, DOI 10.1007/s00534-012-0562-2; Sakamoto Y, 2013, YONSEI MED J, V54, P686, DOI 10.3349/ymj.2013.54.3.686; Sawamura A, 2009, CLIN APPL THROMB-HEM, V15, P561, DOI 10.1177/1076029608323497; Shirahata A, 2014, EUR J PEDIATR, V173, P303, DOI 10.1007/s00431-013-2155-8; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Wiedermann CJ, 2006, CRIT CARE MED, V34, P285, DOI 10.1097/01.CCM.0000194731.08896.99; Wiedermann CJ, 2006, BLOOD COAGUL FIBRIN, V17, P521, DOI 10.1097/01.mbc.0000245302.18010.40; Yamakawa K, 2011, CRIT CARE, V15, DOI 10.1186/cc10228	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	2210-7703	2210-7711		INT J CLIN PHARM-NET	Int. J. Clin. Phar,.	FEB	2015	37	1					139	147		10.1007/s11096-014-0052-5		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA6IW	WOS:000349016600022		
J	Latief, FH; Sherif, ESM; Kakehi, K				Latief, Fahamsyah H.; Sherif, El-Sayed M.; Kakehi, Koji			Role of Aluminide Coating on Oxidation Resistance of Ni-Based Single Crystal Superalloy at 900 degrees C	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Ni-base superalloy; aluminide coatings; oxidation; microstructure; X-ray diffraction	HIGH-TEMPERATURE OXIDATION; PACK CEMENTATION PROCESS; STRESS RUPTURE BEHAVIOR; DIFFUSION COATINGS; THETA-ALPHA-AL2O3 TRANSFORMATION; ALLOY	In the present study, the role of aluminide coating on oxidation resistance of Ni-based single crystal superalloy was studied at 900 degrees C. The oxidation kinetics curves obey the parabolic law in both conditions. However, the significant difference was found after 100 h oxidation in both conditions. The coated specimens showed a better oxidation resistance than the uncoated ones. This is due to the phase transformation occurred from theta-Al2O3 to alpha-Al2O3 in the coated specimens with increasing oxidation time but not in the uncoated ones. The production of more alpha-Al2O3 during oxidation is expected since alpha-Al2O3 acts as a protective layer against oxidation due to its stability at high temperatures. It could be also recognized from the surface morphology of the oxidized coated specimen after 500 h oxidation.	[Latief, Fahamsyah H.] Al Imam Mohammad Ibn Saud Islamic Univ IMSIU, Dept Mech Engn, Riyadh 11432, Saudi Arabia; [Sherif, El-Sayed M.] King Saud Univ, Coll Engn, Riyadh 11421, Saudi Arabia; [Sherif, El-Sayed M.] Natl Res Ctr NRC, Dept Phys Chem, Electrochem & Corros Lab, Cairo 12622, Egypt; [Kakehi, Koji] Tokyo Metropolitan Univ, Dept Mech Engn, Hachioji, Tokyo 1920397, Japan	Latief, FH (reprint author), Al Imam Mohammad Ibn Saud Islamic Univ IMSIU, Dept Mech Engn, POB 5701, Riyadh 11432, Saudi Arabia.	fhlatief@imamu.edu.sa	Sherif, El-Sayed/A-5890-2008	Sherif, El-Sayed/0000-0003-2080-8552	King Saud University [RGP-160]	The authors would like to gratefully acknowledge to the Light Metal Educational Foundation, Inc. and Dr. Murakami of NIMS (National Institute for Materials Science), Tsukuba, for the aluminide coating preparation. Also, the authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project No. RGP-160.	Angenete J, 2001, MAT SCI ENG A-STRUCT, V316, P182, DOI 10.1016/S0921-5093(01)01236-9; Shirvani K, 2003, CORROS SCI, V45, P1011, DOI 10.1016/S0010-938X(02)00127-0; Xiang ZD, 2001, J MATER SCI, V36, P5673, DOI 10.1023/A:1012534220165; GOWARD GW, 1971, OXID MET, V3, P475, DOI 10.1007/BF00604047; Toma D, 1999, SURF COAT TECH, V120, P8, DOI 10.1016/S0257-8972(99)00332-1; MacLachlan DW, 2001, MAT SCI ENG A-STRUCT, V302, P275, DOI 10.1016/S0921-5093(00)01829-3; Yeh AC, 2005, SCRIPTA MATER, V52, P519, DOI 10.1016/j.scriptamat.2004.10.039; Warnes BM, 1997, SURF COAT TECH, V94-5, P1, DOI 10.1016/S0257-8972(97)00467-2; Choux C, 2008, INTERMETALLICS, V16, P1, DOI 10.1016/j.intermet.2007.07.014; Bae JS, 2001, SCRIPTA MATER, V45, P503, DOI 10.1016/S1359-6462(01)01049-1; JIA CC, 1994, METALL MATER TRANS A, V25, P473, DOI 10.1007/BF02651589; Das DK, 1998, METALL MATER TRANS A, V29, P2173, DOI 10.1007/s11661-998-0042-0; Tian XD, 2009, SURF COAT TECH, V203, P1161, DOI 10.1016/j.surfcoat.2008.10.018; An TF, 2000, OXID MET, V54, P301, DOI 10.1023/A:1004654429687; Li MH, 2003, OXID MET, V60, P195, DOI 10.1023/A:1024629716452; Xiang ZD, 2003, MAT SCI ENG A-STRUCT, V363, P185, DOI 10.1016/S0921-5093(03)00628-2; Huang JF, 2000, OXID MET, V53, P273, DOI 10.1023/A:1004537119922; Jonsta P., 2007, JAMME, V22, P120; Kuppusami P, 2004, SURF COAT TECH, V186, P377, DOI 10.1016/j.surfcoat.2003.12.016; PIERAGGI B, 1987, WERKST KORROS, V38, P584; RYBICKI GC, 1989, OXID MET, V31, P275, DOI 10.1007/BF00846690; Squillace A, 1999, SURF COAT TECH, V120, P118, DOI 10.1016/S0257-8972(99)00347-3; Tolpygo VK, 2007, SURF COAT TECH, V202, P617, DOI 10.1016/j.surfcoat.2007.07.072; Wang B, 2004, CORROS SCI, V46, P519, DOI 10.1016/S0010-938X(03)00184-7; Yuan FH, 2004, SURF COAT TECH, V183, P106, DOI [10.1016/j.surfcoat.2003.09.066, 10.1016/j.surfcoat.003.09.066]; Zhao K, 2005, MATER TRANS, V46, P54, DOI 10.2320/matertrans.46.54	26	1	1	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	FEB	2015	10	2					1873	1882				10	Electrochemistry	Electrochemistry	AZ6YS	WOS:000348365800066		
J	Suzuki, T; Kusumoto, S; Masaki, A; Ishida, T; Inagaki, H; Iida, S; Mori, F				Suzuki, Tomotaka; Kusumoto, Shigeru; Masaki, Ayako; Ishida, Takashi; Inagaki, Hiroshi; Iida, Shinsuke; Mori, Fumiko			CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Editorial Material									[Suzuki, Tomotaka; Mori, Fumiko] Toyokawa City Hosp, Dept Hematol, Yawata, Toyokawa 4428561, Japan; [Kusumoto, Shigeru; Ishida, Takashi; Iida, Shinsuke] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Masaki, Ayako; Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Dept Pathol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Suzuki, T (reprint author), Toyokawa City Hosp, Dept Hematol, 23 Noji, Yawata, Toyokawa 4428561, Japan.	let.me.be.92@gmail.com						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					109	111		10.1007/s12185-014-1714-8		3	Hematology	Hematology	CB3KH	WOS:000349526200002		
J	Mitsuguro, M; Okamoto, A; Shironouchi, Y; Sano, M; Miyata, S; Neki, R; Araki, T; Hamamoto, T; Yoshimatsu, J; Miyata, T				Mitsuguro, Mana; Okamoto, Akira; Shironouchi, Yoshie; Sano, Michitaka; Miyata, Shigeki; Neki, Reiko; Araki, Tatsuya; Hamamoto, Takayoshi; Yoshimatsu, Jun; Miyata, Toshiyuki			Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Anticoagulant monitoring; Anti-Xa activity; APTT; Heparin; Pregnancy	MONITORING UNFRACTIONATED HEPARIN; PARTIAL THROMBOPLASTIN TIME; MOLECULAR-WEIGHT HEPARIN; PREGNANCY; PLASMA; ASSAY	In pregnant women, activated partial thromboplastin time (APTT) does not precisely reflect the anticoagulant effect of a therapeutic dose of heparin. However, the measurement of anti-Xa activity can be used to monitor the anticoagulant effect of heparin, since the plasma concentrations of coagulation factors increase in pregnant women. We evaluated the in vitro effects of increased concentrations of fibrinogen and other coagulation factors (FVII, FVIII, and FIX) on the results of assays of APTT and anti-Xa activity in plasma samples with various therapeutic concentrations of unfractionated heparin (UFH). In the presence of UFH, APTT was shortened by increased concentrations of fibrinogen, FVII, or FVIII, and this effect was much stronger when the FVIII concentration was increased. In the plasma samples containing 0.5 or 0.7 U/mL of UFH, the APTT was shortened by approximately half or one-third, respectively, when 6 U FVIII/mL was added to the sample. The anti-Xa activity was not influenced by increased concentrations of the coagulation factors. In the present study, we also evaluated the sensitivities to UHF of four APTT reagents, and found a 1.65-fold difference in the sensitivity to UFH among APTT reagents. Our results demonstrate that increased FVIII concentration shortens APTT under therapeutic doses of UFH, and that APTT thus underestimates the anticoagulant effect of UFH in pregnant women, mainly due to the increased FVIII concentration.	[Mitsuguro, Mana; Okamoto, Akira; Shironouchi, Yoshie; Sano, Michitaka] Natl Cerebral & Cardiovasc Ctr, Clin Chem Lab, Suita, Osaka 5658565, Japan; [Mitsuguro, Mana; Miyata, Toshiyuki] Osaka Univ, Grad Sch Med, Dept Thrombosis Res, Div Hlth Sci, Suita, Osaka, Japan; [Miyata, Shigeki] Natl Cerebral & Cardiovasc Ctr, Div Transfus Med, Suita, Osaka 5658565, Japan; [Neki, Reiko; Yoshimatsu, Jun] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, Suita, Osaka 5658565, Japan; [Araki, Tatsuya; Hamamoto, Takayoshi] Chemoserotherapeut Res Inst Kumamoto, Blood Plasma Div, Dept Dev, Kumamoto, Japan; [Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka 5658565, Japan	Miyata, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	miyata@ri.ncvc.go.jp			Ministry of Health, Labor, and Welfare of Japan; Japan Society for the Promotion of Science; Uehara Memorial Foundation; Takeda Science Foundation	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan, the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, and the Takeda Science Foundation.	LEVINE MN, 1994, ARCH INTERN MED, V154, P49, DOI 10.1001/archinte.154.1.49; [Anonymous], 2012, CHEST; Vandiver JW, 2012, PHARMACOTHERAPY, V32, P546, DOI 10.1002/j.1875-9114.2011.01049.x; Chunilal SD, 2002, THROMB HAEMOSTASIS, V87, P92; Szecsi PB, 2010, THROMB HAEMOSTASIS, V103, P718, DOI 10.1160/TH09-10-0704; Kitchens CS, 2005, J THROMB HAEMOST, V3, P2607, DOI 10.1111/j.1538-7836.2005.01552.x; Eikelboom JW, 2006, THROMB HAEMOSTASIS, V96, P547, DOI 10.1160/TH06-05-0290; BASU D, 1972, NEW ENGL J MED, V287, P324, DOI 10.1056/NEJM197208172870703; BRANCAZIO LR, 1995, AM J OBSTET GYNECOL, V173, P1240, DOI 10.1016/0002-9378(95)91362-9; CHIU HM, 1977, BLOOD, V49, P171; Gouin-Thibaut I, 2012, THROMB RES, V129, P666, DOI 10.1016/j.thromres.2011.11.016; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; MORABIA A, 1986, LANCET, V1, P1278; Raschke R, 2003, ANN INTERN MED, V138, P720; STIRLING Y, 1984, THROMB HAEMOSTASIS, V52, P176; TEIEN AN, 1976, THROMB RES, V8, P413, DOI 10.1016/0049-3848(76)90034-7; Wool GD, 2013, AM J CLIN PATHOL, V140, P623, DOI 10.1309/AJCPR3JTOK7NKDBJ	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					119	125		10.1007/s12185-014-1702-z		7	Hematology	Hematology	CB3KH	WOS:000349526200005		
J	Matsumoto, T; Nogami, K; Okuda, M; Shima, M				Matsumoto, Tomoko; Nogami, Keiji; Okuda, Masahiro; Shima, Midori			Optimization of the automated, CS-2000i (TM) method for measuring low levels of von Willebrand factor ristocetin cofactor activity (VWF:RCo)	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						VWD; VWF:RCo; Automated CS-2000i (TM); Glass-plate method; DDAVP	VWD TYPE-1; DISEASE; DIAGNOSIS; ASSAY	Measurements of von Willebrand factor ristocetin cofactor activity (VWF:RCo) are necessary for the diagnosis of von Willebrand disease (VWD). However, the conventional manual glass-plate method is technically demanding, and exhibits high intra-/inter-laboratory variation. An automated technique has been recently described utilizing the CS-2000i (TM) with specific VWF:RCo reagents, but measurements at lower levels (< 10 IU/dL) lack reliability. We have optimized this automated system for measuring low levels of VWF:RCo. Using a sample volume (72 mu L) and initial stirring speed (400 rpm), the lowest level of VWF:RCo detected with a CV < 20 % was 2.5 IU/dL. Greater variability was evident at this stirring speed with smaller sample volumes. Decreasing the stirring speed (200 rpm) with a sample volume (72 mu L), however, significantly improved the CV, and enabled measurements at the lowest levels (a parts per thousand currency sign2.5 IU/dL). The optimized assay demonstrated a high correlation (R (2) = 0.841) with the glass-plate method at < 10 IU/dL VWF:RCo, suggesting that the different VWF:RCo reagents did not affect the results. In addition, changes in VWF:RCo post-DDAVP infusions were parallel in both assays, indicating that the automated method is suitable for the clinical monitoring of treatment in VWD. The optimized automated measurement of VWF:RCo offers a promising method for evaluating VWF at low levels of hemostatic activity.	[Matsumoto, Tomoko; Nogami, Keiji; Shima, Midori] Nara Med Univ, Dept Pediat, Kashihara, Nara 6348522, Japan; [Okuda, Masahiro] Sysmex Corp, Prod Div, Kobe, Hyogo, Japan	Nogami, K (reprint author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp			MEXT KAKENHI in Japan [24591558, 25461605]	Okuda M is a chief scientist of Sysmex Corp. The other authors declare that they have no conflict to declare. This work was partly supported by grants for MEXT KAKENHI 24591558 (KN) and 25461605 (TM) in Japan.	Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Redaelli R, 2005, J THROMB HAEMOST, V3, P2684, DOI 10.1111/j.1538-7836.2005.01628.x; Sadler JE, 2005, J THROMB HAEMOST, V3, P775, DOI 10.1111/j.1538-7836.2005.01245.x; Eikenboom J, 2013, BLOOD, V121, P2336, DOI 10.1182/blood-2012-09-455089; Goodeve A, 2007, BLOOD, V109, P112, DOI 10.1182/blood-2006-05-020784; Bolton-Maggs PHB, 2012, HAEMOPHILIA, V18, P66, DOI 10.1111/j.1365-2516.2012.02830.x; Cabrera N, 2013, HAEMOPHILIA, V19, P920, DOI 10.1111/hae.12203; Hubbard AR, 2002, THROMB HAEMOSTASIS, V88, P380; Kunicki TJ, 2004, BLOOD, V104, P2359, DOI 10.1182/blood-2004-01-0349; Laffan M, 2004, HAEMOPHILIA, V10, P100; Lawrie AS, 2011, HAEMOPHILIA, V17, P252, DOI 10.1111/j.1365-2516.2010.02419.x; Lawrie AS, 2013, HAEMOPHILIA, V19, P338, DOI 10.1111/hae.12064; Raut S, 2010, STANDARDIZATION ASSA, P260; RUGGERI ZM, 1980, NEW ENGL J MED, V302, P1047, DOI 10.1056/NEJM198005083021902; Schneppenheim R, 1998, CLIN LAB DIAGNOSTICS, P614; Shibata M, 1999, THROMB HAEMOSTASIS, V81, P793	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					126	132		10.1007/s12185-014-1720-x		7	Hematology	Hematology	CB3KH	WOS:000349526200006		
J	Kikukawa, Y; Yuki, H; Hirata, S; Ide, K; Nakata, H; Miyakawa, T; Matsuno, N; Nosaka, K; Yonemura, Y; Kawaguchi, T; Hata, H; Mitsuya, H; Okuno, Y				Kikukawa, Yoshitaka; Yuki, Hiromichi; Hirata, Sinya; Ide, Kazuhiko; Nakata, Hirotomo; Miyakawa, Toshikazu; Matsuno, Naofumi; Nosaka, Kisato; Yonemura, Yuji; Kawaguchi, Tatsuya; Hata, Hiroyuki; Mitsuya, Hiroaki; Okuno, Yutaka			Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						AL amyloidosis; CyBorD; Bortezomib; Hematologic response; Organ response	PRIMARY SYSTEMIC AMYLOIDOSIS; REFRACTORY MULTIPLE-MYELOMA; STEM-CELL TRANSPLANTATION; LOW-DOSE DEXAMETHASONE; AL AMYLOIDOSIS; PHASE 1/2; MELPHALAN; LENALIDOMIDE; COMBINATION; SURVIVAL	Amyloid light-chain amyloidosis (ALA) is a rare disease with poor prognosis and is often associated with monoclonal gammopathy of undetermined significance, multiple myeloma, or Waldenstrom macroglobulinemia. Only high-dose melphalan with auto-peripheral blood stem cell transplantation (PBSCT) has shown high long-term hematological response rates, but combinations with novel agents, including bortezomib or lenalidomide, have recently shown high hematological response rates for AL amyloidosis patients. In the present study, we treated eight Japanese patients with AL amyloidosis using bortezomib, cyclophosphamide, and dexamethasone (CyBorD). Overall response rate was 100 %; four patients (50 %) had complete remissions (CR), two (25 %) had very good partial responses, and two (25 %) had partial responses. Five of six patients (83 %) had organ responses in the heart and/or kidney. A relapsed patient repeatedly achieved CR with the CyBorD treatment. One patient died of sudden cardiac arrest a month after normalization of his serum free light chain level, which may be attributable to his spending the previous 6 months undergoing PBSCT collection and high-dose melphalan with auto-PBSCT. Altogether, the CyBorD regimen achieved high levels of hematological responses relatively quickly (within 2-3 months). The CyBorD regimen, rather than high-dose melphalan treatment, could serve as a first-line therapy for Japanese patients with ALA.	[Kikukawa, Yoshitaka; Yuki, Hiromichi; Hirata, Sinya; Ide, Kazuhiko; Nakata, Hirotomo; Miyakawa, Toshikazu; Matsuno, Naofumi; Nosaka, Kisato; Yonemura, Yuji; Kawaguchi, Tatsuya; Hata, Hiroyuki; Mitsuya, Hiroaki; Okuno, Yutaka] Kumamoto Univ Med, Dept Hematol, Rheumatol & Infect Dis, Kumamoto 8608556, Japan	Okuno, Y (reprint author), Kumamoto Univ Med, Dept Hematol, Rheumatol & Infect Dis, 1-1-1 Honjo, Kumamoto 8608556, Japan.	yokuno@gpo.kumamoto-u.ac.jp					Mikhael JR, 2012, BLOOD, V119, P4391, DOI 10.1182/blood-2011-11-390930; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Lane C, 2006, NEPHROLOGY, V11, P245, DOI 10.1111/j.1440-1797.2006.00564.x; Madan S, 2012, BLOOD, V119, P1117, DOI 10.1182/blood-2011-07-370031; Dispenzieri A, 2003, LANCET, V361, P1787, DOI 10.1016/S0140-6736(03)13396-X; Gertz MA, 2010, LEUKEMIA LYMPHOMA, V51, P2181, DOI 10.3109/10428194.2010.524329; Kastritis E, 2010, J CLIN ONCOL, V28, P1031, DOI 10.1200/JCO.2009.23.8220; KYLE RA, 1992, BLOOD, V79, P1817; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Hideshima T, 2013, INT J HEMATOL, V97, P324, DOI 10.1007/s12185-013-1290-3; Watanabe R, 2013, INT J HEMATOL, V97, P333, DOI 10.1007/s12185-013-1294-z; Venner CP, 2012, BLOOD, V119, P4387, DOI 10.1182/blood-2011-10-388462; Jakubowiak AJ, 2012, J CLIN ONCOL, V30, P1960, DOI 10.1200/JCO.2011.37.7069; Shah G, 2013, CLIN THER, V35, P1614, DOI 10.1016/j.clinthera.2013.08.015; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Kourelis TV, 2013, J CLIN ONCOL, V31, P4319, DOI 10.1200/JCO.2013.50.8499; Berenson JR, 2014, ANN HEMATOL, V93, P89, DOI 10.1007/s00277-013-1910-2; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Palladini G, 2013, HAEMATOLOGICA, V98, P433, DOI 10.3324/haematol.2012.073593; Richardson PG, 2014, BLOOD, V123, P1826, DOI 10.1182/blood-2013-11-538835; Price CP, 2005, CLIN CHEM, V51, P1577, DOI 10.1373/clinchem.2005.049742; Jain Salvia, 2011, Core Evid, V6, P43, DOI 10.2147/CE.S13838; Kapoor P, 2011, AM J MED, V124, P1006, DOI 10.1016/j.amjmed.2011.04.013; Kastritis E, 2012, BLOOD, V119, P5384, DOI 10.1182/blood-2011-12-396903; Kumar SK, 2012, BLOOD, V119, P4860, DOI 10.1182/blood-2012-01-407791; Paiva B, 2011, BLOOD, V117, P3613, DOI 10.1182/blood-2010-12-324665; Palladini G, 2014, HAEMATOLOGICA, V99, P743, DOI 10.3324/haematol.2013.095463; Sanchorawala V, 2007, BLOOD, V110, P3561, DOI 10.1182/blood-2007-07-099481	28	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					133	139		10.1007/s12185-014-1705-9		7	Hematology	Hematology	CB3KH	WOS:000349526200007		
J	Shirane, S; Araki, M; Morishita, S; Edahiro, Y; Sunami, Y; Hironaka, Y; Noguchi, M; Koike, M; Sato, E; Ohsaka, A; Komatsu, N				Shirane, Shuichi; Araki, Marito; Morishita, Soji; Edahiro, Yoko; Sunami, Yoshitaka; Hironaka, Yumi; Noguchi, Masaaki; Koike, Michiaki; Sato, Eriko; Ohsaka, Akimichi; Komatsu, Norio			Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Polycythemia vera (PV); Essential thrombocythemia (ET); Secondary myelofibrosis; Myeloproliferative neoplasms (MPN); JAK2V617F; Allele burden	TYROSINE KINASE JAK2; MYELOPROLIFERATIVE NEOPLASMS; PERIPHERAL-BLOOD; RISK-FACTORS; BONE-MARROW; MUTATION; V617F; HYDROXYUREA; DISORDERS; DIAGNOSIS	Patients diagnosed with polycythemia vera (PV) or essential thrombocythemia (ET) sometimes suffer transformation of the disease into myelofibrosis (MF), which is associated with a poorer prognosis. This study investigated the prognostic value of the allele burden of JAK2V617F, a somatic driver mutation in these diseases, by comparing the allele burden between formalin-fixed paraffin-embedded bone marrow collected at initial diagnosis and peripheral blood from follow-up visits. Although the annual changes in the JAK2V617F allele burden were comparable between MF-transformed (n = 11) and untransformed (n = 23) patients, the burden was significantly increased in MF-transformed patients exhibiting a longer disease duration than untransformed patients. Furthermore, MF transformation was only observed in patients whose JAK2V617F allele burden exceeded the mean values for each disease (PV, 71.7 %; ET, 35.5 %) at initial diagnosis or during follow-up. Finally, we showed that hydroxycarbamide treatment exerted neither a preventive effect on MF transformation nor a suppressive effect on the increased JAK2V617F allele burden. In conclusion, a high JAK2V617F allele burden at initial diagnosis or during follow-up is predictive of MF transformation in PV and ET. Therefore, routine measurement of the JAK2V617F allele burden using an accurate assay system is recommended to predict MF transformation.	[Shirane, Shuichi; Edahiro, Yoko; Sunami, Yoshitaka; Hironaka, Yumi; Komatsu, Norio] Juntendo Univ, Grad Sch Med, Dept Hematol, Bunkyo Ku, Tokyo 1138421, Japan; [Araki, Marito; Morishita, Soji; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo 1138421, Japan; [Noguchi, Masaaki] Juntendo Univ, Urayasu Hosp, Chiba, Japan; [Koike, Michiaki] Juntendo Univ, Shizuoka Hosp, Shizuoka, Japan; [Sato, Eriko] Juntendo Univ, Nerima Hosp, Tokyo 1138421, Japan	Komatsu, N (reprint author), Juntendo Univ, Grad Sch Med, Dept Hematol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	komatsun@juntendo.ac.jp			JSPS KAKENHI [25860416]; Ministry of Education, Culture, Sports, Science and Technology	We thank Kensuke Usuki (NTT Kanto Medical Center), Masafumi Ito (Japanese Red Cross Nagoya Daiichi Hospital), Makoto Kashimura (Matsudo Municipal Hospital), Shiro Tsuchiya (Soka Municipal Hospital) and Takao Hirano (Juntendo Nerima Hospital) for providing patient specimens and clinical information, Joe Matsuoka (Clinical Research Support Center, Graduate School of Medicine) for performing statistical analysis, and Satoshi Tsuneda (Department of Life Science and Medical Bioscience, Waseda University) for fruitful discussions. We also thank Kyoko Kubo, Kazuko Kawamura, Junko Enomoto, and Megumi Hasegawa for providing secretarial assistance and other members of the Department of Hematology for providing support in this study. We also acknowledge the Laboratory of Morphology and Image Analysis, Biomedical Research Center, Juntendo University Graduate School of Medicine, for technical assistance. This work was funded in part by JSPS (http://www.jsps.go.jp/english/e-grants/)KAKENHI grant #25860416 (SM) and Ministry of Education, Culture, Sports, Science and Technology, the Project for Development of Innovative Research on Cancer Therapeutics (NK, MA, SM, YE, YS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Larran A, 2007, LEUKEMIA, V21, P1218, DOI 10.1038/sj.leu.2404693; Alvarez-Larran A, 2014, AM J HEMATOL, V89, P517, DOI 10.1002/ajh.23676; Tam CS, 2009, J CLIN ONCOL, V27, P5587, DOI 10.1200/JCO.2009.22.8833; Antonioli E, 2010, HAEMATOL-HEMATOL J, V95, P1435, DOI 10.3324/haematol.2009.021444; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Alvarez-Larran A, 2009, BRIT J HAEMATOL, V146, P504, DOI 10.1111/j.1365-2141.2009.07804.x; Barosi G, 2008, LEUKEMIA, V22, P437, DOI 10.1038/sj.leu.2404914; Tefferi A, 2006, CANCER, V106, P631, DOI 10.1002/cncr.21645; Mesa RA, 2011, LEUKEMIA RES, V35, P12, DOI 10.1016/j.leukres.2010.07.019; Passamonti F, 2008, HAEMATOL-HEMATOL J, V93, P1645, DOI 10.3324/haematol.13346; Vannucchi AM, 2007, BLOOD, V110, P840, DOI 10.1182/blood-2006-12-064287; Passamonti F, 2010, LEUKEMIA, V24, P1574, DOI 10.1038/leu.2010.148; Silver RT, 2011, LEUKEMIA RES, V35, P177, DOI 10.1016/j.leukres.2010.06.017; Koren-Michowitz M, 2012, LEUKEMIA LYMPHOMA, V53, P2210, DOI 10.3109/10428194.2012.682308; Hussein K, 2009, EXP HEMATOL, V37, P1186, DOI 10.1016/j.exphem.2009.07.005; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Passamonti F, 2008, BLOOD, V111, P3383, DOI 10.1182/blood-2007-11-121434; Lange T, 2013, HAEMATOLOGICA, V98, P722, DOI 10.3324/haematol.2012.076901; Marchioli R, 2005, J CLIN ONCOL, V23, P2224, DOI 10.1200/JCO.2005.07.062; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Besses C, 2011, BRIT J HAEMATOL, V152, P413, DOI 10.1111/j.1365-2141.2010.08467.x; Edahiro Y, 2014, INT J HEMATOL, V99, P625, DOI 10.1007/s12185-014-1567-1; Girodon F, 2008, HAEMATOL-HEMATOL J, V93, P1723, DOI 10.3324/haematol.13081; Larsen TS, 2008, LEUKEMIA, V22, P194, DOI 10.1038/sj.leu.2404861; Larsen TS, 2009, HEMATOLOGY, V14, P11, DOI 10.1179/102453309X385188; Morishita S, 2011, LEUKEMIA RES, V35, P1632, DOI 10.1016/j.leukres.2011.06.016; Rapado I, 2008, ANN HEMATOL, V87, P741, DOI 10.1007/s00277-008-0512-x; Ricksten Anne, 2008, Haematologica, V93, P1260, DOI 10.3324/haematol.12801; Takahashi K, 2013, BLOOD, V122, P3784, DOI 10.1182/blood-2013-07-515676; Theocharides A, 2008, HAEMATOL-HEMATOL J, V93, P1890, DOI 10.3324/haematol.13074; Zalcberg Ilana Renault, 2011, Haematologica, V96, pe18, DOI 10.3324/haematol.2010.037846	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					148	153		10.1007/s12185-014-1721-9		6	Hematology	Hematology	CB3KH	WOS:000349526200009		
J	Nakaseko, C; Takahashi, N; Ishizawa, K; Kobayashi, Y; Ohashi, K; Nakagawa, Y; Yamamoto, K; Miyamura, K; Taniwaki, M; Okada, M; Kawaguchi, T; Shibata, A; Fujii, Y; Ono, C; Ohnishi, K				Nakaseko, Chiaki; Takahashi, Naoto; Ishizawa, Kenichi; Kobayashi, Yukio; Ohashi, Kazuteru; Nakagawa, Yasunori; Yamamoto, Kazuhito; Miyamura, Koichi; Taniwaki, Masafumi; Okada, Masaya; Kawaguchi, Tatsuya; Shibata, Atsushi; Fujii, Yosuke; Ono, Chiho; Ohnishi, Kazunori			A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Phase 1/2; Bosutinib; Tyrosine kinase inhibitor; Chronic myeloid leukemia; Japan	TYROSINE KINASE INHIBITOR; IMATINIB-RESISTANT; IN-VITRO; DASATINIB; NILOTINIB; CELLS; INTOLERANCE; BMS-354825; EFFICACY; THERAPY	This phase 1/2 study evaluated the safety and pharmacokinetics (part 1) and efficacy and safety (part 2) of bosutinib in Japanese Philadelphia chromosome-positive (Ph+) chronic-phase (CP) or advanced-phase chronic myeloid leukemia (CML) patients resistant/intolerant to previous imatinib (2L) or imatinib+dasatinib/nilotinib (3L). Based on dose-limiting toxicities and previous studies, the part 2 bosutinib starting dose was 500 mg/day (n = 63). For CP CML 2L (n = 28), the cumulative major cytogenetic response (MCyR) rate by week 24 was 36 % (primary endpoint); the cumulative major molecular response (MMR) rate through the study was 43 %. Transformation to accelerated/blast phase (AP/BP) was observed in one patient. Progression-free survival (PFS) and overall survival (OS) rates at 96 weeks were 94 and 96 %, respectively. Of seven advanced-phase 2L patients, one had confirmed complete hematologic response at week 84, and one had AP/BP transformation. PFS and OS rates at week 96 were 21 and 43 %. For 3L (n = 11), cumulative MCyR rate by week 24 was 18 %; cumulative MMR rate was 18 %; no transformations occurred. Common non-hematologic adverse events (AEs) were diarrhea (95 %), rash (57 %), and nasopharyngitis (51 %). Sixteen patients discontinued due to adverse events; no deaths occurred within 30 days of the last dose. Bosutinib 500 mg/day demonstrated efficacy and manageable toxicity in Japanese Ph+ CML patients resistant/intolerant to imatinib.	[Nakaseko, Chiaki] Chiba Univ Hosp, Dept Hematol, Chuo Ku, Chiba 2608677, Japan; [Takahashi, Naoto] Akita Univ, Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan; [Ishizawa, Kenichi] Tohoku Univ Hosp, Dept Rheumatol & Hematol, Sendai, Miyagi, Japan; [Kobayashi, Yukio] Natl Canc Ctr, Dept Hematol & Oncol, Tokyo, Japan; [Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Hematol, Tokyo, Japan; [Nakagawa, Yasunori] Japanese Red Cross Med Ctr, Dept Chemotherapy, Tokyo, Japan; [Yamamoto, Kazuhito] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Div Hematol, Nagoya, Aichi, Japan; [Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Dept Hematol & Oncol, Univ Hosp, Kyoto, Japan; [Okada, Masaya] Hosp Hyogo Coll Med, Div Hematol, Nishinomiya, Hyogo, Japan; [Kawaguchi, Tatsuya] Kumamoto Univ Hosp, Dept Hematol & Infect Dis, Kumamoto, Japan; [Shibata, Atsushi] Pfizer Japan, Oncol Clin Res, Tokyo, Japan; [Fujii, Yosuke] Pfizer Japan, Clin Stat, Tokyo, Japan; [Ono, Chiho] Pfizer Japan, Clin Pharmacol, Tokyo, Japan; [Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Oncol, Shizuoka, Japan	Nakaseko, C (reprint author), Chiba Univ Hosp, Dept Hematol, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	chiaki-nakaseko@faculty.chiba-u.jp			Pfizer Inc.; Wyeth Research	Editorial and medical writing support was provided by Simon J. Slater, PhD, of Complete Healthcare Communications, Inc., and was funded by Pfizer Inc. This study was sponsored by Wyeth Research, which was acquired by Pfizer Inc in October 2009.	[Anonymous], 2014, TAS NIL; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Usuki K, 2012, INT J HEMATOL, V95, P409, DOI 10.1007/s12185-012-1026-9; Cortes JE, 2011, BLOOD, V118, P4567, DOI 10.1182/blood-2011-05-355594; Tojo A, 2009, INT J HEMATOL, V89, P679, DOI 10.1007/s12185-009-0327-0; Daud AI, 2012, CLIN CANCER RES, V18, P1092, DOI 10.1158/1078-0432.CCR-11-2378; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Cortes JE, 2012, J CLIN ONCOL, V30, P3486, DOI 10.1200/JCO.2011.38.7522; Kantarjian H, 2007, BLOOD, V109, P5143, DOI 10.1182/blood-2006-11-056028; [Anonymous], 2013, BOSULIF BOS; Sakamaki H, 2009, INT J HEMATOL, V89, P332, DOI 10.1007/s12185-009-0260-2; Gleixner KV, 2006, BLOOD, V107, P752, DOI 10.1182/blood-2005-07-3022; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; [Anonymous], 2014, SPRYCEL DAS; Cervantes F, 2003, HAEMATOLOGICA, V88, P1117; Chen ZM, 2006, MOL PHARMACOL, V69, P1527, DOI 10.1124/mol.105020172; Gambacorti-Passerini C, 2010, J CLIN ONCOL, V28; Irvine E, 2013, PHARMACOTHERAPY, V33, P868, DOI 10.1002/phar.1266; Nakamae H, 2011, INT J HEMATOL, V93, P624, DOI 10.1007/s12185-011-0841-8	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					154	164		10.1007/s12185-014-1722-8		11	Hematology	Hematology	CB3KH	WOS:000349526200010		
J	Yabe, M; Ohtsuka, Y; Watanabe, K; Inagaki, J; Yoshida, N; Sakashita, K; Kakuda, H; Yabe, H; Kurosawa, H; Kudo, K; Manabe, A				Yabe, Miharu; Ohtsuka, Yoshitoshi; Watanabe, Kenichiro; Inagaki, Jiro; Yoshida, Nao; Sakashita, Kazuo; Kakuda, Harumi; Yabe, Hiromasa; Kurosawa, Hidemitsu; Kudo, Kazuko; Manabe, Atsushi		Japanese Pediat Myelodysplastic	Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Juvenile myelomonocytic leukemia; Hematopoietic stem cell transplantation; Fludarabine; Alternative donors; PTPN11	STEM-CELL TRANSPLANTATION; CLASSIFICATION; MUTATIONS; HSCT; JMML	We report the outcomes of 30 patients with juvenile myelomonocytic leukemia (JMML) who received unmanipulated hematopoietic stem cell transplantation (HSCT) with oral or intravenous busulfan, fludarabine, and melphalan between 2001 and 2011. Mutations in PTPN11 were detected in 15 patients. Six patients received human leukocyte antigen (HLA)-matched HSCT from related donors, and 24 patients received HSCT from alternative donors, including 13 HLA-mismatched donors. Primary engraftment failed in five patients, all of whom had received allografts from HLA-mismatched donors. HLA-mismatched HSCT resulted in poorer event-free survival than HLA-matched HSCT (28.8 vs. 70.6 %). Three patients died of transplantation-related causes, and eight patients experienced hematological relapse (including five patients who died due to disease progression). Eight patients received a second HSCT, and four of these patients have survived. The 5-year estimated overall survival for all patients was 72.4: 88.9 % for the patients without a mutation in PTPN11 (n = 10) and 58.3 % for the patients with a mutation in PTPN11 (n = 15) (P = 0.092). The conditioning regimen reported in the present study achieved hematological and clinical remission in > 50 % of patients with JMML who received HSCT from alternative donors, and may also be effective for JMML patients with PTPN11 mutation.	[Yabe, Miharu; Yabe, Hiromasa] Tokai Univ Hosp, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 2591193, Japan; [Ohtsuka, Yoshitoshi] Hyogo Coll Med, Dept Pediat, Nishinomiya, Hyogo 6638501, Japan; [Watanabe, Kenichiro] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; [Inagaki, Jiro] Kyushu Natl Canc Ctr, Dept Pediat, Fukuoka, Japan; [Yoshida, Nao] Japanese Red Cross Nagoya First Hosp, Dept Hematol & Oncol, Childrens Med Ctr, Nagoya, Aichi, Japan; [Sakashita, Kazuo] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Kakuda, Harumi] Chiba Childrens Hosp, Dept Hematol & Oncol, Chiba, Japan; [Kurosawa, Hidemitsu] Dokkyo Med Univ, Dept Pediat, Sch Med, Mibu, Tochigi, Japan; [Kudo, Kazuko] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan; [Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan	Yabe, M (reprint author), Tokai Univ Hosp, Dept Cell Transplantat & Regenerat Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	miharu@is.icc.u-tokai.ac.jp					Yoshimi A, 2007, LEUKEMIA, V21, P556, DOI 10.1038/sj.leu.2404537; Locatelli F, 2013, BLOOD, V122, P2135, DOI 10.1182/blood-2013-03-491589; Niemeyer CM, 2008, BRIT J HAEMATOL, V140, P610, DOI 10.1111/j.1365-2141.2007.06958.x; Yoshida N, 2009, PEDIATR RES, V65, P334, DOI 10.1203/PDR.0b013e3181961d2a; Yoshimi A, 2005, LEUKEMIA, V19, P971, DOI 10.1038/sj.leu.2403721; Wall DA, 2010, PEDIATR BLOOD CANCER, V54, P291, DOI 10.1002/pbc.22227; Horibe K, 2013, INT J HEMATOL, V98, P74, DOI 10.1007/s12185-013-1364-2; Hasle H, 2003, LEUKEMIA, V17, P277, DOI 10.1038/sj.leu.240765; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; Niemeyer CM, 1997, BLOOD, V89, P3534; Locatelli F, 2005, BLOOD, V105, P410, DOI 10.1182/blood-2004-05-1944; Inagaki J, 2012, PEDIAT BLOOD CANC, V60, P116; Manabe A, 2002, LEUKEMIA, V16, P645, DOI 10.1038/sj/leu/2402407; Matsuda K, 2012, BRIT J HAEMATOL, V157, P647, DOI 10.1111/j.1365-2141.2012.09063.x; Yabe M, 2008, PEDIATR TRANSPLANT, V12, P862, DOI 10.1111/j.1399-3046.2008.00931.x; Yoshimi A, 2005, BRIT J HAEMATOL, V129, P542, DOI 10.1111/j.1365-2141.2005.05489.x	16	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					184	190		10.1007/s12185-014-1715-7		7	Hematology	Hematology	CB3KH	WOS:000349526200013		
J	Imashuku, S; Fujita, N; Shioda, Y; Noma, H; Seto, S; Minato, T; Sakashita, K; Ito, N; Kobayashi, R; Morimoto, A				Imashuku, Shinsaku; Fujita, Naoto; Shioda, Yoko; Noma, Haruyoshi; Seto, Shiro; Minato, Toshinori; Sakashita, Kazuo; Ito, Nobuhiro; Kobayashi, Ryoji; Morimoto, Akira		Japan LCH Study Grp JLSG	Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Langerhans cell histiocytosis; Neurodegenerative disease; Central nervous system; Intravenous immunoglobulin; EDSS score	CENTRAL-NERVOUS-SYSTEM; INTRAVENOUS IMMUNOGLOBULIN; HYDROCEPHALUS; CHILDREN; PATTERN; SCALE	The follow-up of eight Japanese children with Langerhans cell histiocytosis (LCH)-related neurodegenerative central nervous system (ND-CNS) disease who were treated with intravenous immunoglobulin (IVIG) for > 3 years is described. The patients developed ND-CNS disease at a median age of 5.2 (range 3.5-10.0) years and received IVIG treatment for a median duration of 6.5 + (range 3.7 to 10+) years. After a median follow-up period of 11.6 + (8.3+ to 13.9+) years after ND-CNS disease diagnosis, the median Expanded Disability Status Scale (EDSS) score of the eight patients was 4.0 (range 2.0-9.5). At the last follow-up as of March 2014, three patients have low EDSS scores (< 3.0) and can walk without any assistance. Another three patients have EDSS scores of 3.5-4.5 and can walk by themselves, albeit occasionally with supports. However, the remaining two patients are wheelchair bound or bed ridden. The school performance of seven of the eight patients was below average. IVIG appeared to be most beneficial when it was administered soon after ND-CNS disease diagnosis when the EDSS scores were low (1.0-2.5). The patients who began receiving IVIG when their high EDSS scores were higher (4.5-7.0) appeared to obtain less benefit. To prevent progression of ND-CNS disease in patients with LCH, it is recommended to introduce IVIG early and to continue this therapy for > 3 years.	[Imashuku, Shinsaku] Uji Tokushukai Med Ctr, Dept Lab Med, Uji, Kyoto, Japan; [Fujita, Naoto] Hiroshima Red Cross Hosp, Dept Pediat, Hiroshima, Japan; [Fujita, Naoto] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Shioda, Yoko] Natl Ctr Child Hlth & Dev, Div Pediat Oncol Hematol, Tokyo, Japan; [Noma, Haruyoshi] Osaka Gen Med Ctr, Div Pediat, Osaka, Japan; [Seto, Shiro] Shizuoka Childrens Hosp, Shizuoka, Japan; [Minato, Toshinori] Toyooka Publ Hosp, Div Pediat, Toyooka, Japan; [Sakashita, Kazuo] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Ito, Nobuhiro] Sasebo City Cent Hosp, Div Pediat, Sasebo, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Div Pediat, Sapporo, Hokkaido, Japan; [Morimoto, Akira] Jichi Med Univ, Dept Pediat, Shimotsuke, Japan	Imashuku, S (reprint author), Uji Tokushukai Med Ctr, Dept Lab Med, Uji, Kyoto, Japan.	shinim95@mbox.kyoto-inet.or.jp; nfujita@hiroshima-med.jrc.or.jp; shioda-y@ncchd.go.jp; haruyoshi@gh.opho.jp; shiro-seto@i.shizuoka-pho.jp; to-minato@ares.eonet.ne.jp; sakasita@shinshu-u.ac.jp; n-ito@hospital.sasebo.nagasaki.jp; akira@jichi.ac.jp					Grois NG, 1998, HEMATOL ONCOL CLIN N, V12, P287, DOI 10.1016/S0889-8588(05)70511-6; Fahrner B, 2012, PEDIATR BLOOD CANCER, V58, P606, DOI 10.1002/pbc.24042; KURTZKE JF, 1983, NEUROLOGY, V33, P1444; Grois N, 2005, HISTIOCYTIC DISORDERS OF CHILDREN AND ADULTS, P208; Allen CE, 2010, PEDIATR BLOOD CANCER, V54, P416, DOI 10.1002/pbc.22326; Greenlee JE, 2013, CURR TREAT OPTION NE, V15, P185, DOI 10.1007/s11940-012-0215-4; Gavhed D, 2011, ACTA PAEDIATR, V100, pe36, DOI 10.1111/j.1651-2227.2010.02125.x; Wnorowski M, 2008, J PEDIATR-US, V153, P127, DOI 10.1016/j.jpeds.2007.12.042; GROIS N, 1993, AM J PEDIAT HEMATOL, V15, P245; Prosch H, 2007, AM J NEURORADIOL, V28, P1022, DOI 10.3174/ajnr.A0509; Grois N, 2005, BRAIN, V128, P829, DOI 10.1093/brain/awh403; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Badalian-Very G, 2013, ANNU REV PATHOL-MECH, V8, P1, DOI 10.1146/annurev-pathol-020712-163959; Imashuku S, 2009, CNS NEUROL DISORD-DR, V8, P380; Idbaih A, 2004, PEDIATR BLOOD CANCER, V43, P55, DOI 10.1002/pbc.20040; Barthez MA, 2000, J CHILD NEUROL, V15, P150, DOI 10.1177/088307380001500302; Winkelmann A, 2012, CURR PHARM DESIGN, V18, P4570; Imashuku S, 2008, PEDIATR BLOOD CANCER, V50, P308, DOI 10.1002/pbc.21259; Imashuku S, 2008, HAEMATOL-HEMATOL J, V93, P615, DOI 10.3324/haematol.11827; Kershenovich A, 2008, J NEUROS-PEDIATR, V2, P304, DOI 10.3171/PED.2008.2.11.304; Laurencikas E, 2011, PEDIATR BLOOD CANCER, V56, P250, DOI 10.1002/pbc.22791; Martin-Duverneuil N, 2006, EUR RADIOL, V16, P2074, DOI 10.1007/s00330-006-0200-y; Morimoto Y, 2014, INT J HEMATOL, V99, P597, DOI 10.1007/s12185-014-1551-9; POE LB, 1994, AM J NEURORADIOL, V15, P1921	24	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					191	197		10.1007/s12185-014-1717-5		7	Hematology	Hematology	CB3KH	WOS:000349526200014		
J	Hoshino, A; Nomura, K; Hamashima, T; Isobe, T; Seki, M; Hiwatari, M; Yoshida, K; Shiraishi, Y; Chiba, K; Tanaka, H; Miyano, S; Ogawa, S; Takita, J; Kanegane, H				Hoshino, Akihiro; Nomura, Keiko; Hamashima, Takeru; Isobe, Tomoya; Seki, Masafumi; Hiwatari, Mitsuteru; Yoshida, Kenichi; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru; Ogawa, Seishi; Takita, Junko; Kanegane, Hirokazu			Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						ALK; Anaplastic large cell lymphoma; Aggressive transformation; RNA sequencing; TPM3-ALK	LEUKEMIC PHASE; FEATURES; CANCER; KINASE; IMPACT	Pediatric anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) usually has a benign clinical course. A small fraction of patients with ALCL develops an aggressive clinical course; however, its etiology remains unclear. Here we report on an ALK-positive ALCL patient, who had complex translocations with TPM3-ALK revealed by RNA sequencing, with a very aggressive clinical course. On admission, the patient had extraordinarily high white blood cell count with double ALK-translocated chromosomes, and subsequently developed a more aggressive transformation with invasion into multiple organs with triple ALK-translocated chromosomes. The aggressive clinical course may have been related to these additional chromosomal aberrations. Our report provides new insights into the clonal evolution in ALCL and suggests the importance of monitoring examinations including fluorescence in situ hybridization analysis.	[Hoshino, Akihiro; Nomura, Keiko; Kanegane, Hirokazu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 9300194, Japan; [Hamashima, Takeru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 9300194, Japan; [Isobe, Tomoya] Univ Tokyo, Sch Med, Tokyo 113, Japan; [Seki, Masafumi; Hiwatari, Mitsuteru; Takita, Junko] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Kanegane, Hirokazu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Tokyo, Japan	Hoshino, A (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, 2630 Sugitani, Toyama 9300194, Japan.	nrb52665@yahoo.co.jp		Seki, Masafumi/0000-0003-4671-7026	Project for the Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by the Project for the Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to JT).	Le Deley MC, 2008, BLOOD, V111, P1560, DOI 10.1182/blood-2007-07-100958; Ait-Tahar K, 2010, BLOOD, V115, P3314, DOI 10.1182/blood-2009-11-251892; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Lamant L, 2011, J CLIN ONCOL, V29, P4669, DOI 10.1200/JCO.2011.36.5411; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Wright D, 1997, J CLIN PATHOL, V50, P128, DOI 10.1136/jcp.50.2.128; Fabarius A, 2011, BLOOD, V118, P6760, DOI 10.1182/blood-2011-08-373902; BASSAN R, 1992, CANCER, V69, P396, DOI 10.1002/1097-0142(19920115)69:2<396::AID-CNCR2820690220>3.0.CO;2-E; Grewal JS, 2007, ANN HEMATOL, V86, P499, DOI 10.1007/s00277-007-0289-3; Nguyen JT, 2009, PATHOL INT, V59, P345, DOI 10.1111/j.1440-1827.2009.02376.x; Oshikawa G, 2010, CANCER GENET CYTOGEN, V199, P56, DOI 10.1016/j.cancergencyto.2010.01.018; Piccaluga PP, 2014, INT J HEMATOL, V99, P219, DOI 10.1007/s12185-014-1522-1; Ries S, 2010, DIAGN CYTOPATHOL, V38, P141, DOI 10.1002/dc.21170	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	FEB	2015	101	2					198	202		10.1007/s12185-014-1701-0		5	Hematology	Hematology	CB3KH	WOS:000349526200015		
J	Kohara, K; Kurita, K; Kuroiwa, Y; Goto, S; Umemura, E				Kohara, K.; Kurita, K.; Kuroiwa, Y.; Goto, S.; Umemura, E.			Usefulness of mandibular third molar coronectomy assessed through clinical evaluation over three years of follow-up	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						coronectomy; prevent paraesthesia; long-term safety; migration pattern of the retained roots	INTENTIONAL PARTIAL ODONTECTOMY; INFERIOR ALVEOLAR NERVE; SURGERY; REMOVAL	The aim of this study was to investigate the 3-year morbidity of coronectomy of the lower third molar and to monitor the behaviour and migration pattern of the retained roots postoperatively. A total of 92 patients (111 teeth) who had undergone a coronectomy between October 2005 and July 2009 were investigated. Patients were followed up at 3 months and 1, 2, and 3 years for clinical evaluation and dental computed tomography imaging of the coronectomy sites. In total, 10 cases (9%) required tooth root extraction within the 3 years after coronectomy. In seven of them, the distal pocket of the lower second molars remained connected to the roots within the first year. Of the cases in whom a pocket did not remain at an early stage, none showed pen-apical lesions on transmission images of the retained roots in the apical area, which usually result from necrosis of the pulp. Root migration increased in the first 2 years after coronectomy but stabilized between the second and third years. In addition, a significant difference was noted in root migration between patients of different ages and sex. Retained roots after coronectomy in the lower third molars led to no complications in terms of infection or the development of pathologies within the first 3 years postoperatively.	[Kohara, K.; Kurita, K.; Kuroiwa, Y.; Goto, S.; Umemura, E.] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4648651, Japan; [Goto, S.] Sakura Gen Hosp, Dept Oral & Maxillofacial Surg, Oguchi, Japan	Kohara, K (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg, 2-11 Suemori Dori Chikusa Ku, Nagoya, Aichi 4648651, Japan.	agudkohara@gmail.com					Leung YY, 2012, J ORAL MAXIL SURG, V70, P1515, DOI 10.1016/j.joms.2011.12.029; O'Riordan BC, 2004, ORAL SURG ORAL MED O, V98, P274, DOI 10.1016/j.tripleo.2003.12.040; JOHNSON DL, 1974, J ORAL SURG, V32, P829; Gulicher D, 2001, INT J ORAL MAX SURG, V30, P306, DOI 10.1054/ijom.2001.0057; Leung YY, 2009, ORAL SURG ORAL MED O, V108, P821, DOI 10.1016/j.tripleo.2009.07.004; Nakagawa Y, 2007, J ORAL MAXIL SURG, V65, P1303, DOI 10.1016/j.joms.2006.10.028; CARMICHAEL FA, 1992, BRIT J ORAL MAX SURG, V30, P78, DOI 10.1016/0266-4356(92)90074-S; Hatano Y, 2009, J ORAL MAXIL SURG, V67, P1806, DOI 10.1016/j.joms.2009.04.018; Pogrel MA, 2004, J ORAL MAXIL SURG, V62, P1447, DOI 10.1016/j.joms.2004.08.003; Renton T, 2005, BRIT J ORAL MAX SURG, V43, P7, DOI 10.1016/j.bjorns.2004.09.002; Goto S, 2012, J ORAL MAXIL SURG, V70, P1023, DOI 10.1016/j.joms.2011.09.037; Leung YY, 2011, INT J ORAL MAX SURG, V40, P1, DOI 10.1016/j.ijom.2010.09.005; Dolanmaz D, 2009, J ORAL MAXIL SURG, V67, P1234, DOI 10.1016/j.joms.2008.12.031; BRUCE RA, 1980, J AM DENT ASSOC, V101, P240; Long H, 2012, J DENT RES, V91, P659, DOI 10.1177/0022034512449346; Sencimen M, 2010, J ORAL MAXIL SURG, V68, P2385, DOI 10.1016/j.joms.2010.02.024; FREEDMAN GL, 1992, J ORAL MAXIL SURG, V50, P419, DOI 10.1016/0278-2391(92)90412-S; Freedman GL, 1997, J ORAL MAXIL SURG, V55, P524, DOI 10.1016/S0278-2391(97)90708-4; Goto S, 2011, J ORAL MAXILLOFAC SU, V57, P459; Ishii T, 1997, P JAP SOC OR FAC NEU, P4; Plata RL, 1976, ORAL SURG ORAL MED O, V42, P101; Richard KG, 1986, J ORAL MAXILLOFAC SU, V15, P33; SCHULTZEMOSGAU S, 1993, INT J ORAL MAX SURG, V22, P214, DOI 10.1016/S0901-5027(05)80638-1; Tolstunov L, 2011, J ORAL MAXIL SURG, V69, P1858, DOI 10.1016/j.joms.2011.03.002; Zola MB, 1992, J ORAL MAXILLOFAC SU, V50, P954	25	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	FEB	2015	44	2					259	266		10.1016/j.ijom.2014.10.003		8	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CB3CZ	WOS:000349507100015		
J	Mizushima, D; Nishijima, T; Yashiro, S; Teruya, K; Kikuchi, Y; Katai, N; Oka, S; Gatanaga, H				Mizushima, Daisuke; Nishijima, Takeshi; Yashiro, Shigeko; Teruya, Katsuji; Kikuchi, Yoshimi; Katai, Naomichi; Oka, Shinichi; Gatanaga, Hiroyuki			Diagnostic Utility of Quantitative Plasma Cytomegalovirus DNA PCR for Cytomegalovirus End-Organ Diseases in Patients With HIV-1 Infection	JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES			English	Article						cytomegalovirus infection; CMV-DNA PCR; HIV-1 infection; CMV retinitis; CMV end-organ diseases	HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; REAL-TIME PCR; CMV DISEASE; VIRAL LOAD; AIDS; RETINITIS; VIREMIA; BLOOD; ASSAYS	Objective:To investigate the diagnostic value of quantitative plasma cytomegalovirus (CMV)-DNA polymerase chain reaction (PCR) for CMV end-organ diseases (CMV-EOD) in patients with HIV-1 infection.Design:Single-center cross-sectional study.Methods:The study subjects were HIV-1-infected patients with CD4 200 per microliter, who had undergone ophthalmologic examination with plasma CMV-DNA PCR measured within 7 days. CMV retinitis and other CMV-EOD were diagnosed according to the ACTG criteria. PCR value was converted into the WHO international standard.Results:CMV retinitis and all CMV-EOD were diagnosed in 23 (5%) and 37 (8%) of the 461 study patients, respectively. CMV-DNA was undetectable (<185 IU/mL) in 2 patients with CMV retinitis and 1 with encephalitis. The area under the receiver operating characteristic curve of CMV-DNA for CMV retinitis and all CMV-EOD were 0.80 [95% confidence interval (CI): 0.71 to 0.89] and 0.82 (0.75 to 0.89), respectively. The sensitivity, specificity, positive predictive value, and negative predictive value for each cutoff value of CMV-DNA were as follows: for CMV retinitis, 10,086 IU/mL: 26.1%, 94.1%, 18.8%, 96%; 2946 IU/mL; 56.5%, 86.8%, 18.3%, 97.4%; 959 IU/mL; 60.9%, 78.1%, 12.7%, 97.4%; detectable CMV-DNA (185 IU/mL): 91.3%, 48.2%, 8.5%, 99.1%; for all CMV-EOD: 10,086 IU/mL: 32.4%, 95.3%, 37.5%, 94.2%; 2946 IU/mL; 54.1%, 88%, 28.2%, 95.6%; 959 IU/mL; 62.2%, 79.5%, 20.9%, 96%; detectable CMV-DNA; 91.9%, 49.5%, 13.7%, 98.6%.Conclusions:Plasma CMV-DNA PCR has a high diagnostic value for both CMV retinitis and all CMV-EOD in patients with advanced HIV-1 infection. A cutoff value of CMV-DNA 10,086 IU/mL and 2946 IU/mL yields high specificity, whereas undetectable CMV-DNA load (<185 IU/mL) likely rules out CMV-EOD.	[Mizushima, Daisuke; Nishijima, Takeshi; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo 1620052, Japan; [Mizushima, Daisuke; Nishijima, Takeshi; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Yashiro, Shigeko; Katai, Naomichi] Natl Ctr Global Hlth & Med, Dept Ophthalmol, Tokyo 1620052, Japan	Gatanaga, H (reprint author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1620052, Japan.	higatana@acc.ncgm.go.jp			Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001, H24-AIDS-003]	Supported by Grant-in Aids for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001; H24-AIDS-003).	Abdul-Ali D, 2011, J CLIN VIROL, V52, P222, DOI 10.1016/j.jcv.2011.08.005; Wohl DA, 2005, JAIDS-J ACQ IMM DEF, V38, P538, DOI 10.1097/01.qai.0000155204.96973.c3; Hsiao NY, 2013, J CLIN VIROL, V58, P74, DOI 10.1016/j.jcv.2013.05.002; Nishijima T, 2014, AIDS, V28, P1903, DOI 10.1097/QAD.0000000000000347; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Jabs DA, 2002, AIDS, V16, P877, DOI 10.1097/00002030-200204120-00007; Pang XL, 2009, AM J TRANSPLANT, V9, P258, DOI 10.1111/j.1600-6143.2008.02513.x; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143; Sugar EA, 2012, AM J OPHTHALMOL, V153, P1016, DOI 10.1016/j.ajo.2011.11.014; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; KUPPERMANN BD, 1993, AM J OPHTHALMOL, V115, P575; Machida U, 2000, J CLIN MICROBIOL, V38, P2536; ARRIBAS JR, 1995, J INFECT DIS, V172, P527; Baroco Allison L, 2008, Curr Gastroenterol Rep, V10, P409, DOI 10.1007/s11894-008-0077-9; Brantsaeter AB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-127; Dodt KK, 1997, AIDS, V11, pF21, DOI 10.1097/00002030-199703110-00001; Fryer JF, 2010, WHOBS102138 ECBS COL; Gourlain K, 2003, J MED VIROL, V69, P401, DOI 10.1002/jmv.10303; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077763; Heiden D, 2007, PLOS MED, V4, P1845, DOI 10.1371/journal.pmed.0040334; Hirsch HH, 2013, CLIN INFECT DIS, V56, P367, DOI 10.1093/cid/cis900; Hu Huiling, 2002, Journal of Infectious Diseases, V185, P861, DOI 10.1086/339603; Jabs DA, 2005, J INFECT DIS, V192, P640, DOI 10.1086/432012; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Mizushima D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065348; Paltiel AD, 2001, CLIN INFECT DIS, V32, P783, DOI 10.1086/319223; Pang X, 2010, 26 CLIN VIR S; Pellegrin I, 1999, J CLIN MICROBIOL, V37, P3124; Piiparinen H, 2004, J CLIN VIROL, V30, P258, DOI 10.1016/j.jcv.2003.12.010; PILLAY D, 1993, AIDS, V7, P969, DOI 10.1097/00002030-199307000-00010; Salmon-Ceron D, 1999, CLIN INFECT DIS, V28, P901; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; Walmsley S, 1998, CLIN INFECT DIS, V27, P573, DOI 10.1086/514703; WILKES MS, 1988, LANCET, V2, P85; Yoshida A, 2001, CLIN INFECT DIS, V33, P1756, DOI 10.1086/323782; Yust I, 2004, EUR J CLIN MICROBIOL, V23, P550, DOI 10.1007/s10096-004-1160-2	37	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1525-4135	1077-9450		JAIDS-J ACQ IMM DEF	JAIDS	FEB 1	2015	68	2					140	146		10.1097/QAI.0000000000000410		7	Immunology; Infectious Diseases	Immunology; Infectious Diseases	AZ8IF	WOS:000348458200009		
J	Feng, T; Momihara, K				Feng, Tao; Momihara, Koji			Nonsymmetric primitive translation schemes of prime power order	JOURNAL OF ALGEBRAIC COMBINATORICS			English	Article						Nonsymmetric primitive translation scheme; Cyclotomic scheme; Gauss sum	COMMUTATIVE ASSOCIATION SCHEMES; DISTANCE-REGULAR DIGRAPHS; HADAMARD DIFFERENCE SETS; CHARACTERISTIC-4; SYMMETRIZATIONS; GRAPHS; RINGS	It is well-known that translation schemes of prime order are exactly the cyclotomic schemes. In this paper, we show that there do not exist any two-, three-, or four-class nonsymmetric primitive translation schemes of prime square order. On the other hand, we find new nonsymmetric four-and five-class association schemes from cyclotomy as fission schemes of certain symmetric three-class association schemes. Moreover, we provide an affirmative answer to the following question raised by Song (J Algebr Comb 5:47-55, 1996): are there any other two-class primitive association schemes that admit symmetrizable fission schemes besides the cyclotomic scheme of index 2 for q equivalent to 5 (mod 8)? To be more specific, we show that a certain two-class primitive association scheme in the finite field F-373 constructed by Feng and Xiang (J Comb Theory Ser A 119:245-256, 2012) admits a four-class fission scheme. This fission scheme is realized as a fusion scheme of the cyclotomic scheme of index 28.	[Feng, Tao] Zhejiang Univ, Dept Math, Hangzhou 310027, Zhejiang, Peoples R China; [Momihara, Koji] Kumamoto Univ, Fac Educ, Kumamoto 8608555, Japan	Momihara, K (reprint author), Kumamoto Univ, Fac Educ, 2-40-1 Kurokami, Kumamoto 8608555, Japan.	tfeng@zju.edu.cn; momihara@educ.kumamoto-u.ac.jp	Feng, Tao/B-7751-2012		Fundamental Research Fund for the Central Universities of China; Zhejiang Provincial Natural Science Foundation [LQ12A01019]; National Natural Science Foundation of China [11201418]; Ministry of Education of China [20120101120089]; JSPS [25800093, 24540013]	The authors thank the referees and the editor for very detailed suggestions and comments that helped to improve the presentation of the paper. T. Feng was supported by Fundamental Research Fund for the Central Universities of China, Zhejiang Provincial Natural Science Foundation under Grant LQ12A01019, the National Natural Science Foundation of China under Grant 11201418, and the Research Fund for Doctoral Programs from the Ministry of Education of China under Grant 20120101120089. The work of K. Momihara was supported by JSPS under Grant-in-Aid for Young Scientists (B) 25800093 and Scientific Research (C) 24540013	Feng T, 2012, J COMB THEORY B, V102, P982, DOI 10.1016/j.jctb.2011.10.006; Hanaki A, 2006, J ALGEBR COMB, V23, P189, DOI 10.1007/s10801-006-6923-7; van Dam ER, 2010, J COMB THEORY A, V117, P111, DOI 10.1016/j.jcta.2009.03.018; Feng T, 2012, DESIGN CODE CRYPTOGR, V65, P247, DOI 10.1007/s10623-011-9595-9; IVANOV AA, 1994, EUR J COMBIN, V15, P105, DOI 10.1006/eujc.1994.1013; Yang J, 2010, SCI CHINA MATH, V53, P2525, DOI 10.1007/s11425-010-3155-z; Bannai E., 1984, ALGEBRAIC COMBINATOR, VI; BANNAI E, 1993, EUR J COMBIN, V14, P385, DOI 10.1006/eujc.1993.1043; BANNAI E, 1991, J ALGEBRA, V144, P167, DOI 10.1016/0021-8693(91)90134-T; Berndt B., 1997, GAUSS JACOBI SUMS; Bosma W, 1997, J SYMB COMPUT, V24, P235, DOI 10.1006/jsco.1996.0125; Brouwer A. E., 1989, ERGEBNISSE MATH IHRE, P18; Brouwer AE, 2012, UNIVERSITEXT, P1, DOI 10.1007/978-1-4614-1939-6; Chia GL, 2006, DISCRETE MATH, V306, P3189, DOI 10.1016/j.disc.2006.06.005; ENOMOTO H, 1987, J COMB THEORY B, V43, P293, DOI 10.1016/0095-8956(87)90005-0; Faradzev . I. A., 1994, INVESTIGATIONS ALGEB, P1; Feng KQ, 2005, ACTA MATH SIN, V21, P1425, DOI 10.1007/s10114-005-0610-9; Feng T., ARXIV12010701; Feng T, 2012, J COMB THEORY A, V119, P245, DOI 10.1016/j.jcta.2011.08.007; GOLDBACH RW, 1994, EUR J COMBIN, V15, P519, DOI 10.1006/eujc.1994.1053; Goldbach RW, 1996, DISCRETE MATH, V159, P111, DOI 10.1016/0012-365X(96)00103-3; Golfand JA. JU., 1994, INVESTIGATIONS ALGEB, P167; Ivanov A. A., 1984, PREPRINT; Jorgensen LK, 2009, ALGORITHMIC ALGEBRAIC COMBINATORICS AND GROBNER BASES, P251, DOI 10.1007/978-3-642-01960-9_8; Jorgensen LK, 2010, DISCRETE MATH, V310, P3259, DOI 10.1016/j.disc.2010.03.002; Lidl R., 1997, FINITE FIELDS; LIEBLER RA, 1988, J COMB THEORY A, V47, P111, DOI 10.1016/0097-3165(88)90045-3; Ma JM, 2007, GRAPH COMBINATOR, V23, P73, DOI 10.1007/s00373-006-0667-y; Ma JM, 2011, J COMB THEORY A, V118, P1381, DOI 10.1016/j.jcta.2010.12.002; Ma JM, 2010, EUR J COMBIN, V31, P1671, DOI 10.1016/j.ejc.2010.04.004; Ma S. L., 1994, Designs, Codes and Cryptography, V4, DOI 10.1007/BF01388454; Momihara K, 2013, EUR J COMBIN, V34, P706, DOI 10.1016/j.ejc.2012.10.006; Muzychuk M.E., 1987, THESIS KIEV STATE U; Pott A., 1995, LECT NOTES MATH, V1601; Song SY, 1996, J ALGEBR COMB, V5, P47, DOI 10.1023/A:1022488330352; SONG SY, 1995, J COMB THEORY A, V70, P1, DOI 10.1016/0097-3165(95)90077-2	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0925-9899	1572-9192		J ALGEBR COMB	J. Algebr. Comb.	FEB	2015	41	1					1	20		10.1007/s10801-014-0523-8		20	Mathematics	Mathematics	CA9MD	WOS:000349247100001		
J	Kusumoto, B; Shiono, T; Miyoshi, M; Maeshiro, R; Fujii, S; Kuuluvainen, T; Kubota, Y				Kusumoto, Buntarou; Shiono, Takayuki; Miyoshi, Mai; Maeshiro, Ryo; Fujii, Shin-jiro; Kuuluvainen, Timo; Kubota, Yasuhiro			Functional response of plant communities to clearcutting: management impacts differ between forest vegetation zones	JOURNAL OF APPLIED ECOLOGY			English	Article						biodiversity; ecosystem functioning; forest management; functional divergence; functional redundancy; functional richness; phytosociological data; resilience	SPECIES-DIVERSITY; SUBTROPICAL FOREST; TROPICAL FOREST; TREE COMMUNITY; DISTURBANCE; METAANALYSIS; SUCCESSION; REDUNDANCY; DATABASES; ECOLOGY	Understanding of the ecological impacts of logging practices on biodiversity and associated ecosystem processes is essential for developing sustainable forest management approaches. We documented the impacts of clearcutting on the functional structure of tree and herbaceous communities in hemiboreal, cool-temperate, warm-temperate and subtropical forests in the Japanese archipelago and identified forest vegetation that is vulnerable to deterioration of important ecosystem functions. We combined species data for leaf, stem, flower and fruit traits related to productivity, nutrient cycling and habitat quality for wildlife with phytosociological vegetation data from unmanaged and previously clearcut forests, then calculated functional structure indices [community mean (CM) of trait values, functional richness (FRic) and functional divergence (RaoQ)] of plant communities. For tree species, functional structure indices of specific leaf area (SLA), leaf carbon and nitrogen concentrations, maximum height, wood density and flower size differed between unmanaged and clearcut forests, while for herb species, only maximum height differed between the two forest types. Functional structure indices showed divergent patterns across forest vegetation zones. In hemiboreal, cool-temperate and warm-temperate forests, the CMs of SLA and leaf nitrogen concentration were greater and that of leaf carbon concentration was smaller in clearcut than in unmanaged forests. Although clearcut forests had greater species richness than unmanaged forests, FRic and/or RaoQ of maximum height were smaller in clearcut forests. In hemiboreal and cool-temperate forests, FRic and RaoQ of SLA were also smaller in clearcut forests. In contrast, subtropical forests showed no differences in species richness and functional structures between unmanaged and clearcut forests.Synthesis and applications. Functional redundancy of plant communities differs among traits and among forest vegetation zones. After intensive logging, hemiboreal, cool-temperate and warm-temperate forests were more vulnerable to the loss of ecosystem functions related to leaf and stem traits of tree species than were subtropical forests, which appeared relatively resilient. Locally adaptive management to maintain multiple ecosystem functions should be developed based on the degree of functional complementarity among plant species in forest communities. Functional redundancy of plant communities differs among traits and among forest vegetation zones. After intensive logging, hemiboreal, cool-temperate and warm-temperate forests were more vulnerable to the loss of ecosystem functions related to leaf and stem traits of tree species than were subtropical forests, which appeared relatively resilient. Locally adaptive management to maintain multiple ecosystem functions should be developed based on the degree of functional complementarity among plant species in forest communities.	[Kusumoto, Buntarou; Shiono, Takayuki; Miyoshi, Mai; Maeshiro, Ryo; Fujii, Shin-jiro; Kubota, Yasuhiro] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 9030213, Japan; [Kuuluvainen, Timo] Univ Helsinki, Dept Forest Sci, FIN-00014 Helsinki, Finland	Kusumoto, B (reprint author), Univ Ryukyus, Fac Sci, Senbaru 1, Nishihara, Okinawa 9030213, Japan.	kusumoto.buntarou@gmail.com			Japan Society for the Promotion of Science [21310025, 21247006, 22405006, 24651037]	We thank Ms. K. Kubota for compiling the flora data. We are also grateful to a number of people for permission to sample and to researchers who helped to collect woody plants. This study is part of the Project of Mapping Biodiversity in Japan led by Y.K. Financial support was provided by the Japan Society for the Promotion of Science (Nos. 21310025, 21247006, 22405006, and 24651037).	Rosenfeld JS, 2002, OIKOS, V98, P156, DOI 10.1034/j.1600-0706.2002.980116.x; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Baraloto C, 2012, J APPL ECOL, V49, P861, DOI 10.1111/j.1365-2664.2012.02164.x; Weedon JT, 2009, ECOL LETT, V12, P45, DOI 10.1111/j.1461-0248.2008.01259.x; Katovai E, 2012, BIOL CONSERV, V145, P214, DOI 10.1016/j.biocon.2011.11.008; Lindenmayer DB, 2012, CONSERV LETT, V5, P421, DOI 10.1111/j.1755-263X.2012.00257.x; Brunet J, 2011, FOREST ECOL MANAG, V262, P1863, DOI 10.1016/j.foreco.2011.08.007; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Duguid MC, 2013, FOREST ECOL MANAG, V303, P81, DOI 10.1016/j.foreco.2013.04.009; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Dalerum F, 2012, THEOR ECOL-NETH, V5, P129, DOI 10.1007/s12080-010-0104-y; Lusk CH, 2008, TRENDS ECOL EVOL, V23, P299, DOI 10.1016/j.tree.2008.02.006; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Klein AM, 2012, J APPL ECOL, V49, P723, DOI 10.1111/j.1365-2664.2012.02144.x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Knollova I, 2005, J VEG SCI, V16, P479, DOI 10.1658/1100-9233(2005)016[0479:SROPDS]2.0.CO;2; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Janecek S, 2013, J VEG SCI, V24, P898, DOI 10.1111/jvs.12012; Aubin I, 2007, ECOSCIENCE, V14, P259, DOI 10.2980/1195-6860(2007)14[259:HRANHF]2.0.CO;2; Carreno-Rocabado G, 2012, J ECOL, V100, P1453, DOI 10.1111/j.1365-2745.2012.02015.x; Chessel D., 2013, ADE4 ANAL ECOLOGICAL; Fujii S, 2009, J FOREST RES-JPN, V14, P373, DOI 10.1007/s10310-009-0151-7; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Haveman R, 2008, J VEG SCI, V19, P355, DOI 10.3170/2008-8-18375; HIURA T, 1995, OECOLOGIA, V104, P265, DOI 10.1007/BF00328360; Kubota Y, 2004, J ECOL, V92, P230, DOI 10.1111/j.0022-0477.2004.00875.x; Kusumoto B., 2015, DRYAD DIGITAL REPOSI; Lohbeck M, 2013, ECOLOGY, V94, P1211, DOI 10.1890/12-1850.1; Maeshiro R, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00125.1; Mea, 2005, EC HUM WELL BEING OU; Messier C, 2013, MANAGING FORESTS COM; Oksanen J., 2012, VEGAN COMMUNITY ECOL; R-Core-Development-Team, 2012, R LANG ENV STAT COMP; Taylor AR, 2013, FOREST ECOL MANAG, V310, P19, DOI 10.1016/j.foreco.2013.08.017; WCFSD, 1999, OUR FOR OUR FUT; Yonekura K., 2003, BG PLANTS JAPANESE S	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8901	1365-2664		J APPL ECOL	J. Appl. Ecol.	FEB	2015	52	1					171	180		10.1111/1365-2664.12367		10	Ecology	Environmental Sciences & Ecology	CA2LU	WOS:000348740800019		
J	Wu, Q; Nozawa, S				Wu, Qian; Nozawa, S.			Mesospheric and thermospheric observations of the January 2010 stratospheric warming event	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article						Stratospheric warming; Lower thermospheric winds; Thermospheric winds	FABRY-PEROT-INTERFEROMETER; MESOPAUSE REGION; FORT-COLLINS; WINDS; 105-DEGREES-W; TEMPERATURE; VARIABILITY; MIDLATITUDE; WAVES; TIDE	We use two ground based Fabry-Perot interferometers (FPI) at Boulder (40 degrees N, 105 degrees W), Resolute (75 degrees N, 95 degrees W), and a meteor radar at Bear Island (75 degrees N, 19 degrees E) to examine the mesospheric and thermospheric winds during a sudden stratospheric warming (SSW) event in January 2010. The two high latitude wind instruments allow us, for the first time, to infer the zonal wavenumber of the semidiumal tide on a daily basis during an SSW event. The ground based FPIs recorded enhanced lower thermosphere semidiurnal tide before and during the SSW. The two high latitude stations did not show much westward propagating semidiurnal tide with zonal wavenumber one (SW1) as predicted by model simulations. Several indications of westward propagating zonal wavenumber three semidiurnal tide (SW3) require further verification. In addition, the TIMED TIDI lower thermospheric winds at 95 km also appear to show sign of SW3. High latitude terdiurnal and quaddiurnal oscillations were observed. Enhancements in the midlatitude thermospheric semidiurnal and terdiumal tides during the SSW were observed, which may be related to the gravity wave filtering by solar tides in the stratosphere and mesosphere. Unusually large thermospheric winds were observed before the SSW at Boulder, its connection to the planetary wave activity related to the SSW is still to be determined. (C) 2014 Elsevier Ltd. All rights reserved.	[Wu, Qian] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [Nozawa, S.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan	Wu, Q (reprint author), Natl Ctr Atmospher Res, High Altitude Observ, POB 3000, Boulder, CO 80307 USA.	qwu@ucar.edu		Wu, Qian/0000-0002-7508-3803	NSF [AGS-0334595, AGS-0640745]; NASA [NNX13AF93G, NNX07AB76G, NNX09AG64G]; National Science Foundation; Special Funds for Education and Research (Energy Transport Processes in Geospace), Ministry of Education, Culture, Sports, Science, and Technology of Japan; internal funding from The Arctic University of Norway	This work is supported by NSF grants AGS-0334595, AGS-0640745 and NASA grants NNX13AF93G, NNX07AB76G, and NNX09AG64G. NCAR is support by the National Science Foundation. We thank Tromso Geophysical Observatory, The Arctic University of Norway for maintenance of the meteor radar at Bear Island. The meteor radar at Bear Island has been supported by Special Funds for Education and Research (Energy Transport Processes in Geospace) by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and also by internal funding from The Arctic University of Norway. Stratospheric temperature data from Dr. Paul Newman of GSFC were used. We would like to thank Dr. Astrid Maute for many helpful comments and suggestions. We thank the journal referees for many thoughtful suggestions.	Matthias V, 2013, ANN GEOPHYS-GERMANY, V31, P1397, DOI 10.5194/angeo-31-1397-2013; Liu HL, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015188; Goncharenko L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035684; Chen X, 2012, ANN GEOPHYS-GERMANY, V30, P991, DOI 10.5194/angeo-30-991-2012; Wu Q, 2011, J ATMOS SOL-TERR PHY, V73, P2482, DOI 10.1016/j.jastp.2011.08.007; Goncharenko LP, 2013, J GEOPHYS RES-SPACE, V118, P472, DOI 10.1029/2012JA018251; Yuan T, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017142; Chau JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036785; MATSUNO T, 1971, J ATMOS SCI, V28, P1479, DOI 10.1175/1520-0469(1971)028<1479:ADMOTS>2.0.CO;2; Chau JL, 2012, SPACE SCI REV, V168, P385, DOI 10.1007/s11214-011-9797-5; Hoffmann P, 2007, J ATMOS SOL-TERR PHY, V69, P2355, DOI 10.1016/j.jastp.2007.06.010; Fejer BG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049788; Wang H, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA017081; Wu Q, 2004, P SOC PHOTO-OPT INS, V5660, P218, DOI 10.1117/12.573084; Goncharenko LP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043125; Forbes J. M., 2002, J GEOPHYS RES, V107; Iimura H, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012733; Kelley MC, 2009, INT GEOPHYS SER, V96, P1; Liu H.-L., 2002, J GEOPHYS RES, V107, P15; Murphy, 2006, J GEOPHYS RES, V111; Nozawa S, 2012, J ATMOS SOL-TERR PHY, V90-91, P26, DOI 10.1016/j.jastp.2012.05.002; RANDEL WJ, 1993, J ATMOS SCI, V50, P3308, DOI 10.1175/1520-0469(1993)050<3308:GVOZMO>2.0.CO;2; She CY, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001189; SIVJEE GG, 1994, PLANET SPACE SCI, V42, P447, DOI 10.1016/0032-0633(94)00085-9; Smith AK, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004421; Wu Q, 2005, ADV SPACE RES, V35, P1895, DOI 10.1016/j.asr.2005.05.112; Yigit E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053812; Yuan T, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008697; Yuan T, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2004JD005486	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	FEB	2015	123						22	38		10.1016/j.jastp.2014.11.006		17	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CB3BY	WOS:000349504400003		
J	Kumar, GK; Kumar, KK; Baumgarten, G; Ramkumar, G				Kumar, G. Kishore; Kumar, K. Kishore; Baumgarten, G.; Ramkumar, Geetha			Validation of MERRA reanalysis upper-level winds over low latitudes with independent rocket sounding data	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article						MERRA; Reanalysis; RH-200; Rocket soundings; Validation; SSA	MIDDLE-ATMOSPHERE; NORTHERN-HEMISPHERE; MODEL SIMULATIONS; ZONAL WIND; WAVES; CLIMATOLOGY; MESOSPHERE	An evaluation of upper stratosphere lower mesosphere (USLM) horizontal winds from MERRA reanalysis is performed using rocket sounding observations that span more than 5 years (November 2002-November 2007) over Thumba (8.5 degrees N, 77 degrees E). With Rocket sonde profiles as reference, bias and root mean square deviation (RMSD) are computed between 10 hPa and 0.1 hPa (similar to 30-65 km) on annual and seasonal time scales. The present results reveal that observations and reanalysis correlate reasonably well in zonal winds below 60 km. The detailed comparison showed increasing RMSDs with height reaching largest value at 0.1 hPa. RMSD noted in the zonal winds are larger than in the meridional winds. Positive biases are noted in the zonal winds around 50 km with large values during seasonal transition period that led to 30% overestimation of the stratospheric semiannual amplitude. The meridional winds are not well reproduced in the reanalysis. Possible reasons for the differences between MERRA and rocket soundings are discussed. The present study is the first attempt to validate MERRA reanalysis data with observations in the USLM region. Over all good agreement in the zonal winds between MERRA reanalysis data and RI-I-200 is very encouraging and vouches for using the MERRA reanalysis zonal winds below Prod. Type: FTP 0.1 hPa, but with caution around 1 hPa. (C) 2014 Elsevier Ltd. All rights reserved.	[Kumar, G. Kishore; Baumgarten, G.] Univ Rostock, Leibniz Inst Atmospher Phys, Kuhlungsborn, Germany; [Kumar, K. Kishore; Ramkumar, Geetha] Vikram Sarabhai Space Ctr, Space Phys Lab, Trivandrum 695022, Kerala, India	Kumar, GK (reprint author), Kyoto Univ, RISH, Gokasho, Kyoto 6110011, Japan.	kishoreg@rish.kyoto-u.ac.jp			Alexander von Humboldt Foundation, Germany	MERRA data used in this study/project have been provided by the Global Modeling and Assimilation Office (GMAO) at NASA Goddard Space Flight Center through the NASA GES DISC online archive. G. Kishore Kumar acknowledges the Alexander von Humboldt Foundation, Germany, for support.	Andrews D. G., 1987, MIDDLE ATMOSPHERE DY; [Anonymous], 2008, J GEOPHYS RES SPACE, DOI DOI 10.1029/2008JA013668; Schubert S, 2011, J CLIMATE, V24, P4773, DOI 10.1175/JCLI-D-10-05035.1; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; Kumar GK, 2014, J GEOPHYS RES-ATMOS, V119, P5913, DOI 10.1002/2014JD021610; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Randel W, 2004, J CLIMATE, V17, P986, DOI 10.1175/1520-0442(2004)017<0986:TSIOMC>2.0.CO;2; Hedin AE, 1996, J ATMOS TERR PHYS, V58, P1421, DOI 10.1016/0021-9169(95)00122-0; Mapes BE, 2012, J CLIMATE, V25, P6202, DOI 10.1175/JCLI-D-11-00424.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Garcia RR, 1997, J GEOPHYS RES-ATMOS, V102, P26019, DOI 10.1029/97JD00207; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Ramaswamy V, 2001, REV GEOPHYS, V39, P71, DOI 10.1029/1999RG000065; Baumgarten G, 2010, ATMOS MEAS TECH, V3, P1509, DOI 10.5194/amt-3-1509-2010; Bloom S., 2005, NASA TECH REP SERIES, V26; DEVARAJAN M, 1984, INDIAN J RADIO SPACE, V13, P48; Kumar GK, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010511; Kumar GK, 2010, ANN GEOPHYS-GERMANY, V28, P1859, DOI 10.5194/angeo-28-1859-2010; Liu HL, 2001, GEOPHYS RES LETT, V28, P1903, DOI 10.1029/2000GL012689; Kumar GK, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009862; Ramkumar G, 2006, ANN GEOPHYS-GERMANY, V24, P2471; Ratnam MV, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035390; Ratnam MV, 2013, GEOPHYS RES LETT, V40, P397, DOI 10.1002/grl.50158; Singer W., 2012, CLIMATE WEATHER SUN; Zuo ZY, 2013, J CLIMATE, V26, P8947, DOI 10.1175/JCLI-D-12-00691.1	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	FEB	2015	123						48	54		10.1016/j.jastp.2014.12.001		7	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CB3BY	WOS:000349504400005		
J	Shibata, T; Nishihara, M				Shibata, Takashi; Nishihara, Michi			Investment-based financing constraints and debt renegotiation	JOURNAL OF BANKING & FINANCE			English	Article						Real option; Credit constraints; Strategic debt service; Capital structure	CAPITAL STRUCTURE; CORPORATE-DEBT; REORGANIZATION; OWNERSHIP; SERVICE; COSTS; RISK	We consider how equity holders' bargaining power during financial distress influences the interactions between financing and investment decisions when the firm faces the upper limit of debt issuance. We obtain four results. First, weaker equity holders' bargaining power is more likely that the firm is financially constrained. Second, the investment quantity is independent of equity holders' bargaining power. Third, the constrained credit spreads are increasing with equity holders' bargaining power, contrary to the unconstrained ones. Fourth, higher volatility and weaker equity holders' bargaining power are likely that the firm prefers to issue debt with renegotiation, compared with debt without renegotiation. (C) 2014 Elsevier B.V. All rights reserved.	[Shibata, Takashi] Tokyo Metropolitan Univ, Grad Sch Social Sci, Hachioji, Tokyo 1920397, Japan; [Nishihara, Michi] Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 5600043, Japan; [Nishihara, Michi] Ecole Polytech Fed Lausanne, Swiss Finance Inst, CH-1015 Lausanne, Switzerland	Shibata, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Social Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	tshibata@tmu.ac.jp; nishihara@econ.osaka-u.ac.jp		Shibata, Takashi/0000-0001-9724-6469	Ishii Memorial Securities Research Promotion Foundation; JSPS Postdoctoral Fellowships; Telecommunications Advances Foundation; JSPS KAKENHI [26242028, 26285071, 26350424]	We thank Carol Alexander (the editor) and two anonymous referees for their useful comments and suggestions that have helped to improve the paper substantially. We also thank participants of AMMF Conference (Angers), CFE Conference (London), EURO XXVI Conference (Rome), NUS-UTolcyo Workshop (Singapore), and seminar participants at Akita Prefecture University, Bank of Japan, F-bukai (Tokyo), and HKUST for providing helpful comments. This research was supported by a Grant-in-Aid from the Ishii Memorial Securities Research Promotion Foundation, the JSPS KAKENHI (Grant Nos. 26242028, 26285071, and 26350424), the JSPS Postdoctoral Fellowships for Research Abroad, and the Telecommunications Advances Foundation.	Broadie M, 2007, J FINANC, V62, P1341, DOI 10.1111/j.1540-6261.2007.01238.x; Sundaresan S, 2007, AM ECON REV, V97, P256, DOI 10.1257/aer.97.2.256; Shibata T, 2015, EUR J OPER RES, V241, P513, DOI 10.1016/j.ejor.2014.09.011; Panousi V, 2012, J FINANC, V67, P1113, DOI 10.1111/j.1540-6261.2012.01743.x; Shibata T, 2012, J BANK FINANC, V36, P981, DOI 10.1016/j.jbankfin.2011.10.014; Nishihara M, 2013, J BANK FINANC, V37, P1160, DOI 10.1016/j.jbankfin.2012.11.014; Fan H, 2000, REV FINANC STUD, V13, P1057, DOI 10.1093/rfs/13.4.1057; Cleary S, 2006, J BANK FINANC, V30, P1559, DOI 10.1016/j.jbankfin.2005.03.023; MYERS SC, 1977, J FINANC ECON, V5, P147, DOI 10.1016/0304-405X(77)90015-0; Francois P, 2004, J BUS, V77, P387, DOI 10.1086/381280; BLACK F, 1976, J FINANC, V31, P351, DOI 10.2307/2326607; Brown DT, 1989, REV FINANC STUD, V2, P109, DOI 10.1093/rfs/2.1.109; GILSON SC, 1990, J FINANC ECON, V27, P315, DOI 10.1016/0304-405X(90)90059-9; Gomes JF, 2010, J FINANC, V65, P467, DOI 10.1111/j.1540-6261.2009.01541.x; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; LELAND HE, 1994, J FINANC, V49, P1213, DOI 10.2307/2329184; Lyandres E, 2014, J CORP FINANC, V24, P21, DOI 10.1016/j.jcorpfin.2013.06.006; MCDONALD R, 1986, Q J ECON, V101, P707, DOI 10.2307/1884175; MellaBarral P, 1997, J FINANC, V52, P531, DOI 10.1111/j.1540-6261.1997.tb04812.x; MERTON RC, 1974, J FINANC, V29, P449, DOI 10.2307/2978814; Pindyck R. S., 1994, INVESTMENT UNCERTAIN; Wong K. P., 2010, ANN FINANCE, V6, P335	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4266	1872-6372		J BANK FINANC	J. Bank Financ.	FEB	2015	51						79	92		10.1016/j.jbankfin.2014.11.005		14	Business, Finance; Economics	Business & Economics	CB3CW	WOS:000349506800006		
J	Ogawa, A; Watanabe, T; Shoji, S; Furihata, C				Ogawa, Akira; Watanabe, Takashi; Shoji, Sayaka; Furihata, Chie			Enzyme Kinetics of an Alternative Splicing Isoform of Mitochondrial 8-Oxoguanine DNA Glycosylase, OGG1-1b, and Compared with the Nuclear OGG1-1a	JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY			English	Article						Mitochondrial OGG1-1b; Nuclear OGG1-1a; Enzyme Activity; Single-turnover Condition; Multiple-turnover Condition	REPAIR ACTIVITIES; DAMAGE; CELLS; 8-HYDROXYGUANINE; EXPRESSION; CLONING	Eight alternatively spliced isoforms of human 8-oxoguanine DNA glycosylase (OGG1) (OGG1-1a to -1c and -2a to -2e) are registered in the National Center for Biotechnology Information. OGG1(s) in mitochondria have not yet been fully characterized biochemically. In this study, we purified mitochondrial recombinant OGG1-1b protein and compared its activity with nuclear OGG1-1a protein. The reaction rate constant (k(g)) of the 7,8-dihydro-8-oxoguanine (8-oxoG) glycosylase activity of OGG1-1b was 8-oxoG:C >> 8-oxoG:T >> 8-oxoG:G > 8-oxoG:A (7.96, 0.805, 0.070, and 0.015 min(-1), respectively) and that of the N-glycosylase/DNA lyase activity (k(gl)) of OGG1-1b was 8-oxoG:C > 8-oxoG:T similar or equal to 8-oxoG:G >> 8-oxoG:A (0.286, 0.079, 0.040, and negligible min(-1), respectively). These reaction rate constants were similar to those of OGG1-1a except for k(gl) against 8-oxoG:A. APEX nuclease 1 was required to promote DNA strand breakage by OGG1-1b. These results suggest that OGG1-1b is associated with 8-oxoG cleavage in human mitochondria and that the mechanism of this repair is similar to that of nuclear OGG1-1a. (C) 2014Wiley Periodicals, Inc.	[Ogawa, Akira; Watanabe, Takashi; Shoji, Sayaka; Furihata, Chie] Aoyama Gakuin Univ, Sch Sci & Engn, Funct Genom Lab, Sagamihara, Kanagawa 2525258, Japan; [Furihata, Chie] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan	Furihata, C (reprint author), Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan.	chiefurihata@gmail.com			High-Tech Research Center Project of Private Universities; Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was partly supported by a High-Tech Research Center Project of Private Universities with a matching fund subsidy from the Japanese Ministry of Education, Culture, Sports, Science and Technology (C. Furihata).	Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Hashiguchi K, 2004, NUCLEIC ACIDS RES, V32, P5596, DOI 10.1093/nar/gkh863; Nishioka K, 1999, MOL BIOL CELL, V10, P1637; Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917; Aburatani H, 1997, CANCER RES, V57, P2151; Dorszewska J, 2009, DNA CELL BIOL, V28, P579, DOI 10.1089/dna.2009.0926; Panduri V, 2009, FREE RADICAL BIO MED, V47, P750, DOI 10.1016/j.freeradbiomed.2009.06.010; Kim SJ, 2014, J BIOL CHEM, V289, P6165, DOI 10.1074/jbc.M113.515130; Karahalil B, 2010, ANTICANCER RES, V30, P4963; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338; Janssen K, 2001, MUTAT RES-DNA REPAIR, V486, P207, DOI 10.1016/S0921-8777(01)00096-9; KASAI H, 1984, GANN, V75, P1037; McKibbin PL, 2012, J AM CHEM SOC, V134, P1653, DOI 10.1021/ja208510m; Su YH, 2013, ENVIRON MOL MUTAGEN, V54, P54, DOI 10.1002/em.21742; Watanabe T, 2010, CANCER CELL INT, V21, P2	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1095-6670	1099-0461		J BIOCHEM MOL TOXIC	J. Biochem. Mol. Toxicol.	FEB	2015	29	2					49	56		10.1002/jbt.21605		8	Biochemistry & Molecular Biology; Toxicology	Biochemistry & Molecular Biology; Toxicology	CB4XR	WOS:000349632200001		
J	Matsugaki, A; Isobe, Y; Saku, T; Nakano, T				Matsugaki, Aira; Isobe, Yoshihiro; Saku, Taro; Nakano, Takayoshi			Quantitative regulation of bone-mimetic, oriented collagen/apatite matrix structure depends on the degree of osteoblast alignment on oriented collagen substrates	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						microbeam X-ray diffraction; bone anisotropy; osteoblast morphology; apatite orientation; bone quality	MECHANICAL FUNCTION; ORIENTATION; CELLS; ADHESION; DIFFERENTIATION; FIBROBLASTS; ANISOTROPY; PATTERNS; SURFACES; POLARITY	Bone tissue has a specific anisotropic morphology derived from collagen fiber alignment and the related apatite crystal orientation as a bone quality index. However, the precise mechanism of cellular regulation of the crystallographic orientation of apatite has not been clarified. In this study, anisotropic construction of cell-produced mineralized matrix in vitro was established by initiating organized cellular alignment and subsequent oriented bone-like matrix (collagen/apatite) production. The oriented collagen substrates with three anisotropic levels were prepared by a hydrodynamic method. Primary osteoblasts were cultured on the fabricated substrates until mineralized matrix formation is confirmed. Osteoblast alignment was successfully regulated by the level of substrate collagen orientation, with preferential alignment along the direction of the collagen fibers. Notably, both fibrous orientation of newly synthesized collagen matrix and c-axis of produced apatite crystals showed preferential orientation along the cell direction. Because the degree of anisotropy of the deposited apatite crystals showed dependency on the directional distribution of osteoblasts cultured on the oriented collagen substrates, the cell orientation determines the crystallographic anisotropy of produced apatite crystals. To the best of our knowledge, this is the first report demonstrating that bone tissue anisotropy, even the alignment of apatite crystals, is controllable by varying the degree of osteoblast alignment via regulating the level of substrate orientation. (C) 2014 Wiley Periodicals, Inc.	[Matsugaki, Aira; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Suita, Osaka 5650871, Japan; [Isobe, Yoshihiro; Saku, Taro] Atree Inc, Shibuya Ku, Tokyo 1500012, Japan	Nakano, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	nakano@mat.eng.osaka-u.ac.jp			Japan Society for Promotion of Science (JSPS)	Contract grant sponsor: Grants-in-Aid for Scientific Research (S) from the Japan Society for Promotion of Science (JSPS)	Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.0.CO;2-U; Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus; Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051; Eaton S, 2011, CURR OPIN GENET DEV, V21, P747, DOI 10.1016/j.gde.2011.08.010; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Kirkwood JE, 2009, LANGMUIR, V25, P3200, DOI 10.1021/la803736x; Ishimoto T, 2013, J BONE MINER RES, V28, P1170, DOI 10.1002/jbmr.1825; Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Kotani H, 2000, J APPL PHYS, V87, P6191, DOI 10.1063/1.372652; Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024; Nakano T, 2012, BONE, V51, P741, DOI 10.1016/j.bone.2012.07.003; El-Ghannam AR, 2004, J BIOMED MATER RES A, V68A, P615, DOI 10.1002/jbm.a.20051; Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.0.CO;2-6; Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064; Petroll WM, 2003, J CELL SCI, V116, P1481, DOI 10.1242/jcs.00357; Seto J, 2008, ADV FUNCT MATER, V18, P1905, DOI 10.1002/adfm.200800214; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Birk DE, 1986, J CELL BIOL, V103, P230; CHUN JS, 1992, MOL BIOL CELL, V3, P481; ELSDALE T, 1974, J CELL BIOL, V63, P343, DOI 10.1083/jcb.63.1.343; Fisher N. I., 1993, STAT ANAL CIRCULAR D; GUIDO S, 1993, J CELL SCI, V105, P317; Hamilton DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015129; Isobe Y, 2012, MATERIALS, V5, P501, DOI 10.3390/ma5030501; Ivanova VP, 2013, CELL TISSUE BIOL, V7, P21; JONES SJ, 1976, ISRAEL J MED SCI, V12, P98; Matsugaki A, 2013, ACTA BIOMATER, V9, P7227, DOI 10.1016/j.actbio.2013.03.015; Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022; Tenboll A, 2010, LANGMUIR, V26, P12165, DOI 10.1021/la1018136; TRELSTAD RL, 1979, DEV BIOL, V71, P228, DOI 10.1016/0012-1606(79)90166-0; Wu LY, 2011, LANGMUIR, V27, P9490, DOI 10.1021/la201580v; Zhang HM, 2010, CURR OPIN CELL BIOL, V22, P575, DOI 10.1016/j.ceb.2010.08.011; Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	FEB	2015	103	2					489	499		10.1002/jbm.a.35189		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA7MP	WOS:000349101700007		
J	Yumoto, H; Hirota, K; Hirao, K; Miyazaki, T; Yamamoto, N; Miyamoto, K; Murakami, K; Fujiwara, N; Matsuo, T; Miyake, Y				Yumoto, Hiromichi; Hirota, Katsuhiko; Hirao, Kouji; Miyazaki, Tsuyoshi; Yamamoto, Nobuyuki; Miyamoto, Koji; Murakami, Keiji; Fujiwara, Natsumi; Matsuo, Takashi; Miyake, Yoichiro			Anti-inflammatory and protective effects of 2-methacryloyloxyethyl phosphorylcholine polymer on oral epithelial cells	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						2-Methacryloyloxyethyl phosphorylcholine; oral epithelial cells; toll-like receptor; lipopolysaccharide; interleukin-8	NEUTROPHIL EXTRACELLULAR TRAPS; COLONY-STIMULATING FACTOR; TOLL-LIKE RECEPTOR-2; PORPHYROMONAS-GINGIVALIS; ANTIBIOTIC-RESISTANCE; PERIODONTAL BACTERIA; CYTOKINE RESPONSE; BINDING PROTEIN; LIPID RAFTS; ACTIVATION	Periodontitis is a chronic inflammatory disease initiated by a microbial biofilm formed in the periodontal pocket. Gingival epithelium plays important roles as the first physical barrier to bacterial invasion and in orchestrating the innate immune reaction via toll-like receptors (TLRs), which recognize various bacterial products, and maintaining its function. Newly developed oral care products to inhibit bacterial adherence, subsequent inflammatory reaction and protect the gingival epithelium are expected. We previously reported that 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymer coating decreased bacterial adhesion to human oral keratinocytes, RT-7, and mouth-rinsing with MPC-polymer inhibited the increase of oral bacteria. In this study, regarding the possibility of MPC-polymer application for preventing the adherence of periodontal pathogen, subsequent inflammatory reaction and protection of gingival epithelium, we examined the effects of MPC-polymer on the adherence of Porphyromonas gingivalis, major periodontitis-related pathogen, and TLR2 ligand to RT-7 and subsequent interleukin (IL) 28 production. MPC-polymer treatment significantly reduced P. gingivalis adherence by 44% and TLR2-mediated IL-8 production by blocking the binding of its specific-ligand in a concentration-dependent manner. Furthermore, MPC-polymer pretreatment protected RT-7 from injury by chemical irritants, cetylpyridinium chloride. These findings suggest that MPC-polymer is potentially useful for oral care to prevent oral infection and to maintain oral epithelial function. (C) 2014 Wiley Periodicals, Inc.	[Yumoto, Hiromichi; Hirao, Kouji; Matsuo, Takashi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Conservat Dent, Tokushima 7708504, Japan; [Hirota, Katsuhiko; Murakami, Keiji; Fujiwara, Natsumi; Miyake, Yoichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Microbiol, Tokushima 7708504, Japan; [Miyazaki, Tsuyoshi] NOF Corp, Life Sci Prod Div, Shibuya Ku, Tokyo 1506019, Japan; [Yamamoto, Nobuyuki; Miyamoto, Koji] NOF Corp, Life Sci Prod Div, Life Sci Res Lab, Tsukuba, Ibaraki 3002635, Japan	Miyake, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Microbiol, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	miyake@tokushima-u.ac.jp			Japan Society for the Promotion of Science [24592872]	Contract grant sponsor: Scientific Research from the Japan Society for the Promotion of Science; contract grant number: 24592872	Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Soletti L, 2011, J BIOMED MATER RES A, V96A, P436, DOI 10.1002/jbm.a.32997; Lin XJ, 2014, BIOMACROMOLECULES, V15, P150, DOI 10.1021/bm401430k; Gibson FC, 2008, FRONT BIOSCI-LANDMRK, V13, P2041, DOI 10.2741/2822; Triantafilou M, 2004, BIOCHEM J, V381, P527; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Klausner M, 2007, TOXICOL IN VITRO, V21, P938, DOI 10.1016/j.tiv.2007.01.024; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Dale BA, 2002, PERIODONTOL 2000, V30, P70, DOI 10.1034/j.1600-0757.2002.03007.x; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Kikkert R, 2007, ORAL MICROBIOL IMMUN, V22, P145, DOI 10.1111/j.1399-302X.2007.00335.x; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Iwasaki Y, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064101; Ishiyama N, 2011, J BONE JOINT SURG AM, V93A, P142, DOI 10.2106/JBJS.I.01634; Triantafilou M, 2002, J CELL SCI, V115, P2603; Aiello AE, 2003, LANCET INFECT DIS, V3, P501, DOI 10.1016/S1473-3099(03)00723-0; Sugiyama A, 2002, J MED MICROBIOL, V51, P27; Burns E, 2006, J IMMUNOL, V177, P8296; Ishihara K, 1999, POLYM J, V31, P1231, DOI 10.1295/polymj.31.1231; Vitkov L, 2009, J PERIODONTAL RES, V44, P664, DOI 10.1111/j.1600-0765.2008.01175.x; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Ren L, 2005, J PERIODONTOL, V76, P1950, DOI 10.1902/jop.2005.76.11.1950; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; Sugawara Y, 2006, J DENT RES, V85, P524; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559; Burgalassi S, 2001, TOXICOL LETT, V122, P1, DOI 10.1016/S0378-4274(01)00261-2; Fujii K, 2008, J VET MED SCI, V70, P167, DOI 10.1292/jvms.70.167; Fujimoto R, 2002, J JPN ORAL MUCO MEMB, V8, P1; Goda T, 2010, BIOMATERIALS, V31, P2380, DOI 10.1016/j.biomaterials.2009.11.095; Grant MM, 2010, J CLIN PERIODONTOL, V37, P1039, DOI 10.1111/j.1600-051X.2010.01622.x; Hirota K, 2005, FEMS MICROBIOL LETT, V248, P37, DOI 10.1016/j.femsle.2005.05.019; Hirota K, 2011, J DENT RES, V90, P900, DOI 10.1177/0022034511402996; Kano S, 2006, PHARM RES, V23, P329, DOI 10.1007/s11095-006-9141-z; Kojima R, 2011, POLYM J, V43, P718, DOI 10.1038/pj.2011.49; Liu D, 2008, CELL MICROBIOL, V10, P262, DOI 10.1111/j.1462-5822.2007.01040.x; Mitchell GB, 2003, INFECT IMMUN, V71, P1643, DOI 10.1128/IAI.71.41643-1649.2003; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; Ohta K, 2011, J DENT RES, V90, P1286, DOI 10.1177/0022034511420431; Page R. C., 1997, PERIODONTOL, V14, P9; Refaai W, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-193; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Yamamoto N, 2006, J OLEO SCI, V55, P465; Yanagita M, 1999, J IMMUNOL, V162, P3559	49	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	FEB	2015	103	2					555	563		10.1002/jbm.a.35201		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA7MP	WOS:000349101700013		
J	Sasaki, JI; Matsumoto, T; Imazato, S				Sasaki, Jun-Ichi; Matsumoto, Takuya; Imazato, Satoshi			Oriented bone formation using biomimetic fibrin hydrogels with three-dimensional patterned bone matrices	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						fibrin gel; biomimetic material; cell patterning; bone regeneration; mesenchymal stem cells	TISSUE-ENGINEERED BONE; HYDROXYAPATITE FORMATION; OSTEOPONTIN; CELL; MINERALIZATION; BIOMATERIALS; REGENERATION; SCAFFOLDS; CARTILAGE; PROTEINS	Cortical bone exerts its biological properties through internal orientations of hydroxyapatite. Recently, we succeeded in fabricating three-dimensional (3D) patterns of bone matrices using fibrin gels. We hypothesized that these fibrin gels would induce cortical bone-like tissue in vivo and offer promising prospects for biomimetic materials. The purposes of this study were to assess the characteristics of osteoblastic-induced fibrin gels in vitro and evaluate whether fibrin gels with biomimetic matrices formed cortical bone-like tissue in vivo. When bone marrow stromal cell (BMSC)-containing fibrin gels were uniaxially fixed and cultured, BMSCs became aligned parallel to the fixed direction. The tensile strengths of the gels increased dramatically from 1.5 to 218 kPa after 50 days in culture. Furthermore, Fourier-transform infrared spectroscopy revealed that the fibrin gel constituents changed into those of native bone. Quantitative analyses of specific components demonstrated that the amounts of calcium and osteopontin in the gels increased with prolonged culture. After subcutaneous implantation into immunodeficient mice, cortical bone-like tissues that possessed layered structures were formed. The results indicated that 3D patterned bone matrices induced 3D patterned cortical bone formation in vivo. These biomimetic materials containing 3D patterned bone matrices are promising tools for the field of bone regenerative medicine. (C) 2014 Wiley Periodicals, Inc.	[Sasaki, Jun-Ichi; Imazato, Satoshi] Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Suita, Osaka 5650871, Japan; [Matsumoto, Takuya] Okayama Univ, Dept Biomat, Okayama 7008558, Japan	Sasaki, JI (reprint author), Osaka Univ, Grad Sch Dent, Dept Biomat Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	jun1-s@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24792141, 24659846]	Contract grant sponsor: Japan Society for the Promotion of Science (JSPS; Grants-in-Aid for Scientific Research); contract grant numbers: 24792141, 24659846	Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151; Cardoso DA, 2012, J BIOMED MATER RES B, V100B, P2316, DOI 10.1002/jbm.b.32794; Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/nmat3357, 10.1038/NMAT3357]; Ishimoto T, 2013, J BONE MINER RES, V28, P1170, DOI 10.1002/jbmr.1825; Hunter GK, 1996, BIOCHEM J, V317, P59; Schantz JT, 2003, TISSUE ENG, V9, pS113; Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/bioreprod.103.020651; Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279; Egusa H, 2013, TISSUE ENG PT A, V19, P770, DOI [10.1089/ten.TEA.2012.0164, 10.1089/ten.tea.2012.0164]; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019; Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041; Pagni G, 2012, ADV DRUG DELIVER REV, V64, P1310, DOI 10.1016/j.addr.2012.03.005; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Boskey AL, 2012, BIOCHEM BIOPH RES CO, V419, P333, DOI 10.1016/j.bbrc.2012.02.024; Holnthoner W, J TISSUE EN IN PRESS; Matsumoto T, 2011, MATERIALS, V4, P327, DOI 10.3390/ma4010327; Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211; Sasaki JI, 2010, SOFT MATTER, V6, P1662, DOI 10.1039/b922418a; Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	FEB	2015	103	2					622	627		10.1002/jbm.a.35212		6	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA7MP	WOS:000349101700020		
J	Recker, RR; Benson, CT; Matsumoto, T; Bolognese, MA; Robins, DA; Alam, J; Chiang, AY; Hu, LJ; Krege, JH; Sowa, H; Mitlak, BH; Myers, SL				Recker, Robert R.; Benson, Charles T.; Matsumoto, Toshio; Bolognese, Michael A.; Robins, Deborah A.; Alam, Jahangir; Chiang, Alan Y.; Hu, Leijun; Krege, John H.; Sowa, Hideaki; Mitlak, Bruce H.; Myers, Stephen L.			A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						BLOSOZUMAB; SCLEROSTIN ANTIBODY; ANABOLICS; BONE MINERAL DENSITY; OSTEOPOROSIS TREATMENT	MONOCLONAL-ANTIBODY; OSTEOPOROSIS; PERSPECTIVES; OSTEOCYTES; FRACTURES; FEATURES	Sclerostin, a SOST protein secreted by osteocytes, negatively regulates formation of mineralized bone matrix and bone mass. We report the results of a randomized, double-blind, placebo-controlled multicenter phase 2 clinical trial of blosozumab, a humanized monoclonal antibody targeted against sclerostin, in postmenopausal women with low bone mineral density (BMD). Postmenopausal women with a lumbar spine T-score -2.0 to -3.5, inclusive, were randomized to subcutaneous blosozumab 180mg every 4 weeks (Q4W), 180mg every 2 weeks (Q2W), 270mg Q2W, or matching placebo for 1 year, with calcium and vitamin D. Serial measurements of spine and hip BMD and biochemical markers of bone turnover were performed. Overall, 120 women were enrolled in the study (mean age 65.8 years, mean lumbar spine T-score -2.8). Blosozumab treatment resulted in statistically significant dose-related increases in spine, femoral neck, and total hip BMD as compared with placebo. In the highest dose group, BMD increases from baseline reached 17.7% at the spine, and 6.2% at the total hip. Biochemical markers of bone formation increased rapidly during blosozumab treatment, and trended toward pretreatment levels by study end. However, bone specific alkaline phosphatase remained higher than placebo at study end in the highest-dose group. CTx, a biochemical marker of bone resorption, decreased early in blosozumab treatment to a concentration less than that of the placebo group by 2 weeks, and remained reduced throughout blosozumab treatment. Mild injection site reactions were reported more frequently with blosozumab than placebo. In conclusion, treatment of postmenopausal women with an antibody targeted against sclerostin resulted in substantial increases in spine and hip BMD. These results support further study of blosozumab as a potential anabolic therapy for osteoporosis. (c) 2014 American Society for Bone and Mineral Research.	[Recker, Robert R.] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68131 USA; [Benson, Charles T.; Robins, Deborah A.; Alam, Jahangir; Chiang, Alan Y.; Hu, Leijun; Krege, John H.; Mitlak, Bruce H.; Myers, Stephen L.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Matsumoto, Toshio] Univ Tokushima, Fuji Mem Inst Med Sci, Tokushima 770, Japan; [Bolognese, Michael A.] Bethesda Hlth Res, Bethesda, MD USA; [Sowa, Hideaki] Lilly Res Labs Japan, Kobe, Hyogo, Japan	Recker, RR (reprint author), Creighton Univ, Osteoporosis Res Ctr, 601 N 30th St, Omaha, NE 68131 USA.	rrecker@creighton.edu			Eli Lilly and Company	This study was funded by Eli Lilly and Company. We acknowledge Jennifer Meyer Harris, Pharm.D., an employee of Eli Lilly and Company, for assistance with manuscript preparation; and we acknowledge the patients, investigators, and study personnel participating in this study. We also acknowledge the work of personnel in the Laboratory for Experimental Medicine, Eli Lilly and Company, who were responsible for developing and optimizing the screening and neutralizing immunogenicity assays for blosozumab.	Marcus R, 2003, J BONE MINER RES, V18, P18, DOI 10.1359/jbmr.2003.18.1.18; Silva I, 2011, ACTA REUMATOL PORT, V36, P209; van Lierop AH, 2013, J BONE MINER RES, V28, P848, DOI 10.1002/jbmr.1794; McColm J, 2014, J BONE MINER RES, V29, P935, DOI 10.1002/jbmr.2092; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Mallinckrodt CH, 2008, DRUG INF J, V42, P303; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Atkins GJ, 2012, OSTEOPOROSIS INT, V23, P2067, DOI 10.1007/s00198-012-1915-z; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Rossini M, 2013, CALCIFIED TISSUE INT, V93, P121, DOI 10.1007/s00223-013-9749-z; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Li XD, 2008, J BONE MINER RES, V23, P860, DOI [10.1359/jbmr.080216, 10.1359/JBMR.080216]; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; [Anonymous], 1996, GUID GOOD CLIN PRACT, VE6; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Burgers TA, 2013, BONE, V54, P244, DOI 10.1016/j.bone.2013.02.022; Beighton PH, 2002, GENEREVIEWS; Benson CT, 2013, EUR CALC TISS SOC C, V1, DOI [10.1530/boneabs.01.OC5.3, DOI 10.1530/BONEABS.01.OC5.3]; PECK WA, 1993, AM J MED, V94, P646; Costa AG, 2012, CURR OSTEOPOROS REP, V10, P64, DOI 10.1007/s11914-011-0089-5; Das S, 2013, CURR DRUG TARGETS, V14, P1667; Evenepoel E, 2014, NEW ENGL J MED, V370, P1664, DOI [10.1056/NEJMc1402398, DOI 10.1056/NEJMC1402398]; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; International Osteoporosis Foundation, 2014, EPIDEMIOLOGY; Kogawa M, 2013, J BONE MINER RES, V28, P2436, DOI 10.1002/jbmr.2003; Lewiecki EM, 2011, EXPERT OPIN BIOL TH, V11, P117, DOI 10.1517/14712598.2011.540565; Ma YL, 2012, J BONE MINER RES S1, V27; Matsumoto T, 2013, IBMS BONEKEY, V10; National Center for Biotechnology Information, GEN EXPR OMN PUBL FU; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; World Medical Association, DECL HELS ETH PRINC	35	17	17	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	FEB	2015	30	2					216	224		10.1002/jbmr.2351		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CA4CM	WOS:000348851900003		
J	Niimi, R; Kono, T; Nishihara, A; Hasegawa, M; Matsumine, A; Kono, T; Sudo, A				Niimi, Rui; Kono, Toshibumi; Nishihara, Atsushi; Hasegawa, Masahiro; Matsumine, Akihiko; Kono, Toshihiko; Sudo, Akihiro			Cortical Thickness of the Femur and Long-Term Bisphosphonate Use	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						OSTEOPOROSIS; BISPHOSPHONATE; CORTICAL THICKNESS; ATYPICAL FEMORAL FRACTURE; CASE-CONTROL STUDY	FEMORAL FRACTURES; BONE TURNOVER; ALENDRONATE; WOMEN; THERAPY; SHAFT; RISK	Femoral cortical thickening has been mentioned in reports of atypical subtrochanteric/femoral shaft (ST/FS) fractures, which are associated with long-term bisphosphonate (BP) use. However, whether thickening precedes BP use or results from BP use, as well as the role BPs may play in cortical thickening remain unclear. The purpose of this study was to investigate the relationship between cortical thickness and BP use. We enrolled 142 patients (mean age 79 years) who had taken BPs for more than 5 years, and enrolled 426 osteoporosis patients who had not used BPs as controls. We performed a case-control study of patients with long-term BP use and controls matched for age, sex, and levels of activities of daily living (ADLs) (1:3 ratio). On femoral radiographs, we measured femoral cortical thickness in three regions: 5cm and 12.5cm below the lesser trochanter and in the region of maximal cortical thickness. We compared cortical thicknesses between patients taking BP and controls and evaluated longitudinal changes in cortical thickness. There were no significant differences in cortical thickness between long-term BP users and controls. In addition, after further use of BP for a minimum of 1 year, we observed no significant differences in the changes in cortical thickness at any level of the femur. In conclusion, our study did not find evidence of cortical thickening at the ST/FS area of the femur with long-term BP use. (c) 2014 American Society for Bone and Mineral Research.	[Niimi, Rui; Kono, Toshibumi; Nishihara, Atsushi; Kono, Toshihiko] Tomidahama Hosp, Dept Orthopaed Surg, Yokaichi, Mie 5108008, Japan; [Hasegawa, Masahiro; Matsumine, Akihiko; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 514, Japan	Niimi, R (reprint author), Tomidahama Hosp, Dept Orthopaed Surg, 26-14 Tomidahamacho, Yokaichi, Mie 5108008, Japan.	furikakefuri@hotmail.co.jp					Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Odvina CV, 2010, CLIN ENDOCRINOL, V72, P161, DOI 10.1111/j.1365-2265.2009.03581.x; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Unnanuntana A, 2012, CLIN ORTHOP RELAT R, V470, P291, DOI 10.1007/s11999-011-1985-9; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Bauer DC, 2004, J BONE MINER RES, V19, P1250, DOI 10.1359/JBMR.040512; Thompson RN, 2012, J BONE JOINT SURG BR, V94B, P385, DOI 10.1302/0301-620X.94B3.27999; Giusti A, 2011, BONE, V48, P966, DOI 10.1016/j.bone.2010.12.033; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Beck TJ, 2008, J CLIN DENSITOM, V11, P351, DOI 10.1016/j.jocd.2008.04.001; Burghardt AJ, 2010, J BONE MINER RES, V25, P2282, DOI 10.1002/jbmr.157; Chen F, 2014, BONE, V62, P64, DOI 10.1016/j.bone.2014.01.011; Koeppen VA, 2012, OSTEOPOROSIS INT, V23, P2893, DOI 10.1007/s00198-012-2173-9; Lehman F, 2007, NONPARAMETRICS STAT, P55; Lo JC, 2012, BONE, V51, P181; Loewen S, 2006, MOD LANG J, V90, P536, DOI 10.1111/j.1540-4781.2006.00465.x; Napoli N, 2012, J CLIN ENDOCR METAB, V97, P2414, DOI 10.1210/jc.2011-3256; Niimi R, 2014, BONE, V66, P26, DOI 10.1016/j.bone.2014.05.017; Ott SM, 2005, J CLIN ENDOCR METAB, V90, P1897, DOI 10.1210/jc.2005-0057; Sah AP, OSTEOPOROS INT, V18, P1119; Saita Y., 2014, J BONE MINER METAB; Shkolnikova J, 2013, ANZ J SURG, V83, P175, DOI 10.1111/ans.12018	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	FEB	2015	30	2					225	231		10.1002/jbmr.2345		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CA4CM	WOS:000348851900004		
J	Hayata, T; Ezura, Y; Asashima, M; Nishinakamura, R; Noda, M				Hayata, Tadayoshi; Ezura, Yoichi; Asashima, Makoto; Nishinakamura, Ryuichi; Noda, Masaki			Dullard/Ctdnep1 Regulates Endochondral Ossification via Suppression of TGF-beta Signaling	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						DULLARD; CTDNEP1; PRX1-CRE; TGF-; CHONDROCYTES; ENDOCHONDRAL OSSIFICATION	WEILL-MARCHESANI-SYNDROME; GROWTH-FACTOR-BETA; BONE-FORMATION; CHONDROCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; SKELETAL DEVELOPMENT; AORTIC-ANEURYSM; IN-VITRO; MUTATIONS; CARTILAGE	Transforming growth factor (TGF)- signaling plays critical roles during skeletal development and its excessive signaling causes genetic diseases of connective tissues including Marfan syndrome and acromelic dysplasia. However, the mechanisms underlying prevention of excessive TGF- signaling in skeletogenesis remain unclear. We previously reported that Dullard/Ctdnep1 encoding a small phosphatase is required for nephron maintenance after birth through suppression of bone morphogenetic protein (BMP) signaling. Unexpectedly, we found that Dullard is involved in suppression of TGF- signaling during endochondral ossification. Conditional Dullard-deficient mice in the limb and sternum mesenchyme by Prx1-Cre displayed the impaired growth and ossification of skeletal elements leading to postnatal lethality. Dullard was expressed in early cartilage condensations and later in growth plate chondrocytes. The tibia growth plate of newborn Dullard mutant mice showed reduction of the proliferative and hypertrophic chondrocyte layers. The sternum showed deformity of cartilage primordia and delayed hypertrophy. Micromass culture experiments revealed that Dullard deficiency enhanced early cartilage condensation and differentiation, but suppressed mineralized hypertrophic chondrocyte differentiation, which was reversed by treatment with TGF- type I receptor kinase blocker LY-364947. Dullard deficiency induced upregulation of protein levels of both phospho-Smad2/3 and total Smad2/3 in micromass cultures without increase of Smad2/3 mRNA levels, suggesting that Dullard may affect Smad2/3 protein stability. The phospho-Smad2/3 level was also upregulated in perichondrium and hypertrophic chondrocytes in Dullard-deficient embryos. Response to TGF- signaling was enhanced in Dullard-deficient primary chondrocyte cultures at late, but not early, time point. Moreover, perinatal administration of LY-364947 ameliorated the sternum deformity in vivo. Thus, we identified Dullard as a new negative regulator of TGF- signaling in endochondral ossification. (c) 2014 American Society for Bone and Mineral Research.	[Hayata, Tadayoshi; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Tokyo 1138510, Japan; [Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Ibaraki, Japan; [Nishinakamura, Ryuichi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, Kumamoto, Japan; [Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence COE Program, Tokyo 1138510, Japan	Noda, M (reprint author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	noda.mph@mri.tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Global COE Programs from MEXT; International Research Center for Molecular Science in Tooth and Bone Diseases (Tokyo Medical & Dental University); Cell Fate Regulation Research and Education Unit (Kumamoto University); program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University	This research was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by the Global COE Programs from MEXT; International Research Center for Molecular Science in Tooth and Bone Diseases (Tokyo Medical & Dental University) and Cell Fate Regulation Research and Education Unit (Kumamoto University) and by the program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University. We thank Drs. Clifford J. Tabin and Noriyuki Tsumaki for Prx1-Cre mice, and Drs. Ken W.Y. Cho, Kohei Miyazono, and Kunikazu Tsuji for plasmids.	Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Candia AF, 1997, DEVELOPMENT, V124, P4467; Li TF, 2006, J BONE MINER RES, V21, P4, DOI 10.1359/JBMR.050911; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Liu Z, 2011, DEV GROWTH DIFFER, V53, P822, DOI 10.1111/j.1440-169X.2011.01289.x; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; ROARK EF, 1994, DEV DYNAM, V200, P103; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Carlevaro MF, 2000, J CELL SCI, V113, P59; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Le Goff C, 2012, NAT GENET, V44, P85, DOI 10.1038/ng.1016; Sueyoshi T, 2012, MATRIX BIOL, V31, P352, DOI 10.1016/j.matbio.2012.07.002; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Fujimaki R, 2006, J BONE MINER METAB, V24, P191, DOI 10.1007/s00774-005-0671-y; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Gerstenfeld LC, 1996, J CELL BIOCHEM, V62, P1; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Dunker N, 2002, ANAT EMBRYOL, V206, P73, DOI 10.1007/s00429-002-0273-6; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Estrada KD, 2011, J BONE MINER RES, V26, P2498, DOI 10.1002/jbmr.443; Hogan B, 1994, MANIPULATING MOUSE E; Le Goff C, 2012, AM J MED GENET C, V160C, P145, DOI 10.1002/ajmg.c.31337; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Matsunobu T, 2009, DEV BIOL, V332, P325, DOI 10.1016/j.ydbio.2009.06.002; Miyajima D, 2012, J BIOL CHEM, V287, P33545, DOI 10.1074/jbc.M111.329938; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V234, P206, DOI 10.1006/bbrc.1997.6528; Sakaguchi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2408; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Tanaka SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057428; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b	57	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	FEB	2015	30	2					318	329		10.1002/jbmr.2343		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CA4CM	WOS:000348851900014		
J	Okamoto, Y; Nohmi, T; Higa, Y; Seki, K; Yamashita, A				Okamoto, Yasuhisa; Nohmi, Toshihiro; Higa, Yuki; Seki, Kouichiro; Yamashita, Akihide			Vasopressin Does Not Raise Cardiac Enzymes Following Cardiac Surgery: A Randomized Double-Blind Clinical Trial	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						vasopressin; cardiac surgery; cardiac enzymes; vasoplegia; vasoconstrictor	ADVANCED VASODILATORY SHOCK; SEPTIC SHOCK; ARGININE-VASOPRESSIN; NOREPINEPHRINE; ASSOCIATION; MANAGEMENT; ELEVATION; ISCHEMIA; INFUSION	Objective: The aim of this study was to investigate the relationship between intraoperative vasopressin infusion and postoperative cardiac enzymes. Design: A prospective, double-blind, randomized, controlled study. Setting: A single tertiary cardiac center. Participants: One hundred consecutive patients undergoing cardiac surgery with or without cardiopulmonary bypass. Interventions: The study was approved by the Institutional Review Board, and patients provided informed consent to participate. Patients were randomized by computer into 2 equal groups: Vasopressin or control. The blinded study included vasopressin administered at a dose of 1.8 U/h or 1.8 mL/h of normal saline, along with catecholamines. The drug was administered continually during surgery while patients needed catecholamines. The intervention was discontinued upon admission to the intensive care unit when information regarding the true character of the drug was reported to the doctor in charge of patients in the intensive care unit by one of the investigators. Primary outcomes were CK-MB and troponin T levels measured at 0, 6, and 12 hours postoperatively. Measurements and Main Results: Of the 100 patients, 8 were excluded; the remaining 92 were randomized to either the vasopressin (n = 47) or control (n = 45) group. There were no significant differences in demographic data between the groups. Postoperatively at 0, 6, and 12 hours, there were no differences in CK-MB (U/I) (37.5 +/- 57.9 v32.0 +/- 21.5,29.4 +/- 41.1 v24.4 +/- 23.1, and 21.4 +/- 21.3 v. 21.8 +/- 32.4, respectively) and troponin T (752.4 +/- 638.2 v762.7 +/- 557.1, 753.8 +/- 507.3 v 777.6 +/- 515.0, and 774.6 +/- 572.6 v698.7 +/- 540.2, respectively) values. Conclusions: Vasopressin infusion has been used to treat catecholamine-unresponsive shock. In this study, intraoperative vasopressin was used safely as a possible first-line drug for treating hypotension; however, it did not increase the levels of cardiac enzymes after cardiac surgery. (C) 2014 Elsevier Inc. All rights reserved.	[Okamoto, Yasuhisa; Nohmi, Toshihiro; Higa, Yuki; Seki, Kouichiro; Yamashita, Akihide] IMS Katusika Heart Ctr, Dept Anesthesia, Katusika Ku, Tokyo 1240006, Japan	Okamoto, Y (reprint author), IMS Katusika Heart Ctr, Dept Anesthesia, Katusika Ku, 3-30-1 Horikiri, Tokyo 1240006, Japan.	yasuhisao@yahoo.co.jp					Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Argenziano M, 1998, J THORAC CARDIOV SUR, V116, P973, DOI 10.1016/S0022-5223(98)70049-2; Luckner G, 2005, CRIT CARE MED, V33, P2659, DOI 10.1097/01.CCM.0000186749.34028.40; Dunser MW, 2003, CIRCULATION, V107, P2313, DOI 10.1161/01.CIR.0000066692.71008.BB; Landesberg G, 2014, CRIT CARE MED, V42, P790, DOI 10.1097/CCM.0000000000000107; Egi M, 2007, ANN THORAC SURG, V83, P715, DOI 10.1016/j.athoracsur.2006.08.041; Papadopoulos G, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-17; Fellahi JL, 2013, ANESTHESIOLOGY, V118, P1460, DOI 10.1097/ALN.0b013e31828f4fc3; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Landry DW, 1997, CIRCULATION, V95, P1122; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Arsenault KA, 2013, COCHRANE DB SYST REV, V31, P1; Colson PH, 2011, CRIT CARE, V15, DOI 10.1186/cc10516; Elgebaly Ahmed Said, 2012, Ann Card Anaesth, V15, P128, DOI 10.4103/0971-9784.95076; Mehta S, 2013, CRIT CARE, V17, DOI 10.1186/cc12789; Olivero Juan Jose, 2012, Methodist Debakey Cardiovasc J, V8, P31; Polito A, 2012, CRIT CARE, V16, DOI 10.1186/cc11887; Shizad M, 2010, REV ESP CARDIOLOGIA, V63, P1054; Yimin Hu, 2013, J Cardiothorac Surg, V8, P49, DOI 10.1186/1749-8090-8-49	20	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	FEB	2015	29	1					46	51		10.1053/j.jvca.2014.07.007		6	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	CB1ZP	WOS:000349426800008		
J	Unami, K; Mohawesh, O; Sharifi, E; Takeuchi, J; Fujihara, M				Unami, Koichi; Mohawesh, Osama; Sharifi, Erfaneh; Takeuchi, Junichiro; Fujihara, Masayuki			Stochastic modelling and control of rainwater harvesting systems for irrigation during dry spells	JOURNAL OF CLEANER PRODUCTION			English	Article						Rainwater harvesting; Irrigation; Langevin equation; Stochastic control; Rule curve; Jordan Rift Valley	JACOBI-BELLMAN EQUATIONS; FINITE-ELEMENT APPROXIMATION; GENETIC ALGORITHM; WATER MANAGEMENT; RULE CURVES; MICRO-DAM; RESERVOIR; SIMULATION; JORDAN	A generic rainwater harvesting system including a catchment area and a command area is often equipped with rainwater storage tanks. The stochastic nature of precipitation dominates water balance of rainwater harvesting systems, and the theory of stochastic control better serves for determining optimal strategies for water management. A mathematical model consisting of stochastic differential equations, with few model parameters that can be identified from observed data, is developed to describe dynamics of rainwater harvesting systems for irrigation. Stochastic control problems are formulated and then solved to obtain the optimal irrigation strategies during dry spells. This procedure can be inversely applicable to designing dimensions of a system. Identification of the model parameters is demonstrated with the data observed in an experimental micro rainwater harvesting system in Japan as well as in semiarid savanna of Ghana. Then, a real life application is discussed in the context of the Jordan Rift Valley, where a rainwater harvesting system will be developed. (C) 2014 Elsevier Ltd. All rights reserved.	[Unami, Koichi; Sharifi, Erfaneh; Takeuchi, Junichiro; Fujihara, Masayuki] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Mohawesh, Osama] Mutah Univ, Prince Faisal Ctr Dead Sea Environm & Energy Res, Al Karak, Jordan; [Mohawesh, Osama] Mutah Univ, Dept Plant Prod, Fac Agr, Al Karak, Jordan	Unami, K (reprint author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	unami@adm.kais.kyoto-u.ac.jp					Agyare WA, 2002, AGROFOREST SYST, V54, P197, DOI 10.1023/A:1016087905272; Al-Ayyash S., 2012, Journal of Water Resource and Protection, V4, P127, DOI 10.4236/jwarp.2012.43015; Moghaddasi M, 2013, WATER RESOUR MANAG, V27, P1651, DOI 10.1007/s11269-012-0255-2; Eum HI, 2012, WATER RESOUR MANAG, V26, P3785, DOI 10.1007/s11269-012-0103-4; Pachpute JS, 2009, WATER RESOUR MANAG, V23, P2815, DOI 10.1007/s11269-009-9411-8; Ngoc TA, 2014, PADDY WATER ENVIRON, V12, P125, DOI 10.1007/s10333-013-0366-2; Khan NM, 2012, WATER RESOUR MANAG, V26, P3173, DOI 10.1007/s11269-012-0066-5; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Napoles-Rivera F, 2013, J CLEAN PROD, V47, P102, DOI 10.1016/j.jclepro.2013.01.038; Chang NB, 2011, J CLEAN PROD, V19, P1180, DOI 10.1016/j.jclepro.2011.02.008; Closson D, 2007, ENVIRON GEOL, V52, P155, DOI 10.1007/s00254-006-0469-9; Jothiprakash V, 2006, WATER RESOUR MANAG, V20, P917, DOI 10.1007/s11269-005-9014-y; Authority Jordan Valley, 2004, GEN INF 3 CPIMTR TRA; Boulbrachene M, 2009, NUMER FUNC ANAL OPT, V30, P421, DOI 10.1080/01630560902987683; Boulbrachene M, 2004, APPL MATH COMPUT, V158, P585, DOI 10.1016/j.amc.2003.10.002; Boulbrachene M, 2001, COMPUT MATH APPL, V41, P993, DOI 10.1016/S0898-1221(00)00334-5; de Moraes AFJ, 2013, J CLEAN PROD, V60, P163, DOI 10.1016/j.jclepro.2013.03.015; GUERRA LC, 1990, AGR WATER MANAGE, V17, P351, DOI 10.1016/0378-3774(90)90085-D; Karczewska A, 2009, J MATH ANAL APPL, V349, P301, DOI 10.1016/j.jmaa.2008.09.005; Kumar S, 2004, OPER RES, V52, P563, DOI 10.1287/opre.1030.0107; Makurira H, 2007, PHYS CHEM EARTH, V32, P1090, DOI 10.1016/j.pce.2007.07.020; Kahinda JM, 2011, PHYS CHEM EARTH, V36, P968, DOI 10.1016/j.pce.2011.08.011; Ngigi SN, 2005, AGR WATER MANAGE, V73, P21, DOI 10.1016/j.agwat.2004.09.021; Oksendal B., 2007, STOCHASTIC DIFFERENT; Panigrahi B, 2007, RESOUR CONSERV RECY, V50, P459, DOI 10.1016/j.resconrec.2006.08.002; Senga Y., 1991, Irrigation and Drainage Systems, V5, P129, DOI 10.1007/BF01140517; Shreve S.E., 1991, BROWNIAN MOTION STOC; Suiadee W, 2007, HYDROL PROCESS, V21, P3211, DOI 10.1002/hyp.6528; Tarawneh Q, 2003, THEOR APPL CLIMATOL, V74, P123, DOI 10.1007/s00704-002-0705-5; Thanawong K., 2014, J CLEAN PROD, P1; Unami K, 2013, STOCH ENV RES RISK A, V27, P77, DOI 10.1007/s00477-012-0555-3; Unami K, 2005, PADDY WATER ENVIRON, V3, P191, DOI 10.1007/s10333-005-0022-6; Unami K, 2010, STOCH ENV RES RISK A, V24, P725, DOI 10.1007/s00477-009-0359-2; Vallentin A., 2003, GUIDELINES BRACKISH	34	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-6526	1879-1786		J CLEAN PROD	J. Clean Prod.	FEB 1	2015	88						185	195		10.1016/j.jclepro.2014.03.100		11	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AY7YG	WOS:000347771100020		
J	Ooba, M; Hayashi, K; Fujii, M; Fujita, T; Machimura, T; Matsui, T				Ooba, Makoto; Hayashi, Kiichiro; Fujii, Minoru; Fujita, Tsuyoshi; Machimura, Takashi; Matsui, Takanori			A long-term assessment of ecological-economic sustainability of woody biomass production in Japan	JOURNAL OF CLEANER PRODUCTION			English	Article						Cost analysis; Forest ecosystem model; Footprint; Occupancy rate time index (ORT); Woody biomass	BIOGEOCHEMICAL MODEL; ECOSYSTEM SERVICES; BGC-ES; FOREST; ENERGY; CAPACITY; TOYOTA; BASIN	The forestry process in Japan, from plantation stage to wood biomass production, was assessed using a process-based ecological model, forestry cost calculation model, and an ecological footprint-like index. In order to estimate ecosystem dynamics under various forest management practices, the ecosystem model simulated material cycles. The cost calculation model estimated the economic cost for each stage of woody biomass (wood chip) production. An occupancy rate time index (ORT) was defined by a 200-year usage span for land, material, pollution and labor against the amount available for woody biomass production. The models and the index were combined and four forest management scenarios were evaluated on a community scale in Japan: business as usual (BAU), a forest management recommended by the local government to enhance and improve forest management to include woody biomass production; FM1, modified practices; FM2, extended practices; and CNV, converting part of a plantation into natural broadleaf forest under the FM2 scenario, considering the biodiversity of the forests. The results for long-term simulations revealed that the current forest management (BAU and FM1) was not efficient in the production of woody biomass in terms of economic cost and ORT. The FM2 scenario modified from the FM1 scenario would produce ecological and economical improvements, but integrated assessment by using ORT indicated an increase in carbon emissions and labor due to enhanced forest practices. Woody biomass production under the FM2 scenario needs to be supported by carbon offsetting, such as reduction of coal combustion in thermal power plants. Under the CNV scenario, ORT values were the same as those under BAU and FM1 if the carbon offset was considered. The CNV scenario was found to be the best, considering the impact on ecological and social systems. (C) 2014 Elsevier Ltd. All rights reserved.	[Ooba, Makoto; Hayashi, Kiichiro] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648601, Japan; [Fujii, Minoru; Fujita, Tsuyoshi] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Machimura, Takashi; Matsui, Takanori] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Ooba, M (reprint author), Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648601, Japan.	ooba.makoto@nies.go.jp			Funding Program for Next Generation World-Leading Researchers (MEXT, Japan); Environment Research and Technology Development Fund (MOE, Japan) [K113002, 2-1404]; JSPS, Japan [GZ003]	This study was supported by the Funding Program for Next Generation World-Leading Researchers (MEXT, Japan) and the Environment Research and Technology Development Fund (K113002 and 2-1404, MOE, Japan). Development of the BGE-ES model was supported by a Grant-in-Aid from special coordination funds for promoting science and technology (GZ003, JSPS, Japan). Forest environmental information was provided by Aichi Prefecture.	Zuwala J, 2012, J CLEAN PROD, V35, P164, DOI 10.1016/j.jclepro.2012.06.001; Mirata M, 2005, J CLEAN PROD, V13, P981, DOI 10.1016/j.jclepro.2004.12.018; Kinoshita T, 2009, APPL ENERG, V86, P1, DOI 10.1016/j.apenergy.2008.03.017; Sacchelli S, 2014, J CLEAN PROD, V66, P431, DOI 10.1016/j.jclepro.2013.11.059; Valente C, 2011, J CLEAN PROD, V19, P1931, DOI 10.1016/j.jclepro.2011.06.026; Hirata R, 2008, AGR FOREST METEOROL, V148, P761, DOI 10.1016/j.agrformet.2007.11.016; McIlveen-Wright DR, 2011, FUEL, V90, P11, DOI 10.1016/j.fuel.2010.08.022; Buehlmann U, 2009, J CLEAN PROD, V17, P271, DOI 10.1016/j.jclepro.2008.06.002; Dhakal Ambika, 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P198, DOI 10.1080/21513732.2014.920420; Fujii M., 2010, ENV SCI, V23, P410; Fujii M, 2014, ECOL INDIC, V46, P52, DOI 10.1016/j.ecolind.2014.06.001; Gonzalez-Garcia S., 2013, J CLEAN PROD, V64, P356; Jamali-Zghal N., 2012, J CLEAN PROD, V47, P446; Kanamori Hiroki, 2008, Honyurui Kagaku, V48, P57; Kinoshita T, 2010, APPL ENERG, V87, P2923, DOI 10.1016/j.apenergy.2009.08.025; Ministry of Agriculture Forestry and Fisheries, 2008, REP RES 2005 CENS AG; Ministry of Agriculture Forestry and Fisheries, 2013, STAT YB WOOD SUPPL D; Ministry of Economy Trading and Industry Japan Agency for Natural Resources, 2010, EST STRAT EN PLAN JA; Ministry of the Environment, 2011, STUD POT INTR REN EN; Monteith J.L., 1990, PRINCIPLES ENV PHYS; Nansai K., 2010, EMBODIED ENERGY EMIS; National Institute of Population and Social Security Research, 2003, POP PROJ JAP; Ng RS, 2014, J CLEAN PROD, V65, P447, DOI 10.1016/j.jclepro.2013.07.053; Ooba M, 2012, PROCEDIA ENVIRON SCI, V13, P274, DOI 10.1016/j.proenv.2012.01.026; Ooba M, 2014, J AGRIC METEOROL, V70, P41, DOI 10.2480/agrmet.D-13-00006; Ooba M, 2012, WASTE BIOMASS VALORI, V3, P425, DOI 10.1007/s12649-012-9157-z; Ooba M, 2010, ECOL MODEL, V221, P1979, DOI 10.1016/j.ecolmodel.2010.05.008; Reegle, 2012, COUNTR EN PROF JAP; Ueyama M, 2011, ECOL MODEL, V222, P3216, DOI 10.1016/j.ecolmodel.2011.05.006; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107	30	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-6526	1879-1786		J CLEAN PROD	J. Clean Prod.	FEB 1	2015	88						318	325		10.1016/j.jclepro.2014.09.072		8	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AY7YG	WOS:000347771100034		
J	Kobayashi, M; Nanri, K; Taguchi, T; Ishiko, T; Yoshida, M; Yoshikawa, N; Sugisaki, K; Tanaka, N				Kobayashi, Masatake; Nanri, Kazunori; Taguchi, Takeshi; Ishiko, Tomoko; Yoshida, Masaharu; Yoshikawa, Noriko; Sugisaki, Kentaro; Tanaka, Nobuyuki			Immunoadsorption Therapy for Neuromyelitis Optica Spectrum Disorders Long After the Acute Phase	JOURNAL OF CLINICAL APHERESIS			English	Article						neuromyelitis optica; plasmapheresis; steroid therapy	MULTIPLE-SCLEROSIS; PLASMA-EXCHANGE	Neuromyelitis optica (NMO) is a severe inflammatory demyelinating disease with exacerbations involving recurrent or bilateral optic neuritis and longitudinally extensive transverse myelitis. Pulse steroid therapy is recommended as the initial, acute-phase treatment for NMO. If ineffective, treatment with plasma exchange (PE) should commence. However, no evidence exists to support the effectiveness of PE long after the acute phase. Immunoadsorption therapy (IA) eliminates pathogenic antibodies while sparing other plasma proteins. With IA, side effects of PE resulting from protein substitution can be avoided. However, whether IA is effective for NMO remains unclear. We describe a patient with anti-aquaporin-4-positive myelitis who responded to IA using a tryptophan polyvinyl alcohol gel column that was begun 52 days after disease onset following the acute phase. Even long after the acute phase when symptoms appear to be stable, IA may be effective and should not be excluded as a treatment choice. J. Clin. Apheresis 30:43-45, 2015. (c) 2014 Wiley Periodicals, Inc.	[Kobayashi, Masatake] Tokyo Med Univ, Hachioji Med Ctr, Dept Cardiol, Hachioji, Tokyo 1930998, Japan; [Nanri, Kazunori; Taguchi, Takeshi; Ishiko, Tomoko; Tanaka, Nobuyuki] Tokyo Med Univ, Hachioji Med Ctr, Dept Neurol, Hachioji, Tokyo 1930998, Japan; [Yoshida, Masaharu; Yoshikawa, Noriko; Sugisaki, Kentaro] Tokyo Med Univ, Hachioji Med Ctr, Dept Nephrol, Hachioji, Tokyo 1930998, Japan	Nanri, K (reprint author), Tokyo Med Univ, Hachioji Med Ctr, Dept Neurol, 1163 Tatemachi, Hachioji, Tokyo 1930998, Japan.	synapse@tokyo-med.ac.jp					Sato D, 2012, ARQ NEURO-PSIQUIAT, V70, P59, DOI 10.1590/S0004-282X2012000100012; Heigl F, 2013, ATHEROSCLEROSIS SUPP, V14, P167, DOI 10.1016/j.atherosclerosissup.2012.10.025; Keegan M, 2002, NEUROLOGY, V58, P143; Bonnan M, 2012, MULT SCLER INT, DOI [10.1155/2012/787630, DOI 10.1155/2012/787630]; Gwathmey K, 2012, J CLIN APHERESIS, V27, P138, DOI 10.1002/jca.21219; Kim SH, 2013, J CLIN NEUROL, V9, P36, DOI 10.3988/jcn.2013.9.1.36; Kohsaka M, 2010, CLIN NEUROL, V50, P111; Koziolek MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-80; Lana-Peixoto MA, 2012, ARQ NEURO-PSIQUIAT, V70, P807, DOI 10.1590/S0004-282X2012001000010; Munemoto M, 2011, J CLIN NEUROSCI, V18, P478, DOI 10.1016/j.jocn.2010.07.141	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2459	1098-1101		J CLIN APHERESIS	J. Clin. Apheresis	FEB	2015	30	1					43	45		10.1002/jca.21324		3	Hematology	Hematology	CB1LK	WOS:000349388800008		
J	Kawaguchi, J; Matsuura, N; Kasahara, M; Ichinohe, T				Kawaguchi, Jun; Matsuura, Nobuyuki; Kasahara, Masataka; Ichinohe, Tatsuya			Cervical Sympathetic Block Prolongs the Latency and Reduces the Amplitude of Trigeminal Somatosensory Evoked Potentials on the Contralateral Side	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Cervical sympathetic block; Trigeminal somatosensory evoked potentials	STELLATE GANGLION BLOCK; CAROTID-ENDARTERECTOMY; PLEXUS BLOCK; NERVE; ISCHEMIA; PAIN	Purpose:The purpose of this study was to investigate the latency and amplitude of trigeminal somatosensory evoked potentials to clarify how nerve function on the contralateral side is affected after cervical sympathetic block (CSB).Methods:Subjects comprised 16 volunteers. For CSB, the tip of a needle was contacted with the transverse process of the sixth cervical vertebra on the right side, and lidocaine was injected. Trigeminal somatosensory evoked potentials were recorded bilaterally from C5/C6 scalp positions. Pupil diameters were also measured. Electrical stimulations were applied to the left-side lower lip, and trigeminal somatosensory evoked potentials waveforms derived from both sides of the scalp were recorded. Then, electrical stimulations were applied to the right-side of the lower lip, and recording was again performed. Recordings were performed at 5, 15, and 30 minutes after CSB.Results:On the CSB side, pupil diameter decreased at 5 and 15 minutes after CSB. Trigeminal somatosensory evoked potentials at contralateral stimulation showed a prolongation of the latency in both P20 and N25 components on bilateral recording sites 5 and 15 minutes after CSB. Trigeminal somatosensory evoked potentials' amplitude at contralateral stimulation was smaller than at ipsilateral stimulation 5 minutes after CSB.Conclusions:Cervical sympathetic block prolongs the latency and reduces the amplitude of trigeminal somatosensory evoked potentials on the contralateral side.	[Kawaguchi, Jun; Matsuura, Nobuyuki; Ichinohe, Tatsuya] Tokyo Dent Coll, Dept Dent Anesthesiol, Chiba 2618502, Japan; [Kasahara, Masataka] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Tokyo, Japan	Kawaguchi, J (reprint author), Tokyo Dent Coll, Dept Dent Anesthesiol, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	kawaguchij@tdc.ac.jp					Florence G, 2004, NEUROPHYSIOL CLIN, V34, P17, DOI 10.1016/S0987-7053(04)00002-4; Tamura Y, 2008, NEUROIMAGE, V43, P128, DOI 10.1016/j.neuroimage.2008.06.040; BARKER GR, 1987, BRIT J ORAL MAX SURG, V25, P308, DOI 10.1016/0266-4356(87)90070-2; BARON HC, 1979, SURG GYNECOL OBSTET, V148, P534; BENNETT AJ, 1987, INT J ORAL MAX SURG, V16, P408, DOI 10.1016/S0901-5027(87)80076-0; Elias M, 2000, Pain Physician, V3, P294; Hanamatsu N, 2002, REGION ANESTH PAIN M, V27, P268, DOI 10.1053/rapm.2002.31206; Hasegawa A, 2005, AICHI GAKUIN DENT SC, V43, P47; Higa K, 2006, ANESTHESIOLOGY, V105, P1238, DOI 10.1097/00000542-200612000-00024; Iwama H, 1992, Masui, V41, P1250; Kang CK, 2010, ANESTHESIOLOGY, V113, P936, DOI 10.1097/ALN.0b013e3181ec63f5; Kasahara M, 2012, J ORAL MAXIL SURG, V70, P45, DOI 10.1016/j.joms.2011.06.217; Kwok AOK, 2006, ANESTH ANALG, V102, P376, DOI 10.1213/01.ane.0000189189.47768.42; LESNICK JE, 1984, J NEUROSURG, V60, P490, DOI 10.3171/jns.1984.60.3.0490; Malcharek MJ, 2011, CLIN NEUROPHYSIOL, V122, P1048, DOI 10.1016/j.clinph.2010.08.017; Melis M, 2002, J OROFAC PAIN, V16, P93; MILLIGAN NS, 1985, PAIN, V23, P381, DOI 10.1016/0304-3959(85)90008-9; Murakawa K, 1994, EUR ARCH OTO-RHINO-L, P532; Salvaggio I, 2008, PAIN MED, V9, P958, DOI 10.1111/j.1526-4637.2008.00515.x; Seki Y, 1987, No To Shinkei, V39, P105; Seki Y, 1987, No To Shinkei, V39, P455; Stecker M, 2013, CLIN NEUROPHYSIOL, V124, P792, DOI 10.1016/j.clinph.2012.09.013; Suzuki A, 1984, CLIN EEG, V26, P499; Terakawa Y, 2009, REGION ANESTH PAIN M, V34, P553, DOI 10.1097/AAP.0b013e3181b4c505; Weiss A, 2005, ACTA ANAESTH SCAND, V49, P715, DOI 10.1111/j.1399-6576.2005.00694.x; Yamazaki Y, 1998, Masui, V47, P1233; Yanagisawa S, 1986, J ORAL MAXILLOFAC SU, V32, P895; YOUNG MJ, 1992, DIABETOLOGIA, V35, P1146, DOI 10.1007/BF00401368	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	FEB	2015	32	1					39	43		10.1097/WNP.0000000000000122		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB2FS	WOS:000349443000010		
J	Takeuchi, N; Mori, T; Nishijima, K; Kondo, T; Izumi, SI				Takeuchi, Naoyuki; Mori, Takayuki; Nishijima, Kazunori; Kondo, Takeo; Izumi, Shin-Ichi			Inhibitory Transcranial Direct Current Stimulation Enhances Weak Beta Event-Related Synchronization After Foot Motor Imagery in Patients With Lower Limb Amputation	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Rehabilitation; Brain computer interface; Brain stimulation; Reorganization; Amputation	BRAIN-COMPUTER INTERFACE; INPATIENT REHABILITATION; EEG; WALKING; CORTEX; DESYNCHRONIZATION; REORGANIZATION; MODULATION; MOVEMENTS; AMPUTEES	Purpose:Sensorimotor rhythm patterns in patients with lower limb amputations might be altered because of reorganization of the sensorimotor cortices. The authors evaluated the sensorimotor rhythm of motor imagery (MI) in healthy subjects and patients with lower limb amputations. In addition, the authors investigated whether transcranial direct current stimulation (tDCS) could modulate sensorimotor rhythm control.Methods:Six healthy subjects and six patients with lower limb amputations were assigned to receive anodal, cathodal, or sham tDCS over the foot motor area in a randomized order. The authors evaluated event-related desynchronization and event-related synchronization (ERS) of unilateral hand and bilateral foot MI before and after tDCS.Results:Beta ERS of foot MI in patients with lower limb amputations was significantly lesser than that in healthy subjects. Compared with sham stimulation, cathodal tDCS enhanced beta ERS of foot MI in patients with lower limb amputations. In contrast, anodal tDCS decreased beta ERS of foot MI in healthy subjects.Conclusions:This is the first study to demonstrate that cathodal tDCS can enhance a weak beta ERS of foot MI in patients with lower limb amputations. These findings might contribute in improving the effectiveness of sensorimotor rhythm-based brain computer interface for gait restoration after lower limb amputation.	[Takeuchi, Naoyuki; Mori, Takayuki; Kondo, Takeo; Izumi, Shin-Ichi] Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Sendai, Miyagi 9808575, Japan; [Nishijima, Kazunori] Miyagi Prefectural Govt, Rehabil Support Ctr, Natori, Miyagi, Japan	Takeuchi, N (reprint author), Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	naoyuki@m.tohoku.ac.jp			JSPS [25242054]	This study was supported by JSPS Grant-in-Aid for Scientific Research Number 25242054.	Tombini M, 2012, NEUROREHAB NEURAL RE, V26, P275, DOI 10.1177/1545968311408919; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Wei PF, 2013, IEEE T NEUR SYS REH, V21, P404, DOI 10.1109/TNSRE.2013.2249111; IKEDA A, 1992, BRAIN, V115, P1017, DOI 10.1093/brain/115.4.1017; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; Casadio M, 2012, J MOTOR BEHAV, V44, P419, DOI 10.1080/00222895.2012.700968; Stineman MG, 2008, ARCH PHYS MED REHAB, V89, P1863, DOI 10.1016/j.apmr.2008.03.013; Karl A, 2001, J NEUROSCI, V21, P3609; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Kaiser V, 2012, STROKE, V43, P2735, DOI 10.1161/STROKEAHA.112.665489; Neuper C, 1999, J CLIN NEUROPHYSIOL, V16, P373, DOI 10.1097/00004691-199907000-00010; Pfurtscheller G, 2009, CLIN NEUROPHYSIOL, V120, P24, DOI 10.1016/j.clinph.2008.09.027; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Cassim F, 2001, NEUROREPORT, V12, P3859, DOI 10.1097/00001756-200112040-00051; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; Czerniecki JM, 2012, ARCH PHYS MED REHAB, V93, P1384, DOI 10.1016/j.apmr.2012.03.019; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Sansam K, 2009, J REHABIL MED, V41, P593, DOI 10.2340/16501977-0393; Malouin F, 2010, PHYS THER, V90, P240, DOI 10.2522/ptj.20090029; Chen R, 1998, J NEUROSCI, V18, P3443; Dillingham TR, 2008, ARCH PHYS MED REHAB, V89, P1038, DOI 10.1016/j.apmr.2007.11.034; Friedrich EVC, 2009, BIOL PSYCHOL, V80, P169, DOI 10.1016/j.biopsycho.2008.08.004; MacIver K, 2008, Brain, V131, P2181, DOI 10.1093/brain/awn124; Malouin F, 2009, NEUROREHAB NEURAL RE, V23, P449, DOI 10.1177/1545968308328733; MARKS DF, 1995, BRIT J PSYCHOL, V86, P271; Matsumoto J, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-27; Webster JB, 2012, J REHABIL RES DEV, V49, P1493, DOI 10.1682/JRRD.2012.01.0001	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	FEB	2015	32	1					44	50		10.1097/WNP.0000000000000123		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB2FS	WOS:000349443000011		
J	Matsuo, T; Okunaga, T; Kamada, K; Izumo, T; Hayashi, N; Nagata, I				Matsuo, Takayuki; Okunaga, Tomohiro; Kamada, Kensaku; Izumo, Tsuyoshi; Hayashi, Nobuyuki; Nagata, Izumi			Long-term follow-up results of linear accelerator-based radiosurgery for vestibular schwannoma using serial three-dimensional spoiled gradient-echo MRI	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Linac-based radiosurgery; Long-term follow-up; Vestibular schwannoma; 3D volume measurements	GAMMA-KNIFE SURGERY; TUMOR-VOLUME CHANGES; STEREOTACTIC RADIOSURGERY; ACOUSTIC NEUROMA; CLINICAL ARTICLE; 13 GY; EXPERIENCE; OUTCOMES; MICROSURGERY; RADIOTHERAPY	We examined the characteristic changes in vestibular schwannoma (VS) volume after treatment with linear accelerator-based radiosurgely (LBRS) and the long-term therapeutic effects, by performing three-dimensional (3D) MRI evaluations of tumor volumes. We included 44 patients in whom tumor volume changes could be observed using 3D-spoiled gradient-echo MRI for at least 5 years. Examinations were performed every 3-4 months for the first 2 years after treatment and every 6-12 months thereafter. Enlargement or shrinkage was determined as a change of at least 20% from the volume at the time of treatment. The median observation period was 13.8 years (range, 5.5-19.5 years). The tumor control rates at 5 and 10 years after treatment and at the final MRI were 90.9%, 90.0%, and 88.6%, respectively. Tumor volume changes were categorized into the following four patterns: enlargement, five patients (11.4%); stable, three patients (6.8%); transient enlargement, 24 patients (54.5%); and direct shrinkage, 12 patients (27.3%). Bimodal peaks were observed in three of the 24 patients with transient enlargement. Tumor volume changes from 5 and 10 years post-LBRS to the final observation point were observed in 27 (64.2%) and 10 patients (33.3%), respectively. The long-term tumor volume changes observed after LBRS suggest that radiation exerts long-term effects on tumors. Furthermore, while transient enlargements in tumor volume were characteristic, true tumor enlargements should be characterized by increased volumes of more than two-fold and continued growth for at least 2 years. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsuo, Takayuki] Nagasaki Univ, Sch Med, Dept Neurosurg, Nagasaki 8528501, Japan; Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki 8528501, Japan	Matsuo, T (reprint author), Nagasaki Univ, Sch Med, Dept Neurosurg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	takayuki@nagasaki-u.ac.jp					Andrews DW, 2001, INT J RADIAT ONCOL, V50, P1265, DOI 10.1016/S0360-3016(01)01559-0; Yu CP, 2000, J NEUROSURG, V93, P82; Combs SE, 2006, INT J RADIAT ONCOL, V64, P1341, DOI 10.1016/j.ijrobp.2005.10.024; Kondziolka D, 1998, NEW ENGL J MED, V339, P1426, DOI 10.1056/NEJM199811123392003; Meijer OWM, 2008, AM J NEURORADIOL, V29, P906, DOI 10.3174/ajnr.A0969; Spiegelmann R, 2001, J NEUROSURG, V94, P7, DOI 10.3171/jns.2001.94.1.0007; Flickinger JC, 2004, INT J RADIAT ONCOL, V60, P225, DOI 10.1016/j.ijrobp.2004.02.019; Kalogeridi MA, 2009, J CANC RES THER, V5, P8, DOI 10.4103/0973-1482.48764; Nakamura H, 2000, AM J NEURORADIOL, V21, P1540; Hsu PW, 2010, J CLIN NEUROSCI, V17, P556, DOI 10.1016/j.jocn.2009.09.036; Chopra R, 2007, INT J RADIAT ONCOL, V68, P845, DOI 10.1016/j.ijrobp.2007.01.001; LEKSELL L, 1951, ACTA CHIR SCAND, V102, P316; Lunsford LD, 2005, J NEUROSURG, V102, P195; Wowra B, 2005, J NEUROSURG, V102, P114; Prasad D, 2000, J NEUROSURG, V92, P745, DOI 10.3171/jns.2000.92.5.0745; Meijer OWM, 2003, INT J RADIAT ONCOL, V56, P1390, DOI 10.1016/S0360-3016(03)00444-9; van de Langenberg R, 2009, NEURORADIOLOGY, V51, P517, DOI 10.1007/s00234-009-0529-4; Okunaga T, 2005, J NEUROSURG, V103, P53, DOI 10.3171/jns.2005.103.1.0053; Yen CP, 2013, J NEUROSURG, V118, P63, DOI 10.3171/2012.10.JNS12402; van de Langenberg R, 2012, INT J RADIAT ONCOL, V84, P343, DOI 10.1016/j.ijrobp.2011.12.023; Chuang CC, 2012, J NEUROSURG, V117, P63, DOI 10.3171/2012.7.GKS121003; Hasegawa T, 2005, J NEUROSURG, V102, P10, DOI 10.3171/jns.2005.102.1.0010; Karpinos M, 2002, INT J RADIAT ONCOL, V54, P1410, DOI 10.1016/S0360-3016(02)03651-9; KOBAYASHI T, 1994, ACT NEUR S, V62, P93; LEKSELL L, 1971, ACTA CHIR SCAND, V137, P763; LINSKEY ME, 1991, AM J NEURORADIOL, V12, P1165; Milligan BD, 2012, J NEUROSURG, V116, P598, DOI 10.3171/2011.11.JNS11811; Myrseth E, 2005, NEUROSURGERY, V56, P927, DOI 10.1227/01.NEU.0000158315.64079.0A; Nagano O, 2008, J NEUROSURG, V109, P811, DOI 10.3171/JNS/2008/109/11/0811; Oyama Hirofumi, 1994, Neurologia Medico-Chirurgica, V34, P607, DOI 10.2176/nmc.34.607; Pannullo SC, 2011, J NEURO-ONCOL, V103, P1, DOI 10.1007/s11060-010-0360-0; Sun SB, 2012, J NEUROSURG, V117, P57, DOI 10.3171/2012.7.GKS12783; THOMSEN J, 1990, AM J OTOL, V11, P330; Timmer FCA, 2011, LARYNGOSCOPE, V121, P1359, DOI 10.1002/lary.21763; Yamamoto Masaaki, 1996, Neurologia Medico-Chirurgica, V36, P358, DOI 10.2176/nmc.36.358	35	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2015	22	2					320	325		10.1016/j.jocn.2014.06.100		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB4EH	WOS:000349580500015		
J	Minobe, S; Matsuda, A; Mitsuhashi, T; Ishikawa, M; Nishimura, Y; Shibata, K; Ito, E; Goto, Y; Nakaoka, T; Sakura, H				Minobe, Shoko; Matsuda, Akiko; Mitsuhashi, Tetsuya; Ishikawa, Motonao; Nishimura, Yoshiko; Shibata, Koichi; Ito, Eiichi; Goto, Yu-ichi; Nakaoka, Takashi; Sakura, Hiroshi			Vasodilatation of multiple cerebral arteries in early stage of stroke-like episode with MELAS	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						CTA; MELAS; MRA; Stroke-like episode; Vasodilatation	MITOCHONDRIAL MYOPATHY; LACTIC-ACIDOSIS; ENCEPHALOPATHY	We describe a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), with multiple cerebral vasodilatations in a stroke-like episode visualised by using magnetic resonance angiography (MRA) and CT angiography (CTA). In the acute stroke-like episode stage, T2-weighted and fluid-attenuated inversion recovery MRI showed high-intensity areas in the left occipital area. In addition, MRA and CTA revealed prominent dilatation of the left posterior cerebral artery and temporal branches of the middle cerebral artery with focal hyperperfusions using CT perfusion (CTP) that corresponded to the MRI. After 10 days, with the development of aphasia, MRI indicated the lesions had spread to the temporal and parietal regions, and this distribution was not confined to major vascular territories. The patient's symptoms gradually improved, accompanied by the attenuation of MRI, CTA, and CTP findings. These characteristic features along with the MRI changes that spread beyond vascular boundaries and the multiple cerebral vasodilatations prior to the development of clinical symptoms are not fully explained by the mitochondrial angiopathy or cytopathy theories. These findings provide further evidence supporting neuronal hyperexcitability in stroke-like episodes of MELAS. (C) 2014 Elsevier Ltd. All rights reserved.	[Minobe, Shoko; Matsuda, Akiko; Mitsuhashi, Tetsuya; Ishikawa, Motonao; Nishimura, Yoshiko; Shibata, Koichi; Nakaoka, Takashi; Sakura, Hiroshi] Tokyo Womans Med Univ, Med Ctr East, Dept Internal Med, Arakawa, Tokyo 1168567, Japan; [Ito, Eiichi] Tokyo Womans Med Univ, Dept Neurol, Shinjuku Ku, Tokyo, Japan; [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo, Japan	Shibata, K (reprint author), Tokyo Womans Med Univ, Med Ctr East, Dept Internal Med, 2-1-10 Nishiogu, Arakawa, Tokyo 1168567, Japan.	kshbtgm@dnh.twmu.ac.jp					Amagasaki K, 2001, J NEUROSURG, V94, P133, DOI 10.3171/jns.2001.94.1.0133; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Iizuka T, 2010, FUTURE NEUROL, V5, P61, DOI 10.2217/fnl.09.71; Yeh HL, 2013, BRAIN DEV-JPN, V35, P158, DOI 10.1016/j.braindev.2012.03.017; Yoshida T, 2012, INTERNAL MED, V52, P1389	5	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2015	22	2					407	408		10.1016/j.jocn.2014.05.021		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB4EH	WOS:000349580500035		
J	Sugaya, T; Nakatsuka, M; Inoue, K; Tanaka, S; Miyaji, H; Sakagami, R; Kawamami, M				Sugaya, Tsutomu; Nakatsuka, Megumi; Inoue, Kana; Tanaka, Saori; Miyaji, Hirofumi; Sakagami, Ryuji; Kawamami, Masamitsu			Comparison of Fracture Sites and Post Lengths in Longitudinal Root Fractures	JOURNAL OF ENDODONTICS			English	Article						Fractures originating in the apical region; fractures originating in the cervical region; post length; site of fracture; vertical root fracture	CALCIUM HYDROXIDE; CANAL PREPARATION; TREATED TEETH; RESISTANCE; TOOTH; RESTORATIONS; CONDENSATION; DEFECTS	Introduction: Comparing the epidemiology of fractures originating in the cervical and apical regions may help to understand the causes and risk of a vertical root fracture. We aimed to determine the frequency of vertical root fractures in different fracture sites and how the fracture site relates to fracture direction and post length. Methods: Teeth diagnosed with a vertical root fracture were retrospectively surveyed for age and sex of the patient, type of tooth, a fracture region in the longitudinal axial direction, site of the fracture, and presence of a post The fracture region in the longitudinal axial direction was classified as an incomplete fracture, complete fracture, and uncertain. Incomplete fractures were further classified into a fracture originating in the cervical region, a fracture originating in the midregion, and a fracture originating in the apical region. Posts were evaluated by loss of post and length of post. Results: Fractures originating in the cervical and apical region occurred around the same frequency, whereas fractures originating in the midregion were extremely scarce. Of the fractures originating in the cervical region, 36.2% were in a mesial and/or distal site and 57.4% in a buccal and/or lingual site. Of the fractures originating in the apical region, 90.8% were in the buccal and/ or lingual site. The number of cases of fractures Originating in the apical region decreased with increased post length. Conclusions: Sites of fracture and post length differed greatly between fractures originating in the cervical region and the apical region, suggesting that risk factors for fractures originating in the cervical and apical regions are different.	[Sugaya, Tsutomu; Nakatsuka, Megumi; Inoue, Kana; Tanaka, Saori; Miyaji, Hirofumi; Kawamami, Masamitsu] Hokkaido Univ, Grad Sch Dent Med, Dept Periodontol & Eridodontol, Sapporo, Hokkaido 0608586, Japan; [Sakagami, Ryuji] Fukuoka Dent Coll, Dept Periodontol, Fukuoka, Japan	Sugaya, T (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Periodontol & Eridodontol, N13 W7 Kita Ku, Sapporo, Hokkaido 0608586, Japan.	sugaya@den.hokudai.ac.jp					Adorno CG, 2013, INT ENDOD J, V46, P763, DOI 10.1111/iej.12056; TESTORI T, 1993, J ENDODONT, V19, P87, DOI 10.1016/S0099-2399(06)81202-1; Doyon GE, 2005, J ENDODONT, V31, P895, DOI 10.1097/01.don.0000194542.02521.af; Versluis A, 2006, INT ENDOD J, V39, P931, DOI 10.1111/j.1365-2591.2006.01164.x; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; Liu R, 2013, J ENDODONT, V39, P129, DOI 10.1016/j.joen.2012.09.019; Bitter K, 2007, AM J DENT, V20, P353; Shemesh H, 2010, INT ENDOD J, V43, P995, DOI 10.1111/j.1365-2591.2010.01740.x; Barreto MS, 2012, J ENDODONT, V38, P1135, DOI 10.1016/j.joen.2012.05.002; Cecchin D, 2010, J ORAL REHABIL, V37, P116, DOI 10.1111/j.1365-2842.2009.02028.x; Juloski J, 2012, J ENDODONT, V38, P11, DOI 10.1016/j.joen.2011.09.024; Lertchirakarn V, 2003, J ENDODONT, V29, P523, DOI 10.1097/00004770-200308000-00008; Isidor F, 1996, INT J PROSTHODONT, V9, P131; Mai S, 2010, J DENT, V38, P201, DOI 10.1016/j.jdent.2009.10.004; Andreasen JO, 2002, DENT TRAUMATOL, V18, P134, DOI 10.1034/j.1600-9657.2002.00097.x; Wilcox LR, 1997, J ENDODONT, V23, P533, DOI 10.1016/S0099-2399(97)80316-0; Zandbiglari T, 2006, ORAL SURG ORAL MED O, V101, P126, DOI 10.1016/j.tripleo.2005.01.019; Ona M, 2013, INT ENDOD J, V46, P47, DOI 10.1111/j.1365-2591.2012.02092.x; Tay FR, 2007, J ENDODONT, V33, P391, DOI 10.1016/j.joen.2006.10.009; Bier CAS, 2009, J ENDODONT, V35, P236, DOI 10.1016/j.joen.2008.10.021; Hayashi M, 2006, DENT MATER, V22, P477, DOI 10.1016/j.dental.2005.03.017; Uzunoglu E, 2012, J ENDODONT, V38, P1110, DOI 10.1016/j.joen.2012.04.026; Buttel L, 2009, INT ENDOD J, V42, P47, DOI 10.1111/j.1365-2591.2008.01492.x; Chai H, 2012, J BIOMECH, V45, P1673, DOI 10.1016/j.jbiomech.2012.03.022; Chan CP, 1999, ORAL SURG ORAL MED O, V87, P504, DOI 10.1016/S1079-2104(99)70252-0; HOLCOMB JQ, 1987, J ENDODONT, V13, P277, DOI 10.1016/S0099-2399(87)80044-4; Junge T, 1998, INT J PROSTHODONT, V11, P558; Kahler W, 2008, AM J DENT, V21, P275; Lertchirakarn V, 2003, J ENDODONT, V29, P529, DOI 10.1097/00004770-200308000-00009; Naumann M, 2008, J ENDODONT, V34, P1006, DOI 10.1016/j.joen.2008.05.010; Poison AM., 1977, J PERIODONTOL, V48, P27; Schei J., 1959, J PERIODONTOL, V30, P7; Seghi RR, 2013, J ENDODONT, V39, pS57, DOI 10.1016/j.joen.2012.10.029; STANDLEE JP, 1980, J PROSTHET DENT, V44, P398, DOI 10.1016/0022-3913(80)90097-9; Zarei M, 2013, DENT TRAUMATOL, V29, P156, DOI 10.1111/j.1600-9657.2012.01158.x	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	FEB	2015	41	2					159	163		10.1016/j.joen.2014.09.017		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB1YQ	WOS:000349424300004		
J	Nassar, M; Hiraishi, N; Tamura, Y; Otsuki, M; Aoki, K; Tagami, J				Nassar, Mohannad; Hiraishi, Noriko; Tamura, Yukihiko; Otsuki, Masayuki; Aoki, Kazuhiro; Tagami, Junji			Phytic Acid: An Alternative Root Canal Chelating Agent	JOURNAL OF ENDODONTICS			English	Article						Chelating agent; EDTA; phytic acid; root canal; smear layer	SMEAR LAYER; EDTA; HEXAKISPHOSPHATE; PHOSPHATES; CULTURE; REMOVAL; BINDING; DENTIN	Introduction: The objectives of this study were to investigate the effect of phytic acid, inositol hexakisphosphate (IP6), as a final rinse on the surface of instrumented root canals and smear-layered flat dentin surfaces treated with sodium hypochlorite (NaOCl) and to evaluate its effect on the viability and alkaline phosphatase activity of osteoblast-like cells (MC3T3-E1). Methods: The universally accepted chelating agent EDTA was used as the control in all conducted experiments. Root canals of human canines were instrumented with rotary files and irrigated with 5% NaOCl, followed by a final rinse of 17% EDTA (1 minute), 1% IP6 (1 minute or 30 seconds), or distilled water. NaOCl-treated flat coronal dentin surfaces were also treated with 17% EDTA (1 minute), 1% IP6 (1 minute or 30 seconds), or distilled water. The presence or absence of smear layer was evaluated with scanning electron microscopy. Cell viability and alkaline phosphatase assays were performed to evaluate the effect of IP6 and EDTA on cultured MC3T3-E1 cells. Results: The results demonstrated the ability of IP6 to remove the smear layer from instrumented root canals and flat coronal dentin surfaces. When compared with EDTA, IP6 was less cytotoxic and did not affect the differentiation of MC3T3-E1 cells. Conclusions: IP6 shows the potential to be an effective and biocompatible chelating agent.	[Nassar, Mohannad; Hiraishi, Noriko; Otsuki, Masayuki; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Tokyo 1138549, Japan; [Nassar, Mohannad; Tagami, Junji] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo 1138549, Japan; [Tamura, Yukihiko; Aoki, Kazuhiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Biomatrix, Tokyo 1138549, Japan	Hiraishi, N (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	hiraope@tmd.ac.jp	Hiraishi, Noriko/H-8751-2015				Amaral KF, 2007, INT ENDOD J, V40, P338, DOI 10.1111/j.1365-2591.2007.01220.x; Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Calt S, 2002, J ENDODONT, V28, P17, DOI 10.1097/00004770-200201000-00004; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Torres J, 2005, J INORG BIOCHEM, V99, P828, DOI 10.1016/j.jinorgbio.2004.12.011; SASAKAWA N, 1995, BIOCHEM PHARMACOL, V50, P137, DOI 10.1016/0006-2952(95)00059-9; Zehnder M, 2006, J ENDODONT, V32, P389, DOI 10.1016/j.joen.2005.09.014; Xu Q, 2008, TOXICOLOGY, V245, P101, DOI 10.1016/j.tox.2007.12.017; Tay FR, 2010, J ENDODONT, V36, P745, DOI 10.1016/j.joen.2009.11.022; O'Connell MS, 2000, J ENDODONT, V26, P739, DOI 10.1097/00004770-200012000-00019; Torabinejad M, 2003, J ENDODONT, V29, P170, DOI 10.1097/00004770-200303000-00002; Marending M, 2007, J ENDODONT, V33, P1325, DOI 10.1016/j.joen.2007.08.005; Segura JJ, 1996, J ENDODONT, V22, P337, DOI 10.1016/S0099-2399(96)80213-5; Elvers B, 2014, ULLMANNS FINE CHEM, P647; GRAF E, 1983, J AM OIL CHEM SOC, V60, P1861, DOI 10.1007/BF02901539; Hiilsmann M, 2003, INT ENDOD J, V36, P810; Lanigan Rebecca S, 2002, Int J Toxicol, V21 Suppl 2, P95; LUTTRELL BM, 1993, J BIOL CHEM, V268, P1521; Nygaard-Ostby B, 1957, ODONTOL TIDSKR, V65, P3; RASMUSSEN L, 1986, IN VITRO CELL DEV B, V22, P177; Sillanpää M, 1997, Rev Environ Contam Toxicol, V152, P85; SZWERGOLD BS, 1987, BIOCHEM BIOPH RES CO, V149, P874, DOI 10.1016/0006-291X(87)90489-X	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	FEB	2015	41	2					242	247		10.1016/j.joen.2014.09.029		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB1YQ	WOS:000349424300018		
J	Hayashi, S; Murakami, S; Xu, KQ; Watanabe, M				Hayashi, Seiji; Murakami, Shogo; Xu, Kai-Qin; Watanabe, Masataka			Simulation of the reduction of runoff and sediment load resulting from the Gain for Green Program in the Jialingjiang catchment, upper region of the Yangtze River, China	JOURNAL OF ENVIRONMENTAL MANAGEMENT			English	Article						Hydrologic modeling; Sediment yield; Flood protection; HSPF; Yangtze River	TRANSPORT CAPACITY; BASIN; DELIVERY; 3-GORGES	A distributed catchment hydrologic model (Hydrological Simulation Program - FORTRAN; HSPF) with improved sediment production processes was used to evaluate the effect of restoration of cultivated land to forest on the reduction of runoff and sediment load in the Jialingjiang basin, which forms part of the Yangtze River basin, China. The simulation results showed that restoration to forest reduced sediment production even in the case of minimum restoration at a threshold catchment slope of 25 degrees as advocated in the "Gain for Green Program" planned by the Chinese government, even though reduction of the peak flow rate in the river channel was small. The increase in forest area resulting from lowering of the threshold catchment slope reduced sediment production further. (C) 2014 Elsevier Ltd. All rights reserved.	[Hayashi, Seiji] Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Murakami, Shogo] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Xu, Kai-Qin] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan; [Watanabe, Masataka] Keio Univ, Grad Sch Media & Governance, Fujisawa, Kanagawa 2528520, Japan	Hayashi, S (reprint author), Natl Inst Environm Studies, Ctr Reg Environm Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	shayashi@nies.go.jp; murakami@nies.go.jp; joexu@nies.go.jp; masawata@sfc.keio.ac.jp			Asia-Pacific Environmental Innovation Strategy Project (APEIS) - Ministry of the Environment of Japan	This study obtained financial support from the first phase of Asia-Pacific Environmental Innovation Strategy Project (APEIS) primarily funded by the Ministry of the Environment of Japan.	Alberts E.E., 1987, 872542 AM SOC AGR EN; ALONSO CV, 1981, T ASAE, V24, P1211; American Society of Civil Engineers, 1993, J IRRIGATION DRAINAG, V119, P429; Xu JT, 2006, ECOL ECON, V57, P595, DOI 10.1016/j.ecolecon.2005.05.008; SELLERS PJ, 1995, REMOTE SENS ENVIRON, V51, P3, DOI 10.1016/0034-4257(94)00061-Q; Higgitt DL, 2001, GEOMORPHOLOGY, V41, P143, DOI 10.1016/S0169-555X(01)00112-X; MOORE ID, 1986, WATER RESOUR RES, V22, P1350, DOI 10.1029/WR022i008p01350; Lu XX, 2001, GEOMORPHOLOGY, V41, P157, DOI 10.1016/S0169-555X(01)00113-1; Hu BQ, 2009, HYDROL EARTH SYST SC, V13, P2253; Zhang YD, 2008, J AM WATER RESOUR AS, V44, P1144, DOI 10.1111/j.1752-1688.2008.00239.x; Zhang XB, 2004, CHINESE SCI BULL, V49, P1953, DOI 10.1360/04wd0106; LI G, 1995, HYDROL PROCESS, V9, P227, DOI 10.1002/hyp.3360090208; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Asia-Pacific Innovation Strategy Project, 2004, TECHN SUMM INT ENV M; Bagnold R.A., 1966, 4221 US GEOL SURV; Bicknell B.R., 1997, EPA600R97080; Brown C.B., 1950, SEDIMENT TRANSPORTAT, P769; Changjiang Water Resources Commission, 1987, ANN REP CHANGJ WAT S; Chiew C.Y., 1991, RES J WATER POLLUT C, V63, P10; Donigian Jr A.S., 1983, PREDICTING WATER QUA, P200; Donigian Jr A.S., 1976, EPA600376083 ENV RES; Donigian Jr A.S., 1976, EPA6002776043 ENV RE; Fontaine TA, 1997, J AM WATER RESOUR AS, V33, P313, DOI 10.1111/j.1752-1688.1997.tb03512.x; GHUMAN BS, 1991, SOIL SCI SOC AM J, V55, P178; Graf W.H., 1968, B IAHS, VXIII, P20; Hayashi S, 2008, J HYDROL ENG, V13, P846, DOI 10.1061/(ASCE)1084-0699(2008)13:9(846); Hayashi S, 2004, J ENVIRON ENG-ASCE, V130, P801, DOI 10.1061/(ASCE)0733-9372(2004)130:7(801); Hunter M.H., 2008, AUSTR J HYDROL, V356, P131; Iguchi S., 1972, STREAM FLOW RAINFALL, P567; Im S. J., 2003, Journal of the American Water Resources Association, V39, P1465, DOI 10.1111/j.1752-1688.2003.tb04432.x; Kitahara H., 2000, J FOR RES, V5, P231, DOI DOI 10.1007/BF02767115; Linsley RK, 1982, HYDROLOGY ENG; Liu J.Y., 1996, MACROSCALE SURVEY DY; Lumb A. M., 1994, 944168 US GEOL SURV; Matheron G., 1971, THEORY REGIONALIZED; MOORE LW, 1992, WATER ENVIRON RES, V64, P241; Murai H., 1976, B GOV FOR EXP STN, V286, P1; Nagao M., 1975, P JPN SOC CIV ENG, V243, P33; Nanking Institute of Soil Science, 1980, SOILS CHIN THEIR US; Nanking Institute of Soil Science, 1986, SOIL ATL CHIN; Nash J. E., 1970, J HYDROL, V10, P282, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Renard K.G., 1997, PREDICTING SOIL EROS; Shi D.M., 1992, INT J SEDIMENT RES, V7, P1; Sustainable Agricultural Resources Section, 2003, REV UN SOIL LOSS EQ; Tsujimoto T., 1989, P INT WORKSH FLUV HY, pA79; Wischmeier W. H., 1978, AGR HDB, V537; WISCHMEI.WH, 1971, J SOIL WATER CONSERV, V26, P189; Xiang Z.A., 1998, P 13 JAP CHIN RIV C, P211; Xu K.-Q., 2000, J WATER WASTE, V42, P31; Zhang XB, 2004, GLOBAL PLANET CHANGE, V41, P221, DOI 10.1016/j.gloplacha.2004.01.008	50	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0301-4797	1095-8630		J ENVIRON MANAGE	J. Environ. Manage.	FEB 1	2015	149						126	137		10.1016/j.jenvman.2014.10.004		12	Environmental Sciences	Environmental Sciences & Ecology	AZ2TA	WOS:000348084000014		
J	Ito, E; Yamagishi, M; Takigami, S; Sakakibara, M; Fujito, Y; Lukowiak, K				Ito, Etsuro; Yamagishi, Miki; Takigami, Satoshi; Sakakibara, Manabu; Fujito, Yutaka; Lukowiak, Ken			The Yerkes-Dodson law and appropriate stimuli for conditioned taste aversion in Lymnaea	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Conditioned taste aversion; Electric shock; Lymnaea; Yerkes-Dodson law	POND SNAIL LYMNAEA; STAGNALIS; ACQUISITION	The pond snail Lymnaea stagnalis can learn conditioned taste aversion and then consolidate it into long-term memory (LTM). A high-voltage electric shock was used as the unconditioned stimulus, where we have previously used KCl. We varied the strength of both the conditioned and unconditioned stimuli to determine whether the so-called Yerkes-Dodson law prevailed. This is an empirical relationship between the state of arousal and LTM formation, showing that there is an optimal level of arousal leading to memory formation. However, too little or too much arousal results in poorer LTM. We found here that the most appropriate stimuli to use in taste aversion training in Lymnaea were a 10 mmol l(-1) sucrose solution as the conditioned stimulus and a 3 s electric shock as the unconditioned stimulus.	[Ito, Etsuro; Yamagishi, Miki] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Funct Biol, Sanuki 7692193, Japan; [Takigami, Satoshi; Sakakibara, Manabu] Tokai Univ, Sch High Technol Human Welf, Dept Biol Sci & Technol, Numazu 4100321, Japan; [Fujito, Yutaka] Sapporo Med Univ, Sch Med, Dept Syst Neurosci, Sapporo, Hokkaido 0608556, Japan; [Lukowiak, Ken] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	Ito, E (reprint author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Funct Biol, Sanuki 7692193, Japan.	eito@kph.bunri-u.ac.jp			KAKENHI from JSPS [24657055, 25291074]; NSERC	This work was supported by KAKENHI from JSPS (Nos. 24657055 and 25291074) to E. I. and a grant from NSERC to K. L.	Takigami S, 2014, NEUROBIOL LEARN MEM, V107, P79, DOI 10.1016/j.nlm.2013.10.022; Kojima S, 1996, ZOOL SCI, V13, P803, DOI 10.2108/zsj.13.803; Mita K, 2014, NEUROBIOL LEARN MEM, V107, P1, DOI 10.1016/j.nlm.2013.10.013; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; Sugai R, 2007, J EXP BIOL, V210, P1225, DOI 10.1242/jeb.02735; Ito E, 2013, CAN J ZOOL, V91, P405, DOI 10.1139/cjz-2012-0292; Takigami S, 2013, NEUROSCI LETT, V555, P149, DOI 10.1016/j.neulet.2013.09.042; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; BROWN WP, 1965, PSYCHOL REP, V17, P663; BERLYNE DE, 1969, ANN NY ACAD SCI, V159, P1059, DOI 10.1111/j.1749-6632.1969.tb12997.x; BROADHURST PL, 1957, J EXP PSYCHOL, V54, P345, DOI 10.1037/h0049114; Dalesman S, 2011, ANIM BEHAV, V82, P311, DOI 10.1016/j.anbehav.2011.05.005; Diamond David M, 2007, Neural Plast, V2007, P60803; Ito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043151; Lukowiak K, 2014, J EXP BIOL, V217, P76, DOI 10.1242/jeb.089441; Mita K, 2014, NEUROBIOL LEARN MEM, V116, P132, DOI 10.1016/j.nlm.2014.10.006; Orr M, 2009, J EXP BIOL, V212, P3911, DOI 10.1242/jeb.024281; Otsuka E., 2013, BIOPHYSICS-USSR, V9, P161; Staal M. A., 2004, 2004212824 NASA AM R; Sunada H., 2014, BIOPHYSICS-USSR, V10, P121; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075276	21	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	FEB	2015	218	3					336	339		10.1242/jeb.113266		4	Biology	Life Sciences & Biomedicine - Other Topics	CB1QZ	WOS:000349404300010		
J	Murakami, T; Kitabatake, N; Tani, F				Murakami, Tetsuya; Kitabatake, Naofumi; Tani, Fumito			Dispersion in the Presence of Acetic Acid or Ammonia Confers Gliadin-Like Characteristics to the Glutenin in Wheat Gluten	JOURNAL OF FOOD SCIENCE			English	Article						dispersion; dough; ethanol extractability; gliadin; glutenin	SUBUNITS; PROTEINS	Spray-dried gluten has unique properties and is commercially available in the food industry worldwide. In this study, we examined the viscoelastic properties of gluten powder prepared by dispersion in the presence of acetic acid or an ammonia solvent and then followed by lyophilization instead of a spray drying. Mixograph measurements showed that the acid- and ammonia-treated gluten powders had marked decreases in the time to peak dough resistance when compared with the control gluten powder. The integrals of the dough resistance and bandwidth for 3 min after peak dough resistance decreased in both treated gluten powders. Similar phenomena were observed when gliadin was supplemented to gluten powders. Basic and acidic conditions were applied to the acid- and ammonia-treated gluten powders, respectively, and the viscoelastic behaviors were found to depend on the pH in the gluten dispersion just before lyophilization. These behaviors suggest that gluten may assume a reversible change in viscoelasticity by a fluctuation in pH during gluten dispersion. SDS-PAGE showed that the extractable proteins substantially increased in some polymeric glutenins including the low molecular weight-glutenin subunit (LMW-GS) when the ammonia-treated gluten powder was extracted with 70% ethanol. In contrast, the extractable proteins markedly increased in many polymeric glutenins including the high molecular weight-glutenin subunit and/or the LMW-GS when the acid-treated gluten powder was extracted with 70% ethanol. It thus follows that the extractability of polymeric glutenin to ethanol increases similarly to gliadin when gluten is exposed to an acidic or a basic pH condition; therefore, glutenin adopts gliadin-like characteristics. Practical Application The acid-treated or the ammonia-treated gluten powders can be manufactured from wheat gluten that has been dispersed in the presence of acetic acid or ammonia solvent, respectively, and then followed by spray drying. In this study, we explained the unique viscoelastic properties of these gluten powders and revealed the molecular characteristics of the wheat gluten proteins with the pH change in gluten dispersion. The results from this study show that these spray-dried glutens improve food quality and develop new food functionality.	[Murakami, Tetsuya; Tani, Fumito] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan; [Murakami, Tetsuya] Glico Nutr Co Ltd, Div Res & Dev, Nishiyodogawa Ku, Osaka 5558502, Japan; [Kitabatake, Naofumi] Notre Dame Seishin Univ, Fac Human Life Sci, Dept Foods & Human Nutr, Kita Ku, Okayama 7008516, Japan	Murakami, T (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan.	murakami-tetsuya@gf.glico.co.jp		Murakami, Tetsuya/0000-0001-7924-8073			LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; BIETZ JA, 1973, CEREAL CHEM, V50, P537; Bean SR, 1998, CEREAL CHEM, V75, P75, DOI 10.1094/CCHEM.1998.75.1.75; Branlard G. P., 2006, Gliadin and glutenin: the unique balance of wheat quality, P115; Bushuk W, 1989, WHEAT IS UNIQUE, P263; Conway E. J., 1962, MICRODIFFUSION ANAL; GUPTA RB, 1991, J CEREAL SCI, V14, P105; Hamer RJ, 2003, WHEAT GLUTEN PROTEIN ANALYSIS, P19; Juhász A., 2006, Gliadin and glutenin: the unique balance of wheat quality, P171; Larre C, 1997, J CEREAL SCI, V25, P143, DOI 10.1006/jcrs.1996.0079; Liao L, 2010, FOOD CHEM, V123, P123, DOI 10.1016/j.foodchem.2010.04.017; LUSENA CV, 1950, CEREAL CHEM, V27, P167; MATSUDOMI N, 1986, AGR BIOL CHEM TOKYO, V50, P1989; McCONNELL W. B., 1955, CANADIAN JOUR TECHNOL, V33, P256; Mori K, 1974, EIYO TO SHOKURYO, V27, P153; Ponte Jr JG, 2000, HDB CEREAL SCI TECHN, P755; Shewry P., 2003, ELASTOMERIC PROTEINS, P279, DOI 10.1017/CBO9780511546327.016; Shewry P. R., 2006, Gliadin and glutenin: the unique balance of wheat quality, P143; Shewry PR, 2003, WHEAT GLUTEN PROTEIN ANALYSIS, P1; Staff FE, 1959, FOOD ENG, V31, P73; VansDer Borght A, 2005, J CEREAL SCI, V41, P221; Wieser H., 2006, Gliadin and glutenin: the unique balance of wheat quality, P213; WU CH, 1976, J AGR FOOD CHEM, V24, P504, DOI 10.1021/jf60205a057	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	FEB	2015	80	2					C269	C278		10.1111/1750-3841.12757		10	Food Science & Technology	Food Science & Technology	CB0IC	WOS:000349308200008		
J	Yao, T				Yao, Tsuneyoshi			History of the official publication of the Japanese Society of Gastroenterology: from Gastroenterologia Japonica to Journal of Gastroenterology	JOURNAL OF GASTROENTEROLOGY			English	Editorial Material									[Yao, Tsuneyoshi] Fukuoka Univ, Chikushino Fukuoka 8188502, Japan; [Yao, Tsuneyoshi] Sada Hosp, Chuo Ku, Fukuoka 8100004, Japan	Yao, T (reprint author), Fukuoka Univ, Zokumyoin 1-1-1, Chikushino Fukuoka 8188502, Japan.	yao12_25@yahoo.co.jp					Yao T, 1994, J GASTROENTEROL, V29, P1	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					123	124		10.1007/s00535-014-1029-9		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000001		
J	Miwa, H; Kusano, M; Arisawa, T; Oshima, T; Kato, M; Joh, T; Suzuki, H; Tominaga, K; Nakada, K; Nagahara, A; Futagami, S; Manabe, N; Inui, A; Haruma, K; Higuchi, K; Yakabi, K; Hongo, M; Uemura, N; Kinoshita, Y; Sugano, K; Shimosegawa, T				Miwa, Hiroto; Kusano, Motoyasu; Arisawa, Tomiyasu; Oshima, Tadayuki; Kato, Mototsugu; Joh, Takashi; Suzuki, Hidekazu; Tominaga, Kazunari; Nakada, Koji; Nagahara, Akihito; Futagami, Seiji; Manabe, Noriaki; Inui, Akio; Haruma, Ken; Higuchi, Kazuhide; Yakabi, Koji; Hongo, Michio; Uemura, Naomi; Kinoshita, Yoshikazu; Sugano, Kentaro; Shimosegawa, Tooru			Evidence-based clinical practice guidelines for functional dyspepsia	JOURNAL OF GASTROENTEROLOGY			English	Article						Dyspepsia; Guideline; Proton pump inhibitor; Prokinetics; Antianxiety drug; Antidepressant; Japanese traditional medicine; H. pylori eradication treatment; H. pylori associated dyspepsia; Algorithm; Chronic gastritis	QUALITY-OF-LIFE; HELICOBACTER-PYLORI ERADICATION; IRRITABLE-BOWEL-SYNDROME; RANDOMIZED-CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; HEART-RATE-VARIABILITY; GASTROINTESTINAL DISORDERS; NONULCER DYSPEPSIA; DOUBLE-BLIND; GENERAL-POPULATION	General interest in functional gastrointestinal disorders is increasing among Japanese doctors as well as patients. This increase can be attributed to a number of factors, including recent increased interest in quality of life and advances in our understanding of the pathophysiology of gastrointestinal disease. Japan recently became the world's first country to list "functional dyspepsia" as a disease name for national insurance billing purposes. However, recognition and understanding of functional dyspepsia (FD) remain poor, and no standard treatment strategy has yet been established. Accordingly, the Japanese Society of Gastroenterology (JSGE) developed an evidence-based clinical practice guideline for FD, consisting of five sections: concept, definition, and epidemiology; pathophysiology; diagnosis; treatment; and prognosis and complications. This article summarizes the Japanese guideline, with particular focus on the treatment section. Once a patient is diagnosed with FD, the doctor should carefully explain the pathophysiology and benign nature of this condition, establish a good doctor-patient relationship, and then provide advice for daily living (diet and lifestyle modifications, explanations, and reassurance). The proposed pharmacological treatment is divided into two steps: initial treatment including an acid inhibitory drug (H2RA or PPI) or prokinetics, (strong recommendation); second-line treatment including anxiolytics, antidepressants, and Japanese traditional medicine (weak recommendation). H. pylori eradication, strongly recommended with a high evidence level, is positioned separately from other treatment flows. Conditions that do not respond to these treatment regimens are regarded as refractory FD. Patients will be further examined for other organic disorders or will be referred to specialists using other approaches such as psychosomatic treatment.	[Miwa, Hiroto; Kusano, Motoyasu; Arisawa, Tomiyasu; Oshima, Tadayuki; Kato, Mototsugu; Joh, Takashi; Suzuki, Hidekazu; Tominaga, Kazunari; Nakada, Koji; Nagahara, Akihito; Futagami, Seiji; Manabe, Noriaki; Inui, Akio; Haruma, Ken; Higuchi, Kazuhide; Yakabi, Koji; Hongo, Michio; Uemura, Naomi; Kinoshita, Yoshikazu; Sugano, Kentaro; Shimosegawa, Tooru] Japanese Soc Gastroenterol JSGE, Guidelines Comm Creating & Evaluating Evidence Ba, Chuo Ku, Tokyo 1040061, Japan	Miwa, H (reprint author), Japanese Soc Gastroenterol JSGE, Guidelines Comm Creating & Evaluating Evidence Ba, Chuo Ku, K-18 Bldg 8F,8-9-13 Ginza, Tokyo 1040061, Japan.	miwahgi@hyo-med.ac.jp			JSGE	This article was supported by a Grant-in-Aid from the JSGE. The authors thank Shiko Kuribayashi, Osamu Kawamura, Hiroko Hosaka, Yasuyuki Shimoyama, Akiyo Kawada (Gunma University), Takeshi Kamiya, Michiko Shikano (Nagoya City University Graduate School of Medical Sciences), Tatsuhiro Masaoka (Keio University), and Mariko Hojo (Juntendo University) for great assistance with data collection, data analysis, and manuscript preparation.	Miwa H, 2009, AM J GASTROENTEROL, V104, P2779, DOI 10.1038/ajg.2009.427; Mahadeva S, 2006, WORLD J GASTROENTERO, V12, P2661; Moayyedi P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002096.pub4; Mazzoleni LE, 2011, ARCH INTERN MED, V171, P1929, DOI 10.1001/archinternmed.2011.533; Hammer J, 2006, ALIMENT PHARM THERAP, V24, P405, DOI 10.1111/j.1365-2036.2006.02992.x; Park YC, 2009, J ALTERN COMPLEM MED, V15, P879, DOI 10.1089/acm.2008.0369; Stanghellini V, 1999, Scand J Gastroenterol Suppl, V231, P20; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; Lan L, 2011, WORLD J GASTROENTERO, V17, P3242, DOI 10.3748/wjg.v17.i27.3242; Irvine EJ, 2006, GASTROENTEROLOGY, V130, P1538, DOI 10.1053/j.gastro.2005.11.058; Talley NJ, 2006, ALIMENT PHARM THERAP, V23, P923, DOI 10.1111/j.1365-2036.2006.02845.x; Miwa H, 2012, NEUROGASTROENT MOTIL, V24, P464, DOI 10.1111/j.1365-2982.2011.01872.x; Quartero AO, 1998, DIGEST DIS SCI, V43, P2028, DOI 10.1023/A:1018803129779; Su CY, 2004, GASTROENTEROLOGY, V126, P1257, DOI 10.1053/j.gastro.2004.01.024; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Holtmann G, 2004, GASTROENTEROLOGY, V126, P971, DOI 10.1053/j.gastro.2004.01.006; Tack J, 2002, GASTROENTEROLOGY, V122, P1738, DOI 10.1053/gast.2002.33663; Bjornsson E, 2006, ALIMENT PHARM THERAP, V24, P945, DOI 10.1111/j.1365-2036.2006.03084.x; Kawamura A, 2001, J GASTROEN HEPATOL, V16, P384, DOI 10.1046/j.1440-1746.2001.02454.x; Straus WL, 2002, AM J GASTROENTEROL, V97, P1951; Calvert EL, 2002, GASTROENTEROLOGY, V123, P1778, DOI 10.1053/gast.2002.37071; Samsom M, 1999, GASTROENTEROLOGY, V116, P515, DOI 10.1016/S0016-5085(99)70171-X; Enck P, 2009, NEUROGASTROENT MOTIL, V21, P370, DOI 10.1111/j.1365-2982.2008.01241.x; Mearin F, 2005, GASTROENTEROLOGY, V129, P98, DOI 10.1016/j.gast.2005.04.012; Liu S, 2008, NEUROGASTROENT MOTIL, V20, P1204, DOI 10.1111/j.1365-2982.2008.01164.x; Sugano K, 2011, J NEUROGASTROENTEROL, V17, P366, DOI 10.5056/jnm.2011.17.4.366; Aro P, 2011, ALIMENT PHARM THER, V33, P1215, DOI 10.1111/j.1365-2036.2011.04640.x; Tominaga K, 2013, J GASTROENTEROL, V48, P452, DOI 10.1007/s00535-013-0788-z; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Lunding JA, 2006, SCAND J GASTROENTERO, V41, P1028, DOI 10.1080/00365520600590513; Nakao H, 2007, DIGEST DIS SCI, V52, P2152, DOI 10.1007/s10620-006-9204-3; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Vakil N, 2008, AM J GASTROENTEROL, V103, P1906, DOI 10.1111/j.1572-0241.2008.01953.x; Bortolotti M, 2002, ALIMENT PHARM THERAP, V16, P1075, DOI 10.1046/j.1365-2036.2002.01280.x; ANDERSEN BN, 1982, HEPATO-GASTROENTEROL, V29, P35; Olafsdottir LB, 2010, DIGESTION, V81, P53, DOI 10.1159/000243783; Matsueda K, 2012, GUT, V61, P821, DOI 10.1136/gutjnl-2011-301454; Futagami S, 2010, AM J GASTROENTEROL, V105, P1835, DOI 10.1038/ajg.2010.151; de la Loge C, 2004, QUAL LIFE RES, V13, P1751, DOI 10.1007/s11136-004-8751-3; Ilnyckyj A, 1997, GASTROENTEROLOGY, V112, P1854, DOI 10.1053/gast.1997.v112.pm9178676; Okumura T, 2010, J GASTROENTEROL, V45, P187, DOI 10.1007/s00535-009-0168-x; Locke GR, 2000, MAYO CLIN PROC, V75, P907; Miwa H, 2007, ALIMENT PHARM THERAP, V26, P257, DOI 10.1111/j.1365-2036.2007.03367.x; Bolling-Sternevald E, 2003, ALIMENT PHARM THERAP, V18, P117, DOI 10.1046/j.0269-2813.2003.01651.x; Dimenas E, 2010, ARQ GASTROENTEROL, V47, P354; Drossman DA, 1997, AM J GASTROENTEROL, V92, P1418; Francis C, 2006, ROME 3 FUNCTIONAL GA, P295; FRAZZONI M, 1993, J CLIN GASTROENTEROL, V17, P101, DOI 10.1097/00004836-199309000-00004; Gutierrez A, 2003, J GASTROEN HEPATOL, V15, P1175; Haag S, 2008, ALIMENT PHARM THERAP, V27, P561, DOI 10.1111/j.1365-2036.2008.03619.x; Haug TT, 2002, SCAND J GASTROENTERO, V37, P294, DOI 10.1080/003655202317284192; HAUG TT, 1994, J PSYCHOSOM RES, V38, P735, DOI 10.1016/0022-3999(94)90026-4; Hirakawa K, 1999, J GASTROEN HEPATOL, V14, P1083, DOI 10.1046/j.1440-1746.1999.02012.x; Hojo M, 2005, J GASTROENTEROL, V40, P1036, DOI 10.1007/s00535-005-1687-8; Holtmann G, 2006, AM J GASTROENTEROL, V101, P593, DOI 10.1111/j.1572-0241.2006.00480.x; Holtmann G, 2004, DIGEST DIS SCI, V49, P672, DOI 10.1023/B:DDAS.0000026317.00071.75; Hongo M, 2011, J GASTROEN HEPATOL, V26, P19, DOI 10.1111/j.1440-1746.2011.06632.x; Kaji M, 2010, J GASTROEN HEPATOL, V25, P1151, DOI 10.1111/j.1440-1746.2010.06249.x; Kakuta E, 2011, INTERNAL MED, V50, P1517, DOI 10.2169/internalmedicine.50.5390; KANEKO H, 1993, J GASTROEN HEPATOL, V8, P322, DOI 10.1111/j.1440-1746.1993.tb01521.x; Kawamura A, 2000, THER RES, V21, P1341; Kinoshita K, 1992, NIHON SHOKAKIBYO GAK, V89, P1973; Kinoshita Y, 2011, INTERNAL MED, V50, P2269, DOI 10.2169/internalmedicine.50.5678; KOK L P, 1989, SMJ Singapore Medical Journal, V30, P346; Kusano M, 2012, NEUROGASTROENT MOTIL, V24, P451, DOI 10.1111/j.1365-2982.2012.01876.x; Kusunoki H, 2012, NEUROGASTROENT MOTIL, V24, P540, DOI 10.1111/j.1365-2982.2012.01897.x; Lee HJ, 2010, GEN HOSP PSYCHIAT, V32, P499, DOI 10.1016/j.genhosppsych.2010.05.002; Lee KJ, 2006, J GASTROEN HEPATOL, V21, P515, DOI 10.1111/j.1440-1746.2005.03976.x; LEMANN M, 1991, DIGEST DIS SCI, V36, P1249, DOI 10.1007/BF01307517; Loreno M, 2004, DIGEST DIS SCI, V49, P404, DOI 10.1023/B:DDAS.0000020493.86898.b6; Lundquist P, 1998, EUR J SURG, V164, P345; Maconi G, 2009, EUR J GASTROEN HEPAT, V21, P297, DOI 10.1097/MEG.0b013e3283069db0; Manabe N, 2010, SCAND J GASTROENTERO, V45, P567, DOI 10.3109/00365521003592663; Meineche-Schmidt V, 1999, SCAND J GASTROENTERO, V34, P566; Misiara GP, 2008, ANN NUCL MED, V22, P761, DOI 10.1007/s12149-008-0182-8; Miwa H, 2006, J GASTROEN HEPATOL, V21, P1826, DOI 10.1111/j.1440-1746.2006.04446.x; Moayyedi P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001960.pub3; Moayyedi P, 2011, ARCH INTERN MED, V171, P1936, DOI 10.1001/archinternmed.2011.541; Muth ER, 2000, DIGEST DIS SCI, V45, P854, DOI 10.1023/A:1005500403066; Pajala M, 2005, ALIMENT PHARM THERAP, V21, P277, DOI 10.1111/j.1365-2036.2005.02296.x; Passos Mdo C, 2008, PAIN PHYSICIAN, V11, P597; Pilichiewicz AN, 2008, AM J GASTROENTEROL, V103, P2613, DOI 10.1111/j.1572-0241.2008.02041.x; Sattar A, 2010, J PAK MED ASSOC, V60, P995; SCHLEMPER RJ, 1993, SCAND J GASTROENTERO, V28, P33, DOI 10.3109/00365529309101573; Lorena SLS, 2002, DIGEST DIS SCI, V47, P27; Talley NJ, 2001, ALIMENT PHARM THERAP, V15, P1603, DOI 10.1046/j.1365-2036.2001.01074.x; Talley NJ, 1998, J GASTROEN HEPATOL, V13, P335, DOI 10.1111/j.1440-1746.1998.tb00644.x	87	2	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					125	139		10.1007/s00535-014-1022-3		15	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000002		
J	Satoh, K; Hamada, S; Shimosegawa, T				Satoh, Kennichi; Hamada, Shin; Shimosegawa, Tooru			Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma	JOURNAL OF GASTROENTEROLOGY			English	Review						EMT; Pancreatic ductal adenocarcinoma; Cancer development	CANCER STEM-CELLS; TUMOR PROGRESSION; DRUG-RESISTANCE; CARCINOMA CELLS; UP-REGULATION; E-CADHERIN; EXPRESSION; PHENOTYPE; GROWTH; ACTIVATION	Pancreatic ductal adenocarcinoma (PDAC) is an intractable disease as a result of its rapid dissemination and resistance to conventional chemotherapy and radiotherapy. Surgical resection is the only curative therapy, but most of the tumors are unresectable at the time of diagnosis. The molecular mechanisms underlying the biological aggressiveness of this tumor type remain to be clarified. Epithelial to mesenchymal transition (EMT) is a developmental process that leads the phenotype shift from an epithelial morphology to a motile, fibroblast-like morphology. Recent studies showed that EMT is involved in the invasion and metastasis of many types of carcinomas including PDAC. In addition, PDAC cells with the EMT phenotype also exhibit chemoresistance and the cancer stem cell property. Various factors such as cytokines, growth factors, or transcriptional factors were found to promote the EMT program in PDAC cells. In this review, we summarize the current knowledge about the EMT in PDAC cells, focusing on the involvement of this process and its regulatory molecules including microRNA during the development of PDAC cells.	[Satoh, Kennichi] Miyagi Canc Ctr Res Inst, Div Canc Stem Cell, Natori, Miyagi, Japan; [Hamada, Shin; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan	Satoh, K (reprint author), Miyagi Canc Ctr Res Inst, Div Canc Stem Cell, 47-1 Nodayama, Natori, Miyagi, Japan.	ksatoh-gi@umin.ac.jp					Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Hamada S, 2012, J CELL PHYSIOL, V227, P729, DOI 10.1002/jcp.22781; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Satoh K, 2008, AM J PATHOL, V172, P926, DOI 10.2353/ajpath.2008.070346; Gungor C, 2011, CANCER RES, V71, P5009, DOI 10.1158/0008-5472.CAN-11-0036; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Wey JS, 2005, CANCER, V104, P427, DOI 10.1002/cncr.21145; Hay ED, 1995, ACTA ANAT, V154, P8; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; [Anonymous], 2013, MON CANC INC JAP SUR; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Ellenrieder V, 2001, CANCER RES, V61, P4222; Wang Zhiwei, 2011, Nat Rev Gastroenterol Hepatol, V8, P27, DOI 10.1038/nrgastro.2010.188; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Li YW, 2013, CANCER LETT, V338, P94, DOI 10.1016/j.canlet.2012.03.018; Hong SM, 2012, CLIN CANCER RES, V18, P700, DOI 10.1158/1078-0432.CCR-11-1718; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Castellanos JA, 2013, ONCOTARGETS THER, V6, P1261, DOI 10.2147/OTT.S34670; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Hong SM, 2011, ARCH PATHOL LAB MED, V135, P716, DOI 10.1043/2010-0566-RA.1; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Salem AF, 2011, CELL CYCLE, V10, P3692, DOI 10.4161/cc.10.21.17895; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; Hamada S, 2007, J CELL PHYSIOL, V213, P768, DOI 10.1002/jcp.21148; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Hamada S, 2013, J CELL PHYSIOL, V228, P1255, DOI 10.1002/jcp.24280; Bo HJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-496; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Funamizu N, 2012, INT J CANCER, V132, P785; Harazono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062757; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Matsuda A, 2013, JPN J CLIN ONCOL, V44, P388; Ouyang H, 2014, ONCOGENE, V33, P4664, DOI 10.1038/onc.2013.405; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Salnikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046391; Shaah AN, 2007, ANN SURG ONCOL, V14, P3629; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5471CAN-05-3086; Zhou W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087409	51	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					140	146		10.1007/s00535-014-0997-0		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000003		
J	Hanada, K; Okazaki, A; Hirano, N; Izumi, Y; Teraoka, Y; Ikemoto, J; Kanemitsu, K; Hino, F; Fukuda, T; Yonehara, S				Hanada, Keiji; Okazaki, Akihito; Hirano, Naomichi; Izumi, Yoshihiro; Teraoka, Yuji; Ikemoto, Juri; Kanemitsu, Kozue; Hino, Fumiaki; Fukuda, Toshikatsu; Yonehara, Shuji			Diagnostic strategies for early pancreatic cancer	JOURNAL OF GASTROENTEROLOGY			English	Review						Early diagnosis; Endoscopic nasopancreatic drainage; Carcinoma in situ of pancreatic cancer; Physician community	POSITRON-EMISSION-TOMOGRAPHY; HIGH-RISK INDIVIDUALS; CARCINOMA IN-SITU; ENDOSCOPIC ULTRASONOGRAPHY; DUCTAL ADENOCARCINOMA; CYTOLOGIC EXAMINATION; SERUM METABOLOMICS; LESIONS; NEOPLASIA; JUICE	Diagnosis of pancreatic cancer (PC) at an early stage with curative surgery is the approach with the potential to significantly improve long-term patient outcome. Recently, some reports showed that patients with pancreatic tumors smaller than 10 mm showed a favorable prognosis. However, the rate of tumor detection on computed tomography in patients with small pancreatic tumors is low. For the diagnoses of PC with tumors smaller than 10 mm, the rate of tumor detection was higher on endoscopic ultrasonography (EUS) than on computed tomography or other modalities, and histologic diagnosis using EUS-guided fine-needle aspiration was helpful in confirming the diagnosis. For the diagnosis of PC in situ, EUS and magnetic resonance cholangiopancreatography may play important roles in detecting the local irregular stenosis of the pancreatic duct. Endoscopic retrograde pancreatography and sequential cytodiagnosis using pancreatic juice obtained by endoscopic nasopancreatic drainage multiple times was useful in the final diagnosis of PC in situ. At present, improving survival lies in identifying those individuals with high-risk factors or precursor lesions through an effective screening method. For example, these should include ultrasonography, various biological markers, or national familial pancreatic cancer registration. Additionally, the relationship between specialists in PC from medical centers and practicing physicians plays an important role in the early diagnosis of PC.	[Hanada, Keiji; Okazaki, Akihito; Hirano, Naomichi; Izumi, Yoshihiro; Teraoka, Yuji; Ikemoto, Juri; Kanemitsu, Kozue; Hino, Fumiaki] Onomichi Gen Hosp, Dept Gastroenterol, Onomichi 7228508, Japan; [Fukuda, Toshikatsu] Onomichi Gen Hosp, Dept Surg, Onomichi 7228508, Japan; [Yonehara, Shuji] Onomichi Gen Hosp, Dept Pathol, Onomichi 7228508, Japan	Hanada, K (reprint author), Onomichi Gen Hosp, Dept Gastroenterol, 1-10-23 Hirahara, Onomichi 7228508, Japan.	kh-ajpbd@nifty.com					Yasuda I, 2011, DIGEST ENDOSC, V23, P22, DOI 10.1111/j.1443-1661.2011.01113.x; Poley JW, 2009, AM J GASTROENTEROL, V104, P2175, DOI 10.1038/ajg.2009.276; Rosewicz S, 1997, LANCET, V349, P485; NAKAIZUMI A, 1995, CANCER, V76, P750, DOI 10.1002/1097-0142(19950901)76:5<750::AID-CNCR2820760507>3.0.CO;2-#; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c; Tada M, 2006, CLIN GASTROENTEROL H, V4, P1265, DOI 10.1016/j.cgh.2006.07.013; Mori Y, 2013, PANCREAS, V42, P187, DOI 10.1097/MPA.0b013e3182649979; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Canto MI, 2013, GUT, V62, P339, DOI 10.1136/gutjnl-2012-303108; Riker A, 1997, SURG ONCOL, V6, P157, DOI 10.1016/S0960-7404(97)00025-X; Takaori K, 1998, PANCREAS, V17, P102, DOI 10.1097/00006676-199807000-00015; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Hruban RH, 1999, ANN ONCOL, V10, P69, DOI 10.1023/A:1008345021197; Nishiumi S, 2010, METABOLOMICS, V6, P518, DOI 10.1007/s11306-010-0224-9; Maguchi H, 2011, PANCREAS, V40, P364, DOI 10.1097/MPA.0b013e31820a5975; Kastrinos F, 2009, JAMA-J AM MED ASSOC, V302, P1790, DOI 10.1001/jama.2009.1529; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Uehara H, 2011, J GASTROEN HEPATOL, V26, P1256, DOI 10.1111/j.1440-1746.2011.06747.x; Klein AP, 2013, NAT REV CANCER, V13, P66, DOI 10.1038/nrc3420; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Kimmey MB, 2002, GASTROINTEST ENDOSC, V56, pS82, DOI 10.1067/mge.2002.127753; Vasen HFA, 2011, GASTROENTEROLOGY, V140, P850, DOI 10.1053/j.gastro.2010.11.048; Canto MI, 2004, CLIN GASTROENTEROL H, V2, P606, DOI 10.1053/S1542-3565(04)00244-7; FURUTA K, 1992, CANCER, V69, P1327, DOI 10.1002/1097-0142(19920315)69:6<1327::AID-CNCR2820690605>3.0.CO;2-N; Egawa S, 2012, PANCREAS, V41, P985, DOI 10.1097/MPA.0b013e318258055c; Iiboshi T, 2012, PANCREAS, V41, P523, DOI 10.1097/MPA.0b013e31823c0b05; Ballehaninna Umashankar K, 2012, J Gastrointest Oncol, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Fukasawa M, 2013, KAN TAN SUI, V66, P277; Geenhalf W, 2006, NAT CLIN PRACT ONCOL, V3, P346; Hanada Keiji, 2013, Nihon Shokakibyo Gakkai Zasshi, V110, P2051; Hanada K, 2006, DIGEST ENDOSC, V18, pS68, DOI 10.1111/j.1443-1661.2006.00625.x; Hanada K, 2012, GASTROENTEROL ENDOSC, V54, P3773; Hanada K, 2012, PANCREAS, V41, P1156; Hanada K, 2009, TAN TO SUI, V30, P343; Hijioka S, 2007, HEPATO-GASTROENTEROL, V54, P389; Ikeda S, 2009, PANCREAS, V38, pE102, DOI 10.1097/MPA.0b013e31819f65c3; Irisawa A, 2009, DIGEST ENDOSC, V21, pS92, DOI 10.1111/j.1443-1661.2009.00866.x; Kamata K, 2014, ENDOSCOPY, V46, P22, DOI 10.1055/s-0033-1353603; Kimura K, 2011, NIHON SHOKAKIBYO GAK, V108, P928; Maguchi H, 2004, J HEPATO-BILIARY-PAN, V11, P1, DOI 10.1007/s00534-002-0752-4; Matsumoto I, 2013, CLIN GASTROENTEROL H, V11, P712, DOI 10.1016/j.cgh.2012.12.033; Mikata R, 2012, J GASTROENTEROL, V48, P866; Ministry of Health Labor and Welfare, 2014, VIT STAT JAP 2012 CA; NAKAIZUMI A, 1992, CANCER, V70, P2610, DOI 10.1002/1097-0142(19921201)70:11<2610::AID-CNCR2820701107>3.0.CO;2-Y; Okano K, 2011, WORLD J GASTROENTERO, V17, P231, DOI 10.3748/wjg.v17.i2.231; Sakamoto H, 2009, TAN SUI, V30, P335; Seki M, 2008, PANCREATOLOGY, V8, P142, DOI 10.1159/000123839; Seo S, 2008, J HEPATO-BILIARY-PAN, V15, P634, DOI 10.1007/s00534-007-1339-x; Serrano Oscar K, 2010, Adv Surg, V44, P313; Takagi T, 2009, TAN SUI, V30, P361; Takeshita K, 2010, BRIT J RADIOL, V83, P823, DOI 10.1259/bjr/80905803; Tanaka S, 2010, RADIOLOGY, V254, P965, DOI 10.1148/radiol.09090992; Tricoli James V, 2007, Cancer Res, V67, P4553, DOI 10.1158/0008-5472.CAN-07-0563; Vesen HF, 2000, INT J CANCER, V87, P809; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yamaguchi K, 2014, JPN J CLIN ONCOL, V44, P883, DOI 10.1093/jjco/hyu127; Yokohata K, 2000, SCAND J GASTROENTERO, V11, P1229	59	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					147	154		10.1007/s00535-014-1026-z		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000004		
J	Okita, K; Izumi, N; Matsui, O; Tanaka, K; Kaneko, S; Moriwaki, H; Ikeda, K; Osaki, Y; Numata, K; Nakachi, K; Kokudo, N; Imanaka, K; Nishiguchi, S; Okusaka, T; Nishigaki, Y; Shiomi, S; Kudo, M; Ido, K; Karino, Y; Hayashi, N; Ohashi, Y; Makuuchi, M; Kumada, H				Okita, Kiwamu; Izumi, Namiki; Matsui, Osamu; Tanaka, Katsuaki; Kaneko, Shuichi; Moriwaki, Hisataka; Ikeda, Kenji; Osaki, Yukio; Numata, Kazushi; Nakachi, Kohei; Kokudo, Norihiro; Imanaka, Kazuho; Nishiguchi, Shuhei; Okusaka, Takuji; Nishigaki, Yoichi; Shiomi, Susumu; Kudo, Masatoshi; Ido, Kenichi; Karino, Yoshiyasu; Hayashi, Norio; Ohashi, Yasuo; Makuuchi, Masatoshi; Kumada, Hiromitsu		Peretinoin Study Grp	Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study	JOURNAL OF GASTROENTEROLOGY			English	Article						Liver neoplasms; Recurrence; Multicentric de novo carcinogenesis; Retinoids; Dose-response relationship	2ND PRIMARY TUMORS; UNITED-STATES; LIVER RESECTION; INTERFERON; PREVENTION; METAANALYSIS; RECURRENCE; EXPRESSION; INDUCTION; PROGNOSIS	Effective prophylactic therapies have not been established for hepatocellular carcinoma recurrence. Peretinoin represents one novel option for patients with hepatitis C virus-related hepatocellular carcinoma (HCV-HCC), and it was tested in a multicenter, randomized, double-blind, placebo-controlled study. Patients with curative therapy were assigned to one of the following regimens: peretinoin 600, 300 mg/day, or placebo for up to 96 weeks. The primary outcome was recurrence-free survival (RFS). Of the 401 patients initially enrolled, 377 patients were analyzed for efficacy. The RFS rates in the 600-mg group, the 300-mg group, and the placebo group were 71.9, 63.6, and 66.0 % at 1 year, and 43.7, 24.9, and 29.3 % at 3 years, respectively. The primary comparison of peretinoin (300 and 600-mg) with placebo was not significant (P = 0.434). The dose-response relationship based on the hypothesis that "efficacy begins to increase at 600 mg/day" was significant (P = 0.023, multiplicity-adjusted P = 0.048). The hazard ratios for RFS in the 600-mg group vs. the placebo group were 0.73 [95 % confidence interval (CI) 0.51-1.03] for the entire study period and 0.27 (95 % CI 0.07-0.96) after 2 years of the randomization. Common adverse events included ascites, increased blood pressure, headache, presence of urine albumin, and increased transaminases. Although the superiority of peretinoin to placebo could not be validated, 600 mg/day was shown to be the optimal dose, and treatment may possibly reduce the recurrence of HCV-HCC, particularly after 2 years. The efficacy and safety of peretinoin 600 mg/day should continue to be evaluated in further studies.	[Okita, Kiwamu] Shimonoseki Kohsei Hosp, Shimonoseki, Yamaguchi 7500061, Japan; [Izumi, Namiki] Musashino Red Cross Hosp, Musashino, Tokyo 1808610, Japan; [Matsui, Osamu; Kaneko, Shuichi] Kanazawa Univ Hosp, Kanazawa, Ishikawa 9208641, Japan; [Tanaka, Katsuaki; Numata, Kazushi] Yokohama City Univ, Med Ctr, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Moriwaki, Hisataka] Gifu Univ Hosp, Gifu 5011194, Japan; [Ikeda, Kenji; Kumada, Hiromitsu] Toranomon Gen Hosp, Minato Ku, Tokyo 1058470, Japan; [Osaki, Yukio] Osaka Red Cross Hosp, Tennoji Ku, Osaka 5438555, Japan; [Nakachi, Kohei] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan; [Kokudo, Norihiro] Tokyo Univ Hosp, Bunkyo Ku, Tokyo 1138655, Japan; [Imanaka, Kazuho] Osaka Med Ctr Canc & Cardiovasc Dis, Higashinari Ku, Osaka 5378511, Japan; [Nishiguchi, Shuhei] Hyogo Coll Med Hosp, Nishinomiya, Hyogo 6638501, Japan; [Okusaka, Takuji] Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan; [Nishigaki, Yoichi] Gifu Municipal Hosp, Gifu 5008513, Japan; [Shiomi, Susumu] Osaka City Univ Hosp, Abeno Ku, Osaka 5458585, Japan; [Kudo, Masatoshi] Kinki Univ Hosp, Sayama, Osaka 5898511, Japan; [Ido, Kenichi] Jichi Med Univ Hosp, Shimotsuke, Tochigi 3290498, Japan; [Karino, Yoshiyasu] Sapporo Kosei Gen Hosp, Chuo Ku, Sapporo, Hokkaido 0600033, Japan; [Hayashi, Norio] Kansai Rosai Hosp, Amagasaki, Hyogo 6608511, Japan; [Ohashi, Yasuo] Univ Tokyo, Bunkyo Ku, Tokyo 1138654, Japan; [Makuuchi, Masatoshi] Japanese Red Cross Med Ctr, Shibuya Ku, Tokyo 1508935, Japan	Okita, K (reprint author), Shimonoseki Kohsei Hosp, Kamishinchi Machi 3-3-8, Shimonoseki, Yamaguchi 7500061, Japan.	k.okita@kousei-h.jp			Kowa Company, Ltd.	The authors would like to thank Yoshiro Niitsu, Yutaka Aoyagi, Kunihiko Hayasi, Shigehiro Katayama, and Akira Itabashi, who all served on the independent data and safety monitoring committee; special thanks also goes to Tomoaki Ichikawa and Kazuhiko Ueda who served as independent CT image reviewers. The authors would like to acknowledge Statcom Co., Ltd, for their assistance in the preparation and editing of this manuscript. This study was financially supported by Kowa Company, Ltd. Additionally, the authors thank the following principal investigators who enrolled patients in the peretinoin study: (The principal investigators listed below are members of the Peretinoin Study Group) Toshiya Kamiyama, Yoshiyasu Karino, Kunihiko Tsuji, Kazuhiro Kasai, Kenichi Ido, Norio Isoda, Norihiro Kokudo, Fuminori Moriyasu, Shigeki Arii, Takuji Okusaka, Junji Furuse, Kohei Nakachi, Katsumi Sasaki, Kenji Ikeda, Namiki Izumi, Shigehiro Kokubu, Takahide Nakazawa, Kazushi Numata, Hisataka Moriwaki, Yoichi Nishigaki, Fumihiro Urano, Susumu Shiomi, Masatoshi Kudo, Kiyohide Kioka, Yukio Osaki, Michio Kato, Eiji Mita, Hiroshi Kasugai, Kazuho Imanaka, Harumasa Yoshihara, Toshihito Seki, Takefumi Nakamura, Toyokazu Fukunaga, Shuhei Nishiguchi, Kazuaki Chayama, Mikiya Kitamoto, Isao Sakaida, Satoyoshi Yamashita, Norio Horiike, Yoichi Hiasa, Makoto Tokumatsu, Nobuhiko Higashi, Shotaro Sakisaka, Yozo Iida, Hiromi Ishibashi, Takashi Kanematsu, Masataka Seike, Yutaka Sasaki, and Hirohito Tsubouchi.	Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; NAKAMURA N, 1995, BIOCHEM BIOPH RES CO, V207, P382, DOI 10.1006/bbrc.1995.1199; ARAKI H, 1995, BIOCHEM BIOPH RES CO, V209, P66, DOI 10.1006/bbrc.1995.1471; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Shiratori Y, 2003, ANN INTERN MED, V138, P299; Suzui M, 2002, CANCER RES, V62, P3997; Samuel M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001199.pub2; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Iwasaki Y, 2006, HEPATOLOGY, V43, P54, DOI 10.1002/hep.20984; El-Serag H, 2003, ANN INTERN MED, V139, P817; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Mathurin P, 2003, ALIMENT PHARM THERAP, V17, P1247, DOI 10.1046/j.0269-2813.2003.01580.x; Nudo CG, 2006, CAN J GASTROENTEROL, V20, P589; Armstrong GL, 2006, ANN INTERN MED, V144, P705; CASTELLS A, 1993, HEPATOLOGY, V18, P1121; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Gollnick HPM, 1996, BRIT J DERMATOL, V135, P6, DOI 10.1111/j.1365-2133.1996.tb15661.x; Honda M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-191; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kudo M, 2007, ONCOLOGY-BASEL, V72, P2, DOI 10.1159/000111702; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Okusaka T, 2011, HEPATOL RES, V41, P542, DOI 10.1111/j.1872-034X.2011.00800.x; SPORN MB, 1979, FED PROC, V38, P2528; Westfall P., 1993, RESAMPLING BASED MUL; Yasuda I, 2002, J HEPATOL, V36, P660, DOI 10.1016/S0168-8278(02)00044-2	30	6	6	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					191	202		10.1007/s00535-014-0956-9		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000008		
J	Kubota, Y; Kawakami, H; Natsuizaka, M; Kawakubo, K; Marukawa, K; Kudo, T; Abe, Y; Kubo, K; Kuwatani, M; Hatanaka, Y; Mitsuhashi, T; Matsuno, Y; Sakamoto, N				Kubota, Yoshimasa; Kawakami, Hiroshi; Natsuizaka, Mitsuteru; Kawakubo, Kazumichi; Marukawa, Katsuji; Kudo, Taiki; Abe, Yoko; Kubo, Kimitoshi; Kuwatani, Masaki; Hatanaka, Yutaka; Mitsuhashi, Tomoko; Matsuno, Yoshihiro; Sakamoto, Naoya			CTNNB1 mutational analysis of solid-pseudopapillary neoplasms of the pancreas using endoscopic ultrasound-guided fine-needle aspiration and next-generation deep sequencing	JOURNAL OF GASTROENTEROLOGY			English	Article						CTNNB1; Solid-pseudopapillary neoplasms of the pancreas; Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA); Next-generation sequencing	BETA-CATENIN GENE; NEUROENDOCRINE TUMORS; CASE SERIES; DIAGNOSIS; CANCER; ADENOCARCINOMAS; DEREGULATION; CARCINOMAS; ACTIVATION; EXPERIENCE	Solid-pseudopapillary neoplasm (SPN), a rare neoplasm of the pancreas, frequently harbors mutations in exon 3 of the cadherin-associated protein beta 1 (CTNNB1) gene. Here, we analyzed SPN tissue for CTNNB1 mutations by deep sequencing using next-generation sequencing (NGS). Tissue samples from 7 SPNs and 31 other pancreatic lesions (16 pancreatic ductal adenocarcinomas (PDAC), 11 pancreatic neuroendocrine tumors (PNET), 1 acinar cell carcinoma, 1 autoimmune pancreatitis lesion, and 2 focal pancreatitis lesions) were analyzed by NGS for mutations in exon 3 of CTNNB1. A single-base-pair missense mutations in exon 3 of CTNNB1 was observed in all 7 SPNs and in 1 of 11 PNET samples. However, mutations were not observed in the tissue samples of any of the 16 PDAC or other four pancreatic disease cases. The variant frequency of CTNNB1 ranged from 5.4 to 48.8 %. Mutational analysis of CTNNB1 by NGS is feasible and was achieved using SPN samples obtained by endoscopic ultrasound-guided fine needle aspiration.	[Kubota, Yoshimasa; Kawakami, Hiroshi; Natsuizaka, Mitsuteru; Kawakubo, Kazumichi; Kudo, Taiki; Abe, Yoko; Kubo, Kimitoshi; Kuwatani, Masaki; Sakamoto, Naoya] Hokkaido Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Marukawa, Katsuji; Hatanaka, Yutaka; Mitsuhashi, Tomoko; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan	Kawakami, H (reprint author), Hokkaido Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	hiropon@med.hokudai.ac.jp	Kawakubo, Kazumichi/F-2937-2011				Adamthwaite Jonathan A, 2006, JOP, V7, P635; Angulo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043842; Notohara K, 2000, AM J SURG PATHOL, V24, P1361, DOI 10.1097/00000478-200010000-00005; Bardales RH, 2004, AM J CLIN PATHOL, V121, P654, DOI 10.1039/DKK2B9V4N0W26A8Q; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yu PF, 2010, WORLD J GASTROENTERO, V16, P1209, DOI 10.3748/wjg.v16.i10.1209; Haba S, 2013, J GASTROENTEROL, V48, P973, DOI 10.1007/s00535-012-0695-8; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Kloppel G, 2007, VIRCHOWS ARCH, V451, pS9, DOI 10.1007/s00428-007-04961-0; Eto K, 2013, BRIT J CANCER, V108, P1488, DOI 10.1038/bjc.2013.108; Takahashi Y, 2006, VIRCHOWS ARCH, V448, P561, DOI 10.1007/s00428-006-0174-9; Klimstra DS, 2000, SEMIN DIAGN PATHOL, V17, P66; Wu R, 2001, CANCER RES, V61, P8247; Ross JS, 2013, GYNECOL ONCOL, V130, P554, DOI 10.1016/j.ygyno.2013.06.019; Palacios J, 1998, CANCER RES, V58, P1344; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kloppel G, 2009, NEUROENDOCRINOLOGY, V90, P162, DOI 10.1159/000182196; Jani N, 2008, ENDOSCOPY, V40, P200, DOI 10.1055/s-2007-995364; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Gerdes B, 1999, DIGESTION, V60, P544, DOI 10.1159/000007704; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; Maimone A, 2013, DIGEST LIVER DIS, V45, P957, DOI 10.1016/j.dld.2013.06.005; Tanaka Y, 2001, CANCER RES, V61, P8401; Kim JT, 2013, CARCINOGENESIS, V34, P953, DOI 10.1093/carcin/bgt018; Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Vassos N, 2013, INT J CLIN EXP PATHO, V6, P1051; Miyoshi Y, 1998, CANCER RES, V58, P2524; Liu BA, 2010, WORLD J GASTROENTERO, V16, P1025, DOI 10.3748/wjg.v16.i8.1025; Papavramidis T, 2005, J AM COLL SURGEONS, V200, P965, DOI 10.1016/j.jmacollsurg.2005.02.011; Frantz V. K., 1959, TUMORS PANCREAS ATLA; Hooper K, 2013, CANCER CYTOPATHOL, V121, P653, DOI 10.1002/cncy.21332; Huang SC, 2011, ANN SURG ONCOL S3, V19, pS438; Master SS, 2003, GASTROINTEST ENDOSC, V57, P965, DOI 10.1067/mge.2003.228; Nadler EP, 2002, J PEDIATR SURG, V37, P1370, DOI 10.1053/jpsu.2002.35028; Rinner B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-594; Voeller HJ, 1998, CANCER RES, V58, P2520	38	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					203	210		10.1007/s00535-014-0954-y		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000009		
J	Mukai, S; Itoi, T; Sofuni, A; Itokawa, F; Kurihara, T; Tsuchiya, T; Ishii, K; Tsuji, S; Ikeuchi, N; Tanaka, R; Umeda, J; Tonozuka, R; Honjo, M; Gotoda, T; Moriyasu, F				Mukai, Shuntaro; Itoi, Takao; Sofuni, Atsushi; Itokawa, Fumihide; Kurihara, Toshio; Tsuchiya, Takayoshi; Ishii, Kentaro; Tsuji, Shujiro; Ikeuchi, Nobuhito; Tanaka, Reina; Umeda, Junko; Tonozuka, Ryosuke; Honjo, Mitsuyoshi; Gotoda, Takuji; Moriyasu, Fuminori			Expanding endoscopic interventions for pancreatic pseudocyst and walled-off necrosis	JOURNAL OF GASTROENTEROLOGY			English	Article						Endoscopic ultrasonography; Pancreatic pseudocyst drainage; Walled-off necrosis	PROSPECTIVE RANDOMIZED-TRIAL; TRANSMURAL DRAINAGE; NECROTIZING PANCREATITIS; NECROSECTOMY; MULTICENTER; DEBRIDEMENT; THERAPY; ABSCESS; VIDEOS; EUS	Recently, several endoscopists have described the usefulness of the endoscopic ultrasonography (EUS)-guided, single transluminal gateway technique (SGT) using transmural placement of single or multiple plastic stents or metal stents for a pancreatic pseudocyst (PC) and walled-off necrosis (WON). Moreover, the uses of the multiple transluminal gateway technique (MTGT) and single transluminal gateway transcystic multiple drainages (SGTMD) for complicated pancreatic walled-off necrosis have recently been reported. The aim of this study is to evaluate retrospectively the feasibility and efficacy of endotherapy for the treatment of complicated PC and WON cases. Eighty-nine patients with a PC (n = 14) and WON (n = 75) were treated under EUS guidance. In a total of 89 cases using SGT in combination with MTGT or SGTMD, the present study showed a technical success rate of 100 %, a final clinical success rate of 97.8 %, an adverse event during procedure rate of 0 %, an early adverse event rate of 12.4 %, and a mortality rate of 2.2 %. Even complicated WON cases can be treated using combination endotherapies, although a surgical approach as well as a percutaneous approach should be considered in the cases refractory to endoscopic therapies.	[Mukai, Shuntaro; Itoi, Takao; Sofuni, Atsushi; Itokawa, Fumihide; Kurihara, Toshio; Tsuchiya, Takayoshi; Ishii, Kentaro; Tsuji, Shujiro; Ikeuchi, Nobuhito; Tanaka, Reina; Umeda, Junko; Tonozuka, Ryosuke; Honjo, Mitsuyoshi; Gotoda, Takuji; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan	Mukai, S (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	maezora1031@yahoo.co.jp					Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; van Santvoort HC, 2010, NEW ENGL J MED, V362, P1491, DOI 10.1056/NEJMoa0908821; Seewald S, 2005, GASTROINTEST ENDOSC, V62, P92, DOI 10.1016/S0016-5107(05)00541-9; Seifert H, 2009, GUT, V58, P1260, DOI 10.1136/gut.2008.163733; Varadarajulu S, 2011, GASTROINTEST ENDOSC, V74, P74, DOI 10.1016/j.gie.2011.03.1122; Varadarajulu S, 2008, GASTROINTEST ENDOSC, V68, P1102, DOI 10.1016/j.gie.2008.04.028; Bakker OJ, 2012, JAMA-J AM MED ASSOC, V307, P1053, DOI 10.1001/jama.2012.276; Ross A, 2010, GASTROINTEST ENDOSC, V71, P79, DOI 10.1016/j.gie.2009.06.037; Seifert H, 2000, LANCET, V356, P653, DOI 10.1016/S0140-6736(00)02611-8; Yasuda I, 2013, ENDOSCOPY, V45, P627, DOI 10.1055/s-0033-1344027; Baron TH, 1996, GASTROENTEROLOGY, V111, P755, DOI 10.1053/gast.1996.v111.pm8780582; Giovannini M, 1998, GASTROINTEST ENDOSC, V48, P200, DOI 10.1016/S0016-5107(98)70165-8; Yu SC, 1997, CLIN RADIOL, V52, P912; BINMOELLER KF, 1995, GASTROINTEST ENDOSC, V42, P219, DOI 10.1016/S0016-5107(95)70095-1; Baron TH, 2012, CLIN GASTROENTEROL H, V10, P1202, DOI 10.1016/j.cgh.2012.07.009; Park DH, 2009, ENDOSCOPY, V41, P842, DOI 10.1055/s-0029-1215133; Baron TH, 2002, GASTROINTEST ENDOSC, V56, P7, DOI 10.1067/mge.2002.125106; Gardner TB, 2011, GASTROINTEST ENDOSC, V73, P718, DOI 10.1016/j.gie.2010.10.053; Harrison S, 2010, J GASTROINTEST SURG, V14, P245, DOI 10.1007/s11605-009-1100-7; Itoi T, 2013, J HEPATOBIL IN PRESS; Itoi T, 2013, DIGEST ENDOSC, V25, P241, DOI 10.1111/den.12048; Mukai S, 2014, GASTROINTEST ENDOSC, V79, P531, DOI 10.1016/j.gie.2013.10.004; Sofuni A, 2012, J GASTROEN HEPATOL, V1, P233; Vosoghi M, 2002, MEDGENMED, V18, P2; Warner Elizabeth A, 2009, Curr Gastroenterol Rep, V11, P128	25	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					211	220		10.1007/s00535-014-0957-8		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000010		
J	Tazuma, S; Igarashi, Y; Inui, K; Ohara, H; Tsuyuguchi, T; Ryozawa, S				Tazuma, Susumu; Igarashi, Yoshinori; Inui, Kazuo; Ohara, Hirotaka; Tsuyuguchi, Toshio; Ryozawa, Shomei		BTI Therapy Res Grp	Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator	JOURNAL OF GASTROENTEROLOGY			English	Article						Biliary tract infection; Doripenem; Imipenem/cilastatin; Randomized controlled trial (RCT)	BETA-LACTAMASE; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC USE; HIGH-POTENCY; CARBAPENEM; CIPROFLOXACIN; CHOLECYSTITIS; CHOLANGITIS; GUIDELINES; RESISTANCE	We conducted a randomized controlled trial to evaluate the clinical efficacy and safety of intravenous doripenem (DRPM) in patients with biliary tract infection requiring biliary drainage in comparison with imipenem/cilastatin (IPM/CS). After the initial collection of bile, patients were randomly assigned by the registration system of the Clinical Research Organization to receive intravenous drip infusion of DRPM 0.5 g or IPM/CS 0.5 g three times daily in a randomized, open-label manner. A total of 127 patients were enrolled in the trial (DRPM 62, IPM/CS 65). The characteristics of the 122 patients evaluated for efficacy were well balanced, except for the percentage of patients previously receiving antimicrobials, which was higher in the DRPM group than in the IPM/CS group. The clinical response rate was not significantly different between the DRPM group (93.1 %, 54/58 patients) and the IPM/CS group (93.8 %, 60/64). Non-inferiority assessment using confidence intervals demonstrated the non-inferiority of DRPM-IPM/CS. The incidence of adverse events, for which a causal relationship with either treatment was not ruled out, was 3.3 % (2/60) in the DRPM group and 3.1 % (2/65) in the IPM/CS group, and none was serious. The clinical efficacy of DRPM in treating moderate or severe biliary tract infection requiring drainage was comparable to that of IPM/CS. DRPM was associated with no serious adverse events and a low incidence of adverse events. The results of this trial demonstrate that DRPM is a useful therapeutic option for moderate or severe biliary tract infection.	[Tazuma, Susumu] Hiroshima Univ, Grad Sch Med Sci, Programs Appl Med, Dept Gen Internal Med, Hiroshima, Japan; [Igarashi, Yoshinori] Toho Univ, Omori Med Ctr, Div Gastroenterol & Hepatol, Tokyo, Japan; [Inui, Kazuo] Fujita Hlth Univ, Sch Med, Banbuntane Houtokukai Hosp, Dept Internal Med, Nagoya, Aichi, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi, Japan; [Tsuyuguchi, Toshio] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Ryozawa, Shomei] Saitama Med Univ, Int Med Ctr, Saitama, Japan	Tazuma, S (reprint author), Hiroshima Univ, Grad Sch Med Sci, Programs Appl Med, Dept Gen Internal Med, Hiroshima, Japan.	stazuma@hiroshima-u.ac.jp					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; SUNG JJY, 1995, J ANTIMICROB CHEMOTH, V35, P855, DOI 10.1093/jac/35.6.855; Tsuyuguchi T, 2012, J HEPATO-BIL-PAN SCI, V19, P557, DOI 10.1007/s00534-012-0538-2; Melzer M, 2007, POSTGRAD MED J, V83, P773, DOI 10.1136/pgmj.2007.064683; Bassotti G, 2004, WORLD J GASTROENTERO, V10, P2281; Choi SH, 2008, ANTIMICROB AGENTS CH, V52, P995, DOI 10.1128/AAC.01083-07; Committee on Guidelines for the Management of Acute Cholangitis, 2005, GUID MAN AC CHOL CHO; Csendes A, 2009, OBES SURG, V19, P890, DOI 10.1007/s11695-008-9702-9; Elkhaili H, 1997, CHEMOTHERAPY, V43, P245; Hirakata Y, 1998, ANTIMICROB AGENTS CH, V42, P2006; Kanafani ZA, 2005, J INFECTION, V51, P128, DOI 10.1016/j.jinf.2004.11.007; Keam SJ, 2008, DRUGS, V68, P2021, DOI 10.2165/00003495-200868140-00007; Okamoto K, 2013, J HEPATO-BIL-PAN SCI, V20, P55, DOI 10.1007/s00534-012-0562-2; Sakyo S, 2006, J ANTIBIOT, V59, P220; Shinagawa Nagao, 1997, Japanese Journal of Antibiotics, V50, P862; Takada T, 2007, J HEPATO-BILIARY-PAN, V14, P1, DOI 10.1007/s00534-006-1150-0; Tanimoto K, 2008, ANTIMICROB AGENTS CH, V52, P3795, DOI 10.1128/AAC.00464-08; Tazuma S, 2003, J BILIARY TRACT PANC, V24, P781; Tazuma S, 2011, HEPATOL RES, V41, P340, DOI 10.1111/j.1872-034X.2011.00783.x; Tazuma S, 2009, J GASTROENTEROL, V44, P781, DOI 10.1007/s00535-009-0067-1	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					221	229		10.1007/s00535-014-0960-0		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000011		
J	Miyake, T; Kumagi, T; Hirooka, M; Furukawa, S; Kawasaki, K; Koizumi, M; Todo, Y; Yamamoto, S; Nunoi, H; Tokumoto, Y; Ikeda, Y; Abe, M; Kitai, K; Matsuura, B; Hiasa, Y				Miyake, Teruki; Kumagi, Teru; Hirooka, Masashi; Furukawa, Shinya; Kawasaki, Keitarou; Koizumi, Mitsuhito; Todo, Yasuhiko; Yamamoto, Shin; Nunoi, Hiroaki; Tokumoto, Yoshio; Ikeda, Yoshio; Abe, Masanori; Kitai, Kohichiro; Matsuura, Bunzo; Hiasa, Yoichi			Significance of exercise in nonalcoholic fatty liver disease in men: a community-based large cross-sectional study	JOURNAL OF GASTROENTEROLOGY			English	Article						Lifestyle; Exercise; Exercise consciousness; Nonalcoholic fatty liver disease	ACTIVITY THERMOGENESIS; METABOLIC SYNDROME; HEPATIC STEATOSIS; PHYSICAL-ACTIVITY; RISK-FACTORS; PREVALENCE; STEATOHEPATITIS; POPULATION; DIAGNOSIS; ONSET	Nonalcoholic fatty liver disease (NAFLD) is a risk factor for diabetes and cardiovascular disease that could progress to nonalcoholic steatohepatitis, cirrhosis, and liver failure. We aimed to assess the relationship between NAFLD and lifestyle habits. Using a community-based, cross-sectional design, the records of 11,094 Japanese subjects who had undergone at least 1 annual health checkup were reviewed. Of the 6,370 subjects who qualified for enrolment, 1,346 met the diagnostic criteria for NAFLD. The prevalence rate (PR) of NAFLD increased significantly to 36.6, 41.5, and 41.1 % with no snacking, snacking less than once/day, and snacking a parts per thousand yen2 times/day, respectively, in men (P = 0.0495) and to 10.8, 11.7, and 15.3 %, respectively, in women (P = 0.002). In men, the NAFLD PR decreased significantly to 48.8, 36.9, and 29.9 % with no exercise, exercise consciousness, and periodical exercise, respectively (P < 0.001). In women, the NAFLD PR decreased significantly to 19.3, 13.5, 11, and 8 % with sleep durations of a parts per thousand currency sign4, 5-6, 7-8, and a parts per thousand yen9 h, respectively (P = 0.003). Periodical exercise was identified as an independent factor associated with NAFLD in men (odds ratio 0.707, 95 % confidence interval 0.546-0.914; P = 0.008). Performing regular exercise was associated with a reduced risk for NAFLD in men. Men with a high risk for NAFLD can be identified using questionnaires on exercise in an outpatient setting. Disease progression and further complications may be prevented by educating high-risk NAFLD patients about the importance of exercise.	[Miyake, Teruki; Kumagi, Teru; Hirooka, Masashi; Kawasaki, Keitarou; Koizumi, Mitsuhito; Todo, Yasuhiko; Yamamoto, Shin; Nunoi, Hiroaki; Tokumoto, Yoshio; Ikeda, Yoshio; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan; [Kumagi, Teru; Kitai, Kohichiro] Ehime Univ, Grad Sch Med, Dept Community Med, Toon, Ehime 7910295, Japan; [Furukawa, Shinya] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Toon, Ehime 7910295, Japan; [Kawasaki, Keitarou; Koizumi, Mitsuhito] Ehime Gen Hlth Care Assoc, Matsuyama, Ehime 7900814, Japan	Hiasa, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan.	hiasa@m.ehime-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [25750045]; Ehime University	This work was supported in part by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI No. 25750045) and a research grant from Ehime University.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Levine JA, 2004, NUTR REV, V62, pS82, DOI 10.1301/nr.2004.jul.S82-S97; Miyake T, 2013, J GASTROENTEROL, V48, P413, DOI 10.1007/s00535-012-0650-8; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Bellentani S, 2000, ANN INTERN MED, V132, P112; Zelber-Sagi S, 2008, HEPATOLOGY, V48, P1791, DOI 10.1002/hep.22525; Joy D, 2003, EUR J GASTROEN HEPAT, V15, P539, DOI 10.1097/01.meg.0000059112.41030.2e; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Oosthuyse T, 2012, CURR OPIN PHARMACOL, V12, P363, DOI 10.1016/j.coph.2012.02.008; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Bacchi E, 2013, HEPATOLOGY, V58, P1287, DOI 10.1002/hep.26393; Miyake T, 2012, J GASTROENTEROL, V47, P696, DOI 10.1007/s00535-012-0534-y; Astrup A, 2001, Public Health Nutr, V4, P499; Bae JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046819; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Hamasaki H, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-26; Miyake T, 2013, J GASTROENTEROL, V48, P550, DOI 10.1007/s00535-012-0735-4; Miyake T, 2013, J GASTROEN HEPATOL, V28, P71, DOI 10.1111/jgh.12251; Perez NE, 2007, J CLIN GASTROENTEROL, V41, P624, DOI 10.1097/01.mcg.0000225680.45088.01; Rodrigues MH, 2014, GYNECOL ENDOCRINOL, V30, P325, DOI 10.3109/09513590.2013.875992; Shi L, 2012, BIOMED ENVIRON SCI, V25, P383, DOI 10.3967/0895-3988.2012.04.002; Shimada M, 2002, J HEPATOL, V37, P154, DOI 10.1016/S0168-8278(02)00099-5; Tobari M, 2009, INTERNAL MED, V48, P739, DOI 10.2169/internalmedicine.48.1869; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020	28	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					230	237		10.1007/s00535-014-0959-6		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000012		
J	Hayashi, N; Mobashery, N; Izumi, N				Hayashi, Norio; Mobashery, Niloufar; Izumi, Namiki			Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II study	JOURNAL OF GASTROENTEROLOGY			English	Article						Vaniprevir; Hepatitis C virus; Peginterferon; Ribavirin; Japan	NS3/4A PROTEASE INHIBITOR; RESISTANCE	Vaniprevir (MK-7009) is a hepatitis C virus (HCV) non-structural 3/4a protease inhibitor which significantly increases virologic response rates in HCV genotype (GT) 1-infected patients when added to peginterferon and ribavirin (PR). This was a phase II, multicenter, double-blind, randomized, dose-ranging study in Japanese patients with HCV GT1 infection and previous relapse. Patients received twice daily vaniprevir 100, 300, or 600 mg, or placebo plus PR for 4 weeks then PR alone for 2 weeks. Further treatment with PR was continued up to a maximum of 72 weeks. The primary endpoint was rapid virologic response (RVR; undetectable HCV RNA at treatment week 4). Ninety patients completed 4 weeks of vaniprevir/placebo plus PR. Rates of RVR were significantly higher with vaniprevir compared with placebo (86, 95, and 76 % in the vaniprevir 100-, 300-, and 600-mg arms versus 20 % with control; p < 0.001 for all comparisons). Rates of SVR, an exploratory analysis, in the vaniprevir 100-, 300-, 600-mg, and control arms were 95, 100, 100, and 72 %, respectively. No patient had virologic breakthrough or non-response while receiving vaniprevir. There were no serious adverse events (AEs) or discontinuations due to an AE during vaniprevir treatment. Diarrhea and nausea were more common with vaniprevir 600 mg than control or lower vaniprevir doses. The addition of vaniprevir to PR was associated with an increase in RVR and SVR. Combined with a generally safe and well-tolerated profile, these data supported the further evaluation of vaniprevir in Japanese patients with HCV GT1 infection (#NCT00880763).	[Hayashi, Norio] Kansai Rosai Hosp, Amagasaki, Hyogo 6608511, Japan; [Mobashery, Niloufar] Merck & Co Inc, Whitehouse Stn, NJ USA; [Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo 1808610, Japan	Hayashi, N (reprint author), Kansai Rosai Hosp, 1-69 Inabasou 3 Chome, Amagasaki, Hyogo 6608511, Japan.	hayashin@kanrou.net			MSD K.K.; Merck and Co., Inc., Whitehouse Station, NJ	We thank all patients, their families, investigators, and their staff in the following 38 study sites for completion of the study (ordered according to the site number assigned in the study): Tetsuo Takehara (Osaka University Hospital); Atsuo Inoue (Osaka General Medical Center); Namiki Izumi (Musashino Red Cross Hospital); Junichi Tazawa (Tsuchiura Kyodo General Hospital); Hideki Hagiwara (Kansai Rosai Hospital); Harumasa Yoshihara (Osaka Rosai Hospital); Masahide Oshita (Osaka Police Hospital); Toshihide Shima (Saiseikai Suita Hospital); Shoichi Takahashi (Hiroshima University Hospital); Keisuke Iizuka (Isesaki municipal hospital); Kiyomi Yasuda (Kiyokawa Hospital); Takashi Kumada (Ogaki Municipal Hospital); Eiji Mita (National Hospital Organization Osaka National Hospital); Kazuyoshi Nagayama (Namegata District General Hospital); Tatsuji Komatsu (National Hospital Organization Yokohama Medical Center); Teruaki Kawanishi (Hokkaido Health Coop Sapporo Ryokuai Hospital); Kunihiko Tsuji (Teine Keijinkai Hospital); Akira Ohashi (Japanese Red Cross Koga Hospital); Makoto Shimizu (International Goodwill Hospital); Satoru Kaneda (National Hospital Organization Chiba Medical Center); Michiyasu Yagura (National Hospital Organization Tokyo National Hospital); Toshifumi Ito (Osaka Koseinenkin Hospital); Ryo Nakata (Japanese Red Cross Medical Center); Yasuyuki Aisaka (Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital); Yuji Yoshikawa (Sanraku Hospital); Akihisa Ishikawa (Hitachi General Hospital); Kazuhiro Katayama (Osaka Medical Center for Cancer and Cardiovascular Diseases); Eijiro Hayashi (Kinki Central Hospital of the Mutual Aid Association of Public School Teachers); Seiji Kawazoe (Saga-Ken Medical Centre KOSEIKAN); Yasuharu Imai (Ikeda Municipal Hospital); Tatsuho Sugimoto (Tonami General Hospital); Hiroshi Yatsuhashi (National Hospital Organization Nagasaki Medical Center); Michio Kato (National Hospital Organization Minamiwakayama Medical Center); Yutaka Sasaki (Kumamoto University Hospital); Makoto Nakamuta (National Hospital Organization Kyushu Medical Center); Youichi Morimoto (Kurashiki Central Hospital); Akio Ido (Kagoshima University Hospital); Yoshiaki Inui (Hyogo Prefectural Nishinomiya Hospital). We also thank Go Fujimoto, Richard J.O. Barnard, Luzelena Caro, Takashi Iwasa, Keisuke Nakamura, Akiko Takase, Victoria Enwemadu, and Yoshiyuki Tanaka of Merck and MSD K.K. for their support in data analysis and/or preparation of this manuscript. This study was funded by MSD K.K., a subsidiary of Merck and Co., Inc., Whitehouse Station, NJ, USA. Medical writing and editorial assistance were provided by Tim Ibbotson, PhD, and Bianca B Ruzicka, PhD, of ApotheCom, Yardley, PA. This assistance was funded by Merck and Co., Inc., Whitehouse Station, NJ.	LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Manns MP, 2012, HEPATOLOGY, V56, P884, DOI 10.1002/hep.25743; McCauley JA, 2010, J MED CHEM, V53, P2443, DOI 10.1021/jm9015526; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Chung H, 2010, INTERVIROLOGY, V53, P39, DOI 10.1159/000252782; Rodriguez-Torres M, 2014, CLIN GASTROENTEROL H, V12, P1029, DOI 10.1016/j.cgh.2013.09.067; Barnard RJO, 2013, VIROLOGY, V443, P278, DOI 10.1016/j.virol.2013.05.013; Olsen DB, 2011, ANTIMICROB AGENTS CH, V55, P937, DOI 10.1128/AAC.00990-10; Lawitz E, 2013, ANTIVIR RES, V99, P214, DOI [10.1016/j.antiviral.2013.05.015, 10.1016/j.antivira1.2013.05.015]; Editors of the Drafting Committee for Hepatitis Management Guidelines: the Japan Society of Hepatology, 2013, HEPATOL RES, V43, P1; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Lawitz E, 2013, J HEPATOL; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	FEB	2015	50	2					238	248		10.1007/s00535-014-0979-2		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB3VA	WOS:000349556000013		
J	Matsuki, T; Hirose, F; Ito, S; Hata, M; Hirami, Y; Kurimoto, Y				Matsuki, Takaaki; Hirose, Fumitaka; Ito, Shin-ichiro; Hata, Masayuki; Hirami, Yasuhiko; Kurimoto, Yasuo			Influence of Anterior Segment Biometric Parameters on the Anterior Chamber Angle Width in Eyes With Angle Closure	JOURNAL OF GLAUCOMA			English	Article						angle closure; anterior segment optical coherence tomography; angle opening distance; iris thickness; iris convexity	OPTICAL COHERENCE TOMOGRAPHY; ULTRASOUND BIOMICROSCOPY; GLAUCOMA; CHINESE; DEPTH; BLOCK	Purpose: To predict angle narrowing in eyes with angle closure in a Japanese population using anterior segment optical coherence tomography (AS-OCT) quantitative parameters. Patients and Methods: AS-OCT was used to examine 118 eyes of 118 patients with angle closure and 40 eyes of 40 patients with open angle under dark conditions. After measuring the angle opening distance 500 (AOD500), anterior chamber depth, iris thickness (IT), iris convexity (IC), pupil diameter, anterior chamber width, and crystalline lens rise, multivariate regression analyses were performed for the AOD500 in each group. Results: With the exception of IT, significant differences were observed between the AS-OCT parameters for the angle closure and open-angle groups. Anterior chamber depth, IT, and IC were the explanatory variables associated with AOD500 for each group (P <= 0.001). A significant negative association was found between IT and IC only in the angle-closure group (P < 0.001). Conclusions: This study quantitatively confirmed that shallow anterior chamber depth was a major mechanism of angle narrowing, and that both IT and IC had a strong impact on angle narrowing. Moreover, the negative association found between IT and IC in only the angle closure group indicated the existence of the stretch force placed on the iris by relative pupillary block.	[Matsuki, Takaaki; Hirose, Fumitaka; Ito, Shin-ichiro; Hata, Masayuki; Hirami, Yasuhiko; Kurimoto, Yasuo] Kobe City Med Ctr Gen Hosp, Dept Ophthalmol, Kobe, Hyogo 6500047, Japan	Hirose, F (reprint author), Kobe City Med Ctr Gen Hosp, Dept Ophthalmol, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	hirose@kcho.jp					Alsbirk PH, 1976, ACTA OPHTHALMOL    S, V127, P5; Goldsmith JA, 2005, OPHTHALMOLOGY, V112, P238, DOI 10.1016/j.ophtha.2004.09.019; Moghimi S, 2013, AM J OPHTHALMOL, V155, P664, DOI 10.1016/j.ajo.2012.10.014; He MG, 2007, OPHTHALMOLOGY, V114, P1513, DOI 10.1016/j.ophtha.2006.11.032; CONGDON N, 1992, SURV OPHTHALMOL, V36, P411, DOI 10.1016/S0039-6257(05)80022-0; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Leung CKS, 2007, INVEST OPHTH VIS SCI, V48, P4116, DOI 10.1167/iovs.07-0010; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; PAVLIN CJ, 1992, AM J OPHTHALMOL, V113, P381; Radhakrishnan S, 2005, ARCH OPHTHALMOL-CHIC, V123, P1053, DOI 10.1001/archopht.123.8.1053; Congdon NG, 1997, OPHTHALMOLOGY, V104, P1489; He MG, 2008, OPHTHALMOLOGY, V115, P1286, DOI 10.1016/j.ophtha.2007.12.003; Tan GS, 2012, AM J OPHTHALMOL, V154, P39, DOI 10.1016/j.ajo.2012.01.015; Nongpiur ME, 2011, CURR OPIN OPHTHALMOL, V22, P96, DOI 10.1097/ICU.0b013e32834372b9; Marchini G, 1998, OPHTHALMOLOGY, V105, P2091, DOI 10.1016/S0161-6420(98)91132-0; Baikoff G, 2005, J CATARACT REFR SURG, V31, P674, DOI 10.1016/j.jcrs.2004.09.034; Leung CK, 2010, BRIT J OPHTHALMOL, V94, P1184, DOI 10.1136/bjo.2009.167296; MAPSTONE R, 1968, BRIT J OPHTHALMOL, V52, P19, DOI 10.1136/bjo.52.1.19; Nonaka A, 2007, AM J OPHTHALMOL, V143, P695, DOI 10.1016/j.ajo.2006.11.018; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Woo EK, 1999, AM J OPHTHALMOL, V127, P43, DOI 10.1016/S0002-9394(98)00283-9	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1057-0829	1536-481X		J GLAUCOMA	J. Glaucoma	FEB	2015	24	2					144	148		10.1097/IJG.0000000000000090		5	Ophthalmology	Ophthalmology	CB0WU	WOS:000349349200011		
J	Moritomo, H; Arimitsu, S; Kubo, N; Masatomi, T; Yukioka, M				Moritomo, Hisao; Arimitsu, Sayuri; Kubo, Nobuyuki; Masatomi, Takashi; Yukioka, Masao			Computed Tomography Arthrography Using a Radial Plane View for the Detection of Triangular Fibrocartilage Complex Foveal Tears	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Computed tomography arthrography; triangular fibrocartilage complex foveal tear; diagnostic accuracy; radial plane view; ulnar-sided wrist pain	MAGNETIC-RESONANCE ARTHROGRAPHY; WRIST ARTHROGRAPHY; MR ARTHROGRAPHY; CT ARTHROGRAPHY; INTEROSSEOUS LIGAMENT; STANDARD MRI; ARTHROSCOPY; PAIN; INJURY	Purpose To classify triangular fibrocartilage complex (TFCC) foveal lesions on the basis of computed tomography (CT) arthrography using a radial plane view and to correlate the CT arthrography results with surgical findings. We also tested the interobserver and intra-observer reliability of the radial plane view. Methods A total of 33 patients with a suspected TFCC foveal tear who had undergone wrist CT arthrography and subsequent surgical exploration were enrolled. We classified the configurations of TFCC foveal lesions into 5 types on the basis of CT arthrography with the radial plane view in which the image slices rotate clockwise centered on the ulnar styloid process. Sensitivity, specificity, and positive predictive values were calculated for each type of foveal lesion in CT arthrography to detect foveal tears. We determined interobserver and intra-observer agreements using kappa statistics. We also compared accuracies with the radial plane views with those with the coronal plane views. Results Among the tear types on CT arthrography, type 3, a roundish defect at the fovea, and type 4, a large defect at the overall ulnar insertion, had high specificity and positive predictive value for the detection of foveal tears. Specificity and positive predictive values were 90% and 89% for type 3 and 100% and 100% for type 4, respectively, whereas sensitivity was 35% for type 3 and 22% for type 4. Interobserver and intra-observer agreement was substantial and almost perfect, respectively. The radial plane view identified foveal lesion of each palmar and dorsal radioulnar ligament separately, but accuracy results with the radial plane views were not statistically different from those with the coronal plane views. Conclusions Computed tomography arthrography with a radial plane view exhibited enhanced specificity and positive predictive value when a type 3 or 4 lesion was identified in the detection of a TFCC foveal tear compared with historical controls. (Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.)	[Moritomo, Hisao; Arimitsu, Sayuri; Kubo, Nobuyuki; Masatomi, Takashi; Yukioka, Masao] Osaka Yukioka Coll Hlth Sci, Yukioka Hosp Hand Ctr, Osaka 5300021, Japan	Moritomo, H (reprint author), Osaka Yukioka Coll Hlth Sci, Yukioka Hosp Hand Ctr, Kita Ku, 2-2-3 Ukita, Osaka 5300021, Japan.	hisao-moritomo@yukioka-u.ac.jp					Amrami KK, 2006, J HAND SURG-AM, V31A, P669, DOI 10.1016/j.jhsa.2006.03.015; Potter HG, 1997, J BONE JOINT SURG AM, V79A, P1675; Haims AH, 2003, RADIOLOGY, V227, P701, DOI 10.1148/; Morley J, 2001, J HAND SURG-BRIT EUR, V26, P544, DOI 10.1054/jhsb.2001.0645; HERBERT TJ, 1990, J HAND SURG-BRIT EUR, V15B, P233, DOI 10.1016/0266-7681(90)90129-R; Weiss APC, 1996, J BONE JOINT SURG AM, V78A, P348; Tanaka T, 2006, J HAND SURG-AM, V31A, P1308, DOI 10.1016/j.jha.2006.05.001; Koskinen SK, 2013, SKELETAL RADIOL, V42, P649, DOI 10.1007/s00256-012-1516-0; Adams BD, 2002, J HAND SURG-AM, V27A, P243, DOI 10.1053/jhsu.2002.31731; KIRSCHENBAUM D, 1995, J BONE JOINT SURG AM, V77A, P1207; Smith TO, 2012, J BONE JOINT SURG AM, V94A, P824, DOI 10.2106/JBJS.J.01775; Bille B, 2007, J HAND SURG-AM, V32A, P834, DOI 10.1016/j.jhsa.2007.04.005; Bergin D, 2003, SKELETAL RADIOL, V32, P551, DOI 10.1007/s00256-003-0669-2; PALMER AK, 1983, J HAND SURG-AM, V8, P15; Schmid MR, 2005, RADIOLOGY, V237, P1008, DOI 10.1148/radiol.2373041450; BLAIR WF, 1985, J HAND SURG-AM, V10A, P350; CEROFOLINI E, 1990, J COMPUT ASSIST TOMO, V14, P963, DOI 10.1097/00004728-199011000-00018; Chung KC, 1996, J HAND SURG-AM, V21A, P591, DOI 10.1016/S0363-5023(96)80008-6; GOLIMBU CN, 1989, RADIOLOGY, V173, P731; Hiams AH, 2002, AJR, V178, P419; Iordache SD, 2012, J HAND SURG-AM, V37A, P98, DOI 10.1016/j.jhsa.2011.10.006; Johnstone DJ, 1997, J HAND SURG-BRIT EUR, V22B, P714, DOI 10.1016/S0266-7681(97)80431-7; LEVINSOHN EM, 1991, RADIOLOGY, V179, P231; Machiels F, 2001, JBR-BTR, V84, P114; METZ VM, 1993, AM J ROENTGENOL, V160, P1239; Mikic AD, 1984, J BONE JOINT SURG AM, V66, P371; Oneson SR, 1997, AM J ROENTGENOL, V168, P1513; QUINN SF, 1989, SKELETAL RADIOL, V17, P565; Scheck RJ, 1997, SKELETAL RADIOL, V26, P263; Scheck RJ, 1999, JMRI-J MAGN RESON IM, V9, P468, DOI 10.1002/(SICI)1522-2586(199903)9:3<468::AID-JMRI16>3.0.CO;2-T; WILSON AJ, 1991, AM J ROENTGENOL, V157, P105; Zanetti M, 1997, JMRI-J MAGN RESON IM, V7, P590, DOI 10.1002/jmri.1880070322; Zingberg EM, 1988, J HAND SURG A, V13, P803	33	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	FEB	2015	40	2					245	251		10.1016/j.jhsa.2014.10.051		7	Orthopedics; Surgery	Orthopedics; Surgery	CB3GE	WOS:000349515400007		
J	Shimada, M				Shimada, Mitsuo			Highlights of topic "Intrahepatic cholangiocarcinoma: recent advancements in pathogenesis, diagnosis and treatment"	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Editorial Material									Univ Tokushima, Dept Surg, Tokushima 7708503, Japan	Shimada, M (reprint author), Univ Tokushima, Dept Surg, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	mitsuo.shimada@tokushima-u.ac.jp					Aishima S, 2015, J HEPATO-BIL-PAN SCI, V22, P94, DOI 10.1002/jhbp.154; Andersen JB, 2015, J HEPATO-BIL-PAN SCI, V22, P101, DOI 10.1002/jhbp.155; Bektas H, 2015, J HEPATO-BIL-PAN SCI, V22, P131, DOI 10.1002/jhbp.158; Haga H, 2015, J HEPATO-BIL-PAN SCI, V22, P114, DOI 10.1002/jhbp.156; Hashimoto K, 2015, J HEPATO-BIL-PAN SCI, V22, P138, DOI 10.1002/jhbp.159; Lubezky N, 2015, J HEPATO-BIL-PAN SCI, V22, P124, DOI 10.1002/jhbp.157	6	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	FEB	2015	22	2					91	93		10.1002/jhbp.153		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CB1DL	WOS:000349366800002		
J	Aishima, S; Oda, Y				Aishima, Shinichi; Oda, Yoshinao			Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Cholangiocarcinoma; Cholangiolocellular carcinoma; Perihilar; Peripheral	CANCER-ASSOCIATED FIBROBLASTS; VON-MEYENBURG COMPLEXES; TUMOR PROGRESSION; VIRAL-HEPATITIS; MOLECULAR-FEATURES; PANCREATIC-CANCER; EXPRESSION; S100P; LIVER; CARCINOMA	Intrahepatic cholangiocarcinomas (ICCs) are made up of heterogenous carcinomas arising from different anatomical sites of the liver. Two types of candidate stem/progenitor cells of the biliary tree are postulated to exist at the peribiliary glands for large bile ducts and at the canals of Hering for small ducts and hepatocytes. According to the recent observations, ICCs can be subclassified into two types: tumors involving the large bile ducts comparable in size to the intrahepatic second branches and composed of a tubular or papillary component with tall columnar epithelium, and tumors involving the smaller duct than segmental branches and composed of small tubules with cuboidal epithelium. Perihilar large duct type ICCs can be interpreted as arising from large bile duct type ICCs, and peripheral small duct type ICCs may arise from small bile duct type or ductular type ICCs. Chronic biliary inflammation induces neoplastic change of the large bile ducts and thereby progression to the perihilar large duct type ICC, which can be grossly classified into periductal filtrating type ICC and intraductal growth type ICC, while chronic hepatitis or cirrhosis induces mass-forming peripheral small duct type ICC. The different morphological and molecular features, including stromal components and tumor vasculature, support the hypothesis that perihilar large duct type ICCs and peripheral small duct type ICCs arise from different backgrounds, have different carcinogenetic pathways, and exhibit different biologic behaviors.	[Aishima, Shinichi] Saga Univ, Fac Med, Saga 8498501, Japan; [Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Fukuoka 812, Japan	Aishima, S (reprint author), Saga Univ, Fac Med, 1-1 Nabeshima 5 Chome, Saga 8498501, Japan.	saish@surgpath.med.kyushu-u.ac.jp					Aishima S, 2010, AM J CLIN PATHOL, V134, P457, DOI [10.1309/AJCP53YVVJCNDZIR, 10.1309/AJCP53YWJCNDZIR]; Aishima S, 2002, INT J SURG PATHOL, V10, P47, DOI 10.1177/106689690201000108; Aishima S, 2008, HUM PATHOL, V39, P939, DOI 10.1016/j.humpath.2007.10.031; Aishima S, 2009, HISTOPATHOLOGY, V54, P452, DOI 10.1111/j.1365-2559.2009.03240.x; Aishima S, 2008, MODERN PATHOL, V21, P256, DOI 10.1038/modpathol.3800985; Aishima S, 2007, AM J SURG PATHOL, V31, P1059, DOI 10.1097/PAS.0b013e31802b34b6; Aishima S, 2011, AM J SURG PATHOL, V35, P590, DOI 10.1097/PAS.0b013e31820ffdf1; Xu J, 2012, LIVER INT, V32, P1156, DOI 10.1111/j.1478-3231.2012.02783.x; Asayama Y, 2006, RADIOLOGY, V238, P150, DOI 10.1148/radiol.2381041765; Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238; Cadamuro M, 2013, HEPATOLOGY, V58, P1042, DOI 10.1002/hep.26384; Kipp BR, 2012, HUM PATHOL, V43, P1552, DOI 10.1016/j.humpath.2011.12.007; Sirica AE, 2012, NAT REV GASTRO HEPAT, V9, P44, DOI 10.1038/nrgastro.2011.222; Aishima S, 2006, HISTOPATHOLOGY, V49, P35, DOI 10.1111/j.1365-2559.2006.02414.x; Nakanuma Y, 2014, J HEPATO-BIL-PAN SCI, V21, P441, DOI 10.1002/jhbp.70; Aishima S, 2007, HUM PATHOL, V38, P1819, DOI 10.1016/j.humpath.2007.04.016; Nakanuma Y, 1997, MICROSC RES TECHNIQ, V38, P552, DOI 10.1002/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H; Ebata T, 2014, BRIT J SURG, V101, P79, DOI 10.1002/bjs.9379; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Jain D, 2000, AM J SURG PATHOL, V24, P1131, DOI 10.1097/00000478-200008000-00011; Liau JY, 2014, MODERN PATHOL, V27, P1163, DOI 10.1038/modpathol.2013.241; Carpino G, 2012, J ANAT, V220, P186, DOI 10.1111/j.1469-7580.2011.01462.x; Sell S, 1998, HEPATOLOGY, V27, P317, DOI 10.1002/hep.510270202; Lin F, 2008, AM J SURG PATHOL, V32, P78; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Blanc JF, 2000, EUR J GASTROEN HEPAT, V12, P233, DOI 10.1097/00042737-200012020-00016; Song JS, 2008, PATHOL INT, V58, P503, DOI 10.1111/j.1440-1827.2008.02264.x; Asayama Y, 2010, EUR J RADIOL, V75, pE120, DOI 10.1016/j.ejrad.2009.09.010; Asayama Y, 2002, PATHOL INT, V52, P300, DOI 10.1046/j.1440-1827.2002.01349.x; Cardinale Vincenzo, 2012, World J Gastrointest Oncol, V4, P94, DOI 10.4251/wjgo.v4.i5.94; Guedj N, 2009, J HEPATOL, V51, P93, DOI 10.1016/j.jhep.2009.03.017; Hamada S, 2011, CANCER SCI, V102, P150, DOI 10.1111/j.1349-7006.2010.01757.x; Ishikawa A, 2004, LAB INVEST, V84, P629, DOI 10.1038/labinvest.3700087; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Kozaka K, 2007, HISTOPATHOLOGY, V51, P390, DOI 10.1111/j.1365-2559.2007.02735.x; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Mosnier JF, 2009, MODERN PATHOL, V22, P182, DOI 10.1038/modpathol.2008.123; Nakanuma Yasuni, 2010, World J Hepatol, V2, P419, DOI 10.4254/wjh.v2.i12.419; Nakanuma Yasuni, 2009, World J Hepatol, V1, P35, DOI 10.4254/wjh.v1.i1.35; Nakeeb A, 1996, ANN SURG, V224, P463, DOI 10.1097/00000658-199610000-00005; Nishihara Y, 2009, HISTOPATHOLOGY, V55, P423, DOI 10.1111/j.1365-2559.2009.03398.x; Ohuchida K, 2006, CLIN CANCER RES, V12, P5411, DOI 10.1158/1078-0432.CCR-06-0298; Shimada K, 2007, WORLD J SURG, V31, P2016, DOI 10.1007/s00268-007-9194-0; Shindo K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-168; Sobin LH, 2009, UICC TNM CLASSIFICAT; Suh KS, 2002, J AM COLL SURGEONS, V195, P782, DOI 10.1016/S1072-7515(02)01343-1; TERADA T, 1995, GASTROENTEROLOGY, V108, P1236, DOI 10.1016/0016-5085(95)90225-2; Tsai JH, 2012, HISTOPATHOLOGY, V61, P1106, DOI 10.1111/j.1365-2559.2012.04316.x; Yu TH, 2011, MODERN PATHOL, V24, P810, DOI 10.1038/modpathol.2011.41	49	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	FEB	2015	22	2					94	100		10.1002/jhbp.154		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CB1DL	WOS:000349366800003		
J	Tanaka, T; Sugawara, Y; Akamatsu, N; Kaneko, J; Tamura, S; Aoki, T; Sakamoto, Y; Hasegawa, K; Kurosaki, M; Izumi, N; Kokudo, N				Tanaka, Tomohiro; Sugawara, Yasuhiko; Akamatsu, Nobuhisa; Kaneko, Junichi; Tamura, Sumihito; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kurosaki, Masayuki; Izumi, Namiki; Kokudo, Norihiro			Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot study	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Direct-acting antiviral drugs; Hepatitis C; Living donor liver transplantation; Simeprevir	GENOTYPE 1; MULTICENTER EXPERIENCE; ANTIVIRAL THERAPY; VIRUS-INFECTION; RIBAVIRIN; SURVIVAL; PEGINTERFERON/RIBAVIRIN; ASSOCIATION; TELAPREVIR; INHIBITORS	BackgroundThe management of recurrent hepatitis C following liver transplantation remains a challenge. MethodsWe prospectively investigated the efficacy and safety of simeprevir in combination with pegylated interferon and ribavirin in five patients undergoing living donor liver transplantation (LDLT) with recurrent hepatitis due to hepatitis C virus (HCV) genotype 1b. ResultsAs the immunosuppressive regimen, four received cyclosporine A (CsA) and one received tacrolimus (FK); no dose adjustment was made prior to the introduction of simeprevir, but the dose was accordingly modified afterwards. All five patients completed the intended 12-week treatment course without significant adverse events greater than grade 2, and no episodes of rejection were detected during the study period. The trough levels of CsA and FK were stably maintained. At week 12, HCV-RNA was not detectable in three of the five patients, whereas the HCV titer of the other two patients, including one with Q80L and V170I mutations at the HCV NS3 position, was at the lower level of quantification (1.2 log(10) IU/ml). ConclusionsBased on this pilot study, simeprevir-based triple therapy is safe and somewhat effective within the first 12 weeks in LDLT recipients with HCV recurrence. Further studies are warranted to obtain robust conclusions.	[Tanaka, Tomohiro] Tokyo Univ Hosp, Organ Transplantat Serv, Tokyo 113, Japan; [Sugawara, Yasuhiko; Akamatsu, Nobuhisa; Kaneko, Junichi; Tamura, Sumihito; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div,Bunkyo Ku, Tokyo 1138655, Japan; [Kurosaki, Masayuki; Izumi, Namiki] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Tokyo, Japan	Sugawara, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasusuga-tky@umin.ac.jp					Neumann UP, 2004, TRANSPLANTATION, V77, P226, DOI 10.1097/01.TP.0000101738.27552.9D; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Gane EJ, 2014, AM J TRANSPLANT, V14, P994, DOI 10.1111/ajt.12714; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Paolucci S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-355; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Berenguer M, 2008, J HEPATOL, V49, P274, DOI 10.1016/j.jhep.2008.05.002; Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993; Coilly A, 2014, J HEPATOL, V60, P78, DOI 10.1016/j.jhep.2013.08.018; Tischer S, 2014, J HEPATOL, V60, P872, DOI 10.1016/j.jhep.2013.11.013; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Tamura S, 2010, TRANSPL INT, V23, P580, DOI 10.1111/j.1432-2277.2009.01023.x; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Guillouche P, 2011, ALIMENT PHARM THER, V33, P163, DOI 10.1111/j.1365-2036.2010.04505.x; Harada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090462; Kawaoka T, 2014, HEPATOL RES, V44, P1259, DOI 10.1111/hepr.12296; Kishi Y, 2005, CLIN TRANSPLANT, V19, P769, DOI 10.1111/j.1399-0012.2005.00419.x; Kwo PY, 2014, CLIN TRANSPLANT, V28, P722, DOI 10.1111/ctr.12372; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Pungpapong S, 2013, LIVER TRANSPLANT, V19, P690, DOI 10.1002/lt.23669; Sugawara Y, 2002, CLIN TRANSPLANT, V16, P102, DOI 10.1034/j.1399-0012.2002.1o106.x; Tanaka T, 2013, TRANSPL INT, V26, P42, DOI 10.1111/j.1432-2277.2012.01571.x	29	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	FEB	2015	22	2					144	150		10.1002/jhbp.171		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CB1DL	WOS:000349366800009		
J	Kawakubo, K; Kawakami, H; Kuwatani, M; Kudo, T; Abe, Y; Kawahata, S; Kubo, K; Kubota, Y; Sakamoto, N				Kawakubo, Kazumichi; Kawakami, Hiroshi; Kuwatani, Masaki; Kudo, Taiki; Abe, Yoko; Kawahata, Shuhei; Kubo, Kimitoshi; Kubota, Yoshimasa; Sakamoto, Naoya			Single-step simultaneous side-by-side placement of a self-expandable metallic stent with a 6-Fr delivery system for unresectable malignant hilar biliary obstruction: a feasibility study	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Malignant hilar biliary obstruction; Self-expandable metallic stent; Side-by-side placement	CHOLANGIOCARCINOMA; DRAINAGE	BackgroundBilateral self-expandable metallic stent (SEMS) placement for the management of unresectable malignant hilar biliary obstruction (UMHBO) is technically challenging to perform using the existing metallic stents with thick delivery systems. The recently developed 6-Fr delivery systems could facilitate a single-step simultaneous side-by-side placement through the accessory channel of the duodenoscope. The aim of this study was to evaluate the feasibility of this procedure. MethodsBetween May and September 2013, 13 consecutive patients with UMHBO underwent a single-step simultaneous side-by-side placement of SEMS with the 6-Fr delivery system. The technical success rate, stent patency, and rate of complications were evaluated from the prospectively collected database. ResultsTechnical success was achieved in 11 (84.6%, 95% confidence interval [CI]: 57.8-95.8) patients. The median procedure time was 25min. Early and late complications were observed in 23% (one segmental cholangitis and two liver abscesses) and 15% (one segmental cholangitis and one cholecystitis) patients, respectively. Median dysfunction free patency was 263 days (95% CI: 37-263). Five patients (38%) experienced stent occlusion that was successfully managed by endoscopic stent placement. ConclusionsA single-step simultaneous side-by-side placement of SEMS with a 6-Fr delivery system was feasible for the management of UMHBO.	[Kawakubo, Kazumichi; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Kawakami, Hiroshi; Kudo, Taiki; Abe, Yoko; Kawahata, Shuhei; Kubo, Kimitoshi; Kubota, Yoshimasa] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Kuwatani, Masaki] Hokkaido Univ Hosp, Div Endoscopy, Sapporo, Hokkaido 0608648, Japan	Kawakami, H (reprint author), Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Kita 14,Nishi 5, Sapporo, Hokkaido 0608648, Japan.	hiropon@med.hokudai.ac.jp	Kawakubo, Kazumichi/F-2937-2011				Kawakami H, 2011, J HEPATO-BIL-PAN SCI, V18, P630, DOI 10.1007/s00534-011-0404-7; Freeman ML, 2003, GASTROINTEST ENDOSC, V58, P41, DOI 10.1067/mge.2003.292; Naitoh I, 2009, J GASTROEN HEPATOL, V24, P552, DOI 10.1111/j.1440-1746.2008.05750.x; Mukai T, 2013, J HEPATO-BIL-PAN SCI, V20, P214, DOI 10.1007/s00534-012-0508-8; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Takada T, 2013, J HEPATO-BIL-PAN SCI, V20, P1, DOI 10.1007/s00534-012-0566-y; Kawakami H, 2009, ENDOSCOPY, V41, P959, DOI 10.1055/s-0029-1215178; BISMUTH H, 1988, WORLD J SURG, V12, P39; Kondo S, 2004, ANN SURG, V240, P95, DOI 10.1097/01.sla.0000129491.43855.6b; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Chennat J, 2010, GASTROINTEST ENDOSC, V72, P632, DOI 10.1016/j.gie.2010.04.037; Dumas R, 2000, GASTROINTEST ENDOSC, V51, P334, DOI 10.1016/S0016-5107(00)70364-6; Iwanos H, 2012, DIGEST ENDOSC, V23, P43; Kims JY, 2009, GASTROINTEST ENDOSC, V70, P1109; Kims KM, 2012, HEPATO-GASTROENTEROL, V59, P341; Kogure H, 2014, DIGEST ENDOSC, V26, P93, DOI 10.1111/den.12055; Laws R, 2013, DIGEST DIS SCI, V58, P2667; Lees TH, 2013, DIGEST DIS SCI, V58, P547; Naitoh I, 2012, DIGEST DIS SCI, V57, P3279, DOI 10.1007/s10620-012-2270-9; Nguyen-Tang T, 2011, ENDOSCOPY, V43, pE24, DOI 10.1055/s-0030-1255945; Peynircioglu B, 2007, J VASC INTERV RADIOL, V18, P567, DOI 10.1016/j.jvir.2007.02.003; Siddiqui A, 2013, CLIN GASTROENTEROL H, V11, P1169, DOI 10.1016/j.cgh.2013.05.035	22	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	FEB	2015	22	2					151	155		10.1002/jhbp.173		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CB1DL	WOS:000349366800010		
J	Nitta, H; Beppu, T; Itoyama, A; Higashi, T; Sakamoto, K; Nakagawa, S; Mima, K; Okabe, H; Imai, K; Hayashi, H; Hashimoto, D; Chikamoto, A; Ishiko, T; Baba, H				Nitta, Hidetoshi; Beppu, Toru; Itoyama, Akari; Higashi, Takaaki; Sakamoto, Keita; Nakagawa, Shigeki; Mima, Kosuke; Okabe, Hirohisa; Imai, Katsunori; Hayashi, Hiromitsu; Hashimoto, Daisuke; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo			Poor outcomes after hepatectomy in patients with ascites infected by methicillin-resistant staphylococci	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Ascites; Hepatectomy; Methicillin-resistant staphylococci	PORTAL-VEIN EMBOLIZATION; HEPATOCELLULAR-CARCINOMA; LIVER RESECTION; RISK-FACTORS; CIRRHOTIC-PATIENTS; HEPATIC RESECTION; MANAGEMENT; MORTALITY; COMPLICATIONS; PREDICTORS	BackgroundThis study was designed to investigate the association between infectious ascites, clinical parameters and treatment outcomes after hepatectomy. MethodsOf 891 patients who underwent hepatectomy between 2006 and 2013, 74 who underwent paracentesis for bacterial cultivation of postoperative ascites after hepatectomy were analyzed. ResultsOf the 74 patients, 42 had positive bacterial cultures (positive group) and 32 patients had negative cultures (negative group). Hospital mortality was significantly higher in the positive group than in the negative group [9/42 (21.4%) vs. 2/32 (6.3%); P = 0.035]. Hospital mortality associated with each bacterial strain was as follows: methicillin-resistant staphylococci (MRS) (5/13, 38.5%), staphylococci (2/11, 18.2%), enterococci (2/12, 16.7%), Enterobacter (0/3, 0%), Klebsiella (0/2, 0%), and others (0/1, 0%). Cox proportional multivariate analysis revealed that MRS infection in ascites was the only risk factor of hospital death (HR = 5.08, P = 0.041) and MRS wound infection was the only risk factor to predict MRS infection in ascites (HR = 5.67, P = 0.015). ConclusionPostoperative MRS infection in postoperative ascites after hepatectomy is a potentially fatal complication; therefore, the prevention of MRS wound infection is critical to decrease postoperative hospital mortality.	[Nitta, Hidetoshi; Beppu, Toru; Itoyama, Akari; Higashi, Takaaki; Sakamoto, Keita; Nakagawa, Shigeki; Mima, Kosuke; Okabe, Hirohisa; Imai, Katsunori; Hayashi, Hiromitsu; Hashimoto, Daisuke; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Innovat Ctr Translat Res, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Farid SG, 2010, ANN SURG, V251, P91, DOI 10.1097/SLA.0b013e3181bfda3c; SALERNO F, 1993, AM J GASTROENTEROL, V88, P514; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; Moore KP, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.099580; Ishizawa T, 2009, ARCH SURG-CHICAGO, V144, P46, DOI 10.1001/archsurg.2008.511; Beppu T, 2012, HEPATO-GASTROENTEROL, V59, P542, DOI 10.5754/hge09737; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Okabe H, 2014, INT J CLIN ONCOL, V19, P614, DOI 10.1007/s10147-013-0591-0; Tzeng CWD, 2014, HPB, V16, P459, DOI 10.1111/hpb.12155; Shimada M, 1998, BRIT J SURG, V85, P195; Grazi GL, 2001, ANN SURG, V234, P71, DOI 10.1097/00000658-200107000-00011; Yoshida M, 2012, JPN J RADIOL, V30, P255, DOI 10.1007/s11604-011-0041-8; Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010; Chan KM, 2012, WORLD J SURG, V36, P392, DOI 10.1007/s00268-011-1367-1; Melloul E, 2012, WORLD J SURG, V36, P2161, DOI 10.1007/s00268-012-1621-1; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Chen LP, 2012, HEPATO-GASTROENTEROL, V59, P292, DOI 10.5754/hge11399; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Casewell MW, 1998, J HOSP INFECT, V40, pS3, DOI 10.1016/S0195-6701(98)90199-2; Di Carlo I, 2012, WORLD J SURG, V36, P1719, DOI 10.1007/s00268-012-1569-1; Fuster J, 1996, ANN SURG, V223, P297, DOI 10.1097/00000658-199603000-00011; Hoekstra LT, 2012, DIGEST SURG, V29, P468, DOI 10.1159/000345583; HUDSON IRB, 1994, J HOSP INFECT, V27, P81, DOI 10.1016/0195-6701(94)90001-9; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Ishiko T, 2012, HEPATO-GASTROENTEROL, V59, P1907, DOI 10.5754/hge10088; Jarnagin William R, 2002, Ann Surg, V236, P397; Meguro M, 2014, J HEPATO-BIL-PAN SCI, V21, P489, DOI 10.1002/jhbp.87; Mehtar S, 1998, J HOSP INFECT, V40, pS39, DOI 10.1016/S0195-6701(98)90203-1; Melendez J, 2001, J AM COLL SURGEONS, V192, P47, DOI 10.1016/S1072-7515(00)00745-6; RUNYON BA, 1990, J CLIN MICROBIOL, V28, P2811; Shimizu Y, 2007, J GASTROEN HEPATOL, V22, P837, DOI 10.1111/j.1440-1746.2007.04872.x; Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984	36	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	FEB	2015	22	2					166	176		10.1002/jhbp.175		11	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CB1DL	WOS:000349366800012		
J	Itoi, T; Watanabe, H; Gotoda, T; Tsuda, H; Ootaka, H				Itoi, Takao; Watanabe, Hiroyuki; Gotoda, Takuji; Tsuda, Hidehiko; Ootaka, Himoto			Therapeutic endoscopic retrograde cholangiopancreatography using a large dilating balloon in a patient with upside-down stomach and bile duct stones (with video)	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Editorial Material						Bile duct stones; Endoscopic retrograde Cholangiopancreatography; Large balloon; Upside-down stomach	HERNIA		[Itoi, Takao; Gotoda, Takuji] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan; [Watanabe, Hiroyuki; Tsuda, Hidehiko; Ootaka, Himoto] Akita Kousei Med Ctr, Dept Gastroenterol & Hepatol, Akita, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp					Al Akerlund, 1926, ACTA RADIOL, V6, P3, DOI 10.3109/00016922609139467; Itoi T, 2009, AM J GASTROENTEROL, V104, P560, DOI 10.1038/ajg.2008.67; BETTEX M, 1969, J PEDIATR SURG, V4, P526, DOI 10.1016/0022-3468(69)90092-X; Itoi T, 2013, J HEPATO-BIL-PAN SCI, V20, P71, DOI 10.1007/s00534-012-0569-8; Itoi T, 2010, J HEPATO-BIL-PAN SCI, V17, P725, DOI 10.1007/s00534-010-0291-3; Itokawa F, 2015, J GASTROEN HEPATOL, V30, P223, DOI 10.1111/jgh.12675; Krahenbuhl L, 1998, J AM COLL SURGEONS, V187, P231, DOI 10.1016/S1072-7515(98)00156-2; Schiergens TS, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-55; Tonozuka R, 2014, DIGEST DIS SCI, V59, P2299, DOI 10.1007/s10620-014-3156-9	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	FEB	2015	22	2					177	179		10.1002/jhbp.172		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CB1DL	WOS:000349366800013		
J	Hirono, S; Yamaue, H				Hirono, Seiko; Yamaue, Hiroki			Tips and tricks of the surgical technique for borderline resectable pancreatic cancer: mesenteric approach and modified distal pancreatectomy with en-bloc celiac axis resection	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Borderline resectable pancreatic cancer; Mesenteric approach; Modified distal pancreatectomy with en-bloc celiac axis resection	EXPERT CONSENSUS STATEMENT; VENOUS INVASION; PORTAL-VEIN; ARTERY; PANCREATICODUODENECTOMY; ADENOCARCINOMA; THERAPY; CARCINOMA; OUTCOMES; BODY	Borderline resectable (BR) pancreatic cancer involves the portal vein and/or superior mesenteric vein (PV/SMV), major arteries including the superior mesenteric artery (SMA) or common hepatic artery (CHA), and sometimes includes the involvement of the celiac axis. We herein describe tips and tricks for a surgical technique with video assistance, which may increase the R0 rates and decrease the mortality and morbidity for BR pancreatic cancer patients. First, we describe the techniques used for the artery-first approach for BR pancreatic cancer with involvement of the PV/SMV and/or SMA. Next, we describe the techniques used for distal pancreatectomy with en-bloc celiac axis resection (DP-CAR) and tips for decreasing the delayed gastric emptying (DGE) rates for advanced pancreatic body cancer. The mesenteric approach, followed by the dissection of posterior tissues of the SMV and SMA, is a feasible procedure to obtain R0 rates and decrease the mortality and morbidity, and the combination of this aggressive procedure and adjuvant chemo(radiation) therapy may improve the survival of BR pancreatic cancer patients. The DP-CAR procedure may increase the R0 rates for pancreatic cancer patients with involvement within 10mm from the root of the splenic artery, as well as the CHA or celiac axis, and preserving the left gastric artery may lead to a decrease in the DGE rates in cases where there is more than 10mm between the tumor edge and the root of the left gastric artery. The development of safer surgical procedures is necessary to improve the survival of BR pancreatic cancer patients.	[Hirono, Seiko; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Sch Med, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Dept Surg 2, Sch Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	yamaue-h@wakayama-med.ac.jp					FORTNER JG, 1973, SURGERY, V73, P307; Okada K, 2013, SURGERY, V153, P365, DOI 10.1016/j.surg.2012.07.036; Nakao A, 2006, WORLD J SURG, V30, P976, DOI 10.1007/s00268-005-0438-6; Kang CM, 2012, J GASTROINTEST SURG, V16, P509, DOI 10.1007/s11605-011-1784-3; Amano H, 2009, J HEPATO-BILIARY-PAN, V16, P850, DOI 10.1007/s00534-009-0190-7; Sanjay P, 2012, BRIT J SURG, V99, P1027, DOI 10.1002/bjs.8763; Barugola G, 2012, AM J SURG, V203, P132, DOI 10.1016/j.amjsurg.2011.03.008; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Stokes JB, 2011, ANN SURG ONCOL, V18, P619, DOI 10.1245/s10434-010-1456-7; Strasberg SM, 2012, J GASTROINTEST SURG, V16, P1048, DOI 10.1007/s11605-012-1841-6; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Li H, 2005, J COMPUT ASSIST TOMO, V29, P170, DOI 10.1097/01.rct.0000155060.73107.83; Kondo S, 2003, LANGENBECK ARCH SURG, V388, P101, DOI 10.1007/s00423-003-0375-5; NAKAO A, 1993, HEPATO-GASTROENTEROL, V40, P426; Wong JC, 2008, CLIN GASTROENTEROL H, V6, P1301, DOI 10.1016/j.cgh.2008.09.014; Pessaux P, 2006, J GASTROINTEST SURG, V10, P607, DOI 10.1016/j.gassur.2005.05.001; Varadhachary GR, 2006, ANN SURG ONCOL, V13, P1035, DOI 10.1245/ASO.2006.08.011; Evans DB, 2009, ANN SURG ONCOL, V16, P1736, DOI 10.1245/s10434-009-0416-6; Christians KK, 2014, ONCOLOGIST, V19, P266, DOI 10.1634/theoncologist.2013-0273; Hirono S, 2014, LANGENBECK ARCH SURG, V399, P461, DOI 10.1007/s00423-014-1182-x; Howlader N., 2012, SEER CANC STAT REV; Kurosaki Isao, 2011, JOP, V12, P220; Lee JL, 2012, SURGERY, V152, P851, DOI 10.1016/j.surg.2012.03.010; National Comprehensive Cancer Network, NCCN PRACT GUID PANC; Ohigashi H, 2004, HEPATO-GASTROENTEROL, V51, P4; Okada K, 2014, WORLD J SURG, V38, P2980, DOI 10.1007/s00268-014-2702-0; Weiz J, 2010, J AM COLL SURGEONS, V210, pe1; WHO Regional Office for Europe, 2012, EUR HLTH REP 2012 CH	28	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	FEB	2015	22	2					E4	E7		10.1002/jhbp.184		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CB1DL	WOS:000349366800001		
J	Kanno, A; Kuri, T; Morohashi, I; Hosako, I; Kawanishi, T; Yoshida, Y; Kitayama, K				Kanno, Atsushi; Kuri, Toshiaki; Morohashi, Isao; Hosako, Iwao; Kawanishi, Tetsuya; Yoshida, Yuki; Kitayama, Ken-ichi			Coherent Terahertz Wireless Signal Transmission Using Advanced Optical Fiber Communication Technology	JOURNAL OF INFRARED MILLIMETER AND TERAHERTZ WAVES			English	Article						Terahertz communication; Coherent communication; Radio over fiber; Optical frequency comb	MICROWAVE PHOTONICS; GHZ; THZ; OSCILLATORS; PHOTODIODE; FREQUENCY; BANDWIDTH; 110-GHZ; SYSTEM; RADIO	Coherent terahertz signal transmission with multilevel modulation and demodulation is demonstrated using an optical sub-harmonic IQ mixer (SHIQM), which consists of optical components in advanced optical fiber communication technologies. An optical-frequency-comb-employed signal generator is capable of vector modulation as well as frequency tunability. Digital signal processing (DSP) adopted from the recently developed optical digital coherent communication can easily demodulate multi-level modulated terahertz signals by using electrical heterodyning for intermediate-frequency (IF) down conversion. This technique is applicable for mobile backhauling in the next-generation mobile communication technology directly connected to an optical fiber network as a high-speed wireless transmission link.	[Kanno, Atsushi; Kuri, Toshiaki; Morohashi, Isao; Hosako, Iwao; Kawanishi, Tetsuya] Natl Inst Informat & Commun Technolgy, Koganei, Tokyo 1848795, Japan; [Yoshida, Yuki; Kitayama, Ken-ichi] Osaka Univ, Suita, Osaka 2748601, Japan	Kanno, A (reprint author), Natl Inst Informat & Commun Technolgy, 4-2-1 Nukui Kitamachi, Koganei, Tokyo 1848795, Japan.	kanno@nict.go.jp			Ministry of Internal Affairs and Communications, Japan; "Agile Deployment Capability of Highly Resilient Optical and Radio Seamless Communication Systems" program of the commissioned research of the NICT	This work is conducted as a part of the project "R&D on amplifier technology in 300GHz band, in a part of R&D program on key technology in terahertz frequency bands", funded by the Ministry of Internal Affairs and Communications, Japan.; Y. Yoshida and K. Kitayama are thankful for the financial support received from the "Agile Deployment Capability of Highly Resilient Optical and Radio Seamless Communication Systems" program of the commissioned research of the NICT.	Al-Raweshidy H., 2002, RADIO OVER FIBER TEC; Jastrow C, 2008, ELECTRON LETT, V44, P213, DOI 10.1049/el:20083359; Seo M, 2011, IEEE J SOLID-ST CIRC, V46, P2203, DOI 10.1109/JSSC.2011.2163213; [Anonymous], 2001, ATTENUATION ATMOSPHE; Zhang JW, 2013, IEEE PHOTONIC TECH L, V25, P780, DOI 10.1109/LPT.2013.2251623; [Anonymous], THZ COMM STAT RES ST; WANG SY, 1983, ELECTRON LETT, V19, P554, DOI 10.1049/el:19830376; Song HJ, 2011, IEEE T THZ SCI TECHN, V1, P256, DOI 10.1109/TTHZ.2011.2159552; Koenig S, 2013, NAT PHOTONICS, V7, P977, DOI [10.1038/nphoton.2013.275, 10.1038/NPHOTON.2013.275]; Deal W, 2011, IEEE T THZ SCI TECHN, V1, P25, DOI 10.1109/TTHZ.2011.2159539; Kanno A, 2012, OPT EXPRESS, V20, P29395, DOI 10.1364/OE.20.029395; Kawanishi T, 2007, IEEE J SEL TOP QUANT, V13, P79, DOI 10.1109/JSTQE.2006.889044; Seeds AJ, 2006, J LIGHTWAVE TECHNOL, V24, P4628, DOI 10.1109/JLT.2006.885787; [Anonymous], 2009, M21351 ITU; Capmany J, 2007, NAT PHOTONICS, V1, P319, DOI 10.1038/nphoton.2007.89; Ito H, 2000, ELECTRON LETT, V36, P1809, DOI 10.1049/el:20001274; Pinel S, 2009, IEEE J SEL AREA COMM, V27, P1347, DOI 10.1109/JSAC.2009.091005; Ito H, 2005, SEMICOND SCI TECH, V20, pS191, DOI 10.1088/0268-1242/20/7/008; FRIIS HT, 1946, P IRE, V34, P254, DOI 10.1109/JRPROC.1946.234568; Baig A., 2011, P IEEE INT VACC EL C, P275; Basten M. A., 2012, P IEEE IVEC APR, P39; Birk M, 2011, J LIGHTWAVE TECHNOL, V29, P417, DOI 10.1109/JLT.2010.2093507; Daniels RC, 2010, IEEE MICROW MAG, V11, pS44, DOI 10.1109/MMM.2010.938581; Davis M., 2012, MOB BACKH C INT CELL; Horiguchi S, 2013, ASIA PACIF MICROWAVE, P660, DOI 10.1109/APMC.2013.6694897; Hoshina H, 2008, J QUANT SPECTROSC RA, V109, P2303, DOI 10.1016/j.jqsrt.2008.03.005; Ishibashi T., 1997, TECH DIG ULTRAFAST E, V13, P83; ITU-T Recommendation, 2004, FORW ERR CORR HIGH B; Kaminow I., 2008, OPTICAL FIBER TELECO; Kanno A., 2012, IEEE INT TOP M MICR; Kanno A., 2011, C LAS EL BALT US JWA; Kanno A., 2013, TECH IEEE MTT S INT; Kanno A., 2013, IEEE GLOBECOM; Kanno A., 2012, APPL BASED TERAHERTZ; Kanno A., 2012, TECH IEEE MTT S INT; Kanno A, 2012, IEICE ELECTRON EXPR, V9, P1473, DOI 10.1587/elex.9.1473; KATO K, 1994, IEEE PHOTONIC TECH L, V6, P719, DOI 10.1109/68.300173; Kawanishi T., 2004, IEICE Electronics Express, V1, DOI 10.1587/elex.1.217; Koenig S., 2013, OPT FIB COMM C EXP N; Kuri T., 2006, IEEE INT TOP M MICR; Kurner T., 2013, J INFRARED MILLIMETE, V35, P53; Nakajima N, 2001, IEEE COMMUN MAG, V39, P146, DOI 10.1109/35.952929; Nakazawa M., 2010, HIGH SPECTRAL DESNSI, P11; Okada K., 2011, IEEE J SOLID-ST CIRC, V14, P2988; Optical Internetworking Forum, 2009, OIFFD100GDWGN010; Pang X., 2011, OPT EXPRESS, V19, P24994; Pukala D, 2008, IEEE MICROW WIREL CO, V18, P61, DOI 10.1109/LMWC.2007.912047; Sekine N., 2013, 30 GBPS CLASS TERAHE; Song H.-J., 2010, IEEE INT TOPM MICR P; TESSMANN A, 2009, P IND PHOSPH REL MAT, P196; Tousi YM, 2012, IEEE J SOLID-ST CIRC, V47, P3032, DOI 10.1109/JSSC.2012.2217853; Tucek J. C., 2012, P IEEE 13 IVEC APR 2, P553; WEY YG, 1995, J LIGHTWAVE TECHNOL, V13, P1490	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6892	1866-6906		J INFRARED MILLIM TE	J. Infrared Millim. Terahertz Waves	FEB	2015	36	2			SI		180	197		10.1007/s10762-014-0132-6		18	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB4XQ	WOS:000349632100006		
J	Motosugi, U; Bannas, P; Sano, K; Reeder, SB				Motosugi, Utaroh; Bannas, Peter; Sano, Katsuhiro; Reeder, Scott. B.			Hepatobiliary MR Contrast Agents in Hypovascular Hepatocellular Carcinoma	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Review						liver MRI; gadoxetic acid; gadoxetate disodium; gadobenate dimeglumine; hepatocellular carcinoma; early HCC; hepatocarcinogenesis	GD-EOB-DTPA; ACID-ENHANCED MRI; CHRONIC LIVER-DISEASE; MAGNETIC-RESONANCE IMAGES; MULTISTEP HUMAN HEPATOCARCINOGENESIS; ANGLE IMPROVE CONSPICUOUSNESS; GADOXETIC-ACID; HEPATOCYTE-PHASE; GADOBENATE DIMEGLUMINE; ARTERIAL PHASE	Hepatocellular carcinoma (HCC) develops via multistep hepatocarcinogenesis, during which hypovascular/early HCC precedes the typical hypervascular HCC. The hypovascular HCC lacks the typical hallmark imaging features of HCC, such as late arterial phase enhancement and portal venous washout, limiting early detection using conventional extracellular contrast agents for dynamic magnetic resonance imaging (MRI) or computed tomography (CT) imaging. In recent years, gadolinium-based contrast agents with hepatobiliary uptake have garnered interest from radiologists and hepatologists due to their potential for improved detection of HCC during hepatobiliary phase MRI. Lesions with reduced or absent hepatocyte function appear hypointense in the hepatobiliary phase of gadoxetic acid-enhanced MRI. This behavior can be exploited for earlier detection of hypovascular HCC. This review describes the general characteristics and advantages of gadoxetic acid for the diagnosis of HCC with a particular focus on hypovascular/early HCC. J. Magn. Reson. Imaging 2015;41:251-265.(c) 2013 Wiley Periodicals, Inc.	[Motosugi, Utaroh; Bannas, Peter; Reeder, Scott. B.] Univ Wisconsin, Dept Radiol, Madison, WI 53792 USA; [Motosugi, Utaroh; Sano, Katsuhiro] Univ Yamanashi, Dept Radiol, Kofu, Yamanashi, Japan; [Bannas, Peter] Univ Hosp Hamburg Eppendorf, Dept Radiol, Hamburg, Germany; [Reeder, Scott. B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53792 USA; [Reeder, Scott. B.] Univ Wisconsin, Dept Med Phys, Madison, WI 53792 USA; [Reeder, Scott. B.] Univ Wisconsin, Dept Med, Madison, WI 53792 USA; [Reeder, Scott. B.] Univ Wisconsin, Dept Emergency Med, Madison, WI 53792 USA	Motosugi, U (reprint author), Univ Wisconsin, Ctr Clin Sci, Dept Radiol, 600 Highland Ave, Madison, WI 53792 USA.	umotosugi@uwhealth.org			National Institutes of Health (NIH) [RC1 EB010384]	Contract grant sponsor: National Institutes of Health (NIH); Contract grant number: RC1 EB010384 (to PI S.B. Reeder).	Kitao A, 2011, EUR RADIOL, V21, P2056, DOI 10.1007/s00330-011-2165-8; Chou CT, 2010, J MAGN RESON IMAGING, V32, P895, DOI 10.1002/jmri.22316; Joishi D, 2013, MAGN RESON MED SCI, V12, P281, DOI 10.2463/mrms.2012-0097; Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Davenport MS, 2014, RADIOLOGY, V272, P123, DOI 10.1148/radiol.14132269; Rossi S, 2011, HEPATOLOGY, V53, P136, DOI 10.1002/hep.23965; Tamada T, 2009, J MAGN RESON IMAGING, V29, P636, DOI 10.1002/jmri.21689; Tsuboyama T, 2010, RADIOLOGY, V255, P824, DOI 10.1148/radiol.10091557; Kim JY, 2013, AM J ROENTGENOL, V201, P322, DOI 10.2214/AJR.12.9478; Tanimoto A, 2012, MAGN RESON MED SCI, V11, P91; Fidler J, 2011, HEPATOLOGY, V53, P678, DOI 10.1002/hep.24158; Frydrychowicz A, 2012, J MAGN RESON IMAGING, V36, P632, DOI 10.1002/jmri.23683; Sun HY, 2010, INVEST RADIOL, V45, P96, DOI 10.1097/RLI.0b013e3181c5faf7; Gatto A, 2013, ABDOM IMAGING, V38, P736, DOI 10.1007/s00261-012-9950-y; Imai Y, 2000, HEPATOLOGY, V32, P205, DOI 10.1053/jhep.2000.9113; Zech CJ, 2013, AM J ROENTGENOL, V201, P97, DOI 10.2214/AJR.12.9491; Nagle SK, 2012, J MAGN RESON IMAGING, V36, P890, DOI 10.1002/jmri.23713; Goshima S, 2011, EUR J RADIOL, V79, pE108, DOI 10.1016/j.ejrad.2011.04.041; Kumada T, 2011, AM J ROENTGENOL, V197, P58, DOI 10.2214/AJR.10.5390; Shinagawa Y, 2012, AM J ROENTGENOL, V199, P1010, DOI 10.2214/AJR.11.8204; UEDA K, 1992, HUM PATHOL, V23, P619, DOI 10.1016/0046-8177(92)90316-U; Park G, 2010, BRIT J RADIOL, V83, P1010, DOI 10.1259/bjr/66686028; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Bashir MR, 2013, J MAGN RESON IMAGING, V37, P398, DOI 10.1002/jmri.23818; Fowler KJ, 2011, HEPATOLOGY, V54, P2227, DOI 10.1002/hep.24679; Hwang J, 2012, BRIT J RADIOL, V85, pE314, DOI 10.1259/bjr/27727228; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Kim YK, 2010, CLIN RADIOL, V65, P358, DOI 10.1016/j.crad.2009.11.012; Higaki A, 2012, MAGN RESON IMAGING, V30, P689, DOI 10.1016/j.mri.2012.01.004; Hwang J, 2010, J MAGN RESON IMAGING, V32, P629, DOI 10.1002/jmri.22287; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Ahn SS, 2010, RADIOLOGY, V255, P459, DOI 10.1148/radiol.10091388; Midorikawa Y, 2013, J HEPATOL, V58, P306, DOI 10.1016/j.jhep.2012.09.026; MATSUI O, 1991, RADIOLOGY, V178, P493; Murakami T, 2012, MAGN RESON MED SCI, V11, P75; Bolondi L, 2005, HEPATOLOGY, V42, P27, DOI 10.1002/hep.20728; Motosugi U, 2011, INVEST RADIOL, V46, P141, DOI 10.1097/RLI.0b013e3181f9c487; Akai H, 2012, EUR J RADIOL, V81, P2973, DOI 10.1016/j.ejrad.2012.01.007; Golfieri R, 2011, EUR RADIOL, V21, P1233, DOI 10.1007/s00330-010-2030-1; Roskams T, 2010, SEMIN LIVER DIS, V30, P17, DOI 10.1055/s-0030-1247129; Kitao A, 2012, RADIOLOGY, V265, P780, DOI 10.1148/radiol.12120226; Haradome H, 2010, J MAGN RESON IMAGING, V32, P334, DOI 10.1002/jmri.22241; Park MJ, 2012, RADIOLOGY, V264, P761, DOI 10.1148/radiol.12112517; Motosugi U, 2013, RADIOLOGY, V267, P317, DOI 10.1148/radiol.13122186; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Regimbeau JM, 2004, J SURG ONCOL, V85, P36, DOI 10.1002/jso.10284; Takechi M, 2012, JPN J RADIOL, V30, P743, DOI 10.1007/s11604-012-0120-5; Lee MH, 2011, AM J ROENTGENOL, V197, pW868, DOI 10.2214/AJR.10.6237; Kim JY, 2012, EUR J RADIOL, V81, P3877, DOI 10.1016/j.ejrad.2012.07.021; Feuerlein S, 2012, EUR J RADIOL, V81, P2037, DOI 10.1016/j.ejrad.2011.06.014; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Onishi H, 2012, EUR RADIOL, V22, P845, DOI 10.1007/s00330-011-2316-y; Hwang J, 2012, J MAGN RESON IMAGING, V36, P881, DOI 10.1002/jmri.23728; Huppertz A, 2005, RADIOLOGY, V234, P468, DOI 10.1148/radiol.2342040278; [Anonymous], 2012, J HEPATOL, V56, P908; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Kim JE, 2011, AM J ROENTGENOL, V196, pW758, DOI 10.2214/AJR.10.4394; Adam R, 2012, ANN SURG, V256, P883, DOI 10.1097/SLA.0b013e318273bad0; Davenport MS, 2013, RADIOLOGY, V266, P452, DOI 10.1148/radiol.12120826; Ward J, 2000, RADIOLOGY, V216, P154; Motosugi U, 2011, J MAGN RESON IMAGING, V34, P88, DOI 10.1002/jmri.22630; Pietryga JA, 2014, RADIOLOGY, V271, P426, DOI 10.1148/radiol.13131988; Rhee H, 2012, BRIT J RADIOL, V85, pE837, DOI 10.1259/bjr/13212920; Muhi A, 2009, J MAGN RESON IMAGING, V30, P1005, DOI 10.1002/jmri.21931; Kudo M, 2013, ONCOLOGY-BASEL, V84, P21, DOI 10.1159/000345885; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Chen NX, 2013, J COMPUT ASSIST TOMO, V37, P466, DOI 10.1097/RCT.0b013e3182873799; Motosugi U, 2010, RADIOLOGY, V256, P151, DOI 10.1148/radiol.10091885; Sakamoto M, 2009, J GASTROENTEROL, V44, P108, DOI 10.1007/s00535-008-2245-y; Bashir MR, 2011, EUR RADIOL, V21, P291, DOI 10.1007/s00330-010-1917-1; Narita M, 2009, J GASTROENTEROL, V44, P793, DOI 10.1007/s00535-009-0056-4; Brismar TB, 2009, ACTA RADIOL, V50, P709, DOI 10.1080/02841850903055603; Yoneda N, 2013, JPN J RADIOL, V31, P480, DOI 10.1007/s11604-013-0224-6; Kogita S, 2010, EUR RADIOL, V20, P2405, DOI 10.1007/s00330-010-1812-9; Kim YK, 2012, RADIOLOGY, V265, P104, DOI 10.1148/radiol.12112649; Inoue T, 2012, J GASTROENTEROL, V47, P1036, DOI 10.1007/s00535-012-0571-6; Choi YS, 2013, J MAGN RESON IMAGING, V37, P1384, DOI 10.1002/jmri.23940; Marin D, 2009, RADIOLOGY, V251, P85, DOI 10.1148/radiol.2511080400; Motosugi U, 2013, MAGN RESON MED SCI, V12, P161, DOI 10.2463/mrms.2012-0085; Watanabe H, 2012, AM J ROENTGENOL, V198, P589, DOI 10.2214/AJR.11.6844; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P849, DOI 10.1002/jmri.21913; Silva MA, 2008, GUT, V57, P1592, DOI 10.1136/gut.2008.149062; Nakamura Y, 2013, J MAGN RESON IMAGING, V37, P684, DOI 10.1002/jmri.23855; Frydrychowicz A, 2011, J MAGN RESON IMAGING, V34, P585, DOI 10.1002/jmri.22713; Choi JW, 2013, RADIOLOGY, V267, P776, DOI 10.1148/radiol.13120775; Frydrychowicz A, 2012, J MAGN RESON IMAGING, V35, P492, DOI 10.1002/jmri.22833; Suh YJ, 2011, AM J ROENTGENOL, V197, pW44, DOI 10.2214/AJR.10.5845; Kudo M, 2009, J GASTROENTEROL, V44, P112, DOI 10.1007/s00535-008-2274-6; Haradome H, 2011, J MAGN RESON IMAGING, V34, P69, DOI 10.1002/jmri.22588; Takayasu K, 2013, LIVER INT, V33, P762, DOI 10.1111/liv.12130; Bashir MR, 2012, J MAGN RESON IMAGING, V35, P611, DOI 10.1002/jmri.22850; Zech CJ, 2009, INVEST RADIOL, V44, P305; Hayashi M, 1999, AM J ROENTGENOL, V172, P969; Rhee H, 2012, J MAGN RESON IMAGING, V35, P393, DOI 10.1002/jmri.22828; Toyoda H, 2013, J HEPATOL, V58, P1174, DOI 10.1016/j.jhep.2013.01.030; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Okada M, 2010, J MAGN RESON IMAGING, V32, P903, DOI 10.1002/jmri.22333; Kim HY, 2012, LIVER TRANSPLANT, V18, P850, DOI 10.1002/lt.23426; Zhou ZP, 2014, EUR J GASTROEN HEPAT, V26, P339, DOI 10.1097/MEG.0000000000000012; Bartolozzi C, 2013, ABDOM IMAGING, V38, P290, DOI 10.1007/s00261-012-9952-9; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Sung HY, 2011, PANCREAS, V40, P1080, DOI 10.1097/MPA.0b013e31821fde24; Doo KW, 2009, AM J ROENTGENOL, V193, pW490, DOI 10.2214/AJR.08.1732; Kitao A, 2010, RADIOLOGY, V256, P817, DOI 10.1148/radiol.10092214; Haradome H, 2012, J MAGN RESON IMAGING, V35, P132, DOI 10.1002/jmri.22805; Golfieri R, 2012, J MAGN RESON IMAGING, V36, P648, DOI 10.1002/jmri.23685; Asayama Y, 2008, AM J ROENTGENOL, V190, pW28, DOI 10.2214/AJR.07.2117; Cha DI, 2014, J MAGN RESON IMAGING, V39, P842, DOI 10.1002/jmri.24237; Chou CT, 2011, J MAGN RESON IMAGING, V33, P625, DOI 10.1002/jmri.22500; DisMartino M, 2010, RADIOLOGY, V256, P806; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Higaki A, 2013, J MAGN RESON IMAGING, V37, P1377, DOI 10.1002/jmri.23933; Ichikawa S, 2014, J MAGN RESON IMAGING, V39, P293, DOI 10.1002/jmri.24164; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Kakihara D, 2013, J MAGN RESON IMAGING; Kim KA, 2012, J MAGN RESON IMAGING, V35, P629, DOI 10.1002/jmri.22876; Kim YK, 2010, INVEST RADIOL, V45, P740, DOI 10.1097/RLI.0b013e3181e943a7; Komatsu N, 2014, HEPATOL RES; Lee S, 2010, J MAGN RESON IMAGING, V32, P719, DOI 10.1002/jmri.22291; Lim K.C., 2014, HEPATOLOGY; Lim S, 2014, J MAGN RESON IMAGING, V39, P1238, DOI 10.1002/jmri.24265; Matsuda M, 2014, HPB SURG, V2014, P8; Matsui O, 2007, HEPATOL RES, V37, pS200, DOI 10.1111/j.1872-034X.2007.00185.x; Motosugi U, 2012, INVEST RADIOL, V47, P566, DOI 10.1097/RLI.0b013e318260ac9e; Nakamura S, 2012, JPN J RADIOL, V30, P25, DOI 10.1007/s11604-011-0003-1; Pietryga JA, 2014, RADIOLOGY; Sirlin CB, 2013, J MAGN RESON IMAGING; Tahir B, 2011, CLIN RADIOL, V66, P845, DOI 10.1016/j.crad.2011.03.021; TAKAYASU K, 1995, RADIOLOGY, V194, P101; Tamada T, 2013, J MAGN RESON IMAGING, V37, P1093, DOI 10.1002/jmri.23903; VansBeers BE, 2012, J HEPATOL, V57, P421; Yamamoto A, 2013, AM J ROENTGENOL, V200, P1254, DOI 10.2214/AJR.12.9136	133	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	FEB	2015	41	2					251	265		10.1002/jmri.24712		15	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA4CA	WOS:000348850600002		
J	Okada, M; Murakami, T; Yada, N; Numata, K; Onoda, M; Hyodo, T; Inoue, T; Ishii, K; Kudo, M				Okada, Masahiro; Murakami, Takamichi; Yada, Norihisa; Numata, Kazushi; Onoda, Minori; Hyodo, Tomoko; Inoue, Tatsuo; Ishii, Kazunari; Kudo, Masatoshi			Comparison Between T1 Relaxation Time of Gd-EOB-DTPA-Enhanced MRI and Liver Stiffness Measurement of Ultrasound Elastography in the Evaluation of Cirrhotic Liver	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						Gd-EOB-DTPA; MRI; US; liver fibrosis; elastography; T1 relaxation time	CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; HEPATOCELLULAR-CARCINOMA; TISSUE ELASTOGRAPHY; NONALCOHOLIC STEATOHEPATITIS; NONINVASIVE ASSESSMENT; FIBROSIS STAGES; CONTRAST AGENT; DIAGNOSIS; BIOPSY	PurposeTo compare four imaging approaches in cirrhotic estimation; pre-enhancement T1 relaxation time (T1RT), reduction rate (RR) of T1RT, signal-based liver-to-muscle ratio (L/M ratio) on gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI), and liver stiffness measurement (LSM) of US elastography. Materials and MethodsConsecutive 58 patients with chronic liver diseases who underwent both Gd-EOB-DTPA-enhanced MRI and FibroScan were analyzed. Four imaging approaches were evaluated by fibrosis score from liver biopsy and receiver operating characteristic (ROC) analysis. ResultsRR was found to be inversely correlated with LSM (r=-0.65). RR decreased with degree of fibrosis (F0-F1, 58.56.2%, versus F2-F3-F4, 48.8 +/- 11.7%, P=0.010, F0-F1-F2, 58.2 +/- 6.2% versus F3-F4, 45.5 +/- 12.3%, P=0.010 and F0-F1, 58.5 +/- 6.2%, versus F2-F3, 52.1 +/- 12.0%, P=0.0038). LSM increased with degree of fibrosis (F0-F1, 5.4 +/- 2.2 kPa versus F2-F3-F3, 19.3 +/- 15.5 kPa, P=0.0011 and F0-F1-F2, 6.8 +/- 3.6 kPa versus F3-F4, 23.8 +/- 17.1 kPa, P=0.0029 and F0-F1, 5.4 +/- 2.2 kPa, versus F2-F3, 11.4 +/- 7.2 kPa, P=0.0098). Area under ROC curves were 0.83 (F3-F4), 0.72 (F2-F3-F4), 0.68 (F2-F3) for RR and 0.83 (F3-F4), 0.88 (F2-F3-F4), 0.81 (F2-F3) for LSM in discriminating between patients with fibrosis. ConclusionThe capability by LSM was better than those by RR of T1RT, pre-enhancement T1RT, and L/M ratio to differentiate F2, but LSM and RR of T1RT showed the same value to differentiate F3. J. Magn. Reson. Imaging 2015;41:329-338.(c) 2013 Wiley Periodicals, Inc.	[Okada, Masahiro; Murakami, Takamichi; Onoda, Minori; Hyodo, Tomoko; Ishii, Kazunari] Kinki Univ, Fac Med, Dept Radiol, Osaka 5898511, Japan; [Yada, Norihisa; Inoue, Tatsuo; Kudo, Masatoshi] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka 5898511, Japan; [Numata, Kazushi] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan	Okada, M (reprint author), Kinki Univ, Fac Med, Dept Radiol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	mokada@gaia.eonet.ne.jp					Tsuboyama T, 2010, RADIOLOGY, V255, P824, DOI 10.1148/radiol.10091557; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Hirooka M, 2011, AM J ROENTGENOL, V196, pW766, DOI 10.2214/AJR.10.4867; HAMM B, 1995, RADIOLOGY, V195, P785; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019; Stanisz GJ, 2000, MAGNET RESON MED, V44, P665, DOI 10.1002/1522-2594(200011)44:5<665::AID-MRM1>3.0.CO;2-M; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Sandrin L, 2002, IEEE T ULTRASON FERR, V49, P436, DOI 10.1109/58.996561; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Katsube T, 2011, INVEST RADIOL, V46, P277, DOI 10.1097/RLI.0b013e318200f67d; Salameh N, 2009, RADIOLOGY, V253, P90, DOI 10.1148/radiol.2523081817; Goshima S, 2012, J MAGN RESON IMAGING, V36, P1148, DOI 10.1002/jmri.23758; Tatsumi C, 2008, INTERVIROLOGY, V51, P27, DOI 10.1159/000122602; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506; Tamada T, 2011, EUR J RADIOL, V80, pE311, DOI 10.1016/j.ejrad.2011.01.020; Koizumi Y, 2011, RADIOLOGY, V258, P610, DOI 10.1148/radiol.10100319; Kogita S, 2010, EUR RADIOL, V20, P2405, DOI 10.1007/s00330-010-1812-9; Annet L, 2003, RADIOLOGY, V229, P409, DOI 10.1148/radiol.2292021128; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Nishie A, 2012, J MAGN RESON IMAGING, V36, P664, DOI 10.1002/jmri.23691; Fraquelli M, 2011, DIGEST LIVER DIS, V43, pS25, DOI 10.1016/S1590-8658(10)60689-5; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Boursier J, 2011, AM J GASTROENTEROL, V106, P1255, DOI 10.1038/ajg.2011.100; Okada M, 2010, J MAGN RESON IMAGING, V32, P903, DOI 10.1002/jmri.22333; Yoshida H, 1999, ANN INTERN MED, V131, P174; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Hopper I, 2012, EUR J HEART FAIL, V14, P621, DOI 10.1093/eurjhf/hfs044; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Noren B, 2013, EUR RADIOL, V23, P174, DOI 10.1007/s00330-012-2583-2; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Tsuda N, 2007, INVEST RADIOL, V42, P242, DOI 10.1097/01.rli.0000258058.44876.a5; Tsuda N, 2010, EUR J RADIOL, V73, P137, DOI 10.1016/j.ejrad.2008.09.036; Tsushima Y, 2002, ACAD RADIOL, V9, P276, DOI 10.1016/S1076-6332(03)80370-7; Zech Christoph J, 2007, Magn Reson Med Sci, V6, P43, DOI 10.2463/mrms.6.43	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	FEB	2015	41	2					329	338		10.1002/jmri.24529		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA4CA	WOS:000348850600007		
J	Takayama, Y; Nishie, A; Asayama, Y; Ushijima, Y; Fujita, N; Shimamoto, D; Yoshiura, T; Obara, M; Takemura, A; Yoneyama, M; Honda, H				Takayama, Yukihisa; Nishie, Akihiro; Asayama, Yoshiki; Ushijima, Yasuhiro; Fujita, Nobuhiro; Shimamoto, Dai; Yoshiura, Takashi; Obara, Makoto; Takemura, Atsushi; Yoneyama, Masami; Honda, Hiroshi			Three-Dimensional T2-Weighted Imaging for Liver MRI: Clinical Values of Tissue-Specific Variable Refocusing Flip-Angle Turbo Spin Echo Imaging	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						3D-T2-weighted imaging; variable refocusing flip-angle; tissue-specific; low-constant; liver; magnetic resonance imaging	GD-EOB-DTPA; HIGH-SPATIAL-RESOLUTION; HEPATIC HEMANGIOMA; SINGLE-SLAB; 3-T MRI; 3.0 T; 3D; SEQUENCES; 2D; LESIONS	PurposeTo assess the clinical utility of tissue-specific variable refocusing flip-angle (VRFA) turbo-spin echo imaging for three-dimensional T2-weighted imaging (3D-T2WI) of the liver. Materials and MethodsFifty-nine patients were scanned with three types of fat-suppressed T2WI for the comparison: two-dimensional single-shot turbo spin echo T2WI (ssT2WI), 3D-T2WI with tissue-specific VRFA (VISTA-TSV), and 3D-T2WI with low-constant VRFA (VISTA). Qualitatively, artifacts in the left and right lobes of the liver and black-blood effects in the liver were compared using the Wilcoxon signed-rank test with the Bonferroni correction. The detection and correct characterization rates of liver lesions were compared using McNemar's test. ResultsVISTA-TSV showed reduced artifacts in the left and right lobes of the liver compared with VISTA (P<0.017). The artifacts shown by VISTA-TSV were equivalent to those shown by ssT2WI. The black-blood effects of VISTA-TSV and VISTA were better than that of ssT2WI (P<0.017). VISTA-TSV showed the best detection and correct characterization rate of liver lesions among the three imaging techniques (P<0.05). Conclusion3D-T2WI with tissue-specific VRFA can reduce artifacts of the liver, sufficiently suppress the signal in blood vessels, and has a potential to improve the detection and correct characterization rates of liver lesions. J. Magn. Reson. Imaging 2015;41:339-346.(c) 2013 Wiley Periodicals, Inc.	[Takayama, Yukihisa] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, Fukuoka 8128582, Japan; [Nishie, Akihiro; Asayama, Yoshiki; Ushijima, Yasuhiro; Fujita, Nobuhiro; Shimamoto, Dai; Yoshiura, Takashi; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Obara, Makoto; Takemura, Atsushi] Philips Elect Japan, Minato Ku, Tokyo, Japan; [Yoneyama, Masami] Yaesu Clin, Chuo Ku, Tokyo, Japan	Nishie, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	anishie@radiol.med.kyushu-u.ac.jp			Bayer AG; Philips Healthcare	Y.T. received unrestricted research grants from Bayer AG and Philips Healthcare.	Agrawal G, 2009, AM J ROENTGENOL, V193, pW558, DOI 10.2214/AJR.09.2716; Danet IM, 2003, AM J ROENTGENOL, V181, P809; Balu N, 2008, J MAGN RESON IMAGING, V27, P918, DOI 10.1002/jmri.21282; Hennig J, 2003, MAGNET RESON MED, V49, P527, DOI 10.1002/mrm.10391; Parikh T, 2008, RADIOLOGY, V246, P812, DOI 10.1148/radiol.2463070432; Park J, 2010, MAGN RESON MED, V63, P553, DOI 10.1002/mrm.22261; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Watanabe Y, 2008, J MAGN RESON IMAGING, V28, P478, DOI 10.1002/jmri.21250; Busse RF, 2008, MAGN RESON MED, V60, P640, DOI 10.1002/mrm.21680; Saito K, 2010, J MAGN RESON IMAGING, V32, P229, DOI 10.1002/jmri.22219; Haystead CM, 2008, RADIOLOGY, V246, P589, DOI [10.1148/radiol.2462061674, 10.1148/radio1:2462061674]; Tsurusaki M, 2009, EUR J RADIOL, V72, P314, DOI 10.1016/j.ejrad.2008.07.027; Lichy MP, 2005, INVEST RADIOL, V40, P754, DOI 10.1097/01.rli.0000185880.92346.9e; Rosenkrantz AB, 2010, AM J ROENTGENOL, V194, P446, DOI 10.2214/AJR.09.3217; Tamada T, 2012, J MAGN RESON IMAGING, V35, P852, DOI 10.1002/jmri.23514; Takayama Y, 2012, EUR J RADIOL, V81, P3035, DOI 10.1016/j.ejrad.2012.03.026; Franklin KM, 2008, J MAGN RESON IMAGING, V27, P1443, DOI 10.1002/jmri.21164; Silva AC, 2009, RADIOGRAPHICS, V29, P385, DOI 10.1148/rg.292085123; Fan ZY, 2010, J MAGN RESON IMAGING, V31, P645, DOI 10.1002/jmri.22058; Mugler JP, 2000, RADIOLOGY, V216, P891; Busse RF, 2006, MAGN RESON MED, V55, P1030, DOI 10.1002/mrm.20863; Goshima S, 2010, AM J ROENTGENOL, V195, P941, DOI 10.2214/AJR.09.3730; Ahn SJ, 2011, J MAGN RESON IMAGING, V34, P310, DOI 10.1002/jmri.22658; Arizono S, 2010, EUR J RADIOL, V73, P114, DOI 10.1016/j.ejrad.2008.08.003; Busse RF, 2004, MAGNET RESON MED, V51, P1031, DOI 10.1002/mrm.20056; Morakkabati-Spitz N, 2006, EUR RADIOL, V16, P634, DOI 10.1007/s00330-005-0016-1; Haradome H, 2012, J MAGN RESON IMAGING, V35, P1388, DOI 10.1002/jmri.23573; Hori M, 2011, RADIOLOGY, V258, P154, DOI 10.1148/radiol.10100866; Hussain SM, 2004, RADIOGRAPHICS, V24, P3, DOI 10.1148/rg.241035050; Nakamura M, 2010, P 38 ANN M JSMRM TSU; Narumi S, 2010, NEURORADIOLOGY, V52, P285, DOI 10.1007/s00234-009-0642-4; Takano K, 2012, EUR J RADIOL, V81, pE304, DOI 10.1016/j.ejrad.2011.10.012; Watanabe H, 2012, JPN J RADIOL, V30, P721, DOI 10.1007/s11604-012-0111-6; Yoneyama M, 2010, P 38 ANN M JSMRM TSU	34	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	FEB	2015	41	2					339	346		10.1002/jmri.24554		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA4CA	WOS:000348850600008		
J	Kuwatsuru, R; Takahashi, S; Umeoka, S; Sugihara, R; Zeng, MS; Huan, Y; Peng, WJ; Ma, L; Guo, L; Teng, GJ; Yao, WW; Tozaki, M; Endo, M; Kaji, S; Ro, T; Hahn, ST; Kang, BC; Nishimura, H; Sugawara, Y; Katakami, N; Breuer, J; Aitoku, Y				Kuwatsuru, Ryohei; Takahashi, Satoru; Umeoka, Shigeaki; Sugihara, Ryo; Zeng, Mengsu; Huan, Yi; Peng, Weijun; Ma, Lin; Guo, Liang; Teng, Gaojun; Yao, Weiwu; Tozaki, Mitsuhiro; Endo, Masahiro; Kaji, Shuichiro; Ro, Tokugen; Hahn, Seong Tae; Kang, Byung Chul; Nishimura, Hiroshi; Sugawara, Yoshifumi; Katakami, Nobuyuki; Breuer, Josy; Aitoku, Yasuko			A Multicenter, Randomized, Controlled, Single-Blind Comparison Phase III Study to Determine the Efficacy and Safety of Gadobutrol 1.0 M Versus Gadopentetate Dimeglumine Following Single Injection in Patients Referred for Contrast-Enhanced MRI of the Body Regions or Extremities	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						gadobutrol; gadopentetate dimeglumine; magnetic resonance imaging; contrast agents	MAGNETIC-RESONANCE ANGIOGRAPHY; GADOBENATE DIMEGLUMINE; RENAL LESIONS; BREAST MRI; GADOLINIUM; METASTASES; MEDIA; TRIAL	PurposeTo demonstrate the noninferiority of gadobutrol-enhanced magnetic resonance imaging (MRI) compared with gadopentetate dimeglumine-enhanced MRI in Asian patients referred for contrast-enhanced imaging of the body or extremities. Materials and MethodsA multicenter, parallel-group comparison study of Asian adults referred for contrast-enhanced MRI were randomized (1:1) to either gadobutrol or gadopentetate dimeglumine. Lesions were assessed for three primary visualization variables: degree of contrast enhancement, border delineation, and internal morphology. Secondary efficacy variables included number of lesions detected, match of MRI diagnosis with final clinical diagnosis, and sensitivity and specificity for malignant lesion detection. Safety was monitored for 244 hours after contrast agent administration. ResultsA total of 363 patients received either gadobutrol (n=168) or gadopentetate dimeglumine (n=178). Mean total scores for three primary visualization variables were 9.39 and 9.34 for gadobutrol and gadopentetate dimeglumine, respectively. The proportion of patients with matched MRI and final diagnosis and sensitivity for malignant lesion detection was greater for unenhanced versus combined images (gadobutrol: 72.2% vs. 81.7%; gadopentetate dimeglumine: 76.2% vs. 82.2%, respectively). Both contrast agents were well tolerated. ConclusionGadobutrol (0.1 mmol/kg BW) was well tolerated and effective in Asian patients referred for contrast-enhanced MRI of the body or extremities. J. Magn. Reson. Imaging 2014. (c) 2014 Wiley Periodicals, Inc. J. Magn. Reson. Imaging 2015;41:404-413.(c) 2013 Wiley Periodicals, Inc.	[Kuwatsuru, Ryohei] Juntendo Univ, Dept Radiol, Fac Med, Tokyo, Japan; [Takahashi, Satoru] Kobe Univ, Dept Radiol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Umeoka, Shigeaki] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Sugihara, Ryo] Sumitomo Hosp, Dept Radiol, Osaka, Japan; [Zeng, Mengsu] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Huan, Yi] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Peoples R China; [Peng, Weijun] Fudan Univ, Dept Radiol, Tumor Hosp, Shanghai 200433, Peoples R China; [Ma, Lin] Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Guo, Liang] Suzhou Univ, Dept Radiol, Hosp 1, Nanjing, Jiangsu, Peoples R China; [Teng, Gaojun] Southeast Univ, Dept Radiol, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China; [Yao, Weiwu] Shanghai Sixth Peoples Hosp, Dept Radiol, Shanghai, Peoples R China; [Tozaki, Mitsuhiro] Kameda Med Ctr, Breast Ctr, Kamogawa, Japan; [Endo, Masahiro] Shizuoka Canc Ctr, Diagnost Radiol Div, Shizuoka, Japan; [Kaji, Shuichiro] Inst Biomed Res & Innovat, Div Image Based Med, Kobe, Hyogo, Japan; [Ro, Tokugen] Japanese Red Cross Hosp, Dept Radiol, Fukuoka, Japan; [Hahn, Seong Tae] St Marys Hosp, Dept Radiol, Seoul, South Korea; [Kang, Byung Chul] Ewha Womans Univ, Mokdong Hosp, Dept Radiol, Seoul, South Korea; [Nishimura, Hiroshi] Saiseikai Futsukaichi Hosp, Dept Radiol, Chikushino, Japan; [Sugawara, Yoshifumi] Shikoku Canc Ctr, Dept Diagnost Radiol, Matsuyama, Ehime, Japan; [Katakami, Nobuyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo, Japan; [Breuer, Josy] Bayer Pharma AG, Global Clin Dev Diagnost Imaging, Berlin, Germany; [Aitoku, Yasuko] Bayer Yakuhin Ltd, Global Clin Dev Diagnost Imaging, Osaka, Japan	Kuwatsuru, R (reprint author), Juntendo Univ, Dept Radiol, Fac Med, Tokyo, Japan.	kuwaturu@juntendo.ac.jp			Bayer	Contract grant sponsor: Bayer.	Achenbach M, 2010, J MAGN RESON IMAGING, V32, P1166, DOI 10.1002/jmri.22355; Alomar SA, 2010, SEMIN DIAGN PATHOL, V27, P97, DOI 10.1053/j.semdp.2010.06.001; Yopp AC, 2011, ANN SURG ONCOL, V18, P2192, DOI 10.1245/s10434-011-1570-1; Tombach B, 2002, EUR RADIOL, V12, P1550, DOI 10.1007/s00330-001-1242-9; Pennekamp W, 2011, EUR RADIOL, V21, P1058, DOI 10.1007/s00330-010-2008-z; Hadizadeh DR, 2010, AM J ROENTGENOL, V194, P821, DOI 10.2214/AJR.09.3306; Anzalone N, 2009, ACTA RADIOL, V50, P933, DOI 10.1080/02841850903095385; Huppertz A, 2004, EUR RADIOL, V14, pM12, DOI 10.1007/s10406-004-0048-7; Inglese M, 2010, NMR BIOMED, V23, P865, DOI 10.1002/nbm.1515; Durmus T, 2012, INVEST RADIOL, V47, P183, DOI 10.1097/RLI.0b013e318236e354; Katakami N, 2011, INVEST RADIOL, V46, P411, DOI 10.1097/RLI.0b013e3182145a6c; Tombach B, 2003, RADIOLOGY, V226, P880, DOI 10.1148/radiol.2263011970; Hammerstingl R, 2009, INVEST RADIOL, V44, P168, DOI 10.1097/RLI.0b013e318198a0ae; Voth M, 2011, INVEST RADIOL, V46, P663, DOI 10.1097/RLI.0b013e3182218dc3; Doganay S, 2011, CLIN RADIOL, V66, P420, DOI 10.1016/j.crad.2010.11.013; Bellin MF, 2008, EUR J RADIOL, V66, P160, DOI 10.1016/j.ejrad.2008.01.023; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Cyran CC, 2012, AM J ROENTGENOL, V198, P384, DOI 10.2214/AJR.11.6951; Pediconi F, 2013, EUR RADIOL, V23, P84, DOI 10.1007/s00330-012-2557-4; De Cobelli F, 2012, AM J ROENTGENOL, V198, P809, DOI 10.2214/AJR.11.7118; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Tombach B, 2008, EUR RADIOL, V18, P2610, DOI 10.1007/s00330-008-1054-2; Attenberger UI, 2008, EUR RADIOL, V18, P1260, DOI 10.1007/s00330-008-0873-5; Bayer Pharma, 2011, GAD PROD INF; Forsting M, 2010, EUR J RADIOL, V74, pE187, DOI 10.1016/j.ejrad.2009.06.005; Karamitsos Theodoros D, 2011, Curr Cardiol Rep, V13, P210, DOI 10.1007/s11886-011-0177-2; Khatami SMR, 2012, RENAL FAILURE, V34, P176, DOI 10.3109/0886022X.2011.645942; Noseworthy MD, 2010, SEMIN MUSCULOSKEL R, V14, P257, DOI 10.1055/s-0030-1253166; Razek AAKA, 2010, JPN J RADIOL, V28, P87, DOI 10.1007/s11604-009-0394-4; Seeger A, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-63	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	FEB	2015	41	2					404	413		10.1002/jmri.24566		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA4CA	WOS:000348850600016		
J	Ida, M; Wakayama, T; Nielsen, ML; Abe, T; Grodzki, DM				Ida, Masahiro; Wakayama, Toshiki; Nielsen, Matthew L.; Abe, Takayuki; Grodzki, David M.			Quiet T1-Weighted Imaging Using PETRA: Initial Clinical Evaluation in Intracranial Tumor Patients	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						quiet; contrast-enhanced T1-weighted; intracranial brain tumor; ultra-short TE; ultrashort TE; point-wise; pointwise; PETRA (pointwise encoding time reduction with radial acquisition)	GRADIENT-ECHO SEQUENCE; CONTRAST-ENHANCED MR; BRAIN METASTASES; ACOUSTIC NOISE; MP-RAGE; GADOLINIUM; DISEASE; PULSES; TIME; CT	PurposeTo compare the lesion contrast and signal to noise ratio (SNR) obtained with T1-weighted pointwise encoding time reduction with radial acquisition (PETRA) to those of Magnetization-Prepared RApid Gradient-Echo (MPRAGE) for contrast-enhanced imaging of primary and metastatic intracranial tumors, and to investigate whether PETRA is able to reduce acoustic noise for improved patient comfort. Materials and MethodsFifteen patients with intracranial tumors underwent 3 Tesla MRI including inversion-prepared PETRA and MPRAGE. The two sequences had comparable scan times, spatial resolution and spatial coverage. Tumor conspicuity was rated qualitatively by two radiologists, while enhancing lesion-to-white matter contrast to noise ratio (CNR) and white-matter SNR were analyzed quantitatively using paired t-tests. The acoustic noise generated by each sequence was measured. ResultsQualitative rating of tumor conspicuity by two radiologists resulted in nearly identical average scores for the two sequences. Quantitative analyses revealed that (i) there was no significant difference between the mean CNR values of the two sequences (P = 0.57), (ii) the mean SNR of PETRA was significantly higher than that of MPRAGE (P < 0.01), and (iii) the mean sound level of PETRA was significantly lower than that of MPRAGE (P < 0.01). ConclusionInversion-prepared PETRA was found to be viable as a quiet alternative to MPRAGE for contrast-enhanced T1-weighted studies of intracranial tumors. J. Magn. Reson. Imaging 2015;41:447-453.(c) 2013 Wiley Periodicals, Inc.	[Ida, Masahiro; Wakayama, Toshiki] Tokyo Metropolitan Ebara Hosp, Dept Radiol, Tokyo 1450065, Japan; [Nielsen, Matthew L.; Abe, Takayuki] Siemens Japan KK, H IM Div, Res & Collaborat Dept, Tokyo, Japan; [Grodzki, David M.] Siemens AG, Magnet Resonance, Healthcare Sect, Erlangen, Germany	Ida, M (reprint author), Tokyo Metropolitan Ebara Hosp, Dept Radiol, Ota Ku, 4-5-10 Higashi Yukigaya, Tokyo 1450065, Japan.	rxb00500@nifty.com					Schellinger PD, 1999, J NEURO-ONCOL, V44, P275, DOI 10.1023/A:1006308808769; Segbers M, 2010, MAGN RESON MED, V64, P546, DOI 10.1002/mrm.22366; YUH WTC, 1995, AM J NEURORADIOL, V16, P373; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Weiger M, 2011, MAGN RESON MED, V66, P379, DOI 10.1002/mrm.22799; Idiyatullin D, 2006, J MAGN RESON, V181, P342, DOI 10.1016/j.jmr.2006.05.014; Hennel F, 1999, MAGNET RESON MED, V42, P6, DOI 10.1002/(SICI)1522-2594(199907)42:1<6::AID-MRM2>3.0.CO;2-D; Grodzki DM, 2012, MAGN RESON MED, V67, P510, DOI 10.1002/mrm.23017; BRANTZAWADZKI MN, 1993, JMRI-J MAGN RESON IM, V3, P656, DOI 10.1002/jmri.1880030416; Chamberlain R, 2011, P 19 ANN M ISMRM MON; DAVIS PC, 1991, AM J NEURORADIOL, V12, P293; Filippi M, 1996, ANN NEUROL, V40, P901, DOI 10.1002/ana.410400612; Grodzki DM, 2013, P 21 ANN M ISMRM SAL; Grodzki DM, 2012, J MAGN RESON, V214, P61, DOI 10.1016/j.jmr.2011.10.005; Hedeen RA, 1997, MAGNET RESON MED, V37, P7, DOI 10.1002/mrm.1910370103; Johnson G, 1999, MAGNET RESON MED, V41, P824, DOI 10.1002/(SICI)1522-2594(199904)41:4<824::AID-MRM23>3.0.CO;2-1; MIROWITZ SA, 1992, RADIOLOGY, V185, P529; RUNGE V M, 1985, Magnetic Resonance Imaging, V3, P27, DOI 10.1016/0730-725X(85)90006-2; Runge V M, 1988, Radiographics, V8, P947; Sze G, 1998, RADIOLOGY, V168, P187; SZE G, 1990, AM J NEURORADIOL, V11, P785; Wetzel SG, 2002, AM J NEURORADIOL, V23, P995	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	FEB	2015	41	2					447	453		10.1002/jmri.24575		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA4CA	WOS:000348850600020		
J	Sankarasubramanian, K; Sampath, M; Archana, J; Sethuraman, K; Ramamurthi, K; Hayakawa, Y				Sankarasubramanian, K.; Sampath, M.; Archana, J.; Sethuraman, K.; Ramamurthi, K.; Hayakawa, Y.			Influence of substrate temperature on ethanol sensing properties of CdO thin films prepared by facile spray pyrolysis method	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; ELECTRICAL-PROPERTIES; OPTICAL-PROPERTIES; ROUTE	Transparent conducting CdO thin films were deposited on to glass substrates by spray pyrolysis technique. The depositions were carried out at different substrate temperatures with varying film thickness. The effects of substrate temperature on structural, optical and electrical properties of CdO thin films were systematically studied. The CdO films were polycrystalline in nature with cubic crystal structure showing preferential orientation along (111) direction. Wettability results confirmed that the hydrophobic character of CdO thin film is enhanced with increase in substrate temperatures. The average transmittance is about 80 %, thus the films are transparent in the visible region. The optical band gap value of the CdO films increased from 2.24 to 2.34 eV with increase in the substrate temperature from 200 to 350 degrees C. Surface morphology studies reveal that the grain size and roughness of the films are increased with increase in the substrate temperature. The minimum value of electrical resistivity of the films is 1.40 x 10(-3) Omega cm obtained at 350 degrees C. The maximum ethanol sensitivity of 33.45 % is observed for the substrate temperature of 300 degrees C. Thus the results authenticate that the substrate temperature influences the structural, optical, electrical and sensing properties of the deposited films.	[Sankarasubramanian, K.; Sampath, M.; Sethuraman, K.] Madurai Kamaraj Univ, Sch Phys, Madurai 625021, Tamil Nadu, India; [Archana, J.; Hayakawa, Y.] Shizuoka Univ, Elect Res Inst, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan; [Ramamurthi, K.] SRM Univ, Dept Phys & Nanotechnol, Madras 603203, Tamil Nadu, India	Sethuraman, K (reprint author), Madurai Kamaraj Univ, Sch Phys, Madurai 625021, Tamil Nadu, India.	sethuraman_33@yahoo.com					Al-Quraini A., 1997, P 26 IEEE PHOT SPEC, P415; Anna Selvan J. A., 2006, SOL ENERG MAT SOL C, V90, P3371, DOI 10.1016/j.solmat.2005.09.018; Vigil O, 2001, MATER CHEM PHYS, V68, P249, DOI 10.1016/S0254-0584(00)00358-8; Shinde VR, 2006, MATER CHEM PHYS, V96, P326, DOI 10.1016/j.matchemphys.2005.07.045; Kim H, 1999, J APPL PHYS, V86, P6451, DOI 10.1063/1.371708; Mishra RL, 2009, DIG J NANOMATER BIOS, V4, P511; Bhosale CH, 2005, MAT SCI ENG B-SOLID, V122, P67, DOI 10.1016/j.mseb.2005.04.015; Mane RS, 2006, SOL ENERGY, V80, P185, DOI 10.1016/j.solener.2005.08.013; Dhawale DS, 2008, APPL SURF SCI, V254, P3269, DOI 10.1016/j.apsusc.2007.11.013; Lamb DA, 2011, J CRYST GROWTH, V332, P17, DOI 10.1016/j.jcrysgro.2011.07.020; Salunkhe RR, 2008, SENSOR ACTUAT B-CHEM, V133, P296, DOI 10.1016/j.snb.2008.02.024; Yildirim MA, 2009, SENSOR ACTUAT A-PHYS, V155, P272, DOI 10.1016/j.sna.2009.09.002; Zhao ZY, 2002, THIN SOLID FILMS, V413, P203, DOI 10.1016/S0040-6090(02)00344-9; Chang JF, 2002, SENSOR ACTUAT B-CHEM, V84, P258, DOI 10.1016/S0925-4005(02)00034-5; Patil PS, 1999, MATER CHEM PHYS, V59, P185, DOI 10.1016/S0254-0584(99)00049-8; Saha B, 2008, SOLID STATE COMMUN, V145, P33, DOI 10.1016/j.ssc.2007.10.001; Dakhel AA, 2003, CRYST RES TECHNOL, V38, P979, DOI 10.1002/crat.200310124; Yakuphanoglu F, 2010, APPL SURF SCI, V257, P1413, DOI 10.1016/j.apsusc.2010.08.045; Lewis BG, 2000, MRS BULL, V25, P22, DOI 10.1557/mrs2000.147; Seo DJ, 2004, J KOREAN PHYS SOC, V45, P1575; Lamour G, 2010, J CHEM EDUC, V87, P1403, DOI 10.1021/ed100468u; BURSTEIN E, 1954, PHYS REV, V93, P632, DOI 10.1103/PhysRev.93.632; Cullity BD., 1956, ELEMENTS XRAY DIFFRA; Feitosa AV, 2004, BRAZ J PHYS, V34, P656, DOI 10.1590/S0103-97332004000400034; Ferro R, 2000, PHYS STATUS SOLIDI A, V177, P477, DOI 10.1002/(SICI)1521-396X(200002)177:2<477::AID-PSSA477>3.0.CO;2-3; Kim CR, 2010, CURR APPL PHYS, V10, pS294, DOI 10.1016/j.cap.2009.11.071; Knigin P. I., 1991, APPL SOL ENERGY, V27, P41; Salunkhe RR, 2009, MATER RES BULL, V44, P364, DOI 10.1016/j.materresbull.2008.05.010; Sankarasubramanian K, 2014, SUPERLATTICE MICROST, V69, P29, DOI 10.1016/j.spmi.2014.01.018	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	FEB	2015	26	2					955	961		10.1007/s10854-014-2488-8		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CB2EM	WOS:000349439500046		
J	Iijima, M; Muguruma, T; Kawaguchi, M; Yasuda, Y; Mizoguchi, I				Iijima, Masahiro; Muguruma, Takeshi; Kawaguchi, Masahiro; Yasuda, Yoshitaka; Mizoguchi, Itaru			In vivo degradation of orthodontic miniscrew implants: surface analysis of as-received and retrieved specimens	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							HYDROGEN EMBRITTLEMENT; ANCHORAGE; FAILURE; TORQUE; ALLOY	This study investigated in vivo degradation of Ti-6Al-4V alloy miniscrew implants. Miniscrew implants were placed in patients, and the surfaces were studied upon retrieval by scanning electron microscopy, microscale X-ray photoelectron spectroscopy, elastic recoil detection analysis and nanoindentation testing. Bone-like structures were formed on the retrieved specimens. The hardness and elastic modulus of the surfaces of the retrieved specimens were significantly lower than the as-received specimens, although no statistically significant differences were observed for the hardness and elastic modulus in the bulk region. Thick organic over-layer containing carbon, oxygen, and nitrogen, with the thickness greater than 50 nm, covered the retrieved specimens, and higher concentrations of hydrogen were detected in the retrieved specimens compared with the as-received specimens. Minimal degradation of the bulk mechanical properties of miniscrew implants was observed after clinical use, although precipitation of bone-like structures, formation of a carbonaceous contamination layer, and hydrogen absorption were observed on the surfaces of miniscrew implants.	[Iijima, Masahiro; Muguruma, Takeshi; Mizoguchi, Itaru] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Orthodont & Dentofacial Orthoped, Ishikari, Hokkaido 06102, Japan; [Kawaguchi, Masahiro] Tokyo Metropolitan Ind Technol Res Inst, Commercializat Support Dept, Adv Anal & Dev Sect, Tokyo, Japan; [Yasuda, Yoshitaka] Yasuda Orthodont Off, Nishinomiya, Hyogo, Japan	Iijima, M (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Orthodont & Dentofacial Orthoped, Ishikari, Hokkaido 06102, Japan.	iijima@hoku-iryo-u.ac.jp			Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido	This study was partially supported by the Research Project of the Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido.	Schatzle M, 2009, CLIN ORAL IMPLAN RES, V20, P1351, DOI 10.1111/j.1600-0501.2009.01754.x; Park HS, 2006, AM J ORTHOD DENTOFAC, V130, P18, DOI 10.1016/j.ajodo.2004.11.032; HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0; Rodrigues DC, 2009, J BIOMED MATER RES B, V88B, P206, DOI 10.1002/jbm.b.31171; ROBERTS WE, 1984, AM J ORTHOD DENTOFAC, V86, P95, DOI 10.1016/0002-9416(84)90301-4; Chen YJ, 2006, INT J ORAL MAX IMPL, V21, P283; Miyawaki S, 2003, AM J ORTHOD DENTOFAC, V124, P373, DOI 10.1016/S0889-5406(03)00565-1; Yokoyama K, 2003, J BIOMED MATER RES A, V65A, P182, DOI 10.1002/.jbm.a.10457; Motoyoshi M, 2006, CLIN ORAL IMPLAN RES, V17, P109, DOI 10.1111/j.1600-0501.2005.01211.x; Buchter A, 2005, CLIN ORAL IMPLAN RES, V16, P473, DOI 10.1111/j.1600-0501.2005.01149.x; Bae Seong Min, 2006, J Clin Orthod, V40, P107; BRANEMARK PI, 1964, ANGIOLOGY, V15, P329, DOI 10.1177/000331976401500801; Deguchi T, 2009, CLIN IMPLANT DENT R, V13, P197; Eliades T, 2009, AM J ORTHOD DENTOFAC, V135, P10, DOI 10.1016/j.ajodo.2008.09.018; Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M; Iijima M, 2008, AM J ORTHOD DENTOFAC, V134, P333, DOI 10.1016/j.ajodo.2008.06.011; Ishihara Y, 2013, AM J ORTHOD DENTOFAC, V143, pS113, DOI 10.1016/j.ajodo.2012.09.001; Kanomi R, 1997, J Clin Orthod, V31, P763; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, pS68, DOI 10.1016/j.ajodo.2006.06.017; Zinelis S, 2007, AM J ORTHOD DENTOFAC, V132, P84, DOI 10.1016/j.ajodo.2005.11.039	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	FEB	2015	26	2							71	10.1007/s10856-015-5405-7		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CB1QI	WOS:000349402400011		
J	Ishikawa, K; Tram, NXT; Tsuru, K; Toita, R				Ishikawa, Kunio; Nguyen Xuan Thanh Tram; Tsuru, Kanji; Toita, Riki			Fabrication of porous calcite using chopped nylon fiber and its evaluation using rats	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							BONE-GRAFT SUBSTITUTE; HYDROXIDE COMPACT; DEFECT MODEL; CARBONATE; CORAL; HYDROXYAPATITE; BLOCK; CRANIOPLASTY; COMPOSITE; BEHAVIOR	Although porous calcite has attracted attention as bone substitutes, limited studies have been made so far. In the present study, porous calcite block was fabricated by introducing chopped nylon fiber as porogen. Ca(OH)(2) powder containing 10 wt% chopped nylon fiber was compacted at 150 MPa, and sintered to burn out the fiber and to carbonate the Ca(OH)(2) under stream of 1:2 O-2-CO2. Sintering of Ca(OH)(2) at 750 degrees C or lower temperature resulted in incomplete burning out of the fiber whereas sintering at 800 degrees C or higher temperature resulted in the formation of CaO due to the thermal decomposition of Ca(OH)(2). However, sintering at 770 degrees C resulted in complete burning out of the fiber and complete carbonation of Ca(OH)(2) to calcite without forming CaO. Macro-and micro-porosities of the porous calcite were approximately 23 and 16 %, respectively. Diameter of the macropores was approximately 100 mu m which is suitable for bone tissue penetration. Porous calcite block fabricated by this method exhibited good tissue response when implanted in the bone defect in femur of 12-weeks-old rat. Four weeks after implantation, bone bonded on the surface of calcite. Furthermore, bone tissue penetrated interior to the macropore at 8 weeks. These results demonstrated the good potential value of porous calcite as artificial bone substitutes.	[Ishikawa, Kunio; Nguyen Xuan Thanh Tram; Tsuru, Kanji; Toita, Riki] Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, Fukuoka 8128582, Japan	Ishikawa, K (reprint author), Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ishikawa@dent.kyushu-u.ac.jp	Toita, Riki/C-5710-2014	Toita, Riki/0000-0001-9700-4531	Strategic Promotion of Innovative Research and Development Program, Japan Science and Technology Agency, Japan	This study was supported, in part, by the Strategic Promotion of Innovative Research and Development Program, Japan Science and Technology Agency, Japan.	Ahmad N, 2012, DENT MATER J, V31, P593; ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0; Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029; GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503; Thalgott JS, 1999, SPINE, V24, P1295, DOI 10.1097/00007632-199907010-00005; Ishikawa K, 2010, MATERIALS, V3, P1138, DOI 10.3390/ma3021138; Ishikawa K, 2010, J CERAM SOC JPN, V118, P341, DOI 10.2109/jcersj2.118.341; Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014; Matsuya S, 2007, J MATER SCI-MATER M, V18, P1361, DOI 10.1007/s10856-007-0123-4; Maruta M, 2011, DENT MATER J, V30, P14, DOI 10.4012/dmj.2010-087; Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014; Arnaud E, 2000, CHILD NERV SYST, V16, P659, DOI 10.1007/s003810000321; ARNAUD E, 1994, CALCIFIED TISSUE INT, V54, P493, DOI 10.1007/BF00334331; Bohner M., 2013, BIOMATTER, V3; Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006; Feifel H, 2000, Mund Kiefer Gesichtschir, V4 Suppl 2, pS527, DOI 10.1007/PL00012705; FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806; Irwin R B, 2001, Am J Orthop (Belle Mead NJ), V30, P544; Kania RE, 1998, J BIOMED MATER RES, V43, P38, DOI 10.1002/(SICI)1097-4636(199821)43:1<38::AID-JBM4>3.0.CO;2-N; Lee Y, 2007, J MATER SCI, V42, P5728, DOI 10.1007/s10853-006-0747-7; Lee Y, 2007, J MATER SCI, V42, P7843, DOI 10.1007/s10853-007-1629-3; Lin Xin, 2008, J Mater Sci Mater Med, V19, P479, DOI 10.1007/s10856-006-0028-7; Matsuya S, 2004, PHOSPHOROUS RES B, V17, P159; Otsu A, 2012, DENT MATER J, V31, P593, DOI 10.4012/dmj.2011-252; OUHAYOUN JP, 1992, J MATER SCI-MATER M, V3, P222, DOI 10.1007/BF00713454; Richard M, 1998, CALCIFIED TISSUE INT, V62, P437, DOI 10.1007/s002239900456; ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510; Sunouchi K, 2012, DENT MATER J, V31, P549, DOI 10.4012/dmj.2011-253; WALKER MM, 1983, B HOSP JOINT DIS ORT, V43, P103; Walsh RW, 2004, EUR SPINE J, V13, P359; Wasielewski Ray C, 2008, Orthopedics, V31, P367; YUKNA RA, 1994, J PERIODONTOL, V65, P177; Zaman CT, 2008, DENT MATER J, V27, P710	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	FEB	2015	26	2							94	10.1007/s10856-015-5432-4		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CB1QI	WOS:000349402400033		
J	Macon, ALB; Kim, TB; Valliant, EM; Goetschius, K; Brow, RK; Day, DE; Hoppe, A; Boccaccini, AR; Kim, IY; Ohtsuki, C; Kokubo, T; Osaka, A; Vallet-Regi, M; Arcos, D; Fraile, L; Salinas, AJ; Teixeira, AV; Vueva, Y; Almeida, RM; Miola, M; Vitale-Brovarone, C; Verne, E; Holand, W; Jones, JR				Macon, Anthony L. B.; Kim, Taek B.; Valliant, Esther M.; Goetschius, Kathryn; Brow, Richard K.; Day, Delbert E.; Hoppe, Alexander; Boccaccini, Aldo R.; Kim, Ill Yong; Ohtsuki, Chikara; Kokubo, Tadashi; Osaka, Akiyoshi; Vallet-Regi, Maria; Arcos, Daniel; Fraile, Leandro; Salinas, Antonio J.; Teixeira, Alexandra V.; Vueva, Yuliya; Almeida, Rui M.; Miola, Marta; Vitale-Brovarone, Chiara; Verne, Enrica; Hoeland, Wolfram; Jones, Julian R.			A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							SCAFFOLDS; SYSTEM; GROWTH; HYDROXYAPATITE; DISSOLUTION; IMPLANTS; BEHAVIOR; POWDERS; 45S5; FTIR	The aim of this study was to propose and validate a new unified method for testing dissolution rates of bioactive glasses and their variants, and the formation of calcium phosphate layer formation on their surface, which is an indicator of bioactivity. At present, comparison in the literature is difficult as many groups use different testing protocols. An ISO standard covers the use of simulated body fluid on standard shape materials but it does not take into account that bioactive glasses can have very different specific surface areas, as for glass powders. Validation of the proposed modified test was through round robin testing and comparison to the ISO standard where appropriate. The proposed test uses fixed mass per solution volume ratio and agitated solution. The round robin study showed differences in hydroxyapatite nucleation on glasses of different composition and between glasses of the same composition but different particle size. The results were reproducible between research facilities. Researchers should use this method when testing new glasses, or their variants, to enable comparison between the literature in the future.	[Macon, Anthony L. B.; Kim, Taek B.; Valliant, Esther M.; Jones, Julian R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England; [Goetschius, Kathryn; Brow, Richard K.; Day, Delbert E.] Missouri Univ Sci & Technol, Mat Res Ctr, Rolla, MO 65409 USA; [Hoppe, Alexander; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, D-91058 Erlangen, Germany; [Kim, Ill Yong; Ohtsuki, Chikara] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kokubo, Tadashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Osaka, Akiyoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Vallet-Regi, Maria; Arcos, Daniel; Fraile, Leandro; Salinas, Antonio J.] Univ Complutense Madrid, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain; [Vallet-Regi, Maria; Arcos, Daniel; Fraile, Leandro; Salinas, Antonio J.] CIBER BBN, Madrid, Spain; [Teixeira, Alexandra V.; Vueva, Yuliya; Almeida, Rui M.] Univ Nova Lisboa, Inst Super Tcn, Dept Engn Qum ICEMS, P-1200 Lisbon, Portugal; [Miola, Marta; Vitale-Brovarone, Chiara; Verne, Enrica] Politecn Torino, Inst Mat Phys, Dept Appl Sci & Technol, Turin, Italy; [Miola, Marta; Vitale-Brovarone, Chiara; Verne, Enrica] Politecn Torino, Engn Biomat Lab, Turin, Italy; [Hoeland, Wolfram] Tech Fundamentals, R&D, Dept Inorgan Chem, FL-9494 Liechtenstein, Liechtenstein	Jones, JR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.	julian.r.jones@imperial.ac.uk	Boccaccini, Aldo/C-7905-2013; Salinas, Antonio /M-3316-2014; Vallet-Regi, Maria/M-3378-2014; Macon, Anthony/B-5799-2015; Ohtsuki, Chikara/E-4973-2010; Arcos, Daniel/L-6167-2014; Vitale-Brovarone, Chiara/G-9630-2012	Salinas, Antonio /0000-0002-8408-3389; Vallet-Regi, Maria/0000-0002-6104-4889; Macon, Anthony/0000-0002-9977-4238; Arcos, Daniel/0000-0002-5367-7272; Vitale-Brovarone, Chiara/0000-0003-2413-5594	International Commission on Glass; European Forum of New Glass Application	The International Commission on Glass is thanked for its support of TC04 and its members. The European Forum of New Glass Application is also thanked for its support. The authors would like to thank Vivoxid (Turku, Finland), Mo-Sci (Rolla, MO), RepRegen Ltd (London, UK) and Novabone LLC (Alachua, FL) for generously providing samples.	Allen T., 1997, PARTICLE SIZE MEASUR, V2; Brown RF, 2008, ACTA BIOMATER, V4, P387, DOI 10.1016/j.actbio.2007.07.006; LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103; Jones JR, 2001, J BIOMED MATER RES, V58, P720, DOI 10.1002/jbm.10053; Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T; Stoch A, 2000, J MOL STRUCT, V555, P375, DOI 10.1016/S0022-2860(00)00623-2; Quintero F, 2009, ADV FUNCT MATER, V19, P3084, DOI 10.1002/adfm.200801922; Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001; Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207; Watts SJ, 2010, J NON-CRYST SOLIDS, V356, P517, DOI 10.1016/j.jnoncrysol.2009.04.074; Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008; Fu Q, 2008, ACTA BIOMATER, V4, P1854, DOI 10.1016/j.actbio.2008.04.019; Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023; Oliveira JM, 2002, BIOMATERIALS, V23, P371, DOI 10.1016/S0142-9612(01)00115-6; Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009; Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017; Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G; Jalota S, 2006, J MATER SCI-MATER M, V17, P697, DOI 10.1007/s10856-006-9680-1; O'Donnell MD, 2010, J MATER CHEM, V20, P8934, DOI 10.1039/c0jm01139h; Slosarczyk A, 2005, J MOL STRUCT, V744, P657, DOI 10.1016/j.molstruc.2004.11.078; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6; Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Arcos D, 2010, ACTA BIOMATER, V6, P2876; Du MQ, 2008, AM J DENT, V21, P210; Elliot J. C., 1994, STRUCTURE CHEM APATI; Gisbon IR, 2000, J MATER SCI, V12, P799; Hench L.L., 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Lin S, 2009, J MATER CHEM, V19, P1276, DOI 10.1039/b814292k; Lowell S., 2004, CHARACTERIZATION POR; Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o; Mizuno M, 2014, 23317 ISODIS; O'Donnell MD, 2011, ACTA BIOMATER, V7, P2264, DOI 10.1016/j.actbio.2011.01.021; Ramila A, 2001, BIOMATERIALS, V22, P2301, DOI 10.1016/S0142-9612(00)00419-1; Rohanova D, 2014, J MATER CHEM B, V2, P5068, DOI 10.1039/c4tb00187g	37	5	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	FEB	2015	26	2							115	10.1007/s10856-015-5403-9		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CB1QI	WOS:000349402400054		
J	Nagai, H; Kobayashi-Fujioka, M; Fujisawa, K; Ohe, G; Takamaru, N; Hara, K; Uchida, D; Tamatani, T; Ishikawa, K; Miyamoto, Y				Nagai, Hirokazu; Kobayashi-Fujioka, Masako; Fujisawa, Kenji; Ohe, Go; Takamaru, Natsumi; Hara, Kanae; Uchida, Daisuke; Tamatani, Tetsuya; Ishikawa, Kunio; Miyamoto, Youji			Effects of low crystalline carbonate apatite on proliferation and osteoblastic differentiation of human bone marrow cells	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							IN-VITRO; CHEMICAL-COMPOSITION; GLASS-CERAMICS; PHOSPHATE; OSTEOCALCIN; HYDROXYAPATITE; FABRICATION; EXPRESSION; INVITRO; MATRIX	Carbonated apatite (CO(3)Ap) is the inorganic component of bone. We have proposed a new method for the fabrication of CO(3)Ap blocks based on a dissolution-precipitation method using a synthetic precursor. The aim of this study is to examine the effects of low crystalline CO(3)Ap on initial cell attachment, proliferation and osteoblastic differentiation of human bone marrow cells (hBMCs) using sintered hydroxyapatite and tissue culture plates as controls. Initial cell attachment and proliferation were assessed with a MTT assay. Expression of osteoblastic markers was examined by reverse transcription-polymerase chain reaction. XRD and FT-IR results showed formation of B-type carbonate apatite with lower crystallinity. No difference was observed for initial cell attachment between HAp and CO(3)Ap discs. hBMSC attached more significantly on tissue culture plate than on HAp and CO(3)Ap discs. The number of cells on HAp was higher than that on CO(3)Ap until day 7, after which the number of cells was similar. hBMSC proliferated more significantly on tissue culture plate than on HAp and CO(3)Ap discs. In contrast, hBMCs incubated on CO(3)Ap demonstrated much higher expression of osteoblastic markers of differentiation, such as type I collagen, alkaline phosphatase, osteopontin and osteocalcin, than hBMCs on HAp. On the tissue culture plate, they were not any change throughout the culture period. These results demonstrated that low crystalline CO(3)Ap exhibit higher osteoinductivity than HAp.	[Nagai, Hirokazu; Kobayashi-Fujioka, Masako; Fujisawa, Kenji; Ohe, Go; Takamaru, Natsumi; Hara, Kanae; Uchida, Daisuke; Tamatani, Tetsuya; Miyamoto, Youji] Univ Tokushima, Inst Hlth Biosci, Dept Oral Surg,Grad Sch, Subdiv Mol Oral Med,Div Integrated Sci Translat R, Tokushima 7708504, Japan; [Ishikawa, Kunio] Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, Fukuoka 8128582, Japan	Nagai, H (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Oral Surg,Grad Sch, Subdiv Mol Oral Med,Div Integrated Sci Translat R, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	hnagai@tokushima-u.ac.jp			 [24592989]	This research was supported in part by a Grant-in-Aid for Scientific Research (C) (24592989).	ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6; Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3; Miyamoto Y, 1998, BIOMATERIALS, V19, P707, DOI 10.1016/S0142-9612(97)00186-5; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; STEIN GS, 1990, FASEB J, V4, P3111; [Anonymous], 2000, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-200002000-00003; Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4; Dias AG, 2005, J BIOMED MATER RES A, V74A, P347, DOI 10.1002/jbm.a.30357; Lian JB, 1999, VITAM HORM, V55, P443; Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003; Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2; CHENU C, 1994, J CELL BIOL, V127, P1149, DOI 10.1083/jcb.127.4.1149; Hasegawa M, 2003, J BONE JOINT SURG BR, V85B, P142, DOI 10.1302/0301-620X.85B1.13414; Wakae H, 2008, J BIOMED MATER RES A, V87A, P957, DOI 10.1002/jbm.a.31620; Ishikawa K, 2010, MATERIALS, V3, P1138, DOI 10.3390/ma3021138; Ishikawa K, 2010, J CERAM SOC JPN, V118, P341, DOI 10.2109/jcersj2.118.341; Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Yuasa T, 2001, J BIOMED MATER RES, V54, P344; Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53; FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Beloti MM, 2003, J BIOMED MATER RES A, V64A, P171, DOI 10.1002/jbm.a.10435; DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309; DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9; De Groot K, 1988, Ann N Y Acad Sci, V523, P227; Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.0.CO;2-7; DONATH K, 1987, ORAL SURG ORAL MED O, V63, P651, DOI 10.1016/0030-4220(87)90362-8; FRIEDLAENDER G E, 1987, Journal of Bone and Joint Surgery American Volume, V69, P786; Ganoids PV, 2005, INJURY S3, V36, pS20; Landi E, 2004, BIOMATERIALS, V25, P1763, DOI 10.1016/j.biomaterials.2003.08.026; LIGGETT WH, 1994, J CELL BIOCHEM, V55, P190, DOI 10.1002/jcb.240550206; Lin Xin, 2008, J Mater Sci Mater Med, V19, P479, DOI 10.1007/s10856-006-0028-7; Lin X, 2003, ARCH BIOCERAM RES, V3, P83; OWEN ME, 1987, J CELL SCI, V87, P731; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Rau JV, 2004, J BIOMED MATER RES B, V71B, P441, DOI 10.1002/jbm.b.30111	38	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	FEB	2015	26	2							99	10.1007/s10856-015-5431-5		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CB1QI	WOS:000349402400038		
J	Paldus, J; Sako, T; Diercksen, GHF				Paldus, Josef; Sako, Tokuei; Diercksen, Geerd H. F.			On the cluster structure of linear-chain fermionic wave functions	JOURNAL OF MATHEMATICAL CHEMISTRY			English	Article						Linear chain models; Cyclic polyenes; Coupled cluster approach (CCA); Cluster analysis; Decomposable and indecomposable connected quadruples; CCA to extended linear fermionic chains	FULL CONFIGURATION-INTERACTION; QUADRUPLY EXCITED CLUSTERS; MOLECULAR ORBITAL METHOD; CYCLIC POLYENE MODEL; MANY-ELECTRON THEORY; APPROXIMATE ACCOUNT; GROUND-STATE; PPP APPROXIMATION; QUANTUM-CHEMISTRY; HUBBARD-MODEL	Using the model of cyclic polyenes with a nondegenerate ground state, , as a prototype of extended linear metallic-like systems we explore the cluster structure of the relevant wave functions. Based on the existing configuration interaction and coupled cluster (CC) results, as obtained with the Hubbard and Pariser-Parr-Pople Hamiltonians in the entire range of the coupling constant extending from the uncorrelated Huckel limit to the fully correlated limit, we recall the breakdown of the CCD or CCSD methods as the size of the system increases and the strongly correlated regime is approached. We introduce the concept of the indecomposable quadruply-excited clusters which arise for and represent those connected quadruples that do not possess any corresponding disconnected cluster component. It is shown via explicit enumeration that the ratio of the number of these indecomposables relative to that of the decomposables depends linearly on the size of the polyene , so that the limit of the ratio of the number of indecomposables relative to the total number of quadruples approaches unity as . We then briefly outline the implications of these results for the applicability of CC approaches to extended systems and provide a qualitative argument for an even more extreme behavior of hexa-excited, octa-excited, etc., clusters as N -> infinity	[Paldus, Josef] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Paldus, Josef] Univ Waterloo, Dept Chem, Guelph Waterloo Ctr Grad Work Chem GWC2, Waterloo, ON N2L 3G1, Canada; [Sako, Tokuei] Nihon Univ, Coll Sci & Technol, Phys Lab, Funabashi, Chiba 2748501, Japan; [Diercksen, Geerd H. F.] Max Planck Inst Astrophys, D-85741 Garching, Germany	Paldus, J (reprint author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.	paldus@uwaterloo.ca; sako@phys.ge.cst.nihon-u.ac.jp; ghd@mpa-garching.mpg.de					Lieb EH, 2003, PHYSICA A, V321, P1, DOI 10.1016/S0378-4371(02)01785-5; YANG CN, 1967, PHYS REV LETT, V19, P1312, DOI 10.1103/PhysRevLett.19.1312; Bartlett RJ, 2007, REV MOD PHYS, V79, P291, DOI 10.1103/RevModPhys.79.291; Paldus J, 1999, ADV CHEM PHYS, V110, P1, DOI 10.1002/9780470141694.ch1; Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; LIEB EH, 1968, PHYS REV LETT, V20, P1445, DOI 10.1103/PhysRevLett.20.1445; CIZEK J, 1966, J CHEM PHYS, V45, P4256; RAGHAVACHARI K, 1989, CHEM PHYS LETT, V157, P479, DOI 10.1016/S0009-2614(89)87395-6; OOSHIKA Y, 1957, J PHYS SOC JPN, V12, P1246, DOI 10.1143/JPSJ.12.1246; PALDUS J, 1972, PHYS REV A, V5, P50, DOI 10.1103/PhysRevA.5.50; Crawford TD, 2000, REV COMPUT CHEM, V14, P33, DOI 10.1002/9780470125915.ch2; URBAN M, 1985, J CHEM PHYS, V83, P4041, DOI 10.1063/1.449067; Heisenberg W, 1928, Z PHYS, V49, P619, DOI 10.1007/BF01328601; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Baeriswyl D., 1995, HUBBARD MODEL ITS PH; Bajnok Z, 2011, ACTA PHYS SLOVACA, V61, P129, DOI 10.2478/v10155-011-0002-x; Bartlett RJ, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1191, DOI 10.1016/B978-044451719-7/50085-8; Bartlett R.J., 1995, MODERN ELECT STRUCTU, V1, P1047; Batchelor MT, 2007, PHYS TODAY, V60, P36, DOI 10.1063/1.2709557; Baxter R. J., 1982, EXACTLY SOLVED MODEL; BAXTER RJ, 1972, ANN PHYS-NEW YORK, V70, P193, DOI 10.1016/0003-4916(72)90335-1; BENDAZZOLI GL, 1994, INT J QUANTUM CHEM, V51, P13, DOI 10.1002/qua.560510104; Bendazzoli G. L., 1998, International Journal of Quantum Chemistry, V66; BENDAZZOLI GL, 1991, CHEM PHYS LETT, V185, P125, DOI 10.1016/0009-2614(91)80152-N; Carsky P., 2010, RECENT PROGR COUPLED; CAZES D, 1970, J POLYM SCI POL SYM, P109; Cizek J., 1974, INT J QUANTUM CHEM, V8, P293; Cizek J., 1969, ADV CHEM PHYS, V14, P35, DOI DOI 10.1002/9780470143599.CH2; Cizek J., 1971, International Journal of Quantum Chemistry, V5, DOI 10.1002/qua.560050402; DEHEER J, 1960, J MOL SPECTROSC, V5, P326; Essler F.H.L., 2005, ONE DIMENSIONSL HUBB; EVANGELISTI S, 1992, CHEM PHYS LETT, V196, P511, DOI 10.1016/0009-2614(92)85729-T; Gaudin M, 2014, BETHE WAVEFUNCTION; Ha Z.N.C., 1996, QUANTUM MANY BODY SY; HASHIMOTO K, 1985, INT J QUANTUM CHEM, V28, P581, DOI 10.1002/qua.560280505; HASHIMOTO K, 1988, INT J QUANTUM CHEM, V34, P407, DOI 10.1002/qua.560340502; HUBBARD J, 1958, PROC R SOC LON SER-A, V244, P199, DOI 10.1098/rspa.1958.0036; Hulthen L, 1938, ARK FYS            A, V26A, P1; JEZIORSKI B, 1995, INT J QUANTUM CHEM, V56, P129, DOI 10.1002/qua.560560302; Kondo AE, 1996, J CHEM PHYS, V104, P8566, DOI 10.1063/1.471546; Korepin V. E., 1993, QUANTUM INVERSE SCAT; LI XZ, 1994, J CHEM PHYS, V101, P8812, DOI 10.1063/1.468074; LIEB E, 1966, MATH PHYS ONE DIMENS; Maillet JM, 2007, PROG MATH, V53, P161; Mataga N., 1957, Z PHYS CHEM, V13, P140; Montorsi A., 1992, HUBBARD MODEL REPRIN; MURAI T, 1962, PROG THEOR PHYS, V27, P899, DOI 10.1143/PTP.27.899; Paldus J., 1976, THEORETICAL CHEMISTR, V2, P131; Paldus J., 1988, IMA SERIES, V15, P262; Paldus J., 2003, HDB MOL PHYSICS QU 3, V2, P272; Paldus J, 1975, ADV QUANTUM CHEM, V9, P105, DOI 10.1016/S0065-3276(08)60040-4; PALDUS J, 1984, PHYS REV B, V30, P4267, DOI 10.1103/PhysRevB.30.4267; PALDUS J, 1982, INT J QUANTUM CHEM, V22, P1281, DOI 10.1002/qua.560220611; Paldus J, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P115, DOI 10.1016/B978-044451719-7/50050-0; Paldus J, 2010, CHALL ADV COMPUT CHE, V11, P455, DOI 10.1007/978-90-481-2885-3_17; PALDUS J, 1977, J CHEM PHYS, V67, P303, DOI 10.1063/1.434526; PIECUCH P, 1990, THEOR CHIM ACTA, V78, P65, DOI 10.1007/BF01119191; Parr R.G., 1963, QUANTUM THEORY MOL E; PAUNCZ R, 1962, J CHEM PHYS, V36, P2257, DOI 10.1063/1.1732873; Pauncz R., 1967, ALTERNANT MOL ORBITA; PAUNCZ R, 1962, J CHEM PHYS, V36, P2247, DOI 10.1063/1.1732872; PIECUCH P, 1992, THEOR CHIM ACTA, V83, P69, DOI 10.1007/BF01113244; PIECUCH P, 1995, INT J QUANTUM CHEM, V55, P133, DOI 10.1002/qua.560550208; PIECUCH P, 1992, INT J QUANTUM CHEM, V42, P165, DOI 10.1002/qua.560420111; Piecuch P, 1996, PHYS REV A, V54, P1210, DOI 10.1103/PhysRevA.54.1210; Podeszwa R, 2002, J CHEM PHYS, V116, P480, DOI 10.1063/1.1425408; Shavitt I., 2009, MANY BODY METHODS CH; Sutherland B., 2004, BEAUTIFUL MODELS 70; Thouless D.J., 1972, QUANTUM MECH MANY BO, p[57, 35]; Wormer PES, 2006, ADV QUANTUM CHEM, V51, P59, DOI 10.1016/S0065-3276(06)51002-0	71	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0259-9791	1572-8897		J MATH CHEM	J. Math. Chem.	FEB	2015	53	2					629	650		10.1007/s10910-014-0445-7		22	Chemistry, Multidisciplinary; Mathematics, Interdisciplinary Applications	Chemistry; Mathematics	CA5WW	WOS:000348979800013		
J	Sato, M; Konishi, Y; Park, SJ				Sato, M.; Konishi, Y.; Park, S. -J.			INTERLAYER COUPLING EFFECT ON BUCKLING MODES OF SPHERICAL BILAYERS	JOURNAL OF MECHANICS			English	Article						Complete spherical shell; Buckling; Double-walled structure	EXTERNAL-PRESSURE; PATTERNS; SHELLS	This study examined the critical buckling characteristics of hydrostatically pressurized double-walled complete spherical shells. An analytical model based on small deflection thin shell theory is presented; the equations are solved in conjunction with variational principles. Axisymmetric and inextensional assumptions are not initially used in the exact formulation. This approach therefore avoids any discussion about the validity of the solution and allows the model to be extended to cover more generic nonaxisymmetric cases with relative ease. The analytical results are presented using illustrative buckling modes. Based on the developed formulation, only axisymmetric eigenmodes were found to occur despite the inclusion of the effect of interactions between outer and inner shells. Critical modes that are symmetric or antisymmetric about the equator may be determined depending on the combination of the stiffness connecting the outer and inner shells and the radius-to-wall thickness ratios.	[Sato, M.] Hokkaido Univ, Fac Engn, Div Engn & Policy Sustainable Environm, Sapporo, Hokkaido 060, Japan; Hokkaido Univ, Grad Sch Engn, Div Engn & Policy Sustainable Environm, Sapporo, Hokkaido, Japan; [Park, S. -J.] Incheon Natl Univ, Dept Urban & Environm Engn, Inchon, South Korea	Park, SJ (reprint author), Incheon Natl Univ, Dept Urban & Environm Engn, Inchon, South Korea.	sjpark8775@yahoo.co.jp	Sato, Motohiro/D-6788-2012		University of Incheon, International Cooperative Research Grant	This work was supported by the University of Incheon, International Cooperative Research Grant in 2012.	Trallero-Giner C, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205426; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Baowan D, 2007, EUR PHYS J D, V44, P117, DOI 10.1140/epjd/e2007-00159-8; Yin J, 2008, P NATL ACAD SCI USA, V105, P19132, DOI 10.1073/pnas.0810443105; Brush D. O., 1975, BUCKLING BARS PLATES; Hutchinson J. W., 1960, J APPL MECH T, V34, P49; KOITER WT, 1969, PROC K NED AKAD B-PH, V72, P40; Los JH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155420; Pudlak M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.033202; Ru CQ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3141753; Sato M, 2012, INT J MECH SCI, V59, P22, DOI 10.1016/j.ijmecsci.2012.02.001; TARNAI T, 1989, COMPUT MATH APPL, V17, P639, DOI 10.1016/0898-1221(89)90253-8; THOMPSON JMT, 1962, AERONAUT QUART, V13, P189	13	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1727-7191	1811-8216		J MECH	J. Mech.	FEB	2015	31	1					29	36		10.1017/jmech.2014.64		8	Mechanics	Mechanics	CA6VN	WOS:000349054000004		
J	van der Weiden, RMF; Uhlenbeck, GC; Mori, N				van der Weiden, R. M. F.; Uhlenbeck, G. C.; Mori, N.			European 18th century obstetrical pioneers in Japan - Corrected concordance between European and Japanese figures	JOURNAL OF MEDICAL BIOGRAPHY			English	Letter									[van der Weiden, R. M. F.] St Franciscus Gasthuis, Dept Obstet & Gynecol, NL-3045 PM Rotterdam, Netherlands; [Uhlenbeck, G. C.] Hotei Japanese Prints, Leiden, Netherlands; [Mori, N.] Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan; [Mori, N.] Nagasaki Univ Lib, Nagasaki, Japan	van der Weiden, RMF (reprint author), St Franciscus Gasthuis, Dept Obstet & Gynecol, NL-3045 PM Rotterdam, Netherlands.	rmfvdwei@knmg.nl					van der Weiden RMF, 2010, J MED BIOGR, V18, P99, DOI 10.1258/jmb.2010.010006	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0967-7720	1758-1087		J MED BIOGR	J. Med. Biogr.	FEB	2015	23	1					60	61		10.1177/0967772014549734		2	History & Philosophy Of Science	History & Philosophy of Science	CA9ZH	WOS:000349283800011		
J	Teramura, H; Ushiyama, M; Ogihara, H				Teramura, Hajime; Ushiyama, Masashi; Ogihara, Hirokazu			Evaluation of a novel dry sheet culture method (Sanita-kun(R)) for rapid enumeration of yeasts and molds in foods	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Dry culture media; Rapid detection; Yeasts and molds; Tetrazolium salts		Sanita-kun(R) Yeasts and Molds (SkYM), a novel dry sheet culture method for rapid enumeration of fungi, has been developed. This re-hydrated plate consists of a unique adhesive sheet, non-woven fabric coated with nutrients, antibiotic, water absorption polymer and uniquely synthesized 2-(2-methoxyphenyl)-3-(4-nitrophenyl)-5-phenyl-tetrazolium chloride for rapid enumeration of yeasts and molds. When SkYM was assessed using 37 microbes including 33 fungal strains, 29 fungal strains (87.9%) were formed red colored colonies within 48 h whereas all yeasts and molds tested formed colonies within 72 h. All tested bacteria failed to grow. The SkYM method, with both 48 and 72 h of incubation, was compared with Dichloran Rose-Bengal Chloramphenicol Agar (DRBC; 5 days) according to ISO 21527-1, and with 3 M Petrifilm YM (PYM; 5 days) and Nissui Compact Dry YM (CDYM; 5 days) commercially available dry culture methods using 100 naturally contaminated foods. The linear correlation coefficients of SkYM (48 h) with DRBC, PYM and CDYM were 0.921, 0.929 and 0.947, respectively, whereas the linear correlation coefficients between SkYM (72 h) and DRBC, SkYM (72 h) and PYM, SkYM (72 h) and CDYM were 0.948, 0.877 and 0.911, respectively. These results demonstrated that SkYM was a useful alternative for rapid enumeration of yeasts and molds in foods. (C) 2014 Elsevier B.V. All rights reserved.	[Teramura, Hajime; Ushiyama, Masashi] JNC Corp, Yokohama Res Ctr, Kanazawa Univ, Yokohama, Kanagawa 2368605, Japan; [Teramura, Hajime; Ogihara, Hirokazu] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa 2520880, Japan	Teramura, H (reprint author), JNC Corp, Yokohama Res Ctr, Kanazawa Univ, 5-1 Ookawa, Yokohama, Kanagawa 2368605, Japan.	h.teramura@jnc-corp.co.jp; mushiyama@jnc-corp.co.jp; ogihara.hirokazu@nihon-u.ac.jp		Teramura, Hajime/0000-0001-5801-2678			Morita H, 2003, J AOAC INT, V86, P355; BEUCHAT LR, 1991, J FOOD PROTECT, V54, P443; Beuchat LR, 2007, J FOOD PROTECT, V70, P2661; Beuchat L.R., 2001, COMPENDIUM METHODS M, P209; International Organization for Standardization, 2008, 215271 ISO; International Organization for Standardization, 2003, 16140 ISO; Kodaka H, 2006, J AOAC INT, V89, P127; U. S. Food and Drug Administration, 2014, BACT AN MAN ONL	8	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	FEB	2015	109						16	19		10.1016/j.mimet.2014.11.017		4	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CB4GJ	WOS:000349585900003		
J	Arai, T; Ochiai, K; Senpuku, H				Arai, Toshiaki; Ochiai, Kuniyasu; Senpuku, Hidenobu			Actinomyces naeslundii GroEL-dependent initial attachment and biofilm formation in a flow cell system	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Actinomyces naeslundii; GroEL; Flowcell system; Biofilm; Butyric acid; Initial attachment	HUMAN ORAL BACTERIA; LEGIONELLA-PNEUMOPHILA; DENTAL PLAQUE; SURFACE; COAGGREGATION; STRAINS; HSP60; COLONIZATION; STREPTOCOCCI; ADHERENCE	Actinomyces naeslundii is an early colonizer with important roles in the development of the oral biofilm. The effects of butyric acid, one of short chain fatty acids in A. naeslundii biofilm formation was observed using a flow cell system with Tryptic soy broth without dextrose and with 025% sucrose (TSB sucrose). Significant biofilms were established involving live and dead cells in TSB sucrose with 60 mM butyric acid but not in concentrations of 6, 30, 40, and 50 mM. Biofilm formation failed in 60 mM sodium butyrate but biofilm level in 60 mM sodium butyrate (pH 4.7) adjusted with hydrochloric acid as 60 mM butyric media (pH4.7) was similar to biofilm levels in 60 mM butyric acid. Therefore, butyric acid and low pH are required for significant biofilm formation in the flow cell. To determine the mechanism of biofilm formation, we investigated initial A. naeslundii colonization in various conditions and effects of anti-GroEL antibody. The initial colonization was observed in the 60 mM butyric acid condition and anti-GroEL antibody inhibited the initial colonization. In conclusion, we established a new biofilm formation model in which butyric acid induces GroEL-dependent initial colonization of A. naeslundii resulting in significant biofilm formation in a flow system. (C) 2014 Elsevier B.V. All rights reserved.	[Arai, Toshiaki; Senpuku, Hidenobu] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo 1628640, Japan; [Arai, Toshiaki] Nihon Univ, Grad Sch Dent Matsudo, Dept Maxillofacial Surg, Chiba, Japan; [Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 101, Japan	Senpuku, H (reprint author), Natl Inst Infect Dis, Dept Bacteriol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	hsenpuku@nih.go.jp			Ministry of Education, Science and Culture of Japan [21390506, 24659821]; Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S1001024]	We thank Dr. Ryoma Nakao and Dr. Makoto Ohnishi for their advice and valuable discussions, and Dr. Marnii E. Cueno for English correction. This study was supported in-part by Grants-in-Aid for the Development of Scientific Research (Nos. 21390506 and 24659821) from the Ministry of Education, Science and Culture of Japan. This study was also supported in-part by the "Strategic Research Base Development" Program for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2010-2014 (S1001024).	Ahmed NAAM, 2008, ORAL MICROBIOL IMMUN, V23, P492, DOI 10.1111/j.1399-302X.2008.00460.x; KOLENBRANDER PE, 1990, APPL ENVIRON MICROB, V56, P3890; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400.3409.2003; Bergeron LJ, 2000, J BACTERIOL, V182, P3649, DOI 10.1128/JB.182.13.3649-3654.2000; Hennequin C, 2001, MICROBIOL-UK, V147, P87; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; SYED SA, 1978, INFECT IMMUN, V21, P821; Niederman R, 1997, J DENT RES, V76, P575; Heydorn A, 2000, MICROBIOL-UK, V146, P2395; Yeung MK, 1999, CRIT REV ORAL BIOL M, V10, P120; D'Urzo N, 2014, APPL ENVIRON MICROB, V80, P2176, DOI 10.1128/AEM.03627-13; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Xu P, 2014, VIRULENCE, V5, P424, DOI 10.4161/viru.28532; Motegi M, 2006, APPL ENVIRON MICROB, V72, P6277, DOI 10.1128/AEM.00614-06; Yoneda S, 2013, MOL ORAL MICROBIOL, V28, P354, DOI 10.1111/omi.12029; Garduno RA, 1998, INFECT IMMUN, V66, P4602; Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004; KOLENBRANDER PE, 1988, ANNU REV MICROBIOL, V42, P627; ALLEN PZ, 1990, ARCH ORAL BIOL, V35, P55, DOI 10.1016/0003-9969(90)90115-Q; Bowden G.H.W., 1975, ADV MICROB ECOL, P135; Cisar J.O., 1997, ADV DENT RES, V11, P1168; DACOSTA T, 1968, ARCH ORAL BIOL, V13, P609, DOI 10.1016/0003-9969(68)90139-8; Garduno RA, 1998, J BACTERIOL, V180, P505; Heydorn A, 2000, MICROBIOL-UK, V146, P2409; Ho YR, 2013, MED MICROBIOL IMMUN, V202, P105, DOI 10.1007/s00430-012-0255-0; JORDAN HV, 1972, ARCH ORAL BIOL, V17, P1333, DOI 10.1016/0003-9969(72)90166-5; KILIAN M, 1979, CARIES RES, V13, P319; Kolenbrander P.E., 2000, PERIODONTOL, V42, P47; Lewthwaite J, 1998, TRENDS MICROBIOL, V6, P426, DOI 10.1016/S0966-842X(98)01362-6; Manetti AGO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013864; MOORE WEC, 1987, J PERIODONTAL RES, V22, P335, DOI 10.1111/j.1600-0765.1987.tb01595.x; NEWMAN MG, 1977, J PERIODONTAL RES, V12, P120, DOI 10.1111/j.1600-0765.1977.tb00114.x; Nybad B., 1987, SCAND J DENT RES, V95, P369; Ogawa A, 2011, APPL ENVIRON MICROB, V77, P1572, DOI 10.1128/AEM.02066-10; Paddick JS, 2006, APPL ENVIRON MICROB, V72, P3774, DOI 10.1128/AEM.72.5.3774-3779.2006; Pantzar M, 2006, MICROBES INFECT, V8, P2452, DOI 10.1016/j.micinf.2006.05.009; Park SE, 2012, INFECT IMMUN, V80, P3975, DOI 10.1128/IAI.00699-12; Periasamy S, 2009, APPL ENVIRON MICROB, V75, P3250, DOI 10.1128/AEM.02901-08; Rieu A, 2014, CELL MICROBIOL, V16, P1836, DOI 10.1111/cmi.12331; VANDERHOEVEN JS, 1976, CARIES RES, V10, P33; Wu C, 2011, J BACTERIOL, V193, P3197, DOI 10.1128/JB.00173-11; Yang Q, 2012, ANTON LEEUW INT J G, V102, P277, DOI 10.1007/s10482-012-9736-9	43	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	FEB	2015	109						160	166		10.1016/j.mimet.2014.12.021		7	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CB4GJ	WOS:000349585900025		
J	Cueno, ME; Nagano, K; Imai, K; Tamura, M; Yoshimura, F; Ochiai, K				Cueno, Marni E.; Nagano, Keiji; Imai, Kenichi; Tamura, Muneaki; Yoshimura, Fuminobu; Ochiai, Kuniyasu			Ab initio modeling approach towards establishing the structure and docking orientation of the Porphyromonas gingivalis FimA	JOURNAL OF MOLECULAR GRAPHICS & MODELLING			English	Article						Beta-sheet-rich; Epithelial cell-binding domain; FimA; Ab initio modeling; Poiphyromonas gingivalis	ORAL EPITHELIAL-CELLS; AMYLOID FIBRILS; ARG-GINGIPAIN; FIMBRIAE; GENOTYPES; INVASION; PERIODONTITIS; ADHESION; INVOLVEMENT; PREVALENCE	Porphyromonas gingivalis FimA is a major aetiological agent in periodontal disease development, however, its structure has never been determined. Here, we established the mature P. gingivalis FimA oh initio model of all six FimA variants. We determined the conserved amino acid sequences of each FimA variant and generated mature FimA models. Subsequently, we validated their quality, protein empirical distribution, and radius of gyration. Similarly, structural comparison and topological orientation were elucidated, and the probable protein-protein docking was investigated. We found that the putative mature FimA model is beta-sheet-rich and, likewise, we observed that each mature FimA model has varying levels of structural differences which can be topologically subdivided into the upper, middle, and lower FimA sections. Moreover, we found that the FimA epithelial cell-binding domain (EBD) is structurally conserved within the middle FimA section of all variants and FimA-FimA docking suggests that the FimA EBDs are oriented in opposite and alternating directions of each other. (C) 2014 Elsevier Inc. All rights reserved.	[Cueno, Marni E.; Imai, Kenichi; Tamura, Muneaki; Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 1018310, Japan; [Nagano, Keiji; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi 4648650, Japan	Cueno, ME (reprint author), Nihon Univ, Sch Dent, Dept Microbiol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	marni.cueno@nihon-u.ac.jp; ochiai.kuniyasu@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2010 (S1001024)]	This work was supported by the following grants: Grants-in-Aid for Scientific Research, Nihon University President's Grant for Multidisciplinary Research, Satoh Fund and Dental Research Center-Nihon University School of Dentistry (Tokyo), "Strategic Research Base Development" Program for Private Universities subsidized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) 2010 (S1001024).	Amano A, 1999, INFECT IMMUN, V67, P2399; Amano A, 1996, INFECT IMMUN, V64, P4249; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Kato T, 2007, CELL MICROBIOL, V9, P753, DOI 10.1111/j.1462-5822.2006.00825.x; Hamada S, 1998, ORAL MICROBIOL IMMUN, V13, P129, DOI 10.1111/j.1399-302X.1998.tb00724.x; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Weinberg A, 1997, INFECT IMMUN, V65, P313; Nakayama K, 1996, J BACTERIOL, V178, P2818; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Hospital A, 2012, BIOINFORMATICS, V28, P1278, DOI 10.1093/bioinformatics/bts139; Andrian E, 2006, J DENT RES, V85, P392; Makabe K, 2006, P NATL ACAD SCI USA, V103, P17753, DOI 10.1073/pnas.0606690103; Beikler T, 2003, EUR J ORAL SCI, V111, P390, DOI 10.1034/j.1600-0722.2003.00065.x; Hajishengallis G, 2004, IMMUNOL INVEST, V33, P157, DOI 10.1081/IMM-120030917; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Amano A, 1999, J CLIN MICROBIOL, V37, P1426; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Enersen M, 2008, J CLIN MICROBIOL, V46, P31, DOI 10.1128/JCM.00986-07; Benseny-Cases N, 2007, BIOCHEM BIOPH RES CO, V361, P916, DOI 10.1016/j.bbrc.2007.07.082; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; SLOTS J, 1978, INFECT IMMUN, V19, P254; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Herraez A, 2006, BIOCHEM MOL BIOL EDU, V34, P255, DOI 10.1002/bmb.2006.494034042644; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Zheng C, 2011, MOL ORAL MICROBIOL, V26, P388, DOI 10.1111/j.2041-1014.2011.00626.x; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Umeda JE, 2006, ORAL MICROBIOL IMMUN, V21, P415, DOI 10.1111/j.1399-302X.2006.00312.x; Deane CM, 1999, PROTEIN ENG, V12, P1025, DOI 10.1093/protein/12.12.1025; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Nakagawa I, 2002, INFECT IMMUN, V70, P277, DOI 10.1128/IAI.70.1.277-285.2002; Nakano K, 2004, ORAL MICROBIOL IMMUN, V19, P205, DOI 10.1111/j.0902-0055.2004.00133.x; Kadowaki T, 1998, J BIOL CHEM, V273, P29072, DOI 10.1074/jbc.273.44.29072; Amano A, 2000, J DENT RES, V79, P1664; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Enersen M., 2013, J ORAL MICROBIOL, V5; Keten S, 2009, CELL MOL BIOENG, V2, P66, DOI 10.1007/s12195-009-0047-9; Krasnov I., 2008, PHYS REV LETT, V100; MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580; Nagano K, 2013, MOL ORAL MICROBIOL, V28, P392, DOI 10.1111/omi.12032; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; Njoroge T, 1997, INFECT IMMUN, V65, P1980; Perez-Chaparro PJ, 2009, ORAL MICROBIOL IMMUN, V24, P423, DOI 10.1111/j.1399-302X.2009.00519.x; Shoji M, 2010, CAN J MICROBIOL, V56, P959, DOI 10.1139/w10-084; Sojar HT, 1999, INFECT IMMUN, V67, P6173; Tamai R, 2005, INFECT IMMUN, V73, P6290, DOI 10.1128/IAI.73.10.6290-6298.2005; Tsuda K, 2008, CELL STRUCT FUNCT, V33, P123, DOI 10.1247/csf.08012; YOSHIMURA F, 1985, J BACTERIOL, V163, P730	51	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1093-3263	1873-4243		J MOL GRAPH MODEL	J. Mol. Graph.	FEB	2015	55						65	71		10.1016/j.jmgm.2014.11.001		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Computer Science, Interdisciplinary Applications; Crystallography; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Computer Science; Crystallography; Mathematical & Computational Biology	CB4GV	WOS:000349587100007		
J	Kaneko, YS; Ota, A; Nakashima, A; Nagasaki, H; Kodani, Y; Mori, K; Nagatsu, T				Kaneko, Yoko S.; Ota, Akira; Nakashima, Akira; Nagasaki, Hiroshi; Kodani, Yu; Mori, Keiji; Nagatsu, Toshiharu			Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G(1) phase and protects them from UV light-induced apoptosis	JOURNAL OF NEURAL TRANSMISSION			English	Article						Cell cycle; G(1) arrest; GADD45 alpha ;; p21(Waf1/Cip1); UV irradiation; Lipopolysaccharide	NF-KAPPA-B; PARKINSONS-DISEASE; ACTIVATED MICROGLIA; INFLAMMATORY CYTOKINES; ALZHEIMERS-DISEASE; RESPONSE GENE; P21; INHIBITOR; DEATH; TRIGGERS	We previously reported that an optimal dose of lipopolysaccharide (LPS) markedly extends the lifespan of murine primary-cultured microglia by suppressing cell death pathways. In this study, we investigated the effects of LPS pretreatment on UV light-induced apoptosis of cells from the microglial cell line BV-2. More than half of BV-2 cells were apoptotic, and procaspase-3 was cleaved into its active form at 3 h of UV irradiation. In contrast, in BV-2 cells treated with LPS for 24 h, UV irradiation caused neither apoptosis nor procaspase-3 cleavage. LPS treatment arrested the cell cycle in G(1) phase and upregulated cyclin-dependent kinase inhibitor p21(Waf1/Cip1) and growth arrest and DNA damage-inducible (GADD) 45 alpha in BV-2 cells. When p21(Waf1/Cip1) and GADD45 alpha were knocked down by small interfering RNA, procaspase-3 was cleaved into its active form to induce apoptosis. Our findings suggest that LPS inhibits UV-induced apoptosis in BV-2 cells through arrest of the cell cycle in G(1) phase by upregulation of p21(Waf1/Cip1) and GADD45 alpha. Excessive activation of microglia may play a critical role in the exacerbation of neurodegeneration, therefore, normalizing the precise regulation of apoptosis may be a new strategy to prevent the deterioration caused by neurodegenerative disorders.	[Kaneko, Yoko S.; Ota, Akira; Nakashima, Akira; Nagasaki, Hiroshi; Kodani, Yu; Mori, Keiji] Fujita Hlth Univ, Dept Physiol, Sch Med, Toyoake, Aichi 4701192, Japan; [Mori, Keiji] Kinjo Univ, Dept Occupat Therapy, Fac Hlth Sci, Kanazawa, Ishikawa, Japan; [Nagatsu, Toshiharu] Fujita Hlth Univ, Dept Pharmacol, Sch Med, Toyoake, Aichi 4701192, Japan; [Nagatsu, Toshiharu] Nagoya Univ, Environm Med Res Inst, Dept Brain Funct, Nagoya, Aichi 464, Japan	Kaneko, YS (reprint author), Fujita Hlth Univ, Dept Physiol, Sch Med, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	ykaneko@fujita-hu.ac.jp			Fujita Health University; Kinjo University	We thank Drs. Jau-Shyong Hong and Tongguang Wang (National Institute of Environmental Health Sciences, NC, USA) for providing us with BV-2 cells. We also thank Dr. Makoto Nakanishi (Department of Biochemistry, Nagoya City University School of Medicine, Nagoya, Japan) for helpful discussions. This work was supported by grants-in-aid from Fujita Health University to YSK and AO and by Kinjo University Grant-in-Aid for Special Research to KM.	Zerbini LF, 2005, CELL CYCLE, V4, P18, DOI 10.4161/cc.4.1.1363; Nagatsu T, 2006, CELL MOL NEUROBIOL, V26, P781, DOI 10.1007/s10571-006-9061-9; Mirza B, 2000, NEUROSCIENCE, V95, P425; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Kim YS, 2006, EXP MOL MED, V38, P333; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MCGEER PL, 1988, NEUROLOGY, V38, P1285; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Salerno DM, 2012, J CELL PHYSIOL, V227, P3613, DOI 10.1002/jcp.24067; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Hildesheim J, 2002, CANCER RES, V62, P7305; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Suzuki A, 2000, ONCOGENE, V19, P1346, DOI 10.1038/sj.onc.1203429; Kumar A, 2014, FREE RADICAL BIO MED, V73, P51, DOI 10.1016/j.freeradbiomed.2014.04.014; Dong C, 2005, BLOOD, V105, P1187, DOI 10.1182/blood-2004-06-2188; HARPER JW, 1993, CELL, V75, P805; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI [10.1002/mds.23455, 10.1002/23455]; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.00216.x; Gartel AL, 2002, MOL CANCER THER, V1, P639; Sugama Shuei, 2009, Inflammation & Allergy Drug Targets, V8, P277; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Ring RH, 2003, NEUROSCI LETT, V350, P73, DOI 10.1016/S0304-3940(03)00883-8; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Fujioka H, 2010, BRAIN RES, V1352, P35, DOI 10.1016/j.brainres.2010.07.032; Cretu A, 2009, CANC THER, V7, P268; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P421; DILEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Fan W, 1999, ONCOGENE, V18, P6573, DOI 10.1038/sj.onc.1203054; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Kaneko YS, 2012, CLIN EXP PHARMACOL P, V39, P599, DOI 10.1111/j.1440-1681.2012.05716.x; Kaneko YS, 1999, LIFE SCI, V65, P2251, DOI 10.1016/S0024-3205(99)00490-7; Kaneko YS, 2005, J NEUROCHEM, V94, P393, DOI 10.1111/j.1471-4159.2005.03209.x; Lee P, 2001, BRAIN RES, V892, P380, DOI 10.1016/S0006-8993(00)03257-1; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Lloberas Jorge, 2009, Eur J Immunol, V39, P691, DOI 10.1002/eji.200939262; McCarty MF, 2006, MED HYPOTHESES, V67, P251, DOI 10.1016/j.mehy.2006.01.013; Naert G, 2011, CURR ALZHEIMER RES, V8, P151; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Scatizzi JC, 2009, EUR J IMMUNOL, V39, P820, DOI 10.1002/eji.200838683; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Trakala M, 2009, EUR J IMMUNOL, V39, P810, DOI 10.1002/eji.200838676; Tusell JM, 2009, GLIA, V57, P524, DOI 10.1002/glia.20781; Tusell JM, 2005, GLIA, V49, P52, DOI 10.1002/glia.20095; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Zhang Hui, 1993, Molecular Biology of the Cell, V4, P897	55	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	FEB	2015	122	2					187	199		10.1007/s00702-014-1256-5		13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CA5WA	WOS:000348977300003		
J	Hashimoto, E; Tayama, M; Ishikawa, H; Yamamoto, M; Saito, T				Hashimoto, Eri; Tayama, Masaya; Ishikawa, Hiromi; Yamamoto, Megumi; Saito, Toshikazu			Influence of comorbid alcohol use disorder on treatment response of depressive patients	JOURNAL OF NEURAL TRANSMISSION			English	Article						Alcohol use disorder; Depression; Comorbidity; Antidepressant	IDENTIFICATION TEST AUDIT; MAJOR DEPRESSION; CELL-PROLIFERATION; RATING-SCALE; DEPENDENCE; METAANALYSIS; ASSOCIATION; RELIABILITY; CONSUMPTION; POPULATION	Patients with major depressive disorder (MDD) frequently also have alcohol use disorder (AUD) and they are more likely to experience symptomatic recurrence and resist treatment. How the two disorders interrelate has not yet been fully examined in Japanese subjects. The treatment response of 47 MDD patients was followed for 12 weeks. Depressive symptoms were rated by the 17-item Hamilton Rating Scale for Depression (HAM-D) and those whose HAM-D score was less than 16 were excluded. The MDD patients were divided into a non-alcohol use disorder (NAUD) and an alcohol use disorder (AUD) group according to the Alcohol Use Disorder Identification Test (AUDIT). We applied a cutoff score of 12 in the AUDIT scale. After 8 weeks, HAM-D NAUD group scores were significantly lower compared with AUD patients. The NAUD group, 23 individuals, prescribed therapeutic doses of antidepressant (equivalent to more than 150 mg of imipramine per day) significantly improved their HAM-D scores but no improvement occurred in the AUD subjects. Correlation analysis in all subjects revealed a significant negative correlation between AUDIT score and improved HAM-D score at endpoint. Moreover, a significant negative correlation was found between total alcohol consumption during the study period and improvement of HAM-D score at endpoint in AUD patients. These results suggest that co-occurrence of MDD and AUD is associated with a lower response to antidepressant treatment and it may reflect an inhibitory effect of ethanol on antidepressants action in the brain.	[Hashimoto, Eri; Tayama, Masaya; Ishikawa, Hiromi; Yamamoto, Megumi; Saito, Toshikazu] Sapporo Med Univ, Sch Med, Dept Neuropsychiat, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Hashimoto, E (reprint author), Sapporo Med Univ, Sch Med, Dept Neuropsychiat, Chuo Ku, S-1,W-16, Sapporo, Hokkaido 0608543, Japan.	ehasimot@sapmed.ac.jp					Hasin DS, 2002, ARCH GEN PSYCHIAT, V59, P794, DOI 10.1001/archpsyc.59.9.794; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Sullivan LE, 2005, AM J MED, V118, P330, DOI 10.1016/j.amjmed.2005.01.007; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Pettinati HM, 2013, AM J PSYCHIAT, V170, P23, DOI 10.1176/appi.ajp.2012.12010112; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Iovieno N, 2011, J CLIN PSYCHIAT, V72, P1144, DOI 10.4088/JCP.10m06217; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Gilman SE, 2001, DRUG ALCOHOL DEPEN, V63, P277, DOI 10.1016/S0376-8716(00)00216-7; Hasin D, 2002, ARCH GEN PSYCHIAT, V59, P375, DOI 10.1001/archpsyc.59.4.375; Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Donovan DM, 2006, ADDICTION, V101, P1696, DOI 10.1111/j.1360-0443.2006.01606.x; MUELLER TI, 1994, AM J PSYCHIAT, V151, P701; Badawy AAB, 2009, ALCOHOL ALCOHOLISM, V44, P267, DOI 10.1093/alcalc/agp005; Bertolote José Manoel, 2002, World Psychiatry, V1, P181; Bremner JD, 2002, CNS SPECTRUMS, V7, P135; Conner KR, 2008, PSYCHIAT ANN, V38, P742; Davis LL, 2010, DRUG ALCOHOL DEPEN, V107, P161, DOI 10.1016/j.drugalcdep.2009.10.003; Davis LL, 2006, AM J ADDICTION, V15, P278, DOI 10.1080/10550490600754317; Davis LL, 2005, COMPR PSYCHIAT, V46, P81, DOI 10.1016/j.comppsych.2004.07.025; Fortney JC, 1999, ALCOHOL CLIN EXP RES, V23, P127, DOI 10.1097/00000374-199901000-00018; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P197, DOI 10.1016/0376-8716(95)01160-4; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hiro Hisanori, 1996, Japanese Journal of Alcohol Studies and Drug Dependence, V31, P437; Hiro H, 1997, JPN J CLIN MED, V55, P589; Inagaki A., 2006, JPN J CLIN PSYCHOPHA, V9, P1443; Kessler RC, 1997, ARCH GEN PSYCHIAT, V53, P232; Nandi A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-31; OZAWA H, 1993, J NEURAL TRANSM-GEN, V94, P63, DOI 10.1007/BF01244984; Pandey SC, 2001, ALCOHOL CLIN EXP RES, V25, p46S; Pettinati HM, 2004, BIOL PSYCHIAT, V56, P785, DOI 10.1016/j.biopsych.2004.07.016; Sher L, 2008, J CLIN PSYCHIAT, V69, P907; Tabuse H, 2007, PSYCHIAT RES, V153, P61, DOI 10.1016/j.psychres.2006.07.004; Ukai Wataru, 2009, Japanese Journal of Alcohol Studies & Drug Dependence, V44, P704; World Health Organization, 1992, ICD 10 CLASS MENT BE	37	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	FEB	2015	122	2					301	306		10.1007/s00702-014-1254-7		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CA5WA	WOS:000348977300014		
J	Koizumi, S; Sakai, N; Kawaji, H; Takehara, Y; Yamashita, S; Sakahara, H; Baba, S; Hiramatsu, H; Sameshima, T; Namba, H				Koizumi, Shinichiro; Sakai, Naoto; Kawaji, Hiroshi; Takehara, Yasuo; Yamashita, Shuhei; Sakahara, Harumi; Baba, Satoshi; Hiramatsu, Hisaya; Sameshima, Tetsuro; Namba, Hiroki			Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas	JOURNAL OF NEURO-ONCOLOGY			English	Article						Meningioma; Angiomatous meningioma; MRI	CENTRAL-NERVOUS-SYSTEM; BLOOD-FLOW; BRAIN-TUMORS; ALZHEIMERS-DISEASE; PERFUSION MRI; QUANTIFICATION; STROKE; IMAGES; PCASL	Pseudo-continuous arterial spin labeling (PCASL) can measure tumor blood flow (TBF) reliably. We investigated meningioma TBF using PCASL and assessed for any correlation with histopathological microvascular density (MVD) and the World Health Organization (WHO) classification. Conventional MRI with contrast T1-weighted images and PCASL were acquired with a 3 T scanner before surgery in 25 consecutive patients with meningiomas. Using the PCASL perfusion map, the mean and maximum TBF were calculated from regions of interest placed in the largest cross-sectional plane of each tumor. Tissue sections from 16 patients were stained with CD31 to evaluate MVD and were assigned a WHO classification. The TBFs were statistically compared with MVD and the histopathological meningioma subtypes. There were 16 meningothelial meningiomas, four angiomatous meningiomas, two fibrous meningiomas, one transitional meningioma, and two atypical meningiomas. We observed significant correlation between MVD and both mean and maximum TBF (p < 0.05). The mean and maximum TBF (meanTBF, maxTBF) in angiomatous meningiomas are significantly higher than that in non-angiomatous meningiomas (p < 0.05). PCASL is useful in assessing meningioma vascularity, and in differentiating angiomatous meningiomas from non-angiomatous meningiomas.	[Koizumi, Shinichiro] Seirei Mikatahara Gen Hosp, Dept Neurosurg, Kita Ku, Hamamatsu, Shizuoka 4338558, Japan; [Sakai, Naoto; Kawaji, Hiroshi; Hiramatsu, Hisaya; Sameshima, Tetsuro; Namba, Hiroki] Hamamatsu Univ Sch Med, Dept Neurosurg, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Takehara, Yasuo] Hamamatsu Univ Hosp, Dept Radiol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Yamashita, Shuhei; Sakahara, Harumi] Hamamatsu Univ Sch Med, Dept Radiol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Baba, Satoshi] Hamamatsu Univ Hosp, Dept Diagnost Pathol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Sakai, N (reprint author), Hamamatsu Univ Sch Med, Dept Neurosurg, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	nsakaineurosurg@gmail.com					Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Jung Y, 2010, MAGN RESON MED, V64, P799, DOI 10.1002/mrm.22465; Pfefferbaum A, 2010, PSYCHIAT RES-NEUROIM, V182, P266, DOI 10.1016/j.pscychresns.2010.02.010; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462; Bokkers RPH, 2012, STROKE, V43, P1290, DOI 10.1161/STROKEAHA.110.589234; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Wang DJJ, 2012, STROKE, V43, P1018, DOI 10.1161/STROKEAHA.111.631929; Noguchi T, 2008, AM J NEURORADIOL, V29, P688, DOI [10.3174/ajnr.A0903, 10.3174/ainr.A0903]; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Yamashita K, 2012, NEURORADIOLOGY, V54, P809, DOI 10.1007/s00234-011-0977-5; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Fellah S, 2011, J CLIN ONCOL, V29, pE308, DOI 10.1200/JCO.2010.32.6082; Alsop DC, 2010, J ALZHEIMERS DIS, V20, P871, DOI 10.3233/JAD-2010-091699; Kimura H, 2006, AM J NEURORADIOL, V27, P85; Arita H, 2012, J NEURO-ONCOL, V107, P379, DOI 10.1007/s11060-011-0759-2; Kawaji H, 2013, J NEURORADIOLOGY, V40, P303, DOI 10.1016/j.neurad.2013.04.005; Koretsky AP, 2012, NEUROIMAGE, V62, P602, DOI 10.1016/j.neuroimage.2012.01.005; Sakai N, 2013, AM J NEURORADIOL, V34, P2139, DOI 10.3174/ajnr.A3564; Schmid S, 2010, NEUROSURGERY, V67, P1703, DOI 10.1227/NEU.0b013e3181fb801b; Yamamoto T, 2013, MAGN RESON IMAGING, V31, P1271, DOI 10.1016/j.mri.2013.04.011	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	FEB	2015	121	3					549	556		10.1007/s11060-014-1666-0		8	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CB3KU	WOS:000349527500015		
J	Ogiwara, H; Tsutsumi, Y; Matsuoka, K; Kiyotani, C; Terashima, K; Morota, N				Ogiwara, Hideki; Tsutsumi, Yoshiyuki; Matsuoka, Kentarou; Kiyotani, Chikako; Terashima, Keita; Morota, Nobuhito			Apparent diffusion coefficient of intracranial germ cell tumors	JOURNAL OF NEURO-ONCOLOGY			English	Article						Apparent diffusion coefficient (ADC); Intracranial germ cell tumors; Diffusion weighted imaging (DWI); Magnetic resonance imaging (MRI)	PEDIATRIC BRAIN-TUMORS; POSTERIOR-FOSSA TUMORS; CRANIOSPINAL IRRADIATION; CHILDREN; DIFFERENTIATION; SPECTROSCOPY; EXPERIENCE; PATHOLOGY; PERFUSION; PINEAL	The role of diffusion weighted imaging and apparent diffusion coefficient in intracranial germ cell tumors has not been fully elucidated. The aim of this study was to evaluate whether the ADC correlates with the histologic subtypes of germ cell tumors. We also aimed to investigate whether the ADC values can predict treatment response. The authors retrospectively analyzed the ADC values of the enhancing and solid regions of germ cell tumors. The absolute ADC values and the normalized ADC values were compared among different histologic diagnoses. The ADC values before and after the first course of chemotherapy were also compared between the different prognostic groups. Ten patients were included in the study. The median age at diagnosis was 9.3 years (range 5.3-13.8 years). There were four patients with germinoma and six patients with nongerminomatous germ cell tumor (NGGCT) including five mixed germ cell tumors and one immature teratoma. The mean absolute and normalized ADC values (x10(-3) mm(2)/s) were significantly lower in germinomas [0.835 +/- A 0.065 (standard deviation) and 1.11 +/- A 0.096, respectively] than in NGGCTs (1.271 +/- A 0.145 and 1.703 +/- A 0.223, respectively) (p = 0.01). The ADC values before and after the first course of chemotherapy were available in four patients. The ADC value after the first chemotherapy had a tendency to increase more in patients who eventually demonstrated complete response with chemotherapy than in patients who required second-look surgery. Assessment of the ADC values of germ cell tumors is considered to facilitate differentiation of histological subtypes of germ cell tumors. Evaluation of the ADC may also be useful for predicting treatment response.	[Ogiwara, Hideki; Morota, Nobuhito] Natl Ctr Child Hlth & Dev, Div Neurosurg, Setagaya Ku, Tokyo 1578535, Japan; [Tsutsumi, Yoshiyuki] Natl Ctr Child Hlth & Dev, Div NeuroRadiol, Setagaya Ku, Tokyo 1578535, Japan; [Matsuoka, Kentarou] Natl Ctr Child Hlth & Dev, Div Pathol, Setagaya Ku, Tokyo 1578535, Japan; [Kiyotani, Chikako; Terashima, Keita] Natl Ctr Child Hlth & Dev, Div NeuroOncol, Setagaya Ku, Tokyo 1578535, Japan	Ogiwara, H (reprint author), Natl Ctr Child Hlth & Dev, Div Neurosurg, Setagaya Ku, Okura 2-10-1, Tokyo 1578535, Japan.	hideki_o@d5.dion.ne.jp					Yeom KW, 2013, AM J ROENTGENOL, V200, P895, DOI 10.2214/AJR.12.9249; Bull JG, 2012, EUR RADIOL, V22, P447, DOI 10.1007/s00330-011-2255-7; Calaminus G, 2013, NEURO-ONCOLOGY, V15, P788, DOI 10.1093/neuonc/not019; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Rumboldt Z, 2006, AM J NEURORADIOL, V27, P1362; Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069; Provenzale JM, 2006, RADIOLOGY, V239, P632, DOI 10.1148/radiol.2393042031; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338; DEARNALEY DP, 1990, INT J RADIAT ONCOL, V18, P773; Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Kim JW, 2012, INT J RADIAT ONCOL, V84, P625, DOI 10.1016/j.ijrobp.2011.12.077; Cho KT, 2002, CHILD NERV SYST, V18, P30, DOI 10.1007/s00381-001-0547-y; Chung KHC, 2013, J CLIN NEUROSCI, V20, P514, DOI 10.1016/j.jocn.2012.04.017; Douglas-Akinwande AC, 2009, ACAD RADIOL, V16, P1356, DOI 10.1016/j.acra.2009.05.004; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449; Hirato J, 2001, J NEURO-ONCOL, V54, P239, DOI 10.1023/A:1012721723387; Huang CF, 2010, J NEUROSURG, V113, P97, DOI 10.3171/2010.7.GKS10864; Jaremko JL, 2010, AM J NEURORADIOL, V31, P1613, DOI 10.3174/ajnr.A2155; Kim CY, 2011, J NEURO-ONCOL, V101, P109, DOI 10.1007/s11060-010-0238-1; Kong DS, 2009, J NEUROS-PEDIATR, V3, P392, DOI 10.3171/2009.1.PEDS0857; Li Y, 2011, NEURO-ONCOLOGY, V13, P546, DOI 10.1093/neuonc/noq194; Pillai S, 2011, CHILD NERV SYST, V27, P1407, DOI 10.1007/s00381-011-1499-5; Poussaint TY, 2006, NEUROIMAG CLIN N AM, V16, P169, DOI 10.1016/j.nic.2005.11.005; Rodriguez Gutierrez, 2013, NEURO-ONCOLOGY, V15, P981; Sato K, 2009, PROG NEUROL SURG, V23, P59, DOI 10.1159/000210053; Schneider JF, 2007, J MAGN RESON IMAGING, V26, P1390, DOI 10.1002/jmri.21185; Weiner H, 1999, CHILD NERV SYST, V177, P1	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	FEB	2015	121	3					565	571		10.1007/s11060-014-1668-y		7	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CB3KU	WOS:000349527500017		
J	Hayashi, N; Mitsuya, K; Gorai, K; Inoue, K; Ito, I; Nakagawa, M; Nakasu, Y				Hayashi, Nakamasa; Mitsuya, Koichi; Gorai, Katsuya; Inoue, Keita; Ito, Ichiro; Nakagawa, Masahiro; Nakasu, Yoko			A Novel Graft Material for Preventing Cerebrospinal Fluid Leakage in Skull Base Reconstruction: Technical Note of Perifascial Areolar Tissue	JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE			English	Article						cerebrospinal fluid leakage; perifascial areolar tissue; skull base; transsphenoidal surgery	PERICRANIAL FLAP; SURGERY; DEFECTS; TRANSLABYRINTHINE; COMPLICATIONS; MANAGEMENT; RESECTIONS	ObjectivesPerifascial areolar tissue (PAT), a layer of loose connective tissue on the deep fascias with a rich vascular plexus, serves as a vital cover over defects with scarce vascularity. We report the usefulness of PAT as a nonvascularized alternative to flaps for reconstruction of dural defects in skull base surgery and transsphenoidal surgery while evaluating its effect on control of cerebrospinal fluid (CSF) leakage. DesignA retrospective chart analysis was performed on patients who had undergone repair of a dural defect with PAT during skull base surgery or transsphenoidal surgery between December 2004 and October 2011. ResultsTwenty-one patients were included: 11 patients had received surgical treatment and/or irradiation. Fourteen of the 21 patients had pre- and/or intraoperative CSF leakage. Only one patient (4.8%) had postoperative CSF leakage requiring additional surgical repair. Ten patients underwent postoperative irradiation from 1 to 15 months after transplant of the PAT. None of the patients had postoperative CSF leakage after irradiation. ConclusionWe successfully repaired dural defects using PAT in skull base surgery and transsphenoidal surgery, even in patients with a history of multiple operations and radiotherapy. PAT may serve as a valuable tool for skull base reconstruction.	[Hayashi, Nakamasa; Mitsuya, Koichi; Gorai, Katsuya; Inoue, Keita; Ito, Ichiro; Nakagawa, Masahiro; Nakasu, Yoko] Shizuoka Canc Ctr Hosp, Div Neurosurg Plast & Reconstruct Surg, Shizuoka 4118777, Japan; [Hayashi, Nakamasa; Mitsuya, Koichi; Gorai, Katsuya; Inoue, Keita; Ito, Ichiro; Nakagawa, Masahiro; Nakasu, Yoko] Shizuoka Canc Ctr Hosp, Div Pathol, Shizuoka 4118777, Japan	Hayashi, N (reprint author), Shizuoka Canc Ctr Hosp, Div Neurosurg, Shizuoka 4118777, Japan.	n.hayashi@scchr.jp					Kassam Amin B, 2008, Neurosurgery, V63, pONS44, DOI 10.1227/01.neu.0000335010.53122.75; AB Kassam, 2008, NEUROSURGERY S1, V63, pONS52; HAKUBA A, 1988, SURG NEUROL, V30, P108, DOI 10.1016/0090-3019(88)90095-X; Koizumi T, 2013, J PLAST SURG HAND SU, V47, P276, DOI 10.3109/2000656X.2012.759955; Harvey RJ, 2009, J NEUROSURG, V111, P371, DOI 10.3171/2008.8.JNS08236; Becker SS, 2003, OTOL NEUROTOL, V24, P107, DOI 10.1097/00129492-200301000-00021; Gil Z, 2007, SKULL BASE-INTERD AP, V17, P25, DOI 10.1055/s-2006-959333; Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.c4; Kim BY, 2013, LARYNGOSCOPE, V123, P2605, DOI 10.1002/lary.24098; Harvey RJ, 2008, AM J RHINOL, V22, P516, DOI 10.2500/ajr.2008.22.3223; Berker M, 2013, AURIS NASUS LARYNX, V40, P373, DOI 10.1016/j.anl.2012.11.006; Eloy JA, 2013, INT FORUM ALLERGY RH, V3, P425, DOI 10.1002/alr.21092; Ganly I, 2005, INT COLLABORATIVE ST, V27, P445; Hoffmann T K, 2013, EUR ARCH OTO-RHINO-L, V270, P899; JACKSON IT, 1986, PLAST RECONSTR SURG, V77, P905, DOI 10.1097/00006534-198606000-00005; JOHNS ME, 1981, LARYNGOSCOPE, V91, P952; Kryzanski JT, 2008, SKULL BASE-INTERD AP, V18, P229, DOI 10.1055/s-2007-1003924; Leonetti JP, 2001, SKULL BASE-INTERD AP, V11, P87, DOI 10.1055/s-2001-14428; MANGHAM CA, 1988, OTOLARYNG HEAD NECK, V99, P396; Nakajima H, 2004, SCAND J PLAST RECONS, V38, P261, DOI 10.1080/02844310410029543; Ogawa Y, 2007, NEUROL MED-CHIR, V47, P483, DOI 10.2176/nmc.47.483; PRICE JC, 1988, LARYNGOSCOPE, V98, P1159; Sen Chandranath, 1993, P831	23	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6331	2193-634X		J NEUROL SURG PART B	Journal of Neurol. Surg. Part B	FEB	2015	76	1					7	11		10.1055/s-0034-1386655		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CB2QK	WOS:000349472600002		
J	Ishibashi, K; Onishi, A; Fujiwara, Y; Ishiwata, K; Ishii, K				Ishibashi, Kenji; Onishi, Airin; Fujiwara, Yoshinori; Ishiwata, Kiichi; Ishii, Kenji			Relationship Between Alzheimer Disease-Like Pattern of F-18-FDG and Fasting Plasma Glucose Levels in Cognitively Normal Volunteers	JOURNAL OF NUCLEAR MEDICINE			English	Article						FDG; PET; precuneus; glucose; Alzheimer's disease	POSITRON-EMISSION-TOMOGRAPHY; DEFAULT-MODE NETWORK; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; INSULIN-RESISTANCE; DIABETES-MELLITUS; SERUM GLUCOSE; FDG-PET; DEMENTIA	Increased plasma glucose (PG) levels can alter the cerebral distribution pattern of F-18-FDG uptake and reduce F-18-FDG uptake, especially in the precuneus. The F-18-FDG distribution pattern in cognitively normal subjects is described as an Alzheimer disease (AD)-like pattern. The aim of this study was to determine the fasting PG levels that can reduce F-18-FDG uptake in the precuneus. Methods: Fifty-one cognitively normal volunteers (mean age +/- SD, 69.7 +/- 5.9 y) underwent F-18-FDG PET scanning and were divided into 2 groups according to the level of fasting PG at the time of PET scanning: control (n = 31, 80 mg/dL <= fasting PG < 100 mg/dL) and impaired fasting glucose (IFG) (n = 20, 100 mg/dL <= fasting PG < 110 mg/dL). F-18-FDG uptake was compared between the 2 groups using voxelwise analyses with a global normalization method and volume-of-interest (VOI)-based analyses. VOIs were placed on the precuneus, posterior cingulate, and visual cortex, and the ratio of the uptake value on the precuneus VOI to that on the visual cortex VOI (PreCne/VC ratios) and to that on the posterior cingulate VOI (PreCne/PostCin ratios) was calculated. Results: Whole-brain voxelwise analyses showed that F-18-FDG uptake in the precuneus was significantly lower in the IFG group (P < 0.05, familywise error rate-corrected) than in the control group. VOI analyses showed significantly lower PreCne/VC ratios (P < 0.002) and PreCne/PostCin ratios (P = 0.004) in the IFG group than in the control group. Conclusion: The present study confirmed that increased fasting PG levels decrease F-18-FDG uptake, especially in the precuneus, as in the AD-like pattern. Furthermore, the study provided initial evidence that the AD-like pattern can appear even in an individual with a mildly higher level of fasting PG (100-110 mg/dL).	[Ishibashi, Kenji; Onishi, Airin; Ishiwata, Kiichi; Ishii, Kenji] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo 1730015, Japan; [Fujiwara, Yoshinori] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo 1730015, Japan	Ishibashi, K (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	ishibashi@pet.tmig.or.jp			Nakayama Foundation for Human Science	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This work was supported in part by the Nakayama Foundation for Human Science. No other potential conflict of interest relevant to this article was reported.	American Diabetes Association, 2005, DIABETES CARE S1, V28, pS37; Genuth S, 2003, DIABETES CARE, V26, P3160; Ishii K, 2002, ANN NUCL MED, V16, P515, DOI 10.1007/BF02988628; Luchsinger JA, 2012, J ALZHEIMERS DIS, V30, pS185, DOI 10.3233/JAD-2012-111433; FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Xu WL, 2007, DIABETES, V56, P211, DOI 10.2337/db06-0879; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Musen G, 2012, DIABETES, V61, P2375, DOI 10.2337/db11-1669; Burns CM, 2013, NEUROLOGY, V80, P1557, DOI 10.1212/WNL.0b013e31828f17de; Yaffe K, 2004, NEUROLOGY, V63, P658; Hara T, 2009, ANN NUCL MED, V23, P657, DOI 10.1007/s12149-009-0288-7; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; CAMBIEN F, 1987, ARTERIOSCLEROSIS, V7, P197; Chen CH, 1999, INT J CARDIOL, V68, P179, DOI 10.1016/S0167-5273(98)00366-0; Di Bonito P, 2007, NUTR METAB CARDIOVAS, V17, P203, DOI 10.1016/j.numecd.2005.07.011; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gandhe Mahendra Bhauraoji, 2013, J Clin Diagn Res, V7, P1579, DOI 10.7860/JCDR/2013/6263.3213; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Ishibashi K, 2014, J ALZHEIMERS DIS, V42, P385, DOI 10.3233/JAD-140639; Kawasaki K, 2008, ANN NUCL MED, V22, P191, DOI 10.1007/s12149-007-0099-7; LUCIGNANI G, 1987, J CEREBR BLOOD F MET, V7, P309; Marian T, 2001, ACTA BIOL HUNG, V52, P35, DOI 10.1556/ABiol.52.2001.1.5; Soares JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066500; SUHONENPOLVI H, 1995, J NUCL MED, V36, P1249; WAHL RL, 1992, RADIOLOGY, V183, P643; Wang L, 2013, ADV INTELL SYST, V181, P181; Wienhard K, 2002, METHODS, V27, P218, DOI 10.1016/S1046-2023(02)00077-4; YAMADA K, 1985, EUR J NUCL MED, V10, P341	40	1	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	FEB	2015	56	2					229	233		10.2967/jnumed.114.150045		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB0NW	WOS:000349324300023		
J	Li, Y; Tsui, W; Rusinek, H; Butler, T; Mosconi, L; Pirraglia, E; Mozley, D; Vallabhajosula, S; Harada, R; Furumoto, S; Furukawa, K; Arai, H; Kudo, Y; Okamura, N; de Leon, MJ				Li, Yi; Tsui, Wai; Rusinek, Henry; Butler, Tracy; Mosconi, Lisa; Pirraglia, Elizabeth; Mozley, David; Vallabhajosula, Shankar; Harada, Ryuichi; Furumoto, Shozo; Furukawa, Katsutoshi; Arai, Hiroyuki; Kudo, Yukitsuka; Okamura, Nobuyuki; de Leon, Mony J.			Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease	JOURNAL OF NUCLEAR MEDICINE			English	Article						tau; amyloid beta; neocortical binding; PET	BRAIN; PATHOLOGY; DEMENTIA	Neurofibrillary tau pathology and amyloid beta (A beta) plaques, characteristic lesions of Alzheimer disease (AD), show different neocortical laminar distributions. Neurofibrillary-tangle tau pathology tends to be closer to the gray matter-white matter boundary, whereas A beta is dispersed throughout the width of the cortical ribbon. Methods: Using PET radiotracers for tau and A beta lesions, we developed an image analysis tool to measure the distance of tracer-positive voxels from the gray matter-white matter boundary. We studied 5 AD and 5 healthy subjects with both F-18-THK5117 (tau) and C-11-Pittsburgh compound B (A beta) PET. Results: On average, tau-positive voxels were closer to the white matter than were A beta-positive voxels. This effect was found for all AD subjects and for all regions, both before and after regionally adjusting for the nonspecific white matter binding of both tracers. The differential laminar pattern was validated through postmortem examination. Conclusion: Within cortical lamina, distance measures may be of value in testing PET tracers for their anatomic selectivity.	[Li, Yi; Tsui, Wai; Rusinek, Henry; Butler, Tracy; Mosconi, Lisa; Pirraglia, Elizabeth; de Leon, Mony J.] NYU, Ctr Brain Hlth, New York, NY USA; [Li, Yi] Shandong Univ, Jinan, Shandong, Peoples R China; [Butler, Tracy; Mozley, David; Vallabhajosula, Shankar] Cornell Univ, Ithaca, NY USA; [Harada, Ryuichi; Furukawa, Katsutoshi; Arai, Hiroyuki; Kudo, Yukitsuka; Okamura, Nobuyuki] Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Furumoto, Shozo] Tohoku Univ, Ctr Cyclotron & Radioisotope, Sendai, Miyagi 980, Japan; [Okamura, Nobuyuki] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [de Leon, Mony J.] NYU, Steven & Alexandra Cohen Vet Ctr, New York, NY USA	de Leon, MJ (reprint author), NYU, Sch Med, Dept Psychiat, 145 E 32 St,5th Floor, New York, NY 10016 USA.	mony.deleon@nyumc.org			NIH/NIA [AG035137, AG032554, AG022374, AG013616, AG012101]; Steven and Alexandra Cohen Veterans Center; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology [23390297, 26117003]; GE Healthcare; Sumitomo Electric Industries, Ltd.	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. Work at NYU was supported by NIH/NIA grants AG035137, AG032554, AG022374, AG013616, and AG012101 and by the Steven and Alexandra Cohen Veterans Center. Work at Tohoku University was supported by Health and Labor Sciences research grants from the Ministry of Health, Labor, and Welfare of Japan, a Grant-in-Aid for Scientific Research (B) (23390297), a Grant-in-Aid for Scientific Research on Innovative Areas (26117003), a grant from the Japan Advanced Molecular Imaging Program (J-AMP) of the Ministry of Education, Culture, Sports, Science and Technology, and the research fund from GE Healthcare and Sumitomo Electric Industries, Ltd. No other potential conflict of interest relevant to this article was reported.	BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Rahmim A, 2013, MED PHYS, V40, DOI 10.1118/1.4800806; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Thal DR, 2002, NEUROLOGY, V58, P1791; Mungas D, 2014, NEUROBIOL AGING, V35, P301, DOI 10.1016/j.neurobiolaging.2013.08.007; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ishiki A, 2014, ALZHEIMERS DEMENT S, V10, P131; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064	13	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	FEB	2015	56	2					270	273		10.2967/jnumed.114.149229		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB0NW	WOS:000349324300029		
J	Peltokorpi, V; Allen, DG; Froese, F				Peltokorpi, Vesa; Allen, David G.; Froese, Fabian			Organizational embeddedness, turnover intentions, and voluntary turnover: The moderating effects of employee demographic characteristics and value orientations	JOURNAL OF ORGANIZATIONAL BEHAVIOR			English	Article						organizational embeddedness; turnover intentions; voluntary turnover; age; gender; individualism; risk aversion; Japan	JOB EMBEDDEDNESS; RISK-AVERSION; JAPANESE ORGANIZATIONS; PROACTIVE PERSONALITY; PREDICTING TURNOVER; COMMITMENT; GENDER; STAY; MOBILITY; CAREER	To explain why some employees who experience high embeddedness contemplate leaving their organizations and others do not, we examined the moderating effects of employee demographic characteristics (age and gender) and value orientations (individualism and risk aversion) between organizational embeddedness and turnover intentions. Turnover intentions were further expected to increase voluntary turnover. Data were collected from 643 full-time employees at three points in time over a 12-month time period in a wide range of organizations in Japan, a relatively low turnover context with little prior embeddedness research. Findings show that gender and risk aversion moderate the relationship between organizational embeddedness and turnover intentions, which in turn predict voluntary turnover. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Peltokorpi, Vesa] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan; [Allen, David G.] Univ Memphis, Memphis, TN 38152 USA; [Froese, Fabian] Univ Gottingen, D-37073 Gottingen, Germany	Peltokorpi, V (reprint author), Japan Adv Inst Sci & Technol, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	vesap@jaist.ac.jp					Allen David G., 2007, Human Resource Management Review, V17, DOI 10.1016/j.hrmr.2007.07.001; Allen DG, 2014, J ORGAN BEHAV, V35, pS61, DOI 10.1002/job.1912; MOBLEY WH, 1977, J APPL PSYCHOL, V62, P237, DOI 10.1037/0021-9010.62.2.237; GOMEZMEJIA LR, 1989, IND RELAT, V28, P431, DOI 10.1111/j.1468-232X.1989.tb00736.x; Mitchell TR, 2001, ACAD MANAGE J, V44, P1102, DOI 10.2307/3069391; Lee TW, 2014, ANNU REV ORGAN PSYCH, V1, P199, DOI 10.1146/annurev-orgpsych-031413-091244; Jiang K, 2012, J APPL PSYCHOL, V97, P1077, DOI 10.1037/a0028610; Takeuchi R, 2007, J APPL PSYCHOL, V92, P1069, DOI 10.1037/0021-9010.92.4.1069; Zimmerman RD, 2008, PERS PSYCHOL, V61, P309, DOI 10.1111/j.1744-6570.2008.00115.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Ng TWH, 2009, J ORGAN BEHAV, V30, P1053, DOI 10.1002/job.599; Triandis HC, 1998, J PERS SOC PSYCHOL, V74, P118, DOI 10.1037//0022-3514.74.1.118; Chudzikowski K, 2012, J VOCAT BEHAV, V81, P298, DOI 10.1016/j.jvb.2011.10.005; Halbesleben JRB, 2008, WORK STRESS, V22, P242, DOI 10.1080/02678370802383962; Ramesh A, 2010, J APPL PSYCHOL, V95, P807, DOI 10.1037/a0019464; Bao YQ, 2003, PSYCHOL MARKET, V20, P733, DOI 10.1002/mar.10094; Holtom BC, 2008, ACAD MANAG ANN, V2, P231, DOI 10.1080/19416520802211552; Triandis HC, 2002, ANNU REV PSYCHOL, V53, P133, DOI 10.1146/annurev.psych.53.100901.135200; Zhang MA, 2012, HUM RESOUR MANAGE R, V22, P220, DOI 10.1016/j.hrmr.2012.02.004; Adams RB, 2012, MANAGE SCI, V58, P219, DOI 10.1287/mnsc.1110.1452; Halek M, 2001, J RISK INSUR, V68, P1, DOI 10.2307/2678130; Allen DG, 2005, J APPL PSYCHOL, V90, P980, DOI 10.1037/0021-9010.90.5.980; Burton JP, 2010, J VOCAT BEHAV, V76, P42, DOI 10.1016/j.jvb.2009.06.006; Allen DG, 2010, ACAD MANAGE PERSPECT, V24, P48; Jianakoplos NA, 1998, ECON INQ, V36, P620; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; ALLEN NJ, 1990, J OCCUP PSYCHOL, V63, P1; COHEN A, 1990, HUM RELAT, V43, P1015, DOI 10.1177/001872679004301005; Lyons ST, 2012, CAREER DEV INT, V17, P333, DOI 10.1108/13620431211255824; MARSH RM, 1977, ADMIN SCI QUART, V22, P57, DOI 10.2307/2391746; Ng TWH, 2010, J APPL PSYCHOL, V95, P696, DOI 10.1037/a0019150; Felps W, 2009, ACAD MANAGE J, V52, P545, DOI 10.5465/AMJ.2009.41331075; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Tanova C, 2008, INT J HUM RESOUR MAN, V19, P1553, DOI 10.1080/09585190802294820; Lyness KS, 2001, J APPL PSYCHOL, V86, P1167, DOI 10.1037/0021-9010.86.6.1167; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Ajzen I, 2002, PERS SOC PSYCHOL REV, V6, P107, DOI 10.1207/S15327957PSPR0602_02; Crossley CD, 2007, J APPL PSYCHOL, V92, P1031, DOI 10.1037/0021-9010.914.1031; Allen DG, 2013, J ORGAN BEHAV, V34, P350, DOI 10.1002/job.1805; COTTON JL, 1986, ACAD MANAGE REV, V11, P55, DOI 10.2307/258331; Valcour PM, 2003, INT J HUM RESOUR MAN, V14, P768, DOI 10.1080/0958519032000080794; Piccolo RF, 2006, ACAD MANAGE J, V49, P327; Wasti SA, 2003, APPL PSYCHOL-INT REV, V52, P533; Auer P, 2000, INT LABOUR REV, V139, P379, DOI 10.1111/j.1564-913X.2000.tb00525.x; BECKER HS, 1960, AM J SOCIOL, V66, P32, DOI 10.1086/222820; Brislin R., 1980, HDB CROSS CULTURAL P, V2, P349; Bruggen E, 2011, INT J MARKET RES, V53, P369, DOI 10.2501/IJMR-53-3-369-390; Casio W. F., 2006, MANAGING HUMAN RESOU; Chiu R. K., 2000, HUM RELAT, V53, P869; Colquitt JA, 2006, ORGAN BEHAV HUM DEC, V100, P110, DOI 10.1016/j.obhdp.2005.09.001; Eagly A. H., 1987, SEX DIFFERENCES SOCI; Goritz AS, 2004, INT J MARKET RES, V46, P411; Hair J. F. Jr., 1998, MULTIVARIATE DATA AN; Hayes A. F., 2013, INTRO MEDIATION MODE; Hofstede G., 2001, CULTURES CONSEQUENCE; Hom P. W., 2010, J APPL PSYCHOL, V93, P1; Hom P. W., 1995, EMPLOYEE TURNOVER; International Monetary Fund, 2011, TENS 2 SPEED REC UN; Lewin K., 1951, FIELD THEORY SOCIAL; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Ministry of International Affairs and Communications, 2013, LAB FORC SURV; Ng T. W. H., 2010, J OCCUPATIONAL ORG P, V84, P173; Ng TWH, 2009, J VOCAT BEHAV, V74, P283, DOI 10.1016/j.jvb.2009.01.004; Ng TWH, 2013, J ORGAN BEHAV, V34, P583, DOI 10.1002/job.1802; Ng TWH, 2013, PERS PSYCHOL, V66, P645, DOI 10.1111/peps.12025; OECD, 2014, AG EMPL POL STAT AV; Ogasawara Y., 1991, OFFICE LADIES SALARI; Ono H, 2007, AM SOCIOL REV, V72, P267; Peltokorpi V, 2013, INT J HUM RESOUR MAN, V24, P1551, DOI 10.1080/09585192.2012.723636; PETERS LH, 1981, J OCCUP BEHAV, V2, P89, DOI 10.1002/job.4030020204; Sekiguchi T., 2006, Asia Pacific Journal of Management, V23, DOI 10.1007/s10490-006-6115-y; Sousa-Poza A, 2004, J ECON ISSUES, V38, P113; Super D., 1957, PSYCHOL CAREERS; Vandenberghe C, 2011, J OCCUP ORGAN PSYCH, V84, P403, DOI 10.1348/096317910X491848; Vardaman JM, 2008, HUM RELAT, V61, P1531, DOI 10.1177/0018726708096637; Woo SE, 2014, J BUS PSYCHOL, V29, P683, DOI 10.1007/s10869-013-9303-z; World Economic Forum, 2010, CORP GEN GAP REP 201; Worthley R, 2009, INT J HUM RESOUR MAN, V20, P1503, DOI 10.1080/09585190902983421; Yanadori Y, 2009, INT J HUM RESOUR MAN, V20, P439, DOI 10.1080/09585190802673494	79	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3796	1099-1379		J ORGAN BEHAV	J. Organ. Behav.	FEB	2015	36	2					292	312		10.1002/job.1981		21	Business; Psychology, Applied; Management	Business & Economics; Psychology	CA9AJ	WOS:000349212300008		
J	Fukushima, K; Miki, T; Nakamoto, K; Nishimura, A; Koyama, H; Ichikawa, H; Shibata, N; Tokuyama, S; Sugioka, N				Fukushima, Keizo; Miki, Takahiro; Nakamoto, Kazuo; Nishimura, Asako; Koyama, Hikaru; Ichikawa, Hideki; Shibata, Nobuhito; Tokuyama, Shogo; Sugioka, Nobuyuki			Effect of Intestinal Atrophy and Hepatic Impairment Induced by Parenteral Nutrition on Drug Absorption and Disposition in Rats	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						intestinal atrophy; parenteral nutrition; pharmacokinetics; bioavailability; absorption	BARRIER FUNCTION; MOUSE MODEL; ELEMENTAL DIET; LIVER-DISEASE; INFANT RATS; PERMEABILITY; GLUTAMINE; FAT; EMULSION; BOWEL	Background: Long-term parenteral nutrition (PN) has a high risk of hepatic dysfunction and intestinal atrophy. The present study investigated the effect of PN-induced intestinal atrophy and hepatic impairment on drug pharmacokinetics by using 2 contrasting compounds: phenolsulfonphthalein (PSP) and cyclosporin A (CyA). Materials and Methods: PSP or CyA was administered to 7-day PN-fed Rats (PN rats) and sham operated rats (control rats) via intravenous (IV) or intraloop administration of the intestine. Pharmacokinetic parameters with 2-compartment analysis including area under the concentration vs time curve (AUC) and the permeability after in situ intraloop administration (P-loop) were obtained from both concentration profiles after different administration routes. Results: After IV administration of PSP to control and PN rats, there was no notable difference in any of the pharmacokinetic parameters. In contrast, after intraloop administration, AUC and P-loop in PN rats were approximately 2.6- and 2.0-fold higher than that in control rats, respectively. On the other hand, after IV administration of CyA, the terminal half-life and total body clearance were prolonged and decreased in PN rats, respectively, resulting in 2.0-fold increase in AUC. After intraloop administration, the AUC of PN rats was increased to approximately 1.3-fold that of control rats, whereas no notable difference was observed in P-loop. Conclusion: The intestinal permeability of PSP was enhanced by intestinal atrophy induced by PN, while the metabolism of CyA was diminished by hepatic impairment by PN. These results revealed the physicochemical property-based pharmacokinetic alterations during PN; for a more detailed understanding, however, further studies are needed.	[Fukushima, Keizo; Miki, Takahiro; Sugioka, Nobuyuki] Kobe Gakuin Univ, Dept Clin Pharmacokinet, Kobe, Hyogo 6508586, Japan; [Nakamoto, Kazuo; Tokuyama, Shogo] Kobe Gakuin Univ, Dept Clin Pharm, Kobe, Hyogo 6508586, Japan; [Nishimura, Asako; Shibata, Nobuhito] Doshisha Womens Coll Liberal Arts, Dept Biopharmaceut, Kyoto, Japan; [Koyama, Hikaru] Kyoto Prefectural Univ Med, Dept Hosp Pharm, Kyoto, Japan; [Ichikawa, Hideki] Kobe Gakuin Univ, Dept Phys Pharm, Kobe, Hyogo 6508586, Japan	Sugioka, N (reprint author), Kobe Gakuin Univ, Fac Pharmaceut Sci, Dept Clin Pharmacokinet, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.	nsugioka@pharm.kobegakuin.ac.jp			Japan Society for the Promotion of Science (JSPS) [24790178]	This research was supported by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B), Grant Number 24790178.	PAPPO I, 1994, NUTRITION, V10, P151; Yang H, 2009, ANN NY ACAD SCI, V1165, P338, DOI 10.1111/j.1749-6632.2009.04026.x; Sangild PT, 2006, J PEDIATR GASTR NUTR, V43, P160, DOI 10.1097/01.mpg.0000228122.82723.1b; Ekelund M, 2007, DIGEST DIS SCI, V52, P1833, DOI 10.1007/s10620-006-9678-z; Feng YJ, 2012, ANN NY ACAD SCI, V1258, P71, DOI 10.1111/j.1749-6632.2012.06572.x; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P141, DOI 10.2165/11317350-000000000-00000; DUDRICK SJ, 1968, SURGERY, V64, P134; Yang H, 2002, ANN SURG, V236, P226, DOI 10.1097/01.SLA.0000021594.84448.0E; Burns DL, 2013, JPEN-PARENTER ENTER, V37, P274, DOI 10.1177/0148607112450301; Yang H, 2003, CRIT CARE MED, V31, P1118, DOI 10.1097/01.CCM.0000053523.73064.8A; AUGUST DA, 1991, JPEN-PARENTER ENTER, V15, P323, DOI 10.1177/0148607191015003323; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Stoll B, 2010, J NUTR, V140, P2193, DOI 10.3945/jn.110.125799; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; Fukushima K, 2008, BIOL PHARM BULL, V31, P1209, DOI 10.1248/bpb.31.1209; GERARDBONCOMPAIN M, 1992, JPEN-PARENTER ENTER, V16, P78, DOI 10.1177/014860719201600178; Gertz M, 2013, PHARM RES-DORDR, V30, P761, DOI 10.1007/s11095-012-0918-y; De Segura IAG, 2001, DIGEST DIS SCI, V46, P1985; Haque SMM, 1996, ANN SURG, V223, P334, DOI 10.1097/00000658-199603000-00014; HASKEL Y, 1994, JPEN-PARENTER ENTER, V18, P159, DOI 10.1177/0148607194018002159; Hinton PS, 1998, AM J CLIN NUTR, V67, P1265; IIBOSHI Y, 1994, JPEN-PARENTER ENTER, V18, P346, DOI 10.1177/0148607194018004346; Itagaki S, 2003, EUR J PHARMACOL, V475, P85, DOI 10.1016/S0014-2999(03)02111-3; Kansagra K., 2003, AM J PHYSIOL-GASTR L, V285, P1162; Li J, 2012, JPEN-PARENTER ENTER, V36, P219, DOI 10.1177/0148607111424412; MATUCHANSKY C, 1986, GUT, V27, P81, DOI 10.1136/gut.27.Suppl_1.81; Nelson DW, 2007, ENDOCRINOLOGY, V148, P1954, DOI 10.1210/en.2006-1232; NEY DM, 1986, J NUTR, V116, P2106; Nomura M, 2012, AM J PHYSIOL-RENAL, V302, P1640; Oshita M, 2004, CLIN NUTR, V23, P1060, DOI 10.1016/j.clnu.2004.01.009; PLATELL C, 1991, J GASTROEN HEPATOL, V6, P345, DOI 10.1111/j.1440-1746.1991.tb00868.x; SANGALLI L, 1988, DRUG METAB DISPOS, V16, P749; SCHRODER J, 1995, JPEN-PARENTER ENTER, V19, P502, DOI 10.1177/0148607195019006502; Shaw AA, 2002, DRUG METAB DISPOS, V30, P177, DOI 10.1124/dmd.30.2.177; Suita S, 1999, JPEN J PARENTER ENTE, V23, P106; Suzuki T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-19; Yamaguchi M, 2005, BIOL PHARM BULL, V28, P143, DOI 10.1248/bpb.28.143	37	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	FEB	2015	39	2					218	227		10.1177/0148607113497759		10	Nutrition & Dietetics	Nutrition & Dietetics	CA7HK	WOS:000349088200013		
J	Ishimaru, T; Komura, M; Sugiyama, M; Komura, H; Arai, M; Fujishiro, J; Uotani, C; Miyakawa, K; Kakihara, T; Hoshi, K; Takato, T; Tabata, Y; Komuro, H; Iwanaka, T				Ishimaru, Tetsuya; Komura, Makoto; Sugiyama, Masahiko; Komura, Hiroko; Arai, Mari; Fujishiro, Jun; Uotani, Chizue; Miyakawa, Kyohei; Kakihara, Tomo; Hoshi, Kazuto; Takato, Tsuyoshi; Tabata, Yasuhiko; Komuro, Hiroaki; Iwanaka, Tadashi			Slow release of basic fibroblast growth factor (b-FGF) enhances mechanical properties of rat trachea	JOURNAL OF PEDIATRIC SURGERY			English	Article						Tracheomalacia; Bronchomalacia; Tracheal cartilage; Basic fibroblast growth factor (b-FGF)	CARTILAGE; CHONDROCYTE; DIFFERENTIATION	Aim: Severe tracheomalacia is a life-threatening disease, but symptoms usually improve with growth. The aims of this study were to investigate how slow release basic-Fibroblast Growth Factor (b-FGF) acts on tracheal cartilage, and whether growth-promoted trachea is more resistant against an increase in externally-applied pressure. Methods: Biodegradable gelatin hydrogel sheets soaked in 10 mu l of distilled water (sham) or 0.5 or 5 mu g/10 mu l of b-FGF solution were inserted behind the cervical trachea of three-week-old male Wistar rats. The cervical trachea was harvested 4 weeks later. Extratracheal pressure was increased from 0 to 40 cmH(2)O in a chamber, while video-recording the internal lumen. The luminal area at each pressure was expressed as a proportion to that at 0 cmH2O. The amounts of collagen type II and glycosaminoglycan were measured by ELISA. Results: The luminal areas at 40 cmH2O in the control (no intervention), sham, and each of the b-FGF groups were 0.65, 0.62, 0.72, and 0.73, respectively. The amounts of collagen type II and glycosaminoglycan in each group were 127, 136, 193, 249 mu g/mg, respectively, and 15, 16, 19, 33 mu g/mg, respectively. There were significant differences between the control group and the FGF 5 group (P = 0.02, 0.01, 0.01, for luminal area, collagen, and glycosaminoglycan, respectively). Conclusion: 5 mu g of slow-release b-FGF promotes matrix production (collagen type II and glycosaminoglycan). The growth-enhanced trachea was more resistant to collapse, suggesting that slowly released b-FGF might be useful in patients with severe tracheomalacia. (C) 2015 Elsevier Inc. All rights reserved.	[Ishimaru, Tetsuya; Sugiyama, Masahiko; Komura, Hiroko; Arai, Mari; Fujishiro, Jun; Uotani, Chizue; Miyakawa, Kyohei; Kakihara, Tomo; Komuro, Hiroaki; Iwanaka, Tadashi] Tokyo Univ Hosp, Dept Pediat Surg, Tokyo, Japan; [Komura, Makoto] Saitama Med Univ, Dept Pediat Surg, Saitama 3500495, Japan; [Hoshi, Kazuto; Takato, Tsuyoshi] Univ Tokyo, Grad Sch Med, Dept Tissue Engn, Tokyo 1138654, Japan; [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068501, Japan	Komura, M (reprint author), Saitama Med Univ, Dept Pediat Surg, 38 Morohongo,Moroyamacho, Saitama 3500495, Japan.	komura-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22591977]; Kawano Masanori Memorial Foundation for Promotion of Pediatrics	We appreciate the technical support provided by Nobuyuki Kikuchi, a technician in the Department of Tissue Engineering in the Graduate School of Medicine, The University of Tokyo. We sincerely appreciate Kaken Pharmaceutical Co. Ltd. (Tokyo, Japan) for provision of b-FGF. This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 22591977) and Kawano Masanori Memorial Foundation for Promotion of Pediatrics 2009.	Doshi J, 2007, J ALLERGY CLIN IMMUN, V120, P1276, DOI 10.1016/j.jaci.2007.09.048; Tran-Khanh N, 2005, J ORTHOP RES, V23, P1354, DOI 10.1016/j.orthres.2005.05.009; Ellman MB, 2008, GENE, V420, P82, DOI 10.1016/j.gene.2008.04.019; Schmal H, 2007, CYTOTHERAPY, V9, P184, DOI 10.1080/14653240601182846; Komura M, 2014, J PEDIATR SURG, V49, P296, DOI 10.1016/j.jpedsurg.2013.11.040; Bastiaansen-Jenniskens YM, 2008, OSTEOARTHR CARTILAGE, V16, P359, DOI 10.1016/j.joca.2007.07.003; Goyal V, 2012, COCHRANE DB SYST REV, V10; Ishimaru T, 2013, J PEDIATR SURG, V48, P288, DOI 10.1016/j.jpedsurg.2012.11.003; Isogai N, 2005, J BIOMED MATER RES A, V74A, P408, DOI 10.1002/jbm.a.30343; KLAGSBRUN M, 1980, J BIOL CHEM, V255, P859; Masters Ian Brent, 2009, Expert Rev Respir Med, V3, P425, DOI 10.1586/ers.09.29; Panitch HB, 1998, PEDIATR RES, V43, P832, DOI 10.1203/00006450-199806000-00018; Park KH, 2008, J BIOSCI BIOENG, V106, P74, DOI 10.1263/jbb.106.74; QUATELA VC, 1993, ARCH OTOLARYNGOL, V119, P32	14	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	FEB	2015	50	2					255	259		10.1016/j.jpedsurg.2014.11.012		5	Pediatrics; Surgery	Pediatrics; Surgery	CA3XG	WOS:000348837700007		
J	Saka, R; Yanagihara, I; Sasaki, T; Nose, S; Takeuchi, M; Nakayama, M; Okuyama, H				Saka, Ryuta; Yanagihara, Itaru; Sasaki, Takashi; Nose, Satoko; Takeuchi, Makoto; Nakayama, Masahiro; Okuyama, Hiroomi			Immunolocalization of surfactant protein D in the liver from infants with cholestatic liver disease	JOURNAL OF PEDIATRIC SURGERY			English	Article						Surfactant protein D; Liver; Cholestasis; Biliary atresia	INNATE IMMUNITY; LUNG; COLLECTINS; EXPRESSION; TISSUES	Purpose: Surfactant protein D (SP-D) is one of specific surfactant proteins constituting pulmonary surfactant. Recent studies have revealed that SP-D is detected in various non-pulmonary tissues and is involved in the host defense and immunomodulation. However, the relationship between SP-D and liver diseases has not yet been investigated. The aim of this study was to detect the immunolocalization of SP-D in the livers of infants with cholestatic liver disease. Methods: The expression of immunoreactive SP-D was assessed in infants with cholestasis, including biliary atresia (BA, n = 7), neonatal hepatitis (NH, n = 2), and paucity of the intrahepatic bile duct (PIBD, n = 4). Immunoreactive SP-D was also assessed in six infants who died of non-liver disease as controls. Tissue samples were obtained at liver biopsy, or by post-mortem sampling. The tissue sections were incubated with anti-SP-D polyclonal antibodies and were counterstained with hematoxylin. Results: In the normal livers, SP-D was detected in the intrahepatic bile ducts, but was not detected in hepatocytes. In contrast, intense SP-D staining was noted in the hepatocytes from infants with BA, NH, and PIBD. Although SP-D was detected in the intrahepatic bile ducts in the infants with NH, negative or weak staining was seen in the intrahepatic bile ducts in infants with BA. Conclusion: Our data showed that SP-D is present in the bile ducts of the normal infant liver, and it was found to accumulate in the hepatocytes of cholestatic livers. These results suggest that SP-D is produced in hepatocytes and is secreted into the bile ducts. (C) 2015 Elsevier Inc. All rights reserved.	[Saka, Ryuta; Sasaki, Takashi; Nose, Satoko; Okuyama, Hiroomi] Hyogo Coll Med, Dept Pediat Surg, Nishinomiya, Hyogo 6638501, Japan; [Saka, Ryuta; Okuyama, Hiroomi] Osaka Univ, Dept Pediat Surg, Grad Sch Med, Suita, Osaka 565, Japan; [Yanagihara, Itaru] Osaka Med Ctr, Dept Dev Med, Osaka, Japan; [Yanagihara, Itaru; Takeuchi, Makoto; Nakayama, Masahiro] Res Inst Maternal & Child Hlth, Osaka, Japan; [Takeuchi, Makoto; Nakayama, Masahiro] Osaka Med Ctr, Dept Pathol & Lab Med, Osaka, Japan	Saka, R (reprint author), Hyogo Coll Med, Dept Pediat Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	saka@hyo-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This study was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Stahlman MT, 2002, J HISTOCHEM CYTOCHEM, V50, P651; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; De Bruyne R, 2011, EUR J PEDIATR, V170, P279, DOI 10.1007/s00431-010-1363-8; LeVine AM, 2000, J IMMUNOL, V165, P3934; Ernst LM, 2007, PEDIATR DEVEL PATHOL, V10, P383, DOI 10.2350/06-09-0171.1; Kocak N, 1997, J PEDIATR GASTR NUTR, V24, P44, DOI 10.1097/00005176-199701000-00011; Kurimura Y, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380287; Tang Z, 2013, J EXP MED, V231, P127	12	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	FEB	2015	50	2					297	300		10.1016/j.jpedsurg.2014.11.020		4	Pediatrics; Surgery	Pediatrics; Surgery	CA3XG	WOS:000348837700017		
J	Cochran, DL; Cobb, CM; Bashutski, JD; Chun, YHP; Lin, Z; Mandelaris, GA; McAllister, BS; Murakami, S; Rios, HF				Cochran, David L.; Cobb, Charles M.; Bashutski, Jill D.; Chun, Yong-Hee Patricia; Lin, Zhao; Mandelaris, George A.; McAllister, Bradley S.; Murakami, Shinya; Rios, Hector F.			Emerging Regenerative Approaches for Periodontal Reconstruction: A Consensus Report From the AAP Regeneration Workshop	JOURNAL OF PERIODONTOLOGY			English	Article						Alveolar bone grafting; bonematrix; guided tissue regeneration, periodontal; periodontitis; tissue engineering	SHEATH PROTEIN; IN-VITRO; METABOLISM; PEPTIDES; LIGAMENT; VIVO	Background: Historically, periodontal regeneration has focused predominantly on bone substitutes and/or barrier membrane application to provide for defect fill and/or selected cell repopulation of the lesion. More recently, a number of technologies have evolved that can be viewed as emerging therapeutic approaches for periodontal regeneration, and these technologies were considered in the review paper and by the consensus group. The goal of this consensus report on emerging regenerative approaches for periodontal hard and soft tissue reconstruction was to develop a consensus document based on the accompanying review paper and on additional materials submitted before and at the consensus group session. Methods: The review paper was sent to all the consensus group participants in advance of the consensus conference. In addition and also before the conference, individual consensus group members submitted additional material for consideration by the group. At the conference, each consensus group participant introduced themselves and provided disclosure of any potential conflicts of interest. The review paper was briefly presented by two of the authors and discussed by the consensus group. A discussion of each of the following topics then occurred based on the content of the review: a general summary of the topic, implications for patient-reported outcomes, and suggested research priorities for the future. As each topic was discussed based on the review article, supplemental information was then added that the consensus group agreed on. Last, an updated reference list was created. Results: The application of protein and peptide therapy, cell-based therapy, genetic therapy, application of scaffolds, bone anabolics, and lasers were found to be emerging technologies for periodontal regeneration. Other approaches included the following: 1) therapies directed at the resolution of inflammation; 2) therapies that took into account the influence of the microbiome; 3) therapies involving the local regulation of phosphate and pyrophosphate metabolism; and 4) approaches directed at harnessing current therapies used for other purposes. The results indicate that, with most emerging technologies, the specific mechanisms of action are not well understood nor are the specific target cells identified. Patient-related outcomes were typically not addressed in the literature. Numerous recommendations can bemade for future research priorities for both basic science and clinical application of emerging therapies. The need to emphasize the importance of regeneration of a functional periodontal organ system was noted. The predictability and efficacy of outcomes, as well as safety concerns and the cost-to-benefit ratio were also identified as key factors for emerging technologies. Conclusions: A number of technologies appear viable as emerging regenerative approaches for periodontal hard and soft tissue regeneration and are expanding the potential of reconstructing the entire periodontal organ system. The cost-to-benefit ratio and safety issues are important considerations for any new emerging therapies. Clinical Recommendation: At this time, there is insufficient evidence on emerging periodontal regenerative technologies to warrant definitive clinical recommendations.	[Cochran, David L.; Chun, Yong-Hee Patricia] Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Periodont, San Antonio, TX 78240 USA; [Cobb, Charles M.] Univ Missouri, Sch Dent, Dept Periodont, Kansas City, MO USA; [Bashutski, Jill D.; Rios, Hector F.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Lin, Zhao] Virginia Commonwealth Univ, Dept Periodont, Sch Dent, Richmond, VA USA; [Mandelaris, George A.] Louisiana State Univ, Sch Dent, Dept Oral & Maxillofacial Surg, New Orleans, LA 70119 USA; [Mandelaris, George A.] Univ Illinois, Coll Dent, Dept Grad Periodont, Chicago, IL USA; [McAllister, Bradley S.] Oregon Hlth & Sci Univ, Dept Periodontol, Portland, OR 97201 USA; [Murakami, Shinya] Osaka Univ, Dept Periodontol, Grad Sch Dent, Osaka, Japan	Cochran, DL (reprint author), Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Periodont, 7703 Floyd Curl Dr, San Antonio, TX 78240 USA.	cochran@uthscsa.edu			Sunstar Americas (Chicago, Illinois); OraPharma (Horsham, Pennsylvania); Eli Lilly (Indianapolis, Indiana); Biomet 3i (Palm Beach Gardens, Florida); Osteology Foundation (Lucerne, Switzerland); National Institutes of Health/National Institute of Dental and Craniofacial Research [K08DE022800, 1K23DE019872, R21DE023845-01A1, R56DE022787-01A1]; National Center for Advancing Translational Sciences [UL1TR001120]; ACE Surgical Supply (Brockton, Massachusetts); Nobel Biocare (Zurich, Switzerland); Institute Straumann (Basel, Switzerland); Osteohealth (Shirley, New York); Organogenesis (Canton, Massachusetts); Cytograft Tissue Engineering (Novato, California); Imaging Sciences International (Hatfield, Pennsylvania); Kaken Pharmaceutical (Tokyo, Japan); Osteology Foundation; AAP Foundation; Geistlich Pharma North America; Colgate-Palmolive	Dr. Cochran has received research funding and consulting fees from Sunstar Americas (Chicago, Illinois). Dr. Cobb has received research funding from OraPharma (Horsham, Pennsylvania) and is an unpaid consultant for Hu-Friedy (Chicago, Illinois) and Livionex (Los Gatos, California). Dr. Bashutski has received research funding from Eli Lilly (Indianapolis, Indiana), Biomet 3i (Palm Beach Gardens, Florida), and Osteology Foundation (Lucerne, Switzerland). Research by Dr. Chun was supported by the National Institutes of Health/National Institute of Dental and Craniofacial Research (K08DE022800) and the National Center for Advancing Translational Sciences (UL1TR001120). Dr. McAllister has received research funding and consulting, advisor, and lecture fees from ACE Surgical Supply (Brockton, Massachusetts), Nobel Biocare (Zurich, Switzerland), Institute Straumann (Basel, Switzerland), Osteohealth (Shirley, New York), Organogenesis (Canton, Massachusetts), and Cytograft Tissue Engineering (Novato, California) as well as advisor fees from Imaging Sciences International (Hatfield, Pennsylvania). Dr. Murakami has received research funding and consulting fees from Kaken Pharmaceutical (Tokyo, Japan). Dr. Rios has received research funding from Osteology Foundation, has served as a consultant for Geitslich Pharma (Wolhusen, Switzerland) and Organogenesis, and his research has been supported by the National Institutes of Health/National Institute of Dental and Craniofacial Research (1K23DE019872, R21DE023845-01A1, and R56DE022787-01A1). Drs. Lin and Mandelaris report no conflicts of interest related to this consensus report. The 2014 Regeneration Workshop was hosted by the American Academy of Periodontology (AAP) and supported in part by the AAP Foundation, Geistlich Pharma North America, Colgate-Palmolive, and the Osteology Foundation.	Amin HD, 2014, ACTA BIOMATER, V10, P1930, DOI 10.1016/j.actbio.2013.11.027; Nevins M, 2013, J PERIODONTOL, V84, P456, DOI 10.1902/jop.2012.120141; Maekawa T, 2014, J IMMUNOL, V192, P6020, DOI 10.4049/jimmunol.1400569; Costa PF, 2014, J CLIN PERIODONTOL, V41, P283, DOI 10.1111/jcpe.12214; Mustafa M, 2013, AM J PHYSIOL-CELL PH, V305, pC673, DOI 10.1152/ajpcell.00242.2012; Amin HD, 2012, TISSUE ENG PT A, V18, P1193, DOI [10.1089/ten.TEA.2011.0375, 10.1089/ten.tea.2011.0375]; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Arany PR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008234; Cortellini P, 2009, INT J PERIODONT REST, V29, P257; Das S, 2013, CURR DRUG TARGETS, V14, P1667; Foster BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038393; Fukae M, 2006, EUR J ORAL SCI, V114, P381; Fukae M, 2006, EUR J ORAL SCI, V114, P212, DOI 10.1111/j.1600-0722.2006.00309.x; Fukae M, 2006, EUR J ORAL SCI, V114, P254; Hajishengallis G, 2014, Adv Dent Res, V26, P23, DOI 10.1177/0022034514526240; Hajishengallis G., 2014, J ORAL BIOSCI, V56, P30, DOI DOI 10.1016/J.J0B.2013.09.001; Kakegawa A, 2010, J PERIODONTAL RES, V45, P643, DOI 10.1111/j.1600-0765.2010.01279.x; Kanazashi M, 2006, J PERIODONTAL RES, V41, P193, DOI 10.1111/j.1600-0765.2005.00859.x; Lin Z, 2015, J PERIODONTOL, V86, pS134, DOI 10.1902/jop.2015.130689; Moutsopoulos NM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007696; Oortgiesen DAW, 2014, J TISSUE ENG REGEN M, V8, P202, DOI 10.1002/term.1514; Rodrigues TL, 2011, J PERIODONTOL, V82, P1757, DOI 10.1902/jop.2011.110103; Somerman M, 2011, J DENT RES, V90, P7, DOI 10.1177/0022034510383144; Warotayanont R, 2009, BIOCHEM BIOPH RES CO, V387, P558, DOI 10.1016/j.bbrc.2009.07.058; Yamano S, 2014, BIOMATERIALS, V35, P2446, DOI 10.1016/j.biomaterials.2013.12.006	25	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	FEB	2015	86	2		S			S153	S156		10.1902/jop.2015.140381		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB1JK	WOS:000349383200012		
J	Suzuki, T; Casareto, BE; Shioi, Y; Ishikawa, Y; Suzuki, Y				Suzuki, Toshiyuki; Casareto, Beatriz Estela; Shioi, Yuzo; Ishikawa, Yoshio; Suzuki, Yoshimi			FINDING OF 13(2), 17(3)-CYCLOPHEOPHORBIDE A ENOL AS A DEGRADATION PRODUCT OF CHLOROPHYLL IN SHRUNK ZOOXANTHELLAE OF THE CORAL MONTIPORA DIGITATA	JOURNAL OF PHYCOLOGY			English	Article						'13(2), 17(3)-cyclopheophorbide a enol'; coral bleaching; degraded zooxanthellae; reactive oxygen species; thermal stress	STYLOPHORA-PISTILLATA; REEF CORALS; RUDITAPES-PHILIPPINARUM; BLEACHING EVENT; SYMBIOTIC ALGAE; TEMPERATURE; STRESS; PHOTOSYNTHESIS; ACCLIMATION; SEDIMENTS	We examined the morphology and pigment composition of zooxanthellae in corals subjected to normal temperature (27 degrees C) and thermal stress (32 degrees C). We observed several normal and abnormal morphological types of zooxanthellar cells. Normal cells were intact and their chloroplasts were unbroken (healthy); abnormal cells were shrunken and had partially degraded or broken chloroplasts, or they were bleached and without chloroplasts. At 27 degrees C, most healthy zooxanthellar cells were retained in the coral tissue, whereas shrunken zooxanthellae were expelled. Under thermal stress, the abundance of healthy zooxanthellae declined and the proportion of shrunken/abnormal cells increased in coral tissues. The rate of algal cell expulsion was reduced under thermal stress. Within the shrunken cells, we detected the presence of a chl-like pigment that is not ordinarily found in healthy zooxanthellae. Analysis of the absorption spectrum, absorption maxima, and retention time (by HPLC) indicated that this pigment was 13(2), 17(3)-cyclopheophorbide a enol (cPPB-aE), which is frequently found in marine and lacustrine sediments, and in protozoans that graze on phytoplankton. The production of cPPB-aE in shrunken zooxanthellae suggests that the chls have been degraded to cPPB-aE, a compound that is not fluorescent. The lack of a fluorescence function precludes the formation of reactive oxygen species. We therefore consider the formation of cPPB-aE in shrunken zooxanthellae to be a mechanism for avoiding oxidative stress.	[Suzuki, Toshiyuki; Casareto, Beatriz Estela; Shioi, Yuzo; Suzuki, Yoshimi] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Ishikawa, Yoshio] Inst Environm Sci, Aomori 0393212, Japan	Suzuki, T (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	dtsuzuk@ipc.shizuoka.ac.jp			Mitsubishi Corporation; Japanese Ministry of Education, Culture, Sports, Science and Technology	We are grateful to Mr. Yoshikatsu Nakano of University of the Ryukyus for support in setting up the aquarium and the laboratory, and to Mr. Sunao Uehara for assisting in wild coral sampling. We are indebted to Dr. Yuichiro Kashiyama of Fukui University of Technology for providing the cPPB-aE standard and for valuable suggestions on the manuscript. We thank Dr. Mohan Prasad Niraula of Shizuoka University for valuable comments and English editing. This study was supported by the Mitsubishi Corporation and by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Louda JW, 2008, COMP BIOCHEM PHYS B, V150, P385, DOI 10.1016/j.cbpb.2008.04.008; Bhagooli R, 2003, J EXP MAR BIOL ECOL, V291, P181, DOI 10.1016/S0022-0981(03)00121-7; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Louda JW, 2000, ORG GEOCHEM, V31, P1561; Kashiyama Y, 2012, P NATL ACAD SCI USA, V109, P17328, DOI 10.1073/pnas.1207347109; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; JOHANNES RE, 1970, LIMNOL OCEANOGR, V15, P822; Jones RJ, 1997, MAR ECOL PROG SER, V158, P51, DOI 10.3354/meps158051; Downs CA, 2009, AUTOPHAGY, V5, P211; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; SAKATA K, 1990, TETRAHEDRON LETT, V31, P1165, DOI 10.1016/S0040-4039(00)88754-7; DYKENS JA, 1992, J EXP BIOL, V168, P219; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Aydin N, 2003, CHEMOSPHERE, V52, P937, DOI 10.1016/S0045-6535(03)00296-0; Bhagooli R, 2002, GALAXEA JCRS, V4, P33; Bhagooli R., 2006, GALAXEA JCRS, V8, P1; BROWN BE, 1995, MAR BIOL, V122, P655, DOI 10.1007/BF00350687; CHILLIER XFD, 1993, CHEMOSPHERE, V27, P2103, DOI 10.1016/0045-6535(93)90121-K; Downs CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077173; DUSTAN P, 1979, B MAR SCI, V29, P79; FANKBONE.PV, 1971, BIOL BULL, V141, P222, DOI 10.2307/1540113; Fitt W.K., 1990, P281; Fujise L, 2013, GALAXEA, V15, P29; Fukabori Y., 1998, UMIUSHI TSUSHIN, V18, P2; GATES RD, 1990, CORAL REEFS, V8, P193, DOI 10.1007/BF00265010; Goericke R, 2000, LIMNOL OCEANOGR, V45, P200; HARRIS PG, 1995, ORG GEOCHEM, V23, P183, DOI 10.1016/0146-6380(95)00006-Z; Hernández Luis, 2010, Rev. Mex. Biodiv., V81, P113; Higuchi T, 2013, J EXP MAR BIOL ECOL, V440, P54, DOI 10.1016/j.jembe.2012.11.011; KARUSO P, 1986, TETRAHEDRON LETT, V27, P2177, DOI 10.1016/S0040-4039(00)84480-9; Kashiyama Y, 2013, FEBS LETT, V587, P2578, DOI 10.1016/j.febslet.2013.06.036; Kashiyama Y, 2014, CHEM LETT, V43, P148, DOI 10.1246/cl.131005; Kashiyama Y., 2014, PEER REV 8 INT C PRO; Kuroki T., 1999, GALAXEA, V1, P97, DOI DOI 10.3755/JCRS.1999.97; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; Mawson DH, 2008, ORG GEOCHEM, V39, P203, DOI 10.1016/j.orggeochem.2007.10.005; Mise T., 2003, GALAXEA JCRS, V5, P33, DOI DOI 10.1016/S0921-8009(99)00009-9; Ocampo R, 1999, GEOCHIM COSMOCHIM AC, V63, P3743, DOI 10.1016/S0016-7037(99)00168-4; Papina M, 2007, COMP BIOCHEM PHYS B, V147, P583, DOI 10.1016/j.cbpb.2007.02.011; Paz-Garica D. A., 2012, P 12 INT COR REEF S, V9A-10, P1; Perl-Treves R., 2002, OXIDATIVE STRESS PLA, P1; Reimer James Davis, 2007, South Pacific Studies, V27, P1; Salih A., 1998, P AUSTR COR REEF SOC, P199; Schreiber U., 1998, P320; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1365-2486.2004.00895.x; STEELE RD, 1977, J ZOOL, V181, P421; Suwa R., 2006, P 10 INT COR REEF S, P267; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Titlyanov EA, 1998, MAR BIOL, V130, P471, DOI 10.1007/s002270050267; WATANABE N, 1993, J NAT PROD, V56, P305, DOI 10.1021/np50093a001; Yamada N., 2013, J PHYCOL, V50, P101; YAMAMOTO K, 1992, TETRAHEDRON LETT, V33, P2587, DOI 10.1016/S0040-4039(00)92250-0	65	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	FEB	2015	51	1					37	45		10.1111/jpy.12253		9	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CB1PU	WOS:000349400900004		
J	Idei, M; Sato, S; Nagasato, C; Motomura, T; Toyoda, K; Nagumo, T; Mann, DG				Idei, Masahiko; Sato, Shinya; Nagasato, Chikako; Motomura, Taizo; Toyoda, Kensuke; Nagumo, Tamotsu; Mann, David G.			SPERMATOGENESIS AND AUXOSPORE STRUCTURE IN THE MULTIPOLAR CENTRIC DIATOM HYDROSERA	JOURNAL OF PHYCOLOGY			English	Article						auxospore; Bacillariophyta; diatom; Hydrosera; incunabula; initial cell; morphogenesis; shape generation; spermatogenesis	SEXUAL REPRODUCTION; INITIAL CELL; FINE-STRUCTURE; LIFE-HISTORY; RHOICOSPHENIA BACILLARIOPHYTA; SIZE-REDUCTION; PERIZONIUM; EVOLUTION; ULTRASTRUCTURE; MORPHOLOGY	Spermatogenesis and auxospore development were studied in the freshwater centric diatom Hydrosera triquetra. Spermatogenesis was unusual, lacking depauperating cell divisions within the spermatogonangium. Instead, a series of mitoses occurred within an undivided cell to produce a multinucleate plasmodium with peripheral nuclei, which then underwent meiosis. 32 or 64 sperm budded off from the plasmodium leaving a large residual cell containing all the chloroplasts. Similar development apparently occurs in Pleurosira, Aulacodiscus, and Guinardia, these being so distantly related that independent evolution of plasmodial spermatogenesis seems likely. After presumed fertilization, the Hydrosera egg cell expanded distally to form a triangular end part. However, unlike in other triangular diatoms (Lithodesmium, Triceratium), the development of triradiate symmetry was not controlled by the "canonical" method of a perizonium that constrains expansion to small terminal areas of the auxospore wall. Instead, the auxospore wall lacked a perizonium and possessed only scales and a dense mat of thin, apparently entangled strips of imperforate silica. No such structures have been reported from any other centric diatoms, the closest analogs being instead the incunabular strips of some raphid diatoms (Nitzschia and Pinnularia). Whether these silica structures are formed by the normal method (intracellular deposition within a silica deposition vesicle) is unknown. As well as being more rounded than vegetative cells, the initial cell is aberrant in its structure, since it has a less polarized distribution of the "triptych" pores characteristic of the species.	[Idei, Masahiko] Bunkyo Univ, Koshigaya, Saitama 3438851, Japan; [Sato, Shinya] Fukui Prefectural Univ, Obama, Fukui 9170003, Japan; [Nagasato, Chikako; Motomura, Taizo] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Muroran Marine Stn, Muroran, Hokkaido 0510003, Japan; [Toyoda, Kensuke] Keio Univ, Dept Biol, Yokohama, Kanagawa 2238521, Japan; [Nagumo, Tamotsu] Nippon Dent Univ Tokyo, Chiyoda Ku, Tokyo 1028159, Japan; [Mann, David G.] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; [Mann, David G.] Inst Food & Agr Res & Technol IRTA, E-43540 San Carlos de la Rapita, Catalunya, Spain	Idei, M (reprint author), Bunkyo Univ, 3337 Minami Ogishima, Koshigaya, Saitama 3438851, Japan.	idei@koshigaya.bunkyo.ac.jp	Mann, David/I-9018-2014	Mann, David/0000-0003-0522-6802			Andersen R.A., 2005, ALGAL CULTURING TECH; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.2307/2410994; Amato A, 2005, J PHYCOL, V41, P542, DOI 10.1111/j.1529-8817.2005.00080.x; Ashworth MP, 2012, PHYCOLOGIA, V51, P684, DOI 10.2216/12-004.1; MANN DG, 1989, PLANT SYST EVOL, V163, P43, DOI 10.1007/BF00936152; Toyoda K, 2005, EUR J PHYCOL, V40, P269, DOI 10.1080/09670260500150511; IDEI M, 1992, BOT MAG TOKYO, V105, P649, DOI 10.1007/BF02489438; Sato S, 2008, PHYCOLOGIA, V47, P12, DOI 10.2216/07-34.1; Kaczmarska I, 2013, DIATOM RES, V28, P263, DOI 10.1080/0269249X.2013.791344; Medlin LK, 2004, PHYCOLOGIA, V43, P245, DOI 10.2216/i0031-8884-43-3-245.1; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; SCHMID AMM, 1994, PROTOPLASMA, V181, P43, DOI 10.1007/BF01666388; Poulickova A, 2006, J PHYCOL, V42, P872, DOI 10.1111/j.1529-8817.2006.00235; Jensen KG, 2003, PHYCOLOGIA, V42, P98, DOI 10.2216/i0031-8884-42-1-98.1; Pahlow M, 1997, LIMNOL OCEANOGR, V42, P1660; Mizuno M, 2008, PHYCOL RES, V56, P156, DOI 10.1111/j.1440-1835.2008.00497.x; Idei M, 2013, PROTOPLASMA, V250, P833, DOI 10.1007/s00709-012-0465-8; Mann DG, 2011, J PHYCOL, V47, P1368, DOI 10.1111/j.1529-8817.2011.01058.x; Mann DG, 2013, PHYCOLOGIA, V52, P204, DOI 10.2216/12-077.1; Friedrichs L, 2013, MAR ECOL PROG SER, V481, P41, DOI 10.3354/meps10227; Ichinomiya M, 2011, J PHYCOL, V47, P144, DOI 10.1111/j.1529-8817.2010.00926.x; Bergkvist J, 2012, LIMNOL OCEANOGR, V57, P318, DOI 10.4319/lo.2012.57.1.0318; Trobajo R, 2006, J PHYCOL, V42, P1353, DOI 10.1111/j.1529-8817.2006.00291.x; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Chang KH, 2008, ACTA GEOL SIN-ENGL, V82, P1179; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Schmid AMM, 2001, EUR J PHYCOL, V36, P307, DOI 10.1080/09670260110001735468; Chepurnov VA, 2004, INT REV CYTOL, V237, P91, DOI 10.1016/S0074-7696(04)37003-8; COHN SA, 1989, J PHYCOL, V25, P15, DOI 10.1111/j.0022-3646.1989.00015.x; Coste Michel, 2000, Systematics and Geography of Plants, V70, P373, DOI 10.2307/3668651; Crawford RM, 1975, NOVA HEDWIGIA BEIH, V53, P37; CRAWFORD R M, 1974, British Phycological Journal, V9, P9; Drebes G., 1977, NOVA HEDWIGIA S, V56, P167; Drebes G., 1972, NOVA HEDWIGIA S, V39, P95; Drebes G, 1977, BIOL DIATOMS, P250; Edgar L. A., 1979, THESIS U BRISTOL BRI; EHRLICH A, 1982, BRIT PHYCOL J, V17, P205; GEITLER L, 1969, OSTERR BOT Z, V117, P265, DOI 10.1007/BF01409279; Gersonde R., 1990, P OCEAN DRILLING PRO, V113, P365, DOI DOI 10.2973/0DP.PR0C.SR.113.127.1990; HARWOOD D. M., 2007, PALEONTOLOGICAL SOC, V13, P33; HEATH IB, 1972, J PHYCOL, V8, P51, DOI 10.1111/j.0022-3646.1972.00051.x; Hoppenrath M, 2009, MARINE PHYTOPLANKTON; HUSTEDT F., 1937, ARCH HYDROBIOL S, V15, p[131, 638, 9]; Idei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041890; Idei M, 2013, PHYCOLOGIA, V52, P295, DOI 10.2216/12-021.1; Kaczmarska I, 2001, P 16 INT DIAT S U AT, P153; KUROIWA T, 1980, CELL STRUCT FUNCT, V5, P195; LI CW, 1977, BRIT PHYCOL J, V12, P203; MANN DG, 1994, LINNEAN SOC, P17; Mann D. G., 1984, P 7 INT DIAT S, P113; MANN D. G., 2007, UNRAVELLING ALGAE PR, P231; MANN DG, 1982, J PHYCOL, V18, P264; MANN DG, 1984, J PHYCOL, V20, P544, DOI 10.1111/j.0022-3646.1984.00544.x; Mann DG, 1989, SYSTEMATICS ASS SPEC, V38, P305; Mann DG, 2009, FOTTEA, V9, P211; Mann DG, 1988, ALGAE AQUATIC ENV, P383; Mann DG, 2003, J PHYCOL, V39, P1067, DOI 10.1111/j.0022-3646.2003.03-011.x; Manton I., 1966, J ROY MICROSC SOC, V85, P119; Meyer B, 2001, DIATOM RES, V16, P343; Muller O., 1889, BER DEUT BOT GES, V7, P181; Nagasato C, 2009, J PHYCOL, V45, P404, DOI 10.1111/j.1529-8817.2009.00655.x; Nagumo T., 1995, DIATOM, V10, P88; Osborn M., 1982, METHOD CELL BIOL, V244, P98; PASSYTOLAR SI, 1995, J PHYCOL, V31, P447, DOI 10.1111/j.0022-3646.1995.00447.x; Pickett-Heaps J, 1990, PROGR PHYCOLOGICAL R, V7, P1; Poulickova A, 2008, J PHYCOL, V44, P350, DOI 10.1111/j.1529-8817.2008.00475.x; Poulickova A, 2007, EUR J PHYCOL, V42, P367, DOI 10.1080/09670260701476087; Qi Y. Z., 1984, P 7 INT DIAT S PHIL, P213; REYNOLDS C. S., 1984, ECOLOGY FRESHWATER P; ROEMER SC, 1980, J PHYCOL, V16, P399; Rothpletz A., 1896, Z DSCH GEOL GES, V48, P854; Rothpletz A., 1900, Z DTSCH GEOLOGISCHEN, V52, P154; ROUND FE, 1981, PROC R SOC SER B-BIO, V211, P237, DOI 10.1098/rspb.1981.0004; ROUND F. E., 1990, DIATOMS BIOL MORPHOL; Sato S, 2004, J PHYCOL, V40, P684, DOI 10.1111/j.1529-8817.2004.03164.x; Sato S, 2013, PHYCOLOGIA, V52, P225, DOI 10.2216/12-072.1; Schmid A., 1984, P 7 INT DIAT S, P47; Schmidt A., 1895, ATLAS DIATOMACEEN KU; SIMONSEN REIMER, 1965, INT REV GESAMTEN HYDROBIOL, V50, P49, DOI 10.1002/iroh.19650500104; Sims P. A., 1988, B BRIT MUS NAT HIST, V18, P275; Sommer U, 1998, J PLANKTON RES, V20, P1853, DOI 10.1093/plankt/20.9.1853; Theriot E. C., 2011, THE DIATOM WORLD, P123; Toyoda K, 2006, PHYCOL RES, V54, P173, DOI 10.1111/j.1440-1835.2006.00420.x; von Stosch H. A., 1982, BACILLARIA, V5, P127; VON STOSCH HANS A., 1964, HELGOLANDER WISSENSCHAFTLICHE MEERESUNTERSUCH, V11, P209; von STOSCH H. A., 1962, VORT GESAMTGEBIER BOT, V1, P43; Von Stosch H.A., 1973, HELGOL WISS MEERESUN, V25, P384; Williams D. M., 2001, LANGE BERTALOT FESTC, P225	88	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	FEB	2015	51	1					144	158		10.1111/jpy.12261		15	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CB1PU	WOS:000349400900012		
J	Li, Z; Han, MS; Matsuoka, K; Kim, SY; Shin, HH				Li, Zhun; Han, Myung Soo; Matsuoka, Kazumi; Kim, So Young; Shin, Hyeon Ho			IDENTIFICATION OF THE RESTING CYST OF COCHLODINIUM POLYKRIKOIDES MARGALEF (DINOPHYCEAE, GYMNODINIALES) IN KOREAN COASTAL SEDIMENTS	JOURNAL OF PHYCOLOGY			English	Article						Cochlodinium polykrikoides; morphology; resting cyst; reticulate ornament; sediment	UNARMORED DINOFLAGELLATE; MORPHOLOGY; MODELS; SEA	This study provides the first morphological features of resting cysts of Cochlodinium polykrikoides collected from Korean coastal sediments. Evidence for the existence of resting cysts of C. polykrikoides is based on the morphological and molecular phylogenetic data of the germinated cells and a resting cyst. The morphology of the resting cysts differed from that reported previously in sediments and culture experiments. The distinct feature is that the cyst body was covered by the reticulate ornaments and spines.	[Li, Zhun; Han, Myung Soo] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Li, Zhun; Shin, Hyeon Ho] Korea Inst Ocean Sci & Technol, Geoje 656830, South Korea; [Matsuoka, Kazumi] Nagasaki Univ, Inst East China Sea Res, Nagasaki 8512213, Japan; [Kim, So Young] Korea Polar Res Inst, Arctic Res Ctr, Inchon 406840, South Korea	Shin, HH (reprint author), Korea Inst Ocean Sci & Technol, Geoje 656830, South Korea.	shh961121@kiost.ac			Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [PN65760]	This research was supported by the Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (Development of autonomous microalgal identification system and feasibility analyses of developed HAB control technologies: PN65760).	Sarai C, 2013, REV PALAEOBOT PALYNO, V192, P103, DOI 10.1016/j.revpalbo.2012.12.007; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Richlen ML, 2010, HARMFUL ALGAE, V9, P163, DOI 10.1016/j.hal.2009.08.013; Shin HH, 2013, HARMFUL ALGAE, V28, P37, DOI 10.1016/j.hal.2013.05.011; Takano Y, 2004, PHYCOL RES, V52, P107, DOI 10.1111/j.1440-1835.2004.tb00319.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Matsuoka K, 2010, HARMFUL ALGAE, V9, P548, DOI 10.1016/j.hal.2010.04.003; Kim CH, 2002, PHYCOLOGIA, V41, P667, DOI 10.2216/i0031-8884-41-6-667.1; Matsuoka K, 2009, REV PALAEOBOT PALYNO, V154, P79, DOI 10.1016/j.revpalbo.2008.12.013; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Mertens KN, 2009, MAR MICROPALEONTOL, V70, P54, DOI 10.1016/j.marmicro.2008.10.004; Pospelova V, 2010, MAR MICROPALEONTOL, V76, P37, DOI 10.1016/j.marmicro.2010.04.003; MATSUOKA K, 1985, REV PALAEOBOT PALYNO, V44, P217, DOI 10.1016/0034-6667(85)90017-X; Iwataki M, 2007, PHYCOL RES, V55, P231, DOI 10.1111/j.1440-1835.2007.00466.x; Kim CJ, 2007, HARMFUL ALGAE, V6, P104, DOI 10.1016/j.hal.2006.07.004; Kokinos John P., 1995, Palynology, V19, P143; Matsuoka K, 2008, HARMFUL ALGAE, V7, P261, DOI 10.1016/j.hal.2007.12.002; MATSUOKA K., 2000, TECHNICAL GUIDE MODE; Morse RE, 2013, HARMFUL ALGAE, V28, P71, DOI 10.1016/j.hal.2013.05.013; NFRDI, 2014, HARMF ALG BLOOMS KOR; NFRDI, 2012, ANN REP NAT FISH RES; Orlova TY, 2004, BOT MAR, V47, P184, DOI 10.1515/BOT.2004.019; Park J. S., 2007, THESIS CHONNAM NATL; Park TG, 2010, HARMFUL ALGAE, V9, P59, DOI 10.1016/j.hal.2009.08.002; Rene A, 2013, HARMFUL ALGAE, V25, P39, DOI 10.1016/j.hal.2013.02.004; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Tang YZ, 2012, HARMFUL ALGAE, V20, P71, DOI 10.1016/j.hal.2012.08.001	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	FEB	2015	51	1					204	210		10.1111/jpy.12252		7	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CB1PU	WOS:000349400900016		
J	Itotani, K; Murakami, M; Itotani, M; Nagai, A; Imabori, Y; Fujimoto, K; Tanaka, M; Kato, J				Itotani, Keisuke; Murakami, Masahito; Itotani, Motoko; Nagai, Atsushi; Imabori, Yuzo; Fujimoto, Kazuyuki; Tanaka, Mamoru; Kato, Junichi			Relationship between the weight-bearing ratio on the affected lower extremity and gait ability using a portable electronic foot sensor shoe (Step Aid (R)) in hemiplegic stroke patients	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Stroke; Weight-bearing ratio; Shoe-type load-measuring apparatus		[Purpose] This study investigated the association between the weight-bearing ratio (WBR) and gait ability of a paretic lower limb while walking using a shoe-type load-measuring apparatus. [Subjects] The Subjects comprised 17 stroke patients who were classified into the following two groups: the independent walking group, and the non-independent walking group. [Methods] The 10-m walking time (inside and outside parallel bars) and the Berg Balance Scale (BBS) were measured. The WBR of the paretic lower limb was measured during static standing and while walking inside and outside parallel bars, and the coefficient of variation (CV) was calculated. WBR was evaluated using the Step Aid. [Results] The BBS and WBR were significantly decreased in the non-independent walking group, while the 10-m walking time and the CV were significantly increased in the non-independent walking group. [Conclusion] The CV and WBR of a paretic lower limb while walking appear to be important indices of achievement of independent gait in hemiplegic stroke patients, and they may be used in gait rehabilitation for diseases requiring weight-bearing training to follow the course of training using a shoe-type load-measuring apparatus.	[Itotani, Keisuke; Murakami, Masahito] Kobe Int Univ, Fac Rehabil, Dept Phys Therapy, Higashinada Ku, Kobe, Hyogo 6580032, Japan; [Itotani, Motoko] Hyogo Prefectural Rehabil Hosp, Fac Rehabil, Dept Occupat Therapy, Nishi Harima, Japan; [Nagai, Atsushi] Hyogo Prefectural Rehabil Hosp, Fac Rehabil, Dept Phys Therapy, Nishi Harima, Japan; [Imabori, Yuzo; Fujimoto, Kazuyuki; Tanaka, Mamoru] IMAC Co Ltd, Moriyama, Shiga, Japan; [Kato, Junichi] Hyogo Prefectural Rehabil Hosp, Nishi Harima, Japan; [Itotani, Keisuke] Kobe Univ, Grad Sch Hlth Sci, Masters Program, Kobe, Hyogo, Japan	Itotani, K (reprint author), Kobe Int Univ, Fac Rehabil, Dept Phys Therapy, Higashinada Ku, 9-1-6 Koyou Cho, Kobe, Hyogo 6580032, Japan.	itotani@kobe-kiu.ac.jp					Akezaki Y, 2009, RIGAKURYOHO KAGAKU, V24, P41; Marigold DS, 2006, GAIT POSTURE, V23, P249, DOI 10.1016/j.gaitpost.2005.03.001; BERG K, 1989, Physiotherapy Canada, V41, P304; Bohannon R W, 1991, J Stroke Cerebrovasc Dis, V1, P65, DOI 10.1016/S1052-3057(11)80003-0; Brunnstrom S, 1966, Phys Ther, V46, P357; Femery VG, 2004, ARCH PHYS MED REHAB, V85, P1724, DOI 10.1016/j.apmr.2003.11.031; Hustedt Joshua W., 2012, Yale Journal of Biology and Medicine, V85, P119; Marthins EF, 2011, P 14 INT C INF FUS C, P1; Tanaka S, 2000, J PHYS THER SCI, V12, P101, DOI 10.1589/jpts.12.101	9	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					321	323				3	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100003		
J	Ito, K; Nozoe, T; Okuda, M; Nonaka, K; Yamahara, J; Horie, J; Hayama, Y; Kawamura, H				Ito, Kenichi; Nozoe, Tatsuo; Okuda, Miyuki; Nonaka, Koji; Yamahara, Jun; Horie, Jun; Hayama, Yuka; Kawamura, Hirobumi			Electrically stimulated ventilation feedback improves the ventilation pattern in patients with COPD	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Chronic obstructive pulmonary disease; Electrical stimulation; Ventilation	OBSTRUCTIVE PULMONARY-DISEASE; MUSCLE STIMULATION; LUNG-DISEASE; EXERCISE; REHABILITATION; STRENGTH; BREATHLESSNESS; MANAGEMENT; ENDURANCE; STRATEGY	[Purpose] We aimed to determine the effects of ventilation feedback using electrical stimulation on ventilation pattern during exercise in patients with chronic obstructive pulmonary disease (COPD), and develop new rehabilitation methods. [Subjects] This randomized double-blind placebo-controlled trial included 24 patients with COPD. [Methods] Phasic electrical stimulation during expiration (PESE) or a placebo was given to all the cases. Minute ventilation (VE), tidal volume (TV), respiratory rate (RR), expiratory time (Te), total respiratory time (Ttot), dead-space gas volume to tidal gas volume (VD/VT), oxygen uptake (VO2), carbon dioxide output (VCO2), Borg scale (Borg), and percutaneous oxygen saturation (SpO(2)) during rest and exercise were assessed. [Results] The placebo group showed no obvious change in ventilation measurements at rest or during exercise. However, in the PESE group, TV, Te, and Ttot significantly increased, while RR and VD/VT significantly decreased during exercise compared with the baseline measurements. Borg scores, SpO(2), VO2, or VCO2 did not differ significantly. [Conclusion] PESE improves the ventilation pattern during rest and exercise. Furthermore, PESE does not increase VO2, which may indicate an increased workload. Biofeedback may contribute to PESE effects. Stimulation applied during expiration may evoke sensations increasing prolonged expiration awareness, facilitating prolongation.	[Ito, Kenichi; Nonaka, Koji] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Habikino, Osaka 5838555, Japan; [Nozoe, Tatsuo] AntiTB Assoc, Dept Rehabil Med, Osaka Branch, Tokyo, Japan; [Okuda, Miyuki] AntiTB Assoc, Dept Internal Med, Tokyo, Japan; [Yamahara, Jun] Osaka Minami Med Ctr, Natl Hosp Org, Dept Rehabil Med, Osaka, Japan; [Horie, Jun] Kyoto Tachibana Univ, Fac Hlth Sci, Yamashina, Kyoto, Japan; [Hayama, Yuka] Baika Womens Univ, Fac Nursing, Ibaraki, Japan; [Kawamura, Hirobumi] Konan Womens Univ, Fac Nursing & Rehabil, Kobe, Hyogo, Japan	Ito, K (reprint author), Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, 3-7-30 Habikino, Habikino, Osaka 5838555, Japan.	itok@rehab.osakafu-u.ac.jp					Collins EG, 2008, AM J RESP CRIT CARE, V177, P844, DOI 10.1164/rccm.200703-477OC; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Schou L, 2012, RESP MED, V106, P1071, DOI 10.1016/j.rmed.2012.03.013; CASABURI R, 1991, AM REV RESPIR DIS, V143, P9; Neder JA, 2002, THORAX, V57, P333, DOI 10.1136/thorax.57.4.333; Vivodtzev I, 2006, CHEST, V129, P1540, DOI 10.1378/chest.129.6.1540; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Vivodtzev I, 2008, J CARDIOPULM REHABIL, V28, P79, DOI 10.1097/01.HCR.0000314201.02053.a3; Sillen MJH, 2009, CHEST, V136, P44, DOI 10.1378/chest.08-2481; Bourjeily-Habr G, 2002, THORAX, V57, P1045, DOI 10.1136/thorax.57.12.1045; Wouters EFM, 2002, THORAX, V57, P1067, DOI 10.1136/thorax.57.12.1067; Bianchi R, 2004, CHEST, V125, P459, DOI 10.1378/chest.125.2.459; Uchiyama K, 2011, J PHYS THER SCI, V23, P349; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Casaburi R, 2009, NEW ENGL J MED, V360, P1329, DOI 10.1056/NEJMct0804632; Chigira Y, 2014, J PHYS THER SCI, V26, P1041, DOI 10.1589/jpts.26.1041; Collins EG, 2003, J REHABIL RES DEV, V40, P35; Gerovasili V, 2009, CRIT CARE, V13, DOI 10.1186/cc8123; INGRAM RH, 1967, AM REV RESPIR DIS, V96, P381; Kita K, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-55; RIES AL, 1995, ANN INTERN MED, V122, P823; Ries AL, 2007, CHEST, V131, P4, DOI DOI 10.1378/CHEST.06-2418; Zanotti E, 2003, CHEST, V124, P292, DOI 10.1378/chest.124.1.292	24	1	1	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					325	330				6	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100004		
J	Tsuji, K; Ishida, H; Oba, K; Ueki, T; Fujihashi, Y				Tsuji, Keiichi; Ishida, Hiroyasu; Oba, Kaori; Ueki, Tsutomu; Fujihashi, Yuichiro			Activity of lower limb muscles during treadmill running at different velocities	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Walking; Running; Skeletal muscle	GROUND REACTION FORCES; INJURIES; SPEED; BIOMECHANICS; LOCOMOTION; RUNNERS; WALKING	[Purpose] The present study aimed to determine changes in muscle activity while moving on a treadmill at various speeds. [Subjects] The activities of the left vastus lateralis, vastus medialis, hip adductors, lateral head of gastrocnemius, medial head gastrocnemius, soleus, and tibialis anterior of 10 healthy male university students were analyzed. [Methods] University students walked, jogged, and ran for 10 minutes each in random order, and then myogenic potentials were measured 10 minutes later for 30 seconds. The flexion angle of the lower limb upon initial contact, mid stance, and toe off were measured. [Results] The average walking, jogging, and running speeds were 3.6 +/- 0.4, 6.7 +/- 0.6, and 10.4 +/- 1.3 km/h, respectively. The average electromyographic activities of the vastus medial, tibialis anterior, medial head of gastrocnemius, and lateral head of gastrocnemius significantly differed. All muscles were more active during jogging and running than walking. Only the soleus was more active during running than walking, and the activities of the hip adductors and vastus lateralis did not significantly differ. [Conclusion] Velocity is faster and the angles of the lower limbs and ground reaction force (GRF) are larger during running than walking. The vastus medialis and soleus worked more easily according to the angle of the knee joint, whereas the tibialis anterior worked more easily at faster velocities and the medial and lateral heads of the gastrocnemius worked more easily with an increased GRF.	[Tsuji, Keiichi; Ishida, Hiroyasu; Oba, Kaori; Ueki, Tsutomu; Fujihashi, Yuichiro] Heisei Coll Hlth Sci, Dept Rehabil, Gifu 5011131, Japan	Tsuji, K (reprint author), Heisei Coll Hlth Sci, Dept Rehabil, 180 Kurono, Gifu 5011131, Japan.	k.tsuji@heisei-iryou.ac.jp					Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; KOPLAN JP, 1982, JAMA-J AM MED ASSOC, V248, P3118, DOI 10.1001/jama.248.23.3118; Cheng YL, 2000, J CLIN EPIDEMIOL, V53, P315, DOI 10.1016/S0895-4356(99)00168-7; KOMI PV, 1992, CLIN SPORT MED, V11, P521; MUNRO CF, 1987, J BIOMECH, V20, P147, DOI 10.1016/0021-9290(87)90306-X; Kim MK, 2013, J PHYS THER SCI, V25, P531, DOI 10.1589/jpts.25.531; MANN RA, 1980, AM J SPORT MED, V8, P345, DOI 10.1177/036354658000800510; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; Arampatzis A, 1999, J BIOMECH, V32, P1349, DOI 10.1016/S0021-9290(99)00133-5; Browning KH, 2001, PHYSICIAN SPORTSMED, V29, P23, DOI 10.3810/psm.2001.01.303; Brownstein B, 1985, J Orthop Sports Phys Ther, V6, P309; Chou LH, 2004, ARCH PHYS MED REHAB, V85, pS59, DOI 10.1053/j.apmr.2003.11.009; HRELJAC A, 1995, HUM MOVEMENT SCI, V14, P205, DOI 10.1016/0167-9457(95)00017-M; Hreljac Alan, 2005, Phys Med Rehabil Clin N Am, V16, P651, DOI 10.1016/j.pmr.2005.02.002; Imai K, 2010, JPN J CLIN SPORTS ME, V18, P13; Kluitenberg B, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-235; Lahr D D, 1996, Md Med J, V45, P641; Mercer JA, 2002, EUR J APPL PHYSIOL, V87, P403, DOI 10.1007/s00421-002-0646-9; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Ono T, 2002, J PHYS THER SCI, V14, P57, DOI 10.1589/jpts.14.57; Rose J, 2006, HUMAN WALKING, P111; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Tsuji K, 2012, J PHYS THER SCI, V24, P23	23	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					353	356				4	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100009		
J	Nagano, K; Hori, H; Muramatsu, K				Nagano, Katsuhito; Hori, Hideaki; Muramatsu, Ken			A comparison of at-home walking and 10-meter walking test parameters of individuals with post-stroke hemiparesis	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						At-home walking; Stride length; Step rate	COMMUNITY AMBULATION; STROKE PATIENTS; GAIT; VALIDITY; SPEED	[Purpose] The purpose of this study was to clarify the difference in gait parameters of at-home walking and the 10-meter walking test results of individuals with hemiparesis. [Subjects] A total of 14 hemiparetic stroke recovery patients participated in this study. Inclusion criteria were: living at home, the ability to walk independently, and demonstrated low extremity on recovery stages III-V on the Brunnstrom Approach. The average age of the subjects was 66 years. [Methods] We used video surveillance and the inked footprint technique to record usual walking speed and maximum speed patterns both in subjects' homes and during the 10-meter walking test. From these methods, walking speed, stride length, and step rate were calculated. [Results] While both usual and maximum walking speeds of the 10-meter walking test correlated with stride length and step rate, at-home walking speeds only significantly correlated with stride length. [Conclusion] Walking patterns of the 10-meter walking test are quantifiably distinct from those demonstrated in patients' homes, and this difference is mainly characterized by stride length. In order to enhance in-home walking ability, exercises that improve length of stride rather than step rate should be recommended.	[Nagano, Katsuhito; Hori, Hideaki] Fukui Coll Hlth Sci, Fac Rehabil, Dept Phys Therapy, Fukui 9103190, Japan; [Muramatsu, Ken] Hlth Sci Univ, Dept Phys Therapy, Tobetsu, Hokkaido, Japan	Nagano, K (reprint author), Fukui Coll Hlth Sci, Fac Rehabil, Dept Phys Therapy, 56 Egami Cho 13-1, Fukui 9103190, Japan.	hisano-fchs@kmj.biglobe.ne.jp					Alzahrani M, 2011, REV BRAS FISIOTER, V15, P45, DOI 10.1590/S1413-35552011005000002; Maeda A, 2000, AM J PHYS MED REHAB, V79, P519, DOI 10.1097/00002060-200011000-00008; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P27, DOI 10.1016/S0003-9993(95)80038-7; Lord S, 2008, CLIN REHABIL, V22, P215, DOI 10.1177/0269215507081922; Ng SSM, 2012, J REHABIL MED, V44, P43, DOI 10.2340/16501977-0906; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Mudge S, 2009, ARCH PHYS MED REHAB, V90, P296, DOI 10.1016/j.apmr.2008.07.025; Burns AS, 2011, NEUROREHAB NEURAL RE, V25, P149, DOI 10.1177/1545968310376756; CLARKSON BH, 1983, PHYS THER, V63, P345; Hammaren E, 2014, NEUROMUSCULAR DISORD, V24, P207, DOI 10.1016/j.nmd.2013.12.003; Kollen B, 2006, ARCH PHYS MED REHAB, V87, P358, DOI 10.1016/j.apmr.2005.11.007; SHORES M, 1980, PHYS THER, V60, P1163; Suzuki K, 1999, AM J PHYS MED REHAB, V78, P147, DOI 10.1097/00002060-199903000-00012; Yuasa Takao, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P37, DOI 10.2114/jpa.20.37	14	1	1	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					357	359				3	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100010		
J	Shiozu, H; Higashijima, M; Koga, T				Shiozu, Hiroyasu; Higashijima, Misako; Koga, Tomoshige			Association of sarcopenia with swallowing problems, related to nutrition and activities of daily living of elderly individuals	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Elderly; Dysphagia; Sarcopenia	CIRCUMFERENCE; DYSPHAGIA; WALKING; TIME	[Purpose] The purpose of the current study was to clarify problems associated with swallowing, related to nutrition and activities of daily living (ADL), in elderly individuals with sarcopenia. [Subjects and Methods] Seventy-seven subjects were assigned to a sarcopenia or a non-sarcopenia group according to a definition used by the European Working Group on Sarcopenia in Older People. Analyses were conducted including and excluding subjects with a central nervous system disorders in order to focus on the influence of sarcopenia. The swallowing ability, ADL, and nutrition levels were compared between the 2 groups. [Results] Swallowing function as well as ADL and nutrition levels were significantly lower in the sarcopenia group than in the non-sarcopenia group. [Conclusion] It is important to include dimensions of swallowing, nutrition, and ADL in the assessment and treatment of swallowing problems in elderly individuals with sarcopenia.	[Shiozu, Hiroyasu] Geriatr Hlth Serv Facil KIRARI, Kiinagashima Ku, Kihoku, Mie 5193204, Japan; [Shiozu, Hiroyasu] Kawasaki Univ Med Welf, Grad Sch Hlth Sci & Technol, Doctoral Program Rehabil, Kurashiki, Okayama, Japan; [Higashijima, Misako] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hlth Sci, Nagasaki, Japan; [Koga, Tomoshige] Kawasaki Univ Med Welf, Grad Sch Hlth Sci & Technol, Dept Rehabil, Kurashiki, Okayama, Japan	Shiozu, H (reprint author), Geriatr Hlth Serv Facil KIRARI, Kiinagashima Ku, 2482 Higashinagashima, Kihoku, Mie 5193204, Japan.	hiroyasu.shiozu@gmail.com			Kawasaki University of Medical Welfare research fund	The study was supported by the Kawasaki University of Medical Welfare research fund.	Humbert IA, 2008, PHYS MED REHABIL CLI, V19, P853, DOI 10.1016/j.pmr.2008.06.002; Huo M, 2009, J PHYS THER SCI, V21, P311; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Arango-Lopera VE, 2012, EUR GERIATR MED, V3, P157, DOI 10.1016/j.eurger.2011.12.001; Ney DM, 2009, NUTR CLIN PRACT, V24, P395, DOI 10.1177/0884533609332005; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Maslan J, 2011, J VOICE, V25, P709, DOI [10.1016/j.jvoice.2010.10.002, 10.1016/j.jvoicc.2010.10.002]; Ginocchio D, 2009, NUTR THER METAB, V27, P9, DOI DOI 10.5301/NTM.2012.9588; Hingorjo MR, 2012, J PAK MED ASSOC, V62, P36; JAHNKE V, 1991, HNO, V39, P442; Miyabara H, 2008, J PHYS THER SCI, V20, P59, DOI 10.1589/jpts.20.59; Mizuno K, 2005, CLIN REHABIL, V14, P174; Oguchi K, 2000, JPN J REHABIL MED, V37, P383; Oguchi K, 2000, JPN J REHABIL MED, V37, P375; Onogi K, 2002, J CLIN REHABIL, V11, P797; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366; WHO, 1995, WHO TECHN REP SER, P894; Yoshida T, 2003, JPN J DYSPHAGIA REHA, V7, P143	18	2	2	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					393	396				4	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100019		
J	Han, H; Kubo, A; Kurosawa, K; Maruichi, S; Maruyama, H				Han, Heonsoo; Kubo, Akira; Kurosawa, Kazuo; Maruichi, Shizuka; Maruyama, Hitoshi			Hip rotation range of motion in sitting and prone positions in healthy Japanese adults	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Hip rotation; ROM; Positions		[Purpose] The aim of this study was to elucidate the difference in hip external and internal rotation ranges of motion (ROM) between the prone and sitting positions. [Subjects] The subjects included 151 students. [Methods] Hip rotational ROM was measured with the subjects in the prone and sitting positions. Two-way repeated measures analysis of variance (ANOVA) was used to analyze ipsilateral hip rotation ROM in the prone and sitting positions in males and females. The total ipsilateral hip rotation ROM was calculated by adding the measured values for external and internal rotations. [Results] Ipsilateral hip rotation ROM revealed significant differences between two positions for both left and right internal and external rotations. Hip rotation ROM was significantly higher in the prone position than in the sitting position. Hip rotation ROM significantly differed between the men and women. Hip external rotation ROM was significantly higher in both positions in men; conversely, hip internal rotation ROM was significantly higher in both positions in women. [Conclusion] Hip rotation ROM significantly differed between the sexes and between the sitting and prone positions. Total ipsilateral hip rotation ROM, total angle of external rotation, and total angle of internal rotation of the left and right hips greatly varied, suggesting that hip joint rotational ROM is widely distributed.	[Han, Heonsoo; Kubo, Akira; Kurosawa, Kazuo; Maruyama, Hitoshi] Int Univ Hlth & Welf, Sch Hlth Sci, Dept Phys Therapy, Ohtawara, Tochigi 3248501, Japan	Han, H (reprint author), Int Univ Hlth & Welf, Sch Hlth Sci, Dept Phys Therapy, 2600-1 Kitakanemaru, Ohtawara, Tochigi 3248501, Japan.	han@iuhw.ac.jp					Kouyoumdjian P, 2012, ORTHOP TRAUMATOL-SUR, V98, P17, DOI 10.1016/j.otsr.2011.08.015; Cibulka MT, 2010, CLIN BIOMECH, V25, P56, DOI 10.1016/j.clinbiomech.2009.09.006; Cyriax J, 1991, ORTHOPAEDIC MED, Vone, P54; Darlene H, 1983, ORTHOPAEDIC MED, P68; GELBERMAN RH, 1987, J BONE JOINT SURG BR, V69, P75; Greene WB, 1994, CLIN MEASUREMENT JOI, P99; Katsuhira J, 2012, STAT REHABILITATION, P33; Kendall F. P., 2005, MUSCLES TESTING FUNC; Kikuchi A, 2011, RIGAKURYOHO KAGAKU, V26, P479; Kishi S, 2009, J PHYS THER SCI, V21, P253; Kondou A, 2011, JPN J PHYS THER, V45, P81; Matsui T, 2013, JPN J PHYS FIT SPORT, V62, P223; Matuzawa T, 2012, TXB PHYS THERAPY EVA, P34; Medicine TJAoR Association TJO, 1995, JPN J REHABIL MED, V32, P207; Murayama S, 2003, TOUHOKU RIGAKURYOUHO, V15, P31; Nojima E, 2005, RIGAKURYOHO KAGAKU, V20, P187, DOI 10.1589/rika.20.187; Norkin CC, 1995, MEASUREMENT JOINT MO, P3; Okabe T, 1978, SOGO RIHA, V8, P41; Sato K, 2008, RIGAKURYOHO KAGAKU, V23, P323, DOI 10.1589/rika.23.323; Shimada T, 1988, B ALLIED MED SCI KOB, V4, P103; Shirley S, DIAGNOSIS TREATMENT, P124; Simoneau GG, 1998, J ORTHOP SPORT PHYS, V28, P158; Takemasa S, 1997, KOBE DAIGAKU IGAKUBU, V13, P77; Tamari Kotaro, 2003, J Jpn Phys Ther Assoc, V6, P25, DOI 10.1298/jjpta.6.25; Uritani D, 2012, J PHYS THER SCI, V24, P863	25	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					441	445				5	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100029		
J	Yu, LL; Zhang, Q; Hu, CY; Huang, QC; Ye, M; Li, DS				Yu, Lili; Zhang, Qi; Hu, Chunying; Huang, Qiuchen; Ye, Miao; Li, Desheng			Effects of different frequencies of rhythmic auditory cueing on the stride length, cadence, and gait speed in healthy young females	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Rhythmic auditory cueing; Frequency; Gait speed	PARKINSONS-DISEASE; INDIVIDUALS; PERFORMANCE; STROKE; CUES	[Purpose] The aim of this study was to explore the effects of different frequencies of rhythmic auditory cueing (RAC) on stride length, cadence, and gait speed in healthy young females. The findings of this study might be used as clinical guidance of physical therapy for choosing the suitable frequency of RAC. [Subjects] Thirteen healthy young females were recruited in this study. [Methods] Ten meters walking tests were measured in all subjects under 4 conditions with each repeated 3 times and a 3-min seated rest period between repetitions. Subjects first walked as usual and then were asked to listen carefully to the rhythm of a metronome and walk with 3 kinds of RAC (90%, 100%, and 110% of the mean cadence). The three frequencies (90%, 100%, and 110%) of RAC were randomly assigned. Gait speed, stride length, and cadence were calculated, and a statistical analysis was performed using the SPSS (version 17.0) computer package. [Results] The gait speed and cadence of 90% RAC walking showed significant decreases compared with normal walking and 100% and 110% RAC walking. The stride length, cadence, and gait speed of 110% RAC walking showed significant increases compared with normal walking and 90% and 100% RAC walking. [Conclusion] Our results showed that 110% RAC was the best of the 3 cueing frequencies for improvement of stride length, cadence, and gait speed in healthy young females.	[Yu, Lili; Zhang, Qi; Hu, Chunying; Huang, Qiuchen; Ye, Miao; Li, Desheng] Capital Med Univ, Sch Rehabil Med, Beijing 100077, Peoples R China; [Yu, Lili; Zhang, Qi; Hu, Chunying; Huang, Qiuchen; Ye, Miao; Li, Desheng] China Rehabil Res Ctr, Dept Phys Therapy, Chiba, Japan	Hu, CY (reprint author), Capital Med Univ, Sch Rehabil Med, 10 North Rd, Beijing 100077, Peoples R China.	christinehcy@163.com					Picelli A, 2010, NEUROL SCI, V31, P423, DOI 10.1007/s10072-010-0228-2; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P668, DOI 10.1177/1545968309332879; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Bristol E, 2010, PARKINSONISM RELAT D, pS63; Hashidate H, 2011, J PHYS THER SCI, V23, P607; Hwang S, 2012, J PHYS THER SCI, V24, P553; Lee SH, 2012, J PHYS THER SCI, V24, P311; Suteerawattananon M, 2004, J NEUROL SCI, V219, P63, DOI 10.1016/j.jns.2003.12.007	8	0	0	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					485	487				3	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100040		
J	Hongsuwan, C; Eungpinichpong, W; Chatchawan, U; Yamauchi, J				Hongsuwan, Chanawong; Eungpinichpong, Wichai; Chatchawan, Uraiwan; Yamauchi, Junichiro			Effects of Thai massage on physical fitness in soccer players	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Thai massage; Physical fitness; Soccer players	TRADITIONAL MASSAGE; COMMUNITY; PAIN; EXERCISE; THERAPY; TRIALS; MOTION; RANGE	[Purpose] The aim of this study was to determine the effects of Thai massage on physical fitness in soccer players. [Subjects and Methods] Thirty-four soccer players were randomly assigned to receive either rest (the control group) or three 30-minute sessions of Thai massage over a period of 10 days. Seven physical fitness tests consisting of sit and reach, hand grip strength, 40 yards technical agility, 50-meter sprint, sit-ups, push-ups, and VO2,max were measured before and after Thai massage or rest. [Results] All the physical fitness tests were significantly improved after a single session of Thai massage, whereas only the sit and reach, and the sit-ups tests were improved in the control group. [Conclusion] Thai massage could provide an improvement in physical performance in soccer players.	[Hongsuwan, Chanawong] Khon Kaen Univ, Grad Sch, Div Exercise & Sport Sci, Khon Kaen 40002, Thailand; [Eungpinichpong, Wichai; Chatchawan, Uraiwan] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand; [Yamauchi, Junichiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Hachioji, Tokyo, Japan; [Hongsuwan, Chanawong; Eungpinichpong, Wichai] Khon Kaen Univ, Res & Training Ctr Enhancing Qual Life Working Ag, Khon Kaen, Thailand	Eungpinichpong, W (reprint author), Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand.	wiceun@yahoo.com	Eungpinichpong, Wichai/C-6039-2015	Eungpinichpong, Wichai/0000-0001-7014-1448	Research and Training Center for Enhancing Quality of Life of Working-Age People at Khon Kaen University	The authors would like to thank the subjects who participated in this study. The study was supported by the Research and Training Center for Enhancing Quality of Life of Working-Age People at Khon Kaen University. We also thank the Exercise and Sport Sciences Development and Research Group for providing some tools for data collection.	Altman DG, 1991, PRACTICAL STAT MED R; GRIZZLE JE, 1965, BIOMETRICS, V21, P467, DOI 10.2307/2528104; Hilbert JE, 2003, BRIT J SPORT MED, V37, P72, DOI 10.1136/bjsm.37.1.72; Hernandez-Reif M, 2001, INT J NEUROSCI, V106, P131, DOI 10.3109/00207450109149744; Chatchawan U, 2014, J ALTERN COMPLEM MED, V20, P486, DOI 10.1089/acm.2013.0176; KENWARD MG, 1987, STAT MED, V6, P911, DOI 10.1002/sim.4780060806; Peungsuwan P, 2014, J PHYS THER SCI, V26, P139, DOI 10.1589/jpts.26.139; Drust B, 2003, INT J SPORTS MED, V24, P395; CAFARELLI E, 1992, SPORTS MED, V14, P1, DOI 10.2165/00007256-199214010-00001; Delaney JPA, 2002, J ADV NURS, V37, P364, DOI 10.1046/j.1365-2648.2002.02103.x; Eungpinichpong W, 2008, THERAPEUTIC THAI MAS, P54; Eungpinichpong W, 2002, J ALTERN COMPLEM MED, V14, P151; Hirao A, 2014, J PHYS THER SCI, V26, P1279, DOI 10.1589/jpts.26.1279; Hoeger WW, 2002, PRINCIPLES LABS FITN; Kin S, 2006, J PHYS THER SCI, V18, P133, DOI 10.1589/jpts.18.133; Kubo A, 2012, J PHYS THER SCI, V24, P201; Leelayuwat N, 2001, J MED TECH PHY THER, V13, P13; Leivadi S, 1999, J DANCE MED SCI, V3, P108; MCKECHNIE AA, 1983, J PSYCHOSOM RES, V27, P125, DOI 10.1016/0022-3999(83)90088-0; McNair D, 1971, PROFILE MOOD STATE M; McNair PJ, 1996, BRIT J SPORT MED, V30, P318; McNair PJ, 1996, BRIT J SPORT MED, V30, P313; MORELLI M, 1990, Journal of Orthopaedic and Sports Physical Therapy, V12, P55; Senn S, 2002, CROSS OVER TRIALS CL; Stanley S, 2001, 18 C INT SOC BIOM ZU; Weinberg R, 1988, SPORT PSYCHOL, V2, P202	26	3	3	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					505	508				4	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100046		
J	Makabe, S; Makimoto, K; Kikkawa, T; Uozumi, H; Ohnuma, M; Kawamata, T				Makabe, Sachiko; Makimoto, Kiyoko; Kikkawa, Tomoko; Uozumi, Hiroaki; Ohnuma, Masahiro; Kawamata, Tomomaro			Reliability and validity of the Japanese version of the short questionnaire to assess health-enhancing physical activity (SQUASH) scale in older adults	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Physical activity scale; Older adults; Osteoarthritis	RANDOMIZED CONTROLLED-TRIAL; HIP OSTEOARTHRITIS; TOTAL JOINT; PROSPECTIVE COHORT; RISK-FACTORS; KNEE; REPLACEMENT; ARTHROPLASTY; OUTCOMES; INTERVENTION	[Purpose] We tested the reliability and validity of the Japanese version of the Short Questionnaire to Assess Health-enhancing Physical Activity scale in asymptomatic older adults and sought to confirm discriminator validity in women with osteoarthritis. [Subjects] The participants included an asymptomatic comparison group (men and women) and women with knee or hip osteoarthritis. [Methods] The test-retest method was used to assess reliability. The International Physical Activity Questionnaire was chosen to assess criterion-related validity. Discriminator validity was assessed by comparing the asymptomatic and osteoarthritis groups. [Results] Mean age for the asymptomatic groups was 63 +/- 6 years for men (n = 23) and 61 +/- 7 years for women (n = 51), and it was 63 +/- 9 years for the osteoarthritis group (n = 32). The total score and scores for all items, except for heavy housework items, were significantly correlated with the retest. Criterion-related validity showed significantly weak to moderate correlations between the respective scale categories. For discriminator validity, the total scores and scores for bicycle commuting, light housework, and three leisure items differed significantly between the asymptomatic and osteoarthritis groups. [Conclusion] The Short Questionnaire to Assess Health-enhancing Physical Activity scale is a reliable and valid measure in asymptomatic older adults, and can discriminate between osteoarthritic and asymptomatic women.	[Makabe, Sachiko] Akita Univ, Dept Clin Nursing, Akita 0108543, Japan; [Makabe, Sachiko; Makimoto, Kiyoko] Osaka Univ, Div Hlth Sci, Suita, Osaka 565, Japan; [Kikkawa, Tomoko; Uozumi, Hiroaki] Hiraka Gen Hosp, Dept Orthopaed Surg, Tokyo, Japan; [Ohnuma, Masahiro] Sendai Red Cross Hosp, Dept Orthopaed Surg, Sendai, Miyagi, Japan; [Kawamata, Tomomaro] Sendai Orthopaed Hosp, Sendai, Miyagi, Japan	Makabe, S (reprint author), Akita Univ, Dept Clin Nursing, 1-1-1 Hondo, Akita 0108543, Japan.	smaka@hs.akita-u.ac.jp			Japan Society for the Promotion of Science [23890024 2011-2012]	The authors would like to thank all the participants. We also thank Ms. Megumi Kumagai for her cooperation in data collection. This study was supported by a Grant-in-Aid for Research Activity Start-up (No. 23890024 2011-2012) from the Japan Society for the Promotion of Science.	Ageberg E, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-73; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AMSTUTZ HC, 1984, J BONE JOINT SURG AM, V66A, P228; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Jingushi S, 2010, J ORTHOP SCI, V15, P626, DOI 10.1007/s00776-010-1507-8; Naal FD, 2009, CLIN ORTHOP RELAT R, V467, P958, DOI 10.1007/s11999-008-0358-5; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Terwee CB, 2011, OSTEOARTHR CARTILAGE, V19, P620, DOI 10.1016/j.joca.2011.01.002; Pisters MF, 2012, OSTEOARTHR CARTILAGE, V20, P503, DOI 10.1016/j.joca.2012.02.002; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Hale LA, 2012, ARCH PHYS MED REHAB, V93, P27, DOI 10.1016/j.apmr.2011.08.004; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Dawson J, 1996, QUAL HEALTH CARE, V5, P81, DOI 10.1136/qshc.5.2.81; Sudo A, 2008, J ORTHOP SCI, V13, P413, DOI 10.1007/s00776-008-1254-2; Kochersberger G, 1996, ARCH PHYS MED REHAB, V77, P793, DOI 10.1016/S0003-9993(96)90258-0; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Baker G, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-44; Bossen D, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-61; Kobayashi T, 2011, NATL SURVEY SCHEDULE, P2; Koyama Y, 2008, J ORTHOP NURS, V12, P75, DOI 10.1016/j.joon.2008.07.005; Lim KI, 2014, J PHYS THER SCI, V26, P575, DOI 10.1589/jpts.26.575; Ministry of Health, GUID HLTH ENH PHYS A; Murase N, 2002, KOSEI NO SHIHYO, V49, P1; Ono R, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474/8/61; Sulsky SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031521; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Wang YY, 2011, J RHEUMATOL, V38, P350, DOI 10.3899/jrheum.091138	29	3	3	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	FEB	2015	27	2					517	522				6	Rehabilitation	Rehabilitation	CB1HN	WOS:000349378100049		
J	Inada, K; Shima, T; Ito, M; Ushijima, A; Saito, S				Inada, Kumiko; Shima, Tomoko; Ito, Mika; Ushijima, Akemi; Saito, Shigeru			Helios-positive functional regulatory T cells are decreased in decidua of miscarriage cases with normal fetal chromosomal content	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						Effector Treg; Helios; Human pregnancy; Miscarriage; Naturally occurring Treg	SPONTANEOUS-ABORTION PATIENTS; PERIPHERAL-BLOOD; RECURRENT MISCARRIAGE; INTERLEUKIN-17-PRODUCING T; ADOPTIVE TRANSFER; FOXP3 EXPRESSION; EFFECTOR-CELLS; PREGNANCY; TOLERANCE; PREECLAMPSIA	Regulatory (Treg) T cells play essential roles in the maintenance of allogeneic pregnancy in mice and humans. Recent data show that Foxp3 expression occurs in both immunosuppressive Treg and -nonsuppressive effector T (Teff) cells upon activation in humans. Samstein et al. (2012) reported that inducible Treg (iTreg) cells enforce maternal fetal tolerance in placental mammals. Therefore, we should reanalyze which types of Treg cell play an important role in the maintenance of allogeneic pregnancy. In this study, we studied the frequencies of naive Treg cells, effector Treg cells, Foxp3(+) Teff cells, Helios(+) naturally occurring Treg (nTreg) cells, and Helios(-) iTreg cells using flow cytometry. The frequencies of effector Treg cells and Foxp3(+) Teff cells among CD4(+)Foxp3(+) cells in the decidua of miscarriage cases with a normal embryo karyotype (n = 8) were significantly lower (P = 0.0105) and significantly higher (P = 0.0258) than those in normally progressing pregnancies (n = 11), respectively. However, these frequencies in miscarriages with an abnormal embryo karyotype (n = 15) were similar to those in normally progressing pregnancies. The frequencies of these cell populations in the three groups were unchanged in peripheral blood; on the other hand, most of the effector Treg cells in the decidua were Helios(+) nTreg cells and these frequencies were significantly higher than those in peripheral blood, while those among effector Treg and naive Treg cells in the decidua and peripheral blood were similar among the three groups. These data suggest that decreased Helios(+) effector nTreg might play an important role in the maintenance of pregnancy in humans. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Inada, Kumiko; Shima, Tomoko; Ito, Mika; Ushijima, Akemi; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama 9300194, Japan	Saito, S (reprint author), Toyama Univ, Dept Obstet & Gynecol, Toyama 9300194, Japan.	s30saito@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390386, 23791818, 24791107]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [a Grant-in-Aid for Scientific Research (B) 23390386, a Grant-in-Aid for Young Scientists (B) 23791818, and a Grant-in-Aid for Young Scientists (B) 24791107].	Wang WJ, 2011, J REPROD IMMUNOL, V92, P97, DOI 10.1016/j.jri.2011.08.004; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Zenclussen AC, 2006, EUR J IMMUNOL, V36, P82, DOI 10.1002/eji.200535428; Guerin LR, 2011, BIOL REPROD, V85, P397, DOI 10.1095/biolreprod.110.088591; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Yin YX, 2012, EUR J OBSTET GYN R B, V161, P177, DOI 10.1016/j.ejogrb.2011.12.023; Tilburgs T, 2009, J REPROD IMMUNOL, V82, P148, DOI 10.1016/j.jri.2009.05.003; Mei SS, 2010, FERTIL STERIL, V94, P2244, DOI 10.1016/j.fertnstert.2009.11.020; Chen T, 2013, J IMMUNOL, V191, P2273, DOI 10.4049/jimmunol.1202413; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Jin LP, 2009, CLIN IMMUNOL, V133, P402, DOI 10.1016/j.clim.2009.08.009; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Lee SK, 2011, HUM REPROD, V26, P2964, DOI 10.1093/humrep/der301; Steinborn A, 2012, CLIN EXP IMMUNOL, V167, P84, DOI 10.1111/j.1365-2249.2011.04493.x; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Winger EE, 2011, AM J REPROD IMMUNOL, V66, P320, DOI 10.1111/j.1600-0897.2011.00992.x; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SAITO S, 1992, IMMUNOLOGY, V75, P710; Tilburgs T, 2008, J IMMUNOL, V180, P5737; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; CLIFFORD K, 1994, HUM REPROD, V9, P1328; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Robertson SA, 2009, BIOL REPROD, V80, P1036, DOI 10.1095/biolreprod.108.074658; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Thaxton JE, 2013, J IMMUNOL, V190, P3639, DOI 10.4049/jimmunol.1203488; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Sasaki Y, 2007, CLIN EXP IMMUNOL, V149, P139, DOI 10.1111/j.1365-2249.2007.03397.x; Wang WJ, 2010, HUM REPROD, V25, P2591, DOI 10.1093/humrep/deq198; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Hsu P, 2012, AM J PATHOL, V181, P2149, DOI 10.1016/j.ajpath.2012.08.032; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Yang H, 2008, FERTIL STERIL, V89, P656, DOI 10.1016/j.fertnstert.2007.03.037; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Inada K, 2013, J REPROD IMMUNOL, V97, P104, DOI 10.1016/j.jri.2012.12.001; Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107; Beacher-Allan C., 2001, J IMMUNOL, V167, P1245; Darrasse-Jèze Guillaume, 2006, Immunol Lett, V102, P106; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547	46	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	FEB	2015	107						10	19		10.1016/j.jri.2014:09.053		10	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CB4JB	WOS:000349592900002		
J	Ohno, T; Satoh, M				Ohno, Tomoki; Satoh, Masaki			On the Warm Core of a Tropical Cyclone Formed near the Tropopause	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							SEA INTERACTION THEORY; HURRICANE-ANDREW 1992; YAMADA LEVEL-3 MODEL; PART II; RAPID INTENSIFICATION; VERIFICATION; INTENSITY; STABILITY; DYNAMICS; MOMENTUM	On the basis of numerical results of a three-dimensional model diagnosed using balance dynamics, a mechanism by which the upper-level warm core of tropical cyclones (TCs) forms is proposed. The numerical results reveal that an upper-level warm core develops when TCs intensify just prior to reaching the mature stage. Potential temperature budget analysis reveals that for the tendency of potential temperature, the azimuthal-mean component of advection is dominant at the upper level of the eye at the mature stage. Sawyer-Eliassen diagnosis shows that tendencies due to forced flow by diabatic heating and diffusion of tangential wind are dominant in the eye and are negatively correlated to each other. The distributions of the diabatic heating in the simulated TC are not peculiar. Therefore, it is unlikely that the heating distribution itself is the primary cause of the flow from the lower stratosphere. The analyses of forced circulations of idealized vortices show that the upper-level subsidence is enhanced in the eye when the vortex is sufficiently tall to penetrate the statically stable stratosphere. This result is deduced because the stronger inertial stability extends the response to the heating of the lower stratosphere and causes upper-level adiabatic warming. Therefore, the upper-level warm core emerges if angular momentum is transported into the lower stratosphere due to processes such as convective bursts. The present analysis suggests that TCs can be even stronger than that expected by theories in which the TC vortex is confined in the troposphere.	[Ohno, Tomoki; Satoh, Masaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan	Ohno, T (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778568, Japan.	t-ohno@aori.u-tokyo.ac.jp	Satoh, Masaki/G-3325-2015	Satoh, Masaki/0000-0003-3580-8897	Strategic Programs for Innovative Research (SPIRE) Field 3 (Projection of Planet Earth Variations for Mitigating Natural Disasters)	This study is supported partly by Strategic Programs for Innovative Research (SPIRE) Field 3 (Projection of Planet Earth Variations for Mitigating Natural Disasters), which is promoted by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Zhang DL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050578; Tomita H, 2008, J METEOROL SOC JPN, V86A, P121; Nakanishi M, 2006, BOUND-LAY METEOROL, V119, P397, DOI 10.1007/s10546-005-9030-8; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; SHAPIRO LJ, 1982, J ATMOS SCI, V39, P378, DOI 10.1175/1520-0469(1982)039<0378:TROBHT>2.0.CO;2; LOUIS JF, 1979, BOUND-LAY METEOROL, V17, P187, DOI 10.1007/BF00117978; Zhang DL, 2002, MON WEATHER REV, V130, P2745, DOI 10.1175/1520-0493(2002)130<2745:AMNSOH>2.0.CO;2; Kanada S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016582; HOLLAND GJ, 1984, Q J ROY METEOR SOC, V110, P723, DOI 10.1002/qj.49711046510; Fudeyasu H, 2011, J ATMOS SCI, V68, P430, DOI 10.1175/2010JAS3523.1; Persing J, 2003, J ATMOS SCI, V60, P2349, DOI 10.1175/1520-0469(2003)060<2349:HS>2.0.CO;2; Carsey TP, 2005, MON WEATHER REV, V133, P166, DOI 10.1175/MWR-2844.1; Tomita H, 2004, FLUID DYN RES, V34, P357, DOI 10.1016/j.fluiddyn.2004.03.003; Chen H, 2013, J ATMOS SCI, V70, P146, DOI 10.1175/JAS-D-12-062.1; Halverson JB, 2006, J ATMOS SCI, V63, P309, DOI 10.1175/JAS3596.1; Vigh JL, 2009, J ATMOS SCI, V66, P3335, DOI 10.1175/2009JAS3092.1; EMANUEL KA, 1986, J ATMOS SCI, V43, P585, DOI 10.1175/1520-0469(1986)043<0585:AASITF>2.0.CO;2; Sekiguchi M, 2008, J QUANT SPECTROSC RA, V109, P2779, DOI 10.1016/j.jqsrt.2008.07.013; Kepert J, 2001, J ATMOS SCI, V58, P2485, DOI 10.1175/1520-0469(2001)058<2485:TDOBLJ>2.0.CO;2; Satoh M, 2008, J COMPUT PHYS, V227, P3486, DOI 10.1016/j.jcp.2007.02.006; ROTUNNO R, 1987, J ATMOS SCI, V44, P542, DOI 10.1175/1520-0469(1987)044<0542:AAITFT>2.0.CO;2; Noda AT, 2010, ATMOS RES, V96, P208, DOI 10.1016/j.atmosres.2009.05.007; Dunion JP, 2011, J CLIMATE, V24, P893, DOI 10.1175/2010JCLI3496.1; Simpson J, 1998, METEOROL ATMOS PHYS, V67, P15, DOI 10.1007/BF01277500; FRANK WM, 1977, MON WEATHER REV, V105, P1119, DOI 10.1175/1520-0493(1977)105<1119:TSAEOT>2.0.CO;2; SCHUBERT WH, 1982, J ATMOS SCI, V39, P1687, DOI 10.1175/1520-0469(1982)039<1687:ISATCD>2.0.CO;2; Stern DP, 2013, J ATMOS SCI, V70, P73, DOI 10.1175/JAS-D-11-0329.1; Liu YB, 1997, MON WEATHER REV, V125, P3073, DOI 10.1175/1520-0493(1997)125<3073:AMNSOH>2.0.CO;2; Van Sang N, 2008, Q J ROY METEOR SOC, V134, P563, DOI 10.1002/qj.235; Wang H, 2014, MON WEATHER REV, V142, P29, DOI 10.1175/MWR-D-13-00070.1; Pendergrass AG, 2009, MON WEATHER REV, V137, P805, DOI 10.1175/2008MWR2657.1; Smith RK, 2008, Q J ROY METEOR SOC, V134, P1385, DOI 10.1002/qj.296; Durden SL, 2013, MON WEATHER REV, V141, P4256, DOI 10.1175/MWR-D-13-00021.1; Eliassin A., 1952, Astrophysica Norvegica, V5; Fudeyasu H, 2010, MON WEATHER REV, V138, P4305, DOI 10.1175/2010MWR3475.1; HAWKINS HF, 1968, MON WEATHER REV, V96, P617, DOI 10.1175/1520-0493(1968)096<0617:HH>2.0.CO;2; HAWKINS HF, 1976, MON WEATHER REV, V104, P418, DOI 10.1175/1520-0493(1976)104<0418:TSOASI>2.0.CO;2; Moon IJ, 2007, MON WEATHER REV, V135, P2869, DOI 10.1175/MWR3432.1; Pattnaik S, 2007, METEOROL ATMOS PHYS, V97, P127, DOI 10.1007/s00703-006-0248-x; Schubert WH, 2010, J ADV MODEL EARTH SY, V2, DOI 10.3894/JAMES.2010.2.7; Wang Y, 2007, METEOROL ATMOS PHYS, V97, P93, DOI 10.1007/s00703-006-0246-z; Willoughby HE, 2006, MON WEATHER REV, V134, P1102, DOI 10.1175/MWR3106.1	42	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	FEB	2015	72	2					551	571		10.1175/JAS-D-14-0078.1		21	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CA5NU	WOS:000348955900004		
J	Johnson, RH; Ciesielski, PE; Ruppert, JH; Katsumata, M				Johnson, Richard H.; Ciesielski, Paul E.; Ruppert, James H., Jr.; Katsumata, Masaki			Sounding-Based Thermodynamic Budgets for DYNAMO	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							MADDEN-JULIAN OSCILLATION; GENERAL-CIRCULATION MODEL; PACIFIC WARM POOL; ATMOSPHERE RESPONSE EXPERIMENT; TROPICAL CLOUD CLUSTERS; STATIC ENERGY BUDGET; LARGE-SCALE DYNAMICS; SOUTH CHINA SEA; TOGA-COARE IOP; TRIMODAL CHARACTERISTICS	The Dynamics of the Madden-Julian Oscillation (DYNAMO) field campaign, conducted over the Indian Ocean from October 2011 to March 2012, was designed to study the initiation of the Madden Julian oscillation (WO). Two prominent MJOs occurred in the experimental domain during the special observing period in October and November. Data from a northern and a southern sounding array (NSA and SSA, respectively) have been used to investigate the apparent heat sources and sinks (Q(1) and Q(2)) and radiative heating rates Q(R) throughout the life cycles of the two MJO events. The MJO signal was far stronger in the NSA than the SSA. Time series of Q(1), Q(2), and the vertical eddy flux of moist static energy reveal an evolution of cloud systems for both MJOs consistent with prior studies: shallow, nonprecipitating cumulus during the suppressed phase, followed by cumulus congestus, then deep convection during the active phase, and finally stratiform precipitation. However, the duration of these phases was shorter for the November MJO than for the October event. The profiles of Q(1) and Q(2) for the two arrays indicate a greater stratiform rain fraction for the NSA than the SSA a finding supported by TRMM measurements. Surface rainfall rates and net tropospheric QR determined as residuals from the budgets show good agreement with satellite-based estimates. The cloud radiative forcing was approximately 20% of the column-integrated convective heating and of the same amplitude as the normalized gross moist stability, leaving open the possibility of radiative convective instability for the two MJOs.	[Johnson, Richard H.; Ciesielski, Paul E.; Ruppert, James H., Jr.] Colorado State Univ, Ft Collins, CO 80523 USA; [Katsumata, Masaki] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Johnson, RH (reprint author), Colorado State Univ, Dept Atmospher Sci, 1371 Campus Delivery, Ft Collins, CO 80523 USA.	johnson@atmos.colostate.edu			National Science Foundation [AGS-1059899, AGS-1138353, AGS-1360237]; National Aeronautics and Space Administration [NNX13AF74G]; Department of Energy [DE-SC0008582]	This research has been supported by the National Science Foundation under Grants AGS-1059899, AGS-1138353, and AGS-1360237, the National Aeronautics and Space Administration under Grant NNX13AF74G, and Department of Energy Grant DE-SC0008582. Comments by Adam Sobel and two anonymous reviewers have led to considerable improvements in the manuscript. We thank Zhe Feng of PNNL for generously providing the radiative heating rates for Gan Island, ECMWF for making available its operational analyses, Thomas Birner and Wayne Schubert for helpful discussions, and Rick Taft for assistance with preparation of figures.	Wang JH, 2002, J ATMOS OCEAN TECH, V19, P981, DOI 10.1175/1520-0426(2002)019<0981:COHMEF>2.0.CO;2; Liu CT, 2007, J CLIMATE, V20, P489, DOI 10.1175/JCLI4023.1; Chikira M, 2014, J ATMOS SCI, V71, P615, DOI 10.1175/JAS-D-13-038.1; Virts KS, 2010, J ATMOS SCI, V67, P3113, DOI 10.1175/2010JAS3412.1; Kuo YH, 2004, J METEOROL SOC JPN, V82, P507, DOI 10.2151/jmsj.2004.507; Ciesielski PE, 2014, J ATMOS OCEAN TECH, V31, P741, DOI 10.1175/JTECH-D-13-00165.1; DePasquale A, 2014, J GEOPHYS RES-ATMOS, V119, P6347, DOI 10.1002/2013JD021031; Funk A, 2013, J METEOROL SOC JPN, V91, P257, DOI 10.2151/jmsj.2013-302; Zhang CD, 2013, GEOPHYS RES LETT, V40, P1223, DOI 10.1002/grl.50244; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; Raymond DJ, 2001, J ATMOS SCI, V58, P2807, DOI 10.1175/1520-0469(2001)058<2807:ANMOTM>2.0.CO;2; Hohenegger C, 2013, J ATMOS SCI, V70, P448, DOI 10.1175/JAS-D-12-089.1; L'Ecuyer TS, 2010, J CLIMATE, V23, P519, DOI 10.1175/2009JCLI3018.1; Aonashi K, 2009, J METEOROL SOC JPN, V87A, P119, DOI 10.2151/jmsj.87A.119; Figa-Saldana J, 2002, CAN J REMOTE SENS, V28, P404; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Benedict JJ, 2007, J ATMOS SCI, V64, P2332, DOI 10.1175/JAS3968.1; Xu WX, 2014, J ATMOS SCI, V71, P2859, DOI 10.1175/JAS-D-13-0372.1; Johnson RH, 2013, J ATMOS SCI, V70, P3157, DOI 10.1175/JAS-D-13-065.1; Sobel A, 2012, J ATMOS SCI, V69, P1691, DOI 10.1175/JAS-D-11-0118.1; Jiang XN, 2011, MON WEATHER REV, V139, P3208, DOI 10.1175/2011MWR3636.1; NEELIN JD, 1987, MON WEATHER REV, V115, P3, DOI 10.1175/1520-0493(1987)115<0003:MTCBOT>2.0.CO;2; Johnson RH, 1997, J ATMOS SCI, V54, P2020, DOI 10.1175/1520-0469(1997)054<2020:ETWROT>2.0.CO;2; Powell SW, 2013, J GEOPHYS RES-ATMOS, V118, P11979, DOI 10.1002/2013JD020421; Kiladis GN, 2009, REV GEOPHYS, V47, DOI 10.1029/2008RG000266; Gottschalck J, 2013, MON WEATHER REV, V141, P4173, DOI 10.1175/MWR-D-13-00022.1; Sobel A, 2013, J ATMOS SCI, V70, P187, DOI 10.1175/JAS-D-12-0189.1; Tung WW, 1999, GEOPHYS RES LETT, V26, P3117, DOI 10.1029/1999GL900607; HARTMANN DL, 1984, J ATMOS SCI, V41, P113, DOI 10.1175/1520-0469(1984)041<0113:SIOTMC>2.0.CO;2; Barnes HC, 2013, J GEOPHYS RES-ATMOS, V118, P6996, DOI 10.1002/jgrd.50375; Ruppert JH, 2015, J ATMOS SCI, V72, P1622, DOI 10.1175/JAS-D-14-0218.1; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Yoneyama K, 2013, B AM METEOROL SOC, V94, P1871, DOI 10.1175/BAMS-D-12-00157.1; Zuluaga MD, 2013, J ATMOS SCI, V70, P2713, DOI 10.1175/JAS-D-12-0311.1; JOHNSON RH, 1980, J ATMOS SCI, V37, P733, DOI 10.1175/1520-0469(1980)037<0733:DOCAMM>2.0.CO;2; Hung MP, 2013, J CLIMATE, V26, P6185, DOI 10.1175/JCLI-D-12-00541.1; Kumar BP, 2012, CLIM DYNAM, V38, P1521, DOI 10.1007/s00382-011-1115-0; HARTMANN DL, 1992, J CLIMATE, V5, P1281, DOI 10.1175/1520-0442(1992)005<1281:TEOCTO>2.0.CO;2; Kiladis GN, 2001, Q J ROY METEOR SOC, V127, P1961, DOI 10.1256/smsqj.57605; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Yu JY, 1998, J ATMOS SCI, V55, P1354, DOI 10.1175/1520-0469(1998)055<1354:ETGMSO>2.0.CO;2; Lin X, 1996, J ATMOS SCI, V53, P3367, DOI 10.1175/1520-0469(1996)053<3367:HMAROT>2.0.CO;2; Kubota T, 2007, IEEE T GEOSCI REMOTE, V45, P2259, DOI 10.1109/TGRS.2007.895337; Yoneyama K, 2008, B AM METEOROL SOC, V89, P1889, DOI 10.1175/2008BAMS2519.1; OOYAMA KV, 1990, J ATMOS SCI, V47, P2580, DOI 10.1175/1520-0469(1990)047<2580:ATFFMT>2.0.CO;2; Johnson RH, 2000, J ATMOS SCI, V57, P1497, DOI 10.1175/1520-0469(2000)057<1497:RARHRF>2.0.CO;2; Emanuel KA, 1996, J ATMOS SCI, V53, P3276, DOI 10.1175/1520-0469(1996)053<3276:MCVABS>2.0.CO;2; Raymond DJ, 2009, J ADV MODEL EARTH SY, V1, DOI 10.3894/JAMES.2009.1.9; Sobel A, 2014, J ATMOS SCI, V71, P4276, DOI 10.1175/JAS-D-14-0052.1; Johnson RH, 1999, J CLIMATE, V12, P2397, DOI 10.1175/1520-0442(1999)012<2397:TCOTC>2.0.CO;2; RANDALL DA, 1989, J ATMOS SCI, V46, P1943, DOI 10.1175/1520-0469(1989)046<1943:IARCAL>2.0.CO;2; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; Mapes B, 2006, DYNAM ATMOS OCEANS, V42, P3, DOI 10.1016/j.dynatmoce.2006.03.003; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Del Genio AD, 2012, J CLIMATE, V25, P3755, DOI 10.1175/JCLI-D-11-00384.1; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Kikuchi K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019601; Lin JL, 2004, J ATMOS SCI, V61, P2050, DOI 10.1175/1520-0469(2004)061<2050:RBOTTI>2.0.CO;2; Waite ML, 2010, J ATMOS SCI, V67, P2601, DOI 10.1175/2010JAS3357.1; Feng Z, 2014, J ATMOS OCEAN TECH, V31, P1021, DOI 10.1175/JTECH-D-13-00132.1; Schumacher C, 2003, J CLIMATE, V16, P1739, DOI 10.1175/1520-0442(2003)016<1739:SRITTA>2.0.CO;2; Wheeler MC, 2004, MON WEATHER REV, V132, P1917, DOI 10.1175/1520-0493(2004)132<1917:AARMMI>2.0.CO;2; WEBSTER PJ, 1994, REV GEOPHYS, V32, P427, DOI 10.1029/94RG01873; Zhang CD, 2013, B AM METEOROL SOC, V94, P1849, DOI 10.1175/BAMS-D-12-00026.1; Yuan J, 2013, J ATMOS SCI, V70, P465, DOI 10.1175/JAS-D-12-057.1; Thuburn J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000448; Ao CO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003216; Ciesielski PE, 2014, J METEOROL SOC JPN, V92, P385, DOI 10.2151/jmsj.2014-407; Ciesielski PE, 2003, J CLIMATE, V16, P2370, DOI 10.1175/2790.1; Ciesielski PE, 1997, J ATMOS OCEAN TECH, V14, P1264, DOI 10.1175/1520-0426(1997)014<1264:IOMPAR>2.0.CO;2; Ethicon al-Ghazali, 1992, ISLAMOCHRISTIANA, V18, P73, DOI DOI 10.1175/1520-0477(1992)073<1377:TCTC0R>2.0.C0; Fairall CW, 1996, J GEOPHYS RES-OCEANS, V101, P3747, DOI 10.1029/95JC03205; GOSNELL R, 1995, J GEOPHYS RES-OCEANS, V100, P18437, DOI 10.1029/95JC01833; Holmlund K, 2001, MON WEATHER REV, V129, P517, DOI 10.1175/1520-0493(2001)129<0517:EAQCAT>2.0.CO;2; Johnson RH, 2002, J METEOROL SOC JPN, V80, P561, DOI 10.2151/jmsj.80.561; Katsumata M, 2011, J APPL METEOROL CLIM, V50, P241, DOI 10.1175/2010JAMC2515.1; Lee MI, 2001, J GEOPHYS RES-ATMOS, V106, P14219, DOI 10.1029/2001JD900143; LUO H, 1984, MON WEATHER REV, V112, P966, DOI 10.1175/1520-0493(1984)112<0966:TLSCAH>2.0.CO;2; Mapes BE, 2003, J ATMOS SCI, V60, P2697, DOI 10.1175/1520-0469(2003)060<2697:SEIRB>2.0.CO;2; MCNAB AL, 1978, MON WEATHER REV, V106, P1317, DOI 10.1175/1520-0493(1978)106<1317:AMBSOC>2.0.CO;2; Raymond DJ, 2000, J ATMOS SCI, V57, P1286, DOI 10.1175/1520-0469(2000)057<1286:THCAAR>2.0.CO;2; SHERWOOD SC, 1994, J GEOPHYS RES-ATMOS, V99, P20829, DOI 10.1029/94JD01632; SLINGO A, 1988, Q J ROY METEOR SOC, V114, P1027, DOI 10.1002/qj.49711448209; Slingo A, 1991, Q J R METEOROL SOC, V117, P333, DOI [10.1002/ qj.49711749805, DOI 10.1002/QJ.49711749805]; STEPHENS GL, 1994, J GEOPHYS RES-ATMOS, V99, P18585, DOI 10.1029/94JD01151; Stephens GL, 2004, J CLIMATE, V17, P2213, DOI 10.1175/1520-0442(2004)017<2213:OEFTMR>2.0.CO;2; Tao WK, 2003, J ATMOS SCI, V60, P2929, DOI 10.1175/1520-0469(2003)060<2929:CSOTSC>2.0.CO;2; TRENBERTH KE, 1991, J CLIMATE, V4, P707, DOI 10.1175/1520-0442(1991)004<0707:CDFGAC>2.0.CO;2; Weller RA, 1996, J CLIMATE, V9, P1959, DOI 10.1175/1520-0442(1996)009<1959:SMAASF>2.0.CO;2; Wu XQ, 2000, J ATMOS SCI, V57, P2977, DOI 10.1175/1520-0469(2000)057<2977:EOLSFD>2.0.CO;2; Yanai M., 1993, METEOR MONOGR AM MET, V46, P39	92	9	9	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	FEB	2015	72	2					598	622		10.1175/JAS-D-14-0202.1		25	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CA5NU	WOS:000348955900006		
J	Bellenger, H; Yoneyama, K; Katsumata, M; Nishizawa, T; Yasunaga, K; Shirooka, R				Bellenger, H.; Yoneyama, K.; Katsumata, M.; Nishizawa, T.; Yasunaga, K.; Shirooka, R.			Observation of Moisture Tendencies Related to Shallow Convection	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							MADDEN-JULIAN OSCILLATION; CLOUD-TOP HEIGHT; TOGA COARE; WESTERN PACIFIC; INDIAN-OCEAN; TRIMODAL CHARACTERISTICS; TROPICAL CONVECTION; CUMULUS CONVECTION; DEEP CONVECTION; MJO	Tropospheric moisture is a key factor controlling the global climate and its variability. For instance, moistening of the lower troposphere is necessary to trigger the convective phase of a Madden-Julian oscillation (MJO). However, the relative importance of the processes controlling this moistening has yet to be quantified. Among these processes, the importance of the moistening by shallow convection is still debated. The authors use high-frequency observations of humidity and convection from the Research Vessel (R/V) Mirai that was located in the Indian Ocean ITCZ during the Cooperative Indian Ocean Experiment on Intraseasonal Variability/Dynamics of the MJO (CINDY/DYNAMO) campaign. This study is an initial attempt to directly link shallow convection to moisture variations within the lowest 4 km of the atmosphere from the convective scale to the mesoscale. Within a few tens of minutes and near shallow convection occurrences, moisture anomalies of 0.25-0.5 g kg(-1) that correspond to tendencies on the order of 10-20 g kg(-1) day(-1) between 1 and 4 km are observed and are attributed to shallow convective clouds. On the scale of a few hours, shallow convection is associated with anomalies of 0.5-1 g kg(-1) that correspond to tendencies on the order of 1-4 g kg(-1) day(-1) according to two independent datasets: lidar and soundings. This can be interpreted as the resultant mesoscale effect of the population of shallow convective clouds. Large-scale advective tendencies can be stronger than the moistening by shallow convection; however, the latter is a steady moisture supply whose importance can increase with the time scale. This evaluation of the moistening tendency related to shallow convection is ultimately important to develop and constrain numerical models.	[Bellenger, H.; Yoneyama, K.; Katsumata, M.; Yasunaga, K.; Shirooka, R.] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Nishizawa, T.] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Yasunaga, K.] Toyama Univ, Dept Earth Sci, Toyama 930, Japan	Bellenger, H (reprint author), Japan Agcy Marine Earth Sci & Technol, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	hbellenger@jamstec.go.jp	Bellenger, Hugo /B-1394-2010		NSF; NOAA; DOE; ONR; NASA; JAMSTEC	The authors express their thanks to Captain Y. Ishioka and his crew and technical staff of Global Ocean Development, Inc. for their support of observations onboard R/V Mirai. The authors also thank the editor, the three anonymous reviewers, and Dr. Fabio D'Andrea for their constructive comments and suggestions, which helped improve this article. CINDY/DYNAMO/AMIE/LASP were sponsored by NSF, NOAA, DOE, ONR, NASA, and JAMSTEC.	Agudelo PA, 2006, J CLIMATE, V19, P5519, DOI 10.1175/JCLI3924.1; Zuidema P, 2012, J ATMOS SCI, V69, P258, DOI 10.1175/JAS-D-11-0143.1; Ciesielski PE, 2014, J ATMOS OCEAN TECH, V31, P741, DOI 10.1175/JTECH-D-13-00165.1; Jensen MP, 2006, J CLIMATE, V19, P2105, DOI 10.1175/JCLI3722.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; Hohenegger C, 2013, J ATMOS SCI, V70, P448, DOI 10.1175/JAS-D-12-089.1; Yuter SE, 2005, J APPL METEOROL, V44, P385, DOI 10.1175/JAM2206.1; Masunaga H, 2013, J ATMOS SCI, V70, P2443, DOI 10.1175/JAS-D-12-0273.1; Schumacher C, 2008, MON WEATHER REV, V136, P4289, DOI 10.1175/2008MWR2275.1; Benedict JJ, 2007, J ATMOS SCI, V64, P2332, DOI 10.1175/JAS3968.1; Zuidema P, 1998, J ATMOS SCI, V55, P2220, DOI 10.1175/1520-0469(1998)055<2220:TMMITC>2.0.CO;2; Bellenger H, 2010, MON WEATHER REV, V138, P2426, DOI 10.1175/2010MWR3249.1; Xu WX, 2014, J ATMOS SCI, V71, P2859, DOI 10.1175/JAS-D-13-0372.1; Johnson RH, 2013, J ATMOS SCI, V70, P3157, DOI 10.1175/JAS-D-13-065.1; Kumar VV, 2013, J GEOPHYS RES-ATMOS, V118, P8375, DOI 10.1002/jgrd.50640; Riley EM, 2011, J ATMOS SCI, V68, P3032, DOI 10.1175/JAS-D-11-030.1; Powell SW, 2013, J GEOPHYS RES-ATMOS, V118, P11979, DOI 10.1002/2013JD020421; Gottschalck J, 2013, MON WEATHER REV, V141, P4173, DOI 10.1175/MWR-D-13-00022.1; Barnes HC, 2013, J GEOPHYS RES-ATMOS, V118, P6996, DOI 10.1002/jgrd.50375; Thayer-Calder K, 2009, J ATMOS SCI, V66, P3297, DOI 10.1175/2009JAS3081.1; Ruppert JH, 2015, J ATMOS SCI, V72, P1622, DOI 10.1175/JAS-D-14-0218.1; Yoneyama K, 2013, B AM METEOROL SOC, V94, P1871, DOI 10.1175/BAMS-D-12-00157.1; Zuluaga MD, 2013, J ATMOS SCI, V70, P2713, DOI 10.1175/JAS-D-12-0311.1; Kemball-Cook SR, 2001, J CLIMATE, V14, P780, DOI 10.1175/1520-0442(2001)014<0780:TOOCIT>2.0.CO;2; Johnson RH, 2001, J ATMOS SCI, V58, P2729, DOI 10.1175/1520-0469(2001)058<2729:MVOTAM>2.0.CO;2; Cai QQ, 2013, J CLIMATE, V26, P2417, DOI 10.1175/JCLI-D-12-00127.1; Takayabu YN, 2006, J METEOROL SOC JPN, V84A, P151, DOI 10.2151/jmsj.84A.151; Straub KH, 2002, J ATMOS SCI, V59, P30, DOI 10.1175/1520-0469(2002)059<0030:OOACCK>2.0.CO;2; Redelsperger JL, 2002, J ATMOS SCI, V59, P2438, DOI 10.1175/1520-0469(2002)059<2438:RPAFLC>2.0.CO;2; Johnson RH, 1999, J CLIMATE, V12, P2397, DOI 10.1175/1520-0442(1999)012<2397:TCOTC>2.0.CO;2; Katsumata M, 2008, SOLA, V4, P101, DOI 10.2151/sola.2008-026; STEINER M, 1995, J APPL METEOROL, V34, P1978, DOI 10.1175/1520-0450(1995)034<1978:CCOTDS>2.0.CO;2; Mapes B, 2006, DYNAM ATMOS OCEANS, V42, P3, DOI 10.1016/j.dynatmoce.2006.03.003; Del Genio AD, 2012, J CLIMATE, V25, P3755, DOI 10.1175/JCLI-D-11-00384.1; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Kuang ZM, 2006, J ATMOS SCI, V63, P1895, DOI 10.1175/JAS3723.1; Kikuchi K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019601; Waite ML, 2010, J ATMOS SCI, V67, P2601, DOI 10.1175/2010JAS3357.1; Feng Z, 2014, J ATMOS OCEAN TECH, V31, P1021, DOI 10.1175/JTECH-D-13-00132.1; Takayabu YN, 1996, MON WEATHER REV, V124, P1892, DOI 10.1175/1520-0493(1996)124<1892:OOAQDW>2.0.CO;2; NITTA T, 1974, MON WEATHER REV, V102, P17, DOI 10.1175/1520-0493(1974)102<0017:HAMBAU>2.0.CO;2; Zhang GJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037340; Sakai T, 2003, APPL OPTICS, V42, P7103, DOI 10.1364/AO.42.007103; Rowe AK, 2014, J GEOPHYS RES-ATMOS, V119, P2543, DOI 10.1002/2013JD020799; Bellenger H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051294; Davison JL, 2013, J ATMOS SCI, V70, P3047, DOI 10.1175/JAS-D-12-0323.1; Duvel JP, 2013, CLIM DYNAM, V40, P857, DOI 10.1007/s00382-012-1303-6; Katsumata M, 2013, MON WEATHER REV, V141, P690, DOI 10.1175/MWR-D-12-00011.1; Kerns BW, 2014, MON WEATHER REV, V142, P1326, DOI 10.1175/MWR-D-13-00159.1; Laird NF, 2005, J ATMOS SCI, V62, P3420, DOI 10.1175/JAS3538.1; Nasuno T, 2013, SOLA, V9, P69, DOI 10.2151/sola.2013-016; Nishizawa T., 2012, P 26 INT LAS RAD C P, P147; Perry KD, 1996, J ATMOS SCI, V53, P159, DOI 10.1175/1520-0469(1996)053<0159:IOICCO>2.0.CO;2; Rapp AD, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016143; TELFORD JW, 1980, PURE APPL GEOPHYS, V118, P935, DOI 10.1007/BF01593041; TRENBERTH KE, 1991, J CLIMATE, V4, P707, DOI 10.1175/1520-0442(1991)004<0707:CDFGAC>2.0.CO;2; Wu ZH, 2003, J ATMOS SCI, V60, P377, DOI 10.1175/1520-0469(2003)060<0377:ASCDEM>2.0.CO;2; Zelinka MD, 2009, J CLIMATE, V22, P2389, DOI 10.1175/2008JCLI2452.1	59	3	3	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	FEB	2015	72	2					641	659		10.1175/JAS-D-14-0042.1		19	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CA5NU	WOS:000348955900008		
J	Ratnam, JV; Behera, SK; Yamagata, T				Ratnam, J. V.; Behera, Swadhin K.; Yamagata, Toshio			Role of Cross-Equatorial Waves in Maintaining Long Periods of Low Convective Activity over Southern Africa	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							TROPICAL-TEMPERATE TROUGHS; NORTHERN-HEMISPHERE WINTER; SOUTHWEST INDIAN-OCEAN; TELECONNECTIONS; VARIABILITY; CIRCULATION; RAINFALL; SUMMER; PROPAGATION; SYSTEMS	Periods of low convective activity over southern Africa during the peak rainy season from December to February are known to be due to the northeastward displacement of the tropical temperate trough (TIT) systems from the landmass. In this study, using Interim European Centre for Medium-Range Weather Forecasts (ECMWF) Re-Analysis (ERA-Interim) data, the authors show that the displacement of the TIT systems during long periods of low convective activity has origins in the Northern Hemisphere. Using standardized area-averaged outgoing longwave radiation (OLR) daily anomalies over southern Africa, long periods of low convective activity are defined as periods of positive OLR anomalies lasting consecutively for 5 or more days with a standard deviation of 1 or more. An eddy streamfunction anomaly composite of the periods of low convective activity shows an upper-level anomalous wave originating in the Northern Hemisphere and extending to southern Africa from the eastern Pacific and displacing the tropical-extratropical cloud bands from the southern African landmass into the southwestern Indian Ocean. The wave train is also seen to generate an anticyclonic anomaly over southern Africa, resulting in suppressed convective activity. Understanding the causes of the long periods of low convective activity will help in improving their predictability and also the predictability of seasonal rainfall over southern Africa.	[Ratnam, J. V.; Behera, Swadhin K.; Yamagata, Toshio] JAMSTEC, Applicat Lab, Yokohama, Kanagawa, Japan	Ratnam, JV (reprint author), 3173-25 Showa Machi,Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan.	jvratnam@jamstec.go.jp	Yamagata, Toshio/A-1807-2009		JICA-JST SATREPS	The authors would like to thank two anonymous reviewers for their constructive comments and suggestions, which helped to substantially improve the quality of this paper. The OLR data set used in this research is available from http://www.esrl.noaa.gov/psd/data/gridded/ and the four-times-daily ERA-Interim data was downloaded from the ECMWF data server (http://apps.ecmwf.int/datasets/data/interim_full_daily/). Daily mean values of ERA-Interim data were prepared using Climate Data Operators (CDO) software. The SST anomaly data was downloaded from http://www.esrl.noaa.gov/psd/data/gridded/data.noaa.oisst.v2.highres.html. Authors are thankful to ECMWF and Physical Sciences Division, NOAA/Earth System Research Laboratory for making the datasets available for research. NCAR Command Language (NCL) was used in deriving the streamfunction and divergent component of winds. Anomalies of all the fields were also generated using NCL. This research is funded by JICA-JST SATREPS project for iDEWS South Africa.	Usman MT, 2004, CLIMATE RES, V26, P199, DOI 10.3354/cr026199; TOMAS RA, 1994, J ATMOS SCI, V51, P1417, DOI 10.1175/1520-0469(1994)051<1417:HAVSOC>2.0.CO;2; KILADIS GN, 1992, MON WEATHER REV, V120, P1924, DOI 10.1175/1520-0493(1992)120<1924:EFOTPC>2.0.CO;2; Waugh DW, 2000, GEOPHYS RES LETT, V27, P3857, DOI 10.1029/2000GL012250; Vigaud N, 2012, CLIM DYNAM, V39, P2895, DOI 10.1007/s00382-012-1314-3; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Richard Y, 2001, INT J CLIMATOL, V21, P873, DOI 10.1002/joc.656; BLACKMON ML, 1984, J ATMOS SCI, V41, P961, DOI 10.1175/1520-0469(1984)041<0961:HSOMHF>2.0.CO;2; Macron C, 2014, J CLIMATE, V27, P1633, DOI 10.1175/JCLI-D-13-00175.1; HOSKINS BJ, 1993, J ATMOS SCI, V50, P1661, DOI 10.1175/1520-0469(1993)050<1661:RWPOAR>2.0.CO;2; HSU HH, 1992, MON WEATHER REV, V120, P1169, DOI 10.1175/1520-0493(1992)120<1169:GTITMS>2.0.CO;2; HARRISON MSJ, 1984, J CLIMATOL, V4, P547; Ratna SB, 2013, CLIM DYNAM, V41, P421, DOI 10.1007/s00382-012-1540-8; Ding QH, 2005, J CLIMATE, V18, P3483, DOI 10.1175/JCLI3473.1; SARDESHMUKH PD, 1988, J ATMOS SCI, V45, P1228, DOI 10.1175/1520-0469(1988)045<1228:TGOGRF>2.0.CO;2; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; Lyon B, 2007, J CLIMATE, V20, P5134, DOI 10.1175/JCLI4225.1; Cook KH, 2000, J CLIMATE, V13, P3789, DOI 10.1175/1520-0442(2000)013<3789:TSICZA>2.0.CO;2; Todd MC, 2004, INT J CLIMATOL, V24, P555, DOI 10.1002/joc.1023; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Fauchereau N, 2009, CLIM DYNAM, V32, P575, DOI 10.1007/s00382-008-0426-2; Hart NCG, 2010, MON WEATHER REV, V138, P2608, DOI 10.1175/2010MWR3070.1; Pohl B, 2009, CLIM DYNAM, V33, P1033, DOI 10.1007/s00382-008-0485-4; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; Todd M, 1999, CLIM DYNAM, V15, P937, DOI 10.1007/s003820050323; KAROLY DJ, 1989, J CLIMATE, V2, P1239, DOI 10.1175/1520-0442(1989)002<1239:SHCFAW>2.0.CO;2; Ratnam JV, 2014, J CLIMATE, V27, P3802, DOI 10.1175/JCLI-D-13-00431.1; WEBSTER PJ, 1982, J ATMOS SCI, V39, P722, DOI 10.1175/1520-0469(1982)039<0722:CERTML>2.0.CO;2; Hart N. C. G., 2012, THESIS U CAPE TOWN; LINDESAY JA, 1991, INT J CLIMATOL, V11, P609; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Washington R, 1999, INT J CLIMATOL, V19, P1601, DOI 10.1002/(SICI)1097-0088(19991130)19:14<1601::AID-JOC407>3.3.CO;2-S	33	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	FEB	2015	72	2					682	692		10.1175/JAS-D-14-0063.1		11	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CA5NU	WOS:000348955900010		
J	Kitamura, Y				Kitamura, Yuji			Estimating Dependence of the Turbulent Length Scales on Model Resolution Based on A Priori Analysis	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							LARGE-EDDY SIMULATION; CONVECTIVE BOUNDARY-LAYER; CLOSURE-MODEL	The Reynolds-averaged Navier-Stokes simulation (RANS) and the large-eddy simulation (LES) have been widely used to parameterize unresolved turbulent motions for the atmospheric boundary layer. However, there is an intermediate model resolution, termed terra incognita, in which neither RANS nor LES is appropriate. Although identifying an appropriate turbulent length scale is essential for an eddy-diffusivity model, it is still uncertain how transition of the length scale is between the LES and RANS regimes. In the present study, dependence of the turbulent length scale on the horizontal resolution of a numerical model is investigated using a priori analysis for a convective boundary layer to explore a turbulent parameterization scheme applicable to the terra incognita region. Here, the approaches for estimating the length scales derived from the dissipation rate of the turbulent kinetic energy and the eddy viscosity are proposed. The estimated length scale depends on both the horizontal and vertical grid sizes when the aspect ratio of the grid sizes is close to unity, while it tends to be insensitive to the vertical resolution and asymptotically converges to an upper limit as the aspect ratio increases. Analysis of the length scales divided into horizontal and vertical components reveals that anisotropy of the length scale is remarkable even though the aspect ratio is close to unity. This result suggests that the anisotropic effects of the turbulent flux in subgrid scales should be taken into consideration for a turbulence parameterization scheme.	Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan	Kitamura, Y (reprint author), Japan Meteorol Agcy, Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	kitamura@mri-jma.go.jp					DEARDORFF JW, 1980, BOUND-LAY METEOROL, V18, P495, DOI 10.1007/BF00119502; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Shin HH, 2013, J ATMOS SCI, V70, P3248, DOI 10.1175/JAS-D-12-0290.1; BLACKADAR AK, 1962, J GEOPHYS RES, V67, P3095, DOI 10.1029/JZ067i008p03095; Honnert R, 2011, J ATMOS SCI, V68, P3112, DOI 10.1175/JAS-D-11-061.1; Nakanishi M, 2009, J METEOROL SOC JPN, V87, P895, DOI 10.2151/jmsj.87.895; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Beare RJ, 2006, BOUND-LAY METEOROL, V118, P247, DOI 10.1007/s10546-004-2820-6; Sullivan PP, 2011, J ATMOS SCI, V68, P2395, DOI 10.1175/JAS-D-10-05010.1; GERMANO M, 1991, PHYS FLUIDS A-FLUID, V3, P1760, DOI 10.1063/1.857955; MOENG CH, 1988, J ATMOS SCI, V45, P3573, DOI 10.1175/1520-0469(1988)045<3573:SAOLES>2.0.CO;2; Wyngaard JC, 2004, J ATMOS SCI, V61, P1816, DOI 10.1175/1520-0469(2004)061<1816:TNMITT>2.0.CO;2; Editor, 2014, NATURE, V507, P140, DOI DOI 10.1002/QJ.2214; Hong S. Y., 2011, B AM METEOROL SOC, V93, pES6, DOI DOI 10.1175/2011BAMS3224.1; Horst TW, 2004, J ATMOS SCI, V61, P1566, DOI 10.1175/1520-0469(2004)061<1566:HFOTOS>2.0.CO;2; Kitamura Y, 2010, J METEOROL SOC JPN, V88, P813, DOI 10.2151/jmsj.2010-503; Knaepen B, 2002, PHYS FLUIDS, V14, P4235, DOI 10.1063/1.1514643; Leonard A., 1974, ADV GEOPHYSICS     A, V18, P237, DOI DOI 10.1016/S0065-2687(08)60464-1; Perot JB, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2780195; Ramachandran S, 2011, BOUND-LAY METEOROL, V139, P1, DOI 10.1007/s10546-010-9571-3; Wyngaard J. C., 2010, TURBULENCE ATMOSPHER	21	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	FEB	2015	72	2					750	762		10.1175/JAS-D-14-0189.1		13	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CA5NU	WOS:000348955900014		
J	Inatsu, M; Nakano, N; Kusuoka, S; Mukougawa, H				Inatsu, Masaru; Nakano, Naoto; Kusuoka, Seiichiro; Mukougawa, Hitoshi			Predictability of Wintertime Stratospheric Circulation Examined Using a Nonstationary Fluctuation-Dissipation Relation	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							NORTHERN-HEMISPHERE WINTER; INTERANNUAL VARIABILITY; VACILLATION MODEL; SUDDEN WARMINGS; NON-GAUSSIANITY; PART I; TROPOSPHERE; DYNAMICS; REGIMES; EVENTS	The dynamics and predictability of stratospheric low-frequency variability in the Northern Hemisphere winter are examined using a two-dimensional (2D) phase space spanned by the leading empirical orthogonal functions of the 10-hPa geopotential height field. The 2D phase space represents the variation of the strength of the polar night jet and the amplitude of zonal wavenumber-1 eddy components. A linearized nonstationary fluctuation dissipation relation (NFDR) is developed based on the deterministic drift vector and the stochastic diffusion tensor estimated from a reanalysis dataset. The authors find that the solution of the linearized NFDR with an optimal data sampling time interval for estimating the drift vector and the diffusion tensor provides a good representation in the phase space of the inhomogeneous distribution of the forecast spread of the operational ensemble forecast conducted by the Japan Meteorological Agency. In particular, the linearized NFDR captures the local maximum of the forecast spread during the onset period of the major stratospheric sudden warming events.	[Inatsu, Masaru] Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan; [Nakano, Naoto] Tohoku Univ, Adv Inst Mat Res, Sendai, Miyagi 980, Japan; [Kusuoka, Seiichiro] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 980, Japan; [Mukougawa, Hitoshi] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto, Japan	Inatsu, M (reprint author), Hokkaido Univ, Grad Sch Sci, Kita Ku, Rigaku Bldg 8,N10W8, Sapporo, Hokkaido 0600810, Japan.	inaz@mail.sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22106008, 23340141, 25610028, 26310201]; Research Program on Climate Change Adaptation - Ministry of Education, Culture, Sports, Science, and Technology of Japan; Core Research for Evolution Science and Technology - Ministry of Education, Culture, Sports, Science, and Technology of Japan	The authors thank two anonymous reviewers for providing insightful comments that helped us improve the paper. The Japanese MaeT group encouraged our collaborating works. This study was partly supported by the Research Program on Climate Change Adaptation, by Grants-in-Aid for Scientific Research 22106008, 23340141,25610028, and 26310201, and by the Core Research for Evolution Science and Technology, all funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Figures were drawn using Grid Application Development Software.	Andrews D. G., 1987, INT GEOPHYS SERIES, V40, P489; Berner J, 2005, J ATMOS SCI, V62, P2098, DOI 10.1175/JAS3468.1; NORTH GR, 1982, MON WEATHER REV, V110, P699, DOI 10.1175/1520-0493(1982)110<0699:SEITEO>2.0.CO;2; Garfinkel CI, 2010, J CLIMATE, V23, P3282, DOI 10.1175/2010JCLI3010.1; Palmer TN, 1999, J CLIMATE, V12, P575, DOI 10.1175/1520-0442(1999)012<0575:ANDPOC>2.0.CO;2; Christiansen B, 2000, J ATMOS SCI, V57, P3161, DOI 10.1175/1520-0469(2000)057<3161:CQAIVS>2.0.CO;2; Kuroda Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004123; KIMOTO M, 1993, J ATMOS SCI, V50, P2625, DOI 10.1175/1520-0469(1993)050<2625:MFRITN>2.0.CO;2; MATSUNO T, 1971, J ATMOS SCI, V28, P1479, DOI 10.1175/1520-0469(1971)028<1479:ADMOTS>2.0.CO;2; Kodera K, 2013, J GEOPHYS RES-ATMOS, V118, P8333, DOI 10.1002/jgrd.50650; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Limpasuvan V, 2004, J CLIMATE, V17, P2584, DOI 10.1175/1520-0442(2004)017<2584:TLCOTN>2.0.CO;2; Scott RK, 2006, J ATMOS SCI, V63, P2758, DOI 10.1175/JAS3797.1; Martius O, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038776; Charlton AJ, 2007, J CLIMATE, V20, P449, DOI 10.1175/JCLI3996.1; HOLTON JR, 1976, J ATMOS SCI, V33, P2218, DOI 10.1175/1520-0469(1976)033<2218:SVC>2.0.CO;2; Baschnagel J., 1999, STOCHASTIC PROCESSES; Birner T, 2008, J ATMOS SCI, V65, P3337, DOI 10.1175/2008JAS2770.1; Branstator G, 2005, J ATMOS SCI, V62, P1792, DOI 10.1175/JAS3429.1; Inatsu M, 2007, SOLA, V3, P105, DOI 10.2151/sola.2007-027; Inatsu M, 2013, J ATMOS SCI, V70, P939, DOI 10.1175/JAS-D-12-048.1; Kohma M, 2010, J CLIMATE, V23, P6438, DOI 10.1175/2010JCLI3458.1; Labitzke K., 1965, J APPL METEOROL, V4, P91, DOI 10.1175/1520-0450(1965)004<0091:OTMRBS>2.0.CO;2; Limpasuvan V, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006302; Mukougawa H, 2004, MON WEATHER REV, V132, P1764, DOI 10.1175/1520-0493(2004)132<1764:POSSWA>2.0.CO;2; Mukougawa H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022909; Naito Y, 2003, J ATMOS SCI, V60, P1380, DOI 10.1175/1520-0469(2003)060<1380:APSEOT>2.0.CO;2; Nakano N., 2014, STOCHASTIC PROCESSES, P38; Silverman BW, 1986, DENSITY ESTIMATION F; Sun L, 2012, J ATMOS SCI, V69, P768, DOI 10.1175/JAS-D-11-0144.1; Sura P, 2005, J ATMOS SCI, V62, P1391, DOI 10.1175/JAS3408.1; Taguchi M, 2002, J ATMOS SCI, V59, P3037, DOI 10.1175/1520-0469(2002)059<3037:IIVOTT>2.0.CO;2; Taguchi M, 2006, J CLIMATE, V19, P324, DOI 10.1175/JCLI3655.1; YODEN S, 1987, J ATMOS SCI, V44, P1723, DOI 10.1175/1520-0469(1987)044<1723:BPOASV>2.0.CO;2	34	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	FEB	2015	72	2					774	786		10.1175/JAS-D-14-0088.1		13	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CA5NU	WOS:000348955900016		
J	Kawano, A; Ota, S; Oide, T; Matsushima, J; Suzuki, M; Iwamoto, M; Kishimoto, T; Kitagawa, M; Araki, N; Misawa, S; Kuwabara, S; Sakaida, E; Nakaseko, C				Kawano, Asuka; Ota, Satoshi; Oide, Takashi; Matsushima, Jun; Suzuki, Masaki; Iwamoto, Masami; Kishimoto, Takashi; Kitagawa, Motoo; Araki, Nobuyuki; Misawa, Sonoko; Kuwabara, Satoshi; Sakaida, Emiko; Nakaseko, Chiaki			POEMS Syndrome: A Study of Five Autopsy Cases With Emphasis on the Significance of Subcutaneous Calciphylaxis	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Kawano, Asuka; Ota, Satoshi; Oide, Takashi; Matsushima, Jun; Suzuki, Masaki; Iwamoto, Masami; Kishimoto, Takashi; Kitagawa, Motoo; Araki, Nobuyuki; Misawa, Sonoko; Kuwabara, Satoshi; Sakaida, Emiko; Nakaseko, Chiaki] Chiba Univ, Sch Med, Chiba 280, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		11	6A	6A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000012		
J	Wakasa, B; Ikeda, T; Takeuchi, M; Ishibashi-Ueda, H; Kanayama, N; Tamura, N; Matsuda, Y; Yoshimatsti, J				Wakasa, Brnoko; Ikeda, Tomoaki; Takeuchi, Makoto; Ishibashi-Ueda, Hatsue; Kanayama, Naohiro; Tamura, Naoaki; Matsuda, Yoshio; Yoshimatsti, Jun			Maternal Death Analysis in Japan: An Autopsy-Based Study (2011-2013)	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kindai Hosp, Nara Hosp, Fac Med, Ikoma, Japan; Mie Univ, Sch Med, Tsu, Mie 514, Japan; Osaka Med Ctr Maternal & Child Hlth, Izumi, Japan; Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan; Int Univ Hlth & Welf Hosp, Nasushiobara, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		31	12A	12A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000032		
J	Athanasou, N; Lnagaki, Y; Kashima, T; Hookway, E; Tanaka, Y; Hassan, A; Oppermann, U				Athanasou, Nicholas; Lnagaki, Yusuke; Kashima, Takeshi; Hookway, Edward; Tanaka, Yasuhito; Hassan, Andrew; Oppermann, Udo			Dentine Matrix Protein (DMP-1): A Marker of Bone Formation and Mineralization in Soft Tissue Tumours	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Oxford, Nuffield Orthopaed Ctr, Oxford, England; Nara Med Univ, Kashihara, Nara 634, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		41	14A	14A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000042		
J	Fukunaga, M				Fukunaga, Masaharu			Composite Hemangioendothelioma: A Clinicopathologic Study of Nine Cases	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Fukunaga, Masaharu] Jikei Univ, Daisan Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		55	17A	17A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000056		
J	Kohashi, K; Yamamoto, H; Yamada, Y; Oda, Y				Kohashi, Kenichi; Yamamoto, Hidetaka; Yamada, Yuichi; Oda, Yoshinao			Expressions of Core Subunits of SWI/SNF Chromatin Remodeling Complex in SMARCB1/INI1-Deficient Tumors	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Kohashi, Kenichi; Yamamoto, Hidetaka; Yamada, Yuichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		66	20A	20A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000067		
J	Konishi, E; Nakashima, Y; Mono, M; Tomita, Y; Yanagisawa, A				Konishi, Eiichi; Nakashima, Yasuaki; Mono, Masayuki; Tomita, Yasuhiko; Yanagisawa, Akio			Clinicopathological Prognostic Factors of Primary Central Chondrosarcoma: Analysis of 182 Cases By Numerical Score on Histology	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kyoto Prefectural Univ Med, Kyoto, Japan; Kyoto Univ Hosp, Kyoto 606, Japan; Osaka Natl Hosp, Osaka, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		67	20A	20A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000068		
J	Motoi, T; Kato, I; Yoshida, A; Ikegami, M; Horiguchi, S; Goto, T; Hishima, T				Motoi, Toru; Kato, Ikuma; Yoshida, Akihiko; Ikegami, Masachika; Horiguchi, Shinichiro; Goto, Takahiro; Hishima, Tsunekazu			Fibroma of Tendon Sheath With Fasciitis-Like Pattern Lacks USP6 Rearrangement and Is Genetically Distinct From Nodular Fasciitis: A Chromogenic In Situ Hybridization Study	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; Cent Hosp, Natl Canc Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		75	22A	22A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000076		
J	Yamamoto, H; Taguchi, K; Yoshida, A; Kohashi, K; Oda, Y				Yamamoto, Hidetaka; Taguchi, Kenichi; Yoshida, Akihiko; Kohashi, Kenichi; Oda, Yoshinao			ALK and ROS1 Expression in Inflammatory Myofibroblastic Tumor	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kyushu Univ, Fukuoka 812, Japan; Kyushu Natl Canc Ctr, Fukuoka, Japan; Natl Canc Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		104	29A	29A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000105		
J	Eberle, C; Piscuoglio, S; Rakha, E; Yamaguchi, R; Ng, C; Weigelt, B; Reis-Filho, J; Ellis, I				Eberle, Carey; Piscuoglio, Salvatore; Rakha, Emad; Yamaguchi, Rin; Ng, Charlotte; Weigelt, Britta; Reis-Filho, Jorge; Ellis, Ian			Massively Parallel Sequencing Analysis of Infiltrating Epitheliosis of the Breast	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Nottingham, Nottingham NG7 2RD, England; Kurume Univ, Med Ctr, Kurume, Fukuoka 830, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		158	42A	42A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000159		
J	Fusco, N; Martelotto, L; Ng, C; Fuhrtnann, L; Cyrta, J; Guerini-Rocco, E; Sakr, R; Km, E; Marchio, C; Lim, R; Piscuoglio, S; Vincent-Salomon, A; Badve, S; Ichihara, S; Ellis, I; Reis, J; Weigelt, B				Fusco, Nicola; Martelotto, Luciano; Ng, Charlotte; Fuhrtnann, Lactitia; Cyrta, Joanna; Guerini-Rocco, Elena; Sakr, Rita; Km, Elizabeth; Marchio, Caterina; Lim, Raymond; Piscuoglio, Salvatore; Vincent-Salomon, Anne; Badve, Ssnil; Ichihara, Shu; Ellis, Ian; Reis-Filho, Jorge; Weigelt, Britta			Genetic Events in the Progression of Adenoid Cystic Carcinomas of the Breast To High-Grade Triple-Negative Breast Cancers	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Inst Curie, Paris, France; Indiana Univ Sch Med, Indianapolis, IN 46202 USA; Nagoya Med Ctr, Nagoya, Aichi, Japan; Univ Nottingham, Nottingham NG7 2RD, England			Martelotto, Luciano/D-1946-2015	Martelotto, Luciano/0000-0002-9625-1183				0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		170	45A	45A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000171		
J	Guerini-Rocco, E; Piscuoglio, S; Ng, C; Akram, M; Sakr, R; Fusco, N; Ichihara, S; Vincent-Salomon, A; Ellis, I; Weigelt, B; Wen, YH; Schnitt, S; Reis, J				Guerini-Rocco, Elena; Piscuoglio, Salvatore; Ng, Charlotte; Akram, Muzaffar; Sakr, Rita; Fusco, Nicola; Ichihara, Shu; Vincent-Salomon, Anne; Ellis, Ian; Weigelt, Britta; Wen, Yong Hannah; Schnitt, Stuart; Reis-Filho, Jorge			Massively Parallel Sequencing Reveals That Microglandular Adenosis Is a Clonal Neoplastic Lesion of Triple-Negative Phenotype	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Nagoya Med Ctr, Nagoya, Aichi, Japan; Inst Curie, Paris, France; Univ Nottingham, Nottingham NG7 2RD, England; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		179	47A	47A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000180		
J	Nitta, H; Kelly, B; Zhang, WJ; Farrell, M; Dennis, E; Masuda, S				Nitta, Hiroaki; Kelly, Brian; Zhang, Wenjun; Farrell, Mike; Dennis, Eslie; Masuda, Shinobu			Micro-Intratumoral Heterogeneity and Multiple Tumor Cell Subtypes of HER2-Positive, ER-Positive Breast Cancers	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Ventana Med Syst Inc, Tucson, AZ USA; Nihon Univ, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		219	58A	58A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000220		
J	Hiroshima, K; Wu, D; Hasegawa, M; Sekine, Y; Ozaki, D; Yusa, T; Tada, Y; Shimoda, H; Tagawa, M				Hiroshima, Kenzo; Wu, Di; Hasegawa, Mizue; Sekine, Yasuo; Ozaki, Daisuke; Yusa, Toshikazu; Tada, Yuji; Shimoda, Hideaki; Tagawa, Masatoshi			Usefulness of FISH Analysis Combined With Immunofluorescence in the Cytological Diagnosis of Mesothelioma in Serosal Effusions	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Tokyo Womens Med Univ, Yachiyo, Japan; Chiba Rosai Hosp, Ichihara, Chiba, Japan; Chiba Univ, Chiba, Japan; Toho Univ, Tokyo, Japan; Chiba Canc Ctr, Res Inst, Chiba 2608717, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		360	93A	93A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000361		
J	Goto, K				Goto, Keisuke			Immunohistochemistry for CD117 Is Effective in Distinguishing Cutaneous Adnexal Tumors With Apocrine/Eccrine or Sebaceous Differentiation From Other Non-Merkel Cell Epithelial Tumors of the Skin	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Goto, Keisuke] Kainan Hosp, Yatomi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		469	120A	121A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948000469		
J	Kondo, T; Nakazawa, T; Akaishi, J; Mochizuki, K; Oishi, N; Itoh, K; Katoh, R				Kondo, Tetsuo; Nakazawa, Tadao; Akaishi, Junko; Mochizuki, Kunio; Oishi, Naoki; Itoh, Koichi; Katoh, Ryohei			Clinical Impact of the Minor Proportion of Poorly Differentiated Component in Thyroid Carcinoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Yamanashi, Chuo Ku, Kofu, Yamanashi, Japan; Ito Hop, Shibuya Ku, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		533	136A	136A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001040		
J	Oishi, N; Kondo, T; Ncikazawa, T; Mochizuki, K; Kasai, K; Inoue, T; Tahara, I; Wang, JY; Yabuta, T; Hirokawa, M; Miyauchi, A; Katoh, R				Oishi, Naoki; Kondo, Tetsuo; Ncikazawa, Tadao; Mochizuki, Kunio; Kasai, Kazunari; Inoue, Tomohiro; Tahara, Ippei; Wang, Jieying; Yabuta, Tomonori; Hirokawa, Mitsuyoshi; Miyauchi, Akira; Katoh, Ryohei			BRAF and TERT Promoter Mutations in Papillary Thyroid Carcinoma of Young Age	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Yamanashi, Chuo Ku, Kofu, Yamanashi, Japan; Kuma Hosp, Kobe, Hyogo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		546	139A	139A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001053		
J	Osamura, R; Matsuda, M; Inomoto, C; Kajiwara, H				Osamura, Robert; Matsuda, Midori; Inomoto, Chic; Kajiwara, Hiroshi			High Immunohistochemical Expression of Heat Shock Protein90 in the Metastatic NET/NEC in the Liver: A Next Generation Target?	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Int Univ Hlth & Welf, Tokyo, Japan; Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		547	139A	140A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001054		
J	Osamura, R; Matsuda, M; Inomoto, C; Kajiwara, H; Matsuno, A; Teramoto, A				Osamura, Robert; Matsuda, Midori; Inomoto, Chie; Kajiwara, Hiroshi; Matsuno, Akira; Teramoto, Akira			Immunohistochemical Detection of Therapeutic Biomarkers, SSTR2, SSTR5 and p-mTOR, in Various Human Pituitary Adenomas	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Int Univ Hlth & Welf, Mita Hosp, Tokyo, Japan; Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; Teikyo Univ, Sch Med, Tokyo 173, Japan; Tokyo Rosai Occupat Dis & Injuries Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		548	140A	140A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001055		
J	Kawano, S; Kojima, M; Sugimoto, M; Takahashi, S; Saito, N; Ochiai, A				Kawano, Shingo; Kojima, Motohiro; Sugimoto, Motokazu; Takahashi, Shinichiro; Saito, Norio; Ochiai, Atsushi			Correlation Between the Elastic Modulus of Colorectal Cancer Tissue and Clinicopathological and Histological Findings	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Kawano, Shingo; Kojima, Motohiro; Sugimoto, Motokazu; Takahashi, Shinichiro; Saito, Norio; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		661	168A	168A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001168		
J	Kojima, M; Puppa, G; Richard, K; Basturk, O; Frankel, W; Vieth, M; Lugli, A; Sheahan, K; Yeh, M; Lauwers, G; Risio, M; Shimazaki, H; Iwaya, K; Kage, M; Akiba, J; Ohkura, Y; Horiguchi, S; Shomori, K; Kushima, R; Nomura, S; Ajioka, Y; Adsay, V; Ochiai, A				Kojima, Motohiro; Puppa, Giacomo; Richard, Kirsch; Basturk, Olca; Frankel, Wendy; Vieth, Michael; Lugli, Alessandro; Sheahan, Kieran; Yeh, Matthew; Lauwers, Greg; Risio, Mauro; Shimazaki, Hideyuki; Iwaya, Keiichi; Kage, Masayoshi; Akiba, Jun; Ohkura, Yasuo; Horiguchi, Shitzichiro; Shomori, Kohei; Kushima, Ryoji; Nomura, Shogo; Ajioka, Yoichi; Adsay, Volkan; Ochiai, Atsushi			Construction of an Objective Pathological Diagnostic System of Blood and Lymphatic Vessel Invasion	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Natl Canc Ctr Hosp East, Chiba, Japan; Hop Univ Geneve, Geneva, Switzerland; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; Klinikum Bayreuth, Bayreuth, Germany; Univ Bern, Bern, Switzerland; St Vincents Univ Hosp, Dublin 4, Ireland; Univ Washington, Sch Med, Seattle, WA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Inst Canc Res & Treatment, Turin, Italy; Natl Def Med Coll, Saitama, Japan; Kurume Univ, Scool Med, Fukuoka, Japan; Kyorin Univ, Grad Sch Med, Tokyo, Japan; Tokyo Metropolitan Komagome Hosp, Tokyo, Japan; Sanin Rosai Hosp, Tottori, Japan; Shiga Univ Med Sci Hosp, Otsu, Shiga, Japan; Niigata Univ, Niigata, Japan; Emory Univ, Sch Med, Atlanta, GA USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		673	171A	171A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001180		
J	Maruyama, Y; Uehara, T; Daikuhara, S; Ota, H				Maruyama, Yasuhiro; Uehara, Takeshi; Daikuhara, Seiichi; Ota, Hiroyoshi			CD44v9 Is Expressed in Human Duodenal Carcinoma and CD44v9-Positive Cancer Cells Exhibit Stem Cell-Like Features	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Maruyama, Yasuhiro; Uehara, Takeshi; Daikuhara, Seiichi; Ota, Hiroyoshi] Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		703	178A	179A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001210		
J	Nomura, R; Saito, T; Mitomi, H; Hidaka, Y; Lee, SY; Watanabe, S; Yao, T				Nomura, Ryosuke; Saito, Tsuyoshi; Mitomi, Hiroyuki; Hidaka, Yasuhiro; Lee, Se-yong; Watanabe, Sumio; Yao, Takashi			GNAS Mutation as an Alternative Mechanism of Activation of the Wnt/beta-Catenin Signaling Pathway in Gastric Adenocarcinoma of the Fundic Gland Type	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Juntendo Univ, Sch Med, Tokyo 113, Japan; Dokkyo Univ, Sch Med, Kitakobayashi, Tochigi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		716	181A	182A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001223		
J	Karram, S; Faroj, S; Fujita, K; Munari, E; Shih, LM; Chaux, A; Netto, G				Karram, Sarah; Faroj, Sheila; Fujita, Kazutoshi; Munari, Enrico; Shih, Le-Ming; Chaux, Alcides; Netto, George			Immunohistochemical Expression of ARID1a in Upper Tract Urothelial Carcinomas: A Tissue Microarray Study of 99 Cases	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Osaka Univ, Osaka, Japan; Norte Univ Sch Med, Asuncion, Paraguay								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		929	233A	233A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001436		
J	Maeda, D; Akiyama, Y				Maeda, Daichi; Akiyama, Yoshiyuki			Hunner Type (Classic) Interstitial Cystitis Is a Distinct Inflammatory Disorder Characterized By Epithelial Denudation and Pancystitis With Frequent Expansion of Clonal B-Cells	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Akita Univ, Grad Sch Med, Akita 010, Japan; Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		960	241A	241A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001467		
J	Morikawa, T; Makise, N; Ichimura, T; Fukayama, M				Morikawa, Teppei; Makise, Naohiro; Ichimura, Takashi; Fukayama, Masashi			MAGE-A Expression, Immune Microenvironment and Prognosis in Upper Urinary Tract Carcinoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Morikawa, Teppei; Makise, Naohiro; Ichimura, Takashi; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		980	246A	246A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948001487		
J	Peckova, K; Ohe, C; Kuroda, N; Martinek, P; Bulimbasic, S; Montiel, DP; Lopez, J; Condom-Mundo, E; Daum, O; Rotterova, P; Hora, M; Michal, M; Hes, O				Peckova, Kvetoslava; Ohe, Chisato; Kuroda, Naoto; Martinek, Petr; Bulimbasic, Stela; Montiel, Delia Perez; Lopez, Jose; Condom-Mundo, Enric; Daum, Ondrej; Rotterova, Pavla; Hora, Milan; Michal, Michal; Hes, Ondrej			Chromophobe Renal Cell Carcinoma With Neuroendocrine Differentiation and Neuroendocrine-Like Features. Morphologic, Immunohistochemical, Ultrastructural, and ArrayCGH Analysis of 18 Cases	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Charles Univ Prague, Plzen, Czech Republic; Charles Univ Hosp, Plzen, Czech Republic; Kansai Med Univ, Osaka, Japan; Red Cross Hosp, Kochi, Japan; Univ Hosp Dubrava, Zagreb, Croatia; Inst Nacl Cancerol, Mexico City, DF, Mexico; Cruces Univ Hosp, Baracaldo, Spain; Bellvitge Univ Hosp, Barcelona, Spain								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		995	250A	250A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002014		
J	Sarungbam, J; Hakimi, AA; Sato, Y; Ogawa, S; Jacobsen, A; Homma, Y; Morikawa, T; Kume, H; Fukayama, M; Chen, Y; Gopalan, A; Al-Ahmadie, H; Fine, S; Sirintrapun, S; Russo, P; Hsieh, J; Reuter, V; Tickoo, S				Sarungbam, Judy; Hakimi, A. Ari; Sato, Yusitke; Ogawa, Seishi; Jacobsen, Anders; Homma, Yukio; Morikawa, Teppei; Kume, Haruki; Fukayama, Masahi; Chen, Yingbei; Gopalan, Anuradha; Al-Ahmadie, Hikmat; Fine, Samson; Sirintrapun, Sahussapont; Russo, Paul; Hsieh, James; Reuter, Victor; Tickoo, Satish			TCEB1-Mutated Renal Cell Carcinoma (RCC): An Entity With Clear Cytoplasm and Prominent Fibromuscular Stroma Is Distinct From Clear Cell Renal Cell Carcinoma (ccRCC)	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Kyoto Univ, Kyoto, Kansai, Japan; Univ Tokyo, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1022	257A	257A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002041		
J	Sato, S; Suzuki, S; Naiki-Ito, A; Yamashita, Y; Kuno, T; Takahashi, S				Sato, Shinya; Suzuki, Shugo; Naiki-Ito, Aya; Yamashita, Yoriko; Kuno, Toshiya; Takahashi, Satorn			Suppressive Effect of HDAC Inhibitor, OBP-801, on Prostate Cancer Development, Proliferation, and Invasion In Vivo	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Nagoya City West Med Ctr, Nagoya, Aichi, Japan; Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan			Yamashita, Yoriko/B-9810-2011					0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1024	257A	257A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002043		
J	Sato, S; Takahashi, H; Yarozu, T; Kimura, T; Ikegami, M				Sato, Shun; Takahashi, Hiroyuki; Yarozu, Takashi; Kimura, Takahiro; Ikegami, Masahiro			Disimilar Clinicopathological and Biological Characteristics of Anterior/Transition Zone Prostate Cancer with Emphasis of Lower Incidence of ERG Overexpression	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Sato, Shun; Takahashi, Hiroyuki; Yarozu, Takashi; Kimura, Takahiro; Ikegami, Masahiro] Jikei Univ, Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1025	257A	258A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002044		
J	Tsuzuki, T; Araki, H; Kimura, T; Tanaka, K; Yamada, S; Sassa, N; Yoshino, Y; Hattori, R; Gotoh, M				Tsuzuki, Toyonori; Araki, Hidemori; Kimura, Tohru; Tanaka, Kuniaki; Yamada, Shin; Sassa, Naoto; Yoshino, Yasushi; Hattori, Ryohei; Gotoh, Momokazu			Relationship of Pathological Factors To Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Japanese Red Cross Nagoya Bairn Hosp, Nagoya, Aichi, Japan; Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan; Shakaihoken Chukyo Hosp, Nagoya, Aichi, Japan; Kariya Toyota Gen Hosp, Kariya, Aichi, Japan; Okazaki Municipal Hosp, Okazaki, Aichi, Japan; Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; Japanese Red Cross Nagoya Daiichi Hosp, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1050	263A	264A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002069		
J	Tsuzuki, T; Katoh, M; Kimura, K; Ishida, R; Sassa, N; Yoshino, Y; Hattori, R; Gotoh, M				Tsuzuki, Thyonori; Katoh, Masashi; Kimura, Kyosuke; Ishida, Ryo; Sassa, Naoto; Yoshino, Yasushi; Hattori, Ryohei; Gotoh, Momokazu			The Presence of Intraductal Carcinoma of the Prostate in Needle Biopsy Is a Significant Prognostic Parameter for Prostate Cancer Patients With Distant Metastasis	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Japanese Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan; Nagoya Univ Hosp, Nagoya, Aichi, Japan; Nagoya Med Ctr, Nagoya, Aichi, Japan; Japanese Red Cross Nagoya Daiichi Hosp, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1051	264A	264A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002070		
J	Yorozu, T; Takahashi, H; Sato, S; Miki, J; Ikegami, M				Yorozu, Takashi; Takahashi, Hiroyuki; Sato, Shun; Miki, Jun; Ikegami, Masahiro			HER2 Overexpression in Metastasizing Urothelial Carcinoma of Urinary Bladder and Upper Urinary Tracts	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Yorozu, Takashi; Takahashi, Hiroyuki; Sato, Shun; Miki, Jun; Ikegami, Masahiro] Jikei Univ, Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1074	269A	269A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002093		
J	Aman, M; Ohishi, Y; Oda, Y				Aman, Murasaki; Ohishi, Yoshihiro; Oda, Yoshinao			Expression of Protease Activated Receptor-2 Is Related To Advanced Clinical Stage and Adverse Prognosis in Ovarian Clear Cell Adenocarcinoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Aman, Murasaki; Ohishi, Yoshihiro; Oda, Yoshinao] Kyushu Univ, Fukuoka 812, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1087	272A	273A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002106		
J	Ayhan, A; Ogawa, H; Bahadirli-Talbott, A; Wu, RC; Sugimura, H; Wang, TL; Shih, IM				Ayhan, Ayse; Ogawa, Hiroshi; Bahadirli-Talbott, Asli; Wu, Ren-Chin; Sugimura, Haruhiko; Wang, Tian-Li; Shih, Ie-Ming			CCNE1 Amplification and Overexpression Characterizes Ovarian Clear Cell Carcinoma But Not Ovarian Endometrioid Carcinoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Seirei Mikatahara Hosp, Hamamatsu, Shizuoka, Japan; Chang Gung Mem Hosp, Taoyuan, Taiwan; Chang Gung Univ, Coll Med, Taoyuan, Taiwan; Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1092	273A	274A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002111		
J	Ayhan, A; Mao, TL; Rahmanto, Y; Zeppernick, F; Ogawa, H; Wu, RC; Wang, TL; Shih, IM				Ayhan, Ayse; Mao, Tsui-Lien; Rahmanto, Yohan; Zeppernick, Felix; Ogawa, Hiroshi; Wu, Ren-Chin; Wang, Tian-Li; Shih, Ie-Ming			Increased Proliferation in "Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia" of Endometrium With Concurrent Inactivation of ARID1A and PTEN Tumor Suppressors	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Seirei Mikatahara Hosp, Hamamatsu, Shizuoka, Japan; Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; Univ Hosp Aachen, Aachen, Germany; Chang Gung Mem Hosp, Taoyuan, Taiwan; Chang Gung Univ, Coll Med, Taoyuan, Taiwan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1093	274A	274A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002112		
J	Conlon, N; Kiyokawa, T; Park, K				Conlon, Niamh; Kiyokawa, Takako; Park, Kay			Endocervical Gastric-Type Adenocarcinoma: A Detailed Description of the Morphologic Heterogeneity of a Rare Entity Highlighting the Importance of Adequate Tumor Sampling	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Jikei Univ, Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1118	280A	280A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002137		
J	Fukunaga, M				Fukunaga, Masaharu			Atypical Polypoid Adenomyoma (APA) of the Uterus: A Clinicopathologic Study of 71 Cases	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Fukunaga, Masaharu] Jikei Univ, Daisan Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1135	284A	285A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002154		
J	Fukunaga, M				Fukunaga, Masaharu			Twin Placenta With Complete Hydatidiform Mole in the First Trimester: Histologic Diagnosis and Immunohistochemistry for the Imprint Gene Products P57 (Kip2) and TSSC3	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Fukunaga, Masaharu] Jikei Univ, Daisan Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1136	285A	285A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002155		
J	Maeda, D				Maeda, Daichi			Utility of Claudin-18 and p16 Immunohistochemistry for distinguishing Gastric-Type Adenocarcinoma From Other Subtypes of Cervical Adenocarcinoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Maeda, Daichi] Akita Univ, Akita 010, Japan; [Maeda, Daichi] Univ Tokyo, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1188	296A	297A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002207		
J	Uehara, K; Kawakami, F; Zen, Y; Ltoh, R; Imal, Y				Uehara, Keiichiro; Kawakami, Fumi; Zen, Yoh; Ltoh, Roman; Imal, Yakhiro			Minute Lymphangioleiomyomatosis in Pelvic and Paraaortic Lymph Nodes: A Study of 8 Cases	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Gen Hosp, Kobe City Med Ctr, Kobe, Hyogo, Japan; Kobe Univ Hosp, Kobe, Hyogo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1250	312A	312A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002269		
J	Aida, J; Yokoyama, A; Shimomura, N; Nakamura, K; Ishikawa, N; Fujiwara, M; Matsuda, Y; Arai, T; Takubo, K				Aida, Junko; Yokoyama, Akira; Shimomura, Naotaka; Nakamura, Ken-ichi; Ishikawa, Naoshi; Fujiwara, Mutsunori; Matsuda, Yoko; Arai, Tomio; Takubo, Kaiyo			Telomere Shortening in Oral Epithelium in Relation To ADH-1B and ALDH-2 Genotypes and Clinicopathologic Findings	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; Natl Hosp Org, Kurihama Alcoholism Ctr, Yokosuka, Kanagawa, Japan; Japanese Red Cross Med Ctr, Tokyo, Japan; Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1274	318A	318A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002293		
J	Yamamoto, H; Nakano, T; Nishijima, T; Oda, Y				Yamamoto, Hidetaka; Nakano, Takafumi; Nishijima, Toshimitsu; Oda, Yoshinao			A Novel Variant of EWSR1-ATF1 Fusion Gene in Hyalinizing Clear Cell Carcinoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Yamamoto, Hidetaka; Nakano, Takafumi; Nishijima, Toshimitsu; Oda, Yoshinao] Kyushu Univ, Fukuoka 812, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1338	334A	334A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002357		
J	Oishi, N; Kondo, T; Nakazawa, T; Mochizuki, K; Tanioka, F; Oyama, T; Yamamoto, T; Iizuka, J; Tanabe, K; Shibata, N; Kirito, K; Katoh, R				Oishi, Naoki; Kondo, Tetsuo; Nakazawa, Tadao; Mochizuki, Kunio; Tanioka, Fumihiko; Oyama, Toshio; Yamamoto, Tomoko; Iizuka, Junpei; Tanabe, Kazunari; Shibata, Noriyuki; Kirito, Keita; Katoh, Ryohei			High Prevalence of MYD88 Mutation in Testicular Diffuse Large B-Cell Lymphoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Yamanashi, Chuo Ku, Kofu, Yamanashi, Japan; Iwata City Hosp, Iwata, Shizuoka, Japan; Yamanashi Prefectural Cent Hosp, Kofu, Yamanashi, Japan; Tokyo Womens Med Univ, Shinjuku Ku, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1471	369A	369A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948002489		
J	Hayashi, K; Nakajima, N; Sato, Y; Arashiro, T; Suzuki, T; Katano, H; Nagata, N; Tobiume, M; Yoshida, H; Suzuki, Y; Kumasaka, T; Sata, T; Ariyoshi, K; Hasegawa, H				Hayashi, Kentaro; Nakajima, Noriko; Sato, Yuko; Arashiro, Takeshi; Suzuki, Tadaki; Katano, Harutaka; Nagata, Noriyo; Tobiume, Minoru; Yoshida, Hiroshi; Suzuki, Yoshio; Kumasaka, Toshio; Sata, Tetsutaro; Ariyoshi, Koya; Hasegawa, Hideki			Correlations Among Histopathological Characteristics, Viral Distribution, and Cytokine/Chemokine Expression Level Within an Individual With A/H1N1pdm09 Infection Induced ARDS	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Natl Inst Infect Dis, Tokyo, Japan; Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; Asashi Gen Hosp, Chiba, Japan; Japanese Red Cross Med Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1565	393A	393A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003066		
J	Nakajima, N; Sato, Y; Kotani, O; Suzuki, T; Kamei, T; Takahashi, T; Sata, T; Hasegawa, H				Nakajima, Noriko; Sato, Yuko; Kotani, Osamu; Suzuki, Tadaki; Kamei, Toshiaki; Takahashi, Toru; Sata, Tetsutaro; Hasegawa, Hideki			Modified In Situ Hybridization AT-Tailing To Visualize the Gene Expression in Formalin-Fixed and Paraffin-Embedded Tissues	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Natl Inst Infect Dis, Tokyo, Japan; Yamaguchi Grand Med Ctr, Hofu, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1570	394A	394A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003071		
J	Mai, F; Kazumi, Y; Yonezawa, H; Ueno, M; Minagawa, C; Ikeda, S; Tuneyama, K; Imura, J; Ueda, Y				Mai, Fulaida; Kazumi, Yurie; Yonezawa, Himki; Ueno, Mizuki; Minagawa, Chikage; Ikeda, Syo; Tuneyama, Koichi; Imura, Johji; Ueda, Yoshihiko			Renewed Pathological Findings in Cadmium Nephropathy of Itai-Itai Disease - Characteristic Impairment of the Superficial Nephrons and Proximal Tubules	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Grad Sch Med & Pharmaceut Sci, Toyama, Japan; Koshigaya Hosp, Dokkyo Med Sch, Koshigaya, Saitama, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1632	410A	410A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003133		
J	Muragaki, Y				Muragaki, Yastaeru			An Increased Level of Serum 1,25(OH)2-Vitamin D3 Alleviates Renal Tubulointerstitial Fibrosis Induced By Unilateral Ureteral Obstruction in Homozygous Klotho Mutant Mice	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Muragaki, Yastaeru] Wakayama Med Univ, Wakayama, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1636	411A	411A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003137		
J	Hatanaka, K; Hatanaka, Y; Fujii, K; Kobayashi, H; Kanno, H; Mitsuhashi, T; Nishihara, H; Tanaka, S; Matsuno, Y				Hatanaka, Kanako; Hatanaka, Yutaka; Fujii, Kyoko; Kobayashi, Hiroyuki; Kanno, Hiromi; Mitsuhashi, Tomoko; Nishihara, Hiroshi; Tanaka, Shinya; Matsuno, Yoshihiro			Predictive Value of MGMT Gene Promoter and LINE-1 Methylation Status in Primary Central Nervous System Diffuse Large B-Cell Lymphoma Treated With High-Dose MTX and Radiotherapy	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; Hokkaido Univ Grad Sch Med, Sapporo, Hokkaido, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1722	431A	431A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003222		
J	Sukeda, A; Mori, T; Sekine, S; Maeshima, A; Suzuki, S; Ochiai, T				Sukeda, Aoi; Mori, Taisuke; Sekine, Shigeki; Maeshima, Akiko; Suzuki, Shigenobu; Ochiai, Tsushi			SOX10 Expression and Genetic Alterations Distinguish Pigmented Ciliary Adenocarcinomas or Adenomas From Uveal Melanomas	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Natl Canc Res Ctr Hosp, Tokyo, Japan; Natl Canc Res Ctr, Res Inst, Tokyo, Japan; Natl Hosp Inst, Tokyo Med Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1748	437A	437A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003248		
J	Basturk, O; Mino-Kenudson, M; Furukowa, T; Zamboni, G; Marchegiani, G; Bassi, C; Salvia, R; Malleo, G; Paiella, S; Wolfgang, C; Matthaei, H; Offerhaus, G; Adham, M; Bruno, M; Reid, M; Krasinskas, A; Kloppel, G; Ohike, N; Tajiri, T; Jang, KT; Roa, J; Allen, P; Fernandez-del Castillo, C; Jang, JY; Klimstra, D; Hruban, R; Adsay, V				Basturk, Olca; Mino-Kenudson, Mari; Furukowa, T.; Zamboni, G.; Marchegiani, G.; Bassi, C.; Salvia, R.; Malleo, G.; Paiella, S.; Wolfgang, Christopher; Matthaei, H.; Offerhaus, G.; Adham, M.; Bruno, M.; Reid, M.; Krasinskas, A.; Kloppel, G.; Ohike, N.; Tajiri, T.; Jang, K. T.; Roa, Juan; Allen, P.; Fernandez-del Castillo, C.; Jang, J. Y.; Klimstra, D.; Hruban, R.; Adsay, Volkan			Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas: Recommendations of Verona Consensus Meeting	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; MGH, Boston, MA USA; Tokyo Womens Med Univ, Tokyo, Japan; Univ Verona, I-37100 Verona, Italy; Johns Hopkins Univ, Baltimore, MD USA; Univ Bonn, Bonn, Germany; Univ Med Ctr, Utrecht, Netherlands; E Herriot Hosp, Lyon, France; Erasmus Univ, Med Ctr, Rotterdam, Netherlands; EU, Atlanta, GA USA; Tech Univ Munich, D-80290 Munich, Germany; SMC, Seoul, South Korea; Pontificia Univ, Santiago, Chile; SNU, Seoul, South Korea								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1759	439A	439A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003259		
J	Basturk, O; Hong, SM; Wood, L; Adsay, V; Albores-Saavedra, J; Biankin, A; Brosens, L; Fukushima, N; Goggins, M; Hruban, R; Kato, Y; Kern, S; Klimstra, D; Kloppel, G; Krasinskas, A; Longnecker, D; Maitra, A; Matthei, H; Shimizu, M; Takaori, K; Terris, B; Yachida, S; Esposito, I; Furukawa, T				Basturk, Olca; Hong, Seung-Mo; Wood, Laura; Adsay, Volkan; Albores-Saavedra, Jorge; Biankin, Andrew; Brosens, Lodewijk; Fukushima, Noriyoshi; Goggins, Michael; Hruban, Ralph; Kato, Yo; Kern, Scott; Klimstra, David; Kloppel, Gunter; Krasinskas, Alyssa; Longnecker, Daniel; Maitra, Anirban; Matthei, Hanno; Shimizu, Michio; Takaori, Kyoichi; Terris, Benoit; Yachida, Shinichi; Esposito, Irene; Furukawa, Toru			Revised Recommendations for Assessing Precursor Lesions in the Pancreas	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Asan Med Ctr, Seoul, South Korea; Johns Hopkins Univ, Baltimore, MD USA; Emory Univ, Atlanta, GA 30322 USA; Med Sur Clin, Mexico City, DF, Mexico; Univ Glasgow, Glasgow, Lanark, Scotland; Univ Med Ctr, Utrecht, Netherlands; Jichi Med Univ, Shimotsuke, Japan; Japanese Fdn Canc Res, Tokyo, Japan; Tech Univ Munich, Munich, Germany; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Bonn, Bonn, Germany; Saitama Med Univ, Saitama, Japan; Kyoto Univ, Kyoto, Japan; Hop Cochin, F-75674 Paris, France; Natl CC, Tokyo, Japan; Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1760	440A	440A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003260		
J	Notohara, K; Zhang, LZ; Kobashi, Y; Smyrk, T				Notohara, Kenji; Zhang, Lizhi; Kobashi, Yoichiro; Smyrk, Thomas			Histological Characteristics and the Specificity of Pancreatic Lobular Inflammation in Type 2 Autoimmune Pancreatitis - Comparison With the Inflammation Around Pancreatic Ductal Adenocarcinoma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Kurashiki Cent Hosp, Kurashiki, Okayama, Japan; Mayo Clin, Rochester, MN USA; Tenri Hosp, Tenri, Nara 632, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1788	446A	447A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003288		
J	Reid, M; Ohike, N; Basturk, O; Klimov, S; Bagci, P; Akkas, G; Adsay, V				Reid, Michelle; Ohike, Nobu; Basturk, Olca; Klimov, Sergei; Bagci, Pelin; Akkas, Gizem; Adsay, Volkan			Diagnostic Impact of Intratumoral Heterogeneity of Ki67 Labeling Index in Pancreatic Neuroendocrine Tumors (NETS): Analysis of 91 Cases Shows Hot Spot Counting Correlates Better With Signs of Aggressiveness Than Counting Random Areas	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Emory Univ, Atlanta, GA 30322 USA; Showa Univ, Showa, Japan; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Georgia State Univ, Atlanta, GA 30303 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1789	447A	447A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003289		
J	Sato, D; Mitsuhashi, T; Tsuchikawa, T; Hatanaka, Y; Nakamura, T; Hirano, S; Matsuno, Y				Sato, Daisuke; Mitsuhashi, Tomoko; Tsuchikawa, Takahiro; Hatanaka, Yutaka; Nakamura, Toru; Hirano, Satoshi; Matsuno, Yoshihiro			Stromal Palladin Expression Is an Independent Prognostic Factor of Pancreatic Ductal Adenocarcinoma (PDAC)	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1793	448A	448A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003293		
J	Asaka, S; Yoshizawa, A; Matsuda, K; Yamaguchi, A; Kobayashi, Y; Nakata, R; Meng, Z; Sugano, M; Honda, T				Asaka, Shiho; Yoshizawa, Akihiko; Matsuda, Kazuyuki; Yamaguchi, Akemi; Kobayashi, Yukihiro; Nakata, Rie; Meng, Zhang; Sugano, Mitsutoshi; Honda, Takayuki			A Novel High-Speed Droplet-Polymerase Chain Reaction Can Detect Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer in Less Than 10 Minutes	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Shinshu Univ Hosp, Matsumoto, Nagano, Japan; Seiko Epson Corp, Nagano, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1891	471A	472A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003391		
J	Bozkurtlar, E; Uruga, H; Hariri, L; Mino-Kenudson, M; Mark, E				Bozkurtlar, Emine; Uruga, Hironori; Hariri, Lida; Mino-Kenudson, Mari; Mark, Eugene			Idiopathic Tracheal Stenosis	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Marmara Univ, Istanbul, Turkey; Toranomon Gen Hosp, Tokyo, Japan; Massachusetts Gen Hosp, Boston, MA 02114 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1898	474A	474A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003398		
J	Dairiki, M; Ichikawa, H; Tanaka, T; Taniguchi, H; Johkoh, T; Kataoka, K; Kondoh, Y; Fukuoka, J				Dairiki, Minsumi; Ichikawa, Hiromi; Tanaka, Tomonori; Taniguchi, Hiroyuki; Johkoh, Takeshi; Kataoka, Kensuke; Kondoh, Yasuhiro; Fukuoka, Junya			Histological Difference Between Idiopathic Interstitial Pneumonias and Connective Tissue Disease-Associated Interstitial Pneumonias	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Nagasaki Univ, Sch Med, Nagasaki 852, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; Nagasaki Univ Hosp, Nagasaki, Japan; Tosei Gen Hosp, Seto, Aichi, Japan; Kinki Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Itami, Hyogo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1903	475A	475A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003402		
J	Gallan, A; Ananthanarayanan, V; Hiroshima, K; Marchevsky, A; McGregor, S; Montero, M; Nabeshima, K; Vigneswaran, W; Walts, A; Krausz, T; Husain, A				Gallan, Alexander; Ananthanarayanan, Vijayalakshmi; Hiroshima, Kenzo; Marchevsky, Alberto; McGregor, Stephanie; Montero, MAngeles; Nabeshima, Kazuki; Vigneswaran, Wickii; Walts, Ann; Krausz, Thomas; Husain, Aliya			Necrosis and Solid Growth Pattern Augment Nuclear Grading in Predicting Survival in Epithelioid Malignant Mesothelioma: An International, Multi-Institutional Study	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Chicago, Chicago, IL 60637 USA; Loyola Univ, Maywood, IL 60153 USA; Tokyo Womens Med Univ, Tokyo, Japan; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Royal Brompton Hosp, London SW3 6LY, England; Harefield Hosp, London, England; Fukuoka Univ, Fukuoka 81401, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1908	476A	476A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003407		
J	Hayashi, T; Kumasaka, T; Mitani, K; Saito, T; Hara, K; Ando, K; Seyama, K; Yao, T				Hayashi, Takuo; Kumasaka, Toshio; Mitani, Keiko; Saito, Tsuyoshi; Hara, Kieko; Ando, Katsutoshi; Seyama, Kuniaki; Yao, Takashi			Clinicopathologic and Molecular Analysis of Explanted Lung of Patients With Lymphangioleiomyomatosis: Identification of Destruction of Airway Walls and Lack of Hypoxia Inducible Factor 1 Alpha Expression	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Juntendo Univ, Sch Med, Tokyo 113, Japan; Japanese Red Cross Med Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1911	477A	477A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003410		
J	Hida, T; Matsumoto, S; Hamasaki, M; Abe, S; Tsujimura, T; Hiroshima, K; Nabeshima, K				Hida, Tomoyuki; Matsumoto, Shinji; Hamasaki, Makoto; Abe, Sohsei; Tsujimura, Tohru; Hiroshima, Kenzo; Nabeshima, Kazuki			p16 FISH Deletion Status in Effusion Smear Preparations Correlates With That in Underlying Malignant Pleural Mesothelioma	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Fukuoka Univ, Sch Med & Hosp, Fukuoka 81401, Japan; Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; Tokyo Womens Med Univ, Yachiyo Med Ctr, Chiba, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1913	477A	477A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003412		
J	Leduc, C; Zhang, L; Fukuoka, J; Travis, W; Antonescu, C				Leduc, Charles; Zhang, Lei; Fukuoka, Junya; Travis, William; Antonescu, Cristina			Pulmonary Myoepithelial Tumors (MT): A Pathologic and Molecular Study	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Nagasaki Univ Hosp, Nagasaki, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1932	482A	482A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003431		
J	Li, GY; Wang, XQ; Koul, S; Ohki, R; Maurer, M; Borczuk, A; Halmos, B				Li, Guangyuan; Wang, Xiaoqi; Koul, Sanjay; Ohki, Rieko; Maurer, Matthew; Borczuk, Alain; Halmos, Balazs			PHLDA2 Is a Key Oncogene-induced Negative Feedback Inhibitor of EGFR/ErbB2 Signaling Via Interference With AKT Signaling	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Hosp Case Med Ctr, Cleveland, OH USA; Herbert Irving Comprehens Canc Ctr, New York, NY USA; Columbia Univ, Med Ctr, New York, NY USA; Natl Canc Ctr, Res Inst, Tokyo 104, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1936	483A	483A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003435		
J	Matsubara, O; Ishikawa, Y; Nakatani, Y; Mark, E				Matsubara, Osamu; Ishikawa, Yuichi; Nakatani, Yukio; Mark, Eugene			Pathological Role of Fibroblastic Foci and Bronchiolar Epithelial Proliferation in Idiopathic Pulmonary Fibrosis (IPF)/Usual Interstitial Pneumonia (UIP)	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan; Hiratsuka Kyosai Hosp, Hiratsuka, Kanagawa, Japan; Chiba Univ, Chiba, Japan; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1941	484A	484A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003440		
J	Moroi, N; Matsuura, Y; Ninomiya, H; Nagano, H; Kakita, T; Okumura, S; Ishikawa, Y				Moroi, Noriko; Matsuura, Yosuke; Ninomiya, Hironori; Nagano, Himco; Kakita, Tomoyo; Okumura, Sakae; Ishikawa, Yuichi			Diagnostic Value of Immunohistochemical ROS1 Expression in ROS1-Lung Cancer	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1947	485A	485A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003446		
J	Nake, T; Hatanaka, Y; Kanno, H; Hatanaka, K; Mitsuhashi, T; Matsuno, Y				Nake, Tomoaki; Hatanaka, Yutaka; Kanno, Hiromi; Hatanaka, Kanako; Mitsuhashi, Tomoko; Matsuno, Yoshihiro			PHGDH and TRIM29 as Novel Diagnostic Markers for Malignant Pleural Mesothelioma: An Exploring Approach From FFPE Tissue-Based Gene Expression Profiling of a Synchronous Thoracic Tumor	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Nake, Tomoaki; Hatanaka, Yutaka; Kanno, Hiromi; Hatanaka, Kanako; Mitsuhashi, Tomoko; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1949	485A	486A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003448		
J	Smith, S; Bissonnette, A; Cohen, D; Timmers, C; Jen, J; Fukuoka, J; Franks, T; Travis, W; Carbone, D; Shilo, K				Smith, Stephen; Bissonnette, Adam; Cohen, David; Timmers, Cynthia; Jen, Jin; Fukuoka, Junya; Franks, Teri; Travis, William; Carbone, David; Shilo, Konstantin			Expression of PAK1 and PAK2 Is Associated With Grade of Pulmonary Neuroendocrine Tumors	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Ohio State Univ, Columbus, OH 43210 USA; Mayo Clin, Rochester, MN USA; Nagasaki Univ, Nagasaki 852, Japan; Joint Pathol Ctr, Silver Spring, MD USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1967	490A	490A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003466		
J	Yoshikawa, A; Tanaka, T; Hashisako, M; Kashima, Y; Karata, H; Tabata, K; Fukuoka, J				Yoshikawa, Akira; Tanaka, Tomonori; Hashisako, Mikiko; Kashima, Yukio; Karata, Hiroki; Tabata, Kazuhiro; Fukuoka, Junya			3D Pathology Construction Reveals Framework Structure of the Lung and Increase of Pores of Kohn as an Initial Event of Emphysema	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Yoshikawa, Akira; Tanaka, Tomonori; Hashisako, Mikiko; Kashima, Yukio; Karata, Hiroki; Tabata, Kazuhiro; Fukuoka, Junya] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1984	493A	494A				2	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003483		
J	Yoshizawa, A				Yoshizawa, Akihiko			The Clinicopathological Characteristics of Lung Adenocarcinoma With Lgr5 Expression	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					[Yoshizawa, Akihiko] Kyoto Univ Hosp, Kyoto 606, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		1985	494A	494A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003484		
J	Torlakovic, E; Brynes, R; Hyjek, E; Lee, SH; Kreipe, H; Kremer, M; McKenna, R; Sadahira, Y; Tzankov, A; Reis, M; Porwit, A				Torlakovic, Emina; Brynes, Russell; Hyjek, Elizabeth; Lee, Szu-Hee; Kreipe, Hans; Kremer, Marcus; McKenna, Robert; Sadahira, Yoshito; Tzankov, Alexandar; Reis, Marciano; Porwit, Anna			ICSH Guidelines for the Standardization of Bone Marrow Immunohistochemistry	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; St George Hosp, Sydney, NSW, Australia; Hannover Med Sch, Hannover, Germany; Staedt Klinikum, Munich, Germany; Univ Minnesota, Minneapolis, MN USA; Kawasaki Med Univ, Kurashiki, Okayama, Japan; Univ Basel Hosp, CH-4031 Basel, Switzerland; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		2043	509A	509A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003542		
J	Saegusa-Beecroft, E; Mamou, J; Rohrbach, D; Bui, TM; Coron, A; Yamaguchi, T; Oelze, M; Kobayashi, G; Wong, C; Fung, C; Hata, M; Bridal, SL; Yanagihara, E; Machi, J; Feleppa, EJ				Saegusa-Beecroft, Emi; Mamou, Jonathan; Rohrbach, Daniel; Bui, Thanh Minh; Coron, Alain; Yamaguchi, Tadashi; Oelze, Michael; Kobayashi, Gregory; Wong, Clifford; Fung, Conway; Hata, Masaki; Bridal, S. Lori; Yanagihara, Eugene; Machi, Junji; Feleppa, Ernest J.			Advances in Three-Dimensional (3D) High-Frequency (HF) Quantitative Ultrasound (QUS) for the Detection of Metastases in Lymph Nodes of Breast, Colorectal and Gastric Cancers	LABORATORY INVESTIGATION			English	Meeting Abstract	104th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology	MAR 21-27, 2015	Boston, MA	US & Canadian Acad Pathol					Univ Hawaii, Kuakini Med Ctr, Honolulu, HI 96822 USA; Riverside Res, New York, NY USA; Univ Paris 06, Paris, France; Chiba Univ, Chiba, Japan; Univ Illinois, Urbana, IL 61801 USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95			1		2104	524A	524A				1	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA5KT	WOS:000348948003603		
J	Koh, K; Tomizawa, D; Saito, AM; Watanabe, T; Miyamura, T; Hirayama, M; Takahashi, Y; Ogawa, A; Kato, K; Sugita, K; Sato, T; Deguchi, T; Hayashi, Y; Takita, J; Takeshita, Y; Tsurusawa, M; Horibe, K; Mizutani, S; Ishii, E				Koh, K.; Tomizawa, D.; Saito, A. Moriya; Watanabe, T.; Miyamura, T.; Hirayama, M.; Takahashi, Y.; Ogawa, A.; Kato, K.; Sugita, K.; Sato, T.; Deguchi, T.; Hayashi, Y.; Takita, J.; Takeshita, Y.; Tsurusawa, M.; Horibe, K.; Mizutani, S.; Ishii, E.			Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia	LEUKEMIA			English	Article							CHILDRENS ONCOLOGY GROUP; THERAPY; RISK; INTERFANT-99; BUSULFAN; DOT1L	Sixty-two infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia (MLL-r ALL) were treated with the MLL03 protocol of the Japanese Pediatric Leukemia/Lymphoma Study Group: short-course intensive chemotherapy followed by early allogeneic hematopoietic stem cell transplantation (HSCT) within 4 months of the initial induction. The 4-year event-free survival and overall survival rates were 43.2% (95% confidence interval (CI) = 30.7-55.1%) and 67.2% (53.8-77.4%), respectively. A univariate analysis showed younger age (<90 days at diagnosis), central nervous system disease and poor response to initial prednisolone therapy significantly associated with poor prognosis (P<0.05). In a multivariate analysis, younger age at diagnosis tended to be associated with poor outcome (hazard ratio = 1.969; 95% CI = 0.903-4.291; P = 0.088). Although the strategy of early use of HSCT effectively prevented early relapse and was feasible for infants with MLL-r ALL, the fact that substantial number of patients still relapsed even though transplanted in their first remission indicates the limited efficacy of allogeneic HSCT for infants with MLL-r ALL. Considering the risk of severe late effects, indications for HSCT should be restricted to specific subgroups with poor risk factors. An alternative approach incorporating molecular-targeted drugs should be established.	[Koh, K.] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Tomizawa, D.; Mizutani, S.] Tokyo Med & Dent Univ, Dept Pediat, Tokyo 1138519, Japan; [Saito, A. Moriya; Horibe, K.] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan; [Watanabe, T.] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Nutr Sci, Nagoya, Aichi, Japan; [Miyamura, T.] Osaka Univ, Dept Pediat, Osaka, Japan; [Hirayama, M.] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie, Japan; [Takahashi, Y.] Aomori Prefectural Cent Hosp, Dept Pediat, Aomori, Japan; [Ogawa, A.] Niigata Canc Ctr Hosp, Dept Pediat, Niigata, Japan; [Kato, K.] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Sugita, K.] Univ Yamanashi, Dept Pediat, Kofu, Yamanashi, Japan; [Sato, T.] Chiba Univ Hosp, Dept Control & Treatment Infect Dis, Chiba, Japan; [Hayashi, Y.] Gunma Childrens Med Ctr, Dept Hematol Oncol, Gunma, Japan; [Takita, J.] Univ Tokyo, Dept Pediat, Tokyo, Japan; [Takeshita, Y.] Nara Med Univ, Dept Pediat, Nara, Japan; [Tsurusawa, M.] Ama Municipal Hosp, Dept Pediat, Ama, Aichi, Japan; [Ishii, E.] Ehime Univ, Grad Sch Med, Dept Pediat, Matsuyama, Ehime 790, Japan	Tomizawa, D (reprint author), Tokyo Med & Dent Univ, Dept Pediat, 1-5-45 Yushima, Tokyo 1138519, Japan.	dtomizawa.ped@tmd.ac.jp		Tomizawa, Daisuke/0000-0003-1520-7007	Grant for Clinical Cancer Research; Ministry of Health, Labour and Welfare of Japan	We thank all JPLSG investigators and the following investigators who contributed to the central diagnosis in this study: H Nakamura and S Yamagata (Chiba University, Chiba) for the BU pharmacokinetic study; Y Komada (Mie University Graduate School of Medicine, Mie) and H Ohta (Osaka University, Osaka) for immunophenotypic diagnostics; T Taki (Kyoto Prefectural University of Medicine, Kyoto) for the molecular biological analyses; and J Fujimoto (National Center for Child Health and Development, Tokyo) for the preservation of the diagnostic specimens. This work was supported by a Grant for Clinical Cancer Research and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan.	Hilden JM, 2006, BLOOD, V108, P441, DOI 10.1182/blood-2005-07-3011; Dordelmann M, 1999, BLOOD, V94, P1209; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Tomizawa D, 2009, PEDIATR BLOOD CANCER, V52, P808, DOI 10.1002/pbc.21975; Dreyer ZE, 2011, J CLIN ONCOL, V29, P214, DOI 10.1200/JCO.2009.26.8938; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Salzer WL, 2012, PEDIATR BLOOD CANCER, V59, P834, DOI 10.1002/pbc.24132; Tomizawa D, 2007, LEUKEMIA, V21, P2258, DOI 10.1038/sj.leu.2404903; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Isoyama K, 2002, BRIT J HAEMATOL, V118, P999, DOI 10.1046/j.1365-2141.2002.03754.x; Pieters R, 1998, LEUKEMIA, V12, P1344, DOI 10.1038/sj.leu.2401129; Kosaka Y, 2004, BLOOD, V104, P3527, DOI 10.1182/blood-2004-04-1390; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Nakamura H, 2008, THER DRUG MONIT, V30, P75, DOI 10.1097/FTD.0b013e3181621cde; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Biondi A, 2006, HAEMATOL-HEMATOL J, V91, P534; Chessells JM, 2002, BRIT J HAEMATOL, V117, P306, DOI 10.1046/j.1365-2141.2002.03442.x; Ferster A, 2000, BLOOD, V95, P2729; PUI CH, 1995, LEUKEMIA, V9, P762; Schechter T, 2007, BIOL BLOOD MARROW TR, V13, P307, DOI 10.1016/j.bbmt.2006.10.026; Silverman LB, 1997, CANCER, V80, P2285	23	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	FEB	2015	29	2					290	296		10.1038/leu.2014.172		7	Oncology; Hematology	Oncology; Hematology	CB2GL	WOS:000349445000004		
J	Fukuda, S; Hoggatt, J; Singh, P; Abe, M; Speth, JM; Hu, P; Conway, EM; Nucifora, G; Yamaguchi, S; Pelus, LM				Fukuda, S.; Hoggatt, J.; Singh, P.; Abe, M.; Speth, J. M.; Hu, P.; Conway, E. M.; Nucifora, G.; Yamaguchi, S.; Pelus, L. M.			Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1	LEUKEMIA			English	Article							NORMAL CORD BLOOD; PROGENITOR CELLS; MYELOID-LEUKEMIA; INTERFERON-ALPHA; CD34(+) CELLS; SELF-RENEWAL; CANCER-CELLS; EXPRESSION; PROTEIN; TRANSCRIPTION	The inhibitor of apoptosis protein Survivin regulates hematopoiesis, although its mechanisms of regulation of hematopoietic stem cells (HSCs) remain largely unknown. While investigating conditional Survivin deletion in mice, we found that Survivin was highly expressed in phenotypically defined HSCs, and Survivin deletion in mice resulted in significantly reduced total marrow HSCs and hematopoietic progenitor cells. Transcriptional analysis of Survivin (-/-) HSCs revealed altered expression of multiple genes not previously linked to Survivin activity. In particular, Survivin deletion significantly reduced expression of the Evi-1 transcription factor indispensable for HSC function, and the downstream Evi-1 target genes Gata2, Pbx1 and Sall2. The loss of HSCs following Survivin deletion and impaired long-term HSC repopulating function could be partially rescued by ectopic Evi-1 expression in Survivin -/- HSCs. These data demonstrate that Survivin partially regulates HSC function by modulating the Evi-1 transcription factor and its downstream targets and identify new genetic pathways in HSCs regulated by Survivin.	[Fukuda, S.; Abe, M.; Yamaguchi, S.] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane 6938501, Japan; [Hoggatt, J.; Singh, P.; Speth, J. M.; Hu, P.; Pelus, L. M.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Hoggatt, J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Conway, E. M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada; [Nucifora, G.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Fukuda, S (reprint author), Shimane Univ, Sch Med, Dept Pediat, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	sfukuda@med.shimane-u.ac.jp; lpelus@iupui.edu			Biomedical Research Grant from the Indiana University School of Medicine; Research Support Funds Grants from Indiana University, Indianapolis; Research Support Funds from Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Biomedical Research Foundation; Japan Leukaemia Research Fund; AstraZeneca Research Grant; Naito Memorial Foundation; Japan Society for the Promotion of Science [20390298]; US Public Health Service Grants from the National Institutes of Health [HL69669, HL079654, HL096305]; Purdue University, Indianapolis; Mitsubishi Pharma Research Foundation	We thank Susan Rice and Denessa Lucket for cell sorting. This work was supported by a Biomedical Research Grant from the Indiana University School of Medicine, Research Support Funds Grants from Indiana University and Purdue University, Indianapolis, Research Support Funds from Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Sankyo Biomedical Research Foundation and Mitsubishi Pharma Research Foundation, the Japan Leukaemia Research Fund, an AstraZeneca Research Grant, the Naito Memorial Foundation, a Grant-in-Aid for Scientific Research (B) (20390298) from the Japan Society for the Promotion of Science (to SF) and US Public Health Service Grants (HL69669, HL079654 and HL096305) from the National Institutes of Health (to LMP). EMC is an adjunct scientist with the Canadian Blood Services and holds a Canada Research Chair in Endothelial Biology and a CSL-Behring Research Chair.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Carter BZ, 2001, BLOOD, V97, P2784, DOI 10.1182/blood.V97.9.2784; Adida C, 2000, BRIT J HAEMATOL, V111, P196, DOI 10.1046/j.1365-2141.2000.02328.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Mesri M, 2001, AM J PATHOL, V158, P1757, DOI 10.1016/S0002-9440(10)64131-4; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Gurbuxani S, 2005, P NATL ACAD SCI USA, V102, P11480, DOI 10.1073/pnas.0500303102; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Fukuda S, 2009, BLOOD, V114, P394, DOI 10.1182/blood-2008-11-188714; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032003; Fukuda S, 2002, CELL CYCLE, V1, P322, DOI 10.4161/cc.1.5.149; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Fukuda S, 2001, BLOOD, V98, P2091, DOI 10.1182/blood.V98.7.2091; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Persons DA, 1999, BLOOD, V93, P488; Carter BZ, 2012, BLOOD, V120, P173, DOI 10.1182/blood-2012-02-409888; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Salz W, 2005, CANCER RES, V65, P3531, DOI 10.1158/0008-5472.CAN-04-4284; Berry FB, 2005, MOL CELL BIOL, V25, P1415, DOI 10.1128/MCB.25.4.1415-1424.2005; Asanuma K, 2004, J IMMUNOL, V172, P3922; Balkhi MY, 2008, EXP HEMATOL, V36, P1449, DOI 10.1016/j.exphem.2008.05.008; BROXMEYER HE, 1983, J IMMUNOL, V131, P1300; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chai L, 2011, TRANSFUSION, V51, p87S, DOI 10.1111/j.1537-2995.2011.03371.x; Conway EM, 2000, BLOOD, V95, P1435; Fukuda S, 2004, BLOOD, V103, P120, DOI 10.1182/blood-2003-05-1756; Fukuda S, 2002, BLOOD, V100, P2463, DOI 10.1182/blood.V100.7.2463; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kostrouchova M, 2003, P NATL ACAD SCI USA, V100, P5240, DOI 10.1073/pnas.0730770100; MAGEE WE, 1972, LIFE SCI 2-BIOCH GEN, V11, P1081, DOI 10.1016/0024-3205(72)90216-0; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Pelus LM, 2004, BLOOD, V103, P110, DOI 10.1182/blood-2003-04-1115; PELUS LM, 1988, J IMMUNOL, V140, P479; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Takizawa BT, 2007, CANCER INVEST, V25, P678, DOI 10.1080/07357900701600954	50	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	FEB	2015	29	2					433	440		10.1038/leu.2014.183		8	Oncology; Hematology	Oncology; Hematology	CB2GL	WOS:000349445000020		
J	Suzuki, R; Hideshima, T; Mimura, N; Minami, J; Ohguchi, H; Kikuchi, S; Yoshida, Y; Gorgun, G; Cirstea, D; Cottini, F; Jakubikova, J; Tai, YT; Chauhan, D; Richardson, PG; Munshi, NC; Utsugi, T; Anderson, KC				Suzuki, R.; Hideshima, T.; Mimura, N.; Minami, J.; Ohguchi, H.; Kikuchi, S.; Yoshida, Y.; Gorgun, G.; Cirstea, D.; Cottini, F.; Jakubikova, J.; Tai, Y-T; Chauhan, D.; Richardson, P. G.; Munshi, N. C.; Utsugi, T.; Anderson, K. C.			Anti-tumor activities of selective HSP90 alpha/beta inhibitor, TAS-116, in combination with bortezomib in multiple myeloma	LEUKEMIA			English	Letter							CELLS; APOPTOSIS; INDUCE	Heat shock protein 90 (HSP90) is a highly conserved molecular chaperone that interacts with various client proteins in eukaryotic cells:(1) Akt (PI3K/Akt pathway), interleukin-6 R (JAK/STAT pathway), Bcr-Abl (RAS/ERK pathway), Cyclin-dependent kinase 4, 6, 9 (cell cycling) and I kappa B kinases (NF-kappa B pathway).(2) The expression of HSP90 is upregulated (2- to 10-fold) in tumor cells compared with normal cells, reflecting multiple oncogenic pathways and maintenance of homeostasis within tumor cells.(1,2) Because HSP90 inhibition triggers downregulation /degradation of client proteins and triggers apoptosis, it is considered a promising target for novel targeted therapies. Indeed HSP90 inhibitors (for example, geldanamycin analog 17-allylamino-17-demethoxy-geldanamycin (17-AAG), resorcinol derivatives, purine analogs) have shown early promising results in vitro and in vivo in solid tumors and some hematological malignancies, including multiple myeloma (MM).(3,4) However, some clinical studies have been discontinued due to adverse effects, including ocular toxicity.(3,5) Therefore, development of a next-generation less-toxic HSP90 inhibitor remains an important therapeutic goal.	[Suzuki, R.; Hideshima, T.; Mimura, N.; Minami, J.; Ohguchi, H.; Kikuchi, S.; Yoshida, Y.; Gorgun, G.; Cirstea, D.; Cottini, F.; Jakubikova, J.; Tai, Y-T; Chauhan, D.; Richardson, P. G.; Anderson, K. C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA; [Utsugi, T.] TAIHO PHARMACEUT CO LTD, Tsukuba Res Ctr, Tsukuba, Ibaraki, Japan; [Munshi, N. C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,VA Boston Heal, Boston, MA 02115 USA	Suzuki, R (reprint author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	kenneth_anderson@dfci.harvard.edu					Khong T, 2011, MOL CANCER THER, V10, P1909, DOI 10.1158/1535-7163.MCT-11-0174; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Zhang L, 2014, ONCOTARGET, V5, P1132; Davenport EL, 2010, LEUKEMIA, V24, P1804, DOI 10.1038/leu.2010.168; Cheung WC, 2001, LEUKEMIA, V15, P264, DOI 10.1038/sj.leu.2402022; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Chauhan D, 2003, CANCER RES, V63, P6174; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Hideshima T, 2009, BLOOD, V113, P5228, DOI 10.1182/blood-2008-06-161505; Rajan A, 2011, CLIN CANCER RES, V17, P6831, DOI 10.1158/1078-0432.CCR-11-0821; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kodama Y, 2012, EUR J CANCER, V48, P89; Ohkubo S, 2012, EUR J CANCER, V48, P89; Wu WC, 2010, EXP EYE RES, V91, P211, DOI 10.1016/j.exer.2010.05.005	15	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	FEB	2015	29	2					510	514		10.1038/leu.2014.300		6	Oncology; Hematology	Oncology; Hematology	CB2GL	WOS:000349445000033		
J	Nakajima, Y; Tomita, N; Itabashi, M; Miyashita, K; Watanabe, R; Miyazaki, T; Tachibana, T; Takasaki, H; Kawasaki, R; Tanaka, M; Hashimoto, C; Yamazaki, E; Taguchi, J; Fujimaki, K; Sakai, R; Fujita, H; Fujisawa, S; Harano, H; Motomura, S; Ishigatsubo, Y				Nakajima, Yuki; Tomita, Naoto; Itabashi, Megumi; Miyashita, Kazuho; Watanabe, Reina; Miyazaki, Takuya; Tachibana, Takayoshi; Takasaki, Hirotaka; Kawasaki, Rika; Tanaka, Masatsugu; Hashimoto, Chizuko; Yamazaki, Etsuko; Taguchi, Jun; Fujimaki, Katsumichi; Sakai, Rika; Fujita, Hiroyuki; Fujisawa, Shin; Harano, Hiroshi; Motomura, Shigeki; Ishigatsubo, Yoshiaki			Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy	LEUKEMIA RESEARCH			English	Article						Diffuse large B-cell lymphoma; Infra-diaphragmatic; Supra-diaphragmatic; Prognostic factor; Gastrointestinal involvement	EXTRANODAL INVOLVEMENT; CLINICAL-FEATURES; HODGKINS-LYMPHOMA; RITUXIMAB ERA; DISEASE	The prognostic implications of infra-diaphragmatic (InD) versus supra-diaphragmatic (SpD) primary lesions in limited-stage diffuse large B-cell lymphoma (DLBCL) remains unknown. This retrospective study aimed to assess the prognostic impact of spD and InD lesions as well as presence of gastrointestinal (GI) involvements in adults with limited-stage DLBCL. We analyzed data from 178 patients with limited-stage DLBCL who were treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone therapy at 7 institutions of the Yokohama City University Hematology Group between 2003 and 2009. The median age was 63 years (range, 18-80 years). The primary sites were SpD in 109 patients, and InD in 69. No statistical differences in progression-free survival (PFS) or overall survival (OS) were observed between patients with SpD lesions and those with InD lesions. However, when patients with SpD lesions, InD lesions with (n = 35), and without (n = 34) GI involvement were compared, the presence of GI lesions was associated with favorable PFS. The multivariate analysis revealed that SpD or InD localization had no independent effect on PFS or OS, whereas the presence of GI lesions was correlated with favorable PFS (P = 0.024, HR 0.09). (C) 2014 Elsevier Ltd. All rights reserved.	[Nakajima, Yuki; Tomita, Naoto; Miyazaki, Takuya; Tachibana, Takayoshi; Yamazaki, Etsuko; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 2360004, Japan; [Itabashi, Megumi; Tanaka, Masatsugu; Fujisawa, Shin] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 2360004, Japan; [Miyashita, Kazuho; Kawasaki, Rika; Fujimaki, Katsumichi] Fujisawa City Hosp, Dept Hematol Immunol, Fujisawa, Kanagawa, Japan; [Watanabe, Reina; Takasaki, Hirotaka; Sakai, Rika; Motomura, Shigeki] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan; [Hashimoto, Chizuko] Yamato Municipal Hosp, Dept Hematol Oncol, Yamato, Japan; [Taguchi, Jun; Fujita, Hiroyuki] Shizuoka Red Cross Hosp, Dept Hematol, Shizuoka, Japan; [Harano, Hiroshi] Yokosuka City Hosp, Dept Hematol, Yokosuka, Kanagawa, Japan	Nakajima, Y (reprint author), Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	yuki1234@yokohama-cu.ac.jp					Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Castillo JJ, 2014, AM J HEMATOL, V89, P310, DOI 10.1002/ajh.23638; ROHATINER A, 1994, ANN ONCOL, V5, P397; Takahashi H, 2012, CANCER-AM CANCER SOC, V118, P4166, DOI 10.1002/cncr.27381; Koch P, 2001, J CLIN ONCOL, V19, P3861; Lopez-Guillermo A, 2005, J CLIN ONCOL, V23, P2797; Hui D, 2010, LEUKEMIA LYMPHOMA, V51, P1658, DOI 10.3109/10428194.2010.504872; Tomita N, 2013, BRIT J HAEMATOL, V161, P383, DOI 10.1111/bjh.12281; Darabi K, 2005, LEUKEMIA LYMPHOMA, V46, P1715, DOI 10.1080/10428190500144847; Kalkner KM, 1997, EUR J HAEMATOL, V59, P31; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; MAI DHW, 1991, CANCER, V68, P1476, DOI 10.1002/1097-0142(19911001)68:7<1476::AID-CNCR2820680703>3.0.CO;2-B; Milan M, 2014, ANN HEMATOL, V93, P221; Nakamura S, 2003, CANCER, V97, P2462, DOI 10.1002/cncr.11415; Vassilakopoulos TP, 2006, HAEMATOL-HEMATOL J, V91, P32	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	FEB	2015	39	2					198	203		10.1016/j.leukres.2014.11.030		6	Oncology; Hematology	Oncology; Hematology	AZ5WY	WOS:000348290400014		
J	Kitano, S; Miyagi, A; Oono, Y; Hase, Y; Narumi, I; Yamaguchi, M; Uchimiya, H; Kawai-Yamada, M				Kitano, Sayaka; Miyagi, Atsuko; Oono, Yutaka; Hase, Yoshihiro; Narumi, Issay; Yamaguchi, Masatoshi; Uchimiya, Hirofumi; Kawai-Yamada, Maki			Metabolic alterations in leaves of oxalate-rich plant Rumex obtusifolius L. irradiated by gamma rays	METABOLOMICS			English	Article						Rumex obtusifolius; Oxalate; Gamma ray; Metabolic alterations; Capillary electrophoresis-mass spectrometry	LEAF SHEATHS; CRISPUS L; EXPRESSION; RADIATION; GROWTH; IMPACT; ACID; DOCK	Oxalate in some plants is toxic to vertebrates and causes kidney failure. In the present study, we investigated on the metabolic effectiveness of gamma ray irradiation to seeds of Rumex obtusifolius, which are known to accumulate high level of soluble oxalate, to lower oxalate accumulation in leaves. Reduced rate of germination, discoloration of cotyledons, and deformed true leaves were observed by elevated irradiation. Metabolome analysis of primary metabolites using capillary electrophoresis-mass spectrometry showed a decrease in oxalate contents in the leaves of plants from gamma ray-irradiated seeds. Moreover, organic acids such as malate and 2-oxoglutarate also decreased, whereas amino acids such as glutamate and glutamine increased. These results indicated that seed irradiation by gamma rays leads to dynamic changes in metabolic pathways as well as plant growth/development.	[Kitano, Sayaka; Miyagi, Atsuko; Kawai-Yamada, Maki] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Oono, Yutaka; Hase, Yoshihiro; Narumi, Issay] Japan Atom Energy Agcy, Med & Biotechnol Applicat Div, Quantum Beam Sci Directorate, Takasaki, Gunma 3701292, Japan; [Yamaguchi, Masatoshi; Uchimiya, Hirofumi; Kawai-Yamada, Maki] Saitama Univ, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Yamaguchi, Masatoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kawai-Yamada, M (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 225 Shimo Okubo, Saitama 3388570, Japan.	mkawai@mail.saitama-u.ac.jp	Yamaguchi, Masatoshi/F-2183-2011; Miyagi, Atsuko/N-8621-2015		Funding Program for Next Generation World-Leading Researchers (NEXT Program)	We thank Mr. Y. Kakinuma, Ms. K. Yokoyama and other students (Department of Environmental Science, Faculty of Engineering, Saitama University) for technical help. Edition of this manuscript by Dr. S. M. Uchimiya (USDA-ARS) is appreciated. This research was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program).	Davoine C, 2001, PLANT CELL ENVIRON, V24, P1033, DOI 10.1046/j.1365-3040.2001.00757.x; Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Miyagi A, 2013, METABOLOMICS, V9, P590, DOI 10.1007/s11306-012-0486-5; Kovacs E, 2002, MICRON, V33, P199, DOI 10.1016/S0968-4328(01)00012-9; CAVERS PB, 1964, J ECOL, V52, P737, DOI 10.2307/2257859; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75; Predieri S, 2001, PLANT CELL TISS ORG, V64, P185, DOI 10.1023/A:1010623203554; Zheng SJ, 1998, PLANT PHYSIOL, V117, P745, DOI 10.1104/pp.117.3.745; Naito K, 2005, GENETICS, V169, P881, DOI 10.1534/genetics.104.033654; Miyagi A, 2011, METABOLOMICS, V7, P524, DOI 10.1007/s11306-010-0272-1; Toole E. H., 1946, JOUR AGRIC RES, V72, P201; Cruz JN, 2012, RADIAT PHYS CHEM, V81, P1059, DOI 10.1016/j.radphyschem.2012.02.026; DICKIE CW, 1978, J AM VET MED ASSOC, V173, P73; Fanaro GB, 2011, RADIAT PHYS CHEM, V80, P85, DOI 10.1016/j.radphyschem.2010.08.008; Holm L. G., 1977, WORLDS WORST WEEDS D, P401; HONGO A, 1989, WEED RES, V29, P7, DOI 10.1111/j.1365-3180.1989.tb00834.x; Hongo A., 1986, Weed Research, Japan, V31, P300; Kon Ellyfa, 2007, American Journal of Applied Sciences, V4, DOI 10.3844/ajassp.2007.1090.1093; Le Deunff E, 2004, PLANT J, V38, P421, DOI 10.1111/j.1365-313X.2004.02056.x; Marschner H., 1999, MINERAL NUTR HIGHER, P596; Miyagi A, 2010, METABOLOMICS, V6, P497, DOI 10.1007/s11306-010-0220-0; Miyagi A, 2010, METABOLOMICS, V6, P146, DOI 10.1007/s11306-009-0186-y; Miyagi A, 2013, WEED RES, V53, P30, DOI 10.1111/j.1365-3180.2012.00949.x; Murti H. R., 2013, AFRICAN J BIOTECHNOL, V12, P4803; PANCIERA RJ, 1990, J AM VET MED ASSOC, V196, P1981; PINO J, 1995, WEED RES, V35, P141, DOI 10.1111/j.1365-3180.1995.tb02027.x; REIG R, 1990, VET HUM TOXICOL, V32, P468; Schottelndreier M, 2001, ANN BOT-LONDON, V87, P769, DOI 10.1006/anbo.2001.1405; SPARROW A. H., 1961, RADIATION BOT, V1, P10, DOI 10.1016/S0033-7560(61)80003-3; SPIEGELR.P, 1973, RADIAT BOT, V13, P105, DOI 10.1016/S0033-7560(73)80017-1; Tuazon-Nartea J., 2013, Food and Nutrition Sciences, V4, P838, DOI 10.4236/fns.2013.48109	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1573-3882	1573-3890		METABOLOMICS	Metabolomics	FEB	2015	11	1					134	142		10.1007/s11306-014-0684-4		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AZ6QH	WOS:000348343300013		
J	Furuhashi, T; Ogawa, T; Nakai, R; Nakazawa, M; Okazawa, A; Padermschoke, A; Nishio, K; Hirai, MY; Arita, M; Ohta, D				Furuhashi, Takeshi; Ogawa, Takumi; Nakai, Rai; Nakazawa, Masami; Okazawa, Atsushi; Padermschoke, Adchara; Nishio, Kazuki; Hirai, Masami Yokota; Arita, Masanori; Ohta, Daisaku			Wax ester and lipophilic compound profiling of Euglena gracilis by gas chromatography-mass spectrometry: toward understanding of wax ester fermentation under hypoxia	METABOLOMICS			English	Article						Euglena; Wax ester; Hypoxia	ANAEROBIC ENERGY-METABOLISM; AMINO-ACIDS; TRYPANOSOMATIDS; EUKARYOTES	Lipids are being increasingly used as biodiesel feedstock, and several saturated wax esters from Euglena gracilis are candidates for outdoor bulk production. Wax ester fermentation in Euglena is strongly increased by hypoxia, but key events underlying the metabolic shift toward wax ester biosynthesis are poorly understood. Profiling of wax esters and other lipophilic compounds is the first step for research toward the clarification of wax ester fermentation molecular mechanisms, and thus, a simple and comprehensive platform for their profiling is required. In this study, we established a profiling method for wax esters and lipophilic compounds in Euglena using gas chromatography-mass spectrometry (GC-MS). Using this method, we compared accumulation profiles of wax esters and lipophilic compounds between a wild-type Euglena Z strain and a bleached SM-ZK strain. Both the wild-type and the bleached strains contained C14:0 fatty acid-C14:0 fatty alcohol as a dominant wax ester. Wax ester fermentation initiated 4 h after the cessation of oxygen supply by halting the culture agitation resulting in linear increase and proportional changes of wax ester amounts during 24 h. However, complete anoxia by nitrogen gas aeration inhibited wax ester production and the addition of bicarbonates reversed the inhibition, suggesting that there is a need for an additional carbon source for wax ester fermentation under anoxia. Our simple method enables the investigation of metabolic responses leading to wax ester fermentation in Euglena.	[Furuhashi, Takeshi; Hirai, Masami Yokota; Arita, Masanori] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Ogawa, Takumi; Nakai, Rai; Nakazawa, Masami; Okazawa, Atsushi; Padermschoke, Adchara; Nishio, Kazuki; Ohta, Daisaku] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Nakazawa, Masami] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Meguro Ku, Tokyo 1538902, Japan; [Arita, Masanori] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan	Furuhashi, T (reprint author), RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan.	takeshi.furuhashi@riken.jp	Hirai, Masami/D-5319-2009	Hirai, Masami/0000-0003-0802-6208	Strategic International Cooperative Program (SICORP) - Joint Research Type Japanese (JST) - US (NSF) Joint Research "Metabolomics for a low carbon society" (METABOLOMICS)	Funding was provided by the Strategic International Cooperative Program (SICORP) - Joint Research Type Japanese (JST) - US (NSF) Joint Research "Metabolomics for a low carbon society" (METABOLOMICS).	Teerawanichpan P, 2010, LIPIDS, V45, P263, DOI 10.1007/s11745-010-3395-2; Fitzgerald M, 2007, J LIPID RES, V48, P1231, DOI 10.1194/jlr.D700002-JLR200; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; Tucci S, 2010, J EUKARYOT MICROBIOL, V57, P63, DOI 10.1111/j.1550-7408.2009.00452.x; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; Butovich I. A., 2011, SCI REPORTS, V1, P1; Furuhashi T, 2013, HDB PLANT METABOLOMI, P215; Iven T., 2013, PLANT METHODS, V9, P1; KOREN LE, 1967, J PROTOZOOL, VS 14, P17; Krnacova K, 2012, J MOL EVOL, V75, P119, DOI 10.1007/s00239-012-9523-2; Lee S. H., 2006, CELL, V126, P691; Livore VI, 2007, FEBS J, V274, P264, DOI 10.1111/j.1742-4658.2006.05581.x; MCCALLA DR, 1963, J PROTOZOOL, V10, P491, DOI 10.1111/j.1550-7408.1963.tb01712.x; ODA Y, 1982, J GEN MICROBIOL, V128, P853; TULLOCH AP, 1971, CHEM PHYS LIPIDS, V6, P235, DOI 10.1016/0009-3084(71)90063-6; Urbanova K, 2012, J LIPID RES, V53, P204, DOI 10.1194/jlr.D020834; Zimorski V., 2012, J ENDOCYTOBIOSIS CEL, V23, P64	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1573-3882	1573-3890		METABOLOMICS	Metabolomics	FEB	2015	11	1					175	183		10.1007/s11306-014-0687-1		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AZ6QH	WOS:000348343300017		
J	Cheng, J; Yanagimoto, T; Song, N; Gao, TX				Cheng, Jiao; Yanagimoto, Takashi; Song, Na; Gao, Tian-xiang			Population genetic structure of chub mackerel Scomber japonicus in the Northwestern Pacific inferred from microsatellite analysis	MOLECULAR BIOLOGY REPORTS			English	Article						Scomber japonicus; Gene flow; Population structure; Microsatellite DNA; Northwestern Pacific	MULTILOCUS GENOTYPE DATA; COD GADUS-MACROCEPHALUS; EAST CHINA SEA; ATLANTIC COD; ALLELE FREQUENCIES; MEDITERRANEAN SEA; MARINE FISHES; BALTIC SEA; DISTANCE; DIFFERENTIATION	Marine pelagic fishes are usually characterized by subtle but complex patterns of genetic differentiation, which are influenced by both historical process and contemporary gene flow. Genetic population differentiation of chub mackerel, Scomber japonicus, was examined across most of its range in the Northwestern Pacific by screening variation of eight microsatellite loci. Our genetic analysis detected a weak but significant genetic structure of chub mackerel, which was characterized by areas of gene flow and isolation by distance. Consistent with previous estimates of stock structure, we found genetic discontinuity between Japan and China samples. Local-scale pattern of genetic differentiation was observed between samples from the Bohai Sea and North Yellow Sea and those from the East China Sea, which we ascribed to differences in spawning time and migratory behavior. Furthermore, the observed homogeneity among collections of chub mackerel from the East and South China Seas could be the result of an interaction between biological characteristics and marine currents. The present study underlies the importance of understanding the biological significance of genetic differentiation to establish management strategies for exploited fish populations.	[Cheng, Jiao; Gao, Tian-xiang] Zhejiang Ocean Univ, Fishery Coll, Zhoushan 316000, Peoples R China; [Cheng, Jiao] Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China; [Yanagimoto, Takashi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Song, Na; Gao, Tian-xiang] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China	Gao, TX (reprint author), Zhejiang Ocean Univ, Fishery Coll, Zhoushan 316000, Peoples R China.	gaozhang@ouc.edu.cn			International Cooperation and Exchange of the National Natural Science Foundation of China [31061160187]; Fundamental Research Funds for the Central Universities [201262022]	The present study could not have been carried out without the willing help of those listed below in collecting specimens: Mr. Xi Han, Mr. Dian-Rong Sun, Dr. Xiao Chen, Dr. Long-Shan Lin, Dr. Bo-Nian Shui. This study was supported by the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 31061160187) and the Fundamental Research Funds for the Central Universities (No. 201262022).	RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Infante C, 2007, GENETICA, V130, P1, DOI 10.1007/s10709-006-0014-5; Zhan AB, 2009, MAR BIOTECHNOL, V11, P223, DOI 10.1007/s10126-008-9138-1; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Pritchard JK, 2000, GENETICS, V155, P945; Liu M, 2010, J FISH BIOL, V77, P1071, DOI 10.1111/j.1095-8649.2010.02743.x; Liu JX, 2011, MOL ECOL, V20, P3879, DOI 10.1111/j.1365-294X.2011.05213.x; Ruzzante DE, 1999, FISH RES, V43, P79, DOI 10.1016/S0165-7836(99)00067-3; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Vinas J, 2004, MOL PHYLOGENET EVOL, V33, P32, DOI 10.1016/j.ympev.2004.04.009; Was A, 2008, ICES J MAR SCI, V65, P216, DOI 10.1093/icesjms/fsm187; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Catanese G, 2010, GENE, V452, P35, DOI 10.1016/j.gene.2009.12.004; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Magoulas A, 2006, MOL PHYLOGENET EVOL, V39, P734, DOI 10.1016/j.ympev.2006.01.016; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; CARVALHO GR, 1994, REV FISH BIOL FISHER, V4, P326, DOI 10.1007/BF00042908; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Zardoya R, 2004, MOL ECOL, V13, P1785, DOI 10.1111/j.1365-294X.2004.02198.x; SLATKIN M, 1995, GENETICS, V139, P457; MATSUI T, 1967, COPEIA, P71; Falush D, 2003, GENETICS, V164, P1567; TEMPLETON AR, 1995, GENETICS, V140, P767; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Arnason E, 1996, MOL ECOL, V5, P715, DOI 10.1111/j.1365-294X.1996.tb00368.x; Avise JC., 2000, PHYLOGEOGRAPHY HIST; Bassam BJ, 1991, ANN BIOCH, V19, P680; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Cardenas L, 2009, FISH RES, V100, P109, DOI 10.1016/j.fishres.2009.06.013; Collette BB, 1983, FAO FISHERIES SYNOPS, V125, P1; Cunningham KM, 2009, CAN J FISH AQUAT SCI, V66, P153, DOI 10.1139/F08-199; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Fauvelot C, 2011, BIOL J LINN SOC, V104, P886, DOI 10.1111/j.1095-8312.2011.01754.x; Goudet J., 2001, FSTAT V 2 9 3 PROGRA; Han ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037425; Hsueh Y, 1992, J GEOPHYS RES, V97, P14320; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Li CS, 2006, MARIN BIOL RESOURCES, P599; Liu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050340; Nesbo CL, 2000, P ROY SOC B-BIOL SCI, V267, P281; Nielsen EE, 2001, NATURE, V413, P272, DOI 10.1038/35095112; Ouchi A, 1979, B SEIKAI REG FISH RE, V53, P125; RAYMOND M, 1995, J HERED, V86, P248; Ross KG, 1997, GENETICS, V147, P643; Sambrook J, 2001, MOL CLONING LAB MANU, P74; Schneider S, 2000, ARLEQUIN VERSIN 2 0; Scoles DR, 1998, FISH B-NOAA, V96, P823; Shao F, 2008, J GUANGDONG OCEAN U, V28, P83; Shiraishi T, 2008, FISHERIES SCI, V74, P947, DOI 10.1111/j.1444-2906.2008.01612.x; Smedbol RK, 2002, FISH FISH, V3, P20, DOI 10.1046/j.1467-2979.2002.00062.x; Sun X, 1987, ESSAYS INVESTIGATION, P1; Tang CY, 2009, MOL ECOL RESOUR, V9, P824, DOI 10.1111/j.1755-0998.2008.02278.x; Tzeng Tzong-Der, 2007, Journal of the Fisheries Society of Taiwan, V34, P237; Tzeng TD, 2007, ZOOL STUD, V46, P656; Vis ML, 1997, CAN J FISH AQUAT SCI, V54, P1813, DOI 10.1139/cjfas-54-8-1813; WARD RD, 1994, REV FISH BIOL FISHER, V4, P300, DOI 10.1007/BF00042907; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Wu B, 1982, TAIWAN STRAIT, V1, P1; Yagishita N, 2008, MOL ECOL RESOUR, V8, P302, DOI 10.1111/j.1471-8286.2007.01935.x; Yan YM, 1997, MAR FISH, V19, P69; Yeh FC, 2000, POPGENE 32 MICROSOFT; Yukami R, 2009, FISHERIES SCI, V75, P167, DOI 10.1007/s12562-008-0015-7; Zeng LY, 2012, BIOCHEM SYST ECOL, V42, P83, DOI 10.1016/j.bse.2012.02.014; [张丽艳 Zhang Liyan], 2011, [生态学报, Acta Ecologica Sinica], V31, P7097	72	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	FEB	2015	42	2					373	382		10.1007/s11033-014-3777-2		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA6FZ	WOS:000349006900007		
J	Fukasawa, K; Kagaya, S; Maruyama, S; Kuroiwa, S; Masuda, K; Kameyama, Y; Satoh, Y; Akatsu, Y; Tomura, A; Nishikawa, K; Horie, S; Ichikawa, Y				Fukasawa, Kazuteru; Kagaya, Shigehide; Maruyama, Sakiko; Kuroiwa, Shunsuke; Masuda, Kuniko; Kameyama, Yoshio; Satoh, Yoshitaka; Akatsu, Yuichi; Tomura, Arihiro; Nishikawa, Kiyohiro; Horie, Shigeo; Ichikawa, Yuh-ichiro			A Novel Compound, NK150460, Exhibits Selective Antitumor Activity against Breast Cancer Cell Lines through Activation of Aryl Hydrocarbon Receptor	MOLECULAR CANCER THERAPEUTICS			English	Article							ESTROGEN-RESPONSIVE ELEMENT; VASCULAR ENDOTHELIAL-CELLS; AFLATOXIN B-1-DNA BINDING; AH-RECEPTOR; IN-VITRO; AMINOFLAVONE NSC-686288; PROGESTERONE-RECEPTOR; ALPHA-NAPHTHOFLAVONE; TRANSCRIPTION FACTOR; BETA-NAPHTHOFLAVONE	Antiestrogen agents are commonly used to treat patients with estrogen receptor (ER)-positive breast cancer. Tamoxifen has been the mainstay of endocrine treatment for patients with early and advanced breast cancer for many years. Following tamoxifen treatment failure, however, there are still limited options for subsequent hormonal therapy. Wediscovered a novel compound, NK150460, that inhibits 17 beta-estradiol (E2)-dependent transcription without affecting binding of E2 to ER. Against our expectations, NK150460 inhibited growth of not only most ER-positive, but also some ER-negative breast cancer cell lines, while never inhibiting growth of non-breast cancer cell lines. Cell-based screening using a random shRNA library, identified aryl hydrocarbon receptor nuclear translocator (ARNT) as a key gene involved in NK150460' s antitumor mechanism. siRNAs against not only ARNT but also its counterpart aryl hydrocarbon receptor (AhR) and their target protein, CYP1A1, dramatically abrogated NK150460' s growth-inhibitory activity. This suggests that the molecular cascade of AhR/ARNT plays an essential role in NK150460' s antitumor mechanism. Expression of ERa was decreased by NK150460 treatment, and this was inhibited by an AhR antagonist. Unlike two other AhR agonists now undergoing clinical developmental stage, NK150460 did not induce histone H2AX phosphorylation or p53 expression, suggesting that it did not induce a DNA damage response in treated cells. Cell lines expressing epithelial markers were more sensitive to NK150460 than mesenchymal marker-expressing cells. These data indicate that NK150460 is a novel AhR agonist with selective antitumor activity against breast cancer cell lines, and its features differ from those of the other two AhR agonists. (C) 2014 AACR.	[Fukasawa, Kazuteru; Kagaya, Shigehide; Maruyama, Sakiko; Kuroiwa, Shunsuke; Masuda, Kuniko; Kameyama, Yoshio; Satoh, Yoshitaka; Akatsu, Yuichi; Tomura, Arihiro; Nishikawa, Kiyohiro; Ichikawa, Yuh-ichiro] Nippon Kayaku Co Ltd, Pharmaceut Res Labs, Res & Dev Grp, Kita Ku, Tokyo 1158588, Japan; [Fukasawa, Kazuteru; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Bunkyo Ku, Tokyo, Japan	Fukasawa, K (reprint author), Nippon Kayaku Co Ltd, Kita Ku, 3-31-12 Shimo, Tokyo 1158588, Japan.	kazuteru.fukasawa@nipponkayaku.co.jp					Adamo V, 2007, ANN ONCOL, V18, P53, DOI 10.1093/annonc/mdm225; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Wormke M, 2000, FEBS LETT, V478, P109, DOI 10.1016/S0014-5793(00)01830-5; Bergh J, 2012, J CLIN ONCOL, V30, P921, DOI 10.1200/JCO.2011.35.7376; Cardoso F, 2012, BREAST, V21, P242, DOI 10.1016/j.breast.2012.03.003; Cui JH, 2014, CURR MED CHEM, V21, P519; Wittmann BM, 2007, CANCER RES, V67, P9549, DOI 10.1158/0008-5472.CAN-07-1590; Leong CO, 2003, BRIT J CANCER, V88, P470, DOI 10.1038/sj.bjc.6600719; Barrios CH, 2010, BREAST CANCER RES TR, V121, P121, DOI 10.1007/s10549-010-0788-0; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Jin UH, 2012, J PHARMACOL EXP THER, V343, P333, DOI 10.1124/jpet.112.195339; Tsuchiya Y, 2003, J BIOCHEM, V133, P583, DOI 10.1093/jb/mvg075; Fukasawa K, 2006, CANCER LETT, V243, P135, DOI 10.1016/j.canlet.2005.11.051; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Safe S, 2013, TOXICOL SCI, V135, P1, DOI 10.1093/toxsci/kft128; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leong CO, 2004, MOL CANCER THER, V3, P1565; TAKAHASHI N, 1995, COMP BIOCHEM PHYS C, V110, P273, DOI 10.1016/0742-8413(95)00005-9; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bayraktar S, 2013, BREAST CANCER RES TR, V138, P21, DOI 10.1007/s10549-013-2421-5; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; ONATE SA, 1995, SCIENCE, V270, P1354; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Sogawa K, 1997, J BIOCHEM-TOKYO, V122, P1075; Meng LH, 2005, CANCER RES, V65, P5337, DOI 10.1158/0008-5472.CAN-05-0003; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Arpino G, 2009, ONCOLOGY-BASEL, V77, P23, DOI 10.1159/000258493; Meng LH, 2006, CANCER RES, V66, P9656, DOI 10.1158/0008-5472.CAN-06-0796; Juan SH, 2006, EUR J PHARMACOL, V530, P1, DOI 10.1016/j.ejphar.2005.11.023; Wormke M, 2003, MOL CELL BIOL, V23, P1843, DOI 10.1128/MCB.23.6.1843-1855.2003; Abdelrahim M, 2006, CANCER RES, V66, P2459, DOI 10.1158/0008-5472.CAN-05-3132; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Rabaglio M, 2007, LANCET ONCOL, V8, P940, DOI 10.1016/S1470-2045(07)70317-0; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Finn RS, 2009, J CLIN ONCOL, V27, P3908, DOI 10.1200/JCO.2008.18.1925; Rico-Leo EM, 2013, J BIOL CHEM, V288, P7841, DOI 10.1074/jbc.M112.425009; AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Davies E., 2013, SURGERY, V31, P41; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; GASIEWICZ TA, 1991, MOL PHARMACOL, V40, P607; Gillesby BE, 1997, BIOCHEMISTRY-US, V36, P6080, DOI 10.1021/bi962131b; Hong H, 1997, MOL CELL BIOL, V17, P2735; Jin UH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-498; Katzenellenbogen BS, 2000, J STEROID BIOCHEM, V74, P279, DOI 10.1016/S0960-0760(00)00104-7; KUBOTA T, 1989, JPN J SURG, V19, P446, DOI 10.1007/BF02471626; Kurebayashi J, 1998, ONCOLOGY-BASEL, V55, P23, DOI 10.1159/000055256; Okino ST, 2007, MOL PHARMACOL, V72, P1457, DOI 10.1124/mol.107.039826; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Seckl M, 2012, P 8 NCRI CANC C 2012; Takahashi N, 1996, CARCINOGENESIS, V17, P79, DOI 10.1093/carcin/17.1.79; Xu XJ, 2004, GENE, V328, P143, DOI 10.1016/j.gene.2003.12.003	59	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	FEB	2015	14	2					343	354		10.1158/1535-7163.MCT-14-0158		12	Oncology	Oncology	CB3OV	WOS:000349538700003		
J	Hayashi, N; Kataoka, H; Yano, S; Tanaka, M; Moriwaki, K; Akashi, H; Suzuki, S; Mori, Y; Kubota, E; Tanida, S; Takahashi, S; Joh, T				Hayashi, Noriyuki; Kataoka, Hiromi; Yano, Shigenobu; Tanaka, Mamoru; Moriwaki, Kazuhiro; Akashi, Haruo; Suzuki, Shugo; Mori, Yoshinori; Kubota, Eiji; Tanida, Satoshi; Takahashi, Satoru; Joh, Takashi			A Novel Photodynamic Therapy Targeting Cancer Cells and Tumor-Associated Macrophages	MOLECULAR CANCER THERAPEUTICS			English	Article							MANNOSE RECEPTOR; BREAST-CANCER; IN-VIVO; PROGRESSION; MICROENVIRONMENT; ANGIOGENESIS; CHLORIN; METASTASIS; SURVIVAL; DENSITY	Tumor-associated macrophages (TAM) in cancer stroma play important roles for cancer cell growth, invasion, angiogenesis, and metastases. We synthesized a novel photosensitizer, mannose-conjugated chlorin (M-chlorin), designed to bind mannose receptors highly expressed on TAMs. We evaluated the newly available photodynamic therapy (PDT) with M-chlorin against gastric and colon cancer. We evaluated PDT with Mchlorin for in vitro cytotoxicity and apoptosis induction in cancer cells compared with chlorin alone and glucose-conjugated chlorin (G-chlorin). The subcellular localization of M-chlorin was observed by confocal microscopy, and the M-chlorin PDT effects against TAMs including THP-1-induced M2-polarized macrophages were evaluated. Anticancer effects were also investigated in an allograft model where cytotoxic effects against TAMs in the cancer cell stroma were analyzed by immunohistochemistry. M-chlorin PDT strongly induced cell death in cancer cells to almost the same extent as G-chlorin PDT by inducing apoptosis. M-chlorin was incorporated into cancer cells where it localized mainly in lysosomes and endoplasmic reticula. M-chlorin PDT revealed strong cytotoxicity for M2 macrophages induced from THP-1 cell lines, and it induced stronger cytotoxicity than G-chlorin PDT in the allograft model through killing both cancer cells and TAMs in the cancer stroma. The M-chlorin PDT produced strong cytotoxicity against cancer tissue by inducing apoptosis of both cancer cells and TAMs in the cancer stroma. This novel PDT thus stands as a new candidate for very effective, next-generation PDT. (C) 2014 AACR.	[Hayashi, Noriyuki; Kataoka, Hiromi; Tanaka, Mamoru; Mori, Yoshinori; Kubota, Eiji; Tanida, Satoshi; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Yano, Shigenobu] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300101, Japan; [Yano, Shigenobu] Kyoto Univ, Off Soc Acad Collaborat Innovat, Nishikyo Ku, Kyoto, Japan; [Moriwaki, Kazuhiro; Akashi, Haruo] Okayama Univ Sci, Res Inst Nat Sci, Kita Ku, Okayama, Japan; [Suzuki, Shugo; Takahashi, Satoru] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Kataoka, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hkataoka@med.nagoya-cu.ac.jp			JSPS KAKENHI [23590923, 24790717, 25288028, 219350031, 5288028]; JSPS; Deutsche Forschungsgemeinschaft; Hori Sciences and Arts Foundation; Japan Science and Technology Agency A-step; Japan Science and Technology Agency Molecular Imaging; Japanese Foundation for Research and Promotion of Endoscopy	This work was financially supported by JSPS KAKENHI grant number 23590923, JSPS KAKENHI grant number 24790717, JSPS KAKENHI grant number 25288028, JSPS KAKENHI grant number 219350031, JSPS KAKENHI grant number 5288028, the Japan-German Exchange Program supported by the JSPS and the Deutsche Forschungsgemeinschaft, the Hori Sciences and Arts Foundation (2013), Japan Science and Technology Agency A-step (2011), Japan Science and Technology Agency Molecular Imaging (2011, 2012, 2013), and The Japanese Foundation for Research and Promotion of Endoscopy (2011).	Abels C, 2004, PHOTOCH PHOTOBIO SCI, V3, P765, DOI 10.1039/b314241h; Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Allison Ron R, 2013, Clin Endosc, V46, P24, DOI 10.5946/ce.2013.46.1.24; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; Palaskas N, 2011, CANCER RES, V71, P5164, DOI 10.1158/0008-5472.CAN-10-4633; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Buddingh EP, 2011, CLIN CANCER RES, V17, P2110, DOI 10.1158/1078-0432.CCR-10-2047; Tsutsui S, 2005, ONCOL REP, V14, P425; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Li ZZ, 2013, CANCER LETT, V339, P128, DOI 10.1016/j.canlet.2013.07.012; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; DOUGHERTY TJ, 1990, LASER SURG MED, V10, P485, DOI 10.1002/lsm.1900100514; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; NELSON JS, 1987, CANCER RES, V47, P4681; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Tanaka M, 2011, ANTICANCER RES, V31, P763; Rao GH, 2013, CLIN CANCER RES, V19, P785, DOI 10.1158/1078-0432.CCR-12-2788; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Hirohara S, 2009, J PHOTOCH PHOTOBIO B, V97, P22, DOI 10.1016/j.jphotobiol.2009.07.007; Yano S, 2011, J PHOTOCH PHOTOBIO C, V12, P46, DOI 10.1016/j.jphotochemrev.2011.06.001; Cieslewicz M, 2013, P NATL ACAD SCI USA, V110, P15919, DOI 10.1073/pnas.1312197110; Xing F, 2010, FRONT BIOSCI, V15, P166, DOI 10.2741/3613; Tanaka M, 2014, MOL CANCER THER, V13, P767, DOI 10.1158/1535-7163.MCT-13-0393; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Horimatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038308; Marconi C, 2008, CLIN EXP METASTAS, V25, P225, DOI 10.1007/s10585-007-9136-0; Mroz Pawel, 2011, Cancers (Basel), V3, P2516, DOI 10.3390/cancers3022516; Vasievich EA, 2011, MOL PHARMACEUT, V8, P635, DOI 10.1021/mp1004228	47	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	FEB	2015	14	2					452	460		10.1158/1535-7163.MCT-14-0348		9	Oncology	Oncology	CB3OV	WOS:000349538700013		
J	Sano, Y; Hashimoto, E; Nakatani, N; Abe, M; Satoh, Y; Sakata, K; Fujii, T; Fujimoto-Ouchi, K; Sugimoto, M; Nagahashi, S; Aoki, M; Motegi, H; Sasaki, E; Yatabe, Y				Sano, Yuji; Hashimoto, Eri; Nakatani, Noriaki; Abe, Masaichi; Satoh, Yasuko; Sakata, Kiyoaki; Fujii, Toshihiko; Fujimoto-Ouchi, Kaori; Sugimoto, Masamichi; Nagahashi, Shigehisa; Aoki, Masahiro; Motegi, Hiroshi; Sasaki, Eiichi; Yatabe, Yasushi			Combining Onartuzumab with Erlotinib Inhibits Growth of Non-Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression	MOLECULAR CANCER THERAPEUTICS			English	Article							MET TYROSINE KINASE; C-MET; ACQUIRED-RESISTANCE; T790M MUTATION; GEFITINIB RESISTANCE; SCATTER FACTOR; RECEPTOR; GENE; AMPLIFICATION; ANTIBODY	Erlotinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR-TKI), benefits survival of patients with non-small cell lung cancer (NSCLC) who harbor activating EGFR mutations. However, elevated expression of hepatocyte growth factor (HGF), a ligand of the MET receptor tyrosine kinase, causes erlotinib resistance. Because onartuzumab, a monovalent antibody to MET, blocks HGF-induced MET activation, the addition of onartuzumab to erlotinib may improve therapeutic efficacy. We engineered the human NSCLC cell line PC-9 (MET-positive cells harboring an exon 19 deletion of EGFR) to overexpress hHGF and evaluated the effects of an onartuzumab and erlotinib combination in vitro and in vivo in xenograft models. A stable clone of PC-9/hHGF was less sensitive to erlotinib than the parental PC-9, and the addition of onartuzumab to erlotinib suppressed the proliferation of these cells in vitro. In PC-9/hHGF xenograft tumors, onartuzumab or erlotinib alone minimally inhibited tumor growth; however, combining onartuzumab and erlotinib markedly suppressed tumor growth. The total MET protein level was decreased in PC-9/hHGF cells, because MET is constitutively phosphorylated by autocrine HGF, leading to its ubiquitination and degradation. Onartuzumab reduced phospho-MET levels, inhibited MET ubiquitination, and consequently restored MET protein levels. Moreover, in NSCLC clinical specimens harboring activating EGFR mutations, more than 30% of patients expressed high levels of HGF. Our findings raised the possibility that patients with NSCLC with EGFR mutations who express high levels of HGF may benefit from onartuzumab and erlotinib combination therapy, and that HGF can be a novel biomarker for selecting such patients. (C)2014 AACR.	[Sano, Yuji; Hashimoto, Eri; Satoh, Yasuko; Sakata, Kiyoaki; Fujii, Toshihiko; Fujimoto-Ouchi, Kaori; Sugimoto, Masamichi; Nagahashi, Shigehisa; Aoki, Masahiro] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kamakura, Kanagawa 2478530, Japan; [Nakatani, Noriaki; Motegi, Hiroshi] Chugai Pharmaceut Co Ltd, Project Lifecycle Management Unit, Chuo Ku, Tokyo, Japan; [Abe, Masaichi] Chugai Pharmaceut Co Ltd, Clin Dev Div, Chuo Ku, Tokyo, Japan; [Sasaki, Eiichi; Yatabe, Yasushi] Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan	Sano, Y (reprint author), Chugai Pharmaceut Co Ltd, Discovery Pharmacol Dept, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.	sanoyuj@chugai-pharm.co.jp			Chugai Pharmaceutical Co., Ltd., Kanagawa, Japan	This study was funded by Chugai Pharmaceutical Co., Ltd., Kanagawa, Japan.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Prat M, 1998, J CELL SCI, V111, P237; Wu YL, 2013, LUNG CANCER, V81, P280, DOI 10.1016/j.lungcan.2013.03.004; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Liu XD, 2008, EXPERT OPIN INV DRUG, V17, P997, DOI [10.1517/13543784.17.7.997 , 10.1517/13543780802170147]; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Goetsch L, 2013, FRONT BIOSCI-LANDMRK, V18, P454, DOI 10.2741/4114; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Siegfried JM, 1997, CANCER RES, V57, P433; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Oxnard GR, 2013, J CLIN ONCOL, V31, P1097, DOI 10.1200/JCO.2012.42.9829; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Lai AZ, 2012, J BIOL CHEM, V287, P8048, DOI 10.1074/jbc.M112.339820; Ma Chunyan, 2011, J Thorac Dis, V3, P10, DOI 10.3978/j.issn.2072-1439.2010.12.02; Merchant M, 2008, AACR M, P1336; Nguyen TH, 2003, CANCER GENE THER, V10, P840, DOI 10.1038/sj.cgt.7700640; Olivero M, 1996, BRIT J CANCER, V74, P1862, DOI 10.1038/bjc.1996.646; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Penuel E, 2013, MOL CANCER THER, V12, P1122, DOI 10.1158/1535-7163.MCT-13-0015; RONG S, 1992, MOL CELL BIOL, V12, P5152; Saijo N, 2009, NAT REV CLIN ONCOL, V6, P287, DOI 10.1038/nrclinonc.2009.37; Spigel DR, 2014, J CLIN ONCOL S, V32, p5s; Taher TEI, 2002, J IMMUNOL, V169, P3793; Yu W, 2011, J CLIN ONCOL S, V29	43	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	FEB	2015	14	2					533	541		10.1158/1535-7163.MCT-14-0456		9	Oncology	Oncology	CB3OV	WOS:000349538700021		
J	Chikano, Y; Domoto, T; Furuta, T; Sabit, H; Kitano-Tamura, A; Pyko, IV; Takino, T; Sai, Y; Hayashi, Y; Sato, H; Miyamoto, K; Nakada, M; Minamoto, T				Chikano, Yuri; Domoto, Takahiro; Furuta, Takuya; Sabit, Hemragul; Kitano-Tamura, Ayako; Pyko, Ilya V.; Takino, Takahisa; Sai, Yoshimichi; Hayashi, Yutaka; Sato, Hiroshi; Miyamoto, Ken-ichi; Nakada, Mitsutoshi; Minamoto, Toshinari			Glycogen Synthase Kinase 3 beta Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway	MOLECULAR CANCER THERAPEUTICS			English	Article							CELL-MIGRATION; GLIOMA-CELLS; CANCER-CELLS; KAPPA-B; TUMOR; INHIBITION; TEMOZOLOMIDE; RADIATION; FAK; MAINTENANCE	The failure of current treatment options for glioblastoma stems from their inability to control tumor cell proliferation and invasion. Biologically targeted therapies offer great hope and one promising target is glycogen synthase kinase-3 beta (GSK3 beta), implicated in various diseases, including cancer. We previously reported that inhibition of GSK3 beta compromises the survival and proliferation of glioblastoma cells, induces their apoptosis, and sensitizes them to temozolomide and radiation. Here, we explore whether GSK3 beta also contributes to the highly invasive nature of glioblastoma. The effects of GSK3 beta inhibition on migration and invasion of glioblastoma cells were examined by wound-healing and Transwell assays, as well as in a mouse model of glioblastoma. We also investigated changes in cellular microarchitectures, cytoskeletal components, and proteins responsible for cell motility and invasion. Inhibition of GSK3 beta attenuated the migration and invasion of glioblastoma cells in vitro and that of tumor cells in a mouse model of glioblastoma. These effects were associated with suppression of the molecular axis involving focal adhesion kinase, guanine nucleotide exchange factors/Rac1 and c-Jun N-terminal kinase. Changes in cellular phenotypes responsible for cell motility and invasion were also observed, including decreased formation of lamellipodia and invadopodium-like microstructures and alterations in the subcellular localization, and activity of Rac1 and F-actin. These changes coincided with decreased expression of matrix metalloproteinases. Our results confirm the potential of GSK3 beta as an attractive therapeutic target against glioblastoma invasion, thus highlighting a second role in this tumor type in addition to its involvement in chemo- and radioresistance. (C)2014 AACR.	[Chikano, Yuri; Domoto, Takahiro; Kitano-Tamura, Ayako; Pyko, Ilya V.; Minamoto, Toshinari] Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 9200934, Japan; [Chikano, Yuri; Kitano-Tamura, Ayako; Sai, Yoshimichi; Miyamoto, Ken-ichi] Kanazawa Univ, Dept Hosp Pharm, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Furuta, Takuya; Sabit, Hemragul; Pyko, Ilya V.; Hayashi, Yutaka; Nakada, Mitsutoshi] Kanazawa Univ, Dept Neurosurg, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Takino, Takahisa; Sato, Hiroshi] Kanazawa Univ, Div Mol Virol & Oncol, Canc Res Inst, Kanazawa, Ishikawa 9208641, Japan	Nakada, M (reprint author), Kanazawa Univ, Dept Neurosurg, Grad Sch Med Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	mnakada@med.kanazawa-u.ac.jp; minamoto@staff.kanazawa-u.ac.jp	TAKINO, Takahisa/D-8460-2015; PYKO, ILYA/D-8450-2015; SATO, Hiroshi/D-8454-2015; SAI, Yoshimichi/L-3828-2015	SAI, Yoshimichi/0000-0003-2954-1532	Japanese Ministry of Education, Science, Sports, Technology and Culture; Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science; Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This study was supported by Grant-in-Aids for Scientific Research (T. Minamoto and M. Nakada) from the Japanese Ministry of Education, Science, Sports, Technology and Culture; from the Ministry of Health, Labour and Welfare; from the Japan Society for the Promotion of Science; the grants from Foundation for Promotion of Cancer Research (M. Nakada); Mochida Memorial Foundation for Medical and Pharmaceutical Research (M. Nakada).	Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Wild-Bode C, 2001, CANCER RES, V61, P2744; Golubovskaya VM, 2013, MOL CANCER THER, V12, P162, DOI 10.1158/1535-7163.MCT-12-0701; Hwang SY, 2006, INT J CANCER, V118, P2056, DOI 10.1002/ijc.21574; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Phukan S, 2010, BRIT J PHARMACOL, V160, P1, DOI 10.1111/j.1476-5381.2010.00661.x; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Tanaka S, 2013, NAT REV CLIN ONCOL, V10, P14, DOI 10.1038/nrclinonc.2012.204; Lucio-Eterovic AK, 2009, CLIN CANCER RES, V15, P4589, DOI 10.1158/1078-0432.CCR-09-0575; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Liu C, 2011, CLIN EXP MED, V11, P105, DOI 10.1007/s10238-010-0110-9; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pyko IV, 2013, CARCINOGENESIS, V34, P2206, DOI 10.1093/carcin/bgt182; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Zhai GG, 2006, J NEURO-ONCOL, V76, P227, DOI 10.1007/s11060-005-6499-4; Jones TS, 2012, ONCOGENE, V31, P1995, DOI 10.1038/onc.2011.398; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Thotala DK, 2008, CANCER RES, V68, P5859, DOI 10.1158/0008-5472.CAN-07-6327; [Anonymous], MEXT LIFESCIENCE POR; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Zhang XH, 2012, CANCER SCI, V103, P181, DOI 10.1111/j.1349-7006.2011.02154.x; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Yoon CH, 2011, FEBS LETT, V585, P2331, DOI 10.1016/j.febslet.2011.05.070; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Miyashita K, 2009, ANTI-CANCER AGENT ME, V9, P1114; Mai W, 2009, CLIN CANCER RES, V15, P6810, DOI 10.1158/1078-0432.CCR-09-0973; Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Williams SP, 2011, CANCER RES, V71, P5374, DOI 10.1158/0008-5472.CAN-10-3026; Cloughesy TF, 2011, CLIN CANCER RES, V17, P6, DOI 10.1158/1078-0432.CCR-09-2268; Fortin Ensign SP, 2013, FRONT ONCOL, V3, P241; Kudo T, 2007, CANCER SCI, V98, P563, DOI 10.1111/j.1349-7006.2007.00426.x; Munson JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003016; Nakada M, 2007, CELL MOL LIFE SCI, V64, P58; Nomura N, 2008, ONCOL REP, V20, P705, DOI 10.3892/or_00000063; Zou QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081814	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	FEB	2015	14	2					564	574		10.1158/1535-7163.MCT-14-0479		11	Oncology	Oncology	CB3OV	WOS:000349538700024		
J	Tomatsu, S; Almeciga-Diaz, CJ; Montano, AM; Yabe, H; Tanaka, A; Dung, VC; Giugliani, R; Kubaski, F; Mason, RW; Yasuda, E; Sawamoto, K; Mackenzie, W; Suzuki, Y; Orii, KE; Barrera, LA; Sly, WS; Orii, T				Tomatsu, Shunji; Almeciga-Diaz, Carlos J.; Montatio, Adriana M.; Yabe, Hiromasa; Tanaka, Akemi; Vu Chi Dung; Giugliani, Roberto; Kubaski, Francyne; Mason, Robert W.; Yasuda, Eriko; Sawamoto, Kazuki; Mackenzie, William; Suzuki, Yasuyuki; Orii, Kenji E.; Barrera, Luis A.; Sly, William S.; Orii, Tadao			Therapies for the bone in mucopolysaccharidoses	MOLECULAR GENETICS AND METABOLISM			English	Review						Mucopolysaccharidoses; Skeletal dysplasia; Enzyme replacement therapy; Gene therapy; Hematopoietic stem cell transplantation; Anti-inflammatory drug	ENZYME-REPLACEMENT THERAPY; STEM-CELL TRANSPLANTATION; LYSOSOMAL STORAGE DISORDERS; TERM-FOLLOW-UP; MAROTEAUX-LAMY-SYNDROME; NEONATAL GENE-THERAPY; N-ACETYLGALACTOSAMINE 4-SULFATASE; DRUG-DELIVERY SYSTEM; II HUNTER-SYNDROME; SYNDROME TYPE-A	Patients with mucopolysaccharidoses (MPS) have accumulation of glycosaminoglycans in multiple tissues which may cause coarse facial features, mental retardation, recurrent ear and nose infections, inguinal and umbilical hernias, hepatosplenomegaly, and skeletal deformities. Clinical features related to bone lesions may include marked short stature, cervical stenosis, pectus carinatum, small lungs, joint rigidity (but laxity for MPS IV), kyphoscoliosis, lumbar gibbus, and genu valgum. Patients with MPS are often wheelchair-bound and physical handicaps increase with age as a result of progressive skeletal dysplasia, abnormal joint mobility, and osteoarthritis, leading to 1) stenosis of the upper cervical region, 2) restrictive small lung, 3) hip dysplasia, 4) restriction of joint movement, and 5) surgical complications. Patients often need multiple orthopedic procedures including cervical decompression and fusion, carpal tunnel release, hip reconstruction and replacement, and femoral or tibial osteotomy through their lifetime. Current measures to intervene in bone disease progression are not perfect and palliative, and improved therapies are urgently required. Enzyme replacement therapy (ERT), hematopoietic stem cell transplantation (HSCT), and gene therapy are available or in development for some types of MPS. Delivery of sufficient enzyme to bone, especially avascular cartilage, to prevent or ameliorate the devastating skeletal dysplasias remains an unmet challenge. The use of an anti-inflammatory drug is also under clinical study. Therapies should start at a very early stage prior to irreversible bone lesion, and damage since the severity of skeletal dysplasia is associated with level of activity during daily life. This review illustrates a current overview of therapies and their impact for bone lesions in MPS including ERT, HSCT, gene therapy, and anti-inflammatory drugs. (C) 2014 Elsevier Inc. All rights reserved.	[Tomatsu, Shunji; Kubaski, Francyne; Mason, Robert W.; Yasuda, Eriko; Sawamoto, Kazuki; Mackenzie, William] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19899 USA; [Almeciga-Diaz, Carlos J.; Barrera, Luis A.] Pontificia Univ Javeriana, Inst Study Inborn Enors Metab, Bogota, DC, Colombia; [Montatio, Adriana M.] St Louis Univ, Dept Pediat, St Louis, MO 63103 USA; [Yabe, Hiromasa] Tokai Univ, Sch Med, Dept Cell Transplantat, Isehara, Kanagawa 25911, Japan; [Tanaka, Akemi] Osaka City Univ, Grad Sch Med, Dept Pediat, Osaka 558, Japan; [Vu Chi Dung] Vietnam Natl Hosp Pediat, Dept Endocrinol Metab & Genet, Hanoi, Vietnam; [Tomatsu, Shunji; Giugliani, Roberto] Med Genet Serv HCPA, Porto Alegre, RS, Brazil; [Tomatsu, Shunji; Giugliani, Roberto] Dept Genet UFRGS, Porto Alegre, RS, Brazil; [Kubaski, Francyne] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Suzuki, Yasuyuki] Gifu Univ, Med Educ Dev Ctr, Gifu, Japan; [Orii, Kenji E.; Orii, Tadao] Gifu Univ, Dept Pediat, Gifu 5011194, Japan; [Sly, William S.] St Louis Univ, Edward A Daisy Dept Biochem & Mol Biol, St Louis, MO 63103 USA	Tomatsu, S (reprint author), Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, Skeletal Dysplasia Ctr, 1600 Rockland Rd, Wilmington, DE 19899 USA.	stomatsu@nemours.org; orii.tadao@camel.plala.or.jp	Giugliani, Roberto/G-4790-2015	Giugliani, Roberto/0000-0001-9655-3686			Aldenboven M, 2008, BIOL BLOOD MARROW TR, V14, P485, DOI 10.1016/j.bbmt.2008.01.009; Almeciga-Diaz C, 2012, MEDICINA MEX, V34, P221; Almeciga C, 2009, MOL GENET METAB, V96, pS13, DOI 10.1016/j.ymgme.2008.11.006; Almeciga-Diaz CJ, 2010, FEBS J, V277, P3608, DOI 10.1111/j.1742-4658.2010.07769.x; Almeciga C, 2013, MOL GENET METAB, V108, pS19, DOI 10.1016/j.ymgme.2012.11.022; Ellinwood NM, 2011, MOL THER, V19, P251, DOI 10.1038/mt.2010.265; Connock M, 2006, HEALTH TECHNOL ASSES, V10, P1; Fujisaki J, 1998, J DRUG TARGET, V5, P129; Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936; Prasad VK, 2010, SEMIN HEMATOL, V47, P59, DOI 10.1053/j.seminhematol.2009.10.008; Tomatsu S, 2003, HUM MOL GENET, V12, P3349, DOI 10.1093/hmg/ddg366; SANDS MS, 1993, LAB INVEST, V68, P676; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; Ellinwood NM, 2004, J GENE MED, V6, P481, DOI 10.1002/jgm.581; Tomatsu S, 2013, MOL GENET METAB, V110, P42, DOI 10.1016/j.ymgme.2013.06.007; Harmatz PR, 2014, J INHERIT METAB DIS, V37, P277, DOI 10.1007/s10545-013-9654-7; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Vellodi A, 1999, J INHERIT METAB DIS, V22, P638, DOI 10.1023/A:1005525931994; FIELD RE, 1994, J BONE JOINT SURG BR, V76B, P975; Theroux MC, 2012, PEDIATR ANESTH, V22, P901, DOI 10.1111/j.1460-9592.2012.03904.x; Aronovich EL, 2007, J GENE MED, V9, P403, DOI 10.1002/jgm.1028; Tomatsu S, 2011, CURR PHARM BIOTECHNO, V12, P931, DOI 1389-2010/11 $58.00+.00; Parveen S, 2006, CLIN PHARMACOKINET, V45, P965, DOI 10.2165/00003088-200645100-00002; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Staba SL, 2004, NEW ENGL J MED, V350, P1960, DOI 10.1056/NEJMoa032613; Tajima G, 2013, MOL GENET METAB, V108, P172, DOI 10.1016/j.ymgme.2012.12.010; Boelens JJ, 2013, BLOOD, V121, P3981, DOI 10.1182/blood-2012-09-455238; Okuyama T, 2010, MOL GENET METAB, V99, P18, DOI 10.1016/j.ymgme.2009.08.006; Tolar J, 2008, BONE MARROW TRANSPL, V41, P531, DOI 10.1038/sj.bmt.1705934; Lau AA, 2013, JIMD REP, V8, P121, DOI 10.1007/8904_2012_169; Grewal SS, 2005, GENET MED, V7, P143, DOI 10.1097/01.GIM.0000154299.22120.6A; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; BECK M, 1992, PRENATAL DIAG, V12, P1019, DOI 10.1002/pd.1970121207; Rodriguez ME, 2010, PEDIATR PULM, V45, P679, DOI 10.1002/ppul.21246; Furujo M, 2011, MOL GENET METAB, V104, P597, DOI 10.1016/j.ymgme.2011.08.029; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Visigalli I, 2010, BLOOD, V116, P5130, DOI 10.1182/blood-2010-04-278234; Ferla R, 2013, HUM GENE THER, V24, P163, DOI 10.1089/hum.2012.179; Smith LJ, 2012, MOL GENET METAB, V107, P145, DOI 10.1016/j.ymgme.2012.03.013; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Oikawa H, 2014, J INHERIT METAB DIS, V37, P309, DOI 10.1007/s10545-013-9646-7; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Xing EM, 2013, MOL GENET METAB, V109, P183, DOI 10.1016/j.ymgme.2013.03.013; NAGATA T, 1991, BIOCHEM J, V274, P513; Ohashi A, 2009, ACTA PAEDIATR, V98, P768, DOI [10.1111/j.1651-2227.2009.01134.x, 10.1111/j.1651-2227.2008.01134.x]; Harmatz P, 2008, MOL GENET METAB, V94, P469, DOI 10.1016/j.ymgme.2008.04.001; Aldenhoven M, 2009, ANN RHEUM DIS, V68, P1659, DOI 10.1136/ard.2008.095315; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; Seregin SS, 2011, CURR PHARM DESIGN, V17, P2558; Malatack JJ, 2003, PEDIATR NEUROL, V29, P391, DOI 10.1016/j.pediatrneurol.2003.09.003; Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249; Tylki-Szymanska A, 2010, J INHERIT METAB DIS, V33, P151, DOI 10.1007/s10545-010-9059-9; Ponder KP, 2012, MOL THER, V20, P898, DOI 10.1038/mt.2012.9; SANDS MS, 1994, J CLIN INVEST, V93, P2324, DOI 10.1172/JCI117237; Tomatsu S, 2013, EXPERT OPIN ORPHAN D, V1, P805, DOI 10.1517/21678707.2013.846853; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; Rowan DJ, 2012, MOL GENET METAB, V107, P161, DOI 10.1016/j.ymgme.2012.07.002; Tanaka A, 2012, MOL GENET METAB, V107, P513, DOI 10.1016/j.ymgme.2012.09.004; Souillet G, 2003, BONE MARROW TRANSPL, V31, P1105, DOI 10.1038/sj.bmt.1704105; Rohrbach M, 2007, DRUGS, V67, P2697; McGill JJ, 2010, CLIN GENET, V77, P492, DOI 10.1111/j.1399-0004.2009.01324.x; Cotugno G, 2011, MOL THER, V19, P461, DOI 10.1038/mt.2010.257; Crawley AC, 1997, J CLIN INVEST, V99, P651, DOI 10.1172/JCI119208; Scott CR, 2013, J PEDIATR-US, V163, P498, DOI 10.1016/j.jpeds.2013.01.031; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Paciotti S, 2012, CLIN CHIM ACTA, V413, P1827, DOI 10.1016/j.cca.2012.07.011; MARTIN JJ, 1983, CLIN NEUROPATHOL, V2, P122; Yokogawa K, 2001, ENDOCRINOLOGY, V142, P1228, DOI 10.1210/en.142.3.1228; Dickson P, 2008, J CLIN INVEST, V118, P2868, DOI 10.1172/JCI34676; Baldo G, 2013, MOL GENET METAB, V109, P33, DOI 10.1016/j.ymgme.2013.03.005; Macsai CE, 2012, MOL GENET METAB, V106, P202, DOI 10.1016/j.ymgme.2012.03.022; Montano AM, 2008, MOL GENET METAB, V94, P178, DOI 10.1016/j.ymgme.2008.01.007; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Sekido T, 2001, J DRUG TARGET, V9, P111; Yasuda E, 2013, MOL GENET METAB, V109, P301, DOI 10.1016/j.ymgme.2013.04.009; Soper BW, 2001, BLOOD, V97, P1498, DOI 10.1182/blood.V97.5.1498; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Tylki-Szymanska A, 2012, ACTA PAEDIATR, V101, pE42, DOI 10.1111/j.1651-2227.2011.02385.x; Araya K, 2009, MOL GENET METAB, V98, P255, DOI 10.1016/j.ymgme.2009.05.006; Aronovich EL, 2009, MOL THER, V17, P1136, DOI 10.1038/mt.2009.87; Auclair D, 2003, MOL GENET METAB, V78, P163, DOI 10.1016/S1096-7192(03)00007-6; Boelens JJ, 2006, J INHERIT METAB DIS, V29, P413, DOI 10.1007/s10545-005-0258-8; Chakrapani A, 2001, ARCH DIS CHILD, V84, pF205, DOI 10.1136/fn.84.3.F205; Chen YH, 2012, MOL THER, V20, P1393, DOI 10.1038/mt.2012.100; Cheng SH, 2014, J LIPID RES, V55, P1827, DOI 10.1194/jlr.R047175; Chinen Y., 2014, MOL GENET METAB REP, V1, P31; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; CLEARY MA, 1995, ACTA PAEDIATR, V84, P337, DOI 10.1111/j.1651-2227.1995.tb13640.x; Dierenfeld A.D., 2010, SCI TRANSL MED, V2, P1; Eliyahu E., 2011, PLOS ONE, V6, P1; Frohbergh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100882; Gabrielli O, 2010, PEDIATRICS, V125, pE183, DOI 10.1542/peds.2009-1728; Guffon N, 2009, J PEDIATR-US, V154, P733, DOI 10.1016/j.jpeds.2008.11.041; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Hendriksz CJ, 2014, J INHERIT METAB DIS, V37, P979, DOI 10.1007/s10545-014-9715-6; Herati RS, 2008, J GENE MED, V10, P972, DOI 10.1002/jgm.1229; Herati RS, 2008, MOL GENET METAB, V95, P142, DOI 10.1016/j.ymgme.2008.07.003; Herskhovitz E, 1999, J INHERIT METAB DIS, V22, P50, DOI 10.1023/A:1005447232027; Hodges BL, 2006, CURR GENE THER, V6, P227, DOI 10.2174/156652306776359522; Husain T, 2009, GENE THER, V16, P927, DOI 10.1038/gt.2009.52; Khanna G, 2007, BONE MARROW TRANSPL, V39, P331, DOI 10.1038/sj.bmt.1705586; Kumagai Kenji, 2010, BMC Clin Pharmacol, V10, P7, DOI 10.1186/1472-6904-10-7; Langereis E.J., 2013, ORPHANET J RARE DIS, V8, P1; Lin S.P., 2013, ORPHANET J RARE DIS, V8, P1; Masterson EL, 1996, J PEDIATR ORTHOPED, V16, P731; Neufeld EF, 2001, METABOLIC MOL BASES, VIII, P3421; Orchard PJ, 2007, J PEDIATR-US, V151, P340, DOI 10.1016/j.jpeds.2007.04.054; Osborn MJ, 2008, MOL THER, V16, P1459, DOI 10.1038/mt.2008.119; Patel P., 2014, MOL GENET METAB REP, V1, P184; Patel P., 2014, MOL GENET METAB REP, V1, P5; Pievani A, 2014, BLOOD; Ponder KP, 2007, EXPERT OPIN BIOL TH, V7, P1333, DOI 10.1517/14712598.7.91333; Rovelli AM, 2008, BONE MARROW TRANSPL, V41, pS87, DOI 10.1038/bmt.2008.62; Rowan DJ, 2013, J INHERIT METAB DIS, V36, P235, DOI 10.1007/s10545-012-9522-x; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Schuchman E.H., 2013, PLOS ONE, V8, P1; Stoop FJ, 2013, JIMD REP, V9, P17, DOI 10.1007/8904_2012_175; Tanjuakio J, 2014, MOL GENET METAB; Taylor C, 2008, J PEDIATR ORTHOPED, V28, P163, DOI 10.1097/BPO.0b013e3181649e25; Toietta G, 2001, HUM GENE THER, V12, P2007, DOI 10.1089/104303401753204571; Tomatsu S., 2012, HDB GEOWTH GROWTH MO, V1, P2091; Tomatsu S, 2012, MOL THER, V18, P1094; Tomatsu Shunji, 2014, Pediatr Endocrinol Rev, V12 Suppl 1, P141; Tomatsu S, 2014, MOL GENET METAB; Tomatsu S., 2012, RES REP ENDOCR DISOR, V2012, P65; Traas AM, 2007, MOL THER, V15, P1423, DOI 10.1038/sj.mt.6300201; Tse W, 2005, HEMATOLOGY, V1, P377; Turbeville S, 2011, MOL GENET METAB, V102, P111, DOI 10.1016/j.ymgme.2010.09.010; Vellodi A, 1997, ARCH DIS CHILD, V76, P92; VOGLER C, 1990, AM J PATHOL, V136, P207; Vogler C, 1998, J INHERIT METAB DIS, V21, P575, DOI 10.1023/A:1005423222927; Vogler C, 1996, PEDIATR RES, V39, P1050, DOI 10.1203/00006450-199606000-00019; Wang CC, 2008, WORLD J PEDIATR, V4, P152, DOI 10.1007/s12519-008-0031-9; Weisstein JS, 2004, J PEDIATR ORTHOPED, V24, P97; Wolf DA, 2011, NEUROBIOL DIS, V43, P123, DOI 10.1016/j.nbd.2011.02.015	138	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2					94	109		10.1016/j.ymgme.2014.12.001		16	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100295		
J	Tanjuakio, J; Suzuki, Y; Patel, P; Yasuda, E; Kubaski, F; Tanaka, A; Yabe, H; Mason, RW; Montano, AM; Orii, KE; Orii, KO; Fukao, T; Orii, T; Tomatsu, S				Tanjuakio, Julian; Suzuki, Yasuyuki; Patel, Pravin; Yasuda, Erik; Kubaski, Francyne; Tanaka, Akemi; Yabe, Hiromasa; Mason, Robert W.; Montano, Adriana M.; Orii, Kenji E.; Orii, Koji O.; Fukao, Toshiyuki; Orii, Tadao; Tomatsu, Shunji			Activities of daily living in patients with Hunter syndrome: Impact of enzyme replacement therapy and hematopoietic stem cell transplantation	MOLECULAR GENETICS AND METABOLISM			English	Article						Enzyme replacement therapy; Hematopoietic stem cell transplantation; Activities of daily living; Hunter syndrome; Clinical phenotype	MUCOPOLYSACCHARIDOSIS TYPE-II; DIAGNOSIS; HISTORY; SPOTS	The aim of this study was to assess the activities of daily living (ADL) in patients with Hunter syndrome (mucopolysaccharidosis II; MPS II) using a newly designed ADL questionnaire. We applied the questionnaire to evaluate clinical phenotypes and therapeutic efficacies of enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT). We also explored early signs and symptoms to make early diagnosis feasible. We devised a new ADL questionnaire with three domains: "movement," "movement with cognition," and "cognition." Each domain has four subcategories rated on a 5-point scale based on level of assistance. We also scored signs and symptoms unique to MPS by 12 subcategories (five points per category), providing 60 points in total. The questionnaire was first administered to 138 healthy Japanese controls (0.33-50 years), and successively, to 74 Japanese patients with Hunter syndrome (4-49 years). The patient cohort consisted of 51 severe and 23 attenuated phenotypes; 20 patients treated with HSCT, 23 patients treated early with ERT (<= 8 years), 25 patients treated late with ERT (>8 years), and 4 untreated patients. Among 18 severe phenotypic patients treated by HSCT, 10 were designated as early HSCT (<= 5 years), while 8 were designated as late HSCT (>5 years). Scores from patients with severe phenotypes were lower than controls and attenuated phenotypes in all categories. Among patients with severe phenotypes, there was a trend that HSCT provides a higher ADL score than early ERT, and there was a significant difference in ADL scores between late ERT and HSCT groups. Early ERT and early HSCT provided a higher score than late ERT and late HSCT, respectively. In conclusion, we have evaluated the feasibility of a new questionnaire in control population and patients with Hunter syndrome, leading to a novel evaluation method for clinical phenotypes and therapeutic efficacy. Early treatment with HSCT provides a better consequence in ADL of patients. (C) 2014 Elsevier Inc. All rights reserved.	[Tanjuakio, Julian; Patel, Pravin; Yasuda, Erik; Kubaski, Francyne; Mason, Robert W.; Tomatsu, Shunji] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Suzuki, Yasuyuki] Gifu Univ, Med Educ Dev Ctr, Gifu 5011194, Japan; [Kubaski, Francyne] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Tanaka, Akemi] Osaka City Univ, Grad Sch Med, Dept Pediat, Osaka 558, Japan; [Yabe, Hiromasa] Tokai Univ, Sch Med, Dept Cell Transplantat, Isehara, Kanagawa 25911, Japan; [Montano, Adriana M.] St Louis Univ, Dept Pediat, St Louis, MO 63104 USA; [Montano, Adriana M.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Orii, Kenji E.] Gifu Univ Hosp, Div Neonatal, Intens Care Unit, Gifu, Japan; [Orii, Koji O.; Fukao, Toshiyuki; Orii, Tadao; Tomatsu, Shunji] Gifu Univ, Sch Med, Dept Pediat, Gifu 5011194, Japan	Suzuki, Y (reprint author), Gifu Univ, Med Educ Dev Ctr, Yanagido 1-1, Gifu 5011194, Japan.	ysuz@gifu-u.ac.jp; stomatsu@nemours.org					Gelb MH, 2006, J INHERIT METAB DIS, V29, P397, DOI 10.1007/s10545-006-0265-4; Tomatsu S, 2013, MOL GENET METAB, V110, P42, DOI 10.1016/j.ymgme.2013.06.007; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Richard M, 2009, GENE THER, V16, P746, DOI 10.1038/gt.2009.36; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Muenzer J, 2014, MOL GENET METAB, V111, P63, DOI 10.1016/j.ymgme.2013.11.015; Tanaka A, 2012, MOL GENET METAB, V107, P513, DOI 10.1016/j.ymgme.2012.09.004; Marucha J, 2011, AM J MED GENET A, V155A, P2257, DOI 10.1002/ajmg.a.34146; Cotter E.M., CLIN REHABIL, V16; Guarany Nicole Ruas, 2012, J Pediatr Rehabil Med, V5, P37, DOI 10.3233/PRM-2012-0194; Kato T, 2007, BRAIN DEV-JPN, V29, P298, DOI 10.1016/j.braindev.2006.08.015; Kuratsubo I, 2009, PEDIATR INT, V51, P41, DOI 10.1111/j.1442-200X.2008.02652.x; Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350; Mendelsohn NJ, 2010, GENET MED, V12, P816, DOI 10.1097/GIM.0b013e3181f6e74d; Ochiai T, 2003, BRIT J DERMATOL, V148, P1173, DOI 10.1046/j.1365-2133.2003.05317.x; Patel P., 2014, MOL GENET METAB REP, V1, P184; Patel P., 2014, MOL GENET METAB REP, V1, P5; Shimada T., 2014, MOL GENET METAB; Tomatsu S., 2012, HDB GEOWTH GROWTH MO, V1, P2091; Wiklund I, 2013, QUAL LIFE RES, V22, P875, DOI 10.1007/s11136-012-0196-5; Wiklund I., QUAL LIFE RES, V23; YOUNG ID, 1983, DEV MED CHILD NEUROL, V25, P481	22	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2					161	169		10.1016/j.ymgme.2014.11.002		9	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100302		
J	Tomatsu, S; Montano, AM; Oikawa, H; Dung, VC; Hashimoto, A; Oguma, T; Gutierrez, ML; Takahashi, T; Shimada, T; Orii, T; Sly, WS				Tomatsu, Shunji; Montano, Adriana M.; Oikawa, Hirotaka; Vu Chi Dung; Hashimoto, Amiko; Oguma, Toshihiro; Gutierrez, Monica L.; Takahashi, Tatsuo; Shimada, Tsutomu; Orii, Tadao; Sly, William S.			Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: Early treatment rescues bone lesions?	MOLECULAR GENETICS AND METABOLISM			English	Article						Enzyme replacement therapy; Fibrous cartilage; Hyaline cartilage; Mucopolysaccharidosis IVA; N-acetylgalactosamine-6-sulfate sulfatase	HUMAN N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE; N-ACETYLGALACTOSAMINE 4-SULFATASE; RECOMBINANT BETA-GLUCURONIDASE; LYSOSOMAL STORAGE DISEASES; MAROTEAUX-LAMY-SYNDROME; MORQUIO-A DISEASE; MURINE MODEL; BRITISH-COLUMBIA; GENE-THERAPY; MOUSE MODEL	We treated mucopolysaccharidosis IVA (MPS IVA) mice to assess the effects of long-term enzyme replacement therapy (ERT) initiated at birth, since adult mice treated by ERT showed little improvement in bone pathology [1]. To conduct ERT in newborn mice, we used recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in a CHO cell line. First, to observe the tissue distribution pattern, a dose of 250 units/g body weight was administered intravenously in MPS IVA mice at day 2 or 3. The infused enzyme was primarily recovered in the liver and spleen, with detectable activity in the bone and brain. Second, newborn ERT was conducted after a tissue distribution study. The first injection of newborn ERT was performed intravenously, the second to fourth weekly injections were intraperitoneal, and the remaining injections from 5th to 14th weeks were intravenous into the tail vein. MPS IVA mice treated with GALNS showed clearance of lysosomal storage in the liver and spleen, and sinus lining cells in bone marrow. The column structure of the growth plate was organized better than that in adult mice treated with ERT; however, hyaline and fibrous cartilage cells in the femur, spine, ligaments, discs, synovium, and periosteum still had storage materials to some extent Heart valves were refractory to the treatment. Levels of serum keratan sulfate were kept normal in newborn ERT mice. In conclusion, the enzyme, which enters the cartilage before the cartilage cell layer becomes mature, prevents disorganization of column structure. Early treatment from birth leads to partial remission of bone pathology in MPS WA mice. (C) 2014 Elsevier Inc All rights reserved.	[Tomatsu, Shunji; Shimada, Tsutomu] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19899 USA; [Montano, Adriana M.; Gutierrez, Monica L.] St Louis Univ, Doisy Res Ctr, Dept Pediat, St Louis, MO 63103 USA; [Montano, Adriana M.; Sly, William S.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Oikawa, Hirotaka] Suzuka Univ Med Sci, Sch Pharm, Suzuka, Mie, Japan; [Vu Chi Dung] Vietnam Natl Hosp Pediat, Dept Endocrinol Metab & Genet, Hanoi, Vietnam; [Hashimoto, Amiko] Myojinshita Aoki Dermatol Clin, Tokyo, Japan; [Oguma, Toshihiro] Daiichi Sankyo Pharmaceut Co, Tokyo, Japan; [Takahashi, Tatsuo] Hokuriku Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kanazawa, Ishikawa 92011, Japan; [Orii, Tadao] Gifu Univ, Sch Med, Dept Pediat, Gifu 500, Japan	Tomatsu, S (reprint author), Nemours Alfred I duPont Hosp Children, Dept Biomed Res, 1600 Rockland Rd, Wilmington, DE 19899 USA.	stomatsu@nemours.org					PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Montano AM, 2007, J INHERIT METAB DIS, V30, P165, DOI 10.1007/s10545-007-0529-7; Tomatsu S, 2003, HUM MOL GENET, V12, P3349, DOI 10.1093/hmg/ddg366; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Harmatz P, 2006, J PEDIATR-US, V148, P533, DOI 10.1016/j.jpeds.2005.12.014; Tomatsu S, 2013, MOL GENET METAB, V110, P42, DOI 10.1016/j.ymgme.2013.06.007; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004399900075; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Tomatsu S, 2010, MOL THER, V18, P1094, DOI 10.1038/mt.2010.32; Hendriksz CJ, 2013, MOL GENET METAB, V110, P54, DOI 10.1016/j.ymgme.2013.04.002; BECK M, 1992, PRENATAL DIAG, V12, P1019, DOI 10.1002/pd.1970121207; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10; Gliddon BL, 2004, PEDIATR RES, V56, P65, DOI 10.1203/01.PDR.0000129661.40499.12; Vogler C, 2005, P NATL ACAD SCI USA, V102, P14777, DOI 10.1073/pnas.0506892102; Ohashi A, 2009, ACTA PAEDIATR, V98, P768, DOI [10.1111/j.1651-2227.2009.01134.x, 10.1111/j.1651-2227.2008.01134.x]; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; SANDS MS, 1994, J CLIN INVEST, V93, P2324, DOI 10.1172/JCI117237; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; VANDIGGELEN OP, 1990, CLIN CHIM ACTA, V187, P131, DOI 10.1016/0009-8981(90)90339-T; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Rowan DJ, 2012, MOL GENET METAB, V107, P161, DOI 10.1016/j.ymgme.2012.07.002; Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; Barranger JA, 2001, J INHERIT METAB DIS, V24, P89, DOI 10.1023/A:1012440428282; Macsai CE, 2012, MOL GENET METAB, V106, P202, DOI 10.1016/j.ymgme.2012.03.022; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Yasuda E, 2013, MOL GENET METAB, V109, P301, DOI 10.1016/j.ymgme.2013.04.009; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Nelson J, 1997, HUM GENET, V101, P355, DOI 10.1007/s004390050641; Auclair D, 2003, MOL GENET METAB, V78, P163, DOI 10.1016/S1096-7192(03)00007-6; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Hendriksz C. J., 2014, J INHERIT M IN PRESS; Lavery C., 2014, MORTALITY P IN PRESS; LOWRY RB, 1990, HUM GENET, V85, P389; Rowan DJ, 2013, J INHERIT METAB DIS, V36, P235, DOI 10.1007/s10545-012-9522-x; Tomatsu S, 2007, MOL GENET METAB, V91, P69, DOI 10.1016/j.ymgme.2007.01.004; Tomatsu S, 2012, RES REP ENDOCR DISOR, V2, P65; Tomatsu S., 2012, HDB GROWTH MONITORIN; Tomatsu S., 2014, PEDIAT ENDOCRINOL S1, V12; Tomatsu S, 2005, HUM MOL GENET, V14, P3321, DOI 10.1093/hmg/ddi364; Tomatsu S., 2013, EXPERT OPIN ORPHAN D, V10, P805; Tomatsu S, 2007, MOL GENET METAB, V91, P251, DOI 10.1016/j.ymgme.2007.02.009; VOGLER C, 1993, PEDIATR RES, V34, P837, DOI 10.1203/00006450-199312000-00028; Vogler C, 1998, J INHERIT METAB DIS, V21, P575, DOI 10.1023/A:1005423222927; Vogler C, 1996, PEDIATR RES, V39, P1050, DOI 10.1203/00006450-199606000-00019; Vogler C, 2005, PEDIATR DEVEL PATHOL, V8, P453, DOI 10.1007/s10024-005-0025-8; Xu LF, 2002, MOL THER, V6, P745, DOI 10.1006/mthe.2002.0809	51	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2					195	202		10.1016/j.ymgme.2014.05.013		8	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100306		
J	Gan, Q; Campbell, M; Thomas, A; Tomatsu, S; Suzuki, Y; Yamaguchi, S; Montana, AM				Gan, Qi; Campbell, Mary; Thomas, Anthony; Tomatsu, Shunji; Suzuki, Yasuyuki; Yamaguchi, Seiji; Montana, Adriana M.			Newborn screening for mucopolysaccharidoses: Determination of sensitivity, specificity and cut-off score	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Gan, Qi; Campbell, Mary; Thomas, Anthony; Montana, Adriana M.] St Louis Univ, St Louis, MO 63103 USA; [Tomatsu, Shunji] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Suzuki, Yasuyuki] Gifu Univ, Gifu, Japan; [Yamaguchi, Seiji] Shimane Univ, Izumo, Shimane, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				82	S44	S44		10.1016/j.ymgme.2014.12.084		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100081		
J	Hamazaki, T; Tomita, K; Nakaya, M; Hamasaki, A; Tachibana, D; Tokimasa, S; Tanaka, A; Haruo, S				Hamazaki, Takashi; Tomita, Kazuyoshi; Nakaya, Masaharu; Hamasaki, Arata; Tachibana, Daisuke; Tokimasa, Sadao; Tanaka, Akemi; Haruo, Shintaku			Successful cord blood transplantation for Hurler syndrome patient with high-titer neutralizing antibody against alpha-l-iduronidase	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Hamazaki, Takashi; Tomita, Kazuyoshi; Nakaya, Masaharu; Hamasaki, Arata; Tachibana, Daisuke; Tokimasa, Sadao; Tanaka, Akemi; Haruo, Shintaku] Osaka City Univ, Osaka 558, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				99	S50	S50		10.1016/j.ymgme.2014.12.101		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100098		
J	Karabul, N; Bradley, A; Diaz, JDG; Figuera, L; Gal, A; Giugliani, R; Goker-Alpan, O; Lavery, C; Mehta, A; Thompson, L; Sakai, N; Warnock, DG				Karabul, Nesrin; Bradley, Aoife; Garcia Diaz, Juan de Dios; Figuera, Luis; Gal, Andreas; Giugliani, Roberto; Goker-Alpan, Ozlem; Lavery, Christine; Mehta, Atul; Thompson, Lorraine; Sakai, Norio; Warnock, David G.			Pedigree analysis: A call to action to raise awareness of Fabry disease and the importance of family history evaluation	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Karabul, Nesrin] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany; [Bradley, Aoife] Belfast City Hosp, Belfast BT9 7AD, Antrim, North Ireland; [Garcia Diaz, Juan de Dios] Hosp Univ Principe Asturias, Madrid, Spain; [Figuera, Luis] CIBO IMSS, Guadalajara, Jalisco, Mexico; [Gal, Andreas] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Giugliani, Roberto] Univ Fed Rio Grande do Sul, Dep Genet, Med Genet Serv, HCPA, Porto Alegre, RS, Brazil; [Giugliani, Roberto] INAGEMP, Porto Alegre, RS, Brazil; [Goker-Alpan, Ozlem] CFCT, Lysosomal Disorders Res & Treatment Unit, Fairfax, VA USA; [Lavery, Christine] MPS Soc, Amersham, England; [Mehta, Atul] Royal Free Hosp, London NW3 2QG, England; [Thompson, Lorraine] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Sakai, Norio] Osaka Univ, Grad Sch Med, Osaka, Japan; [Warnock, David G.] Univ Alabama Birmingham, Birmingham, AL USA			Giugliani, Roberto/G-4790-2015	Giugliani, Roberto/0000-0001-9655-3686				0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				124	S60	S61		10.1016/j.ymgme.2014.12.127		2	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100123		
J	Kinoshita, M; Morimoto, H; Yoden, E				Kinoshita, Masafumi; Morimoto, Hideto; Yoden, Eiji			The characterization of mouse model of mucopolysaccharidosis type II	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Kinoshita, Masafumi; Morimoto, Hideto; Yoden, Eiji] JCR Pharmaceut Co Ltd, Kobe, Hyogo, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				132	S64	S64		10.1016/j.ymgme.2014.12.135		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100131		
J	Kitakaze, K; Tasaki, C; Mizutani, Y; Sugiyama, E; Ikuo, M; Kamiya, M; Setou, M; Urano, Y; Itoh, K				Kitakaze, Keisuke; Tasaki, Chikako; Mizutani, Yasumichi; Sugiyama, Eiji; Ikuo, Mariko; Kamiya, Mako; Setou, Mitsutoshi; Urano, Yasuteru; Itoh, Kohji			Development of protease-resistant modified human beta-hexosaminidase B and evaluation of intracerebroventricular replacement effects on GM2 gangliosidosis model mice	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Kitakaze, Keisuke; Tasaki, Chikako; Mizutani, Yasumichi; Ikuo, Mariko; Itoh, Kohji] Univ Tokushima, Tokushima 770, Japan; [Sugiyama, Eiji; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan; [Kamiya, Mako; Urano, Yasuteru] Univ Tokyo, Tokyo, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				135	S65	S65		10.1016/j.ymgme.2014.12.138		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100134		
J	Kubaski, F; Shimada, T; Tomatsu, S; Yasuda, E; Mason, RW; Mackenzie, WG; Shibata, Y; Giugliani, R; Yamaguchi, S; Suzuki, Y; Orii, K; Orii, T				Kubaski, Francyne; Shimada, Tsutomu; Tomatsu, Shunji; Yasuda, Eriko; Mason, Robert W.; Mackenzie, William G.; Shibata, Yuniko; Giugliani, Roberto; Yamaguchi, Seiji; Suzuki, Yasuyuki; Orii, Kenji; Orii, Tadao			Chondroitin 6-sulfate as a novel biomarker for mucopolysaccharidosis IVA and VII	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Kubaski, Francyne] Univ Delaware, Newark, DE USA; [Kubaski, Francyne; Shimada, Tsutomu; Tomatsu, Shunji; Yasuda, Eriko; Mason, Robert W.; Mackenzie, William G.] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Shibata, Yuniko] Seikagaku Co Tokyo, R&D Div, Cent Res Lab, Tokyo, Japan; [Giugliani, Roberto] HCPA, Med Genet Serv, Porto Alegre, RS, Brazil; [Yamaguchi, Seiji] Shimane Univ, Izumo, Shimane, Japan; [Suzuki, Yasuyuki; Orii, Kenji; Orii, Tadao] Gifu Univ, Gifu, Japan			Giugliani, Roberto/G-4790-2015	Giugliani, Roberto/0000-0001-9655-3686				0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				138	S66	S66		10.1016/j.ymgme.2014.12.141		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100137		
J	Kubaski, F; Tomatsu, S; Patel, P; Shimada, T; Xie, SL; Yasuda, E; Mackenzie, WG; Theroux, M; Bober, M; Oldham, HM; Orii, T; Shaffer, TH				Kubaski, Francyne; Tomatsu, Shunji; Patel, Pravin; Shimada, Tsutomu; Xie, Sherlly L.; Yasuda, Eriko; Mackenzie, William G.; Theroux, Mary; Bober, Michael; Oldham, Helen M.; Orii, Tadao; Shaffer, Thomas H.			Noninvasive pulmonary function test on Morquio syndrome type A patients	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Kubaski, Francyne] Univ Delaware, Newark, DE USA; [Kubaski, Francyne; Tomatsu, Shunji; Patel, Pravin; Shimada, Tsutomu; Xie, Sherlly L.; Yasuda, Eriko; Mackenzie, William G.; Theroux, Mary; Bober, Michael; Oldham, Helen M.; Shaffer, Thomas H.] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Orii, Tadao] Gifu Univ, Gifu, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				140	S67	S67		10.1016/j.ymgme.2014.12.143		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100139		
J	Kubaski, F; Shimada, T; Tomatsu, S; Mason, RW; Yasuda, E; Mackenzie, WG; Hossain, J; Shibata, Y; Montano, AM; Giugliani, R; Yamaguchi, S; Suzuki, Y; Orii, KE; Fukao, T; Orii, T				Kubaski, Francyne; Shimada, Tsutomu; Tomatsu, Shunji; Mason, Robert W.; Yasuda, Eriko; Mackenzie, William G.; Hossain, Jobayer; Shibata, Yuniko; Montano, Adriana M.; Giugliani, Roberto; Yamaguchi, Seiji; Suzuki, Yasuyuki; Orii, Kenji E.; Fukao, Toshiyuki; Orii, Tadao			Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis IVA	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Kubaski, Francyne] Univ Delaware, Newark, DE USA; [Kubaski, Francyne; Shimada, Tsutomu; Tomatsu, Shunji; Mason, Robert W.; Yasuda, Eriko; Mackenzie, William G.; Hossain, Jobayer] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Shibata, Yuniko] Seikagaku Co Tokyo, R&D Div, Cent Res Lab, Tokyo, Japan; [Montano, Adriana M.] St Louis Univ, Newark, MO USA; [Giugliani, Roberto] HCPA, Med Genet Serv, Porto Alegre, RS, Brazil; [Yamaguchi, Seiji] Shimane Univ, Izumo, Shimane, Japan; [Suzuki, Yasuyuki; Orii, Kenji E.; Fukao, Toshiyuki; Orii, Tadao] Gifu Univ, Gifu, Japan			Giugliani, Roberto/G-4790-2015	Giugliani, Roberto/0000-0001-9655-3686				0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				139	S66	S67		10.1016/j.ymgme.2014.12.142		2	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100138		
J	Momosaki, K; Yoshida, S; Matsumoto, S; Nakamura, K; Mitsubuchi, H; Endo, F				Momosaki, Ken; Yoshida, Shinichiro; Matsumoto, Shirou; Nakamura, Kimitoshi; Mitsubuchi, Hiroshi; Endo, Fumio			Newborn screening of Pompe disease in Japan: 2 years experience	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Momosaki, Ken; Yoshida, Shinichiro; Matsumoto, Shirou; Nakamura, Kimitoshi; Mitsubuchi, Hiroshi; Endo, Fumio] Kumamoto Univ, Kumamoto, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				177	S82	S82		10.1016/j.ymgme.2014.12.180		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100176		
J	Okuyama, T; Kosuga, M; Kumagai, T				Okuyama, Torayuki; Kosuga, Motomichi; Kumagai, Tadayuki			Effects of pre-symptomatic initiation of enzyme replacement therapy for infantile onset Pompe disease	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Okuyama, Torayuki; Kosuga, Motomichi; Kumagai, Tadayuki] Natl Ctr Child Hlth & Dev, Tokyo, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				194	S88	S89		10.1016/j.ymgme.2014.12.197		2	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100193		
J	Ponder, K; Kobayashi, H; Ohashi, T; Izuka, S; Bell, P; Gurda, B; Wilson, J; Casal, M; Haskins, M				Ponder, Katherine; Kobayashi, Hiroshi; Ohashi, Toya; Izuka, Sayoko; Bell, Peter; Gurda, Brittney; Wilson, James; Casal, Margaret; Haskins, Mark			Intrathecal injection of lentiviral vector results in high expression in the brain of mucopolysaccharidosis VII dogs but the pattern of expression is different than for AAV9 or AAV-rh10	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Ponder, Katherine] Washington Univ, Sch Med, St Louis, MO USA; [Kobayashi, Hiroshi; Ohashi, Toya; Izuka, Sayoko] Jikei Univ, Sch Med, Tokyo, Japan; [Bell, Peter; Wilson, James; Haskins, Mark] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Gurda, Brittney; Casal, Margaret] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				210	S95	S96		10.1016/j.ymgme.2014.12.213		2	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100209		
J	Sakuraba, H; Saito, S; Ohno, K; Maita, N; Tsukimura, T				Sakuraba, Hitoshi; Saito, Seiji; Ohno, Kazuki; Maita, Nobuo; Tsukimura, Takahiro			Determination of the structure of human alpha-I-iduronidase and structural basis of mucopolysaccharidosis type I	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Sakuraba, Hitoshi; Tsukimura, Takahiro] Meiji Pharmaceut Univ, Kiyose, Japan; [Saito, Seiji] Hokkaido Informat Univ, Ebetsu, Hokkaido, Japan; [Ohno, Kazuki] Nonprofit Org Promot Res Intellectual Property To, Tokyo, Japan; [Maita, Nobuo] Univ Tokushima, Inst Enzyme Res, Tokushima 770, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				223	S101	S101		10.1016/j.ymgme.2014.12.226		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100222		
J	Tanaka, A; Hamazaki, T; Okuyama, T; Sakai, N; Kato, K; Suzuki, Y; Yabe, H; Kosuga, M; Shinpo, M; Ishige, M; Kadono, C; Kudo, S; Sawada, T; Mugishima, H; Tabuchi, K; Kato, S				Tanaka, Akemi; Hamazaki, Takashi; Okuyama, Torayuki; Sakai, Norio; Kato, Koji; Suzuki, Yasuyuki; Yabe, Hiromasa; Kosuga, Motomichi; Shinpo, Michiko; Ishige, Mika; Kadono, Chiho; Kudo, Satoshi; Sawada, Tomo; Mugishima, Hideo; Tabuchi, Ken; Kato, Shunichi			Genotype of mucopolysaccharidosis type II severe form and the efficacy of enzyme replacement therapy or hematopoietic stem cell transplantation on cognitive function	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tanaka, Akemi; Hamazaki, Takashi; Kadono, Chiho; Kudo, Satoshi] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Okuyama, Torayuki; Kosuga, Motomichi] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Sakai, Norio; Shinpo, Michiko] Osaka Univ, Grad Sch Med, Osaka, Japan; [Kato, Koji] Japanese Red Cross Nagoya Daiichi Hosp, Childrens Med Ctr, Nagoya, Aichi, Japan; [Suzuki, Yasuyuki] Gifu Univ, Gifu, Japan; [Yabe, Hiromasa; Kato, Shunichi] Tokai Univ, Isehara, Kanagawa, Japan; [Ishige, Mika; Mugishima, Hideo] Nippon Univ, Tokyo, Japan; [Sawada, Tomo] Izumi City Hosp, Izumi, Japan; [Tabuchi, Ken] Tokyo Komagome Hosp, Tokyo, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				251	S111	S112		10.1016/j.ymgme.2014.12.254		2	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100250		
J	Tanaka, N; Morimoto, H; Yoden, E; Yamamoto, R				Tanaka, Noboru; Morimoto, Hideto; Yoden, Eiji; Yamamoto, Ryuji			Novel quantification methods for globotriaosylceramide and globotriaosylsphingosine as biomarkers of Fabry disease	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tanaka, Noboru; Morimoto, Hideto; Yoden, Eiji; Yamamoto, Ryuji] JCR Pharmaceut Co Ltd, Kobe, Hyogo, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				252	S112	S112		10.1016/j.ymgme.2014.12.255		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100251		
J	Tomatsu, S; Barrera, LA; Almeciga-Diaz, CJ; Montano, AM; Yabe, H; Kubaski, F; Orii, T				Tomatsu, Shunji; Barrera, Luis A.; Almeciga-Diaz, Carlos J.; Montano, Adriana M.; Yabe, Hiromasa; Kubaski, Francyne; Orii, Tadao			Therapies for the bone in mucopolysaccharidoses	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tomatsu, Shunji; Kubaski, Francyne] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Barrera, Luis A.; Almeciga-Diaz, Carlos J.] Pontificia Univ Javeriana, Bogota, Colombia; [Montano, Adriana M.] St Louis Univ, St Louis, MO 63103 USA; [Yabe, Hiromasa] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Kubaski, Francyne] Univ Delaware, Newark, DE USA; [Orii, Tadao] Gifu Univ, Gifu, Japan			Giugliani, Roberto/G-4790-2015	Giugliani, Roberto/0000-0001-9655-3686				0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				264	S116	S116		10.1016/j.ymgme.2014.12.267		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100263		
J	Tomatsu, S; Patel, P; Suzuki, Y; Yabe, H; Shimada, T; Mason, RW; Orii, T				Tomatsu, Shunji; Patel, Pravin; Suzuki, Yasuyuki; Yabe, Hiromasa; Shimada, Tsutomu; Mason, Robert W.; Orii, Tadao			Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tomatsu, Shunji; Patel, Pravin; Shimada, Tsutomu; Mason, Robert W.] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Suzuki, Yasuyuki; Orii, Tadao] Gifu Univ, Gifu, Japan; [Yabe, Hiromasa] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				261	S115	S116		10.1016/j.ymgme.2014.12.264		2	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100260		
J	Tomatsu, S; Shimada, T; LaMarr, WA; Vlies, NV; Yasuda, E; Mason, RW; Kubaski, F; Giugliani, R; Yamaguchi, S; Suzuki, Y; Orri, T; Kubaski, F				Tomatsu, Shunji; Shimada, Tsutomu; LaMarr, William A.; Vlies, Naomi V.; Yasuda, Eriko; Mason, Robert W.; Kubaski, Francyne; Giugliani, Roberto; Yamaguchi, Seiji; Suzuki, Yasuyuki; Orri, Tadao; Kubaski, Francyne			Novel heparan sulfate assay by using automated high throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tomatsu, Shunji; Shimada, Tsutomu; Yasuda, Eriko; Mason, Robert W.; Kubaski, Francyne; Kubaski, Francyne] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [LaMarr, William A.] Agilent Technol, Wakefield, MA USA; [Vlies, Naomi V.] Univ Amsterdam, Amsterdam, Netherlands; [Kubaski, Francyne] Univ Delaware, Newark, DE USA; [Giugliani, Roberto] HCPA, Med Genet Serv, Porto Alegre, RS, Brazil; [Yamaguchi, Seiji] Shimane Univ, Matsue, Shimane, Japan; [Suzuki, Yasuyuki; Orri, Tadao] Gifu Univ, Gifu, Japan			Giugliani, Roberto/G-4790-2015	Giugliani, Roberto/0000-0001-9655-3686				0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				263	S116	S116		10.1016/j.ymgme.2014.12.266		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100262		
J	Tomatsu, S; Tanjuakio, J; Suzuki, Y; Patel, P; Yasuda, E; Kubaski, F; Mason, RW; Orii, T				Tomatsu, Shunji; Tanjuakio, Julian; Suzuki, Yasuyuki; Patel, Pravin; Yasuda, Eriko; Kubaski, Francyne; Mason, Robert W.; Orii, Tadao			Activity of daily life in patients with Hunter syndrome: Impact of enzyme replacement therapy and hematopoietic stem cell transplantation	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tomatsu, Shunji; Tanjuakio, Julian; Patel, Pravin; Yasuda, Eriko; Kubaski, Francyne; Mason, Robert W.] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Suzuki, Yasuyuki; Orii, Tadao] Gifu Univ, Gifu, Japan; [Kubaski, Francyne] Univ Delaware, Newark, DE USA								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				259	S115	S115		10.1016/j.ymgme.2014.12.262		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100258		
J	Tomatsu, S; Shimada, T; Mason, RW; Montana, AM; LaMarr, WA; Kubaski, F; Orii, T				Tomatsu, Shunji; Shimada, Tsutomu; Mason, Robert W.; Montana, Adriana M.; LaMarr, William A.; Kubaski, Francyne; Orii, Tadao			Establishment of glycosaminoglycan assays for mucopolysaccharidoses	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tomatsu, Shunji; Shimada, Tsutomu; Mason, Robert W.; Kubaski, Francyne] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Montana, Adriana M.] St Louis Univ, St Louis, MO 63103 USA; [LaMarr, William A.] Agilent Technol, Wakefield, MA USA; [Kubaski, Francyne] Univ Delaware, Newark, CT USA; [Orii, Tadao] Gifu Univ, Gifu, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				260	S115	S115		10.1016/j.ymgme.2014.12.263		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100259		
J	Tondel, C; Kanai, T; Ito, S; Larsen, KK; Politei, JM; Svarstad, E; Warnock, DG				Tondel, Camilla; Kanai, Takahiro; Ito, Suichi; Larsen, Kirstin K.; Manuel Politei, Juan; Svarstad, Einar; Warnock, David G.			Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tondel, Camilla; Larsen, Kirstin K.; Svarstad, Einar] Haukeland Hosp, N-5021 Bergen, Norway; [Kanai, Takahiro] Jichi Med Sch, Tokyo, Japan; [Ito, Suichi] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Manuel Politei, Juan] Fdn Estudio Enfermedades Neurometab, Buenos Aires, DF, Argentina; [Svarstad, Einar] Univ Bergen, Bergen, Norway; [Warnock, David G.] Univ Alabama Birmingham, Birmingham, AL USA								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				265	S117	S117		10.1016/j.ymgme.2014.12.268		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100264		
J	Tsukimura, T; Togawa, T; Sakuraba, H				Tsukimura, Takahiro; Togawa, Tadayasu; Sakuraba, Hitoshi			Comprehensive study of Fabry disease: Gene mutation, GLA activity, GLA protein and globotriaosylsphingosine	MOLECULAR GENETICS AND METABOLISM			English	Meeting Abstract	11th Annual WORLD Symposium of the Lysosomal-Disease-Network	FEB 09-13, 2015	Orlando, FL	Lysosomal Dis Network					[Tsukimura, Takahiro; Togawa, Tadayasu; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Kiyose, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	FEB	2015	114	2				266	S117	S117		10.1016/j.ymgme.2014.12.269		1	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CA5UK	WOS:000348973100265		
J	Ito, T; Bai, T; Tanaka, T; Yoshida, K; Ueyama, T; Miyajima, M; Negishi, T; Kawasaki, T; Takamatsu, H; Kikutani, H; Kumanogoh, A; Yukawa, K				Ito, Takuji; Bai, Tao; Tanaka, Tetsuji; Yoshida, Kenji; Ueyama, Takashi; Miyajima, Masayasu; Negishi, Takayuki; Kawasaki, Takahiko; Takamatsu, Hyota; Kikutani, Hitoshi; Kumanogoh, Atsushi; Yukawa, Kazunori			Semaphorin 4D induces vaginal epithelial cell apoptosis to control mouse postnatal vaginal tissue remodeling	MOLECULAR MEDICINE REPORTS			English	Article						semaphorin; axon guidance; growth cone collapse; apoptosis	GTPASE-ACTIVATING PROTEIN; B-CELL; MICE; PLEXIN-B1; CD100; ABNORMALITIES; MORPHOLOGY; RECEPTOR; SYSTEM; FAMILY	The opening of the mouse vaginal cavity to the skin is a postnatal tissue remodeling process that occurs at approximately five weeks of age for the completion of female genital tract maturation at puberty. The tissue remodeling process is primarily composed of a hormonally triggered apoptotic process predominantly occurring in the epithelium of the distal section of the vaginal cavity. However, the detailed mechanism underlying the apoptotic induction remains to be elucidated. In the present study, it was observed that the majority of BALB/c mice lacking the class 4 semaphorin, semaphorin 4D (Sema4D), developed imperforate vagina and hydrometrocolpos resulting in a perpetually unopened vaginal cavity regardless of a normal estrogen level comparable with that in wild-type (WT) mice. Administration of beta-estradiol to infant Sema4D-deficient (Sema4D(-/-)) mice did not induce precocious vaginal opening, which was observed in WT mice subjected to the same P-estradiol administration, excluding the possibility that the closed vaginal phenotype was due to insufficient estrogen secretion at the time of vaginal opening. In order to assess the role of Sema4D in the postnatal vaginal tissue remodeling process, the expression of Sema4D and its receptor, plexin-B1, was examined as well as the level of apoptosis in the vaginal epithelia of five-week-old WT and Sema4D(-/-) mice. Immunohistochemical analyses confirmed the localization of Sema4D and plexin-B1 in the mouse vaginal epithelia. Terminal deoxynucleotidyl transferase dUTP nick end labeling assay and immunohistochemistry detecting activated caspase-3 revealed significantly fewer apoptotic cells in situ in the vaginal mucosa of five-week-old Sema4D(-/-) mice compared with WT mice. The addition of recombinant Sema4D to Sema4D(-/-) vaginal epithelial cells in culture significantly enhanced apoptosis of the vaginal epithelial cells, demonstrating the apoptosis-inducing activity of Sema4D. The experimental reduction of plexin-B1 expression in vaginal epithelial cells demonstrated the integral role of plexin-B1 in Sema4D-induced apoptotic cell death. These results suggest a non-redundant role of Sema4D in the postnatal tissue remodeling process in five-week-old BALB/c mice, which involves the induction of vaginal epithelial cell apoptosis through Sema4D binding to plexin-B1.	[Ito, Takuji; Yoshida, Kenji; Negishi, Takayuki; Yukawa, Kazunori] Meijo Univ, Fac Pharm, Dept Physiol, Nagoya, Aichi 4688503, Japan; [Bai, Tao; Tanaka, Tetsuji] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama 6418509, Japan; [Ueyama, Takashi] Wakayama Med Univ, Dept Anat, Wakayama 6418509, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Inst Anim Experimentat, Wakayama 6418509, Japan; [Kawasaki, Takahiko] Grad Univ Adv Studies Sokendai, Natl Inst Genet, Div Brain Funct, Mishima, Shizuoka 4118540, Japan; [Takamatsu, Hyota; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 5650871, Japan; [Kikutani, Hitoshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan	Yukawa, K (reprint author), Meijo Univ, Fac Pharm, Dept Physiol, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	kyukawa@meijo-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [19590178]	The authors would like to thank the members of the Department of Physiology, Meijo University for their discussion and technical assistance. This study was primarily supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (no. 19590178).	Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Giacobini P, 2008, J CELL BIOL, V183, P555, DOI 10.1083/jcb.200806160; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; Hubner A, 2010, MOL CELL BIOL, V30, P98, DOI 10.1128/MCB.01155-09; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Yamaguchi W, 2012, MOL CELL NEUROSCI, V49, P290, DOI 10.1016/j.mcn.2011.12.004; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Moretti S, 2008, BLOOD, V111, P2290, DOI 10.1182/blood-2007-06-096529; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Saito Y, 2009, EMBO REP, V10, P614, DOI 10.1038/embor.2009.63; Guan F, 2006, KIDNEY INT, V69, P1564, DOI 10.1038/sj.ki.5000313; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Fazzari P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-55; Giraudon P, 2004, J IMMUNOL, V172, P1246; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; IGUCHI T, 1983, P NATL ACAD SCI-BIOL, V80, P3743, DOI 10.1073/pnas.80.12.3743; Li L, 2009, INT J ONCOL, V34, P905, DOI 10.3892/ijo_00000216; Rodriguez I, 1997, DEV BIOL, V184, P115, DOI 10.1006/dbio.1997.8522; Simpson KJ, 2004, INT J DEV BIOL, V48, P675, DOI 10.1387/ijdb.041849ks; SUNDBERG JP, 1994, LAB ANIM SCI, V44, P380	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	FEB	2015	11	2					829	836		10.3892/mmr.2014.2773		8	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CB3CS	WOS:000349506400010		
J	Kakiuchi, D; Uehara, T; Shiotani, M; Nakano-T, K; Suganuma, A; Aoki, T; Tsukidate, K; Sawada, K				Kakiuchi, Dai; Uehara, Taisuke; Shiotani, Motohiro; Nakano-T, Kyoko; Suganuma, Akiyoshi; Aoki, Toyohiko; Tsukidate, Kazuo; Sawada, Kohei			Oscillatory potentials in electroretinogram as an early marker of visual abnormalities in vitamin A deficiency	MOLECULAR MEDICINE REPORTS			English	Article						vitamin A deficiency; retinoid; oscillatory potentials; contrast sensitivity	9-CIS RETINOIC ACID; CONTRAST SENSITIVITY; RAT RETINA; DOPAMINE; RECEPTORS; LOCALIZATION; DEHYDROGENASE; EXPRESSION; EYES; ERG	Vitamin A deficiency (VAD) caused by malnutrition and certain intestinal diseases induces visual impairments, including night blindness and photoreceptor cell dysfunction as indicated by reduced a- and b-waves in an electroretinogram (ERG). The effects of VAD on the inner retinal layer cells, including amacrine and ganglion cells, remain to be elucidated. The functions of these cells are reflected in oscillatory potentials (OPs), another component of the ERG. The present study investigated inner retinal layer cell function in VAD rats by analyzing OPs. In the present study, VAD was induced by feeding Brown Norway rats a vitamin A deficient diet for 10 weeks. A reduced body weight and pen-papillary pacification indicative of papilledema without histopathological alterations were observed, which are considered early symptoms of VAD. At this stage, the ERG revealed reduced OPs as well as a- and b-waves at various intensities of light stimulation. Further analysis indicated that the ratio of the alterations in OPs was more significant than those of a- and b-waves. After 5 weeks of recovery, these changes returned to control levels. These results suggest that OPs are the most sensitive and early marker of VAD-associated visual impairment in the ERG.	[Kakiuchi, Dai] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058577, Japan; [Kakiuchi, Dai; Uehara, Taisuke; Shiotani, Motohiro; Nakano-T, Kyoko; Suganuma, Akiyoshi; Aoki, Toyohiko; Tsukidate, Kazuo; Sawada, Kohei] Eisai & Co Ltd, Eisai Prod Creat Syst, Tsukuba, Ibaraki 3002635, Japan	Kakiuchi, D (reprint author), Eisai & Co Ltd, Eisai Prod Creat Syst, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	d-kakiuchi@hhc.eisai.co.jp					Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Krezel W, 1998, SCIENCE, V279, P863; Mori M, 2001, INVEST OPHTH VIS SCI, V42, P1312; Nguyen-Legros J, 1999, MOL NEUROBIOL, V19, P181, DOI 10.1007/BF02821713; Yamashita H, 2011, EXP EYE RES, V93, P75, DOI 10.1016/j.exer.2011.04.006; Scott CJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P705, DOI 10.1001/archophthalmol.2010.94; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; BAIN G, 1993, MOL BRAIN RES, V17, P23, DOI 10.1016/0169-328X(93)90068-Z; Bondioni S, 2008, EXP BIOL MED, V233, P439, DOI 10.3181/0704-RM-94; Bremmer JD, 2008, PROG NEURO-PSYCHOPH, V32, P315, DOI 10.1016/j.pnpbp.2007.07.001; DOWLING J E, 1959, Ann N Y Acad Sci, V74, P256; Fischer AJ, 1999, J NEUROCYTOL, V28, P597, DOI 10.1023/A:1007071406746; Gelatt Kirk N, 2007, VET OPHTHALMOLOGY, V2, P1617; Gelatt Kirk N, 2007, VET OPHTHALMOLOGY, V2, P484; JAFFE MJ, 1987, J NEUROL NEUROSUR PS, V50, P847, DOI 10.1136/jnnp.50.7.847; KATZ ML, 1993, EXP EYE RES, V56, P671, DOI 10.1006/exer.1993.1084; KAWASAKI K, 1986, DOC OPHTHALMOL, V64, P209; Lam Byron L, 2005, ELECTROPHYSIOLOGY VI, V1, P1; Lam Byron L, 2005, ELECTROPHYSIOLOGY VI, V1, P407; LEGUIRE LE, 1991, AM J OPHTHALMOL, V111, P427; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; McLaren D S, 1999, J Indian Med Assoc, V97, P320; Romert A, 1998, P NATL ACAD SCI USA, V95, P4404, DOI 10.1073/pnas.95.8.4404; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Veruki ML, 1997, EUR J NEUROSCI, V9, P1096, DOI 10.1111/j.1460-9568.1997.tb01461.x; Veruki ML, 1996, EUR J NEUROSCI, V8, P2286, DOI 10.1111/j.1460-9568.1996.tb01192.x; WACHTMEISTER L, 1980, ACTA OPHTHALMOL, V58, P712; Wang HF, 2005, NEUROSCIENCE, V134, P97, DOI 10.1016/j.neuriscience.2005.04.008	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	FEB	2015	11	2					995	1003		10.3892/mmr.2014.2852		9	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CB3CS	WOS:000349506400033		
J	Yamaguchi, A; Hanaoka, H; Pirmettis, I; Uehara, T; Tsushima, Y; Papadopoulos, M; Arano, Y				Yamaguchi, Aiko; Hanaoka, Hirofumi; Pirmettis, Ioannis; Uehara, Tomoya; Tsushima, Yoshito; Papadopoulos, Minas; Arano, Yasushi			Injection Site Radioactivity of Tc-99m-Labeled Mannosylated Dextran for Sentinel Lymph Node Mapping	MOLECULAR PHARMACEUTICS			English	Article						sentinel lymph node; injection site; mannosylated dextran; mannose receptor; macrophage; dendritic cell	MANNOSE RECEPTOR; DENDRITIC CELLS; GASTRIC-CANCER; IDENTIFICATION; ANTIBODIES; DELIVERY; MACROPHAGES; CLEARANCE; CONJUGATE; CHELATOR	The high and persistent radioactivity at the injection site hinders the accuracy and expansion of sentinel lymph node (SLN) mapping. We investigated the mechanism underlying the undesirable radioactivity after subcutaneous injection of Tc-99m-labeled mannosylated dextran (Tc-99m(CO)(3)-DCM20), a SLN mapping agent targeting mannose receptors on macrophages and dendritic cells, in a mouse model. Biodistribution studies were performed 1 h after subcutaneous injection of Tc-99m(CO)(3)-DCM20 from the rear footpad of mice in the presence of varying molar amounts of DCM20 or DC15, a modified dextran without mannose. Biodistribution studies were also conducted after subcutaneous injection of [I-125]radioiodinated mannosyl-neoglycoalbumin (I-125-NMA) from the rear footpad. The distribution of fluorescence-labeled DCM20 and DC15 at the injection site was also compared 1 h after subcutaneous injection by immunofluorescent histochemistry. The radioactivity levels of Tc-99m(CO)(3)-DCM20 at the injection site and popliteal lymph node, a SLN in this model, decreased with an increase in the molar amounts of DCM20, whereas no significant changes in biodistribution were observed after injection of Tc-99m(CO)(3)-DCM20 with varying molar amounts of DC15. I-125-NMA exhibited rapid elimination of radioactivity from both the popliteal lymph node and the injection site. The fluorescence-labeled DCM20 colocalized well with CD68-positive cells such as macrophages and dendritic cells at the injection site. While partial colocalization was observed between DC15 and CD68-positive cells, the signal intensity was very weak. These findings suggest that specific binding of Tc-99m(CO)(3)-DCM20 to the mannose receptor on macrophages and dendritic cells would be responsible for the sustained radioactivity levels at the injection site. These results also imply that discriminated blockage of Tc-99m(CO)(3)-DCM20 binding to mannose receptors at the injection sites would reduce the radioactivity at the injection site.	[Yamaguchi, Aiko; Hanaoka, Hirofumi; Uehara, Tomoya; Arano, Yasushi] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Yamaguchi, Aiko; Hanaoka, Hirofumi; Tsushima, Yoshito] Gunma Univ, Gradiate Sch Med, Maebashi, Gumma 3718511, Japan; [Pirmettis, Ioannis; Papadopoulos, Minas] NCSR Demokritos, Inst IPRETEA, Ag Paraskevi Athens 15310, Greece	Arano, Y (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	arano@chiba-u.jp			Special Funds for Education and Research (Development of SPECT probes for Pharmaceutical Innovation) from Ministry of Education, Culture, Sports and Technology, Japan	This work is part of the CRP "Development of <SUP>99m</SUP>Tc radiopharmaceuticals for sentinel lymph node detection and cancer diagnosis" of the IAEA, which is acknowledged. The authors also wish to thank both John J. Zaknun and Ambi M. R. Pillai from the NA department of the IAEA, Vienna, for their role in initiating this cooperative research activity (CRP) on sentinel lymph node mapping. This work was supported in part by Special Funds for Education and Research (Development of SPECT probes for Pharmaceutical Innovation) from the Ministry of Education, Culture, Sports and Technology, Japan.	Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Weber RW, 1990, BIOCONJUGATE CHEM, V1, P431, DOI 10.1021/bc00006a010; HOLNESS CL, 1993, BLOOD, V81, P1607; Vera DR, 2001, J NUCL MED, V42, P951; Ueno H, 2005, ANTICANCER RES, V25, P821; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; Nune SK, 2011, ADV DRUG DELIVER REV, V63, P876, DOI 10.1016/j.addr.2011.05.020; GEISSLER F, 1992, CANCER RES, V52, P2907; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Sharma R, 2008, ANN NY ACAD SCI, V1131, P13, DOI 10.1196/annals.1413.002; Sondak VK, 2013, ANN SURG ONCOL, V20, P680, DOI 10.1245/s10434-012-2612-z; ARANO Y, 1994, J NUCL MED, V35, P890; Arano Y, 1998, BIOCONJUGATE CHEM, V9, P497, DOI 10.1021/bc970220a; Cardoso R, 2012, GASTRIC CANCER, V15, pS48, DOI 10.1007/s10120-011-0103-8; CHRISTENSEN EI, 1981, VIRCHOWS ARCH B, V37, P49, DOI 10.1007/BF02892554; Cousins A, 2014, BIOTECHNOL ADV, V32, P269, DOI 10.1016/j.biotechadv.2013.10.011; DUNCAN JR, 1993, J NUCL MED, V34, P1728; HASEMAN MK, 1986, EUR J NUCL MED, V12, P455; Jeong JM, 2004, NUCL MED COMMUN, V25, P1211, DOI 10.1097/00006231-200412000-00010; Jones CI, 2008, J VASC SURG, V48, P715, DOI 10.1016/j.jvs.2008.04.008; Lee JH, 2006, ANN SURG ONCOL, V13, P1168, DOI 10.1245/s10434-006-9038-4; Morais M, 2011, MOL PHARMACEUT, V8, P609, DOI 10.1021/mp100425p; Noorman F, 1997, THROMB HAEMOSTASIS, V78, P1249; Pirmettis I, 2012, MOL PHARMACEUT, V9, P1681, DOI 10.1021/mp300015s; Pitman KT, 2005, SEMIN NUCL MED, V35, P253, DOI 10.1053/j.semnuclmed.2005.05.004; Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107; Subramanian S, 2014, Q J NUCL MED MOL IM, V58, P216; Subramanian S, 2012, CANCER BIOTHER RADIO, V27, P365, DOI 10.1089/cbr.2011.1131; Takagi K, 2004, NUCL MED BIOL, V31, P893, DOI 10.1016/j.nucmedbio.2004.04.008; Vera DR, 1997, J NUCL MED, V38, P530; WILEMAN T, 1985, J BIOL CHEM, V260, P7387	33	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	FEB	2015	12	2					514	519		10.1021/mp500592e		6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CA4PL	WOS:000348886900023		
J	Matsuura, M; Yogo, K				Matsuura, Minami; Yogo, Keiichiro			TMEM225: A Possible Protein Phosphatase 1 gamma 2 ( PP1 gamma 2) Regulator Localizes to the Equatorial Segment in Mouse Spermatozoa	MOLECULAR REPRODUCTION AND DEVELOPMENT			English	Article							TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; SPERM; TESTIS; MICE; SPERMATOGENESIS; CAPACITATION; ACROSOME; CELLS; IDENTIFICATION	Tmem225 encodes a putative four-transmembrane domain protein that has an RVxF motif, which is known to be a consensus site for interacting with serine/threonine protein phosphatase 1 (PP1). We previously identified Tmem225 as one of 53 spermatogenesis-associated transmembrane protein genes, with no known physiological function. In this study, we investigated the expression and molecular characteristics of TMEM225 in mice. Tmem225 production was found to be specific to testicular germ cells, with expression increasing during spermatogenesis. In mature spermatozoa, TMEM225 is localized to the equatorial segment of the acrosome but not to the midpiece or tail. TMEM225 appears to be an outer and/or inner acrosomal membrane protein that is lost from the dorsal region of the acrosome after the acrosome reaction. TMEM225 interacts with PP1 in vivo, and a pull-down assay revealed that the carboxy-terminal region of TMEM225 can bind to PP12, the predominant isoform of PP1 in male germ cells. In addition, TMEM225 inhibited PP12 activity in vitro via its RVxF motif. Our results suggest that in mice, TMEM225 is involved in the differentiation and function of spermatozoa through the regulation of PP12 activity, which is necessary for normal spermatogenesis as well as spermatozoa capacitation and motility. Mol. Reprod. Dev. 82: 139-148, 2015. (c) 2015 Wiley Periodicals, Inc.	[Matsuura, Minami; Yogo, Keiichiro] Shizuoka Univ, Grad Sch Agr, Physiol Anim Lab, Shizuoka 4228529, Japan	Yogo, K (reprint author), Shizuoka Univ, Grad Sch Agr, Physiol Anim Lab, 836 Ohya, Shizuoka 4228529, Japan.	yogo.keiichiro@shizuoka.ac.jp			United Graduate School of Agricultural Science (Gifu University); Education and Research Activation Grants	Grant sponsor: United Graduate School of Agricultural Science (Gifu University); Grant sponsor: Education and Research Activation Grants	Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Fujihara Y, 2010, J CELL SCI, V123, P1531, DOI 10.1242/jcs.067363; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Toshimori K, 1998, BIOL REPROD, V59, P22, DOI 10.1095/biolreprod59.1.22; Hao ZL, 2002, BIOL REPROD, V66, P735, DOI 10.1095/biolreprod66.3.735; Ellis DJ, 2002, J STRUCT BIOL, V138, P187, DOI 10.1016/S1047-8477(02)00025-4; ALLEN MJ, 1995, J STRUCT BIOL, V114, P197, DOI 10.1006/jsbi.1995.1019; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; COHEN P, 1989, J BIOL CHEM, V264, P21435; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; CLERMONT Y, 1972, PHYSIOL REV, V52, P198; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Cohen PTW, 2002, J CELL SCI, V115, P241; BEDFORD JM, 1979, EXP CELL RES, V119, P119, DOI 10.1016/0014-4827(79)90341-0; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; CHUN YS, 1994, P NATL ACAD SCI USA, V91, P3319, DOI 10.1073/pnas.91.8.3319; Cohen N, 2001, INT J DEV BIOL, V45, P569; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Fathi AR, 2002, ANAL BIOCHEM, V310, P208, DOI 10.1016/S0003-2697(02)00377-9; Forgione N, 2010, REPRODUCTION, V139, P1021, DOI 10.1530/REP-10-0063; FURUYA S, 1992, J ASSIST REPROD GEN, V9, P391, DOI 10.1007/BF01203965; Hrabchak C, 2004, J BIOL CHEM, V279, P37079, DOI 10.1074/jbc.M403710200; Hrabchak C, 2007, BIOCHEMISTRY-US, V46, P4635, DOI 10.1021/bi6025837; Hsu SH, 2004, EXP CELL RES, V294, P185, DOI 10.1016/j.yexcr.2003.10.029; Huang Z, 2002, SPERM PP12 IS REGULA; Huang ZH, 2004, BIOL REPROD, V71, P177, DOI 10.1095/biolreprod.104.027284; Jones R, 2008, BIOL REPROD, V79, P421, DOI 10.1095/biolreprod.107.067314; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Malcher A, 2013, FERTIL STERIL, V100, pe1681; PHILLIPS DM, 1977, BIOL REPROD, V16, P128, DOI 10.1095/biolreprod16.1.128; Wolkowicz MJ, 2003, BIOL REPROD, V69, P735, DOI 10.1095/biolreprod.103.016675; Wolkowicz MJ, 2008, J ANDROL, V29, P272, DOI 10.2164/jandrol.106.000604; Yang SR, 2011, DNA CELL BIOL, V30, P9, DOI 10.1089/dna.2010.1048; Yogo K, 2012, HISTOCHEM CELL BIOL, V137, P53, DOI 10.1007/s00418-011-0887-y	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1040-452X	1098-2795		MOL REPROD DEV	Mol. Reprod. Dev.	FEB	2015	82	2					139	148		10.1002/mrd.22453		10	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	CB5IT	WOS:000349661400009		
J	Yoshimura, H; Mizuta, R; Murakami, H				Yoshimura, Hiromasa; Mizuta, Ryo; Murakami, Hiroyuki			A Spectral Cumulus Parameterization Scheme Interpolating between Two Convective Updrafts with Semi-Lagrangian Calculation of Transport by Compensatory Subsidence	MONTHLY WEATHER REVIEW			English	Article							GENERAL-CIRCULATION MODELS; LARGE-SCALE MODELS; CLIMATE SIMULATIONS; MOISTURE BUDGETS; SINGLE-COLUMN; NUMERICAL PREDICTION; CLOUD ENSEMBLE; WATER-CONTENT; HEAT; TEMPERATURE	The authors have developed a new spectral cumulus parameterization scheme that explicitly considers an ensemble of multiple convective updrafts by interpolating in-cloud variables between two convective updrafts with large and small entrainment rates. This cumulus scheme has the advantages that the variables in entraining and detraining convective updrafts are calculated in detail layer by layer as in the Tiedtke scheme, and that a spectrum of convective updrafts with different heights due to the difference in entrainment rates is explicitly represented, as in the Arakawa-Schubert scheme. A conservative and monotonic semi-Lagrangian scheme is used for calculation of transport by convection-induced compensatory subsidence. Use of the semi-Lagrangian scheme relaxes the mass-flux limit due to the Courant-Friedrichs-Lewy (CFL) condition, and moreover ensures nonnegative natural material transport. A global atmospheric model using this cumulus scheme gives an atmospheric simulation that agrees well with the observational climatology.	[Yoshimura, Hiromasa; Mizuta, Ryo] Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Murakami, Hiroyuki] Princeton Univ, NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08544 USA	Yoshimura, H (reprint author), Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	hyoshimu@mri-jma.go.jp	Murakami, Hiroyuki/L-5745-2015		SOUSEI Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	We are grateful to Masato Sugi, Tomoaki Ose, Seiji Yukimoto, Yoshinori Yamada, Eiki Shindo, MRI model development members, and MRI model analysis members for providing important information about cumulus parameterization and MJO, evaluating the cumulus scheme, and encouraging us. This work was conducted under the framework of the "Development of Basic Technology for Risk Information on Climate Change" supported by the SOUSEI Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Figure 11 was made with a diagnostic tool developed by the U.S. CLIVAR MJO Working Group.	FRITSCH JM, 1980, J ATMOS SCI, V37, P1722, DOI 10.1175/1520-0469(1980)037<1722:NPOCDM>2.0.CO;2; RAYMOND DJ, 1986, J ATMOS SCI, V43, P2708, DOI 10.1175/1520-0469(1986)043<2708:ASMMFN>2.0.CO;2; ZHANG GJ, 1995, ATMOS OCEAN, V33, P407; KUO HL, 1965, J ATMOS SCI, V22, P40, DOI 10.1175/1520-0469(1965)022<0040:OFAIOT>2.0.CO;2; Bryan GH, 2003, MON WEATHER REV, V131, P2394, DOI 10.1175/1520-0493(2003)131<2394:RRFTSO>2.0.CO;2; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; ARAKAWA A, 1974, J ATMOS SCI, V31, P674, DOI 10.1175/1520-0469(1974)031<0674:IOACCE>2.0.CO;2; Posselt DJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033029; Yukimoto S, 2012, J METEOROL SOC JPN, V90A, P23, DOI 10.2151/jmsj.2012-A02; TIEDTKE M, 1993, MON WEATHER REV, V121, P3040, DOI 10.1175/1520-0493(1993)121<3040:ROCILS>2.0.CO;2; de Rooy WC, 2013, Q J ROY METEOR SOC, V139, P1, DOI 10.1002/qj.1959; Murakami H, 2012, J CLIMATE, V25, P3237, DOI 10.1175/JCLI-D-11-00415.1; Mizuta R, 2012, J METEOROL SOC JPN, V90A, P233, DOI 10.2151/jmsj.2012-A12; Kuell V, 2009, ATMOS RES, V94, P743, DOI 10.1016/j.atmosres.2009.04.002; MOORTHI S, 1992, MON WEATHER REV, V120, P978, DOI 10.1175/1520-0493(1992)120<0978:RASAPO>2.0.CO;2; MANABE S, 1964, J ATMOS SCI, V21, P361, DOI 10.1175/1520-0469(1964)021<0361:TEOTAW>2.0.CO;2; SUNDQVIST H, 1978, Q J ROY METEOR SOC, V104, P677, DOI 10.1002/qj.49710444110; Murakami H, 2012, CLIM DYNAM, V39, P2569, DOI 10.1007/s00382-011-1223-x; Wagner TM, 2010, J ATMOS SCI, V67, P3854, DOI 10.1175/2010JAS3485.1; Satoh M, 2008, J COMPUT PHYS, V227, P3486, DOI 10.1016/j.jcp.2007.02.006; Lopez P, 2005, Q J ROY METEOR SOC, V131, P409, DOI 10.1256/qj.04.69; [Anonymous], 2005, 35 JAP MET AG; Lin SJ, 1996, MON WEATHER REV, V124, P2046, DOI 10.1175/1520-0493(1996)124<2046:MFFSLT>2.0.CO;2; KAIN JS, 1990, J ATMOS SCI, V47, P2784, DOI 10.1175/1520-0469(1990)047<2784:AODEPM>2.0.CO;2; BETTS AK, 1986, Q J ROY METEOR SOC, V112, P693, DOI 10.1002/qj.49711247308; [Anonymous], 2008, PAP METEOROL GEOPHYS, DOI 10.2467/mripapers.59.19; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Collins WD, 2001, J ATMOS SCI, V58, P3224, DOI 10.1175/1520-0469(2001)058<3224:POGCOF>2.0.CO;2; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Endo H, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017874; Pan DM, 1998, Q J ROY METEOR SOC, V124, P949, DOI 10.1256/smsqj.54713; Kim D, 2009, J CLIMATE, V22, P6413, DOI 10.1175/2009JCLI3063.1; Chikira M, 2010, J ATMOS SCI, V67, P2171, DOI 10.1175/2010JAS3316.1; GREGORY D, 1990, MON WEATHER REV, V118, P1483, DOI 10.1175/1520-0493(1990)118<1483:AMFCSW>2.0.CO;2; PRIESTLEY A, 1993, MON WEATHER REV, V121, P621, DOI 10.1175/1520-0493(1993)121<0621:AQCVOT>2.0.CO;2; Park S, 2009, J CLIMATE, V22, P3449, DOI 10.1175/2008JCLI2557.1; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; TIEDTKE M, 1989, MON WEATHER REV, V117, P1779, DOI 10.1175/1520-0493(1989)117<1779:ACMFSF>2.0.CO;2; Wheeler M, 1999, J ATMOS SCI, V56, P374, DOI 10.1175/1520-0469(1999)056<0374:CCEWAO>2.0.CO;2; Bechtold P, 2008, Q J ROY METEOR SOC, V134, P1337, DOI 10.1002/qj.289; [Anonymous], 2013, 42 JAP MET AG; KUO HL, 1974, J ATMOS SCI, V31, P1232, DOI 10.1175/1520-0469(1974)031<1232:FSOTPO>2.0.CO;2; Loeb NG, 2009, J CLIMATE, V22, P748, DOI 10.1175/2008JCLI2637.1; Gregory D, 1997, Q J ROY METEOR SOC, V123, P1153, DOI 10.1002/qj.49712354103; Wood R, 2006, J CLIMATE, V19, P6425, DOI 10.1175/JCLI3988.1; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; WU XQ, 1994, J ATMOS SCI, V51, P1640, DOI 10.1175/1520-0469(1994)051<1640:EOVWSO>2.0.CO;2; ECMWF, 2006, CY31R1 ECMWF IFS; Eito H, 2010, J METEOROL SOC JPN, V88, P625, DOI 10.2151/jmsj.2010-402; EMANUEL KA, 1991, J ATMOS SCI, V48, P2313, DOI 10.1175/1520-0469(1991)048<2313:ASFRCC>2.0.CO;2; GRAVEL S, 1994, MON WEATHER REV, V122, P243, DOI 10.1175/1520-0493(1994)122<0243:AMCSLS>2.0.CO;2; Hu Q, 1997, J ATMOS SCI, V54, P2292, DOI 10.1175/1520-0469(1997)054<2292:ACPBOA>2.0.CO;2; JMA, 2007, OUTL OP NUM WEATH PR; JOHNSON RH, 1984, MON WEATHER REV, V112, P1590, DOI 10.1175/1520-0493(1984)112<1590:PTHAMB>2.0.CO;2; JOHNSON RH, 1983, J ATMOS SCI, V40, P2138, DOI 10.1175/1520-0469(1983)040<2138:HAMBOT>2.0.CO;2; Kanada S, 2008, SOLA, V4, P105, DOI 10.2151/sola.2008-027; Kawai H., 2006, 36 JAP MET AG, P415; LEARY CA, 1979, J ATMOS SCI, V36, P437, DOI 10.1175/1520-0469(1979)036<0437:TSAEOC>2.0.CO;2; LILLY DK, 1990, Q J ROY METEOR SOC, V116, P779, DOI 10.1002/qj.49711649402; LINDZEN RS, 1988, PURE APPL GEOPHYS, V126, P123, DOI 10.1007/BF00876918; Mizuta R, 2006, J METEOROL SOC JPN, V84, P165, DOI 10.2151/jmsj.84.165; Nagasawa R., 2012, 42 JAP MET AG, P415; Nakagawa M., 2008, 38 JAP MET AG, P409; Nober FJ, 2005, ATMOS CHEM PHYS, V5, P2749; Nordeng T. E., 1994, 206 ECMWF, V206; SMITH RNB, 1990, Q J ROY METEOR SOC, V116, P435, DOI 10.1256/smsqj.49209; Xiao F, 2004, J COMPUT PHYS, V198, P389, DOI 10.1016/j.jcp.2004.01.013; Xie SC, 2000, J GEOPHYS RES-ATMOS, V105, P14983, DOI 10.1029/2000JD900170; YAMASAKI M, 1975, PAP METEOROL GEOPHYS, V26, P63; Yoshimura H., 2003, 33 JAP MET AG, P319; Yukimoto S., 2011, 64 MET RES I	72	7	7	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	FEB	2015	143	2					597	621		10.1175/MWR-D-14-00068.1		25	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CB1XX	WOS:000349422400012		
J	Nasuno, T; Li, T; Kikuchi, K				Nasuno, Tomoe; Li, Tim; Kikuchi, Kazuyoshi			Moistening Processes before the Convective Initiation of Madden-Julian Oscillation Events during the CINDY2011/DYNAMO Period	MONTHLY WEATHER REVIEW			English	Article							TROPICAL INDIAN-OCEAN; MULTIVARIATE MJO INDEX; INTRASEASONAL OSCILLATIONS; ATMOSPHERIC MODEL; FORECAST SKILL; CLIMATE; PRECIPITATION; PERFORMANCE; PREDICTION; DIAGNOSIS	Convective initiation processes in the Madden-Julian oscillation (MJO) events that occurred during the Cooperative Indian Ocean Experiment on Intraseasonal Variability in the Year 2011 (CINDY2011)/Dynamics of the Madden-Julian Oscillation (DYNAMO) intensive observation period (IOP) were investigated. Two episodes that were initiated in mid-October (MJO1) and mid-November (MJO2) 2011 were analyzed using European Centre for Medium-Range Weather Forecasts (ECMWF) reanalysis and satellite data. Moisture budgets in the equatorial Indian Ocean (IO) domain (10 degrees S-10 degrees N, 60 degrees-90 degrees E) were analyzed in detail by separating each variable into basic-state (>80 day), intraseasonal (20-80 day), and high-frequency (<20 day) variations. The quality of the ECMWF reanalysis was also evaluated against the sounding data collected during the field campaign. In both MJO events, the increase in precipitable water started 8-9 days prior to the convective initiation. Moisture advection decomposition revealed that advection of basic moisture by intraseasonal easterly anomalies and of intraseasonal moisture anomalies by the basic zonal wind were pronounced in these two events. The nonlinear high-frequency terms in the meridional moisture advection were the same order of magnitude as the primary term in the middle troposphere, implying systematic upscale transport of moisture. As a possible mechanism of the acceleration of easterly anomalies, amplification of off-equatorial Rossby wave trains that intruded into the equatorial zone was detected during the preconditioning periods in both MJO events.	[Nasuno, Tomoe] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa 2360001, Japan; [Li, Tim; Kikuchi, Kazuyoshi] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Li, Tim] Univ Hawaii Manoa, Dept Meteorol, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	Nasuno, T (reprint author), Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	nasuno@jamstec.go.jp			JAMSTEC IPRC Initiative; JAMSTEC; JSPS KAKENHI [26400475]; China National 973 Project [2015CB453200, NSFC41475084]; NSF [AGS-1005599]; NOAA [NA13OAR4310165]	The first author is indebted to Dr. Kunio Yoneyama for her participation in the CINDY2011 project and for handling the sounding data. Dr. Pang-chi Hsu is acknowledged for support with the time-filtering analysis, and Dr. Mikiko Fujita for handling the TRMM 3B42v7 data. Dr. Yoshiki Fukutomi is acknowledged for discussions. This work was supported by the JAMSTEC IPRC Initiative. TL and KK acknowledge the support provided by the JAMSTEC through its sponsorship of research activities at the IPRC. The first author was also supported by JSPS KAKENHI Grant 26400475. TL was supported by China National 973 Project 2015CB453200 and NSFC41475084. KK acknowledges additional support by NSF Grant AGS-1005599 and by NOAA Grant NA13OAR4310165. The authors also express their sincere gratitude to the two anonymous reviewers for their constructive comments regarding an earlier version of the manuscript.	Ling J, 2013, J ATMOS SCI, V70, P2696, DOI 10.1175/JAS-D-13-029.1; Ciesielski PE, 2014, J ATMOS OCEAN TECH, V31, P741, DOI 10.1175/JTECH-D-13-00165.1; DePasquale A, 2014, J GEOPHYS RES-ATMOS, V119, P6347, DOI 10.1002/2013JD021031; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; Janowiak JE, 2001, B AM METEOROL SOC, V82, P205, DOI 10.1175/1520-0477(2001)082<0205:ARTGHH>2.3.CO;2; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Xu WX, 2014, J ATMOS SCI, V71, P2859, DOI 10.1175/JAS-D-13-0372.1; Gottschalck J, 2010, B AM METEOROL SOC, V91, P1247, DOI 10.1175/2010BAMS2816.1; Matthews AJ, 2008, Q J ROY METEOR SOC, V134, P439, DOI 10.1002/qj.224; Powell SW, 2013, J GEOPHYS RES-ATMOS, V118, P11979, DOI 10.1002/2013JD020421; Seo KH, 2009, J CLIMATE, V22, P2372, DOI 10.1175/2008JCLI2421.1; Satoh M, 2008, J COMPUT PHYS, V227, P3486, DOI 10.1016/j.jcp.2007.02.006; Zuluaga MD, 2013, J ATMOS SCI, V70, P2713, DOI 10.1175/JAS-D-12-0311.1; JOHNSON RH, 1980, J ATMOS SCI, V37, P733, DOI 10.1175/1520-0469(1980)037<0733:DOCAMM>2.0.CO;2; Kemball-Cook SR, 2001, J CLIMATE, V14, P780, DOI 10.1175/1520-0442(2001)014<0780:TOOCIT>2.0.CO;2; Hung MP, 2013, J CLIMATE, V26, P6185, DOI 10.1175/JCLI-D-12-00541.1; BLADE I, 1993, J ATMOS SCI, V50, P2922, DOI 10.1175/1520-0469(1993)050<2922:TIOIAS>2.0.CO;2; DUCHON CE, 1979, J APPL METEOROL, V18, P1016, DOI 10.1175/1520-0450(1979)018<1016:LFIOAT>2.0.CO;2; Zhao CB, 2013, J CLIMATE, V26, P291, DOI 10.1175/JCLI-D-12-00113.1; WANG B, 1994, J ATMOS SCI, V51, P1386, DOI 10.1175/1520-0469(1994)051<1386:CIWBLD>2.0.CO;2; Yoneyama K, 2008, B AM METEOROL SOC, V89, P1889, DOI 10.1175/2008BAMS2519.1; Maloney ED, 2009, J CLIMATE, V22, P711, DOI 10.1175/2008JCLI2542.1; HSU HH, 1990, J ATMOS SCI, V47, P823, DOI 10.1175/1520-0469(1990)047<0823:TIOATR>2.0.CO;2; Sobel AH, 2000, J CLIMATE, V13, P4378, DOI 10.1175/1520-0442(2000)013<4378:MTPIAS>2.0.CO;2; Kim D, 2014, J CLIMATE, V27, P111, DOI 10.1175/JCLI-D-13-00084.1; Kiladis GN, 2005, J ATMOS SCI, V62, P2790, DOI 10.1175/JAS3520.1; Straub KH, 2013, J CLIMATE, V26, P1130, DOI 10.1175/JCLI-D-12-00074.1; Wheeler MC, 2004, MON WEATHER REV, V132, P1917, DOI 10.1175/1520-0493(2004)132<1917:AARMMI>2.0.CO;2; Zhang CD, 2013, B AM METEOROL SOC, V94, P1849, DOI 10.1175/BAMS-D-12-00026.1; MADDEN RA, 1971, J ATMOS SCI, V28, P702, DOI 10.1175/1520-0469(1971)028<0702:DOADOI>2.0.CO;2; Hsu PC, 2011, J CLIMATE, V24, P927, DOI 10.1175/2010JCLI3833.1; Fukutomi Y, 2013, CLIM DYNAM, V40, P1819, DOI 10.1007/s00382-012-1417-x; Hu Q., 1994, J ATMOS SCI, V51, P1089, DOI [10.1175/1520-0469(1994)051<1089:LFOIRC>2.0.CO;2, DOI 10.1175/1520-0469(1994)051]; Jiang XA, 2005, J CLIMATE, V18, P3777, DOI 10.1175/JCLI3516.1; LAU KM, 1987, J ATMOS SCI, V44, P950, DOI 10.1175/1520-0469(1987)044<0950:OOLFOI>2.0.CO;2; Lin H, 2007, J ATMOS SCI, V64, P2422, DOI 10.1175/JAS3955.1; MCNAB AL, 1978, MON WEATHER REV, V106, P1317, DOI 10.1175/1520-0493(1978)106<1317:AMBSOC>2.0.CO;2; Miyakawa T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4769; Nagarajan B, 2004, MON WEATHER REV, V132, P2275, DOI 10.1175/1520-0493(2004)132<2275:POTEOA>2.0.CO;2; Nasuno T, 2013, SOLA, V9, P69, DOI 10.2151/sola.2013-016; Pan L.-L., 2007, CLIM DYNAM, V31, P375, DOI 10.1007/s00382-007-0272-7; Ray P, 2010, J ATMOS SCI, V67, P515, DOI 10.1175/2009JAS3059.1; Wang L, 2012, Q J ROY METEOR SOC, V138, P1740, DOI 10.1002/qj.1905	44	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	FEB	2015	143	2					622	643		10.1175/MWR-D-14-00132.1		22	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CB1XX	WOS:000349422400013		
J	Lee, M; Kiefel, H; LaJevic, MD; Macauley, MS; Kawashima, H; O'Hara, E; Pan, JL; Paulson, JC; Butcher, EC				Lee, Mike; Kiefel, Helena; LaJevic, Melissa D.; Macauley, Matthew S.; Kawashima, Hiroto; O'Hara, Edward; Pan, Junliang; Paulson, James C.; Butcher, Eugene C.			Transcriptional programs of the lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing (vol 15, pg 982, 2014)	NATURE IMMUNOLOGY			English	Correction									[Lee, Mike; Kiefel, Helena; LaJevic, Melissa D.; Macauley, Matthew S.; Kawashima, Hiroto; O'Hara, Edward; Pan, Junliang; Paulson, James C.; Butcher, Eugene C.] Hoshi Univ, Dept Biochem, Sch Pharm & Pharmaceut Sci, Tokyo 142, Japan	Lee, M (reprint author), Hoshi Univ, Dept Biochem, Sch Pharm & Pharmaceut Sci, Tokyo 142, Japan.						Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2										1	Immunology	Immunology	AZ3QZ	WOS:000348143100018		
J	Koyasu, S				Koyasu, Shigeo			Inflammatory ILC2 cells: disguising themselves as progenitors?	NATURE IMMUNOLOGY			English	Editorial Material							INNATE LYMPHOID-CELLS; TYPE-2 IMMUNITY; RESPONSES; ELICITS; IL-25		RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Koyasu, S (reprint author), RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.	shigeo.koyasu@riken.jp	Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038			Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Hurst SD, 2002, J IMMUNOL, V169, P443; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Banh C, 2009, BLOOD, V114, P5299, DOI 10.1182/blood-2009-06-228353; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743	11	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					133	134				2	Immunology	Immunology	AZ3QZ	WOS:000348143100002		
J	Liu, XJ; Miao, Q; Gel'mukhanov, F; Patanen, M; Travnikova, O; Nicolas, C; Agren, H; Ueda, K; Miron, C				Liu, Xiao-Jing; Miao, Quan; Gel'mukhanov, Faris; Patanen, Minna; Travnikova, Oksana; Nicolas, Christophe; Agren, Hans; Ueda, Kiyoshi; Miron, Catalin			Einstein-Bohr recoiling double-slit gedanken experiment performed at the molecular level	NATURE PHOTONICS			English	Article							RAY RAMAN-SCATTERING; ULTRAFAST DISSOCIATION; MOMENTUM SPECTROSCOPY; ATOM INTERFEROMETER; INTERFERENCE; LOCALIZATION; PHOTOIONIZATION; COMPLEMENTARITY; COHERENCE; PHOTON	Double-slit experiments illustrate the quintessential proof for wave-particle complementarity. If information is missing about which slit the particle has traversed, the particle, behaving as a wave, passes simultaneously through both slits. This wave-like behaviour and corresponding interference is absent if 'which-slit' information exists. The essence of Einstein-Bohr's debate about wave-particle duality was whether the momentum transfer between a particle and a recoiling slit could mark the path, thus destroying the interference. To measure the recoil of a slit, the slits should move independently. We showcase a materialization of this recoiling double-slit gedanken experiment by resonant X-ray photoemission from molecular oxygen for geometries near equilibrium (coupled slits) and in a dissociative state far away from equilibrium (decoupled slits). Interference is observed in the former case, while the electron momentum transfer quenches the interference in the latter case owing to Doppler labelling of the counter-propagating atomic slits, in full agreement with Bohr's complementarity.	[Liu, Xiao-Jing; Gel'mukhanov, Faris; Patanen, Minna; Travnikova, Oksana; Nicolas, Christophe; Miron, Catalin] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Miao, Quan; Gel'mukhanov, Faris; Agren, Hans] Royal Inst Technol, Sch Biotechnol, S-10691 Stockholm, Sweden; [Miao, Quan] Shandong Univ Sci & Technol, Coll Elect Commun & Phys, Qingdao 266590, Shandong, Peoples R China; [Ueda, Kiyoshi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Miron, Catalin] Horia Hulubei Natl Inst Phys & Nucl Engn, RO-077125 Magurele, Jud Ilfov, Romania	Miron, C (reprint author), Synchrotron SOLEIL, BP 48, F-91192 Gif Sur Yvette, France.	catalin.miron@synchrotron-soleil.fr	MIRON, Catalin/D-3446-2009	MIRON, Catalin/0000-0002-8302-7158	'Laboratoire d'Excellence Physics Atoms Light Matter' (LabEx PALM) by the French National Research Agency (ANR) [ANR-10-LABX-0039]; European Union [252781]; European Cooperation in Science and Technology (COST) action [CM1204-XUV]; Triangle de la Physique [2007-010T]; Japan Society for the Promotion of Science (JSPS); Swedish Research Council (VR) [621-2012-3675, 621-2012-3347]	Experiments were performed at the PLEIADES beamline at SOLEIL synchrotron, France (proposal no. 99110013). The authors thank N. Kosugi for sharing knowledge of the oxygen molecule, D. Serban and P. Morin for stimulating discussions about the physical interpretation, E. Robert for technical assistance and the SOLEIL staff for the smooth running of the facility. This work is supported by a public grant from the 'Laboratoire d'Excellence Physics Atoms Light Matter' (LabEx PALM) overseen by the French National Research Agency (ANR) as part of the 'Investissements d'Avenir' programme (reference no. ANR-10-LABX-0039). The research leading to these results has also received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 252781 and the European Cooperation in Science and Technology (COST) action CM1204-XUV/X-ray light and fast ions for ultrafast chemistry (XLIC), from Triangle de la Physique under contract no. 2007-010T, from the Japan Society for the Promotion of Science (JSPS) and from the Swedish Research Council (VR) under grants nos 621-2012-3675 (F.G.) and 621-2012-3347 (H.A.).	Akoury D, 2007, SCIENCE, V318, P949, DOI 10.1126/science.1144959; MORIN P, 1986, PHYS REV LETT, V56, P1913, DOI 10.1103/PhysRevLett.56.1913; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Martin F, 2007, SCIENCE, V315, P629, DOI 10.1126/science.1136598; Lindblad A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113018; Gel'mukhanov F, 1999, PHYS REP, V312, P87, DOI 10.1016/S0370-1573(99)00003-4; Miron C, 2012, NAT PHYS, V8, P135, DOI [10.1038/nphys2159, 10.1038/NPHYS2159]; Bjorneholm O, 2000, PHYS REV LETT, V84, P2826, DOI 10.1103/PhysRevLett.84.2826; Zimmermann B, 2008, NAT PHYS, V4, P649, DOI 10.1038/nphys993; CHAPMAN MS, 1995, PHYS REV LETT, V75, P3783, DOI 10.1103/PhysRevLett.75.3783; COHEN HD, 1966, PHYS REV, V150, P30, DOI 10.1103/PhysRev.150.30; WOOTTERS WK, 1979, PHYS REV D, V19, P473, DOI 10.1103/PhysRevD.19.473; GELMUKHANOV F, 1994, PHYS REV A, V49, P4378, DOI 10.1103/PhysRevA.49.4378; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; Sansone G, 2010, NATURE, V465, P763, DOI 10.1038/nature09084; Bertet P, 2001, NATURE, V411, P166, DOI 10.1038/35075517; Sorensen SL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012719; Gelmukhanov F, 1996, PHYS REV A, V54, P379, DOI 10.1103/PhysRevA.54.379; Jahnke T, 2010, NAT PHYS, V6, P139, DOI 10.1038/NPHYS1498; Liu XJ, 2006, J PHYS B-AT MOL OPT, V39, P4801, DOI 10.1088/0953-4075/39/23/001; Durr S, 1998, NATURE, V395, P33; Miron C, 2009, NUCL INSTRUM METH A, V601, P66, DOI 10.1016/j.nima.2008.12.104; Liu XJ, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4794440; TEO BK, 1979, J AM CHEM SOC, V101, P2815, DOI 10.1021/ja00505a003; Travnikova O, 2013, J PHYS CHEM LETT, V4, P2361, DOI 10.1021/jz4011288; Kimberg V, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011017; AHARONOV Y, 1961, PHYS REV, V122, P1649, DOI 10.1103/PhysRev.122.1649; Morin P, 2012, J ELECTRON SPECTROSC, V185, P259, DOI 10.1016/j.elspec.2012.06.002; Schoffler MS, 2008, SCIENCE, V320, P920, DOI 10.1126/science.1154989; Kushawaha RK, 2013, P NATL ACAD SCI USA, V110, P15201, DOI 10.1073/pnas.1306697110; Gel'mukhanov F, 1998, PHYS REV A, V57, P2511, DOI 10.1103/PhysRevA.57.2511; Arndt M, 2011, NAT PHYS, V7, P375, DOI 10.1038/nphys1987; Baev A, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.022509; Bohr N., 1983, QUANTUM THEORY MEASU, P9; Cherepkov NA, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.023420; Guimaraes F. F., 2005, PHYS REV A, V72; Le Guen K, 2002, REV SCI INSTRUM, V73, P3885, DOI 10.1063/1.1511799; Miron C, 1997, REV SCI INSTRUM, V68, P3728, DOI 10.1063/1.1148017; Schmidt LPH, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.103201; Tanaka T, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.022516; THOMAS IL, 1971, PHYS REV A-GEN PHYS, V4, P457, DOI 10.1103/PhysRevA.4.457; Tomkovic J, 2011, NAT PHYS, V7, P379, DOI [10.1038/nphys1961, 10.1038/NPHYS1961]; Wiseman HM, 1997, PHYS REV A, V56, P55, DOI 10.1103/PhysRevA.56.55; YAGISHITA A, 1994, PHYS REV LETT, V72, P3961, DOI 10.1103/PhysRevLett.72.3961	44	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	FEB	2015	9	2					120	125		10.1038/NPHOTON.2014.289		6	Optics; Physics, Applied	Optics; Physics	CB0YT	WOS:000349354300018		
J	Miki, Y; Tanji, K; Mori, F; Wakabayashi, K				Miki, Yasuo; Tanji, Kunikazu; Mori, Fumiaki; Wakabayashi, Koichi			Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease	NEUROBIOLOGY OF DISEASE			English	Article						Sigma-1 receptor; Huntington's disease; Neuronal nuclear inclusions; Ubiquitin-proteasome system; Endoplasmic reticulum chaperone; Endoplasmic reticulum-associated degradation	TRANSCRIPTION FACTOR; NEURODEGENERATIVE DISEASES; PROTEIN RESPONSE; CAG REPEAT; POLYGLUTAMINE; EXPANSION; PROTEASOME; UBIQUITIN; TRINUCLEOTIDE; BINDING	The sigma-1 receptor (SIGMAR1) is one of the endoplasmic reticulum (ER) chaperones, which participate in the degradation of misfolded proteins via the ER-related degradation machinery linked to the ubiquitin-proteasome pathway. ER dysfunction in the formation of inclusion bodies in various neurodegenerative diseases has also become evident. Recently, we demonstrated that accumulation of SIGMAR1 was common to neuronal nuclear inclusions in polyglutamine diseases including Huntington's disease. Our study also indicated that SIGMAR1 might shuttle between the cytoplasm and the nucleus. In the present study, we investigated the role of SIGMAR1 in nuclear inclusion (NI) formation, using HeLa cells transfected with N-terminal mutant huntingtin. Cell harboring the mutant huntingtin produced SIGMAR1-positive NIs.SIGMAR1 siRNA and a specific inhibitor of the proteasome (epoxomicin) caused significant accumulation of aggregates in the cytoplasm and nucleus. A specific inhibitor of exportin 1 (leptomycin B) also caused Nis. Huntingtin became insolubilized in Western blot analysis after treatments with SIGMAR1 siRNA and epoxomicin. Furthermore, proteasome activity increased chronologically along with the accumulation of mutant huntingtin, but was significantly reduced in cells transfected with SIGMAR1 siRNA. By contrast, overexpression of SIGMAR1 reduced the accumulation of Nis containing mutant huntingtin. Although the LC3-I level was decreased in cells treated with both SIGMAR1 siRNA and control siRNA, the levels of LC3-II and p62 were unchanged. SIGMAR1 agonist and antagonist had no effect on cellular viability and proteasome activity. These findings suggest that the ubiquitin-proteasome pathway is implicated in NI formation, and that SIGMAR1 degrades aberrant proteins in the nucleus via the ER-related degradation machinery. SIGMAR1 might be a promising candidate for therapy of Huntington's disease. (C) 2014 Elsevier Inc All rights reserved.	[Miki, Yasuo; Tanji, Kunikazu; Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori 0368562, Japan	Miki, Y (reprint author), Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neuropathol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yasuomiki@hotmail.com			JSPS KAKENHI [26860655, 26430050, 26430049, 24300131]; Hirosaki University Grant for Exploratory Research by Young Scientists; Hirosaki University Institutional Research; Research Committee for Ataxic Disease; Ministry of Health, Labour and Welfare, Japan	This work was supported by JSPS KAKENHI Grant Numbers 26860655 (Y.M.), 26430050 (K.T.), 26430049 (F.M.) and 24300131 (K.W.), Hirosaki University Grant for Exploratory Research by Young Scientists (Y.M.), a Grant for Hirosaki University Institutional Research (K.W.) and the Research Committee for Ataxic Disease (K.W.) from the Ministry of Health, Labour and Welfare, Japan.	Amer MS, 2013, BRIT J PHARMACOL, V168, P1445, DOI 10.1111/bph.12041; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Narain Y, 1999, J MED GENET, V36, P739; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc/E02-03-0122; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; QUIRION R, 1992, TRENDS PHARMACOL SCI, V13, P85, DOI 10.1016/0165-6147(92)90030-A; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Huang SS, 2011, BRAIN, V134, P1943, DOI 10.1093/brain/awr146; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Miki Y, 2011, NEUROPATHOLOGY, V31, P561, DOI 10.1111/j.1440-1789.2011.01200.x; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Spector David L, 2006, Cell, V127, P1071, DOI 10.1016/j.cell.2006.11.026; Huntington G., 1872, MED SURG REP, V26, P317; Hyrskyluoto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.170; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Miki Y, 2014, NEUROPATHOLOGY, V34, P148, DOI 10.1111/neup.12080; Mori F, 2012, NEUROSCI LETT, V522, P134, DOI 10.1016/j.neulet.2012.06.026; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Zhang HX, 2008, NEUROSCI LETT, V434, P170, DOI 10.1016/j.neulet.2008.01.060	41	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	FEB	2015	74						25	31		10.1016/j.nbd.2014.11.005		7	Neurosciences	Neurosciences & Neurology	CB5GQ	WOS:000349655900003		
J	Orakcioglu, B; Kentar, MM; Schiebel, P; Uozumi, Y; Unterberg, A; Sakowitz, OW				Orakcioglu, Berk; Kentar, Modar M.; Schiebel, Patrick; Uozumi, Yoichi; Unterberg, Andreas; Sakowitz, Oliver W.			Perihemorrhagic Ischemia Occurs in a Volume-Dependent Manner as Assessed by Multimodal Cerebral Monitoring in a Porcine Model of Intracerebral Hemorrhage	NEUROCRITICAL CARE			English	Article						Experimental ICH; Ischemia; Multimodal neuromonitoring	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; TISSUE OXYGEN; INTRACRANIAL HYPERTENSION; SUBARACHNOID HEMORRHAGE; PERFUSION-PRESSURE; HEAD-INJURY; MICRODIALYSIS; PENUMBRA; EDEMA	Changes in the perihemorrhagic zone (PHZ) of intracerebral hemorrhage (ICH) are variable. Different mechanisms contribute to secondary neuronal injury after ICH. This multimodal monitoring study investigated early changes in the PHZ of ICH. Twenty-four swine were anesthetized, ventilated, and underwent monitoring of vital parameters. Next to an intracranial pressure-probe (ICP), microdialysis (MD), thermodiffusion cerebral blood flow (td-CBF), and oxygen probes (PbrO2) were placed into the gray white matter junction for 12 h of monitoring. ICH was induced using the autologous blood injection model. Pre-defined volumes were 0 ml (sham), 1.5 ml ipsilateral (1.5 ml), 3.0 ml ipsilateral (3.0 ml), and 3.0 ml contralateral (3.0 ml contra). ICP equally increased in all groups after ICH. In the 3.0 ml group tissue oxygenation decreased to ischemic values of 9 +/- A 7 mmHg early after 6 h of monitoring. This decrease was associated with a significant perfusion reduction from 36 +/- A 8 ml/100 g/min to 20 +/- A 10 ml/100 g/min. MD correlated with a threefold lactate/pyruvate ratio increase. Measurements in all other groups were unchanged. Multimodal monitoring demonstrates volume-dependent changes of tissue oxygenation, blood flow, and ischemic MD markers in the PHZ independent of increased ICP suggesting early moderate ischemia. No evidence was found for the existence of a perihemorrhagic ischemia in the small hematoma groups.	[Orakcioglu, Berk; Kentar, Modar M.; Schiebel, Patrick; Uozumi, Yoichi; Unterberg, Andreas; Sakowitz, Oliver W.] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Orakcioglu, Berk] Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Uozumi, Yoichi] Kamiiida Dai Ichi Gen Hosp, Dept Neurosurg, Nagoya, Aichi, Japan	Orakcioglu, B (reprint author), Univ Heidelberg Hosp, Dept Neurosurg, Neuenheimer Feld 400, Heidelberg, Germany.	berk.orakcioglu@med.uni-heidelberg.de					Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Pascual AM, 2007, CEREBROVASC DIS, V23, P6, DOI 10.1159/000095752; Qureshi AI, 1999, NEUROLOGY, V52, P266; Belayev L, 2003, STROKE, V34, P2221, DOI 10.1161/01.STR.0000088061.06656.1E; Kaufmann AM, 1999, STROKE, V30, P93; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Powers WJ, 2001, NEUROLOGY, V57, P18; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Kirkman MA, 2011, J CEREBR BLOOD F MET, V31, P2135, DOI 10.1038/jcbfm.2011.124; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804; Herweh C, 2007, STROKE, V38, P2941, DOI 10.1161/STROKEAHA.107.486977; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Beseoglu K, 2014, NEURORADIOLOGY; BULLOCK R, 1988, SURG NEUROL, V29, P101, DOI 10.1016/0090-3019(88)90065-1; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; He D, 2009, INT J NEUROSCI, V119, P806, DOI 10.1080/00207450802325496; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/Neurocrit.Care2005;03:260-270; Kirkman MA, 2013, J NEUROSURG ANESTH, V25, P228, DOI 10.1097/ANA.0b013e3182836059; MENDELOW AD, 1993, STROKE, V24, pI115; Mendelow AD., 1993, STROKE, V24, pI118; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.ES; Orakcioglu B, 2005, EXP NEUROL, V193, P369, DOI 10.1016/j.expneurol.2005.01.017; Orakcioglu B, 2011, ACTA NEUROCHIR SUPPL, V111, P19, DOI 10.1007/978-3-7091-0693-8_4; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037	34	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					133	139		10.1007/s12028-014-0027-3		7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300017		
J	Kobayakawa, Y; Sakumi, K; Kajitani, K; Kadoya, T; Horie, H; Kira, J; Nakabeppu, Y				Kobayakawa, Y.; Sakumi, K.; Kajitani, K.; Kadoya, T.; Horie, H.; Kira, J-i; Nakabeppu, Y.			Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						amyotrophic lateral sclerosis; axonal degeneration; axonal spheroid; galectin-1; SOD1	AMYOTROPHIC-LATERAL-SCLEROSIS; NEURAL STEM-CELLS; MOUSE MODEL; OXIDIZED GALECTIN-1; PERIPHERAL-NERVES; SPINAL-CORD; MUTANT SOD1; ALS; DEGENERATION; SURVIVAL	AimsGalectin-1, a member of the -galactoside-binding lectin family, accumulates in neurofilamentous lesions in the spinal cords of both sporadic and familial amyotrophic lateral sclerosis (ALS) patients with a superoxide dismutase 1 gene (SOD1) mutation (A4V). The aim of this study was to evaluate the roles of endogenous galectin-1 in the pathogenesis of ALS. MethodsExpression of galectin-1 in the spinal cord of mutant SOD1 transgenic (SOD1(G93A)) mice was examined by pathological analysis, real-time RT-PCR and Western blotting. The effects of galectin-1 deficiency were evaluated by cross-breeding SOD1(G93A) mice with galectin-1 null (Lgals1(-/-)) mice. ResultsBefore ALS-like symptoms developed in SOD1(G93A)/Lgals1(+/+) mice, strong galectin-1 immunoreactivity was observed in swollen motor axons and colocalized with aggregated neurofilaments. Electron microscopic observations revealed that the diameters of swollen motor axons in the spinal cord were significantly smaller in SOD1(G93A)/Lgals1(-/-) mice, and there was less accumulation of vacuoles compared with SOD1(G93A)/Lgals1(+/+) mice. In symptomatic SOD1(G93A)/Lgals1(+/+) mice, astrocytes surrounding motor axons expressed a high level of galectin-1. ConclusionsGalectin-1 accumulates in neurofilamentous lesions in SOD1(G93A) mice, as previously reported in humans with ALS. Galectin-1 accumulation in motor axons occurs before the development of ALS-like symptoms and is associated with early processes of axonal degeneration in SOD1(G93A) mice. In contrast, galectin-1 expressed in astrocytes may be involved in axonal degeneration during symptom presentation.	[Kobayakawa, Y.; Sakumi, K.; Kajitani, K.; Nakabeppu, Y.] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Genom, Fukuoka 8128582, Japan; [Kobayakawa, Y.; Kira, J-i] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 8128582, Japan; [Sakumi, K.; Nakabeppu, Y.] Kyushu Univ, Res Ctr Nucleotide Pool, Fukuoka 8128582, Japan; [Kajitani, K.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 8128582, Japan; [Kadoya, T.] Maebashi Inst Technol, Dept Biotechnol, Maebashi, Gumma, Japan; [Horie, H.] TechnoMaster Co Ltd, Yokohama, Kanagawa, Japan	Nakabeppu, Y (reprint author), Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Genom,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yusaku@bioreg.kyushu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [22221004, 25110724]; Kyushu University Global COE Program (Cell-fate Decision: Function and Dysfunction in Homeostasis)	This work was supported by the Japan Society for the Promotion of Science KAKENHI (Grant Numbers 22221004 and 25110724) and the Kyushu University Global COE Program (Cell-fate Decision: Function and Dysfunction in Homeostasis). We thank Dr Francoise Poirier (Department of Developmental Biology, Institute Jacques Monod, Universities Paris 6 and Paris 7, France) for kindly providing Lgals1-knockout mice, Mr Ryo Ugawa and Ms Kanako Motomura (Laboratory for Technical Support, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan) for electron microscopy and pathological analysis, respectively, and Ms S. Kitamura, Ms K. Asakawa and Ms T. Kuwano for their technical assistance.	Akazawa C, 2004, NEUROSCIENCE, V125, P171, DOI 10.1016/j.neuroscience.2004.01.034; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Tsuchimoto D, 2001, NUCLEIC ACIDS RES, V29, P2349, DOI 10.1093/nar/29.11.2349; Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P166, DOI 10.1006/bbrc.2001.4556; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Kong JM, 1998, J NEUROSCI, V18, P3241; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Sasaki T, 2004, GLYCOBIOLOGY, V14, P357, DOI 10.1093/glycob/cwh043; Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2; Horie H, 1999, J NEUROSCI, V19, P9964; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; POIRIER F, 1993, DEVELOPMENT, V119, P1229; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Marinkovic P, 2012, P NATL ACAD SCI USA, V109, P4296, DOI 10.1073/pnas.1200658109; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Horie H, 2004, J NEUROSCI, V24, P1873, DOI 10.1523/JNEUROSCI.4483-03.2004; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Chang-Hong R, 2005, EXP NEUROL, V194, P203, DOI 10.1016/j.expneurol.2005.02.011; Imaizumi Y, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-7; Inagaki Y, 2000, EUR J BIOCHEM, V267, P2955, DOI 10.1046/j.1432-1327.2000.01311.x; Kadoya T, 2005, CURR DRUG TARGETS, V6, P375, DOI 10.2174/1389450054022007; Kajitani K, 2009, CELL DEATH DIFFER, V16, P417, DOI 10.1038/cdd.2008.162; Lerman BJ, 2012, BRAIN BEHAV, V2, P563, DOI 10.1002/brb3.75; McGraw J, 2005, PAIN, V114, P7, DOI 10.1016/j.pain.2004.10.009; McGraw J, 2004, EUR J NEUROSCI, V20, P2872, DOI 10.1111/j.1460-9568.2004.03802.x; Miura T, 2004, CELL DEATH DIFFER, V11, P1076, DOI 10.1038/sj.cdd.4401462; Panov A, 2011, NEUROBIOL DIS, V44, P53, DOI 10.1016/j.nbd.2011.06.003; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Pratt A.J., 2012, DEGENER NEUROL NEURO, V2012, P1, DOI DOI 10.2147/DNND.S19803; Sakaguchi M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-33; Sakaguchi M, 2012, DEV NEUROBIOL, V72, P1059, DOI 10.1002/dneu.22023; Sasaki S, 2004, ACTA NEUROPATHOL, V107, P452, DOI 10.1007/s00401-004-0838-y	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	FEB	2015	41	2					227	244		10.1111/nan.12123		18	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CA7PM	WOS:000349109500013		
J	Cui, NA; Negoro, H; Suadicani, S				Cui, Nuan; Negoro, Hiromitsu; Suadicani, Sylvia			CYSTOMETRIC EVALUATION OF BLADDER FUNCTION IN PANNEXIN 1 AND IN P2X7 RECEPTOR DEFICIENT FEMALE MICE	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	Winter Meeting of the Society-of-Urodynamics-Female-Pelvic-Medicine-and-Urogenital-Reconstruction	FEB 24-28, 2015	Scottsdale, AZ	Soc Urodynam, Female Pelv Med & Urogenital Reconstruct					[Cui, Nuan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept OB GYN, Bronx, NY 10467 USA; [Negoro, Hiromitsu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Suadicani, Sylvia] Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	FEB	2015	34			1		12	S81	S81				1	Urology & Nephrology	Urology & Nephrology	CB0CT	WOS:000349293400186		
J	Domcke, V; Schmitz, K; Yanagida, TT				Domcke, Valerie; Schmitz, Kai; Yanagida, Tsutomu T.			Dynamical D-terms in supergravity	NUCLEAR PHYSICS B			English	Article							SUPERSYMMETRY BREAKING; AUXILIARY FIELDS; GAUGE-THEORIES; COSMOLOGICAL CONSTANT; MODELS; SUPERSPACE	Most phenomenological models of supersymmetry breaking rely on nonzero F-terms rather than nonzero D-terms. An important reason why D-terms are often neglected is that it turns out to be very challenging to realize D-terms at energies parametrically smaller than the Planck scale in supergravity. As we demonstrate in this paper, all conventional difficulties may, however, be overcome if the generation of the D-term is based on strong dynamics. To illustrate our idea, we focus on a certain class of vector-like SUSY breaking models that enjoy a minimal particle content and which may be easily embedded into more complete scenarios. We are then able to show that, upon gauging a global flavor symmetry, an appropriate choice of Yukawa couplings readily allows to dynamically generate a D-term at an almost arbitrary energy scale. This includes in particular the natural and consistent realization of D-terms around, above and below the scale of grand unification in supergravity, without the need for fine-tuning of any model parameters. Our construction might therefore bear the potential to open up a new direction for model building in supersymmetry and early universe cosmology. (C) 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license.	[Domcke, Valerie] SISSA INFN, I-34100 Trieste, Italy; [Schmitz, Kai; Yanagida, Tsutomu T.] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan	Schmitz, K (reprint author), Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan.	kai.schmitz@ipmu.jp			European Union [PITAN-GA-2011-289442-INVISIBLES]; Ministry of Education, Science, Sports, and Culture (MEXT), Japan [26104009, 26287039]; World Premier International Research Center Initiative (WPI); MEXT, Japan	The authors would like to thank F. Brummer, W. Buchmuller, K. Harigaya, M. Hindmarsh, R. Kallosh, J. Maltz, and C. Wieck for helpful discussions and comments. V.D. also gratefully acknowledges the hospitality of Kavli IPMU during the initial stages of this project. This work has been supported in part by the European Union through the FP7 Initial Training Network INVISIBLES (Marie Curie Action PITAN-GA-2011-289442-INVISIBLES) (V.D.), by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture (MEXT), Japan, No. 26104009 and No. 26287039 (T.T.Y.) as well as by the World Premier International Research Center Initiative (WPI), MEXT, Japan (K.S. and T.T.Y.).	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; AFFLECK I, 1983, PHYS REV LETT, V51, P1026, DOI 10.1103/PhysRevLett.51.1026; AKULOV VP, 1977, THEOR MATH PHYS+, V31, P285, DOI 10.1007/BF01041233; Intriligator K, 2007, CLASSICAL QUANT GRAV, V24, pS741, DOI 10.1088/0264-9381/24/21/S02; COLEMAN S, 1988, NUCL PHYS B, V310, P643, DOI 10.1016/0550-3213(88)90097-1; LANG W, 1985, PHYS LETT B, V158, P40, DOI 10.1016/0370-2693(85)90735-X; DINE M, 1987, NUCL PHYS B, V289, P589, DOI 10.1016/0550-3213(87)90395-6; WITTEN E, 1982, PHYS LETT B, V115, P202, DOI 10.1016/0370-2693(82)90644-X; SEIBERG N, 1995, NUCL PHYS B, V435, P129, DOI 10.1016/0550-3213(94)00023-8; FAYET P, 1974, PHYS LETT B, VB 51, P461, DOI 10.1016/0370-2693(74)90310-4; GREEN MB, 1984, PHYS LETT B, V149, P117, DOI 10.1016/0370-2693(84)91565-X; GILBERT G, 1989, NUCL PHYS B, V328, P159, DOI 10.1016/0550-3213(89)90097-7; Buchmuller W, 2012, NUCL PHYS B, V862, P587, DOI 10.1016/j.nuclphysb.2012.05.001; Ade PAR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.241101; Buchmuller W, 2013, PHYS LETT B, V726, P467, DOI 10.1016/j.physletb.2013.08.042; GIDDINGS SB, 1988, NUCL PHYS B, V307, P854, DOI 10.1016/0550-3213(88)90109-5; SEIBERG N, 1994, PHYS REV D, V49, P6857, DOI 10.1103/PhysRevD.49.6857; SOHNIUS MF, 1981, PHYS LETT B, V105, P353, DOI 10.1016/0370-2693(81)90778-4; FERRARA S, 1978, PHYS LETT B, V74, P333, DOI 10.1016/0370-2693(78)90670-6; Izawa KI, 1996, PROG THEOR PHYS, V95, P829, DOI 10.1143/PTP.95.829; ORAIFEARTAIGH L, 1975, NUCL PHYS B, V96, P331, DOI 10.1016/0550-3213(75)90585-4; STELLE KS, 1978, PHYS LETT B, V74, P330, DOI 10.1016/0370-2693(78)90669-X; Battye R, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.123512; AFFLECK I, 1984, NUCL PHYS B, V241, P493, DOI 10.1016/0550-3213(84)90058-0; Intriligator K, 1996, NUCL PHYS B, V473, P121, DOI 10.1016/0550-3213(96)00261-1; COUGHLAN GD, 1983, PHYS LETT B, V131, P59, DOI 10.1016/0370-2693(83)91091-2; GIRARDI G, 1984, PHYS LETT B, V147, P81, DOI 10.1016/0370-2693(84)90596-3; Jack I, 2000, PHYS LETT B, V482, P167, DOI 10.1016/S0370-2693(00)00501-3; Banks T, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.084019; Binetruy P., 1996, PHYS LETT B, V388, P241; Buchmuller W., ARXIV14066300HEPPH; Catino F., 2012, J HIGH ENERGY PHYS, V1201, P002; CHACKO Z, 1998, JHEP, V9812, P16; Dienes KR, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.065023; Domcke V., 2014, UNPUB; Dumitrescu T.T., 2010, J HIGH ENERGY PHYS, V1011, P052; FERRARA S, 1975, NUCL PHYS B, VB 87, P207, DOI 10.1016/0550-3213(75)90063-2; FRADKIN ES, 1978, LETT NUOVO CIMENTO, V22, P651, DOI 10.1007/BF02783437; Ibe M, 2008, PHYS LETT B, V668, P28, DOI 10.1016/j.physletb.2008.07.003; Ibe M., 2011, J HIGH ENERGY PHYS, V1104, P077; Izawa K, 1997, PHYS REV D, V56, P2886, DOI 10.1103/PhysRevD.56.2886; Kawamura Y, 2011, PROG THEOR PHYS, V125, P509, DOI 10.1143/PTP.125.509; Komargodski Z., 2010, J HIGH ENERGY PHYS, V1007, P017; Komargodski Z., 2009, JHEP, V0906, P007; Kugo T, 2010, PROG THEOR PHYS, V124, P555; Matos L.F., ARXIV09100451HEPPH; Nakayama Y, 2007, PHYS LETT B, V655, P58, DOI 10.1016/j.physletb.2007.08.064; Nakayama Y, 2008, PHYS LETT B, V663, P281, DOI 10.1016/j.physletb.2008.03.074; Schmitz K., ARXIV13073887HEPPH; Schmitz K., WORK UNPUB; Seiberg N., 2010, JHEP, V1007, P070; Shih D., 2008, JHEP, V0802, P091; SIEGEL W, 1986, CLASSICAL QUANT GRAV, V3, pL47, DOI 10.1088/0264-9381/3/2/008; Wess J., 1992, SUPERSYMMETRY SUPERG; Wieck C., ARXIV14082826HEPTH	55	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	FEB	2015	891						230	258		10.1016/j.nuclphysb.2014.12.007		29	Physics, Particles & Fields	Physics	CB3AG	WOS:000349499400008		
J	Nosaka, M; Katayama, N; Kishida, O				Nosaka, Megumi; Katayama, Noboru; Kishida, Osamu			Feedback between size balance and consumption strongly affects the consequences of hatching phenology in size-dependent predator-prey interactions	OIKOS			English	Article							PHENOTYPIC PLASTICITY; SPECIES INTERACTIONS; INDUCIBLE DEFENSES; CLIMATE-CHANGE; LIFE-HISTORY; TROPHIC INTERACTIONS; PERCA-FLUVIATILIS; LARGEMOUTH BASS; ONTOGENIC NICHE; SHIFTS	In many size-dependent predator-prey systems, hatching phenology strongly affects predator-prey interaction outcomes. Early-hatched predators can easily consume prey when they first interact because they encounter smaller prey. However, this process by itself may be insufficient to explain all predator-prey interaction outcomes over the whole interaction period because the predator-prey size balance changes dynamically throughout their ontogeny. We hypothesized that hatching phenology influences predator-prey interactions via a feedback mechanism between the predator-prey size balance and prey consumption by predators. We experimentally tested this hypothesis in an amphibian predator-prey model system. Frog tadpoles Rana pirica were exposed to a predatory salamander larva Hynobius retardatus that had hatched 5, 12, 19 or 26 days after the frog tadpoles hatched. We investigated how the salamander hatch timing affected the dynamics of prey mortality, size changes of both predator and prey, and their subsequent life history (larval period and size at metamorphosis). The predator-prey size balance favoured earlier hatched salamanders, which just after hatching could successfully consume more frog tadpoles than later hatched salamanders. The early-hatched salamanders grew rapidly and their accelerated growth enabled them to maintain the predator-superior size balance; thus, they continued to exert strong predation pressure on the frog tadpoles in the subsequent period. Furthermore, frog tadpoles exposed to the early-hatched salamanders were larger at metamorphosis and had a longer larval period than other frog tadpoles. These results suggest that feedback between the predator-superior size balance and prey consumption is a critical mechanism that strongly affects the impacts of early hatching of predators in the short-term population dynamics and life history of the prey. Because consumption of large nutrient-rich prey items supports the growth of predators, a similar feedback mechanism may be common and have strong impacts on phenological shifts in size-dependent trophic relationships.	[Nosaka, Megumi] Hokkaido Univ, Grad Sch Environm Sci, JP-0982943 Horonobe, Hokkaido, Japan; [Katayama, Noboru; Kishida, Osamu] Hokkaido Univ, Field Ctr Northern Biosphere, Teshio Expt Forest, JP-0982943 Horonobe, Hokkaido, Japan	Nosaka, M (reprint author), Hokkaido Univ, Grad Sch Environm Sci, JP-0982943 Horonobe, Hokkaido, Japan.	bulgy_tadpoles@hotmail.com			JSPS KAKENHI [24370004]	We are very grateful to Kunio Takatsu, Aya Yamaguchi, Tomoko Sato and Natsuko Sakai and all of the staff members of Teshio Experimental Forest of Hokkaido University for their considerable support during our experiments. We thank David Chalcraft for valuable comments on the early version of the manuscript. This work was supported by JSPS KAKENHI Grant no. 24370004.	SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; DEANGELIS DL, 1980, ECOL MODEL, V8, P133, DOI 10.1016/0304-3800(80)90033-2; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Rasmussen NL, 2014, J ANIM ECOL, V83, P1206, DOI 10.1111/1365-2656.12203; Kishida O, 2011, J ANIM ECOL, V80, P1278, DOI 10.1111/j.1365-2656.2011.01871.x; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Urban MC, 2007, OECOLOGIA, V154, P571, DOI 10.1007/s00442-007-0856-2; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Rudolf VHW, 2012, J ANIM ECOL, V81, P524, DOI 10.1111/j.1365-2656.2011.01935.x; Vonesh JR, 2005, OECOLOGIA, V143, P280, DOI 10.1007/s00442-004-1806-x; FONDS M, 1992, NETH J SEA RES, V29, P127, DOI 10.1016/0077-7579(92)90014-6; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Kishida O, 2004, OECOLOGIA, V140, P414, DOI 10.1007/s00442-004-1609-0; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; ALFORD RA, 1985, ECOLOGY, V66, P1097, DOI 10.2307/1939161; Kopp M, 2003, ECOL LETT, V6, P742, DOI 10.1046/j.1461-0248.2003.00485.x; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Altwegg R, 2003, EVOLUTION, V57, P872; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Boone MD, 2002, COPEIA, P511, DOI 10.1643/0045-8511(2002)002[0511:EOHTFL]2.0.CO;2; Kishida O, 2010, POPUL ECOL, V52, P37, DOI 10.1007/s10144-009-0182-0; Relyea RA, 2002, ECOL MONOGR, V72, P77, DOI 10.1890/0012-9615(2002)072[0077:LPDIPP]2.0.CO;2; Banerji A., 2013, OIKOS, V123, P567; Borcherding J, 2010, J ANIM ECOL, V79, P1101, DOI 10.1111/j.1365-2656.2010.01704.x; Borcherding J, 2000, ECOL FRESHW FISH, V9, P236, DOI 10.1111/j.1600-0633.2000.eff090406.x; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Eitam A, 2005, OECOLOGIA, V146, P36, DOI 10.1007/s00442-005-0185-2; KEAST A, 1985, ENVIRON BIOL FISH, V12, P119, DOI 10.1007/BF00002764; Kishida O, 2014, J ANIM ECOL, V83, P899, DOI 10.1111/1365-2656.12186; Kishida O, 2009, ECOLOGY, V90, P1217, DOI 10.1890/08-0238.1; Kishida O, 2009, ECOLOGY, V90, P3150, DOI 10.1890/08-2158.1; Kishida O, 2006, J ANIM ECOL, V75, P705, DOI 10.1111/j.1365-2656.01091.x; Michimae H, 2002, EVOLUTION, V56, P2029; Mougi A, 2011, EVOLUTION, V65, P1079, DOI 10.1111/j.1558-5646.2010.01187.x; Nakazawa T, 2012, OIKOS, V121, P489, DOI 10.1111/j.1600-0706.2011.20171.x; Philippart CJM, 2003, LIMNOL OCEANOGR, V48, P2171; SREDL MJ, 1991, ECOLOGY, V72, P2232, DOI 10.2307/1941573; Takatsu K, 2013, EVOL ECOL, V27, P1, DOI 10.1007/s10682-012-9572-4; Urbatzka R, 2008, ECOL FRESHW FISH, V17, P475, DOI 10.1111/j.1600-0633.2008.00300.x; VanDongen S, 1997, J ANIM ECOL, V66, P113	46	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0030-1299	1600-0706		OIKOS	Oikos	FEB	2015	124	2					225	234		10.1111/oik.01662		10	Ecology	Environmental Sciences & Ecology	CB4YL	WOS:000349634400012		
J	Shibuya, T; Mori, K; Sumino, Y; Sato, F; Mimata, H				Shibuya, Tadamasa; Mori, Kenichi; Sumino, Yasuhiro; Sato, Fuminori; Mimata, Hiromitsu			Rapidly progressive primitive neuroectodermal tumor of the prostate: A case report and review of the literature	ONCOLOGY LETTERS			English	Article						primitive neuroectodermal tumor; prostate; rapid progression	COOPERATIVE EWINGS-SARCOMA; FAMILY; BONE	The present study reports a rare case of primitive neuroectodermal tumor (PNET) of the prostate. A 23-year-old male presented to Oita Medical Center (Oita, Japan) with the complaint of dysuria and anal pain. A large mass in the prostate and a number of swollen lymph nodes in the pelvic region were identified by a computed tomography scan and magnetic resonance imaging. The patient was, thus, admitted to Oita University Hospital (Yufu, Japan), where a biopsy of the prostate gland was performed. Histological analysis revealed small round cells that were positive for MIC-2 expression and fluorescent in situ hybridization analysis detected a translocation involving Ewing sarcoma breakpoint region 1 at chromosome 22q12. Thus, a diagnosis of PNET of the prostate was established. Systemic chemotherapy was the selected treatment, however, a poor response was obtained. The patient succumbed approximately four months after the initial onset of symptoms. PNET of the prostate has been reported in eight cases worldwide; in comparison, the present case exhibited the most unsatisfactory outcome.	[Shibuya, Tadamasa; Mori, Kenichi; Sumino, Yasuhiro; Sato, Fuminori; Mimata, Hiromitsu] Oita Univ, Fac Med, Dept Urol, Yufu, Oita 8795593, Japan	Shibuya, T (reprint author), Oita Univ, Fac Med, Dept Urol, 1-1 Idaigaoka,Hasama Machi, Yufu, Oita 8795593, Japan.	tadamasa@med.oita-u.ac.jp					Cotterill SJ, 2000, J CLIN ONCOL, V18, P3108; Funahashi Y, 2009, INT J UROL, V16, P769, DOI 10.1111/j.1442-2042.2009.02339.x; Al Haddabi I, 2012, INDIAN J PATHOL MICR, V55, P569, DOI 10.4103/0377-4929.107826; Paulussen M, 2001, J CLIN ONCOL, V19, P1818; de Alava E, 2000, J CLIN ONCOL, V18, P204; Subbiah V, 2009, CURR TREAT OPTION ON, V10, P126, DOI 10.1007/s11864-009-0104-6; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Scotlandi K, 2000, J ORTHOPAED RES, V18, P959, DOI 10.1002/jor.1100180616; Peyromaure M, 2003, J UROLOGY, V170, P182, DOI 10.1097/01.ju.0000065880.06201.5e; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Wu T, 2013, CUAJ-CAN UROL ASSOC, V7, pE458, DOI 10.5489/cuaj.1393; Kumar V, 2008, INDIAN J PATHOL MICR, V51, P386; Ellinger J, 2006, UROLOGY, V68, P257, DOI 10.1016/j.urology.2006.02.037; Colecchia Maurizio, 2003, Arch Pathol Lab Med, V127, pe190; Gupta P, 2013, SINGAP MED J, V54, P463; Ibarburen C, 1996, EUR J RADIOL, V21, P225, DOI 10.1016/0720-048X(95)00731-5; Khong PL, 2002, CLIN RADIOL, V57, P272, DOI 10.1053/crad.2001.0807; Mohsin Rehan, 2011, Urol Ann, V3, P103, DOI 10.4103/0974-7796.82180; Qian Xu, 2013, Eur J Radiol, V82, pe888, DOI 10.1016/j.ejrad.2013.08.049; Seddon Beatrice M, 2008, Paediatr Drugs, V10, P93, DOI 10.2165/00148581-200810020-00004; Thete N, 2007, Br J Radiol, V80, pe180, DOI 10.1259/bjr/57293350; Tsang YP, 2014, HONG KONG MED J, V20, P444, DOI 10.12809/hkmj134127	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	FEB	2015	9	2					634	636		10.3892/ol.2014.2731		3	Oncology	Oncology	CB3CR	WOS:000349506300021		
J	Imai, H; Kiyohara, Y; Yoshikawa, S; Kusutani, N; Ono, A; Taira, T; Kenmotsu, H; Harada, H; Naito, T; Murakami, H; Sano, T; Fuji, H; Endo, M; Nakajima, T; Takahashi, T				Imai, Hisao; Kiyohara, Yoshio; Yoshikawa, Shusuke; Kusutani, Nao; Ono, Akira; Taira, Tetsuhiko; Kenmotsu, Hirotsugu; Harada, Hideyuki; Naito, Tateaki; Murakami, Haruyasu; Sano, Takehisa; Fuji, Hiroshi; Endo, Masahiro; Nakajima, Takashi; Takahashi, Toshiaki			Primary malignant melanoma of the trachea: A case report	ONCOLOGY LETTERS			English	Article						malignant melanoma; trachea; argon plasma coagulation	METASTATIC MELANOMA; TUMORS	Primary cancer of the trachea is rare and accounts for only 0.1-0.4% of all newly diagnosed respiratory tract cancers, worldwide. In the present study, a case of primary tracheal malignant melanoma, a particularly rare type of cancer, is reported. A 68-year-old male presented with a cough and bloody sputum. A chest computed tomography scan revealed a 25x20x15-mm tracheal tumor, located immediately above the carina, which reduced the cross-sectional area of the trachea by similar to 90%. Histopathological analysis of biopsy specimens determined a diagnosis of malignant melanoma. The patient was treated with argon plasma coagulation and chemoradiotherapy, which restored airway patency, however, metastasis was detected in the lungs. The patient refused further treatment and received palliative care. Subsequently, the patient succumbed to the disease within four months. Thus, although primary malignant melanoma of the trachea is extremeley rare, the possibility should be considered during diagnosis.	[Imai, Hisao; Ono, Akira; Taira, Tetsuhiko; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Kiyohara, Yoshio; Yoshikawa, Shusuke; Kusutani, Nao] Shizuoka Canc Ctr, Div Dermatol, Nagaizumi, Shizuoka 4118777, Japan; [Harada, Hideyuki] Shizuoka Canc Ctr, Div Radiat Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Sano, Takehisa] Shizuoka City Hosp, Dept Resp Med, Aoi Ku, Shizuoka 4208630, Japan; [Fuji, Hiroshi] Shizuoka Canc Ctr, Div Proton Therapy, Nagaizumi, Shizuoka 4118777, Japan; [Endo, Masahiro] Shizuoka Canc Ctr, Div Diagnost Radiol, Nagaizumi, Shizuoka 4118777, Japan; [Nakajima, Takashi] Shizuoka Canc Ctr, Div Diagnost Pathol, Nagaizumi, Shizuoka 4118777, Japan	Imai, H (reprint author), Shizuoka Canc Ctr, Div Thorac Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	m06701014@gunma-u.ac.jp					Capaccio P, 2002, AM J OTOLARYNG, V23, P253, DOI 10.1053/ajot.2002.123455; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Ascierto PA, 2013, J CLIN ONCOL, V31, P3205, DOI 10.1200/JCO.2013.49.8691; Urdaneta AI, 2011, AM J CLIN ONCOL-CANC, V34, P32, DOI 10.1097/COC.0b013e3181cae8ab; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Cekin Engin, 2010, Ear Nose Throat J, V89, pE18; Colby TV, 1995, ATLAS TUMOR PATHOL, P483; Duarte IG, 1998, ANN THORAC SURG, V65, P559, DOI 10.1016/S0003-4975(97)01364-7; JENNINGS TA, 1990, AM J CLIN PATHOL, V94, P649; JENSEN OA, 1967, SCAND J RESPIR DIS, V48, P127; KOH HK, 1991, NEW ENGL J MED, V325, P171, DOI 10.1056/NEJM199107183250306; Lentsch EJ, 2001, LARYNGOSCOPE, V111, P1209, DOI 10.1097/00005537-200107000-00014; LI W, 1990, CANCER, V66, P894, DOI 10.1002/1097-0142(19900901)66:5<894::AID-CNCR2820660514>3.0.CO;2-W; Maziak DE, 1996, J THORAC CARDIOV SUR, V112, P1522, DOI 10.1016/S0022-5223(96)70011-9; Nattout Mohamad, 2010, Middle East Journal of Anesthesiology, V20, P607; Nureki S, 2012, INTERNAL MED, V51, P1743, DOI 10.2169/internalmedicine.51.7552; ROSTOM AY, 1978, THORAX, V33, P387, DOI 10.1136/thx.33.3.387; Terra RM, 2008, ANN THORAC SURG, V86, P308, DOI 10.1016/j.athoracsur.2008.01.056; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	FEB	2015	9	2					657	660		10.3892/ol.2014.2782		4	Oncology	Oncology	CB3CR	WOS:000349506300026		
J	Sasaki, H; Maekawa, M; Tatematsu, T; Okuda, K; Moriyama, S; Yano, M; Fujii, Y				Sasaki, Hidefumi; Maekawa, Masahiko; Tatematsu, Tsutomu; Okuda, Katsuhiro; Moriyama, Satoru; Yano, Motoki; Fujii, Yoshitaka			Increased BRAF copy number in lung adenocarcinoma	ONCOLOGY LETTERS			English	Article						BRAF; lung cancer; adnocarcinoma; copy number; V600E	IMPROVED SURVIVAL; V600E MUTATION; MEK INHIBITION; SOLID TUMORS; CANCER; MELANOMA; HYBRIDIZATION; VEMURAFENIB; DABRAFENIB; FEATURES	Point mutation of the BRAF gene is a genetic event that occurs in a subset of lung adenocarcinoma cases. For example, BRAF V600E is a driver mutation that can be effectively targeted using selective BRAF and/or MEK inhibitors. The present study hypothesized that an increase in BRAF copy number may be correlated with certain clinicopathological features of lung adenocarcinoma in Japanese patients. The BRAF gene copy number was analyzed using quantitative polymerase chain reaction amplifications in 29 surgically treated lung adenocarcinoma cases without EGFR or Kras mutations from Nagoya City University Hospital (Nagoya, Japan). Seven BRAF-mutant cases were included. Increased BRAF gene copy number was identified in three lung adenocarcinoma patients (10.3%), all of which exhibited the V600E mutation. Using fluorescence in situ hybridization with BRAF-specific and chromosome 7 centromeric probes, increased copy number status was associated with gene amplification or gain of chromosome 7. Although increased BRAF copy number was correlated with BRAF V600E mutations, numerical changes in BRAF copy number were rare and mild in lung adenocarcinoma, resulting in no significant difference in pathological tumor status or tumor stage.	[Sasaki, Hidefumi; Tatematsu, Tsutomu; Okuda, Katsuhiro; Moriyama, Satoru; Yano, Motoki; Fujii, Yoshitaka] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi 4678601, Japan; [Maekawa, Masahiko] GSP Lab Inc, Kawasaki, Kanagawa 2120032, Japan	Sasaki, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Mizuho Ku, 1 Aza Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hisasaki@hotmail.com			Japan Society for the Promotion of Science [23659674, 24592097, 25293303]	The authors would like to thank Miss Ito Yamamoto for her technical assistance. The present study was supported by Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (grant nos. 23659674, 24592097 and 25293303).	Achcar RDD, 2009, AM J CLIN PATHOL, V131, P694, DOI 10.1309/AJCPBS85VJEOBPDO; Amano J, 2013, GEN THORAC CARDIOVAS, V61, P578; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Sasaki H, 2007, ONCOL REP, V18, P623; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Cardarella S, 2013, CLIN CANCER RES, V19, P4532, DOI 10.1158/1078-0432.CCR-13-0657; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Sasaki H, 2013, LUNG CANCER, V82, P51, DOI 10.1016/j.lungcan.2013.06.014; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Balsara BR, 1997, CANCER RES, V57, P2116; Ciampi R, 2005, ENDOCR PATHOL, V16, P99, DOI 10.1385/EP:16:2:099; El-Naggar AK, 1999, CYTOMETRY, V37, P107, DOI 10.1002/(SICI)1097-0320(19991001)37:2<107::AID-CYTO3>3.0.CO;2-O; Endo K, 2006, ONCOL REP, V16, P533; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Gautschi O, 2012, J THORAC ONCOL, V7, pE23, DOI 10.1097/JTO.0b013e3182629903; Ginsberg RJ, 1993, PRINCIPLES PRACTICE, P673; Postmus PE, 1998, CHEST S, V113, p31S, DOI 10.1378/chest.113.1_Supplement.28S9438687; Rudin CM, 2013, J THORAC ONCOL, V8, pE41, DOI 10.1097/JTO.0b013e31828bb1b3; Sasaki H, 2012, EXP THER MED, V3, P771, DOI 10.3892/etm.2012.500; Ubagai T, 2001, ONCOL REP, V8, P83; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	FEB	2015	9	2					709	712		10.3892/ol.2014.2719		4	Oncology	Oncology	CB3CR	WOS:000349506300036		
J	Ohnishi, Y; Watanabe, M; Fujii, T; Yasui, H; Kubo, H; Kakudo, K				Ohnishi, Yuichi; Watanabe, Masahiro; Fujii, Tomoko; Yasui, Hiroki; Kubo, Hirohito; Kakudo, Kenji			Infiltrating angiolipoma of the lower lip: A case report and literature review	ONCOLOGY LETTERS			English	Article						angiolipoma; lip; vascular endothelial growth factor	OF-THE-LITERATURE; INTRAMUSCULAR LIPOMAS	Infiltrating angiolipoma (JAL) is a rare lesion and is a clinicopathological variant of angiolipoma. IAL occurs most commonly in the trunk and extremities, it is rarely found in the head and neck regions and extremely rare in the oral cavity. This study presents the case of a 74-year-old female with IAL of the lower lip. To the best of our knowledge, this is the first case of IAL arising in the lower lip to be reported. Microscopically, IAL was unencapsulated and mature lipocytes were separated by a branching network of proliferating small vessels that infiltrated the adjacent tissues. Therefore, complete excision was difficult to perform. Magnetic resonance imaging has been reported to be valuable in determining the extent of the tumor and asserting a preoperative diagnosis. According to previous studies, the recurrence-rate of IAL following surgical extirpation is 35-50%. Furthermore, the levels of mRNA expression of the vascular endothelial growth factor (VEGF) family members in the tumor were investigated. VEGF-A and -B expression were detected, however, VEGF-C and -D were expressed at extremely low levels. Excisional biopsy was performed under local anesthesia. During four years of follow-up, no evidence of tumor recurrence had been identified. An operating microscope may be utilized for the total removal of an JAL to minimize damage to normal tissues. This report indicates that mast cell-derived VEGF may be responsible for the enhanced vascularity in the tumor. We would therefore consider careful extirpation with no wide safety margin to be the procedure of choice, except When the tumor invades irregularly into the muscles.	[Ohnishi, Yuichi; Watanabe, Masahiro; Fujii, Tomoko; Yasui, Hiroki; Kubo, Hirohito; Kakudo, Kenji] Osaka Dent Univ, Dept Oral & Maxillofacial Surg 2, Chuo Ku, Osaka 5400008, Japan	Ohnishi, Y (reprint author), Osaka Dent Univ, Dept Oral & Maxillofacial Surg 2, Chuo Ku, 1-5-17 Otemae, Osaka 5400008, Japan.	ohnishi@cc.osaka-dent.ac.jp					AUSTIN RM, 1980, ARCH SURG-CHICAGO, V115, P281; CHEW FS, 1980, AM J ROENTGENOL, V135, P781; Dalambiras S, 2010, J ORAL MAXIL SURG, V68, P681, DOI 10.1016/j.joms.2009.04.131; DIONNE GP, 1974, CANCER, V33, P732, DOI 10.1002/1097-0142(197403)33:3<732::AID-CNCR2820330319>3.0.CO;2-3; Enzinger FM, 1988, SOFT TISSUE, P301; Gozalez-Crussi F, 1966, J BONE JOINT SURG, V48, P1111; Hamakawa H, 2000, J ORAL MAXIL SURG, V58, P674, DOI 10.1053/joms.2000.6218; Ida-Yonemochi H, 2005, J ORAL PATHOL MED, V34, P59, DOI 10.1111/j.1600-0714.2004.00230.x; KINDBLOM LG, 1974, CANCER, V33, P754, DOI 10.1002/1097-0142(197403)33:3<754::AID-CNCR2820330322>3.0.CO;2-F; LIN JJ, 1974, CANCER, V34, P720, DOI 10.1002/1097-0142(197409)34:3<720::AID-CNCR2820340331>3.0.CO;2-K; Lin S C, 1989, Ann Dent, V48, P37; MATSUOKA Y, 1988, SURG NEUROL, V29, P62, DOI 10.1016/0090-3019(88)90124-3; Regan JM, 1946, SURG GYNECOL OBSTET, V54, P87; STIMPSON N, 1971, BRIT J SURG, V58, P464, DOI 10.1002/bjs.1800580617; Sugiura J, 1999, J ORAL MAXIL SURG, V57, P446, DOI 10.1016/S0278-2391(99)90287-2; Weiss SW, 2001, ENZINGER WEISSS SOFT, P571	16	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	FEB	2015	9	2					833	836		10.3892/ol.2014.2737		4	Oncology	Oncology	CB3CR	WOS:000349506300064		
J	Yamauchi, T; Tasaki, T; Tai, K; Ikegaya, S; Takagi, K; Negoro, E; Kishi, S; Yoshida, A; Iwasaki, H; Ueda, T				Yamauchi, Takahiro; Tasaki, Toshiki; Tai, Katsunori; Ikegaya, Satoshi; Takagi, Kazutaka; Negoro, Eiju; Kishi, Shinji; Yoshida, Akira; Iwasaki, Hiromichi; Ueda, Takanori			Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis	ONCOLOGY LETTERS			English	Article						diffuse large B-cell lymphoma; relapse; R-CHOP; peripheral blood cell counts	NON-HODGKINS-LYMPHOMA; RITUXIMAB ERA; PREDICTS SURVIVAL; ABSOLUTE MONOCYTE; PLUS RITUXIMAB; REGIMENS; THERAPY; RELAPSE; RATIO; IPI	The primary objective of the present study was to correlate blood cell counts (lymphocyte, monocyte and platelet counts) with early disease relapse following the attainment of complete remission (CR) by the rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP)-like regimen in patients with advanced diffuse large B-cell lymphoma (DLBCL). In total, 30 patients were evaluated, with a median follow-up period of 43 months. All the participating patients attained CR. In total, eight patients experienced relapse within two years of the diagnosis, and the three-year overall survival rate was recorded as 77%. The peripheral counts for lymphocytes, monocytes and platelets, and the lymphocyte-monocyte ratio, all of which have been reported to be prognostic in DLBCL, were assessed. None of these parameters were correlated with the incidence of early relapse or with the prognosis. The lymphocyte count was higher in the patients with durable remission than in those who relapsed, however, no significant differences were identified. Thus, the present study concluded that early disease relapse was not, predicted by peripheral blood cell counts in advanced DLBCL that reached CR using the R-CHOP-like regimen.	[Yamauchi, Takahiro; Tasaki, Toshiki; Tai, Katsunori; Ikegaya, Satoshi; Takagi, Kazutaka; Negoro, Eiju; Kishi, Shinji; Yoshida, Akira; Iwasaki, Hiromichi; Ueda, Takanori] Univ Fukui, Fac Med Sci, Dept Hematol & Oncol, Fukui 9101193, Japan	Yamauchi, T (reprint author), Univ Fukui, Fac Med Sci, Dept Hematol & Oncol, 23 Shimoaizuki, Fukui 9101193, Japan.	tyamauch@u-fukui.ac.jp					Feng JH, 2012, INT J HEMATOL, V95, P143, DOI 10.1007/s12185-011-0993-6; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Song MK, 2010, ANN ONCOL, V21, P140, DOI 10.1093/annonc/mdp505; Iqbal J, 2011, CLIN CANCER RES, V17, P7785, DOI 10.1158/1078-0432.CCR-11-0267; Watanabe R, 2014, EUR J HAEMATOL, V92, P204, DOI 10.1111/ejh.12221; Perry AM, 2012, CANCER CONTROL, V19, P214; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Rambaldi A, 2013, AM J HEMATOL, V88, P1062, DOI 10.1002/ajh.23566; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Sehn LH, 2012, HEMATOL-AM SOC HEMAT, P402, DOI 10.1182/asheducation-2012.1.402; Kim DH, 2007, LEUKEMIA, V21, P2227, DOI 10.1038/sj.leu.2404780; Wilcox RA, 2011, LEUKEMIA, V25, P1502, DOI 10.1038/leu.2011.112; Porrata LF, 2009, AM J HEMATOL, V84, P93, DOI 10.1002/ajh.21337; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Bari A, 2010, ANN ONCOL, V21, P1486, DOI 10.1093/annonc/mdp531; Chen LP, 2012, CL LYMPH MYELOM LEUK, V12, P32, DOI 10.1016/j.clml.2011.09.215; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Li ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041658; Porrata LF, 2010, LEUKEMIA, V24, P1343, DOI 10.1038/leu.2010.108; Tadmor T, 2014, HAEMATOLOGICA, V99, P125, DOI 10.3324/haematol.2013.088161	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	FEB	2015	9	2					851	856		10.3892/ol.2014.2716		6	Oncology	Oncology	CB3CR	WOS:000349506300067		
J	Isa, SI; Kurahara, Y; Yamamoto, S; Tamiya, A; Omachi, N; Asami, K; Okishio, K; Utsumi, T; Ito, N; Yoon, HE; Matsumura, A; Atagi, S; Kawaguchi, T				Isa, Shun-Ichi; Kurahara, Yu; Yamamoto, Satomi; Tamiya, Akihiro; Omachi, Naoki; Asami, Kazuhiro; Okishio, Kyoichi; Utsumi, Tomoki; Ito, Norimasa; Yoon, Hyung-Eun; Matsumura, Akihide; Atagi, Shinji; Kawaguchi, Tomoya			Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer	ONCOLOGY LETTERS			English	Article						lung cancer; human papillomavirus; never-smokers; prospective registry	HPV; VIRUS; RISK	The causes of lung cancer in never-smokers remain unclear. The potential contribution of human papillomavirus (HPV) to the carcinogenesis of non-small cell lung cancer (NSCLC) has been reported. In 2008, a prospective registry of never-smokers with NSCLC was established at the Kinki-Chuo Chest Medical Center, Sakai, Osaka, Japan. Never-smokers with NSCLC were consecutively enrolled onto the registry. Of these patients, 114 with large tumor specimens, the majority of which were surgical tissues, were selected. In total, 23 of the most clinically relevant HPV types were assayed using polymerase chain reaction amplification of the viral genome. Following exclusion of samples with suboptimal quality, DNA was extracted from 96 formalin-fixed paraffin-embedded samples. These 96 cases consisted of 82 females (85.4%) and 14 males (14.6%), with a median age of 67 years (range, 29-83). Almost all cases (93.8%) were of the adenocarcinoma histological subtype. Despite confirmation of the quality and amount of DNA, HPV type 6 was detected in only one case (1.1%). Furthermore, no other samples examined were positive for any other HPV types. The results therefore suggest that HPV does not play a major role as the driving oncogenic event in never-smokers with NSCLC.	[Isa, Shun-Ichi; Okishio, Kyoichi; Atagi, Shinji] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan; [Kurahara, Yu; Yamamoto, Satomi; Tamiya, Akihiro; Omachi, Naoki; Asami, Kazuhiro; Kawaguchi, Tomoya] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Div Internal Med, Sakai, Osaka, Japan; [Utsumi, Tomoki; Ito, Norimasa; Yoon, Hyung-Eun; Matsumura, Akihide] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Div Chest Surg, Sakai, Osaka, Japan; [Kawaguchi, Tomoya] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka 5458585, Japan	Kawaguchi, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Resp Med, Abeno Ku, 1-4-3 Asahi Cho, Osaka 5458585, Japan.	kawaguchi.tomoya@med.osaka-cu.ac.jp			Osaka Medical Research Foundation for Intractable Disease	The authors would like to thank Dr Yoshikazu Hasegawa of Izumi City Hospital for the critical review and Ms. Risa Sakaguchi for providing secretarial assistance. This study was supported in part by a Grant-in-Aid for Cancer Research from the Osaka Medical Research Foundation for Intractable Disease.	Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Koshiol J, 2011, J NATL CANCER I, V103, P501, DOI 10.1093/jnci/djr003; van Boerdonk RAA, 2013, J THORAC ONCOL, V8, P711, DOI 10.1097/JTO.0b013e3182897c14; Schiffman M, 2013, NEW ENGL J MED, V369, P2324, DOI 10.1056/NEJMcp1210379; Subramanian J, 2008, LANCET ONCOL, V9, P676, DOI 10.1016/S1470-2045(08)70174-8; Raso MG, 2009, CLIN CANCER RES, V15, P5359, DOI 10.1158/1078-0432.CCR-09-0033; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Carpagnano GE, 2011, BRIT J CANCER, V105, P1183, DOI 10.1038/bjc.2011.354; Ermel A, 2010, J VIROL METHODS, V169, P154, DOI 10.1016/j.jviromet.2010.07.016; Hasegawa Y, 2014, LUNG CANCER, V83, P8, DOI 10.1016/j.lungcan.2013.10.002; Kawaguchi T, 2011, CLIN CANCER RES, V17, P39, DOI 10.1158/1078-0432.CCR-10-1773; Kawaguchi T, 2013, CLIN LUNG CANCER, V14, P596, DOI 10.1016/j.cllc.2013.03.001; Mammas IN, 2011, PATHOL ONCOL RES, V17, P103, DOI 10.1007/s12253-010-9288-0	17	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	FEB	2015	9	2					927	929		10.3892/ol.2014.2713		3	Oncology	Oncology	CB3CR	WOS:000349506300081		
J	Bird, DM; Jones, JT; Opperman, CH; Kikuchi, T; Danchin, EGJ				Bird, David McK.; Jones, John T.; Opperman, Charles H.; Kikuchi, Taisei; Danchin, Etienne G. J.			Signatures of adaptation to plant parasitism in nematode genomes	PARASITOLOGY			English	Article						nematodes; genomes; plant parasitism; adaptation; convergence	HORIZONTAL GENE-TRANSFER; ROOT-KNOT NEMATODES; MELOIDOGYNE-INCOGNITA; GLOBODERA-ROSTOCHIENSIS; DRAFT GENOME; BURSAPHELENCHUS-XYLOPHILUS; FUNCTIONAL CLASSIFICATION; HETERODERA-GLYCINES; LESION NEMATODE; LOTUS-JAPONICUS	Plant-parasitic nematodes cause considerable damage to global agriculture. The ability to parasitize plants is a derived character that appears to have independently emerged several times in the phylum Nematoda. Morphological convergence to feeding style has been observed, but whether this is emergent from molecular convergence is less obvious. To address this, we assess whether genomic signatures can be associated with plant parasitism by nematodes. In this review, we report genomic features and characteristics that appear to be common in plant-parasitic nematodes while absent or rare in animal parasites, predators or free-living species. Candidate horizontal acquisitions of parasitism genes have systematically been found in all plant-parasitic species investigated at the sequence level. Presence of peptides that mimic plant hormones also appears to be a trait of plant-parasitic species. Annotations of the few genomes of plant-parasitic nematodes available to date have revealed a set of apparently species-specific genes on every occasion. Effector genes, important for parasitism are frequently found among those species-specific genes, indicating poor overlap. Overall, nematodes appear to have developed convergent genomic solutions to adapt to plant parasitism.	[Bird, David McK.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Bird, David McK.; Opperman, Charles H.] N Carolina State Univ, Dept Plant Pathol, Plant Nematode Genet Grp, Raleigh, NC 27695 USA; [Jones, John T.] James Hutton Inst, Dundee DD2 5DA, Scotland; [Kikuchi, Taisei] Miyazaki Univ, Div Parasitol, Fac Med, Miyazaki 8891692, Japan; [Kikuchi, Taisei] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Danchin, Etienne G. J.] INRA, UMR 1355, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Danchin, Etienne G. J.] Univ Nice Sophia Antipolis, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Danchin, Etienne G. J.] CNRS, UMR 7254, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France	Danchin, EGJ (reprint author), INRA, 400 Route Chappes,BP167, F-06903 Sophia Antipolis, France.	etienne.danchin@gmail.com	Danchin, Etienne/A-6648-2008	Danchin, Etienne/0000-0003-4146-5608	Scottish Government; JSPS KAKENHI [20353659, 23248024]	Each author is, or was, at the time of the work, a paid employee of their affiliated organization. The James Hutton Institute receives funding from the Scottish Government. TK is funded by JSPS KAKENHI Grant Numbers 20353659 and 23248024.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Judelson HS, 2012, EUKARYOT CELL, V11, P1304, DOI 10.1128/EC.00155-12; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; Wang JY, 2010, NEW PHYTOL, V187, P1003, DOI 10.1111/j.1469-8137.2010.03300.x; Haegeman A, 2013, MOL PLANT PATHOL, V14, P379, DOI 10.1111/mpp.12014; Postma WJ, 2012, PLANT PHYSIOL, V160, P944, DOI 10.1104/pp.112.200188; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Poinar G, 2008, NEMATOLOGY, V10, P9, DOI 10.1163/156854108783360159; Weerasinghe RR, 2005, P NATL ACAD SCI USA, V102, P3147, DOI 10.1073/pnas.0407926102; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; McCarter JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r26; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Mitchum MG, 2008, CURR OPIN PLANT BIOL, V11, P75, DOI 10.1016/j.pbi.2007.10.010; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Bobay BG, 2013, FEBS LETT, V587, P3979, DOI 10.1016/j.febslet.2013.10.033; Lambshead PJD, 2003, J BIOGEOGR, V30, P475; Leroy S, 2003, MOL BIOCHEM PARASIT, V128, P91, DOI 10.1016/S0166-6851(03)00023-9; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Schonknecht G, 2014, BIOESSAYS, V36, P9, DOI 10.1002/bies.201300095; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Lee C, 2011, PLANT PHYSIOL, V155, P866, DOI 10.1104/pp.110.167197; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Ohyama K, 2008, PLANT J, V55, P152, DOI 10.1111/j.1365-313X.2008.03464.x; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Bird DM, 1996, J PARASITOL, V82, P881, DOI 10.2307/3284193; Wang XH, 2005, MOL PLANT PATHOL, V6, P187, DOI [10.1111/j.1364-3703.2005.00270.x, 10.1111/J.1364-3703.2005.00270.X]; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Sikora S, 2005, TRENDS MICROBIOL, V13, P522, DOI 10.1016/j.tim.2005.08.010; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Chronis D, 2013, PLANT J, V74, P185, DOI 10.1111/tpj.12125; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Lu SW, 2009, MOL PLANT MICROBE IN, V22, P1128, DOI 10.1094/MPMI-22-9-1128; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Kumar S, 2012, NUCLEIC ACIDS RES, V40, pD1295, DOI 10.1093/nar/gkr826; Desjardins CA, 2013, NAT GENET, V45, P495, DOI 10.1038/ng.2585; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Baldwin JG, 2004, ANNU REV PHYTOPATHOL, V42, P83, DOI 10.1146/annurev.phyto.42.012204.130804; Jones JT, 2005, NEMATOLOGY, V7, P641, DOI 10.1163/156854105775142919; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI [10.1111/j.1364-3703.2007.00461.x, 10.1111/J.1364-3703.2007.00461.X]; Bird DM, 2004, CURR OPIN PLANT BIOL, V7, P372, DOI 10.1016/j.pbi.2004.05.005; Blaxter M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001050; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blok VC, 2008, BIOESSAYS, V30, P249, DOI 10.1002/bies.20717; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castagnone-Sereno P, 2013, ANNU REV PHYTOPATHOL, V51, P203, DOI 10.1146/annurev-phyto-082712-102300; Danchin E. G., 2011, MOB GENET ELEMENTS, V1, P269, DOI DOI 10.4161/MGE.18776); Danchin EGJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00027; De Ley Paul, 2006, WormBook, P1; Doyle EA, 2002, MOL PLANT MICROBE IN, V15, P549, DOI 10.1094/MPMI.2002.15.6.549; Ejima Chika, 2011, Nematological Research, V41, P35; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T., 2013, NEMATOLOGY IN PRESS; Laing R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r88; LAMBSHEAD PJD, 1993, OCEANIS S D, V19, P5; Ledger TN, 2006, GENE, V382, P121, DOI 10.1016/j.gene.2006.06.023; Lohar DP, 2003, PLANT CELL PHYSIOL, V44, P1176, DOI 10.1093/pcp/pcg146; Martin J., 2011, NUCLEIC ACIDS RES, V40, pD720, DOI [10.1093/nar/gkr1194.22139919, DOI 10.1093/NAR/GKR1194]; McCarter J. P., 2009, V15, P239, DOI 10.1007/7089_2008_32; Mitreva-Dautova M, 2006, MOL PLANT MICROBE IN, V19, P521, DOI 10.1094/MPMI-19-0521; Ni J, 2011, PLANT MOL BIOL, V75, P67, DOI 10.1007/s11103-010-9708-2; Olsen AN, 2003, TRENDS PLANT SCI, V8, P55, DOI 10.1016/S1360-1385(03)00003-7; Paganini J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050875; Parkinson J, 2004, NUCLEIC ACIDS RES, V32, pD427, DOI 10.1093/nar/gkh018; Poinar G. O., 2011, EVOLUTIONARY HIST NE; Popeijus H, 2000, NATURE, V406, P36, DOI 10.1038/35017641; Robertson L, 2006, CROP PROT, V25, P440, DOI 10.1016/j.cropro.2005.07.008; Rosso MN, 1999, MOL PLANT MICROBE IN, V12, P585, DOI 10.1094/MPMI.1999.12.7.585; Rybarczyk-Mydlowska K, 2012, PHYTOPATHOLOGY, V102, P1153, DOI 10.1094/PHYTO-05-12-0114-R; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Sharma VK, 2003, PLANT MOL BIOL, V51, P415, DOI 10.1023/A:1022038932376; Sternberg P. W., 2005, WORMBOOK, DOI [10.1895/wormbook.1.6.1, DOI 10.1895/WORMBOOK.1.6.1.AMBIGUOUS]	87	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0031-1820	1469-8161		PARASITOLOGY	Parasitology	FEB	2015	142			1			S71	S84		10.1017/S0031182013002163		14	Parasitology	Parasitology	CB3TT	WOS:000349552500007		
J	Nakajima, J; Takahashi, H; Suda, K; Suzuki, S; Sato, S; Hayashi, Y; Kawashima, H				Nakajima, Junya; Takahashi, Hidekuni; Suda, Kazuto; Suzuki, Shunske; Sato, Satoshi; Hayashi, Yutaka; Kawashima, Hisashi			A 15-Month-Old Boy With Congenital Duodenal Stenosis Due to Food Impaction	PEDIATRIC EMERGENCY CARE			English	Article						congenital duodenal stenosis; food impaction; endoscopic membranectomy; balloon dilatation; ileus	ANNULAR PANCREAS; DELAYED DIAGNOSIS; OBSTRUCTION	Duodenal stenosis is a type of congenital intestinal atresia syndrome. Most patients are diagnosed during the neonatal period based on recurrent vomiting, but some cases develop symptoms at an older age. We report a case with an unusual pathogenic mechanism: sudden ileus due to food impaction. A 15-month-old boy was admitted to our institution with a history of recurrent vomiting and diarrhea for 7 days and fever for 2 days. Abdominal distention was found upon physical examination but other congenital anomalies were not. He was initially treated for acute gastroenteritis, but vomiting resumed after starting oral ingestion. Congenital membranous duodenal stenosis and impaction of a shimeji mushroom into the narrow section of the duodenum was recognized upon endoscopy. Dilatation was successful and restenosis was not seen. Food impaction is a rare (but important) initial event in congenital duodenal stenosis, and this disorder should be included in the differential diagnosis, especially for infants/toddlers with recurrent vomiting that develops at the time of eating solid and more diverse types of food.	[Nakajima, Junya; Takahashi, Hidekuni; Suzuki, Shunske; Sato, Satoshi; Kawashima, Hisashi] Tokyo Med Univ, Dept Pediat, Tokyo 1600023, Japan; [Suda, Kazuto; Hayashi, Yutaka] Tokyo Med Univ, Dept Surg 3, Tokyo 1600023, Japan	Nakajima, J (reprint author), Tokyo Med Univ, Dept Pediat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	ob1.3po@hotmail.co.jp					Bittencourt DG, 2004, PEDIATR SURG INT, V20, P582, DOI 10.1007/s00383-004-1235-2; Diamond IR, 2006, J LAPAROENDOSC ADV S, V16, P317, DOI 10.1089/lap.2006.16.317; Fujiwara T, 1999, EUR J PEDIATR, V158, P108, DOI 10.1007/s004310051028; Kilbride H, 2010, J PERINATOL, V30, P197, DOI 10.1038/jp.2009.143; Krieg EG, 1937, ANN SURG, V106, P33, DOI 10.1097/00000658-193707000-00004; McCollum MO, 2002, J PEDIATR SURG, V37, P1776, DOI 10.1053/jpsu.2002.36722; OKAMATSU T, 1989, J PEDIATR SURG, V24, P367, DOI 10.1016/S0022-3468(89)80271-4; Okumura KUY, 2011, J JPN SOC PEDIAT SUR, V47, P365; Saka RHT, 2010, J JPN SOC EMERG MED, V9, P349; Savino A, 2007, EUR J PEDIATR, V166, P379, DOI 10.1007/s00431-006-0241-x; SMITH GV, 1980, AM J ROENTGENOL, V134, P937; STANLEY P, 1988, AM J DIS CHILD, V142, P459; Tandler J, 1900, MORPH JAHRBUCH, V29, P187	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	FEB	2015	31	2					132	134		10.1097/PEC.0000000000000354		3	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	CB1ND	WOS:000349393700011		
J	Matsuda, Y; Konno, Y; Hashimoto, T; Nagai, M; Taguchi, T; Satsukawa, M; Yamashita, S				Matsuda, Yoshiki; Konno, Yoshihiro; Hashimoto, Takashi; Nagai, Mika; Taguchi, Takayuki; Satsukawa, Masahiro; Yamashita, Shinji			Quantitative Assessment of Intestinal First-pass Metabolism of Oral Drugs Using Portal-vein Cannulated Rats	PHARMACEUTICAL RESEARCH			English	Article						CYP3A; intestinal metabolism; oral absorption; portal vein-cannulated rats; UGT	IN-VITRO; CYNOMOLGUS MONKEYS; PREDICTION; ABSORPTION; HUMANS; 1-AMINOBENZOTRIAZOLE; FEXOFENADINE; RALOXIFENE; MIDAZOLAM; MODEL	Purpose To evaluate the impact of intestinal first-pass metabolism (Fg) by cytochrome P4503A (CYP3A) and uridine 5'-diphosphate-glucuronosyltransferases (UGT) on in vivo oral absorption of their substrate drugs. Methods CYP3A and UGTsubstrates were orally administered to portal-vein cannulated (PV) rats to evaluate their intestinal availability (Fa.Fg). In the case of CYP3A substrates, vehicle or 1-aminobenzotriazole (ABT), a potent inhibitor of CYP enzymes, was pretreated to assess Fg separately from Fa (Enzyme-inhibition method). On the other hand, since potent inhibitors of UGT have not been identified, Fg of UGTsubstrate was calculated from total amount of metabolites generated in enterocytes (Metabolite-distribution method). Results After oral administration of CYP3A substrates in ABT-pretreated rats, the portal and systemic plasma concentrations of the metabolite were nearly the same, indicating almost complete inhibition of intestinal CYP3A-mediated metabolism. Using Enzyme-inhibition method, Fg of midazolam (1 mg/kg) was calculated as 0.71. Additionally, total amount of raloxifene-6-glucuronide generated in enterocytes after oral administration of raloxifene was estimated using Metabolite-distribution method and Fg of raloxifene (0.98 mu mol/kg) was calculated as 0.21. Conclusions PV rats enabled in vivo quantitative assessment of intestinal first-pass metabolism by CYP3A and UGT. This method is useful for clarifying the cause of low bioavailability.	[Matsuda, Yoshiki; Konno, Yoshihiro; Hashimoto, Takashi; Nagai, Mika; Taguchi, Takayuki; Satsukawa, Masahiro] Kaken Pharmaceut Co Ltd, Pharmacokinet & Safety Res Dept, Cent Res Labs, Yamashina Ku, Kyoto 6078042, Japan; [Yamashita, Shinji] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan	Matsuda, Y (reprint author), Kaken Pharmaceut Co Ltd, Pharmacokinet & Safety Res Dept, Cent Res Labs, Yamashina Ku, 14 Shinomiya Minamigawara Cho, Kyoto 6078042, Japan.	matsuda_yoshiki@kaken.co.jp					Ogasawara A, 2007, DRUG METAB DISPOS, V35, P410, DOI 10.1124/dmd.106.011288; Petri N, 2004, PHARM RES, V21, P1398, DOI 10.1023/B:PHAM.0000036913.90332.b1; Jeong EJ, 2004, J PHARMACOL EXP THER, V310, P376, DOI 10.1124/jpet.103.063925; MICO BA, 1988, BIOCHEM PHARMACOL, V37, P2515, DOI 10.1016/0006-2952(88)90240-7; Furukawa T, 2012, DRUG METAB PHARMACOK, V27, P171, DOI 10.2133/dmpk.DMPK-11-RG-088; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Benet LZ, 2011, AAPS J, V13, P519, DOI 10.1208/s12248-011-9290-9; Yang JS, 2007, CURR DRUG METAB, V8, P676, DOI 10.2174/138920007782109733; HOFFMAN DJ, 1995, PHARMACEUT RES, V12, P889, DOI 10.1023/A:1016221322886; Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866; Paine MF, 1996, CLIN PHARMACOL THER, V60, P14, DOI 10.1016/S0009-9236(96)90162-9; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Kadono K, 2010, DRUG METAB DISPOS, V38, P1230, DOI 10.1124/dmd.109.029322; Mizuma T, 2009, INT J PHARMACEUT, V378, P140, DOI 10.1016/j.ijpharm.2009.05.044; Gertz M, 2010, DRUG METAB DISPOS, V38, P1147, DOI 10.1124/dmd.110.032649; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; Gertz M, 2008, CURR DRUG METAB, V9, P785, DOI 10.2174/138920008786049276; Higashikawa F, 1999, J PHARM PHARMACOL, V51, P67, DOI 10.1211/0022357991771971; Hirunpanich V, 2008, INT J PHARMACEUT, V351, P133, DOI 10.1016/j.ijpharm.2007.09.037; Jeong EJ, 2005, DRUG METAB DISPOS, V33, P785, DOI 10.1124/dmd.104.001883; Kosaka K, 2011, DRUG METAB DISPOS, V39, P1495, DOI 10.1124/dmd.111.040030; Matsuda Y, 2013, DRUG METAB DISPOS, V41, P1514, DOI 10.1124/dmd.113.051680; Matsuda Y, 2012, DRUG METAB DISPOS, V40, P2231, DOI 10.1124/dmd.112.048223; MESCHTER CL, 1994, FUND APPL TOXICOL, V22, P369, DOI 10.1006/faat.1994.1042; Nishimuta H, 2010, DRUG METAB DISPOS, V38, P1967, DOI 10.1124/dmd.110.034561; Nishimuta H, 2011, DRUG METAB PHARMACOK, V26, P592, DOI 10.2133/dmpk.DMPK-11-RG-034; Nozawa T, 2011, DRUG METAB DISPOS, V39, P1263, DOI 10.1124/dmd.110.037937; Ohura K, 2012, J PHARM SCI-US, V101, P3264, DOI 10.1002/jps.23182; Strelevitz TJ, 2006, J PHARM SCI-US, V95, P1334, DOI 10.1002/jps.20538; Sun Q, 2011, DRUG METAB DISPOS, V39, P1674, DOI 10.1124/dmd.111.039834; Takahashi M, 2010, BIOL PHARM BULL, V33, P111; WATKINS PB, 1987, J CLIN INVEST, V80, P1029, DOI 10.1172/JCI113156; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; YAMASHITA S, 1994, PHARMACEUT RES, V11, P1646, DOI 10.1023/A:1018926324682; Zhu MS, 2005, DRUG METAB DISPOS, V33, P500, DOI 10.1124/dmd.104.000836	36	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	FEB	2015	32	2					604	616		10.1007/s11095-014-1489-x		13	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	CB1AB	WOS:000349357700021		
J	Tamura, N; Ishiguro, C; Matsuda, T				Tamura, Norio; Ishiguro, Chieko; Matsuda, Tsutomu			Post-approval appending of CSARs to drug package inserts: an analysis of the types of adverse reactions and time to addition	PHARMACOEPIDEMIOLOGY AND DRUG SAFETY			English	Article						unknown risk; pharmacovigilance; drug safety; adverse event; safety-related regulatory actions; post-approval analysis; pharmacoepidemiology	TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; REGULATORY ACTIONS; JAPAN	PurposeThe aim of this study was to quantitatively analyze clinically significant adverse reactions (CSARs) added to drug package inserts after approval and to investigate the time to these post-approval additions as an indicator of safety-related regulatory actions. MethodsDrugs containing new active ingredients that had been approved in Japan from April 2001 to December 2010 were analyzed. We examined CSARs that had been reported in the first version of the package inserts and subsequent additions through notifications from Japan's Ministry of Health, Labour and Welfare until the end of 2011. Relative risks (RRs) for post-approval addition of CSARs were calculated for various categories of disorders. The median lengths of time to post-approval addition of CSARs were compared. ResultsA total of 238 drugs were examined. Of the 2487 CSARs associated with these drugs, 737 had been added after approval. The analysis revealed a higher likelihood for post-approval addition of CSARs for Hepatobiliary disorders (RR: 1.41; 95% confidence interval [CI]: 1.19-1.68), Gastrointestinal disorders (RR: 1.35; 95%CI: 1.10-1.66), and Musculoskeletal and connective tissue disorders (RR: 1.52; 95%CI: 1.11-2.07). In contrast, Cardiac disorders showed reduced likelihood in comparison with other disorders. For the time until post-approval addition of CSARs, Skin and subcutaneous tissue disorders showed the longest durations, with a median of 3020 days. ConclusionsOur quantitative analysis suggests that some CSARs were added more frequently to package inserts after approval and that time to post-approval additions of CSARs varied with the types of adverse drug reactions. These results can support the coherent implementation of pharmacovigilance activities. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tamura, Norio; Matsuda, Tsutomu] Yamagata Univ, Grad Sch Med, Dept Pharmaceut & Med Device Regulatory Sci, Yamagata 990, Japan; [Tamura, Norio] Teikoku Seiyaku Co Ltd, Higashikagawa, Kagawa, Japan; [Ishiguro, Chieko] Pharmaceut & Med Device Agcy, Chiyoda Ku, Tokyo, Japan	Tamura, N (reprint author), Teikoku Seiyaku Co Ltd, Tokyo Off, Chuo Ku, 2-5 Nihonbashi Honcho 2 Chome, Tokyo 1030023, Japan.	tamura@teiyaku.co.jp					NALDI L, 1990, ARCH DERMATOL, V126, P1103; SCHOPF E, 1991, ARCH DERMATOL, V127, P839, DOI 10.1001/archderm.127.6.839; Mol PGM, 2010, DRUG SAFETY, V33, P463, DOI 10.2165/11532840-000000000-00000; ROUJEAU JC, 1990, ARCH DERMATOL, V126, P37, DOI 10.1001/archderm.126.1.37; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Heemstra HE, 2010, DRUG SAFETY, V33, P127, DOI 10.2165/11319870-000000000-00000; Giezen TJ, 2008, JAMA-J AM MED ASSOC, V300, P1887, DOI 10.1001/jama.300.16.1887; Azuma A., 2007, JMAJ - Japan Medical Association Journal, V50, P405; CIOMS, 2010, PRACT ASP SIGN DET P; Collaborating Centre for Drug Statistics Methodology, 2012, ATC DDD IND; Hayashi M, 2009, J JPN SOC HOSP PHARM, V45, P37; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005, NONCL EV POT DEL VEN; International Conference onHarmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2004, PHARM PLANN E2E; International Conference onHarmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2000, SAF PHARM STUD HUM P; OGAMI T, 2012, PHARM MED, V26, P395; Pharmaceutical Affairs Bureau Ministry of Health and Welfare, 1997, 607 PAB MIN HLTH WEL; Pharmaceuticals and Medical Device Agency, REV PRECAUTIONS; Pharmaceuticals and Medical Device Agency, 2012, APPR INF DRUGS QUAS; Takikawa H, 2009, HEPATOL RES, V39, P427, DOI 10.1111/j.1872-034X.2008.00486.x; U.S. Food and Drug Administration, 2002, VIOXX ROF; Yamane Yumiko, 2007, Allergol Int, V56, P419, DOI 10.2332/allergolint.O-07-483	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-8569	1099-1557		PHARMACOEPIDEM DR S	Pharmacoepidemiol. Drug Saf.	FEB	2015	24	2					166	175		10.1002/pds.3629		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CB0FH	WOS:000349300500008		
J	Fan, JL; Kitajima, S; Watanabe, T; Xu, J; Zhang, JF; Liu, EQ; Chen, YE				Fan, Jianglin; Kitajima, Shuji; Watanabe, Teruo; Xu, Jie; Zhang, Jifeng; Liu, Enqi; Chen, Y. Eugene			Rabbit models for the study of human atherosclerosis: From pathophysiological mechanisms to translational medicine	PHARMACOLOGY & THERAPEUTICS			English	Review						Atherosclerosis; Experimental animal models; Hypercholesterolemia; Transgenic rabbits; Translational medicine	CHOLESTEROL-FED RABBITS; EXPRESSING HUMAN APOLIPOPROTEIN(A); LOW-DENSITY-LIPOPROTEIN; HERITABLE HYPERLIPIDEMIC RABBITS; DIET-INDUCED ATHEROSCLEROSIS; TRANSGENIC RABBITS; FAMILIAL HYPERCHOLESTEROLEMIA; AORTIC ATHEROSCLEROSIS; MESSENGER-RNA; ANIMAL-MODEL	Laboratory animal models play an important role in the study of human diseases. Using appropriate animals is critical not only for basic research but also for the development of therapeutics and diagnostic tools. Rabbits are widely used for the study of human atherosclerosis. Because rabbits have a unique feature of lipoprotein metabolism (like humans but unlike rodents) and are sensitive to a cholesterol diet, rabbit models have not only provided many insights into the pathogenesis and development of human atherosclerosis but also made a great contribution to translational research. In fact, rabbit was the first animal model used for studying human atherosclerosis, more than a century ago. Currently, three types of rabbit model are commonly used for the study of human atherosclerosis and lipid metabolism: (1) cholesterol-fed rabbits, (2) Watanabe heritable hyperlipidemic rabbits, analogous to human familial hypercholesterolemia due to genetic deficiency of LDL receptors, and (3) genetically modified (transgenic and knock-out) rabbits. Despite their importance, compared with the mouse, the most widely used laboratory animal model nowadays, the use of rabbit models is still limited. In this review, we focus on the features of rabbit lipoprotein metabolism and pathology of atherosclerotic lesions that make it the optimal model for human atherosclerotic disease, especially for the translational medicine. For the sake of clarity, the review is not an attempt to be completely inclusive, but instead attempts to summarize substantial information concisely and provide a guideline for experiments using rabbits. (C) 2014 Elsevier Inc. All rights reserved.	[Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Chuo City, Yamanashi 4093898, Japan; [Kitajima, Shuji; Watanabe, Teruo] Saga Univ, Div Biol Resources & Dev, Analyt Res Ctr Expt Sci, Saga 840, Japan; [Xu, Jie; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Ctr Adv Models Translat Sci & Therapeut, Ann Arbor, MI 48109 USA; [Liu, Enqi] Xi An Jiao Tong Univ, Sch Med, Res Inst Atherosclerot Dis, Xian 710049, Peoples R China; [Liu, Enqi] Xi An Jiao Tong Univ, Sch Med, Lab Anim Ctr, Xian 710049, Peoples R China	Fan, JL (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Shimokato 1110, Chuo City, Yamanashi 4093898, Japan.	jianglin@yamanashi.ac.p; echenum@umich.edu			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [71790514, 19390099, 21659078, 22390068]; National Institutes of Health [HL105114, HL088391, NS066652, HL068878]; American Heart Association (National Scientist Development) [0835237N]	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (71790514, 19390099, 21659078, and 22390068 to JF), the National Institutes of Health (HL105114, HL088391, NS066652, and HL068878 to Y.E.C.), and the American Heart Association (National Scientist Development 0835237N to J.Z.).	Aikawa M, 1999, CIRCULATION, V100, P1215; Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Koike T, 2009, ARTERIOSCL THROM VAS, V29, P2047, DOI 10.1161/ATVBAHA.109.190264; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; Shiomi M, 2009, ATHEROSCLEROSIS, V207, P1, DOI 10.1016/j.atherosclerosis.2009.03.024; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Suzuki T, 2009, CIRC-HEART FAIL, V2, P334, DOI 10.1161/CIRCHEARTFAILURE.108.802298; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Kitajima S, 2005, LAB INVEST, V85, P1517, DOI 10.1038/labinvest.3700346; Chen YL, 2013, THROMB RES, V132, P565, DOI 10.1016/j.thromres.2013.09.007; WATANABE T, 1985, LAB INVEST, V53, P80; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Shiomi M, 2013, ATHEROSCLEROSIS, V231, P39, DOI 10.1016/j.atherosclerosis.2013.08.030; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Fan JL, 2003, PHARMACOL THERAPEUT, V99, P261, DOI 10.1016/S0163-7258(03)00069-X; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; WATANABE Y, 1980, ATHEROSCLEROSIS, V36, P261, DOI 10.1016/0021-9150(80)90234-8; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Ivics Z, 2014, NAT PROTOC, V9, P794, DOI 10.1038/nprot.2014.009; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Duverger N, 1996, CIRCULATION, V94, P713; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Shiomi M, 2003, ARTERIOSCL THROM VAS, V23, P1239, DOI 10.1161/01.ATV.0000075947.28567.50; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; FAN JL, 1994, P NATL ACAD SCI USA, V91, P8724, DOI 10.1073/pnas.91.18.8724; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Moghadasian MH, 2002, LIFE SCI, V70, P855, DOI 10.1016/S0024-3205(01)01479-5; King VL, 2010, OBESITY, V18, P35, DOI 10.1038/oby.2009.176; Ichikawa T, 2005, ATHEROSCLEROSIS, V179, P87, DOI 10.1016/j.atherosclerosis.2004.10.044; Kobayashi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/406473; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928; Mussolino C, 2013, NAT BIOTECHNOL, V31, P208, DOI 10.1038/nbt.2527; Zhang C, 2010, J COMP PATHOL, V142, P122, DOI [10.1016/j.jcpa.2009.08.159, 10.1016/j.jcpa.2009.07.159]; BADIMON JJ, 1989, LAB INVEST, V60, P455; Fan JL, 2001, J BIOL CHEM, V276, P40071, DOI 10.1074/jbc.M105456200; BESTERMA.EM, 1970, ATHEROSCLEROSIS, V12, P75, DOI 10.1016/0021-9150(70)90085-7; BOCAN TMA, 1993, ATHEROSCLEROSIS, V102, P9, DOI 10.1016/0021-9150(93)90080-E; Bosze Z, 2012, TRANSGENIC RES, V21, P902; BREM G, 1985, ZUCHTHYGIENE, V20, P251; Brown MS, 2004, ATHEROSCLEROSIS SUPP, V5, P13, DOI 10.1016/j.atherosclerosissup.2004.08.007; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; CHIESA G, 1992, J BIOL CHEM, V267, P24369; Corti R, 2007, ATHEROSCLEROSIS, V190, P106, DOI 10.1016/j.atherosclerosis.2006.02.036; DAUGHERTY A, 1989, BRIT J PHARMACOL, V98, P612; Ding YY, 2011, TRANSGENIC RES, V20, P867, DOI 10.1007/s11248-010-9467-5; DUFF GL, 1949, J EXP MED, V89, P611, DOI 10.1084/jem.89.6.611; Duranthon V, 2012, TRANSGENIC RES, V21, P699, DOI 10.1007/s11248-012-9599-x; Duverger N, 1996, ARTERIOSCL THROM VAS, V16, P1424; ENDO A, 1980, SEIKAGAKU, V52, P1033; Fan J, 2000, J Atheroscler Thromb, V7, P26; Fan JL, 2001, ARTERIOSCL THROM VAS, V21, P88; FAN JL, 1995, ARTERIOSCL THROM VAS, V15, P1889; Fan JL, 1998, J CLIN INVEST, V101, P2151, DOI 10.1172/JCI1599; Fan JL, 1999, PATHOL INT, V49, P583, DOI 10.1046/j.1440-1827.1999.00923.x; Fan JL, 1999, BIOCHEM BIOPH RES CO, V255, P639, DOI 10.1006/bbrc.1999.0242; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; GOLDSTEIN JL, 1983, NEW ENGL J MED, V309, P288; HANSSON GK, 1991, ARTERIOSCLER THROMB, V11, P745; HIRATA M, 1988, ACTA PATHOL JAPON, V38, P559; Hoeg J. M., 1998, CIRCULATION S, V98, P1; Hoeg JM, 1996, P NATL ACAD SCI USA, V93, P11448, DOI 10.1073/pnas.93.21.11448; Huang YD, 1997, J BIOL CHEM, V272, P22685, DOI 10.1074/jbc.272.36.22685; Huang YD, 1999, ARTERIOSCL THROM VAS, V19, P2952; Ichikawa T, 2002, AM J PATHOL, V160, P227, DOI 10.1016/S0002-9440(10)64366-0; Ignatowski A. C., 1908, S PETERB IZVIEST IMP, V16, P154; James J, 2002, J MOL CELL CARDIOL, V34, P873, DOI 10.1006/jmcc.2002.2025; KATO H, 1991, PATHOL RES PRACT, V187, P797; Kitajima S, 2007, ATHEROSCLEROSIS, V193, P269, DOI 10.1016/j.atherosclerosis.2006.08.056; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Koike T, 2005, CARDIOVASC RES, V65, P524, DOI 10.1016/j.cardioires.2004.10.022; KRITCHEV.D, 1970, AM J CLIN NUTR, V23, P1105; LI HM, 1993, AM J PATHOL, V143, P1551; Li S, 2014, J ATHEROSCLER THROMB, V21, P648; Li XH, 1996, J LIPID RES, V37, P210; Liu E, 2007, J AM SOC NEPHROL, V18, P2094, DOI 10.1681/ASN.2006010075; MAHLEY RW, 1980, J LIPID RES, V21, P970; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Masson D, 2011, ARTERIOSCL THROM VAS, V31, P766, DOI 10.1161/ATVBAHA.110.215756; Matsuda S, 2011, J THROMB HAEMOST, V9, P201, DOI 10.1111/j.1538-7836.2010.04086.x; Names N., 2004, ATHEROSCLEROSIS SUPP, V5, P21; Niimi M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-166; NORDESTGAARD BG, 1988, J LIPID RES, V29, P1491; OVERTURF ML, 1989, J LIPID RES, V30, P263; Peng XW, 2012, COMPARATIVE MED, V62, P472; Pogwizd S. M., 2008, DRUG DISCOV TODAY DI, V5, P185, DOI DOI 10.1016/J.DDMOD.2009.02.001; POORMAN JA, 1993, J LIPID RES, V34, P1675; ROBERTS DCK, 1974, ATHEROSCLEROSIS, V19, P369, DOI 10.1016/S0021-9150(74)80002-X; ROSENFELD ME, 1992, AM J PATHOL, V140, P291; Rouy D, 1998, J BIOL CHEM, V273, P1247, DOI 10.1074/jbc.273.2.1247; Shiomi M, 2008, CURR OPIN LIPIDOL, V19, P631, DOI 10.1097/MOL.0b013e3283189c18; Steinberg D, 2004, J LIPID RES, V45, P1583, DOI 10.1194/jlr.R400003.JLR200; Sun HJ, 2002, J BIOL CHEM, V277, P47486, DOI 10.1074/jbc.M205814200; Takahashi S, 2011, BIOCHEM BIOPH RES CO, V407, P656, DOI 10.1016/j.bbrc.2011.03.069; TALL AR, 1986, J LIPID RES, V27, P361; Taylor JM, 1997, FRONT BIOSCI, V2, P298; TERRITO MC, 1989, ARTERIOSCLEROSIS, V9, P824; VESSELINOVITCH D, 1988, ARCH PATHOL LAB MED, V112, P1011; Wang Y, 2013, ARTERIOSCL THROM VAS, V33, P224, DOI 10.1161/ATVBAHA.112.300445; Wang Y., 2013, BIOMED RES INT, P1; WARREN RJ, 1991, J LIPID RES, V32, P1333; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang D., 2013, J VIS EXP; Yu Y, 2008, HISTOL HISTOPATHOL, V23, P1503	112	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0163-7258			PHARMACOL THERAPEUT	Pharmacol. Ther.	FEB	2015	146						104	119		10.1016/j.pharmthera.2014.09.009		16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CB3BZ	WOS:000349504500008		
J	Das, A; Roychowdhury, A; Pati, SP; Bandyopadhyay, S; Das, D				Das, A.; Roychowdhury, A.; Pati, S. P.; Bandyopadhyay, S.; Das, D.			Structural, magnetic and hyperfine properties of single-phase SrFe12O19 nanoparticles prepared by a sol-gel route	PHYSICA SCRIPTA			English	Article						ferrite; magnetic properties; Mossbauer spectroscopy; nanoparticles; sol-gels	FERRITE NANOPARTICLES; STRONTIUM; COPRECIPITATION; ANISOTROPY; POWDERS; BIFEO3	Single-phase nanocrystalline strontium hexaferrite (SrFe12O19) powders have been synthesized by a sol-gel method and their structural, magnetic and hyperfine properties are discussed. The optimum annealing temperature of the as-prepared gel for formation of the single-phase SrFe12O19 structure has been found to be 800 degrees C. X-ray diffraction and Fourier transform infrared studies confirmed formation of the hexaferrite phase. The cation distribution at crystallographic inequivalent sites of the hexaferrite structure has been examined by Fe-57 Mossbauer spectroscopy and found to be identical to that reported earlier. Single-phase SrFe12O19 nanoparticles (NPs) showed a magnetic hysteresis loop with high coercivity and saturation magnetization denoting an irreversible magnetization character. The temperature dependent magnetization measurements reveal a difference between the zero-field-cooled and field-cooled curves throughout the measurement range 5-300 K that is attributed to superparamagnetic relaxation of finer hexaferrite particles and disordered spins at the surface of the NPs. Both hyperfine and magnetic studies confirm that magnetic anisotropy plays a crucial role in hexaferrite NPs.	[Das, A.; Roychowdhury, A.; Das, D.] UGC DAE Consortium Sci Res, Kolkata Ctr, Kolkata 700098, India; [Pati, S. P.] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9808579, Japan; [Bandyopadhyay, S.] Univ Calcutta, Dept Phys, Kolkata 700009, India	Das, A (reprint author), UGC DAE Consortium Sci Res, Kolkata Ctr, 3 LB-8 Bidhannagar, Kolkata 700098, India.	ddas@alpha.iuc.res.in			University Grants Commission (UGC), New Delhi	Authors thank Dr A Saha, UGC-DAE CSR, Kolkata for FTIR measurements. AD is grateful to University Grants Commission (UGC), New Delhi for providing the Junior Research Fellowship. The authors acknowledge CRNN, Calcutta University, Salt Lake, for providing the SQUID VSM facility.	Coey JMD, 2001, J ALLOY COMPD, V326, P2, DOI 10.1016/S0925-8388(01)01239-7; Vijayalakshmi A, 1998, J APPL PHYS, V83, P400, DOI 10.1063/1.366654; XU Y, 1990, PHYS STATUS SOLIDI B, V157, P685, DOI 10.1002/pssb.2221570221; Ibusuki T, 2001, IEEE T MAGN, V37, P2223, DOI 10.1109/20.951130; Chen DH, 2002, MATER RES BULL, V37, P801, DOI 10.1016/S0025-5408(01)00590-6; Fang CM, 2003, J PHYS-CONDENS MAT, V15, P6229, DOI 10.1088/0953-8984/15/36/311; Hasab MG, 2007, J EUR CERAM SOC, V27, P3637, DOI 10.1016/j.jeurceramsoc.2007.02.004; Park TJ, 2007, NANO LETT, V7, P766, DOI 10.1021/nl063039w; Fang JY, 2000, J AM CERAM SOC, V83, P1049; Zi ZF, 2008, J MAGN MAGN MATER, V320, P2746, DOI 10.1016/j.jmmm.2008.06.009; Singhal S, 2011, CERAM INT, V37, P1833, DOI 10.1016/j.ceramint.2011.02.001; Jean M, 2010, J ALLOY COMPD, V496, P306, DOI 10.1016/j.jallcom.2010.02.002; Lee SW, 2003, IEEE T MAGN, V39, P2899, DOI 10.1109/TMAG.2003.815741; Dai YR, 2012, PHYSICA B, V407, P560, DOI 10.1016/j.physb.2011.11.055; Fiorani D, 2005, SURFACE EFFECTS MAGN, P257; Ghasemi A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3339004; Gich M, 2005, J APPL PHYS, V98, DOI 10.1063/1.1997297; Kumar N, 2010, J SUPERCOND NOV MAGN, V23, P423, DOI 10.1007/s10948-010-0766-0; Li XY, 1996, J MATER SCI LETT, V15, P397; Liu XM, 2005, MAT SCI ENG B-SOLID, V121, P255, DOI 10.1016/j.mseb.2005.04.009; Masoudpanah SM, 2011, RES CHEM INTERMEDIAT, V37, P259, DOI 10.1007/s11164-011-0286-y; Monshi A., 2012, WORLD J NANOSCI ENG, V2, P154, DOI DOI 10.4236/WJNSE.2012.23020; Singhal S, 2008, HYPERFINE INTERACT, V183, P93, DOI 10.1007/s10751-008-9735-4; THOMPSON GK, 1993, J APPL PHYS, V73, P6295, DOI 10.1063/1.352675; Tzitzios V, 2010, J MATER CHEM, V20, P5418, DOI 10.1039/c0jm00061b; Zhang YD, 1998, APPL PHYS LETT, V72, P2053, DOI 10.1063/1.121262	26	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-8949	1402-4896		PHYS SCRIPTA	Phys. Scr.	FEB	2015	90	2							025802	10.1088/0031-8949/90/2/025802		7	Physics, Multidisciplinary	Physics	CB0IW	WOS:000349310200032		
J	Huang, SC; Minami, T; Naka, K; Chujo, Y				Huang, Shu-Chen; Minami, Takayuki; Naka, Kensuke; Chujo, Yoshiki			Fabrication of Amorphous Calcium Carbonate Composite Particles-Polymer Multilayer Films by a Layer-by-Layer Method	POLYMER COMPOSITES			English	Article							POLYELECTROLYTE MULTILAYERS; ARTIFICIAL NACRE; NANOPARTICLE; SPHERES	Organic-inorganic hybrid multilayer films were prepared on a precoated cationic glass substrate by using a layer-by-layer (LbL) electrostatic self-assembly technique with poly(diallyldimethylammonium chloride) as a polycation and submicron-sized stable amorphous calcium carbonate (ACC) composite particles. The ACC composite particles (ACP) stabilized with poly(acrylic acid) were obtained by a carbonate controlled-addition method. The average particles size of ACP was (1.8 +/- 0.4) x 10(2) nm. An ethanolic dispersion of ACP was used for the LbL electrostatic self-assembly technique on the precoated substrate due to instability of ACP in water. The deposition of the particles was confirmed by SEM analysis. The film thickness of the multilayer assembly increased from 230 to 710 nm with increasing the deposition layers. The FTIR spectra of scratched multilayer samples showed characteristic broaden peaks of ACC. The amorphous phase was stable after the LbL assembly process as well as after 2 months in a dry film state. POLYM. COMPOS., 36:330-335, 2015. (c) 2014 Society of Plastics Engineers	[Huang, Shu-Chen; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Katsura, Kyoto 6158510, Japan; [Huang, Shu-Chen; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Minami, Takayuki; Naka, Kensuke] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan	Naka, K (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan.	kenaka@kit.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24102003]	Contract grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology, Japan; contract grant number: 24102003.	Schmitt J, 1997, ADV MATER, V9, P61, DOI 10.1002/adma.19970090114; Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x; Wei H, 2007, CHEM MATER, V19, P1974, DOI 10.1021/cm062898i; Li M, 2003, ADV MATER, V15, P2032, DOI 10.1002/adma.200305589; Caruso F, 1998, J AM CHEM SOC, V120, P8523, DOI 10.1021/ja9815024; Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+; Schonhoff M, 2003, CURR OPIN COLLOID IN, V8, P86, DOI 10.1016/S1359-0294(03)00003-7; Estroff LA, 2001, CHEM MATER, V13, P3227, DOI 10.1021/cm010110k; Shen Q, 2006, J PHYS CHEM B, V110, P2994, DOI 10.1021/jp055063o; Naka K, 2001, CHEM MATER, V13, P3245, DOI 10.1021/cm011035g; Serizawa T, 2006, J CRYST GROWTH, V292, P67, DOI 10.1016/j.jcrysgro.2006.03.052; Colfen H, 2003, CURR OPIN COLLOID IN, V8, P23, DOI 10.1016/S1359-0294(03)00012-8; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Huang SC, 2007, LANGMUIR, V23, P12086, DOI 10.1021/la701972n; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; Faatz M, 2005, LANGMUIR, V21, P6666, DOI 10.1021/la050604m; Dey S, 2010, LANGMUIR, V26, P9627, DOI 10.1021/la101132z; Finnemore A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1970; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; KOTOV NA, 1995, J PHYS CHEM-US, V99, P13065, DOI 10.1021/j100035a005; Li Q, 2006, CHEM MATER, V18, P5480, DOI 10.1021/cm061626c; Nakamura S, 2013, LANGMUIR, V29, P15888, DOI 10.1021/la403193e; Pichon BP, 2011, CHEM MATER, V23, P3668, DOI 10.1021/cm201139s	23	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-8397	1548-0569		POLYM COMPOSITE	Polym. Compos.	FEB	2015	36	2					330	335		10.1002/pc.22947		6	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	AZ7AQ	WOS:000348371000017		
J	Kato, T; Kikuchi, H; Imai, H				Kato, Takashi; Kikuchi, Hirotsugu; Imai, Hiroaki			Special Issue Fusion Materials: Creative development of materials and exploration of their function through molecular control	POLYMER JOURNAL			English	Editorial Material									[Kato, Takashi] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Kikuchi, Hirotsugu] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 812, Japan; [Imai, Hiroaki] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Yokohama, Kanagawa 223, Japan	Kato, T (reprint author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.	kato@chiral.t.u-tokyo.ac.jp	Imai, Hiroaki/F-8459-2014				Imai H, 2006, B CHEM SOC JPN, V79, P1834, DOI 10.1246/bcsj.79.1834; Arakaki A, 2015, ORG BIOMOL CHEM, V13, P974, DOI 10.1039/c4ob01796j; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Kato T, 2012, POLYM J, V44, P451, DOI 10.1038/pj.2012.62; Mann S., 2001, BIOMINERALIZATION PR; Serizawa T, 2014, POLYM J, V46, P435, DOI 10.1038/pj.2014.55	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		77	77		10.1038/pj.2014.132		1	Polymer Science	Polymer Science	CB2QS	WOS:000349473600001		
J	Kobayashi, M; Osada, M; Kato, H; Kakihana, M				Kobayashi, Makoto; Osada, Minoru; Kato, Hideki; Kakihana, Masato			Design of crystal structures, morphologies and functionalities of titanium oxide using water-soluble complexes and molecular control agents	POLYMER JOURNAL			English	Review							AMORPHOUS CALCIUM-CARBONATE; ROOM-TEMPERATURE SYNTHESIS; RUTILE TIO2; HYDROTHERMAL SYNTHESIS; SELECTIVE SYNTHESIS; PHOTOCATALYTIC ACTIVITY; DIOXIDE NANOCOMPOSITES; DIELECTRIC-CONSTANT; AQUEOUS-SOLUTION; PRECURSOR PHASE	Nature produces materials with excellent physical and chemical properties using water as a medium under ambient temperature and pressure. The current need for more highly functional and compact materials makes the mimicking of natural processes to produce these materials a very interesting approach, not only to obtain highly functionalized materials but also to reduce the environmental impact. Our research group is engaged in the development of new stable water-soluble compounds that follow natural processes for the synthesis of materials using water as a medium. This paper summarizes a hydrothermal synthesis of rutile-type titanium oxide using water-soluble titanium complexes, controlling the crystal morphology by utilizing organic molecules as shape-control agents as well as their speculative formation mechanism and superior dielectric properties of unusually shaped titanium oxide crystals. By recapitulating our results, we indicate that control of the nano-and macro-structures and functional improvement are accomplished through the development of new precursor compounds.	[Kobayashi, Makoto; Kato, Hideki; Kakihana, Masato] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Osada, Minoru] NIMS, Int Ctr Mat Nanoarchitecton WPI MANA, Ibaraki, Japan	Kakihana, M (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	kakihana@tagen.tohoku.ac.jp	Kobayashi, Makoto/C-2748-2015		Japanese Government's Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22107002, 2206]	We thank Dr V. Petrykin (SuperOX Japan) and Dr K. Tomita (Tokai Univ.) for fruitful discussions. This work was supported in part by a Grant-in-Aid for Scientific Research (no. 22107002) on the Innovative Areas: 'Fusion Materials' (area no. 2206) from the Japanese Government's Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Aizenberg J, 2004, J MATER CHEM, V14, P2066, DOI 10.1039/b402558j; Testino A, 2007, J AM CHEM SOC, V129, P3564, DOI 10.1021/ja067050+; Kakihana M, 2010, B CHEM SOC JPN, V83, P1285, DOI 10.1246/bcsj.20100103; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Takahashi H, 2008, NATURE, V453, P376, DOI 10.1038/nature06972; Zhang QH, 2003, LANGMUIR, V19, P967, DOI 10.1021/la020310q; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Zhu FJ, 2013, CHEM-ASIAN J, V8, P3002, DOI 10.1002/asia.201300745; Morishima Y, 2009, J CERAM SOC JPN, V117, P320, DOI 10.2109/jcersj2.117.320; Luckarift HR, 2006, SMALL, V2, P640, DOI 10.1002/smll.200500376; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; Zheng YQ, 2001, J MATER CHEM, V11, P1547; Gopal M, 1997, J MATER SCI, V32, P6001, DOI 10.1023/A:1018671212890; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461; Kakihana M, 2004, INORG CHEM, V43, P4546, DOI 10.1021/ic040031l; Kakihana M, 2001, INORG CHEM, V40, P891, DOI 10.1021/ic001098l; Zhang Y, 2008, J PHYS CHEM C, V112, P16457, DOI 10.1021/jp804524y; ARLT G, 1985, J APPL PHYS, V58, P1619, DOI 10.1063/1.336051; Tomita K, 2006, ANGEW CHEM INT EDIT, V45, P2378, DOI 10.1002/anie.200503565; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Mendive CB, 2008, PHYS CHEM CHEM PHYS, V10, P1960, DOI 10.1039/b800140p; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; Imai H, 2010, CRYSTENGCOMM, V12, P1679, DOI 10.1039/c001474p; Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101; Nada H, 2014, J PHYS CHEM C, V118, P14335, DOI 10.1021/jp502332c; Li GH, 2007, CHEM MATER, V19, P1143, DOI 10.1021/cm061817f; Wang YW, 2007, J PHYS CHEM C, V111, P2709, DOI 10.1021/jp066519k; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Petrykin V, 2006, INORG CHEM, V45, P9251, DOI 10.1021/ic060861u; Kobayashi M, 2007, CHEM MATER, V19, P5373, DOI 10.1021/cm071370q; Patzke GR, 2011, ANGEW CHEM INT EDIT, V50, P826, DOI 10.1002/anie.201000235; CHENG HM, 1995, CHEM MATER, V7, P663, DOI 10.1021/cm00052a010; Li JG, 2007, J PHYS CHEM C, V111, P4969, DOI 10.1021/jp0673258; Kobayashi M, 2008, J MATER SCI, V43, P2158, DOI 10.1007/s10853-007-1912-3; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Tomono H, 2013, J PHYS CHEM B, V117, P14849, DOI 10.1021/jp407721x; Kato T, 2010, MRS BULL, V35, P127, DOI 10.1557/mrs2010.632; Dey D, 2007, J CERAM SOC JPN, V115, P808, DOI 10.2109/jcersj2.115.808; GERVAIS F, 1983, PHYS REV B, V28, P2962, DOI 10.1103/PhysRevB.28.2962; Grunebohm A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.132105; Johnson J. M., 2011, J AM CHEM SOC, V134, P13974; Kinsinger NM, 2010, CRYST GROWTH DES, V10, P5254, DOI 10.1021/cg101105t; Kobayashi M., 2013, NANOMATER NANOTECHNO, V3, P1; Kobayashi M, 2009, J AM CERAM SOC, V92, pS21, DOI 10.1111/j.1551-2916.2008.02641.x; Kobayashi M., 2012, Japanese Patent, Patent No. 5008028; Kobayashi M, 2007, J CERAM SOC JPN, V115, P835, DOI 10.2109/jcersj2.115.835; Kobayashi M, 2012, J CERAM SOC JPN, V120, P494, DOI 10.2109/jcersj2.120.494; Kobayashi M, 2008, J CERAM SOC JPN, V116, P578, DOI 10.2109/jcersj2.116.578; Chemseddine A, 1999, EUR J INORG CHEM, P235, DOI 10.1002/(SICI)1099-0682(19990202)1999:2<235::AID-EJIC235>3.0.CO;2-N; Nakasuji K, 2006, BIOL TRACE ELEM RES, V110, P119, DOI 10.1385/BTER:110:2:119; Osada M, 2013, J CERAM SOC JPN, V121, P593, DOI 10.2109/jcersj2.121.593; Ostwald W., 1897, Z PHYS CHEM, V22, P289; PARKER RA, 1961, PHYS REV, V124, P1719, DOI 10.1103/PhysRev.124.1719; PARKER RA, 1960, PHYS REV, V120, P1631, DOI 10.1103/PhysRev.120.1631; Reyes-Coronado D., 2008, NANOTECHNOLOGY, V19; SAMARA GA, 1973, PHYS REV B, V7, P1131, DOI 10.1103/PhysRevB.7.1131; Tomita K, 2008, J MATER SCI, V43, P2217, DOI 10.1007/s10853-007-2113-9; Truong Q.D., 2011, J CERAM SOC JPN, V119, P513; Yoshizawa M, 2014, J MATER RES, V29, P90, DOI 10.1557/jmr.2013.229	59	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		78	83		10.1038/pj.2014.89		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600002		
J	Nada, H				Nada, Hiroki			Importance of water in the control of calcite crystal growth by organic molecules	POLYMER JOURNAL			English	Review							FLOUNDER ANTIFREEZE PROTEIN; DYNAMICS SIMULATIONS; MAGNESIUM-IONS; ASPARTIC-ACID; SURFACES; INTERFACE; BINDING; MINERALIZATION; CARBONATE; ICE	This review focuses on the effect of water on the binding conformation of an organic molecule at a hydrated calcite crystal surface. A recent molecular dynamics simulation suggested that water strongly affects the binding conformation of aspartic acid (Asp) at the crystal surface. The simulation also suggested that the binding conformation of the acid was different at various parts of the calcite surface, because of a difference in the structure of the water. This explains the change in the step morphology on [104] planes of calcite crystals caused by adding Asp in real systems. Similarly, recent simulations of other species of organic molecule have suggested that water affects the binding conformation of the molecule at the calcite surface. In this review, we discuss how water is crucial in the growth control of calcite crystals by organic molecules, which provides useful insights for the development of organic/inorganic hybrid materials.	Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management & Technol, Tsukuba, Ibaraki 3058569, Japan	Nada, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management & Technol, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	hiroki.nada@aist.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22107004, 2206]	This work was supported by a Grant-in-Aid for Scientific Research (no. 22107004) on Innovation Areas of 'Fusion Materials' (area no. 2206) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). Some of the computations in this work were done using the facilities of the Supercomputer Center, Institute of Solid State Physics, The University of Tokyo.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Cooke DJ, 2010, LANGMUIR, V26, P14520, DOI 10.1021/la100670k; Raiteri P, 2013, METHOD ENZYMOL, V532, P3, DOI 10.1016/B978-0-12-416617-2.00001-1; Zhu FJ, 2013, CHEM-ASIAN J, V8, P3002, DOI 10.1002/asia.201300745; Smith W, 1996, J MOL GRAPHICS, V14, P136, DOI 10.1016/S0263-7855(96)00043-4; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Aschauer U, 2010, J COLLOID INTERF SCI, V346, P226, DOI 10.1016/j.jcis.2010.02.057; Nada H, 2008, J PHYS CHEM B, V112, P7111, DOI 10.1021/jp711977g; Elhadj S, 2006, CRYST GROWTH DES, V6, P197, DOI 10.1021/cg050288+; Raiteri P, 2010, J PHYS CHEM C, V114, P5997, DOI 10.1021/jp910977a; Fenter P, 2012, GEOCHIM COSMOCHIM AC, V97, P58, DOI 10.1016/j.gca.2012.08.021; Freeman CL, 2014, J PHYS CHEM C, V118, P1506, DOI 10.1021/jp407122u; Freeman CL, 2010, ANGEW CHEM INT EDIT, V49, P5135, DOI 10.1002/anie.201000679; Duffy DM, 2004, LANGMUIR, V20, P7630, DOI 10.1021/la049552b; Nada H, 2014, J PHYS CHEM C, V118, P14335, DOI 10.1021/jp502332c; Raiteri P, 2012, FARADAY DISCUSS, V159, P61, DOI 10.1039/c2fd20052j; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; Nada H, 2011, PHYS CHEM CHEM PHYS, V13, P19936, DOI 10.1039/c1cp21929d; Freeman CL, 2012, PHYS CHEM CHEM PHYS, V14, P7287, DOI 10.1039/c2cp23987f; Zhu BB, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4848696; Jorov A, 2004, PROTEIN SCI, V13, P1524, DOI 10.1110/ps.04641104; Nada H, 2012, POLYM J, V44, P690, DOI 10.1038/pj.2012.13; Freeman CL, 2011, J PHYS CHEM C, V115, P8175, DOI 10.1021/jp200145m; Fenter P, 2013, J PHYS CHEM C, V117, P5028, DOI 10.1021/jp310943s; Tomono H, 2013, J PHYS CHEM B, V117, P14849, DOI 10.1021/jp407721x; Kato T, 2010, MRS BULL, V35, P127, DOI 10.1557/mrs2010.632; de Leeuw NH, 2004, CRYST GROWTH DES, V4, P123, DOI 10.1021/cg0341003; Drela I, 1998, WATER RES, V32, P3188, DOI 10.1016/S0043-1354(98)00066-9; Freeman CL, 2009, J PHYS CHEM C, V113, P3666, DOI 10.1021/jp807051u; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mann S., 2000, BIOMINERALIZATION PR; Shen JW, 2013, J PHYS CHEM C, V117, P6904, DOI 10.1021/jp402341w; Sugawara-Narutaki A, 2013, POLYM J, V45, P269, DOI 10.1038/pj.2012.171; Yang MJ, 2008, CRYST GROWTH DES, V8, P4066, DOI 10.1021/cg800508t; Yang MJ, 2009, MOL SIMULAT, V35, P547, DOI 10.1080/08927020802627399	38	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		84	88		10.1038/pj.2014.87		5	Polymer Science	Polymer Science	CB2QS	WOS:000349473600003		
J	Osada, M; Sasaki, T				Osada, Minoru; Sasaki, Takayoshi			Nanosheet architectonics: a hierarchically structured assembly for tailored fusion materials	POLYMER JOURNAL			English	Review							LAYER-BY-LAYER; LANGMUIR-BLODGETT DEPOSITION; THIN PEROVSKITE NANOSHEETS; TITANIA NANOSHEETS; OXIDE NANOSHEETS; MULTILAYER FILMS; DIELECTRIC-PROPERTIES; GRAPHENE ANALOGS; FABRICATION; NANOARCHITECTONICS	Hierarchical self-assembly is a ubiquitous process in nature that underlies the formation of complex biological structures. In recent decades, scientists have aspired to exploit biomimetic approaches to create new artificial materials with hierarchical structures and tailored properties. However, de novo design of such hierarchically structured materials is still a major challenge. In this Focus Review, we provide an overview of new design principles for hierarchical nanoarchitectures using a layer-by-layer (LbL) assembly of two-dimensional (2D) oxide nanosheets. 2D oxide nanosheets have remarkable potential as building blocks for tailoring fusion materials combined with a range of foreign materials such as organic molecules, gels, polymers, and inorganic and metal nanoparticles. The ability to create functionalized, 2D hierarchical systems will lead to various applications in optoelectronics, spinelectronics, energy and environment technologies.	[Osada, Minoru; Sasaki, Takayoshi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan	Osada, M (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	osada.minoru@nims.go.jp			World Premier International Research Center Initiative (WPI Initiative on Materials Nanoarchitronics); MEXT; CREST; JST; MEXT, Japan [2206]	We are grateful to Dr Y Ebina, Dr R Ma, Dr TC Ozawa, Dr N Sakai, Dr B-W Li, Dr K Tsukagoshi (NIMS), Professor W Sugimoto (Shinshu University), Dr K Fukuda (Kyoto University) and Professor K Ono (KEK) for their experimental contributions and stimulating discussions over the years of the authors' research on oxide nanosheets. This work was supported in part by the World Premier International Research Center Initiative (WPI Initiative on Materials Nanoarchitronics), MEXT, CREST, JST and the Grant-in-Aid for Scientific Research on Innovative Areas of 'Fusion Materials' (No. 2206), MEXT, Japan.	Akatsuka K, 2007, LANGMUIR, V23, P6730, DOI 10.1021/la063577o; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Sakai N, 2008, J PHYS CHEM C, V112, P5197, DOI 10.1021/jp7119894; Sakai N, 2010, J MATER CHEM, V20, P4371, DOI 10.1039/c0jm00135j; Osada M, 2012, ADV MATER, V24, P210, DOI 10.1002/adma.201103241; Osada M, 2006, ADV MATER, V18, P1023, DOI 10.1002/adma.200501224; Osada M, 2009, J MATER CHEM, V19, P2503, DOI 10.1039/b820160a; Ozawa TC, 2008, J PHYS CHEM C, V112, P17115, DOI 10.1021/jp805545u; Li BW, 2010, ACS NANO, V4, P6673, DOI 10.1021/nn102144s; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Osada M, 2011, ADV FUNCT MATER, V21, P3482, DOI 10.1002/adfm.201100580; Sasaki T, 2007, J CERAM SOC JPN, V115, P9, DOI 10.2109/jcersj.115.9; Rao CNR, 2013, ANGEW CHEM INT EDIT, V52, P13162, DOI 10.1002/anie.201301548; Dong XP, 2009, CHEM MATER, V21, P4366, DOI 10.1021/cm900210m; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3; Balendhran S, 2013, ADV FUNCT MATER, V23, P3952, DOI 10.1002/adfm.201300125; Geng FX, 2014, J AM CHEM SOC, V136, P5491, DOI 10.1021/ja501587y; Mas-Balleste R, 2011, NANOSCALE, V3, P20, DOI 10.1039/c0nr00323a; Osada M, 2006, ADV MATER, V18, P295, DOI 10.1002/adma.200501810; Osada M, 2011, ACS NANO, V5, P6871, DOI 10.1021/nn200835v; Gunjakar JL, 2014, J PHYS CHEM C, V118, P3847, DOI 10.1021/jp410626y; Shibata T, 2011, ENERG ENVIRON SCI, V4, P535, DOI 10.1039/c0ee00437e; Sun PZ, 2012, CARBON, V50, P4518, DOI 10.1016/j.carbon.2012.05.035; Tanaka T, 2004, ADV MATER, V16, P872, DOI 10.1002/adma.200306470; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Osada M, 2010, ACS NANO, V4, P5225, DOI 10.1021/nn101453v; Ida S, 2008, J AM CHEM SOC, V130, P7052, DOI 10.1021/ja7114772; Schaak RE, 2002, CHEM MATER, V14, P1455, DOI 10.1021/cm010689m; Akatsuka K, 2009, ACS NANO, V3, P1097, DOI 10.1021/nn900104u; Kai K, 2008, J AM CHEM SOC, V130, P15938, DOI 10.1021/ja804503f; Ma RZ, 2006, J MATER CHEM, V16, P3809, DOI 10.1039/b605422f; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Naguib M, 2014, ADV MATER, V26, P992, DOI 10.1002/adma.201304138; Wang LZ, 2014, CHEM REV, V114, P9455, DOI 10.1021/cr400627u; Osada M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.153301; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Sasaki T, 1996, J AM CHEM SOC, V118, P8329, DOI 10.1021/ja960073b; Ma RZ, 2010, ADV MATER, V22, P5082, DOI 10.1002/adma.201001722; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Ma RZ, 2004, J AM CHEM SOC, V126, P10382, DOI 10.1021/ja048855p; Sakai N, 2006, J PHYS CHEM B, V110, P6198, DOI 10.1021/jp0556916; Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P; Sasaki T, 2001, CHEM MATER, V13, P4661, DOI 10.1021/cm010478h; Sugimoto W, 2003, ANGEW CHEM INT EDIT, V42, P4092, DOI 10.1002/anie.200351691; Wang CX, 2014, ACS NANO, V8, P2658, DOI 10.1021/nn406367p; Muramatsu M, 2005, LANGMUIR, V21, P6590, DOI 10.1021/la050293f; ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; GOPALAKRISHNAN J, 1995, CHEM MATER, V7, P1265, DOI 10.1021/cm00055a001; Sasaki T, 1998, J AM CHEM SOC, V120, P4682, DOI 10.1021/ja974262l; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/nchem.1589, 10.1038/NCHEM.1589]; Ozawa TC, 2007, CHEM MATER, V19, P6575, DOI 10.1021/cm702552p; Li L, 2007, J AM CHEM SOC, V129, P8000, DOI 10.1021/ja0719172; Ariga K, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.30; Ebina Y, 2012, CHEM MATER, V24, P4201, DOI 10.1021/cm302480h; Geng FX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2641; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Li BW, 2014, ACS NANO, V8, P5449, DOI 10.1021/nn502014c; Li BW, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NA10; Li WW, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813537; Liu MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3029; Makino S, 2012, RSC ADV, V2, P12144, DOI 10.1039/c2ra22265e; Mann S., 2001, BIOMINERALIZATION; Oaki Yuya, 2005, Angew Chem Int Ed Engl, V44, P6571, DOI 10.1002/anie.200500338; Orzali T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.156101; Osada M, 2013, J MATER CHEM C, V1, P2520, DOI 10.1039/c3tc00952a; Osada M, 2012, INT J APPL CERAM TEC, V9, P29, DOI 10.1111/j.1744-7402.2011.02713.x; Osada M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937094; Osada M, 2008, JPN J APPL PHYS, V47, P7556, DOI 10.1143/JJAP.47.7556; Osada M, 2014, NANOSCALE, V6, P14227, DOI 10.1039/c4nr04465g; Sato J, 2010, LANGMUIR, V26, P18049, DOI 10.1021/la103848f; Tao AR, 2008, ACCOUNTS CHEM RES, V41, P1662, DOI 10.1021/ar8000525; Wang LZ, 2004, ADV MATER, V16, P1412, DOI 10.1002/adma.200306562; Xu XX, 2011, ENERG ENVIRON SCI, V4, P3509, DOI 10.1039/c1ee01389k	75	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		89	98		10.1038/pj.2014.111		10	Polymer Science	Polymer Science	CB2QS	WOS:000349473600004		
J	Okumura, K				Okumura, Ko			Strength and toughness of bio-fusion materials	POLYMER JOURNAL			English	Review							LOBSTER HOMARUS-AMERICANUS; SPIDER SILK; MECHANICAL-PROPERTIES; FRACTURE-MECHANICS; BIOLOGICAL COMPOSITES; BIOINSPIRED DESIGN; HYBRID MATERIALS; ORGANIC MATRIX; NACRE STRONG; ORB-WEB	In nature, there are many strong and tough biomaterials that result from the fusion of soft and hard elements. These materials include nacre, crustacean exoskeletons and spider webs. Here, we review previous studies on such bio-fusion materials, emphasizing the importance of simple models to gain a physical understanding of the emergence of strength and toughness from these structures. Thus, a simple understanding obtained through biologically inspired models provides useful guiding principles for the development of artificial tough composites by mimicking biomaterials.	[Okumura, Ko] Ochanomizu Univ, Dept Phys, Fac Sci, Tokyo 1128610, Japan	Okumura, K (reprint author), Ochanomizu Univ, Dept Phys, Fac Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	okumura@phys.ocha.ac.jp			MEXT, Japan [2206]; JSPS, Japan [24244066]	This research was partly supported by the Grant-in-Aid for Scientific Research on Innovative Areas, 'Fusion Materials (area no. 2206),' of MEXT, Japan, and by the Grant-in-Aid for Scientific Research (A) (no. 24244066) of JSPS, Japan.	Ackbarow T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006015; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Fabritius HO, 2009, ADV MATER, V21, P391, DOI 10.1002/adma.200801219; Sachs C, 2006, J MATER RES, V21, P1987, DOI 10.1557/JMR.2006.0241; Yamamoto Y, 2008, CRYST GROWTH DES, V8, P4062, DOI 10.1021/cg800447w; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Rao MP, 1999, SCIENCE, V286, P102, DOI 10.1126/science.286.5437.102; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0; Sone N, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.074604; Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Ji BH, 2010, ANNU REV MATER RES, V40, P77, DOI 10.1146/annurev-matsci-070909-104424; Corte L, 2007, MACROMOLECULES, V40, P5606, DOI 10.1021/ma0706935; Barthelat F, 2006, J MATER RES, V21, P1977, DOI 10.1557/JMR.2006.0239; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a; Kamat S, 2000, NATURE, V405, P1036; Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1; Meyers MA, 2008, J MECH BEHAV BIOMED, V1, P76, DOI 10.1016/j.jmbbm.2007.03.001; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Fratzl P, 2007, ADV MATER, V19, P2657, DOI 10.1002/adma.200602394; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Kotha SP, 2001, J MATER SCI, V36, P2001, DOI 10.1023/A:1017526830874; Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Osaki S, 1996, NATURE, V384, P419, DOI 10.1038/384419a0; Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P; Aoyanagi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038102; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; Hellmich C, 2004, EUR J MECH A-SOLID, V23, P783, DOI 10.1016/j.euromechsol.2004.05.004; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Okumura K, 2001, EUR PHYS J E, V4, P121, DOI 10.1007/s101890170150; Okumura K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.124802; Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019; Aoyanagi Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.034402; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Meyers MA, 2006, JOM-US, V58, P35, DOI 10.1007/s11837-006-0138-1; EMLET RB, 1982, BIOL BULL, V163, P264, DOI 10.2307/1541265; Sumitomo T, 2008, J MATER RES, V23, P1466, DOI 10.1557/JMR.2008.0184; Aoyanagi Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066108; Beyerlein IJ, 1996, INT J SOLIDS STRUCT, V33, P2543, DOI 10.1016/0020-7683(95)00172-7; Currey J. D., 2002, BONES STRUCTURE MECH; de Gennes PG, 2000, CR ACAD SCI IV-PHYS, V1, P257; Emile O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167402; Evans A., 2001, J MATER RES, V16, P2476; Fischer FD, 2012, INT J FRACTURE, V173, P57, DOI 10.1007/s10704-011-9657-z; GAO HJ, 1991, INT J SOLIDS STRUCT, V27, P1663; Hamamoto Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026118; Hamamoto Y, 2013, ADV ENG MATER, V15, P522, DOI 10.1002/adem.201300061; Hull D., 1996, INTRO COMPOSITE MAT; Kashima Y, 2014, ACS MACRO LETT, V3, P419, DOI 10.1021/mz500122v; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Kolednik O, 2011, ADV FUNCT MATER, V21, P3634, DOI 10.1002/adfm.201100443; LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0; MASTERS WM, 1984, BEHAV ECOL SOCIOBIOL, V15, P207, DOI 10.1007/BF00292977; Muju S, 2000, COMPOS SCI TECHNOL, V60, P2213, DOI 10.1016/S0266-3538(00)00016-6; Nakagawa S, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.114801; Nukala PKVV, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066106; Okumura K, 2005, J PHYS-CONDENS MAT, V17, pS2879, DOI 10.1088/0953-8984/17/31/015; Okumura K, 2003, EUROPHYS LETT, V63, P701, DOI 10.1209/epl/i2003-00578-y; Okumura K, 2002, EUR PHYS J E, V7, P303, DOI 10.1140/epje/i2001-10096-4; Sarikaya M., 1995, BIOMIMETICS DESIGN P, P35; Vincent J, 2012, STRUCTURAL BIOMATERI; WIRTH E, 1992, J COMP PHYSIOL A, V171, P359; WITT PN, 1965, SCIENCE, V149, P1190, DOI 10.1126/science.149.3689.1190; Zhou HJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028104	81	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		99	105		10.1038/pj.2014.97		7	Polymer Science	Polymer Science	CB2QS	WOS:000349473600005		
J	Takeoka, Y				Takeoka, Yukikazu			Fusion materials for biomimetic structurally colored materials	POLYMER JOURNAL			English	Review							COLLOIDAL AMORPHOUS ARRAYS; COHERENT-LIGHT SCATTERING; SHORT-RANGE ORDER; PHOTONIC CRYSTALS; TUNABLE COLORS; PARTICLES; NANOSTRUCTURES; COLORATION; FILMS; POLY(N-ISOPROPYLACRYLAMIDE)	This review addresses recent developments in structurally colored materials composed of submicrometer-sized fine particles, where the structural color is not angle-dependent. Recently, studies on colloidal crystals of submicrometer-sized fine particles for structurally colored materials applications have drawn great attention. Materials researchers have become aware that many living things exhibit bright structural colors that arise from amorphous arrays of particles, pores and fibers, and are now engaged in research related to this phenomenon. In particular, colloidal amorphous arrays composed of submicrometer-sized fine particles, which can display vivid structural color without angle dependence, have become a popular topic of study within recent years. In this paper, I review the possibility of using colloidal amorphous arrays as stimuli-responsive colored materials based on the properties of colloidal amorphous arrays that have been elucidated in recent experimental investigations.	[Takeoka, Yukikazu] Nagoya Univ, Dept Mol Design & Engn, Nagoya, Aichi 4648603, Japan	Takeoka, Y (reprint author), Nagoya Univ, Dept Mol Design & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	ytakeoka@apchem.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23245047, 22107012, 2206]	I acknowledge the support of a Grant-in-Aid for Scientific Research (No. 23245047 and No. 22107012) on Innovative Areas: 'Fusion Materials' (Area no. 2206) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Takeoka Y, 2012, J MATER CHEM, V22, P23299, DOI 10.1039/c2jm33643j; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Garcia PD, 2010, ADV MATER, V22, P12, DOI 10.1002/adma.200900827; Miguez H, 1998, ADV MATER, V10, P480, DOI 10.1002/(SICI)1521-4095(199804)10:6<480::AID-ADMA480>3.0.CO;2-Y; Noh H, 2010, OPT EXPRESS, V18, P11942, DOI 10.1364/OE.18.011942; Park JG, 2014, ANGEW CHEM INT EDIT, V53, P2899, DOI 10.1002/anie.201309306; Takeoka Y, 2013, ANGEW CHEM INT EDIT, V52, P7261, DOI 10.1002/anie.201301321; Hu J, 2009, J MATER CHEM, V19, P5730, DOI 10.1039/b906652g; Prum RO, 1998, NATURE, V396, P28, DOI 10.1038/23838; Prum RO, 2003, INTEGR COMP BIOL, V43, P591, DOI 10.1093/icb/43.4.591; Harun-Ur-Rashid M, 2009, CHEM REC, V9, P87, DOI 10.1002/tcr.20169; Garcia PD, 2007, ADV MATER, V19, P2597, DOI 10.1002/adma.200602426; Shawkey MD, 2006, J EXP BIOL, V209, P1245, DOI 10.1242/jeb.02115; Ge JP, 2011, ANGEW CHEM INT EDIT, V50, P1492, DOI 10.1002/anie.200907091; Mattsson J, 2009, NATURE, V462, P83, DOI 10.1038/nature08457; Takeoka Y, 2009, ACS APPL MATER INTER, V1, P982, DOI 10.1021/am900074v; Kinoshita S, 2005, CHEMPHYSCHEM, V6, P1442, DOI 10.1002/cphc.200500007; Ohko Y, 2003, NAT MATER, V2, P29, DOI 10.1038/nmat796; Arsenault AC, 2007, NAT PHOTONICS, V1, P468, DOI 10.1038/nphoton.2007.140; Shi L, 2013, ADV MATER, V25, P5314, DOI 10.1002/adma.201301909; Takeoka Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02371; Prum RO, 2004, J EXP BIOL, V207, P2157, DOI 10.1242/jeb.00989; Fudouzi H, 2003, LANGMUIR, V19, P9653, DOI 10.1021/la034918q; Aguirre CI, 2010, ADV FUNCT MATER, V20, P2565, DOI 10.1002/adfm.201000143; Ge DT, 2014, CHEM COMMUN, V50, P2469, DOI 10.1039/c3cc48962k; Takeoka Y, 2013, J MATER CHEM C, V1, P6059, DOI 10.1039/c3tc30885e; Forster JD, 2010, ADV MATER, V22, P2939, DOI 10.1002/adma.200903693; Kim SH, 2011, NPG ASIA MATER, V3, P25, DOI 10.1038/asiamat.2010.192; Furumi S, 2012, J MATER CHEM, V22, P21519, DOI 10.1039/c2jm34747d; Ge DT, 2014, J MATER CHEM C, V2, P4395, DOI 10.1039/c4tc00063c; Gotoh Y, 2012, NEW J CHEM, V36, P2171, DOI 10.1039/c2nj40368d; Harun-Ur-Rashid M, 2010, CHEMPHYSCHEM, V11, P579, DOI 10.1002/cphc.200900869; Hirashima R, 2014, J MATER CHEM C, V2, P344, DOI 10.1039/c3tc31438c; Kumoda M, 2006, LANGMUIR, V22, P4403, DOI 10.1021/la060224g; Miguez H, 2001, ADV MATER, V13, P393, DOI 10.1002/1521-4095(200103)13:6<393::AID-ADMA393>3.0.CO;2-4; Nakanishi T, 2011, CURR OPIN COLLOID IN, V16, P482, DOI 10.1016/j.cocis.2011.08.003; Rotstein R, 2014, J POLYM SCI POL PHYS, V52, P611, DOI 10.1002/polb.23458; Suzuki H, 2010, MACROMOLECULES, V43, P9945, DOI 10.1021/ma101439f	38	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		106	113		10.1038/pj.2014.125		8	Polymer Science	Polymer Science	CB2QS	WOS:000349473600006		
J	Tanaka, M; Sato, K; Kitakami, E; Kobayashi, S; Hoshiba, T; Fukushima, K				Tanaka, Masaru; Sato, Kazuhiro; Kitakami, Erika; Kobayashi, Shingo; Hoshiba, Takashi; Fukushima, Kazuki			Design of biocompatible and biodegradable polymers based on intermediate water concept	POLYMER JOURNAL			English	Review							OPENING METATHESIS POLYMERIZATION; POLY(2-METHOXYETHYL ACRYLATE) FILM; BLOOD-COMPATIBLE POLYMERS; FT-IR SPECTROSCOPY; PROTEIN ADSORPTION; ETHER METHACRYLATES; SIDE-CHAIN; POLY(TETRAHYDROFURFURYL ACRYLATE); 3-SUBSTITUTED CYCLOOCTENES; ANIONIC POLYMERIZATIONS	Polymeric biomaterials have significant impact in the aged society. Biocompatible and biodegradable polymers have emerged during the past decades to promise extraordinary breakthroughs in a wide range of diagnostic and therapeutic medical devices. Understanding and controlling the interfacial interactions of the polymeric biomaterials with biological elements, such as water, ions, proteins, bacteria, fungai and cells, are essential toward their successful implementation in biomedical applications. Here we highlight the recent developments of biocompatible and biodegradable fusion polymeric biomaterials for medical devices and provide an overview of the recent progress of the design of the multi-functional biomedical polymers by controlling bio-interfacial water structure through precision polymer synthesis and supramolecular chemistry.	[Tanaka, Masaru; Sato, Kazuhiro; Kitakami, Erika; Kobayashi, Shingo; Hoshiba, Takashi] Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan; [Tanaka, Masaru; Fukushima, Kazuki] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Tanaka, M (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Jonan 4-3-16, Yonezawa, Yamagata 9928510, Japan.	tanaka@yz.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI); Funding Program for Next Generation World-Leading Researchers (NEXT Program, Japan)	This work is supported by Grants-in-Aid and Special Coordination Funds for Promoting Science and Technology of Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI). We greatly acknowledge the financial support from Funding Program for Next Generation World-Leading Researchers (NEXT Program, Japan).	Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Ichikawa K, 2001, J POLYM SCI POL PHYS, V39, P2175, DOI 10.1002/polb.1191; Kitano H, 2001, J COLLOID INTERF SCI, V242, P133, DOI 10.1006/jcis.2001.7785; Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L; Han S, 2003, MACROMOLECULES, V36, P8312, DOI 10.1021/ma0347971; Palermo EF, 2010, APPL MICROBIOL BIOT, V87, P1605, DOI 10.1007/s00253-010-2687-z; Tanaka M, 2011, BBA-GEN SUBJECTS, V1810, P251, DOI 10.1016/j.bbagen.2010.10.002; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809; Yuan YL, 2004, POLYM INT, V53, P121, DOI 10.1002/pi.1122; Neugebauer D, 2007, POLYM INT, V56, P1469, DOI 10.1002/pi.2342; Jeong H, 2013, ORGANOMETALLICS, V32, P4843, DOI 10.1021/om400583t; Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008; Ishizone T, 2008, MACROMOLECULES, V41, P2963, DOI 10.1021/ma702828n; Miwa Y, 2009, POLYMER, V50, P6091, DOI 10.1016/j.polymer.2009.10.037; Martinez H, 2012, ACS CATAL, V2, P2547, DOI 10.1021/cs300549u; Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007; Kobayashi S, 2011, J AM CHEM SOC, V133, P5794, DOI 10.1021/ja201644v; Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004; Engler AC, 2012, NANO TODAY, V7, P201, DOI 10.1016/j.nantod.2012.04.003; Geihe EI, 2012, P NATL ACAD SCI USA, V109, P13171, DOI 10.1073/pnas.1211361109; Hatakeyama T, 2010, J BIOMAT SCI-POLYM E, V21, P1865, DOI 10.1163/092050610X486946; Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3; Tanaka M, 2013, POLYM J, V45, P701, DOI 10.1038/pj.2012.229; Oda Y, 2014, LANGMUIR, V30, P1215, DOI 10.1021/la404802j; Attia ABE, 2013, BIOMATERIALS, V34, P3132, DOI 10.1016/j.biomaterials.2013.01.042; Zhang JH, 2012, ACS MACRO LETT, V1, P1383, DOI 10.1021/mz300535r; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; Mochizuki A, 2009, J BIOMAT SCI-POLYM E, V20, P591, DOI 10.1163/156856209X426411; Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088; Hatakeyma T, 2007, THERMOCHIM ACTA, V465, P59, DOI 10.1016/j.tca.2007.09.005; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Hirata T, 2011, PHYS CHEM CHEM PHYS, V13, P4928, DOI 10.1039/c0cp02101f; Tanaka M, 2010, J BIOMAT SCI-POLYM E, V21, P1849, DOI 10.1163/092050610X517220; ERICKSON HP, 1981, J CELL BIOL, V91, P673, DOI 10.1083/jcb.91.3.673; Morita S, 2007, LANGMUIR, V23, P3750, DOI 10.1021/la0625998; Hatakeyama T, 2012, THERMOCHIM ACTA, V532, P159, DOI 10.1016/j.tca.2011.01.027; Nederberg F, 2009, BIOMACROMOLECULES, V10, P1460, DOI 10.1021/bm900056g; Nederberg F, 2011, NAT CHEM, V3, P409, DOI [10.1038/nchem.1012, 10.1038/NCHEM.1012]; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Oda Y, 2011, BIOMACROMOLECULES, V12, P3581, DOI 10.1021/bm200780r; Kitano H, 2004, MACROMOL CHEM PHYSIC, V205, P1651, DOI 10.1002/macp.200400135; Tanaka M, 2002, COLLOID SURFACE A, V203, P195, DOI 10.1016/S0927-7757(01)01100-1; Morita S, 2014, LANGMUIR, V30, P10698, DOI 10.1021/la502550d; Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y; Martinez H, 2014, POLYM CHEM-UK, V5, P3507, DOI 10.1039/c3py01787g; Kitano H, 2005, LANGMUIR, V21, P11932, DOI 10.1021/la0515571; Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m; Fukushima K, 2012, ACS NANO, V6, P9191, DOI 10.1021/nn3035217; Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219; Zhao B, 2005, MACROMOLECULES, V38, P9509, DOI 10.1021/ma0514572; Liu QS, 2013, BIOMACROMOLECULES, V14, P226, DOI 10.1021/bm301646y; Cao CZ, 2003, J CHEM INF COMP SCI, V43, P643, DOI 10.1021/ci0202990; Fernandez-Garcia M, 2000, POLYM INT, V49, P377, DOI 10.1002/(SICI)1097-0126(200004)49:4<377::AID-PI379>3.0.CO;2-O; Fukushima K., 2014, Patent application pending, Patent No. [JP2014 097237, 2014097237]; Fukushima K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3861; GRINNELL F, 1982, J BIOL CHEM, V257, P4888; Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018; Hayashi T, 2007, BIOINTERPHASES, V2, P119, DOI 10.1116/1.2794712; Hayashi T., 2012, PHYS CHEM CHEM PHYS, V14, P10194; Hoshiba T, 2014, ADV HEALTHC MATER, V3, P775, DOI 10.1002/adhm.201300309; ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J; Javakhishvili I, 2012, MACROMOL RAPID COMM, V33, P319, DOI 10.1002/marc.201100698; Jun Z., 2003, COLLOID SURFACE B, V28, P1, DOI 10.1016/S0927-7765(02)00116-9; Karagkiozaki V., 2014, HORIZONS CLIN NANOME; Kitakami E., 2014, BIOMED RES INT, V2014; Kitano H, 2008, MACROMOL BIOSCI, V8, P77, DOI 10.1002/mabi.200700082; LEE WF, 1994, POLYMER, V35, P2210, DOI 10.1016/0032-3861(94)90253-4; Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706; Martinez H, 2015, APPL PETROCHEM RES, V5, P19, DOI 10.1007/s13203-014-0048-z; Miwa Y, 2011, KOBUNSHI RONBUNSHU, V68, P133; Miwa Y, 2010, J BIOMAT SCI-POLYM E, V21, P1911, DOI 10.1163/092050610X489682; Kishi A, 2009, J APPL POLYM SCI, V111, P476, DOI 10.1002/app.29127; Morita S, 2010, J BIOMAT SCI-POLYM E, V21, P1925, DOI 10.1163/092050610X494613; Morita S, 2007, APPL SPECTROSC, V61, P867, DOI 10.1366/000370207781540051; Nell A. E., 2009, NAT MATER, V8, P543; Newcomb CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4321; Pitet LM, 2013, DALTON T, V42, P9079, DOI 10.1039/c2dt32695g; Severian D., 2002, POLYM BIOMATERIALS; Silva A. D., 2008, CHEM MATER, V20, P7292, DOI 10.1021/cm802295y; Tanabe A, 2008, APPL SPECTROSC, V62, P46, DOI 10.1366/000370208783412555; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; Tanaka M., 2011, Patent application JP, Patent No. [4853905, 20114853905]; Tanaka M., 2014, Patent application pending JP, Patent No. [105221, 2011105221]; Tanaka M., 2014, Patent application pending, Patent No. [JP2014-047347, 2014047347]; Tarannum N, 2013, REV ADV SCI ENG, V2, P90; Tsuruta T, 2010, J BIOMAT SCI-POLYM E, V21, P1831, DOI 10.1163/092050610X488269; Tsuruta T, 1996, ADV POLYM SCI, V126, P1; Tzoneva R, 2012, CLIN HEMORHEOL MICRO, V52, P337, DOI 10.3233/CH-2012-1609; van der Zee M, 2011, HANDBOOK OF BIODEGRADABLE POLYMERS: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS, P263; Yamanaka J, 2011, POLYM CHEM-UK, V2, P1837, DOI 10.1039/c1py00118c; Zhang JH, 2013, MACROMOLECULES, V46, P2535, DOI 10.1021/ma400092z	94	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		114	121		10.1038/pj.2014.129		8	Polymer Science	Polymer Science	CB2QS	WOS:000349473600007		
J	Zhu, FJ; Nishimura, T; Kato, T				Zhu, Fangjie; Nishimura, Tatsuya; Kato, Takashi			Organic/inorganic fusion materials: cyclodextrin-based polymer/CaCO3 hybrids incorporating dye molecules through host-guest interactions	POLYMER JOURNAL			English	Article							THIN-FILM COMPOSITES; CALCIUM-CARBONATE; SELF-ORGANIZATION; ORGANIC POLYMER; CACO3 MICROSPHERES; RELIEF STRUCTURES; BRUSH MATRICES; CRYSTALS; BIOMINERALIZATION; ARAGONITE	In this work, fluorescent and azo dyes were incorporated into CaCO3 and cyclodextrin (CD)-based network polymer thin-film hybrids through host-guest interactions. The hybrid films were prepared on poly(CD)s by a one-pot CaCl2 and Na2CO3 solution process in the presence of poly(acrylic acid). The hybrid-thin films containing fluorescent dyes demonstrate homogeneous fluorescence. The photoisomerization of azo dyes is observed in the solid thin-film hybrids.	[Zhu, Fangjie; Nishimura, Tatsuya; Kato, Takashi] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	Nishimura, T (reprint author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan.	tatsuya@chembio.t.u-tokyo.ac.jp; kato@chiral.t.u-tokyo.ac.jp	Nishimura, Tatsuya/A-3013-2013	Nishimura, Tatsuya/0000-0002-8416-4007	Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) [2206, 22107003]	We acknowledge financial support by a Grant-in-Aid for Scientific Research (No. 22107003) on the Innovative Areas: 'Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control' (Area no. 2206) from the Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT).	Alimada B, 2014, POLYM J, V46, P243, DOI 10.1038/pj.2013.92; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Kajiyama S, 2014, SMALL, V10, P1634, DOI 10.1002/smll.201302745; Oaki Y, 2005, ADV FUNCT MATER, V15, P1407, DOI 10.1002/adfm.200500025; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Hosoda N, 2003, MACROMOLECULES, V36, P6449, DOI 10.1021/ma025869b; Sugawara A, 2003, ANGEW CHEM INT EDIT, V42, P5299, DOI 10.1002/anie.200351541; Zhang Q, 2009, CHEM MATER, V21, P3216, DOI 10.1021/cm900810r; Dsouza RN, 2011, CHEM REV, V111, P7941, DOI 10.1021/cr200213s; Evans RA, 2005, NAT MATER, V4, P249, DOI 10.1038/nmat1326; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Zhu FJ, 2013, CHEM-ASIAN J, V8, P3002, DOI 10.1002/asia.201300745; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Zhu FJ, 2014, CRYSTENGCOMM, V16, P1496, DOI 10.1039/c3ce41649f; Hapiot F, 2006, CHEM REV, V106, P767, DOI 10.1021/cr050576c; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Oaki Y, 2008, ADV MATER, V20, P3633, DOI 10.1002/adma.200800773; Yao HB, 2011, CHEM SOC REV, V40, P3764, DOI 10.1039/c0cs00121j; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; IKEDA T, 1993, NATURE, V361, P428, DOI 10.1038/361428a0; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Oaki Y, 2012, POLYM J, V44, P612, DOI 10.1038/pj.2012.29; Tanaka Y, 2012, POLYM J, V44, P586, DOI 10.1038/pj.2012.28; Bandara HMD, 2012, CHEM SOC REV, V41, P1809, DOI 10.1039/c1cs15179g; Han YL, 2014, POLYM J, V46, P499, DOI 10.1038/pj.2014.36; Han YL, 2014, CRYSTENGCOMM, V16, P3540, DOI 10.1039/c3ce42646g; Kim YY, 2011, NAT MATER, V10, P890, DOI [10.1038/nmat3103, 10.1038/NMAT3103]; Ito K, 2012, POLYM J, V44, P38, DOI 10.1038/pj.2011.85; Gilbert PUPA, 2008, J AM CHEM SOC, V130, P17519, DOI 10.1021/ja8065495; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; Nishimura T, 2008, ANGEW CHEM INT EDIT, V47, P2800, DOI 10.1002/anie.200705062; Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P; Nudelman F, 2012, ANGEW CHEM INT EDIT, V51, P6582, DOI 10.1002/anie.201106715; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Shishido A, 2010, POLYM J, V42, P525, DOI 10.1038/pj.2010.45; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Guo XH, 2006, ANGEW CHEM INT EDIT, V45, P3977, DOI 10.1002/anie.200600029; Imai H, 2012, CRYST GROWTH DES, V12, P876, DOI 10.1021/cg201301x; Imai H, 2010, MRS BULL, V35, P138, DOI 10.1557/mrs2010.634; Kumagai H, 2012, FARADAY DISCUSS, V159, P483, DOI 10.1039/c2fd20057k; Oaki Y, 2008, J MATER CHEM, V18, P4140, DOI 10.1039/b810399b; Gries K, 2011, CRYST GROWTH DES, V11, P729, DOI 10.1021/cg101240e; Kato T, 2010, MRS BULL, V35, P127, DOI 10.1557/mrs2010.632; Sakamoto T, 2009, CRYST GROWTH DES, V9, P622, DOI 10.1021/cg8009628; Bender M. L., 1978, CYCLODEXTRIN CHEM; Cai GB, 2010, CRYSTENGCOMM, V12, P234, DOI 10.1039/b911426m; HARADA A, 1977, MACROMOLECULES, V10, P676, DOI 10.1021/ma60057a036; Harada A., 2012, SUPRAMOLECULAR POLYM; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Kato T, 2000, CHEM LETT, P186; Knopf G, 2013, OPTICAL NANO MICROAC; Lowenstam H. A., 1989, BIOMINERALIZATION; Mann S., 2001, BIOMINERALIZATION PR; Nishimura T, 2011, CHEM LETT, V40, P458, DOI 10.1246/cl.2011.458; Oaki Y, 2010, NANOSCALE, V2, P2362, DOI 10.1039/c0nr00393j; Rodriguez-Tenreiro C, 2006, PHARM RES, V23, P121, DOI 10.1007/s11095-005-8924-y; Sakamoto T, 2006, CHEM LETT, V35, P310, DOI 10.1246/cl.2006.310; Sakamoto T, 2009, POLYM J, V41, P522, DOI 10.1295/polymj.PJ2009024; Sugawara A, 2006, J POLYM SCI POL CHEM, V44, P5153, DOI 10.1002/pola.21604; Sugawara A, 2000, CHEM COMMUN, P487, DOI 10.1039/a909566g; Sugawara-Narutaki A, 2013, POLYM J, V45, P269, DOI 10.1038/pj.2012.171; Szejtli J., 1988, CYCLODEXTRIN TECHNOL; Tajima T, 2012, POLYM J, V44, P620, DOI 10.1038/pj.2012.36; Takashima Y, 2012, POLYM J, V44, P278, DOI 10.1038/pj.2011.128; YABE A, 1988, CHEM LETT, P1, DOI 10.1246/cl.1988.1; Yamaguchi H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1617	68	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		122	127		10.1038/pj.2014.123		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600008		
J	Zhou, SJ; Oda, Y; Shimojima, A; Okubo, T; Aoshima, S; Sugawara-Narutaki, A				Zhou, Shujun; Oda, Yukari; Shimojima, Atsushi; Okubo, Tatsuya; Aoshima, Sadahito; Sugawara-Narutaki, Ayae			Ring assembly of silica nanospheres mediated by amphiphilic block copolymers with oxyethylene moieties	POLYMER JOURNAL			English	Article							LIVING CATIONIC-POLYMERIZATION; COBALT NANOPARTICLE RINGS; FLUX-CLOSURE; QUANTUM DOTS; NANORINGS; SUPERSTRUCTURES; FABRICATION; TEMPLATE; BEHAVIOR; PENDANT	Silica nanospheres (SNSs) of ca. 15 nm in diameter assemble into nanoring structures with the aid of amphiphilic block copolymers containing the oxyethylene side chains poly[(2-ethoxyethyl vinyl ether)-block-(2-methoxyethyl vinyl ether)] [poly(EOVE-b-MOVE)]. Cryo-transmission electron microscope observation confirms that the ring assembly of SNSs occurs in the liquid phase. The SNSs favorably assemble into ring-like nanostructures in the presence of 1-2 wt% EOVE100-b-MOVE310 at pH similar to 7.8 and 45 degrees C. Irregular aggregates of SNSs form at 60 degrees C, most likely because of the hydrophobic collapse of the thermoresponsive block copolymer. A series of poly(EOVE-b-MOVE) with varying block lengths successfully induce the ring assembly of SNSs, whereas a random copolymer fails, indicating that the polymer's molecular structure critically affects the assembly mode of SNSs. Interestingly, SNSs of a larger size (ca. 30 nm) assemble one-dimensionally into chain-like nanostructures in the presence of EOVE100-b-MOVE310.	[Zhou, Shujun; Shimojima, Atsushi; Okubo, Tatsuya; Sugawara-Narutaki, Ayae] Univ Tokyo, Dept Chem Syst Engn, Tokyo, Japan; [Oda, Yukari; Aoshima, Sadahito] Osaka Univ, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan	Aoshima, S (reprint author), Osaka Univ, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan.	aoshima@chem.sci.osaka-u.ac.jp; ayae@apchem.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [2206]; China Scholarship Council (CSC); Global Center of Excellence for Mechanical Systems Innovation (GMSI, The University of Tokyo)	This work was supported by a Grant-in-Aid for Scientific Research on the Innovative Areas: 'Fusion Materials' (Area no. 2206) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. A part of this work was conducted in Center for Nano Lithography & Analysis, The University of Tokyo. S. Zhou is grateful for financial support from the China Scholarship Council (CSC) and the Global Center of Excellence for Mechanical Systems Innovation (GMSI, The University of Tokyo). We thank Professors Shokyoku Kanaoka and Arihiro Kanazawa (Osaka University) for valuable discussions.	Shafi KVPM, 1999, J PHYS CHEM B, V103, P3358, DOI 10.1021/jp984691l; Zhang L, 2008, J MATER CHEM, V18, P2660, DOI 10.1039/b718643f; Li L, 2012, CHEM-EUR J, V18, P11417, DOI 10.1002/chem.201200791; Sugihara S, 2005, MACROMOLECULES, V38, P1919, DOI 10.1021/ma048409m; Larson-Smith K, 2011, SOFT MATTER, V7, P5339, DOI 10.1039/c0sm01497d; Darwich S, 2011, NANOSCALE, V3, P1211, DOI 10.1039/c0nr00750a; Zanella M, 2011, CHEM COMMUN, V47, P203, DOI 10.1039/c0cc02477e; Zahr OK, 2012, NANO LETT, V12, P629, DOI 10.1021/nl203368v; Fukao M, 2009, J AM CHEM SOC, V131, P16344, DOI 10.1021/ja907013u; Yokoi T, 2006, J AM CHEM SOC, V128, P13664, DOI 10.1021/ja065071y; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Chen JX, 2009, ACS NANO, V3, P173, DOI 10.1021/nn800568t; Chang WS, 2009, NANO LETT, V9, P1152, DOI 10.1021/nl803796d; Tripp SL, 2003, ANGEW CHEM INT EDIT, V42, P5591, DOI 10.1002/anie.200352825; AOSHIMA S, 1992, J POLYM SCI POL CHEM, V30, P2407, DOI 10.1002/pola.1992.080301115; Yin YD, 2001, J AM CHEM SOC, V123, P8718, DOI 10.1021/ja011048v; Sun KS, 2010, LANGMUIR, V26, P8015, DOI 10.1021/la904907b; Zhou SJ, 2012, LANGMUIR, V28, P13181, DOI 10.1021/la302443f; Cai Y, 2008, J AM CHEM SOC, V130, P6076, DOI 10.1021/ja801438u; Surve M, 2006, LANGMUIR, V22, P969, DOI 10.1021/la052422y; Hu MJ, 2008, J AM CHEM SOC, V130, P11606, DOI 10.1021/ja804467g; Xiong Y, 2007, J PHYS CHEM C, V111, P6998, DOI 10.1021/jp070957p; Tripp SL, 2002, J AM CHEM SOC, V124, P7914, DOI 10.1021/ja0263285; Cai YJ, 2012, NANO LETT, V12, P4881, DOI 10.1021/nl302428z; Li SP, 2001, PHYS REV LETT, V86, P1102, DOI 10.1103/PhysRevLett.86.1102; AOSHIMA S, 1989, MACROMOLECULES, V22, P1009, DOI 10.1021/ma00193a001; Ciszek JW, 2010, ACS NANO, V4, P259, DOI 10.1021/nn901383d; Foldi P, 2008, NANO LETT, V8, P2556, DOI 10.1021/nl801858a; Fujii S, 2011, LANGMUIR, V27, P8605, DOI 10.1021/la201616s; Iler R.K., 1979, CHEM SILICA; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Kim JH, 2010, LANGMUIR, V26, P18634, DOI 10.1021/la104114f; Watanabe-Tamaki R, 2012, J PHYS CHEM C, V116, P15028, DOI 10.1021/jp302363v; Wei A, 2011, J MATER CHEM, V21, P16686, DOI [10.1039/c1jm1j916h, 10.1039/c1jm11916h]	34	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		128	135		10.1038/pj.2014.115		8	Polymer Science	Polymer Science	CB2QS	WOS:000349473600009		
J	Aoyama, R; Sako, H; Amakatsu, M; Yamanaka, M				Aoyama, Ryohei; Sako, Hiroki; Amakatsu, Mawo; Yamanaka, Masamichi			Palladium ion-induced supramolecular gel formation of tris-urea molecules	POLYMER JOURNAL			English	Article							ORGANIC FLUIDS; WEIGHT GEL; GELATION; DERIVATIVES; TRANSITION; CATALYST; GELATORS; STIMULI; SYSTEMS; WATER	A multicomponent supramolecular gel constructed from the self-assembly of pyridyl-substituted tris-urea 1 and Pd(OAc)(2) is reported. A mixture of 1 and Pd(OAc)(2) in dimethyl sulfoxide provided a supramolecular gel after brief ultrasound irradiation. The supramolecular gel changed into a sol/solution upon addition of chelating agents such as diamines and bidentate phosphine ligands. Dissociation of the coordination bonds between 1 and the palladium ion via addition of a chelating agent caused the phase transition. The Wacker oxidation of styrene was performed in the supramolecular gel. The reaction in the gel phase required a longer induction period to produce acetophenone than did the reaction in the homogeneous solution.	[Aoyama, Ryohei; Sako, Hiroki; Amakatsu, Mawo; Yamanaka, Masamichi] Shizuoka Univ, Grad Sch Sci, Dept Chem, Shizuoka 4228529, Japan	Yamanaka, M (reprint author), Shizuoka Univ, Grad Sch Sci, Dept Chem, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	smyaman@ipc.shizuoka.ac.jp			 [2206];  [23107514];  [25107713];  [24310089]	This work was supported by Grant-in-aid for the Scientific Research on the Innovative Areas: 'Fusion Materials' (Area No. 2206, Nos. 23107514 and 25107713) and Grant-in-aid for the Scientific Research (B) (No. 24310089).	George M, 2005, CHEM-EUR J, V11, P3243, DOI 10.1002/chem.200401066; van Gorp JJ, 2002, J AM CHEM SOC, V124, P14759, DOI 10.1021/ja020984n; Maeda H, 2008, CHEM-EUR J, V14, P11274, DOI 10.1002/chem.200801333; Babu SS, 2014, CHEM REV, V114, P1973, DOI 10.1021/cr400195e; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Hsueh SY, 2010, ANGEW CHEM INT EDIT, V49, P9170, DOI 10.1002/anie.201004090; Xing BG, 2002, CHEM-EUR J, V8, P5028, DOI 10.1002/1521-3765(20021104)8:21<5028::AID-CHEM5028>3.0.CO;2-1; Weiss RG, 2014, J AM CHEM SOC, V136, P7519, DOI 10.1021/ja503363v; Guler MO, 2007, J AM CHEM SOC, V129, P12082, DOI 10.1021/ja075044n; Arai S, 2006, CHEM LETT, V35, P634, DOI 10.1246/cl.2006.634; Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049; Weng WG, 2006, J AM CHEM SOC, V128, P11663, DOI 10.1021/ja063408q; Yamanaka M, 2007, TETRAHEDRON LETT, V48, P8990, DOI 10.1016/j.tetlet.2007.10.090; Estroff LA, 2000, ANGEW CHEM INT EDIT, V39, P3447, DOI 10.1002/1521-3773(20001002)39:19<3447::AID-ANIE3447>3.0.CO;2-X; Higashi D, 2013, CHEM-ASIAN J, V8, P2584, DOI 10.1002/asia.201300779; Byrne P, 2010, NEW J CHEM, V34, P2261, DOI 10.1039/c0nj00278j; Buerkle LE, 2012, CHEM SOC REV, V41, P6089, DOI 10.1039/c2cs35106d; Qi ZH, 2012, CHEM SCI, V3, P2073, DOI 10.1039/c2sc01018f; Yamanaka M, 2009, J ORG CHEM, V74, P5390, DOI 10.1021/jo900894q; Piepenbrock MOM, 2008, CHEM COMMUN, P2644, DOI 10.1039/b804259d; Naota T, 2005, J AM CHEM SOC, V127, P9324, DOI 10.1021/ja050809h; MURATA K, 1994, J AM CHEM SOC, V116, P6664, DOI 10.1021/ja00094a023; Tamaru S, 2002, TETRAHEDRON LETT, V43, P3751, DOI 10.1016/S0040-4039(02)00541-5; van Leeuwen PWNM, 2001, APPL CATAL A-GEN, V212, P61, DOI 10.1016/S0926-860X(00)00844-9; de Loos M, 2000, EUR J ORG CHEM, P3675; Yan XZ, 2012, ADV MATER, V24, P362, DOI 10.1002/adma.201103220; Isozaki K, 2007, ANGEW CHEM INT EDIT, V46, P2855, DOI 10.1002/anie.200605067; de Loos M, 2005, EUR J ORG CHEM, P3615, DOI 10.1002/ejoc.200400723; Hanabusa K, 1996, CHEM LETT, P885, DOI 10.1246/cl.1996.885; Jung J. H., 2012, CHEM SOC REV, V42, P924; Kato T, 2007, CHEM SOC REV, V36, P1857, DOI 10.1039/b612546h; Ogata K, 2012, CHEM LETT, V41, P498, DOI 10.1246/cl.2012.498; Rodriguez-Llansola F, 2009, J AM CHEM SOC, V131, P11478, DOI 10.1021/ja902589f; Schoonbeek FS, 1999, ANGEW CHEM INT EDIT, V38, P1393, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1393::AID-ANIE1393>3.0.CO;2-H; Shirakawa M, 2005, J AM CHEM SOC, V127, P4164, DOI 10.1021/ja042869d; TSUJI J, 1987, TETRAHEDRON LETT, V28, P3683, DOI 10.1016/S0040-4039(00)96354-8; Yabuuchi K, 2003, ORG BIOMOL CHEM, V1, P3464, DOI 10.1039/b307149a; Yamanaka M, 2013, J INCL PHENOM MACRO, V77, P33, DOI 10.1007/s10847-013-0299-9; Yamanaka M, 2011, CHEM-ASIAN J, V6, P1022, DOI 10.1002/asia.201000791; Yamanaka M, 2010, B CHEM SOC JPN, V83, P1127, DOI 10.1246/bcsj.20100136	40	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		136	140		10.1038/pj.2014.96		5	Polymer Science	Polymer Science	CB2QS	WOS:000349473600010		
J	Chen, WQ; Horike, S; Inukai, M; Kitagawa, S				Chen, Wenqian; Horike, Satoshi; Inukai, Munehiro; Kitagawa, Susumu			Study on a 2D layer coordination framework showing order-to-disorder phase transition by ionothermal synthesis	POLYMER JOURNAL			English	Article							METAL-ORGANIC FRAMEWORKS; FORMATE FRAMEWORK; IONIC LIQUIDS; FERROELECTRICITY; PERSPECTIVES; CRYSTALS	In this study, a two-dimensional (2D) layer-type coordination framework showing solid-to-solid phase transition was ionothermally synthesized. [Zn-2(SO4)(3)(bpy)](THMA)(2) contains an anionic 2D grid layer-type coordination framework and an ordered bulky ammonium cation, THMA(+), with multiple hydrogen bonds. The compound shows reversible order-to-disorder transformation, a result of the cations, which were characterized using X-ray diffraction, differential scanning calorimetry and solid state nuclear magnetic resonance. This study suggests the potential use of coordination frameworks, prepared by ionothermal synthesis, in the design of new type of materials that show solid-to-solid phase transition and high thermal stability for dielectric, ferroelectric and electro-optic functions.	[Chen, Wenqian; Horike, Satoshi; Kitagawa, Susumu] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan; [Horike, Satoshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Kitagawa, Susumu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6158510, Japan	Horike, S (reprint author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.	horike@sbchem.kyoto-u.ac.jp; kitagawa@icems.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; PRESTO program of the Japan Science and Technology Agency (JST)	This work was supported by a Grant-in-Aid for Scientific Research on the Innovative Areas: 'Fusion Materials' and Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and the PRESTO program of the Japan Science and Technology Agency (JST).	Jain P, 2008, J AM CHEM SOC, V130, P10450, DOI 10.1021/ja801952e; Freudenmann D, 2011, ANGEW CHEM INT EDIT, V50, P11050, DOI 10.1002/anie.201100904; Shang R, 2014, CHEM-EUR J, V20, P1146, DOI 10.1002/chem.201303425; TIMMERMANS J, 1961, J PHYS CHEM SOLIDS, V18, P1, DOI 10.1016/0022-3697(61)90076-2; Parnham ER, 2007, ACCOUNTS CHEM RES, V40, P1005, DOI 10.1021/ar700025k; Cooper ER, 2004, NATURE, V430, P1012, DOI 10.1038/nature02860; Horiuchi S, 2005, NAT MATER, V4, P163, DOI 10.1038/nmat1298; Zhu QQ, 2014, INORG CHEM, V53, P8708, DOI 10.1021/ic501336x; Zhang W, 2012, CHEM REV, V112, P1163, DOI 10.1021/cr200174w; MacFarlane DR, 2001, ADV MATER, V13, P957, DOI 10.1002/1521-4095(200107)13:12/13<957::AID-ADMA957>3.0.CO;2-#; Tang YY, 2014, CHEM-ASIAN J, V9, P1771, DOI 10.1002/asia.201402132; Pardo E, 2012, ANGEW CHEM INT EDIT, V51, P8356, DOI 10.1002/anie.201202848; Xu GC, 2010, J AM CHEM SOC, V132, P9588, DOI 10.1021/ja104263m; Maczka M, 2014, INORG CHEM, V53, P787, DOI 10.1021/ic4020702; Kreuer KD, 1996, CHEM MATER, V8, P610, DOI 10.1021/cm950192a; Sun ZH, 2012, ANGEW CHEM INT EDIT, V51, P3871, DOI 10.1002/anie.201200407; Stroppa A, 2013, ADV MATER, V25, P2284, DOI 10.1002/adma.201204738; Li MY, 2011, DALTON T, V40, P6038, DOI 10.1039/c1dt10241a; Aidoudi FH, 2011, NAT CHEM, V3, P801, DOI [10.1038/nchem.1129, 10.1038/NCHEM.1129]; Pringle JM, 2010, J MATER CHEM, V20, P2056, DOI 10.1039/b920406g; Weng DF, 2011, CHEM SOC REV, V40, P3157, DOI 10.1039/c0cs00093k; Jain P, 2009, J AM CHEM SOC, V131, P13625, DOI 10.1021/ja904156s; Sanchez-Andujar M, 2010, INORG CHEM, V49, P1510, DOI 10.1021/ic901872g	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		141	145		10.1038/pj.2014.100		5	Polymer Science	Polymer Science	CB2QS	WOS:000349473600011		
J	Matsuura, K; Ueno, G; Fujita, S				Matsuura, Kazunori; Ueno, Genki; Fujita, Seiya			Self-assembled artificial viral capsid decorated with gold nanoparticles	POLYMER JOURNAL			English	Article							COWPEA MOSAIC-VIRUS; DE-NOVO DESIGN; PEPTIDE; DNA; NANOSTRUCTURES; CONSTRUCTION; NANOCRYSTALS; NANOSCALE; SCAFFOLDS; PROTEINS	The decoration of a peptide-based artificial viral capsid with gold nanoparticles (AuNPs) is reported. beta-Annulus GGGCG-bearing peptide as a binding site of AuNPs self-assembled into nanocapsules with a diameter of 50 nm. The addition of AuNPs to the peptide nanocapsules afforded relatively uncontrolled assemblies of AuNPs. In contrast, the self-assembly of AuNP-peptide conjugates afforded, after dialysis, controlled assemblies of AuNPs with sizes of 30-60 nm. zeta-Potential measurements revealed that the surface of the artificial viral capsid self-assembled from beta-annulus peptide was coated with AuNPs.	[Matsuura, Kazunori; Ueno, Genki; Fujita, Seiya] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan	Matsuura, K (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Koyama Minami 4-101, Tottori 6808552, Japan.	ma2ra-k@chem.tottori-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan (MEXT) [2206]; Asahi Glass Foundation	This research was partially supported by a Grant-in-Aid for Scientific Research on the Innovative Areas of 'Fusion Materials' (No. 2206) from the Ministry of Education, Science, Sports and Culture of Japan (MEXT) and by the Asahi Glass Foundation.	Gradisar H, 2013, NAT CHEM BIOL, V9, P362, DOI 10.1038/nchembio.1248; Bronstein LM, 2011, SMALL, V7, P1609, DOI 10.1002/smll.201001992; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Witus LS, 2011, ACCOUNTS CHEM RES, V44, P774, DOI 10.1021/ar2001292; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Gothelf KV, 2005, ORG BIOMOL CHEM, V3, P4023, DOI 10.1039/b510551j; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Mastroianni AJ, 2009, J AM CHEM SOC, V131, P8455, DOI 10.1021/ja808570g; Matsuurua K, 2014, RSC ADV, V4, P2942, DOI 10.1039/c3ra45944f; Blum AS, 2004, NANO LETT, V4, P867, DOI 10.1021/nl0497474; Matsuura K, 2010, ANGEW CHEM INT EDIT, V49, P9662, DOI 10.1002/anie.201004606; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Boyle AL, 2012, J AM CHEM SOC, V134, P15457, DOI 10.1021/ja3053943; Steinmetz NF, 2007, ORG BIOMOL CHEM, V5, P2891, DOI 10.1039/b708175h; Matsuura K, 2013, POLYM J, V45, P529, DOI 10.1038/pj.2012.235; Matsuura K, 2012, POLYM J, V44, P469, DOI 10.1038/pj.2012.16; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Blum AS, 2005, SMALL, V1, P702, DOI 10.1002/smll.200500021; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Niikura K, 2009, BIOCONJUGATE CHEM, V20, P1848, DOI 10.1021/bc900255x; Fujita S, 2014, NANOMATERIALS-BASEL, V4, P778, DOI 10.3390/nano4030778; Kuzuya A, 2012, POLYM J, V44, P452, DOI 10.1038/pj.2012.38; Louis C, 2012, GOLD NANOPARTICLES FOR PHYSICS, CHEMISTRY AND BIOLOGY, P1, DOI 10.1142/p815; Nagakawa K, 2012, CHEM LETT, V41, P113, DOI 10.1246/cl.2012.113; Nonoyama T, 2011, ACS NANO, V5, P6174, DOI 10.1021/nn200711x; Ramakers BEI, 2014, CHEM SOC REV, V43, P2743, DOI 10.1039/c3cs60362h; Ryadnov MG, 2003, J AM CHEM SOC, V125, P9388, DOI 10.1021/ja0352045; Sawada T, 2009, J AM CHEM SOC, V131, P14434, DOI 10.1021/ja905250u; Soto CM, 2004, ELECTROPHORESIS, V25, P2901, DOI 10.1002/elps.200306029; Tamaki T, 2010, CHEM LETT, V39, P1084, DOI 10.1246/cl.2010.1084; Wan XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04529; Wang Q, 2002, ANGEW CHEM INT EDIT, V41, P459	36	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		146	151		10.1038/pj.2014.99		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600012		
J	Karasawa, Y; Kimura, M; Kanazawa, A; Kanaoka, S; Aoshima, S				Karasawa, Yukari; Kimura, Madoka; Kanazawa, Arihiro; Kanaoka, Shokyoku; Aoshima, Sadahito			New initiating systems for cationic polymerization of plant-derived monomers: GaCl3/alkylbenzene-induced controlled cationic polymerization of beta-pinene	POLYMER JOURNAL			English	Article							LIVING CARBOCATIONIC POLYMERIZATION; SOLVENTS; ISOBUTYLENE; COMPLEX; HALIDES; ARENES	An initiating system composed of GaCl3 and an alkylbenzene was demonstrated to be highly effective for the controlled cationic polymerization of a plant-derived monomer, beta-pinene. Alkylbenzenes such as pentamethylbenzene and hexamethylbenzene were shown to function as suitable additives for the polymerization of beta-pinene, an alkene monomer with low reactivity, although the alkylbenzenes are much less basic than conventional additives such as esters and ethers for base-assisting living cationic polymerization. For example, when two equivalents of hexamethylbenzene were added to GaCl3 in conjunction with 2-chloro-2,4,4-trimethylpentane as an initiator, cationic polymerization of beta-pinene successfully proceeded in a living manner at -78 degrees C. Successful control over the reaction, i.e., control of an active-dormant equilibrium, was attributed to the formation of a complex between GaCl3 and the alkylbenzene, as confirmed by UV-vis and Ga-71 NMR analyses.	[Karasawa, Yukari; Kimura, Madoka; Kanazawa, Arihiro; Kanaoka, Shokyoku; Aoshima, Sadahito] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan	Aoshima, S (reprint author), Osaka Univ, Grad Sch Sci, Dept Macromol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	aoshima@chem.sci.osaka-u.ac.jp			MEXT [2206, 22107006]	This work was partially supported by a Grant-in-Aid for Scientific Research (No. 22107006) on Innovative Areas of 'Fusion Materials' (No. 2206) from MEXT.	SAWAMOTO M, 1991, PROG POLYM SCI, V16, P111, DOI 10.1016/0079-6700(91)90008-9; Yao KJ, 2013, MACROMOLECULES, V46, P1689, DOI 10.1021/ma3019574; Aoshima S, 2007, J POLYM SCI POL CHEM, V45, P1801, DOI 10.1002/pola.21995; Aoshima S, 2009, CHEM REV, V109, P5245, DOI 10.1021/cr900225g; Lu J, 1997, MACROMOLECULES, V30, P22, DOI 10.1021/ma960118t; ROBERTS WJ, 1950, J AM CHEM SOC, V72, P1226, DOI 10.1021/ja01159a044; Laurence C, 2010, J ORG CHEM, V75, P4105, DOI 10.1021/jo100461z; Goethals EJ, 2007, PROG POLYM SCI, V32, P220, DOI 10.1016/j.progpolymsci.2007.01.001; Puskas JE, 2000, PROG POLYM SCI, V25, P403, DOI 10.1016/S0079-6700(00)00010-1; Bengtsson L. A., 1995, J CHEM SOC DA, P255; Burroughs S. G., 1943, U.S. Patent, Patent No. [2,335,912, 2335912]; Cerny Z, 1996, INORG CHIM ACTA, V247, P119, DOI 10.1016/0020-1693(95)04947-9; De P., 2007, MACROMOLECULAR ENG P; FAUST R, 1986, POLYM BULL, V15, P317; GUTMANN V, 1976, COORDIN CHEM REV, V18, P225, DOI 10.1016/S0010-8545(00)82045-7; Kennedy J. P, 1992, DESIGNED POLYM CARBO; Kennedy J. P., 1982, CARBOCATIONIC POLYM; Kennedy JP, 1999, J POLYM SCI POL CHEM, V37, P2285, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2285::AID-POLA1>3.0.CO;2-P; KILPATRICK M, 1953, J AM CHEM SOC, V75, P577, DOI 10.1021/ja01099a017; MARCUS Y, 1984, J SOLUTION CHEM, V13, P599, DOI 10.1007/BF00650369; Matyjaszewski K., 1996, CATIONIC POLYM; MCCAULAY DA, 1951, J AM CHEM SOC, V73, P2013, DOI 10.1021/ja01149a033; Musso F, 1997, ORGANOMETALLICS, V16, P4889, DOI 10.1021/om970438g; PELLETIER G, 1989, J ELECTROCHEM SOC, V136, P1082, DOI 10.1149/1.2096788; PERSSON I, 1987, INORG CHIM ACTA, V129, P183, DOI 10.1016/S0020-1693(00)86662-1; Roth M, 1996, MACROMOLECULES, V29, P6104, DOI 10.1021/ma960236g; Satoh K, 2006, GREEN CHEM, V8, P878, DOI 10.1039/b607789g; Satoh K, 2014, POLYM CHEM-UK, V5, P3222, DOI 10.1039/c3py01320k; SOLARI E, 1989, J CHEM SOC CHEM COMM, P1747, DOI 10.1039/c39890001747; SOLARI E, 1994, INORG CHEM, V33, P2018, DOI 10.1021/ic00087a044	30	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		152	157		10.1038/pj.2014.108		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600013		
J	Morimune-Moriya, S; Kondo, S; Sugawara-Narutaki, A; Nishimura, T; Kato, T; Ohtsuki, C				Morimune-Moriya, Seira; Kondo, Sakina; Sugawara-Narutaki, Ayae; Nishimura, Tatsuya; Kato, Takashi; Ohtsuki, Chikara			Hydroxyapatite formation on oxidized cellulose nanofibers in a solution mimicking body fluid	POLYMER JOURNAL			English	Article							TEMPO-MEDIATED OXIDATION; APATITE FORMATION; NANOPAPER STRUCTURES; POLYAMIDE FILMS; SURFACE; ACID; COMPOSITES; CACO3; BIOMINERALIZATION; MACROMOLECULES	Biomimetic processing using a solution mimicking the inorganic composition of the body fluid of humans (simulated body fluid (SBF)) may be one of the more promising routes for the construction of polymer/hydroxyapatite composites by an environmental-friendly method. In this process, hydroxyapatite nucleation on an organic polymer is an important event, yet the optimal surface characteristics of the organic polymer have not been determined. In the present study, a series of oxidized cellulose nanofibers with different contents of the carboxy groups (0-27% per glucose units of cellulose) were prepared. Their capability of forming hydroxyapatite in 1.5SBF (a solution in which the concentration of the inorganic ions was 1.5 times higher than that in SBF) was systematically investigated. It was found that hydroxyapatite formation on the nanofibers was the most enhanced with a nanofiber containing a carboxy group content of 9.9%, indicating that there was an optimum amount of carboxy groups that was required for the effective induction of hydroxyapatite nucleation. Carboxy groups are considered to be involved in the electrostatic interactions between the fibers and the calcium ions in solution and they induce heterogeneous nucleation of hydroxyapatite. Higher contents of carboxy groups, however, reduced the activity of the calcium ions for the nucleation of hydroxyapatite by forming complexes with the calcium ions.	[Morimune-Moriya, Seira; Kondo, Sakina; Sugawara-Narutaki, Ayae; Ohtsuki, Chikara] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan; [Morimune-Moriya, Seira] Nagoya Univ, Venture Business Lab, Nagoya, Aichi 4648603, Japan; [Nishimura, Tatsuya; Kato, Takashi] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan	Ohtsuki, C (reprint author), Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan.	ohtsuki@apchem.nagoya-u.ac.jp	Nishimura, Tatsuya/A-3013-2013; Ohtsuki, Chikara/E-4973-2010	Nishimura, Tatsuya/0000-0002-8416-4007; 	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22107003, 22107005, 22107007, 2206]	This work was supported by a Grant-in-Aid for Scientific Research (No. 22107003, 22107005 and 22107007) on the Innovative Areas of 'Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control' (No. 2206) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082; Ajayan P.M., 2003, NANOCOMPOSITE SCI TE; Kato T, 1999, CHEM LETT, P199; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wang Y, 2012, NAT MATER, V11, P724, DOI [10.1038/nmat3362, 10.1038/NMAT3362]; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Sehaqui H, 2012, ACS APPL MATER INTER, V4, P1043, DOI 10.1021/am2016766; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Fujisawa S, 2013, BIOMACROMOLECULES, V14, P1541, DOI 10.1021/bm400178m; Zhang RY, 2004, MACROMOL BIOSCI, V4, P100, DOI 10.1002/mabi.200300017; Nishino T, 2007, BIOMACROMOLECULES, V8, P2712, DOI 10.1021/bm0703416; Morimune S, 2012, POLYM J, V44, P1056, DOI 10.1038/pj.2012.58; Kljun A, 2011, BIOMACROMOLECULES, V12, P4121, DOI 10.1021/bm201176m; Takeuchi A, 2008, J MATER SCI-MATER M, V19, P387, DOI 10.1007/s10856-007-3179-2; Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n; USUKI A, 1993, J MATER RES, V8, P1179, DOI 10.1557/JMR.1993.1179; Yamamoto Y, 2010, POLYM J, V42, P583, DOI 10.1038/pj.2010.32; Qi HS, 2009, BIOMACROMOLECULES, V10, P1597, DOI 10.1021/bm9001975; Shinoda R, 2012, BIOMACROMOLECULES, V13, P842, DOI 10.1021/bm2017542; OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3; Sehaqui H, 2012, BIOMACROMOLECULES, V13, P3661, DOI 10.1021/bm301105s; Isogai A, 1998, CELLULOSE, V5, P153, DOI 10.1023/A:1009208603673; Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769; CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x; Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6; Tanahashi M, 1997, J BIOMED MATER RES, V34, P305; Chi C, 2009, MATER CHEM PHYS, V115, P808, DOI 10.1016/j.matchemphys.2009.02.026; Rhee SH, 1998, J AM CERAM SOC, V81, P3029; Chujo Y, 2001, MRS BULL, V26, P389, DOI 10.1557/mrs2001.92; Jing H, 2014, POLYM J, V46, P307, DOI 10.1038/pj.2013.100; Kawai T, 2004, BIOMATERIALS, V25, P4529, DOI 10.1016/j.biomaterials.2003.11.039; Kochumalayil JJ, 2013, BIOMACROMOLECULES, V14, P3842, DOI 10.1021/bm400883e; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Mann S., 2001, BIOMINERALIZATION PR; Miyazaki T, 2003, J MATER SCI-MATER M, V14, P569, DOI 10.1023/A:1024000821368; Obara S, 2010, POLYM J, V42, P161, DOI 10.1038/pj.2009.310; Rhee SH, 2000, J MATER SCI-MATER M, V11, P449, DOI 10.1023/A:1008992009826; Saito T, 2014, MATER HORIZONS, V1, P321, DOI 10.1039/c3mh00134b; Sugawara-Narutaki A, 2013, POLYM J, V45, P269, DOI 10.1038/pj.2012.171; Yokoi T., 2013, J ASIAN CERAM SOC, V1, P155	42	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		158	163		10.1038/pj.2014.127		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600014		
J	Takeoka, Y; Hayashi, M; Sugiyama, N; Yoshizawa-Fujita, M; Aizawa, M; Rikukawa, M				Takeoka, Yuko; Hayashi, Miki; Sugiyama, Nami; Yoshizawa-Fujita, Masahiro; Aizawa, Mamoru; Rikukawa, Masahiro			In situ preparation of poly(L-lactic acid-co-glycolic acid)/hydroxyapatite composites as artificial bone materials	POLYMER JOURNAL			English	Article							MECHANICAL-PROPERTIES; LONG-TERM; L-LACTIDE; HYDROXYAPATITE; POLYMERIZATION; DEGRADATION; VITRO; BIOMATERIALS; FABRICATION; COPOLYMERS	Poly(L-lactic acid-co-glycolic acid)/hydroxyapatite (PLGA/HAp) composites were fabricated by the in situ polymerization of L-lactide and glycolide in porous HAp disks, using lipase MM, derived from Mucor miehei, as a catalyst. Various PLGA/HAp composites were obtained by changing the feed ratio of L-lactide and glycolide. The fourier transform infrared spectroscopy, scanning electron microscopy and porosity measurements showed that the porous HAp was completely filled with PLGA after polymerization at 100 degrees C for 9 days. Lactyl unit fractions (FL) of obtained PLGA calculated from the 1H nuclear magnetic resonance were consistent with the feed fraction of L-lactide (fL). The PGA/HAp, PLGA20/HAp, PLGA50/HAp, PLGA80/HAp and PLLA/HAp composites showed maximum bending strengths of 91.1 MPa, 78.8 MPa, 73.4 MPa, 54.3 MPa and 67.0 MPa, respectively. These values were 4.7-2.8 times greater than that of the untreated porous HAp disks and were suitable for artificial bone materials. The cell adhesion and proliferation properties of these materials with osteoblast-like MC3T3-E1 cells suggest that these PLGA/HAp composites have suitably bioactive surfaces. The PLGA/HAp composites showed higher alkaline phosphatase activity after cultivation of rat bone marrow stromal cells.	[Takeoka, Yuko; Hayashi, Miki; Sugiyama, Nami; Yoshizawa-Fujita, Masahiro; Rikukawa, Masahiro] Sophia Univ, Dept Mat & Life Sci, Tokyo 1028554, Japan; [Aizawa, Mamoru] Meiji Univ, Dept Appl Chem, Kawasaki, Kanagawa, Japan	Takeoka, Y (reprint author), Sophia Univ, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.	y-tabuch@sophia.ac.jp			JSPS KAKENHI	This work was partly supported by JSPS KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas 'Fusion Materials'.	Aizawa M., 2004, PHOSPHORUS RES B, V17, P209; FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927; Aizawa M, 2005, BIOMATERIALS, V26, P3427, DOI 10.1016/j.biomaterials.2004.09.044; VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003; Joukainen A, 2007, J ORTHOP SCI, V12, P28, DOI 10.1007/s00776-006-1077-y; Aizawa M, 2000, J CERAM SOC JPN, V108, P249, DOI 10.2109/jcersj.108.1255_249; Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2; Lee JW, 2001, MACROMOLECULES, V34, P3928, DOI 10.1021/ma0022351; Kannan S, 2006, CHEM MATER, V18, P2181, DOI 10.1021/cm052567q; Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9; [Anonymous], 2008, F231310 ASTM; Nazhat SN, 2000, J MATER SCI-MATER M, V11, P621, DOI 10.1023/A:1008957729512; BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323; Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Matsumura S, 2002, MACROMOL BIOSCI, V2, P105, DOI 10.1002/1616-5195(20020401)2:3<105::AID-MABI105>3.0.CO;2-K; Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t; Orefice R, 2010, BIOMACROMOLECULES, V11, P657, DOI 10.1021/bm901228a; Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018; Aydin E, 2011, J MATER SCI-MATER M, V22, P2413, DOI 10.1007/s10856-011-4435-z; Backstrom A., 2005, VET SURG, V34, P11; Chu KT, 2004, BIO-MED MATER ENG, V14, P87; Ehrenfried LM, 2009, BIOMACROMOLECULES, V10, P1976, DOI 10.1021/bm900397d; Isama K, 2003, BIOMATERIALS, V24, P3303, DOI 10.1016/S0142-9612(03)00216-3; Ishii S, 2003, J BIOMED MATER RES B, V66B, P539, DOI 10.1002/jbm.b.10027; Matsumura S, 1998, MACROMOL SYMP, V130, P285, DOI 10.1002/masy.19981300125; MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246; Miyazaki T, 2009, J MATER SCI-MATER M, V20, P157, DOI 10.1007/s10856-008-3556-5; Pearson R., 2000, ACS SYM SER, V759, P1; Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015; Sugiyama N, 2013, CHEM LETT, V42, P465, DOI 10.1246/cl.130013; Sugiyama N, 2013, KOBUNSHI RONBUNSHU, V70, P185; Sugiyama N, 2007, CHEM LETT, V36, P1476, DOI 10.1246/cl.2007.1476; Suriyan R., 2011, J APPL POLYM SCI, V122, P2433; Tanaka H, 2000, PHYS CHEM CHEM PHYS, V2, P2647, DOI 10.1039/b001877p; VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2; White A., 2009, BONE REPAIR BIOMATER, P122; Wiegand T, 2008, CHEM MATER, V20, P5016, DOI 10.1021/cm800895r	38	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		164	170		10.1038/pj.2014.121		7	Polymer Science	Polymer Science	CB2QS	WOS:000349473600015		
J	Nakashima, T; Hayakawa, Y; Mori, M; Kawai, T				Nakashima, Takuya; Hayakawa, Yu; Mori, Midori; Kawai, Tsuyoshi			Preparation of fusion materials based on ionic liquids and cationic gold nanoparticles	POLYMER JOURNAL			English	Article							COLLOIDAL STABILITY; COMPOSITE-MATERIALS; CARBON NANOTUBES; QUANTUM DOTS; MOLTEN-SALTS; IONOGELS; MEDIA; TRANSITION; CATALYSIS; BEHAVIOR	Fusion materials based on cationic gold nanoparticles mixed with ionic liquids were prepared. An anion exchange of the surface-capping ligand on the gold nanoparticles from a halogen anion to bis(trifluoromethanesulfonyl) amide (Tf2N) in an aqueous solution afforded nanoparticles showing infinite miscibility with Tf2N-based ionic liquids. The thermal decomposition temperature of the gold nanoparticle was elevated by 100 degrees C after the anion-exchange process. The ionic liquid-like structure of the surface-capping ligand with Tf2N anions led to a glassy solid material with a densely packed assembly of nanoparticles, in which a portion of nanoparticles formed superlattices. A fusion material of ionic liquid and gold nanoparticles with a gold content as high as 40 wt% was obtained by the co-solvent evaporation method using acetone. The stable dispersion of gold nanoparticles in the fusion materials with a high gold content was confirmed by the clear appearance of the plasmon absorption of gold nanoparticles in an optical microscopic image, as well as in an absorption spectrum. The use of an ionic liquid-based monomer yielded a gold nanoparticle-ionic liquid polymer composite, in which the gold nanoparticles showed a high thermal stability.	[Nakashima, Takuya; Hayakawa, Yu; Mori, Midori; Kawai, Tsuyoshi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan	Nakashima, T (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5 Takayama, Nara 6300192, Japan.	ntaku@ms.naist.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2206]	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas of 'Fusion Materials' (Area no. 2206) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Templeton AC, 2000, J PHYS CHEM B, V104, P564, DOI 10.1021/jp991889c; Bourlinos AB, 2005, ADV MATER, V17, P234, DOI 10.1002/adma.2004001060; Lu YY, 2012, ADV MATER, V24, P4430, DOI 10.1002/adma.201201953; Torimoto T, 2010, ADV MATER, V22, P1196, DOI 10.1002/adma.200902184; Ueno K, 2010, J PHYS CHEM B, V114, P13095, DOI 10.1021/jp106872w; Warren SC, 2006, J AM CHEM SOC, V128, P12074, DOI 10.1021/ja064469r; Ueno K, 2008, LANGMUIR, V24, P5253, DOI 10.1021/la704066v; MacFarlane DR, 2010, PHYS CHEM CHEM PHYS, V12, P1659, DOI 10.1039/b923053j; Dupont J, 2010, CHEM SOC REV, V39, P1780, DOI 10.1039/b822551f; Parvulescu VI, 2007, CHEM REV, V107, P2615, DOI 10.1021/cr050948h; Kato T, 2002, SCIENCE, V295, P2414, DOI 10.1126/science.1070967; Nakashima T, 2005, CHEM COMMUN, P1643, DOI 10.1039/b418001a; Lopes JNAC, 2006, J PHYS CHEM B, V110, P3330, DOI 10.1021/jp056006y; Fumino K, 2008, ANGEW CHEM INT EDIT, V47, P8731, DOI 10.1002/anie.200803446; Dupont J, 2011, ACCOUNTS CHEM RES, V44, P1223, DOI 10.1021/ar2000937; Choudhury AR, 2006, CRYSTENGCOMM, V8, P742, DOI 10.1039/b609598d; Nakashima T, 2008, POLYM ADVAN TECHNOL, V19, P1401, DOI 10.1002/pat.1202; Ueno K, 2011, LANGMUIR, V27, P9105, DOI 10.1021/la103942f; Liu XM, 2012, OPT EXPRESS, V20, P13457, DOI 10.1364/OE.20.013457; Scholten JD, 2012, ACS CATAL, V2, P184, DOI 10.1021/cs200525e; Le Bideau J, 2011, CHEM SOC REV, V40, P907, DOI 10.1039/c0cs00059k; Fukushima T, 2003, SCIENCE, V300, P2072, DOI 10.1126/science.1082289; Fukushima T, 2007, CHEM-EUR J, V13, P5048, DOI 10.1002/chem.200700554; Fredlake CP, 2004, J CHEM ENG DATA, V49, P954, DOI 10.1021/je034261a; Ueno K, 2010, PHYS CHEM CHEM PHYS, V12, P4066, DOI 10.1039/b923571j; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Antonietti M, 2004, ANGEW CHEM INT EDIT, V43, P4988, DOI 10.1002/anie.200460091; Nakashima T, 2003, J AM CHEM SOC, V125, P6386, DOI 10.1021/ja034954b; Han X, 2007, ACCOUNTS CHEM RES, V40, P1079, DOI 10.1021/ar700044y; Greaves TL, 2008, CHEM SOC REV, V37, P1709, DOI 10.1039/b801395k; Hayes R, 2010, PHYS CHEM CHEM PHYS, V12, P1709, DOI 10.1039/b920393a; Kimizuka N, 2001, LANGMUIR, V17, P6759, DOI 10.1021/la015523e; Zhong ZY, 2004, J PHYS CHEM B, V108, P4046, DOI 10.1021/jp037056a; Sha ML, 2010, LANGMUIR, V26, P12667, DOI 10.1021/la101107b; Bernardi F, 2009, CHEM PHYS LETT, V479, P113, DOI 10.1016/j.cplett.2009.07.110; Itoh H, 2004, J AM CHEM SOC, V126, P3026, DOI 10.1021/ja039895g; Nakashima T, 2012, POLYM J, V44, P665, DOI 10.1038/pj.2012.73; Triolo A, 2007, J PHYS CHEM B, V111, P4641, DOI 10.1021/jp067705t; Smiglak M, 2014, CHEM COMMUN, V50, P9228, DOI 10.1039/c4cc02021a; Ma Z, 2010, ADV MATER, V22, P261, DOI 10.1002/adma.200900603; Bara JE, 2010, ACCOUNTS CHEM RES, V43, P152, DOI 10.1021/ar9001747; Moganty SS, 2012, CHEM MATER, V24, P1386, DOI 10.1021/cm300424v; Israelachvili J. N., 1991, INTERMOLECULAR SURFA; Kauling A, 2013, LANGMUIR, V29, P14301, DOI 10.1021/la403388b; Kim Y, 2012, J MATER CHEM, V22, P11488, DOI 10.1039/c2jm30815k; Liu XM, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3276914; Nakashima T, 2005, CHEM LETT, V34, P1410, DOI 10.1246/cl.2005.1410; Nakashima T, 2010, NANOSCALE, V2, P2084, DOI 10.1039/b9nr00333a; Nakashima T, 2011, LANGMUIR, V27, P1281, DOI 10.1021/la1038987; Ono T, 2012, ACS MACRO LETT, V1, P1270, DOI 10.1021/mz3002879; Tatumi R, 2005, CHEM COMMUN, P83, DOI 10.1039/b413385d; Torimoto T., 2006, APPL PHYS LETT, V89; Yonezawa T, 2002, CHEM LETT, P1172, DOI 10.1246/cl.2002.1172	53	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		171	176		10.1038/pj.2014.103		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600016		
J	Kuzuya, A; Kaino, M; Hashizume, M; Matsumoto, K; Uehara, T; Matsuo, Y; Mitomo, H; Niikura, K; Ijiro, K; Ohya, Y				Kuzuya, Akinori; Kaino, Masafumi; Hashizume, Mirai; Matsumoto, Kazuki; Uehara, Takeaki; Matsuo, Yasutaka; Mitomo, Hideyuki; Niikura, Kenichi; Ijiro, Kuniharu; Ohya, Yuichi			Encapsulation of a gold nanoparticle in a DNA origami container	POLYMER JOURNAL			English	Article							NANOSTRUCTURES; SCAFFOLDS; BOX	A box-shaped' three-dimensional (3D) DNA origami of similar to 40-nm dimensions was selectively formed by closing a symmetric open motif with three orthogonal faces. This 3D DNA origami was used as an intelligent nano-container to encapsulate exactly one 10-nm gold nanoparticle (AuNP). AuNPs were functionalized with thiol-modified DNA strands and attached to one of the faces of the open motif, which was designed to be an interior surface of the box and decorated with three complementary strands. The open motif was then closed into the box shape as triggered by the addition of DNA strands joining the remaining edges. An examination of the suitable folding path of an M13 scaffold using fluorescently labeled staple strands revealed that the flexibility at the hinge was essential for the efficient closing of the DNA origami container. Atomic force microscope and transmission electron microscope imaging of agarose-gel-purified complexes clearly showed the successful encapsulation of one AuNP inside the shell.	[Kuzuya, Akinori; Kaino, Masafumi; Hashizume, Mirai; Matsumoto, Kazuki; Uehara, Takeaki; Ohya, Yuichi] Kansai Univ, Dept Chem & Mat Engn, Suita, Osaka 5648680, Japan; [Kuzuya, Akinori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Matsuo, Yasutaka; Mitomo, Hideyuki; Niikura, Kenichi; Ijiro, Kuniharu] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan	Kuzuya, A (reprint author), Kansai Univ, Dept Chem & Mat Engn, 3-3-35 Yamate, Suita, Osaka 5648680, Japan.	kuzuya@kansai-u.ac.jp; yohya@kansai-u.ac.jp	Mitomo, Hideyuki/D-6705-2012		Ministry of Education, Science, Sports, Culture and Technology, Japan (MEXT) [25107734]; MEXT; PRESTO, JST; Kansai University	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas 'Fusion Materials' (25107734) from the Ministry of Education, Science, Sports, Culture and Technology, Japan (MEXT), and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2014, and was partially performed under the Cooperative Research Program of 'Network Joint Research Center for Materials and Devices' (for AK, YM, HM, KN and KI). Support from PRESTO, JST and from the Kansai University Subsidy for Supporting Young Scholars, 2012 is also acknowledged.	Shen XB, 2012, J AM CHEM SOC, V134, P146, DOI 10.1021/ja209861x; Schreiber R, 2014, NAT NANOTECHNOL, V9, P74, DOI [10.1038/nnano.2013.253, 10.1038/NNANO.2013.253]; Ding BQ, 2010, J AM CHEM SOC, V132, P3248, DOI 10.1021/ja9101198; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Pal S, 2011, J AM CHEM SOC, V133, P17606, DOI 10.1021/ja207898r; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Ohya Y, 2012, SMALL, V8, P2335, DOI 10.1002/smll.201200092; Yamazaki T, 2014, NANOSCALE, V6, P9122, DOI 10.1039/c4nr01598c; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Yurke B, 2000, NATURE, V406, P605; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Numajiri K, 2010, J AM CHEM SOC, V132, P9937, DOI 10.1021/ja104702q; Kuzuya A, 2010, SMALL, V6, P2664, DOI 10.1002/smll.201001484; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Endo M, 2009, J AM CHEM SOC, V131, P15570, DOI 10.1021/ja904252e; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Zhao Z, 2011, ANGEW CHEM INT EDIT, V50, P2041, DOI 10.1002/anie.201006818; Endo M, 2011, CHEM COMMUN, V47, P10743, DOI 10.1039/c1cc13984c; Pal S, 2013, J PHYS CHEM C, V117, P12735, DOI 10.1021/jp312422n; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Zadegan RM, 2012, ACS NANO, V6, P10050, DOI 10.1021/nn303767b; Ruiz-Hitzky E, 2010, ADV MATER, V22, P323, DOI 10.1002/adma.200901134; Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Kuzuya A, 2009, CHEM COMMUN, P4182, DOI 10.1039/b907800b; Kuzuya A, 2014, ACCOUNTS CHEM RES, V47, P1742, DOI 10.1021/ar400328v; Kuzuya A, 2012, POLYM J, V44, P452, DOI 10.1038/pj.2012.38; Wen YQ, 2010, BIOCONJUGATE CHEM, V21, P1413, DOI 10.1021/bc100160k	31	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		177	182		10.1038/pj.2014.128		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600017		
J	Oaki, Y; Muramatsu, R; Imai, H				Oaki, Yuya; Muramatsu, Ryo; Imai, Hiroaki			Polymer-mediated dendritic growth of a transition metal salt crystal as a template for morphogenesis	POLYMER JOURNAL			English	Article							CACO3 THIN-FILMS; CALCIUM-CARBONATE; SELF-ORGANIZATION; MOLECULAR RECOGNITION; ORGANIC/INORGANIC COMPOSITES; INORGANIC CRYSTALS; RELIEF STRUCTURES; VATERITE CRYSTAL; MATRIX; MINERALIZATION	Dendritic morphologies of a metal oxide, metal and conductive polymer were obtained by using the dendrites of a transition metal salt as a template. Dendrites of the transition metal salt, copper acetate monohydrate (Cu(CH3COO)(2)center dot H2O), were prepared under diffusion-controlled conditions in a polymer matrix, such as poly(vinyl alcohol; PVA). The resultant dendrites of Cu (CH3COO)(2)center dot H2O acted as a self-template and were converted to divalent copper oxide (CuO) by the thermal treatment with the removal of PVA. The macroscopic CuO dendritic shapes consisting of the nanocrystals were obtained, and the resultant CuO was reduced to metallic copper (Cu) without morphological changes. The dendritic morphologies of polypyrrole (PPy) were obtained by the diffusion of pyrrole (Py) vapor to the Cu(CH3COO)(2)center dot H2O dendrites, which acted as the reactive template. The oxidative polymerization of Py provided PPy in the PVA matrix. These results suggest that the approach to morphogenesis presented herein can be applied to other metal oxides, metals and polymers.	[Oaki, Yuya; Muramatsu, Ryo; Imai, Hiroaki] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan	Oaki, Y (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	oakiyuya@applc.keio.ac.jp; hiroaki@applc.keio.ac.jp	Imai, Hiroaki/F-8459-2014		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22107010, 2206]	This work was partially supported by a Grant-in-Aid for Scientific Research (no. 22107010) on the Innovative Areas: 'Fusion Materials' (area no. 2206) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Kato T, 1999, CHEM LETT, P199; Uemura T, 2009, CHEM SOC REV, V38, P1228, DOI 10.1039/b802583p; Oaki Y, 2005, ADV FUNCT MATER, V15, P1407, DOI 10.1002/adfm.200500025; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Qi LM, 2001, CHEM-EUR J, V7, P3526, DOI 10.1002/1521-3765(20010817)7:16<3526::AID-CHEM3526>3.0.CO;2-Z; Hosoda N, 2003, MACROMOLECULES, V36, P6449, DOI 10.1021/ma025869b; Sugawara A, 2003, ANGEW CHEM INT EDIT, V42, P5299, DOI 10.1002/anie.200351541; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Imai H, 2004, ANGEW CHEM INT EDIT, V43, P1363, DOI 10.1002/anie.200352891; Oaki Y, 2004, J AM CHEM SOC, V126, P9271, DOI 10.1021/ja048661+; Zhu FJ, 2014, CRYSTENGCOMM, V16, P1496, DOI 10.1039/c3ce41649f; Yu SH, 2003, NANO LETT, V3, P379, DOI 10.1021/nl025722y; Naka K, 2001, CHEM MATER, V13, P3245, DOI 10.1021/cm011035g; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/nchem.444, 10.1038/NCHEM.444]; TIAN B, 1990, J CHEM PHYS, V92, P3886, DOI 10.1063/1.457794; Oaki Y, 2006, SMALL, V2, P66, DOI 10.1002/smll.200500246; Tokutomi D, 2013, CRYST GROWTH DES, V13, P3011, DOI 10.1021/cg400418n; Zhou L, 2008, SMALL, V4, P1566, DOI 10.1002/smll.200800520; KOSTIC R, 1995, J CHEM PHYS, V102, P3104; Oaki Y, 2012, POLYM J, V44, P612, DOI 10.1038/pj.2012.29; Yu SH, 2004, J MATER CHEM, V14, P2124, DOI 10.1039/b401420k; Han YL, 2014, CRYSTENGCOMM, V16, P3540, DOI 10.1039/c3ce42646g; Kotachi A, 2006, CRYST GROWTH DES, V6, P1636, DOI 10.1021/cg050528l; Im SG, 2007, ADV MATER, V19, P2863, DOI 10.1002/adma.200701170; RUIZHITZKY E, 1993, ADV MATER, V5, P334, DOI 10.1002/adma.19930050503; Oaki Y, 2007, LANGMUIR, V23, P5466, DOI 10.1021/la063663o; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Oaki Y, 2006, ADV FUNCT MATER, V16, P1633, DOI 10.1002/adfm.200600262; Imai H, 2010, CRYSTENGCOMM, V12, P1679, DOI 10.1039/c001474p; Imai H, 2006, B CHEM SOC JPN, V79, P1834, DOI 10.1246/bcsj.79.1834; van Bommel KJC, 2003, ANGEW CHEM INT EDIT, V42, P980, DOI 10.1002/anie.200390284; Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m; Yamamoto Y, 2010, POLYM J, V42, P583, DOI 10.1038/pj.2010.32; Nishimura T, 2008, ANGEW CHEM INT EDIT, V47, P2800, DOI 10.1002/anie.200705062; Bhattacharyya D, 2012, J POLYM SCI POL PHYS, V50, P1329, DOI 10.1002/polb.23138; Hosoda N, 2001, CHEM MATER, V13, P688, DOI 10.1021/cm000817r; Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Imai H, 2010, MRS BULL, V35, P138, DOI 10.1557/mrs2010.634; Oaki Y, 2003, CRYST GROWTH DES, V3, P711, DOI 10.1021/cg034053e; SAITO Y, 1989, PHYS REV A, V40, P3408, DOI 10.1103/PhysRevA.40.3408; Sakamoto T, 2011, ANGEW CHEM INT EDIT, V50, P5856, DOI 10.1002/anie.201008191; Liu XY, 2002, ANGEW CHEM INT EDIT, V41, P3641, DOI 10.1002/1521-3773(20021004)41:19<3641::AID-ANIE3641>3.0.CO;2-2; Kato T, 2010, MRS BULL, V35, P127, DOI 10.1557/mrs2010.632; Sakamoto T, 2009, CRYST GROWTH DES, V9, P622, DOI 10.1021/cg8009628; Bauerlein E., 2007, HDB BIOMINERALIZATIO; Henisch H. K., 1988, CRYSTALS GELS LIESEG; Ise R, 2013, J CERAM SOC JPN, V121, P555, DOI 10.2109/jcersj2.121.555; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Kato T, 2000, CHEM LETT, P186; Kotachi A, 2006, CHEM LETT, V35, P204, DOI 10.1246/cl.2006.204; Oaki Yuya, 2005, Angew Chem Int Ed Engl, V44, P6571, DOI 10.1002/anie.200500338; Oaki Y, 2007, CHEM COMMUN, P2841, DOI 10.1039/b704129b; Petrova P. I., 2002, CRYST GROWTH DES, V2, P573; Sakamoto T, 2006, CHEM LETT, V35, P310, DOI 10.1246/cl.2006.310; Sakamoto T, 2009, POLYM J, V41, P522, DOI 10.1295/polymj.PJ2009024; Tajima T., 2013, POLYM J, V44, P620; Takaguchi Y, 2002, CHEM LETT, P1102, DOI 10.1246/cl.2002.1102; Tanaka Y., 2013, POLYM J, V44, P586; Xu Y, 2013, CHEM-ASIAN J, V8, P1120, DOI 10.1002/asia.201300078	65	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		183	189		10.1038/pj.2014.113		7	Polymer Science	Polymer Science	CB2QS	WOS:000349473600018		
J	Katagiri, K; Yamazaki, S; Inumaru, K; Koumoto, K				Katagiri, Kiyofumi; Yamazaki, Shin-ichiro; Inumaru, Kei; Koumoto, Kunihito			Anti-reflective coatings prepared via layer-by-layer assembly of mesoporous silica nanoparticles and polyelectrolytes	POLYMER JOURNAL			English	Article							HOT-WATER TREATMENT; SOL-GEL PROCESS; ALUMINA THIN-FILMS; FLOWERLIKE ALUMINA; REFRACTIVE-INDEX; GLASS; SIO2	Mesoporous silica nanoparticles (NPs) with diameters of similar to 30 nm were fabricated using a dialysis process. The resulting NPs exhibit high colloidal stability and are applicable for the preparation of coating films on glass substrates via electrostatic layer-by-layer (LbL) assembly using cationic polyelectrolytes. The thickness and packing density of coating films can be controlled by layer number and mesoporous silica NP dispersion concentration. It was found that glass substrates that were coated with mesoporous silica NPs in an LbL process exhibited high anti-reflective (AR) performance. The highest AR effects (<1% in the wavelength region of 450-600 nm) were obtained with films prepared with six bilayers of cationic polyelectrolytes and mesoporous silica NPs at a concentration of 40 mu gml(-1).	[Katagiri, Kiyofumi; Inumaru, Kei] Hiroshima Univ, Grad Sch Sci & Engn, Dept Appl Chem, Higashihiroshima, Hiroshima 7398527, Japan; [Yamazaki, Shin-ichiro; Koumoto, Kunihito] Nagoya Univ, Grad Sch Sci & Engn, Dept Appl Chem, Nagoya, Aichi 4648601, Japan	Katagiri, K (reprint author), Hiroshima Univ, Grad Sch Sci & Engn, Dept Appl Chem, 1-4-1 Kagamiyama, Higashihiroshima, Hiroshima 7398527, Japan.	kktgr@hiroshima-u.ac.jp	Katagiri, Kiyofumi/D-8515-2012; Inumaru, Kei/J-9292-2015		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2206, 22107011]	This work was supported by a Grant-in-Aid for Scientific Research (No. 22107011) on the Innovative Areas: 'Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control' (Area No. 2206) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Li YF, 2010, NANO TODAY, V5, P117, DOI 10.1016/j.nantod.2010.03.001; Kobayashi M, 2005, LANGMUIR, V21, P5761, DOI 10.1021/la046829z; Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x; Chattopadhyay S, 2010, MAT SCI ENG R, V69, P1, DOI 10.1016/j.mser.2010.04.001; Chen DG, 2001, SOL ENERG MAT SOL C, V68, P313, DOI 10.1016/S0927-0248(00)00365-2; Nishii J, 2003, J CERAM SOC JPN, V111, P24, DOI 10.2109/jcersj.111.24; MUKHERJEE SP, 1982, J NON-CRYST SOLIDS, V48, P177, DOI 10.1016/0022-3093(82)90254-X; Yamaguchi N, 2005, J SOL-GEL SCI TECHN, V33, P117, DOI 10.1007/s10971-005-6711-1; Makita K, 1999, J SOL-GEL SCI TECHN, V14, P175, DOI 10.1023/A:1008738117124; Hoshikawa Y, 2010, CHEM MATER, V22, P12, DOI 10.1021/cm902239a; YOLDAS BE, 1984, APPL OPTICS, V23, P1418; Wicht G, 2010, MACROMOL MATER ENG, V295, P628, DOI 10.1002/mame.201000045; Bryleva EY, 2007, J COLLOID INTERF SCI, V316, P712, DOI 10.1016/j.jcis.2007.07.036; Chen YP, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/215303; Fraunhofer J., 1888, VERSUCHE URSACHEN AN; Macleod H.A., 1986, THIN FILM OPTICAL FI; Mark J. E., 1999, POLYM DATA HDB; Ohishi T, 1997, J SOL-GEL SCI TECHN, V8, P511, DOI 10.1007/BF02436891; Rayleigh L, 1879, P LOND MATH SOC, V1, P51, DOI 10.1112/plms/s1-11.1.51; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Tadanaga K, 2008, THIN SOLID FILMS, V516, P4526, DOI 10.1016/j.tsf.2007.05.089; Uhlmann DR, 1997, J NON-CRYST SOLIDS, V218, P113, DOI 10.1016/S0022-3093(97)00162-2; Urata C, 2009, CHEM COMMUN, P5094, DOI 10.1039/b908625k; Yamaguchi M, 2009, OPT LETT, V34, P2060, DOI 10.1364/OL.34.002060; Yamaguchi N, 2007, THIN SOLID FILMS, V515, P3914, DOI 10.1016/j.tsf.2006.11.009; Yamaguchi N, 2006, SURF COAT TECH, V201, P3653, DOI 10.1016/j.surfcoat.2006.08.122	26	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		190	194		10.1038/pj.2014.104		5	Polymer Science	Polymer Science	CB2QS	WOS:000349473600019		
J	Sato, S; Ishii, A; Yamada, C; Kim, J; Song, CH; Fujiwara, A; Takata, M; Hasegawa, M				Sato, Saki; Ishii, Ayumi; Yamada, Chisaki; Kim, Junguen; Song, Chul Ho; Fujiwara, Akihiko; Takata, Masaki; Hasegawa, Miki			Luminescence of fusion materials of polymeric chain-structured lanthanide complexes	POLYMER JOURNAL			English	Article							METAL-ORGANIC FRAMEWORKS; THIN-FILMS; SOLID-STATE; THERMOMETER; EMISSION; FUNDAMENTALS; COMPOSITES; DYNAMICS; CRYSTAL; SERIES	Polymeric chain-structured complexes were prepared with helical lanthanide complexes (LnL; Ln = Eu-III, Tb-III, Gd-III) and benzene-dicarboxylate derivatives (benzene-1,4-dicarboxylate (bdc), 2-aminoterephtalate (atpa) and 2-hydoloxyterephtalate (htpa)), which show some noteworthy physicochemical properties, photoluminescence and thermal stabilities. The complex EuL-bdc shows bright luminescence originating from Eu-III by UV excitation. The emission color can be tuned by mixing with TbL. The structures of these chain complexes were clarified with synchrotron X-ray powder diffraction measurements. The derivation of the linker moiety (bdc, atpa or htpa) was found to affect the intermetal energy transfer from Tb-III to Eu-III.	[Sato, Saki; Ishii, Ayumi; Yamada, Chisaki; Hasegawa, Miki] Aoyama Gakuin Univ, Coll Sci & Engn, Sagamihara, Kanagawa 2525258, Japan; [Kim, Junguen; Song, Chul Ho; Fujiwara, Akihiko] JASRI, SPring 8, Kobe, Hyogo, Japan; [Takata, Masaki] RIKEN, SPring 8, Kobe, Hyogo, Japan	Hasegawa, M (reprint author), Aoyama Gakuin Univ, Coll Sci & Engn, Chuo Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	hasemiki@chem.aoyama.ac.jp	Fujiwara, Akihiko/F-3031-2015	Fujiwara, Akihiko/0000-0002-1319-388X	MEXT [2206, 23107528, 25107730, 23656544, 20685011, 70406833]; Supported Program for the Strategic Research Foundation at Private Universities	Synchrotron radiation experiments were performed at the BL02B2 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; Proposal No. 2013B1776, 2013A1020 and 2011B1893). This work was partly supported by the Grants-in-Aid of MEXT for Scientific Research on Innovative Areas of 'Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control (Area Number: 2206)' (No. 23107528 and 25107730), Challenging Exploratory Research (No. 23656544) Young Scientists A (No. 20685011), Young Scientists B (No. 70406833) and the Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017, with a matching fund subsidy.	Kobayashi A, 2011, INORG CHEM, V50, P2061, DOI 10.1021/ic102361d; Bradshaw D, 2012, CHEM SOC REV, V41, P2344, DOI 10.1039/c1cs15276a; Cui YJ, 2014, CHEM COMMUN, V50, P719, DOI 10.1039/c3cc47225f; Amghouz Z, 2012, INORG CHEM, V51, P1703, DOI 10.1021/ic202020z; Betard A, 2012, CHEM REV, V112, P1055, DOI 10.1021/cr200167v; Cadiau A, 2013, ACS NANO, V7, P7213, DOI 10.1021/nn402608w; Soulie M, 2014, CHEM-EUR J, V20, P8636, DOI 10.1002/chem.201402415; Doherty CM, 2014, ACCOUNTS CHEM RES, V47, P396, DOI 10.1021/ar400130a; Lu WG, 2009, INORG CHEM, V48, P6997, DOI 10.1021/ic900506z; Suzuki K, 2009, PHYS CHEM CHEM PHYS, V11, P9850, DOI 10.1039/b912178a; Masoomi MY, 2012, COORDIN CHEM REV, V256, P2921, DOI 10.1016/j.ccr.2012.05.032; Parker D, 2010, EUR J INORG CHEM, P3961, DOI 10.1002/ejic.201000501; Lan YQ, 2011, ADV MATER, V23, P5015, DOI 10.1002/adma.201102880; Rao XT, 2013, J AM CHEM SOC, V135, P15559, DOI 10.1021/ja407219k; Higuchi M, 2009, POLYM J, V41, P511, DOI 10.1295/polymj.PJ2009053; Cui YJ, 2012, J AM CHEM SOC, V134, P3979, DOI 10.1021/ja2108036; He HY, 2013, CRYST GROWTH DES, V13, P3154, DOI 10.1021/cg400531j; D'Vries RF, 2013, J MATER CHEM C, V1, P6316, DOI 10.1039/c3tc30858h; Wierzbicka E, 2014, SPECTROCHIM ACTA A, V130, P488, DOI 10.1016/j.saa.2014.03.125; D'Vries RF, 2012, J MATER CHEM, V22, P1191, DOI 10.1039/c1jm14677g; Thielemann DT, 2011, INORG CHEM, V50, P11990, DOI 10.1021/ic201157m; Kawamura Y, 2004, JPN J APPL PHYS 1, V43, P7729, DOI 10.1143/JJAP.43.7729; Decadt R, 2012, INORG CHEM, V51, P11623, DOI 10.1021/ic301544q; Hasegawa M, 2014, NEW J CHEM, V38, P1225, DOI 10.1039/c3nj00910f; Hosseini MW, 2005, ACCOUNTS CHEM RES, V38, P313, DOI 10.1021/ar0401799; Ishii A, 2007, PHOTOCH PHOTOBIO SCI, V6, P804, DOI 10.1039/b703751c; Kobayashi A, 2010, CHEM LETT, V39, P282, DOI 10.1246/cl.2010.282; Li ZY, 2007, INORG CHEM, V46, P5174, DOI 10.1021/ic061666i; Miyata K., 2013, ANGEW CHEM, V125, P6541; Natur FL, 2013, INORG CHEM, V52, P6720; Ohashi H, 2004, APPL PHYS LETT, V84, P520, DOI 10.1063/1.1638882; Yu Y., 2012, CRYSTENGCOMM, V14, P7175	32	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		195	200		10.1038/pj.2014.88		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600020		
J	Tsuchido, Y; Sasaki, Y; Sawada, S; Akiyoshi, K				Tsuchido, Yuji; Sasaki, Yoshihiro; Sawada, Shin-ichi; Akiyoshi, Kazunari			Protein nanogelation using vitamin B-6-bearing pullulan: effect of zinc ions	POLYMER JOURNAL			English	Article							HYDROGEL; SYSTEM; CYCLODEXTRIN; BIOMATERIALS	Nanogels are nanometer-sized hydrogel nanoparticles with three-dimensional networks of crosslinked polymer chains. We have previously reported a method for constructing protein nanogels using vitamin B-6 (pyridoxal)-bearing pullulan (PLPP) as a bio-crosslinker. To validate the potential for using this bio-crosslinker to prepare protein nanogels, we developed an improved method using metal ions to enhance the affinity between the protein and the bio-crosslinker. We investigated the binding of PLPP as a bio-crosslinker to a protein to produce protein nanogels using anionic bovine serum albumin (BSA) as a model protein. Ultraviolet-visible spectroscopic titration of PLPP with BSA showed that the binding of the PLPP to the BSA via the formation of Schiff bases was significantly enhanced in the presence of zinc ions because of the coordination of the Schiff base to metal ions, which shifted the equilibrium of the reaction to the Schiff base formation side. Dynamic light scattering measurements, high-performance liquid chromatography and transmission electron microscopy confirmed that the zinc ions enhanced the ability of PLPP to form nanogels by crosslinking with the anionic BSA despite the strong electrostatic repulsion between the two molecules.	[Tsuchido, Yuji; Sasaki, Yoshihiro; Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Sasaki, Yoshihiro; Sawada, Shin-ichi; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6158510, Japan; [Sawada, Shin-ichi; Akiyoshi, Kazunari] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Tokyo, Japan	Akiyoshi, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	akiyoshi@bio.polym.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23107510, 2206]	This work was supported by Grants-in-Aid for Scientific Research (No. 23107510) in the Innovative Area 'Fusion Materials' (Area No. 2206) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Daoud-Mahammed S, 2009, BIOMACROMOLECULES, V10, P547, DOI 10.1021/bm801206f; Sasaki Y, 2011, POLYM CHEM-UK, V2, P1267, DOI 10.1039/c1py00100k; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/nmat2784, 10.1038/NMAT2784]; Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002; Hasegawa U, 2009, J CONTROL RELEASE, V140, P312, DOI 10.1016/j.jconrel.2009.06.025; MATSUO Y, 1957, J AM CHEM SOC, V79, P2016, DOI 10.1021/ja01565a069; West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k; Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044; Sasaki Y, 2010, CHEM REC, V10, P366, DOI 10.1002/tcr.201000008; Sasaki Y, 2012, CHEM LETT, V41, P202, DOI 10.1246/cl.2012.202; Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619; Hirakura T, 2004, BIOMACROMOLECULES, V5, P1804, DOI 10.1021/bm049860o; Nagahara S, 1996, POLYM GELS NETW, V4, P111, DOI 10.1016/0966-7822(96)00001-9; Obaidat AA, 1996, PHARMACEUT RES, V13, P989, DOI 10.1023/A:1016090103979; Reamdonck K., 2009, SOFT MATTER, V5, P707; Sasaki Y, 2010, CURR PHARM BIOTECHNO, V11, P300; Shen XC, 2007, ANGEW CHEM INT EDIT, V46, P7104, DOI 10.1002/anie.200701368; Shu SJ, 2009, CARBOHYD RES, V344, P1197, DOI 10.1016/j.carres.2009.04.018; Snell E.E., 1970, ENZYMES, VII; Subr V., 1990, BIOMATER SCI POLYM E, V1, P261	21	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		201	205		10.1038/pj.2014.120		5	Polymer Science	Polymer Science	CB2QS	WOS:000349473600021		
J	Kawamura, A; Katoh, T; Uragami, T; Miyata, T				Kawamura, Akifumi; Katoh, Tomoya; Uragami, Tadashi; Miyata, Takashi			Design of molecule-responsive organic-inorganic hybrid nanoparticles bearing cyclodextrin as ligands	POLYMER JOURNAL			English	Article							TRANSFER RADICAL POLYMERIZATION; SENSOR CHIPS; HYDROGEL; GLUCOSE; ANTIGEN; TEMPERATURE; SURFACES; BEHAVIOR; LECTIN; LAYERS	Novel organic-inorganic hybrid nanoparticles with a bisphenol A (BPA)-responsive hydrogel layer on the surface of SiO2 nanoparticles were prepared via surface-initiated atom transfer radical polymerization of acrylamide (AAm), acryloyl-modified beta-cyclodextrin (CD) and N, N'-methylenebisacrylamide. The resulting CD-PAAm/SiO2 nanoparticles underwent a change in size in response to BPA. The BPA-responsive shrinkage of the CD-PAAm/SiO2 nanoparticles was caused by an increase in the crosslinking density of the CD-PAAm hydrogel layer, which resulted from the formation of CD-BPA-CD complexes acting as dynamic crosslinks. The smart functions of BPA-responsive organic-inorganic hybrid nanoparticles can provide useful tools for constructing molecular sensors and adsorption materials.	[Kawamura, Akifumi; Katoh, Tomoya; Uragami, Tadashi; Miyata, Takashi] Kansai Univ, Dept Chem & Mat Engn, Suita, Osaka 5468680, Japan; [Kawamura, Akifumi; Uragami, Tadashi; Miyata, Takashi] Kansai Univ, ORDIST, Suita, Osaka, Japan	Miyata, T (reprint author), Kansai Univ, Dept Chem & Mat Engn, 3-3-35 Yamate Cho, Suita, Osaka 5468680, Japan.	tmiyata@kansai-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25107735]; Japan Society for the Promotion of Science [24300175]	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas of 'Fusion Materials' (No. 25107735) and from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by Grant-in-Aid for Scientific Research (B) (No. 24300175) from the Japan Society for the Promotion of Science.	STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; von Werne T, 2001, J AM CHEM SOC, V123, P7497, DOI 10.1021/ja010235q; Wu T, 2008, CHEM MATER, V20, P101, DOI 10.1021/cm702073f; Pasternack RM, 2008, LANGMUIR, V24, P12963, DOI 10.1021/la8024827; Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a; Kawamura A, 2014, CHEM COMMUN, V50, P11101, DOI 10.1039/c4cc01187b; Zha LS, 2002, ADV MATER, V14, P1090, DOI 10.1002/1521-4095(20020805)14:15<1090::AID-ADMA1090>3.0.CO;2-6; Li DJ, 2006, LANGMUIR, V22, P3344, DOI 10.1021/la053103+; Miyata T, 2006, P NATL ACAD SCI USA, V103, P1190, DOI 10.1073/pnas.0506786103; Zou H, 2008, CHEM REV, V108, P3893, DOI 10.1021/cr068035q; Miyata T, 1996, MACROMOL CHEM PHYSIC, V197, P1135, DOI 10.1002/macp.1996.021970330; Miyata T, 2010, POLYM J, V42, P277, DOI 10.1038/pj.2010.12; Miyata T, 1999, MACROMOLECULES, V32, P2082, DOI 10.1021/ma981659g; Kim DJ, 2005, MACROMOL CHEM PHYSIC, V206, P1941, DOI 10.1002/macp.200500268; von Werne T, 1999, J AM CHEM SOC, V121, P7409, DOI 10.1021/ja991108l; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619; Karg M, 2006, CHEMPHYSCHEM, V7, P2298, DOI 10.1002/cphc.200600483; Kawamura A, 2012, COLLOID SURFACE B, V99, P74, DOI 10.1016/j.colsurfb.2011.10.008; Kuriu Y, 2012, CHEM LETT, V41, P1660, DOI 10.1246/cl.2012.1660; Kuriu Y, 2014, CHEM LETT, V43, P825, DOI 10.1246/cl.140103; Miyata T, 2009, J POLYM SCI POL PHYS, V47, P2144, DOI 10.1002/polb.21812; Miyata T, 2004, J BIOMAT SCI-POLYM E, V15, P1085, DOI 10.1163/1568562041753061; Miyata T, 2012, J MOL RECOGNIT, V25, P336, DOI 10.1002/jmr.2190	24	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		206	211		10.1038/pj.2014.122		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600022		
J	Oyaizu, K; Tatsuhira, H; Nishide, H				Oyaizu, Kenichi; Tatsuhira, Hanae; Nishide, Hiroyuki			Facile charge transport and storage by a TEMPO-populated redox mediating polymer integrated with polyaniline as electrical conducting path	POLYMER JOURNAL			English	Article							ELECTRODE-ACTIVE MATERIAL; ORGANIC RADICAL BATTERY; SENSITIZED SOLAR-CELLS; AQUEOUS-ELECTROLYTE; RECHARGEABLE DEVICE; NITROXIDE RADICALS; CATHODE MATERIAL; CONJUGATED POLYMERS; HIGH-DENSITY; FILMS	A copolymer of TEMPO-and aniline-substituted norbornene was prepared by ring-opening metathesis polymerization of the corresponding monomers. Electropolymerization of the pendant aniline groups in the copolymer gave a layer of polynorbornene populated with the redox-active TEMPO pendants, in which polyaniline chain was incorporated. Electroactivity of the TEMPO pendants throughout the layer and its excellent charging/discharging cyclability, in addition to the amorphous nature of the layer, suggested that the polyaniline chain was homogeneously dispersed in the layer and that each chain served as crosslinking moiety. The effect of the polyaniline chains was further enhanced when they were formed by in-situ electropolymerization of the aniline group in the preformed layer of the copolymer/polyaniline composite. The polyaniline chain served as a conducting path to reduce the charge-transfer resistance for redox mediation, which gave rise to an excellent rate performance for the charging/discharging process of the layer, compared with those for the composite layers of TEMPO-substituted polymers with polyaniline and other conductive additives prepared by the conventional grinding methods.	[Oyaizu, Kenichi; Tatsuhira, Hanae; Nishide, Hiroyuki] Waseda Univ, Dept Appl Chem, Tokyo 1698555, Japan	Oyaizu, K (reprint author), Waseda Univ, Dept Appl Chem, Tokyo 1698555, Japan.	oyaizu@waseda.jp; nishide@waseda.jp	Oyaizu, Kenichi/E-5290-2013	Oyaizu, Kenichi/0000-0002-8425-1063	MEXT, Japan [25107733, 24225003, 25288056, 26620108]	This work was supported by a Grant-in-Aid for Scientific Research (No. 25107733) on the Innovative Areas, 'Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control' from MEXT, Japan. This work was partially supported by Grants-in-Aid for Scientific Research (Nos. 24225003, 25288056 and 26620108) from MEXT, Japan. We thank Dr Takeo Suga for helpful discussion on the polymer synthesis.	Suga T, 2009, ADV MATER, V21, P1627, DOI 10.1002/adma.200803073; Oyaizu K, 2010, J MATER CHEM, V20, P5404, DOI 10.1039/c0jm00042f; Oyaizu K, 2011, POLYM ADVAN TECHNOL, V22, P1242, DOI 10.1002/pat.1968; NGUYEN MT, 1994, CHEM MATER, V6, P952, DOI 10.1021/cm00043a015; BLAUCH DN, 1992, J AM CHEM SOC, V114, P3323, DOI 10.1021/ja00035a025; Guo W, 2012, ELECTROCHIM ACTA, V72, P81, DOI 10.1016/j.electacta.2012.03.162; Koshika K, 2010, GREEN CHEM, V12, P1573, DOI 10.1039/b926296b; Zhuang XL, 2010, J POLYM SCI POL CHEM, V48, P5404, DOI 10.1002/pola.24345; Oyaizu K, 2009, ADV MATER, V21, P2339, DOI 10.1002/adma.200803554; Koshika K, 2009, MACROMOL CHEM PHYSIC, V210, P1989, DOI 10.1002/macp.200900257; Janoschka T, 2012, ADV MATER, V24, P6397, DOI 10.1002/adma.201203119; Sukegawa T, 2013, MACROMOLECULES, V46, P1361, DOI 10.1021/ma302278h; Novak P, 1997, CHEM REV, V97, P207, DOI 10.1021/cr941181o; Oyaizu K, 2008, MACROMOLECULES, V41, P6646, DOI 10.1021/ma702576z; Suga T, 2004, B CHEM SOC JPN, V77, P2203, DOI 10.1246/bcsj.77.2203; Oyaizu K, 2008, J AM CHEM SOC, V130, P14459, DOI 10.1021/ja803742b; Sano N, 2013, ACS APPL MATER INTER, V5, P1355, DOI 10.1021/am302647w; Bugnon L, 2007, CHEM MATER, V19, P2910, DOI 10.1021/cm063052h; Takahashi Y, 2007, J PHOTOPOLYM SCI TEC, V20, P29, DOI 10.2494/photopolymer.20.29; Sukegawa T, 2014, ACS MACRO LETT, V3, P240, DOI 10.1021/mz400644y; Behrends F, 2013, MACROMOLECULES, V46, P2553, DOI 10.1021/ma400351q; Kato F, 2010, CHEM LETT, V39, P464, DOI 10.1246/cl.2010.464; Oyaizu K, 2013, DALTON T, V42, P16090, DOI 10.1039/c3dt51698a; Gracia R, 2013, POLYM CHEM-UK, V4, P2206, DOI 10.1039/c3py21118e; Hyakutake T, 2010, J MATER CHEM, V20, P9616, DOI 10.1039/c0jm02241a; Nishide H, 2009, PURE APPL CHEM, V81, P1961, DOI 10.1351/PAC-CON-08-12-03; Takahashi Y, 2008, POLYM J, V40, P763, DOI 10.1295/polymj.PJ2008071; Kim Y, 2012, J MATER CHEM, V22, P1453, DOI 10.1039/c1jm15053g; Nakahara K, 2011, CHEM LETT, V40, P222, DOI 10.1246/cl.2011.222; Yan JF, 2013, RSC ADV, V3, P166, DOI 10.1039/c2ra21546b; Beaujuge PM, 2010, ACCOUNTS CHEM RES, V43, P1396, DOI 10.1021/ar100043u; Suga T, 2011, ADV MATER, V23, P751, DOI 10.1002/adma.201003525; Yoshihara S, 2011, J POWER SOURCES, V196, P7806, DOI 10.1016/j.jpowsour.2010.10.092; Suga T, 2009, CHEM LETT, V38, P1160, DOI 10.1246/cl.2009.1160; Choi W, 2011, J AM CHEM SOC, V133, P19839, DOI 10.1021/ja206961t; Nishide H, 2008, SCIENCE, V319, P737, DOI 10.1126/science.1151831; Choi W, 2013, J MATER CHEM A, V1, P2999, DOI 10.1039/c3ta01588b; Choi W, 2011, ADV MATER, V23, P4440, DOI 10.1002/adma.201102372; Yonekuta Y, 2007, J AM CHEM SOC, V129, P14128, DOI 10.1021/ja075553p; Tokue H, 2014, ACS APPL MATER INTER, V6, P4043, DOI 10.1021/am405527y; Yoshihara S, 2010, J PHYS CHEM B, V114, P8335, DOI 10.1021/jp1019526; Hung MK, 2012, J MATER CHEM, V22, P1570, DOI 10.1039/c1jm13911h; Yonekuta Y, 2007, CHEM LETT, V36, P866, DOI 10.1246/cl.2007.866; Lin CH, 2012, POLYM CHEM-UK, V3, P1467, DOI 10.1039/c2py20048a; Nishihara H, 2007, COORDIN CHEM REV, V251, P2674, DOI 10.1016/j.ccr.2007.04.002; Barbero C, 2000, ELECTROCHIM ACTA, V45, P3895, DOI 10.1016/S0013-4686(00)00452-7; Bard AJ, 2001, ELECTROCHEMICAL METH; Chae IS, 2013, J MATER CHEM A, V1, P9608, DOI 10.1039/c3ta12076g; Chae IS, 2013, J MATER CHEM A, V1, P1326, DOI 10.1039/c2ta00785a; Grumelli DE, 2006, J PHYS CHEM B, V110, P15345, DOI 10.1021/jp062282g; Ibe T, 2010, CHEM LETT, V39, P356, DOI 10.1246/cl.2010.356; INZELT G, 1992, ELECTROCHIM ACTA, V37, P647, DOI 10.1016/0013-4686(92)80067-V; Kang H. A., 2008, MACROMOLECULES, V41, P5540, DOI 10.1021/ma8006416; Kato F., 2012, ANGEW CHEM, V124, P10324; Kato R, 2014, CHEM LETT, V43, P480, DOI 10.1246/cl.131120; Koshika K, 2009, GREEN CHEM LETT REV, V2, P169, DOI 10.1080/17518250903251775; Koshika K, 2009, CHEM COMMUN, P836, DOI 10.1039/b818087c; Kumar A, 2008, POLYMER, V49, P3686, DOI 10.1016/j.polymer.2008.05.009; Lin C. H., 2013, MACROMOL RAPID COMM, V33, P107; Murakami T, 2010, J PHOTOPOLYM SCI TEC, V23, P353, DOI 10.2494/photopolymer.23.353; Murray R. W., 1992, MOL DESIGN ELECTRODE; Nakahara K, 2012, J MATER CHEM, V22, P13669, DOI 10.1039/c2jm31907a; Nesvadba P., 2009, CHEM MATER, V22, P783; Nishide H, 2001, J ORG CHEM, V66, P1680, DOI 10.1021/jo0013204; Oyaizu K, 2010, MACROMOLECULES, V43, P10382, DOI 10.1021/ma1020159; Oyaizu K, 2011, CHEM LETT, V40, P184, DOI 10.1246/cl.2011.184; Oyaizu K, 2012, MACROMOL SYMP, V317, P248, DOI 10.1002/masy.201200012; Oyaizu K, 2013, J INORG ORGANOMET P, V23, P243, DOI 10.1007/s10904-012-9751-3; Oyaizu K, 2014, CHEM LETT, V43, P1134, DOI 10.1246/cl.140276; Oyaizu K, 1999, CHEM-EUR J, V5, P3193; Zhuang XL, 2010, MACROMOL BIOSCI, V10, P1203, DOI 10.1002/mabi.201000031	71	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		212	219		10.1038/pj.2014.124		8	Polymer Science	Polymer Science	CB2QS	WOS:000349473600023		
J	Hoshino, Y; Arata, Y; Yonamine, Y; Lee, SH; Yamasaki, A; Tsuhara, R; Yano, K; Shea, KJ; Miura, Y				Hoshino, Yu; Arata, Yuka; Yonamine, Yusuke; Lee, Shih-Hui; Yamasaki, Aki; Tsuhara, Ryousuke; Yano, Katsuhiko; Shea, Kenneth J.; Miura, Yoshiko			Preparation of nanogel-immobilized porous gel beads for affinity separation of proteins: fusion of nano and micro gel materials	POLYMER JOURNAL			English	Article							SYNTHETIC-POLYMER NANOPARTICLES; ANTIBODY PURIFICATION; THIN-FILMS; SILICEOUS MATERIALS; RATIONAL DESIGN; TOXIC PEPTIDE; L-SELECTIN; PARTICLES; RELEASE; BINDING	We describe the preparation and evaluation of nanogel-immobilized porous gel beads (GB) for application as a protein purification medium. Nanogel particles (NP) that bind with the Fc fragment of immunoglobulin G (IgG) were immobilized on the pore surface of macroporous hard GB containing quaternary ammonium cations on the surface via multipoint electrostatic interactions. The amount of NPs that were irreversibly immobilized in 1ml of GB slurry was determined to be similar to 30mg using fluorescent-labeled NPs. Images obtained via scanning electron microscopy established that the NPs were uniformly immobilized on the surface of the pores without blocking the macropores. The model target protein (IgG) was reversibly captured by the NP-immobilized GBs through NP-IgG interactions. NP-immobilized GBs have potential applications as novel affinity purification media for proteins, combining inexpensive and stable ligands with high-performance supports.	[Hoshino, Yu; Arata, Yuka; Miura, Yoshiko] Kyushu Univ, Dept Chem Engn, Fukuoka 8190395, Japan; [Yonamine, Yusuke; Lee, Shih-Hui; Shea, Kenneth J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Yamasaki, Aki; Tsuhara, Ryousuke; Yano, Katsuhiko] Mitsubishi Chem Corp, Tokyo, Japan	Hoshino, Y (reprint author), Kyushu Univ, Dept Chem Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	yhoshino@chem-eng.kyushu-u.ac.jp			MEXT [25107726]; JSPS [23750193]; Ogasawara Foundation; Kao Foundation for Arts and Sciences	The financial support from MEXT (25107726), JSPS (23750193), Ogasawara Foundation and the Kao Foundation for Arts and Sciences is greatly appreciated.	Hoshino Y, 2009, SMALL, V5, P1562, DOI 10.1002/smll.200900186; Hoshino Y, 2014, ADV MATER, V26, P3718, DOI 10.1002/adma.201305957; Kelley B, 2007, BIOTECHNOL PROGR, V23, P995, DOI 10.1021/bp070117s; Nolan CM, 2004, BIOMACROMOLECULES, V5, P1940, DOI 10.1021/bm049750h; Yonamine Y, 2012, BIOMACROMOLECULES, V13, P2952, DOI 10.1021/bm300986j; Serpe MJ, 2005, BIOMACROMOLECULES, V6, P408, DOI 10.1021/bm049455x; Nakamoto M, 2014, BIOMACROMOLECULES, V15, P541, DOI 10.1021/bm401536v; Koch SJ, 2006, ANGEW CHEM INT EDIT, V45, P6352, DOI 10.1002/anie.200601161; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.chromb.2006.09.030; Hoshino Y, 2012, J AM CHEM SOC, V134, P15209, DOI 10.1021/ja306053s; Cabaleiro-Lago C, 2008, J AM CHEM SOC, V130, P15437, DOI 10.1021/ja8041806; Hoshino Y, 2010, J AM CHEM SOC, V132, P13648, DOI 10.1021/ja1058982; Serpe MJ, 2003, LANGMUIR, V19, P8759, DOI 10.1021/la034391h; Seto H, 2012, ACS APPL MATER INTER, V4, P411, DOI 10.1021/am2014713; Hoshino Y, 2011, J MATER CHEM, V21, P3517, DOI 10.1039/c0jm03122d; Lee SH, 2012, J AM CHEM SOC, V134, P15765, DOI 10.1021/ja303612d; Wenck K, 2007, J AM CHEM SOC, V129, P16015, DOI 10.1021/ja075507p; Dernedde J, 2010, P NATL ACAD SCI USA, V107, P19679, DOI 10.1073/pnas.1003103107; Hoshino Y, 2008, J AM CHEM SOC, V130, P15242, DOI 10.1021/ja8062875; Yoshimatsu K, 2012, ANGEW CHEM INT EDIT, V51, P2405, DOI 10.1002/anie.201107797; Weinhart M, 2011, MACROMOL BIOSCI, V11, P1088, DOI 10.1002/mabi.201100051; Weinhart M, 2011, BIOMACROMOLECULES, V12, P2502, DOI 10.1021/bm200250f; Perez-Almodovar EX, 2009, J CHROMATOGR A, V1216, P8339, DOI 10.1016/j.chroma.2009.09.017; Hoshino Y, 2012, P NATL ACAD SCI USA, V109, P33, DOI 10.1073/pnas.1112828109; Arendt M, 2006, CHEM-ASIAN J, V1, P544, DOI 10.1002/asia.200600125; Hoshino Y, 2014, POLYM J, V46, P537, DOI 10.1038/pj.2014.33; Katoh S, 2007, J CHROMATOGR A, V1161, P36, DOI 10.1016/j.chroma.2007.04.023; KUSANO H, 1990, P91; Ogata Yutaro, 2013, Membranes (Basel), V3, P169, DOI 10.3390/membranes3030169; Seto H, 2012, ACS APPL MATER INTER, V4, P5125, DOI 10.1021/am301637q; TAKAYANAGI H, 1988, CHROMATOGRAPHIA, V25, P647, DOI 10.1007/BF02327665; Tokunaga K., 2012, Bunrizai. Patent, Patent No. [JP 2012/018135 A, 2012018135]; Weisman A, 2014, BIOMACROMOLECULES, V15, P3290, DOI 10.1021/bm500666j; Yonamine Y, 2013, ACS APPL MATER INTER, V5, P374, DOI 10.1021/am302404q; Yoshimatsu K, 2014, J AM CHEM SOC, V136, P1194, DOI 10.1021/ja410817p	35	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	FEB	2015	47	2			SI		220	225		10.1038/pj.2014.101		6	Polymer Science	Polymer Science	CB2QS	WOS:000349473600024		
J	Komoda, Y; Takafuji, D; Suzuki, H; Usui, H				Komoda, Yoshiyuki; Takafuji, Daisuke; Suzuki, Hiroshi; Usui, Hiromoto			Rheological characterization of metal particle suspension and its relationship with spray-dried granule properties	POWDER TECHNOLOGY			English	Article						Cemented carbide; Suspension rheology; Surfactant; Aggregation; Spray drying	TUNGSTEN CARBIDE; SHEAR RATE; SLURRY; VISCOSITY; MODEL	Cemented carbide is usually produced by sintering particles of metal carbides with binders. The non-aqueous suspension of both materials is spray-dried to produce granules having uniform material distribution, resulting in the excellent toughness of final products after sintering. Although the status of particle aggregation in a suspension should have a strong relationship with granule properties, the effect of surfactant on aggregative nature of particles has not been systematically investigated. In the present study, a new instrument was developed to measure apparent viscosity of metal particle suspension without sedimentation in order to investigate particle aggregation from the theological point of view. Additionally, the particle interaction has been quantitatively evaluated based on Usui's thixotropy model. It is found that the particle interaction was gradually reduced as increasing surfactant concentration, whereas granule properties changed only at higher concentrations. We also found the suspension stability and product functionality are balanced at the critical concentration. (C) 2014 Elsevier B.V. All rights reserved.	[Komoda, Yoshiyuki; Takafuji, Daisuke; Suzuki, Hiroshi; Usui, Hiromoto] Kobe Univ, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan	Komoda, Y (reprint author), 1-1 Rokko Dai Cho, Kobe, Hyogo 6578501, Japan.	komoda@kobe--u.ac.jp					Acchar W, 2006, J MATER SCI, V41, P3299, DOI 10.1007/s10853-005-5457-z; Akroyd TJ, 2003, MINER ENG, V16, P731, DOI 10.1016/S0892-6875(03)00167-5; KRIEGER IM, 1959, T SOC RHEOL, V3, P137; Fan P, 2013, INT J REFRACT MET H, V36, P2, DOI 10.1016/j.ijrmhm.2012.02.006; Ghandi A, 2012, J FOOD ENG, V113, P194, DOI 10.1016/j.jfoodeng.2012.06.005; Walker WJ, 1999, J AM CERAM SOC, V82, P1711; Upadhyaya GS, 2001, MATER DESIGN, V22, P483, DOI 10.1016/S0261-3069(01)00007-3; Minoshima H, 2001, J CHEM ENG JPN, V34, P472, DOI 10.1252/jcej.34.472; Bertrand G, 2003, J EUR CERAM SOC, V23, P263, DOI 10.1016/S0955-2219(02)00171-1; Carreau P. J., 1997, RHEOLOGY POLYM SYSTE; Kwon KC, 2000, CHEM ENG COMMUN, V183, P71, DOI 10.1080/00986440008960503; Mahdjoub H., 2003, J EUR CERAM SOC, V23, P1637; Nishiura D, 2006, KAGAKU KOGAKU RONBUN, V32, P341, DOI 10.1252/kakoronbunshu.32.341; Saito H, 2006, WEAR, V261, P126, DOI 10.1016/j.wear.2005.09.034; TAKAHASHI H, 1995, J AM CERAM SOC, V78, P903, DOI 10.1111/j.1151-2916.1995.tb08412.x; Ueda T, 2009, J CHEM ENG JPN, V42, P71; Upadhyaya G. S., 1998, CEMENTED TUNGSTEN CA; Usui H, 2001, CHEM ENG SCI, V56, P2979, DOI 10.1016/S0009-2509(00)00476-0; Usui H., 2004, J CHEM ENG JAPAN, V37, P31; Usui H, 1999, KAGAKU KOGAKU RONBUN, V25, P459	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0032-5910	1873-328X		POWDER TECHNOL	Powder Technol.	FEB	2015	271						93	99		10.1016/j.powtec.2014.10.033		7	Engineering, Chemical	Engineering	CB3FA	WOS:000349512400010		
J	Weerapol, Y; Limmatvapirat, S; Takeuchi, H; Sriamornsak, P				Weerapol, Yotsanan; Limmatvapirat, Sontaya; Takeuchi, Hirofumi; Sriamornsak, Pornsak			Fabrication of spontaneous emulsifying powders for improved dissolution of poorly water-soluble drugs	POWDER TECHNOLOGY			English	Article						Spontaneous emulsifying powders; Poorly water-soluble drugs; Dissolution; Solid carrier; Porous calcium silicate	DELIVERY-SYSTEMS; DROPLET SIZE; FORMULATIONS; SURFACTANTS; ABSORPTION; CARRIERS; RELEASE	The aim of the present study was to fabricate spontaneous emulsifying powders (SEP) for improving dissolution of poorly water-soluble drugs for oral drug delivery. The effect of drugs with different lipophilicity (logP), that is, nifedipine, felodipine, manidipine, and itraconazole on crystalline properties and dissolution profiles of SEP was also examined. The liquid spontaneous emulsifying formulation (SEF), composing of polyoxyl 35 castor oil, caprylic/capric glyceride and diethylene glycol monoethyl ether at a ratio of 1:1:8, was solidified with three different solid carriers, namely, fumed silica, porous silicon dioxide and porous calcium silicate (at 20%-50%). Porous calcium silicate at a concentration of 50% produced an excellent solid SEP formulation with the highest drug dissolution. The SEP formulations were free flowing with similar characteristics as that of liquid SEF. The differential scanning calorimetry and powder X-ray diffraction studies revealed the transformation of crystalline drugs (in pure drugs) to amorphous drugs (in the SEP formulations). This was further confirmed by scanning electron microscopy. Also, SEP containing 50% porous calcium silicate significantly improved the dissolution rate of all drugs tested due to the fast spontaneous emulsion formation and the decreased droplet size. Accordingly, this novel SEP formulation is the versatile and useful formulation that could be used to enhance the oral bioavailability of drugs by improving the dissolution of poorly water-soluble drugs. (C) 2014 Elsevier B.V. All rights reserved.	[Weerapol, Yotsanan; Limmatvapirat, Sontaya; Sriamornsak, Pornsak] Silpakorn Univ, Fac Pharm, Dept Pharmaceut Technol, Nakhon Pathom 73000, Thailand; [Weerapol, Yotsanan; Limmatvapirat, Sontaya; Sriamornsak, Pornsak] Silpakorn Univ, Fac Pharm, Pharmaceut Biopolymer Grp PBiG, Nakhon Pathom 73000, Thailand; [Takeuchi, Hirofumi] Gifu Pharmaceut Univ, Lab Pharmaceut Engn, Gifu 5011196, Japan	Sriamornsak, P (reprint author), Silpakorn Univ, Fac Pharm, Dept Pharmaceut Technol, Nakhon Pathom 73000, Thailand.	pornsak@su.ac.th			Thailand Research Fund [BRG5480013]; Royal Golden jubilee Ph.D. Program [PHD/0346/2550]	The authors wish to acknowledge The Thailand Research Fund for the financial support (grant number BRG5480013). Y.W. is financially supported by the Royal Golden jubilee Ph.D. Program (grant number PHD/0346/2550). Thanks to BASF (Thai) Co., Ltd. (Thailand), Evonik Industries, Eisai R&D Management Co., Ltd, Gattefosse, Fuji Silysia Chemical, Ltd. (Japan) and Sriprasit Pharma Co., Ltd. (Thailand) who kindly supported samples.	Abbaspour Mohammadreza, 2014, Adv Pharm Bull, V4, P113, DOI 10.5681/apb.2014.018; Sawant PD, 2010, INT J PHARMACEUT, V396, P45, DOI 10.1016/j.ijpharm.2010.06.008; Weerapol Y, 2014, AAPS PHARMSCITECH, V15, P456, DOI 10.1208/s12249-014-0078-y; Pouton CW, 2008, ADV DRUG DELIVER REV, V60, P625, DOI 10.1016/j.addr.2007.10.010; Kallakunta VR, 2012, POWDER TECHNOL, V221, P375, DOI 10.1016/j.powtec.2012.01.032; Hauss DJ, 2007, ADV DRUG DELIVER REV, V59, P667, DOI 10.1016/j.addr.2007.05.006; Hentzschel CM, 2011, DRUG DEV IND PHARM, V37, P1200, DOI 10.3109/03639045.2011.564184; Planinsek O, 2011, INT J PHARMACEUT, V406, P41, DOI 10.1016/j.ijpharm.2010.12.035; CONSTANTINIDES PP, 1995, PHARMACEUT RES, V12, P1561, DOI 10.1023/A:1016268311867; Ito Y, 2005, J CONTROL RELEASE, V105, P23, DOI 10.1016/j.jconrel.2005.03.017; TARR BD, 1989, PHARMACEUT RES, V6, P40, DOI 10.1023/A:1015843517762; Balakrishnan P, 2009, EUR J PHARM BIOPHARM, V72, P539, DOI 10.1016/j.ejpb.2009.03.001; Wu W, 1996, POWDER TECHNOL, V89, P129, DOI 10.1016/S0032-5910(96)03158-0; Araya Hiroshi, 2005, Drug Metab Pharmacokinet, V20, P244, DOI 10.2133/dmpk.20.244; Bakker MG, 1999, LANGMUIR, V15, P3078, DOI 10.1021/la9814743; Gumaste SG, 2013, PHARM RES-DORDR, V30, P3170, DOI 10.1007/s11095-013-1114-4; Kang JH, 2012, EUR J PHARM BIOPHARM, V80, P289, DOI 10.1016/j.ejpb.2011.11.005; Milovic M, 2012, INT J PHARMACEUT, V436, P58, DOI 10.1016/j.ijpharm.2012.06.032; Patel Vishal R, 2011, J Adv Pharm Technol Res, V2, P81, DOI 10.4103/2231-4040.82950; Patil Pradeep, 2006, AAPS PharmSciTech, V7, pE28; Pouton CW, 1997, ADV DRUG DELIVER REV, V25, P47, DOI 10.1016/S0169-409X(96)00490-5; Savjani KT, 2012, ISRN PHARM, V2012, DOI [10.5402/2012/195727, DOI 10.5402/2012/195727]; Thi Thao Do, 2009, Eur J Pharm Sci, V38, P479, DOI 10.1016/j.ejps.2009.09.012; Yap SP, 2004, INT J PHARM, V281, P67, DOI 10.1016/j.ijpharm.2004.05.015	24	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0032-5910	1873-328X		POWDER TECHNOL	Powder Technol.	FEB	2015	271						100	108		10.1016/j.powtec.2014.10.037		9	Engineering, Chemical	Engineering	CB3FA	WOS:000349512400011		
J	Gao, W; Mogi, T; Rong, JZ; Yu, JL; Yan, XQ; Dobashi, R				Gao, Wei; Mogi, Toshio; Rong, Jianzhong; Yu, Jianliang; Yan, Xingqing; Dobashi, Ritsu			Motion behaviors of the unburned particles ahead of flame front in hexadecanol dust explosion	POWDER TECHNOLOGY			English	Article						Hexadecanol dust explosion; Otsu's automatic threshold segmentation model; Particle image velocimetry; Motion behaviors of the unburned particles; Flame propagation mechanism	IMAGE VELOCIMETRY; PROPAGATION; PIV; FUSION; CLOUDS	To reveal clearly the motion behaviors and velocity distributions of the unburned particles ahead of flame front in hexadecanol dust explosion, the flame propagation process was recorded by a high speed camera combining the particle image velocimetry (PIV) techniques. Flame region was recognized from the direct-light-emission photographs by the color model; Otsu's automatic threshold segmentation model and Fast Fourier Transform were adopted to set the threshold and to measure the flow field, respectively. It was observed that the propagating flame consisted of blue-spots of flame at the leading zone and luminous flame behind them. The flame firstly propagated towards the small particles nearby, when the small particles were completely pyrolyzed, the local pre-mixing flame would continue to heat the larger particles, establishing the local diffusion flame, and then the isolated blue luminous spots. Single dust particle velocity changed with the distance to the flame front. There existed a stagnation region, in which the particle velocities approached zero. Beyond this region, the particles settled down at a constant velocity. Vortex structures appeared in the regions where the settlement particles encountered with the outward movement particles. (C) 2014 Elsevier B.V. All rights reserved.	[Gao, Wei; Yu, Jianliang; Yan, Xingqing] Dalian Univ Technol, Sch Chem Machinery, Dalian 116024, Liaoning, Peoples R China; [Gao, Wei; Mogi, Toshio; Dobashi, Ritsu] Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Rong, Jianzhong] Minist Publ Secur, Sichuan Fire Res Inst, Chengdu 610036, Sichuan, Peoples R China	Gao, W (reprint author), Dalian Univ Technol, Sch Chem Machinery, Dalian 116024, Liaoning, Peoples R China.	gaoweidlut@dlut.edu.cn			National Natural Science Foundation of China [51406023]; China Postdoctoral Science Foundation [2014M560213]; Fundamental Research Funds for the Central Universities [DUT14RC(3)061]	The authors appreciate the financial support by the National Natural Science Foundation of China (no. 51406023), project funded by the China Postdoctoral Science Foundation (no. 2014M560213) and "the Fundamental Research Funds for the Central Universities" (no. DUT14RC(3)061).	Trunk PJ, 2013, P COMBUST INST, V34, P3565, DOI 10.1016/j.proci.2012.06.025; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; WILLERT CE, 1991, EXP FLUIDS, V10, P181; Narayanaswamy V, 2013, P COMBUST INST, V34, P1455, DOI 10.1016/j.proci.2012.06.018; Hartung G, 2009, APPL PHYS B-LASERS O, V96, P843, DOI 10.1007/s00340-009-3647-0; Rong JZ, 2013, OPT LASER TECHNOL, V47, P283, DOI 10.1016/j.optlastec.2012.08.040; Otsuka T, 2001, J LOSS PREVENT PROC, V14, P503, DOI 10.1016/S0950-4230(01)00045-6; Balusamy S, 2011, EXP FLUIDS, V50, P1109, DOI 10.1007/s00348-010-1027-5; Liu CB, 2004, INT C PATT RECOG, P134, DOI 10.1109/HPD.2004.1346686; Baker W. E., 1991, GAS DUST HYBRID EXPL; Chen J, 2010, BUILD ENVIRON, V45, P1113, DOI 10.1016/j.buildenv.2009.10.017; Chen T. H., 2003, P IEEE 37 ANN 2003 I, P111; Gao W, 2013, POWDER TECHNOL, V249, P168, DOI 10.1016/j.powtec.2013.08.007; Han OS, 2001, J LOSS PREVENT PROC, V14, P153, DOI 10.1016/S0950-4230(00)00049-8; Hertzberg M., 1992, P COMBUST INST, V24, P1827; Li Y, 2008, MEAS SCI TECHNOL, V19, P1; Ma Q.F., 1986, HDB PRACTICAL THERMA, Vfirst; Nichols G, 2006, J CHEM ENG DATA, V51, P475, DOI 10.1021/je0503857; Rahbari A, 2011, COMBUST EXPLO SHOCK+, V47, P528, DOI 10.1134/S0010508211050066; Sun JH, 2006, J LOSS PREVENT PROC, V19, P135, DOI 10.1016/j.jlp.2005.05.017; Zabetakis M. G., 1965, BUR MIN B, V627	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0032-5910	1873-328X		POWDER TECHNOL	Powder Technol.	FEB	2015	271						125	133		10.1016/j.powtec.2014.11.003		9	Engineering, Chemical	Engineering	CB3FA	WOS:000349512400013		
J	Kitayama, S; Park, J; Boylan, JM; Miyamoto, Y; Levine, CS; Markus, HR; Karasawa, M; Coe, CL; Kawakami, N; Love, GD; Ryff, CD				Kitayama, Shinobu; Park, Jiyoung; Boylan, Jennifer Morozink; Miyamoto, Yuri; Levine, Cynthia S.; Markus, Hazel Rose; Karasawa, Mayumi; Coe, Christopher L.; Kawakami, Norito; Love, Gayle D.; Ryff, Carol D.			Expression of Anger and Ill Health in Two Cultures: An Examination of Inflammation and Cardiovascular Risk	PSYCHOLOGICAL SCIENCE			English	Article						anger expression; inflammation; cardiovascular malfunctioning; culture	CORONARY-HEART-DISEASE; SOCIAL-STATUS; NEGATIVE AFFECT; UNITED-STATES; HOSTILITY; EMOTION; ASSOCIATION; PERSPECTIVE; HYPOTHESIS; ADULTS	Expression of anger is associated with biological health risk (BHR) in Western cultures. However, recent evidence documenting culturally divergent functions of the expression of anger suggests that its link with BHR may be moderated by culture. To test this prediction, we examined large probability samples of both Japanese and Americans using multiple measures of BHR, including pro-inflammatory markers (interleukin-6 and C-reactive protein) and indices of cardiovascular malfunction (systolic blood pressure and ratio of total to HDL cholesterol). We found that the link between greater expression of anger and increased BHR was robust for Americans. As predicted, however, this association was diametrically reversed for Japanese, among whom greater expression of anger predicted reduced BHR. These patterns were unique to the expressive facet of anger and remained after we controlled for age, gender, health status, health behaviors, social status, and reported experience of negative emotions. Implications for sociocultural modulation of bio-physiological responses are discussed.	[Kitayama, Shinobu] Univ Michigan, Ann Arbor, MI 48109 USA; [Park, Jiyoung] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Boylan, Jennifer Morozink] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Miyamoto, Yuri; Coe, Christopher L.; Love, Gayle D.; Ryff, Carol D.] Univ Wisconsin Madison, Madison, WI USA; [Levine, Cynthia S.] Northwestern Univ, Evanston, IL 60208 USA; [Markus, Hazel Rose] Stanford Univ, Stanford, CA 94305 USA; [Karasawa, Mayumi] Tokyo Womans Christian Univ, Tokyo, Japan; [Kawakami, Norito] Univ Tokyo, Tokyo 1138654, Japan	Kitayama, S (reprint author), Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA.	kitayama@umich.edu			National Institute on Aging [5R37AG027343]; Midlife in the United States survey (National Institute on Aging) [P01-AG020166]	This research was supported by a grant from the National Institute on Aging (5R37AG027343) to conduct the Midlife in Japan survey for comparative analysis with the Midlife in the United States survey (National Institute on Aging Grant P01-AG020166).	Adams G, 2001, CULT PSYCHOL, V7, P283, DOI 10.1177/1354067X0173002; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Miyamoto Y, 2013, BRAIN BEHAV IMMUN, V34, P79, DOI 10.1016/j.bbi.2013.07.173; Hurd PL, 2001, CAN J ZOOL, V79, P931, DOI 10.1139/cjz-79-6-931; O'Connor MF, 2009, BRAIN BEHAV IMMUN, V23, P887, DOI 10.1016/j.bbi.2009.04.005; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3; Goodman E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e31; Leu JX, 2008, SOC SCI MED, V66, P1152, DOI 10.1016/j.socscimed.2007.11.028; Smith TW, 2004, J PERS, V72, P1217, DOI 10.1111/j.1467-6494.2004.00296.x; Schum JL, 2003, J BEHAV MED, V26, P395, DOI 10.1023/A:1025767900757; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Kitayama S, 2011, ANNU REV PSYCHOL, V62, P419, DOI 10.1146/annurev-psych-120709-145357; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Kitayama S, 1997, J PERS SOC PSYCHOL, V72, P1245, DOI 10.1037/0022-3514.72.6.1245; Chida Y, 2009, J AM COLL CARDIOL, V53, P936, DOI 10.1016/j.jacc.2008.11.044; Marsland AL, 2008, BRAIN BEHAV IMMUN, V22, P753, DOI 10.1016/j.bbi.2007.11.008; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Graham JE, 2006, BRAIN BEHAV IMMUN, V20, P389, DOI 10.1016/j.bbi.2005.11.002; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Kawachi I, 1996, CIRCULATION, V94, P2090; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V80, P86, DOI 10.1037//0022-3514.80.1.86; Beatty DL, 2009, PSYCHOSOM MED, V71, P813, DOI 10.1097/PSY.0b013e3181b3b6f8; BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037//0033-2909.106.1.59; Boylan JM, 2013, PSYCHOSOM MED, V75, P566, DOI 10.1097/PSY.0b013e31829683bd; Coe CL, 2011, BRAIN BEHAV IMMUN, V25, P494, DOI 10.1016/j.bbi.2010.11.013; Conley D., 2008, SOCIAL CLASS DOES IT, P366; Consedine Nathan S, 2006, Cultur Divers Ethnic Minor Psychol, V12, P541, DOI 10.1037/1099-9809.12.3.541; Consedine NS, 2005, J GERONTOL B-PSYCHOL, V60, pP165; Curhan KB, 2014, PSYCHOL SCI, V25, P2277, DOI 10.1177/0956797614543802; Elovainio M, 2011, BIOL PSYCHOL, V87, P234, DOI 10.1016/j.biopsycho.2011.03.002; Mohamed Mafauzy, 2005, Malays J Med Sci, V12, P20; Park J, 2013, EMOTION, V13, P1122, DOI 10.1037/a0034273; Spielberger C. D., 1996, STATE TRAIT ANGER EX; VanderVoort DJ, 1996, CURR PSYCHOL, V15, P179, DOI 10.1007/BF02686950	37	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0956-7976	1467-9280		PSYCHOL SCI	Psychol. Sci.	FEB	2015	26	2					211	220		10.1177/0956797614561268		10	Psychology, Multidisciplinary	Psychology	CB4TV	WOS:000349622000010		
J	Yamagishi, S; Matsui, T; Fukami, K				Yamagishi, Sho-ichi; Matsui, Takanori; Fukami, Kei			Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk	REJUVENATION RESEARCH			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; HUMAN BREAST-CANCER; GROWTH-FACTOR EXPRESSION; ANGIOGENESIS IN-VITRO; NF-KAPPA-B; DIABETES-MELLITUS; TUMOR-GROWTH; SOLUBLE RECEPTOR; CHEMOATTRACTANT PROTEIN-1; MALIGNANT-MELANOMA	Reducing sugars can react non-enzymatically with the amino groups of proteins, lipids, and nucleic acids to initiate a complex series of rearrangements and dehydrations, and then to produce a class of irreversibly cross-linked heterogeneous fluorescent moieties, termed advanced glycation end products (AGEs). The formation and accumulation of AGEs in numerous tissues have been known to progress in a normal aging process and at an accelerated rate under hyperglycemic and/or oxidative stress conditions. There is a growing body of evidence that interaction of AGEs with a cell-surface receptor termed receptor for AGEs (RAGE) elicits oxidative stress generation and subsequently evokes proliferative, angiogenic, and inflammatory reactions, thereby being involved in the development and progression of various types of cancers. These observations suggest that accumulation of AGEs and resultant activation of the RAGE signaling pathway could partly explain the increased risk of a variety of cancers in patients with diabetes or in elderly subjects. This article summarizes the pathological role of RAGE activation by AGEs and other ligands in tumor growth and metastasis and its therapeutic interventions for the life-threatening disorders.	[Yamagishi, Sho-ichi; Matsui, Takanori] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan; [Fukami, Kei] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 8300011, Japan	Yamagishi, S (reprint author), Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (S. Yamagishi).	Abe R, 2007, MINI-REV MED CHEM, V7, P649; Adeline LYT, 2007, SEMIN NEPHROL, V27, P130; Elangovan I, 2012, BIOCHEM BIOPH RES CO, V417, P1133, DOI 10.1016/j.bbrc.2011.12.060; Takino J, 2012, WORLD J GASTROENTERO, V18, P1781, DOI 10.3748/wjg.v18.i15.1781; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Yamagishi S, 2005, CURR PHARM DESIGN, V11, P2279, DOI 10.2174/1381612054367300; Bierhaus A, 1998, CARDIOVASC RES, V37, P586, DOI 10.1016/S0008-6363(97)00233-2; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Ji YF, 2014, INT J MOL MED, V33, P769, DOI 10.3892/ijmm.2014.1633; Kuriki K, 2007, EUR J CANCER PREV, V16, P83, DOI 10.1097/01.cej.0000228404.37858.40; Arumugam T, 2011, AMINO ACIDS, V41, P893, DOI 10.1007/s00726-010-0496-4; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Grote VA, 2012, CANCER EPIDEM BIOMAR, V21, P619, DOI 10.1158/1055-9965.EPI-11-1139; Rousseau MC, 2006, INT J CANCER, V118, P2105, DOI 10.1002/ijc.21600; Chen HB, 2014, MOL CELL ENDOCRINOL, V395, P69, DOI 10.1016/j.mce.2014.07.021; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Kang R, 2012, AUTOPHAGY, V8, P989, DOI 10.4161/auto.20258; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Abe R, 2008, CURR PHARM DESIGN, V14, P940, DOI 10.2174/138161208784139765; Puddu Alessandra, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P132; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089; Zhu L, 2013, J DERMATOL, V40, P973, DOI 10.1111/1346-8138.12323; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; Yamagishi SI, 2008, CURR PHARM DESIGN, V14, P487, DOI 10.2174/138161208783597416; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; Stitt AW, 1997, ANN NY ACAD SCI, V811, P115, DOI 10.1111/j.1749-6632.1997.tb51994.x; Schneider BP, 2007, NAT CLIN PRACT ONCOL, V4, P181, DOI 10.1038/ncponc0740; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Tafani M, 2011, CARCINOGENESIS, V32, P1167, DOI 10.1093/carcin/bgr101; Leclerc E, 2009, GEN PHYSIOL BIOPHYS, V28, pF65; Moy KA, 2013, HEPATOLOGY, V57, P2338, DOI 10.1002/hep.26264; Abe R, 2004, J INVEST DERMATOL, V122, P461, DOI 10.1046/j.0022-202X.2004.22218.x; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Glenn JV, 2009, BBA-GEN SUBJECTS, V1790, P1109, DOI 10.1016/j.bbagen.2009.04.016; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Antognelli C, 2013, INT J BIOCHEM CELL B, V45, P836, DOI 10.1016/j.biocel.2013.01.003; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Fukami K, 2014, CURR PHARM DESIGN, V20, P2395; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Meghnani V, 2014, BBA-MOL BASIS DIS, V1842, P1017, DOI 10.1016/j.bbadis.2014.02.013; Yamagishi S, 2010, CURR DRUG TARGETS, V11, P875; Okamoto T, 2002, FASEB J, V16, P1928, DOI 10.1096/fj.02-0030fje; Shimomoto T, 2012, J GASTROENTEROL, V47, P1073, DOI 10.1007/s00535-012-0572-5; Jiao L, 2011, CANCER RES, V71, P3582, DOI 10.1158/0008-5472.CAN-10-2573; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Col NF, 2012, BREAST CANCER RES TR, V135, P639, DOI 10.1007/s10549-012-2170-x; Perrot-Applanat M, 2012, CELL ADHES MIGR, V6, P547, DOI 10.4161/cam.23332; Hiwatashi K, 2008, ANN SURG ONCOL, V15, P923, DOI 10.1245/s10434-007-9698-8; DiNorcia J, 2010, J GASTROINTEST SURG, V14, P1680, DOI 10.1007/s11605-010-1347-z; DYER DG, 1991, J BIOL CHEM, V266, P11654; Jilma-Stohlawetz P, 2011, THROMB HAEMOSTASIS, V106, P539, DOI 10.1160/TH11-02-0069; Enomoto M, 2006, METABOLISM, V55, P912, DOI 10.1016/j.metabol.2006.02.019; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Hoshina D, 2010, CURR MOL MED, V10, P292; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Rahbar S, 2003, ARCH BIOCHEM BIOPHYS, V419, P63, DOI 10.1016/j.abb.2003.08.009; Takenaka K, 2006, CURR NEUROVASC RES, V3, P73, DOI 10.2174/156720206775541804; Yamagishi S, 2012, REJUV RES, V15, P564, DOI 10.1089/rej.2012.1335; Bartling B, 2011, MOL MED, V17, P980, DOI 10.2119/molmed.2011.00085; Heijmans J, 2013, ONCOGENE, V32, P1202, DOI 10.1038/onc.2012.119; Ueno T, 2000, CLIN CANCER RES, V6, P3282; van Heijst JWJ, 2006, CANCER LETT, V241, P309, DOI 10.1016/j.canlet.2005.10.042; Taguchi A, 2000, NATURE, V405, P354; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Yamagishi SI, 2008, CARDIOVASC THER, V26, P50, DOI 10.1111/j.1527-3466.2007.00038.x; Sasahira T, 2007, VIRCHOWS ARCH, V450, P287, DOI 10.1007/s00428-006-0359-2; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Treins C, 2001, J BIOL CHEM, V276, P43836, DOI 10.1074/jbc.M106534200; Zhao CB, 2014, AM J CANCER RES, V4, P369; Zill H, 2001, BIOCHEM BIOPH RES CO, V288, P1108, DOI 10.1006/bbrc.2001.5901; Yamagishi SI, 2008, OPHTHAL RES, V40, P10, DOI 10.1159/000111152; Antognelli C, 2014, BRIT J CANCER, V111, P395, DOI 10.1038/bjc.2014.280; Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185, DOI 10.1007/s11864-005-0002-5; Bondeva T, 2013, MOL ENDOCRINOL, V27, P1918, DOI 10.1210/me.2013-1036; Bucala R, 1992, Adv Pharmacol, V23, P1, DOI 10.1016/S1054-3589(08)60961-8; Chakraborty S, 2014, IUBMB LIFE, V66, P667, DOI 10.1002/iub.1324; Chang JS, 2008, CIRC RES, V102, P905, DOI 10.1161/CIRCRESAHA.107.165308; Chiavarina B, 2014, ONCOTARGET, V5, P5472; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Fukami K, 2013, REJUV RES, V16, P460, DOI 10.1089/rej.2013.1459; Genga XF, 2014, ONCOL RES TREAT, V37, P570, DOI 10.1159/000367800; Inagaki Y, 2003, DIABETOLOGIA, V46, P284, DOI 10.1007/s00125-002-1013-4; Ishibashi Y, 2011, CLIN EXP MED, V11, P131, DOI 10.1007/s10238-010-0109-2; Ishibashi Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-60; Ishibashi Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-125; Ishibashi Y, 2013, HORM METAB RES, V45, P387, DOI 10.1055/s-0032-1331204; Ito R, 2014, J SURG RES, V192, P503, DOI 10.1016/j.jss.2014.06.028; Kan H., 2014, J CLIN LAB ANAL, DOI [10.1002/jcla.21797, DOI 10.1002/JCLA.21797]; Lata K, 2014, BBA-GEN SUBJECTS, V1840, P1083, DOI 10.1016/j.bbagen.2013.11.014; Liu LS, 2013, INT J DERMATOL, V52, P523, DOI 10.1111/j.1365-4632.2012.05829.x; MIKI S, 1993, BIOCHEM BIOPH RES CO, V196, P984, DOI 10.1006/bbrc.1993.2346; GLOMB MA, 1995, J BIOL CHEM, V270, P10017; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Nass N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101473; Niiya Y, 2012, J STROKE CEREBROVASC, V21, P293, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.002; Niiya Y, 2006, BRAIN RES, V1108, P179, DOI 10.1016/j.brainres.2006.06.038; Ohta M, 2002, INT J CANCER, V102, P220, DOI 10.1002/ijc.10705; Ojima A, 2014, LAB INVEST, V94, P422, DOI 10.1038/labinvest.2014.5; Pichiule P, 2007, J BIOL CHEM, V282, P36330, DOI 10.1074/jbc.M706407200; Popa I, 2014, BIOCHEM CELL BIOL, V92, P127, DOI 10.1139/bcb-2013-0064; Radia AM, 2013, INT J MOL SCI, V14, P7959, DOI 10.3390/ijms14047959; Sakuraoka Y, 2010, WORLD J GASTROENTERO, V16, P5334, DOI 10.3748/wjg.v16.i42.5334; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; Schmidt A M, 2000, Curr Atheroscler Rep, V2, P430, DOI 10.1007/s11883-000-0082-4; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Tahara N, 2013, REJUV RES, V16, P344, DOI 10.1089/rej.2013.1434; Takino J., 2010, J ONCOL, V2010; Unoki H, 2008, CURR PHARM DESIGN, V14, P977; Xu XC, 2013, EUR J HISTOCHEM, V57, P240, DOI 10.4081/ejh.2013.e36; Yamagishi S, 2009, PHARMACOL RES, V60, P174, DOI 10.1016/j.phrs.2009.01.006; Yamagishi S, 2004, AM J PATHOL, V165, P1865, DOI 10.1016/S0002-9440(10)63239-7; Yamagishi Sho-ichi, 2010, Front Biosci (Elite Ed), V2, P1184; Yamagishi SI, 2008, MICROVASC RES, V75, P130, DOI 10.1016/j.mvr.2007.05.001; Yamagishi SI, 2007, HORM METAB RES, V39, P233, DOI 10.1055/s-2007-970425; Yamamoto KI, 2013, ONCOL REP, V29, P1073, DOI 10.3892/or.2012.2191; Yamamoto Y, 1996, BIOCHEM BIOPH RES CO, V222, P700, DOI 10.1006/bbrc.1996.0807; Yan W, 2012, CHINESE J GEOPHYS-CH, V55, P1, DOI 10.6038/j.issn.0001-5733.2012.01.001; Zhang HM, 2013, EXP THER MED, V5, P1519, DOI 10.3892/etm.2013.1015	125	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-1684	1557-8577		REJUV RES	Rejuv. Res.	FEB 1	2015	18	1					48	56		10.1089/rej.2014.1625		9	Geriatrics & Gerontology	Geriatrics & Gerontology	CB5QO	WOS:000349682800007		
J	Gross, JJ; Kawashima, C; Dohme-Meier, F; Miyamoto, A; Bruckmaier, RM				Gross, J. J.; Kawashima, C.; Dohme-Meier, F.; Miyamoto, A.; Bruckmaier, R. M.			Metabolic load affects resumption of ovarian cycle postpartum of dairy cow in herbage-based feeding systems	REPRODUCTION IN DOMESTIC ANIMALS			English	Meeting Abstract	48th Annual Conference on Physiology and Pathology of Reproduction / 40th Joint Congress of Veterinary and Human Medicine	FEB 11-13, 2015	Zurich, SWITZERLAND						[Gross, J. J.; Bruckmaier, R. M.] Univ Bern, Vetsuisse Fac, CH-3012 Bern, Switzerland; [Kawashima, C.; Miyamoto, A.] Obihiro Univ Agr & Vet Med, Obihiro, Hokkaido 080, Japan; [Dohme-Meier, F.] Agroscope Inst Livestock Sci ILS, Posieux, Switzerland								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0936-6768	1439-0531		REPROD DOMEST ANIM	Reprod. Domest. Anim.	FEB	2015	50			1	SI	P105	68	68				1	Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary Sciences	Agriculture; Reproductive Biology; Veterinary Sciences	CA7NS	WOS:000349104800149		
J	Fujii, H; Cao, J; Managi, S				Fujii, Hidemichi; Cao, Jing; Managi, Shunsuke			Decomposition of Productivity Considering Multi-environmental Pollutants in Chinese Industrial Sector	REVIEW OF DEVELOPMENT ECONOMICS			English	Article							SUSTAINABLE DEVELOPMENT; PERFORMANCE; EFFICIENCY; POLLUTION	The objective of this study is to calculate and decompose productivity incorporating multi-environmental pollutants in Chinese industrial sectors from 1992 to 2008. We apply a weighted Russell directional distance model to calculate productivity from both the economic and environmental performance. The main findings are: (1) Chinese industrial sectors increased productivity, with the main contributing factors being labor saving prior to 2000; (2) The main contributing factors for productivity growth in coastal areas include both economic and environmental performance improvement. While central and western regions improved productivity owing to economic development, they have a trade-off relationship between economic and environmental performance.	[Fujii, Hidemichi] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Managi, Shunsuke] Kyushu Univ, Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Cao, Jing] Tsinghua Univ, Sch Econ & Management, Beijing 100084, Peoples R China; [Cao, Jing] Tsinghua Univ, Hang Lung Ctr Real Estate, Beijing 100084, Peoples R China; [Managi, Shunsuke] Queensland Univ Technol, Brisbane, Qld 4000, Australia	Fujii, H (reprint author), Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	hidemichifujii@nagasaki-u.ac.jp	Managi, Shunsuke /G-1740-2013; Fujii, Hidemichi/E-8261-2014	Managi, Shunsuke /0000-0001-7883-1427; Fujii, Hidemichi/0000-0002-3043-1122			Akao KI, 2007, J ECON DYN CONTROL, V31, P3778, DOI 10.1016/j.jedc.2007.01.013; Li Q, 2009, J ECONOMETRICS, V148, P186, DOI 10.1016/j.jeconom.2008.10.007; Wang M, 2008, J ENVIRON MANAGE, V86, P648, DOI 10.1016/j.jenvman.2006.12.019; Fujii H, 2014, J BANK FINANC, V38, P41, DOI 10.1016/j.jbankfin.2013.09.022; Managi S, 2009, ECOL ECON, V68, P1643, DOI 10.1016/j.ecolecon.2008.04.005; Zhang KM, 2008, J ENVIRON MANAGE, V88, P1249, DOI 10.1016/j.jenvman.2007.06.019; Aparicio J, 2013, EUR J OPER RES, V226, P154, DOI 10.1016/j.ejor.2012.10.028; Balk BM, 2008, ECON THEOR, V35, P187, DOI 10.1007/s00199-007-0228-5; Barros CP, 2012, OMEGA-INT J MANAGE S, V40, P1, DOI 10.1016/j.omega.2011.02.005; Cao Jing, 1991, ASIAN ECON J, V21, P425; Chen P., 2011, WORKING PAPER; Chen SY, 2013, REV DEV ECON, V17, P644, DOI 10.1111/rode.12056; Fujii Hidemichi, 2011, ENVIRON DEV ECON, V15, P485; Fujii Hidemichi, 2013, J CLEAN PROD, V59, P22; Hoa Tran V., 2010, REV DEV ECON, V14, P577; Managi Shunsuke, 2010, CHINESE EC DEV ENV; Shao WY, 2010, SCI TOTAL ENVIRON, V408, P690, DOI 10.1016/j.scitotenv.2009.11.019	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1363-6669	1467-9361		REV DEV ECON	Rev. Dev. Econ.	FEB	2015	19	1					75	84		10.1111/rode.12123		10	Economics; Planning & Development	Business & Economics; Public Administration	CA4LD	WOS:000348874700006		
J	Xu, N; Ueji, R; Fujii, H				Xu, N.; Ueji, R.; Fujii, H.			Enhanced mechanical properties of 70/30 brass joint by multi-pass friction stir welding with rapid cooling	SCIENCE AND TECHNOLOGY OF WELDING AND JOINING			English	Article						70/30 brass; Friction stir welding; Rapid cooling; Microstructure; Mechanical properties; Grain refinement	AUSTENITIC STAINLESS-STEEL; STRUCTURAL RESPONSE; TEXTURE DEVELOPMENT; LIQUID CO2; DUCTILITY; ALLOY; BOUNDARIES; EVOLUTION; STRENGTH; TORSION	70/30 (Cu/Zn) brass plates with a 2 mm thickness were jointed by repeated rapid cooling friction stir welding. The joints from each FSW cycle showed the typical construction of a microstructure which includes the stir zone and the thermo-mechanically affected zone, but the morphology and boundary characteristics in these zones changed with the different cycles. In the stir zone, the grain size decreased and the number fraction of the high angle boundaries increased with the increasing number of FSW cycles. The texture analysis suggested that the post-annealing effect, which frequently occurred after the FSW process, was remarkably restricted by the liquid CO2 cooling, which accelerated the refinement of the microstructure. As a result, a joint with an ultrafine grained structure (0.8 mu m) and an excellent strength ductility matching (548 MPa and 34% respectively) can be achieved by multi-pass rapid cooling FSW process.	[Xu, N.; Ueji, R.; Fujii, H.] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Xu, N (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	xu@jwri.osaka-u.ac.jp			Japan Science and Technology Agency (JST); Priority Assistance for the Formation of Worldwide Renowned Centers of Research-The Global COE Program (Project: Center of Excellence for Advanced Structural and Functional Materials Design); Cooperative Research Project of Nationwide Joint from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for Promotion of Science	The authors are thankful for the financial support of the project for heterostructure control from the Japan Science and Technology Agency (JST), the Priority Assistance for the Formation of Worldwide Renowned Centers of Research-The Global COE Program (Project: Center of Excellence for Advanced Structural and Functional Materials Design) and the Cooperative Research Project of Nationwide Joint from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and a Grant-in-Aid for Science Research from the Japan Society for Promotion of Science.	MONTHEILLET F, 1985, ACTA METALL MATER, V33, P705, DOI 10.1016/0001-6160(85)90035-5; Xu N, 2014, MAT SCI ENG A-STRUCT, V610, P132, DOI 10.1016/j.msea.2014.05.037; Kim YG, 2006, MAT SCI ENG A-STRUCT, V415, P250, DOI 10.1016/j.msea.2005.09.072; Fujii H, 2006, MAT SCI ENG A-STRUCT, V429, P50, DOI 10.1016/j.msea.2006.04.118; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Pasebani S, 2010, MAT SCI ENG A-STRUCT, V527, P2050, DOI 10.1016/j.msea.2010.01.005; Ueji R, 2008, SCRIPTA MATER, V59, P963, DOI 10.1016/j.scriptamat.2008.06.050; Xue P, 2013, SCRIPTA MATER, V68, P751, DOI 10.1016/j.scriptamat.2013.01.003; Jeon J, 2013, ACTA MATER, V61, P3465, DOI 10.1016/j.actamat.2013.02.039; Zhao YH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2870014; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Mironov S, 2011, ACTA MATER, V59, P5472, DOI 10.1016/j.actamat.2011.05.021; Zhao YH, 2005, MAT SCI ENG A-STRUCT, V410, P188, DOI 10.1016/j.msea.2005.08.074; Zhao YH, 2010, ADV ENG MATER, V12, P769, DOI 10.1002/adem.200900335; Fonda RW, 2011, SCI TECHNOL WELD JOI, V16, P288, DOI 10.1179/1362171811Y.0000000010; Mishra RS, 2005, MAT SCI ENG R, V50, P1, DOI 10.1016/j.mser.2005.07.001; El-Rayes MM, 2012, J MATER PROCESS TECH, V212, P1157, DOI 10.1016/j.jmatprotec.2011.12.017; Sun YF, 2014, MAT SCI ENG A-STRUCT, V589, P228, DOI 10.1016/j.msea.2013.09.094; Brown R, 2009, MAT SCI ENG A-STRUCT, V513-14, P115, DOI 10.1016/j.msea.2009.01.041; Jeon J, 2011, ACTA MATER, V59, P7439, DOI 10.1016/j.actamat.2011.09.013; Mironov S, 2008, ACTA MATER, V56, P2602, DOI 10.1016/j.actamat.2008.01.040; Cam G, 2008, MATERIALWISS WERKST, V39, P394, DOI 10.1002/mawe.200800314; Bhadeshia HKDH, 2012, SCRIPTA MATER, V66, P955, DOI 10.1016/j.scriptamat.2012.04.006; Biro E, 2002, METALL MATER TRANS A, V33, P2019, DOI 10.1007/s11661-002-0034-4; Fujii H, 2013, SCI TECHNOL WELD JOI, V18, P500, DOI 10.1179/1362171813Y.0000000128; Humphreys H. J., 2004, RECRYSTALLIZATION RE; Meran C, 2004, SCI TECHNOL WELD JOI, V9, P131, DOI 10.1179/136217104225017053; Moghaddam MS, 2011, MATER DESIGN, V32, P2749, DOI 10.1016/j.matdes.2011.01.015; Nesterova Y. V., 1985, PHYS MET METALLOGR, V59, P169; Thomas W. M., 1991, [GB Patent Application, International Patent Application], Patent No. [9125978.8, PCT/GB92/02203, 91259788]; TOTH LS, 1989, ACTA METALL MATER, V37, P2197, DOI 10.1016/0001-6160(89)90145-4; Xu N, 2014, MATER DESIGN, V56, P20, DOI 10.1016/j.matdes.2013.10.076	32	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1362-1718			SCI TECHNOL WELD JOI	Sci. Technol. Weld. Join.	FEB	2015	20	2					91	99		10.1179/1362171814Y.0000000261		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB3YQ	WOS:000349565800001		
J	Morisada, Y; Imaizumi, T; Fujii, H				Morisada, Y.; Imaizumi, T.; Fujii, H.			Clarification of material flow and defect formation during friction stir welding	SCIENCE AND TECHNOLOGY OF WELDING AND JOINING			English	Article						Friction stir welding; Defect formation mechanism; X-ray radiography; Material flow; Material flow velocity	ALUMINUM; TOOL; SIMULATION; ALLOY; MODEL; HEAT	The defect formation mechanism during friction stir welding (FSW) was investigated by the three-dimensional visualisation of material flow around a tool. The three-dimensional flow patterns under various FSW conditions were obtained using two pairs of X-ray transmission real time imaging systems. The flow patterns revealed that the tilt of horizontal material flow around the tool and the stagnation of material flow on the advancing side (AS) of the tool were significantly correlated to the formation of defects. The material flow velocity during FSW was directly calculated based on the results of three-dimensional visualisation. The material flow velocity on the AS obviously decreased under the condition where defects were formed.	[Morisada, Y.; Imaizumi, T.; Fujii, H.] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Morisada, Y (reprint author), Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan.	morisada@jwri.osaka-u.ac.jp			Collaborative Research, 'Heterogeneous Structure Control' in the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; ISIJ Research Promotion Grant; New Energy and Industrial Technology Development Organization (NEDO) under the 'Innovative Structural Materials Project (Future Pioneering Projects)'	The present study was supported by Collaborative Research, 'Heterogeneous Structure Control' in the Japan Science and Technology Agency, Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, ISIJ Research Promotion Grant, and the New Energy and Industrial Technology Development Organization (NEDO) under the 'Innovative Structural Materials Project (Future Pioneering Projects)'.	Nandan R, 2007, ACTA MATER, V55, P883, DOI 10.1016/j.actamat.2006.09.009; Fujii H, 2006, MAT SCI ENG A-STRUCT, V419, P25, DOI 10.1016/j.msea.2005.11.045; Atharifar H, 2009, J MATER ENG PERFORM, V18, P339, DOI 10.1007/s11665-008-9298-1; Kim YG, 2006, MAT SCI ENG A-STRUCT, V415, P250, DOI 10.1016/j.msea.2005.09.072; Song M, 2003, P I MECH ENG B-J ENG, V217, P73, DOI 10.1243/095440503762502297; Schmidt HNB, 2006, ACTA MATER, V54, P1199, DOI 10.1016/j.actamat.2005.10.052; Nandan R, 2008, PROG MATER SCI, V53, P980, DOI 10.1016/j.pmatsci.2008.05.001; Morisada Y, 2011, SCRIPTA MATER, V65, P1085, DOI 10.1016/j.scriptamat.2011.09.021; Reynolds AP, 2000, SCI TECHNOL WELD JOI, V5, P120, DOI 10.1179/136217100101538119; Sato YS, 2001, METALL MATER TRANS A, V32, P941, DOI 10.1007/s11661-001-0351-z; Morisada Y, 2007, COMPOS PART A-APPL S, V38, P2097, DOI 10.1016/j.compositesa.2007.07.004; Mishra RS, 2005, MAT SCI ENG R, V50, P1, DOI 10.1016/j.mser.2005.07.001; Kumar K, 2008, MAT SCI ENG A-STRUCT, V485, P367, DOI 10.1016/j.msea.2007.08.013; Field DP, 2001, METALL MATER TRANS A, V32, P2869, DOI 10.1007/s11661-001-1037-2; Ulysse P, 2002, INT J MACH TOOL MANU, V42, P1549, DOI 10.1016/S0890-6955(02)00114-1; Doude HR, 2014, METALL MATER TRANS A, V45A, P4411, DOI 10.1007/s11661-014-2384-0; Schmidt H, 2005, MODEL SIMUL MATER SC, V13, P77, DOI 10.1088/0965-0393/13/1/006; Xu S, 2001, SCI TECHNOL WELD JOI, V6, P191, DOI 10.1179/136217101101538640; Colligan K., 1999, WELD J, P229; Guerra M., 2003, MATER CHARACT, V49, P95; Hirasawa S., 2004, P JSME ANN M, V3, P39; Horie S, 2010, SCI TECHNOL WELD JOI, V15, P666, DOI 10.1179/136217110X12785889550145; Kokawa H., 2006, FRICTION STIR WELDIN, P1; Liechty BC, 2007, J MATER PROCESS TECH, V184, P240, DOI 10.1016/j.jmatprotec.2006.10.049; Shibayanagi T., 2011, REP JPN I LIGHT MET, V56, P55; Sun N, 2010, SCI TECHNOL WELD JOI, V15, P239, DOI [10.1179/136217110X12665778348542, 10.1179/136217109X12665778348542]; Takai H., 2001, J LIGHT MET WELD CON, V39, P29; Thomas W.M., 1991, Int. patent Appl. No, Patent No. [PCT/GB92/02203, 9202203]; Tomimura T., 2004, PREPRINTS NATL M JWS, V75, P32; Yoshikawa G, 2012, SCI TECHNOL WELD JOI, V17, P255, DOI 10.1179/1362171811Y.0000000099; Zettler R, 2006, ADV ENG MATER, V8, P487, DOI 10.1002/adem.200600062	31	2	2	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1362-1718			SCI TECHNOL WELD JOI	Sci. Technol. Weld. Join.	FEB	2015	20	2					130	137		10.1179/1362171814Y.0000000266		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB3YQ	WOS:000349565800006		
J	Bayam, Y; Logeeswaran, VJ; Katzenmeyer, AM; Sadeghian, RB; Chacon, RJ; Wong, MC; Hunt, CE; Motomiya, K; Jeyadevan, B; Islam, MS				Bayam, Yavuz; Logeeswaran, V. J.; Katzenmeyer, Aaron M.; Sadeghian, Ramin Banan; Chacon, Rebecca J.; Wong, Michael C.; Hunt, Charles E.; Motomiya, Kenichi; Jeyadevan, Balachandran; Islam, M. Saif			Synthesis of Ga2O3 Nanorods with Ultra-Sharp Tips for High-Performance Field Emission Devices	SCIENCE OF ADVANCED MATERIALS			English	Article						Gallium Oxide; Nanorod; Field Emission; Field Enhancement Factor	WALLED CARBON NANOTUBES; BETA-GA2O3 NANOWIRES; VACUUM MICROELECTRONICS; COALESCENCE GROWTH; ELECTRON-EMISSION; GALLIUM-ARSENIDE; GAS SENSORS; ARRAYS; GAAS; NANOSTRUCTURES	We synthesized catalyst-free beta-Ga2O3 nanorods with terminated ultra-sharp tips by heat treating single crystalline GaAs in a chemical vapor deposition (CVD) chamber without introducing a precursor. The unique, straight-forward, synthetic route and a possible growth mechanism are discussed to explain the different morphology of the grown nanorods and the ultra-sharp nanostructures. The morphology and structure of the nanorods were characterized by scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDS), X-ray diffraction (XRD) and Raman-spectroscopy. The ultra-sharp tips were found to have radii of similar to 3-5 nnn and were utilized to achieve enhanced field emission. The field emission characteristics demonstrated a turn-on field of 2.1 V mu m(-1), a threshold electric field of 5.6 V mu m(-1), and a geometrical field enhancement factor of 3786, making them comparable to nanostructured diamond and highly oriented single wall carbon nanotubes.	[Bayam, Yavuz; Logeeswaran, V. J.; Katzenmeyer, Aaron M.; Sadeghian, Ramin Banan; Chacon, Rebecca J.; Wong, Michael C.; Hunt, Charles E.; Islam, M. Saif] Univ Calif Davis, Dept Elect & Comp Engn, Davis, CA 95616 USA; [Bayam, Yavuz] Gediz Univ, Dept Elect & Elect Engn, TR-35665 Izmir, Turkey; [Motomiya, Kenichi; Jeyadevan, Balachandran] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan; [Jeyadevan, Balachandran] Univ Shiga Prefecture, Dept Mat Sci, Hikone, Shiga 5228533, Japan	Islam, MS (reprint author), Univ Calif Davis, Dept Elect & Comp Engn, Davis, CA 95616 USA.	sislam@ucdavis.edu			University of California CITRIS research grant, NSF [0547679]; Army Research Office (ARO) research grant [55176-EL-DRP]	The work reported herein was partially supported by a University of California CITRIS research grant, NSF grant #0547679 and an Army Research Office (ARO) research grant 55176-EL-DRP.	Zhang DQ, 2012, J AM CHEM SOC, V134, P14283, DOI 10.1021/ja3050184; LOWES TD, 1993, J APPL PHYS, V73, P4937, DOI 10.1063/1.353812; Lin J, 2010, ACS NANO, V4, P2452, DOI 10.1021/nn100254f; Tian W, 2012, J MATER CHEM, V22, P17984, DOI 10.1039/c2jm33189f; He DY, 2000, DIAM RELAT MATER, V9, P1600, DOI 10.1016/S0925-9635(00)00313-7; SPINDT CA, 1991, IEEE T ELECTRON DEV, V38, P2355, DOI 10.1109/16.88525; Mano T, 2005, NANO LETT, V5, P425, DOI 10.1021/nl048192+; Forbes RG, 1999, J VAC SCI TECHNOL B, V17, P526, DOI 10.1116/1.590588; ZINKEALLMANG M, 1992, PHYS REV LETT, V68, P2358, DOI 10.1103/PhysRevLett.68.2358; Lin WH, 2012, DIAM RELAT MATER, V22, P124, DOI 10.1016/j.diamond.2011.12.036; Kang SJ, 2007, NAT NANOTECHNOL, V2, P230, DOI 10.1038/nnano.2007.77; Liu F, 2008, ADV MATER, V20, P2609, DOI 10.1002/adma.200800137; Zhang ZJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2166479; Du N, 2007, ADV MATER, V19, P1641, DOI 10.1002/adma.200602128; Kuykendall T, 2004, NAT MATER, V3, P524, DOI 10.1038/nmat1177; Sharma S, 2002, J AM CHEM SOC, V124, P12288, DOI 10.1021/ja027086b; Tersoff J, 2009, SCIENCE, V324, P236, DOI 10.1126/science.1169546; Liu JP, 2007, J PHYS CHEM C, V111, P4990, DOI 10.1021/jp067782o; Tang YB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1899763; Li GH, 2011, J PHYS CHEM C, V115, P9740, DOI 10.1021/jp200398s; Rao AM, 2000, APPL PHYS LETT, V76, P3813, DOI 10.1063/1.126790; Banan-Sadeghian R, 2008, IEEE ELECTR DEVICE L, V29, P312, DOI 10.1109/LED.2008.917114; BRODIE I, 1992, ADV ELECTRON EL PHYS, V83, P1; Cao CB, 2008, J PHYS CHEM C, V112, P95, DOI 10.1021/jp0738762; Choi YC, 2000, ADV MATER, V12, P746, DOI 10.1002/(SICI)1521-4095(200005)12:10<746::AID-ADMA746>3.0.CO;2-N; Chung HS, 2009, J KOREAN PHYS SOC, V55, P68; Golberg D, 2003, APPL PHYS A-MATER, V76, P499, DOI 10.1007/s00339-002-2047-7; Guo H, 2012, J POWER SOURCES, V219, P280, DOI 10.1016/j.jpowsour.2012.07.063; Heyn C, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075317; Hu JQ, 2002, J PHYS CHEM B, V106, P9536, DOI 10.1021/jp020734t; Huang Y, 2009, J PHYS CHEM C, V113, P1980, DOI 10.1021/jp809800n; Liu ZF, 2008, SENSOR ACTUAT B-CHEM, V129, P666, DOI 10.1016/j.snb.2007.09.055; Lo KC, 2004, J APPL PHYS, V95, P8178, DOI 10.1063/1.1715137; Lopez I, 2012, PHYS STATUS SOLIDI A, V209, P113, DOI 10.1002/pssa.201127406; MELMED AJ, 1961, J CHEM PHYS, V34, P1802, DOI 10.1063/1.1701081; MONTEIRO OR, 1989, J VAC SCI TECHNOL A, V7, P49, DOI 10.1116/1.575730; Passlack M., 1995, COMPOUND SEMICONDUCT, V1994, P597; Peng SM, 2012, MICROELECTRON ENG, V100, P16, DOI 10.1016/j.mee.2012.04.034; Robertson J, 2006, MAT SCI ENG B-SOLID, V135, P267, DOI 10.1016/j.mseb.2006.08.017; Shin TI, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345305; Shorlin K, 2007, SURF SCI, V601, P2438, DOI 10.1016/j.susc.2007.04.019; STRATTON R, 1955, P PHYS SOC LOND B, V68, P746, DOI 10.1088/0370-1301/68/10/307; Tien LC, 2012, J ELECTRON MATER, V41, P3056, DOI 10.1007/s11664-012-2239-7; Wang YW, 2001, J MATER SCI LETT, V20, P1687, DOI 10.1023/A:1012477520377; Yamashita T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1869549; Yang YH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2234838; Yeh CM, 2006, NANOTECHNOLOGY, V17, P5930, DOI [10.1088/0957-4484/17/24/005, 10.1088/0957/17/24/005]; Zhan JH, 2004, CHEM MATER, V16, P5158, DOI 10.1021/cm048909u; Zhi CY, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1938248; Zoltan H., 1999, J APPL PHYS, V86, P3792	50	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1947-2935	1947-2943		SCI ADV MATER	Sci. Adv. Mater.	FEB	2015	7	2					211	218		10.1166/sam.2015.2160		8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CA8BE	WOS:000349140700002		
J	Oshio, T; Tsutsumi, A; Inoue, A				Oshio, Takashi; Tsutsumi, Akizumi; Inoue, Akiomi			Do time-invariant confounders explain away the association between job stress and workers' mental health?: Evidence from Japanese occupational panel data	SOCIAL SCIENCE & MEDICINE			English	Article						Japan; Job stress; Mental health; Psychological distress; Fixed effects models	EFFORT-REWARD IMBALANCE; ORGANIZATIONAL JUSTICE; PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS; POPULATION; STRAIN; VERSION; QUESTIONNAIRE; EMPLOYEES; RELIABILITY	It is well known that job stress is negatively related to workers' mental health, but most recent studies have not controlled for unobserved time-invariant confounders. In the current study, we attempted to validate previous observations on the association between job stress and workers' mental health, by removing the effects of unobserved time-invariant confounders. We used data from three to four waves of an occupational Japanese cohort survey, focusing on 31,382 observations of 9741 individuals who participated in at least two consecutive waves. We estimated mean-centered fixed effects models to explain psychological distress in terms of the Kessler 6 (K6) scores (range: 0-24) by eight job stress indicators related to the job demands-control, effort-reward imbalance, and organizational injustice models. Mean-centered fixed effects models reduced the magnitude of the association between jobs stress and K6 scores to 44.8-54.2% of those observed from pooled ordinary least squares. However, the association remained highly significant even after controlling for unobserved time-invariant confounders for all job stress indicators. In addition, alternatively specified models showed the robustness of the results. In all, we concluded that the validity of major job stress models, which link job stress and workers' mental health, was robust, although unobserved time-invariant confounders led to an overestimation of the association. (C) 2014 Elsevier Ltd. All rights reserved.	[Oshio, Takashi] Hitotsubashi Univ, Inst Econ Res, Kunitachi, Tokyo 1868603, Japan; [Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Inoue, Akiomi] Univ Occupat & Environm Hlth, Dept Mental Hlth, Inst Ind Ecol Sci, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Oshio, T (reprint author), Hitotsubashi Univ, Inst Econ Res, 2-1 Naka, Kunitachi, Tokyo 1868603, Japan.	oshio@ier.hit-u.ac.jp			JSPS [4102-21119001, 22000001]; JSPS KAKENHI [26253042]	The present study was supported by (1) JSPS Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area) 2009-2013, Grant Number 4102-21119001, (2) JSPS Grant-in-Aid for Specially Promoted Research 2010-2014, Grant Number 22000001, and (3) JSPS KAKENHI, Grant Number 26253042.	Andres Antonio R, 2004, J Ment Health Policy Econ, V7, P99; Tsutsumi A, 2001, WORK STRESS, V15, P86, DOI 10.1080/02678370118173; Inoue A, 2013, J OCCUP HEALTH, V55, P47; Flint E, 2013, J EPIDEMIOL COMMUN H, V67, P796, DOI 10.1136/jech-2013-202425; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Inoue A, 2009, J OCCUP HEALTH, V51, P74; Clays E, 2007, SCAND J WORK ENV HEA, V33, P252; Dragano N, 2008, SOC PSYCH PSYCH EPID, V43, P72, DOI 10.1007/s00127-007-0267-z; Tornroos M, 2012, J OCCUP ENVIRON MED, V54, P875, DOI 10.1097/JOM.0b013e31824fe0e4; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; de Jonge J, 2000, SOC SCI MED, V50, P1317, DOI 10.1016/S0277-9536(99)00388-3; Stansfeld SA, 2012, AM J PUBLIC HEALTH, V102, P2360, DOI 10.2105/AJPH.2011.300589; Elovainio M, 2001, J APPL PSYCHOL, V86, P418, DOI 10.1037//0021-9010.86.3.418; Siegrist J, 2009, INT ARCH OCC ENV HEA, V82, P1005, DOI 10.1007/s00420-008-0384-3; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Elovainio M, 2002, AM J PUBLIC HEALTH, V92, P105, DOI 10.2105/AJPH.92.1.105; Theorell T, 2014, J EPIDEMIOL COMMUN H, V68, P78, DOI 10.1136/jech-2012-202294; Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P27, DOI 10.1136/oem.60.1.27; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Oshio T, 2014, SOC SCI MED, V115, P121, DOI 10.1016/j.socscimed.2014.06.016; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; BURKE MJ, 1993, J APPL PSYCHOL, V78, P402, DOI 10.1037/0021-9010.78.3.402; Mckenzie SK, 2014, J EPIDEMIOL COMMUN H, V68, P253, DOI 10.1136/jech-2013-203013; Mikolajczak M, 2007, J RES PERS, V41, P1107, DOI 10.1016/j.jrp.2007.01.003; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879; Inoue A, 2013, INT J BEHAV MED, V20, P265, DOI 10.1007/s12529-012-9224-7; Wang JL, 2008, J EPIDEMIOL COMMUN H, V62, P42, DOI 10.1136/jech.2006.050591; Ayyagari P, 2010, BE J ECON ANAL POLI, V10; Azagba S, 2012, INT J PUBLIC HEALTH, V57, P807, DOI 10.1007/s00038-012-0348-y; Baltagi BH., 2013, ECONOMETRIC ANAL PAN; Buddeberg-Fischer B, 2008, INT ARCH OCC ENV HEA, V82, P31, DOI 10.1007/s00420-008-0303-7; Feldt T, 1997, WORK STRESS, V11, P134, DOI 10.1080/02678379708256830; Garbarino S., 2013, INT ARCH OCC ENV HEA, V87, P295; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Karasek R.A., 1985, JOB CONTENT WUESTION; Kurioka S, 2013, J OCCUP HEALTH, V55, P340; LANDSBERGIS PA, 1994, SCAND J WORK ENV HEA, V20, P349; MOORMAN RH, 1991, J APPL PSYCHOL, V76, P845, DOI 10.1037/0021-9010.76.6.845; Oginska-Bulik Nina, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P167; Oshio T, 2014, IND HEALTH, V52, P313; Sapp AL, 2010, J OCCUP ENVIRON MED, V52, P740, DOI 10.1097/JOM.0b013e3181e80842; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037//1076-8998.1.1.27; Urakawa K, 2009, IND HEALTH, V47, P503; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	FEB	2015	126						138	144		10.1016/j.socscimed.2014.12.021		7	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Biomedical Social Sciences	CB2AM	WOS:000349429100015		
J	Tabata, A; Imori, Y				Tabata, Akimori; Imori, Yoshikazu			Current density-voltage and admittance characteristics of hydrogenated nanocrystalline cubic SiC/crystalline Si heterojunction diodes prepared with varying H-2 gas flow rates	SOLID-STATE ELECTRONICS			English	Article						Silicon carbide; Nanocrystalline; Hot-wire chemical vapor deposition; Heterojunction; Current density-voltage characteristics; Admittance characteristics	CHEMICAL-VAPOR-DEPOSITION; CARBIDE THIN-FILMS; SILICON SOLAR-CELLS; HOT-WIRE CVD; N-TYPE; TRANSPORT MECHANISMS; SIH4/CH4/H-2; TEMPERATURE; GROWTH; CRYSTALLIZATION	N-doped hydrogenated nanocrystalline cubic SiC (nc-3C-SiC:H) thin films were deposited on p-type crystalline Si (c-Si) substrates by hot-wire chemical vapor deposition from a SiH4/CH4/H-2/N-2 gas mixture. The current density-voltage and the admittance characteristics of the nc-3C-SiC:H/c-Si heterojunction diodes were investigated. As the H-2 gas flow rate (F(H-2)) increased from 25 to 100 sccm, the ideality factor and saturation current density deceased from 1.87 to 1.47 and 1.6 x 10(-7) to 9.9 x 10(-9) A/cm(2), respectively. However, they increased to 1.82 and 3.0 x 10(-7) A/cm(2), respectively, when F(H-2) was further increased to 1000 sccm. The relaxation time, evaluated from the admittance characteristics, decreased from 2.9 x 10(-5) to 2.4 x 10(-6) s with an increase in F(H-2). The apparent built-in voltage, evaluated from the capacitance-voltage characteristics, decreased from 1.05 to 0.60 eV. These findings were mainly caused by interfacial defects, generated by a high density of H radicals during the nc-3C-SiC:H deposition process. The interfacial defect density increased with an increase in F(H-2), resulting in deterioration of the diode characteristics. (C) 2014 Elsevier Ltd. All rights reserved.	[Tabata, Akimori; Imori, Yoshikazu] Nagoya Univ, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Tabata, A (reprint author), Nagoya Univ, Dept Elect Engn & Comp Sci, Chikusa Ku, C3-1 631 Furo Cho, Nagoya, Aichi 4648603, Japan.	tabata@nuee.nagoya-u.ac.jp					ALIM MA, 1989, J AM CERAM SOC, V72, P28, DOI 10.1111/j.1151-2916.1989.tb05948.x; Anderson AR, 1962, SOLID STATE ELECT, V5, P341; Jensen N, 2000, J APPL PHYS, V87, P2639, DOI 10.1063/1.372230; Miyajima S, 2006, JPN J APPL PHYS 2, V45, pL432, DOI 10.1143/JJAP.45.L432; van Veen MK, 2003, APPL PHYS LETT, V82, P287, DOI 10.1063/1.1536710; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Miyajima S, 2007, JPN J APPL PHYS 1, V46, P1415, DOI 10.1143/JJAP.46.1415; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Komura Y, 2006, J NON-CRYST SOLIDS, V352, P1367, DOI 10.1016/j.jnoncrysol.2005.11.102; Tabata A, 2009, THIN SOLID FILMS, V517, P3516, DOI 10.1016/j.tsf.2009.01.042; Matsuda A, 2004, JPN J APPL PHYS 1, V43, P7909, DOI 10.1143/JJAP.43.7909; Hoshide Y, 2009, THIN SOLID FILMS, V517, P3520, DOI 10.1016/j.tsf.2009.01.046; Tabata A, 2010, MATER SCI ENG B-ADV, V175, P201, DOI 10.1016/j.mseb.2010.07.027; Mikolasek M, 2014, THIN SOLID FILMS, V558, P315, DOI 10.1016/j.tsf.2014.02.068; Miyajima S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3460917; Komura Y, 2008, THIN SOLID FILMS, V516, P633, DOI 10.1016/j.tsf.2007.06.065; Banerjee C, 2007, JPN J APPL PHYS 1, V46, P1, DOI 10.1143/JJAP.46.1; Bube RH, 1998, PHOTOVOLTAIC MAT, P28; Chen T, 2012, SOL ENERG MAT SOL C, V98, P370, DOI 10.1016/j.solmat.2011.11.039; Colder H, 2006, SOLID STATE ELECTRON, V50, P209, DOI 10.1016/j.sse.2005.12.012; Debye P., 1929, POLAR MOL; Donnelly JP, 1967, IEEE T ELECTRON DEV, V63, pED14; FORREST SR, 1982, J APPL PHYS, V53, P5738, DOI 10.1063/1.331462; GRANT FA, 1958, J APPL PHYS, V29, P76, DOI 10.1063/1.1722949; Gudovskikh AS, 2004, THIN SOLID FILMS, V451, P345, DOI 10.1016/j.tsf.2003.10.127; Harris G.L., 1995, PROPERTIES SILICON C; Ishida Y, 1997, JPN J APPL PHYS 1, V36, P6633, DOI 10.1143/JJAP.36.6633; Jensen N, 2002, PROG PHOTOVOLTAICS, V10, P1, DOI 10.1002/pip.398; JOHNSON AD, 1993, J PHYS CHEM-US, V97, P12937, DOI 10.1021/j100151a049; Komura Y, 2007, JPN J APPL PHYS 1, V46, P45, DOI 10.1143/JJAP.46.45; Musumeci P, 1997, PHILOS MAG B, V76, P323, DOI 10.1080/01418639708241097; OLDHAM WG, 1972, SOLID STATE ELECTRON, V15, P1085, DOI 10.1016/0038-1101(72)90167-0; Saha P, 2004, VACUUM, V72, P129; Schulze TF, 2010, J APPL PHYS, V107, DOI 10.1063/1.3267316; Sze MS, 2002, SEMICONDUCTOR DEVISE; Sze MS, 2002, SEMICONDUCTOR DEVISE; Tabata A, 2007, SURF COAT TECH, V201, P8986, DOI 10.1016/j.surfcoat.2007.04.100; Tabata A, 2010, J NON-CRYST SOLIDS, V356, P1131, DOI 10.1016/j.jnoncrysol.2010.04.011; Tabata A, 2008, JPN J APPL PHYS, V47, P561, DOI 10.1143/JJAP.47.561; Toyama T, 2003, JPN J APPL PHYS 2, V42, pL1347, DOI 10.1143/JJAP.42.L1347; Umenoto H, 2002, J APPL PHYS, V91, P1650; WERNER JH, 1988, APPL PHYS A-MATER, V47, P291, DOI 10.1007/BF00615935; Yamamoto M, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.026501; Yu W, 2007, SOLID STATE COMMUN, V143, P228, DOI 10.1016/j.ssc.2007.05.015; Zetterling C-M, 2002, PROCESS TECHNOLOGY S, P6	45	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	FEB	2015	104						33	38		10.1016/j.sse.2014.11.005		6	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CB1ZQ	WOS:000349426900006		
J	Tsukuda, M; Imaki, H; Omura, I				Tsukuda, Masanori; Imaki, Hironori; Omura, Ichiro			Ultrafast lateral 600 V silicon SOI PiN diode with geometric traps for preventing waveform oscillation	SOLID-STATE ELECTRONICS			English	Article						Diode; Waveform oscillation; Reverse recovery; Forward voltage drop; Geometric trap	DESIGN; TRENCH; EMI	An ultrafast lateral silicon PiN diode with geometric traps is proposed using a silicon-on-insulator (SOI) substrate with the traps. The proposed diode successfully suppresses waveform oscillation because the trapped hole suppresses electric field penetration and prevents the oscillation trigger known as "dynamic punch-through." Because of the short current path caused by the oscillation prevention, the reverse recovery speed was higher and the reverse recovery loss was strongly reduced. The proposed trap structure and design method would contribute to performance improvement of all power semiconductor devices including IGBTs and power MOSFETs. (C) 2014 Elsevier Ltd. All rights reserved.	[Tsukuda, Masanori] Asian Growth Res Inst, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan; [Tsukuda, Masanori; Imaki, Hironori; Omura, Ichiro] Kyushu Inst Technol, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan	Tsukuda, M (reprint author), Asian Growth Res Inst, Wakamatsu Ku, 1-8 Hibikino, Kitakyushu, Fukuoka, Japan.	tsukuda@agi.or.jp					Luo XR, 2008, IEEE T ELECTRON DEV, V55, P1756, DOI 10.1109/TED.2008.924048; [Anonymous], 2013, Hard-switching and soft-switching, Patent No. 3959125; [Anonymous], 2007, NEDO Research Report, Patent No. 3950105; Omura I, 2007, PROCEEDINGS OF THE 2007 INTERNATIONAL WORKSHOP ON THE PHYSICS OF SEMICONDUCTOR DEVICES: IWPSD-2007, P781, DOI 10.1109/IWPSD.2007.4472634; Hille F, 2007, INT SYM POW SEMICOND, P109, DOI 10.1109/ISPSD.2007.4294944; Holger Kapels, 2000, P ISPSD, P205; Josef Lutz, 2011, SEMICONDUCTOR POWER; Kaschani KT, 1995, P SMICND, P571; Luo XR, 2005, INT C COMMUN CIRCUIT, P1403; Luo XR, 2007, IEEE ELECTR DEVICE L, V28, P422, DOI 10.1109/LED.2007.894648; Masanori Tsukuda, 2005, P IEEJ, V4, P5; Masanori Tsukuda, 2014, P ISPSD, P31; MORI M, 1991, PROCEEDINGS OF THE 3RD INTERNATIONAL SYMPOSIUM ON POWER SEMICONDUCTOR DEVICES AND ICS, P113, DOI 10.1109/ISPSD.1991.146079; Nemoto M., 2004, Proceedings of the 16th International Symposium on Power Semiconductor Devices & IC's; Ohashi H, 2012, PROC INT SYMP POWER, P9, DOI 10.1109/ISPSD.2012.6229010; Omura Ichiro, 2000, HARD SWITCHING SOFT, Patent No. 6,049,109; Omura Ichiro, 2007, Japanese Patent, Patent No. [3950105, 6049109]; Omura Ichiro, 2007, RES GREEN ELECT TECH, Patent No. 3959125; Robert Plikat, 1998, P IEEE INT SOI C, P59; Satoh K, 2000, P ISPSD 2000, P249; Shiraki S, 2010, PROC INT SYMP POWER, P261; Takahama K, 2010, PROC INT SYMP POWER, P169; Tsukuda M, 2008, INT SYM POW SEMICOND, P185; Tsukuda M, 2011, MICROELECTRON RELIAB, V51, P1972, DOI 10.1016/j.microrel.2011.07.012; Tsukuda M, 2009, PROC INT SYMP POWER, P128, DOI 10.1109/ISPSD.2009.5158018; Yang X., 2011, P AS PAC POW EN ENG, P1	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	FEB	2015	104						61	69		10.1016/j.sse.2014.11.011		9	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CB1ZQ	WOS:000349426900011		
J	Kazumata, K; Tha, KK; Narita, H; Kusumi, I; Shichinohe, H; Ito, M; Nakayama, N; Houkin, K				Kazumata, Ken; Tha, Khin Khin; Narita, Hisashi; Kusumi, Ichiro; Shichinohe, Hideo; Ito, Masaki; Nakayama, Naoki; Houkin, Kiyohiro			Chronic Ischemia Alters Brain Microstructural Integrity and Cognitive Performance in Adult Moyamoya Disease	STROKE			English	Article						diffusion; ischemia; magnetic resonance imaging; moyamoya disease; white matter disease	CHRONIC CEREBRAL HYPOPERFUSION; VOXEL-BASED MORPHOMETRY; GRAY-MATTER LOSS; WHITE-MATTER; ALZHEIMERS-DISEASE; WORKING-MEMORY; INCREASED DIFFUSION; CINGULATE CORTEX; DEFAULT-MODE; IMPAIRMENT	Background and Purpose-The mechanisms underlying frontal lobe dysfunction in moyamoya disease (MMD) are unknown. We aimed to determine whether chronic ischemia induces subtle microstructural brain changes in adult MMD and evaluated the association of changes with neuropsychological performance. Methods-MRI, including 3-dimensional T1-weighted imaging and diffusion tensor imaging, was performed in 23 adult patients with MMD and 23 age-matched controls and gray matter density and major diffusion tensor imaging indices were compared between them; any alterations in the patients were tested for associations with age, ischemic symptoms, hemodynamic compromise, and neuropsychological performance. Results-Decrease in gray matter density, associated with hemodynamic compromise (P<0.05), was observed in the posterior cingulate cortex of patients with MMD. Widespread reduction in fractional anisotropy and increases in radial diffusivity and mean diffusivity in some areas were also observed in bilateral cerebral white matter. The fractional anisotropy (r=0.54; P<0.0001) and radial diffusivity (r=-0.41; P<0.01) of white matter significantly associated with gray matter density of the cingulate cortex. The mean fractional anisotropy of the white matter tracts of the lateral prefrontal, cingulate, and inferior parietal regions were significantly associated with processing speed, executive function/attention, and working memory. Conclusions-In adult MMD, there were more white matter abnormalities than gray matter changes. Disruption of white matter may play a pivotal role in the development of cognitive dysfunction.	[Kazumata, Ken; Shichinohe, Hideo; Ito, Masaki; Nakayama, Naoki; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido 0608638, Japan; [Tha, Khin Khin] Hokkaido Univ, Grad Sch Med, Dept Radiobiol & Med Engn, Sapporo, Hokkaido 0608638, Japan; [Narita, Hisashi; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido 0608638, Japan	Kazumata, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, N 15 W 7, Sapporo, Hokkaido 0608638, Japan.	kazumata@med.hokudai.ac.jp	Tha, Khin/A-4762-2012	Tha, Khin/0000-0002-9072-4509	Research Committee on moyamoya disease; Ministry of Health, Labor, and Welfare of Japan	This study was supported by a grant from the Research Committee on moyamoya disease, sponsored by the Ministry of Health, Labor, and Welfare of Japan.	Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Zaharchuk G, 2011, STROKE, V42, P2485, DOI [10.1161/STROKEAHA.111.616466, 10.1161/STROKEAHA.111.61646]; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Black S, 2009, STROKE, V40, pS48, DOI 10.1161/STROKEAHA.108.537704; Conklin J, 2010, STROKE, V41, P1610, DOI 10.1161/STROKEAHA.110.579540; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Behrens TEJ, 2003, MAGNET RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Park DC, 2003, J COGNITIVE NEUROSCI, V15, P1122, DOI 10.1162/089892903322598094; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Cheng HL, 2012, STROKE, V43, P2567, DOI 10.1161/STROKEAHA.111.645614; Kurumatani T, 1998, STROKE, V29, P1058; Calviere L, 2010, J NEUROSURG, V113, P753, DOI 10.3171/2010.4.JNS091808; Calviere L, 2012, J NEUROL NEUROSUR PS, V83, P591, DOI 10.1136/jnnp-2011-301388; Chetelat G, 2002, NEUROREPORT, V13, P1939; Jeong H, 2011, AM J NEURORADIOL, V32, P1893, DOI 10.3174/ajnr.A2683; Jurcoane A, 2014, NEURORADIOLOGY, V56, P5, DOI 10.1007/s00234-013-1289-8; Karzmark P, 2012, NEUROSURGERY, V70, P634, DOI 10.1227/NEU.0b013e3182320d1a; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Mogensen MA, 2012, AM J NEURORADIOL, V33, P721, DOI 10.3174/ajnr.A2852; Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, 2012, NEUROL MED CHIR TOKY, V52, P245; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Whitwell Jennifer L, 2005, Top Magn Reson Imaging, V16, P409, DOI 10.1097/01.rmr.0000245457.98029.e1; Williams Leanne M, 2008, Expert Rev Neurother, V8, P1049, DOI 10.1586/14737175.8.7.1049	35	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	FEB	2015	46	2					354	360		10.1161/STROKEAHA.114.007407		7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AZ8AS	WOS:000348437800024		
J	Irie, F; Kamouchi, M; Hata, J; Matsuo, R; Wakisaka, Y; Kuroda, J; Ago, T; Kitazono, T				Irie, Fumi; Kamouchi, Masahiro; Hata, Jun; Matsuo, Ryu; Wakisaka, Yoshinobu; Kuroda, Junya; Ago, Tetsuro; Kitazono, Takanari		FSR Investigators	Sex Differences in Short-Term Outcomes After Acute Ischemic Stroke The Fukuoka Stroke Registry	STROKE			English	Article						brain infarction; prognosis; sex	CLINICAL PRESENTATION; JAPANESE GUIDELINES; ATRIAL-FIBRILLATION; MANAGEMENT; EPIDEMIOLOGY; SEVERITY; TRIAL; BRAIN; CARE; AGE	Background and Purpose-Variable sex differences in clinical outcomes after stroke have been reported worldwide. This study aimed to elucidate whether sex is an independent risk factor of poor functional outcome after acute ischemic stroke. Methods-Using the database of patients with acute stroke registered in the Fukuoka Stroke Registry in Japan from 1999 to 2013, 6236 previously independent patients with first-ever ischemic stroke who were admitted within 24 hours of onset were included in this study. Baseline characteristics were assessed on admission. Study outcomes included neurological improvement, neurological deterioration, and poor functional outcome (modified Rankin Scale score, 3-6 at discharge). Logistic regression analyses were performed to evaluate the association between sex and clinical outcomes. Results-Overall, 2398 patients (38.5%) were women. Severe stroke (National Institutes of Health Stroke Scale score, >= 8) on admission was more prevalent in women than in men. The frequency of neurological improvement or deterioration during hospitalization was not different between the sexes. After adjusting for possible confounders, including age, stroke subtype and severity, risk factors, and poststroke treatments, it was found that female sex was independently associated with poor functional outcome at discharge (odds ratio, 1.30; 95% confidence interval, 1.08-1.57). There was heterogeneity of the association between sex and poor outcome according to age: women had higher risk of poor outcome than men among patients aged >= 70 years, but no clear sex difference was found in patients aged <70 years. Conclusions-Female sex was associated with the risk of poor functional outcome at discharge after acute ischemic stroke.	[Irie, Fumi; Hata, Jun; Matsuo, Ryu; Wakisaka, Yoshinobu; Kuroda, Junya; Ago, Tetsuro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Kamouchi, Masahiro; Matsuo, Ryu] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 8128582, Japan; [Kamouchi, Masahiro; Hata, Jun; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Fukuoka 8128582, Japan; [Wakisaka, Yoshinobu; Kuroda, Junya; Ago, Tetsuro; Kitazono, Takanari] Kyushu Univ Hosp, Dept Nephrol Hypertens & Strokol, Fukuoka 812, Japan	Kamouchi, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	kamouchi@hcam.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [22249069, 24310024, 26293158]; Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported by Japan Society for the Promotion of Science KAKENHI grant numbers 22249069, 24310024, and 26293158 and Coordination, Support and Training Program for Translational Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Lin HJ, 1996, STROKE, V27, P1760; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Gall SL, 2010, NEUROLOGY, V74, P975, DOI 10.1212/WNL.0b013e3181d5a48f; Roquer J, 2003, STROKE, V34, P1581, DOI 10.1161/01.STR.0000078562.82918.F6; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; HART RG, 1986, ARCH NEUROL-CHICAGO, V43, P71; Bushnell CD, 2008, NAT CLIN PRACT NEURO, V4, P22, DOI 10.1038/ncpneuro0686; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Kamouchi M, 2011, STROKE, V42, P2788, DOI 10.1161/STROKEAHA.111.617415; Matteis M, 1998, STROKE, V29, P963; Kamouchi M, 2012, STROKE, V43, P3085, DOI 10.1161/STROKEAHA.112.672501; Gray LJ, 2007, STROKE, V38, P2960, DOI 10.1161/STROKEAHA.107.488304; [Anonymous], 1990, STROKE, V21, P637; Yong M, 2008, STROKE, V39, P2749, DOI 10.1161/STROKEAHA.108.514307; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Paolucci S, 2006, STROKE, V37, P2989, DOI 10.1161/01.STR.0000248456.41647.3d; Shinohara Y, 2008, INT J STROKE, V3, P55, DOI 10.1111/j.1747-4949.2008.00178.x; Holroyd-Leduc JM, 2000, STROKE, V31, P1833; Olsen TS, 2007, NEUROEPIDEMIOLOGY, V29, P218, DOI 10.1159/000112464; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Barrett Kevin M, 2007, J Stroke Cerebrovasc Dis, V16, P34, DOI 10.1016/j.jstrokecerebrovasdis.2006.11.002; Lai Sue-Min, 2005, Prev Chronic Dis, V2, pA13; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS1, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.002; Zhang L, 2002, MOL BRAIN RES, V103, P1	31	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	FEB	2015	46	2					471	476		10.1161/STROKEAHA.114.006739		6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AZ8AS	WOS:000348437800042		
J	Matsuzono, K; Yokota, C; Takekawa, H; Okamura, T; Miyamatsu, N; Nakayama, H; Nishimura, K; Ohyama, S; Ishigami, A; Okumura, K; Toyoda, K; Miyamoto, Y; Minematsu, K				Matsuzono, Kosuke; Yokota, Chiaki; Takekawa, Hidehiro; Okamura, Tomonori; Miyamatsu, Naomi; Nakayama, Hirofumi; Nishimura, Kunihiro; Ohyama, Satoshi; Ishigami, Akiko; Okumura, Kosuke; Toyoda, Kazunori; Miyamoto, Yoshihiro; Minematsu, Kazuo		Tochigi Jr High Sch Stroke Educ	Effects of Stroke Education of Junior High School Students on Stroke Knowledge of Their Parents Tochigi Project	STROKE			English	Article						acute stroke; health education; schools		Background and purpose-Educating the youth about stroke is a promising approach for spreading stroke knowledge. The aim of this study was to verify communication of stroke knowledge to parents by educating junior high school students about stroke. Methods-We enrolled 1127 junior high school students (age, 13-15 years) and their parents in the Tochigi prefecture, Japan. All students received a stroke lesson, watched an animated cartoon, and read the related Manga comic as educational aids. The students took back home the Manga and discussed what they learned with their parents. Questionnaires on stroke knowledge were given to all at baseline and immediately after the lesson. Results-A total of 1125 students and 915 parents answered the questionnaires. In the students, the frequency of correct answers increased significantly for all questions on stroke symptoms except for headache, and for all questions on risk factors after the lesson. In the parents, the correct answer rates increased for stroke symptoms except for headache and numbness in one side of the body, and for all questions on risk factors except for hypertension. Ninety-one percent of students and 92.7% of parents correctly understood the Face, Arm, Speech, and Time (FAST) mnemonic after the lesson. Conclusions-Improvement of stroke knowledge immediately after the stroke lesson was observed in parents as well as their children, which indicated that our teaching materials using the Manga was effective in delivering the stroke knowledge to parents through their children.	[Matsuzono, Kosuke; Yokota, Chiaki; Ohyama, Satoshi; Ishigami, Akiko; Okumura, Kosuke; Toyoda, Kazunori; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Takekawa, Hidehiro] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Miyamatsu, Naomi] Shiga Univ Med Sci, Dept Clin Nursing, Shiga, Japan; [Nakayama, Hirofumi] Japan Stroke Assoc, Osaka, Japan; [Nishimura, Kunihiro; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka 5658565, Japan; [Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan	Yokota, C (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	cyokota@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015; Okamura, Tomonori/L-1693-2013	Toyoda, Kazunori/0000-0002-8346-9845; 	National Cerebral and Cardiovascular Center [22-4-1]	This study was supported by the Intramural Research Fund of the National Cerebral and Cardiovascular Center (22-4-1).	Amano T, 2014, J STROKE CEREBROVASC, V23, P1040, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.021; Miyashita F, 2014, J STROKE CEREBROVASC, V23, P1385, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.016; Williams O, 2012, STROKE, V43, P163, DOI 10.1161/STROKEAHA.111.621029; Morgenstern LB, 2007, STROKE, V38, P2972, DOI 10.1161/STROKEAHA.107.490078; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Shigehatake Y, 2014, J STROKE CEREBROVASC, V23, P1623, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.001; Wall Hilary K, 2008, Prev Chronic Dis, V5, pA49	7	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	FEB	2015	46	2					572	574		10.1161/STROKEAHA.114.007907		3	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AZ8AS	WOS:000348437800059		
J	Tanaka, E; Fukunaga, Y; Nakashima, M; Nagasue, Y; Akiyoshi, T; Konishi, T; Nagayama, S; Fujimoto, Y; Ueno, M; Yamaguchi, T				Tanaka, Eiji; Fukunaga, Yosuke; Nakashima, Masayuki; Nagasue, Yasutomo; Akiyoshi, Takashi; Konishi, Tsuyoshi; Nagayama, Satoshi; Fujimoto, Yoshiya; Ueno, Masashi; Yamaguchi, Toshiharu			Laparoscopic Incisionless Stoma Creation for Patients With Colorectal Malignant Stricture	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						ostomy; laparoscopy; minimally invasive surgical procedure; single incision	TREPHINE COLOSTOMY; FECAL DIVERSION; LOOP ILEOSTOMY; SINGLE-SITE; SURGERY	Background: Minimally invasive techniques have been applied with increasing frequency to stoma creation. A recent focus in the field of minimally invasive surgery is laparoscopic single-site surgery. The aim of this study was to assess whether this procedure is a feasible option compared with other techniques of stoma creation. Materials and Methods: We introduced laparoscopic surgery to fecal diversion in April 2010 at the Cancer Institute Hospital of the Japanese Foundation for Cancer Research. This technique was performed on 53 patients, including 15 laparoscopic single-site surgeries, from April 2010 to December 2011. Results: Of these 15 cases, 8 ileostomies and 7 colostomies were created. The mean operative time was 65.9 minutes (range, 32 to 93 min). The estimated volume of blood loss was small in all cases. There were no intraoperative complications. All patients started an oral diet on the second postoperative day with the exception of 1 patient who suffered from prolonged paralytic ileus. Conclusions: A laparoscopic single-site approach to stoma creation may be a feasible option in fecal diversion.	[Tanaka, Eiji; Fukunaga, Yosuke; Akiyoshi, Takashi; Konishi, Tsuyoshi; Nagayama, Satoshi; Fujimoto, Yoshiya; Ueno, Masashi; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Gastroenterol Surg, Koto, Tokyo 1358550, Japan; [Tanaka, Eiji; Nakashima, Masayuki; Nagasue, Yasutomo] Japanese Red Cross Kumamoto Hosp, Dept Surg, Kumamoto, Kumamoto, Japan	Fukunaga, Y (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Gastroenterol Surg, 3-8-31 Ariake, Koto, Tokyo 1358550, Japan.	yosuke.fukunaga@jfcr.or.jp					Albert M, 2011, TECH COLOPROCTOL, V15, P345; ANDERSON ID, 1992, BRIT J SURG, V79, P1080, DOI 10.1002/bjs.1800791031; Young CJ, 1998, DIS COLON RECTUM, V41, P190, DOI 10.1007/BF02238247; Bucher P, 2011, BRIT J SURG, V98, P1695, DOI 10.1002/bjs.7689; Diana M, 2011, J MINIM ACCESS SURG, V7, P52, DOI 10.4103/0972-9941.72382; Frizelle FA, 1996, ANN ROY COLL SURG, V78, P157; Gunnar N, 1997, EUR J SURG, V163, P627; Kader N, 1993, AM J OBSTET GYNECOL, V8, P1493; KHOO REH, 1993, DIS COLON RECTUM, V36, P966, DOI 10.1007/BF02050635; Kirk A, 1996, DIS COLON RECTUM, V39, P285; Lange V, 1991, J Laparoendosc Surg, V1, P307, DOI 10.1089/lps.1991.1.307; Lucia O, 2003, SEMIN LAPAROSC SURG, V10, P191; LYERLY HK, 1994, ANN SURG, V219, P317, DOI 10.1097/00000658-199403000-00013; Opitz I, 2005, LANGENBECK ARCH SURG, V390, P128, DOI 10.1007/s00423-004-0538-z; Patel P, 2001, Colorectal Dis, V3, P270, DOI 10.1046/j.1463-1318.2001.00266.x; Peter BL, 1995, ANN R COLL SURG ENGL, V77, P462; Scheidbach H, 2009, LANGENBECK ARCH SURG, V394, P371, DOI 10.1007/s00423-007-0220-3; Seiichiro Y, 2007, SURG ENDOSC, V21, P2248; SENAPATI A, 1991, ANN ROY COLL SURG, V73, P305; Zaghiyan KN, 2011, DIS COLON RECTUM, V54, P1542, DOI 10.1097/DCR.0b013e31822b71eb	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					37	39				3	Surgery	Surgery	CB2IL	WOS:000349450500020		
J	Ojima, T; Nakamori, M; Nakamura, M; Katsuda, M; Iida, T; Hayata, K; Takifuji, K; Hotta, T; Yokoyama, S; Matsuda, K; Iwahashi, M; Yamaue, H				Ojima, Toshiyasu; Nakamori, Mikihito; Nakamura, Masaki; Katsuda, Masahiro; Iida, Takeshi; Hayata, Keiji; Takifuji, Katsunari; Hotta, Tsukasa; Yokoyama, Shozo; Matsuda, Kenji; Iwahashi, Makoto; Yamaue, Hiroki			Laparoscopic Combined Resection of Synchronous Gastric and Colorectal Cancer	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						laparoscopic surgery; gastric cancer; colorectal cancer	ASSISTED DISTAL GASTRECTOMY; RANDOMIZED-TRIAL; COLON-CANCER; OUTCOMES; SURGERY	Purpose: The aim of this study was to examine the feasibility of performing combined laparoscopic resection in patients with synchronous gastric and colorectal cancer. Methods: Thirty-six consecutive patients with synchronous gastric and colorectal cancer who underwent simultaneous combined resection were enrolled in this retrospective study. Results: Six patients underwent laparoscopic combined resection (lap group), whereas the other 30 patients underwent conventional open combined surgery (open group). Although the operative time was longer in the lap group than in the open group, there were no differences in the amount of intraoperative bleeding. Although there were no differences in the rates of postoperative complications between the 2 groups, the postoperative hospital stay was significantly shorter in the lap group. During a mean follow-up of 35 months, all 6 patients who underwent laparoscopic combined resection survived without any signs of recurrence. Conclusions: Simultaneous laparoscopic resection is a feasible procedure in patients with synchronous gastric and colorectal cancer.	[Ojima, Toshiyasu; Nakamori, Mikihito; Nakamura, Masaki; Katsuda, Masahiro; Iida, Takeshi; Hayata, Keiji; Takifuji, Katsunari; Hotta, Tsukasa; Yokoyama, Shozo; Matsuda, Kenji; Iwahashi, Makoto; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Sch Med, Dept Surg 2, 811-1,Kimiidera, Wakayama 6418510, Japan.	yamaue-h@wakayama-med.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Ojima T, 2009, J GASTROINTEST SURG, V13, P1821, DOI 10.1007/s11605-009-0973-9; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Hayashi H, 2005, SURG ENDOSC, V19, P1172, DOI 10.1007/s00464-04-8207-4; Edge S, 2009, AJCC CANC STAGING MA; Hotta T, 2011, DIS COLON RECTUM, V54, P495, DOI 10.1007/DCR.0b013e318207026f; Hotta Tsukasa, 2012, World J Gastrointest Surg, V4, P1, DOI 10.4240/wjgs.v4.i1.1; Jackson TD, 2007, J AM COLL SURGEONS, V204, P439, DOI 10.1016/j.jamcollsurg.2006.12.008; Kim HO, 2009, J GASTROEN HEPATOL, V24, P1740, DOI 10.1111/j.1440-1746.2009.05922.x; Kitano S, 2002, SURGERY, V131, pS306, DOI 10.1067/msy.2002.120115; Matsui H, 2009, SURG TODAY, V39, P434, DOI 10.1007/s00595-008-3870-z; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Ojima T, 2012, LANGENBECK ARCH SURG, V397, P437, DOI 10.1007/s00423-011-0883-7; Park DI, 2010, J CLIN GASTROENTEROL, V44, P102, DOI 10.1097/MCG.0b013e3181a15849; Tokunaga M, 2010, LANGENBECK ARCH SURG, V395, P207, DOI 10.1007/s00423-009-0514-8; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					43	46				4	Surgery	Surgery	CB2IL	WOS:000349450500022		
J	Komatsu, S; Ichikawa, D; Kubota, T; Okamoto, K; Shiozaki, A; Fujiwara, H; Konishi, H; Morimura, R; Murayama, Y; Kuriu, Y; Ikoma, H; Nakanishi, M; Sakakura, C; Otsuji, E				Komatsu, Shuhei; Ichikawa, Daisuke; Kubota, Takeshi; Okamoto, Kazuma; Shiozaki, Atsushi; Fujiwara, Hitoshi; Konishi, Hirotaka; Morimura, Ryo; Murayama, Yasutoshi; Kuriu, Yoshiaki; Ikoma, Hisashi; Nakanishi, Masayoshi; Sakakura, Chohei; Otsuji, Eigo			Clinical Outcomes and Quality of Life According to Types of Reconstruction Following Laparoscopy-assisted Distal Gastrectomy for Gastric Cancer	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						Billroth-I; Roux-en-Y; reconstruction; LADG; gastric cancer; QOL; GSRS	ROUX-EN-Y; LYMPH-NODE DISSECTION; BILLROTH-I; GASTROINTESTINAL SYMPTOMS; SUBTOTAL GASTRECTOMY; TRIAL; ULCER; JAPAN	Purposes: Laparoscopy-assisted distal gastrectomy (LADG) has gained wide acceptance and is being more commonly performed at the period of introduction. This study was designed to determine the clinical outcomes and quality of life (QOL) according to types of reconstruction following LADG for gastric cancer. Patients and Methods: Between 2007 and 2010, 117 consecutive patients underwent LADG. These patients were classified into 2 groups: Billroth-I group (n=74) and Roux-en-Y group (n=48). Results: Although there were no significant differences in background factors such as sex, body mass index, pN stage, pT stage, or extent of lymphadenectomy between both the groups, patients with Billroth-I reconstruction were found more frequently in the lower portion of gastric cancer (P=0.0173), shorter surgical durations (P<0.0001), and less blood loss (P<0.0001). The overall postoperative complication rates did not significantly differ between both the groups (P=0.0675). However, the incidence of patients with postoperative stasis (P=0.0170) and long hospital stay (P=0.0039) was significantly higher in patients with Roux-en-Y reconstruction. Concerning the evaluation of long-term QOL using the Gastrointestinal Symptom Rating Scale, there were no significant differences in total score between both the groups (P=0.4387). Conclusions: Billroth-I technique might comparatively be accessible and safe in the reconstruction of LADG. However, the differences of reconstruction do not affect long-term QOL.	[Komatsu, Shuhei; Ichikawa, Daisuke; Kubota, Takeshi; Okamoto, Kazuma; Shiozaki, Atsushi; Fujiwara, Hitoshi; Konishi, Hirotaka; Morimura, Ryo; Murayama, Yasutoshi; Kuriu, Yoshiaki; Ikoma, Hisashi; Nakanishi, Masayoshi; Sakakura, Chohei; Otsuji, Eigo] Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Kyoto 6028566, Japan	Komatsu, S (reprint author), Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	skomatsu@koto.kpu-m.ac.jp					Montesani C, 2002, HEPATO-GASTROENTEROL, V49, P1469; Naka T, 2005, HEPATO-GASTROENTEROL, V52, P293; Nunobe S, 2007, INT J CLIN ONCOL, V12, P433, DOI 10.1007/s10147-007-0706-6; Tanimura S, 2005, SURG ENDOSC, V19, P1177, DOI 10.1007/s00464-004-8936-4; Adachi Y, 2000, ARCH SURG-CHICAGO, V135, P806, DOI 10.1001/archsurg.135.7.806; Shinoto K, 2003, SURG TODAY, V33, P169; Mochiki E, 2002, WORLD J SURG, V26, P1145, DOI 10.1007/s00268-002-6286-8; Miura S, 2004, J AM COLL SURGEONS, V198, P933, DOI 10.1016/j.jamcollsurg.2004.01.021; Ohtani H, 2010, J GASTROINTEST SURG, V14, P958, DOI 10.1007/s11605-010-1195-x; Huscher CGS, 2005, ANN SURG, V241, P232, DOI 10.1097/01.sla.0000151892.35922.f2; Kumagai K, 2011, J GASTROINTEST SURG, V15, P2145, DOI 10.1007/s11605-011-1683-7; Ishikawa M, 2005, WORLD J SURG, V29, P1415, DOI 10.1007/s00268-7830-0; Noshiro H, 2005, SURG ENDOSC, V19, P1592, DOI 10.1007/s00464-005-0175-9; DIMENAS E, 1995, SCAND J GASTROENTERO, V30, P1046, DOI 10.3109/00365529509101605; Mochiki E, 2005, SURGERY, V137, P317, DOI 10.1016/j.surg.2004.10.012; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Fukuhara K, 2004, HEPATO-GASTROENTEROL, V51, P1241; HAGLUND UH, 1990, AM J SURG, V159, P546, DOI 10.1016/S0002-9610(06)80062-0; Hiki N, 2008, LANGENBECK ARCH SURG, V393, P963, DOI 10.1007/s00423-008-0374-7; Hongo M, 1999, DIAGNOSIS TREATMENT, V87, P731; Ichikawa Daisuke, 2009, Surg Laparosc Endosc Percutan Tech, V19, pe163, DOI 10.1097/SLE.0b013e3181b6c867; Inoue H, 2007, ARCH SURG-CHICAGO, V142, P947, DOI 10.1001/archsurg.142.10.947; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Kitano S, 2002, SURGERY, V131, pS306, DOI 10.1067/msy.2002.120115; Kojima K, 2008, ANN SURG, V247, P962, DOI 10.1097/SLA.0b013e31816d9526; Kurokawa Y, 2008, JPN J CLIN ONCOL, V38, P501, DOI 10.1093/jjco/hyn055; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Oka M, 1995, J Am Coll Surg, V181, P366; Sobin LH, 2002, TNM CLASSIFICATION M, P170; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Takiguchi S, 2012, GASTRIC CANCER, V15, P198, DOI 10.1007/s10120-011-0098-1	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					69	73				5	Surgery	Surgery	CB2IL	WOS:000349450500027		
J	Chikamori, F; Okamoto, H; Kuniyoshi, N				Chikamori, Fumio; Okamoto, Hiroshi; Kuniyoshi, Nobutoshi			New Transjugular Retrograde Obliteration Without the Use of Ethanolamine Oleate for Gastric Varices	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						gastric varices; transjugular retrograde obliteration; gastrorenal shunt; 5% ethanolamine oleate	ESOPHAGEAL-VARICES; TRANSVENOUS OBLITERATION; GASTROESOPHAGEAL VARICES; SCLEROTHERAPY; EMBOLIZATION; FOAM; HEMODYNAMICS; HAPTOGLOBIN; EXPERIENCE	Objectives: The purpose of this study was to investigate the short-term effects of new transjugular retrograde obliteration (TJO) without the use of ethanolamine oleate for gastric varices with a gastrorenal shunt. Patients and Methods: Ten patients with gastric varices and a gastrorenal shunt were included in this study. Through the right internal jugular vein, a 5- or 6-Fr angiographic catheter with an occlusive balloon was inserted into the gastrorenal shunt. The balloon was inflated to occlude the gastrorenal shunt blood flow. Microcoils were used to obliterate the main blood drainage routes of gastric vein, such as inferior phrenic and and/or retroperitoneal veins. Continuous injection of 0.5 to 1.0mL of absolute ethanol and 2 to 15mL of 50% glucose solution into the gastrorenal shunt was carried out under fluoroscopy. This procedure was repeated at 5-minute intervals until gastric varices were clearly visualized. 5% ethanolamine oleate with iopamidol (5% EOI) was not used as a sclerosant. Results: TJO without 5% EOI technically succeeded in all cases. Total volumes of absolute ethanol and 50% glucose solution for the variceal obliteration were 6 +/- 4 and 56 +/- 46 mL, respectively. To produce thrombi in the gastric varices, the catheter had to be retained for 24 hours in 7 patients and for 48 hours in 3. The volumes of absolute ethanol and 50% glucose solution were 4 +/- 2 and 37 +/- 20 in the former 7 patients and 11 +/- 4 and 100 +/- 64mL in the latter 3 patients, respectively. Only minor complications were observed, which were as follows: fever >38 degrees C in 6 patients, epigastric pain in 8 patients, and temporary hypertension in 2 patients. Computed tomography scan and endoscopic examination 3 months after TJO revealed complete eradication of gastric varices in all cases. Conclusions: We conclude that new TJO without the use of 5% EOI is an effective and safe method for gastric varices.	[Chikamori, Fumio] Kuniyoshi Hosp, Dept Surg, Kochi 7800901, Japan; [Okamoto, Hiroshi; Kuniyoshi, Nobutoshi] Kuniyoshi Hosp, Dept Internal Med, Kochi 7800901, Japan	Chikamori, F (reprint author), Kuniyoshi Hosp, Dept Surg, 1-3-4 Kamimachi, Kochi 7800901, Japan.	chikamo2300@gmail.com					Kanagawa H, 1996, J GASTROEN HEPATOL, V11, P51, DOI 10.1111/j.1440-1746.1996.tb00010.x; Schwartz MJ, 2007, BJU INT, V99, P881, DOI 10.1111/j.1464-410X.2006.06653.x; Park SJ, 2010, J VASC INTERV RADIOL, V21, P503, DOI 10.1016/j.jvir.2009.11.023; HASHIZUME M, 1988, LANCET, V2, P340; Ninoi T, 2004, AM J ROENTGENOL, V183, P369; Gervais DA, 2011, AM J ROENTGENOL, V197, P789, DOI 10.2214/AJR.11.7656; Tajiri T, 2010, DIGEST ENDOSC, V22, P1, DOI 10.1111/j.1443-1661.2009.00929.x; MIYOSHI H, 1991, AM J GASTROENTEROL, V86, P1638; Sabri SS, 2011, J VASC INTERV RADIOL, V22, P309, DOI 10.1016/j.jvir.2010.11.022; OLSON E, 1984, AM J ROENTGENOL, V143, P627; Forlee MV, 2006, J VASC SURG, V43, P162, DOI 10.1016/j.jvs.2005.09.032; WATANABE K, 1988, GASTROENTEROLOGY, V95, P434; Chikamori F, 2001, SURGERY, V129, P414, DOI 10.1067/msy.2001.112000; Ceulen RPM, 2008, NEW ENGL J MED, V358, P1525, DOI 10.1056/NEJMc0707265; Chikamori F, 2001, DIGEST SURG, V18, P176, DOI 10.1159/000050126; Chikamori F, 1996, ABDOM IMAGING, V21, P299, DOI 10.1007/s002619900068; Chikamori F, 2000, DIGEST SURG, V17, P17, DOI 10.1159/000018795; LEE H, 1992, CRIT CARE MED, V20, P1555, DOI 10.1097/00003246-199211000-00013; Mitchell SE, 2006, J VASC INTERV RADIOL, V17, P253, DOI 10.1097/01.RVI.0000196273.82991.03; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P333, DOI 10.1055/s-0031-1284460; Sabri Saher S, 2011, Semin Intervent Radiol, V28, P303, DOI 10.1055/s-0031-1284457; SUZUKI N, 1992, GASTROENTEROL JPN, V27, P309; TAKASE Y, 1990, HEPATOLOGY, V11, P348, DOI 10.1002/hep.1840110303; UFLACKER R, 1983, RADIOLOGY, V146, P621	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					E27	E32				6	Surgery	Surgery	CB2IL	WOS:000349450500008		
J	Eto, K; Omura, N; Haruki, K; Uno, Y; Ohkuma, M; Nakajima, S; Anan, T; Kosuge, M; Fujita, T; Yanaga, K				Eto, Ken; Omura, Nobuo; Haruki, Koichiro; Uno, Yoshiko; Ohkuma, Masahisa; Nakajima, Shintaro; Anan, Tadashi; Kosuge, Makoto; Fujita, Tetsuji; Yanaga, Katsuhiko			A Comparison of Laparoscopic Energy Devices on Charges in Thermal Power After Application to Porcine Mesentery	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						laparoscopy; energy device; thermal injury	HARMONIC SCALPEL; ULTRASONIC ENERGY; MONOPOLAR; LIGASURE; ARTERIES; ELECTROCOAGULATION; CHOLECYSTECTOMY; HEMOSTASIS; DISSECTION; DIATHERMY	Introduction: Advances in energy devices have played a major role in the rapid expansion of laparoscopic surgery. However, complications due to these energy devices are occasionally reported, and if the characteristics of these devices are not well understood, serious complications may occur. This study evaluated various typical energy devices and measured temperature rises in the adjacent tissue and in the devices themselves. Equipment and Methods: We used the following 7 types of energy devices: AutoSonix (AU), SonoSurg (SS), Harmonic Scalpel (HS), LigaSure Atlas (LA), LigaSure Dolphin Tip (LD), monopolar diathermy (Mono), and bipolar scissors (Bi). Laparoscopy was performed under general anesthesia in pigs, and the mesentery was dissected using each energy device. Tissue temperature at a distance of 1mm from the energy device blade before and after dissection was measured. Temperature of the device blade both before and after dissection, time required for dissection, and interval until the temperature fell to 100 degrees C, 75 degrees C, and 50 degrees C were documented. Results: Temperature of the surrounding tissue using each device rose the most with the Mono (50.5 +/- 8.0 degrees C) and the least with the HS in full mode (6.2 +/- 0.7 degrees C). Device temperature itself rose the highest with the AU in full mode (318.2 +/- 49.6 degrees C), and the least with the Bi (61.9 +/- 4.8 degrees C). All ultrasonic coagulation and cutting devices (AU, SS, and HS) had device temperatures increase up to >= 100 degrees C, and even at 8 seconds after completing dissection, temperatures remained at >= 100 degrees C. Conclusions: Because the adjacent tissue temperature peaked with the Mono, cautious use near the intestine and blood vessels is necessary. In addition, the active blades of all ultrasonic coagulation and cutting devices, regardless of model, developed high temperatures exceeding 100 degrees C. Therefore, an adequate cooling period after using these devices is therefore necessary between applications.	[Eto, Ken; Omura, Nobuo; Haruki, Koichiro; Uno, Yoshiko; Ohkuma, Masahisa; Nakajima, Shintaro; Anan, Tadashi; Kosuge, Makoto; Fujita, Tetsuji; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan	Eto, K (reprint author), Jikei Univ, Sch Med, Dept Surg, Minato Ku, 3-25-8,Nishi Shinbashi, Tokyo 1058461, Japan.	etoken@jikei.ac.jp					Abe K, 2005, WORLD J SURG, V29, P106, DOI 10.1007/s00268-004-7547-5; Sietses C, 2001, SURG ENDOSC-ULTRAS, V15, P69, DOI 10.1007/s004640010061; Sutton PA, 2010, BRIT J SURG, V97, P428, DOI 10.1002/bjs.6901; Clements RH, 2007, SURG ENDOSC, V21, P2203, DOI 10.1007/s00464-007-9345-2; Emam TA, 2003, ANN SURG, V237, P186; van der Voort M, 2004, BRIT J SURG, V91, P1253, DOI 10.1002/bjs.4716; Lamberton GR, 2008, J ENDOUROL, V22, P2307, DOI 10.1089/end.2008.9715; Perko Z, 2006, SURG ENDOSC, V20, P322, DOI 10.1007/s00464-005-0089-6; Kim FJ, 2008, SURG ENDOSC, V22, P1464, DOI 10.1007/s00464-007-9650-9; Campbell PA, 2003, SURG ENDOSC, V17, P1640, DOI 10.1007/s00464-002-8781-2; Harold KL, 2003, SURG ENDOSC, V17, P1228, DOI 10.1007/s00464-002-8833-7; Druzijanic N, 2012, CAN J SURG, V55, P317, DOI 10.1503/cjs.000711; Kennedy JS, 1998, SURG ENDOSC-ULTRAS, V12, P876, DOI 10.1007/s004649900733; Diamantis T, 2006, SURG TODAY, V36, P908, DOI 10.1007/s00595-006-3254-1; Humes DJ, 2010, ARCH SURG-CHICAGO, V145, P96, DOI 10.1001/archsurg.2009.236; Katsuno G, 2010, J LAPAROENDOSC ADV S, V20, P747, DOI 10.1089/lap.2009.0438; Koch C, 2003, ULTRASOUND MED BIOL, V29, P301, DOI 10.1016/S0301-5629(02)00727-5; MATEK W, 1989, ENDOSCOPY, V21, P31, DOI 10.1055/s-2007-1012890	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					E37	E41				5	Surgery	Surgery	CB2IL	WOS:000349450500010		
J	Ikoma, N; Itano, O; Oshima, G; Kitagawa, Y				Ikoma, Naruhiko; Itano, Osamu; Oshima, Go; Kitagawa, Yuko			Laparoscopic Liver Mobilization: Tricks of the Trade to Avoid Complications	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						liver mobilization; laparoscopic surgery; laparoscopic hepatectomy	RESECTION	Laparoscopic liver resection is gaining popularity because of the availability of new laparoscopic instruments and advanced techniques. Laparoscopic liver mobilization is not only necessary for pure laparoscopic liver resection but also for laparoscopy-assisted hepatectomy. Laparoscopy-assisted hepatectomy significantly reduces the length of the laparotomy incision, and it is a good educational transition to the more advanced laparoscopic liver resection. Laparoscopic liver mobilization is a simple and easy procedure if surgeons know what challenges to expect. Here, the technique of liver mobilization is summarized, along with those challenges.	[Ikoma, Naruhiko; Itano, Osamu; Oshima, Go; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan; [Ikoma, Naruhiko] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA	Itano, O (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	itano@z8.keio.jp					Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Kluger MD, 2013, J HEPATO-BIL-PAN SCI, V20, P131, DOI 10.1007/s00534-012-0571-1; Dagher I, 2007, SURG ENDOSC, V21, P619, DOI 10.1007/s00464-006-9137-0; Itano O, 2009, J HEPATO-BILIARY-PAN, V16, P711, DOI 10.1007/s00534-009-0141-3; Itano O, 2011, J LAPAROENDOSC ADV B, V21, P6; Mostaedi Rouzbeh, 2012, World J Gastrointest Oncol, V4, P187, DOI 10.4251/wjgo.v4.i8.187	7	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					E21	E23				3	Surgery	Surgery	CB2IL	WOS:000349450500006		
J	Itano, O; Ikoma, N; Takei, H; Oshima, G; Kitagawa, Y				Itano, Osamu; Ikoma, Naruhiko; Takei, Hidehiro; Oshima, Go; Kitagawa, Yuko			The Superficial Precoagulation, Sealing, and Transection Method: A "Bloodless" and "Ecofriendly" Laparoscopic Liver Transection Technique	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						laparoscopic liver resection; precoagulation; VIO soft-coagulation system; VIO BiClamp; SonoSurg; reusable devices	PARENCHYMAL TRANSECTION; RESECTION; SYSTEM	Background: Minimizing blood loss is an important aspect of laparoscopic liver resection. Liver transection is the most challenging part of liver resection, but no standard method is available for this step at present. Herein, we have introduced the superficial pre-coagulation, sealing, and transection (SPST) method, a potentially "bloodless" and "ecofriendly" laparoscopic liver transection technique involving reusable devices: the VIO soft-coagulation system; VIO BiClamp (bipolar electrosurgical coagulation); Olympus SonoSurg (ultrasonic surgical system); and CUSA (ultrasonic aspirator). Furthermore, we have reported the short-term outcomes of laparoscopic liver transection with the SPST method. Methods: The study included 14 consecutive patients who underwent laparoscopic partial liver resection with the SPST method at a single institution between August 2008 and June 2010. Results: The median operative time was 201 minutes (range, 97 to 332 min) and the median blood loss was 5mL (range, 5 to 250 mL). There was no requirement for blood transfusion, no intraoperative complications, and no cases of conversion to open laparotomy. There were no liver transection-related complications such as postoperative bile leakage, bleeding, or infection. All surgical margins were negative, with a mean margin of 4.6 mm, and no local recurrence was observed at an average follow-up of 37.6 months. Conclusions: The SPST method is a simple, efficient, and cost-effective surgical technique for laparoscopic liver resection. It is associated with low intraoperative blood loss and good short-term outcomes. We recommend that the SPST method should be used as a standard technique for laparoscopic liver transection (Supplemental Digital Content 1, http://links.lww.com/SLE/A103).	[Itano, Osamu; Ikoma, Naruhiko; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan; [Itano, Osamu; Ikoma, Naruhiko; Oshima, Go] Eiju Gen Hosp, Endoscop Surg Ctr, Tokyo, Japan; [Ikoma, Naruhiko] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Takei, Hidehiro] Methodist Hosp, Dept Pathol & Genet Med, Houston, TX 77030 USA	Itano, O (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	itano@z8.keio.jp					Shiba H, 2009, J GASTROINTEST SURG, V13, P1636, DOI 10.1007/s11605-009-0963-y; Aldrighetti L, 2008, AM J SURG, V195, P270, DOI 10.1016/j.amjsurg.2007.02.022; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Itoh S, 2012, SURG TODAY, V42, P1176, DOI 10.1007/s00595-012-0306-6; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Kluger MD, 2013, J HEPATO-BIL-PAN SCI, V20, P131, DOI 10.1007/s00534-012-0571-1; Dagher I, 2007, SURG ENDOSC, V21, P619, DOI 10.1007/s00464-006-9137-0; Hirokawa F, 2011, SURGERY, V149, P438, DOI 10.1016/j.surg.2009.11.015; Itano O, 2009, J HEPATO-BILIARY-PAN, V16, P711, DOI 10.1007/s00534-009-0141-3; Itano O, 2011, J LAPAROENDOSC ADV B, V21; Koffron AJ, 2008, HPB, V10, P225, DOI 10.1080/13651820802166864; Mbah NA, 2012, HPB, V14, P126, DOI 10.1111/j.1477-2574.2011.00414.x; Mostaedi Rouzbeh, 2012, World J Gastrointest Oncol, V4, P187, DOI 10.4251/wjgo.v4.i8.187; NAKAGAWA Y, 2008, J HEPATOBILIARY PANC, V15, P359; Nii A, 2008, J HEPATO-BILIARY-PAN, V15, P522, DOI 10.1007/s00534-007-1292-8; Ogata S, 2005, J HEPATO-BILIARY-PAN, V12, P498, DOI 10.1007/s00534-005-1012-1; Santambrogio R, 2009, LANGENBECK ARCH SURG, V394, P255, DOI 10.1007/s00423-008-0349-8	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					E33	E36				4	Surgery	Surgery	CB2IL	WOS:000349450500009		
J	Mizuguchi, T; Kawamoto, M; Nakamura, Y; Meguro, M; Hui, TT; Hirata, K				Mizuguchi, Toru; Kawamoto, Masaki; Nakamura, Yukio; Meguro, Makoto; Hui, Thomas T.; Hirata, Koichi			New Technique of Extracorporeal Hepatic Inflow Control for Pure Laparoscopic Liver Resection	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						hepatic inflow vascular control; liver resection; pure laparoscopic surgery	HEPATOCELLULAR-CARCINOMA; PRINGLE MANEUVER; HEPATECTOMY; EXPERIENCE; FEASIBILITY; SURGERY; TUMORS	We have developed a new technique of the Pringle maneuver by clamping outside the abdominal wall for pure laparoscopic liver resection (pure Lap). Our technique successfully controls bleeding and enables pure Lap to be completed without any events, even for a large tumor. Between 2008 and 2010, we compared consecutive patients who received pure Lap with (n = 11) and without (n = 7) this Pringle maneuver. Although tumor size in the Pringle group was significantly larger than in the no-Pringle group (3.35 +/- 1.64 vs. 1.11 +/- 0.29 cm, respectively), intraoperative bleeding was not significantly different (165.5 +/- 188.5 vs. 177.9 +/- 364.4 mL, respectively). In contrast, operation time in the Pringle group was significantly longer than in the no-Pringle group (343.1 +/- 99.5 vs. 199.6 +/- 63.2 min, respectively). Pure Lap for large tumors is feasible when employing a new Pringle maneuver outside the abdominal wall.	[Mizuguchi, Toru; Kawamoto, Masaki; Nakamura, Yukio; Meguro, Makoto; Hirata, Koichi] Sapporo Med Univ, Sapporo Med Univ Hosp, Dept Surg 1, Sapporo, Hokkaido 0608543, Japan; [Hui, Thomas T.] Childrens Hosp, Dept Surg, Oakland, CA 94609 USA; [Hui, Thomas T.] Res Ctr Oakland, Oakland, CA USA	Mizuguchi, T (reprint author), Sapporo Med Univ, Sch Med, Dept Surg, Chuo Ku, S-1,W-16, Sapporo, Hokkaido 0608543, Japan.	tmizu@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23591993]; Yuasa Memorial Foundation	Supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 23591993) and a grant from the Yuasa Memorial Foundation.	Fong Y, 2000, ARCH SURG-CHICAGO, V135, P854, DOI 10.1001/archsurg.135.7.854; Targarona EM, 2008, SURG INNOV, V15, P266, DOI [10.1177/1553350608324931, 10.1177/1533350608324931]; REICH H, 1991, OBSTET GYNECOL, V78, P956; Koffron A, 2006, HEPATOLOGY, V44, P1694, DOI 10.1002/hep.21485; Shen P, 2003, J SURG ONCOL, V83, P36, DOI 10.1002/jso.10235; Sasaki A, 2009, BRIT J SURG, V96, P274, DOI 10.1002/bjs.6472; Vibert E, 2006, BRIT J SURG, V93, P67, DOI 10.1002/bjs.5150; Cherqui D, 2000, ANN SURG, V232, P753, DOI 10.1097/00000658-200012000-00004; Cho A, 2009, SURG ENDOSC, V23, P906, DOI 10.1007/s00464-008-0257-6; Chouillard Elie K, 2010, Ann Surg Innov Res, V4, P2, DOI 10.1186/1750-1164-4-2; Cuschieri A, 2001, Semin Laparosc Surg, V8, P104, DOI 10.1053/slas.2001.25147; Descottes B, 2000, ANN SURG, V232, P641, DOI 10.1097/00000658-200011000-00004; Dulucq JL, 2005, SURG ENDOSC, V19, P886, DOI 10.1007/s00464-004-2044-3; Hüscher C G, 1998, Semin Laparosc Surg, V5, P204; Kitaoka F, 2005, SURG TODAY, V35, P172, DOI 10.1007/s00595-004-2891-5; Lee KF, 2009, HPB, V11, P332, DOI 10.1111/j.1477-2574.2009.00053.x; Maehara SI, 2007, J AM COLL SURGEONS, V205, P816, DOI 10.1016/j.jamcollsurg.2007.06.297; Mizuguchi T, 2008, HEPATO-GASTROENTEROL, V55, P2188; Nguyen KT, 2009, ANN SURG ONCOL, V16, P1765, DOI 10.1245/s10434-009-0496-3; Smyrniotis V, 2005, WORLD J SURG, V29, P1384, DOI 10.1007/s00268-005-0025-x; Uchiyama K, 2009, LANGENBECK ARCH SURG, V394, P243, DOI 10.1007/s00423-008-0297-3; Zhen ZJ, 2010, WORLD J SURG, V34, P314, DOI 10.1007/s00268-009-0320-z	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					E16	E20				5	Surgery	Surgery	CB2IL	WOS:000349450500005		
J	Ohno, T; Ogawa, A; Yanai, M; Toyomasu, Y; Ogata, K; Ando, H; Aihara, R; Mochiki, E; Asao, T; Hanawa, M; Kuwano, H				Ohno, Tetsuro; Ogawa, Atsushi; Yanai, Mitsuhiro; Toyomasu, Yoshitaka; Ogata, Kyoichi; Ando, Hiroyuki; Aihara, Ryuusuke; Mochiki, Erito; Asao, Takayuki; Hanawa, Mineo; Kuwano, Hiroyuki			The Usefulness and Safety of the Introducer Technique Using a Bumper-Button-Type Device as Compared With the Pull Method for Percutaneous Endoscopic Gastrostomy	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						PEG; pull method; introducer method; complication; peristomal infection	ANTIBIOTIC-PROPHYLAXIS; PERISTOMAL INFECTION; METAANALYSIS; PLACEMENT; CANCER; PEG	Purpose: To describe our initial experiences with the standardized introducer technique for percutaneous endoscopic gastrostomy and to compare clinical outcomes and complications with the pull technique. Methods: The introducer technique was used on 91 patients. The clinical outcomes of procedures were retrospectively collected and compared with those of 22 patients who had procedures using the pull technique. Results: Mean operation time was significantly longer in the introducer technique group as compared with the pull technique group. Increased inflammation markers (body temperature, white blood cell count, and C-reactive protein) were observed in the pull technique group as compared with the introducer technique group. Incidences of peristomal infection and pneumonia were lower in the introducer method group than in the pull method group. Conclusions: The introducer technique is a useful and safe method for percutaneous endoscopic gastrostomy in terms of reduced incidences of peristomal infection, pneumonia, pain, and discomfort.	[Ohno, Tetsuro; Ogawa, Atsushi; Yanai, Mitsuhiro; Toyomasu, Yoshitaka; Ogata, Kyoichi; Ando, Hiroyuki; Aihara, Ryuusuke; Mochiki, Erito; Asao, Takayuki; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Maebashi, Gunma 371, Japan; [Ohno, Tetsuro; Hanawa, Mineo] Kajin Kai Chichibu Hosp, Dept Surg, Chichibu, Saitama 3691874, Japan	Ohno, T (reprint author), Kajin Kai Chichibu Hosp, Dept Surg, 20 Izumi Cho, Chichibu, Saitama 3691874, Japan.	tetsuro.ohno@chichibu-med.jp					Rey JR, 1998, ENDOSCOPY, V30, P318; Hiki N, 2008, J AM COLL SURGEONS, V207, P737, DOI 10.1016/j.jamcollsurg.2008.06.335; GAUDERER MWL, 1980, J PEDIATR SURG, V15, P872, DOI 10.1016/S0022-3468(80)80296-X; Horiuchi A, 2008, ENDOSCOPY, V40, P722, DOI 10.1055/s-2008-1077490; Banerjee S, 2008, GASTROINTEST ENDOSC, V67, P791, DOI 10.1016/j.gie.2008.02.068; Jafri NS, 2007, ALIMENT PHARM THERAP, V25, P647, DOI 10.1111/j.1365-2036.2007.03247.x; Campoli PMM, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-48; Campoli PMO, 2012, GASTROINTEST ENDOSC, V75, P988, DOI 10.1016/j.gie.2012.01.003; FERGUSON DR, 1993, AM J GASTROENTEROL, V88, P501; Hashiba K, 1980, Rev Paul Med, V95, P37; Maetani I, 2003, GASTROINTEST ENDOSC, V57, P837, DOI 10.1067/mge.2003.274; SACKS BA, 1979, SURGERY, V85, P575; Tucker AT, 2003, LARYNGOSCOPE, V113, P1898, DOI 10.1097/00005537-200311000-00007	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	FEB	2015	25	1					E1	E4				4	Surgery	Surgery	CB2IL	WOS:000349450500001		
J	Kumazaki, T				Kumazaki, Tsutomu			Persecutory delusions and first-person authority	THEORY & PSYCHOLOGY			English	Article						common-sense proposition; content externalism; definition; first-person authority; intention; persecutory delusion; philosophy of psychiatry; schizophrenia	MIND	Although clinical diagnosis of delusions is usually not difficult, defining delusions is more complicated. This study analyzes the concept of delusions, in particular persecutory delusions. Patients with persecutory delusions are convinced of others' malicious intentions and are impervious to counterevidence. Conventionally, expression of intention is accepted at face value unless contradictory evidence is available. First-person authority regarding intention is respected in human society. Contemporary philosophy tends to limit the scope of first-person authority, but it cannot be eliminated. Persecutory delusions contravene first-person authority as one of the fundamental principles of daily life, even in the absence of malicious intention on the part of the patients. Two ways of denying others' first-person authority are investigated. This study adds new insight to Manfred Spitzer's formal definition of delusions.	[Kumazaki, Tsutomu] Toranomon Branch Hosp, Dept Psychiat, Kawasaki, Kanagawa 2138587, Japan	Kumazaki, T (reprint author), Toranomon Branch Hosp, Dept Psychiat, Takatsu Ku, 1-3-1 Kajigaya, Kawasaki, Kanagawa 2138587, Japan.	tkumazak-tky@umin.ac.jp					Scherzer P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00432; Langdon R, 2010, SCHIZOPHRENIA BULL, V36, P321, DOI 10.1093/schbul/sbn069; Frith CD, 2004, PSYCHOL MED, V34, P385, DOI 10.1017/S0033291703001326; Bertelsen P, 2012, THEOR PSYCHOL, V22, P46, DOI 10.1177/0959354310384759; Bentall RP, 2001, CLIN PSYCHOL REV, V21, P1143, DOI 10.1016/S0272-7358(01)00106-4; Scholl BJ, 1999, MIND LANG, V14, P131, DOI 10.1111/1468-0017.00106; Mehl S, 2010, J NERV MENT DIS, V198, P516, DOI 10.1097/NMD.0b013e3181e4c8d2; Knobe J, 2003, ANALYSIS, V63, P190, DOI 10.1111/1467-8284.00419; Anscombe GEM, 1963, INTENTION; Bar-On D., 2004, SPEAKING MY MIND EXP; Berrios G. E., 1996, HIST MENTAL SYMPTOMS, P85, DOI 10.1017/CBO9780511526725.007; Bratman M. E., 1999, CAMBRIDGE DICT PHILO, P440; Bruckner B, 2009, J PHILOS PSYCHIAT, V2; Coulter J., 1973, APPROACHES INSANITY; Coulter J., 1989, MIND IN ACTION; Cromby J, 2009, THEOR PSYCHOL, V19, P335, DOI 10.1177/0959354309104158; Davidson D., 2001, SUBJECTIVE INTERSUBJ, P15; Davidson D., 2001, SUBJECTIVE INTERSUBJ, P3; Davidson D., 2001, ESSAYS ACTIONS EVENT, P83; Finkelstein D., 2003, EXPRESSION INNER; Fricker M., 2007, EPISTEMIC INJUSTICE; Frith C. D., 2008, COGNITIVE NEUROPSYCH; Gallagher Shaun, 2009, PSYCHIAT COGNITIVE N, P245; Gallois A., 1996, WORLD MIND ESSAY 1 P; Garety PA, 1994, DELUSIONS INVESTIGAT; Gertler B, 2011, NEW PROBL PHILOS, P1; Gigerenzer G., 1997, MACHAVELLIAN INTELLI, P265; Gigerenzer G., 2000, ADAPTIVE THINKING RA; Hohwy J, 2013, MIND LANG, V28, P57, DOI 10.1111/mila.12008; Hohwy J, 2002, PAC PHILOS QUART, V83, P235, DOI 10.1111/1468-0114.t01-1-00149; Ikuta T., 2004, JAPANESE J PSYCHOPAT, V25, P111; Ikuta T., 2003, JAPANESE J PSYCHOPAT, V24, P3; Ikuta T., 2008, SEISHIN IGAKU TAIWA, P3; Jaspers K, 1997, GEN PSYCHOPATHOLOGY; Jaspers K., 1959, GEN PSYCHOPATHOLOGY; Kocha H., 2009, PSYCHIAT NEUROLOGIA, V111, P373; Kozakai T., 2007, MEANING ACTION CONST, P289; Kozakai T., 2008, SEKININ TO IU KYOKOU; Kumazaki T, 2011, HIST PSYCHIATR, V22, P315, DOI 10.1177/0957154X10390438; Kumazaki T., 2008, JAPANESE J PSYCHOPAT, V29, P61; Langdon R., 2005, OTHER MINDS HUMANS B, P323; Lau J., 2012, STANFORD ENCY PHILOS; MAHER BA, 1992, PSYCHIAT ANN, V22, P260; Moore G. E., 1993, SELECTED WRITINGS, P106; Moran R., 2011, ESSAYS ANSCOMBES INT, P33; Moran Richard, 2001, AUTHORITY ESTRANGEME; Mundt C, 1996, NERVENARZT, V67, P515; Murphy D, 2013, MIND LANG, V28, P113, DOI 10.1111/mila.12012; Nuccetelli S., 2003, NEW ESSAYS SEMANTIC, P1; Owens J., 2003, NEW ESSAYS SEMANTIC, P201; Putnam Hilary, 1975, MIND LANGUAGE REALIT, P215, DOI 10.1017/CBO9780511625251.014; Radoilska L., 2012, AUTONOMY MENTAL DISO, pix; Reimer M, 2010, PHILOS PSYCHIAT PSYC, V17/4, P315; Sadock B. J., 2005, KAPLAN SADOCKS POCKE; Sass LA, 2014, K JASPERS PHILOS PSY, P125; Sass L.A., 1994, PARADOXES DELUSION W; Schneider K., 1952, UBER DEN WAHN; Setiya K., 2011, STANFORD ENCY PHILOS; Shoemaker Sydney, 1963, SELF KNOWLEDGE SELF; Spitzer M., 1988, PSYCHOPATHOLOGY PHIL, P128; Stenlund M., 2014, THESIS U HELSINKI FI; Stenlund M., 2011, DIALOGUES PHILOS MEN, V4, P31; Stoutland F., 2011, ESSAYS ON ANSCOMBES, P1; Talbot M., 2011, ROMP PHILOS MIND 4; Wittgenstein L, 2001, PHILOS INVESTIGATION; Wittgenstein L., 1969, CERTAINTY	66	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0959-3543	1461-7447		THEOR PSYCHOL	Theory Psychol.	FEB	2015	25	1					80	95		10.1177/0959354314553152		16	Psychology, Multidisciplinary	Psychology	CB0BG	WOS:000349289100005		
J	Ishkitiev, N; Yaegaki, K; Imai, T; Tanaka, T; Fushimi, N; Mitev, V; Okada, M; Tominaga, N; Ono, S; Ishikawa, H				Ishkitiev, Nikolay; Yaegaki, Ken; Imai, Toshio; Tanaka, Tomoko; Fushimi, Naho; Mitev, Vanyo; Okada, Mio; Tominaga, Noriko; Ono, Sachie; Ishikawa, Hiroshi			Novel Management of Acute or Secondary Biliary Liver Conditions Using Hepatically Differentiated Human Dental Pulp Cells	TISSUE ENGINEERING PART A			English	Article							MESENCHYMAL STEM-CELLS; PROGENITOR-CELL; TRANSPLANTATION; REGENERATION; DISEASE; MICE; THERAPIES; FIBROSIS; FUTURE; MODEL	The current definitive treatment for acute or chronic liver condition, that is, cirrhosis, is liver transplantation from a limited number of donors, which might cause complications after donation. Hence, bone marrow stem cell transplantation has been developed, but the risk of carcinogenesis remains. We have recently developed a protocol for hepatic differentiation of CD117(+) stem cells from human exfoliated deciduous teeth (SHED). In the present study, we examine whether SHED hepatically differentiated (hd) in vitro could be used to treat acute liver injury (ALI) and secondary biliary cirrhosis. The CD117(+) cell fraction was magnetically separated from SHED and then differentiated into hepatocyte-like cells in vitro. The cells were transplanted into rats with either ALI or induced secondary biliary cirrhosis. Engraftment of human liver cells was determined immunohistochemically and by in situ hybridization. Recovery of liver function was examined by means of histochemical and serological tests. Livers of transplanted animals were strongly positive for human immunohistochemical factors, and in situ hybridization confirmed engraftment of human hepatocytes. The tests for recovery of liver function confirmed the presence of human hepatic markers in the animals' blood serum and lack of fibrosis and functional integration of transplanted human cells into livers. No evidence of malignancy was found. We show that in vitro hdSHED engraft morphologically and functionally into the livers of rats having acute injury or secondary biliary cirrhosis. SHED are readily accessible adult stem cells, capable of proliferating in large numbers before differentiating in vitro. This makes SHED an appropriate and safe stem cell source for regenerative medicine.	[Ishkitiev, Nikolay; Yaegaki, Ken; Imai, Toshio; Tanaka, Tomoko; Okada, Mio] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Oral Hlth, Tokyo 1028159, Japan; [Ishkitiev, Nikolay; Mitev, Vanyo] Med Univ Sofia, Dept Med Chem & Biochem, Sofia, Bulgaria; [Fushimi, Naho; Tominaga, Noriko] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Sect Dev & Regenerat Dent, Tokyo 1028159, Japan; [Ono, Sachie] Nippon Dent Univ, Sch Life Dent Niigata, Dept Community & Prevent Dent, Niigata, Japan; [Ishikawa, Hiroshi] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept NDU Lifesci, Tokyo 1028159, Japan	Yaegaki, K (reprint author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Oral Hlth, 1-9-20 Chiyoda Ku, Tokyo 1028159, Japan.	yaegaki-k@tky.ndu.ac.jp	Ishkitiev, Nikolay/I-4654-2012	Ishkitiev, Nikolay/0000-0002-4351-5579			Ishkitiev N, 2010, J ENDODONT, V36, P469, DOI 10.1016/j.joen.2009.12.022; Curtis RE, 1997, NEW ENGL J MED, V336, P897, DOI 10.1056/NEJM199703273361301; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Matthes G, 2003, WORLD J SURG, V27, P1124, DOI 10.1007/s00268-003-6981-0; Feldmann G, 2001, CELL BIOL TOXICOL, V17, P77, DOI 10.1023/A:1010954020488; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Hirata TM, 2010, J ENDODONT, V36, P1139, DOI 10.1016/j.joen.2010.03.002; Taniguchi E, 2006, GASTROENTEROLOGY, V130, P521, DOI 10.1053/j.gastro.2005.10.050; Fukumitsu K, 2011, TRANSPL P, V43, P2137, DOI 10.1016/j.transproceed.2011.05.014; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Flohr TR, 2009, CURR OPIN ORGAN TRAN, V14, P64, DOI 10.1097/MOT.0b013e328320fd7b; Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x; Baumann U, 1999, HEPATOLOGY, V30, P112, DOI 10.1002/hep.510300140; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; OGAWA M, 1993, BLOOD, V81, P2844; Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; Ishkitiev N, 2012, J ENDODONT, V38, P475, DOI 10.1016/j.joen.2011.12.011; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Iyer SS, 2008, EXPERT OPIN BIOL TH, V8, P569, DOI [10.1517/14712598.8.5.569 , 10.1517/14712590801997652]; Christensen E, 2004, J HEPATOL, V41, P344, DOI 10.1016/j.jhep.2004.06.005; Crowder SW, 2013, FASEB J, V27, P2788, DOI 10.1096/fj.13-228288; Gronthos S, 2002, J DENT RES, V81, P531; GUPTA S, 1992, HEPATOLOGY, V15, P156, DOI 10.1002/hep.1840150126; Hoffnagle J. H., 1995, HEPATOLOGY, V21, P240; Ishkitiev N, 2013, REGEN MED, V8, P597, DOI 10.2217/rme.13.42; Ishkitiev N, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/017103; Jacobs Lenworth, 2013, Conn Med, V77, P159; Kaibori M, 2012, TRANSPL P, V44, P1107, DOI 10.1016/j.transproceed.2012.01.088; Kakinuma S, 2009, J GASTROENTEROL, V44, P167, DOI 10.1007/s00535-008-2297-z; Kisseleva T, 2010, CURR OPIN GASTROEN, V26, P395, DOI 10.1097/MOG.0b013e32833a6bec; Lo CM, 2003, TRANSPLANTATION, V75, pS12, DOI 10.1097/01.TP.0000046534.45645.47; Lysy PA, 2008, WORLD J GASTROENTERO, V14, P864, DOI 10.3748/wjg.14.864; Okada M., 2014, INT ENDOD J, DOI 10.1111/iej.1.2262; Soto-Gutierrez A, 2009, CURR OPIN ORGAN TRAN, V14, P667, DOI 10.1097/MOT.0b013e3283328070	39	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	FEB 1	2015	21	3-4					586	593		10.1089/ten.tea.2014.0162		8	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CB4PZ	WOS:000349611600017		
J	Otani, Y; Komura, M; Komura, H; Ishimaru, T; Konishi, K; Komuro, H; Hoshi, K; Takato, T; Tabata, Y; Iwanaka, T				Otani, Yushi; Komura, Makoto; Komura, Hiroko; Ishimaru, Tetsuya; Konishi, Kenichiro; Komuro, Hiroaki; Hoshi, Kazuto; Takato, Tsuyoshi; Tabata, Yasuhiko; Iwanaka, Tadashi			Optimal Amount of Basic Fibroblast Growth Factor in Gelatin Sponges Incorporating beta-Tricalcium Phosphate with Chondrocytes	TISSUE ENGINEERING PART A			English	Article							MESENCHYMAL STEM-CELLS; CHRONIC SKIN ULCERS; SUSTAINED-RELEASE; COLLAGEN/GELATIN SCAFFOLD; CARTILAGE TISSUE; CHONDROGENIC DIFFERENTIATION; ARTICULAR-CARTILAGE; CLINICAL-TRIAL; REGENERATION; BFGF	Background: A gelatin sponge with slowly releasing basic fibroblast growth factor (b-FGF) enhances chondrogenesis. This study investigated the optimal amount of b-FGF in gelatin sponges to fabricate engineered cartilage. Materials and Methods: b-FGF (0, 10, 100, 500, 1000, and 2000 mu g/cm(3))-impregnated gelatin sponges incorporating beta-tricalcium phosphate (beta-TCP) were produced. Chondrocytes were isolated from the auricular cartilage of C57B6J mice and expanded. The expanded auricular chondrocytes (10x10(6) cells/cm(3)) were seeded onto the gelatin sponges, which served as scaffolds. The construct assembly was implanted in the subcutaneous space of mice through a syngeneic fashion. Thereafter, constructs were retrieved at 2, 4, or 6 weeks. Results: (1) Morphology: The size of implanted constructs was larger than the size of the scaffold with 500, 1000, and 2000 mu g/cm(3) b-FGF-impregnated gelatin sponges incorporating beta-TCP at 4 and 6 weeks after implantation. (2) The weight of the constructs increased roughly proportional to the increase in volume of the b-FGF-impregnated scaffold at 2, 4, and 6 weeks after implantation, except in the 2000 mu g/cm(3) b-FGF-impregnated constructs group. (3) Histological examination: Extracellular matrix in the center of the constructs was observed in gelatin sponges impregnated with more than 100 mu g/cm(3) b-FGF at 4 weeks after implantation. The areas of cells with an abundant extracellular matrix were positive for cartilage-specific marker type 2 collagen in the constructs. (4) Protein assay: Glycosaminoglycan and collagen type 2 expression were significantly increased at 4 and 6 weeks on implantation of gelatin sponges impregnated with more than 100 mu g/cm(3) b-FGF. At 6 weeks after implantation, the ratio of type 2 collagen to type 1 collagen in constructs impregnated with 100 mu g/cm(3) or more b-FGF was higher than that in mice auricular cartilage. Conclusion: Gelatin sponges impregnated with more than 100 mu g/cm(3) b-FGF incorporating beta-TCP with chondrocytes (10x10(6) cells/cm(3)) can fabricate engineered cartilage at 4 weeks after implantation.	[Otani, Yushi; Komura, Makoto; Komura, Hiroko; Ishimaru, Tetsuya; Konishi, Kenichiro; Komuro, Hiroaki; Iwanaka, Tadashi] Univ Tokyo, Grad Sch Med, Dept Pediat Surg, Tokyo 1138655, Japan; [Komura, Makoto] Saitama Med Univ, Dept Pediat Surg, Saitama, Japan; [Hoshi, Kazuto; Takato, Tsuyoshi] Tokyo Univ Hosp, Dept Tissue Engn, Tokyo 113, Japan; [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto, Japan	Komura, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Pediat Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	komura-tky@umin.ac.jp			JSPS KAKEN [23592625]	This study was supported by the grant titled "Tracheoplasty by combined growth factor and chondrocyte implantation," JSPS KAKEN Grant Number 23592625. The authors appreciate the technical support provided by Nobuyuki Kikuchi, a technician in the Department of Tissue Engineering in the Graduate School of Medicine, University of Tokyo. The authors are thankful to Kaken Pharmaceutical Co. Ltd. for providing human recombinant fibroblast growth factor-2 (b-FGF).	Ushida T, 2002, CELL TRANSPLANT, V11, P489; Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W; Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181; Takagi T, 2012, PLAST RECONSTR SURG, V130, P866, DOI 10.1097/PRS.0b013e318262f36e; Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046; Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027; Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012; Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus; EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513; SPRUGEL KH, 1987, AM J PATHOL, V129, P601; Bader A, 2010, J CELL MOL MED, V14, P1877, DOI 10.1111/j.1582-4934.2010.01073.x; Morimoto N, 2012, AM J TRANSL RES, V4, P52; Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215; Morimoto N, 2013, TISSUE ENG PT A, V19, P1931, DOI [10.1089/ten.TEA.2012.0634, 10.1089/ten.tea.2012.0634]; OKEEFE EJ, 1988, J INVEST DERMATOL, V90, P2, DOI 10.1111/1523-1747.ep12462409; Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127; Komura M, 2008, J PEDIATR SURG, V43, P2141, DOI 10.1016/j.jpedsurg.2008.08.038; Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9; Leddy HA, 2004, J BIOMED MATER RES B, V70B, P397, DOI 10.1002/jbm.b.30053; Kanda N, 2012, ANN PLAS SURG, V69, P569, DOI 10.1097/SAP.0b013e318222832f; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95; Okumura M, 1996, BIOL PHARM BULL, V19, P530; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; Enjo M., 2013, PLAST RECONSTR SURG, V131, P335; Furukawa A., 1996, KISO TO RINSHO, V30, P1579; GOSPODAR.D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; Guo XM, 2004, TISSUE ENG, V10, P1830, DOI 10.1089/ten.2004.10.1830; Hannouche D, 2007, TISSUE ENG, V13, P87, DOI 10.1089/ten.2006.0067; Hashimoto T, 2009, EUR J VASC ENDOVASC, V38, P71, DOI 10.1016/j.ejvs.2009.02.005; Isogai N, 2005, J BIOMED MATER RES A, V74A, P408, DOI 10.1002/jbm.a.30343; Ito R, 2013, TISSUE ENG PT A, V19, P1398, DOI [10.1089/ten.TEA.2012.0375, 10.1089/ten.tea.2012.0375]; Jadin KD, 2007, BIOMATERIALS, V28, P230, DOI 10.1016/j.biomaterials.2006.08.053; Kanda N, 2014, J TISSUE ENG REGEN M, V8, P29, DOI 10.1002/term.1492; KLAGSBRUN M, 1980, J BIOL CHEM, V255, P859; Komura M, 2008, PEDIATR SURG INT, V24, P1117, DOI 10.1007/s00383-008-2218-5; Kusuhara H, 2011, J HAND SURG-EUR VOL, V36E, P455, DOI 10.1177/1753193411402761; Lazarous DF, 1997, CARDIOVASC RES, V36, P78, DOI 10.1016/S0008-6363(97)00142-9; LEGUELLEC D, 1994, HISTOCHEM J, V26, P695; Miyoshi M, 2005, J BIOMAT SCI-POLYM E, V16, P893, DOI 10.1163/1568562054255709; Morotomi T, 2012, CELLS TISSUES ORGANS, V196, P398, DOI 10.1159/000336029; Park KH, 2008, J BIOSCI BIOENG, V106, P74, DOI 10.1263/jbb.106.74; PRESTA M, 1986, MOL CELL BIOL, V6, P4060; QUATELA VC, 1993, ARCH OTOLARYNGOL, V119, P32; Takahashi T, 2005, CELL TRANSPLANT, V14, P683, DOI 10.3727/000000005783982675; Terada S, 2005, J BIOMED MATER RES A, V75A, P907, DOI 10.1002/jbm.a.30505; Yamaoka H, 2010, J BIOMED MATER RES A, V93A, P123, DOI 10.1002/jbm.a.32509; Yokoyama A, 2007, CELL TISSUE RES, V329, P469, DOI 10.1007/s00441-007-0438-y	47	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	FEB 1	2015	21	3-4					627	636		10.1089/ten.tea.2013.0655		10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CB4PZ	WOS:000349611600021		
J	Sekine, S; Ito, K; Watanabe, H; Nakano, T; Moriya, K; Shintani, Y; Fujie, H; Tsutsumi, T; Miyoshi, H; Fujinaga, H; Shinzawa, S; Koike, K; Hone, T				Sekine, Shuichi; Ito, Konomi; Watanabe, Haruna; Nakano, Takafumi; Moriya, Kyoji; Shintani, Yoshizumi; Fujie, Hajime; Tsutsumi, Takeya; Miyoshi, Hideyuki; Fujinaga, Hidetake; Shinzawa, Seiko; Koike, Kazuhiko; Hone, Toshiharu			Mitochondrial iron accumulation exacerbates hepatic toxicity caused by hepatitis C virus core protein	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Ca2+ uniporter; Fenton reaction; Reactive oxygen species; Ru360; Hepatitis C virus	CHRONIC VIRAL-HEPATITIS; HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; PERMEABILITY TRANSITION; CA2+ UNIPORTER; ROS PRODUCTION; INJURY; PHLEBOTOMY; THERAPY; CELLS	Patients with long-lasting hepatitis C virus (HCV) infection are at major risk of hepatocellular carcinoma (HCC). Iron accumulation in the livers of these patients is thought to exacerbate conditions of oxidative stress. Transgenic mice that express the HCV core protein develop HCC after the steatosis stage and produce an excess of hepatic reactive oxygen species (ROS). The overproduction of ROS in the liver is the net result of HCV core protein-induced dysfunction of the mitochondrial respiratory chain. This study examined the impact of ferric nitrilacetic acid (Fe-NTA)-mediated iron overload on mitochondrial damage and ROS production in HCV core protein-expressing HepG2 (human HCC) cells (Hep39b cells). A decrease in mitochondrial membrane potential and ROS production were observed following Fe-NTA treatment. After continuous exposure to Fe-NTA for six days, cell toxicity was observed in Hep39b cells, but not in mock (vector-transfected) HepG2 cells. Moreover, mitochondrial iron (Fe-59) uptake was increased in the livers of HCV core protein-expressing transgenic mice. This increase in mitochondrial iron uptake was inhibited by Ru360, a mitochondrial Ca2+ uniporter inhibitor. Furthermore, the Fe-NTA-induced augmentation of mitochondrial dysfunction, ROS production, and cell toxicity were also inhibited by Ru360 in Hep39b cells. Taken together, these results indicate that Ca2+ uniporter-mediated mitochondrial accumulation of iron exacerbates hepatocyte toxicity caused by the HCV core protein. (C) 2014 Elsevier Inc. All rights reserved.	[Sekine, Shuichi; Ito, Konomi; Watanabe, Haruna; Nakano, Takafumi; Hone, Toshiharu] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Biopharmaceut, Chuo Ku, Chiba 2608675, Japan; [Moriya, Kyoji; Shintani, Yoshizumi; Fujie, Hajime; Tsutsumi, Takeya; Miyoshi, Hideyuki; Fujinaga, Hidetake; Shinzawa, Seiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo 1138655, Japan	Hone, T (reprint author), Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, 4-21-2 Nakano, Tokyo 1648530, Japan.	t.horie@thu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21249003, 21790141]	This work was supported by a grant-in-aid for scientific research (A) 548 (21249003) and a grant-in-aid for young scientists (B) (21790141) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-1; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Moriya K, 2001, CANCER RES, V61, P4365; Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999; Wang T, 2010, J VIRAL HEPATITIS, V17, P784, DOI 10.1111/j.1365-2893.2009.01238.x; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Muckenthaler MU, 2008, CELL METAB, V8, P1, DOI 10.1016/j.cmet.2008.06.009; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Bernardi P, 1999, PHYSIOL REV, V79, P1127; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Maeda T, 2010, CANCER CHEMOTH PHARM, V65, P1117, DOI 10.1007/s00280-009-1119-1; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; Masubuchi Y, 2002, HEPATOLOGY, V35, P544, DOI 10.1053/jhep.2002.31871; Bonkovsky HL, 1997, HEPATOLOGY, V25, P759, DOI 10.1002/hep.510250345; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; Kato J, 2001, CANCER RES, V61, P8697; Otani K, 2005, GASTROENTEROLOGY, V128, P96, DOI 10.1053/j.gastro.2004.10.045; Kowdley KV, 2004, GASTROENTEROLOGY, V127, pS79, DOI 10.1016/j.gastro.2004.09.019; HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986; AWAI M, 1979, AM J PATHOL, V95, P663; Raffaello A, 2012, CELL CALCIUM, V52, P16, DOI 10.1016/j.ceca.2012.04.006; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Bartenschlager R, 2000, J GEN VIROL, V81, P1631; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Kageyama F, 1998, BIOL TRACE ELEM RES, V64, P185, DOI 10.1007/BF02783335; Lau JYN, 1998, SEMIN LIVER DIS, V18, P169, DOI 10.1055/s-2007-1007152; Moriya K, 2010, J MED VIROL, V82, P776, DOI 10.1002/jmv.21661; NISHIOKA K, 1991, CANCER, V67, P429, DOI 10.1002/1097-0142(19910115)67:2<429::AID-CNCR2820670218>3.0.CO;2-#; Oberley TD, 2002, AM J PATHOL, V160, P403, DOI 10.1016/S0002-9440(10)64857-2; OLYNYK JK, 1995, GASTROENTEROLOGY, V108, P1104, DOI 10.1016/0016-5085(95)90209-0; Silva VSS, 2005, J GASTROEN HEPATOL, V20, P243, DOI 10.1111/j.1400-1746.2004.03549.x; Wang T, 2006, J GASTROEN HEPATOL, V21, pS34, DOI 10.1111/j.1440-1746.2006.04591.x	33	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	FEB 1	2015	282	3					237	243		10.1016/j.taap.2014.12.004		7	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CB3EB	WOS:000349509900001		
J	Fujimura, M; Usuki, F				Fujimura, Masatake; Usuki, Fusako			Methylmercury causes neuronal cell death through the suppression of the TrkA pathway: In vitro and in vivo effects of TrkA pathway activators	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Methylmercury; TrkA pathway; GM1 ganglioside; Neurite extension; Apoptosis	P75 NEUROTROPHIN RECEPTOR; PC12 CELLS; MONOSIALOGANGLIOSIDE GM1; NEURITE OUTGROWTH; PERIPHERAL-NERVES; MINAMATA-DISEASE; NEUROTOXICITY; PROTEIN; RAT; INTOXICATION	Methylmercury (MeHg) is an environmental toxin which induces cell death specific for the nervous systems. Here we show that MeHg causes neuronal cell death through the suppression of the tropomyosin receptor kinase A (TrkA) pathway, and that compounds activating the TrkA pathway prevent MeHg-induced nerve damage in vitro and in vivo. We first investigated the mechanism of MeHg-induced neurotoxicity in differentiating neurons using PC12 cells. Exposure to 100 nM MeHg for 1 day induced apoptosis in differentiating PC12 cells. Further, MeHg-induced apoptosis was preceded by inhibition of neurite extension, as determined by ELISA analyses of the neurite-specific protein neurofilament triplet H protein (NF-H). To determine the mechanism of MeHg-induced apoptosis, we evaluated the effects of MeHg on the TrkA pathway, which is known to regulate neuronal differentiation and viability. Western blot analysis demonstrated that, like the TrkA phosphorylation inhibitor K252a, MeHg inhibited phosphorylation of TrkA and its downstream effectors. Furthermore, GM1 ganglioside and its analog MCC-257, which enhance TrkA phosphorylation, overcame the effect of MeHg in neurons, supporting the involvement of the TrkA pathway in MeHg-induced nerve damage. Finally, we demonstrated that MCC-257 rescued the clinical sign and pathological changes in MeHg-exposed rats. These findings indicate that MeHg-induced apoptosis in neuron is triggered by inhibition of the TrkA pathway, and that GM1 ganglioside and MCC-257 effectively prevent MeHg-induced nerve damage. (C) 2014 Elsevier Inc. All rights reserved.	[Fujimura, Masatake] Natl Inst Minamata Dis, Dept Basic Med Sci, Minamata, Kumamoto 8670008, Japan; [Usuki, Fusako] Natl Inst Minamata Dis, Dept Clin Med, Minamata, Kumamoto 8670008, Japan	Fujimura, M (reprint author), Natl Inst Minamata Dis, Dept Basic Med Sci, 4058-18 Hama, Minamata, Kumamoto 8670008, Japan.	fujimura@nimd.go.jp					Okada T, 2007, J MOL BIOL, V371, P481, DOI 10.1016/j.jmb.2007.05.069; BAKIR F, 1973, SCIENCE, V181, P230, DOI 10.1126/science.181.4096.230; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; MULLER HW, 1984, P NATL ACAD SCI-BIOL, V81, P1248, DOI 10.1073/pnas.81.4.1248; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Eto K, 1997, TOXICOL PATHOL, V25, P614; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; Usuki F, 2011, J BIOL CHEM, V286, P6641, DOI 10.1074/jbc.M110.168872; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Fujimura M, 2011, TOXICOL APPL PHARM, V250, P1, DOI 10.1016/j.taap.2010.09.011; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; CHANG LW, 1977, ENVIRON RES, V14, P329, DOI 10.1016/0013-9351(77)90044-5; Fujimura M, 2009, NEUROTOXICOLOGY, V30, P1000, DOI 10.1016/j.neuro.2009.08.001; Fujimura M, 2009, NEUROTOXICOLOGY, V30, P16, DOI 10.1016/j.neuro.2008.10.002; Chakrabarti SK, 2000, ARCH TOXICOL, V74, P196, DOI 10.1007/s002040000112; Dare E, 2000, J NEUROSCI RES, V62, P557, DOI 10.1002/1097-4547(20001115)62:4<557::AID-JNR10>3.0.CO;2-9; Eto K, 2002, TOXICOL PATHOL, V30, P714, DOI 10.1080/01926230290166805; Ferrari G, 1983, Brain Res, V284, P215; Fujimura M, 2014, ARCH TOXICOL, V88, P109, DOI 10.1007/s00204-013-1089-2; Gasso S, 2001, J NEUROSCI RES, V66, P135, DOI 10.1002/jnr.1205; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Kakinoki B, 2006, DIABETES, V55, P616, DOI 10.2337/diabetes.55.03.06.db05-1091; Lachyankar MB, 2003, J NEUROSCI RES, V71, P157, DOI 10.1002/jnr.10480; Moretto MB, 2005, TOXICOL SCI, V85, P639, DOI 10.1093/toxsci/kfi114; Moretto MB, 2005, TOXICOLOGY, V214, P57, DOI 10.1016/j.tox.2005.05.022; Park ST, 1996, NEUROTOXICOLOGY, V17, P37; Parran DK, 2004, DEV BRAIN RES, V149, P53, DOI 10.1016/j.devbrainres.2003.10.017; Parran DK, 2003, DEV BRAIN RES, V141, P71, DOI 10.1016/S0165-3806(02)00644-2; SABEL BA, 1984, SCIENCE, V225, P340, DOI 10.1126/science.6740316; Sakai Y, 2000, J BIOSCI BIOENG, V90, P20; Takeuchi T, 1982, Acta Pathol Jpn, V32 Suppl 1, P73; TSUJI S, 1988, J NEUROCHEM, V50, P414, DOI 10.1111/j.1471-4159.1988.tb02928.x; Usuki F, 2001, NEUROSCI LETT, V304, P199, DOI 10.1016/S0304-3940(01)01764-5; Wakabayashi K, 1995, BRAIN RES, V705, P267, DOI 10.1016/0006-8993(95)01208-7; Yamada MK, 2008, J PHARMACOL SCI, V108, P131, DOI 10.1254/jphs.08109SC; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200; Zhang JZ, 2010, BRAIN RES, V1344, P200, DOI 10.1016/j.brainres.2010.05.044	37	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	FEB 1	2015	282	3					259	266		10.1016/j.taap.2014.12.008		8	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CB3EB	WOS:000349509900004		
J	Yokoyama, K; Takahashi, M				Yokoyama, Kazuto; Takahashi, Masaki			Energy shaping non-linear acceleration control for a pendulum-type mobility and experimental verification	VEHICLE SYSTEM DYNAMICS			English	Article						instability; inverted pendulum; energy shaping; non-linear control	DAMPING ASSIGNMENT; MECHANICAL SYSTEMS; INVERTED PENDULUM; INTERCONNECTION	A dynamics-based non-linear controller with energy shaping to accelerate a pendulum-type mobility is proposed. The concept of this study is to control translational acceleration of the vehicle in a dynamically reasonable manner. The body angle is controlled to maintain a reference state where the vehicle is statically unstable but dynamically stable, which leads to a constant translational acceleration due to instability of the system. The accelerating motion is like a sprinter moving from crouch start and it fully exploits dynamics of the vehicle. To achieve it, the total energy of the system is shaped to have the minimum at a given reference state and the system is controlled to converge to it. The controller can achieve various properties through the energy shaping procedure. Especially, an energy function that will lead to safe operation of the vehicle is proposed. The effectiveness of the controller is verified in simulations and experiments.	[Yokoyama, Kazuto] Keio Univ, Sch Sci Open & Environm Syst, Yokohama, Kanagawa 223, Japan; [Takahashi, Masaki] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan	Yokoyama, K (reprint author), Keio Univ, Sch Sci Open & Environm Syst, Yokohama, Kanagawa 223, Japan.	kazuto_yokoyama@2008.jukuin.keio.ac.jp			Japan Society for the Promotion of Science [6559]	This work was supported in part by Japan Society for the Promotion of Science [grant number 6559].	Acar C, 2010, IEEJ T IND APPL, V130, P742, DOI [10.1541/ieejias.130.742, DOI 10.1541/IEEJIAS.130.742]; Acosta JA, 2005, IEEE T AUTOMAT CONTR, V50, P1936, DOI 10.1109/TAC.2005.860292; Ortega R, 2001, IEEE CONTR SYST MAG, V21, P18, DOI 10.1109/37.915398; Pathak K, 2005, IEEE T ROBOT, V21, P505, DOI [10.1109/TRO.2004.840905, 10.1109/TRO.840905]; Nasrallah DS, 2007, IEEE T ROBOT, V23, P564, DOI 10.1109/TRO.2007.898953; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Chan RPM, 2013, ANNU REV CONTROL, V37, P89, DOI 10.1016/j.arcontrol.2013.03.004; Grasser F, 2002, IEEE T IND ELECTRON, V49, P107, DOI 10.1109/41.982254; Hatakeyama Naoya, 2008, Transactions of the Society of Instrument and Control Engineers, V44; Hori Y, 1989, IEEJ T IND APPL, V109, P470, DOI [10.1541/ieejias.109.470, DOI 10.1541/IEEJIAS.109.470]; KARNOPP D, 1985, J DYN SYST-T ASME, V107, P100; Matsumoto O., 1993, Advanced Robotics, V7; Ortega R., 1998, PASSIVITY BASED CONT; Ortega R, 2002, IEEE T AUTOMAT CONTR, V47, P1218, DOI 10.1109/TAC.2002.800770; TAKEGAKI M, 1981, J DYN SYST-T ASME, V103, P119; van der Schaft A., 1999, L2 GAIN PASSIVITY TE; Yokoyama Kazuto, 2011, Journal of System Design and Dynamics, V5, DOI 10.1299/jsdd.5.1605	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0042-3114	1744-5159		VEHICLE SYST DYN	Veh. Syst. Dyn.	FEB 1	2015	53	2					179	196		10.1080/00423114.2014.993325		18	Engineering, Mechanical	Engineering	CB3JF	WOS:000349523400004		
J	Moqsud, MA; Yoshitake, J; Bushra, QS; Hyodo, M; Omine, K; Strik, D				Moqsud, M. A.; Yoshitake, J.; Bushra, Q. S.; Hyodo, M.; Omine, K.; Strik, David			Compost in plant microbial fuel cell for bioelectricity generation	WASTE MANAGEMENT			English	Article						Bioelectricity; Carbon fiber; Compost; Plant microbial fuel cell; Voltage and waste	ELECTRICITY PRODUCTION; MANAGEMENT; MICROCOSMS; BACTERIA; WASTE; SOIL	Recycling of organic waste is an important topic in developing countries as well as developed countries. Compost from organic waste has been used for soil conditioner. In this study, an experiment has been carried out to produce green energy (bioelectricity) by using paddy plant microbial fuel cells (PMFCs) in soil mixed with compost. A total of six buckets filled with the same soil were used with carbon fiber as the electrodes for the test. Rice plants were planted in five of the buckets, with the sixth bucket containing only soil and an external resistance of 100 ohm was used for all cases. It was observed that the cells with rice plants and compost showed higher values of voltage and power density with time. The highest value of voltage showed around 700 mV when a rice plant with 1% compost mixed soil was used, however it was more than 95% less in the case of no rice plant and without compost. Comparing cases with and without compost but with the same number of rice plants, cases with compost depicted higher voltage to as much as 2 times. The power density was also 3 times higher when the compost was used in the paddy PMFCs which indicated the influence of compost on bio-electricity generation. (C) 2014 Elsevier Ltd. All rights reserved.	[Moqsud, M. A.; Yoshitake, J.; Bushra, Q. S.; Hyodo, M.] Yamaguchi Univ, Dept Civil & Environm Engn, Ube, Yamaguchi 7558611, Japan; [Omine, K.] Nagasaki Univ, Dept Civil Engn, Nagasaki, Japan; [Strik, David] Wageningen Univ, Subdept Environm Technol, NL-6700 AP Wageningen, Netherlands	Moqsud, MA (reprint author), Yamaguchi Univ, Dept Civil & Environm Engn, Tokiwadai 2-16-1, Ube, Yamaguchi 7558611, Japan.	moqsud@gmail.com			Japan Society for the Promotion of Science [26630220]	The authors wish to acknowledge the financial support by Grant-in-Aid for Scientific Research (26630220) from Japan Society for the Promotion of Science. Special thanks to Prof. M. Hossain for his support for statistical analysis.	Moqsud MA, 2013, WASTE MANAGE, V33, P2465, DOI 10.1016/j.wasman.2013.07.026; Logan BE, 2006, TRENDS MICROBIOL, V14, P512, DOI 10.1016/j.tim.2006.10.003; ALLEN RM, 1993, APPL BIOCHEM BIOTECH, V39, P27, DOI 10.1007/BF02918975; Strik DPBTB, 2008, INT J ENERG RES, V32, P870, DOI 10.1002/er.1397; Timmers RA, 2010, APPL MICROBIOL BIOT, V86, P973, DOI 10.1007/s00253-010-2440-7; Donovan C, 2011, J POWER SOURCES, V196, P1171, DOI 10.1016/j.jpowsour.2010.08.099; Liu ST, 2013, INT J PHOTOENERGY, DOI 10.1155/2013/172010; Strik DPBTB, 2011, TRENDS BIOTECHNOL, V29, P41, DOI 10.1016/j.tibtech.2010.10.001; Bennetto HP, 1990, BIOTECHNOL ED, V1, P163; Chin KJ, 1999, APPL ENVIRON MICROB, V65, P5042; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Helder M, 2010, BIORESOURCE TECHNOL, V101, P3541, DOI 10.1016/j.biortech.2009.12.124; Kaku N., 2008, APPL MICROBIOL BIOT, V10, P1007; Khare A., 2014, INT J ENG SCI RES TE, V3, P760; Ministry of Agriculture Forestry and Fisheries, 2006, STAT AGR FOR FISH; Moqsud M.A., 2012, P 27 INT C SOL WAST, P1052; Moqsud MA, 2011, WASTE MANAGE RES, V29, P1286, DOI 10.1177/0734242X10383621; Moqsud MA, 2014, WASTE MANAGE RES, V32, P124, DOI 10.1177/0734242X13517160; Moqsud M.A., 2012, 47 JAP GEOT SOC ANN, P440; Schamphelaire D., 2008, ENVIRON SCI TECHNOL, V42, P3053; Takai Y., 1969, JPN AGR RES, V4, P20	21	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	FEB	2015	36						63	69		10.1016/j.wasman.2014.11.004		7	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CB3FG	WOS:000349513000007		
J	Li, Q; Qiao, W; Wang, XC; Takayanagi, K; Shofie, M; Li, YY				Li, Qian; Qiao, Wei; Wang, Xiaochang; Takayanagi, Kazuyuki; Shofie, Mohammad; Li, Yu-You			Kinetic characterization of thermophilic and mesophilic anaerobic digestion for coffee grounds and waste activated sludge	WASTE MANAGEMENT			English	Article						Anaerobic digestion; Rate-limiting step; Thermophilic; Mesophilic; Propionic acid degradation	SEWAGE-SLUDGE; CO-DIGESTION; HYDROLYSIS; STABILITY; REACTOR	This study was conducted to characterize the kinetics of an anaerobic process (hydrolysis, acetogenesis, acidogenesis and methanogenesis) under thermophilic (55 degrees C) and mesophilic (35 degrees C) conditions with coffee grounds and waste activated sludge (WAS) as the substrates. Special focus was given to the kinetics of propionic acid degradation to elucidate the accumulation of VFAs. Under the thermophilic condition, the methane production rate of all substrates (WAS, ground coffee and raw coffee) was about 1.5 times higher than that under the mesophilic condition. However, the effects on methane production of each substrate under the thermophilic condition differed: WAS increased by 35.8-48.2%, raw coffee decreased by 76.3-64.5% and ground coffee decreased by 74.0-57.9%. Based on the maximum reaction rate (R-max) of each anaerobic stage obtained from the modified Gompertz model, acetogenesis was found to be the rate-limiting step for coffee grounds and WAS. This can be explained by the kinetics of propionate degradation under thermophilic condition in which a long lag-phase (more than 18 days) was observed, although the propionate concentration was only 500 mg/L. Under the mesophilic condition, acidogenesis and hydrolysis were found to be the rate-limiting step for coffee grounds and WAS, respectively. Even though reducing the particle size accelerated the methane production rate of coffee grounds, but did not change the rate-limiting step: acetogenesis in thermophilic and acidogenesis in mesophilic. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Qian; Wang, Xiaochang] Xian Univ Architecture & Technol, MOE, Key Lab Northwest Water Resource Environm & Ecol, Xian 710055, Peoples R China; [Li, Qian; Takayanagi, Kazuyuki; Li, Yu-You] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Qiao, Wei] China Agr Univ, Coll Engn, Beijing 10081, Peoples R China; [Shofie, Mohammad; Li, Yu-You] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan; [Qiao, Wei] Tsinghua Univ, Minist Educ China, Key Lab Solid Waste Management & Environm Safety, Beijing 100084, Peoples R China	Li, YY (reprint author), Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan.	yyli@epl1.civil.tohoku.ac.jp			Japan Society for the Promotion of Science [24-02053]; Key Laboratory for Solid Waste Management and Environment Safety, Ministry of Education of China [SWMES 2011-04]; China Scholarship Council (CSC)	This work was partially supported by Japan Society for the Promotion of Science (24-02053) and Key Laboratory for Solid Waste Management and Environment Safety, Ministry of Education of China (SWMES 2011-04). The overseas study conducted by the first author was finically supported by China Scholarship Council (CSC).	MCCARTY PL, 1991, WATER SCI TECHNOL, V24, P17; Ge HQ, 2011, WATER RES, V45, P1597, DOI 10.1016/j.watres.2010.11.042; Qiao W, 2013, BIORESOURCE TECHNOL, V149, P92, DOI 10.1016/j.biortech.2013.09.023; Lay JJ, 1998, J FERMENT BIOENG, V86, P467, DOI 10.1016/S0922-338X(98)80153-0; Chiu YC, 1997, WATER SCI TECHNOL, V36, P155, DOI 10.1016/S0273-1223(97)00681-1; Christ O, 2000, WATER SCI TECHNOL, V41, P61; Nges IA, 2010, RENEW ENERG, V35, P2200, DOI 10.1016/j.renene.2010.02.022; Neves L, 2006, WASTE MANAGE, V26, P176, DOI 10.1016/j.wasman.2004.12.022; KASPAR HF, 1978, APPL ENVIRON MICROB, V36, P1; PAVLOSTATHIS SG, 1991, WATER SCI TECHNOL, V24, P35; Batstone DJ, 2002, WATER SCI TECHNOL, V45, P65; Labatut RA, 2014, WATER RES, V53, P249, DOI 10.1016/j.watres.2014.01.035; Dinsdale RM, 1997, WATER RES, V31, P1931, DOI 10.1016/S0043-1354(97)00041-9; FERNANDEZ N, 1993, BIORESOURCE TECHNOL, V45, P223, DOI 10.1016/0960-8524(93)90115-R; GHOSH S, 1975, J WATER POLLUT CON F, V47, P30; Hill D.T., 1977, J WPCF, V46, P667; Isa M. H., 1993, Indian Journal of Environmental Health, V35, P1; Jeihanipour A, 2011, PROCESS BIOCHEM, V46, P1509, DOI 10.1016/j.procbio.2011.04.003; Lier J.B., 1993, APPL ENVIRON MICROB, V59, P1003; Ristow NE, 2006, WATER SCI TECHNOL, V54, P91, DOI 10.2166/wst.2006.551; SOUZA ME, 1992, WATER SCI TECHNOL, V25, P213	21	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	FEB	2015	36						77	85		10.1016/j.wasman.2014.11.016		9	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CB3FG	WOS:000349513000009		
J	Matsuto, T; Zhang, X; Matsuo, T; Yamada, S				Matsuto, Toshihiko; Zhang, Xin; Matsuo, Takayuki; Yamada, Shuhei			Onsite survey on the mechanism of passive aeration and air flow path in a semi-aerobic landfill	WASTE MANAGEMENT			English	Article						Landfill; Semi-aerobic; Aeration; Passive vent		The semi-aerobic landfill is a widely accepted landfill concept in Japan because it promotes stabilization of leachates and waste via passive aeration without using any type of mechanical equipment. Ambient air is thought to be supplied to the landfill through a perforated pipe network made of leachate collection pipe laid along the bottom and a vertically erected gas vent. However, its underlying air flow path and driving forces are unclear because empirical data from real-world landfills is inadequate. The objective of this study is to establish scientific evidence about the aeration mechanisms and air flow path by an on-site survey of a full-scale, semi-aerobic landfill. First, all passive vents located in the landfill were monitored with respect to temperature level and gas velocity in different seasons. We found a linear correlation between the outflow rate and gas temperature, suggesting that air flow is driven by a buoyancy force caused by the temperature difference between waste in the landfill and the ambient temperature. Some vents located near the landfill bottom acted as air inflow vents. Second, we conducted a tracer test to determine the air flow path between two vents, by injecting tracer gas from an air sucking vent. The resulting slowly increasing gas concentration at the neighboring vent suggested that fresh air flow passes through the waste layer toward the gas vents from leachate collection pipes, as well as directly flowing through the pipe network. Third, we monitored the temperature of gas flowing out of a vent at night. Since the temperature drop of the gas was much smaller than that of the environment, the air collected at the gas vents was estimated to flow mostly through the waste layer, i.e., the semi-aerobic landfill has considerable aeration ability under the appropriate conditions. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsuto, Toshihiko; Zhang, Xin; Matsuo, Takayuki; Yamada, Shuhei] Hokkaido Univ, Fac Engn, Lab Solid Waste Disposal Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Matsuto, T (reprint author), Hokkaido Univ, Fac Engn, Lab Solid Waste Disposal Engn, Kita Ku, Kira 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	matsuto@eng.hokudai.ac.jp					Ritzkowski M, 2012, WASTE MANAGE, V32, P1411, DOI 10.1016/j.wasman.2012.02.020; Raga R, 2014, WASTE MANAGE, V34, P683, DOI 10.1016/j.wasman.2013.12.011; Heyer K.-U., 1999, SARDINIA, VIV, P563; Heyer K.-U., 2001, SARDINIA; Hirata O, 2012, J MATER CYCLES WASTE, V14, P47, DOI 10.1007/s10163-011-0036-7; Kim HJ, 2010, WASTE MANAGE, V30, P465, DOI 10.1016/j.wasman.2009.10.005; Leikam K., 1997, SARD 1997 6 INT LAND, VIV, P451; Matsufuji Y., 1998, HIST SEMIAEROBIC LAN, p[21, 65]; Matsufuji Y., 2007, LANDFILL AERATION, P109; Park S., 1997, J JPN SOC WASTE MANA, V8, P147; Ritzkowski M., 2007, LANDFILL AERATION; Stegmann R., 2007, LANDFILL AERATION; Yanase R., 2010, P 21 ANN C JAP SOC M, P539	13	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	FEB	2015	36						204	212		10.1016/j.wasman.2014.11.007		9	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CB3FG	WOS:000349513000024		
J	Suda, A; Makino, T				Suda, Aomi; Makino, Tomoyuki			Methodological Drawbacks of the Extraction of Trace Metals from Fe and Mn Oxides in Soil Samples with Oxalic Acid-Ammonium Oxalate-Ascorbic Acid Solution	WATER AIR AND SOIL POLLUTION			English	Article						Ascorbic acid; Coprecipitation; Fe oxide; Mn oxide; Oxalate; Trace metal	SEQUENTIAL EXTRACTION; MANGANESE-OXIDE; DISSOLUTION; APPLICABILITY; FRACTIONATION	Extractions with mixtures of oxalic acid, ammonium oxalate, and ascorbic acid have been used to analyze trace metals that are occluded in Fe and Mn oxides in soil samples. In our experiments, the amount of Fe extracted from two Andisols decreased with increased extraction time using a mixture of 0.1 mol L-1 oxalic acid, 0.175 mol L-1 ammonium oxalate, and 0.19 mol L-1 ascorbic acid (OxAsc). Differential Xray diffraction analysis showed the presence of Fe(II)C2O4 center dot 2H(2)O in the residue after the extraction, and the amount of this precipitate increased with extraction time. These results indicate that the decrease in Fe extraction with time was caused by precipitation of Fe(II)C2O4 center dot 2H(2)O. The amounts of some trace metals (Cd, Co, Mn, Ni, and Zn) extracted with OxAsc showed trends similar to that of Fe, whereas As, Cu, and Pb did not show this trend. A coprecipitation experiment showed that the concentrations of Cd, Co, Mn, Ni, and Zn markedly decreased after the precipitation of Fe(II)C2O4 center dot 2H(2)O, whereas those of As, Cu, and Pb did not noticeably change. These results indicate that some trace metals coprecipitated with Fe(II)C2O4 center dot 2H(2)O during extraction with OxAsc. This coprecipitation results in underestimation of oxide-occluded trace metals in soils; therefore, using mixtures of oxalic acid, ammonium oxalate, and ascorbic acid to extract some trace metals occluded in Fe and Mn oxides may yield erroneous data.	[Suda, Aomi; Makino, Tomoyuki] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan	Suda, A (reprint author), Natl Inst Agroenvironm Sci, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	suda_aomi@affrc.go.jp; t_makino@affrc.go.jp					AFONSO MD, 1990, J COLLOID INTERF SCI, V138, P74; Schramel O, 2000, SCI TOTAL ENVIRON, V263, P11, DOI 10.1016/S0048-9697(00)00606-9; Sahuquillo A, 1999, ANAL CHIM ACTA, V382, P317, DOI 10.1016/S0003-2670(98)00754-5; Nogueira TAR, 2010, PEDOSPHERE, V20, P545, DOI 10.1016/S1002-0160(10)60044-6; MILLER WP, 1986, SOIL SCI SOC AM J, V50, P598; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Silveira ML, 2006, CHEMOSPHERE, V64, P1929, DOI 10.1016/j.chemosphere.2006.01.018; SHUMAN LM, 1985, SOIL SCI, V140, P11, DOI 10.1097/00010694-198507000-00003; Benitez LN, 1999, INT J ENVIRON AN CH, V75, P261, DOI 10.1080/03067319908047315; Blakemore LC, 1987, METHODS CHEM ANAL SO, P71; BRYANT R B, 1983, Soil Science Society of America Journal, V47, P168; CORNELL RM, 1987, CLAY CLAY MINER, V35, P347, DOI 10.1346/CCMN.1987.0350504; Davidson CM, 2004, ANAL CHIM ACTA, V508, P193, DOI 10.1016/j.aca.2003.11.076; Pardo F., 2010, WATER AIR SOIL POLL, V217, P535; Sadamoto H., 1994, Japanese Journal of Soil Science and Plant Nutrition, V65, P645; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHUMAN LM, 1982, SOIL SCI SOC AM J, V46, P1099; Stumm W., 1992, CHEM SOLID WATER INT, P309; Suda A, 2011, GEODERMA, V163, P291, DOI 10.1016/j.geoderma.2011.04.015; Suda A, 2013, SOIL SCI PLANT NUTR, V59, P840, DOI 10.1080/00380768.2013.857580; TAYLOR R. M., 1966, AUSTRALIAN J SOIL RES, V4, P29, DOI 10.1071/SR9660029; Vandecasteele C., 1997, MODERN METHODS TRACE, P9	22	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-6979	1573-2932		WATER AIR SOIL POLL	Water Air Soil Pollut.	FEB	2015	226	2							12	10.1007/s11270-014-2285-2		10	Environmental Sciences; Meteorology & Atmospheric Sciences; Water Resources	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Water Resources	CA6NB	WOS:000349029900020		
J	Tian, Z; Zhang, Y; Li, YY; Chi, YZ; Yang, M				Tian, Zhe; Zhang, Yu; Li, Yuyou; Chi, Yongzhi; Yang, Min			Rapid establishment of thermophilic anaerobic microbial community during the one-step startup of thermophilic anaerobic digestion from a mesophilic digester	WATER RESEARCH			English	Article						One-step startup; Thermophilic anaerobic digestion; Thermophilic anaerobic microbial community; Establishment	TETRACYCLINE RESISTANCE GENES; METHANOGENIC POPULATION-DYNAMICS; WASTE-ACTIVATED-SLUDGE; MUNICIPAL SOLID-WASTE; DEGRADES FATTY-ACIDS; SYNTROPHIC ASSOCIATION; BACTERIAL DIVERSITY; PROCESS STABILITY; LOW-TEMPERATURE; CATTLE MANURE	The purpose of this study was to explore how fast the thermophilic anaerobic microbial community could be established during the one-step startup of thermophilic anaerobic digestion from a mesophilic digester. Stable thermophilic anaerobic digestion was achieved within 20 days from a mesophilic digester treating sewage sludge by adopting the one-step startup strategy. The succession of archaeal and bacterial populations over a period of 60 days after the temperature increment was followed by using 454-pyrosequencing and quantitative PCR. After the increase of temperature, thermophilic methanogenic community was established within 11 days, which was characterized by the fast colonization of Methanosarcina thermophila and two hydrogenotrophic methanogens (Methanothermobacter spp. and Methanoculleus spp.). At the same time, the bacterial community was dominated by Fervidobacterium, whose relative abundance rapidly increased from 0 to 28.52 % in 18 days, followed by other potential thermophilic genera, such as Clostridium, Coprothemobacter, Anaerobaculum and EM3. The above result demonstrated that the one-step startup strategy could allow the rapid establishment of the thermophilic anaerobic microbial community. (C) 2014 Elsevier Ltd. All rights reserved.	[Tian, Zhe; Zhang, Yu; Chi, Yongzhi; Yang, Min] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Key Lab Drinking Water Sci & Technol, Beijing 100085, Peoples R China; [Li, Yuyou] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Zhang, Y (reprint author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Key Lab Drinking Water Sci & Technol, POB 2871, Beijing 100085, Peoples R China.				National Natural Scientific Foundation of China [51178449]; Funds for the Creative Research Groups of China [51221892]; State Hi-tech Research and Development Project of the Ministry of Science and Technology, Peoples Republic of China [2012AA063401]	This study was supported by National Natural Scientific Foundation of China (No. 51178449), Funds for the Creative Research Groups of China (No. 51221892) and State Hi-tech Research and Development Project of the Ministry of Science and Technology, Peoples Republic of China (Grand) (2012AA063401). We thank Mr. Li Kuixiao for his kind help in collecting sewage sludge.	MCINERNEY MJ, 1979, ARCH MICROBIOL, V122, P129, DOI 10.1007/BF00411351; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Ma JX, 2013, WATER RES, V47, P859, DOI 10.1016/j.watres.2012.11.013; Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07; Zabranska J, 2002, WATER SCI TECHNOL, V46, P447; Bolzonella D, 2005, PROCESS BIOCHEM, V40, P1453, DOI 10.1016/j.procbio.2004.06.036; Niu QG, 2013, BIORESOURCE TECHNOL, V137, P358, DOI 10.1016/j.biortech.2013.03.080; Diehl DL, 2010, ENVIRON SCI TECHNOL, V44, P9128, DOI 10.1021/es102765a; Cha GC, 1997, WATER SCI TECHNOL, V36, P247, DOI 10.1016/S0273-1223(97)00529-5; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113; Bouskova A, 2005, WATER RES, V39, P1481, DOI 10.1016/j.watres.2004.12.042; Bandara WMKRTW, 2012, WATER RES, V46, P5756, DOI 10.1016/j.watres.2012.07.061; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Yabu H, 2011, J BIOSCI BIOENG, V111, P312, DOI 10.1016/j.jbiosc.2010.10.011; Hori T, 2006, APPL ENVIRON MICROB, V72, P1623, DOI 10.1128/AEM.72.2.1623-1630.2006; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; Shigematsu T, 2006, J BIOSCI BIOENG, V102, P535, DOI 10.1263/jbb.102.535; Bjornsson L, 2001, WATER RES, V35, P2833, DOI 10.1016/S0043-1354(00)00585-6; Liu YT, 1999, INT J SYST BACTERIOL, V49, P545; Hugenholtz P, 1998, J BACTERIOL, V180, P366; Liu MM, 2012, ENVIRON SCI TECHNOL, V46, P7551, DOI 10.1021/es301145m; Salinas MB, 2004, INT J SYST EVOL MICR, V54, P645, DOI 10.1099/ijs.0.02732-0; ZINDER SH, 1984, APPL ENVIRON MICROB, V47, P796; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Khemkhao M, 2012, J ENVIRON MANAGE, V103, P74, DOI 10.1016/j.jenvman.2012.03.004; Griffin ME, 1998, BIOTECHNOL BIOENG, V57, P342, DOI 10.1002/(SICI)1097-0290(19980205)57:3<342::AID-BIT11>3.0.CO;2-I; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; ZINDER SH, 1979, APPL ENVIRON MICROB, V38, P996; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; KALLE GP, 1984, J BIOSCIENCE, V6, P315, DOI 10.1007/BF02716746; Ghosh S, 2009, APPL MICROBIOL BIOT, V84, P791, DOI 10.1007/s00253-009-2125-2; Cai JG, 2007, INT J SYST EVOL MICR, V57, P2333, DOI 10.1099/ijs.0.64758-0; CHEN M, 1983, APPL ENVIRON MICROB, V45, P1271; de la Rubia MA, 2005, AICHE J, V51, P2581, DOI 10.1002/aic.10546; Friedrich AB, 1996, APPL ENVIRON MICROB, V62, P2875; GARBER WF, 1982, J WATER POLLUT CON F, V54, P1170; Greenberg A. E., 1992, STANDARD METHODS EXA; HUBER R, 1990, ARCH MICROBIOL, V154, P105, DOI 10.1007/BF00423318; Iranpour R, 2002, WATER ENVIRON RES, V74, P494, DOI 10.2175/106143002X140297; Kardos L, 2011, APPL ECOL ENV RES, V9, P293; KROEKER EJ, 1979, J WATER POLLUT CON F, V51, P718; Kugelman U., 1989, COMP EVALUATION MESO; Liu K, 2009, J BIOSCI BIOENG, V107, P54, DOI 10.1016/j.jbiosc.2008.09.007; Ma YJ, 2011, ENVIRON SCI TECHNOL, V45, P7855, DOI 10.1021/es200827t; Maroun R, 2007, ENVIRON SCI TECHNOL, V41, P6808, DOI 10.1021/es070686w; Mladenovska Z, 2000, FEMS MICROBIOL ECOL, V31, P225, DOI 10.1111/j.1574-6941.2000.tb00687.x; PATEL BKC, 1985, ARCH MICROBIOL, V141, P63, DOI 10.1007/BF00446741; RIMKUS RR, 1982, J WATER POLLUT CON F, V54, P1447; Sofer S.S., 1981, BIOMASS CONVERSION P; Sumino H, 2012, J ENVIRON SCI HEAL A, V47, P1803, DOI 10.1080/10934529.2012.689241; VANLIER JB, 1993, BIORESOURCE TECHNOL, V43, P227, DOI 10.1016/0960-8524(93)90035-A; Watanabe H, 1997, WATER SCI TECHNOL, V36, P25, DOI 10.1016/S0273-1223(97)00503-9; Wei F., 2002, MONITORING ANAL METH; Weiss A, 2008, APPL MICROBIOL BIOT, V81, P163, DOI 10.1007/s00253-008-1717-6; Wu SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030440; Zhang DD, 2012, BIORESOURCE TECHNOL, V104, P136, DOI 10.1016/j.biortech.2011.10.086	60	3	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0043-1354			WATER RES	Water Res.	FEB 1	2015	69						9	19		10.1016/j.watres.2014.11.001		11	Engineering, Environmental; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CB3BQ	WOS:000349503600002		
J	Xue, WC; Tobino, T; Nakajima, F; Yamamoto, K				Xue, Wenchao; Tobino, Tomohiro; Nakajima, Fumiyuki; Yamamoto, Kazuo			Seawater-driven forward osmosis for enriching nitrogen and phosphorous in treated municipal wastewater: Effect of membrane properties and feed solution chemistry	WATER RESEARCH			English	Article						Forward osmosis; Seawater driven; Nutrient enrichment; Membrane properties; Feed solution pH	INTERNAL CONCENTRATION POLARIZATION; AMMONIA-CARBON DIOXIDE; REVERSE-OSMOSIS; STRUVITE CRYSTALLIZATION; CONTACTOR PROCESSES; PROCESS PERFORMANCE; NUTRIENT RECOVERY; HUMAN URINE; DRAW; DESALINATION	Seawater-driven forward osmosis (FO) is considered to be a novel strategy to concentrate nutrients in treated municipal wastewater for further recovery as well as simultaneous discharge of highly purified wastewater into the sea with low cost. As a preliminary test, the performance of FO membranes in concentrating nutrients was investigated by both batch experiments and model simulation approaches. With synthetic seawater as the draw solution, the dissolved organic carbon, phosphate, and ammonia in the effluent from a membrane bioreactor (MBR) treating municipal wastewater were 2.3-fold, 2.3-fold, and 2.1-fold, respectively, concentrated by the FO process with approximately 57% of water reduction. Most of the dissolved components, including trace metals in the MBR effluent, were highly retained (>80%) in the feed side, indicating high water quality of permeate to be discharged. The effect of membrane properties on the nutrient enrichment performance was investigated by comparing three types of FO membranes. Interestingly, a polyamide membrane possessing a high negative charge demonstrated a poor capability of retaining ammonia, which was hypothesized because of an ion exchange-like mechanism across the membrane prompted by the high ionic concentration of the draw solution. A feed solution pH of 7 was demonstrated to be an optimum condition for improving the overall retention of nutrients, especially for ammonia because of the pH-dependent speciation of ammonia/ammonium forms. The modeling results showed that higher than 10-fold concentrations of ammonia and phosphate are achievable by seawater-driven FO with a draw solution to feed solution volume ratio of 2:1. The enriched municipal wastewater contains nitrogen and phosphorous concentrations comparable with typical animal wastewater and anaerobic digestion effluent, which are used for direct nutrient recovery. (C) 2014 Elsevier Ltd. All rights reserved.	[Xue, Wenchao; Nakajima, Fumiyuki] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Tobino, Tomohiro; Yamamoto, Kazuo] Univ Tokyo, Ctr Environm Sci, Bunkyo Ku, Tokyo 1130033, Japan	Yamamoto, K (reprint author), Univ Tokyo, Ctr Environm Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	setsuna0308@gmail.com			New Energy and Industrial Technology Development Organization (NEDO); Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) of the Council for Science and Technology Policy, Cabinet Office, Government of Japan; Bureau of Sewerage, Tokyo Metropolitan Government	This study was conducted under the support of the New Energy and Industrial Technology Development Organization (NEDO) and Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) of the Council for Science and Technology Policy, Cabinet Office, Government of Japan, and a collaboration research with Bureau of Sewerage, Tokyo Metropolitan Government.	Song YH, 2007, CHEMOSPHERE, V69, P319, DOI 10.1016/j.chemosphere.2007.06.001; Gray GT, 2006, DESALINATION, V197, P1, DOI 10.1016/j.desal.2006.02.003; Ge QC, 2012, WATER RES, V46, P1318, DOI 10.1016/j.watres.2011.12.043; Liu Y, 2011, DESALINATION, V277, P364, DOI 10.1016/j.desal.2011.04.056; van Voorthuizen EM, 2005, WATER RES, V39, P3657, DOI 10.1016/j.watres.2005.06.005; Cai T, 2013, RENEW SUST ENERG REV, V19, P360, DOI 10.1016/j.rser.2012.11.030; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; Achilli A, 2009, DESALINATION, V239, P10, DOI 10.1016/j.desal.2008.02.022; Hancock NT, 2011, ENVIRON SCI TECHNOL, V45, P10642, DOI 10.1021/es202608y; Lee S, 2010, J MEMBRANE SCI, V365, P34, DOI 10.1016/j.memsci.2010.08.036; Yip NY, 2010, ENVIRON SCI TECHNOL, V44, P3812, DOI 10.1021/es1002555; Lee S, 2001, ENVIRON SCI TECHNOL, V35, P3008, DOI 10.1021/es0018724; Xie H, 2011, LANGMUIR, V27, P4721, DOI 10.1021/la105120f; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Cath TY, 2005, J MEMBRANE SCI, V257, P85, DOI 10.1016/j.memsci.2004.08.039; Phillip WA, 2010, ENVIRON SCI TECHNOL, V44, P5170, DOI 10.1021/es100901n; Zhang JF, 2014, ENVIRON SCI TECHNOL, V48, P3386, DOI 10.1021/es405266d; Tang CYY, 2010, J MEMBRANE SCI, V354, P123, DOI 10.1016/j.memsci.2010.02.059; Nayak CA, 2010, SEP PURIF TECHNOL, V71, P144, DOI 10.1016/j.seppur.2009.11.013; LEE KL, 1981, J MEMBRANE SCI, V8, P141, DOI 10.1016/S0376-7388(00)82088-8; Jiao B, 2004, J FOOD ENG, V63, P303, DOI 10.1016/j.jfoodeng.2003.08.003; McCutcheon JR, 2006, J MEMBRANE SCI, V278, P114, DOI 10.1016/j.memsci.2005.10.048; Childress AE, 1996, J MEMBRANE SCI, V119, P253, DOI 10.1016/0376-7388(96)00127-5; Jin X, 2011, ENVIRON SCI TECHNOL, V45, P2323, DOI 10.1021/es103771a; Mi BX, 2010, J MEMBRANE SCI, V348, P337, DOI 10.1016/j.memsci.2009.11.021; Doyle JD, 2002, WATER RES, V36, P3925, DOI 10.1016/S0043-1354(02)00126-4; Chen L, 2014, WATER RES, V50, P114, DOI 10.1016/j.watres.2013.12.009; Linares RV, 2011, WATER RES, V45, P6737, DOI 10.1016/j.watres.2011.10.037; Song YH, 2011, J HAZARD MATER, V190, P140, DOI 10.1016/j.jhazmat.2011.03.015; Cath TY, 2005, J MEMBRANE SCI, V257, P111, DOI 10.1016/j.memsci.2004.07.039; Phuntsho S, 2012, ENVIRON SCI TECHNOL, V46, P4567, DOI 10.1021/es300002w; Holloway RW, 2007, WATER RES, V41, P4005, DOI 10.1016/j.watres.2007.05.054; Richards LA, 2010, DESALINATION, V261, P331, DOI 10.1016/j.desa1.2010.06.025; Ng HY, 2006, ENVIRON SCI TECHNOL, V40, P2408, DOI 10.1021/es0519177; Loeb S, 1997, J MEMBRANE SCI, V129, P243, DOI 10.1016/S0376-7388(96)00354-7; Cornelissen ER, 2008, J MEMBRANE SCI, V319, P158, DOI 10.1016/j.memsci.2008.03.048; BILSTAD T, 1995, J MEMBRANE SCI, V102, P93, DOI 10.1016/0376-7388(94)00279-8; Chen J., 2012, CONC BIOM PROD IN LI; EPA U.S., 1994, SHORT TERM METH EST; Lind BB, 2001, ECOL ENG, V16, P561, DOI 10.1016/S0925-8574(00)00107-5; Lind BB, 2000, BIORESOURCE TECHNOL, V73, P169, DOI 10.1016/S0960-8524(99)90157-8; Paugam L, 2004, J MEMBRANE SCI, V231, P37, DOI 10.1016/j.memsci.2003.11.003; Qin JJ, 2003, J MEMBRANE SCI, V217, P261, DOI 10.1016/S0376-7388(03)00141-8	43	2	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0043-1354			WATER RES	Water Res.	FEB 1	2015	69						120	130		10.1016/j.watres.2014.11.007		11	Engineering, Environmental; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CB3BQ	WOS:000349503600013		
J	Araki, D; Kurosaki, K; Kimura, H; Muta, H; Ohishi, Y; Konashi, K; Yamanaka, S				Araki, Daichi; Kurosaki, Ken; Kimura, Hiroaki; Muta, Hiroaki; Ohishi, Yuji; Konashi, Kenji; Yamanaka, Shinsuke			Thermal and mechanical properties of hydrides of Zr-Hf alloys	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						hafnium hydrides; zirconium; high-temperature stability; thermal properties; mechanical properties	ZIRCONIUM HYDRIDE; HAFNIUM HYDRIDE	Polycrystalline bulk samples of delta-phase Hf hydrides with various Zr contents were prepared and their high-temperature stability and thermal and mechanical properties were investigated. The phase structure was examined between room temperature and 973K using high-temperature X-ray diffraction and thermogravimetric-differential thermal analysis. From room temperature to 673K, the coefficient of linear thermal expansion, specific heat capacity, and thermal conductivity were evaluated. The Vickers hardness and sound velocity were measured at room temperature, and the elastic modulus was evaluated. The effect of the Zr content on the high-temperature stability and the thermal and mechanical properties of Hf hydrides was studied.	[Araki, Daichi; Kurosaki, Ken; Kimura, Hiroaki; Muta, Hiroaki; Ohishi, Yuji; Yamanaka, Shinsuke] Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan; [Konashi, Kenji] Tohoku Univ, Inst Mat Res, Oarai, Ibaraki 3111313, Japan; [Yamanaka, Shinsuke] Univ Fukui, Res Inst Nucl Engn, Fukui 9108507, Japan	Kurosaki, K (reprint author), Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kurosaki@see.eng.osaka-u.ac.jp	Kurosaki, Ken/E-8081-2012				Yamanaka S, 1999, J ALLOY COMPD, V293, P23, DOI 10.1016/S0925-8388(99)00389-8; Ito M, 2010, J NUCL SCI TECHNOL, V47, P156; Ito M, 2009, J NUCL SCI TECHNOL, V46, P814, DOI 10.3327/jnst.46.814; Konashi Kenji, 2010, Advances in Science and Technology, V73, DOI 10.4028/www.scientific.net/AST.73.51; Massalski T. B., 1990, BINARY ALLOY PHASE D; Miyake M, 1999, J NUCL MATER, V270, P233, DOI 10.1016/S0022-3115(98)00779-X; Morocoima M, 1997, J PHYS CHEM SOLIDS, V58, P503, DOI 10.1016/S0022-3697(96)00048-0; Tahara Y, 2010, J NUCL SCI TECHNOL, V47, P421, DOI 10.3327/jnst.47.421; Yamanaka S, 2001, J NUCL MATER, V294, P94, DOI 10.1016/S0022-3115(01)00457-3	9	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					162	170		10.1080/00223131.2014.935509		9	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500003		
J	Sakon, A; Hashimoto, K; Sugiyama, W; Hohara, S; Pyeon, CH; Sano, T; Yagi, T; Ohsawa, T				Sakon, Atsushi; Hashimoto, Kengo; Sugiyama, Wataru; Hohara, Sin-ya; Pyeon, Cheol Ho; Sano, Tadafumi; Yagi, Takahiro; Ohsawa, Takaaki			Determination of prompt-neutron decay constant from phase shift between beam current and neutron detection signals for an accelerator-driven system in the Kyoto University Critical Assembly	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						KUCA; ADS; 14 MeV neutron; accelerator-driven system; subcriticality; reactor noise; power spectrum	RESEARCH-AND-DEVELOPMENT; 100 MEV PROTONS; SUBCRITICAL REACTOR; 14MEV NEUTRONS; TRANSMUTATION; REACTIVITY; PROGRAM	A unique power spectral analysis for a subcritical reactor system driven by a pulsed 14 MeV neutron source was carried out at the Kyoto University Critical Assembly (KUCA). In this analysis, a complex cross-power spectral density between time-sequence signal data from an accelerator beam ammeter and a neutron detector was measured to determine the prompt-neutron decay constant of an accelerator-driven system (ADS) from the phase data of the spectral density. Assuming the one-point kinetics model, in theory, the decay constant can be arithmetically derived from the phase at the integral multiples of the pulse repetition frequency. However, the actual derivation from the phase at a pulse repetition frequency of 20Hz considerably underestimated the prompt-neutron decay constant, compared with that obtained by a previous pulsed neutron experiment, and the derived decay constant apparently decreased with an increase in the multiple of the pulsed repetition frequency. Considering a lag time in detector response, the above underestimation and the above apparent decrease were solved to obtain the consistent decay constant. While both previous power spectral analysis and Feynman-alpha analysis for pulsed neutron source require non-linear least-squares fits of the respective complicated formulae, the present analysis makes the fitting unnecessary except at regular calibration of the lag time. This feature is advantageous for a robust online monitoring of subcritical reactivity of an actual ADS.	[Sakon, Atsushi; Hashimoto, Kengo; Sugiyama, Wataru; Hohara, Sin-ya; Ohsawa, Takaaki] Kinki Univ, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Engn, Higashiosaka, Osaka 5778502, Japan; [Pyeon, Cheol Ho; Sano, Tadafumi; Yagi, Takahiro] Kyoto Univ, Inst Res Reactor, Nucl Engn Sci Div, Kumatori, Osaka 5900494, Japan	Hashimoto, K (reprint author), Kinki Univ, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Engn, Higashiosaka, Osaka 5778502, Japan.	kengoh@pp.iij4u.or.jp					Abderrahim HA, 2007, J NUCL SCI TECHNOL, V44, P491; Pyeon CH, 2009, J NUCL SCI TECHNOL, V46, P1091; Pyeon CH, 2013, NUCL ENG TECHNOL, V45, P81, DOI 10.5516/NET.08.2012.003; Pyeon CH, 2011, ANN NUCL ENERGY, V38, P2298, DOI 10.1016/j.anucene.2011.06.024; Sakon A, 2014, J NUCL SCI TECHNOL, V51, P116, DOI 10.1080/00223131.2013.852488; Taninaka H, 2011, J NUCL SCI TECHNOL, V48, P873, DOI 10.3327/jnst.48.873; Warin D, 2007, J NUCL SCI TECHNOL, V44, P410, DOI 10.3327/jnst.44.410; Ichihara C, 1983, KURRITR240; Kitamura Y, 2004, ANN NUCL ENERGY, V31, P163, DOI 10.1016/S0306-4549(03)00188-9; Lebrat JF, 2008, NUCL SCI ENG, V158, P49; Mishima K, 2007, J NUCL SCI TECHNOL, V44, P499, DOI 10.3327/jnst.44.499; Pyeon CH, 2008, J NUCL SCI TECHNOL, V45, P1171, DOI 10.3327/jnst.45.1171; Pyeon CH, 2012, ANN NUCL ENERGY, V40, P229, DOI 10.1016/j.anucene.2011.10.011; Pyeon CH, 2007, J NUCL SCI TECHNOL, V44, P1368, DOI 10.3327/jnst.44.1368; Pyeon CH, 2009, J NUCL SCI TECHNOL, V46, P965; Sakon A, 2013, J NUCL SCI TECHNOL, V50, P481, DOI 10.1080/00223131.2013.785268; Sasa T, 2004, NUCL ENG DES, V230, P209, DOI 10.1016/j.nucengdes.2003.11.033; Soule R, 2004, NUCL SCI ENG, V148, P124; Taninaka H, 2010, J NUCL SCI TECHNOL, V47, P376, DOI 10.3327/jnst.47.376; Taninaka H, 2011, J NUCL SCI TECHNOL, V48, P1272; Tsujimoto K, 2007, J NUCL SCI TECHNOL, V44, P483, DOI 10.3327/jnst.44.483	21	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					204	213		10.1080/00223131.2014.941026		10	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500007		
J	Uozumi, Y; Yamada, T; Nakano, M				Uozumi, Yusuke; Yamada, Takahiro; Nakano, Masahiro			Intranuclear cascade model for 50-MeV-region (p, p ' x) reactions over a wide target mass range	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						intranuclear cascade model, (p, p ' x) reactions; collective excitation; barrier transmission coefficient; double-differential cross sections	TRANSPORT CODE SYSTEM; NUCLEAR-REACTIONS; EVAPORATION SPECTRA; CROSS-SECTIONS; PARTICLE; COMPOUND; HEAVY; APPROXIMATION; CONTINUUM; EMISSION	In our previous study, the applicable range of the intranuclear cascade model was successfully extended to lower incident energy (p, p ' x) reactions by introducing trajectory deflections and low-energy-loss process due to collective excitations. However, the model's validity was confirmed only for a Fe-56 target. In the present work we widen the applicable range of masses of the target nucleus. First, we derive an expression for the response function, which gives the probability of collective excitation strengths, to fit the distorted-wave Born approximation results as a function of the target mass number and the beam energy. Second, the barrier transmission coefficient was investigated. An expression with a modified Gamow penetration factor was chosen from four phenomenological forms of one-dimensional barrier transmission coefficients. Calculations with the proposed model followed by a generalized evaporation model were carried out for double-differential cross sections of (p, p ' x) reactions at 30-60 MeV. Although the response function and the transmission coefficient were only parameterized approximately, the proposed model showed good agreements with experimental observations for a variety of nuclear targets from C-12 to Bi-209.	[Uozumi, Yusuke; Yamada, Takahiro] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Nishi Ku, Fukuoka 8190395, Japan; [Nakano, Masahiro] Junshin Gakuen Univ, Fac Hlth Sci, Minami Ku, Fukuoka 8158510, Japan	Uozumi, Y (reprint author), Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	uozumi@nucl.kyushu-u.ac.jp					ALEXANDER JM, 1982, Z PHYS A-HADRON NUCL, V305, P313, DOI 10.1007/BF01419079; Iwamoto O, 2007, J NUCL SCI TECHNOL, V44, P687, DOI 10.3327/jnst.44.687; WONG CY, 1973, PHYS REV LETT, V31, P766, DOI 10.1103/PhysRevLett.31.766; BJORNHOLM S, 1980, REV MOD PHYS, V52, P725, DOI 10.1103/RevModPhys.52.725; Boudard A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014606; Weisskopf VF, 1940, PHYS REV, V57, P472, DOI 10.1103/PhysRev.57.472; Cugnon J, 2011, J KOREAN PHYS SOC, V59, P955, DOI 10.3938/jkps.59.955; Sawada Y, 2012, NUCL INSTRUM METH B, V291, P38, DOI 10.1016/j.nimb.2012.08.025; Cugnon J, 1996, NUCL INSTRUM METH B, V111, P215, DOI 10.1016/0168-583X(95)01384-9; NEGELE JW, 1970, PHYS REV C, V1, P1260, DOI 10.1103/PhysRevC.1.1260; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; FESHBACH H, 1980, ANN PHYS-NEW YORK, V125, P429, DOI 10.1016/0003-4916(80)90140-2; Weisskopf V, 1937, PHYS REV, V52, P0295, DOI 10.1103/PhysRev.52.295; Andreyev AN, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.014612; Ballarini F, 2007, ADV SPACE RES, V40, P1339, DOI 10.1016/j.asr.2007.05.031; BERTRAND FE, 1973, PHYS REV C, V8, P1045, DOI 10.1103/PhysRevC.8.1045; Blatt J M, 1952, THEORETICAL NUCL PHY; Bowler M G, 1973, NUCL PHYS; Cugnon J, 2003, EUR PHYS J A, V16, P393, DOI 10.1140/epja/i2002-10096-6; DOSTROVSKY I, 1959, PHYS REV, V116, P683, DOI 10.1103/PhysRev.116.683; Duarte H, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.024611; ERICSON T, 1958, NUCL PHYS, V8, P284, DOI 10.1016/0029-5582(58)90156-1; Filges D, 2001, EUR PHYS J A, V11, P467, DOI 10.1007/s100500170058; Furihata S, 2000, NUCL INSTRUM METH B, V171, P251, DOI 10.1016/S0168-583X(00)00332-3; Furihata S., 2002, J NUCL SCI TECHNOL S, V2, P758; HUIZENGA JR, 1989, PHYS REV C, V40, P668, DOI 10.1103/PhysRevC.40.668; Iwamoto H, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.034604; KAWAI M, 1992, PHYS REV C, V45, P1856, DOI 10.1103/PhysRevC.45.1856; KNOX WJ, 1960, PHYS REV, V120, P2120, DOI 10.1103/PhysRev.120.2120; Letourneau A, 2002, NUCL PHYS A, V712, P133, DOI 10.1016/S0375-9474(02)01133-8; LUO YL, 1991, PHYS REV C, V43, P2367, DOI 10.1103/PhysRevC.43.2367; Mashnik SG, 2004, ADV SPACE RES, V34, P1288, DOI 10.1016/j.asr.2003.08.057; MURTHY KHN, 1982, Z PHYS A-HADRON NUCL, V305, P73, DOI 10.1007/BF01415082; Preston M.A., 1962, PHYS NUCL; QUINT AB, 1993, Z PHYS A-HADRON NUCL, V346, P119, DOI 10.1007/BF01294627; SARANTITES DG, 1990, PHYS REV LETT, V64, P2129, DOI 10.1103/PhysRevLett.64.2129; Sin M, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.054601; TAMURA T, 1982, PHYS REV C, V26, P379, DOI 10.1103/PhysRevC.26.379; Uozumi Y, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.034610; Uozumi Y, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.064617; Wang CB, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.014609; Yoshida H, 1998, NUCL INSTRUM METH A, V411, P46, DOI 10.1016/S0168-9002(98)00287-3	42	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					264	273		10.1080/00223131.2014.945505		10	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500012		
J	Yoshioka, K; Kikuchi, T; Gunji, S; Kumanomido, H; Mitsuhashi, I; Umano, T; Yamaoka, M; Okajima, S; Fukushima, M; Nagaya, Y; Mori, T; Kitada, T; Takeda, T				Yoshioka, Kenichi; Kikuchi, Tsukasa; Gunji, Satoshi; Kumanomido, Hironori; Mitsuhashi, Ishi; Umano, Takuya; Yamaoka, Mitsuaki; Okajima, Shigeaki; Fukushima, Masahiro; Nagaya, Yasunobu; Mori, Takamasa; Kitada, Takanori; Takeda, Toshikazu			Void reactivity evaluation by modified conversion ratio measurements in LWR critical experiments	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						void reactivity; modified conversion ratio; reduced-moderation LWR; NCA; critical experiments; Monte Carlo; MVP	SIMULATED CORES; LATTICE; REACTOR; PHYSICS	We have developed a void reactivity evaluation method by using modified conversion ratio measurements in a light water reactor (LWR) critical lattice. Assembly-wise void reactivity is evaluated from the "finite neutron multiplication factor", k*, deduced from the modified conversion ratio of each fuel rod. The distributions of modified conversion ratio and k* on a reduced-moderation LWR lattice, for which the improvement of negative void reactivity is a serious issue, were measured. Measured values were analyzed with a continuous-energy Monte Carlo method. The measurements and analyses agreed within the measurement uncertainty. The developed method is useful for validating the nuclear design methodology concerning void reactivity.	[Yoshioka, Kenichi; Kikuchi, Tsukasa; Gunji, Satoshi; Kumanomido, Hironori; Mitsuhashi, Ishi; Umano, Takuya; Yamaoka, Mitsuaki] Toshiba Co Ltd, Power Syst Co, Kawasaki Ku, Kawasaki, Kanagawa 2100862, Japan; [Okajima, Shigeaki; Fukushima, Masahiro; Nagaya, Yasunobu; Mori, Takamasa] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Kitada, Takanori; Takeda, Toshikazu] Osaka Univ, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan	Yoshioka, K (reprint author), Toshiba Co Ltd, Power Syst Co, Kawasaki Ku, 4-1 Ukishima Cho, Kawasaki, Kanagawa 2100862, Japan.	kenichi.yoshioka@toshiba.co.jp			Ministry of Education, Science and Technology in Japan	The study had been conducted under the sponsorship of the Ministry of Education, Science and Technology in Japan.	AIHARA N, 1991, NUCL SCI ENG, V109, P158; Shibata K, 2002, J NUCL SCI TECHNOL, V39, P1125, DOI 10.3327/jnst.39.1125; Briesmeister J. F., 2000, LA13709M LOS AL NAT; CHAWLA R, 1984, NUCL TECHNOL, V67, P360; KIKUCHI H, 1969, J NUCL SCI TECHNOL-T, V6, P458; Kikuchi H, 1970, J NUCL SCI TECHNOL-T, V7, P545; KOWATA Y, 1988, NUCL SCI ENG, V99, P299; Nagaya Y., 2005, MVP GMVP 2 GEN PURPO; NAKAJIMA K, 1994, NUCL SCI ENG, V116, P138; NAKAJIMA K, 1995, NUCL SCI ENG, V119, P175; UEDA M, 1975, J NUCL SCI TECHNOL, V12, P229; Yoshioka K, 2003, INT C ADV NUCL POW P, P3125	12	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					282	293		10.1080/00223131.2014.937781		12	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500014		
J	Shimoda, H; Kato, T				Shimoda, Hiroshi; Kato, Tatsuya			Recent activities in the field of NPP I & C and human factor	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Editorial Material							NUCLEAR-POWER-PLANTS; HUMAN ERROR PROBABILITIES; CONTROL ROOM; RELIABILITY; PROTECTION; OPERATION; SYSTEMS; REACTOR; HTTR		[Shimoda, Hiroshi] Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan; Toshiba Co Ltd, Dept Nucl Safety Syst Design & Engn, Isogo Ku, Yokohama, Kanagawa 2358523, Japan	Shimoda, H (reprint author), Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	shimoda@energy.kyoto-u.ac.jp	Blynskiy, Petr/D-3486-2015				Groth KM, 2014, RELIAB ENG SYST SAFE, V128, P32, DOI 10.1016/j.ress.2014.03.010; Preischl W, 2013, RELIAB ENG SYST SAFE, V109, P150, DOI 10.1016/j.ress.2012.08.004; Kim BG, 2013, NUCL ENG DES, V265, P1005, DOI 10.1016/j.nucengdes.2013.06.019; Behera RP, 2014, J NUCL SCI TECHNOL, V51, P521, DOI 10.1080/00223131.2013.878231; Goto M, 2012, NUCL ENG DES, V251, P181, DOI 10.1016/j.nucengdes.2011.10.047; Honda Y, 2014, J NUCL SCI TECHNOL, V51, P1387, DOI 10.1080/00223131.2014.919241; Ito C, 2014, J NUCL SCI TECHNOL, V51, P944, DOI 10.1080/00223131.2014.924883; Kim DY, 2014, J NUCL SCI TECHNOL, V51, P1288, DOI 10.1080/00223131.2014.923792; Kim J, 2013, J NUCL SCI TECHNOL, V50, P1110, DOI 10.1080/00223131.2013.836065; Kim Y, 2014, J NUCL SCI TECHNOL, V51, P744, DOI 10.1080/00223131.2014.897267; Koo B, 2014, J NUCL SCI TECHNOL, V51, P390, DOI 10.1080/00223131.2014.864456; Podofillini L, 2013, NUCL ENG TECHNOL, V45, P151, DOI 10.5516/NET.04.2013.702; Shimizua A, 2014, NUCL ENG DES, V271, P499, DOI 10.1016/j.nucengdes.2013.12.022; Takeuchi T, 2014, J NUCL SCI TECHNOL, V51, P939, DOI 10.1080/00223131.2014.907549; Zhou Y, 2012, WORK, V41, P714, DOI 10.3233/WOR-2012-0231-714	15	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					299	300		10.1080/00223131.2014.947348		2	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500016		
J	Kunugi, K; Kojima, H; Trivailo, PM				Kunugi, Kouta; Kojima, Hirohisa; Trivailo, Pavel M.			Modeling of tape tether vibration and vibration sensing using smart film sensors	ACTA ASTRONAUTICA			English	Article						Tape tether; Smart film sensor; Bending and torsion; Vibration sensing	NODAL COORDINATE FORMULATION; DYNAMICS; SYSTEM	Tape-tethered satellite systems use long and flexible tape tethers, the bending and torsional vibrations of which affect the positions and attitude of attached satellites and climbers. Owing to the distribution characteristics of a tape tether, ordinary point sensors and actuators cannot be used easily to control the vibrations. Other types of sensors and actuators are required for this purpose. The flexibility and deformability of smart materials make them particularly suitable for integration into a tape-tethered system. Thus, in this paper, we propose a method for modeling the bending and torsional vibrations of a tape tether, and report our investigation into the feasibility of using smart film sensors to distinguish between the two vibration types. We formulate equations of motion for the tape tether using multibody dynamics techniques, and perform numerical simulations to study the behavior of the bending and torsional vibrations. The results of our experiments show that the bending and torsional vibrations of a tape tether can be measured using smart film sensors attached to the tether. (C) 2014 IAA. Published by Elsevier Ltd. All rights reserved.	[Kunugi, Kouta; Kojima, Hirohisa] Tokyo Metropolitan Univ, Dept Aerosp Engn, Hino, Tokyo 1910065, Japan; [Trivailo, Pavel M.] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic 3083, Australia	Kojima, H (reprint author), Tokyo Metropolitan Univ, Dept Aerosp Engn, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.	hkojima@tmu.ac.jp		Kojima, Hirohisa/0000-0002-8704-9362			Williams RB, 2004, J COMPOS MATER, V38, P855, DOI 10.1177/0021998304040555; Dmitrochenko ON, 2003, MULTIBODY SYST DYN, V10, P17, DOI 10.1023/A:1024553708730; Fujii HA, 2008, J GUID CONTROL DYNAM, V31, P436, DOI 10.2514/1.26240; Buckham B, 2004, J APPL MECH-T ASME, V71, P476, DOI 10.1115/1.1755691; Gerstmayr J, 2006, NONLINEAR DYNAM, V45, P109, DOI 10.1007/s11071-006-1856-1; Kojima H, 2011, ACTA ASTRONAUT, V69, P96, DOI 10.1016/j.actaastro.2011.02.009; Cohen SS, 2007, J GUID CONTROL DYNAM, V30, P1711, DOI 10.2514/1.29010; Cosmo M. L., 1997, TETHERS SPACE HDB; Dombrowski S.V., 2002, MULTIBODY SYST DYN, V8, P409; Fujii HA, 2009, ACTA ASTRONAUT, V64, P313, DOI 10.1016/j.actaastro.2008.07.006; Gates SS, 2001, J SPACECRAFT ROCKETS, V38, P60, DOI 10.2514/2.3655; Iwamoto H., 2005, T JPN SOC MECH ENG-C, V71, P1827; LORENZINI EC, 1990, ACTA ASTRONAUT, V21, P545, DOI 10.1016/0094-5765(90)90082-V; Nishigaki T., 1999, T JPN SOC MECH ENG-C, V65, P1937; Sanada T., 2004, DYN DES C, P555; Takahashi Y., 1997, TECHNICAL REPORT IEI, V218, P39; van de Heijning S.P.A., 2005, 56 INT ASTR C INT AS; Watanabe T., 2012, J SPACE TECHNOL SCI, V26, P14; Watanabe T., AIAA AAS ASTR SPEC C, P1442; Williams P, 2008, ADV ASTRONAUT SCI, V129, P1813; Yano H., 2010, SPAC PLASM C IAXA; Yasumitsu R., 2001, THESIS U TOKYO; Yoneyama S., 2010, T JPN SOC MECH ENG-C, V76, P2059; Yoneyama S., 2010, T JPN SOC MECH ENG-C, V76, P565; Yukizane M., 2006, P 16 WORKSH JAXA AST, P297; Zhu Z.H., 2006, INT J SOLIDS STRUCT, V43, P1492, DOI DOI 10.1016/J.IJS0LSTR.2005.03.053	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	FEB-MAR	2015	107						97	111		10.1016/j.actaastro.2014.11.024		15	Engineering, Aerospace	Engineering	CA6XQ	WOS:000349061200009		
J	Tanaka, T; Kawamura, Y; Tanaka, T				Tanaka, Takushi; Kawamura, Yoshiyuki; Tanaka, Takakazu			Development and operations of nano-satellite FITSAT-1 (NIWAKA)	ACTA ASTRONAUTICA			English	Article						CubeSat; High speed transmission; Flashing LEDs; FITSAT; NIWAKA; Optical communication		FITSAT-1 (NIWAKA) is a 10 cm(3) satellite that was deployed from the International Space Station (ISS) on October 5, 2012. It continued to operate until its orbit decayed on July 4, 2013. The main FITSAT-1 mission was to demonstrate a high speed transmitter module developed by our group (115.2 kbps, 5.84 GHz, FSK, 2W RF output). Each of the JPEG VGA image (640 x 480 pixels) taken at the time of deployment was received in 2-6 s. The second mission was to make the satellite twinkle as an "artificial star" using high-output LEDs and investigate the possibility of visible light communication between the satellite and the ground. This light from the satellite was photographed in many places. Our FITSAT team succeeded in acquiring the light signal using a photomultiplier attached to a telescope. Moreover, we discovered that the FITSAT-1 rotation speed gradually increased. (C) 2014 IAA. Published by Elsevier Ltd. All rights reserved.	[Tanaka, Takushi] Fukuoka Inst Technol, Dept Comp Sci & Engn, Higashi Ku, Fukuoka 8110295, Japan; [Kawamura, Yoshiyuki] Fukuoka Inst Technol, Dept Intelligent Mech Engn, Higashi Ku, Fukuoka 8110295, Japan; [Tanaka, Takakazu] Logical Prod Corp, Minami Ku, Fukuoka 8111314, Japan	Tanaka, T (reprint author), Fukuoka Inst Technol, Dept Comp Sci & Engn, Higashi Ku, 3-30-1 Wajiro Higashi, Fukuoka 8110295, Japan.						Kawamura Y, 2013, AIP ADV, V3, DOI 10.1063/1.4824853; Tanaka Takakazu, 2013, ULTRA SMALL SATELLIT, V22, P77; Tanaka T, 2013, PROCEEDINGS OF 6TH INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN SPACE TECHNOLOGIES (RAST 2013), P887	3	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	FEB-MAR	2015	107						112	129		10.1016/j.actaastro.2014.10.023		18	Engineering, Aerospace	Engineering	CA6XQ	WOS:000349061200010		
J	Dicaire, I; Nakamura, R; Arikawa, Y; Okada, K; Itahashi, T; Summerer, L				Dicaire, Isabelle; Nakamura, Ryoko; Arikawa, Yoshihisa; Okada, Kazuyuki; Itahashi, Takamasa; Summerer, Leopold			Space options for tropical cyclone hazard mitigation	ACTA ASTRONAUTICA			English	Article						Space systems; Remote sensing; Natural disaster prevention; Space solar power; Tropical cyclones; Hazard mitigation	INTENSITY; HURRICANES; LASER; AEROSOLS; SURFACE; FILAMENTATION; CONDENSATION; ENVIRONMENT; SIMULATION; RADIOMETER	This paper investigates potential space options for mitigating the impact of tropical cyclones on cities and civilians. Ground-based techniques combined with space-based remote sensing instrumentation are presented together with space-borne concepts employing space solar power technology. Two space-borne mitigation options are considered: atmospheric warming based on microwave irradiation and laser-induced cloud seeding based on laser power transfer. Finally technology roadmaps dedicated to the space-borne options are presented, including a detailed discussion on the technological viability and technology readiness level of our proposed systems. Based on these assessments, the space-borne cyclone mitigation options presented in this paper may be established in a quarter of a century. (C) 2014 IAA. Published by Elsevier Ltd. All rights reserved.	[Dicaire, Isabelle; Summerer, Leopold] ESA, Adv Concepts Team, Noordwijk, Netherlands; [Nakamura, Ryoko; Arikawa, Yoshihisa; Okada, Kazuyuki; Itahashi, Takamasa] Japan Aerosp Explorat Agcy JAXA, Tsukuba, Ibaraki, Japan	Dicaire, I (reprint author), ESA, Adv Concepts Team, Noordwijk, Netherlands.	isabelle.dicaire@esa.int		Summerer, Leopold/0000-0001-7742-5216	Florian Pantillon of the Karlsruher Institut fur Technologie (KIT); Fabrice Chauvin; Marie-Dominique Leroux from Meteo-France	The authors would like to thank Florian Pantillon of the Karlsruher Institut fur Technologie (KIT) and Fabrice Chauvin and Marie-Dominique Leroux from Meteo-France for their support and encouragement. Any opinions or conclusions expressed in this paper are those of the authors and do not necessarily reflect the views of their respective agencies.	Aida Y, 2013, PROC SPIE, V8889, DOI 10.1117/12.2029457; Alamaro M., 2006, J WEATHER MODIF, V38, P82; Delanoe J, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012346; ROSS DB, 1974, J GEOPHYS RES, V79, P444, DOI 10.1029/JC079i003p00444; Reul N, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007474; Wang Y, 2004, METEOROL ATMOS PHYS, V87, P257, DOI 10.1007/s00703-003-0055-6; Velden C, 2006, B AM METEOROL SOC, V87, P1195, DOI 10.1175/BAMS-87-9-1195; Frank WM, 2001, MON WEATHER REV, V129, P2249, DOI 10.1175/1520-0493(2001)129<2249:EOVWSO>2.0.CO;2; Wang Y, 2014, NAT CLIM CHANGE, V4, P368, DOI 10.1038/NCLIMATE2144; Rodriguez M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036607; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Imaoka K, 2010, P IEEE, V98, P717, DOI 10.1109/JPROC.2009.2036869; Uhlhorn EW, 2007, MON WEATHER REV, V135, P3070, DOI 10.1175/MWR3454.1; EMANUEL KA, 1986, J ATMOS SCI, V43, P585, DOI 10.1175/1520-0469(1986)043<0585:AASITF>2.0.CO;2; Couairon A, 2007, PHYS REP, V441, P47, DOI 10.1016/j.physrep.2006.12.005; Wille H, 2002, EUR PHYS J-APPL PHYS, V20, P183, DOI 10.1051/epjap:2002090; Mejean G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026611; Ju JJ, 2012, OPT LETT, V37, P1214, DOI 10.1364/OL.37.001214; Jacobson MZ, 2014, NAT CLIM CHANGE, V4, P195, DOI [10.1038/nclimate2120, 10.1038/NCLIMATE2120]; ISAACS JD, 1976, OCEAN ENG, V3, P175, DOI 10.1016/0029-8018(76)90022-6; Wood R, 2012, MON WEATHER REV, V140, P2373, DOI 10.1175/MWR-D-11-00121.1; Rosenfeld D, 2012, B AM METEOROL SOC, V93, P987, DOI 10.1175/BAMS-D-11-00147.1; Salter S, 2008, PHILOS T R SOC A, V366, P3989, DOI 10.1098/rsta.2008.0136; Miao Q, 2013, ADV ATMOS SCI, V30, P1025, DOI 10.1007/s00376-012-2128-2; DeMaria M, 1996, J ATMOS SCI, V53, P2076, DOI 10.1175/1520-0469(1996)053<2076:TEOVSO>2.0.CO;2; Tang BH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021072; Latham J, 2012, ATMOS SCI LETT, V13, P231, DOI 10.1002/asl.402; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Breed D., 2013, J APPL METEOROL CLIM, V53, P282; Cotton W.R., 2007, J WEATHER MODIFICAT, V39, P70; DVORAK VF, 1975, MON WEATHER REV, V103, P420, DOI 10.1175/1520-0493(1975)103<0420:TCIAAF>2.0.CO;2; Enz R., 2006, NATURAL CATASTROPHES; Henderson JM, 2005, Q J ROY METEOR SOC, V131, P3037, DOI 10.1256/qj.05.72; Henin S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1462; Hoffman RN, 2004, SCI AM, V291, P68; Hoffman R.N., 2002, B AM METEOROL SOC, V83; Horstmann J, 2013, OCEANOGRAPHY, V26, P46; Kasparian J, 2012, PHYS CHEM CHEM PHYS, V14, P9291, DOI 10.1039/c2cp23576e; Katzberg SJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026825; Katzberg SJ, 2013, RADIO SCI, V48, P371, DOI 10.1002/rds.20042; Kitamoto A., 2005, 4 INT S DIG EARTH; Kithil P.W., 2006, 27 C HURR TROP MET, p3B; Klima K, 2011, ENVIRON SCI TECHNOL, V45, P4242, DOI 10.1021/es104336u; Lotshaw W.T., 2011, 1 AER CORP; Maki K., 2013, 3 SMALL SCI SAT S JA, pP48; Mankins John C., 2011, SPACE SOLAR POWER 1; MONAHAN EC, 1986, INT J REMOTE SENS, V7, P627; Nakamura R., 2012, P 63 INT ASTR C NAPL, V12, P018; Partanen AI, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016428; Petrarca M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3646397; Rosenfeld D, 2007, ATMOS CHEM PHYS, V7, P3411; Ruf C., 2013, GEOSCI REMOTE SENS M, V1, P52; SFORZA PM, 1978, INT J HEAT MASS TRAN, V21, P371, DOI 10.1016/0017-9310(78)90070-4; Shen WX, 2000, J CLIMATE, V13, P109, DOI 10.1175/1520-0442(2000)013<0109:ASSOTT>2.0.CO;2; Sieron SB, 2013, GEOPHYS RES LETT, V40, P5332, DOI 10.1002/grl.50973; Strachan J, 2013, WEATHER, V68, P122, DOI 10.1002/wea.2096; Takayama Y., 2004, 06A0970665 I MET RES; White A, 2010, J ATMOS OCEAN TECH, V27, P385, DOI 10.1175/2009JTECHO679.1; WILLOUGHBY HE, 1985, B AM METEOROL SOC, V66, P505, DOI 10.1175/1520-0477(1985)066<0505:PSASC>2.0.CO;2	59	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	FEB-MAR	2015	107						208	217		10.1016/j.actaastro.2014.11.022		10	Engineering, Aerospace	Engineering	CA6XQ	WOS:000349061200017		
J	Matsui, T; Arima, Y; Takemoto, N; Lwata, H				Matsui, Toshiki; Arima, Yusuke; Takemoto, Naohiro; Iwata, Hiroo			Cell patterning on polylactic acid through surface-tethered oligonucleotides	ACTA BIOMATERIALIA			English	Article						Cell patterning; ssDNA-PEG-lipid; Polylactic acid; Surface modification	ADHESION; BIOMATERIALS; TRANSPLANTATION; RECONSTRUCTION; POLYMERS; CULTURE; TISSUES; SHEETS; DNA	Polylactic acid (PLA) is a candidate material to prepare scaffolds for 3-D tissue regeneration. However, cells do not adhere or proliferate well on the surface of PIA because it is hydrophobic. We report a simple and rapid method for inducing cell adhesion to PLA through DNA hybridization. Single-stranded DNA (ssDNA) conjugated to poly(ethylene glycol) (PEG) and to a terminal phospholipid (ssDNA-PEG-lipid) was used for cell surface modification. Through DNA hybridization, modified cells were able to attach to PLA surfaces modified with complementary sequence (ssDNA'). Different cell types can be attached to PLA fibers and films in a spatially controlled manner by using ssDNAs with different sequences. In addition, they proliferate well in a culture medium supplemented with fetal bovine serum. The coexisting modes of cell adhesion through DNA hybridization and natural cytoskeletal adhesion machinery revealed no serious effects on cell growth. The combination of a 3-D scaffold made of PLA and cell immobilization on the PLA scaffold through DNA hybridization will be useful for the preparation of 3-D tissue and organs. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Matsui, Toshiki; Arima, Yusuke; Takemoto, Naohiro; Iwata, Hiroo] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Lwata, H (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	iwata@frontier.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [2306]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Jacobs T, 2013, J MATER SCI-MATER M, V24, P469, DOI 10.1007/s10856-012-4807-z; Yamada K, 1997, J NEUROSURG, V86, P1012, DOI 10.3171/jns.1997.86.6.1012; Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035; Hsiao SC, 2009, LANGMUIR, V25, P6985, DOI 10.1021/la900150n; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631; Guillotin B, 2011, TRENDS BIOTECHNOL, V29, P183, DOI 10.1016/j.tibtech.2010.12.008; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Gobin AS, 2003, J BIOMED MATER RES A, V67A, P255, DOI 10.1002/jbm.a.10110; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Selden NS, 2012, J AM CHEM SOC, V134, P765, DOI 10.1021/ja2080949; Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024; Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001; JAMSHIDI K, 1988, POLYMER, V29, P2229, DOI 10.1016/0032-3861(88)90116-4; Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005; Sakurai K, 2011, BIOMATERIALS, V32, P3596, DOI 10.1016/j.biomaterials.2011.01.066; Hook AL, 2009, ACTA BIOMATER, V5, P2350, DOI 10.1016/j.actbio.2009.03.040; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762; Chandra RA, 2006, ANGEW CHEM INT EDIT, V45, P896, DOI 10.1002/ANIE.200502421; Delaittre C, SOFT MATTER; HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568; Itagaki T, J ROYAL SOC IN UNPUB; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Sakurai K, 2013, BIOMATERIALS, V34, P361, DOI 10.1016/j.biomaterials.2012.09.080; Teramura Y, 2008, BIOMATERIALS, V29, P1346; Treiser M, 2013, BIOMATERIALS SCI, P179, DOI 10.1016/B978-0-08-087780-8.00021-8.	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	FEB	2015	13						32	41		10.1016/j.actbio.2014.11.011		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA2QZ	WOS:000348753700003		
J	Kakinoki, S; Seo, JH; Inoue, Y; Ishihara, K; Yui, N; Yamaoka, T				Kakinoki, Sachiro; Seo, Ji-Hun; Inoue, Yuuki; Ishihara, Kazuhiko; Yui, Nobuhiko; Yamaoka, Tetsuji			Mobility of the Arg-Gly-Asp ligand on the outermost surface of biomaterials suppresses integrin-mediated mechanotransduction and subsequent cell functions	ACTA BIOMATERIALIA			English	Article						Molecular mobility; Polyrotaxane; RGDS; Cell adhesion; Cell differentiation	NERVE GROWTH-FACTOR; EXTRACELLULAR-MATRIX; NEURITE OUTGROWTH; FOCAL ADHESION; PC12 CELLS; PHOSPHOLIPID POLYMERS; MOLECULAR MOBILITY; PROTEIN ADSORPTION; SUBSTRATE RIGIDITY; ENDOTHELIAL-CELLS	Mechanotransduction in the regulation of cellular responses has been previously studied using elastic hydrogels. Because cells interact only with the surface of biomaterials, we are focusing on the molecular mobility at the outermost surface of biomaterials. In this study, surfaces with the mobile Arg-Gly-Asp-Ser (RGDS) peptide have been constructed. Cell culture substrates were coated with ABA-type block copolymers composed of poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) segments (A) and a polyrotaxane (PRX) unit with RGDS bound to cc-cyclodextrin (B). Adhesion, morphological changes and actin filament formation of human umbilical vein endothelial cells were reduced on the surfaces containing mobile PRX-RGDS in comparison to the immobile RGDS surfaces constructed from random copolymers with RGDS side groups (Prop-andom-RGDS). In the neurite outgrowth assay using rat adrenal pheochromocytoma cells (PC12), only similar to 20% of adherent PC12 cells had neurites on PRX-RGDS surfaces, but more than 50% did on the Random-RGDS surface. The beating colony of dimethyl-sulfoxide-treated mouse embryonic carcinoma cells (P19CL6) were found 10 and 14 days after induction on PRX-RGDS and Random-RGDS surfaces, respectively. After 22 days, the beating colony disappeared on PRX-RGDS surfaces, but many colonies remained on Random-RGDS surfaces. These data suggest that the molecular mobility of the cell-binding ligand on the outermost surface of materials effectively suppresses the actin filament formation and differentiation of these functional cell lines, and may be used as a culture substrate for immature stem cells or progenitor cells. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Kakinoki, Sachiro; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan; [Seo, Ji-Hun; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; [Inoue, Yuuki; Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kakinoki, Sachiro; Seo, Ji-Hun; Inoue, Yuuki; Ishihara, Kazuhiko; Yui, Nobuhiko; Yamaoka, Tetsuji] JST CREST, Chiyoda Ku, Tokyo 1020076, Japan	Yamaoka, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	yamtet@ncvc.go.jp					Andreasson-Ochsner M, 2011, LAB CHIP, V11, P2876, DOI 10.1039/c1lc20067d; Seo JH, 2012, SOFT MATTER, V8, P5477, DOI 10.1039/c2sm25318f; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Seo JH, 2013, BIOMATERIALS, V34, P3206, DOI 10.1016/j.biomaterials.2013.01.080; Seo JH, 2013, BIOMATERIALS, V34, P55, DOI 10.1016/j.biomaterials.2012.09.063; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Ivaska J, 2012, NAT CELL BIOL, V14, P981, DOI 10.1038/ncb2592; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/nmat2732, 10.1038/NMAT2732]; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Cha C, 2012, ACS NANO, V6, P9353, DOI 10.1021/nn304773b; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; DAVIES PF, 1993, CIRC RES, V72, P239; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Ooya T, 2003, J AM CHEM SOC, V125, P13016, DOI 10.1021/ja034583z; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Seo JH, 2013, J AM CHEM SOC, V135, P5513, DOI 10.1021/ja400817q; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Miskon A, 2009, J ARTIF ORGANS, V12, P111, DOI 10.1007/s10047-009-0449-4; Raymond K, 2011, EMBO J, V30, P1896, DOI 10.1038/emboj.2011.113; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101; ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Collins T. J., 2007, BIOTECHNIQUES, V43, pS25, DOI DOI 10.2144/000112517; Fathi F, 2009, INT J CARDIOL, V134, P75, DOI 10.1016/j.ijcard.2008.01.046; FIELDS C G, 1991, Peptide Research, V4, P95; Hyden MAG, 2003, CARDIOVASC RES, V58, P292; Inoue Y, 2012, COLLOID SURFACE B, V89, P223, DOI 10.1016/j.colsurfb.2011.09.020; Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998; Jianping F, 2010, NAT METHODS, V7, P733; Juin A, 2013, BIOL CELL, V105, P46, DOI 10.1111/boc.201200037; Kakinoki S, 2013, J BIOMAT SCI-POLYM E, V24, P1320, DOI 10.1080/09205063.2012.757726; Kakinoki S, 2012, J BIOMATER APPL, V28, P544; Lee JH, 2012, ACTA BIOMATER, V8, P165, DOI 10.1016/j.actbio.2011.08.024; Levental I., 2006, SOFT MATTER, V2, P1; lshihara K, 1991, J BIOMED MATER RES A, V25, P1397; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Tsai J, 2010, CELL MOL BIOENG, V3, P84, DOI 10.1007/s12195-010-0104-4; Walowitz JL, 1999, J NEUROSCI RES, V57, P847, DOI 10.1002/(SICI)1097-4547(19990915)57:6<847::AID-JNR10>3.3.CO;2-M	64	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	FEB	2015	13						42	51		10.1016/j.actbio.2014.11.020		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA2QZ	WOS:000348753700004		
J	Kawamura, T; Kobayashi, T; Watanabe, N				Kawamura, Takashi; Kobayashi, Tomoki; Watanabe, Nobuhisa			Analysis of the HindIII-catalyzed reaction by time-resolved crystallography	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article							RESTRICTION-ENDONUCLEASE-HINDIII; KINETIC-ANALYSIS; DNA CLEAVAGE; SITES; MECHANISM; DATABASE; COMPLEX; ENZYMES; BINDING; IONS	In order to investigate the mechanism of the reaction catalyzed by HindIII, structures of HindIII-DNA complexes with varying durations of soaking time in cryoprotectant buffer containing manganese ions were determined by the freeze-trap method. In the crystal structures of the complexes obtained after soaking for a longer duration, two manganese ions, indicated by relatively higher electron density, are clearly observed at the two metal ion-binding sites in the active site of HindIII. The increase in the electron density of the two metalion peaks followed distinct pathways with increasing soaking times, suggesting variation in the binding rate constant for the two metal sites. DNA cleavage is observed when the second manganese ion appears, suggesting that HindIII uses the two-metal-ion mechanism, or alternatively that its reactivity is enhanced by the binding of the second metal ion. In addition, conformational change in a loop near the active site accompanies the catalytic reaction.	[Kawamura, Takashi; Watanabe, Nobuhisa] Nagoya Univ, Synchrotron Radiat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kobayashi, Tomoki; Watanabe, Nobuhisa] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Watanabe, N (reprint author), Nagoya Univ, Synchrotron Radiat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	nobuhisa@nagoya-u.jp			JSPS KAKENHI [22370036]	We thank the beamline staff at the Photon Factory for their assistance in the synchrotron experiments. This study was supported by JSPS KAKENHI Grant No. 22370036.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Deibert M, 2000, NAT STRUCT BIOL, V7, P792, DOI 10.1038/79032; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Lukacs CM, 2000, NAT STRUCT BIOL, V7, P134; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Watanabe N, 2009, ACTA CRYSTALLOGR D, V65, P1326, DOI 10.1107/S0907444909041134; Tang DH, 2000, PROTEIN ENG, V13, P283, DOI 10.1093/protein/13.4.283; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; Geremia S, 2006, STRUCTURE, V14, P393, DOI 10.1016/j.str.2005.12.007; Horton JR, 2000, J MOL BIOL, V300, P1049, DOI 10.1006/jmbi.2000.3938; Horton NC, 2004, BIOCHEMISTRY-US, V43, P6841, DOI 10.1021/bi0499056; Lambert AR, 2008, STRUCTURE, V16, P558, DOI 10.1016/j.str.2008.01.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pingoud V, 2009, J MOL BIOL, V393, P140, DOI 10.1016/j.jmb.2009.08.011; Prasannan CB, 2010, J BIOL INORG CHEM, V15, P533, DOI 10.1007/s00775-010-0621-6; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; Xie FQ, 2008, BIOCHEMISTRY-US, V47, P12540, DOI 10.1021/bi801027k	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	FEB	2015	71		2				256	265		10.1107/S1399004714025188		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CB2EQ	WOS:000349439900007		
J	Shrestha, R; Zhang, KYJ				Shrestha, Rojan; Zhang, Kam Y. J.			A fragmentation and reassembly method for ab initio phasing	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article							PROTEIN-STRUCTURE PREDICTION; NOVO STRUCTURE PREDICTION; MOLECULAR-REPLACEMENT; CRYSTAL-STRUCTURES; TRUNCATE APPROACH; NMR STRUCTURES; MODELS; RESOLUTION; ROSETTA; PHASER	Ab initio phasing with de novo models has become a viable approach for structural solution from protein crystallographic diffraction data. This approach takes advantage of the known protein sequence information, predicts de novo models and uses them for structure determination by molecular replacement. However, even the current state-of-the-art de novo modelling method has a limit as to the accuracy of the model predicted, which is sometimes insufficient to be used as a template for successful molecular replacement. A fragment-assembly phasing method has been developed that starts from an ensemble of low-accuracy de novo models, disassembles them into fragments, places them independently in the crystallographic unit cell by molecular replacement and then reassembles them into a whole structure that can provide sufficient phase information to enable complete structure determination by automated model building. Tests on ten protein targets showed that the method could solve structures for eight of these targets, although the predicted de novo models cannot be used as templates for successful molecular replacement since the best model for each target is on average more than 4.0 angstrom away from the native structure. The method has extended the applicability of the ab initio phasing by de novo models approach. The method can be used to solve structures when the best de novo models are still of low accuracy.	[Shrestha, Rojan; Zhang, Kam Y. J.] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Struct Bioinformat Team, Yokohama, Kanagawa 2300045, Japan; [Shrestha, Rojan; Zhang, Kam Y. J.] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan	Zhang, KYJ (reprint author), RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Struct Bioinformat Team, Yokohama, Kanagawa 2300045, Japan.	kamzhang@riken.jp	Zhang, Kam/B-3552-2012	Zhang, Kam/0000-0002-9282-8045	International Program Associate (IPA) program of RIKEN	We would like to thank the Advanced Center for Computing and Communication, RIKEN, Japan for the computing resources of the RIKEN Integrated Cluster of Clusters (RICC) system. We are grateful to Dr Kevin Cowtan for his advice on the Clipper library. RS is supported by the International Program Associate (IPA) program of RIKEN.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Abergel C, 2013, ACTA CRYSTALLOGR D, V69, P2167, DOI 10.1107/S0907444913015291; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/nmeth.1365, 10.1038/NMETH.1365]; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Berenger F, 2011, BIOINFORMATICS, V27, P939, DOI 10.1093/bioinformatics/btr072; Bibby J, 2012, ACTA CRYSTALLOGR D, V68, P1622, DOI 10.1107/S0907444912039194; Bibby J, 2013, ACTA CRYSTALLOGR D, V69, P2194, DOI 10.1107/S0907444913018453; Chen YW, 2000, STRUCTURE, V8, pR213, DOI 10.1016/S0969-2126(00)00524-4; Das R, 2009, ACTA CRYSTALLOGR D, V65, P169, DOI 10.1107/S0907444908020039; Mao BC, 2011, STRUCTURE, V19, P757, DOI 10.1016/j.str.2011.04.005; Mccoy AJ, 2013, ACTA CRYSTALLOGR D, V69, P2216, DOI 10.1107/S0907444913021811; Propper K, 2014, ACTA CRYSTALLOGR D, V70, P1743, DOI 10.1107/S1399004714007603; Rigden DJ, 2008, ACTA CRYSTALLOGR D, V64, P1288, DOI 10.1107/S0907444908033192; Sammito M, 2014, FEBS J, V281, P4029, DOI 10.1111/febs.12897; Sammito M, 2013, NAT METHODS, V10, P1099, DOI [10.1038/nmeth.2644, 10.1038/NMETH.2644]; Shrestha R, 2011, ACTA CRYSTALLOGR D, V67, P804, DOI 10.1107/S090744491102779X; Shrestha R, 2012, ACTA CRYSTALLOGR D, V68, P1522, DOI 10.1107/S0907444912037961; Shrestha R, 2014, PROTEINS, V82, P2240, DOI 10.1002/prot.24587; Simoncini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038799	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	FEB	2015	71		2				304	312		10.1107/S1399004714025449		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CB2EQ	WOS:000349439900012		
J	Leysen, S; Van Herreweghe, JM; Yoneda, K; Ogata, M; Usui, T; Araki, T; Michiels, CW; Strelkov, SV				Leysen, Seppe; Van Herreweghe, Joris M.; Yoneda, Kazunari; Ogata, Makoto; Usui, Taichi; Araki, Tomohiro; Michiels, Christiaan W.; Strelkov, Sergei V.			The structure of the proteinaceous inhibitor PliI from Aeromonas hydrophila in complex with its target lysozyme	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article							GRAM-NEGATIVE BACTERIA; CLAM MERETRIX-LUSORIA; DATA QUALITY; SYSTEM; FAMILY; MODEL	Recent microbiological data have revealed that Gram-negative bacteria are able to protect themselves against the lytic action of host lysozymes by secreting proteinaceous inhibitors. Four distinct classes of such inhibitors have been discovered that specifically act against c-type, g-type and i-type lysozymes. Here, the 1.24 angstrom resolution crystal structure of the periplasmic i-type lysozyme inhibitor from Aeromonas hydrophila (PliI-Ah) in complex with the i-type lysozyme from Meretrix lusoria is reported. The structure is the first to explain the inhibitory mechanism of the PliI family at the atomic level. A distinct 'ridge' formed by three exposed PliI loops inserts into the substrate-binding groove of the lysozyme, resulting in a complementary 'key-lock' interface. The interface is principally stabilized by the interactions made by the PliI-Ah residues Ser104 and Tyr107 belonging to the conserved SGxY motif, as well as by the other conserved residues Ser46 and Asp76. The functional importance of these residues is confirmed by inhibition assays with the corresponding point mutants of PliI-Ah. The accumulated structural data on lysozyme-inhibitor complexes from several classes indicate that in all cases an extensive interface of either a single or a double 'key-lock' type is formed, resulting in highly efficient inhibition. These data provide a basis for the rational development of a new class of antibacterial drugs.	[Leysen, Seppe; Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, B-3000 Leuven, Belgium; [Van Herreweghe, Joris M.; Michiels, Christiaan W.] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr, Lab Food Microbiol, B-3000 Leuven, Belgium; [Yoneda, Kazunari; Araki, Tomohiro] Tokai Univ, Sch Agr, Dept Biosci, Minamiaso, Kumamoto 8691404, Japan; [Ogata, Makoto] Fukushima Natl Coll Technol, Dept Chem & Biochem, Iwaki, Fukushima 9708034, Japan; [Usui, Taichi] Shizuoka Univ, Grad Sch Sci & Technol, Dept Biosci, Shizuoka 4228529, Japan	Strelkov, SV (reprint author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, B-3000 Leuven, Belgium.	sergei.strelkov@pharm.kuleuven.be			BiostructX project [6131]; KU Leuven; Research Foundation-Flanders (FWO); FWO [G.0363.08]; KU Leuven [METH/07/03]	Access to the PROXIMA1 beamline at Synchrotron SOLEIL (France), supported by the BiostructX project 6131, and especially the help of Dr Andrew Thompson is gratefully acknowledged. We also thank Dr Stephen Weeks for feedback on the manuscript. SL received a doctoral fellowship from KU Leuven. JMVH held a doctoral fellowship of the Research Foundation-Flanders (FWO). This work was further supported by grants G.0363.08 from the FWO and METH/07/03 from KU Leuven.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Leysen S, 2011, J MOL BIOL, V405, P1233, DOI 10.1016/j.jmb.2010.12.007; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Yum S, 2009, BIOCHEM BIOPH RES CO, V378, P244, DOI 10.1016/j.bbrc.2008.11.039; Callewaert L, 2012, TRENDS MICROBIOL, V20, P501, DOI 10.1016/j.tim.2012.06.005; Leysen S, 2012, J STRUCT BIOL, V180, P235, DOI 10.1016/j.jsb.2012.05.006; Voet A, 2011, BIOCHEM BIOPH RES CO, V405, P527, DOI 10.1016/j.bbrc.2011.01.053; Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Vanderkelen L, 2011, CELL MOL LIFE SCI, V68, P1053, DOI 10.1007/s00018-010-0507-3; Leysen S, 2013, CELL MOL LIFE SCI, V70, P1113, DOI 10.1007/s00018-012-1184-1; Um SH, 2013, BIOCHEMISTRY-US, V52, P9385, DOI 10.1021/bi401241c; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Van Herreweghe JM, 2012, J BIOSCIENCES, V37, P327, DOI 10.1007/s12038-012-9201-y; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Kuwano Y, 2013, BIOSCI BIOTECH BIOCH, V77, P2269, DOI 10.1271/bbb.130534; Kuwano Y, 2013, ACTA CRYSTALLOGR F, V69, P1202, DOI 10.1107/S1744309113028170; Novotny M, 2007, ACTA CRYSTALLOGR D, V63, P270, DOI 10.1107/S0907444906044118; Vanderkelen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045954; Van Herreweghe JM, 2010, CELL MOL LIFE SCI, V67, P1177, DOI 10.1007/s00018-009-0241-x	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	FEB	2015	71		2				344	351		10.1107/S1399004714025863		8	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CB2EQ	WOS:000349439900017		
J	Morita, K; Kim, BN; Yoshida, H; Hiraga, K; Sakka, Y				Morita, Koji; Kim, Byung-Nam; Yoshida, Hidehiro; Hiraga, Keijiro; Sakka, Yoshio			Spectroscopic study of the discoloration of transparent MgAl2O4 spinel fabricated by spark-plasma-sintering (SPS) processing	ACTA MATERIALIA			English	Article						Spark plasma sintering (SPS); Densification; Optical transmission; Ceramic material; Spinels	MAGNESIUM-ALUMINATE SPINEL; YTTRIA-STABILIZED-ZIRCONIA; MGO SINGLE-CRYSTALS; OPTICAL-ABSORPTION; RAMAN-SPECTRA; DEFECT CENTERS; PRESSURE; MICROSTRUCTURE; DENSIFICATION; DEFORMATION	Discoloration of spark-plasma-sintered spinel was investigated by spectroscopic techniques and transmission electron microscopy. The discoloration is explained by the combination of carbon contaminations and lattice defects (color centers), which are introduced in the spinel matrix depending on the spark-plasma-sintering conditions. For low heating rates of <= 10 degrees C min(-1), the trace carbonate CO3 pre-existing in the starting powder remained as glassy carbon within the matrix, irrespective of the sintering temperature. For a high heating rate of >= 50 degrees C min(-1), additional carbon contamination occurred by evaporating the carbon phases from the carbon papers and graphite dies during the heating process, and tended to be enhanced by the increasing heating rate. The present data indicate that the color center (F+-center) may be generated by the formation of oxygen vacancies, which are mainly introduced by dislocation motion depending on the sintering conditions. Since the rate of sintering, namely the deformation rate, increased with the heating rate, the concentration of the dislocation-related color centers increased with the heating rate, but decreased with the sintering temperature due to the bleaching of the oxygen vacancies. For the present spinel, the discoloration due to the carbon contamination and the formation of F+-centers deteriorates the light transmission, depending on the sintering conditions. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Morita, Koji; Kim, Byung-Nam; Yoshida, Hidehiro; Hiraga, Keijiro; Sakka, Yoshio] Natl Inst Mat Sci, Nanoceram Ctr, Tsukuba, Ibaraki 3050047, Japan; [Hiraga, Keijiro] Kitami Inst Technol, Kitami, Hokkaido 0908507, Japan	Morita, K (reprint author), Natl Inst Mat Sci, Nanoceram Ctr, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	MORITA.Koji@nims.go.jp			Amada Foundation [AF-2008016]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22560675, 21360328]	This study was financially supported by the Amada Foundation (AF-2008016) and a Grant-in-Aid for Scientific Research ((C)22560675 and (B)21360328) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	An LQ, 2012, J EUR CERAM SOC, V32, P1035, DOI 10.1016/j.jeurceramsoc.2011.11.023; Grasso S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/5/053001; Morita K, 2009, J MATER RES, V24, P2863, DOI 10.1557/JMR.2009.0335; Gunasekaran S, 2006, J RAMAN SPECTROSC, V37, P892, DOI 10.1002/jrs.1518; Wang SF, 2013, PROG SOLID STATE CH, V41, P20, DOI 10.1016/j.progsolidstchem.2012.12.002; Chaim R, 2004, J MATER RES, V19, P2527, DOI 10.1557/JMR.2004.0334; Ganesh I, 2013, INT MATER REV, V58, P63, DOI 10.1179/1743280412Y.0000000001; Lazzeri M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.140301; Tewell CR, 2002, J PHYS CHEM B, V106, P2946, DOI 10.1021/jp012840l; Krell A, 2009, OPT MATER, V31, P1144, DOI 10.1016/j.optmat.2008.12.009; Frage N, 2010, J EUR CERAM SOC, V30, P3331, DOI 10.1016/j.jeurceramsoc.2010.08.006; Kim BN, 2010, J AM CERAM SOC, V93, P2158, DOI 10.1111/j.1551-2916.2010.03699.x; Meir S, 2009, J AM CERAM SOC, V92, P358, DOI 10.1111/j.1551-2916.2008.02893.x; Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Dericioglu AF, 2003, J EUR CERAM SOC, V23, P951, DOI 10.1016/S0955-2219(02)00205-4; Frost RL, 2008, J RAMAN SPECTROSC, V39, P374, DOI 10.1002/jrs.1829; Orru R, 2009, MAT SCI ENG R, V63, P127, DOI 10.1016/j.mser.2008.09.003; Lallemant L, 2012, J EUR CERAM SOC, V32, P2909, DOI 10.1016/j.jeurceramsoc.2012.02.041; Morita K, 2008, SCRIPTA MATER, V58, P1114, DOI 10.1016/j.scriptamat.2008.02.008; Bonnefont G, 2012, CERAM INT, V38, P131, DOI 10.1016/j.ceramint.2011.06.045; Palmer SJ, 2008, J RAMAN SPECTROSC, V39, P395, DOI 10.1002/jrs.1838; du Merac MR, 2013, J AM CERAM SOC, V96, P3341, DOI 10.1111/jace.12637; Reimanis I, 2009, J AM CERAM SOC, V92, P1472, DOI 10.1111/j.1551-2916.2009.03108.x; Casolco SR, 2008, SCRIPTA MATER, V58, P516, DOI 10.1016/j.scriptamat.2007.11.014; Alaniz JE, 2009, OPT MATER, V32, P62, DOI 10.1016/j.optmat.2009.06.004; Spina G, 2012, J EUR CERAM SOC, V32, P2957, DOI 10.1016/j.jeurceramsoc.2012.02.052; HOWARD WF, 1975, INORG CHEM, V14, P767, DOI 10.1021/ic50146a013; Raja EA, 2009, J LUMIN, V129, P829, DOI 10.1016/j.jlumin.2009.03.001; Jiang D, 2008, J AM CERAM SOC, V91, P151, DOI 10.1111/j.1551-2916.2007.02086.x; Sepelak V, 2006, SOLID STATE IONICS, V177, P2487, DOI 10.1016/j.ssi.2006.04.014; Kim BN, 2007, SCRIPTA MATER, V57, P607, DOI 10.1016/j.scriptamat.2007.06.009; Botha A, 2003, J THERM ANAL CALORIM, V71, P987, DOI 10.1023/A:1023355016208; Bernard-Granger G, 2009, SCRIPTA MATER, V60, P164, DOI 10.1016/j.scriptamat.2008.09.027; Krell A, 2009, J EUR CERAM SOC, V29, P275, DOI 10.1016/j.jeurceramsoc.2008.03.024; Burrueco MI, 2013, J MOL STRUCT, V1034, P38, DOI 10.1016/j.molstruc.2012.09.006; Morita K, 2009, J AM CERAM SOC, V92, P1208, DOI 10.1111/j.1551-2916.2009.03074.x; Kim BN, 2009, J EUR CERAM SOC, V29, P323, DOI 10.1016/j.jeurceramsoc.2008.03.015; Goldstein A, 2013, J AM CERAM SOC, V96, P3523, DOI 10.1111/jace.12525; KROGER FA, 1956, SOLID STATE PHYS, V3, P307; IBARRA A, 1991, PHYS REV B, V44, P7256, DOI 10.1103/PhysRevB.44.7256; Krell A, 2010, J AM CERAM SOC, V93, P2656, DOI 10.1111/j.1551-2916.2010.03814.x; Morita K, 2010, SCRIPTA MATER, V63, P565, DOI 10.1016/j.scriptamat.2010.06.012; Zhang HB, 2011, J AM CERAM SOC, V94, P2739, DOI 10.1111/j.1551-2916.2011.04680.x; Wang C, 2009, SCRIPTA MATER, V61, P193, DOI 10.1016/j.scriptamat.2009.03.039; OHORO MP, 1973, J PHYS CHEM SOLIDS, V34, P23, DOI 10.1016/0022-3697(73)90058-9; Anselmi-Tamburini U, 2007, ADV FUNCT MATER, V17, P3267, DOI 10.1002/adfm.200600959; Ball JA, 2008, SOLID STATE SCI, V10, P717, DOI 10.1016/j.solidstatesciences.2007.04.005; Bertrand A., 2013, J AM CERAM SOC, V97, P163; CAIN LS, 1988, PHYS REV B, V37, P2645, DOI 10.1103/PhysRevB.37.2645; CAPWELL RJ, 1972, CHEM PHYS LETT, V12, P443, DOI 10.1016/0009-2614(72)90002-4; Frage N, 2007, J MATER SCI, V42, P3273, DOI 10.1007/s10853-007-1672-0; Ibarra A, 2005, J NUCL MATER, V336, P156, DOI 10.1016/j.jnucmat.2004.09.003; Kanzaki S., 1978, J JPN CERAM SOC, V86, P485; Kim BN, 2009, ACTA MATER, V57, P1319, DOI 10.1016/j.actamat.2008.11.010; Kim BN, 2010, ACTA MATER, V58, P4527, DOI 10.1016/j.actamat.2010.04.049; Kim BN, 2014, SCRIPTA MATER, V80, P29, DOI 10.1016/j.scriptamat.2014.02.015; Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y; Mitchell TE, 1999, J AM CERAM SOC, V82, P3305; Morita K., J AM CERAM IN PRESS; NEWTON RD, 1977, PHYS STATUS SOLIDI A, V41, P569; Olhero SM, 2008, LANGMUIR, V24, P9525, DOI 10.1021/la801300m; Omori M, 2000, MAT SCI ENG A-STRUCT, V287, P183, DOI 10.1016/S0921-5093(00)00773-5; Osada M., 2007, TANSO, V228, P174; Roussel N, 2013, J AM CERAM SOC, V96, P1039, DOI 10.1111/jace.12255; Sainz MA, 2004, MATER CHEM PHYS, V86, P399, DOI 10.1016/j.matchemphys.2004.04.007; Sano H, 2002, SURF SCI, V502, P70, DOI 10.1016/S0039-6028(01)01900-8; Savoini B, 1998, PHYS REV B, V57, P13439, DOI 10.1103/PhysRevB.57.13439; Sawai S, 2012, J APPL PHYS, V112, DOI 10.1063/1.4767228; SIBLEY WA, 1969, PHYS STATUS SOLIDI, V31, P223, DOI 10.1002/pssb.19690310126; Singh V, 2012, APPL PHYS B-LASERS O, V108, P437, DOI 10.1007/s00340-012-4970-4; Ting CJ, 1999, J AM CERAM SOC, V82, P841; TURNER TJ, 1973, PHYS STATUS SOLIDI B, V58, P843, DOI 10.1002/pssb.2220580247; VEYSSIERE P, 1988, PHIL MAG LETT, V57, P211, DOI 10.1080/09500838808214710; WHITE GS, 1979, APPL PHYS LETT, V35, P1, DOI 10.1063/1.90916; Yoshida H., 2001, J AM CERAM SOC, V94, P3301; Zhang HB, 2011, J AM CERAM SOC, V94, P3206, DOI 10.1111/j.1551-2916.2011.04789.x; Zhang HB, 2011, J AM CERAM SOC, V94, P2981, DOI 10.1111/j.1551-2916.2011.04477.x; Zhang HB, 2010, J ALLOY COMPD, V508, P196, DOI 10.1016/j.jallcom.2010.08.045	78	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						9	19		10.1016/j.actamat.2014.10.030		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300002		
J	Tane, M; Mayama, T; Oda, A; Nakajima, H				Tane, M.; Mayama, T.; Oda, A.; Nakajima, H.			Effect of crystallographic texture on mechanical properties in porous magnesium with oriented cylindrical pores	ACTA MATERIALIA			English	Article						Porous material; Magnesium; Crystal plasticity; Finite-element modeling (FEM); Crystallographic texture	PLATEAU STRESS REGION; ALUMINUM-ALLOY FOAMS; COMPRESSIVE DEFORMATION; ELASTIC-CONSTANTS; DIRECTIONAL PORES; RATE DEPENDENCE; NONBASAL SLIP; CARBON-STEEL; BEHAVIOR; METALS	The tensile and compressive deformation in porous Mg with unidirectionally oriented cylindrical pores and a unique fiber texture in which the normal direction of the {10 $(1) over bar $3} plane was preferentially oriented was studied. Porous Mg specimens with unidirectional pores and texture were prepared by unidirectional solidification in a hydrogen atmosphere using a continuous-casting technique and their quasi-static tensile deformation and quasi-static and dynamic compressions were investigated. In tensile loading parallel to the orientation direction of the pores (the "pore direction"), the porous Mg exhibited a large tensile elongation of similar to 60% strain despite the presence of, similar to 42% porosity, whereas it showed high energy absorption of similar to 30 kJ kg(-1) along the same direction. To clarify these superior mechanical properties, the underlying operative deformation modes and rotation of crystallographic orientation during loadings were analyzed by X-ray pole figures, optical microscopy and crystal plasticity finiteelement modeling. The analyses revealed that in the initial stage of both the compression and tensile loadings along the pore direction, basal slip mainly operated. Importantly, the activity of basal slip was enhanced during the tensile loading by rotation of the crystallographic orientation, which resulted in high tensile elongation. On the other hand, the activation of basal slip was initially suppressed by the crystal rotation during compression. However, the localization of basal slip originating from the elongated grains with the unique texture subsequently enhanced the activity of basal slip, which suppressed the steep increase in the flow stress. This unique localized deformation gave rise to the superior impact energy absorption. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Tane, M.; Oda, A.; Nakajima, H.] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Mayama, T.] Kumamoto Univ, Prior Org Innovat & Excellence, Chuo Ku, Kumamoto 8608555, Japan	Tane, M (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	mtane@sanken.osaka-u.ac.jp	Tane, Masakazu/D-2772-2011	Tane, Masakazu/0000-0002-1478-6820	JSPS KAKENHI [24109505, 26109713, 26709053]; Light Metal Educational Foundation; Cooperative Research Program of "Network Joint Research Center for Materials and Devices"	This work was supported by JSPS KAKENHI Grant Nos. 24109505, 26109713 and 26709053 and a research grant from the Light Metal Educational Foundation. This work was also supported by the Cooperative Research Program of "Network Joint Research Center for Materials and Devices"). Analyses by XRD and X-ray pole figure were performed at the Comprehensive Analysis Center, ISIR, Osaka University. The authors would like to thank Dr. T. Ide of Osaka University for the preparation of nonporous and porous Mg ingots.	Tuncer N, 2009, J MATER SCI, V44, P1477, DOI 10.1007/s10853-008-3167-z; Bart-Smith H, 1998, ACTA MATER, V46, P3583, DOI 10.1016/S1359-6454(98)00025-1; Xu ZG, 2012, MATER DESIGN, V34, P40, DOI 10.1016/j.matdes.2011.07.066; PEIRCE D, 1983, ACTA METALL MATER, V31, P1951, DOI 10.1016/0001-6160(83)90014-7; Meyers MA, 2001, ACTA MATER, V49, P4025, DOI 10.1016/S1359-6454(01)00300-7; Yang DH, 2010, MAT SCI ENG A-STRUCT, V527, P5405, DOI 10.1016/j.msea.2010.05.017; Sugimura Y, 1997, ACTA MATER, V45, P5245, DOI 10.1016/S1359-6454(97)00148-1; [Anonymous], 2011, COMP MATER SCI; SHAPOVALOV V, 1994, MRS BULL, V19, P24; Mayama T, 2011, INT J PLASTICITY, V27, P1916, DOI 10.1016/j.ijplas.2011.02.007; Amsterdam E, 2008, ACTA MATER, V56, P609, DOI 10.1016/j.actamat.2007.10.034; EROS S, 1961, ACTA METALL MATER, V9, P14, DOI 10.1016/0001-6160(61)90033-5; Zhang J, 2012, J MECH PHYS SOLIDS, V60, P945, DOI 10.1016/j.jmps.2012.01.005; Ramamurty U, 2004, ACTA MATER, V52, P869, DOI 10.1016/j.actamat.2003.10.021; San Marchi C, 2004, ACTA MATER, V52, P2895, DOI 10.1016/j.actamat.2004.02.035; Song YH, 2012, ACTA MATER, V60, P1149, DOI 10.1016/j.actamat.2011.11.001; McCullough KYG, 1999, ACTA MATER, V47, P2323, DOI 10.1016/S1359-6454(99)00128-7; Tane M, 2004, J APPL PHYS, V96, P3696, DOI 10.1063/1.1776316; HUTCHINSON JW, 1976, PROC R SOC LON SER-A, V348, P101, DOI 10.1098/rspa.1976.0027; Stanford N, 2010, METALL MATER TRANS A, V41A, P734, DOI 10.1007/s11661-009-0107-8; Deshpande VS, 2000, INT J IMPACT ENG, V24, P277, DOI 10.1016/S0734-743X(99)00153-0; Nakajima H, 2007, PROG MATER SCI, V52, P1091, DOI 10.1016/j.pmatsci.2006.09.001; Tane M, 2010, J MATER RES, V25, P1179, DOI 10.1557/JMR.2010.0147; Markaki AE, 2001, ACTA MATER, V49, P1677, DOI 10.1016/S1359-6454(01)00072-6; Korner C, 2004, ADV ENG MATER, V6, P385, DOI [10.1002/adem.200405147, 10.1002/adem.2004.05147]; Agnew SR, 2005, ACTA MATER, V53, P3135, DOI 10.1016/j.actamat.2005.02.019; Kanahashi H, 2001, MAT SCI ENG A-STRUCT, V308, P283, DOI 10.1016/S0921-5093(01)01199-6; [Anonymous], 1957, INT J PLASTICITY; Park JS, 2007, ACTA MATER, V55, P5646, DOI 10.1016/j.actamat.2007.06.022; Li JC, 2011, ACTA MATER, V59, P146, DOI 10.1016/j.actamat.2010.09.019; Seki H, 2007, J MATER RES, V22, P3120, DOI 10.1557/JMR.2007.0385; [Anonymous], 2004, J JPN I LIGHT MET, DOI 10.2464/jilm.54.388; Andrews E, 1999, MAT SCI ENG A-STRUCT, V270, P113, DOI 10.1016/S0921-5093(99)00170-7; Mayama T, 2009, COMP MATER SCI, V47, P448, DOI 10.1016/j.commatsci.2009.09.009; Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0; Staroselsky A, 2003, INT J PLASTICITY, V19, P1843, DOI 10.1016/S0749-6419(03)00039-1; Song YH, 2012, MAT SCI ENG A-STRUCT, V534, P504, DOI 10.1016/j.msea.2011.11.099; Fischer SF, 2013, ACTA MATER, V61, P5152, DOI 10.1016/j.actamat.2013.04.069; Ashby M.F., 2000, METAL FOAMS A DESIGN; Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5; Cox ME, 2013, ACTA MATER, V61, P5937, DOI 10.1016/j.actamat.2013.06.028; Gibson L. J., 1997, CELLULAR SOLIDS STRU; Kolsky H., 1949, Proceedings of the Physical Society. Section B, V62, DOI 10.1088/0370-1301/62/11/302; Marcadon V, 2012, ACTA MATER, V60, P5626, DOI 10.1016/j.actamat.2012.06.045; Mukai T, 2001, SCRIPTA MATER, V45, P89, DOI 10.1016/S1359-6462(01)00996-4; Olurin OB, 2000, MAT SCI ENG A-STRUCT, V291, P136, DOI 10.1016/S0921-5093(00)00954-0; PAN J, 1983, INT J SOLIDS STRUCT, V19, P973, DOI 10.1016/0020-7683(83)90023-9; Partridge P. G., 1967, METALL REV, V12, P169; PETTERSEN K, 1989, METALL TRANS A, V20, P847, DOI 10.1007/BF02651651; REEDHILL RE, 1957, T AM I MIN MET ENG, V209, P496; Renger K, 2005, ADV ENG MATER, V7, P117, DOI 10.1002/adem.200400191; Tane M, 2014, MAT SCI ENG A-STRUCT, V591, P150, DOI 10.1016/j.msea.2013.10.078; VANHOUTTE P, 1978, ACTA METALL MATER, V26, P591; Yoshinaga H., 1963, T JIM, V5, P14	54	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						80	94		10.1016/j.actamat.2014.10.024		15	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300008		
J	Li, YJ; Kostka, A; Choi, P; Goto, S; Ponge, D; Kirchheim, R; Raabe, D				Li, Y. J.; Kostka, A.; Choi, P.; Goto, S.; Ponge, D.; Kirchheim, R.; Raabe, D.			Mechanisms of subgrain coarsening and its effect on the mechanical properties of carbon-supersaturated nanocrystalline hypereutectoid steel	ACTA MATERIALIA			English	Article						Cold-drawn pearlitic steel; Nanocrystalline steels; Strength softening; Annealing; Subgrain coarsening	HEAVILY COLD-DRAWN; ATOM-PROBE TOMOGRAPHY; VACANCY FORMATION ENERGIES; DEFORMED PEARLITIC STEEL; REDUCING GRAIN-BOUNDARY; CEMENTITE DISSOLUTION; PLASTIC-DEFORMATION; SOLUTE SEGREGATION; DISLOCATION LINE; WIRES	Carbon-supersaturated nanocrystalline hypereutectoid steels with a tensile strength of 6.35 GPa were produced from severely cold-drawn pearlite. The nanocrystalline material undergoes softening upon annealing at temperatures between 200 and 450 degrees C. The ductility in terms of elongation to failure exhibits a non-monotonic dependence on temperature. Here, the microstructural mechanisms responsible for changes in the mechanical properties were studied using transmission electron microscopy (TEM), TEM-based automated scanning nanobeam diffraction and atom probe tomography (APT). TEM and APT investigations of the nanocrystalline hypereutectoid steel show subgrain coarsening upon annealing, which leads to strength reduction following a Hall Petch law. APT analyzes of the Mn distribution near subgrain boundaries and in the cementite give strong evidence of capillary-driven subgrain coarsening occurring through subgrain boundary migration. The pronounced deterioration of ductility after annealing at temperatures above 350 degrees C is attributed to the formation of cementite at subgrain boundaries. The overall segregation of carbon atoms at ferrite subgrain boundaries gives the nanocrystalline material excellent thermal stability upon annealing. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Li, Y. J.; Kostka, A.; Choi, P.; Goto, S.; Ponge, D.; Raabe, D.] Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany; [Goto, S.] Akita Univ, Fac Engn & Resource Sci, Dept Mat Sci & Engn, Akita 0108502, Japan; [Kirchheim, R.] Univ Gottingen, Inst Materialphys, D-37077 Gottingen, Germany	Li, YJ (reprint author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany.	y.li@mpie.de; d.raabe@mpie.de	Raabe, Dierk/A-6470-2009	Raabe, Dierk/0000-0003-0194-6124	Deutsche Forschungsgemeinschaft [SFB 602, KI230/34-1]	The authors thank Dr. H. Yarita, Suzuki Metal Industry Co. Ltd., for providing the cold-drawn specimens. We are grateful to the Deutsche Forschungsgemeinschaft for co-sponsoring some of this research (SFB 602 and KI230/34-1).	Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Li YJ, 2011, ACTA MATER, V59, P3965, DOI 10.1016/j.actamat.2011.03.022; Huang XX, 2006, SCIENCE, V312, P249, DOI 10.1126/science.1124268; Kirchheim R, 2007, ACTA MATER, V55, P5129, DOI 10.1016/j.actamat.2007.05.047; BECK PA, 1949, J APPL PHYS, V20, P633, DOI 10.1063/1.1698446; Borchers C, 2009, MAT SCI ENG A-STRUCT, V502, P131, DOI 10.1016/j.msea.2008.10.018; Herbig M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.126103; Valiev RZ, 2003, SCRIPTA MATER, V49, P669, DOI 10.1016/S1359-6462(03)00395-6; Upmanyu M, 2002, ACTA MATER, V50, P1405, DOI 10.1016/S1359-6454(01)00446-3; Marquis EA, 2009, MRS BULL, V34, P725; Danoix F, 1998, MAT SCI ENG A-STRUCT, V250, P8, DOI 10.1016/S0921-5093(98)00529-2; Kirchheim R, 2007, ACTA MATER, V55, P5139, DOI 10.1016/j.actamat.2007.05.033; Moeck P, 2011, CRYST RES TECHNOL, V46, P589, DOI 10.1002/crat.201000676; Hono K, 2001, SCRIPTA MATER, V44, P977, DOI 10.1016/S1359-6462(00)00690-4; Takeda K, 2008, ISIJ INT, V48, P1122, DOI 10.2355/isijinternational.48.1122; Hasnaoui A, 2002, ACTA MATER, V50, P3927, DOI 10.1016/S1359-6454(02)00195-7; Raabe D, 2010, MRS BULL, V35, P982, DOI 10.1557/mrs2010.703; LI JCM, 1962, J APPL PHYS, V33, P2958, DOI 10.1063/1.1728543; Li YJ, 2013, ULTRAMICROSCOPY, V132, P233, DOI 10.1016/j.ultramic.2012.10.010; Languillaume J, 1997, ACTA MATER, V45, P1201, DOI 10.1016/S1359-6454(96)00216-9; Maruyama N, 2002, SCRIPTA MATER, V46, P599, DOI 10.1016/S1359-6462(02)00037-4; Li YJ, 2012, ACTA MATER, V60, P4005, DOI 10.1016/j.actamat.2012.03.006; LANGFORD G, 1970, METALL TRANS, V1, P465, DOI 10.1007/BF02811557; Kar'kina LE, 2013, PHYS MET METALLOGR+, V114, P234, DOI 10.1134/S0031918X13030095; Li YJ, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.106104; Zhang XD, 2011, ACTA MATER, V59, P3422, DOI 10.1016/j.actamat.2011.02.017; RAABE D, 1995, Z METALLKD, V86, P405; Seidman DN, 2007, ANNU REV MATER RES, V37, P127, DOI 10.1146/annurev.matsci.37.052506.084200; BLUM W, 1995, Z METALLKD, V86, P631; Borchers C, 2010, PHIL MAG LETT, V90, P581, DOI 10.1080/09500839.2010.484400; CAHN RW, 1950, P PHYS SOC LOND A, V63, P323, DOI 10.1088/0370-1298/63/4/302; Chen YZ, 2013, METALL MATER TRANS A, V44A, P3882, DOI 10.1007/s11661-013-1723-x; Cottrell A.H., 1953, PROGR METAL PHYS, V4, P251; DOLLAR M, 1988, ACTA METALL MATER, V36, P311, DOI 10.1016/0001-6160(88)90008-9; EMBURY JD, 1966, ACTA METALL MATER, V14, P147, DOI 10.1016/0001-6160(66)90296-3; FRIDBERG J, 1969, JKA-JERNKONTORET ANN, V153, P263; GALINA AV, 1987, FIZ MET METALLOVED+, V63, P1220; Gottstein G, 2010, SCRIPTA MATER, V62, P914, DOI 10.1016/j.scriptamat.2010.03.017; Goyal A, 1996, APPL PHYS LETT, V68, P711, DOI 10.1063/1.116600; GRIDNEV VN, 1972, PHYS STATUS SOLIDI A, V14, P689, DOI 10.1002/pssa.2210140238; Hong MH, 1999, METALL MATER TRANS A, V30, P717, DOI 10.1007/s11661-999-0063-3; HOSFORD WF, 1964, T METALL SOC AIME, V230, P12; INOUE A, 1976, T JPN I MET, V17, P149; Kindle W. F., 1970, Metallography, V3, DOI 10.1016/0026-0800(70)90042-X; Languillaume J, 1997, MATER LETT, V33, P241, DOI 10.1016/S0167-577X(97)00109-2; Li YJ, 2011, ULTRAMICROSCOPY, V111, P628, DOI 10.1016/j.ultramic.2010.11.010; Makii K, 1997, SCRIPTA MATER, V37, P1753, DOI 10.1016/S1359-6462(97)00326-6; Miller M. K., 2000, ATOM PROBE TOMOGRAPH; Miller M.K., 1996, ATOM PROBE FIELD ION; MINTZ B, 1992, MATER SCI TECH SER, V8, P537; MINTZ B, 1984, MET TECHNOL, V11, P265; Porter D.A., 1966, ACTA METALL, P147; Raabe D., 1995, ACTA METALL MATER, V43, P407; Read HG, 1997, SCRIPTA MATER, V37, P1221, DOI 10.1016/S1359-6462(97)00223-6; Sauvage S., 2009, SCRIPTA MATER, V60, P1056; Sauvage X, 2000, PHILOS MAG A, V80, P781; Sauvage X, 2001, J PHYS IV, V11, P27; SEVILLANO JG, 1991, J PHYS III, V1, P967; Smith E., 1968, INT J FRACT MECH, V4, P132; Takahashi J, 2009, ULTRAMICROSCOPY, V109, P193, DOI 10.1016/j.ultramic.2008.10.013; Takahashi J, 2012, ACTA MATER, V60, P387, DOI 10.1016/j.actamat.2011.09.014; Takahashi J, 2012, SCRIPTA MATER, V66, P207, DOI 10.1016/j.scriptamat.2011.10.026; Takahashi T., 1995, NIPPON STEEL TECH RE, V64, P45; Tarui T., 2005, 91 NIPP STEEL; Tarui T., 1996, PROCESSING APPL META, P87; Tarui T., 1999, NIPPON STEEL TECH RE, V80, P44; Tarui T., 1994, IRON STEELMAKER, V21, P25; URAY L, 1984, PHYS STATUS SOLIDI A, V84, P65, DOI 10.1002/pssa.2210840108; Valley RZ, 2000, PROG MATER SCI, V45, P103, DOI DOI 10.1016/S0079-6425(99)00007-9; Wang YM, 2004, SCRIPTA MATER, V51, P1023, DOI 10.1016/j.scriptamat.2004.08.015; Wilson D. V., 1967, MET SCI J, V1, P40, DOI 10.1179/msc.1967.1.1.40	71	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						110	123		10.1016/j.actamat.2014.10.027		14	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300010		
J	Xu, XD; Liu, P; Guo, S; Hirata, A; Fujita, T; Nieh, TG; Liu, CT; Chen, MW				Xu, X. D.; Liu, P.; Guo, S.; Hirata, A.; Fujita, T.; Nieh, T. G.; Liu, C. T.; Chen, M. W.			Nanoscale phase separation in a fcc-based CoCrCuFeNiAl0.5 high-entropy alloy	ACTA MATERIALIA			English	Article						Phase separation; High-entropy alloy; Cs-corrected TEM; Atom probe tomography; Lattice distortion	MICROSTRUCTURE CHARACTERIZATION; SINGLE-PHASE; STABILITY; ELEMENTS; PLASTICITY; SYSTEM	Nano-scale phase separation is reported in a nominal single-phase, high-entropy alloy (HEA), which was characterized using scanning transmission electron microscopy (STEM) combined with atom probe tomography (APT). Despite the fact that X-ray diffraction exhibits a single face-centered-cubic (fcc) phase feature of the as-cast alloy prepared by melt spinning, selected area electron diffraction reveals weak L1(2) ordering in the as-spun alloy. High-resolution STEM shows the presence of two coherent nanophases with distinct L1(2) and fcc structures, coupling with compositional segregations. The ordering of the L1(2) domains is enhanced after annealing at 500 degrees C. Electron energy loss spectroscopy and APT analyses reveal that the L1(2) nano-phase is enriched with Fe, Co, Cr and Ni, while the fcc domains are a Cu-rich phase. The nano-scale phase separation can effectively minimize the lattice distortions caused by the atomic size difference in the constituent elements, which may offer structural insights into the unusual mechanical behavior and phase stability of fcc HEA. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Xu, X. D.; Liu, P.; Hirata, A.; Fujita, T.; Chen, M. W.] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Guo, S.; Liu, C. T.] City Univ Hong Kong, Ctr Adv Struct Mat, Kowloon, Hong Kong, Peoples R China; Chalmers, SE-41296 Gothenburg, Sweden; [Nieh, T. G.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Chen, M. W.] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China	Chen, MW (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	mwchen@wpi-aimr.tohoku.ac.jp	Fujita, Takeshi/B-1867-2009; Guo, Sheng/C-7746-2009; Hirata, Akihiko/A-4850-2010; Chen, Mingwei/A-4855-2010; Liu, Pan/H-5469-2012; 	Fujita, Takeshi/0000-0002-2318-0433; Guo, Sheng/0000-0001-8349-3135; Chen, Mingwei/0000-0002-2850-8872; Liu, Chain Tsuan/0000-0001-7888-9725	MEXT; National Natural Science Foundation of China [51271113]; Research Grant Council (RGC) of the Hong Kong government through the General Research Fund (GRF) [11209314]; US National Science Foundation [DMR-1408722]	This work was sponsored by: "WPI Research Center Initiative for Atoms, Molecules and Materials"; MEXT; National Natural Science Foundation of China (51271113); Research Grant Council (RGC) of the Hong Kong government through the General Research Fund (GRF) with account number CityU 11209314; and TGN is supported by US National Science Foundation under Contract DMR-1408722.	Ng C, 2012, INTERMETALLICS, V31, P165, DOI 10.1016/j.intermet.2012.07.001; Wen YR, 2013, ACTA MATER, V61, P7726, DOI 10.1016/j.actamat.2013.09.011; Senkov ON, 2010, INTERMETALLICS, V18, P1758, DOI 10.1016/j.intermet.2010.05.014; Pradeep KG, 2013, ACTA MATER, V61, P4696, DOI 10.1016/j.actamat.2013.04.059; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; Tong CJ, 2005, METALL MATER TRANS A, V36A, P881, DOI 10.1007/s11661-005-0283-0; Wu Y, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863748; Otto F, 2013, ACTA MATER, V61, P2628, DOI 10.1016/j.actamat.2013.01.042; Guo W, 2013, METALL MATER TRANS A, V44A, P1994, DOI 10.1007/s11661-012-1474-0; Takeuchi A, 2005, MATER TRANS, V46, P2817, DOI 10.2320/matertrans.46.2817; Singh S, 2011, ULTRAMICROSCOPY, V111, P619, DOI 10.1016/j.ultramic.2010.12.001; Zhu C, 2013, ACTA MATER, V61, P2993, DOI 10.1016/j.actamat.2013.01.059; Zou Y, 2014, ACTA MATER, V65, P85, DOI 10.1016/j.actamat.2013.11.049; GEROLD V, 1989, ACTA METALL MATER, V37, P2177, DOI 10.1016/0001-6160(89)90143-0; Wang ZL, 2003, MICRON, V34, P141, DOI 10.1016/S0968-4328(03)00024-6; Manzoni A, 2013, ULTRAMICROSCOPY, V132, P212, DOI 10.1016/j.ultramic.2012.12.015; Jones NG, 2014, INTERMETALLICS, V54, P148, DOI 10.1016/j.intermet.2014.06.004; He JY, 2014, ACTA MATER, V62, P105, DOI 10.1016/j.actamat.2013.09.037; Gao MC, 2013, JOM-US, V65, P1749, DOI 10.1007/s11837-013-0788-8; Chen Y.C., 2014, ENTROPY, V16, P870; Egami T., 1984, J NON-CRYST SOLIDS, V64, P113; Gao MC, 2013, ENTROPY-SWITZ, V15, P4504, DOI 10.3390/e15104504; Gerold V., 1989, ACTA METALL, V37, P2177; Hirata A., 2012, NAT MATER, V10, P922; Manzoni A., 2011, ULTRAMICROSCOPY, V111, P619; Tsai M.-H., 2014, MAT RES LETT, V2, P107, DOI DOI 10.1080/21663831.2014.912690.; Wen YR, 2013, ACTA MATER, V61, P2133, DOI 10.1016/j.actamat.2012.12.034; Yao MJ, 2014, SCRIPTA MATER, V72-73, P5, DOI 10.1016/j.scriptamat.2013.09.030; Yeh J.W., 2006, SCI MATER, V31, P633	29	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						145	152		10.1016/j.actamat.2014.10.033		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300013		
J	Li, JH; Wang, XD; Ludwig, TH; Tsunekawa, Y; Arnberg, L; Jiang, JZ; Schumacher, P				Li, J. H.; Wang, X. D.; Ludwig, T. H.; Tsunekawa, Y.; Arnberg, L.; Jiang, J. Z.; Schumacher, P.			Modification of eutectic Si in Al-Si alloys with Eu addition	ACTA MATERIALIA			English	Article						Al-Si alloy; Eu additions; Eutectic solidification; TEM; X-ray absorption spectroscopy	ALUMINUM-SILICON ALLOYS; AL-5SI ALLOYS; NUCLEATION; MICROSTRUCTURE; SOLIDIFICATION; ELEMENTS; GROWTH	Al-5 wt.% Si-based alloys with 0.05 wt.% Eu addition were produced by controlled sand-casting and melt-spinning, respectively. The modification of eutectic Si caused by 0.05 wt.% Eu addition was investigated by thermal analysis, differential scanning calorimetry and multi-scale microstructure characterization techniques. In the case of controlled sand-casting, 0.05 wt.% Eu addition was found to modify the eutectic Si into a fibrous morphology. Multiply twinned Si particles were observed within eutectic Si. Furthermore, the Al2Si2Eu phase was also observed both in the vicinity of eutectic Si and within eutectic Si, which was believed to hinder Si growth. In the case of melt-spun samples, nanometer-sized Al2Si2Eu phases were observed. However, after controlled cooling in a differential scanning calorimeter, multiply twinned Si particles were observed. The formation of multiply twinned Si particles was attributed to the adsorption of Eu atoms along the < 112 >(si) growth direction of Si and at the intersection of two {111}(si) facets. Twinning was observed in both fundamentally different casting processes: controlled sand-casting and melt-spinning. This is fully consistent with the well-known poisoning of the twin plane re-entrant edge and the impurity-induced twinning modification mechanisms. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Li, J. H.; Schumacher, P.] Univ Leoben, Inst Casting Res, A-8700 Leoben, Austria; [Wang, X. D.; Jiang, J. Z.] Zhejiang Univ, ICNSM, Lab New Struct Mat, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China; [Wang, X. D.; Jiang, J. Z.] Zhejiang Univ, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Ludwig, T. H.] Hydro Aluminium AS, N-6882 Ovre Ardal, Norway; [Tsunekawa, Y.] Toyota Technol Inst, Nagoya, Aichi 4688511, Japan; [Arnberg, L.] Norwegian Univ Sci & Technol, Dept Mat Sci & Engn, N-7491 Trondheim, Norway; [Schumacher, P.] Austrian Foundry Res Inst, A-8700 Leoben, Austria	Li, JH (reprint author), Univ Leoben, Inst Casting Res, A-8700 Leoben, Austria.	jie-hua.li@hotmail.com; jiangjz@zju.edu.cn			National Key Basic Research Program of China [2012CB825700]; National Natural Science Foundation of China [51371157, U1432105]; Fundamental Research Funds for the Central Universities	J.H. Li gratefully acknowledges the access to TEM at the Erich Schmid Institute of Materials Science of the Austrian Academy of Sciences. X.D. Wang and J.Z. Jiang gratefully acknowledge financial support from the National Key Basic Research Program of China (2012CB825700), National Natural Science Foundation of China (grant 51371157 and U1432105), and the Fundamental Research Funds for the Central Universities.	Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Li JH, 2013, METALL MATER TRANS A, V44A, P669, DOI 10.1007/s11661-012-1410-3; Zarif M, 2011, METALL MATER TRANS A, V42A, P1684, DOI 10.1007/s11661-010-0553-3; Nogita K, 2004, MATER TRANS, V45, P323, DOI 10.2320/matertrans.45.323; HO CR, 1995, ACTA METALL MATER, V43, P3231, DOI 10.1016/0956-7151(94)00480-6; Timpel M, 2012, ACTA MATER, V60, P3920, DOI 10.1016/j.actamat.2012.03.031; Ludwig TH, 2014, J ALLOY COMPD, V586, P180, DOI 10.1016/j.jallcom.2013.09.127; Nogita K, 2010, J ALLOY COMPD, V489, P415, DOI 10.1016/j.jallcom.2009.09.138; Li JH, 2014, ACTA MATER, V72, P80, DOI 10.1016/j.actamat.2014.03.030; Cho Y.H., 2008, METALL MATER TRANS A, V10A, P2435; Crosley P.B., 1966, MOD CAST, V49, P63; DAY MG, 1968, PROC R SOC LON SER-A, V305, P473, DOI 10.1098/rspa.1968.0128; Hamilton R. D., 1960, J APPL PHYS, V31, P1165; KNUUTINEN A, 2001, J LIGHT METALS, V1, P229, DOI DOI 10.1016/S1471-5317(02)00004-4; Li JH, 2015, ACTA MATER, V83, P187, DOI 10.1016/j.actamat.2014.09.040; Li JH, 2012, PHILOS MAG, V92, P3789, DOI 10.1080/14786435.2012.687840; LU SZ, 1987, METALL TRANS A, V18, P1721, DOI 10.1007/BF02646204; Ludwig TH, 2013, METALL MATER TRANS A, V44A, P3783, DOI 10.1007/s11661-013-1694-y; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Nogita K., 2001, J LIGHT MET, V1, P219, DOI 10.1016/S1471-5317(02)00005-6; Pacz A., 1921, US Patent, Patent No. [1387900, US. 1387900 A.]; Wanger R. S., 1960, ACTA METALL, V8, P57	22	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						153	163		10.1016/j.actamat.2014.10.064		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300014		
J	Masumura, T; Nakada, N; Tsuchiyama, T; Takaki, S; Koyano, T; Adachi, K				Masumura, Takuro; Nakada, Nobuo; Tsuchiyama, Toshihiro; Takaki, Setsuo; Koyano, Tamotsu; Adachi, Kazuhiko			The difference in thermal and mechanical stabilities of austenite between carbon- and nitrogen-added metastable austenitic stainless steels	ACTA MATERIALIA			English	Article						Austenite stability; Stainless steel; Carbon; Nitrogen; Stacking-fault energy	INDUCED MARTENSITIC-TRANSFORMATION; FCC->HCP TRANSFORMATION; MICROSTRUCTURE; PLASTICITY; ALLOYS; STRAIN	In order to evaluate the effects of carbon and nitrogen addition on the stability of austenite, athermal and deformation-induced alpha'-martensitic transformation behaviors were investigated using type 304-metastable austenitic stainless steels containing 0.1 mass% carbon or nitrogen. The difference in the development of the deformation microstructure in particular is discussed in terms of the stacking-fault energy (SFE). Since carbon-added steel has a lower SFE than that of nitrogen-added steel, deformation twins and epsilon-martensite were preferentially formed in the carbon-added steel, whereas a dislocation cell structure developed in the nitrogen-added steel. Crystallographic analysis using the electron backscatter diffraction method revealed that the difference in the deformation microstructure has a significant influence on the growth behavior of deformation-induced alpha'-martensite, that is, the interface of the deformation twins and epsilon-martensite suppresses the growth of alpha'-martensite, whereas dislocation cell boundaries are not effective. As a result, the mechanical stability of carbon-added steel is slightly higher than that of nitrogen-added steel, although the thermal stabilization effect of carbon is much lower than that of nitrogen. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Masumura, Takuro] Kyushu Univ, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Nakada, Nobuo; Tsuchiyama, Toshihiro; Takaki, Setsuo] Kyushu Univ, Dept Mat Sci & Engn, Nishi Ku, Fukuoka 8190395, Japan; [Nakada, Nobuo; Tsuchiyama, Toshihiro; Takaki, Setsuo] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Koyano, Tamotsu] Univ Tsukuba, Res Facil Ctr, Cryogen Div, Tsukuba, Ibaraki 3058577, Japan; [Adachi, Kazuhiko] Nippon Steel & Sumitomo Met Co, Steel Res Lab, Titanium & Specialty Stainless Steel Res Lab, Futtsu, Chiba 2938511, Japan	Masumura, T (reprint author), Kyushu Univ, Grad Sch Engn, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.	masumura11@takaki.zaiko.kyushu-u.ac.jp					Matsuoka Y, 2013, ISIJ INT, V53, P1224, DOI 10.2355/isijinternational.53.1224; De AK, 2004, SCRIPTA MATER, V50, P1445, DOI 10.1016/j.scriptamat.2004.03.011; REMY L, 1977, MATER SCI ENG, V28, P99, DOI 10.1016/0025-5416(77)90093-3; Allain S, 2004, MAT SCI ENG A-STRUCT, V387, P158, DOI 10.1016/j.msea.2004.01.059; VENABLES JA, 1962, PHILOS MAG, V7, P35, DOI 10.1080/14786436208201856; ANGEL T, 1954, J IRON STEEL I, V177, P165; EICHELMAN GH, 1953, T AM SOC METAL, V45, P77; Hsu TY, 1999, MAT SCI ENG A-STRUCT, V273, P494, DOI 10.1016/S0921-5093(99)00386-X; LING HC, 1981, ACTA METALL MATER, V29, P1721, DOI 10.1016/0001-6160(81)90006-7; Miyamoto G, 2012, ACTA MATER, V60, P1139, DOI 10.1016/j.actamat.2011.11.018; Nakada N, 2010, ACTA MATER, V58, P895, DOI 10.1016/j.actamat.2009.10.004; Ngo H. K. L., 2012, TETSU TO HAGANE, V98, P25; Nohara K., 1977, TETSU TO HAGANE, V63, P772; OLSON GB, 1976, METALL TRANS A, V7, P1897, DOI 10.1007/BF02659822; ONODERA H, 1978, J JPN I MET, V42, P898; Schumann H., 1967, ARCH EISENHUTTENWES, V38, P647; SHIMIZU K, 1970, ACTA METALL MATER, V18, P1005, DOI 10.1016/0001-6160(70)90056-8; Takano K, 2000, TETSU TO HAGANE, V86, P123; Tsuchida N, 2008, J JPN I MET, V72, P769, DOI 10.2320/jinstmet.72.769; Tsuchida N, 2000, MAT SCI ENG A-STRUCT, V285, P345; Volosevich P.U.Y., 1976, PHYS MET METALLOGR, V42, P126; Yoshitake M, 2012, TETSU TO HAGANE, V98, P223	22	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						330	338		10.1016/j.actamat.2014.10.041		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300030		
J	Zhang, YJ; Miyamoto, G; Shinbo, K; Furuhara, T; Ohmura, T; Suzuki, T; Tsuzaki, K				Zhang, Y. -J.; Miyamoto, G.; Shinbo, K.; Furuhara, T.; Ohmura, T.; Suzuki, T.; Tsuzaki, K.			Effects of transformation temperature on VC interphase precipitation and resultant hardness in low-carbon steels	ACTA MATERIALIA			English	Article						Interphase precipitation; Orientation relationship; Atom probe tomography; Nano-indentation; Precipitation hardening	ROLLED SHEET STEEL; TENSILE BEHAVIOR; VANADIUM CARBIDE; SIZED CARBIDES; ALLOY-STEELS; FERRITE; AUSTENITE; MICROSTRUCTURES; ORIENTATION; DIFFUSION	The effects of transformation temperature on VC interphase precipitation in low-carbon steels were investigated mainly by using an Fe-0.1C-1.5Mn-0.4V-0.05Si (mass%) alloy isothermally transformed at different temperatures. The crystallographic relationship between ferrite and austenite as well as the precipitates and resultant hardness were characterized by combining electron backscatter diffraction, three-dimensional atom probe and nanoindentation measurements in the same ferrite grains. It was found that the number density of sheet-like interphase precipitation at non-K-S (Kurdjumov-Sachs) interfaces is significantly increased by decreasing the transformation temperature from 993 K to 923 K, while no great change can be obtained by further lowering the temperature to 873 K. The nanohardness of ferrite grains shows the same trend as that of VC number density. The effects of transformation temperature on VC interphase precipitation are discussed in terms of the driving force for VC nucleation. On the other hand, the temperature dependence of macroscopic hardness does not agree with that for nanohardness due to the fact that fraction of ferrite holding near the K-S orientation relationship with austenite changes substantially with transformation temperature. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Zhang, Y. -J.] Tohoku Univ, Grad Sch Engn, Dept Met, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Miyamoto, G.; Shinbo, K.; Furuhara, T.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Ohmura, T.; Suzuki, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Tsuzaki, K.] Kyushu Univ, Dept Mech Engn, Nishi Ku, Fukuoka 8190395, Japan	Zhang, YJ (reprint author), Tohoku Univ, Grad Sch Engn, Dept Met, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	yongjie@imr.tohoku.ac.jp	Miyamoto, Goro/G-2802-2010; Zhang, Yongjie/C-1120-2015; Furuhara, Tadashi/B-2149-2010				Aaronson H. I., 1962, DECOMPOSITION AUSTEN; Aaronson H.I., 2010, MECH DIFFUSIONAL PHA; Miyamoto G, 2010, ACTA MATER, V58, P6393, DOI 10.1016/j.actamat.2010.08.001; Funakawa Y, 2004, ISIJ INT, V44, P1945, DOI 10.2355/isijinternational.44.1945; BALLIGER NK, 1980, METALL TRANS A, V11, P421, DOI 10.1007/BF02654566; Vaumousse D, 2003, ULTRAMICROSCOPY, V95, P215, DOI 10.1016/S0304-3991(02)00319-4; Liu ZQ, 2013, ACTA MATER, V61, P3120, DOI 10.1016/j.actamat.2013.02.003; COATES DE, 1972, METALL TRANS, V3, P1203, DOI 10.1007/BF02642453; Gault B, 2012, ULTRAMICROSCOPY, V113, P182, DOI 10.1016/j.ultramic.2011.06.005; BATTE AD, 1973, J IRON STEEL I, V211, P284; Batte A. D., 1973, Metal Science Journal, V7; Dunlop G. L., 1976, Metal Science, V10; FRIDBERG J, 1969, JKA-JERNKONTORET ANN, V153, P263; Funakawa Y, 2007, TETSU TO HAGANE, V93, P49; Gladman T., 2002, PHYS METALLURGY MICR; GRAY JM, 1968, ASM TRANS Q, V61, P255; HONEYCOMBE RWK, 1976, METALL TRANS A, V7, P915, DOI 10.1007/BF02644057; HULTGREN A, 1947, T AM SOC METAL, V39, P915; Kamikawa N, 2014, ISIJ INT, V54, P212, DOI 10.2355/isijinternational.54.212; Kamikawa N, 2013, TETSU TO HAGANE, V99, P352, DOI 10.2355/tetsutohagane.99.352; Lagneborg R, 2001, METALL MATER TRANS A, V32, P39, DOI 10.1007/s11661-001-0249-9; Miyamoto G, 2013, METALL MATER TRANS A, V44A, P3436, DOI 10.1007/s11661-013-1702-2; Miyamoto G, 2011, SOLID STATE PHENOMEN, V172-174, P420, DOI 10.4028/www.scientific.net/SSP.172-174.420; Miyamoto G, 2011, ISIJ INT, V51, P1733, DOI 10.2355/isijinternational.51.1733; Okamoto R, 2010, ACTA MATER, V58, P4783, DOI 10.1016/j.actamat.2010.05.014; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; PARSONS SA, 1987, MATER SCI TECH SER, V3, P894; RICKS RA, 1983, ACTA METALL MATER, V31, P853, DOI 10.1016/0001-6160(83)90113-X; SAKUMA T, 1984, MET SCI, V18, P449; Seto K., 2007, JFE TECH REP, V10, P19; Zhang Y., UNPUB; Zhang YJ, 2013, SCRIPTA MATER, V69, P17, DOI 10.1016/j.scriptamat.2013.03.020	32	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						375	384		10.1016/j.actamat.2014.10.049		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300035		
J	Cui, WB; Sepehri-Amin, H; Takahashi, YK; Hono, K				Cui, W. B.; Sepehri-Amin, H.; Takahashi, Y. K.; Hono, K.			Hard magnetic properties of spacer-layer-tuned NdFeB/Ta/Fe nanocomposite films	ACTA MATERIALIA			English	Article						Permanent magnet; Nanocomposite magnet; Exchange coupling; Coercivity; Maximum energy product	PERMANENT-MAGNETS; NONMAGNETIC SPACER; ENERGY PRODUCT; EXCHANGE; OPTIMIZATION; ENHANCEMENT; COERCIVITY; REMANENCE; BOUNDARY	Anisotropic Ti(20 nm)/NdFeB(100 nm)Nd(10 nm)/Ta(x nm)/Fe(y nm)/Ti(20 nm) multilayer films were prepared, and the magnetic coupling mechanism between soft-/hard-magnetic (SM/HM) layers were systematically studied in order to understand the potential of anisotropic SM/HM nanocomposite magnets. Recoil behaviors were also investigated in films with various thicknesses of Fe layer. From experimental results, the roles of exchange coupling and magnetostatic coupling in the demagnetization process were clarified, which was further supported by micromagnetic simulations. For different thicknesses of Ta spacer layer, the demagnetization process was analyzed, and the coupling energy was estimated. This work also indicated that, using the proper thickness of Ta spacer layer, the (BH)(max) can be enhanced in the SM/HM nanocomposite magnets by a combination of weakened exchange coupling and magnetostatic coupling. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Cui, W. B.; Sepehri-Amin, H.; Takahashi, Y. K.; Hono, K.] Natl Inst Mat Sci, ESSICM, Tsukuba, Ibaraki 3050047, Japan	Hono, K (reprint author), Natl Inst Mat Sci, ESSICM, Tsukuba, Ibaraki 3050047, Japan.	kazuhiro.hono@nims.go.jp	Hono, Kazuhiro/B-9202-2008	Hono, Kazuhiro/0000-0001-7367-0193	JST, CREST	This research was partly supported by JST, CREST.	Amato M, 1999, PHYS REV B, V60, P3414, DOI 10.1103/PhysRevB.60.3414; SKOMSKI R, 1993, PHYS REV B, V48, P15812, DOI 10.1103/PhysRevB.48.15812; COEHOORN R, 1989, J MAGN MAGN MATER, V80, P101, DOI 10.1016/0304-8853(89)90333-8; Shindo M, 1997, J APPL PHYS, V81, P4444, DOI 10.1063/1.364970; PARKIN SSP, 1990, PHYS REV LETT, V64, P2304, DOI 10.1103/PhysRevLett.64.2304; Sepehri-Amin H, 2012, ACTA MATER, V60, P819, DOI 10.1016/j.actamat.2011.10.043; SCHREFL T, 1994, PHYS REV B, V49, P6100, DOI 10.1103/PhysRevB.49.6100; Liu W, 2002, ADV MATER, V14, P1832, DOI 10.1002/adma.200290012; Fidler J, 2000, J PHYS D APPL PHYS, V33, pR135, DOI 10.1088/0022-3727/33/15/201; Murakami Y, 2014, ACTA MATER, V71, P370, DOI 10.1016/j.actamat.2014.03.013; Cui WB, 2012, ADV MATER, V24, P6530, DOI 10.1002/adma.201202328; BRUNO P, 1995, PHYS REV B, V52, P411, DOI 10.1103/PhysRevB.52.411; Yang B, 2013, J RARE EARTH, V31, P49, DOI 10.1016/S1002-0721(12)60233-6; Cui WB, 2008, J APPL PHYS, V104, DOI 10.1063/1.2973688; KNELLER EF, 1991, IEEE T MAGN, V27, P3588, DOI 10.1109/20.102931; Sawatzki S, 2011, J APPL PHYS, V109, DOI 10.1063/1.3596756; SAGAWA M, 1985, J APPL PHYS, V57, P4094, DOI 10.1063/1.334629; Cui WB, 2011, ACTA MATER, V59, P7768, DOI 10.1016/j.actamat.2011.09.006; Kato H, 2001, IEEE T MAGN, V37, P2567, DOI 10.1109/20.951237; Coey J. M., 2010, MAGNETISM MAGNETIC M, P242; Cui WB, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/24/245007; Cui WB, 2012, J APPL PHYS, V111, DOI 10.1063/1.3671774; Gabay AM, 2007, J APPL PHYS, V101, DOI 10.1063/1.2710739; Garcia F, 2003, APPL PHYS LETT, V83, P3537, DOI 10.1063/1.1619562; Horimoto D., 2007, HITACHI MET TECHNICA, V23, P69; Lee D, 2006, J APPL PHYS, V99, DOI 10.1063/1.2171959; Ogawa D., 2012, J MAGN SOC JPN, V36, P5; Saravanan P, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/15/155002; Thomas L, 2000, J APPL PHYS, V87, P5061, DOI 10.1063/1.373248	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						405	412		10.1016/j.actamat.2014.10.008		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300038		
J	Kim, JW; Tsuda, M; Wada, T; Yubuta, K; Kim, SG; Kato, H				Kim, Joung Wook; Tsuda, Masashi; Wada, Takeshi; Yubuta, Kunio; Kim, Sung Gyoo; Kato, Hidemi			Optimizing niobium dealloying with metallic melt to fabricate porous structure for electrolytic capacitors	ACTA MATERIALIA			English	Article						Dealloying; Porous material; Nb electrolytic capacitor; Nanostructure	REACTIVE DIFFUSION; GROWTH-BEHAVIOR; LIQUID AL; CU; ALLOYS; COPPER; LAYERS; IRON; NB	The transition behavior from a Nb-Ni precursor to porous Nb and the coarsening of ligaments by a dealloying reaction in a Mg melt are investigated. Based on these results, the kinetics of the reaction are discussed. When a Nb25Ni75 (at.%) disk was immersed in a Mg melt, the Ni content decreased the most at the surface of the disk and less so towards the interior of the disk. In this disk, it was found that transition layers of body-centered cubic-Nb and Ni6Nb7 formed. These transition layers grew, following a parabolic law, and the activation energy of such growth was close to values reported for the diffusion of solute atoms in liquids, suggesting that diffusion of Ni in the Mg melt was the rate-controlling process of the dealloying reaction. The ligament size depended on time and temperature, following a power law with an exponent of 4, suggesting that surface diffusion was a key part of coarsening. These results agree well with those reported for conventional dealloying in an aqueous solution. Based on the kinetics analyses, the dealloying conditions were optimized to maximize the specific surface area, allowing a Nb electrolytic capacitor to be produced with a maximum mass-specific capacitance of 650,000 mu FV g-(1), about three times larger than the highest value previously reported. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Kim, Joung Wook; Tsuda, Masashi] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan; [Wada, Takeshi; Yubuta, Kunio; Kato, Hidemi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kim, Sung Gyoo] Pukyong Natl Univ, Dept Mat Syst Engn, Pusan 608739, South Korea	Kato, H (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	hikato@imr.tohoku.ac.jp	Kato, Hidemi/B-2492-2015; Wada, Takeshi/B-2431-2015		Integrated Materials Research Center for Low-Carbon Society at the Institute for Materials Research, Tohoku University, Japan	The authors would like to thank K. Ohmura (CRDAM, IMR, Tohoku University, Japan) for performing the XPS measurements. This research was supported financially by the Integrated Materials Research Center for Low-Carbon Society at the Institute for Materials Research, Tohoku University, Japan.	Qian LH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773757; Lang XY, 2011, SCRIPTA MATER, V64, P923, DOI 10.1016/j.scriptamat.2011.01.038; FORTY AJ, 1979, NATURE, V282, P597, DOI 10.1038/282597a0; Luo XK, 2013, CORROS SCI, V67, P100, DOI 10.1016/j.corsci.2012.10.010; Wada T, 2011, SCRIPTA MATER, V65, P532, DOI 10.1016/j.scriptamat.2011.06.019; LOHRENGEL MM, 1993, MAT SCI ENG R, V11, P243, DOI 10.1016/0927-796X(93)90005-N; Tsuda M, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821066; Kim JW, 2014, MATER LETT, V116, P223, DOI 10.1016/j.matlet.2013.11.036; DONA JM, 1993, J PHYS CHEM-US, V97, P4714, DOI 10.1021/j100120a026; HERRING C, 1950, J APPL PHYS, V21, P301, DOI 10.1063/1.1699658; Wada T, 2013, SCRIPTA MATER, V68, P723, DOI 10.1016/j.scriptamat.2013.01.011; [Anonymous], J ELECTROANAL CHEM; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; Hakamada M, 2009, J ALLOY COMPD, V485, P583, DOI 10.1016/j.jallcom.2009.06.031; Nishino A, 1996, J POWER SOURCES, V60, P137, DOI 10.1016/S0378-7753(96)80003-6; Du Y, 2003, MAT SCI ENG A-STRUCT, V363, P140, DOI 10.1016/S0921-5093(03)00624-5; Wada T, 2011, MATER LETT, V65, P1076, DOI 10.1016/j.matlet.2011.01.054; MIN US, 1994, J MATER RES, V9, P2878, DOI 10.1557/JMR.1994.2878; ISHIDA T, 1986, J MATER SCI, V21, P1171, DOI 10.1007/BF00553249; BURKE JE, 1949, T AM I MIN MET ENG, V180, P73; CLUM JA, 1970, SCRIPTA METALL MATER, V4, P463, DOI 10.1016/0036-9748(70)90086-4; Haas H., 2004, P CARTS C, P5; Hakamada M, 2009, J ALLOY COMPD, V479, P326, DOI 10.1016/j.jallcom.2008.12.078; Jung SM, 2007, MATER TRANS, V48, P3197, DOI 10.2320/matertrans.MRP2007619; Matsuda Y., 2009, CAPACITOR HDB, P418; MCLEAN DA, 1956, P IRE, V44, P872, DOI 10.1109/JRPROC.1956.275141; Meguro M.O.K., 2012, J MATER SCI, V47, P4955; Muranishi Y, 2005, MAT SCI ENG A-STRUCT, V404, P33, DOI 10.1016/j.msea.2005.05.044; Nonaka K, 1995, MATER T JIM, V36, P1463; Okamoto H., 2000, DESK HDB PHASE DIAGR; Pugh DV, 2003, J MATER RES, V18, P216, DOI 10.1557/JMR.2003.0030; SCHWARTZ N, 1961, J ELECTROCHEM SOC, V108, P750, DOI 10.1149/1.2428210; Semboshi S, 2010, THIN SOLID FILMS, V519, P719, DOI 10.1016/j.tsf.2010.08.131; Stormer H, 2009, J EUR CERAM SOC, V29, P1743, DOI 10.1016/j.jeurceramsoc.2008.10.019; Tanaka Y, 2007, MAT SCI ENG A-STRUCT, V445, P355, DOI 10.1016/j.msea.2006.09.047	35	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						497	505		10.1016/j.actamat.2014.11.002		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300046		
J	Sasaki, TT; Ohkubo, T; Une, Y; Kubo, H; Sagawa, M; Hono, K				Sasaki, T. T.; Ohkubo, T.; Une, Y.; Kubo, H.; Sagawa, M.; Hono, K.			Effect of carbon on the coercivity and microstructure in fine-grained Nd-Fe-B sintered magnet	ACTA MATERIALIA			English	Article						Nd-Fe-B; Sintered magnet; Coercivity; Microstructure	NUCLEATION CONTROLLED MAGNETS; PERMANENT-MAGNETS; MAGNETIZATION REVERSAL; PARTICLE-SIZE; RICH PHASE; DEPENDENCE; POWDER; OXYGEN	We have investigated the effect of carbon on the coercivity and microstructure in fine-grained Nd-Fe-B sintered magnets fabricated by the pressless sintering method. The coercivity of the sample with the carbon content of 730 ppm (low-C) was 1.59 T while that of the sample with 1500 ppm (high-C) was 1.44 T in the as-sintered state. The low-C sample exhibited a larger coercivity increase by a post-sinter annealing, reaching the highest coercivity of 1.85 T, while the high-C sample reached a lower coercivity of 1.54 T. Detailed microstructure investigations using scanning electron microscopy, scanning transmission electron microscopy and atom probe tomography revealed that the high carbon content resulted in the formation of a Nd-carbide with a tetragonal structure and the reduction in the volume fraction of an alpha-Nd phase at triple junctions. This in turn decreased the Nd + Pr concentration in thin Nd-rich grain boundary phase, resulting in the lower coercivity. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Sasaki, T. T.; Ohkubo, T.; Hono, K.] Natl Inst Mat Sci, Elements Strategy Initiat, Ctr Magnet Mat, Tsukuba, Ibaraki 3050047, Japan; [Une, Y.; Kubo, H.; Sagawa, M.] Intermetall Co Ltd, Moriyama Ku, Nagoya, Aichi 4630003, Japan	Sasaki, TT (reprint author), Natl Inst Mat Sci, Elements Strategy Initiat, Ctr Magnet Mat, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	sasaki.taisuke@nims.go.jp	Sasaki, Taisuke/H-2866-2011; Hono, Kazuhiro/B-9202-2008	Hono, Kazuhiro/0000-0001-7367-0193	JST, CREST	This work was supported by JST, CREST.	Uestuener K, 2006, IEEE T MAGN, V42, P2897, DOI 10.1109/TMAG.2006.879889; Woodcock TG, 2014, ACTA MATER, V77, P111, DOI 10.1016/j.actamat.2014.05.045; Sepehri-Amin H, 2011, SCRIPTA MATER, V65, P396, DOI 10.1016/j.scriptamat.2011.05.006; Scott DW, 1996, J APPL PHYS, V79, P5501, DOI 10.1063/1.362291; RAMESH R, 1988, J APPL PHYS, V64, P6416, DOI 10.1063/1.342055; RAMESH R, 1988, J APPL PHYS, V64, P6406, DOI 10.1063/1.342054; Sepehri-Amin H, 2012, ACTA MATER, V60, P819, DOI 10.1016/j.actamat.2011.10.043; Vial F, 2002, J MAGN MAGN MATER, V242, P1329, DOI 10.1016/S0304-8853(01)00967-2; PAUL DI, 1982, J APPL PHYS, V53, P1649, DOI 10.1063/1.330614; Sasaki TT, 2013, ULTRAMICROSCOPY, V132, P222, DOI 10.1016/j.ultramic.2013.01.006; NOTHNAGEL P, 1991, J MAGN MAGN MATER, V101, P379, DOI 10.1016/0304-8853(91)90786-A; Li WF, 2009, J MAGN MAGN MATER, V321, P1100, DOI 10.1016/j.jmmm.2008.10.032; Liu J, 2013, ACTA MATER, V61, P5387, DOI 10.1016/j.actamat.2013.05.027; Woodcock TG, 2011, ACTA MATER, V59, P1026, DOI 10.1016/j.actamat.2010.10.033; Li WF, 2009, ACTA MATER, V57, P1337, DOI 10.1016/j.actamat.2008.11.019; Mo WJ, 2008, SCRIPTA MATER, V59, P179, DOI 10.1016/j.scriptamat.2008.03.004; Shinba Y, 2005, J APPL PHYS, V97, DOI 10.1063/1.1851017; Kim TH, 2014, ACTA MATER, V66, P12, DOI 10.1016/j.actamat.2013.11.063; Lukin AA, 2001, INTERMETALLICS, V9, P169, DOI 10.1016/S0966-9795(00)00112-6; Massalski T. B., 1996, BINARY ALLOY PHASE D; MINOWA T, 1991, J MAGN MAGN MATER, V97, P107, DOI 10.1016/0304-8853(91)90167-9; Pan F., 1988, J PHYS D, V31, P488; Sepehri-Amin H., 2014, SCRIPTA MATER, V78, P29; Sepehri-Amin H, 2010, ACTA MATER, V58, P1309, DOI 10.1016/j.actamat.2009.10.035; Une Y., 2010, P 21 WORKSH RAR EART	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						506	514		10.1016/j.actamat.2014.10.047		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300047		
J	Tane, M; Okuda, Y; Todaka, Y; Ogi, H; Nagakubo, A				Tane, M.; Okuda, Y.; Todaka, Y.; Ogi, H.; Nagakubo, A.			Elastic properties of single-crystalline omega phase in titanium (vol 61, pg 7543, 2013)	ACTA MATERIALIA			English	Correction									[Tane, M.; Okuda, Y.] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Todaka, Y.] Toyohashi Univ Technol, Dept Mech Engn, Toyohashi, Aichi 4418580, Japan; [Ogi, H.; Nagakubo, A.] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Tane, M (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	mtane@sanken.osaka-u.ac.jp	Tane, Masakazu/D-2772-2011; Todaka, Yoshikazu/D-3809-2015	Tane, Masakazu/0000-0002-1478-6820; 			Tane M, 2013, ACTA MATER, V61, P7543, DOI 10.1016/j.actamat.2013.08.036	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	FEB 1	2015	84						515	515		10.1016/j.actamat.2014.11.006		1	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CA1RC	WOS:000348688300048		
J	Nakata, T				Nakata, T.			Limit theorems for nonnegative independent random variables with truncation	ACTA MATHEMATICA HUNGARICA			English	Article						dominatedly varying; truncation; strong law of large numbers; central limit theorem	ST-PETERSBURG GAME	We investigate asymptotic behavior of sums of independent and truncated random variables specified by P (0 ) = 1 and P for . By varying truncation levels we study strong laws of large numbers and central limit theorems. These are extensions of the results of GyArfi and Kevei [12] concerning the St. Petersburg game.	Fukuoka Univ Educ, Dept Math, Fukuoka 8114192, Japan	Nakata, T (reprint author), Fukuoka Univ Educ, Dept Math, Akama Bunkyomachi, Fukuoka 8114192, Japan.	nakata@fukuoka-edu.ac.jp			Japan Society for the Promotion of Science [KAKENHI 21540133]	This research was supported by KAKENHI 21540133 of Japan Society for the Promotion of Science.	Adler A., 1990, J THEORET PROBAB, V3, P587, DOI 10.1007/BF01046098; Billingsley P, 2012, PROBABILITY MEASURE; Bingham N. H., 1989, REGULAR VARIATION; Csorgo S, 1996, STAT PROBABIL LETT, V26, P65, DOI 10.1016/0167-7152(94)00253-3; Embrechts P., 1997, MODELLING EXTREMAL E; Feller W, 1968, INTRO PROBABILITY TH, VI; Feller W., 1966, INTRO PROBABILITY TH, VII; Gnedenko B. V., 1968, LIMIT DISTRIBUTIONS; Gut A., 2013, RES REPORT, P3; Gut A, 2010, J APPL PROBAB, V47, P752; Gut A., 2005, PROBABILITY GRADUATE; Gyorfi L, 2011, PERIOD MATH HUNG, V62, P13, DOI 10.1007/s10998-011-5013-3; Matsumoto K, 2013, J APPL PROBAB, V50, P54; Petrov V.V., 1995, LIMIT THEOREMS PROBA	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5294	1588-2632		ACTA MATH HUNG	Acta Math. Hung.	FEB	2015	145	1					1	16		10.1007/s10474-014-0474-5		16	Mathematics	Mathematics	AZ9LO	WOS:000348536200001		
J	Nunokawa, M; Sokol, J; Trabka-Wieclaw, K				Nunokawa, M.; Sokol, J.; Trabka-Wieclaw, K.			On the order of strongly starlikeness in some classes of starlike functions	ACTA MATHEMATICA HUNGARICA			English	Article						analytic; univalent; convex; starlike; strongly starlike; uniformly convex; order of strongly starlikeness		We consider the order of strongly starlikeness in the class of analytic functions f, f(0) = 0, f'(0) = 1, such that vertical bar 1 + zf ''(z)/f'(z)/zf'(z)/f(z)-1 vertical bar < b for z is an element of D. We consider also the same problem for alpha-convex functions of order beta.	[Nunokawa, M.] Gunma Univ, Chuou Ward, Chiba 2600808, Japan; [Sokol, J.] Rzeszow Univ Technol, Dept Math, PL-35959 Rzeszow, Poland; [Trabka-Wieclaw, K.] Lublin Univ Technol, Dept Math, PL-20618 Lublin, Poland	Sokol, J (reprint author), Rzeszow Univ Technol, Dept Math, Al Powstancow Warszawy 12, PL-35959 Rzeszow, Poland.	mamoru_nuno@doctor.nifty.jp; jsokol@prz.edu.pl; k.trabka@pollub.pl	Trabka-Wieclaw, Katarzyna/A-9144-2013				BRANNAN DA, 1969, J LONDON MATH SOC, V1, P431; Mocanu P.T., 1969, MATH CLUJ, V11, P127; NUNOKAWA M, 1993, P JPN ACAD A-MATH, V69, P234; NUNOKAWA M, 1992, P JPN ACAD A-MATH, V68, P152; Obradovic M., 2000, FOL SCI U TECH RES, V181, P59; Silverman H., 1999, INT J MATH MATH SCI, V22, P75, DOI 10.1155/S0161171299220753; Stankiewicz J, 1966, ANN U M CURIE SKLO A, V20, P59; Tuneski N, 2003, MATH NACHR, V248, P200, DOI 10.1002/mana.200310015	8	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5294	1588-2632		ACTA MATH HUNG	Acta Math. Hung.	FEB	2015	145	1					142	149		10.1007/s10474-014-0467-4		8	Mathematics	Mathematics	AZ9LO	WOS:000348536200011		
J	Matsubara, S; Baba, Y; Ohkuchi, A				Matsubara, Shigeki; Baba, Yosuke; Ohkuchi, Akihide			Cesarean incision in case of placenta previa: does the transplacental approach cause fetal anemia?	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter									[Matsubara, Shigeki; Baba, Yosuke; Ohkuchi, Akihide] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Norgaard LN, 2012, ACTA OBSTET GYN SCAN, V91, P546, DOI 10.1111/j.1600-0412.2012.01375.x; Crane JMG, 1999, OBSTET GYNECOL, V93, P541, DOI 10.1016/S0029-7844(98)00480-3; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; Baba Y, 2014, J OBSTET GYNAECOL RE, V40, P1243, DOI 10.1111/jog.12340; Jang DG, 2011, INT J MED SCI, V8, P554; Matsubara S, 2012, ARCH GYNECOL OBSTET, V285, P557, DOI 10.1007/s00404-011-2107-3	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	FEB	2015	94	2					226	227		10.1111/aogs.12512		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CA2DJ	WOS:000348718800017		
J	Kitajima, H; Kanazawa, T; Mori, R; Hirano, S; Ogihara, T; Fujimura, M				Kitajima, Hiroyuki; Kanazawa, Tadahiro; Mori, Rintaro; Hirano, Shinya; Ogihara, Tohru; Fujimura, Masanori			Long-term alpha-tocopherol supplements may improve mental development in extremely low birthweight infants	ACTA PAEDIATRICA			English	Article						Alpha-tocopherol; Extremely low birthweight; Mental development; Synapse elimination; Vitamin E deficiency	MUSCLE-CELL-PROLIFERATION; VITAMIN-E STATUS; BRONCHOPULMONARY DYSPLASIA; AUTISTIC-CHILDREN; CONTROLLED TRIAL; OUTCOMES; PROTEIN; DEXAMETHASONE; INHIBITION; PLASMA	AimMethods to improve the mental development of extremely low birthweight (ELBW) children are currently lacking. We assessed the effects of long-term supplementation of alpha-tocopherol on the neurological development of 259 school-aged ELBW children. MethodsExtremely low birthweight participants were divided into three groups: group A with no alpha-tocopherol supplementation (n=121); group B with the supplementation for <6months (n=104) and group C with the supplementation for more than 6months (n=34). We analysed the participants' data at birth and between the ages of one-and-a-half to 8years and evaluated potential factors associated with intellectual disabilities. ResultsChildren from group C had the best outcome. The groups' mean gestational weeks and mean ventilator days were as follows: 27.5weeks, 16.1days (group A); 25.7weeks, 41.7days (group B); and 25.1weeks, 75.5days (group C). Multivariate regression analysis revealed that the odds ratios for impaired mental development at 8years were 1.5 in group B and 0.19 (p=0.017) in group C, compared with 1.0 in group A. The association between the duration of alpha-tocopherol administration and performance intelligence quotient (IQ) was dose dependent (p=0.03). ConclusionLong-term supplementation of alpha-tocopherol appeared to improve mental development, in particular, performance IQ, in school-aged ELBW children.	[Kitajima, Hiroyuki; Hirano, Shinya; Fujimura, Masanori] Osaka Med Ctr, Dept Neonatal Med, Izumi Ku, Osaka 5941101, Japan; [Kitajima, Hiroyuki; Hirano, Shinya; Fujimura, Masanori] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Kanazawa, Tadahiro] Osaka Univ, Sch Human Sci, Dept Comparat & Dev Psychol, Suita, Osaka, Japan; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Ogihara, Tohru] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 569, Japan	Kitajima, H (reprint author), Osaka Med Ctr, Dept Neonatal Med, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	kitajima@mch.pref.osaka.jp					MAUER AM, 1985, PEDIATRICS, V75, P976; Muller DPR, 2010, MOL NUTR FOOD RES, V54, P710, DOI 10.1002/mnfr.200900460; O'Shea TM, 1999, PEDIATRICS, V104, P15, DOI 10.1542/peds.104.1.15; Chen K, 2009, EARLY HUM DEV, V85, P421, DOI 10.1016/j.earlhumdev.2009.02.001; Herrera E, 2001, J PHYSIOL BIOCHEM, V57, P43; Koscik RL, 2005, J PEDIATR-US, V147, pS51, DOI 10.1016/j.jped.2005.08.003; Anderson PJ, 2006, SEMIN PERINATOL, V30, P227, DOI 10.1053/j.semperi.2006.05.010; Yamauchi J, 2001, BIOCHEM BIOPH RES CO, V285, P295, DOI 10.1006/bbrc.2001.5162; Ishii N, 2013, PEDIATRICS, V132, P62, DOI 10.1542/peds.2012-2857; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Al-Gadani Y, 2009, CLIN BIOCHEM, V42, P1032, DOI 10.1016/j.clinbiochem.2009.03.011; Tasinato A, 1995, P NATL ACAD SCI USA, V92, P12190, DOI 10.1073/pnas.92.26.12190; Koscik RL, 2004, PEDIATRICS, V113, P1549, DOI 10.1542/peds.113.6.1549; Rimbach G, 2002, P NUTR SOC, V61, P415, DOI 10.1079/PNS2002183; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; AVERY GB, 1985, PEDIATRICS, V75, P106; Koyama T, 2009, PSYCHIAT CLIN NEUROS, V63, P241, DOI 10.1111/j.1440-1819.2009.01931.x; Boshtam M, 2002, INT J VITAM NUTR RES, V72, P309, DOI 10.1024/0300-9831.72.5.309; CHATELAIN E, 1993, BIOCHIM BIOPHYS ACTA, V1176, P83, DOI 10.1016/0167-4889(93)90181-N; desDiego-Otero Y, 2009, NEUROPSYCHOPHARMACOL, V34, P1011; Krajcovicova-Kudlackova M, 2009, BRATISL MED J, V110, P247; MINO M, 1985, AM J CLIN NUTR, V41, P631; Mishra GD, 2003, EUR J CLIN NUTR, V57, P1418, DOI 10.1038/sj.ejcn.1601706; Myklebust HR, 1981, PUPIL RATING SCALE; Society for the Kyoto Scale of Psychological Development Test, 2008, SHINP K SHIK HATT KE; TANAKA H, 1988, J NUTR SCI VITAMINOL, V34, P293	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	FEB	2015	104	2					E82	E89		10.1111/apa.12854		8	Pediatrics	Pediatrics	CA2IB	WOS:000348731000008		
J	Ohba, S; Soai, NV; Anh, DTV; Nguyen, YT; Takagi, M				Ohba, Shin-ya; Nguyen Van Soai; Dinh Thi Van Anh; Nguyen, Yen T.; Takagi, Masahiro			Study of mosquito fauna in rice ecosystems around Hanoi, Northern Vietnam	ACTA TROPICA			English	Article						Agriculture; Culex vishnui subgroup; Integrated vector management; Mosquito control	JAPANESE ENCEPHALITIS-VIRUS; CULEX TRITAENIORHYNCHUS DIPTERA; LARVIVOROUS PREDATORS; WEST JAVA; SRI-LANKA; CULICIDAE; ABUNDANCE; FIELDS; MANAGEMENT; INFECTION	Species of the Culex vishnui subgroup, Culex fuscocephala and Culex gelidus, which are known Japanese encephalitis (JE) vectors, are distributed in rice agroecosystems in Asian countries. Hence, although ecological studies of rice agroecosystems in northern Vietnam are necessary, very few integrated studies of breeding habitats of mosquitoes, including JE vectors, have been conducted. We carried out a field study and investigated the mosquito fauna in six rice production areas in northern Vietnam during the rainy and dry seasons of 2009. Mosquitoes and potential mosquito predators were collected from aquatic habitats by using larval dippers. We collected 1780 Culex individuals (including 254 Culex tritaeniorhynchus; 113 Culex vishnui, 58 Culex vishnui complex, consisting of Culex vishnui and Culex pseudovishnui; 12 Culex gelidus; 1 Culex bitaeniorhynchus; and 1 Culex fuscocephala), 148 Anopheles individuals (including 5 Anopheles vagus), 1 Mansonia annulifera, and 1 Mimomyia chamberlaini during the rainy season. During the dry season, we collected 176 Culex individuals (including 33 Culex vishnui, 24 Culex tritaeniorhynchus, 8 Culex vishnui complex, and 1 Culex gelidus) and 186 Anopheles individuals (including 9 Anopheles tessellatus, 2 Anopheles kochi, and 2 Anopheles barbumbrosus). We found mosquitoes in all aquatic habitats, namely, rice fields, ditches, ponds, wetlands, irrigation canals, and rice nurseries, and Culex tritaeniorhynchus and Culex vishnui complex were found in all the above six areas. Heteroptera such as Micronecta, Veliidae, and Pleidae were abundant and widely distributed in both the seasons. The abundance of mosquito larvae was higher in the rice fields, ditches, and ponds during the rainy season than during the dry season. Culex tritaeniorhynchus, Culex vishnui complex, Culex fuscocephala, and Culex gelidus were abundant in rice agroecosystems (rice fields, ditches, ponds, and wetlands) in northern Vietnam, and their abundance was high during the rainy season. These findings deepen our understanding of mosquito ecology and strengthen mosquito control strategies to be applied in rice ecosystems Vietnam in the future. (C) 2014 Elsevier B.V. All rights reserved.	[Ohba, Shin-ya; Takagi, Masahiro] Nagasaki Univ, Inst Trop Med, Dept Vector Ecol & Environm, Nagasaki 8528523, Japan; [Nguyen Van Soai; Dinh Thi Van Anh; Nguyen, Yen T.] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam	Ohba, S (reprint author), Nagasaki Univ, Fac Educ, Biol Lab, Bunkyo Ku, Nagasaki 8512125, Japan.	ooba@nagasaki-u.ac.jp			KAKENHI [19256002]; Japan Society for the Promotion of Science (JSPS); Nagasaki University; Sumitomo Chemical (Osaka, Japan); Ministry of Education, Culture, Sports, Science and Technology (MEXT)	We thank the entomological staff of the National Institute of Hygiene and Epidemiology. This study was partially supported by KAKENHI 19256002, the Japan Society for the Promotion of Science (JSPS), the joint research fund between Nagasaki University and Sumitomo Chemical (Osaka, Japan), and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to M.T.	Takagi M, 1997, J MED ENTOMOL, V34, P272; Ohba S, 2006, LIMNOLOGY, V7, P41, DOI 10.1007/s10201-006-0161-5; Shaalan EAS, 2009, TROP BIOMED, V26, P223; Kuwata R, 2013, AM J TROP MED HYG, V88, P681, DOI 10.4269/ajtmh.12-0407; Sunahara T, 2002, J VECTOR ECOL, V27, P8; Ohba SY, 2011, J AM MOSQUITO CONTR, V27, P384, DOI 10.2987/11-6163.1; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; GINGRICH JB, 1992, J MED ENTOMOL, V29, P436; GOULD DOUGLAS J., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P429, DOI 10.1016/0035-9203(62)90018-4; Hasegawa M, 2008, AM J TROP MED HYG, V78, P159; Keiser J, 2005, ACTA TROP, V95, P40, DOI 10.1016/j.actatropica.2005.04.012; Lacey L.A., 1990, J AM MOSQ CONTROL S2, V6, P1; MOGI M, 1990, J MED ENTOMOL, V27, P530; MOGI M, 1978, Tropical Medicine, V20, P173; Mogi M, 2007, J AM MOSQUITO CONTR, V23, P93, DOI 10.2987/8756-971X(2007)23[93:IAOIP]2.0.CO;2; MOGI M, 1993, J MED ENTOMOL, V30, P309; Nguyen H., 1995, SE ASIAN J TROP ME S, V26, P47; Nguyen T.K.T., 1974, SE ASIAN J TROP MED, V5, P408; Okuno T, 1978, World Health Stat Q, V31, P120; R Development Core Team, 2011, R LANG ENV STAT COMP; Rattanarithikul Rampa, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 1, P1; Rattanarithikul Rampa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1; Reuben R, 1994, J AM MOSQUITO CONTR, V26, P75; Stoops CA, 2008, J VECTOR ECOL, V33, P216, DOI 10.3376/1081-1710(2008)33[216:LCROCS]2.0.CO;2; Takagi M, 1996, J MED ENTOMOL, V33, P698; TAKAGI M, 1995, J MED ENTOMOL, V32, P112; VANPEENEN PFD, 1975, J MED ENTOMOL, V12, P573; Victor T. John, 1999, Indian Journal of Malariology, V36, P19; Vythilingam I, 1997, J MED ENTOMOL, V34, P257; Watanabe M., 1968, Japanese Journal of Sanitary Zoology, V19, P35; Yasuoka Junko, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P646; Yasuoka J, 2006, T ROY SOC TROP MED H, V100, P995, DOI 10.1016/j.trstmh.2005.12.014; Zuur A.F., 2009, MIXED EFFECTS MODELS, P574	34	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	FEB	2015	142						89	95		10.1016/j.actatropica.2014.11.002		7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CA8UU	WOS:000349197200013		
J	Oka, M; Abe, H; Ikegami, T				Oka, Mizuki; Abe, Hirotake; Ikegami, Takashi			Dynamic homeostasis in packet switching networks	ADAPTIVE BEHAVIOR			English	Article						Homeostasis; Ashby's law of requisite variety; packet switching network; Internet; congestion; attractor; adaptability	EVOLUTION; EMERGENCE; INTERNET; GAIA	In this study, we investigate the adaptation and robustness of a packet switching network (PSN), the fundamental architecture of the Internet. We claim that the adaptation introduced by a transmission control protocol congestion control mechanism is interpretable as the self-organization of complex itinerant behavior among many quasi-attracting states. To discuss this argument quantitatively, we study the adaptation of the Internet by simulating a PSN using ns-2. Our hypothesis is that the robustness and fragility of the Internet can be attributed to the inherent dynamics of the PSN feedback mechanism called the congestion window size, or cwnd. By varying the data input into the PSN system, we demonstrate the possible self-organization of attractors in cwnd temporal dynamics and discuss the adaptability and robustness of PSNs. The present study provides an example of Ashby's Law of Requisite Variety in action.	[Oka, Mizuki; Abe, Hirotake] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki 3058577, Japan; [Ikegami, Takashi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1138654, Japan	Oka, M (reprint author), Univ Tsukuba, Dept Comp Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	mizuki@cs.tsukuba.ac.jp			Japan Society for the Promotion of Science [25730184, 24700031, 24120704]	This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) (grant numbers 25730184 'Burst Analysis of Twitter time series based on RT diffusion and its application to Web services' and 24700031 'Wide-area distributed archival storage with replica allocation mechanism based on throughput prediction') and partially by Grant-in-Aid for Scientific Research on Innovative Areas (grant number 24120704 'The study on the neural dynamics for understanding communication in terms of complex hetero systems') as well as Grant-in-Aid for RIKEN 'Promotion of the Integrated Medical Science' (2012-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; KANEKO K, 1990, PHYSICA D, V41, P137, DOI 10.1016/0167-2789(90)90119-A; McKeown N, 2008, ACM SIGCOMM COMP COM, V38, P69, DOI 10.1145/1355734.1355746; WATSON AJ, 1983, TELLUS B, V35, P284; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Low SH, 1999, IEEE ACM T NETWORK, V7, P861, DOI 10.1109/90.811451; Lenton TM, 1998, NATURE, V394, P439, DOI 10.1038/28792; ASHBY R, 1958, CYBERNETICA, V1, P83; Ashby R.W., 1960, DESIGN BRAIN ORIGIN; CANNON W. B., 1963, WISDOM BODY, P25; DIPAOLO EA, 2000, COM ADAP SY, P440; Dyke JG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003050; Fetterly D., 2003, P 12 INT WORLD WID W, P669; Franchi S, 2013, CONSTR FOUND, V9, P93; Free A, 2007, TRENDS ECOL EVOL, V22, P611, DOI 10.1016/j.tree.2007.07.007; Gilbert AC, 2005, UND COM SYS, P21; Harvey I., 2004, P 9 INT C SIM SYNTH, P309; Iizuka H, 2007, ADAPT BEHAV, V15, P359, DOI 10.1177/1059712307084687; Ikeda K., 1989, PROG THEOR PHYS SUPP, V99, P295, DOI 10.1143/PTPS.99.295; Ikegami T, 1992, CHAOS, V2, P397, DOI 10.1063/1.165882; Ikegami T, 2008, BIOSYSTEMS, V91, P388, DOI 10.1016/j.biosystems.2007.05.014; Ikegami T, 2007, J CONSCIOUSNESS STUD, V14, P111; IKEGAMI T, 1990, PHYSICA D, V42, P235, DOI 10.1016/0167-2789(90)90077-3; Ikegami T., 2011, P 20 EUR C ART LIF P, P364; Lovelock J. E., 1974, TELLUS B, V26, P299; Ntoulas A., 2004, P 13 INT C WORLD WID, P1, DOI 10.1145/988672.988674; Oka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060398; Stratton G. M., 1896, PSYCHOL REV, V3, P611, DOI 10.1037/h0072918; Takayasu M, 2005, UND COM SYS, P329; Tsuda I., 2001, BEHAV BRAIN SCI, V24, P575; Umpleby SA, 2009, INT J GEN SYST, V38, P231, DOI 10.1080/03081070802601509; Vattay G, 2005, UND COM SYS, P49; Veres A., 2005, COMPLEX DYNAMICS COM, P1, DOI 10.1007/10973509_1; Wood AJ, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000217; Zhang H, 2005, UND COM SYS, P251	35	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1059-7123	1741-2633		ADAPT BEHAV	Adapt. Behav.	FEB	2015	23	1					50	63		10.1177/1059712314556369		14	Computer Science, Artificial Intelligence; Psychology, Experimental; Social Sciences, Interdisciplinary	Computer Science; Psychology; Social Sciences - Other Topics	CA7OK	WOS:000349106700004		
J	Suwazono, T; Nakamura, N; Yamashita, A				Suwazono, Tsukasa; Nakamura, Norihito; Yamashita, Atsushi			Development of the remote-controlled platform truck for handling heavy object and the remote control human interface for the disaster response	ADVANCED ROBOTICS			English	Article						handling heavy object; remote control; human interface		General interest for robotic technology has been increased by the public and the media after Fukushima Daiichi Nuclear Power Plant (hereafter referred to as 1F) disaster. Especially, robots which can work under the very severe condition where personnel cannot access have demands for development. As to respond to such high demands, NEDO established 'Disaster response unmanned systems development project' in 2012.[1] This project is specialized in the development of various remote-controlled equipment, such as remote-controlled platform truck and remote control human interface under 'Mobile Robot Development'. Remote-controlled platform truck is designed to safely and surely deliver robots and supplies, instead of using stairs and elevator, etc. in and out of building where it is too critical for personnel to work under. Remote control human interface for robots is designed to standardize the command and operation screen for operator, based on opinions from project members, and manned facility construction.[2] In this article, mechanical structure and development tasks for remote-controlled platform truck, and commonalization approach for operation and camera display of various remote-controlled equipment and robot for remote control human interface are stated. Background: due to hydrogen explosion triggered by The Great East Japan Earthquake on 11 March 2011, a reactor building at Fukushima Daiichi Nuclear Power Plant was severely damaged. It is required to reduce high radiation dose in the atmosphere of the reactor building to perform restoration. To pursue decontamination of the reactor building, equipment to lift and carry decontamination devices to upper floor are required.	[Suwazono, Tsukasa; Nakamura, Norihito] Toshiba Co Ltd, Control Rod Drive & Serv Syst Engn Grp, Syst Design & Engn Dept, Yokohama, Kanagawa, Japan; [Yamashita, Atsushi] Univ Tokyo, Dept Precis Engn, Tokyo, Japan	Nakamura, N (reprint author), Toshiba Co Ltd, Control Rod Drive & Serv Syst Engn Grp, Syst Design & Engn Dept, Yokohama, Kanagawa, Japan.	norihito1.nakamura@toshiba.co.jp						0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0169-1864	1568-5535		ADV ROBOTICS	Adv. Robot.	FEB 1	2015	29	3			SI		165	169		10.1080/01691864.2014.1001787		5	Robotics	Robotics	CB3IQ	WOS:000349521800001		
J	Gay-Balmaz, F; Yoshimura, H				Gay-Balmaz, Francois; Yoshimura, Hiroaki			Dirac reduction for nonholonomic mechanical systems and semidirect products	ADVANCES IN APPLIED MATHEMATICS			English	Article						Dirac structures; Reduction by symmetry; Nonholonomic systems; Variational structures; Semidirect products; Rivlin-Ericksen fluids	CONSERVING PHYSICAL SYSTEMS; EULER-POINCARE EQUATIONS; VARIATIONAL-PRINCIPLES; LAGRANGIAN SYSTEMS; PART I; FLUIDS; SYMMETRY; LIE; ALGEBROIDS; POISSON	This paper develops the theory of Dirac reduction by symmetry for nonholonomic systems on Lie groups with broken symmetry. The reduction is carried out for the Dirac structures, as well as for the associated Lagrange-Dirac and Hamilton-Dirac dynamical systems. This reduction procedure is accompanied by reduction of the associated variational structures on both Lagrangian and Hamiltonian sides. The reduced dynamical systems obtained are called the implicit Euler-Poincare-Suslov equations with advected parameters and the implicit Euler-Poisson-Suslov equations with advected parameters. The theory is illustrated with the help of finite and infinite dimensional examples. It is shown that equations of motion for second order Rivlin-Ericksen fluids can be formulated as an infinite dimensional nonholonomic system in the framework of the present paper. (C) 2014 Elsevier Inc. All rights reserved.	[Gay-Balmaz, Francois] CNRS, F-75005 Paris, France; [Gay-Balmaz, Francois] Ecole Normale Super Paris, Meteorol Dynam Lab, F-75005 Paris, France; [Yoshimura, Hiroaki] Waseda Univ, Shinjuku Ku, Tokyo 1698555, Japan	Gay-Balmaz, F (reprint author), CNRS, 24 Rue Lhomond, F-75005 Paris, France.	francois.gay-balmaz@lmd.ens.fr; yoshimura@waseda.jp			ANR project GEOMFLUID [ANR-14-CE23-0002-01]; JSPS [26400408]; JST (CREST); Waseda University [SR 2014B-162]; IRSES project "Geomech" within the 7th European Community Framework Programme [246981]	F.G.B. is partially supported by the ANR project GEOMFLUID, ANR-14-CE23-0002-01; H.Y. is partially supported by JSPS (26400408), JST (CREST), Waseda University (SR 2014B-162), and the IRSES project "Geomech" (246981) within the 7th European Community Framework Programme.	DUNN JE, 1974, ARCH RATION MECH AN, V56, P191, DOI 10.1007/BF00280970; Ellis DCP, 2010, ARCH RATION MECH AN, V197, P811, DOI 10.1007/s00205-010-0305-y; Holm DD, 1998, PHYS REV LETT, V80, P4173, DOI 10.1103/PhysRevLett.80.4173; Bou-Rabee N, 2009, FOUND COMPUT MATH, V9, P197, DOI 10.1007/s10208-008-9030-4; MARSDEN J, 1983, PHYSICA D, V7, P305, DOI 10.1016/0167-2789(83)90134-3; RIVLIN RS, 1955, J RATION MECH ANAL, V4, P323; Gay-Balmaz F, 2009, ADV APPL MATH, V42, P176, DOI 10.1016/j.aam.2008.06.002; Holm DD, 1998, ADV MATH, V137, P1, DOI 10.1006/aima.1998.1721; Liu ZJ, 1998, COMMUN MATH PHYS, V192, P121, DOI 10.1007/s002200050293; DIRAC PAM, 1950, CAN J MATH, V2, P129, DOI 10.4153/CJM-1950-012-1; FOSDICK RL, 1979, ARCH RATION MECH AN, V70, P145; Bursztyn H, 2007, ADV MATH, V211, P726, DOI 10.1016/j.aim.2006.09.008; DUNN JE, 1995, INT J ENG SCI, V33, P689, DOI 10.1016/0020-7225(94)00078-X; Gay-Balmaz F, 2010, PHYSICA D, V239, P1929, DOI 10.1016/j.physd.2010.07.002; MARSDEN JE, 1984, T AM MATH SOC, V281, P147, DOI 10.2307/1999527; KOILLER J, 1992, ARCH RATION MECH AN, V118, P113, DOI 10.1007/BF00375092; ARNOLD V, 1966, ANN I FOURIER, V16, P319; Koon WS, 1998, REP MATH PHYS, V42, P101; COURANT TJ, 1990, T AM MATH SOC, V319, P631, DOI 10.2307/2001258; Bates L., 1993, Reports on Mathematical Physics, V32, DOI 10.1016/0034-4877(93)90073-N; Blankenstein G, 2001, REP MATH PHYS, V47, P57, DOI 10.1016/S0034-4877(01)90006-0; Bloch AM, 1996, ARCH RATION MECH AN, V136, P21, DOI 10.1007/BF02199365; Bloch A. M., 2003, INTERDISCIP APPL MAT, V24; BLOCH AM, 1997, AM MATH SOC PROVIDEN, V64, P103; BRETHERT.FP, 1970, J FLUID MECH, V44, P19, DOI 10.1017/S0022112070001660; Campos CM, 2012, RACSAM REV R ACAD A, V106, P225, DOI 10.1007/s13398-011-0053-3; Cendra H., 2001, MATH UNLIMITED 2001, P221; Cendra H, 2007, REGUL CHAOTIC DYN, V12, P56, DOI 10.1134/S1560354707010054; Cendra H., 2001, MEM AM MATH SOC, VV, P152; CENDRA H, 1987, PHYSICA D, V27, P63, DOI 10.1016/0167-2789(87)90005-4; Cendra H., 1987, Journal of Geometry and Physics, V4, DOI 10.1016/0393-0440(87)90026-X; Cendra H, 2003, MOSC MATH J, V3, P833; Cortes J, 2009, DISCRETE CONT DYN S, V24, P213, DOI 10.3934/dcds.2009.24.213; Courant T., 1988, TRAVAUX COURS, V27, P39; Dalsmo M, 1998, SIAM J CONTROL OPTIM, V37, P54, DOI 10.1137/S0363012996312039; DORFMAN IY, 1987, PHYS LETT A, V125, P240, DOI 10.1016/0375-9601(87)90201-5; Dorfman I.Ya., 1993, NONLINEAR SCI THEORY; Gay-Balmaz F., 2014, PHYS D IN PRESS; Gay-Balmaz F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.244303; Gay-Balmaz F, 2011, DYNAM PART DIFFER EQ, V8, P5; Gay-Balmaz F, 2009, J GEOM MECH, V1, P417, DOI 10.3934/jgm.2009.1.417; Grabowska K, 2011, J GEOM PHYS, V61, P2233, DOI 10.1016/j.geomphys.2011.06.018; Holm D.D., 2008, GEOMETRIC MECH; Joseph D. D., 1990, FLUID DYNAMICS VISCO; Koon W.S., 1997, REP MATH PHYS, V40, P21, DOI DOI 10.1016/S0034-4877(97)85617-0; Kozlov V.V., 1988, FUNKT ANAL PRIL, V22, P69; Marie C.-M., 1998, REP MATH PHYS, V42, P211; Marsden J. E., 1999, TEXTS APPL MATH, V17; Marsden J E, 2007, LECT NOTES MATH, V1913; Marsden J.E., 1982, ATTI ACAD SCI TORINO, V117, P289; Schneider D, 2002, DYNAM SYST, V17, P87, DOI 10.1080/02681110110112852; Truesdell C., 1999, INTRO MECH FLUIDS; Truesdell C., 2008, INTRO MECH FLUIDS; TULCZYJEW WM, 1977, ANN I H POINCARE A, V27, P101; VANDERSCHAFT A, 1995, AEU-ARCH ELEKTRON UB, V49, P362; Yoshimura H, 2009, J GEOM MECH, V1, P87, DOI 10.3934/jgm.2009.1.87; Yoshimura H, 2006, J GEOM PHYS, V57, P133, DOI 10.1016/j.geomphys.2006.02.009; Yoshimura H, 2007, REP MATH PHYS, V60, P381, DOI 10.1016/S0034-4877(08)00004-9; Yoshimura H, 2006, J GEOM PHYS, V57, P209, DOI 10.1016/j.geomphys.2006.02.012	59	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0196-8858	1090-2074		ADV APPL MATH	Adv. Appl. Math.	FEB	2015	63						131	213		10.1016/j.aam.2014.10.004		83	Mathematics, Applied	Mathematics	CA4OC	WOS:000348883100006		
J	Getling, AV; Ishikawa, R; Buchnev, AA				Getling, A. V.; Ishikawa, R.; Buchnev, A. A.			Doubts about the crucial role of the rising-tube mechanism in the formation of sunspot groups	ADVANCES IN SPACE RESEARCH			English	Article						Solar photosphere; Solar convection; Magnetic fields; Sunspot formation; Hinode observations	SOLAR OPTICAL TELESCOPE; EMERGING FLUX TUBES; MAGNETIC-FIELDS; HYDROMAGNETIC DYNAMO; CONVECTION ZONE; SCALE MOTIONS; HINODE; PHOTOSPHERE; GENERATION; EMERGENCE	Some preliminary processing results are presented for a dataset obtained with the Solar Optical Telescope on the Hinode satellite. The idea of the project is to record, nearly simultaneously, the full velocity and magnetic-field vectors in growing active regions and sunspot groups at a photospheric level. Our ultimate aim is to elaborate observational criteria to distinguish between the manifestations of two mechanisms of sunspot-group formation - the rising of an Omega-shaped flux tube of a strong magnetic field and the in situ amplification and structuring of magnetic field by convection (the convective mechanism is briefly described). Observations of a young bipolar subregion developing within AR 11313 were carried out on 9-10 October 2011. During each 2-h observational session, 5576-angstrom filtergrams and Dopplergrams were obtained at a time cadence of 2 min, and one or two 32-min-long spectropolarimetric fast-mode scans were done. Based on the series of filtergrams, the trajectories of corks are computed, using a technique similar to but more reliable than local correlation tracking (LCT), and compared with the magnetic maps. At this stage of the investigation, only the vertical magnetic field and the horizontal flows are used for a qualitative analysis. According to our preliminary findings, the velocity pattern in the growing active region has nothing to do with a spreading flow on the scale of the entire bipolar region, which could be expected if a tube of strong magnetic field emerged. No violent spreading flows on the scale of the entire growing magnetic region can be identified. Instead, normal mesogranular and supergranular flows are preserved: Signs of small-scale structuring of the magnetic field can be detected in the area where new spots develop, and signs of the presence of separatrices between the magnetic polarities can be found, such that the surface flows converge to but not diverge from these separatrix curves. The observed scenario of evolution seems to agree with Bumba's inference that the development of an active region does not entail the destruction of the existing convective-velocity field. The convective mechanism appears to be better compatible with observations than the rising-tube mechanism. In the umbras of the well-developed sunspots, flows converging to the umbra centres are revealed. Spreading streams are present around these spots. (C) 2014 COSPAR. Published by Elsevier Ltd. All rights reserved.	[Getling, A. V.] Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys, Moscow 119991, Russia; [Ishikawa, R.] Natl Astron Observ Japan, Hinode Sci Ctr, Mitaka, Tokyo 1818588, Japan; [Buchnev, A. A.] Inst Computat Math & Math Geophys, Novosibirsk 630090, Russia	Getling, AV (reprint author), Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys, Moscow 119991, Russia.	A.Getling@mail.ru; ryoko.ishikawa@nao.ac.jp; baa@ooi.sscc.ru			Russian Foundation for Basic Research [12-02-00792-a]	Hinode is a Japanese mission developed and launched by ISAS/JAXA, with NAOJ as domestic partner and NASA and STFC (UK) as international partners. It is operated by these agencies in cooperation with ESA and NSC (Norway). The work of A.V.G. and A.A.B. was supported by the Russian Foundation for Basic Research (project no. 12-02-00792-a).	PARKER EN, 1970, ASTROPHYS J, V160, P383, DOI 10.1086/150442; PARKER EN, 1955, ASTROPHYS J, V122, P293, DOI 10.1086/146087; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Stein RF, 2012, ASTROPHYS J LETT, V753, DOI 10.1088/2041-8205/753/1/L13; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Lites BW, 2013, SOL PHYS, V283, P579, DOI 10.1007/s11207-012-0206-3; Ichimoto K, 2008, SOL PHYS, V249, P233, DOI 10.1007/s11207-008-9169-9; CALIGARI P, 1995, ASTROPHYS J, V441, P886, DOI 10.1086/175410; BUMBA V, 1965, ASTROPHYS J, V141, P1492, DOI 10.1086/148237; Shimizu T, 2008, SOL PHYS, V249, P221, DOI 10.1007/s11207-007-9053-z; BRANDENBURG A, 1991, GEOPHYS ASTRO FLUID, V61, P179, DOI 10.1080/03091929108229043; Bumba V., 1963, B ASTRON I CZECH, V14, P1; Bumba V., 1967, REND SCUOL INT FIS E, P77; Caligari P, 1998, ASTROPHYS J, V502, P481, DOI 10.1086/305875; Cattaneo F, 1999, ASTROPHYS J, V515, pL39, DOI 10.1086/311962; Charbonneau P, 1996, ASTROPHYS J, V473, pL59, DOI 10.1086/310387; Dobler W., 2004, P IAU S, V223, P239; ELSASSER WM, 1956, REV MOD PHYS, V28, P135, DOI 10.1103/RevModPhys.28.135; Fan Y., 2013, ARXIV13056370ASTROPH; Getling AV, 2001, ASTRON REP+, V45, P569, DOI 10.1134/1.1383816; Getling AV, 2010, ASTRON REP+, V54, P254, DOI 10.1134/S1063772910030078; Getling A.V., 2013, P IAU S, P137; Gurevich L.E., 1946, J PHYS USSR, V16, p[832, 337]; Kitchatinov LL, 2000, SOL PHYS, V191, P325, DOI 10.1023/A:1005213708194; Kitiashvili I.N., 2013, ARXIV13120982V1ASTRO; Kosovichev AG, 2008, ASTROPHYS J LETT, V688, pL115, DOI 10.1086/595619; Kosovichev AG, 2009, SPACE SCI REV, V144, P175, DOI 10.1007/s11214-009-9487-8; Lites B., 2007, MEM SOC ASTRON ITAL, V78, P148; NASA, 2007, SCI NEWS GIANT TRAIL; PARKER EN, 1957, P NATL ACAD SCI USA, V43, P8, DOI 10.1073/pnas.43.1.8; PARKER EN, 1955, ASTROPHYS J, V121, P491, DOI 10.1086/146010; PARKER EN, 1970, ASTROPHYS J, V162, P665, DOI 10.1086/150697; Rempel M, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/90; Suematsu Y, 2008, SOL PHYS, V249, P197, DOI 10.1007/s11207-008-9129-4; Tverskoii caron  B.A., 1966, Geomagnetizm i Aeronomiya, V6; Vainshtein S.I., 1982, SOV PHYS JETP, V56, P86; Vogler A, 2007, ASTRON ASTROPHYS, V465, pL43, DOI [10.1051/0004-6361:20077253, 10.1051/004-6361:20077253]; Warnecke J, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/2/L37; WOOD WP, 1985, GEOPHYS ASTRO FLUID, V32, P135, DOI 10.1080/03091928508208782	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0273-1177	1879-1948		ADV SPACE RES	Adv. Space Res.	FEB 1	2015	55	3					862	870		10.1016/j.asr.2014.07.024		9	Astronomy & Astrophysics; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geology; Meteorology & Atmospheric Sciences	CA5MW	WOS:000348953500014		
J	Yagioka, A; Komatsuzaki, M; Kaneko, N; Ueno, H				Yagioka, Atsushi; Komatsuzaki, Masakazu; Kaneko, Nobuhiro; Ueno, Hideto			Effect of no-tillage with weed cover mulching versus conventional tillage on global warming potential and nitrate leaching	AGRICULTURE ECOSYSTEMS & ENVIRONMENT			English	Article						No tillage; Weed cover mulch; Global warming potential; Soil carbon; Nitrate leaching	NITROUS-OXIDE EMISSIONS; LONG-TERM; METHANE OXIDATION; CLIMATE-CHANGE; POTATO FIELDS; CH4 FLUXES; SOIL; CARBON; CROP; MANAGEMENT	Abandoned agricultural land could potentially accumulate soil organic carbon (SOC) when it is no longer used for cultivation and is allowed to revert to natural vegetation. In Japan, no tillage with weed mulching will be adopted in marginal farmland as a new organic farming system because this system minimizes the disturbance of the soil ecosystem and reduces the cost for crop production. The present study aimed to compare the effects of two organic farming systems, namely no-tillage with weed cover mulching and conventional tillage (CT), and two organic fertilizer application modes, namely no fertilizer (N-) and organic fertilizer (N+; 50 kg N ha(-1) during 2010 and 2011 and 80 kg N ha(-1) during 2012) on greenhouse gas (GHG) fluxes, soil carbon sequestration, net global warming potential (GWP), and nitrate leaching. Pumpkin (Cucurbita spp.) was cultivated as the main crop in 2010 and 2011, whereas mixed cropping of okra (Abelmoschus esculentus L.), bell pepper (Capsicum annuum L.), and eggplant (Solanum melongena L.) was implemented in 2012. Tillage management increased CH4 uptake immediately after the tillage; however, the effects did not continue in the long term. On the contrary, NTW increased CH4 uptake, and the soil carbon content at the soil surface linearly increased every year after conversion to NTW indicating that improving soil physics by continuing NTW contributed to enhanced CH4 uptake. N2O emissions in NTW were higher only immediately after a weed mowing; however, NTW did not increase the annual N2O emission. In addition, the difference between initial and final SOC (Delta SOC) was greater in NTW than in CT, which significantly decreased net GWP in NTW in comparison with CT. Nitrate leaching was 48.6% and 47.3% lower in NTW than in CT at soil depths of 30-60 and 60-90 cm, respectively. These results show that no-tillage with weed cover mulching contributed to conserve the regional and global environment by reducing nitrate leaching and net GWP from the agro-ecosystem by increasing the annual CH4 uptake and soil carbon sequestration. This system will be adopted for abandoned agricultural land because it reduces net GWP shortly after conversion to this management. (C) 2014 Elsevier B.V. All rights reserved.	[Yagioka, Atsushi] Tokyo Univ Agr Technol, Unite Grad Sch Agr, Ibaraki 3000393, Japan; [Komatsuzaki, Masakazu] Ibaraki Univ, Ctr Field Sci Res & Educ, Coll Agr, Ibaraki 3000393, Japan; [Kaneko, Nobuhiro] Yokohama Natl Univ, Soil Ecol Res Grp, Yokohama, Kanagawa 2408501, Japan; [Ueno, Hideto] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	Komatsuzaki, M (reprint author), Ibaraki Univ, Ctr Field Sci Res & Educ, Coll Agr, 3-21-1 Ami, Ibaraki 3000393, Japan.	50013954007@st.tuat.ac.jp; komachan@mx.ibaraki.ac.jp; kanekono@ynu.ac.jp; uenoh@agr.ehime-u.ac.jp			JSPS KAKENHI Grant [21241010, 25281053]	The authors would like to thank Mr. T. Shimotai, Ms. K. Kobayakawa, Ms. M. Yamamoto, Ms. I. Toyosaki, and Ms. R. Wako (College of Agriculture, Ibaraki University) for their assistance in field management and sample collection. This study was supported by JSPS KAKENHI Grant numbers 21241010 and 25281053.	Altieri M., 2002, AGR ECOSYST ENVIRON, V1971, P1, DOI DOI 10.1016/S0167-8809(02)00085-3; Regina K, 2010, SOIL TILL RES, V109, P144, DOI 10.1016/j.still.2010.05.009; KITUR BK, 1984, AGRON J, V76, P240; Potter KN, 1999, SOIL SCI, V164, P718, DOI 10.1097/00010694-199910000-00002; King GM, 1997, GLOBAL CHANGE BIOL, V3, P351, DOI 10.1046/j.1365-2486.1997.00090.x; Henebry GM, 2009, NATURE, V457, P1089, DOI 10.1038/4571089a; RANDALL GW, 1995, J ENVIRON QUAL, V24, P360; Flessa H, 2002, GEODERMA, V105, P307, DOI 10.1016/S0016-7061(01)00110-0; Hansen EM, 1997, SOIL TILL RES, V41, P203, DOI 10.1016/S0167-1987(96)01097-5; Yao ZS, 2009, SOIL BIOL BIOCHEM, V41, P2131, DOI 10.1016/j.soilbio.2009.07.025; Di HJ, 2002, NUTR CYCL AGROECOSYS, V64, P237, DOI 10.1023/A:1021471531188; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; SCHUTZ H, 1990, BIOGEOCHEMISTRY, V11, P77; Beare MH, 2009, SOIL BIOL BIOCHEM, V41, P611, DOI 10.1016/j.soilbio.2008.12.024; Shively JM, 2001, CURR OPIN MICROBIOL, V4, P301, DOI 10.1016/S1369-5274(00)00207-1; HANSEN S, 1993, SOIL BIOL BIOCHEM, V25, P621, DOI 10.1016/0038-0717(93)90202-M; Maeda M, 2003, ENVIRON POLLUT, V121, P477, DOI 10.1016/S0269-7491(02)00233-6; Rochette P, 2008, SOIL SCI SOC AM J, V72, P1363, DOI 10.2136/sssaj2007.0371; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Liu XJJ, 2007, SOIL BIOL BIOCHEM, V39, P2362, DOI 10.1016/j.soilbio.2007.04.008; Ma YC, 2013, AGR ECOSYST ENVIRON, V164, P209, DOI 10.1016/j.agee.2012.11.003; Ruser R, 1998, SOIL SCI SOC AM J, V62, P1587; BENDER M, 1994, J GEOPHYS RES-ATMOS, V99, P16531, DOI 10.1029/94JD00266; Constantin J, 2010, AGR ECOSYST ENVIRON, V135, P268, DOI 10.1016/j.agee.2009.10.005; Six J, 2004, GLOBAL CHANGE BIOL, V10, P155, DOI 10.1111/j.1529-8817.2003.00730.x; ALTIERI MA, 1985, CROP PROT, V4, P201, DOI 10.1016/0261-2194(85)90018-3; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Arai M, 2014, GEODERMA, V221, P50, DOI 10.1016/j.geoderma.2014.01.022; Ball BC, 1997, J GEOPHYS RES-ATMOS, V102, P23301, DOI 10.1029/97JD00870; BrandiDohrn FM, 1997, J ENVIRON QUAL, V26, P181; Editorial Committee of Soil Environmental Analysis, 2008, SOIL ENV AN; Fukuoka M., 1978, ONE STRAW REVOLUTION; Hashimi R., 2014, JAPN J FARM WORK RES, V1, P24; Higashi T, 2014, SOIL TILL RES, V138, P64, DOI 10.1016/j.still.2013.12.010; IPCC, 2007, CLIM CHANG 2007 CONT; Kawaguchi Y., 2000, NATURAL FARMING; Komatsuzaki M, 2012, JAP J ORG AGRIC SCI, V5, P53; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Muramoto J., 2009, CONVERSION SUSTAINAB, P274; Pearse A., 1980, SEEDS PLENTY SEEDS W; SAS Institute, 1998, STATV WIND V 5 0 1 C; Sato Y, 2010, MICROBES ENVIRON, V25, P321, DOI 10.1264/jsme2.ME10134; Shiva V., 1991, VIOLENCE GREEN REVOL, P56; SMITH KA, 1995, PHILOS T R SOC A, V351, P327, DOI 10.1098/rsta.1995.0037; Syswerda SP, 2012, AGR ECOSYST ENVIRON, V149, P10, DOI 10.1016/j.agee.2011.12.007; TYLER DD, 1977, J ENVIRON QUAL, V6, P63; Wyland LJ, 1996, AGR ECOSYST ENVIRON, V59, P1, DOI 10.1016/0167-8809(96)01048-1; Yagioka A., 2014, BIOL AGR HORTIC; Yamaki A., 2003, Japanese Journal of Soil Science and Plant Nutrition, V74, P195; Zhaorigetu, 2008, MICROBES ENVIRON, V23, P201, DOI 10.1264/jsme2.23.201	51	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8809	1873-2305		AGR ECOSYST ENVIRON	Agric. Ecosyst. Environ.	FEB 1	2015	200						42	53		10.1016/j.agee.2014.09.011		12	Agriculture, Multidisciplinary; Ecology; Environmental Sciences	Agriculture; Environmental Sciences & Ecology	CA5ML	WOS:000348952400005		
J	Khairunisa, SQ; Kotaki, T; Witaningrum, AM; Yunifiar, MQ; Sukartiningrum, SD; Nasronudin; Kameoka, M				Khairunisa, Siti Qamariyah; Kotaki, Tomohiro; Witaningrum, Adiana Mutamsari; Yunifiar M, Muhammad Qushai; Sukartiningrum, Septhia Dwi; Nasronudin; Kameoka, Masanori			Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Derived from Drug-Treated Indonesian Patients	AIDS RESEARCH AND HUMAN RETROVIRUSES			English	Article							MOLECULAR EPIDEMIOLOGY; HIV; SUBTYPES	Although HIV-1 drug resistance is a major obstacle in Indonesia, information on drug resistance is limited. In this study, the viral subtype and appearance of drug resistance mutations in the HIV-1 protease (PR) and reverse transcriptase (RT) genes were determined among drug-treated, HIV-1-infected patients in Surabaya. HIV-1 patients who received antiretroviral therapy (ART) more than 2 years were randomly recruited regardless of the viral load or ART failure. Fifty-eight HIV-1 PR genes and 53 RT genes were sequenced. CRF01_AE viruses were identified as the predominant strain. Major drug resistance mutations were not detected in the PR genes. In contrast, 37.7% (20/53) of the participants had one or more major drug resistance mutations in the RT genes, predominantly M184V (28.3%), K103N (11.3%), and thymidine analogue mutations (TAMs) (20.8%). The high prevalence of drug resistance mutations in RT genes indicated the necessity of monitoring the effectiveness of ART in Indonesia.	[Khairunisa, Siti Qamariyah; Kotaki, Tomohiro; Witaningrum, Adiana Mutamsari; Yunifiar M, Muhammad Qushai; Sukartiningrum, Septhia Dwi; Nasronudin] Airlangga Univ, Indonesian Japan Collaborat Res Ctr Emerging & Re, Inst Trop Dis, Surabaya, Indonesia; [Kotaki, Tomohiro; Kameoka, Masanori] Kobe Univ Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo, Japan; [Nasronudin] Airlangga Univ, Fac Med, Surabaya, Indonesia; [Kameoka, Masanori] Kobe Univ Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo, Japan	Kameoka, M (reprint author), Kobe Univ Grad Sch Hlth Sci, Dept Int Hlth, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	mkameoka@port.kobe-u.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, Science and Technology of Japan; Institute of Tropical Disease as the Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); by the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Institute of Tropical Disease as the Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia.	Sahbandar IN, 2009, AIDS RES HUM RETROV, V25, P637, DOI 10.1089/aid.2008.0266; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Auwanit W, 2009, AIDS RES HUM RETROV, V25, P625, DOI 10.1089/aid.2008.0298; Fibriani A, 2013, J MED VIROL, V85, P1394, DOI 10.1002/jmv.23606; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lan YC, 2008, J MED VIROL, V80, P183, DOI 10.1002/jmv.21065; Mohamad S, 2012, BRAZ J INFECT DIS, V16, P284, DOI 10.1590/S1413-86702012000300012; Requejo HIZ, 2006, REV SAUDE PUBL, V40, P331, DOI 10.1590/s0034-89102006000200023; Somnuek S, 2011, CLIN INFECT DIS, V52, P1053; Somnuek S, 2012, J INT AIDS SOC, V15, P12; Tomohiro K, 2013, PLOS ONE, V8, P489; Trotter AB, 2013, AIDS REV, V15, P162; UNAIDS, UNAIDS REP GLOB AIDS; WHO (World Health Organization), 2005, SUMM COUNTR PROF HIV	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0889-2229	1931-8405		AIDS RES HUM RETROV	Aids Res. Hum. Retrovir.	FEB 1	2015	31	2					255	259		10.1089/aid.2014.0221		5	Immunology; Infectious Diseases; Virology	Immunology; Infectious Diseases; Virology	CB0KP	WOS:000349315100016		
J	Kusa, S; Komatsu, Y; Taniguchi, H; Uchiyama, T; Takagi, T; Nakamura, H; Miyazaki, S; Hachiya, H; Iesaka, Y				Kusa, Shigeki; Komatsu, Yuki; Taniguchi, Hiroshi; Uchiyama, Takashi; Takagi, Takamitsu; Nakamura, Hiroaki; Miyazaki, Shinsuke; Hachiya, Hitoshi; Iesaka, Yoshito			Left atrial appendage flow velocity after successful ablation of persistent atrial fibrillation: Clinical perspective from transesophageal echocardiographic assessment during sinus rhythm	AMERICAN HEART JOURNAL			English	Article							CATHETER ABLATION; CHA(2)DS(2)-VASC SCORES; THROMBOEMBOLIC RISK; COMPUTED-TOMOGRAPHY; FILLING PRESSURES; PULMONARY VEIN; FOLLOW-UP; STROKE; ANTICOAGULATION; STRATIFICATION	Background Left atrial appendage flow velocity (LAAFV) is a predictor of thromboembolism in atrial fibrillation (AF) patients, as well as CHA(2)DS(2)-VASc score. However, little is known about LAAFV in sinus rhythm (SR) after catheter ablation. The aim of this study was to determine clinical predictors of low LAAFV in patients in whom stable SR had been maintained after catheter ablation for persistent AF. Methods The study comprised 104 patients with persistent AF (median AF duration 24 months) in whom SR had been achieved and maintained for at least 6 months after the final ablation procedure. Transesophageal echocardiography was performed to assess LAAFV during SR after ablation. Lower LAAFV was defined as <= 40 cm/s. Results Mean LAAFV before ablation was 29 +/- 11 cm/s (range 10-67 cm/s). In 23 (22%) patients, LAAFV remained low even after being in SR for at least 6 months. Multiple logistic regression analysis showed that CHA(2)DS(2)-VASc scores of >= 2 (odds ratio 2.18, 95% CI 1.19-3.99, P = .012) was an independent predictor of lower LAAFV after successful ablation. Seventeen (74%) of the 23 patients with low LAAFV during SR presented CHA(2)DS(2)-VASc scores of >= 2 complicated by spontaneous echo contrast during AF. Conclusions Long-term maintenance of SR after catheter ablation for persistent AF does not guarantee LAAFV recovery. The CHA(2)DS(2)-VASc score appears to predict poor recovery of LAAFV. Further studies are necessary to confirm the usefulness of LAAFV during SR as a surrogate marker predicting thromboembolism in patients after AF ablation.	[Kusa, Shigeki; Komatsu, Yuki; Taniguchi, Hiroshi; Uchiyama, Takashi; Takagi, Takamitsu; Nakamura, Hiroaki; Miyazaki, Shinsuke; Hachiya, Hitoshi; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Ctr Cardiovasc, Tsuchiura, Ibaraki, Japan	Kusa, S (reprint author), Tsuchiura Kyodo Gen Hosp, Ctr Cardiovasc, 11-7 Manabe Shinmachi, Tsuchiura, Ibaraki, Japan.	shigeki_kusa@wine.ocn.ne.jp					Agmon Y, 2000, AM J CARDIOL, V86, P769, DOI 10.1016/S0002-9149(00)01078-X; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; Ommen SR, 2000, CIRCULATION, V102, P1788; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Themistoclakis S, 2010, J AM COLL CARDIOL, V55, P735, DOI 10.1016/j.jacc.2009.11.039; Matsuo S, 2009, J AM COLL CARDIOL, V54, P788, DOI 10.1016/j.jacc.2009.01.081; Donal E, 2005, AM J CARDIOL, V95, P941, DOI 10.1016/j.amjcard.2004.12.031; Chao TF, 2011, J AM COLL CARDIOL, V58, P2380, DOI 10.1016/j.jacc.2011.08.045; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Verma A, 2006, J CARDIOVASC ELECTR, V17, P741, DOI 10.1111/j.1540-8167.2006.00488.x; Lee SH, 2008, J NEUROL SCI, V271, P148, DOI 10.1016/j.jns.2008.04.006; Machino-Ohtsuka T, 2013, CIRC J, V77, P1695, DOI 10.1253/circj.CJ-12-1518; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Wang M, 2005, J AM COLL CARDIOL, V45, P272, DOI 10.1016/j.jacc.2004.09.059; Gaita F, 2014, EUROPACE, V16, P980, DOI 10.1093/europace/eut406; Handke M, 2005, J AM SOC ECHOCARDIOG, V18, P1366, DOI 10.1016/j.echo.2005.05.006; Kumagai K, 2013, CIRC J, V77, P1416, DOI 10.1253/circj.CJ-12-0934; Miyazaki S, 2013, HEART RHYTHM, V10, P338, DOI 10.1016/j.hrthm.2012.11.025; Omran H, 1997, J AM COLL CARDIOL, V29, P131; Teh AW, 2012, HEART RHYTHM, V9, P473, DOI 10.1016/j.hrthm.2011.11.013; VERHORST PMJ, 1993, AM J CARDIOL, V71, P192, DOI 10.1016/0002-9149(93)90737-W; Willens HJ, 2013, J AM SOC ECHOCARDIOG, V26, P175, DOI 10.1016/j.echo.2012.11.002	28	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-8703	1097-5330		AM HEART J	Am. Heart J.	FEB	2015	169	2					211	221		10.1016/j.ahj.2014.11.009		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CA9AN	WOS:000349212800005		
J	Nazare, JA; Smith, J; Borel, AL; Aschner, P; Barter, P; Van Gaal, L; Tan, CE; Wittchen, HU; Matsuzawa, Y; Kadowaki, T; Ross, R; Brulle-Wohlhueter, C; Almeras, N; Haffner, SM; Balkau, B; Despres, JP				Nazare, Julie-Anne; Smith, Jessica; Borel, Anne-Laure; Aschner, Pablo; Barter, Phil; Van Gaal, Luc; Tan, Chee Eng; Wittchen, Hans-Ulrich; Matsuzawa, Yuji; Kadowaki, Takashi; Ross, Robert; Brulle-Wohlhueter, Claire; Almeras, Natalie; Haffner, Steven M.; Balkau, Beverley; Despres, Jean-Pierre		INSPIRE ME IAA Invest	Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							CORONARY-HEART-DISEASE; OF-THE-LITERATURE; CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; METABOLIC SYNDROME; INTRAABDOMINAL ADIPOSITY; COLLABORATIVE ANALYSIS; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; 52 COUNTRIES	Despite its well-documented relation with visceral adiposity (VAT) and cardiometabolic risk (CMR), whether waist circumference (WC) should be measured in addition to body mass index (BMI) remains debated. This study tested the relevance of adding WC to BMI for the estimation of VAT and CMR. In the International Study of Prediction of Infra-abdominal Adiposity and Its Relationship with Cardiometabolic Risk/Intra-abdominal Adiposity, 297 physicians recruited 4,504 patients (29 countries). Both BMI and WC were measured, whereas VAT and liver fat were assessed by computed tomography. A composite CMR score was calculated. From the 4,109 patients included in the present analyses (20 5 BMI < 40 kg/m(2), 47% women), about 30% displayed discordant values for WC and BMI quintiles, despite a strong correlation between the 2 anthropometric variables (r = 0.87 and r = 0.84 for men and women, respectively, p < 0.001). Within each single BMI unit, VAT and WC showed substantial variability between subjects (mean difference between 90th and 10th percentiles: 175 cm(2)/16 cm and 137 cm(2)/18 cm for VAT/WC in men and women, respectively). Within each BMI category, increasing gender-specific WC tertiles were associated with significantly higher VAT, liver fat, and with a more adverse CMR profile. In conclusion, this large international cardiometabolic study highlights the frequent discordance between BMI and WC, driven by the substantial variability in VAT for a given BMI. Within each BMI category, WC was cross-sectionally associated with VAT, liver fat, and CMR factors. Thus, WC allows a further refinement of the CMR related to any given BMI. (C) 2015 Elsevier Inc. All rights reserved.	[Nazare, Julie-Anne; Smith, Jessica; Almeras, Natalie; Despres, Jean-Pierre] Univ Cardiol & pneumol, Ctr Rech Inst, Quebec City, PQ, Canada; [Nazare, Julie-Anne] CENS, CARMEN Lab, INSERM U1060, INRA 1235, Pierre Benite, France; [Smith, Jessica] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Borel, Anne-Laure] Hop Univ Grenoble, Pole DIGI DUNE, INSERM U1042, Dept Endocrinol Diabetol Maladie Nutr,HP2 Lab, Grenoble, France; [Aschner, Pablo] Ignacio Univ Hosp, Sch Med, Javeriana Univ, Bogota, Colombia; [Barter, Phil] Univ New S Wales, Fac Med, Ctr Vasc Res, Sydney, NSW, Australia; [Van Gaal, Luc] Univ Antwerp Hosp, Department Endocrinol Diabetol Metab & Clin Nutr, Edegem, Belgium; [Tan, Chee Eng] Gleneagles Med Ctr, Singapore, Singapore; [Wittchen, Hans-Ulrich] Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies, CELOS, D-01062 Dresden, Germany; [Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychothe, D-01062 Dresden, Germany; [Matsuzawa, Yuji] Sumitomo Hosp, Dept Endocrinol & Metab, Osaka, Japan; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Ross, Robert] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Brulle-Wohlhueter, Claire] Sanofi Rech, Paris, France; [Haffner, Steven M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Balkau, Beverley] Univ Paris Sud 11, Paris, France; [Balkau, Beverley] INSERM, CESP, Ctr Res Epidemiol & Populat Hlth, UMRS 1018, Villejuif, France	Despres, JP (reprint author), Univ Cardiol & pneumol, Ctr Rech Inst, Quebec City, PQ, Canada.	jean-pierre.despres@criucpq.ulaval.ca			Sanofi; Paris; Canadian Institutes of Health Research [MI-E-112982]; Agiradom, France; region "Rhone-Alpes," France; Merck; Novartis; Abbott, US; Servier, France; Pfizer; Sanofi, France; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec, Canada; Theratechnologies; Torrent Pharmaceuticals/Abbott; AstraZeneca; Pfizer, Canada; Merck, Canada; GSK	This work was supported by Sanofi, Paris, by the Canadian Institutes of Health Research (grant number MI-E-112982, Dr. Nazare), by Agiradom, France (Dr. Borel), and region "Rhone-Alpes," France (Dr. Borel).; Drs Nazare, Smith, Borel, Matsuzawa, Almeras, Aschner, Barter, Kadowaki, Van Gaal, Ross, and Tan have no competing of interest to disclose related to the submitted work. Dr. Haffner has received speaker's fees from Merck and is a member of the consultant/advisory board from Novartis. Dr. Balkan has received research grants from Abbott, US, and Servier, France, is a member of the advisory board for Eli Lilly, Sanofi, BMS, Boehringer Ingelhelm, and AstraZeneca. Dr. Brulle-Wohlhueter is an employee of Sanofi. Dr. Wittchen has received a grant from Pfizer and travel and speaker's fees from Sanofi and Novartis. Dr. Despres has received a research grant from Sanofi, France, and Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec, Canada, and personal fees from Novartis, Theratechnologies, Torrent Pharmaceuticals/Abbott, AstraZeneca, Pfizer, Canada, Merck, Canada, and GSK.	Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Despres JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Janssen I, 2002, AM J CLIN NUTR, V75, P683; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Hanley AJG, 2005, CIRCULATION, V112, P3713, DOI 10.1161/CIRCULATIONAHA.105.559633; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Kahn HS, 2003, AM J CLIN NUTR, V78, P928; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Carlsson AC, 2013, INT J OBESITY, V37, P1579, DOI 10.1038/ijo.2013.46; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Berrington D. G., 2010, NEW ENGL J MED, V363, P2211, DOI DOI 10.1056/NEJM0A1000367; Despres JP, 2011, J AM COLL CARDIOL, V57, P1887, DOI 10.1016/j.jacc.2010.10.063; Despres JP, 2014, AM J CARDIOL, V114, P320, DOI 10.1016/j.amjcard.2014.04.043; Fox KAA, 2009, EUR HEART J, V30, P3055, DOI 10.1093/eurheartj/ehp371; Grundy Scott M., 2008, Metabolic Syndrome and Related Disorders, V6, P281, DOI 10.1089/met.2008.0026; [NHLBI NIH], 1998, OBES RES S2, V6, p51S; PIEKARSKI J, 1980, RADIOLOGY, V137, P727; Sniderman AD, 2006, J INTERN MED, V259, P455, DOI 10.1111/j.1365-2796.2006.01649.x; World Health Organization, 2007, PREV CARD DIS GUID A	30	5	5	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	FEB 1	2015	115	3					307	315		10.1016/j.amjcard.2014.10.039		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CA0TN	WOS:000348629400006		
J	Xu, DZ; Murakoshi, N; Sairenchi, T; Lrie, F; Igarashi, M; Nogami, A; Tomizawa, T; Yamaguchi, I; Yamagishi, K; Iso, H; Ota, H; Aonuma, K				Xu, DongZhu; Murakoshi, Nobuyuki; Sairenchi, Toshimi; Lrie, Fujiko; Igarashi, Miyako; Nogami, Akihiko; Tomizawa, Takuji; Yamaguchi, Iwao; Yamagishi, Kazumasa; Iso, Hiroyasu; Ota, Hitoshi; Aonuma, Kazutaka			Anemia and Reduced Kidney Function as Risk Factors for New Onset of Atrial Fibrillation (from the Ibaraki Prefectural Health Study)	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; ATHEROSCLEROSIS RISK; RENAL-INSUFFICIENCY; MORTALITY; HEART; SYSTEM; IMPACT	Chronic kidney disease (CKD) is a potential independent risk factor for atrial fibrillation (AF). It remains unclear whether anemia is synergistically associated with increased risk of AF onset in subjects with CKD. We evaluated the association of kidney function, hemoglobin (Hb), and their combination with new-onset AF in a population-based cohort study. We conducted a 15-year prospective cohort study of 132,250 Japanese subjects aged 40 to 79 years who participated in annual health checkups from 1993. Kaplan-Meier survival analysis was used to compare freedom from new-onset AF between groups classified by estimated glomerular filtration rate grade, Hb grade, and their combination. Cox proportional hazard model analysis was used to estimate hazard ratios (HRs) for new-onset AF. During a 13.8-year mean follow-up period, 1,232 (0.93%) subjects with new-onset AF were identified. Lower estimated glomerular filtration rate and lower Hb grades were significantly associated with a higher incidence of new-onset AF. Multivariate HRs and 95% confidence intervals (CIs) of new-onset AF were 1.38 (1.21 to 1.56) for mild CKD group, 2.56 (2.09 to 3.13) for CKD group, and 1.50 (1.24 to 1.83) for anemia group. Borderline Hb level was not significantly associated with increased risk for new-onset AF (HR 1.07, CI 0.91 to 1.25, p = 0.4284). In the model with interaction term between CKD and anemia, the risk was significantly higher (p = 0.0343 for the interaction) than that predicted by each factor independently. In conclusion, decreased kidney function and lower Hb level are associated with increased risk for new-onset AF, especially when both are present. (C) 2015 Elsevier Inc. All rights reserved.	[Xu, DongZhu; Murakoshi, Nobuyuki; Igarashi, Miyako; Nogami, Akihiko; Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki, Japan; [Yamagishi, Kazumasa] Univ Tsukuba, Dept Publ Hlth Med, Tsukuba, Ibaraki, Japan; [Xu, DongZhu; Murakoshi, Nobuyuki; Sairenchi, Toshimi; Igarashi, Miyako; Yamagishi, Kazumasa; Ota, Hitoshi] Ibarakhi Hlth Serv Assoc, Mito, Ibaraki, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Dept Publ Hlth Sci, Mibu, Tochigi, Japan; [Lrie, Fujiko] Ibarald Prefectural Govt, Dept Hlth & Welf, Mito, Ibaraki, Japan; [Tomizawa, Takuji; Yamaguchi, Iwao] Ibaraki Hlth Serv Associat, Mito, Ibaraki, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan	Murakoshi, N (reprint author), Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki, Japan.	n.murakoshi@md.tsukuba.ac.jp			Ministry of Health, Labor and Welfare, and Health and Labor Sciences Research Grants, Japan [H17-Kenkou-007]; Comprehensive Research on Cardiovascular and Life-Style Related Diseases [H18-Junkankitou[Seishuu]-Ippan-012]; Comprehensive Research on Cardiovascular and Life-Style Related Diseases	`This research was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare, and Health and Labor Sciences Research Grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H18-Junkankitou[Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H20-Junkankitou[Seishuu]-Ippan-013; Intractable Diseases Conquest Research: H21-Nanchi-Ippan-059; Intractable Diseases Conquest Research: H22-Nanchi-Ippan-144; and Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou [Seishuu]-Ippan-005). All authors have no conflicts of interest to disclose concerning this study.	Horio T, 2010, J HYPERTENS, V28, P1738, DOI 10.1097/HJH.0b013e32833a7dfe; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; Ananthapanyasut W, 2010, CLIN J AM SOC NEPHRO, V5, P173, DOI 10.2215/CJN.03170509; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Al-Ahmad A, 2001, J AM COLL CARDIOL, V38, P955, DOI 10.1016/S0735-1097(01)01470-X; Jurkovitz CT, 2003, J AM SOC NEPHROL, V14, P2919, DOI 10.1097/01.ASN.0000092138.65211.71; Palazzuoli A, 2008, INT J CLIN PRACT, V62, P281, DOI 10.1111/j.1742-1241.2007.01650.x; Iguchi Y, 2008, AM J CARDIOL, V102, P1056, DOI 10.1016/j.amjcard.2008.06.018; McManus DD, 2009, AM J CARDIOL, V104, P1551, DOI 10.1016/j.amjcard.2009.07.026; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Naruse Y, 2011, HEART RHYTHM, V8, P335, DOI 10.1016/j.hrthm.2010.10.047; Bohm M, 2009, EUR HEART J, V30, P1364, DOI 10.1093/eurheartj/ehp124; Fabbian F, 2000, CLIN NEPHROL, V54, P234; Hirakata H, 2010, CLIN EXP NEPHROL, V14, P28, DOI 10.1007/s10157-009-0212-4; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Takahashi Y, 2011, CIRCULATION, V124, P2380, DOI 10.1161/CIRCULATIONAHA.111.047266	23	2	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	FEB 1	2015	115	3					328	333		10.1016/j.amjcard.2014.10.041		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CA0TN	WOS:000348629400009		
J	Kajimoto, K; Sato, N; Takano, T				Kajimoto, Katsuya; Sato, Naoki; Takano, Teruo		Invest Acute Decompensated Heart	Relation of Left Ventricular Ejection Fraction and Clinical Features or Co-morbidities to Outcomes Among Patients Hospitalized for Acute Heart Failure Syndromes	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							PRESERVED SYSTOLIC FUNCTION; CORONARY-ARTERY-DISEASE; DIABETES-MELLITUS; MORTALITY; ANEMIA; DYSFUNCTION; COMMUNITY; REGISTRY; MANAGEMENT; IMPACT	The aim of this study was to evaluate the heterogeneity of the association of a preserved or reduced ejection fraction (EF) with the increased risk of outcomes among patients with acute heart failure syndromes. Of the 4,842 patients enrolled in the Acute Decompensated Heart Failure Syndromes (ATTEND) registry in Japan, 4,720 patients were evaluated to investigate the association of EF and clinical features or co-morbidities with all-cause mortality after admission. The median follow-up period after admission was 519 (388 to 781) days. The all-cause mortality rate did not differ between the reduced EF and preserved EF groups (24.9% and 24.5%, respectively). To evaluate the heterogeneity of the influence of a preserved or reduced EF on all-cause mortality, subgroup analyses were performed. As a result, there were significant interactions in the association of a preserved or reduced EF with all-cause mortality when the patients were stratified by an ischemic cause, a hypertensive cause, previous hospitalization for heart failure, diabetes mellitus, and anemia. The influence of a nonischemic cause, a hypertensive cause, or new-onset heart failure on the risk of all-cause mortality was significantly greater in patients with preserved EF than in those with reduced EF. In contrast, the influence of diabetes mellitus or anemia on the risk of all-cause mortality was significantly greater in patients with reduced EF than in those with preserved EF. In conclusion, the present analysis demonstrated that the association of a preserved or reduced EF with the clinical outcome differs markedly in relation to the clinical features or co-morbidities of these patients. (C) 2015 Elsevier Inc. All rights reserved.	[Kajimoto, Katsuya] Towa Hosp, Div Cardiol, Tokyo, Japan; [Sato, Naoki] Nippon Med Sch, Musashi Kosugi Hosp, Internal Med Cardiol & Intens Care Unit, Kanazawa, Ishikawa, Japan; [Takano, Teruo] Nippon Med Sch, Dept Internal Med, Tokyo 113, Japan	Kajimoto, K (reprint author), Towa Hosp, Div Cardiol, Tokyo, Japan.	kkajimoto@gmail.com			Japan Heart Foundation (Tokyo, Japan)	This work was supported by the Japan Heart Foundation (Tokyo, Japan), which had no role in the conduct of the study, but provided funding for statistical support and administration. before commencing the ATTEND registry, information on the objectives of this study, its social significance, and an abstract were provided for clinical trial registration with the University Hospital Medical Information Network (UMIN; Clinical Trial Registration ID UMIN000000736). The funding organization did not participate in the design and conduct of this study; in the collection, analysis, and interpretation of data; or in the preparation, review, or approval of the manuscript.	Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Kajimoto K, 2013, INT J CARDIOL, V168, P554, DOI 10.1016/j.ijcard.2013.01.187; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Ho JE, 2012, EUR HEART J, V33, P1734, DOI 10.1093/eurheartj/ehs070; Nunez J, 2010, EUR J HEART FAIL, V12, P38, DOI 10.1093/eurjhf/hfp176; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Kosiborod M, 2005, ARCH INTERN MED, V165, P2237, DOI 10.1001/archinte.165.19.2237; Komajda M, 2007, EUR HEART J, V28, P1310, DOI 10.1093/eurheartj/ehl443; Hoenig MR, 2008, CURR VASC PHARMACOL, V6, P292, DOI 10.2174/157016108785909779; Ohara T, 2010, CURR OPIN CARDIOL, V25, P613, DOI 10.1097/HCO.0b013e32833f0438; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Sato N, 2010, AM HEART J, V159, P949, DOI 10.1016/j.ahj.2010.03.019; Al-Ahmad A, 2001, J AM COLL CARDIOL, V38, P955, DOI 10.1016/S0735-1097(01)01470-X; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Velagaleti RS, 2010, CIRCULATION, V122, P1700, DOI 10.1161/CIRCULATIONAHA.109.929661; Shindler DM, 1996, AM J CARDIOL, V77, P1017, DOI 10.1016/S0002-9149(97)89163-1; Kazory A, 2009, J AM COLL CARDIOL, V53, P639, DOI 10.1016/j.jacc.2008.10.046; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Anand IS, 2008, J AM COLL CARDIOL, V52, P501, DOI 10.1016/j.jacc.2008.04.044; Brouwers FP, 2013, EUR HEART J, V34, P1424, DOI 10.1093/eurheartj/eht066; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Dries DL, 2001, J AM COLL CARDIOL, V38, P421, DOI 10.1016/S0735-1097(01)01408-5; Choudhury L, 2002, AM J CARDIOL, V89, P719, DOI 10.1016/S0002-9149(01)02345-1; de Groote P, 2004, EUR HEART J, V25, P656, DOI 10.1016/j.ehj.2004.01.010; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Redfield MM, 2011, BRAUNWALDS HEART DIS, P586; Smith J Gustav, 2010, J Am Coll Cardiol, V56, P1712, DOI 10.1016/j.jacc.2010.05.049	28	3	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	FEB 1	2015	115	3					334	340		10.1016/j.amjcard.2014.11.007		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CA0TN	WOS:000348629400010		
J	Matsumoto, C; Petrone, AB; Sesso, HD; Gaziano, JM; Djousse, L				Matsumoto, Chisa; Petrone, Andrew B.; Sesso, Howard D.; Gaziano, J. Michael; Djousse, Luc			Chocolate consumption and risk of diabetes mellitus in the Physicians' Health Study	AMERICAN JOURNAL OF CLINICAL NUTRITION			English	Article						chocolate; diabetes mellitus; nutrition; epidemiology; risk factors	FOOD FREQUENCY QUESTIONNAIRE; INSULIN SENSITIVITY; PROSPECTIVE COHORT; OXIDATIVE STRESS; DARK CHOCOLATE; GREEN TEA; WOMEN; CAFFEINE; COCOA; REPRODUCIBILITY	Background: Previous studies reported beneficial effects of cocoa or chocolate on insulin resistance, oxidative stress, and inflammation, which are important risk factors of type 2 diabetes mellitus (DM). However, it is unclear whether chocolate consumption is associated with risk of DM. Objective: We tested the hypothesis that chocolate consumption is inversely associated with incident DM in the Physicians' Health Study (PHS). Design: We prospectively analyzed data on 18,235 PHS participants who were free of DM at baseline (1997-2001). Chocolate consumption was obtained from a baseline food-frequency questionnaire Incident DM was ascertained via annual follow-up questionnaires and validated in a subsample by a review of medical records. We used Cox proportional hazards models to estimate HRs and 95% CIs of DM. Results: The mean (+/- SD) age at baseline was 66.3 +/- 9.2 y. During a mean follow up of 9.2 y, 1123 men (6.2%) developed DM. For self-reported chocolate consumption of none, 1-3 servings/mo, 1 serving/wk, and >= 2 servings/wk, multivariable-adjusted HiRs (95% CIs) of DM adjusted for lifestyle, clinical, and dietary risk factors including total energy intake were 1.00 (referent), 0.93 (0.79, 1.09), 0.86 (0.72, 1.04), and 0.83 (0.69, 0.99), respectively (P-trend = 0.047). In secondary analyses, the inverse association of chocolate consumption and risk of DM was slightly stronger in subjects without a history of cardiovascular disease or heart failure (P-trend = 0.023). In addition, both age and BMI modified the chocolate-DM relation (P < 0.05 each). Conclusion: Our data support an inverse relation of chocolate intake with incident DM, which appears only to apply in younger and normal-body weight men after controlling for comprehensive life styles including total energy consumption.	[Matsumoto, Chisa] Tokyo Med Univ, Div Cardiol, Tokyo 1600023, Japan; [Petrone, Andrew B.; Sesso, Howard D.; Gaziano, J. Michael; Djousse, Luc] Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA; [Sesso, Howard D.; Gaziano, J. Michael] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Sesso, Howard D.; Gaziano, J. Michael; Djousse, Luc] Harvard Univ, Sch Med, Boston, MA USA; [Gaziano, J. Michael; Djousse, Luc] Boston Vet Affairs Healthcare Syst, Boston, MA USA	Matsumoto, C (reprint author), Tokyo Med Univ, Div Cardiol, Shinjyuku Ku, 6-7-1 Nishishinjyuku, Tokyo 1600023, Japan.	chisamatsumoto@post.harvard.edu			National Heart, Lung, and Blood Institute, Bethesda, MD [R21 HL088081, HL-26490, HL-34595]; National Cancer Institute [CA-34944, CA-40360, CA-097193]	Supported by grant R21 HL088081 from the National Heart, Lung, and Blood Institute, Bethesda, MD. The Physicians' Health Study was supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, MD.	Inoue M, 2012, ENDOCR-RELAT CANCER, V19, pF1, DOI 10.1530/ERC-12-0142; Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894; Kochar J, 2010, EUR J CLIN NUTR, V64, P75, DOI 10.1038/ejcn.2009.121; Hu FB, 1999, AM J EPIDEMIOL, V149, P531; Jalil AMM, 2008, J AGR FOOD CHEM, V56, P7877, DOI 10.1021/jf8015915; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Knekt P, 2002, AM J CLIN NUTR, V76, P560; Dreosti IE, 2000, NUTRITION, V16, P692, DOI 10.1016/S0899-9007(00)00304-X; Curtis PJ, 2012, DIABETES CARE, V35, P226, DOI 10.2337/dc11-1443; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114; Grassi D, 2005, AM J CLIN NUTR, V81, P611; Iso H, 2006, ANN INTERN MED, V144, P554; Davison G, 2012, EUR J NUTR, V51, P69, DOI 10.1007/s00394-011-0193-4; van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512; Hillon P, 2010, GASTROEN CLIN BIOL, V34, P529, DOI 10.1016/j.gcb.2010.07.021; Bruno G, 2011, TRANSPL P, V43, P327, DOI 10.1016/j.transproceed.2010.09.098; Kochar J, 2007, OBESITY, V15, P3039, DOI 10.1038/oby.2007.362; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Djousse L, 2013, NUTR METAB CARDIOVAS, V23, P17, DOI 10.1016/j.numecd.2011.08.002; Food and Drug Administration Department of Health and Human Services, TITL 21 FOOD DRUGS C; Greenberg JA, 2015, CLIN NUTR, V34, P129, DOI 10.1016/j.clnu.2014.02.005; Greenland S, 1998, ANONYMOUS MODERN EPI, P258; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129; Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966; Selmi Carlo, 2008, Mol Nutr Food Res, V52, P1340, DOI 10.1002/mnfr.200700435; Sies H, 2005, AM J CLIN NUTR, V81, P304; The National Agricultural Library, NAT NUTR DAT STAND R; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51	30	1	1	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0002-9165	1938-3207		AM J CLIN NUTR	Am. J. Clin. Nutr.	FEB	2015	101	2					362	367		10.3945/ajcn.114.092221		6	Nutrition & Dietetics	Nutrition & Dietetics	CA5US	WOS:000348973900016		
J	Kaku, Y; Fukumoto, T; Opada, GL; Anan, T; Kimura, T				Kaku, Yo; Fukumoto, Takaya; Opada, Gayle Louise; Anan, Takashi; Kimura, Tetsunori			A Clinicopathologic and Immunohistochemical Study of 7 Cases of Sclerosing Perineurioma	AMERICAN JOURNAL OF DERMATOPATHOLOGY			English	Article						sclerosing perineurioma; claudin-1; GLUT1; EMA; morphology; immunohistochemistry	SOFT-TISSUE PERINEURIOMA; PERIPHERAL-NERVE; CELL TUMOR; EXPRESSION; GLUT1; GENE	Sclerosing perineurioma is a relatively rare tumor that has remained widely unknown since first reported by Fetsch in 1997. To our knowledge, no large or small series of claudin-1 in sclerosing perineurioma has been confirmed to date. We collected 7 new cases of sclerosing perineurioma. Six patients were female, and 1 was male. The patients' age ranged from 15 to 58 years (mean, 36.6 years; median, 42.0 years). The primary reason for consultation at the outpatient clinics was a slowly enlarging mass. The preoperative durations were available for 4 of the 7 cases and ranged from 2 to 7 years. Six tumors were located in the fingers, and the other tumor was found in the palm. The sizes ranged from 4 to 12 mm in diameter (mean, 6.7 mm; median, 6.0 mm). Microscopically, all tumors were nodular lesions, with sclerotic stroma involving reticular dermis primarily consisting of small oval epithelioid cells and plump spindle cells, scattered and arranged in corded, trabecular, reticular, and/or whorled growth patterns. The neoplastic cells were immunoreactive for epithelial membrane antigen (7 of 7) and glucose transporter 1 (7 of 7). The periodic acid-Schiff reaction and positive immunostaining for type IV collagen were observed directly adjacent to the lesional cells in all cases (6 of 6). Claudin-1 immunostaining was positive in all 7 cases, suggesting that claudin-1 may serve as a helpful diagnostic marker for sclerosing perineurioma.	[Kaku, Yo; Fukumoto, Takaya; Opada, Gayle Louise; Anan, Takashi; Kimura, Tetsunori] Sapporo Dermatopathol Inst, Sapporo, Hokkaido 0010018, Japan	Kaku, Y (reprint author), Sapporo Dermatopathol Inst, Kita Ward, 3-2-21,Kita 18 Jo Nishi, Sapporo, Hokkaido 0010018, Japan.	montreux77@live.jp					Pummi KP, 2004, J HISTOCHEM CYTOCHEM, V52, P1037, DOI 10.1369/jhc.3a6217.2004; LAZARUS SS, 1978, CANCER, V41, P1823, DOI 10.1002/1097-0142(197805)41:5<1823::AID-CNCR2820410525>3.0.CO;2-J; Morita K, 2011, EUR J DERMATOL, V21, P12, DOI 10.1684/ejd.2010.1192; Fetsch JF, 1997, AM J SURG PATHOL, V21, P1433, DOI 10.1097/00000478-199712000-00005; Pina-Oviedo S, 2008, ADV ANAT PATHOL, V15, P147, DOI 10.1097/PAP.0b013e31816f8519; Giannini C, 1997, AM J SURG PATHOL, V21, P164, DOI 10.1097/00000478-199702000-00005; Brock JE, 2005, AM J SURG PATHOL, V29, P1164, DOI 10.1097/01.pas.0000158397.65190.9f; Folpe AL, 2002, AM J SURG PATHOL, V26, P1620, DOI 10.1097/00000478-200212000-00010; Huang HY, 2002, BRIT J DERMATOL, V146, P129, DOI 10.1046/j.0007-0963.2001.04612.x; MUONA P, 1992, DIABETES, V41, P1587, DOI 10.2337/diabetes.41.12.1587; Sciot R, 1999, AM J SURG PATHOL, V23, P849, DOI 10.1097/00000478-199907000-00015; SHANTHAV.TR, 1966, SCIENCE, V154, P1464, DOI 10.1126/science.154.3755.1464; WEIDENHEIM KM, 1986, VIRCHOWS ARCH A, V408, P375, DOI 10.1007/BF00707695; Yamaguchi U, 2003, VIRCHOWS ARCH, V443, P159, DOI 10.1007/s00428-003-0849-4	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0193-1091	1533-0311		AM J DERMATOPATH	Am. J. Dermatopathol.	FEB	2015	37	2					122	128				7	Dermatology	Dermatology	CA0HE	WOS:000348597000007		
J	Nakamura, Y; Nakamura, A; Muto, M				Nakamura, Yoshitaka; Nakamura, Akiko; Muto, Masahiko			A Case of Pleomorphic Fibroma of the Skin Presenting as Intradermal Nodule	AMERICAN JOURNAL OF DERMATOPATHOLOGY			English	Letter							SCLEROTIC FIBROMA		[Nakamura, Yoshitaka; Nakamura, Akiko; Muto, Masahiko] Yamaguchi Univ, Grad Sch Med, Dept Dermatol, Ube, Yamaguchi 755, Japan	Nakamura, Y (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Dermatol, Ube, Yamaguchi 755, Japan.						Chen TM, 2002, AM J DERMATOPATH, V24, P54, DOI 10.1097/00000372-200202000-00011; Dore Amanda, 2003, Australas J Dermatol, V44, P287, DOI 10.1046/j.1440-0960.2003.00012.x; KAMINO H, 1989, AM J SURG PATHOL, V13, P107, DOI 10.1097/00000478-198902000-00003; Mahmood MN, 2003, J CUTAN PATHOL, V30, P631, DOI 10.1034/j.1600-0560.2003.00126.x; McCoppin HH, 2010, ARCH DERMATOL, V146, P1037, DOI 10.1001/archdermatol.2010.215-a	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0193-1091	1533-0311		AM J DERMATOPATH	Am. J. Dermatopathol.	FEB	2015	37	2					175	176				2	Dermatology	Dermatology	CA0HE	WOS:000348597000018		
J	Bokulich, NA; Swadener, M; Sakamoto, K; Mills, DA; Bisson, LF				Bokulich, Nicholas A.; Swadener, Michael; Sakamoto, Koichi; Mills, David A.; Bisson, Linda F.			Sulfur Dioxide Treatment Alters Wine Microbial Diversity and Fermentation Progression in a Dose-Dependent Fashion	AMERICAN JOURNAL OF ENOLOGY AND VITICULTURE			English	Article						sulfur dioxide; microbial dynamics; native fermentation	MOLECULAR-IDENTIFICATION; INDEPENDENT METHODS; SEQUENCES; COMMUNITIES; TAXONOMY; DATABASE; UNITE; FUNGI	The use of sulfur dioxide (SO2) as an antimicrobial in winemaking is a well-established, common practice. Although much is known about the antimicrobial effects of SO2 at single concentrations, little is known about its effects on microbial growth dynamics across a range of concentrations or when used in conjunction with yeast inoculation. Using high-throughput marker-gene sequencing, we investigated the cumulative impacts of yeast inoculation and SO2 treatments across a broad concentration range (0 to 150 mg/L SO2) on the bacterial and fungal communities in wine fermentations. Our results indicated a dose-dependent effect of SO2, with lactic acid bacteria and Gluconobacter proliferating in fermentations with <25 mg/L SO2, but other bacteria and fungi were unaffected by the SO2 addition. Microbial profiles stabilized at concentrations >= 25 mg/L SO2, and fermentation performance decreased at higher concentrations (100 to 150 mg/L SO2). Yeast inoculation alone conferred a stabilizing effect, reducing the bacterial growth observed in unsulfited fermentations, but this effect was not additive with an increase in SO2 concentrations.	[Bokulich, Nicholas A.; Swadener, Michael; Sakamoto, Koichi; Mills, David A.; Bisson, Linda F.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Swadener, Michael; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Sakamoto, Koichi] Minist Finance, Natl Tax Agcy, Chiyoda Ku, Tokyo 1008978, Japan	Bisson, LF (reprint author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	lfbisson@ucdavis.edu			American Wine Society Educational Foundation Endowment Fund scholarship; American Society for Enology and Viticulture scholarship; Samuel Adams Scholarship Fund - American Society of Brewing Chemists Foundation; NIGMS-NIH [T32-GM008799]; American Vineyard Foundation; National Tax Agency of Japan	The authors thank Charles Brenneman, Chad Masarweh, and Morgan Lee for logistical and technical support during this study. Nicholas A. Bokulich was supported by an American Wine Society Educational Foundation Endowment Fund scholarship, an American Society for Enology and Viticulture scholarship, the Samuel Adams Scholarship Fund (awarded by the American Society of Brewing Chemists Foundation), and Grant Number T32-GM008799 from NIGMS-NIH during the completion of this work. This work was supported in part by funding from the American Vineyard Foundation and the National Tax Agency of Japan.	Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Bisson LF, 1999, AM J ENOL VITICULT, V50, P107; Constanti M, 1998, INT J FOOD MICROBIOL, V41, P169, DOI 10.1016/S0168-1605(98)00041-5; Andorra I, 2008, FOOD MICROBIOL, V25, P849, DOI 10.1016/j.fm.2008.05.005; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Bokulich NA, 2012, BMB REP, V45, P377, DOI 10.5483/BMBRep.2012.45.7.148; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Nisiotou AA, 2011, INT J FOOD MICROBIOL, V145, P432, DOI 10.1016/j.ijfoodmicro.2011.01.017; Bokulich NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066437; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Bokulich NA, 2012, J AM SOC BREW CHEM, V70, P150, DOI 10.1094/ASBCJ-2012-0709-01; Boulton R.B., 1996, PRINCIPLES PRACTICES; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cocolin L, 2003, AM J ENOL VITICULT, V54, P125; du Toit WJ, 2005, J APPL MICROBIOL, V98, P862, DOI 10.1111/j.1365-2672.2004.02549.x; HEARD GM, 1986, J APPL BACTERIOL, V60, P477, DOI 10.1111/j.1365-2672.1986.tb01086.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Takahashi M, 2014, J BIOSCI BIOENG, V117, P569, DOI 10.1016/j.jbiosc.2013.10.012	28	1	1	AMER SOC ENOLOGY VITICULTURE	DAVIS	PO BOX 1855, DAVIS, CA 95617-1855 USA	0002-9254	1943-7749		AM J ENOL VITICULT	Am. J. Enol. Vitic.	FEB	2015	66	1					73	79		10.5344/ajev.2014.14096		7	Biotechnology & Applied Microbiology; Food Science & Technology; Horticulture	Biotechnology & Applied Microbiology; Food Science & Technology; Agriculture	CA2XL	WOS:000348769100009		
J	Sasaki, K; Takase, H; Tanzawa, F; Kobayashi, H; Saito, H; Matsuo, H; Takata, R				Sasaki, Kanako; Takase, Hideki; Tanzawa, Fumiko; Kobayashi, Hironori; Saito, Hiroshi; Matsuo, Hironori; Takata, Ryoji			Identification of Furaneol Glucopyranoside, the Precursor of Strawberry-like Aroma, Furaneol, in Muscat Bailey A	AMERICAN JOURNAL OF ENOLOGY AND VITICULTURE			English	Article						aroma; furaneol; glucopyranoside; Muscat Bailey A; strawberry; Vitis labrusca	FLAVOR COMPOUNDS; 4-HYDROXY-2,5-DIMETHYL-3(2H)-FURANONE; WINES; 2,5-DIMETHYL-4-HYDROXY-3(2H)-FURANONE; CONSTITUENTS; BERRIES; CONCORD	2,5-Dimethyl-4-hydroxy-3(2H)-furanone (furaneol) was reported to be responsible for the strawberry-like aroma in some Vitis labrusca and hybrid (V. labrusca x V. vinifera) winegrapes. This study identified furaneol glucopyranoside in the juice of a Japanese hybrid grape, Muscat Bailey A [V. labrusca (Bailey) x V. vinifera (Muscat Hamburg)], using high-performance liquid chromatography-tandem mass spectrometry. The concentrations of furaneol glucopyranoside and furaneol in the juices of Concord (V. labrusca) and Muscat Bailey A were much higher than those in the juices of other V. vinifera varieties. It was also demonstrated that furaneol and its glucopyranoside were accumulated mainly in Muscat Bailey A berry flesh. These findings are expected to contribute to the elucidation of the mechanism of formation in grapes and to the understanding of the characteristic strawberry-like aroma of Muscat Bailey A wines.	[Sasaki, Kanako; Takase, Hideki; Tanzawa, Fumiko; Takata, Ryoji] Mercian Corp, New Prod & Proc Dev, Fujisawa, Kanagawa 2510057, Japan; [Kobayashi, Hironori; Saito, Hiroshi; Matsuo, Hironori] Chateau Mercian, Koshu, Yamanashi 4091313, Japan	Sasaki, K (reprint author), Mercian Corp, New Prod & Proc Dev, 4-9-1 Jonan, Fujisawa, Kanagawa 2510057, Japan.	sasaki-kn@mercian.co.jp					SANZ C, 1994, J FOOD SCI, V59, P139, DOI 10.1111/j.1365-2621.1994.tb06918.x; Kobayashi H, 2013, VITIS, V52, P9; Des Gachons CP, 2002, J AGR FOOD CHEM, V50, P4076, DOI 10.1021/jf020002y; NOBLE AC, 1988, AM J ENOL VITICULT, V39, P129; RAPP A, 1980, VITIS, V19, P13; RODIN JO, 1965, J FOOD SCI, V30, P280, DOI 10.1111/j.1365-2621.1965.tb00302.x; SCHREIER P, 1981, CAN I FOOD SC TECH J, V14, P112; STRAUSS CR, 1987, J AGR FOOD CHEM, V35, P519, DOI 10.1021/jf00076a020; Ferreira V, 2002, J AGR FOOD CHEM, V50, P4048, DOI 10.1021/jf0115645; Perez AG, 1999, J AGR FOOD CHEM, V47, P655, DOI 10.1021/jf980404z; Perez AG, 1996, J AGR FOOD CHEM, V44, P3620, DOI 10.1021/jf960099m; SHURE KB, 1994, J AGR FOOD CHEM, V42, P350, DOI 10.1021/jf00038a022; MAYERL F, 1989, PHYTOCHEMISTRY, V28, P631, DOI 10.1016/0031-9422(89)80068-8; PYYSALO T, 1979, J AGR FOOD CHEM, V27, P19, DOI 10.1021/jf60221a042; Honkanen E., 1980, UNTERS FORSCH, P180; Ichikawa M, 2011, FOOD SCI TECHNOL RES, V17, P335, DOI 10.3136/fstr.17.335; Kitao S, 2000, BIOSCI BIOTECH BIOCH, V64, P134, DOI 10.1271/bbb.64.134; Ohloff G., 1969, FORTSCHRITTE CHEMISC, V12, P185; Pinho P.G., 1995, AM J ENOL VITICULT, V46, P181; RE L, 1973, HELV CHIM ACTA, V56, P1882, DOI 10.1002/hlca.19730560609	20	1	1	AMER SOC ENOLOGY VITICULTURE	DAVIS	PO BOX 1855, DAVIS, CA 95617-1855 USA	0002-9254	1943-7749		AM J ENOL VITICULT	Am. J. Enol. Vitic.	FEB	2015	66	1					91	94		10.5344/ajev.2014.14072		4	Biotechnology & Applied Microbiology; Food Science & Technology; Horticulture	Biotechnology & Applied Microbiology; Food Science & Technology; Agriculture	CA2XL	WOS:000348769100012		
J	Tsuboya, T; Aida, J; Osaka, K; Kawachi, I				Tsuboya, Toru; Aida, Jun; Osaka, Ken; Kawachi, Ichiro			Working Overtime and Risk Factors for Coronary Heart Disease: A Propensity Score Analysis Based in the J-SHINE (Japanese Study of Stratification, Health, Income, and Neighborhood) Study	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						physical inactivity; cigarette smoking; sleep deprivation; psychological stress; overweight; obesity; excessive alcohol consumption	SLEEP DURATION; MORTALITY; WOMEN; TIME; METAANALYSIS; ASSOCIATION; CHINESE; OBESITY; WORKERS; COHORT	BackgroundEvidence on the causal relationship between working overtime and the risk of coronary heart disease is limited. MethodsWe surveyed 2355 workers in Japan and conducted propensity-matched logistic regression analysis, using propensity-matched 438 pairs, to evaluate the associations between working overtime (more than 50hr per week) and coronary risk factors: physical inactivity, cigarette smoking, sleep deprivation (<5hr/day), psychological stress, overweight/obesity, and excessive alcohol consumption. The exposure and outcomes were self-reported. ResultsAmong 2355 workers, 476 participants worked overtime. Propensity-matched analysis revealed that the associations between working overtime and sleep deprivation (odds ratios (OR) and 95% confidence intervals: 2.33, 1.39-3.88) and high stress (2.13, 1.60-2.82). The associations between working overtime and physical inactivity, current smoking, and overweight/obesity were not statistically significant. Excessive alcohol consumption was inversely associated with working overtime. ConclusionsWorking overtime was positively associated with two coronary risk factors: sleep deprivation and increased psychological stress. Am. J. Ind. Med. 58:229-237, 2015. (c) 2015 Wiley Periodicals, Inc.	[Tsuboya, Toru; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Tsuboya, Toru; Aida, Jun; Osaka, Ken] Tohoku Univ, Grad Sch Dent, Dept Int & Community Oral Hlth, Sendai, Miyagi 980, Japan	Tsuboya, T (reprint author), 677 Huntington Ave,Kresge Bldg 7th Floor, Boston, MA 02115 USA.	tsubo828@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan [21119002, 21119001, 21119002111, 21119007]	The study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 2009-2013 (No. 21119002, No. 21119001 and 21119002111 and 21119007) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. These sponsors were not involved in study design and the collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication.	Virtanen M, 2009, SLEEP, V32, P737; Ko GTC, 2007, INT J OBESITY, V31, P254, DOI 10.1038/sj.ijo.0803389; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Brick JM, 2013, ANN AM ACAD POLIT SS, V645, P36, DOI 10.1177/0002716212456834; Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Virtanen M, 2012, EXPERT REV NEUROTHER, V12, P497, DOI [10.1586/ern.12.29, 10.1586/ERN.12.29]; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Ikehara S, 2009, SLEEP, V32, P295; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Nakanishi N, 2001, J EPIDEMIOL COMMUN H, V55, P316, DOI 10.1136/jech.55.5.316; Ferrie JE, 2007, SLEEP, V30, P1659; Patel SR, 2004, SLEEP, V27, P440; Popham F, 2006, J EPIDEMIOL COMMUN H, V60, P270, DOI 10.1136/jech.2005.041194; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Basner M, 2007, SLEEP, V30, P1085; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Christian TJ, 2012, J URBAN HEALTH, V89, P746, DOI 10.1007/s11524-012-9678-6; Kroenke CH, 2007, AM J EPIDEMIOL, V165, P175, DOI 10.1093/aje/kwj355; Cho Young-Seung, 2013, Saf Health Work, V4, P197, DOI 10.1016/j.shaw.2013.09.001; Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002; Ho Daniel, 2013, MATCHIT NONPARAMETRI; Houdmont J, 2011, OCCUP MED-OXFORD, V61, P270, DOI 10.1093/occmed/kqr029; Inoue A, 2014, IND HLTH; JENKINS, 2010, IS AN OUT THER RESP; Marchand A, 2011, INT J ENV RES PUB HE, V8, P2692, DOI 10.3390/ijerph8072692; Ministry of Health Labour and Welfare, 2013, HLTH JAP 21 2; Ministry of Internal Affairs and Communications, 2011, NAT SURV ALL TIM; Rubin DB, 1997, ANN INTERN MED, V127, P757; Sangheon Lee, 2007, WORKING TIME WORLD I; Sinclair M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-132; Takada M, 2014, J EPIDEMIOL; World Health Organisation, 1995, WHO TECHN REP SER, V854, P1	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	FEB	2015	58	2					229	237		10.1002/ajim.22409		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AZ9UW	WOS:000348563100011		
J	Lam, CH; Shimakura, H				Lam, Ching Hung; Shimakura, Hiroki			CLASSIFICATION OF HOLOMORPHIC FRAMED VERTEX OPERATOR ALGEBRAS OF CENTRAL CHARGE 24	AMERICAN JOURNAL OF MATHEMATICS			English	Article							CONFORMAL FIELD-THEORIES; BINARY-CODES; REPRESENTATIONS; V-L(+); MODULE	This article is a continuation of our work on the classification of holomorphic framed vertex operator algebras of central charge 24. We show that a holomorphic framed VOA of central charge 24 is uniquely determined by the Lie algebra structure of its weight one subspace. As a consequence, we completely classify all holomorphic framed vertex operator algebras of central charge 24 and show that there exist exactly 56 such vertex operator algebras, up to isomorphism.	[Lam, Ching Hung] Acad Sinica, Inst Math, Taipei 10617, Taiwan; [Lam, Ching Hung] Natl Ctr Theoret Sci Taiwan, Taipei, Taiwan; [Shimakura, Hiroki] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan	Lam, CH (reprint author), Acad Sinica, Inst Math, Taipei 10617, Taiwan.	chlam@math.sinica.edu.tw; shimakura@m.tohoku.ac.jp			NSC of Taiwan [100-2628-M-001005-MY4]; JSPS [23540013]	Research of the first author supported in part by NSC grant 100-2628-M-001005-MY4 of Taiwan; research of the second author supported in part by Grants-in-Aid for Scientific Research (No. 23540013), JSPS.	Dong CY, 2004, INT MATH RES NOTICES, P2989; HUANG YZ, 1995, J PURE APPL ALGEBRA, V100, P141, DOI 10.1016/0022-4049(95)00049-3; Dong CY, 2004, PAC J MATH, V213, P253; DONG CY, 1993, J ALGEBRA, V161, P245, DOI 10.1006/jabr.1993.1217; Abe T, 2005, COMMUN MATH PHYS, V253, P171, DOI 10.1007/s00220-004-1132-5; Lam CH, 2012, P LOND MATH SOC, V104, P540, DOI 10.1112/plms/pdr041; Miyamoto M, 2004, ANN MATH, V159, P535; FRENKEL IB, 1992, DUKE MATH J, V66, P123, DOI 10.1215/S0012-7094-92-06604-X; Shimakura H, 2011, J LOND MATH SOC, V83, P493, DOI 10.1112/jlms/jdq078; Betsumiya K, 2012, J LOND MATH SOC, V86, P1, DOI 10.1112/jlms/jdr054; BORCHERDS RE, 1986, P NATL ACAD SCI USA, V83, P3068, DOI 10.1073/pnas.83.10.3068; Conway J. H., 1999, GRUNDLEHREN MATH WIS, V290; Dolan L, 1996, COMMUN MATH PHYS, V179, P61, DOI 10.1007/BF02103716; Dong C. Y., 1994, P S PURE MATH, V56, P295; Dong CY, 2007, AM J MATH, V129, P583, DOI 10.1353/ajm.2007.0009; Dong CY, 1998, COMMUN MATH PHYS, V193, P407, DOI 10.1007/s002200050335; Frenkel I., 1993, MEM AM MATH SOC, V104, P494; Frenkel I. B., 1988, PURE APPL MATH, V134; KAC V. G., 1990, INFINITE DIMENSIONAL; Lam CH, 2011, COMMUN MATH PHYS, V305, P153, DOI 10.1007/s00220-011-1212-2; Lam CH, 2008, COMMUN MATH PHYS, V277, P237, DOI 10.1007/s00220-007-0323-2; Miyamoto M, 1998, J ALGEBRA, V201, P115, DOI 10.1006/jabr.1997.7257; Miyamoto M, 1996, J ALGEBRA, V181, P207, DOI 10.1006/jabr.1996.0116; SCHELLEKENS AN, 1993, COMMUN MATH PHYS, V153, P159, DOI 10.1007/BF02099044; Shimakura H, 2004, J ALGEBRA, V280, P29, DOI 10.1016/j.jalgebra.2004.05.018	25	0	0	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	0002-9327	1080-6377		AM J MATH	Am. J. Math.	FEB	2015	137	1					111	137				27	Mathematics	Mathematics	CA5TD	WOS:000348969800004		
J	Tsutaya, T; Yoneda, M				Tsutaya, Takumi; Yoneda, Minoru			Reconstruction of Breastfeeding and Weaning Practices Using Stable Isotope and Trace Element Analyses: A Review	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Review						biogeochemical methods; infant feeding practice; palaeodiet; mammalian nursing	PREHISTORIC HUMAN DIET; EARLY-CHILDHOOD DIET; HUMAN TOOTH ENAMEL; PLASMA-MASS SPECTROMETRY; NITROGEN-ISOTOPE; BONE-COLLAGEN; LIFE-HISTORIES; AMINO-ACIDS; NUTRITIONAL STRESS; DENTAL DEVELOPMENT	Biogeochemical methods using stable isotopes and trace elements have been increasingly developed and applied to reconstruct modern and ancient breastfeeding and weaning practices of mammals, including humans, because they offer direct proxies for the dietary intake of subadults. Carbon, nitrogen, and oxygen isotopes have been used to evaluate breast milk lipid, protein, and water intake, respectively. Carbon and sulfur isotopes have been used to estimate the content of weaning foods. The elemental concentrations of Sr and Ba in subadult tissues differ because of the dietary change during the weaning process. For analyses, various tissues have been used, such as hair, nail, blood, and feces for modern mammals and bone and teeth for ancient ones. Of these, trace element analysis of tooth enamel offers a good opportunity for the reconstruction of breastfeeding and weaning practices of the more distant past at finer resolution, although further understanding of the metabolism of trace elements is necessary. There are various tissue- and element-specific advantages and disadvantages, and a combination of different proxies can illuminate practices from various viewpoints. Finally, applying the geochemical reconstruction of breastfeeding and weaning practices to human ecology, primatology, and paleoanthropology is important; basic studies of the underlying physiological mechanisms and technical improvements in the analyses will further highlight avenues for future research. Yrbk Phys Anthropol 156:2-21, 2015. (c) 2014 American Association of Physical Anthropologists	[Tsutaya, Takumi; Yoneda, Minoru] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Yoneda, Minoru] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	Tsutaya, T (reprint author), Univ Tokyo, Univ Museum, Lab Radiocarbon Dating, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	127309@ib.k.u-tokyo.ac.jp			Japan Society for the Promotion of Science [KAKENHI: 17107006, 18500769, 20370095, 20255007, 24-785]	Grant sponsor: The Japan Society for the Promotion of Science; Grant numbers: KAKENHI: 17107006, 18500769, 20370095, 20255007, and 24-785.	Adami S, 2008, CALCIFIED TISSUE INT, V83, P388, DOI 10.1007/s00223-008-9184-8; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; BUIKSTRA JE, 1986, AM ANTIQUITY, V51, P528, DOI 10.2307/281750; Reid DJ, 1998, J HUM EVOL, V35, P427, DOI 10.1006/jhev.1998.0248; Eerkens JW, 2011, J ARCHAEOL SCI, V38, P3101, DOI 10.1016/j.jas.2011.07.010; Tcherkez G, 2013, NEW PHYTOL, V200, P44, DOI 10.1111/nph.12314; Valeggia C, 2009, AM J HUM BIOL, V21, P559, DOI 10.1002/ajhb.20907; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Wright LE, 1999, J ARCHAEOL SCI, V26, P1159, DOI 10.1006/jasc.1998.0351; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Tanz N, 2010, J AGR FOOD CHEM, V58, P3139, DOI 10.1021/jf903251k; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; DEAN MC, 1995, INT J OSTEOARCHAEOL, V5, P349, DOI 10.1002/oa.1390050405; Sellen DW, 2001, J NUTR, V131, P2707; Sellen DW, 2001, HUM NATURE-INT BIOS, V12, P47, DOI 10.1007/s12110-001-1013-y; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Reid DJ, 1998, J HUM EVOL, V35, P463, DOI 10.1006/jhev.1998.0233; Kramer KL, 2010, ANNU REV ANTHROPOL, V39, P417, DOI 10.1146/annurev.anthro.012809.105054; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; TAUBER H, 1981, NATURE, V292, P332, DOI 10.1038/292332a0; SCHOENINGER MJ, 1982, NATURE, V297, P577, DOI 10.1038/297577a0; Kang D, 2004, ANAL BIOANAL CHEM, V378, P1608, DOI 10.1007/s00216-004-2504-6; Copley MS, 2003, P NATL ACAD SCI USA, V100, P1524, DOI 10.1073/pnas.0335955100; EASTOE JE, 1955, BIOCHEM J, V61, P589; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Bouhallab S, 2004, REPROD NUTR DEV, V44, P493, DOI 10.1051/rnd:2004053; Humphrey LT, 2010, SEMIN CELL DEV BIOL, V21, P453, DOI 10.1016/j.semcdb.2009.11.003; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Katzenberg MA, 1999, INT J OSTEOARCHAEOL, V9, P316, DOI 10.1002/(SICI)1099-1212(199909/10)9:5<316::AID-OA500>3.0.CO;2-D; Humphrey LT, 2008, P NATL ACAD SCI USA, V105, P6834, DOI 10.1073/pnas.0711513105; Reid DJ, 2008, J HUM EVOL, V54, P225, DOI 10.1016/j.jhevol.2007.09.015; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Jones JH, 2011, CURR BIOL, V21, pR708, DOI 10.1016/j.cub.2011.08.025; BROWN TA, 1988, RADIOCARBON, V30, P171; Kohn MJ, 1999, GEOCHIM COSMOCHIM AC, V63, P2737, DOI 10.1016/S0016-7037(99)00208-2; DANSGAARD W, 1964, TELLUS, V16, P436; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; MYERS RJ, 1951, ANN NY ACAD SCI, V53, P562, DOI 10.1111/j.1749-6632.1951.tb31957.x; Howland MR, 2003, INT J OSTEOARCHAEOL, V13, P54, DOI 10.1002/oa.658; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Reitsema LJ, 2013, AM J HUM BIOL, V25, P445, DOI 10.1002/ajhb.22398; Kramer MS, 2004, ADV EXP MED BIOL, V554, P63; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Williams JS, 2005, AM J PHYS ANTHROPOL, V128, P781, DOI 10.1002/ajpa.20229; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; O'Connell TC, 1999, AM J PHYS ANTHROPOL, V108, P409, DOI 10.1002/(SICI)1096-8644(199904)108:4<409::AID-AJPA3>3.0.CO;2-E; SILK JB, 1983, AM NAT, V121, P56, DOI 10.1086/284039; Olsen KC, 2014, AM J PHYS ANTHROPOL, V153, P598, DOI 10.1002/ajpa.22459; Howcroft R, 2012, AM J PHYS ANTHROPOL, V149, P217, DOI 10.1002/ajpa.22113; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Jans MME, 2004, J ARCHAEOL SCI, V31, P87, DOI 10.1016/j.jas.2003.07.007; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Kramer KL, 2005, EVOL ANTHROPOL, V14, P224, DOI 10.1002/evan.20082; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.arplant.40.1.503; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Dudd SN, 1998, SCIENCE, V282, P1478, DOI 10.1126/science.282.5393.1478; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P45, DOI 10.1002/ajpa.20244; DETTWYLER KA, 1992, ANNU REV ANTHROPOL, V21, P171; Bogin B, 1997, YEARB PHYS ANTHROPOL, V40, P63; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Rossipal E, 2000, ACTA PAEDIATR, V89, P1190, DOI 10.1080/080352500750027556; Boesch C, 1997, ANIM BEHAV, V54, P811, DOI 10.1006/anbe.1996.0510; HARKEY MR, 1993, FORENSIC SCI INT, V63, P9, DOI 10.1016/0379-0738(93)90255-9; Eriksson G, 2004, J ANTHROPOL ARCHAEOL, V23, P135, DOI 10.1016/j.jaa.2003.12.005; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Beaumont J, 2013, ARCHAEOMETRY, V55, P277, DOI 10.1111/j.1475-4754.2012.00682.x; Beaumont J, 2013, AM J PHYS ANTHROPOL, V150, P87, DOI 10.1002/ajpa.22179; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Sandberg PA, 2012, AM J PRIMATOL, V74, P969, DOI 10.1002/ajp.22053; Richards MP, 2003, INT J OSTEOARCHAEOL, V13, P37, DOI 10.1002/oa.654; Burt NM, 2013, J ARCHAEOL SCI, V40, P3854, DOI 10.1016/j.jas.2013.05.022; SCHOENINGER MJ, 1992, J WORLD PREHIST, V6, P247, DOI 10.1007/BF00975551; Romek KM, 2013, AMINO ACIDS, V45, P1365, DOI 10.1007/s00726-013-1597-7; Trueman CN, 2002, REV MINERAL GEOCHEM, V48, P489, DOI 10.2138/rmg.2002.48.13; Austin C, 2013, NATURE, V498, P216, DOI 10.1038/nature12169; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.ecolsys.18.1.293; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; Balasse M, 2002, J ARCHAEOL SCI, V29, P853, DOI 10.1006/jasc.2001.0725; Murphy BP, 2006, FUNCT ECOL, V20, P1062, DOI 10.1111/j.1365-2435.2006.01186.x; BARRY H, 1971, ETHNOLOGY, V10, P466; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Waters-Rist AL, 2010, INT J OSTEOARCHAEOL, V20, P172, DOI 10.1002/oa.1017; Henderson RC, 2014, AM J PHYS ANTHROPOL, V154, P585, DOI 10.1002/ajpa.22554; Garvie-Lok SJ, 2004, J ARCHAEOL SCI, V31, P763, DOI 10.1016/j.jas.2003.10.014; Lee-Thorp JA, 2008, ARCHAEOMETRY, V50, P925, DOI 10.1111/j.1475-4754.2008.00441.x; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; REES CE, 1978, GEOCHIM COSMOCHIM AC, V42, P377, DOI 10.1016/0016-7037(78)90268-5; Zazzo A, 2005, GEOCHIM COSMOCHIM AC, V69, P3631, DOI 10.1016/j.gca.2005.02.031; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Hinz EA, 2010, GEOCHIM COSMOCHIM AC, V74, P3213, DOI 10.1016/j.gca.2010.03.011; McCullagh JSO, 2005, RAPID COMMUN MASS SP, V19, P3227, DOI 10.1002/rcm.2150; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; CHISHOLM BS, 1982, SCIENCE, V216, P1131, DOI 10.1126/science.216.4550.1131; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.2307/2408653; AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; FOMON SJ, 1987, J PEDIATR-US, V111, P221, DOI 10.1016/S0022-3476(87)80071-9; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Hare D, 2011, J DENT, V39, P397, DOI 10.1016/j.jdent.2011.03.004; Hartman G, 2011, FUNCT ECOL, V25, P122, DOI 10.1111/j.1365-2435.2010.01782.x; Bourbou C, 2013, J ARCHAEOL SCI, V40, P3903, DOI 10.1016/j.jas.2013.04.020; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Bell LS, 1996, FORENSIC SCI INT, V82, P129, DOI 10.1016/0379-0738(96)01984-6; Bahar B, 2014, RAPID COMMUN MASS SP, V28, P1011, DOI 10.1002/rcm.6872; Balaisse M, 2001, J ARCHAEOL SCI, V28, P235, DOI 10.1006/jasc.1999.0535; Balzer A, 1997, ARCHAEOMETRY, V39, P415, DOI 10.1111/j.1475-4754.1997.tb00817.x; Bell LS, 2001, AM J PHYS ANTHROPOL, V116, P66, DOI 10.1002/ajpa.1103; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J, 1983, FERTILITY BIOL BEHAV; BONGAARTS J, 1982, STUD FAMILY PLANN, V13, P179, DOI 10.2307/1965445; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Braun A, 2013, RAPID COMMUN MASS SP, V27, P2676, DOI 10.1002/rcm.6737; BROWN A B, 1974, Contributions to Geology University of Wyoming, V13, P47; Browning E., 1969, TOXICITY IND METALS; Bryant JD, 1996, PALAIOS, V11, P397, DOI 10.2307/3515249; Bryant JD, 1996, PALAEOGEOGR PALAEOCL, V126, P75, DOI 10.1016/S0031-0182(96)00071-5; Burt NM, 2013, AM J PHYS ANTHROPOL, V152, P407, DOI 10.1002/ajpa.22370; Burt NM, 2014, ARCH ORAL BIOL, V59, P1226, DOI 10.1016/j.archoralbio.2014.07.014; Burton J., 2008, BIOL ANTHR HUMAN SKE, P443, DOI 10.1002/9780470245842.ch14; Burton JH, 1999, J ARCHAEOL SCI, V26, P609, DOI 10.1006/jasc.1998.0378; Chukhrov F, 1980, ORG GEOCHEM, V2, P69, DOI 10.1016/0146-6380(80)90022-4; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, P131; Codron D, 2011, CAN J ZOOL, V89, P453, DOI [10.1139/Z11-010, 10.1139/z11-010]; COMAR CL, 1957, P SOC EXP BIOL MED, V95, P386; Comar CL, 1963, TRANSFER CALCIUM STR, P405; Crowley BE, 2012, INT J PRIMATOL, V33, P673, DOI 10.1007/s10764-012-9582-7; Cunningham AS., 1995, BREASTFEEDING BIOCUL, P243; Dean MC, 1993, INT J OSTEOARCHAEOL, V3, P249, DOI 10.1002/oa.1390030404; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Deschner T, 2012, RAPID COMMUN MASS SP, V26, P69, DOI 10.1002/rcm.5312; desLuca A, 2012, PEDIATR RES, V71, P598; Dettwyler KA, 2004, CLIN OBSTET GYNECOL, V47, P712, DOI 10.1097/01.grf.0000137217.97573.01; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; Ducatez S, 2008, MAR BIOL, V155, P413, DOI 10.1007/s00227-008-1039-3; Duggleby SL, 2002, CURR OPIN CLIN NUTR, V5, P503, DOI 10.1097/00075197-200209000-00008; Dupras TL, 2007, AM J PHYS ANTHROPOL, V134, P63, DOI 10.1002/ajpa.20639; Dupras TL, 2001, AM J PHYS ANTHROPOL, V115, P204, DOI 10.1002/ajpa.1075; Eerkens JW, 2013, AM J PHYS ANTHROPOL, V152, P471, DOI 10.1002/ajpa.22384; Emery Thompson M, 2013, ANNU REV ANTHROPOL, V42, P287; Eriksson G, 2013, J ANTHROPOL ARCHAEOL, V32, P288, DOI 10.1016/j.jaa.2012.01.002; Eriksson G, 2008, J ANTHROPOL ARCHAEOL, V27, P520, DOI 10.1016/j.jaa.2008.08.004; Fagre T., 1993, PREHISTORIC HUMAN BO, P121; Fahy GE, 2014, AM J PHYS ANTHROPOL, V153, P653; Fazekas IGY, 1978, FORENSIC FETAL OSTEO; Ferembach D, 1980, J HUM EVOL, V9, P517; Fildes V., 1995, BREASTFEEDING BIOCUL, P101; FINKELSTEIN JD, 1988, J BIOL CHEM, V263, P11750; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Fitzgerald CM, 2005, AM J PHYS ANTHROPOL, V127, P277, DOI 10.1002/ajpa.10442; Fogel ML, 1989, ANN REPORT DIRECTOR, V88, P111; FOMON SJ, 1988, J PEDIATR-US, V113, P515, DOI 10.1016/S0022-3476(88)80643-7; Ford CS, 1964, COMP STUDY HUMAN REP; Franz-Odendaal TA, 2003, J BIOSCIENCES, V28, P765, DOI 10.1007/BF02708437; Frisch T, 2000, ANN OTO RHINOL LARYN, V109, P33; Froehle AW, 2012, AM J PHYS ANTHROPOL, V147, P352, DOI 10.1002/ajpa.21651; Fry B., 2006, STABLE ISOTOPE ECOLO; Fuller BT, 2003, THESIS U OXFORD UK; Fuller BT, 2003, J ARCHAEOL SCI, V30, P1673, DOI 10.1016/S0305-4403(03)00073-6; Gibbons A, 2008, SCIENCE, V322, P1040, DOI 10.1126/science.322.5904.1040; Gillespie Brenda, 2006, Int Breastfeed J, V1, P4, DOI 10.1186/1746-4358-1-4; Gillis R, 2013, WORLD ARCHAEOL, V45, P447, DOI 10.1080/00438243.2013.820652; Gonzalez-Martin I, 2001, MEAT SCI, V58, P25, DOI 10.1016/S0309-1740(00)00126-1; GRUPE G, 1995, J ARCHAEOL SCI, V22, P193, DOI 10.1006/jasc.1995.0021; Grupe G, 2013, EUR J ARCHAEOL, V16, P137, DOI 10.1179/1461957112Y.0000000021; Grupe G, 1993, Anthropol Anz, V51, P317; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; HAMBRAEUS L, 1978, ACTA PAEDIATR SCAND, V67, P561, DOI 10.1111/j.1651-2227.1978.tb17802.x; Haydock H, 2013, AM J PHYS ANTHROPOL, V151, P604, DOI 10.1002/ajpa.22316; HEATON THE, 1986, NATURE, V322, P822, DOI 10.1038/322822a0; HEINE W, 1984, J PEDIATR GASTR NUTR, V3, P709, DOI 10.1097/00005176-198411000-00013; Hewlett B., 2005, HUNTER GATHERER CHIL; Hill K., 1996, ACHE LIFE HIST ECOLO; Hillson S., 1996, DENT ANTHR; Hoefs J., 2010, STABLE ISOTOPE GEOCH; Howcroft R, 2014, J ANTHROPOL ARCHAEOL, V34, P42, DOI 10.1016/j.jaa.2014.01.001; Howell N., 1979, DEMOGRAPHY DOBE KUNG; Hühne-Osterloh G, 1989, Z Morphol Anthropol, V77, P247; Humphrey LT, 2007, VERTEBR PALEOBIOL PA, P303, DOI 10.1007/978-1-4020-5845-5_21; Humphrey LT, 2014, ANN HUM BIOL, V41, P348, DOI 10.3109/03014460.2014.923939; Humphrey LT, 2008, FOLIA PRIMATOL, V79, P197, DOI 10.1159/000113457; Ip S, 2007, BREASTFEEDING MAT IN; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Jenkins SG, 2001, OECOLOGIA, V129, P336, DOI 10.1007/s004420100663; Jorkov MLS, 2009, AM J PHYS ANTHROPOL, V138, P199, DOI 10.1002/ajpa.20919; Jovani M, 2001, FOOD SCI TECHNOL INT, V7, P191, DOI 10.1106/R4EB-XXLA-9MLP-BQYK; Kachel AF, 2011, P ROY SOC B-BIOL SCI, V278, P384, DOI 10.1098/rspb.2010.1247; Katzenberg M. A., 2008, BIOL ANTHR HUMAN SKE, P413; Katzenberg MA, 1997, J ARCHAEOL RES, V5, P265, DOI 10.1007/BF02229154; Katzenberg MA, 1996, YEARB PHYS ANTHROPOL, V39, P177; KATZENBERG MA, 1993, AM J PHYS ANTHROPOL, V90, P267, DOI 10.1002/ajpa.1330900302; Kinaston RL, 2009, J ARCHAEOL SCI, V36, P2780, DOI 10.1016/j.jas.2009.09.004; Knoff A, 2008, MAR MAMMAL SCI, V24, P128, DOI 10.1111/j.1748-7692.2007.00174.x; Kohn MJ, 2013, P NATL ACAD SCI USA, V110, P419, DOI 10.1073/pnas.1209513110; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kohn MJ, 2013, J ARCHAEOL SCI, V40, P1689, DOI 10.1016/j.jas.2012.11.012; Krachler M, 1999, BIOL TRACE ELEM RES, V68, P121, DOI 10.1007/BF02784401; Krouse H. R., 1991, Stable isotopes: natural and anthropogenic sulphur in the environment., P267; Krouse H. R., 1987, APPL GEOCHEM, V2, P205, DOI 10.1016/0883-2927(87)90034-5; KRUEGER HW, 1984, ACS SYM SER, V258, P205; KULP JL, 1962, SCIENCE, V136, P619, DOI 10.1126/science.136.3516.619; Lee P. C., 1996, Evolutionary Anthropology, V5, P87, DOI 10.1002/(SICI)1520-6505(1996)5:3<87::AID-EVAN4>3.0.CO;2-T; Lewis ME, 2007, CAM S BIO EVOL ANTHR, V50, P1; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LOUGH SA, 1963, P SOC EXP BIOL MED, V112, P631; Luz B., 1989, Applied Geochemistry, V4, P317, DOI 10.1016/0883-2927(89)90035-8; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Maher V, 1992, ANTHR BREAST FEEDING; Maresh MM, 1970, HUMAN GROWTH DEV, P157; Metcalfe JZ, 2010, PALAEOGEOGR PALAEOCL, V298, P257, DOI 10.1016/j.palaeo.2010.09.032; Michaelsen KF, 2000, EUROPEAN SERIES, V87; Millard AD, 2000, PERSPECTIVES AMINO A, P51; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MOLLESON T, 1993, J HUM EVOL, V24, P455, DOI 10.1006/jhev.1993.1031; Nanci A, 2013, CATES ORAL HISTOLOGY; Nehlich O, 2011, GEOCHIM COSMOCHIM AC, V75, P4963, DOI 10.1016/j.gca.2011.06.009; Nino-Torres CA, 2006, MAR MAMMAL SCI, V22, P831, DOI 10.1111/j.1748-7692.2006.00065.x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Oftedal O. T., 1995, HDB MILK COMPOSITION, P749, DOI 10.1016/B978-012384430-9/50035-4; Orr AJ, 2012, MAR MAMMAL SCI, V28, P714, DOI 10.1111/j.1748-7692.2011.00522.x; Parfitt AM, 2002, BONE, V30, P807, DOI 10.1016/S8756-3282(02)00735-4; Passey BH, 2005, GEOCHIM COSMOCHIM AC, V69, P4101, DOI 10.1016/j.gca.2004.12.002; Pate F. D., 1994, J ARCHAEOL METHOD TH, V1, P161, DOI DOI 10.1007/BF02231415; Pearson JA, 2010, AM J PHYS ANTHROPOL, V143, P448, DOI 10.1002/ajpa.21335; Podlesak DW, 2006, PHYSIOL BIOCHEM ZOOL, V79, P534, DOI 10.1086/502813; Poupin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028046; Redfern RC, 2012, J ARCHAEOL SCI, V39, P1249, DOI 10.1016/j.jas.2011.12.023; Reitsema LJ, 2012, AM J PRIMATOL, V74, P926, DOI 10.1002/ajp.22045; Rivera J, 1965, 163 US AT EN COMM HL; Roberts SB, 1988, AM J PHYSIOL-REG I, V254, P622; Rountrey AN, 2007, QUATERN INT, V169, P166, DOI 10.1016/j.quaint.2006.08.002; Sare DTJ, 2005, CAN J ZOOL, V83, P712, DOI 10.1139/Z05-054; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SCHOENINGER MJ, 1982, AM J PHYS ANTHROPOL, V58, P37, DOI 10.1002/ajpa.1330580105; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SCHOUR ISAAC, 1936, JOUR AMER DENTAL ASSOC, V23, P1946; SCHROEDE.HA, 1972, J CHRON DIS, V25, P491, DOI 10.1016/0021-9681(72)90150-6; Schurr MR, 2005, AM J PHYS ANTHROPOL, V126, P278, DOI 10.1002/ajpa.20034; Schwarcz HP, 1999, J ARCHAEOL SCI, V26, P629, DOI 10.1006/jasc.1998.0380; Sellen DW, 2007, ANNU REV NUTR, V27, P123, DOI 10.1146/annurev.nutr.25.050304.092557; SILLEN A, 1984, J ARCHAEOL SCI, V11, P237, DOI 10.1016/0305-4403(84)90004-9; SILLEN A, 1981, AM J PHYS ANTHROPOL, V56, P131, DOI 10.1002/ajpa.1330560204; SILLEN A, 1982, Yearbook of Physical Anthropology, V25, P67; Silva R., 1997, J PEDIAT GASTROENTER, V24, P328; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; SMITH BH, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P143; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Stenhouse MJ, 1979, RADIOCARBON DATING, P324; Stuart-Macadam P, 1995, BREASTFEEDING BIOCUL; TANAKA I, 1992, ANIM BEHAV, V44, P129, DOI 10.1016/S0003-3472(05)80762-6; Tea I, 2013, RAPID COMMUN MASS SP, V27, P1345, DOI 10.1002/rcm.6582; Trussell J., 1979, NATURAL FERTILITY PA, P29; Tsutaya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072327; Tsutaya T, 2013, J ARCHAEOL SCI, V40, P3914, DOI 10.1016/j.jas.2013.05.015; Tsutaya T, 2014, AM J PHYS ANTHROPOL, V153, P559, DOI 10.1002/ajpa.22454; Turner BL, 2007, INT J OSTEOARCHAEOL, V17, P1, DOI 10.1002/oa.862; Ubelaker D.H., 1999, HUMAN SKELETAL REMAI; vansder Merwe NJ, 1978, NATURE, V276, P815; vansder Merwe NJ, 1981, NATURE, V292, P536; vansKlinken G. J., 1999, J ARCHAEOL SCI, V26, P687; Vitzthum Virginia J., 1994, Yearbook of Physical Anthropology, V37, P307; Vogel ER, 2012, INT J PRIMATOL, V33, P567, DOI 10.1007/s10764-011-9543-6; Waters-Rist AL, 2011, AM J PHYS ANTHROPOL, V146, P225, DOI 10.1002/ajpa.21568; WHO, 1998, COMPL FEED YOUNG CHI; Witt GB, 2001, J ARCHAEOL SCI, V28, P247, DOI 10.1006/jasc.1999.0539; Wood J., 1988, NATURAL HUMAN FERTIL, P39; Wood JW., 1994, DYNAMICS HUMAN REPRO; World Health Organization, 2008, IND ASS INF YOUNG CH; World Health Organization (WHO), 2009, INF YOUNG CHILD FEED; Wright LE, 2013, ARCHAEOMETRY, V55, P113, DOI 10.1111/j.1475-4754.2012.00668.x; York AE, 2008, CAN J ZOOL, V86, P33, DOI 10.1139/Z07-108; Yurimoto H, 2011, SCIENCE, V333, P1116, DOI 10.1126/science.1207776	297	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	FEB	2015	156			59			2	21		10.1002/ajpa.22657		20	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CA2IA	WOS:000348730900002		
J	Ramila, KC; Jong, CJ; Pastukh, V; Ito, T; Azuma, J; Schaffer, SW				Ramila, K. C.; Jong, Chian Ju; Pastukh, Viktor; Ito, Takashi; Azuma, Junichi; Schaffer, Stephen W.			Role of protein phosphorylation in excitation-contraction coupling in taurine deficient hearts	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						taurine; cardiomyopathy; protein phosphorylation; troponin I; phospholamban; sarcoplasmic reticular Ca2+ ATPase activity	SARCOPLASMIC-RETICULUM; KINASE-II; CARDIAC-HYPERTROPHY; RAT-HEART; DILATED CARDIOMYOPATHY; FAILURE; PHOSPHOLAMBAN; CAMKII; DEPLETION; DYSFUNCTION	Taurine is a beta-amino acid found in very high concentration in the heart. Depletion of these intracellular stores results in the development of cardiomyopathy, thought to be mediated by abnormal sarcoplasmic reticular (SR) Ca2+ transport. There is also evidence that taurine directly alters the Ca2+ sensitivity of myofibrillar proteins. Major regulators of SR Ca2+ ATPase (SERCA2a) are the phosphorylation status of a regulatory protein, phospholamban, and SERCA2a expression, which are diminished in the failing heart. The failing heart also exhibits reductions in myofibrillar Ca2+ sensitivity, a property regulated by the phosphorylation of the muscle protein, troponin I. Therefore, we tested the hypothesis that taurine deficiency leads to alterations in SR Ca2+ ATPase activity related to reduced phospholamban phosphorylation and expression of SERCA2a. We found that a sequence of events, which included elevated protein phosphatase 1 activity, reduced autophosphorylation of CaMKII, and reduced phospholamban phosphorylation, supports the reduction in SR Ca2+ ATPase activity. However, the reduction in SR Ca2+ ATPase activity was not caused by reduced SERCA2a expression. Taurine transporter knockout (TauTKO) hearts also exhibited a rightward shift in the Ca2+ dependence of the myofibrillar Ca2+ ATPase, a property that is associated with an elevation in phosphorylated troponin I. The findings support the observation that taurine deficient hearts develop systolic and diastolic defects related to reduced SR Ca2+ ATPase activity, a change mediated in part by reduced phospholamban phosphorylation.	[Ramila, K. C.; Jong, Chian Ju; Pastukh, Viktor; Schaffer, Stephen W.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Ito, Takashi; Azuma, Junichi] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Kobe, Hyogo, Japan	Schaffer, SW (reprint author), Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA.	sschaffe@southalabama.edu			Taisho Pharmaceutical Company	This study was supported in part by a grant from Taisho Pharmaceutical Company.	Ahmed Z, 1989, J BIOL CHEM, V264, P3859; ALLO SN, 1990, BIOCHIM BIOPHYS ACTA, V1023, P206, DOI 10.1016/0005-2736(90)90415-K; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; STEELE DS, 1990, J PHYSIOL-LONDON, V422, P499; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Marston SB, 2008, J MOL CELL CARDIOL, V45, P603, DOI 10.1016/j.yjmcc.2008.07.004; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Schaffer SW, 1998, AMINO ACIDS, V15, P135, DOI 10.1007/BF01345286; GANGULY PK, 1983, AM J PHYSIOL, V244, pE528; Huke S, 2007, J MOL CELL CARDIOL, V42, P590, DOI 10.1016/j.yjmcc.2006.12.007; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; NOVOTNY MJ, 1991, AM J PHYSIOL, V261, pH121; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; MOZAFFARI MS, 1986, BIOCHEM PHARMACOL, V35, P985, DOI 10.1016/0006-2952(86)90087-0; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; AZUMA J, 1985, CLIN CARDIOL, V8, P276; Berrebi-Bertrand I, 1998, FEBS LETT, V439, P224, DOI 10.1016/S0014-5793(98)01364-7; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Gray CBB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00015; Gupta RC, 2003, AM J PHYSIOL-HEART C, V285, pH2373, DOI 10.1152/ajpheart.00442.2003; HUXTABLE R J, 1982, Drug-Nutrient Interactions, V1, P153; Ito T, 2014, AMINO ACIDS, V46, P111, DOI 10.1007/s00726-013-1507-z; KATZ AM, 1970, BIOCHIM BIOPHYS ACTA, V205, P473, DOI 10.1016/0005-2728(70)90113-1; Lombardini JB, 1996, J MOL CELL CARDIOL, V28, P1957, DOI 10.1006/jmcc.1996.0188; Mattiazzi A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00005; Mishra S, 2003, AM J PHYSIOL-HEART C, V284, pH876, DOI 10.1152/ajpheart.00266.2002; Netticadan T, 2000, CIRC RES, V86, P596; PIERCE GN, 1985, AM J PHYSIOL, V248, pE170; Pion PD, SCIENCE, V237, P764; Schaffer S, 2000, ADV EXP MED BIOL, V483, P57; Schaffer SW, 2014, AMINO ACIDS, V46, P21, DOI 10.1007/s00726-012-1378-8; Schaffer SW, 2014, AMINO ACIDS, V46, P47, DOI 10.1007/s00726-012-1414-8; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P846, DOI 10.1016/j.yjmcc.2008.09.003; SEDDON B, 1973, ANAL BIOCHEM, V56, P566, DOI 10.1016/0003-2697(73)90221-2; SHENOLIKAR S, 1984, METHOD ENZYMOL, V107, P102; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; Sivakumaran V, 2013, ANTIOXID REDOX SIGN, V19, P1185, DOI 10.1089/ars.2012.5057; TRAUTWEIN EA, 1990, AM J CLIN NUTR, V52, P758; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021	52	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	FEB 1	2015	308	3					H232	H239		10.1152/ajpheart.00497.2014		8	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	CB0FB	WOS:000349299900007		
J	Morton, JS; Quon, A; Cheung, PY; Sawamura, T; Davidge, ST				Morton, Jude S.; Quon, Anita; Cheung, Po-Yin; Sawamura, Tatsuya; Davidge, Sandra T.			Effect of sodium tanshinone IIA sulfonate treatment in a rat model of preeclampsia	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						preeclampsia; pregnancy; vascular function; tanshinone; LOX-1; PAF receptor	UTERINE PERFUSION-PRESSURE; ACTIVATING-FACTOR RECEPTOR; ISCHEMIA-INDUCED HYPERTENSION; SCAVENGER RECEPTOR; PLACENTAL ISCHEMIA; DOWN-REGULATION; ENDOTHELIAL DYSFUNCTION; ANGIOGENIC IMBALANCE; VASCULAR DYSFUNCTION; OXIDATIVE STRESS	Preeclampsia is a disorder of pregnancy with a significant impact on maternal and fetal health. The complexity of this multifactorial condition has precluded development of effective therapies and, although many potential pathways have been investigated, the etiology still requires clarification. Our group has investigated the scavenger lectin-like oxidized LDL (LOX-1) receptor, which may respond to factors released from the distressed placenta that contribute to the vascular pathologies observed in preeclampsia. Given the known beneficial effects of sodium tanshinone IIA sulfonate (STS; a component of Salvia miltiorrhiza) on vasodilation, reduction of oxidative stress, and lipid profiles, we have investigated its role as a potential treatment strategy. We hypothesized that STS would improve vascular endothelial function and, combined with a reduction in oxidative stress, would improve pregnancy outcomes in a rat model of preeclampsia (reduced uteroplacental perfusion pressure, RUPP). We further hypothesized this may occur via the action of STS on the LOX-1 and/or platelet-activating factor (PAF) receptor axes. The RUPP model increased maternal blood pressure, vascular oxidative stress, and involvement of the vascular PAF receptor. Treatment with STS during pregnancy decreased both oxidative stress and involvement of the PAF receptor; however, it also increased involvement of the LOX-1 receptor, which is in line with the concept that scavenger receptors, such as LOX-1 and PAF, are upregulated in response to ligand binding and/or under pathological conditions. In this model of preeclampsia, however, the vascular actions of STS did not lead to improvements in pregnancy outcome such as fetal biometrics or maternal blood pressure.	[Morton, Jude S.; Quon, Anita; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynaecol, Edmonton, AB T6G 2S2, Canada; [Morton, Jude S.; Quon, Anita; Cheung, Po-Yin; Davidge, Sandra T.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Morton, Jude S.; Quon, Anita; Cheung, Po-Yin; Davidge, Sandra T.] Cardiovasc Res Ctr, Edmonton, AB, Canada; [Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada; [Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Vasc Physiol, Suita, Osaka, Japan; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada	Davidge, ST (reprint author), Univ Alberta, Dept Obstet Gynaecol, 232 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	sandra.davidge@ualberta.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523	Canadian Institutes of Health Research (CIHR); Women and Children's Health Research Institute; Canada Research Chair (CRC) in Maternal and Fetal Cardiovascular Health	This work was supported by a research grant from the Canadian Institutes of Health Research (CIHR). J. Morton is supported by the Women and Children's Health Research Institute. S. T. Davidge is a Canada Research Chair (CRC) in Maternal and Fetal Cardiovascular Health.	Andersson IJ, 2010, STRESS, V13, P454, DOI 10.3109/10253891003758901; Ramirez RJJ, 2011, HYPERTENS PREGNANCY, V30, P45, DOI 10.3109/10641950903322923; Morton JS, 2012, HYPERTENSION, V59, P1014, DOI 10.1161/HYPERTENSIONAHA.112.191825; Granger JP, 2006, METH MOLEC MED, V122, P383; Tang FT, 2011, EUR J PHARMACOL, V650, P275, DOI 10.1016/j.ejphar.2010.07.038; Honda Z, 2002, J BIOCHEM, V131, P773; Wang LJ, 2008, EUR J PHARMACOL, V597, P75, DOI 10.1016/j.ejphar.2008.08.031; Mao CP, 2009, AM J CHINESE MED, V37, P1031, DOI 10.1142/S0192415X09007478; Tian XH, 2013, EXPERT OPIN THER PAT, V23, P19, DOI 10.1517/13543776.2013.736494; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; Vohra RS, 2006, TRENDS CARDIOVAS MED, V16, P60, DOI 10.1016/j.tcm.2005.12.001; Chen WY, 2012, EUR J PHARMACOL, V674, P359, DOI 10.1016/j.ejphar.2011.10.040; Xu SW, 2013, CELL MOL LIFE SCI, V70, P2859, DOI 10.1007/s00018-012-1194-z; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Xu SW, 2012, TRANSL RES, V160, P114, DOI 10.1016/j.trsl.2012.01.008; George EM, 2013, AM J PHYSIOL-REG I, V305, pR397, DOI 10.1152/ajpregu.00216.2013; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Banek CT, 2013, AM J PHYSIOL-HEART C, V304, pH1159, DOI 10.1152/ajpheart.00903.2012; Zhou LH, 2012, ASIAN PAC J CANCER P, V13, P4453, DOI 10.7314/APJCP.2012.13.9.4453; Bauer AJ, 2013, HYPERTENSION, V61, P1103, DOI 10.1161/HYPERTENSIONAHA.111.00226; Niu XL, 2000, FREE RADICAL RES, V33, P305, DOI 10.1080/10715760000301471; SHUKLA SD, 1992, FASEB J, V6, P2296; Brennan LJ, 2014, MICROCIRCULATION, V21, P4, DOI 10.1111/micc.12079; Li Chun-fang, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P68; Chen J, 2003, CHINESE MED HERBOLOG; Chen XP, 2010, AM J PHYSIOL-HEART C, V299, pH605, DOI 10.1152/ajpheart.01096.2009; Fan GW, 2011, J CARDIOVASC PHARM, V57, P340, DOI 10.1097/FJC.0b013e31820a0da1; Hag AMF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008170; Ishii S, 2002, PROSTAG OTH LIPID M, V68-9, P599, DOI 10.1016/S0090-6980(02)00058-8; Lin JH, 2010, CHINESE MED J-PEKING, V123, P2548, DOI 10.3760/cma.j.issn.0366-6999.2010.18.010; Liu JQ, 2009, AM J PHYSIOL-HEART C, V297, pH1217, DOI 10.1152/ajpheart.00477.2009; Liu S Y, 1994, Zhonghua Fu Chan Ke Za Zhi, V29, P648; Nagase M, 1997, BIOCHEM BIOPH RES CO, V237, P496, DOI 10.1006/bbrc.1997.7176; Pan Chunshui, 2011, Ther Adv Cardiovasc Dis, V5, P99, DOI 10.1177/1753944710396538; Reho JJ, 2011, HYPERTENS PREGNANCY, V30, P208, DOI 10.3109/10641955.2010.507853; Sankaralingam S, 2009, HYPERTENSION, V53, P270, DOI 10.1161/HYPERTENSIONAHA.108.122630; Sun Yongxing, 2014, Brain Sci, V4, P311, DOI 10.3390/brainsci4020311; Taye A, 2013, EUR J CLIN INVEST, V43, P740, DOI 10.1111/eci.12092; Walsh SK, 2009, HYPERTENSION, V54, P345, DOI 10.1161/HYPERTENSIONAHA.109.132191; Wang Xue-feng, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P969; WHO, WHO REC PREV TREATM; Wu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094957; Xu SW, 2014, INT J CARDIOL, V174, P878, DOI 10.1016/j.ijcard.2014.04.226; Xu Y, 2008, J CLIN IMMUNOL, V28, P512, DOI 10.1007/s10875-008-9206-3; Zhang YF, 2009, DRUG CHEM TOXICOL, V32, P362, DOI 10.1080/01480540903176594	48	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	FEB 1	2015	308	3					R163	R172		10.1152/ajpregu.00222.2014		10	Physiology	Physiology	CB0ER	WOS:000349298700002		
J	Agetsuma, N; Koda, R; Tsujino, R; Agetsuma-Yanagihara, Y				Agetsuma, Naoki; Koda, Ryosuke; Tsujino, Riyou; Agetsuma-Yanagihara, Yoshimi			Effective Spatial Scales for Evaluating Environmental Determinants of Population Density in Yakushima Macaques	AMERICAN JOURNAL OF PRIMATOLOGY			English	Article						agriculture; alien carnivore; forestry; habitat management; hunting pressure; Macaca fuscata yakui	MAHAFALY SPECIAL RESERVE; MACACA-FUSCATA YAKUI; JAPANESE MACAQUES; SEASONAL-VARIATIONS; PHOTOGRAPHIC RATES; EQUATORIAL-GUINEA; DIETARY SELECTION; DECIDUOUS FORESTS; FOOD AVAILABILITY; CRYPTIC MAMMALS	Population densities of wildlife species tend to be correlated with resource productivity of habitats. However, wildlife density has been greatly modified by increasing human influences. For effective conservation, we must first identify the significant factors that affect wildlife density, and then determine the extent of the areas in which the factors should be managed. Here, we propose a protocol that accomplishes these two tasks. The main threats to wildlife are thought to be habitat alteration and hunting, with increases in alien carnivores being a concern that has arisen recently. Here, we examined the effect of these anthropogenic disturbances, as well as natural factors, on the local density of Yakushima macaques (Macaca fuscata yakui). We surveyed macaque densities at 30 sites across their habitat using data from 403 automatic cameras. We quantified the effect of natural vegetation (broad-leaved forest, mixed coniferous/broad-leaved forest, etc.), altered vegetation (forestry area and agricultural land), hunting pressure, and density of feral domestic dogs (Canis familiaris). The effect of each vegetation type was analyzed at numerous spatial scales (between 150 and 3,600-m radii from the camera locations) to determine the best scale for explaining macaque density (effective spatial scale). A model-selection procedure (generalized linear mixed model) was used to detect significant factors affecting macaque density. We detected that the most effective spatial scale was 400m in radius, a scale that corresponded to group range size of the macaques. At this scale, the amount of broad-leaved forest was selected as a positive factor, whereas mixed forest and forestry area were selected as negative factors for macaque density. This study demonstrated the importance of the simultaneous evaluation of all possible factors of wildlife population density at the appropriate spatial scale. Am. J. Primatol. 77:152-161, 2015. (c) 2014 Wiley Periodicals, Inc.	[Agetsuma, Naoki] Hokkaido Univ, Wakayama Expt Forest, Wakayama 6494563, Japan; [Koda, Ryosuke] Res Inst Environm Agr & Fisheries, Osaka, Japan; [Tsujino, Riyou] Nara Univ Educ, Ctr Nat Environm Educ, Nara, Japan	Agetsuma, N (reprint author), Hokkaido Univ, Wakayama Expt Forest, 559 Hirai, Wakayama 6494563, Japan.	agetsuma@fsc.hokudai.ac.jp			RIHN; NACS-J; JSPS; GCOE Program; PRI of Kyoto University	Contract grant sponsor: RIHN; contract grant sponsor: NACS-J; contract grant sponsor: JSPS; contract grant sponsor: GCOE Program and PRI of Kyoto University	AGETSUMA N, 1995, INT J PRIMATOL, V16, P595; Agetsuma N, 2001, ECOL RES, V16, P759, DOI 10.1046/j.1440-1703.2001.00431.x; Agetsuma N, 1998, PRIMATES, V39, P275, DOI 10.1007/BF02573077; AGETSUMA N, 1995, INT J PRIMATOL, V16, P611; Agetsuma N, 2007, INT J PRIMATOL, V28, P97, DOI 10.1007/s10764-006-9101-9; Agriculture Forestry and Fisheries Research Council Forestry and Forest Products Research Institute National Agriculture and Bio-oriented Research Organization, 2003, NOR NIOK YAS JUR HIG; Aiba S, 2007, ECOL RES, V22, P439, DOI 10.1007/s11284-007-0338-3; Saj T, 1999, INT J PRIMATOL, V20, P977, DOI 10.1023/A:1020886820759; LaFleur M, 2009, FOLIA PRIMATOL, V80, P233, DOI 10.1159/000240968; McKinney T, 2011, AM J PRIMATOL, V73, P439, DOI 10.1002/ajp.20919; Luck GW, 2007, J BIOGEOGR, V34, P201, DOI 10.1111/j.1365-2699.2006.01575.x; Anderson DP, 2005, J WILDLIFE MANAGE, V69, P298, DOI 10.2193/0022-541X(2005)069<0298:SSRSBR>2.0.CO;2; Bracebridge CE, 2012, BIOTROPICA, V44, P560, DOI 10.1111/j.1744-7429.2012.00854.x; Hanya G, 2004, AM J PRIMATOL, V63, P165, DOI 10.1002/ajp.20049; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Pettorelli N, 2009, AM NAT, V173, P698, DOI 10.1086/597379; Brockman DK, 2008, INT J PRIMATOL, V29, P135, DOI 10.1007/s10764-007-9145-5; Pyritz LW, 2010, INT J PRIMATOL, V31, P796, DOI 10.1007/s10764-010-9429-z; Fletcher RJ, 2008, LANDSCAPE ECOL, V23, P727, DOI 10.1007/s10980-008-9233-8; Rist J, 2009, BIOTROPICA, V41, P700, DOI 10.1111/j.1744-7429.2009.00527.x; Dunham AE, 2008, BIOL CONSERV, V141, P287, DOI 10.1016/j.biocon.2007.10.006; Rovero F, 2012, BIOL CONSERV, V146, P89, DOI 10.1016/j.biocon.2011.09.017; Hanya G, 2004, ECOL RES, V19, P485, DOI 10.1111/j.1440-1703.2004.00662.x; Umapathy G, 2011, INT J PRIMATOL, V32, P889, DOI 10.1007/s10764-011-9508-9; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Coulon A, 2008, LANDSCAPE ECOL, V23, P603, DOI 10.1007/s10980-008-9220-0; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Jennelle CS, 2002, ANIM CONSERV, V5, P119, DOI 10.1017/S1367943002002160; Hanya G, 2003, PRIMATES, V44, P51, DOI 10.1007/s10329-002-0007-7; Agetsuma N, 2007, ECOL RES, V22, P390, DOI 10.1007/s11284-007-0358-z; Arroyo-Rodriguez V, 2008, AM J PRIMATOL, V70, P69, DOI 10.1002/ajp.20458; Baillie JEM, 2004, 2004 IUCN RED LIST T; Burnham K. P., 2002, MODEL SELECTION MULT; Carbone C, 2002, ANIM CONSERV, V5, P121, DOI 10.1017/S1367943002002172; Chatterjee S., 1977, REGRESSION ANAL EXAM; Conservation Measures Partnership, 2007, OP STAND PRACT CONS; de Oliveira VB, 2008, REV BRAS ZOOL, V25, P376, DOI 10.1590/S0101-81752008000200026; de Thoisy B, 2005, ORYX, V39, P149, DOI 10.1017/S0030605305000384; Environment Agency, 1984, NAT OF YAK; Erb WM, 2012, AM J PRIMATOL, V74, P580, DOI 10.1002/ajp.22010; Estrada A, 2013, AM J PRIMATOL, V75, P30, DOI 10.1002/ajp.22080; FURUICHI T, 1982, FOLIA PRIMATOL, V37, P77, DOI 10.1159/000156021; Gumert MD, 2013, ORYX, V47, P535, DOI 10.1017/S0030605312000130; Guo ST, 2008, CONSERV BIOL, V22, P1055, DOI 10.1111/j.1523-1739.2008.00975.x; Hanya G, 2005, AM J PRIMATOL, V66, P245, DOI 10.1002/ajp.20142; Hanya G., 2010, Forestry Studies in China, V12, P184, DOI 10.1007/s11632-010-0403-9; Hill David A., 1994, Primate Research, V10, P85; Hirao T, 2008, ECOL RES, V23, P189, DOI 10.1007/s11284-007-0370-3; Hoffman TS, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-1; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jaman MF, 2013, PRIMATES, V54, P49, DOI 10.1007/s10329-012-0330-6; Kumpel NF, 2008, INT J PRIMATOL, V29, P1065, DOI 10.1007/s10764-008-9254-9; Maruhashi T, 1998, PRIMATES, V39, P291, DOI 10.1007/BF02573078; Mekonnen A, 2012, AM J PRIMATOL, V74, P423, DOI 10.1002/ajp.21999; Ohsawa M, 2006, WORLD HERITAGE; Okabe F, 2007, J MAMMAL, V88, P1090, DOI 10.1644/06-MAMM-A-117R2.1; Phoonjampa R, 2011, BIOTROPICA, V43, P619, DOI 10.1111/j.1744-7429.2010.00743.x; R Core Team, 2014, R LANG ENV STAT COMP; Tagawa H, 1994, NATURAL WORLD HERITA; TAKASAKI H, 1981, BEHAV ECOL SOCIOBIOL, V9, P277, DOI 10.1007/BF00299883; Tesfaye D, 2013, INT J PRIMATOL, V34, P615, DOI 10.1007/s10764-013-9684-x; Tsujino R., 2006, Japanese Journal of Conservation Ecology, V11, P167; Vie J.-C., 2009, WILDLIFE CHANGING WO; Yamada A, 2010, PRIMATES, V51, P159, DOI 10.1007/s10329-009-0183-9; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x	65	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-2565	1098-2345		AM J PRIMATOL	Am. J. Primatol.	FEB	2015	77	2					152	161		10.1002/ajp.22318		10	Zoology	Zoology	CA2DO	WOS:000348719300003		
J	Setou, M; Yao, I				Setou, Mitsutoshi; Yao, Ikuko			Alisa G. Woods and Costel C. Darie (Eds.): Advancements of mass spectrometry in biomedical research	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Software Review									[Setou, Mitsutoshi] Hamamatsu Univ Hosp, Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, Pok Fu Lam, Hong Kong, Peoples R China; [Yao, Ikuko] JST, ERATO, Sato Project, Tokyo 1608582, Japan; [Yao, Ikuko] Hamamatsu Univ Hosp, Sch Med, Med Photon Res Ctr, Dept Opt Imaging, Hamamatsu, Shizuoka 4313192, Japan	Setou, M (reprint author), Hamamatsu Univ Hosp, Sch Med, Dept Cell Biol & Anat, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp						0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	FEB	2015	407	5					1283	1284		10.1007/s00216-014-8372-9		2	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB0SF	WOS:000349336400002		
J	Yamamoto, S; Nagai, E; Asada, Y; Kinoshita, M; Suzuki, S				Yamamoto, Sachio; Nagai, Eriko; Asada, Yuki; Kinoshita, Mitsuhiro; Suzuki, Shigeo			A rapid and highly sensitive microchip electrophoresis of mono- and mucin-type oligosaccharides labeled with 7-amino-4-methylcoumarin	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Microchip electrophoresis; 7-Amino-4-methylcoumarin; Borate complex; Monosaccharide analysis; O-linked glycan	CAPILLARY-ELECTROPHORESIS; PRECONCENTRATOR; BIOSYNTHESIS; CARCINOMA; CELLS; GELS	A selective separation method using a poly(methylmethacrylate) microchip was developed for 7-amino-4-methylcoumarin-labeled saccharides in a crude reaction mixture. In an alkaline borate buffer, saccharide derivatives formed strong anionic borate complexes. These complexes moved from the cathode to the anode in an electric field and were detected near the anode. Excess labeling reagents and other foreign substances remained at the inlet reservoir. A confocal fluorimetric detection system enabled the determination of monosaccharide derivatives with good linearity between at least 5 and 100 nM, corresponding to 50 fmol to 1 pmol per injection. The lower limit of detection (signal-to-noise=5) was 2 nM. The sensitivity and linear quantitation range were comparable to reported values using fluorometric detection, capillary electrophoresis, or liquid chromatography. Application of the method showed excellent resolution in the analysis of O-linked glycans chemically released from glycoproteins.	[Yamamoto, Sachio; Nagai, Eriko; Asada, Yuki; Kinoshita, Mitsuhiro; Suzuki, Shigeo] Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan	Yamamoto, S (reprint author), Kinki Univ, Fac Pharm, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	yamamoto@phar.kindai.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology	We would like to thank Mr. Takashi Fukuzawa of Nippon Sheet Glass Co., Ltd. for providing information on the SELFOC system. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and by the Antiaging Center Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, 2008-2012.	NAKAMORI S, 1993, CANCER RES, V53, P3632; Yodoshi M, 2008, J CHROMATOGR A, V1203, P137, DOI 10.1016/j.chroma.2008.07.053; Hounsell EF, 1996, GLYCOCONJUGATE J, V13, P19, DOI 10.1007/BF01049675; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Brockhausen I, 2003, ADV EXP MED BIOL, V535, P163; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brockhausen I, 2003, BIOCHEM SOC T, V31, P318, DOI 10.1042/BST0310318; Hanski C, 1996, GLYCOCONJ J, V13, P723; HOFFSTETTERKUHN S, 1991, ANAL CHEM, V63, P1541, DOI 10.1021/ac00015a009; KAKEHI K, 1994, J CHROMATOGR A, V680, P209, DOI 10.1016/0021-9673(94)80069-3; Suzuki S, 1998, ELECTROPHORESIS, V19, P2539, DOI 10.1002/elps.1150191503; Yamada K, 2007, ANAL BIOCHEM, V371, P52, DOI 10.1016/j.ab.2007.06.013; Yamamoto S, 2012, ANALYST, V137, P2211, DOI 10.1039/c2an16015c; Yamamoto S, 2011, J SEP SCI, V34, P2879, DOI 10.1002/jssc.201100423; Yamamoto S, 2008, ANAL CHEM, V80, P8224, DOI 10.1021/ac801245n; Yodoshi M, 2013, ELECTROPHORESIS, V34, P3198, DOI 10.1002/elps.201200612	16	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	FEB	2015	407	5					1499	1503		10.1007/s00216-014-8363-x		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB0SF	WOS:000349336400020		
J	Riley, KR; Gagliano, J; Xiao, JJ; Libby, K; Saito, S; Yu, G; Cubicciotti, R; Macosko, J; Colyer, CL; Guthold, M; Bonin, K				Riley, Kathryn R.; Gagliano, Jason; Xiao, Jiajie; Libby, Kara; Saito, Shingo; Yu, Guo; Cubicciotti, Roger; Macosko, Jed; Colyer, Christa L.; Guthold, Martin; Bonin, Keith			Combining capillary electrophoresis and next-generation sequencing for aptamer selection	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Separations; Instrumentation; Capillary electrophoresis; Electrophoresis; Next-generation sequencing; Bioanalytical methods	EQUILIBRIUM MIXTURES; SMART APTAMERS; AFFINITY PROBE; HUMAN THROMBIN; LIGANDS	Next-generation sequencing (NGS) machines can sequence millions of DNA strands in a single run, such as oligonucleotide (oligo) libraries comprising millions to trillions of discrete oligo sequences. Capillary electrophoresis is an attractive technique to select tight binding oligos or "aptamers" because it requires minimal sample volumes (e.g., 100 nL) and offers a solution-phase selection environment through which enrichment of target-binding oligos can be determined quantitatively. We describe here experiments using capillary transient isotachophoresis (ctITP)-based nonequilibrium capillary electrophoresis of equilibrium mixtures (NECEEM) as a method for selecting aptamers from a randomized library containing a known (29mer) thrombin-binding aptamer. Our capillary electrophoresis (CE)-selected samples were sequenced by the Ion Torrent Personal Genome Machine (PGM) and analyzed for selection efficiency. We show that a single round of CE selection can enrich a randomer synthetic DNA oligo mixture for thrombin-binding activity from 0.4 % aptamer content before selection to > 15 % aptamer content.	[Riley, Kathryn R.; Colyer, Christa L.] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Gagliano, Jason; Xiao, Jiajie; Macosko, Jed; Guthold, Martin; Bonin, Keith] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Libby, Kara; Yu, Guo; Cubicciotti, Roger] NanoMed LLC, Winston Salem, NC 27101 USA; [Saito, Shingo] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan	Bonin, K (reprint author), Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA.	bonin@wfu.edu			North Carolina Biotechnology Center [2011-MRG-1115, 2012-CFG-8008]; NIH [5R43GM102987]; Wake Forest University Translational Science Institute; UNC Charlotte	We are grateful to the North Carolina Biotechnology Center for their support of this work through two grants (NC Biotech Grant Award # 2011-MRG-1115) and the Kenan Fellowship Award (NC Biotech Grant Award # 2012-CFG-8008) to primary co-author Jason Gagliano. This work was also supported by the NIH (5R43GM102987) and by a collaborative pilot grant from the Wake Forest University Translational Science Institute and UNC Charlotte.	ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Drabovich AP, 2006, ANAL CHEM, V78, P3171, DOI 10.1021/ac060144h; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Berezovski M, 2002, J AM CHEM SOC, V124, P13674, DOI 10.1021/ja028212e; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Drabovich A, 2005, J AM CHEM SOC, V127, P11224, DOI 10.1021/ja0530016; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Lin PH, 2011, COLLOID SURFACE B, V88, P552, DOI 10.1016/j.colsurfb.2011.07.032; Berezovski M, 2003, ANAL CHEM, V75, P1382, DOI 10.1021/ac026214b; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; FORET F, 1992, J CHROMATOGR, V608, P3, DOI 10.1016/0021-9673(92)87100-M; Li HY, 2010, ELECTROPHORESIS, V31, P2452, DOI 10.1002/elps.201000131; Li YL, 2008, ELECTROPHORESIS, V29, P2570, DOI 10.1002/elps.200700798; Riley KR, 2014, J CHROMATOGR A, V1368, P183, DOI 10.1016/j.chroma.2014.09.062; Song MY, 2009, J CHROMATOGR A, V1216, P873, DOI 10.1016/j.chroma.2008.11.085	15	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	FEB	2015	407	6					1527	1532		10.1007/s00216-014-8427-y		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB0SK	WOS:000349337100001		
J	Takahashi, C; Kalita, G; Ogawa, N; Moriguchi, K; Tanemura, M; Kawashima, Y; Yamamoto, H				Takahashi, Chisato; Kalita, Golap; Ogawa, Noriko; Moriguchi, Keiichi; Tanemura, Masaki; Kawashima, Yoshiaki; Yamamoto, Hiromitsu			Electron microscopy of Staphylococcus epidermidis fibril and biofilm formation using image-enhancing ionic liquid	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Fibril; Gram-positive bacteria; Staphylococcus epidermidis; Ionic liquid; Electron microscopy	INTERCELLULAR-ADHESION; BACTERIAL ADHESION; FE-SEM; PROTEIN; COLONIZATION; ACCUMULATION; INFECTIONS; MECHANISMS; CATHETERS; NANOTUBES	We established an optimized biofilm observation method using a hydrophilic ionic liquid (IL), 1-butyl-3-methylimidazolium tetrafluoroborate ([BMIM][BF4]). In the present study, a biofilm was formed by Staphylococcus epidermidis. Using field emission (FE) scanning electron microscopy (SEM) and transmission electron microscopy (TEM), the colonization of assemblages formed by microbial cells was observed as a function of the cultivation time. FE-TEM analysis revealed that the fibril comprises three types of protein. In addition, the ultrastructure of each protein monomer was visualized. It was expected that the curly-structured protein plays an important role in extension during fibril formation. Compared to the conventional sample preparation method for electron microscopy, a fine structure was easily obtained by the present method using IL. This observation technique can provide valuable information to characterize the ultrastructure of the fibril and biofilm that has not been revealed till date. Furthermore, these findings of the molecular architecture of the fibril and the colonization behavior of microbial cells during biofilm formation are useful for the development of antibacterial drugs and microbial utilization.	[Takahashi, Chisato; Ogawa, Noriko; Moriguchi, Keiichi; Kawashima, Yoshiaki; Yamamoto, Hiromitsu] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Kalita, Golap; Tanemura, Masaki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan	Takahashi, C (reprint author), Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	chisato@dpc.agu.ac.jp			Institute of Pharmaceutical Life Sciences, Aichi Gakuin University	This study was partially supported by the research grant from the Institute of Pharmaceutical Life Sciences, Aichi Gakuin University. The authors are grateful to Dr. Y. Morita of Aichi Gakuin University, Japan, for useful discussions.	Hussain M, 1997, INFECT IMMUN, V65, P519; DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; FRANSON TR, 1984, J CLIN MICROBIOL, V20, P500; Torimoto T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2404975; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Donlan RM, 2001, EMERG INFECT DIS, V7, P277; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P415, DOI 10.1002/jemt.20924; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Wang Y, 2013, CHEM SOC REV, V42, P2930, DOI 10.1039/c2cs35332f; Mahmoudi M, 2011, NANOSCALE, V3, P1127, DOI 10.1039/c0nr00733a; Kuwabata S, 2010, J PHYS CHEM LETT, V1, P3177, DOI 10.1021/jz100876m; An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Takahashi C, 2013, MICROSC RES TECHNIQ, V76, P66, DOI 10.1002/jemt.22137; MACK D, 1992, INFECT IMMUN, V60, P2048; Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011; Potter A, 2009, J MICROBIOL, V47, P319, DOI 10.1007/s12275-009-0008-y; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Ishii S, 2004, APPL ENVIRON MICROB, V70, P5026, DOI 10.1128/AEM.70.8.5026-5029.2004; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Macintosh RL, 2009, J BACTERIOL, V191, P7007, DOI 10.1128/JB.00764-09; Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06; CHARACKLIS W. G., 1990, BIOFILMS; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Kolari M, 2002, J BACTERIOL, V184, P2473, DOI 10.1128/JB.184.9.2473.2480.2002; Mack D, 2013, STAPHYLOCOCCUS EPIDE; Mangel S, 2014, J AM CHEM SOC, V136, P12564, DOI 10.1021/ja506323s; Nelson A, 2009, PEDIATR RES, V66, P174, DOI 10.1203/PDR.0b013e3181a9d80c; Pei L, 2001, J INFECT DIS, V184, P52, DOI 10.1086/321003; Saka H, 2006, MICROSC MICROANAL, V12, P764, DOI 10.1017/S1431927606061228; Schmid T, 2008, ANAL BIOANAL CHEM, V391, P1899, DOI 10.1007/s00216-008-2100-2; Takahashi C, 2012, MATER CHEM PHYS, V133, P565, DOI 10.1016/j.matchemphys.2012.01.089; Takahashi C, 2014, CARBON, V75, P277, DOI 10.1016/j.carbon.2014.04.002; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965; Yamasaki J, 2004, J ELECTRON MICROSC, V53, P129, DOI 10.1093/jmicro/53.2.129; Zakharov VV, 2010, J STRUCT BIOL, V170, P470, DOI 10.1016/j.jsb.2010.01.010	39	2	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	FEB	2015	407	6					1607	1613		10.1007/s00216-014-8391-6		7	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB0SK	WOS:000349337100009		
J	Sasaki, A; Fukuda, H; Shiida, N; Tanaka, N; Furugen, A; Ogura, J; Shuto, S; Mano, N; Yamaguchi, H				Sasaki, Ai; Fukuda, Hayato; Shiida, Narumi; Tanaka, Nobuaki; Furugen, Ayako; Ogura, Jiro; Shuto, Satoshi; Mano, Nariyasu; Yamaguchi, Hiroaki			Determination of omega-6 and omega-3 PUFA metabolites in human urine samples using UPLC/MS/MS	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Eicosanoids; Polyunsaturated fatty acids; Specialized pro-resolving mediators; UPLC/MS/MS; Urine	TANDEM MASS-SPECTROMETRY; PROSTAGLANDIN E-2 METABOLITE; LIPID MEDIATORS; IN-VIVO; OXIDATIVE STRESS; CANCER RISK; FATTY-ACIDS; LC-MS/MS; INFLAMMATION; THROMBOXANE	The omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) such as arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are the precursors of various bioactive lipid mediators including prostaglandins, thromboxanes, leukotrienes, hydroxyeicosatetraenoic acid, isoprostanes, lipoxins, and resolvins (Rvs). These lipid mediators play important roles in various physiological and pathological processes. The quantitative determination of PUFA metabolites seems necessary for disease research and for developing biomarkers. However, there is a paucity of analytical methods for the quantification of omega-6 and omega-3 PUFA metabolites-the specialized pro-resolving mediators (SPMs) present in the human urine. We developed a method for the quantification of omega-6 and omega-3 PUFA metabolites present in human urine using ultra-performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS). The developed method shows good linearity, with a correlation coefficient > 0.99 for all of the analytes. The validation results indicate that our method is adequately reliable, accurate, and precise. The method was successfully used to examine urine samples obtained from 43 healthy volunteers. We could identify 20 PUFA metabolites, and this is the first report of the quantitative determination of RvD1, 17(R)-RvD1, 11-dehydro thromboxane B-3, RvE2, and 5(S)-HETE in human urine. The urinary 8-iso PGF(2 alpha) and PGE(2) levels were significantly higher in the men smokers than in the men nonsmokers (p < 0.05). In this study, we developed an accurate, precise, and novel analytical method for estimating the omega-6 and omega-3 PUFA metabolites, and this is the first report that the SPMs derived from EPA and DHA are present in human urine.	[Sasaki, Ai; Shiida, Narumi; Furugen, Ayako; Ogura, Jiro] Hokkaido Univ, Fac Pharmaceut Sci, Lab Clin Pharmaceut & Therapeut, Sapporo, Hokkaido 0600812, Japan; [Fukuda, Hayato; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Organ Chem Drug Dev, Sapporo, Hokkaido 0600812, Japan; [Tanaka, Nobuaki; Mano, Nariyasu; Yamaguchi, Hiroaki] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Clin Pharm, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Mano, Nariyasu; Yamaguchi, Hiroaki] Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan	Yamaguchi, H (reprint author), Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	yamaguchi@hosp.tohoku.ac.jp	Ogura, Jiro/F-7260-2012	Ogura, Jiro/0000-0001-5139-137X	Japan Society for the Promotion of Science (JSPS) KAKENHI [25460184]; Towa Foundation for Food Research	We thank volunteers for donating urine samples. This work was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 25460184 (HY), and by the Towa Foundation for Food Research (HY).	Abd El-Motaleb Ghada Saad, 2014, Int J Gen Med, V7, P131, DOI 10.2147/IJGM.S56660; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Dong LM, 2009, CANCER EPIDEM BIOMAR, V18, P3075, DOI 10.1158/1055-9965.EPI-09-0680; Yan WY, 2007, J LIPID RES, V48, P1607, DOI 10.1194/jlr.M700097-JLR200; Ridker PM, 2009, J THROMB HAEMOST, V7, P332, DOI 10.1111/j.1538-7836.2009.03404.x; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Liu JM, 2011, CANCER EPIDEM BIOMAR, V20, P1760, DOI 10.1158/1055-9965.EPI-10-0987; Sterz K, 2012, J LIPID RES, V53, P1026, DOI 10.1194/jlr.D023739; Ono E, 2009, CLIN EXP ALLERGY, V39, P72, DOI 10.1111/j.1365-2222.2008.03104.x; Medina S, 2012, RAPID COMMUN MASS SP, V26, P1249, DOI 10.1002/rcm.6224; Yan Z, 2010, ANAL BIOCHEM, V403, P126, DOI 10.1016/j.ab.2010.04.016; Ohnishi H, 2013, J ATHEROSCLER THROMB, V20, P861; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Janakiram NB, 2011, CANCER METAST REV, V30, P507, DOI 10.1007/s10555-011-9311-2; Yamaguchi H, 2011, CLIN EXP ALLERGY, V41, P1711, DOI 10.1111/j.1365-2222.2011.03839.x; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Tsikas D, 2014, J CHROMATOGR B, V964, P79, DOI 10.1016/j.jchromb.2014.03.017; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Murphey LJ, 2004, ANAL BIOCHEM, V334, P266, DOI 10.1016/j.ab.2004.08.019; Gosetti F, 2010, J CHROMATOGR A, V1217, P3929, DOI 10.1016/j.chroma.2009.11.060; Leitzmann MF, 2004, AM J CLIN NUTR, V80, P204; Cai QY, 2006, J CLIN ONCOL, V24, P5010, DOI 10.1200/JCO.2006.06.4931; Balgoma David, 2013, Anal Chem, V85, P7866, DOI 10.1021/ac401461b; Blatnik M, 2010, PROSTAG OTH LIPID M, V93, P8, DOI 10.1016/j.prostaglandins.2010.04.002; Chappell DL, 2011, J PHARMACEUT BIOMED, V56, P600, DOI 10.1016/j.jpba.2011.06.019; FAULER J, 1994, PEDIATR RES, V36, P449, DOI 10.1203/00006450-199410000-00006; FISCHER S, 1988, BIOCHIM BIOPHYS ACTA, V963, P501, DOI 10.1016/0005-2760(88)90318-9; Gonzalez-Nunez D, 2001, HYPERTENSION, V37, P334; Hishinuma T, 1999, PROSTAG OTH LIPID M, V58, P263, DOI 10.1016/S0090-6980(99)00029-5; Kim KM, 2004, BRAIN RES BULL, V64, P47, DOI 10.1016/j.brainreswell.2004.04.016; LORENZ R, 1989, PROSTAGLANDINS, V38, P157, DOI 10.1016/0090-6980(89)90079-8; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Neale JR, 2008, J CHROMATOGR B, V871, P72, DOI 10.1016/j.jchromb.2008.06.042; Olson MT, 2012, J THROMB HAEMOST, V10, P2462, DOI 10.1111/jth.12026; Pelikan Z, 2011, RESPIRATION, V82, P225, DOI 10.1159/000324542; SCHWEER H, 1986, EUR J CLIN PHARMACOL, V31, P303, DOI 10.1007/BF00981128; Sublette ME, 2014, INT J NEUROPSYCHOPH, V17, P383, DOI 10.1017/S1461145713001399; Taylor AW, 2008, LIPIDS, V43, P925, DOI 10.1007/s11745-008-3222-1; Tsikas D, 1998, J CHROMATOGR B, V717, P201, DOI 10.1016/S0378-4347(98)00210-2; Zhou Y, 2010, INT IMMUNOPHARMACOL, V10, P461, DOI 10.1016/j.intimp.2009.12.019	42	4	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	FEB	2015	407	6					1625	1639		10.1007/s00216-014-8412-5		15	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB0SK	WOS:000349337100011		
J	Nakano, H; Sato, S; Uemoto, Y; Kikuchi, T; Shibata, T; Kadowaki, H; Kobayashi, E; Suzuki, K				Nakano, Hikaru; Sato, Shuji; Uemoto, Yoshinobu; Kikuchi, Takashi; Shibata, Tomoya; Kadowaki, Hiroshi; Kobayashi, Eiji; Suzuki, Keiichi			Effect of VRTN gene polymorphisms on Duroc pig production and carcass traits, and their genetic relationships	ANIMAL SCIENCE JOURNAL			English	Article						genetic parameter; pig; thoracic vertebral number; VRTN gene	RESOURCE POPULATION; LOCI ANALYSIS; NUMBER; VERTEBRAE; SWINE; IDENTIFICATION; CHROMOSOME-7; CROSS	The thoracic vertebral number is associated with body length and carcass traits, and represents one of the most important traits in the pig industry. Recent studies have shown that vertnin (VRTN) gene is associated with variations in the vertebral number in commercial European pigs. However, the genetic relationships and effect of this VRTN gene in pig production and carcass traits remain uncertain. Therefore, we investigated the genetic relationships among traits such as vertebral numbers, carcass weight and length-related traits, and meat production traits, and the effect of VRTN gene polymorphisms on these traits in a Duroc purebred population selected for its meat production traits. Highly positive genetic correlations were obtained between the thoracic vertebral numbers and length-related traits (0.56 to 0.84), whereas low correlations were obtained with production traits and carcass weight (-0.16 to 0.05). VRTN gene polymorphisms indicated that the number of thoracic vertebrae and length-related traits were significantly associated with the VRTN genotype, but had no significant effect on production traits and carcass weight. The results indicate that VRTN gene may be used as an effective selection marker to obtain pigs with high thoracic vertebral numbers and length-related traits, without adversely affecting meat production traits.	[Nakano, Hikaru; Suzuki, Keiichi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Nakano, Hikaru; Sato, Shuji; Uemoto, Yoshinobu; Kikuchi, Takashi] Natl Livestock Breeding Ctr, Nishigo, Japan; [Shibata, Tomoya; Kadowaki, Hiroshi] Miyagi Prefecture Anim Ind Expt Stn, Oosaki, Japan; [Kobayashi, Eiji] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan	Suzuki, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.	k1suzuki@bios.tohoku.ac.jp					Mikawa S, 2005, J ANIM SCI, V83, P2247; Perez-Enciso M, 2004, BIOINFORMATICS, V20, P2792, DOI 10.1093/bioinformatics/bth331; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Holl JW, 2008, J ANIM SCI, V86, P1765, DOI 10.2527/jas.2007-0628; Ren DR, 2012, ANIM GENET, V43, P545, DOI 10.1111/j.1365-2052.2011.02313.x; Sato S, 2003, J ANIM SCI, V81, P2938; Rohrer GA, 1998, J ANIM SCI, V76, P2255; Borchers N, 2004, J ANIM BREED GENET, V121, P392, DOI 10.1111/j.1439-0388.2004.00482.x; Hirose K, 2013, ANIM SCI J, V84, P213, DOI 10.1111/j.1740-0929.2012.01066.x; Suzuki K, 2005, LIVEST PROD SCI, V97, P193, DOI 10.1016/j.livprodsci.2005.04.007; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Mikawa S, 2007, GENOME RES, V17, P586, DOI 10.1101/gr.6085507; Wada Y, 2000, ANIM GENET, V31, P376, DOI 10.1046/j.1365-2052.2000.00696.x; Fan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062534; FREDEEN H. T., 1962, CANADIAN JOUR ANIMAL SCI, V42, P240; Gilmour A. R., 2009, ASREML USER GUIDE RE; Hirose K, 2013, ANIMAL SCI J, V85, P198; KING J. W. B., 1960, Animal Prod., V2, P59; Mackay T. F. C., 1996, INTRO QUANTITATIVE G; Mikawa S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-5; Sellier P, 1998, GENETICS OF THE PIG, P463; SUZUKI K, 1991, Japanese Journal of Swine Science, V28, P248; Uemoto Y, 2008, J ANIM SCI, V86, P2833, DOI 10.2527/jas.2007-0293	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					125	131		10.1111/asj.12260		7	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500001		
J	Hisamatsu, S; Sakaue, M; Takizawa, A; Kato, T; Kamoshita, M; Ito, J; Kashiwazaki, N				Hisamatsu, Shin; Sakaue, Motoharu; Takizawa, Akiko; Kato, Tsubasa; Kamoshita, Maki; Ito, Junya; Kashiwazaki, Naomi			Knockout of targeted gene in porcine somatic cells using zinc-finger nuclease	ANIMAL SCIENCE JOURNAL			English	Article						embryo; genome editing; pig; zinc finger nuclease	EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; PIGS; RATS; GENERATION; MICE; PHOSPHORYLATION; MICROINJECTION; MUTAGENESIS; PIGLETS	Targeted genome editing is a widely applicable approach for efficiently modifying any sequence of interest in animals. It is very difficult to generate knock-out and knock-in animals except for mice up to now. Very recently, a method of genome editing using zinc-finger nucleases (ZFNs) has been developed to produce knockout rats. Since only injection of ZFNs into the pronuclear (PN) embryo is required, it seems to be useful for generating gene-targeted animals, including domestic species. However, no one has reported the successful production of knockout pigs by direct injection of ZFNs into PN embryos. We examined whether ZFN works on editing the genome of porcine growth hormone receptor in two kinds of cell lines (ST and PT-K75) derived from the pig as a preliminary study. Our data showed that pZFN1/2 vectors were efficiently transfected into both ST and PT-K75 cells. In both cell lines, results from Cel-I assay showed that modification of the targeted gene was confirmed. We injected ZFN1/2 mRNAs into the nucleus of PN stage embryos and then they were transferred to the recipients. However, pups were not delivered. Taken together, ZFN can be an available technology of genome editing even in the pig but further improvement will be required for generating genome-modified pigs.	[Hisamatsu, Shin] Azabu Univ, Sch Life & Environm Sci, Dept Environm Sci, Sagamihara, Kanagawa 2525201, Japan; [Sakaue, Motoharu] Azabu Univ, Grad Sch Vet Sci, Dept Anat 2, Sagamihara, Kanagawa 2525201, Japan; [Sakaue, Motoharu; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2525201, Japan; [Kato, Tsubasa; Kamoshita, Maki; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Lab Anim Reprod, Sagamihara, Kanagawa 2525201, Japan; [Takizawa, Akiko] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Sakaue, M (reprint author), Azabu Univ, Grad Sch Vet Sci, Dept Anat 2, Sagamihara, Kanagawa 2525201, Japan.	sakaue@azabu-u.ac.jp; itoj@azabu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) (KAKENHI) [24780272, 22658085]; Azabu University Research Services Division	We thank the members of the Laboratory of Animal Reproduction, School of Veterinary Medicine, Azabu University. This research was partially supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (KAKENHI, 24780272 to J.I and 22658085 to N.K.) and by a research project grant awarded by the Azabu University Research Services Division to J.I and N.K. This study was partially supported by a project grant (Creative Research Project 2010) awarded by the Azabu University Research Services Division.	Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Nakai M, 2010, REPRODUCTION, V139, P331, DOI 10.1530/REP-09-0509; Malaver-Ortega LF, 2012, THERIOGENOLOGY, V78, P1749, DOI 10.1016/j.theriogenology.2012.03.031; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Somfai T, 2009, BIOL REPROD, V80, P42, DOI 10.1095/biolreprod.108.070235; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Hirose M, 2013, ANIM SCI J, V84, P693, DOI 10.1111/asj.12061; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Ezashi T, 2012, REPROD DOMEST ANIM, V47, P92, DOI 10.1111/j.1439-0531.2012.02061.x; Galli C, 2010, XENOTRANSPLANTATION, V17, P397, DOI 10.1111/j.1399-3089.2010.00590.x; Ito J, 2012, ANIM SCI J, V83, P669, DOI 10.1111/j.1740-0929.2012.01044.x; Ito J, 2010, ANIM SCI J, V81, P34, DOI 10.1111/j.1740-0929.2009.00699.x; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kawano N, 2010, REPROD DOMEST ANIM, V45, P263, DOI 10.1111/j.1439-0531.2008.01279.x; Kikuchi K, 2008, REPROD DOMEST ANIM, V43, P401, DOI 10.1111/j.1439-0531.2008.01191.x; Mansouri A, 2001, METH MOL B, V175, P397; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Sander JD, 2011, METHOD CELL BIOL, V104, P51, DOI 10.1016/B978-0-12-374814-0.00003-3; Sato K, 2013, ANIM SCI J, V84, P359, DOI 10.1111/asj.12044; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					132	137		10.1111/asj.12259		6	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500002		
J	Sathanawongs, A; Fujiwara, K; Kato, T; Hirose, M; Kamoshita, M; Wojcikiewicz, RJH; Parys, JB; Ito, J; Kashiwazaki, N				Sathanawongs, Anucha; Fujiwara, Katsuyoshi; Kato, Tsubasa; Hirose, Masahiko; Kamoshita, Maki; Wojcikiewicz, Richard J. H.; Parys, Jan B.; Ito, Junya; Kashiwazaki, Naomi			The effect of M-phase stage-dependent kinase inhibitors on inositol 1,4,5-trisphosphate receptor 1 (IP(3)R1) expression and localization in pig oocytes	ANIMAL SCIENCE JOURNAL			English	Article						inositol 1,4,5-trisphosphate receptor; maturation; oocyte; pig; polo-like kinase 1	MATURED PORCINE OOCYTES; IN-VITRO MATURATION; MEIOTIC MATURATION; CALCIUM-RELEASE; BOVINE OOCYTES; CELL-CYCLE; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTORS; CA2+ OSCILLATIONS; P34(CDC2) KINASE	At fertilization, inositol 1,4,5-trisphosphate receptor type 1 (IP(3)R1) has a crucial role in Ca2+ release in mammals. Expression levels, localization and phosphorylation of IP(3)R1 are important for its function, but it still remains unclear which molecule(s) regulates IP(3)R1 behavior in pig oocytes. We examined whether there was a difference in localization of IP(3)R1 after in vitro or in vivo maturation of pig oocytes. In mouse oocytes, large clusters of IP(3)R1 were formed in the cortex of the oocyte except in a ring-shaped band of cortex adjacent to the spindle. However, no such clusters of IP(3)R1 were observed in pig oocytes and there was no difference in its localization between in vitro and in vivo matured oocytes. We next tried to clarify which factor(s) regulates IP(3)R1 localization, phosphorylation and expression using M-phase stage-dependent kinase inhibitors. Our results show that treatments with roscovitine (p34(cdc2) kinase inhibitor) or U0126 (mitogen-activated protein kinase inhibitor) did not affect IP(3)R1 expression or localization in pig oocytes, although the latter strongly inhibited phosphorylation. However, treatment with BI-2536, an inhibitor of polo-like kinase 1 (Plk1), dramatically decreased the expression level of IP(3)R1 in pig oocytes in a dose-dependent manner. From these results, it is suggested that Plk1 is involved in the regulation of IP(3)R1 expression in pig oocytes.	[Sathanawongs, Anucha] Chiang Mai Univ, Fac Vet Med, Chiang Mai 50000, Thailand; [Sathanawongs, Anucha; Fujiwara, Katsuyoshi; Kato, Tsubasa; Hirose, Masahiko; Kamoshita, Maki; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Lab Anim Reprod, Sagamihara, Kanagawa 2525201, Japan; [Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2525201, Japan; [Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Parys, Jan B.] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Leuven, Belgium	Ito, J (reprint author), Azabu Univ, Sch Vet Med, Lab Anim Reprod, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan.	itoj@azabu-u.ac.jp		Parys, Jan/0000-0002-3591-4967	JSPS (KAKENHI) [24780272]; Azabu University; Azabu University Research Services Division; International exchange committee of Azabu University;  [NIH R01 DK049194]	We would like to thank the members of the Laboratory of Animal Reproduction, School of Veterinary Medicine, Azabu University. This work was supported in part by a Grant-in-Aid for Scientific Research from JSPS (KAKENHI, 24780272 to J.I.). This research was also partially supported by a research project grant awarded by the Azabu University to J.I and N.K. This study was partially supported by a project grant (Creative Research Project, 2010) awarded by the Azabu University Research Services Division (to N.K.) and International exchange committee of Azabu University (to A.S and J.I.). This study was also partially supported by a grant (NIH R01 DK049194) to R.W.	Anas MKI, 1998, THERIOGENOLOGY, V50, P347, DOI 10.1016/S0093-691X(98)00144-7; Ito J, 2008, DEV BIOL, V320, P402, DOI 10.1016/j.ydbio.2008.05.548; FUJIWARA T, 1993, DEV BIOL, V156, P69, DOI 10.1006/dbio.1993.1059; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Vanderheyden V, 2009, CELL CALCIUM, V46, P56, DOI 10.1016/j.ceca.2009.04.004; PARYS JB, 1995, CELL CALCIUM, V17, P239, DOI 10.1016/0143-4160(95)90070-5; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; Malathi K, 2003, J CELL BIOCHEM, V90, P1186, DOI 10.1002/jcb.10720; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; Wang L, 2005, CLONING STEM CELLS, V7, P306, DOI 10.1089/clo.2005.7.306; Sebastian M, 2010, J THORAC ONCOL, V5, P1060, DOI 10.1097/JTO.0b013e3181d95dd4; CARROLL J, 1992, J BIOL CHEM, V267, P11196; Liu YS, 2005, CHEM BIOL, V12, P99, DOI 10.1016/j.chembiol.2004.11.009; Saunders CM, 2002, DEVELOPMENT, V129, P3533; JONES KT, 1995, DEVELOPMENT, V121, P3259; Kline D, 2000, CURR TOP DEV BIOL, V50, P125, DOI 10.1016/S0070-2153(00)50007-6; Ito J, 2011, MOL REPROD DEV, V78, P846, DOI 10.1002/mrd.21359; Bai GR, 2006, BIOCHEM BIOPH RES CO, V348, P1319, DOI 10.1016/j.bbrc.2006.07.208; Mehlmann LM, 1996, DEV BIOL, V180, P489, DOI 10.1006/dbio.1996.0322; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291; Nagashima H, 1996, MOL REPROD DEV, V45, P359, DOI 10.1002/(SICI)1098-2795(199611)45:3<359::AID-MRD13>3.0.CO;2-U; Hirose M, 2013, ANIM SCI J, V84, P693, DOI 10.1111/asj.12061; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; Carroll J, 2004, EUR J OBSTET GYN R B, V115, pS61, DOI 10.1016/j.ejogrb.2004.01.024; Ito J, 2012, ANIM SCI J, V83, P669, DOI 10.1111/j.1740-0929.2012.01044.x; Ito J, 2010, ANIM SCI J, V81, P34, DOI 10.1111/j.1740-0929.2009.00699.x; Ito J, 2004, REPRODUCTION, V128, P409, DOI 10.1530/rep.1.00230; Ito JY, 2004, BIOL REPROD, V70, P797, DOI 10.1095/biolreprod.103.020610; Jellerette T, 2004, DEV BIOL, V274, P94, DOI 10.1016/j.ydbio.2004.06.020; Kohaya N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058063; Kume S, 1997, DEV BIOL, V182, P228, DOI 10.1006/dbio.1996.8479; Malcuit C, 2005, BIOL REPROD, V73, P2, DOI 10.1095/biolreprod.104.037333; MIYAZAKI S, 1992, FEBS LETT, V309, P180, DOI 10.1016/0014-5793(92)81090-9; Runft LL, 1999, DEV BIOL, V214, P399, DOI 10.1006/dbio.1999.9415; Soto E, 2010, CLIN PHARMACOL THER, V88, P660, DOI 10.1038/clpt.2010.148; Wakai T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006767; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; YUE CP, 1995, DEVELOPMENT, V121, P2645	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					138	147		10.1111/asj.12258		10	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500003		
J	Kawai, K; Korematsu, K; Akiyama, K; Okita, M; Yoshimura, Y; Isobe, N				Kawai, Kazuhiro; Korematsu, Kiyoshi; Akiyama, Kiyoshi; Okita, Miki; Yoshimura, Yukinori; Isobe, Naoki			Dynamics of lingual antimicrobial peptide, lactoferrin concentrations and lactoperoxidase activity in the milk of cows treated for clinical mastitis	ANIMAL SCIENCE JOURNAL			English	Article						antibiotic; clinical mastitis; dairy cow; lactoferrin; lingual antimicrobial peptide	SOMATIC-CELL COUNT; DAIRY-COWS; MAMMARY-GLAND; IMMUNOLOCALIZATION; TISSUE; SYSTEM	The aim of the present study was to examine changes in innate immune factors in the milk of mastitic dairy cows treated with antibiotics. Cows in the antibiotics group (n=13) were infused into the mammary gland with cefazolin on the sixth day after mastitis was diagnosed (the day of the mastitis diagnosis=day -6). The control group (n=12) was not treated. Milk samples were collected once every 2 days from days -6 to 12 and somatic cell count (SCC), lingual antimicrobial peptide (LAP), and lactoferrin (LF) concentrations and lactoperoxidase (LPO) activity were measured. SCC and LF concentrations in the antibiotics group markedly decreased after the antibiotic treatment. When cows in the antibiotics group were divided according to SCC on day 0, LAP concentrations and LPO activity in cows with a lower SCC on day 0 (<5x10(6)cell/mL) were significantly higher and lower than those in cows with a higher SCC, respectively. These results suggest that LF concentration decreased with decrease in SCC after treatment and that LAP concentration and LPO activity differed depending on the severity of mastitis. This is the first report to reveal the dynamics of innate immune factor in milk of cows treated for clinical mastitis.	[Kawai, Kazuhiro] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan; [Korematsu, Kiyoshi] Kirishima Veterinarians, Kobayashi, Japan; [Akiyama, Kiyoshi] Kanagawa Prefectural Livestock Ind Technol Ctr, Hiratsuka, Kanagawa, Japan; [Okita, Miki; Yoshimura, Yukinori; Isobe, Naoki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan	Isobe, N (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan.	niso@hiroshima-u.ac.jp			JSPS [24580410]	This work was supported by JSPS Grants-in-Aid for Scientific Research to N. Isobe (24580410).	Isobe N, 2011, J DAIRY SCI, V94, P3868, DOI 10.3168/jds.2010-4133; Shin K, 2001, J APPL MICROBIOL, V90, P489, DOI 10.1046/j.1365-2672.2001.01268.x; Bosch EH, 2000, J APPL MICROBIOL, V89, P215, DOI 10.1046/j.1365-2672.2000.01098.x; ARNOLD RR, 1977, SCIENCE, V197, P263, DOI 10.1126/science.327545; WEINBERG ED, 1978, MICROBIOL REV, V42, P45; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Swanson K, 2004, INFECT IMMUN, V72, P7311, DOI 10.1128/IAI.72.12.7311-7314.2004; HURLEY WL, 1993, CELL BIOL INT, V17, P283, DOI 10.1006/cbir.1993.1064; Hogan JS, 1999, LAB HDB BOVINE MASTI; Huang YQ, 2012, VET IMMUNOL IMMUNOP, V145, P499, DOI 10.1016/j.vetimm.2011.10.017; Isobe N, 2009, ANIM SCI J, V80, P446, DOI 10.1111/j.1740-0929.2009.00652.x; Isobe N, 2009, J DAIRY SCI, V92, P6046, DOI 10.3168/jds.2009-2594; Isobe N, 2009, J DAIRY SCI, V92, P2691, DOI 10.3168/jds.2008-1940; Isobe N, 2013, ANIM SCI J, V84, P751, DOI 10.1111/asj.12113; Kawai K, 2013, VET IMMUNOL IMMUNOP, V153, P298, DOI 10.1016/j.vetimm.2013.03.002; KITCHEN BJ, 1980, J DAIRY SCI, V63, P978; National Research Council, 2001, NUTR REQ DAIR CATTL; Rainard P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063471; Schalm OW, 1971, BOVINE MASTITIS, P94	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					153	158		10.1111/asj.12269		6	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500005		
J	Obitsu, T; Hata, H; Taniguchi, K				Obitsu, Taketo; Hata, Hiroshi; Taniguchi, Kohzo			Nitrogen digestion and urea recycling in Hokkaido native horses fed hay-based diets	ANIMAL SCIENCE JOURNAL			English	Article						digestion; horse; nitrogen utilization; urea recycling	LARGE-INTESTINE; PROTEIN; EQUINE; DIGESTIBILITY; METABOLISM; KINETICS; SHEEP; NUTRITION; KNOWLEDGE; HUMANS	Nitrogen (N) digestion and urea-N metabolism in Hokkaido native horses fed roughage-based diets containing different types and levels of protein sources were studied. Horses (173 +/- 4.8kg) fitted with an ileum cannula were fed four diets consisting of 100% timothy hay (TH), 88% TH and 12% soybean meal (SBM), 79% TH and 21% SBM, and 51% TH and 49% alfalfa hay at 2.2% of body weight. Dietary protein content varied from 5% to 15% of dry matter. Apparent N digestibilities in the pre-cecum and total tract for the TH diet were lower than those for other diets. However, the proportion of post-ileum N digestion to N intake was not affected by the diets. Urea-N production was linearly related to N intake, but gut urea-N entry was not affected by the diets. The proportion of gut urea-N entry to urea-N production tended to be higher for the TH diet (57%) than the two SBM diets (39%). Anabolic use of urea-N entering the gut was not affected by the diets (20-36% of gut urea-N entry). These results indicate that urea-N recycling provides additional N sources for microbial fermentation in the hindgut of Hokkaido native horses fed low-quality roughages.	[Obitsu, Taketo; Taniguchi, Kohzo] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Hata, Hiroshi] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Shinhidaka, Japan	Obitsu, T (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan.	tobitsu@hiroshima-u.ac.jp					Lobley GE, 2000, BRIT J NUTR, V84, P459; Hendriks WH, 2012, BRIT J NUTR, V108, pS247, DOI 10.1017/S0007114512002395; GIBBS PG, 1988, J ANIM SCI, V66, P400; Torrallardona D, 2003, AM J PHYSIOL-ENDOC M, V284, pE1177, DOI 10.1152/ajpendo.00465.2002; Russell K, 2000, BRIT J NUTR, V84, P597; Obitsu T, 2011, ANIM SCI J, V82, P531, DOI 10.1111/j.1740-0929.2011.00880.x; EL-Sabagh M, 2013, ANIMAL, V7, P1622, DOI 10.1017/S1751731113001225; AOAC, 1990, OFFICIAL METHODS ANA; Farley EB, 1995, J EQUINE VET SCI, V15, P391, DOI 10.1016/S0737-0806(07)80483-7; Gibbs PG, 1996, J EQUINE VET SCI, V16, P60, DOI 10.1016/S0737-0806(96)80157-2; JACKSON AA, 1993, J NUTR, V123, P2129; Japan Racing Association, 2004, JAP FEED STAND HORS; Kawai Masahito, 1995, Journal of Equine Science, V6, P121, DOI 10.1294/jes.6.121; Kobayashi Y, 2006, ECOL RES, V21, P285, DOI 10.1007/s11284-005-0118-x; Lapierre H., 2001, J DAIRY SCI S, V84, pE223, DOI DOI 10.3168/JDS.S0022-0302(01)70222-6; Marini JC, 2003, J ANIM SCI, V81, P545; Martin RG, 1996, BRIT J NUTR, V76, P373, DOI 10.1079/BJN19960043; Obitsu T, 2009, ASIAN AUSTRAL J ANIM, V22, P440; PRIOR RL, 1974, J ANIM SCI, V38, P565; Ragnarsson S, 2010, J ANIM PHYSIOL AN N, V94, P623, DOI 10.1111/j.1439-0396.2009.00947.x; REMOND D, 1993, J ANIM SCI, V71, P2785; Rey F, 2001, J ANIM PHYSIOL AN N, V85, P251, DOI 10.1046/j.1439-0396.2001.00323.x; Reynolds C K, 2008, J Anim Sci, V86, pE293; ROBINSON DW, 1974, J ANIM SCI, V39, P1045; Santos AS, 2011, ANIMAL, V5, P48, DOI 10.1017/S1751731110001588; SAS Institute Inc, 2004, SAS STAT 9 1 US GUID; Shingu Yuko, 2001, Journal of Equine Science, V12, P145, DOI 10.1294/jes.12.145; Shingu Yuko, 2000, Journal of Equine Science, V11, P69, DOI 10.1294/jes.11.69; SWANSON EW, 1977, J DAIRY SCI, V60, P1583; Takezawa T, 1992, W JAPAN J ANIMAL SCI, V35, P26; Taniguchi K, 2003, J VET MED SCI, V65, P927, DOI 10.1292/jvms.65.927; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					159	165		10.1111/asj.12256		7	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500006		
J	Yani, S; Ishida, K; Goda, S; Azumai, S; Murakami, T; Kitagawa, M; Okano, K; Oishi, K; Hirooka, H; Kumagai, H				Yani, Srita; Ishida, Kyohei; Goda, Shuzo; Azumai, Shigeyoshi; Murakami, Tomoyuki; Kitagawa, Masayuki; Okano, Kanji; Oishi, Kazato; Hirooka, Hiroyuki; Kumagai, Hajime			Effects of utilization of local food by-products as total mixed ration silage materials on fermentation quality and intake, digestibility, rumen condition and nitrogen availability in sheep	ANIMAL SCIENCE JOURNAL			English	Article						digestibility; food by-product; nitrogen balance; total mixed ration silage; wether	WET BREWERS GRAINS; RUMINAL FERMENTATION; NUTRITIVE-VALUE; FORAGE; REPLACEMENT; PROTEIN; LAMBS; COWS	Four wethers were used in a 4x4 Latin square design experiment to evaluate in vivo digestibility of total mixed ration (TMR) silage with food by-products for dairy cows, and the ruminal condition and nitrogen (N) balance were examined. Five by-products (i.e. potato waste, noodle waste, soybean curd residue, soy sauce cake and green tea waste) were obtained. Four types of TMR silage were used: control (C) containing roughage and commercial concentrate, T1:20% and T1:40% containing the five by-products replacing 20% and 40% of the commercial concentrate on a dry matter (DM) basis, respectively, and T2:40% containing three by-products (potato waste, noodle waste and soybean curd residue) replacing 40% of the commercial concentrate on a DM basis. The ingredients were mixed and preserved in oil drum silos for 4 months. The TMR silages showed 4.02-4.44% and 1.75-2.19% for pH and lactic acid contents, respectively. The digestibility of DM and neutral detergent fiber, and total digestible nutrient content were higher (P<0.05) for T2:40% feeding than for C feeding. Urinary nitrogen excretion tended to be lower (P=0.07) for T2:40% than for C. The results suggested 40% replacing of commercial concentrate by using the three food by-products can be most suitable for TMR silage.	[Yani, Srita; Ishida, Kyohei; Kitagawa, Masayuki; Oishi, Kazato; Hirooka, Hiroyuki; Kumagai, Hajime] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources, Kyoto 6068502, Japan; [Goda, Shuzo; Azumai, Shigeyoshi; Murakami, Tomoyuki] Kyoto Livestock Ctr, Kyoto, Japan; [Okano, Kanji] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga, Japan	Kumagai, H (reprint author), Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan.	hkuma@kais.kyoto-u.ac.jp			Research and Development Projects for Utilization of Un-used Resources for Feed from Japan Livestock Industry Association	This study was financially supported by the Research and Development Projects for Utilization of Un-used Resources for Feed from Japan Livestock Industry Association.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Gomori G, 1942, J LAB CLIN MED, V27, P955; Atkinson RL, 2007, J ANIM SCI, V85, P3322, DOI 10.2527/jas.2006-417; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Tolera A, 1997, ANIM FEED SCI TECH, V67, P181, DOI 10.1016/S0377-8401(96)01119-4; Amelchanka SL, 2010, ANIM FEED SCI TECH, V155, P111, DOI 10.1016/j.anifeedsci.2009.10.007; Chiou PWS, 1998, ANIM FEED SCI TECH, V74, P123; Wang F, 2008, J DAIRY SCI, V91, P2380, DOI 10.3168/jds.2007-0821; AOAC, 2000, OFFICIAL METHODS ANA; Barnett AJG, 1951, BIOCHEM J, V49, P524; Cao Y, 2009, ANIM FEED SCI TECH, V151, P1, DOI 10.1016/j.anifeedsci.2008.10.010; CHIOU PWS, 1995, ANIM FEED SCI TECH, V55, P215, DOI 10.1016/0377-8401(95)00798-R; Conway EJ, 1962, MICRODIFUSSION ANAL; HEANEY DP, 1963, J ANIM SCI, V22, P956; Imai A, 2001, JAPANESE J RASSLAND, V47, P307; Ishida K, 2012, ANIM SCI J, V83, P735, DOI 10.1111/j.1740-0929.2012.01016.x; Kajikawa H, 1996, UTILIZATION BY PRODU; McDonald P., 1973, CHEMISTRY BIOCHEMIST, P33; National Agriculture and Food Research Organization (NARO), 2007, JAP FEED STAND DAIR; National Agriculture and Food Research Organization (NARO), 2010, STAND TABL FEED COMP; NUNEZHERNANDEZ G, 1991, J ANIM SCI, V69, P1167; ONWUBUEMELI C, 1985, J DAIRY SCI, V68, P1207; Price WJ., 1979, SPECTROCHEMICAL ANAL, P248; Santoso B, 2009, J INDONES TROP ANIM, V34, P189; Statistical Analysis System (SAS), 1998, SAS STAT US GUID VER; Sugimoto M, 2006, ANIM SCI J, V77, P587, DOI 10.1111/j.1740-0929.2006.00390.x; Van Soest PJ, 1994, NUTR ECOLOGY RUMINAN; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583; Wang FJ, 2009, ANIM FEED SCI TECH, V149, P265, DOI 10.1016/j.anifeedsci.2008.06.012; Woodward A, 1997, J ANIM SCI, V75, P1130; Xu CC, 2007, ANIM FEED SCI TECH, V138, P228, DOI 10.1016/j.anifeedsci.2006.11.014	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					174	180		10.1111/asj.12263		7	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500008		
J	Iio, W; Tokutake, Y; Koike, H; Matsukawa, N; Tsukahara, T; Chohnan, S; Toyoda, A				Iio, Wataru; Tokutake, Yuka; Koike, Hiroaki; Matsukawa, Noriko; Tsukahara, Takamitsu; Chohnan, Shigeru; Toyoda, Atsushi			Effects of chronic mild food restriction on behavior and the hypothalamic malonyl-CoA signaling pathway	ANIMAL SCIENCE JOURNAL			English	Article						anorexia; depression; food restriction; hypothalamus; malonyl-CoA	CALORIE RESTRICTION; SYNAPTIC PLASTICITY; SOCIAL DEFEAT; ANIMAL-MODEL; MAP KINASE; COENZYME-A; STRESS; RATS; EXPRESSION; DEPRESSION	Depression induces anorexia, leading to suppressed feeding behaviors and energy intake. Previously, we revealed that chronic social defeat induced a mild suppression of feeding in rats with elevated levels of hypothalamic malonyl-CoA which regulates feeding. Therefore, we attempted to elucidate the effects of chronic mild food restriction on behavior and on hypothalamic malonyl-CoA. The chronic mild food restricted rats were fed a restricted diet approximately 80% to 90% amount of diet compared to the control for 5 weeks. Ratios of restriction were adjusted with feed consumption in the chronic social defeat stressed rats. Chronic mild food restricted rats exhibited a suppression of body weight gain similar to that of the chronic social defeat stressed rats. Also these rats showed increased time spent in the center area of an open field (OF), prolonged immobility time in forced swim, increased phosphorylation of hypothalamic adenosine monophosphate-activated protein kinase (AMPK) and acetyl-CoA carboxylase and a decreased concentration of hypothalamic malonyl-CoA. Weight of the adrenal glands, locomotion in an OF, mitogen-activated protein kinase cascade and calcium/calmodulin-dependent protein kinases II in the hippocampus were not affected by chronic mild food restriction. Our findings suggest that chronic mild food restriction activates AMPK following a decreased hypothalamic malonyl-CoA.	[Iio, Wataru; Tokutake, Yuka; Chohnan, Shigeru; Toyoda, Atsushi] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo, Japan; [Iio, Wataru; Tokutake, Yuka; Koike, Hiroaki; Chohnan, Shigeru; Toyoda, Atsushi] Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan; [Matsukawa, Noriko; Tsukahara, Takamitsu] Kyoto Inst Nutr & Pathol, Kyoto, Japan	Toyoda, A (reprint author), Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan.	atoyoda@mx.ibaraki.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22580303, 23126501]; School of Agriculture, Ibaraki University	We would like to thank Dr. Hiroko Toyoda (Ibaraki University) for helpful comments regarding the manuscript. WI and AT designed research and wrote this manuscript; WI and HK performed the animal experiments, behavioral tests and biochemical analysis; YT, NM, TT and SC performed biochemical analyses. All co-authors agreed to the final manuscript. This research was supported in part by Grants-in-Aid No.22580303 to A.T., and No.23126501 to S.C. from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a grant from the School of Agriculture, Ibaraki University.	American Psychiatric Publishing, 2000, DIAGN STAT MAN MENT; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Chuang JC, 2010, BIOL PSYCHIAT, V67, P1075, DOI 10.1016/j.biopsych.2009.12.003; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Kiliaan AJ, 1998, AM J PHYSIOL-GASTR L, V275, pG1037; Iio W, 2012, AMINO ACIDS, V43, P2037, DOI 10.1007/s00726-012-1282-2; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Levay EA, 2010, NUTR RES, V30, P366, DOI 10.1016/j.nutres.2010.05.001; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Iio W, 2011, NEUROSCI LETT, V504, P281, DOI 10.1016/j.neulet.2011.09.047; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Rosenbrock H, 2005, BRAIN RES, V1040, P55, DOI 10.1016/j.brainres.2005.01.065; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Wolfgang MJ, 2008, MOL ENDOCRINOL, V22, P2012, DOI 10.1210/me.2007-0538; Iio W, 2012, BIOCHEM BIOPH RES CO, V421, P301, DOI 10.1016/j.bbrc.2012.04.004; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Jahng JW, 2007, BRAIN RES, V1150, P100, DOI 10.1016/j.brainres.2007.02.080; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Barbiero VS, 2007, NEUROPSYCHOPHARMACOL, V32, P2511, DOI 10.1038/sj.npp.1301378; Han F, 2009, BRAIN RES, V1265, P205, DOI 10.1016/j.brainres.2009.02.014; Kanai M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-8; Levay EA, 2007, PHYSIOL BEHAV, V92, P889, DOI 10.1016/j.physbeh.2007.06.018; Paxinos G, 2004, RAT BRAIN STEREOTAXI; Qi XL, 2009, BEHAV BRAIN RES, V199, P203, DOI 10.1016/j.bbr.2008.11.051; Qi XL, 2006, BEHAV BRAIN RES, V175, P233, DOI 10.1016/j.bbr.2006.08.035; SAUNDERS PR, 1994, AM J PHYSIOL-GASTR L, V267, pG794; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7; Tiraboschi E, 2004, NEUROREPORT, V15, P2393, DOI 10.1097/00001756-200410250-00018; Tokutake Y, 2012, BIOCHEM BIOPH RES CO, V423, P781, DOI 10.1016/j.bbrc.2012.06.037; West BD, 2006, PHARMACOL BIOCHEM BE, V84, P158, DOI 10.1016/j.pbb.2006.04.022; Wu AG, 2003, NEUROSCI LETT, V339, P166, DOI 10.1016/S0304-3940(03)00008-9; Zeng J, 2003, LIFE SCI, V73, P1131, DOI 10.1016/S0024-3205(03)00417-X	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					181	188		10.1111/asj.12255		8	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500009		
J	Mizunoya, W; Tashima, A; Sato, Y; Tatsumi, R; Ikeuchi, Y				Mizunoya, Wataru; Tashima, Ayumi; Sato, Yusuke; Tatsumi, Ryuichi; Ikeuchi, Yoshihide			The growth-promoting activity of egg white proteins in the C2C12 myoblast cell line	ANIMAL SCIENCE JOURNAL			English	Article						C2C12; egg white; ovalbumin; ovomucoid; skeletal muscle	SKELETAL-MUSCLE; ANTIHYPERTENSIVE ACTIVITY; NITRIC-OXIDE; OVALBUMIN; LYSOZYME; BODY; MASS	In this study, we examined the effects of several egg white proteins (ovalbumin, ovomucoid, ovotransferrin and lysozyme) on proliferation and myotube growth in C2C12 murine myoblast cells. Cell proliferation was measured using a water-soluble tetrazolium salt (WST-8)-based assay and then validated using Giemsa staining. Significant proliferative activities of C2C12 cells were observed in response to the addition of 10(-5)-10(-4)mol/L ovalbumin or ovomucoid. Ovotransferrin decreased C2C12 cell proliferation and lysozyme showed no significant effects on the proliferation of C2C12 cells. In contrast, the proliferative effects of ovalbumin and ovomucoid were not observed in 3T3-L1 murine preadipocyte cells. We also measured the effects of ovalbumin and ovomucoid on C2C12 myotube diameters by using histological analysis. In comparison to control cells, myotube diameters were significantly increased in cells cultured in 10(-6)-10(-4)mol/L ovalbumin or ovomucoid, suggesting that ovalbumin and ovomucoid stimulate the growth of myotubes. Thus, our results clearly demonstrated that ovalbumin or ovomucoid stimulated the proliferation of myoblasts and growth of myotubes.	[Mizunoya, Wataru; Tashima, Ayumi; Sato, Yusuke; Tatsumi, Ryuichi; Ikeuchi, Yoshihide] Kyushu Univ, Grad Sch Agr, Dept Bioresource Sci, Fukuoka 8128581, Japan	Mizunoya, W (reprint author), Kyushu Univ, Grad Sch Agr, Dept Bioresource Sci, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	wataru_m@agr.kyushu-u.ac.jp			Kieikai Research Foundation; Faculty of Agriculture, Kyushu University	This research was supported by a research grant from the Kieikai Research Foundation. The publication was supported in part by the Research Grant for Young Investigators of Faculty of Agriculture, Kyushu University.	Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P1416, DOI 10.1021/jf9507147; Tatsumi R, 2006, AM J PHYSIOL-CELL PH, V290, pC1487, DOI 10.1152/ajpcell.00513.2005; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Matoba N, 1999, FEBS LETT, V452, P181, DOI 10.1016/S0014-5793(99)00587-6; SNOW MH, 1977, ANAT REC, V188, P201, DOI 10.1002/ar.1091880206; VALENTI P, 1983, INT J TISSUE REACT, V5, P97; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Burk A, 2009, NUTR RES, V29, P405, DOI 10.1016/j.nutres.2009.03.008; Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003; Fujita H, 1995, BIOSCI BIOTECH BIOCH, V59, P2344; Besler M, 1999, INT S FOOD ALLERGENS, V1, P137; Cao ZhiChen, 2012, African Journal of Biotechnology, V11, P9683, DOI 10.5897/AJB11.3320; HOLEN E, 1990, INT ARCH ALLER A IMM, V91, P136; Hulmi JJ, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-51; HUSBY S, 1987, GUT, V28, P1062, DOI 10.1136/gut.28.9.1062; Fujita H, 2000, J FOOD SCI, V65, P564; OTANI H, 1994, FOOD SCI TECHNOL-LEB, V27, P42; Peterson JM, 2008, AM J PHYSIOL-CELL PH, V295, pC521, DOI 10.1152/ajpcell.00073.2008; Sugahara T, 2002, BBA-GEN SUBJECTS, V1572, P19, DOI 10.1016/S0304-4165(02)00272-6; Willoughby DS, 2007, AMINO ACIDS, V32, P467, DOI 10.1007/s00726-006-0398-7	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					194	199		10.1111/asj.12257		6	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500011		
J	Hayashida, M; Souma, K; Sugo, K; Araki, S; Ishizaka, F; Ueda, M; Kasai, T; Masuko, T				Hayashida, Maki; Souma, Kousaku; Sugo, Kazuki; Araki, Shin-ichi; Ishizaka, Fumiaki; Ueda, Masami; Kasai, Takamasa; Masuko, Takayoshi			Sex and age differences in meat composition of Yeso sika deer (Cervus nippon yesoensis) reared for a short period after capture in the wild	ANIMAL SCIENCE JOURNAL			English	Article						age; nutrients in meat; sex; short-term rearing; wild Yeso sika deer	FATTY-ACID-COMPOSITION; GROWTH-PERFORMANCE; MINERAL CONTENTS; QUALITY; ELAPHUS; PARAMETERS; MUSCLE	Yeso sika deer captured in winter around Lake Akan in Hokkaido were reared for 8-10 months at Tokyo University of Agriculture in Abashiri. Six 1-year-old females and males and six 2-year-old or older (adult) females and males were slaughtered and their carcasses were processed. The chemical composition, mineral contents and fatty acid composition of the loin were measured. No marked influence of gender or age was noted in the chemical composition of loin. In the mineral contents, significant differences were noted. The potassium and sulfur contents were lower and the sodium content was higher in adult deer meat (P<0.05, respectively) and the potassium content was higher in male deer meat (P<0.05). Arsenic, cadmium or lead were not detected. In the unsaturated fatty acid, a significant interaction was detected (P<0.05), and it was high in 1-year-old female deer meat and low in 1-year-old male deer meat. Significant gender or age differences were noted only in the mineral contents in the loin of deer reared for a short period after capture.	[Hayashida, Maki; Ishizaka, Fumiaki; Ueda, Masami] Tokyo Univ Agr, Jr Coll, Dept Bioprod Technol, Tokyo, Japan; [Souma, Kousaku; Sugo, Kazuki; Araki, Shin-ichi; Kasai, Takamasa; Masuko, Takayoshi] Tokyo Univ Agr, Fac Bioind, Abashiri, Hokkaido 0992493, Japan	Souma, K (reprint author), Tokyo Univ Agr, Fac Bioind, Abashiri, Hokkaido 0992493, Japan.	k3soma@bioindustry.nodai.ac.jp			Japan Society for the Promotion of Science [23580375]	This study was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) (grant number: 23580375). We are grateful to staff of Maeda Ippoen Foundation for cooperation in the capture and transport of deer and staff of the Deer Farming Division, Hokusen KK, for cooperation in carcass dressing.	Agriculture Forestry and Fisheries Research Council, 1996, 1996 JAP FEED STAND; Lazarus M, 2008, FOOD ADDIT CONTAM, V25, P270, DOI 10.1080/02652030701364923; Barton L, 2011, MEAT SCI, V89, P444, DOI 10.1016/j.meatsci.2011.05.007; Wiklund E, 2003, J SCI FOOD AGR, V83, P419, DOI 10.1002/jsfa.1384; Volpelli LA, 2003, MEAT SCI, V65, P555, DOI 10.1016/S0309-1740(02)00248-6; DOYLE JJ, 1978, J ANIM SCI, V47, P398; Daszkiewicz T, 2012, SMALL RUMINANT RES, V103, P169, DOI 10.1016/j.smallrumres.2011.09.044; Bures D, 2012, CZECH J ANIM SCI, V57, P34; Commonwealth Scientific and Industrial Research Organization (CSIRO), 2007, NUTR REQ DOM RUM; Food ingredients Research Committee, 2006, STAND TABL FOOD COMP, P160; Hachiya N, 1994, METHODS PREPARING OS, P97; Hayashida M, 2012, ANIM SCI J, V83, P227, DOI 10.1111/j.1740-0929.2011.00948.x; Hayashida M, 2013, HOKKAIDO J LIVESTOCK, V1, P55; Hokkaido, 2006, YES SIK DEER SAN MEA, V1-57; Ishida Mitsuharu, 1996, Animal Science and Technology, V67, P567; Ishizuka Yuzuru, 2001, Animal Science Journal, V72, pJ551; Itoh S, 2005, J HOKKAIDO ANIMAL SC, V47, P79; Kasai T, 1999, J JPN SOC FOOD SCI, V46, P710; Kasai Takamasa, 1996, Animal Science and Technology, V67, P1086; Kunishige K, 2003, B HOKKAIDO ANIMAL RE, V25, P24; Lee SD, 2005, ASIAN AUSTRAL J ANIM, V18, P1294; Masuko T., 2012, Japanese Journal of Grassland Science, V58, P200; Masuko T, 2007, NEW EDITION SPECIAL, P106; Mielnik MB, 2011, MEAT SCI, V89, P526, DOI 10.1016/j.meatsci.2011.05.021; Ministry of Education Culture Sports Science and Technology-Japan (MEXT), 2006, STAND TABL FOOD COMP; National Agriculture and Research Organization (NARO), 2009, 2009 STAND TABL FEED; NRC, 2007, NUTR REQ SMALL RUM S; Okamoto M., 2004, Journal of Japanese Society of Nutrition and Food Science, V57, P147; Quaresma MAG, 2012, MEAT SCI, V92, P519, DOI 10.1016/j.meatsci.2012.05.021; Self-supplied Feed Quality Evaluation Study Group, 2001, GUID BOOK FOR QUAL E; Souma K, 1998, J HOKKAIDO ANIMAL SC, V40, P27; Underwood E. J., 1999, MINERAL NUTR LIVESTO	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					207	213		10.1111/asj.12274		7	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500013		
J	Shimmura, T; Maruyama, Y; Fujino, S; Kamimura, E; Uetake, K; Tanaka, T				Shimmura, Tsuyoshi; Maruyama, Yuji; Fujino, Saori; Kamimura, Eriko; Uetake, Katsuji; Tanaka, Toshio			Persistent effect of broody hens on behaviour of chickens	ANIMAL SCIENCE JOURNAL			English	Article						behavior; broodiness; chick; laying hens; welfare	GALLUS-GALLUS-DOMESTICUS; FEATHER-PECKING; LAYING HENS; GENE-EXPRESSION; CANNIBALISM; FOWL; MANAGEMENT; PROLACTIN; SELECTION; WELFARE	We reported previously that behavioral development of chicks was promoted remarkably by the presence of a broody hen. Here we report that these effects at an early age persist after maturity. A total of 60 female chicks were randomly assigned to one of two treatment groups: six pens with five chicks (brooded group) each were reared by a broody hen and six pens with five chicks (non-brooded group) each were provided with an infrared heating lamp. We evaluated the persistent effects of broody hens by measures of behavior, physical condition and production at 9, 16, 35 and 55 weeks of age. The numbers of threatening, aggressive pecking, fighting and severe feather pecking behaviors were higher in non-brooded than in brooded chickens (all P<0.05). Egg production was lower in brooded than in non-brooded chickens (P<0.05), while the number of brooding chickens was higher in the brooded than in the non-brooded group (P<0.05). In conclusion, the presence of broody hens at an early stage of chicks' lives has a persistent effect on behavior. Although brooded chickens showed more brooding and lower egg production than non-brooded chickens, feather pecking and aggressive interaction were decreased in brooded hens.	[Shimmura, Tsuyoshi] Natl Inst Basic Biol, Div Seasonal Biol, Okazaki, Aichi 4448585, Japan; [Shimmura, Tsuyoshi] Grad Univ Adv Studies, Dept Basic Biol, Miura, Kanagawa, Japan; [Shimmura, Tsuyoshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shimmura, Tsuyoshi; Maruyama, Yuji; Fujino, Saori; Kamimura, Eriko; Uetake, Katsuji; Tanaka, Toshio] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan	Shimmura, T (reprint author), Natl Inst Basic Biol, Div Seasonal Biol, Okazaki, Aichi 4448585, Japan.	tsuyoshi_shimmura@yahoo.co.jp; tanakat@azabu-u.ac.jp			Japanese Society for the Promotion of Science [19-11909]; Azabu University	This research was supported in part by a Grant-in-Aid for JSPS Fellows (No. 19-11909) from the Japanese Society for the Promotion of Science and by a research project grant awarded by the Azabu University. We are grateful to Senior Researcher S. Hirahara, Kanagawa Prefectural Livestock Industry Technology Centre, for technical assistance and to Professor N. Kansaku, Azabu University, for valuable advice.	Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Perre Y, 2002, APPL ANIM BEHAV SCI, V75, P133, DOI 10.1016/S0168-1591(01)00189-7; Jiang RS, 2005, POULTRY SCI, V84, P839; KENT JP, 1987, BEHAVIOUR, V102, P1, DOI 10.1163/156853986X00018; Jensen AB, 2006, APPL ANIM BEHAV SCI, V99, P287, DOI 10.1016/j.applanim.2005.10.017; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Shimmura T, 2010, APPL ANIM BEHAV SCI, V126, P125, DOI 10.1016/j.applanim.2010.06.011; Nicol CJ, 1996, ANIM BEHAV, V52, P767, DOI 10.1006/anbe.1996.0221; Liu D, 2000, NAT NEUROSCI, V3, P799; Tauson R, 2005, WORLD POULTRY SCI J, V61, P477, DOI 10.1079/WPS200569; Appleby M.C., 2004, POULTRY BEHAV WELFAR; Blockhuis HJ, 2007, WORLDS POULTRY SCI J, V63, P101; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P145, DOI 10.1016/0168-1591(84)90104-7; BLOKHUIS HJ, 1989, APPL ANIM BEHAV SCI, V22, P65, DOI 10.1016/0168-1591(89)90080-4; Huber-Eicher B, 1998, ANIM BEHAV, V55, P861, DOI 10.1006/anbe.1997.0715; Johnsen PF, 1998, APPL ANIM BEHAV SCI, V60, P25, DOI 10.1016/S0168-1591(98)00149-X; JONES RB, 1989, PSYCHOL REC, V39, P397; KANSAKU N, 1994, GEN COMP ENDOCR, V96, P197, DOI 10.1006/gcen.1994.1174; Martin P., 1993, MEASURING BEHAV INTR; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Nicol CJ, 2001, APPL ANIM BEHAV SCI, V73, P141, DOI 10.1016/S0168-1591(01)00126-5; NORGAARDNIELSEN G, 1993, APPL ANIM BEHAV SCI, V38, P345, DOI 10.1016/0168-1591(93)90032-K; Riber AB, 2007, APPL ANIM BEHAV SCI, V106, P39, DOI 10.1016/j.applanim.2006.07.012; Roden C, 1998, APPL ANIM BEHAV SCI, V55, P317, DOI 10.1016/S0168-1591(97)00073-7; Rodenburg TB, 2009, ANIM WELFARE, V18, P427; Rodenburg TB, 2008, APPL ANIM BEHAV SCI, V110, P217, DOI 10.1016/j.applanim.2007.09.009; SAVORY CJ, 1995, WORLD POULTRY SCI J, V51, P215, DOI 10.1079/WPS19950016; Yanagii H, 2007, 4STEPS EXCEL STAT, V7; Zimmerman PH, 2006, APPL ANIM BEHAV SCI, V101, P111, DOI 10.1016/j.applanim.2006.01.005	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					214	220		10.1111/asj.12253		7	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500014		
J	Guo, Y; Fukuda, T; Donai, K; Kuroda, K; Masuda, M; Nakamura, S; Yoneyama, H; Isogai, E				Guo, Yijie; Fukuda, Tomokazu; Donai, Kenichiro; Kuroda, Kengo; Masuda, Mizuki; Nakamura, Shuichi; Yoneyama, Hiroshi; Isogai, Emiko			Leptospiral lipopolysaccharide stimulates the expression of toll-like receptor 2 and cytokines in pig fibroblasts	ANIMAL SCIENCE JOURNAL			English	Article						Leptospiral lipopolysaccharide; pig fibroblasts; toll-like receptor 2	LIPID-A; DENDRITIC CELLS; HUMAN GINGIVAL; INTERROGANS; RECOGNITION; ENDOTOXIN; TLR2	Pigs throughout the world are afflicted with leptospirosis, causing serious economic losses and potential hazards to human health. Although it has been known that leptospiral lipopolysaccharide (L-LPS) is involved in an immunological reaction between an antigen and a host cell, little is known about how the immune system of pigs can respond to L-LPS. Here, we stimulated pig fibroblasts by L-LPS and then quantitatively measured gene and protein expression levels of two toll-like receptors (TLRs), TLR2 and TLR4, by real-time PCR and Western blotting. As a result, expression of TLR2 was found to be significantly up-regulated within 24h after L-LPS stimulation whereas induction of TLR4 expression was relatively weak. We also revealed that of myeloid differentiation primary response gene 88 (MyD88), interleukin 6 (IL-6) and IL-8 gene expressions were markedly up-regulated by L-LPS stimulation. These results may suggest that the pig cell can activate TLR2 rather than TLR4 by L-LPS stimulation, thereby inducing expression of cytokines.	[Guo, Yijie; Kuroda, Kengo; Masuda, Mizuki; Yoneyama, Hiroshi; Isogai, Emiko] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Microbiol, Sendai, Miyagi 9818555, Japan; [Fukuda, Tomokazu; Donai, Kenichiro] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Breeding & Genet, Sendai, Miyagi 9818555, Japan; [Nakamura, Shuichi] Tohoku Univ, Grad Sch Engn, Dept Appl Phys, Sendai, Miyagi 9818555, Japan	Isogai, E (reprint author), Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Lab Anim Microbiol,Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	emiko@bios.tohoku.ac.jp					Chen BL, 2005, J IMMUNOL, V175, P1310; VINH T, 1986, J GEN MICROBIOL, V132, P103; Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x; Donai K, 2014, J BIOTECHNOL, V176, P50, DOI 10.1016/j.jbiotec.2014.02.017; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; ISOGAI E, 1989, ZBL BAKT-INT J MED M, V271, P186; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V142, P285, DOI 10.1111/j.1365-2249.2005.02912.x; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; Nahori MA, 2005, J IMMUNOL, V175, P6022; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Fukuda T, 2000, ANAL BIOCHEM, V285, P274, DOI 10.1006/abio.2000.4787; DESOUZA L, 1992, CAN J MICROBIOL, V38, P284; Faine S, 1994, LEPTOSPIRA LEPTOSPIR; Girard R, 2003, J CELL SCI, V116, P293, DOI 10.1242/jcs.00212; Hartleben CP, 2013, CURR MICROBIOL, V66, P106, DOI 10.1007/s00284-012-0237-x; Islam MA, 2012, VET IMMUNOL IMMUNOP, V146, P62, DOI 10.1016/j.vetimm.2012.02.001; Jaekal J, 2007, J MICROBIOL BIOTECHN, V17, P1862; Kemenes F, 1967, Monatsh Veterinarmed, V22, P224; Raymond CR, 2005, VET IMMUNOL IMMUNOP, V107, P235, DOI 10.1016/j.vetimm.2005.05.008; Strutzberg-Minder K, 2011, BERL MUNCH TIERARZTL, V124, P345, DOI 10.2376/0005-9366-124-345; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Uddin MJ, 2012, VET IMMUNOL IMMUNOP, V147, P211, DOI 10.1016/j.vetimm.2012.04.020	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	FEB	2015	86	2					238	244		10.1111/asj.12254		7	Agriculture, Dairy & Animal Science	Agriculture	CA7DK	WOS:000349077500017		
J	Suzuki, H; Kiyoshima, M; Kitahara, M; Asato, Y; Amemiya, R				Suzuki, Hisashi; Kiyoshima, Moriyuki; Kitahara, Miyuki; Asato, Yuji; Amemiya, Ryuta			Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer	ANNALS OF THORACIC SURGERY			English	Article							PROGNOSTIC ASSESSMENT; LUNG METASTASECTOMY; SURVIVAL; RECURRENCE; CARCINOMA; TRIAL	Background. Surgical resection has been widely performed on patients with pulmonary metastases from colorectal cancer with favorable outcomes. However, there are currently no standard surgical indications for pulmonary metastases. Methods. We reviewed 94 patients who underwent complete resection of pulmonary metastases from colorectal cancer between November 1991 and April 2013. The cumulative survival rate after pulmonary metastasectomy was calculated, and prognostic factors for long-term survival were analyzed. Results. There were 60 men and 34 women, and their median age was 66 years. The 5-year survival rate was 45.5% after pulmonary metastasectomy. The 5-year survival of patients with colon and rectal cancers was 62.4% and 33.8%, respectively (p = 0.030), and the 5-year survival of those with normal and high carcinoembryonic antigen (CEA) levels before pulmonary resection was 57.0% and 30.9%, respectively (p = 0.038). Multivariate analysis revealed the preoperative CEA level was an independent prognostic factor. Recurrence was identified in 65 of the 94 patients (69.1%) after pulmonary metastasectomy, and the patients who underwent surgical resection for recurrent lesions in the liver or lungs, or both, had better survival than those who received other treatments or palliative care. Conclusions. Surgical resection offers a chance to prolong survival in colorectal cancer patients with resectable pulmonary metastases. Owing to the high recurrence rate, careful postoperative follow-up for early detection is recommended, and even for recurrence, surgical resection should be considered for better survival if the lesions are limited to the liver or lungs, or both. (C) 2015 by The Society of Thoracic Surgeons	[Suzuki, Hisashi; Kiyoshima, Moriyuki; Kitahara, Miyuki; Asato, Yuji; Amemiya, Ryuta] Ibaraki Cent Hosp, Dept Thorac Surg, Kasama, Ibaraki 3091793, Japan	Suzuki, H (reprint author), Ibaraki Cent Hosp, Dept Thorac Surg, 6528 Koibuchi, Kasama, Ibaraki 3091793, Japan.	hsuzuki-jpn@umin.ac.jp					Iida T, 2013, ANN SURG, V257, P1059, DOI 10.1097/SLA.0b013e31826eda3b; PIHL E, 1987, DIS COLON RECTUM, V30, P417, DOI 10.1007/BF02556487; Borasio P, 2011, INT J COLORECTAL DIS, V26, P183, DOI 10.1007/s00384-010-1075-6; Gonzalez M, 2013, ANN SURG ONCOL, V20, P572, DOI 10.1245/s10434-012-2726-3; Zabaleta J, 2011, EJSO-EUR J SURG ONC, V37, P786, DOI 10.1016/j.ejso.2011.05.014; Iizasa T, 2006, ANN THORAC SURG, V82, P254, DOI 10.1016/j.athoracsur.2006.02.027; THOMFORD NR, 1965, J THORAC CARDIOV SUR, V49, P357; Hwang MR, 2010, ANN THORAC SURG, V90, P398, DOI 10.1016/j.athoracsur.2010.04.058; Watanabe K, 2009, BRIT J SURG, V96, P1058, DOI 10.1002/bjs.6682; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Kanemitsu Y, 2004, BRIT J SURG, V91, P112, DOI 10.1002/bjs.4370; Saito Y, 2002, J THORAC CARDIOV SUR, V124, P1007, DOI 10.1067/mtc.2002.125165; Pfannschmidt J, 2003, J THORAC CARDIOV SUR, V126, P732, DOI 10.1016/S0022-5223(03)000587-7; Welter S, 2007, ANN THORAC SURG, V84, P203, DOI 10.1016/j.athoracsur.2007.03.028; Bendell J, 2006, LANCET, V368, P2039, DOI 10.1016/S0140-6736(06)69818-8; Girard P, 1997, EUR J CARDIO-THORAC, V12, P385, DOI 10.1016/S1010-7940(97)00203-0; Landes U, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-17; Lee WS, 2007, WORLD J SURG, V31, P1502, DOI 10.1007/s00268-007-9060-0; Rena O, 2002, EUR J CARDIO-THORAC, V21, P906, DOI 10.1016/S1010-7940(02)00088-X; Salah S, 2013, ANN SURG ONCOL, V20, P1955, DOI 10.1245/s10434-012-2860-y; Treasure T, 2012, THORAX, V67, P185, DOI 10.1136/thoraxjnl-2011-200015	21	3	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	FEB	2015	99	2					435	440		10.1016/j.athoracsur.2014.09.027		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CA3WU	WOS:000348836500021		
J	Moon, J; Hoashi, T; Kagisaki, K; Kurosaki, K; Shiraishi, I; Ichikawa, H				Moon, Jiyong; Hoashi, Takaya; Kagisaki, Koji; Kurosaki, Kenichi; Shiraishi, Isao; Ichikawa, Hajime			Clinical Outcomes of Mitral Valve Replacement With the 16-mm ATS Advanced Performance Valve in Neonates and Infants	ANNALS OF THORACIC SURGERY			English	Article							PULMONARY AUTOGRAFT; CHORDAE TENDINEAE; CHILDREN; SURVIVAL; PANNUS; REGURGITATION; OBSTRUCTION; EXPERIENCE; PROSTHESES; POSITION	Background. Although mitral valve repair is the preferred treatment for mitral regurgitation in neonates and infants, mitral valve replacement (MVR) is sometimes necessary. Methods. From 1999 through 2013, 18 patients younger than 1 year underwent MVR with the smallest (16 mm) commercially available mechanical valve. At surgery, mean age was 4.0 +/- 1.8 months (range, 4 days to 7 months), and mean body weight was 5.3 +/- 1.6 kg (range, 3.2 to 8.3 kg). Prosthetic valves were implanted in the supra-annular position in 17 of the 18 patients. Results. All patients were followed up, and the mean follow-up period was 4.5 +/- 3.8 years (range, 0.2 to 14 years). The rates of overall survival and freedom from redo MVR at 10 years were 88.9% and 57.8%, respectively. The causes of redo MVR were pulmonary hypertension in patients with left ventricular outflow obstruction (n = 2), hemolysis (n = 1), and a stuck valve (n = 1). The estimated effective orifice area index (effective orifice area/body surface area) was significantly inversely correlated with peak transmitral pressure gradient (r = -0.784, p < 0.01). The rate of freedom from permanent pacemaker implantation at 10 years was 71.2%. Three of the 5 pacemaker implantation procedures were for postoperative sick sinus syndrome. Although intracranial hemorrhage developed in 3 infants, all neurologic sequelae resolved. Conclusions. The implanted valves were durable, and no premature increase in transmitral pressure gradient was observed. Complications included injury of the sinus node artery and hemorrhage related to anticoagulation therapy. (C) 2015 by The Society of Thoracic Surgeons	[Hoashi, Takaya] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka, Japan; Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka, Japan	Hoashi, T (reprint author), 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	thoashi@surg1.med.osaka-u.ac.jp					Alexiou C, 2001, EUR J CARDIO-THORAC, V20, P105, DOI 10.1016/S1010-7940(01)00763-1; Berdajs D, 2008, EUR J CARDIO-THORAC, V34, P55, DOI 10.1016/j.ejcts.2008.03.051; Alsoufi B, 2010, J THORAC CARDIOV SUR, V139, P1189, DOI 10.1016/j.jtcvs.2009.10.038; Teshima H, 2003, J THORAC CARDIOV SUR, V126, P401, DOI 10.1016/S0022-5223(03)00702-5; Kabbani S, 2007, J THORAC CARDIOV SUR, V134, P902, DOI 10.1016/j.jtcvs.2007.05.056; Torigoe T, 2012, EUR J PEDIATR, V171, P259, DOI 10.1007/s00431-011-1528-0; Adatia I, 1997, J AM COLL CARDIOL, V29, P1089; Berdajs D, 2003, ANN THORAC SURG, V76, P732, DOI 10.1016/S0003-4975(03)00660-X; Athanasiou T, 2004, ANN THORAC SURG, V78, P1489, DOI 10.1016/j.athoracsur.2004.02.074; ATS Medical Inc., 2000, PREM APPR APPL SUMM; Beiertein W, 2007, EUR J CARDIO-THORAC, V31, P860, DOI 10.1016/j.ejcts.2007.02.006; Bradley SM, 1997, ANN THORAC SURG, V64, P30, DOI 10.1016/S0003-4975(97)00453-0; Brown JW, 2012, ANN THORAC SURG, V93, P626, DOI 10.1016/j.athoracsur.2011.08.085; Dinarevic S, 1996, PEDIATR CARDIOL, V17, P257, DOI 10.1007/BF02524805; Erez E, 2003, J HEART VALVE DIS, V12, P25; Henaine R, 2010, ANN THORAC SURG, V90, P1570, DOI 10.1016/j.athoracsur.2010.06.121; KADOBA K, 1990, J THORAC CARDIOV SUR, V100, P762; Kanter KR, 2011, ANN THORAC SURG, V92, P2221, DOI 10.1016/j.athoracsur.2011.06.023; Kojori F, 2004, J THORAC CARDIOV SUR, V128, P703, DOI 10.1016/j/jtcvs.2004.07.024; Murashita T, 2012, ANN THORAC SURG, V94, P581, DOI 10.1016/j.athoracsur.2012.03.064; Radford DJ, 2002, CARDIOL YOUNG, V12, P183, DOI 10.1017/S1047951102000380; Raghuveer G, 2003, CIRCULATION, V108, P174, DOI 10.1161/01.cir.0000087659.65791.42; Selamet T., 2008, J THORAC CARDIOVASC, V136, P954; Shiraishi I, 2014, CIRCULATION, V130, P1053, DOI 10.1161/CIRCULATIONAHA.114.008592	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	FEB	2015	99	2					653	659		10.1016/j.athoracsur.2014.09.035		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CA3WU	WOS:000348836500067		
J	Tarui, T; Tomita, S; Ishikawa, N; Ohtake, H; Watanabe, G				Tarui, Tatsuya; Tomita, Shigeyuki; Ishikawa, Norihiko; Ohtake, Hiroshi; Watanabe, Go			A Novel One-Shot Circular Stapler Closure for Atrial Septal Defect in a Beating-Heart Porcine Model	ANNALS OF THORACIC SURGERY			English	Article							DEVICE CLOSURE	Purpose. In surgical atrial septal defect (ASD) closure, there are no techniques or devices that can close the ASD accurately in a short time under a beating heart. We have developed a simple and automatic ASD closure technique using a circular stapler. This study assessed the feasibility and efficacy of a new circular stapler closure for ASD. Description. Under a continuous beating heart, hand-sewn patch plasty ASD closure was performed in 6 pigs (group A) and circular stapler ASD closure was performed in 6 pigs (group B). The time to close the ASD and the effectiveness of the closure were compared. Evaluation. Closure was significantly faster in group B (10.5 +/- 1.0 seconds) than in group A (664 +/- 10 seconds; p < 0.05). There was no leakage at the closure site, and sufficient tolerance was confirmed. Conclusions. A circular stapler can be used to treat ASD faster than hand-sewn patch plasty, with sufficient pressure tolerance in a beating heart porcine model. (C) 2015 by The Society of Thoracic Surgeons	[Tarui, Tatsuya; Tomita, Shigeyuki; Ishikawa, Norihiko; Ohtake, Hiroshi; Watanabe, Go] Kanazawa Univ, Sch Med, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa 9208641, Japan	Tarui, T (reprint author), Kanazawa Univ, Sch Med, Dept Gen & Cardiothorac Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	tatsuya.tarui@gmail.com			Kanazawa University, Department of General and Cardiothoracic Surgery	The source of all funds in the study was from the authors' department, Kanazawa University, Department of General and Cardiothoracic Surgery. The authors had full control of the design of the study, methods used, outcome parameters, analysis of data, and production of the written report.	Hope WW, 2009, SURG ENDOSC, V23, P800, DOI 10.1007/s00464-008-0079-6; Varma C, 2004, CATHETER CARDIO INTE, V61, P131, DOI 10.1002/ccd.10700; DiBardino DJ, 2009, J THORAC CARDIOV SUR, V137, P1334, DOI 10.1016/j.jtcvs.2009.02.032; Butera G, 2008, AM HEART J, V156, P706, DOI 10.1016/j.ahj.2008.06.008; Choy PY, 2011, COCHRANE DB SYST REV, V7, P9; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836; Tantraworasin Apichat, 2014, Asian Cardiovasc Thorac Ann, V22, P309, DOI 10.1177/0218492313491754; Ueda H, 2012, CIRC J, V76, P1229, DOI 10.1253/circj.CJ-11-1379	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	FEB	2015	99	2					677	680		10.1016/j.athoracsur.2014.10.023		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CA3WU	WOS:000348836500071		
J	Ito, S; Yoshimura, T; Kondo, T; Tamura, K; Yamashita, N; Hanawa, T				Ito, Shinya; Yoshimura, Takashi; Kondo, Takeshi; Tamura, Koichi; Yamashita, Naoki; Hanawa, Takeshi			Long-Term Survival With Chest Wall Resection and Pulmonary Metastasectomy for Hepatocellular Carcinoma	ANNALS OF THORACIC SURGERY			English	Editorial Material							PROGNOSTIC-FACTORS; CLINICAL-FEATURES; RADIOTHERAPY	A case of rib and pulmonary metastases of hepatocellular carcinoma (HCC) successfully treated with transcatheter arterial embolization (TAE) followed by surgery is reported. A 66-year-old male with a history of HCC treated previously with hepatectomy was admitted to our hospital for examination of a chest wall tumor. Before the admission, TAE targeting the chest wall tumor was performed. TAE followed by surgery for postresection metastases of HCC was performed and provided an excellent result with long-term survival. The combination of TAE plus salvage surgery could be an option in select patients with limited disease. (C) 2015 by The Society of Thoracic Surgeons	Kyoto Katsura Hosp, Chest Dis Ctr, Dept Thorac Surg, Kyoto, Japan; Fukui Red Cross Hosp, Dept Chest Surg, Fukui, Japan	Ito, S (reprint author), Kyoto Katsura Hosp, Nishikyo Ku, Yamadahirao Cho 17, Kyoto, Japan.	shinyaitos@gmail.com					Lencioni R, 2012, RADIOLOGY, V262, P43, DOI 10.1148/radiol.11110144; He J, 2009, CANCER, V115, P2710, DOI 10.1002/cncr.24300; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Cho S, 2010, J THORAC ONCOL, V5, P1251, DOI 10.1097/JTO.0b013e3181e2fc9b; Chua TC, 2012, SURG ONCOL, V21, P95, DOI 10.1016/j.suronc.2011.01.005; Kaizu T, 1998, AM J GASTROENTEROL, V93, P2167; Nakagawa T, 2006, J THORAC CARDIOV SUR, V131, P1248, DOI 10.1016/j.jtcvs.2006.02.009	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	FEB	2015	99	2					695	698				5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CA3WU	WOS:000348836500079		
J	Karasaki, T; Tanaka, M				Karasaki, Takahiro; Tanaka, Makoto			Imaging of Thoracic Duct in a Patient With Right-Sided Descending Aorta	ANNALS OF THORACIC SURGERY			English	Editorial Material									[Karasaki, Takahiro; Tanaka, Makoto] JR Tokyo Gen Hosp, Dept Thorac Surg, Tokyo, Japan	Karasaki, T (reprint author), 2-1-3 Yoyogi,Shibuya Ku, Tokyo 1518528, Japan.	tak.karasaki@gmail.com					Okuda I, 2011, JPN J RADIOL, V29, P39, DOI 10.1007/s11604-010-0515-0	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	FEB	2015	99	2					713	713		10.1016/j.athoracsur.2014.10.019		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CA3WU	WOS:000348836500087		
J	Kido, T; Kuata, A; Uetani, T; Tanabe, Y; Nishiyama, H; Ogimoto, A; Izutani, H; Mochizuki, T				Kido, Teruhito; Kuata, Akira; Uetani, Teruyoshi; Tanabe, Yuki; Nishiyama, Hikaru; Ogimoto, Akiyoshi; Izutani, Hironori; Mochizuki, Teruhito			Fusion Image of Coronary Artery and Myocardial Perfusion Using Computed Tomography	ANNALS OF THORACIC SURGERY			English	Editorial Material									[Kido, Teruhito] Ehime Univ, Dept Radiol, Toon, Ehime 7910295, Japan; Ehime Univ, Dept Cardiol, Toon, Ehime 7910295, Japan; Ehime Univ, Dept Cardiothorac Surg, Toon, Ehime 7910295, Japan	Kido, T (reprint author), Ehime Univ, Dept Radiol, Toon, Ehime 7910295, Japan.	t.k.ehime@gmail.com					Wai B, 2013, EUR J RADIOL, V82, pE337, DOI 10.1016/j.ejrad.2013.02.023	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	FEB	2015	99	2					715	715		10.1016/j.athoracsur.2014.09.065		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CA3WU	WOS:000348836500089		
J	Fukayama, T; Takagi, K; Tanaka, R; Hatakeyama, Y; Aytemiz, D; Suzuki, Y; Asakura, T				Fukayama, Toshiharu; Takagi, Keisuke; Tanaka, Ryou; Hatakeyama, Yui; Aytemiz, Derya; Suzuki, Yu; Asakura, Tetsuo			Biological Reaction to Small-Diameter Vascular Grafts Made of Silk Fibroin Implanted in the Abdominal Aortae of Rats	ANNALS OF VASCULAR SURGERY			English	Article							BOMBYX-MORI; IN-VIVO; PROSTHESIS; COLLAGEN; MODEL; IMMOBILIZATION; BIOMATERIALS; REGENERATION; PERFORMANCE; SCAFFOLDS	Background: Bombyx mori silk fibroin (SF) is biocompatible and degradable and has been proposed as a new material for small-diameter vascular grafts. We compared biological reactions to vascular grafts made of SF and polyethylene terephthalate (PET) to reveal the potential ability of SF as a base and/or coating materials for vascular prostheses. Methods: SF was combined with PET or gelatin (G) to make 4 types of vascular grafts (SF/SF, SF/G, PET/SF, and PET/G, shown as "base/coating material," respectively), which are 1.5 mm in diameter and 10 mm in length. The 4 types of grafts (n=6, respectively) were implanted into rat abdominal aortae and explanted 2 weeks or 3 months later. Results: Two weeks after implantation, there are no significant differences among the 4 kinds of grafts in biological reactions evaluated by histopathologic examination. However, a remarkable difference was observed after 3 months. The area of tissue infiltration into the inside of the graft wall was approximately 2.5 times larger in SF/SF than that in PET/G. The endothelialization was achieved almost 100% in SF/SF, despite only 50% was achieved in PET/G. Conclusions: Results show that SF has a higher potential as a base of vascular grafts than the commercially available PET/G graft. The larger tissue infiltration area in PET/SF compared with that in PET/G also indicates the potential of SF as a coating material. In the present study, SF delivered promising results as base and coating materials for small-diameter vascular prostheses.	[Fukayama, Toshiharu; Takagi, Keisuke; Tanaka, Ryou] Tokyo Univ Agr & Technol, Dept Vet Surg, Fuchu, Tokyo 1838509, Japan; [Hatakeyama, Yui; Aytemiz, Derya; Suzuki, Yu; Asakura, Tetsuo] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 184, Japan	Fukayama, T (reprint author), Tokyo Univ Agr & Technol, Dept Vet Surg, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	t.fukayama0710@gmail.com			Ministry of Agriculture, Forestry and Fisheries of Japan [3300]	The authors wish to thank Fukui Tateami Kogyo Co. Ltd. for providing us the tubes of the SF or PET vascular grafts with 1.5 mm diameter. This study was funded by a grant (3300) from the Ministry of Agriculture, Forestry and Fisheries of Japan (Agri-Health Translational Research Project [2010-2015]).	Yagi T, 2011, J ARTIF ORGANS, V14, P89, DOI 10.1007/s10047-011-0554-z; Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007; Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04; Baguneid M, 2011, BIOTECHNOL APPL BIOC, V58, P14, DOI 10.1002/bab.8; Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]; Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015; Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x; Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012; Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058; Nakazawa Y, 2011, J BIOMAT SCI-POLYM E, V22, P195, DOI 10.1163/092050609X12586381656530; Yang M, 2007, TISSUE ENG, V13, P2941, DOI 10.1089/ten.2006.0448; Begovac PC, 2003, EUR J VASC ENDOVASC, V25, P432, DOI 10.1053/ejvs.2002.1909; Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001; Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005; Tatterton M, 2012, VASC ENDOVASC SURG, V46, P212, DOI 10.1177/1538574411433299; Janairo RRR, 2012, IEEE T NANOBIOSCI, V11, P22, DOI 10.1109/TNB.2012.2188926; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012; Soldani G, 2010, BIOMATERIALS, V31, P2592, DOI 10.1016/j.biomaterials.2009.12.017; Noishiki Y, 1996, NAT MED, V2, P90, DOI 10.1038/nm0196-90; Aytemiz D, 2013, ADV HEALTHC MATER, V2, P361, DOI 10.1002/adhm.201200227; Shin YM, 2012, BIOMACROMOLECULES, V13, P2020, DOI 10.1021/bm300194b; Kuwabara F, 2012, J ARTIF ORGANS, V15, P399, DOI 10.1007/s10047-012-0652-6; ABBOTT WM, 1987, J VASC SURG, V5, P376; Higa K, 2011, J BIOMAT SCI-POLYM E, V22, P2261, DOI 10.1163/092050610X538218; McClure MJ, 2012, J MECH BEHAV BIOMED, V10, P48, DOI 10.1016/j.jmbbm.2012.02.026; Huang FH, 2008, ARTIF ORGANS, V32, P932, DOI 10.1111/j.1525-1594.2008.00655.x; Asakura T, 2004, BIOMATERIALS, V25, P617, DOI 10.1016/S0142-9612(03)00570-2; Asakura T, 2003, BIOMACROMOLECULES, V4, P815, DOI 10.1021/bm034020f; Goëau-Brissonnière O, 1991, Ann Vasc Surg, V5, P408, DOI 10.1007/BF02133043; Heise M, 2006, EUR J VASC ENDOVASC, V32, P418, DOI 10.1016/j.ejvs.2006.03.002,; Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4; Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032; SCOTT SM, 1987, J CARDIOVASC SURG, V28, P498	34	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	FEB	2015	29	2					341	352		10.1016/j.avsg.2014.10.008		12	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CA8VY	WOS:000349200200023		
J	Mori, M; Kobayashi, R; Kato, K; Maeda, N; Fukushima, K; Goto, H; Inoue, M; Muto, C; Okayama, A; Watanabe, K; Liuk, P				Mori, Masaaki; Kobayashi, Ryoji; Kato, Koji; Maeda, Naoko; Fukushima, Keitaro; Goto, Hiroaki; Inoue, Masami; Muto, Chieko; Okayama, Akifumi; Watanabe, Kenichi; Liuk, Ping			Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch Regimens in Immunocompromised Japanese Pediatric Patients	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article							INVASIVE FUNGAL-INFECTIONS; CLINICAL-PRACTICE GUIDELINES; PLASMA-CONCENTRATIONS; DISEASES SOCIETY; HEALTHY-ADULTS; CHILDREN; EFFICACY; ASPERGILLOSIS; TOLERABILITY; MULTICENTER	The aim of this study was to investigate the pharmacokinetics, safety, and tolerability of voriconazole following intravenous-tooral switch regimens used with immunocompromised Japanese pediatric subjects (age 2 to <15 years) at high risk for systemic fungal infection. Twenty-one patients received intravenous-to-oral switch regimens based on a recent population pharmacokinetic modeling; they were given 9 mg/kg of body weight followed by 8 mg/kg of intravenous (i.v.) voriconazole every 12 h (q12h), and 9 mg/ kg (maximum, 350 mg) of oral voriconazole q12h (for patients age 2 to <12 or 12 to <15 years and <50 kg) or 6 mg/ kg followed by 4 mg/ kg of i.v. voriconazole q12h and 200 mg of oral voriconazole q12h (for patients age 12 to <15 years and >50 kg). The steady-state area under the curve over the 12-h dosing interval (AUC(0-12,ss)) was calculated using the noncompartmental method and compared with the predicted exposures in Western pediatric subjects based on the abovementioned modeling. The geometric mean (coefficient of variation) AUC0-12, ss values for the intravenous and oral regimens were 51.1 mu g.h/ml (68%) and 45.8 mu g.h/ml (90%), respectively; there was a high correlation between AUC(0-12,ss) and trough concentration. Although the average exposures were higher in the Japanese patients than those in the Western pediatric subjects, the overall voriconazole exposures were comparable between these two groups due to large interindividual variability. The exposures in the 2 cytochrome P450 2C19 poor metabolizers were among the highest. Voriconazole was well tolerated. The most common treatment-related adverse events were photophobia and abnormal hepatic function. These recommended doses derived from the modeling appear to be appropriate for Japanese pediatric patients, showing no additional safety risks compared to those with adult patients.	[Mori, Masaaki] Yokohama City Univ, Med Ctr, Dept Pediat, Yokohama, Kanagawa 232, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Maeda, Naoko] Natl Hosp Org Nagoya Med Ctr, Dept Pediat, Nagoya, Aichi, Japan; [Fukushima, Keitaro] Dokkyo Med Univ, Sch Med, Dept Pediat, Mibu, Tochigi, Japan; [Goto, Hiroaki] Kanagawa Childrens Med Ctr, Dept Hematol & Regenerat Med, Yokohama, Kanagawa, Japan; [Inoue, Masami] Osaka Med Ctr, Dept Hematol Oncol, Osaka, Japan; [Inoue, Masami] Res Inst Maternal & Child Hlth, Osaka, Japan; [Muto, Chieko] Pfizer Japan Inc, Clin Res, Clin Pharmacol, Tokyo, Japan; [Okayama, Akifumi] Pfizer Japan Inc, Clin Stat, Dev Operat, Tokyo, Japan; [Watanabe, Kenichi] Pfizer Japan Inc, Infect Dis, Clin Res, Tokyo, Japan; [Liuk, Ping] Pfizer Inc, Global Established Pharma Business, Clin Pharmacol, Groton, CT 06340 USA	Mori, M (reprint author), Yokohama City Univ, Med Ctr, Dept Pediat, Yokohama, Kanagawa 232, Japan.	mmori@med.yokohama-cu.ac.jp			Pfizer, Inc.	This study was sponsored by Pfizer, Inc. Editorial support was provided by Annette Smith of Complete Medical Communications and was funded by Pfizer, Inc.; Chieko Muto, Akifumi Okayama, Kenichi Watanabe, and Ping Liu are employees of Pfizer, Inc. Masaaki Mori served as the consultant medical adviser to Pfizer Japan, Inc. for this study. Other non-Pfizer authors, Ryoji Kobayashi, Koji Kato, Naoko Maeda, Keitaro Fukushima, Hiroaki Goto, and Masami Inoue, were investigators in this study, and their institutions received a grant from Pfizer, Inc., for clinical trial costs. Outside the submitted work, Masaaki Mori has received lecture fees from MSD, Sumitomo Dainippon Pharma, and Pfizer Japan, Inc., and has served as a consultant adviser to Bristol-Myers Squibb and Astellas Pharma. Ryoji Kobayashi has received fees and nonfinancial support for lectures/advisory board participation from Pfizer, Inc., Astellas Pharma, Inc., and Sumitomo Dainippon Pharma. Naoko Maeda has received a grant from MSD, Inc., for clinical trial costs. Masami Inoue has received fees and nonfinancial support for advisory board participation from Pfizer, Inc.	Andrews E, 2008, BRIT J CLIN PHARMACO, V65, P531, DOI 10.1111/j.1365-2125.2007.03084.x; Hamada Y, 2012, J INFECT CHEMOTHER, V18, P501, DOI 10.1007/s10156-011-0363-6; Driscoll TA, 2011, ANTIMICROB AGENTS CH, V55, P5770, DOI 10.1128/AAC.00531-11; Ueda K, 2009, INT J HEMATOL, V89, P592, DOI 10.1007/s12185-009-0296-3; Murayama N, 2007, BIOCHEM PHARMACOL, V73, P2020, DOI 10.1016/j.bcp.2007.03.012; Yanni SB, 2010, DRUG METAB DISPOS, V38, P25, DOI 10.1124/dmd.109.029769; Driscoll TA, 2011, ANTIMICROB AGENTS CH, V55, P5780, DOI 10.1128/AAC.05010-11; Miyakis S, 2010, CLIN MICROBIOL INFEC, V16, P927, DOI 10.1111/j.1469-0691.2009.02990.x; Park WB, 2012, CLIN INFECT DIS, V55, P1080, DOI 10.1093/cid/cis599; Racil Z, 2012, MYCOSES, V55, P483, DOI 10.1111/j.1439-0507.2012.02186.x; Troke PF, 2011, ANTIMICROB AGENTS CH, V55, P4782, DOI 10.1128/AAC.01083-10; Walsh TJ, 2010, ANTIMICROB AGENTS CH, V54, P4116, DOI 10.1128/AAC.00896-10; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Pascual A, 2008, CLIN INFECT DIS, V46, P201, DOI 10.1086/524669; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Hyland R, 2003, DRUG METAB DISPOS, V31, P540, DOI 10.1124/dmd.31.5.540; Maertens J, 2011, BONE MARROW TRANSPL, V46, P709, DOI 10.1038/bmt.2010.175; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Mitsani D, 2012, ANTIMICROB AGENTS CH, V56, P2371, DOI 10.1128/AAC.05219-11; Dolton MJ, 2012, ANTIMICROB AGENTS CH, V56, P4793, DOI 10.1128/AAC.00626-12; Seyedmousavi S, 2013, EXPERT REV ANTI-INFE, V11, P931, DOI 10.1586/14787210.2013.826989; Michael C, 2010, ANTIMICROB AGENTS CH, V54, P3225, DOI 10.1128/AAC.01731-09; Neely M, 2010, CLIN INFECT DIS, V50, P27, DOI 10.1086/648679; Chu HY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-105; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, pS19; Friberg LE, 2012, ANTIMICROB AGENTS CH, V56, P3032, DOI 10.1128/AAC.05761-11; Hamada Y, 2013, J INFECT CHEMOTHER, V19, P381, DOI 10.1007/s10156-013-0607-8; Liu P, 2014, ANTIMICROB AGENTS CH, V58, P4718, DOI 10.1128/AAC.02808-13; Mori M, 2013, J INFECT CHEMOTHER, V19, P946, DOI 10.1007/s10156-013-0624-7; Mori M, 2013, J INFECT CHEMOTHER, V19, P174, DOI 10.1007/s10156-012-0438-z; Purkins L, 2002, ANTIMICROB AGENTS CH, V46, P2546, DOI 10.1128/AAC.46.8.2546-2553.2002; Shimizu Takako, 2003, Drug Metab Pharmacokinet, V18, P48, DOI 10.2133/dmpk.18.48; The Japanese Mycology Study Group, 2014, GUID MAN DEEP SEAT M; Walsh TJ, 2004, ANTIMICROB AGENTS CH, V48, P2166, DOI 10.1128/AAC.48.6.2166-2172.2004	34	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	FEB	2015	59	2					1004	1013		10.1128/AAC.04093-14		10	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	CA0LT	WOS:000348610000031		
J	Watanabe, T; Hamada-Tsutsumi, S; Yokomaku, Y; Imamura, J; Sugiura, W; Tanaka, Y				Watanabe, Tsunamasa; Hamada-Tsutsumi, Susumu; Yokomaku, Yoshiyuki; Imamura, Junji; Sugiura, Wataru; Tanaka, Yasuhito			Postexposure Prophylactic Effect of Hepatitis B Virus (HBV)-Active Antiretroviral Therapy against HBV Infection	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL-HEPATITIS; NK CELLS; C VIRUS; HEPATOCYTES; COINFECTION; EXPOSURE; ADULTS; MICE	Retrospective study indicates that hepatitis B virus (HBV)-active nucleoside (nucleotide) analogues (NAs) used for antiretroviral therapy reduce the incidence of acute HBV infections in human immunodeficiency virus (HIV)-infected patients. Learning from HIV postexposure prophylaxis (PEP), we explored the possibility of using NAs in PEP following HBV exposure, if preexposure prophylaxis is feasible clinically. Using freshly isolated primary human hepatocytes cultured in vitro, we analyzed the effect of HBV-active tenofovir and lamivudine in primary HBV infection and also the effect of treatment with these NAs after HBV infection. HBV-active NAs applied from 24 h before inoculation could not prevent the secretion of hepatitis B surface antigen into the culture medium, and cessation of the NAs after inoculation allowed the cells to establish an apparent HBV infection. In contrast, hepatitis B immune globulin was able to prevent HBV infection completely. NA treatment before infection, however, can control the spread of HBV infection, as detected by immunohistochemistry. Practically, starting NA treatment within 2 days of primary HBV infection inhibited viral spread effectively, as well as preexposure treatment. We demonstrated that preexposure NA treatment was not able to prevent the acquisition of HBV infection but prevented viral spread by suppressing the production of mature progeny HBV virions. The effect of postexposure treatment within 2 days was similar to the effect of preexposure treatment, suggesting the possibility of HBV PEP using HBV-active NAs in HIV- and HBV-susceptible high-risk groups.	[Watanabe, Tsunamasa; Hamada-Tsutsumi, Susumu; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Watanabe, Tsunamasa; Hamada-Tsutsumi, Susumu; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Watanabe, Tsunamasa; Yokomaku, Yoshiyuki; Imamura, Junji; Sugiura, Wataru] Natl Hosp Org, Nagoya Med Ctr, Dept Infect Dis, Nagoya, Aichi, Japan; [Watanabe, Tsunamasa; Yokomaku, Yoshiyuki; Imamura, Junji; Sugiura, Wataru] Natl Hosp Org, Nagoya Med Ctr, Clin Immunol Res Ctr, Nagoya, Aichi, Japan	Tanaka, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan.	ytanaka@med.nagoya-cu.ac.jp			Ministry of Health, Labor, and Welfare of Japan [B (009)]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported, in part, by a grant for Practical Research on Hepatitis B (009) from the Ministry of Health, Labor, and Welfare of Japan and a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Gatanaga H, 2013, CLIN INFECT DIS, V56, P1812, DOI 10.1093/cid/cit145; Rivas P, 2007, AIDS REV, V9, P173; Yamasaki C, 2010, DRUG METAB PHARMACOK, V25, P539, DOI 10.2133/dmpk.DMPK-10-RG-047; Thio CL, 2003, SEMIN LIVER DIS, V23, P125; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Abe A, 1999, J CLIN MICROBIOL, V37, P2899; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Torres HA, 2012, NAT REV CLIN ONCOL, V9, P156, DOI 10.1038/nrclinonc.2012.1; Sugden PB, 2014, J HEPATOL, V61, P738, DOI 10.1016/j.jhep.2014.05.013; Kuhar DT, 2013, INFECT CONT HOSP EP, V34, P875, DOI 10.1086/672271; Fujiwara K, 2005, J VIROL, V79, P14404, DOI 10.1128/JVI.79.22.14404-14410.2005; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Innaimo SF, 1997, ANTIMICROB AGENTS CH, V41, P1444; Summers J, 2003, P NATL ACAD SCI USA, V100, P11652, DOI 10.1073/pnas.1635109100; Werner JM, 2013, HEPATOLOGY, V58, P1621, DOI 10.1002/hep.26353; Heuft MM, 2014, AIDS, V28, P999, DOI 10.1097/QAD.0000000000000180; Delaney WE, 2006, ANTIMICROB AGENTS CH, V50, P2471, DOI 10.1128/AAC.00138-06; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Launay O, 2011, JAMA-J AM MED ASSOC, V305, P1432, DOI 10.1001/jama.2011.351; Maini MK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00057; Sakamoto T, 2013, J VIRAL HEPATITIS, V20, pe27, DOI 10.1111/jvh.12022; Sa-nguanmoo P, 2011, VIRUS RES, V158, P209, DOI 10.1016/j.virusres.2011.04.002; U. S. Public Health Service, 2001, MMWR RECOMM REP, V50, P1; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	25	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	FEB	2015	59	2					1292	1298		10.1128/AAC.04459-14		7	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	CA0LT	WOS:000348610000066		
J	Wiederhold, NP; Najvar, LK; Fothergill, AW; Bocanegra, R; Olivo, M; McCarthy, DI; Kirkpatrick, WR; Fukuda, Y; Mitsuyama, J; Patterson, TF				Wiederhold, Nathan P.; Najvar, Laura K.; Fothergill, Annette W.; Bocanegra, Rosie; Olivo, Marcos; McCarthy, Dora I.; Kirkpatrick, William R.; Fukuda, Yoshiko; Mitsuyama, Junichi; Patterson, Thomas F.			The Novel Arylamidine T-2307 Maintains In Vitro and In Vivo Activity against Echinocandin-Resistant Candida albicans	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article							BLOOD-STREAM INFECTIONS; SURVEILLANCE; EFFICACY	We evaluated the in vitro and in vivo activities of the investigational arylamidine T-2307 against echinocandin-resistant Candida albicans. T-2307 demonstrated potent in vitro activity, and daily subcutaneous doses between 0.75 and 6 mg/kg of body weight significantly improved survival and reduced fungal burden compared to placebo control and caspofungin (10 mg/kg/day) in mice with invasive candidiasis caused by an echinocandin-resistant strain. Thus, T-2307 may have potential use in the treatment of echinocandin-resistant C. albicans infections.	[Wiederhold, Nathan P.; Najvar, Laura K.; Fothergill, Annette W.; Bocanegra, Rosie; Olivo, Marcos; McCarthy, Dora I.; Kirkpatrick, William R.; Patterson, Thomas F.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Najvar, Laura K.; Bocanegra, Rosie; Olivo, Marcos; Kirkpatrick, William R.; Patterson, Thomas F.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Fukuda, Yoshiko; Mitsuyama, Junichi] Toyama Chem Co Ltd, Toyama, Japan	Wiederhold, NP (reprint author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.	wiederholdn@uthscsa.edu			National Institute of Allergy and Infectious Diseases, National Institutes of Health; Department of Health and Human Services [HHS272201000018I, HHSN272201000038I]; Astellas; Dow; F2G; Merck; Merz; Viamet	This project utilized preclinical services funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and Department of Health and Human Services under contract no. HHS272201000018I and HHSN272201000038I, Task Orders A03 and A13, respectively.; N.P.W. has received research support from Astellas, Dow, F2G, Merck, Merz, and Viamet and has served on advisory boards for Merck, Astellas, Toyama, and Viamet. T.F.P. has received research grants to UT Health Science Center San Antonio from Astellas and Merck and has served as a consultant for Astellas, Merck, Toyama, Viamet, and SCYN-EXIS. L.K.N. has received travel support from Viamet. Y.F. and J.M. are employees of Toyama Chemical Co., Ltd.	Wiederhold NP, 2011, ANTIMICROB AGENTS CH, V55, P3254, DOI 10.1128/AAC.01750-10; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160; Wiederhold NP, 2008, ANTIMICROB AGENTS CH, V52, P4145, DOI 10.1128/AAC.00959-08; Quindos G, 2014, REV IBEROAM MICOL, V31, P42, DOI 10.1016/j.riam.2013.10.001; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Fothergill AW, 2014, 54 INT C ANT AG CHEM; Mitsuyama J, 2008, ANTIMICROB AGENTS CH, V52, P1318, DOI 10.1128/AAC.01159-07; Najvar LK, 2008, CLIN MICROBIOL INFEC, V14, P595, DOI 10.1111/j.1469-0691.2008.01994.x; Shibata T, 2012, ANTIMICROB AGENTS CH, V56, P5892, DOI 10.1128/AAC.05954-11; Yamada E, 2010, ANTIMICROB AGENTS CH, V54, P3630, DOI 10.1128/AAC.00355-10	13	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	FEB	2015	59	2					1341	1343		10.1128/AAC.04228-14		3	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	CA0LT	WOS:000348610000074		
J	Kayama, S; Shigemoto, N; Kuwahara, R; Oshima, K; Hirakawa, H; Hisatsune, J; Jove, T; Nishio, H; Yamasaki, K; Wada, Y; Ueshimo, T; Miura, T; Sueda, T; Onodera, M; Yokozaki, M; Hattori, M; Ohge, H; Sugai, M				Kayama, Shizuo; Shigemoto, Norifumi; Kuwahara, Ryuichi; Oshima, Kenshiro; Hirakawa, Hideki; Hisatsune, Junzo; Jove, Thomas; Nishio, Hisaaki; Yamasaki, Katsutoshi; Wada, Yasunao; Ueshimo, Takeshi; Miura, Tetsuya; Sueda, Taijiro; Onodera, Makoto; Yokozaki, Michiya; Hattori, Masahira; Ohge, Hiroki; Sugai, Motoyuki			Complete Nucleotide Sequence of the IncN Plasmid Encoding IMP-6 and CTX-M-2 from Emerging Carbapenem-Resistant Enterobacteriaceae in Japan	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article							KLEBSIELLA-PNEUMONIAE; DNA-SEQUENCE; GENE; MEROPENEM; DATABASE; STRAIN	We have determined the DNA sequence of Klebsiella pneumoniae multidrug resistance plasmid pKPI-6, which is a self-transmissible IncN-type plasmid. pKPI-6 harboring bla(IMP-6) and bla(CTX-M-2) confers a stealth-type carbapenem resistance phenotype on members of the family Enterobacteriaceae that is not detectable with imipenem. pKPI-6 is already epidemic in Japan, favoring the dissemination of IMP-6 and CTX-M-2 in members of the family Enterobacteriaceae.	[Kayama, Shizuo; Shigemoto, Norifumi; Kuwahara, Ryuichi; Hisatsune, Junzo; Onodera, Makoto; Yokozaki, Michiya; Ohge, Hiroki; Sugai, Motoyuki] Hiroshima Univ, Project Res Ctr Nosocomial Infect Dis, Hiroshima, Japan; [Kayama, Shizuo; Shigemoto, Norifumi; Kuwahara, Ryuichi; Hisatsune, Junzo; Sugai, Motoyuki] Hiroshima Univ, Grad Sch Biomed Hlth Sci, Dept Bacteriol, Hiroshima, Japan; [Shigemoto, Norifumi; Sueda, Taijiro] Hiroshima Univ, Grad Sch Biomed Hlth Sci, Dept Surg 1, Hiroshima, Japan; [Kuwahara, Ryuichi] West Japan Railway Co, Hiroshima Gen Hosp, Clin Lab, Hiroshima, Japan; [Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Ctr Omics & Bioinformat, Kashiwa, Chiba, Japan; [Hirakawa, Hideki] Kazusa DNA Res Inst, Dept Plant Genome Res, Kisarazu, Chiba, Japan; [Jove, Thomas] Fac Med Limoges, INSERM, U1092, F-87025 Limoges, France; [Nishio, Hisaaki] Shiga Med Ctr Adults, Clin Lab, Moriyama, Shiga, Japan; [Yamasaki, Katsutoshi] Wakayama Rosai Hosp, Dept Clin Lab, Wakayama, Japan; [Wada, Yasunao] Hyogo Med Univ Hosp, Clin Lab, Nishinomiya, Hyogo, Japan; [Ueshimo, Takeshi; Miura, Tetsuya] Hyogo Kenritsu Amagasaki Hosp, Amagasaki, Hyogo, Japan; [Onodera, Makoto; Yokozaki, Michiya] Hiroshima Univ Hosp, Clin Lab, Hiroshima, Japan; [Ohge, Hiroki] Hiroshima Univ Hosp, Dept Infect Dis, Hiroshima, Japan	Sugai, M (reprint author), Hiroshima Univ, Project Res Ctr Nosocomial Infect Dis, Hiroshima, Japan.	sugai@hiroshima-u.ac.jp					Ewing B, 1998, GENOME RES, V8, P175; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; Garcia-Fernandez A, 2011, J ANTIMICROB CHEMOTH, V66, P1987, DOI 10.1093/jac/dkr225; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chattoraj DK, 2000, MOL MICROBIOL, V37, P467, DOI 10.1046/j.1365-2958.2000.01986.x; Kouda S, 2009, J ANTIMICROB CHEMOTH, V64, P46, DOI 10.1093/jac/dkp142; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Shigemoto N, 2012, DIAGN MICR INFEC DIS, V72, P109, DOI 10.1016/j.diagmicrobio.2011.09.019; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Harino T, 2013, J CLIN MICROBIOL, V51, P2735, DOI 10.1128/JCM.02649-12; LAMBERT T, 1994, FEMS MICROBIOL LETT, V115, P297, DOI 10.1016/0378-1097(94)90030-2; MENDIOLA MV, 1992, J BACTERIOL, V174, P1345; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Shen P, 2008, J ANTIMICROB CHEMOTH, V62, P1252, DOI 10.1093/jac/dkn397; Yamaguchi T, 2000, MOL MICROBIOL, V38, P694, DOI 10.1046/j.1365-2958.2000.02169.x; Yano H, 2001, ANTIMICROB AGENTS CH, V45, P1343, DOI 10.1128/AAC.45.5.1343-1348.2001	19	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	FEB	2015	59	2					1356	1359		10.1128/AAC.04759-14		4	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	CA0LT	WOS:000348610000078		
J	Kayama, S; Koba, Y; Shigemoto, N; Kuwahara, R; Kakuhama, T; Kimura, K; Hisatsune, J; Onodera, M; Yokozaki, M; Ohge, H; Sugai, M				Kayama, Shizuo; Koba, Yumiko; Shigemoto, Norifumi; Kuwahara, Ryuichi; Kakuhama, Tomoko; Kimura, Kimie; Hisatsune, Junzo; Onodera, Makoto; Yokozaki, Michiya; Ohge, Hiroki; Sugai, Motoyuki			Imipenem-Susceptible, Meropenem-Resistant Klebsiella pneumoniae Producing OXA-181 in Japan	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Letter							D BETA-LACTAMASE; GENES		[Kayama, Shizuo; Koba, Yumiko; Shigemoto, Norifumi; Kuwahara, Ryuichi; Hisatsune, Junzo; Onodera, Makoto; Yokozaki, Michiya; Ohge, Hiroki; Sugai, Motoyuki] Hiroshima Univ, Project Res Ctr Nosocomial Infect Dis, Hiroshima, Japan; [Kayama, Shizuo; Koba, Yumiko; Kuwahara, Ryuichi; Hisatsune, Junzo; Sugai, Motoyuki] Hiroshima Univ, Dept Bacteriol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Koba, Yumiko; Onodera, Makoto; Yokozaki, Michiya] Hiroshima Univ Hosp, Clin Lab, Hiroshima, Japan; [Shigemoto, Norifumi] Hiroshima Univ Hosp, Dept Infect Dis, Hiroshima, Japan; [Kuwahara, Ryuichi] West Japan Railway Co, Hiroshima Gen Hosp, Clin Lab, Hiroshima, Japan; [Kakuhama, Tomoko; Kimura, Kimie] Hiroshima City Hosp, Clin Lab, Hiroshima, Japan	Sugai, M (reprint author), Hiroshima Univ, Project Res Ctr Nosocomial Infect Dis, Hiroshima, Japan.	sugai@hiroshima-u.ac.jp					Villa L, 2013, ANTIMICROB AGENTS CH, V57, P1965, DOI 10.1128/AAC.01297-12; Potron A, 2013, INT J ANTIMICROB AG, V41, P325, DOI 10.1016/j.ijantimicag.2012.11.007; Richter DC, 2007, BIOINFORMATICS, V23, P1573, DOI 10.1093/bioinformatics/btm153; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Lascols C, 2013, ANTIMICROB AGENTS CH, V57, P130, DOI 10.1128/AAC.01686-12; Kouda S, 2009, J ANTIMICROB CHEMOTH, V64, P46, DOI 10.1093/jac/dkp142; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Shigemoto N, 2012, DIAGN MICR INFEC DIS, V72, P109, DOI 10.1016/j.diagmicrobio.2011.09.019; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4896, DOI 10.1128/AAC.00481-11; Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Shigemoto N, 2013, DIAGN MICR INFEC DIS, V76, P119, DOI 10.1016/j.diagmicrobio.2013.02.030	13	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	FEB	2015	59	2					1379	1380		10.1128/AAC.04330-14		2	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	CA0LT	WOS:000348610000086		
J	Cousin, FJ; Lynch, SM; Harris, HMB; McCann, A; Lynch, DB; Neville, BA; Irisawa, T; Okada, S; Endo, A; O'Toole, PW				Cousin, Fabien J.; Lynch, Shonagh M.; Harris, Hugh M. B.; McCann, Angela; Lynch, Denise B.; Neville, B. Anne; Irisawa, Tomohiro; Okada, Sanae; Endo, Akihito; O'Toole, Paul W.			Detection and Genomic Characterization of Motility in Lactobacillus curvatus: Confirmation of Motility in a Species outside the Lactobacillus salivarius Clade	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-5; SP-NOV.; BACTERIAL FLAGELLIN; GENUS LACTOBACILLUS; PHYLOGENETIC TREES; SEQUENCE; RUMINIS; WINE; MICROBIOTA	Lactobacillus is the largest genus within the lactic acid bacteria (LAB), with almost 180 species currently identified. Motility has been reported for at least 13 Lactobacillus species, all belonging to the Lactobacillus salivarius clade. Motility in lactobacilli is poorly characterized. It probably confers competitive advantages, such as superior nutrient acquisition and niche colonization, but it could also play an important role in innate immune system activation through flagellin-Toll-like receptor 5 (TLR5) interaction. We now report strong evidence of motility in a species outside the L. salivarius clade, Lactobacillus curvatus (strain NRIC 0822). The motility of L. curvatus NRIC 0822 was revealed by phase-contrast microscopy and soft-agar motility assays. Strain NRIC 0822 was motile at temperatures between 15 degrees C and 37 degrees C, with a range of different carbohydrates, and under varying atmospheric conditions. We sequenced the L. curvatus NRIC 0822 genome, which revealed that the motility genes are organized in a single operon and that the products are very similar (>98.5% amino acid similarity over >11,000 amino acids) to those encoded by the motility operon of Lactobacillus acidipiscis KCTC 13900 (shown for the first time to be motile also). Moreover, the presence of a large number of mobile genetic elements within and flanking the motility operon of L. curvatus suggests recent horizontal transfer between members of two distinct Lactobacillus clades: L. acidipiscis in the L. salivarius clade and L. curvatus in the L. sakei clade. This study provides novel phenotypic, genetic, and phylogenetic insights into flagellum-mediated motility in lactobacilli.	[Cousin, Fabien J.; Lynch, Shonagh M.; Harris, Hugh M. B.; McCann, Angela; Lynch, Denise B.; Neville, B. Anne; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Cousin, Fabien J.; Lynch, Shonagh M.; Harris, Hugh M. B.; McCann, Angela; Lynch, Denise B.; Neville, B. Anne; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Irisawa, Tomohiro; Okada, Sanae] Tokyo Univ Agr, Dept Appl Biol & Chem, Tokyo, Japan; [Endo, Akihito] Tokyo Univ Agr, Dept Food & Cosmet Sci, Hokkaido, Japan	O'Toole, PW (reprint author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.	pwotoole@ucc.ie	O'Toole, Paul/G-1593-2012	O'Toole, Paul/0000-0001-5377-0824	Science Foundation Ireland	Work in the laboratory of P.W.O. was supported by Science Foundation Ireland through a Centre award to the Alimentary Pharmabiotic Centre.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37; Merino S, 2014, INT J MOL SCI, V15, P2840, DOI 10.3390/ijms15022840; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Smith KD, 2002, CURR TOP MICROBIOL, V270, P93; Koyanagi T, 2011, LETT APPL MICROBIOL, V53, P635, DOI 10.1111/j.1472-765X.2011.03155.x; Koyanagi T, 2013, BIOSCI BIOTECH BIOCH, V77, P2125, DOI 10.1271/bbb.130550; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Claesson MJ, 2007, FEMS MICROBIOL LETT, V269, P22, DOI 10.1111/j.1574-6968.2006.00596.x; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201; Manes-Lazaro R, 2009, INT J SYST EVOL MICR, V59, P2215, DOI 10.1099/ijs.0.008276-0; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Lawley B, 2013, APPL ENVIRON MICROB, V79, P5661, DOI 10.1128/AEM.01887-13; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Castellano P, 2003, INT J FOOD MICROBIOL, V85, P35, DOI 10.1016/S0168-1605(02)00479-8; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Salvetti E, 2012, PROBIOTICS ANTIMICRO, V4, P217, DOI 10.1007/s12602-012-9117-8; Hebert EM, 2012, J BACTERIOL, V194, P538, DOI 10.1128/JB.06416-11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Taweechotipatr M, 2009, FEMS MICROBIOL LETT, V293, P65, DOI 10.1111/j.1574-6968.2009.01506.x; Bui Thi Phuong Nam, 2011, Int J Syst Evol Microbiol, V61, P772, DOI 10.1099/ijs.0.021386-0; CARR JG, 1970, J APPL BACTERIOL, V33, P768, DOI 10.1111/j.1365-2672.1970.tb02261.x; Chao SH, 2008, INT J SYST EVOL MICR, V58, P2555, DOI 10.1099/ijs.0.65834-0; Edwards CG, 2000, INT J SYST EVOL MICR, V50, P699; Endo A, 2005, INT J SYST EVOL MICR, V55, P83, DOI 10.1099/ijs.0.63248-0; Forde BM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S13; Renuka Goyal, 2012, African Journal of Biotechnology, V11, P14448; Herbel SR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-27; Irisawa T, 2009, INT J SYST EVOL MICR, V59, P2662, DOI 10.1099/ijs.0.006478-0; Irisawa T, 2010, FOOD PRESERV SCI, V36, P83; Josenhans C, 2000, INFECT IMMUN, V68, P4598, DOI 10.1128/IAI.68.8.4598-4603.2000; Kim DS, 2011, J BACTERIOL, V193, P5053, DOI 10.1128/JB.05659-11; Kubori T, 1997, MOL MICROBIOL, V24, P399, DOI 10.1046/j.1365-2958.1997.3341714.x; Manes-Lazaro R, 2009, INT J SYST EVOL MICR, V59, P2010, DOI 10.1099/ijs.0.007567-0; Manes-Lazaro R, 2008, SYST APPL MICROBIOL, V31, P425, DOI 10.1016/j.syapm.2008.09.001; MCGROARTY JA, 1994, FEMS MICROBIOL LETT, V124, P405; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Naser SM, 2006, INT J SYST EVOL MICR, V56, P1681, DOI 10.1099/ijs.0.64229-0; Neville BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040592; Neville BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068919; Nielsen DS, 2007, INT J SYST EVOL MICR, V57, P1468, DOI 10.1099/ijs.0.64811-0; O'Donnell Michelle M, 2011, Microb Cell Fact, V10 Suppl 1, pS12, DOI 10.1186/1475-2859-10-S1-S12; Paco RS, 2003, BRAZ J MICROBIOL, V34, P236, DOI 10.1590/S1517-83822003000300010; Pilhofer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm836; Puertas AI, 2014, INT J SYST EVOL MICR, V64, P2949, DOI 10.1099/ijs.0.059980-0; Rodas AM, 2006, INT J SYST EVOL MICR, V56, P513, DOI 10.1099/ijs.0.63877-0; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Torriani S, 1996, INT J SYST BACTERIOL, V46, P1158; WEISS N, 1981, ZBL BAKT MIK HYG I C, V2, P242	59	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	FEB	2015	81	4					1297	1308		10.1128/AEM.03594-14		12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CA5DF	WOS:000348927600012		
J	Futagami, T; Mori, K; Wada, S; Ida, H; Kajiwara, Y; Takashita, H; Tashiro, K; Yamada, O; Omori, T; Kuhara, S; Goto, M				Futagami, Taiki; Mori, Kazuki; Wada, Shotaro; Ida, Hiroko; Kajiwara, Yasuhiro; Takashita, Hideharu; Tashiro, Kosuke; Yamada, Osamu; Omori, Toshiro; Kuhara, Satoru; Goto, Masatoshi			Transcriptomic Analysis of Temperature Responses of Aspergillus kawachii during Barley Koji Production	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							CITRIC-ACID ACCUMULATION; STABLE ALPHA-AMYLASE; SOLID-STATE CULTURE; HEAT-SHOCK; SACCHAROMYCES-CEREVISIAE; CARBOHYDRATE-METABOLISM; NUCLEOTIDE-SEQUENCE; MODELING APPROACH; PYRUVATE-KINASE; GENE ONTOLOGY	The koji mold Aspergillus kawachii is used for making the Japanese distilled spirit shochu. During shochu production, A. kawachii is grown in solid-state culture (koji) on steamed grains, such as rice or barley, to convert the grain starch to glucose and produce citric acid. During this process, the cultivation temperature of A. kawachii is gradually increased to 40 degrees C and is then lowered to 30 degrees C. This temperature modulation is important for stimulating amylase activity and the accumulation of citric acid. However, the effects of temperature on A. kawachii at the gene expression level have not been elucidated. In this study, we investigated the effect of solid-state cultivation temperature on gene expression for A. kawachii grown on barley. The results of DNA microarray and gene ontology analyses showed that the expression of genes involved in the glycerol, trehalose, and pentose phosphate metabolic pathways, which function downstream of glycolysis, was downregulated by shifting the cultivation temperature from 40 to 30 degrees C. In addition, significantly reduced expression of genes related to heat shock responses and increased expression of genes related with amino acid transport were also observed. These results suggest that solid-state cultivation at 40 degrees C is stressful for A. kawachii and that heat adaptation leads to reduced citric acid accumulation through activation of pathways branching from glycolysis. The gene expression profile of A. kawachii elucidated in this study is expected to contribute to the understanding of gene regulation during koji production and optimization of the industrially desirable characteristics of A. kawachii.	[Futagami, Taiki; Mori, Kazuki; Tashiro, Kosuke; Kuhara, Satoru; Goto, Masatoshi] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Ida, Hiroko; Kajiwara, Yasuhiro; Takashita, Hideharu; Omori, Toshiro] Sanwa Shurui Co Ltd, Res & Dev Lab, Usa, Oita, Japan; [Yamada, Osamu] Natl Res Inst Brewing, Higashihiroshima, Japan	Goto, M (reprint author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 812, Japan.	mgoto@brs.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24580116, 25450106]	This work was supported in part by Grants-in-Aid for Scientific Research (no. 24580116 to M. G. and no. 25450106 to T. F.) from the Japan Society for the Promotion of Science.	Albrecht D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-32; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Vienken K, 2006, MOL MICROBIOL, V61, P544, DOI 10.1111/j.1365-2958.2006.05257.x; Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Karaffa L, 2003, APPL MICROBIOL BIOT, V61, P189, DOI 10.1007/s00253-002-1201-7; HABISON A, 1983, BIOCHEM J, V209, P669; MEIXNERMONORI B, 1984, CAN J MICROBIOL, V30, P16; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Georg RC, 2007, EUKARYOT CELL, V6, P1053, DOI 10.1128/EC.00053-07; Yamada O, 2011, J BIOSCI BIOENG, V112, P233, DOI 10.1016/j.jbiosc.2011.05.005; Panneman H, 1998, EUR J BIOCHEM, V258, P223, DOI 10.1046/j.1432-1327.1998.2580223.x; TORRES NV, 1994, BIOTECHNOL BIOENG, V44, P112, DOI 10.1002/bit.260440116; REISSIG JL, 1955, J BIOL CHEM, V217, P959; TORRES NV, 1994, BIOTECHNOL BIOENG, V44, P104, DOI 10.1002/bit.260440115; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108; GOTO M, 1994, APPL ENVIRON MICROB, V60, P3926; Ashburner M, 2000, NAT GENET, V25, P25; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Hong SB, 2014, APPL MICROBIOL BIOT, V98, P555, DOI 10.1007/s00253-013-5332-9; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Futagami T, 2011, EUKARYOT CELL, V10, P1586, DOI 10.1128/EC.05224-11; Gibbons JG, 2013, TRENDS MICROBIOL, V21, P14, DOI 10.1016/j.tim.2012.09.005; Abrashev RI, 2008, CAN J MICROBIOL, V54, P977, DOI 10.1139/W08-091; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Flipphi M, 2009, FUNGAL GENET BIOL, V46, pS19, DOI 10.1016/j.fgb.2008.07.018; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; ARTS E, 1987, J GEN MICROBIOL, V133, P1195; Baker SE, 2006, MED MYCOL, V44, pS17, DOI 10.1080/13693780600921037; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; Frisvad JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023496; Fujii F, 1992, J SOC BREW JPN, V87, P757; Hagiwara D, 2008, BIOSCI BIOTECH BIOCH, V72, P2756, DOI 10.1271/bbb.80001; Hashimoto R, 2013, JSM MYCOTOXINS, V63, P179; Hata Y, 1997, J FERMENT BIOENG, V84, P532, DOI 10.1016/S0922-338X(97)81907-1; Hata Y, 1998, GENE, V207, P127, DOI 10.1016/S0378-1119(97)00612-4; Iwano K., 1987, Journal of the Brewing Society of Japan [Nippon Jozo Kyokai Zasshi], V82, P200; Kajiwara Y, 1997, J FERMENT BIOENG, V84, P224, DOI 10.1016/S0922-338X(97)82058-2; Kaneko A, 1996, J FERMENT BIOENG, V81, P292, DOI 10.1016/0922-338X(96)80579-4; Kitahara K, 1949, J FERMENT TECHNOL, V27, P162; KITOS PA, 1953, APPL MICROBIOL, V1, P156; Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6803, DOI 10.1021/bi962870s; Morsy MR, 2010, BIOCHEM BIOPH RES CO, V401, P225, DOI 10.1016/j.bbrc.2010.09.034; OMORI T, 1994, J FERMENT BIOENG, V78, P27, DOI 10.1016/0922-338X(94)90173-2; Sakamoto K, 2009, FUNGAL GENET BIOL, V46, P887, DOI 10.1016/j.fgb.2009.09.004; Suganurna T, 2007, J BIOSCI BIOENG, V104, P353, DOI 10.1263/jbb.104.353; Svanstrom A, 2013, RES MICROBIOL, V164, P91, DOI 10.1016/j.resmic.2012.10.018	49	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	FEB	2015	81	4					1353	1363		10.1128/AEM.03483-14		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CA5DF	WOS:000348927600017		
J	Honda, T; Yasuda, T; Tanaka, T; Hagiwara, K; Arai, T; Yoshino, T				Honda, Toru; Yasuda, Takayuki; Tanaka, Tsuyoshi; Hagiwara, Koji; Arai, Tohru; Yoshino, Tomoko			Functional Expression of Full-Length TrkA in the Prokaryotic Host Magnetospirillum magneticum AMB-1 by Using a Magnetosome Display System	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							NERVE GROWTH-FACTOR; FACTOR BINDING-SITE; ESCHERICHIA-COLI; ANCHOR MOLECULE; PARTICLES; RECEPTOR; PROTEIN; PROTOONCOGENE; IMMUNOASSAY; DISEASE	Tropomyosin receptor kinase A (TrkA), a receptor tyrosine kinase, is known to be associated with various diseases. Thus, TrkA has become a major drug-screening target for these diseases. Despite the fact that the production of recombinant proteins by prokaryotic hosts has advantages, such as fast growth and ease of genetic engineering, the efficient production of functional receptor tyrosine kinase by prokaryotic hosts remains a major experimental challenge. Here, we report the functional expression of full-length TrkA on magnetosomes in Magnetospirillum magneticum AMB-1 by using a magnetosome display system. TrkA was fused with the magnetosome-localized protein Mms13 and expressed on magnetosome surfaces. Recombinant TrkA showed both nerve growth factor (NGF)-binding and autophosphorylation activities. TrkA expressed on magnetosomes has the potential to be used, not only for further functional analysis of TrkA, but also for ligand screening.	[Honda, Toru; Yasuda, Takayuki; Tanaka, Tsuyoshi; Yoshino, Tomoko] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Hagiwara, Koji; Arai, Tohru] Eisai & Co Ltd, Next Generat Syst CFU, Eisai Prod Creat Syst, Tsukuba, Ibaraki, Japan	Yoshino, T (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Koganei, Tokyo, Japan.	y-tomoko@cc.tuat.ac.jp	Tanaka, Tsuyoshi/B-9949-2013; Yoshino, Tomoko/E-9066-2013	Tanaka, Tsuyoshi/0000-0003-2601-2256; Yoshino, Tomoko/0000-0002-4505-2774	Japan Society for the Promotion of Science [23226016, 26289308]	This work was funded in part by Grants-in-Aid for Scientific Research (S, no. 23226016, and B, no. 26289308) from the Japan Society for the Promotion of Science.	Yoshino T, 2006, APPL ENVIRON MICROB, V72, P465, DOI 10.1128/AEM.72.1.465-471.2006; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Makino T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-32; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kanetsuki Y, 2012, BIOCHEM BIOPH RES CO, V426, P7, DOI 10.1016/j.bbrc.2012.07.116; Counts SE, 2004, ANN NEUROL, V56, P520, DOI 10.1002/ana.20233; Yoshino T, 2010, APPL ENVIRON MICROB, V76, P1152, DOI 10.1128/AEM.01755-09; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Okamura Y, 2003, APPL ENVIRON MICROB, V69, P4274, DOI 10.1128/AEM.69.7.4274-4277.2003; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; MATSUNAGA T, 1991, APPL MICROBIOL BIOT, V35, P651; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Arakaki A, 2003, J BIOL CHEM, V278, P8745, DOI 10.1074/jbc.M211729200; Singla N, 2011, CHEM BIOL, V18, P361, DOI 10.1016/j.chembiol.2011.01.011; Matsunaga T, 2007, ANAL CHIM ACTA, V597, P331, DOI 10.1016/j.aca.2007.05.065; Yoshino T, 2008, ANAL CHIM ACTA, V626, P71, DOI 10.1016/j.aca.2008.07.046; Sugamata Y, 2013, INT J MOL SCI, V14, P14426, DOI 10.3390/ijms140714426; SNYDER WB, 1995, J BACTERIOL, V177, P953; Tanaka T, 2000, ANAL CHEM, V72, P3518, DOI 10.1021/ac9912505; Holden PH, 1997, NAT BIOTECHNOL, V15, P668, DOI 10.1038/nbt0797-668; Iacaruso María Florencia, 2011, J Mol Biol, V414, P681, DOI 10.1016/j.jmb.2011.09.022; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; MATSUNAGA T, 1987, APPL MICROBIOL BIOT, V26, P328; Matusica D, 2013, J BIOL CHEM, V288, P11144, DOI 10.1074/jbc.M112.436469; McInnes C, 1997, BIOPOLYMERS, V43, P339, DOI 10.1002/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W; Robertson AGS, 2001, BIOCHEM BIOPH RES CO, V282, P131, DOI 10.1006/bbrc.2001.4462; Wang Jun, 2008, Curr Chem Genomics, V1, P27, DOI 10.2174/1875397300801010027; WINDISCH JM, 1995, J BIOL CHEM, V270, P28133; Yoshino T, 2004, APPL ENVIRON MICROB, V70, P2880, DOI 10.1128/AEM.70.5.2880-2885.2004; Zhang J, 2006, NEUROSIGNALS, V15, P26, DOI 10.1159/000094385	31	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	FEB	2015	81	4					1472	1476		10.1128/AEM.03112-14		5	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CA5DF	WOS:000348927600028		
J	Wang, ZM; Ooga, H; Hirotsu, T; Wang, WL; Wu, QY; Hu, HY				Wang, Zheng-Ming; Ooga, Hiroko; Hirotsu, Takahiro; Wang, Wen-Long; Wu, Qian Yuan; Hu, Hong-Yin			Matrix-enhanced adsorption removal of trace BPA by controlling the interlayer hydrophobic environment of montmorillonite	APPLIED CLAY SCIENCE			English	Article						Organoclay; Hydrophobicity; BPA; Trace amount; Adsorption; Matrix organic materials	QUATERNARY AMMONIUM CATIONS; BISPHENOL-A; HUMAN EXPOSURE; WATER; SORPTION; CETYLTRIMETHYLAMMONIUM; CETYLPYRIDINIUM; SURFACTANTS; ORGANOCLAYS; BENTONITES	There is an increased concern recently toward Bisphenol A (BPA), a typical phenolic type estrogenic endocrine disruptor compound, because of its potential impact toward both human beings as well as wildlife at a trace concentration level. In this research, the surfactant-modified montmorillonite materials were used aiming at the complete removal of trace BPA in water environment. Through a detailed examination on the intercalation properties of alkyltrimethylammonium ions, the interlayer hydrophobic environment properties of the clay minerals, and their relationship with the BPA equilibrium adsorption, it is concluded that BPA at a trace concentration level can be completely removed through increasing the chain length of the surfactant intercalates. Sufficient interlayer hydrophobicity, realized by near or excess cation exchange capacity intercalation of longer chain surfactants, is found significant to the enhancement of selective adsorption of BPA while coexisting with matrix organic substances, which is substantially instructive to the removal of other kinds of non-ionic emerged organic contaminants. (C) 2014 Elsevier B.V. All rights reserved.	[Wang, Zheng-Ming; Ooga, Hiroko] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Adsorpt & Decomposit Technol Res Grp, Tsukuba, Ibaraki 3058569, Japan; [Hirotsu, Takahiro] Natl Inst Adv Ind Sci & Technol, Shikoku Ctr, Takamatsu, Kagawa 7610395, Japan; [Wang, Wen-Long; Wu, Qian Yuan; Hu, Hong-Yin] Tsinghua Univ, Grad Sch, State Environm Protect Key Lab Microorgan Applica, Shenzhen 518055, Peoples R China; [Hu, Hong-Yin] Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing 100084, Peoples R China	Wang, ZM (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Adsorpt & Decomposit Technol Res Grp, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	zm-wang@aist.go.jp			water project of AIST	This work is financially supported by the water project of AIST. The authors thank the generousness of Japan (Kyoto University)-China (Tsinghua University) Center for Environment Research for providing a LC-MS/MS apparatus for BPA analysis. Dr Kosuge K is grateful for valuable discussions on clay minerals.	SMITH JA, 1990, ENVIRON SCI TECHNOL, V24, P1167, DOI 10.1021/es00078a003; Kleywegt S, 2011, SCI TOTAL ENVIRON, V409, P1481, DOI 10.1016/j.scitotenv.2011.01.010; Zhao Q, 2012, LANGMUIR, V28, P16393, DOI 10.1021/la303422p; He HP, 2006, APPL CLAY SCI, V31, P262, DOI 10.1016/j.clay.2005.10.011; Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275; Xi YF, 2007, J COLLOID INTERF SCI, V305, P150, DOI 10.1016/j.jcis.2006.09.033; [Anonymous], 2010, BISPH ACT PLAN CASRN; Jiang WW, 2012, J ENVIRON SCI-CHINA, V24, P320, DOI 10.1016/S1001-0742(11)60746-8; Yui T, 2002, LANGMUIR, V18, P891, DOI 10.1021/la011297x; Park Y, 2014, CHEMOSPHERE, V107, P249, DOI 10.1016/j.chemosphere.2013.12.050; SLOSIARIKOVA H, 1992, J INCLUS PHENOM MOL, V13, P267, DOI 10.1007/BF01042785; Oyanedel-Craver VA, 2007, J COLLOID INTERF SCI, V309, P485, DOI 10.1016/j.jcis.2006.10.001; Praus P, 2006, J COLLOID INTERF SCI, V304, P29, DOI 10.1016/j.jcis.2006.08.038; Heinz H, 2007, CHEM MATER, V19, P59, DOI 10.1021/cm062019s; Sun Y, 2013, ENVIRON POLLUT, V180, P339, DOI 10.1016/j.envpol.2013.05.006; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Liao CY, 2011, ENVIRON SCI TECHNOL, V45, P9372, DOI 10.1021/es202507f; LAGALY G, 1981, CLAY MINER, V16, P1, DOI 10.1180/claymin.1981.016.1.01; LAGALY G, 1976, CLAY MINER, V11, P173, DOI 10.1180/claymin.1976.011.3.01; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Yilmaz N, 2004, APPL CLAY SCI, V27, P223, DOI 10.1016/j.clay.2004.08.001; Brindley GW, 1980, CRYSTAL STRUCTURES C; Fuller M, 2007, J COLLOID INTERF SCI, V313, P405, DOI 10.1016/j.jcis.2007.04.010; Gerrity D., 2012, HUMAN PHARM ENV, V4, P225; Lide D. R., 2004, CRC HDB CHEM PHYS; Pospisil M, 2001, J COLLOID INTERF SCI, V236, P127, DOI 10.1006/jcis.2000.7360; Rouquerol J, 1998, ADSORPTION POWDERS P; STUL MS, 1978, CLAY CLAY MINER, V26, P309, DOI 10.1346/CCMN.1978.0260501; Sun Y., 2014, ENV SCI ENG, V8, P18; VAIA RA, 1994, CHEM MATER, V6, P1017, DOI 10.1021/cm00043a025; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Weers J.G., 1990, ACS SYM SER, V447, P87; Wen XY, 2006, J COLLOID INTERF SCI, V299, P754, DOI 10.1016/j.jcis.2006.02.046; Yang R. T., 2003, ADSORBENTS FUNDAMENT	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	FEB	2015	104						81	87		10.1016/j.clay.2014.11.011		7	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CA2PB	WOS:000348748900010		
J	Fujii, K; Hashizume, H; Shimomura, S; Ariga, K; Ando, T				Fujii, Kazuko; Hashizume, Hideo; Shimomura, Shuichi; Ariga, Katsuhiko; Ando, Toshihiro			Intercalation compounds of a synthetic alkylammonium-smectite with alkanolamines and their unique humidity response properties	APPLIED CLAY SCIENCE			English	Article						Inorganic/organic hybrid; Intercalation compound; Coadsorption; Alkanolamine; Humidity response	RESONANCE ENERGY-TRANSFER; CLAY; PHYLLOSILICATE; LAYER; INTERLAYER; SYSTEMS; CATIONS; HYBRID; WATER	Triethanolamine (TEA) and diethylethanolamine (DEEA) were introduced into the interlayer space of a synthetic alkylammonium smectite (Synth A-Sm) in order to prepare novel intercalation compounds. The inorganic and organic moieties bond covalently with each other in Synth A-Sm. The intercalation compounds prepared (Synth A-Sm TEA and DEEA) showed unique humidity response. A wide range of preparation conditions was tested for the intercalation of the alkanolamines. Then it was revealed that the intercalation was achieved with alkanolamines/Synth A-Sm ratios x of 20-375 mmol/g from room temperature (RT) to 180 degrees C. X-ray diffraction (XRD) analysis showed that the basal spacing increased by the intercalation of TEA or DEEA in the interlayer space of the Synth A-Sm. The basal spacing was independent of x, indicating that TEA was intercalated less than or equal to the saturation value. The interlayer space of Synth A-Sm did not infinitely swell with the introduction of TEA. The basal spacing did not change under dry nitrogen flow in the case of the Synth A-Sm TEA compounds. On the other hand, the basal spacing decreased under dry nitrogen flow in the case of Synth A-Sm DEEA compounds. DEEA easily deintercalated under nitrogen flow at RT. Fourier transform infrared (FT-IR) spectra of the prepared intercalation compounds were simple superimpositions of the spectra of Synth A-Sm and the guest alkanolamines (TEA or DEEA). The Synth A-Sm TEA compounds prepared were characterized under controlled relative humidity. The XRD measurements indicated that the basal spacing was independent of the relative humidity. However, as relative humidity increased, the X-ray reflections from the Synth A-Sm TEA compounds drastically weakened. The XRD analysis was performed under repeated humidification-drying cycles. The XRD results revealed that the unique humidity response is reversible. (c) 2014 Elsevier B.V. All rights reserved.	[Fujii, Kazuko; Hashizume, Hideo; Shimomura, Shuichi; Ando, Toshihiro] Natl Inst Mat Sci, Adv Mat Proc Unit, Tsukuba, Ibaraki 3050044, Japan; [Ariga, Katsuhiko] Natl Inst Mat Sci, WPI Res Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan	Fujii, K (reprint author), Natl Inst Mat Sci, Adv Mat Proc Unit, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	FUJII.Kazuko@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011		Japan Society for the Promotion of Science	We thank Mr. Satoshi Takenouchi, NIMS for the elemental analyses; Dr. Takayoshi Sasaki, NIMS for the XRD measurements; and Professor Atsuko Nakayama, Niigata University, and Dr. Takashi Taniguchi, NIMS for discussions. This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science.	Takagi S, 2007, RES CHEM INTERMEDIAT, V33, P177, DOI 10.1163/156856707779160889; GHOSH PK, 1984, J PHYS CHEM-US, V88, P5519, DOI 10.1021/j150667a012; Carrado KA, 2001, CHEM MATER, V13, P3766, DOI 10.1021/cm010104o; RUIZHITZKY E, 1980, NATURE, V287, P28, DOI 10.1038/287028a0; Slade PG, 2004, APPL CLAY SCI, V25, P93, DOI 10.1016/j.clay.2003.07007; Bujdak J, 2010, J PHYS CHEM C, V114, P1246, DOI 10.1021/jp9098107; Sheng GY, 1998, CLAY CLAY MINER, V46, P10; Tenorio RP, 2010, LANGMUIR, V26, P9703, DOI 10.1021/la100377s; Hagerman ME, 2003, CHEM MATER, V15, P443, DOI 10.1021/cm0209160; Bergaya F., 2013, HDB CLAY SCI; Brindley GW, 1980, CRYSTAL STRUCTURES C; Corredor JI, 2014, APPL CLAY SCI, V95, P9, DOI 10.1016/j.clay.2014.02.030; Da Fonseca MG, 2000, CLAY CLAY MINER, V48, P638, DOI 10.1346/CCMN.2000.0480605; Fujii K, 2003, CHEM MATER, V15, P1189, DOI 10.1021/cm0209665; Fujii K, 2009, CHEM MATER, V21, P1179, DOI 10.1021/cm803315h; Fujii K, 2005, APPL CLAY SCI, V29, P235, DOI 10.1016/j.clay.2005.01.005; Fujii K., 2001, P 12 INT CLAY C, P443; Fujii K, 2008, CHEM MATER, V20, P2994, DOI 10.1021/cm0716452; Fujii K, 2011, J PHOTOCH PHOTOBIO A, V225, P125, DOI 10.1016/j.jphotochem.2011.10.009; Fujii K, 2013, NEW J CHEM, V37, P1142, DOI 10.1039/c3nj41008k; Fukushima Y, 1996, B CHEM SOC JPN, V69, P3667, DOI 10.1246/bcsj.69.3667; Hashizume H., 1996, POWDER DIFFR, V11, P288; Jaber M, 2005, CHEM MATER, V17, P5275, DOI 10.1021/cm050754i; SITHOLE B B, 1985, Environment International, V11, P499, DOI 10.1016/0160-4120(85)90184-9; UEDA S, 1985, T IRON STEEL I JPN, V25, P857	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	FEB	2015	104						88	95		10.1016/j.clay.2014.11.013		8	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CA2PB	WOS:000348748900011		
J	Khaorapapong, N; Khumchoo, N; Ogawa, M				Khaorapapong, Nithima; Khumchoo, Nuttapom; Ogawa, Makoto			Preparation of copper oxide in smectites	APPLIED CLAY SCIENCE			English	Article						Copper oxide; Smectites; Optical property; Thermal property	CUO NANOPARTICLES; LAYERED SILICATES; MESOPOROUS SILICA; SUPPORTED CUO; MONTMORILLONITE; NANOCOMPOSITES; ROUTE; CLAY; INTERCALATION; IRRADIATION	Copper oxide nanoparticles were prepared in the interlayer spaces of sodium- and cetyltrimethylammonium-smectites by a titration of an aqueous solution of copper nitrate at 70 degrees C in the presence of dispersed smectites. The resulting hybrids were characterized by powder XRD, SEM, TEM, TG-DTA, as well as FT-IR and UV-visible spectroscopies. A massive blue shift (from 490 nm to 232-478 nm) of the UV-visible absorption observed for the hybrids confirmed the formation of nanometer-sized copper oxide (3-7 nm) in the interlayer spaces. A small amount of larger CuO particle with the size of around 0.6-2.9 mu m formed at the external surface of clay mineral particles. The nature of the broad absorption band (at around 490 nm) of pure copper oxide and the hybrids with high copper oxide loading was attributed to the overlapping of the Cu2+ to O2- charge transfer as well as d-d transition of copper oxide. The interactions with smectites played a role in stabilizing and protecting the formed copper oxide nanoparticles. (c) 2014 Elsevier B.V. All rights reserved.	[Khaorapapong, Nithima; Khumchoo, Nuttapom] Khon Kaen Univ, Fac Sci, Dept Chem, Khon Kaen 40002, Thailand; [Khaorapapong, Nithima; Khumchoo, Nuttapom] Khon Kaen Univ, Ctr Excellence Innovat Chem, Fac Sci, Khon Kaen 40002, Thailand; [Ogawa, Makoto] Waseda Univ, Dept Earth Sci, Shinjuku Ku, Tokyo 1698050, Japan; [Ogawa, Makoto] Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, Tokyo 1698050, Japan	Khaorapapong, N (reprint author), Khon Kaen Univ, Fac Sci, Dept Chem, Khon Kaen 40002, Thailand.	nithima@kku.ac.th			Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Advanced Functional Materials Cluster of Khon Kaen University; Center of Excellence for Innovation in Chemistry (PERCH-CIC), Commission on Higher Education, Ministry of Education, Thailand	This work was supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Advanced Functional Materials Cluster of Khon Kaen University and the Center of Excellence for Innovation in Chemistry (PERCH-CIC), Commission on Higher Education, Ministry of Education, Thailand.	Ogawa M, 1997, B CHEM SOC JPN, V70, P2593, DOI 10.1246/bcsj.70.2593; Nemeth J, 2003, LANGMUIR, V19, P3762, DOI 10.1021/la0266536; Zhu JW, 2004, MATER LETT, V58, P3324, DOI 10.1016/j.matlet.2004.06.031; Cao JL, 2008, CATAL COMMUN, V9, P2555, DOI 10.1016/j.catcom.2008.07.016; Liu Q, 2006, MATER RES BULL, V41, P697, DOI 10.1016/j.materresbull.2005.10.013; Ogawa M, 1998, CHEM MATER, V10, P1382, DOI 10.1021/cm970770i; Tsoncheva T, 2013, APPL CATAL A-GEN, V453, P1, DOI 10.1016/j.apcata.2012.12.007; Yang ZH, 2007, J SOLID STATE CHEM, V180, P1390, DOI 10.1016/j.jssc.2007.02.008; Ogawa M, 2014, DALTON T, V43, P10340, DOI 10.1039/c4dt00147h; Kida T, 2007, J AM CERAM SOC, V90, P107, DOI 10.1111/j.1551-2916.2006.01402.X; Zhang YG, 2006, J CRYST GROWTH, V291, P196, DOI 10.1016/j.jcrysgro.2006.02.044; Bisio C, 2011, LANGMUIR, V27, P7250, DOI 10.1021/la200892d; Maji SK, 2010, J SOLID STATE CHEM, V183, P1900, DOI 10.1016/j.jssc.2010.06.007; Carja G, 2013, CHEM ENG J, V222, P60, DOI 10.1016/j.cej.2013.02.039; Wang H, 2002, J CRYST GROWTH, V244, P88, DOI 10.1016/S0022-0248(02)01571-3; Kim JY, 2003, J AM CHEM SOC, V125, P10684, DOI 10.1021/ja0301673; Okada T, 2012, CHEM-ASIAN J, V7, P1980, DOI 10.1002/asia.201101015; OGAWA M, 1995, CHEM REV, V95, P399, DOI 10.1021/cr00034a005; Sohrabnezhad S, 2014, SPECTROCHIM ACTA A, V125, P73, DOI 10.1016/j.saa.2014.01.080; Ontam A, 2012, J MATER CHEM, V22, P20001, DOI 10.1039/c2jm33327a; Kong AG, 2009, MICROPOR MESOPOR MAT, V118, P348, DOI 10.1016/j.micromeso.2008.09.006; Kun R, 2006, APPL CLAY SCI, V32, P99, DOI 10.1016/j.clay.2005.09.007; Chen M.-G., 2011, P ICMREE, V1, P906; Dekany I, 1999, J COLLOID INTERF SCI, V213, P584, DOI 10.1006/jcis.1999.6174; Gil A, 2010, PILLARED CLAYS AND RELATED CATALYSTS, P1, DOI 10.1007/978-1-4419-6670-4; Hao XY, 2006, MICROPOR MESOPOR MAT, V88, P38, DOI 10.1016/j.micromeso.2005.08.019; Ide Y., 2013, J NANOSCI NANOTECHNO, V13, P1; KARICKHO.SW, 1973, CLAY CLAY MINER, V21, P59, DOI 10.1346/CCMN.1973.0210109; Khaorapapong N, 2011, MATER LETT, V65, P657, DOI 10.1016/j.matlet.2010.11.052; Khaorapapong N., 2011, Clay Science, V15, P147; Lagaly G, 2006, DEV CLAY SCI, V1, P309, DOI 10.1016/S1572-4352(05)01010-X; Li SZ, 2004, NANOTECHNOLOGY, V15, P1428, DOI 10.1088/0957-4484/15/11/007; Li ZP, 2003, J PHYS CHEM SOLIDS, V64, P223, DOI 10.1016/S0022-3697(02)00281-0; Liu Q, 2006, MATER CHEM PHYS, V98, P519, DOI 10.1016/j.matchemphys.2005.09.073; Nezamzadeh-Ejhieh A, 2014, APPL CATAL A-GEN, V477, P83, DOI 10.1016/j.apcata.2014.02.031; Nezamzadeh-Ejhieh A, 2013, CHEM ENG J, V228, P631, DOI 10.1016/j.cej.2013.05.035; Ogawa M., 2004, HDB LAYERED MAT, P191; Okada T., 2011, Clay Science, V15, P103; Ontam A, 2012, COLLOID SURFACE A, V411, P27, DOI 10.1016/j.colsurfa.2012.06.038; Ontam A, 2011, J COLLOID INTERF SCI, V357, P554, DOI 10.1016/j.jcis.2011.02.016; Renjie N., 2009, J THERM ANAL CALORIM, V96, P943; Suh MJ, 2010, TOP CATAL, V53, P447, DOI 10.1007/s11244-010-9471-2; VAIA RA, 1994, CHEM MATER, V6, P1017, DOI 10.1021/cm00043a025; van Olphen H., 1977, INTRO CLAY COLLOID C; Wang PY, 2012, MICROPOR MESOPOR MAT, V149, P181, DOI 10.1016/j.micromeso.2011.07.002; Xia JX, 2009, J PHYS CHEM SOLIDS, V70, P1461, DOI 10.1016/j.jpcs.2009.08.006; Yasuda Yusuke, 2011, OPEN SURFACE SCI J, V3, P123	47	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	FEB	2015	104						238	244		10.1016/j.clay.2014.11.038		7	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CA2PB	WOS:000348748900029		
J	Chakraborty, S; Bhattacharjee, D; Soda, H; Tominaga, M; Suzuki, Y; Kawamata, J; Hussain, SA				Chakraborty, Santanu; Bhattacharjee, D.; Soda, Honami; Tominaga, Makoto; Suzuki, Yasutaka; Kawamata, Jun; Hussain, Syed Arshad			Temperature and concentration dependence of J-aggregate of a cyanine dye in a Laponite film fabricated by Langmuir-Blodgett technique	APPLIED CLAY SCIENCE			English	Article						Langmuir-Blodgett; J-aggregate; Laponite; Second harmonic generation; Hybrid film	MEROCYANINE DYE; RADIATIVE LIFETIME; ARACHIDIC ACID; CLAY; MOLECULES; ABSORPTION; MONOLAYERS; CRYSTALS; SPECTRA; BAND	In this communication, we report the temperature and concentration dependence of J-aggregate of a cyanine dye N, N'-dioctadecylthiacyanine perchlorate (NK) in the Laponite film fabricated by Langmuir-Blodgett technique. Surface pressure area per molecule isotherm revealed the formation of stable Langmuir monolayer at the air-water interface. Spectroscopic characterization confirmed the formation of J-aggregates in the NK LB film without Laponite. In the hybrid film, J-aggregate forms at lower Laponite concentration (1 ppm), higher deposited surface pressure and at lower subphase temperature. Both the J-aggregated films were found to be optical second harmonic generation (SHG) active and mechanically very stable, although intrinsically NK is SHG inactive. (c) 2014 Elsevier B.V. All rights reserved.	[Chakraborty, Santanu; Bhattacharjee, D.; Hussain, Syed Arshad] Tripura Univ, Thin Film & Nanosci Lab, Dept Phys, Suryamaninagar 799022, Tripura, India; [Chakraborty, Santanu; Soda, Honami; Tominaga, Makoto; Suzuki, Yasutaka; Kawamata, Jun] Yamaguchi Univ, Fac Sci, Dept Chem, Yamaguchi 7538512, Japan	Kawamata, J (reprint author), Yamaguchi Univ, Fac Sci, Dept Chem, Yamaguchi 7538512, Japan.	j_kawa@yamaguchi-u.ac.jp; sa_h153@hotmail.com			DST; CSIR through DST Fast-Track Project [SE/FTP/PS-54/2007]; CSIR [03(1146)/09/EMR-II]; Yamaguchi University	The author SAH is grateful to DST and CSIR for financial support to carry out this work through DST Fast-Track Project Ref. No. SE/FTP/PS-54/2007, CSIR project Ref. 03(1146)/09/EMR-II. The author SC acknowledges the financial support provided by Yamaguchi University.	Kaiser TE, 2009, J PHYS CHEM B, V113, P15836, DOI 10.1021/jp905246r; Lvov Y, 1996, LANGMUIR, V12, P3038, DOI 10.1021/la951002d; [Anonymous], 1999, KIKAN KAGAKU SOSETSU, V42; Jelley EE, 1936, NATURE, V138, P1009, DOI 10.1038/1381009a0; Lu LD, 2002, LANGMUIR, V18, P7706, DOI 10.1021/la0259306; Hussain SA, 2013, THIN SOLID FILMS, V536, P261, DOI 10.1016/j.tsf.2013.03.015; Hussain SA, 2010, LANGMUIR, V26, P11870, DOI 10.1021/la101078f; Kotov NA, 1997, J AM CHEM SOC, V119, P6821, DOI 10.1021/ja964409t; Scheblykin IG, 2000, CHEM PHYS LETT, V316, P37, DOI 10.1016/S0009-2614(99)01252-X; LUPO D, 1988, J OPT SOC AM B, V5, P300, DOI 10.1364/JOSAB.5.000300; BLIZNYUK VN, 1993, J PHYS CHEM-US, V97, P569, DOI 10.1021/j100105a008; Bucher H, 1970, CHEM PHYS LETT, V6, P183, DOI 10.1016/0009-2614(70)80212-3; Chakraborty S, 2014, J PHOTOCH PHOTOBIO A, V293, P57, DOI 10.1016/j.jphotochem.2014.07.018; Chibisov AK, 2008, HIGH ENERG CHEM+, V42, P614, DOI 10.1134/S0018143908070369; Czikklely V, 1970, CHEM PHYS LETT, V6, P207, DOI 10.1016/0009-2614(70)80220-2; DUSCHL C, 1985, THIN SOLID FILMS, V133, P65, DOI 10.1016/0040-6090(85)90425-0; DUSCHL C, 1988, THIN SOLID FILMS, V160, P251, DOI 10.1016/0040-6090(88)90068-5; Hirano Y, 2007, LANGMUIR, V23, P7003, DOI 10.1021/la700254p; Hussain SA, 2010, J PHYS CHEM SOLIDS, V71, P323, DOI 10.1016/j.jpcs.2009.12.084; Hussain SA, 2013, CURR PHYS CHEM, V3, P322; ICHINOSE I, 1995, J PHYS CHEM-US, V99, P3736, DOI 10.1021/j100011a048; Ikegami K, 2001, THIN SOLID FILMS, V393, P193, DOI 10.1016/S0040-6090(01)01068-9; Ikegami K, 1999, J PHYS CHEM B, V103, P11261, DOI 10.1021/jp991859+; Jelley EE, 1937, NATURE, V139, P631, DOI 10.1038/139631b0; Kamalov VF, 1996, J PHYS CHEM-US, V100, P8640, DOI 10.1021/jp9522472; Kawamata J., 2000, MOL CRYST LIQ CRYST, V343, P53, DOI 10.1080/10587250008023502; KIRSTEIN S, 1992, CHEM PHYS LETT, V189, P408, DOI 10.1016/0009-2614(92)85223-W; KNOLL W, 1981, J CHEM PHYS, V75, P4795, DOI 10.1063/1.441915; Kobayashi T, 1996, J AGGREGATES; Kuhn H., 1996, J AGGREGATES; Kushida M, 2008, THIN SOLID FILMS, V516, P2586, DOI 10.1016/j.tsf.2007.04.071; Lan MB, 2001, THIN SOLID FILMS, V384, P120, DOI 10.1016/S0040-6090(00)01823-X; Paul P.K., 2009, MOD PHYS LETT B, V23, P1; Ras RHA, 2004, PHYS CHEM CHEM PHYS, V6, P4174, DOI 10.1039/b405862c; Saito K, 1999, JPN J APPL PHYS 1, V38, P2804, DOI 10.1143/JJAP.38.2804; Scheibe G, 1937, ANGEW CHEM-GER EDIT, V50, P0212, DOI 10.1002/ange.19370501103; Schoonheydt RA, 2014, APPL CLAY SCI, V96, P9, DOI 10.1016/j.clay.2014.04.010; Sturmer D.M., 1977, THEORY PHOTOGRAPHIC; Tachibana H, 2001, J PHYS CHEM B, V105, P10282, DOI 10.1021/jp0104841; Tachibana H, 2000, JPN J APPL PHYS 2, V39, pL884, DOI 10.1143/JJAP.39.L884; TSUTSUMI N, 1992, CHEM LETT, P1465, DOI 10.1246/cl.1992.1465; Ulman A., 1991, INTRO ULTRATHIN ORGA; Umemura Y, 2005, LANGMUIR, V21, P4520, DOI 10.1021/la0469497; Yamaguchi A, 2005, J PHYS CHEM B, V109, P1408, DOI 10.1021/jp0405557; YU ZX, 1983, CHEM PHYS, V79, P289, DOI 10.1016/0301-0104(83)85160-X	45	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	FEB	2015	104						245	251		10.1016/j.clay.2014.11.039		7	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CA2PB	WOS:000348748900030		
J	Aziz, M; Prawisudha, P; Prabowo, B; Budiman, BA				Aziz, Muhammad; Prawisudha, Pandji; Prabowo, Bayu; Budiman, Bentang Arief			Integration of energy-efficient empty fruit bunch drying with gasification/combined cycle systems	APPLIED ENERGY			English	Article						Empty fruit bunch; Drying; Enhanced process integration; Energy efficiency; Gasification; Combined cycle	FLUIDIZED-BED; SUPERHEATED STEAM; BIOMASS GASIFICATION; PALM; PERFORMANCE; COMBUSTION; GENERATION; PARTICLES; QUALITY; FIBERS	A high-energy-efficient process for empty fruit bunch drying with integration to gasification and combined cycle processes is proposed. The enhancement is due to greater exergy recovery and more effident process integration. Basically, the energy/heat involved in a single process is recovered as much as possible, leading to minimization of exergy destruction. In addition, the unrecoverable energy/heat is utilized for other processes through process integration. During drying, a fluidized bed dryer with superheated steam is used as the main evaporator. Exergy recovery is performed through exergy elevation via compression and effective heat coupling in a dryer and heat exchangers. The dried empty fruit bunches are gasified in a fluidized bed gasifier using air as the fluidizing gas. Furthermore, the produced syngas is utilized as fuel in the combined cycle module. From process analysis, the proposed integrated processes can achieve a relatively high energy efficiency. Compared to a standalone drying process employing exergy recovery, the proposed integrated drying can reduce consumed energy by about 1/3. In addition, the overall integrated processes can reach a total power generation efficiency of about 44%. (C) 2014 Elsevier Ltd. All rights reserved.	[Aziz, Muhammad] Tokyo Inst Technol, Solut Res Lab, Meguro Ku, Tokyo 1528550, Japan; [Prawisudha, Pandji] Inst Teknol Bandung, Dept Mech Engn, Bandung, Indonesia; [Prabowo, Bayu] Tokyo Inst Technol, Dept Environm Sci & Technol, Tokyo 1528550, Japan; [Budiman, Bentang Arief] Tokyo Inst Technol, Dept Engn Sci & Mech, Dept Mech Sci & Engn, Tokyo 1528550, Japan	Aziz, M (reprint author), Tokyo Inst Technol, Solut Res Lab, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	maziz@ssr.titech.ac.jp	Aziz, Muhammad/B-9248-2015	Aziz, Muhammad/0000-0003-2433-8500			Abu Bakar R, 2011, NUTR CYCL AGROECOSYS, V89, P341, DOI 10.1007/s10705-010-9398-9; Aziz M, 2013, APPL ENERG, V109, P163, DOI 10.1016/j.apenergy.2013.04.004; SHAH MM, 1979, INT J HEAT MASS TRAN, V22, P547, DOI 10.1016/0017-9310(79)90058-9; Matsumura Y, 2005, BIOMASS BIOENERG, V29, P269, DOI 10.1016/j.biombioe.2005.04.006; Konsomboon S, 2011, APPL ENERG, V88, P298, DOI 10.1016/j.apenergy.2010.07.008; Mohammed MAA, 2011, RENEW SUST ENERG REV, V15, P1258, DOI 10.1016/j.rser.2010.10.003; Demirbas A, 2004, PROG ENERG COMBUST, V30, P219, DOI 10.1016/j.pecs.2003.10.004; Mohammed MAA, 2012, BIORESOURCE TECHNOL, V110, P628, DOI 10.1016/j.biortech.2012.01.056; Hoffmann BS, 2011, APPL ENERG, V88, P3917, DOI 10.1016/j.apenergy.2011.04.002; Chaiwatanodom P, 2014, APPL ENERG, V114, P10, DOI 10.1016/j.apenergy.2013.09.052; van Deventer HC, 2001, DRY TECHNOL, V19, P2033, DOI 10.1081/DRT-100107287; Chaudhari ST, 2003, ENERG FUEL, V17, P1062, DOI 10.1021/ef030017d; Daud WRW, 2008, ADV POWDER TECHNOL, V19, P403, DOI 10.1163/156855208X336675; Lee HH, 2014, APPL ENERG, V131, P425, DOI 10.1016/j.apenergy.2014.06.044; Puspasari I, 2012, DRY TECHNOL, V30, P619, DOI 10.1080/07373937.2012.654873; Basiron Y, 2007, EUR J LIPID SCI TECH, V109, P289, DOI 10.1002/ejlt.200600223; Yang HP, 2006, FUEL PROCESS TECHNOL, V87, P935, DOI 10.1016/j.fuproc.2006.07.001; Lahijani P, 2011, BIORESOURCE TECHNOL, V102, P2068, DOI 10.1016/j.biortech.2010.09.101; Majoumerd MM, 2014, APPL ENERG, V113, P452, DOI 10.1016/j.apenergy.2013.07.051; Aziz M, 2014, ENERGY, V70, P307, DOI 10.1016/j.energy.2014.03.126; Aziz M, 2014, DRY TECHNOL, V32, P1621, DOI 10.1080/07373937.2014.915219; Chen JC, 1998, FLUIDIZATION SOLIDS, P153, DOI 10.1016/B978-081551427-5.50005-3; COBBINAH S, 1987, INT J HEAT MASS TRAN, V30, P395, DOI 10.1016/0017-9310(87)90127-X; Harsono SS, 2013, RESOUR CONSERV RECY, V77, P108, DOI 10.1016/j.resconrec.2013.04.005; Hasibuan R, 2007, ASIA-PAC J CHEM ENG, V2, P35, DOI [10.1002/apj.53, 10.1002/apj.053]; Hasibuan R, 2009, DRY TECHNOL, V27, P194, DOI 10.1080/07373930802603383; Indonesia Palm Oil Advocacy Team-Indonesian Palm Oil Board (TAMSI-DMSI), 2010, FACTS IND OIL PALM; Kerdsuwan S, 2011, RENEWABLE ENERGY TRE, P123; Kunii D., 1991, FLUIDIZATION ENG; Lim K. C., 2000, Journal of Oil Palm Research, V12, P55; Luk HT, 2013, ENERGY, V63, P205, DOI 10.1016/j.energy.2013.10.056; Mohammed M. A. A., 2011, Journal of Applied Sciences, V11, DOI 10.3923/jas.2011.2416.2420; Ogi T, 2013, FUEL, V104, P28, DOI 10.1016/j.fuel.2010.08.028; O-Thong S, 2012, APPL ENERG, V93, P648, DOI 10.1016/j.apenergy.2011.12.092; Paepatung N, 2009, ASIAN J ENERGY ENV, V10, P19; USDA Indonesia, IND OILS PROD ANN 20	36	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	FEB 1	2015	139						188	195		10.1016/j.apenergy.2014.11.038		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CA6YF	WOS:000349063000016		
J	Dong, YP; Huang, G; Miyazaki, R; Takeuchi, Y				Dong, Yueping; Huang, Gang; Miyazaki, Rinko; Takeuchi, Yasuhiro			Dynamics in a tumor immune system with time delays	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Tumor-immune system interaction; Delay differential equations; Stable periodic oscillation; Hopf bifurcation; Heteroclinic cycle; Stabilization	DIFFERENTIAL-EQUATIONS; BIFURCATION-ANALYSIS; SENSITIVITY-ANALYSIS; PARAMETER-ESTIMATION; INTRACELLULAR DELAY; VIRAL DYNAMICS; MODEL; COMPETITION; STABILITY; GROWTH	In this paper, we study the dynamical behavior of a tumor-immune system (T-IS) interaction model with two discrete delays, namely the immune activation delay for effector cells (ECs) and activation delay for helper T cells (HTCs). By analyzing the characteristic equations, we establish the stability of two equilibria (tumor-free equilibrium and immunecontrol equilibrium) and the existence of Hopf bifurcations when two delays are used as the bifurcation parameter. Our results exhibit that both delays do not affect the stability of tumor-free equilibrium. However, they are able to destabilize the immune-control equilibrium and cause periodic solutions. We numerically illustrate how these two delays can change the stability region of the immune-control equilibrium and display the different impacts to the control of tumors. The numerical simulation results show that the immune activation delay for HTCs can induce heteroclinic cycles to connect the tumor-free equilibrium and immune-control equilibrium. Furthermore, we observe that the immune activation delay for HTCs can even stabilize the unstable immune-control equilibrium. (c) 2014 Elsevier Inc. All rights reserved.	[Dong, Yueping] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328561, Japan; [Huang, Gang] China Univ Geosci, Sch Math & Phys, Wuhan 430074, Peoples R China; [Miyazaki, Rinko] Shizuoka Univ, Dept Math & Syst Engn, Hamamatsu, Shizuoka 4328561, Japan; [Takeuchi, Yasuhiro] Aoyama Gakuin Univ, Dept Math & Phys, Sagamihara, Kanagawa 2525258, Japan	Takeuchi, Y (reprint author), Aoyama Gakuin Univ, Dept Math & Phys, Sagamihara, Kanagawa 2525258, Japan.	takeuchi@gem.aoyama.ac.jp			China Scholarship Council [2011646020]; Fundamental Research Funds for the Central Universities [CUG130415]; National Natural Science Foundation of China [11201435]; Japan Society for Promotion of Science [22540223, 26400211]	Y.D. gratefully acknowledges the financial support provided by China Scholarship Council No. 2011646020. G.H. was partially supported by the Fundamental Research Funds for the Central Universities No. CUG130415 and the National Natural Science Foundation of China No. 11201435. R.M. and Y.T. were partially supported by Grants-in-Aid Scientific Research (C) Nos. 22540223 and 26400211 respectively, Japan Society for Promotion of Science.	Adam J.A., 1997, SURVEY MODELS TUMOR; Eftimie R, 2011, B MATH BIOL, V73, P2, DOI 10.1007/s11538-010-9526-3; Villasana M, 2003, J MATH BIOL, V47, P270, DOI 10.1007/s00285-003-0211-0; Atay FM, 2006, SIAM J APPL DYN SYST, V5, P508, DOI 10.1137/060652531; Song YL, 2006, NONLINEAR ANAL-REAL, V7, P265, DOI 10.1016/j.nonrwa.2005.03.002; Pawelek KA, 2012, MATH BIOSCI, V235, P98, DOI 10.1016/j.mbs.2011.11.002; Rihan FA, 2014, APPL MATH COMPUT, V232, P606, DOI 10.1016/j.amc.2014.01.111; MAY RM, 1975, SIAM J APPL MATH, V29, P243, DOI 10.1137/0129022; Banerjee S, 2008, BIOSYSTEMS, V91, P268, DOI 10.1016/j.biosystems.2007.10.002; Yafia R, 2007, SIAM J APPL MATH, V67, P1693, DOI 10.1137/060657947; Piotrowska MJ, 2013, NONLINEAR ANAL-REAL, V14, P1601, DOI 10.1016/j.nonrwa.2012.10.020; Huang G, 2011, JPN J IND APPL MATH, V28, P383, DOI 10.1007/s13160-011-0045-x; d'Onofrio A, 2010, MATH COMPUT MODEL, V51, P572, DOI 10.1016/j.mcm.2009.11.005; KUZNETSOV VA, 1994, B MATH BIOL, V56, P295, DOI 10.1007/BF02460644; Ruan SG, 2003, DYNAM CONT DIS SER A, V10, P863; Gakkhar S, 2012, COMMUN NONLINEAR SCI, V17, P914, DOI 10.1016/j.cnsns.2011.05.047; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Bi P, 2013, SIAM J APPL DYN SYST, V12, P1847, DOI 10.1137/120887898; Feyissa S, 2013, NONLINEAR ANAL-REAL, V14, P35, DOI 10.1016/j.nonrwa.2012.05.001; Dingli D, 2006, MATH BIOSCI, V199, P55, DOI 10.1016/j.mbs.2005.11.001; Dong YP, 2014, DISCRETE CONT DYN-B, V19, P55, DOI 10.3934/dcdsb.2014.19.55; Engelborghs K., 2001, TW330 U LEUV; Galach M., 2003, International Journal of Applied Mathematics and Computer Science, V13; Kirschner D, 1998, J MATH BIOL, V37, P235, DOI 10.1007/s002850050127; Li MY, 2012, J MATH BIOL, V64, P1005, DOI 10.1007/s00285-011-0436-2; Tsai TL, 2013, PHYSICA D, V262, P14, DOI 10.1016/j.physd.2013.07.009; Tsygvintsev A., 2013, MATH METHODS MODELS, P367	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	FEB 1	2015	252						99	113		10.1016/j.amc.2014.11.096		15	Mathematics, Applied	Mathematics	CA6NW	WOS:000349032500010		
J	Jojima, T; Noburyu, R; Sasaki, M; Tajima, T; Suda, M; Yukawa, H; Inui, M				Jojima, Toru; Noburyu, Ryoji; Sasaki, Miho; Tajima, Takahisa; Suda, Masako; Yukawa, Hideaki; Inui, Masayuki			Metabolic engineering for improved production of ethanol by Corynebacterium glutamicum	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Corynebacterium glutamicum; Oxygen deprivation; Ethanol; Glycolytic enzymes; Mixed sugars	OXYGEN-DEPRIVATION CONDITIONS; EFFICIENT ISOBUTANOL PRODUCTION; L-VALINE PRODUCTION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; HEXOSE TRANSPORTERS; XYLOSE ISOMERASE; D-GLUCOSE; OVEREXPRESSION; FERMENTATION	Recombinant Corynebacterium glutamicum harboring genes for pyruvate decarboxylase (pdc) and alcohol dehydrogenase (adhB) can produce ethanol under oxygen deprivation. We investigated the effects of elevating the expression levels of glycolytic genes, as well as pdc and adhB, on ethanol production. Overexpression of four glycolytic genes (pgi, pfkA, gapA, and pyk) in C. glutamicum significantly increased the rate of ethanol production. Overexpression of tpi, encoding triosephosphate isomerase, further enhanced productivity. Elevated expression of pdc and adhB increased ethanol yield, but not the rate of production. Fed-batch fermentation using an optimized strain resulted in ethanol production of 119 g/L from 245 g/L glucose with a yield of 95 % of the theoretical maximum. Further metabolic engineering, including integration of the genes for xylose and arabinose metabolism, enabled consumption of glucose, xylose, and arabinose, and ethanol production (83 g/L) at a yield of 90 %. This study demonstrated that C. glutamicum has significant potential for the production of cellulosic ethanol.	[Jojima, Toru; Noburyu, Ryoji; Sasaki, Miho; Tajima, Takahisa; Suda, Masako; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth, Kyoto 6190292, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.	inui@rite.or.jp					Oreb M, 2012, BIOENGINEERED, V3, P347, DOI 10.4161/bioe.21444; Kawaguchi H, 2008, APPL MICROBIOL BIOT, V77, P1053, DOI 10.1007/s00253-007-1244-x; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Sasaki M, 2010, APPL MICROBIOL BIOT, V86, P1057, DOI 10.1007/s00253-009-2372-2; Sasaki M, 2008, APPL MICROBIOL BIOT, V81, P691, DOI 10.1007/s00253-008-1703-z; Hasegawa S, 2012, APPL ENVIRON MICROB, V78, P865, DOI 10.1128/AEM.07056-11; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; Kotrba P, 2001, BIOCHEM BIOPH RES CO, V289, P1307, DOI 10.1006/bbrc.2001.6116; Yamamoto S, 2012, APPL ENVIRON MICROB, V78, P4447, DOI 10.1128/AEM.07998-11; Sakai S, 2007, APPL ENVIRON MICROB, V73, P2349, DOI 10.1128/AEM.02880-06; Emmerling M, 2000, BIOTECHNOL BIOENG, V67, P623, DOI 10.1002/(SICI)1097-0290(20000305)67:5<623::AID-BIT13>3.0.CO;2-W; Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Emmerling M, 1999, METAB ENG, V1, P117, DOI 10.1006/mben.1998.0109; Farwick A, 2014, P NATL ACAD SCI USA, V111, P5159, DOI 10.1073/pnas.1323464111; Hasegawa S, 2013, APPL ENVIRON MICROB, V79, P1250, DOI 10.1128/AEM.02806-12; Kawaguchi H, 2006, APPL ENVIRON MICROB, V72, P3418, DOI 10.1128/AEM.72.5.3418-3128.2006; Huerta-Beristain G, 2008, J MOL MICROB BIOTECH, V15, P55, DOI 10.1159/000111993; Goncalves DL, 2014, ENZYME MICROB TECH, V63, P13, DOI 10.1016/j.enzmictec.2014.05.003; Cao LM, 2014, METAB ENG, V24, P150, DOI 10.1016/j.ymben.2014.05.001; Smits HP, 2000, YEAST, V16, P1325, DOI 10.1002/1097-0061(200010)16:14<1325::AID-YEA627>3.0.CO;2-E; Okino S, 2005, APPL MICROBIOL BIOT, V68, P475, DOI 10.1007/s00253-005-1900-y; Young EM, 2014, P NATL ACAD SCI USA, V111, P131, DOI 10.1073/pnas.1311970111; Sasaki M, 2009, APPL MICROBIOL BIOT, V85, P105, DOI 10.1007/s00253-009-2065-x; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Jojima T, 2013, CORYNEBACTERIUM GLUT; Kinoshita S, 1985, BIOL IND MICROORGANI, P115; Lau MW, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-11; Lee SM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0122-x; Smith J, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-41; Suzuki N, 2005, APPL MICROBIOL BIOT, V69, P151, DOI 10.1007/s00253-005-1976-4; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	32	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	3					1165	1172		10.1007/s00253-014-6223-4		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CA2YG	WOS:000348771400012		
J	Jojima, T; Igari, T; Moteki, Y; Suda, M; Yukawa, H; Inui, M				Jojima, Toru; Igari, Takafumi; Moteki, Yasuhiro; Suda, Masako; Yukawa, Hideaki; Inui, Masayuki			Promiscuous activity of (S,S)-butanediol dehydrogenase is responsible for glycerol production from 1,3-dihydroxyacetone in Corynebacterium glutamicum under oxygen-deprived conditions	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Corynebacterium glutamicum; Glycerol; 2,3-Butanediol dehydrogenase; ButA; Enzyme promiscuity	BREVIBACTERIUM-SACCHAROLYTICUM C-1012; ESCHERICHIA-COLI; L-2,3-BUTANEDIOL DEHYDROGENASE; LYSINE PRODUCTION; OSMOTIC-STRESS; METABOLISM; FRUCTOSE; PATHWAY; GENE; FLUX	Corynebacterium glutamicum can consume glucose to excrete glycerol under oxygen deprivation. Although glycerol synthesis from 1,3-dihydroxyacetone (DHA) has been speculated, no direct evidence has yet been provided in C. glutamicum. Enzymatic and genetic investigations here indicate that the glycerol is largely produced from DHA and, unexpectedly, the reaction is catalyzed by (S,S)-butanediol dehydrogenase (ButA) that inherently catalyzes the interconversion between S-acetoin and (S,S)-2,3-butanediol. Consequently, the following pathway for glycerol biosynthesis in the bacterium emerges: dihydroxyacetone phosphate is dephosphorylated by HdpA to DHA, which is subsequently reduced to glycerol by ButA. This study emphasizes the importance of promiscuous activity of the enzyme in vivo.	[Jojima, Toru; Igari, Takafumi; Moteki, Yasuhiro; Suda, Masako; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth, Kyoto 6190292, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth, 9-2 Kizugawadai, Kyoto 6190292, Japan.	mmg-lab@rite.or.jp					Kromer JO, 2004, J BACTERIOL, V186, P1769, DOI 10.1128/JB.186.6.1769-1784.2004; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x; Jojima T, 2012, FEBS LETT, V586, P4228, DOI 10.1016/j.febslet.2012.10.028; Wang ZX, 2001, BIOTECHNOL ADV, V19, P201, DOI 10.1016/S0734-9750(01)00060-X; Takusagawa Y, 2001, BIOSCI BIOTECH BIOCH, V65, P1876, DOI 10.1271/bbb.65.1876; Kiefer P, 2004, APPL ENVIRON MICROB, V70, P229, DOI 10.1128/AEM.70.1.229-239.2004; Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480; Wittmann C, 2004, APPL ENVIRON MICROB, V70, P7277, DOI 10.1128/AEM.70.12.7277-7287.2004; BLOMBERG A, 1992, ADV MICROB PHYSIOL, V33, P145, DOI 10.1016/S0065-2911(08)60217-9; Dominguez H, 1998, EUR J BIOCHEM, V254, P96, DOI 10.1046/j.1432-1327.1998.2540096.x; Becker J, 2005, APPL ENVIRON MICROB, V71, P8587, DOI 10.1128/AEM.71.12.8587-8596.2005; Otagiri M, 2010, FEBS LETT, V584, P219, DOI 10.1016/j.febslet.2009.11.068; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; Nissen TL, 2000, YEAST, V16, P463, DOI 10.1002/(SICI)1097-0061(20000330)16:5<463::AID-YEA535>3.3.CO;2-V; Lindner SN, 2012, J BIOTECHNOL, V159, P216, DOI 10.1016/j.jbiotec.2012.02.003; Wang Y, 2014, J BIOL CHEM, V289, P6080, DOI 10.1074/jbc.M113.525535; Becker J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-8; Garcia-Martinez J, 2014, MICROBIOL-SGM, V160, P26, DOI 10.1099/mic.0.071761-0; Hasegawa S, 2011, APPL ENVIRON MICROB, V78, P865; HORBACH S, 1994, FEMS MICROBIOL LETT, V120, P37; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; JIN RZ, 1983, J MOL EVOL, V19, P429, DOI 10.1007/BF02102318; Jojima T, 2013, CORYNEBACTERIUM GLUT, V23, P149; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; Machielsen R, 2006, APPL ENVIRON MICROB, V72, P233, DOI 10.1128/AEM.72.1.233-238.2006; NEISH AC, 1945, CAN J RES B, V23, P290; PEPPER RE, 1964, J BACTERIOL, V87, P303; RASPOET D, 1991, SYST APPL MICROBIOL, V14, P1; Suzuki N, 2006, APPL ENVIRON MICROB, V72, P3750, DOI 10.1128/AEM.72.5.3750-3755.2006; Ui S, 1998, J FERMENT BIOENG, V86, P290, DOI 10.1016/S0922-338X(98)80132-3; UI S, 1983, J FERMENT TECHNOL, V61, P467; VEIGADACUNHA M, 1993, J BACTERIOL, V175, P3941; VIIKARI L, 1988, Critical Reviews in Biotechnology, V7, P237, DOI 10.3109/07388558809146603; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	35	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	3					1427	1433		10.1007/s00253-014-6170-0		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CA2YG	WOS:000348771400034		
J	Minoda, A; Sawada, H; Suzuki, S; Miyashita, S; Inagaki, K; Yamamoto, T; Tsuzuki, M				Minoda, Ayumi; Sawada, Hitomi; Suzuki, Sonoe; Miyashita, Shin-ichi; Inagaki, Kazumi; Yamamoto, Takaiku; Tsuzuki, Mikio			Recovery of rare earth elements from the sulfothermophilic red alga Galdieria sulphuraria using aqueous acid	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Galdieria sulphuraria; Metal recovery; Red algae; Rare earth elements; Copper	BACTERIAL-CELL WALLS; CYANIDIUM-CALDARIUM; WASTE-WATER; BIOSORPTION; CADMIUM; ADSORPTION; TOLERANCE; DIGESTION; SORPTION; STORAGE	The demand for rare earth elements has increased dramatically in recent years because of their numerous industrial applications, and considerable research efforts have consequently been directed toward recycling these materials. The accumulation of metals in microorganisms is a low-cost and environmentally friendly method for the recovery of metals present in the environment at low levels. Numerous metals, including rare earth elements, can be readily dissolved in aqueous acid, but the efficiency of metal biosorption is usually decreased under the acidic conditions. In this report, we have investigated the use of the sulfothermophilic red alga Galdieria sulphuraria for the recovery of metals, with particular emphasis on the recovery of rare earth metals. Of the five different growth conditions investigated where G. sulphuraria could undergo an adaptation process, Nd(III), Dy(III), and Cu(II) were efficiently recovered from a solution containing a mixture of different metals under semi-anaerobic heterotrophic condition at a pH of 2.5. G. sulphuraria also recovered Nd(III), Dy(III), La(III), and Cu(II) with greater than 90 % efficiency at a concentration of 0.5 ppm. The efficiency remained unchanged at pH values in the range of 1.5-2.5. Furthermore, at pH values in the range of 1.0-1.5, the lanthanoid ions were collected much more efficiently into the cell fractions than Cu(II) and therefore successfully separated from the Cu(II) dissolved in the aqueous acid. Microscope observation of the cells using alizarin red suggested that the metals were accumulating inside of the cells. Experiments using dead cells suggested that this phenomenon was a biological process involving specific activities within the cells.	[Minoda, Ayumi; Sawada, Hitomi; Suzuki, Sonoe] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Minoda, Ayumi] JST, PRESTO, Chiyoda Ku, Tokyo 1020076, Japan; [Miyashita, Shin-ichi; Inagaki, Kazumi] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Yamamoto, Takaiku] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Tsuzuki, Mikio] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan	Minoda, A (reprint author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	minoda.ayumi.gb@u.tsukuba.ac.jp			PRESTO from the Japan Science and Technology Agency; Chemical Analysis Division of the University of Tsukuba	We would like to thank the Chemical Analysis Division of the University of Tsukuba for their helpful support with the ICP-MS measurements. This study was supported by PRESTO (to A.M.) from the Japan Science and Technology Agency, as well as a research grant from the Chemical Analysis Division of the University of Tsukuba (to A.M.).	AHLF W, 1988, APPL MICROBIOL BIOT, V28, P512; ALLEN MB, 1959, ARCH MIKROBIOL, V32, P270, DOI 10.1007/BF00409348; Andres Y, 2003, ENVIRON TECHNOL, V24, P1367; Cordero B, 2004, ENVIRON CHEM, V1, P180, DOI 10.1071/EN04039; Oesterhelt C, 2007, PLANT J, V51, P500, DOI 10.1111/j.1365-313X.2007.03159.x; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571; SECKBACH J, 1970, NATURE, V227, P744, DOI 10.1038/227744a0; Graverholt OS, 2007, APPL MICROBIOL BIOT, V77, P69, DOI 10.1007/s00253-007-1150-2; KUYUCAK N, 1989, BIOTECHNOL BIOENG, V33, P809, DOI 10.1002/bit.260330703; Takahashi Y, 2005, CHEM GEOL, V219, P53, DOI 10.1016/j.chemgeo.2005.02.009; Jiang MY, 2010, CHEM GEOL, V277, P61, DOI 10.1016/j.chemgeo.2010.07.010; Karavaiko GI, 1996, BIOTECHNOL LETT, V18, P1291, DOI 10.1007/BF00129957; Texier AC, 1999, ENVIRON SCI TECHNOL, V33, P489, DOI 10.1021/es9807744; Minoda A, 2004, PLANT CELL PHYSIOL, V45, P667, DOI 10.1093/pcp/pch087; Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002; Kuroda K, 2010, APPL MICROBIOL BIOT, V87, P53, DOI 10.1007/s00253-010-2581-8; Ascione R, 1966, SCIENCE, V12, P752; Boyanov MI, 2003, GEOCHIM COSMOCHIM AC, V67, P3299, DOI 10.1016/S0016-7037(02)01343-1; Buchler JW, 1997, BIOINORG CHEM, P570; Fukuda I, 1958, BOT MAG TOKYO, V71, P79; Gorss W, 1995, PLANT CELL PHYSL, V36, P633; Guzel Y, 2013, ANALYST, V138, P2897, DOI 10.1039/c3an00066d; Hosomomi Y, 2013, J CHEM ENG JPN, V46, P450, DOI 10.1252/jcej.13we031; Kuepper Hendrik, 2006, V25, P67; LAFRAIE MA, 1985, PLANTA, V163, P38, DOI 10.1007/BF00395895; Matsunaga T, 1999, J BIOTECHNOL, V70, P33, DOI 10.1016/S0168-1656(99)00055-3; Mehta SK, 2002, J APPL PHYCOL, V14, P267, DOI 10.1023/A:1021149119472; Nagasaka S, 2004, BIOMETALS, V17, P177, DOI 10.1023/B:BIOM.0000018403.37716.ff; Nagasaka S, 2003, BIOMETALS, V16, P465, DOI 10.1023/A:1022563600525; Wood J.M., 1983, ENVIRON SCI TECHNOL, P582; Yoshimura E, 1999, SOIL SCI PLANT NUTR, V45, P721	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	3					1513	1519		10.1007/s00253-014-6070-3		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CA2YG	WOS:000348771400041		
J	Yoshino, T; Liang, Y; Arai, D; Maeda, Y; Honda, T; Muto, M; Kakunaka, N; Tanaka, T				Yoshino, Tomoko; Liang, Yue; Arai, Daichi; Maeda, Yoshiaki; Honda, Toru; Muto, Masaki; Kakunaka, Natsumi; Tanaka, Tsuyoshi			Alkane production by the marine cyanobacterium Synechococcus sp NKBG15041c possessing the alpha-olefin biosynthesis pathway	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Synechococcus sp; NKBG15041c; Alkane; alpha-Olefin; Acyl carrier protein (ACP) reductase; Aldehyde-deformylating oxygenase	SYNECHOCYSTIS-SP; FATTY-ACIDS; PCC 7002; GENE; SYSTEM; STRAIN; EXPRESSION; ALDEHYDES	The production of alkanes in a marine cyanobacterium possessing the alpha-olefin biosynthesis pathway was achieved by introducing an exogenous alkane biosynthesis pathway. Cyanobacterial hydrocarbons are synthesized via two separate pathways: the acyl-acyl carrier protein (ACP) reductase/aldehyde-deformylating oxygenase (AAR/ADO) pathway for the alkane biosynthesis and the alpha-olefin synthase (OLS) pathway for the alpha-olefin biosynthesis. Coexistence of these pathways has not yet been reported. In this study, the marine cyanobacterium Synechococcus sp. NKBG15041c was shown to produce alpha-olefins similar to those of Synechococcus sp. PCC7002 via the alpha-olefin biosynthesis pathway. The production of heptadecane in Synechococcus sp. NKBG15041c was achieved by expressing the AAR/ADO pathway genes from Synechococcus elongatus PCC 7942. The production yields of heptadecane in Synechococcus sp. NKBG15041c varied with the expression level of the aar and ado genes. The maximal yield of heptadecane was 4.2 +/- 1.2 mu g/g of dried cell weight in the transformant carrying a homologous promoter. Our results also suggested that the effective activation of ADO may be more important for the enhancement of alkane production by cyanobacteria.	[Yoshino, Tomoko; Liang, Yue; Arai, Daichi; Maeda, Yoshiaki; Honda, Toru; Muto, Masaki; Kakunaka, Natsumi; Tanaka, Tsuyoshi] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan; [Yoshino, Tomoko; Arai, Daichi] JST, CREST, Chiyoda Ku, Tokyo, Japan	Tanaka, T (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan.	tsuyo@cc.tuat.ac.jp	Yoshino, Tomoko/E-9066-2013; Maeda, Yoshiaki/H-9910-2013	Yoshino, Tomoko/0000-0002-4505-2774; Maeda, Yoshiaki/0000-0001-9206-2601	JST, CREST	This study was supported by JST, CREST.	Sakamoto T, 1997, FEMS MICROBIOL LETT, V152, P313, DOI 10.1016/S0378-1097(97)00217-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; Hu P, 2013, APPL ENERG, V102, P850, DOI 10.1016/j.apenergy.2012.08.047; MATSUNAGA T, 1995, J APPL PHYCOL, V7, P77, DOI 10.1007/BF00003555; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Hiroe A, 2012, APPL ENVIRON MICROB, V78, P3177, DOI 10.1128/AEM.07715-11; Knothe G, 2010, PROG ENERG COMBUST, V36, P364, DOI 10.1016/j.pecs.2009.11.004; Lennen RM, 2013, CURR OPIN BIOTECH, V24, P1044, DOI 10.1016/j.copbio.2013.02.028; Yu R, 2000, LIPIDS, V35, P1061, DOI 10.1007/s11745-000-0619-6; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Vidal R, 2009, J BACTERIOL, V191, P4383, DOI 10.1128/JB.00183-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Coates RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085140; Kaiser BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058307; Kloft N, 2005, MICROBIOL-SGM, V151, P1275, DOI 10.1099/mic.0.27771-0; Liu AQ, 2013, APPL ENERG, V111, P383, DOI 10.1016/j.apenergy.2013.05.008; Ruffing Anne M, 2011, Bioeng Bugs, V2, P136, DOI 10.4161/bbug.2.3.15285; SODE K, 1994, J BIOTECHNOL, V33, P243, DOI 10.1016/0168-1656(94)90072-8; SODE K, 1992, APPL MICROBIOL BIOT, V37, P369, DOI 10.1007/BF00210994; Sode K, 1998, J MAR BIOTECHNOL, V6, P174; Wang WH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-69; Wilmotte A, 2001, BERGEYS MANUAL SYSTE; Yoshino T, 2013, GENOME ANNOUNCEMENTS, V1, DOI DOI 10.1128/GENOMEA.00954-13; Zhang JJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-86	28	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	FEB	2015	99	3					1521	1529		10.1007/s00253-014-6286-2		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CA2YG	WOS:000348771400042		
J	Hamano, K; Miyoshi, T; Aue-umneoy, D; Srisapoome, P; Maeno, Y; Tsutsui, I				Hamano, K.; Miyoshi, T.; Aue-umneoy, D.; Srisapoome, P.; Maeno, Y.; Tsutsui, I.			Waterborne and cannibalism-mediated transmission of the Yellow head virus in Penaeus monodon	AQUACULTURE			English	Article						Yellow head virus; Penaeus monodon; Closed system; Infection; Waterborne; Cannibalism	SPOT SYNDROME VIRUS; BACULO-LIKE VIRUS; EXPERIMENTAL-INFECTION; LITOPENAEUS-VANNAMEI; COMMODITY SHRIMP; TAURA SYNDROME; YHV INFECTION; DISEASE; STYLIROSTRIS; THAILAND	Disease outbreaks caused by yellow head virus (YHV) can result in significant economic losses for shrimp aquaculture; however, little is known about how YHV is transmitted. Here we evaluate the role of direct and indirect contact with YHV among Penaeus monodon. One in 3 specimens released into 5 experimental tanks was inoculated with the virus, and 100 mu m-filtered water from each tank was allowed to circulate through another tank containing an additional set of 3 naive P. monodon. All of the injected shrimps died within 4 d; 9 of the 10 shrimps cohabitating with them died within 10 d. Only 5 of the 15 shrimps in the water-exposed tanks died within 14 d. As determined by RT-nested PCR, YHV infection was also lower among shrimp exposed to water. To assess the potential of moribund shrimp to transmit disease, gill samples from individuals inoculated with YHV at either 12 h or 24 h after the onset of the first obvious signs of morbidity were injected into naive P. monodon housed in individual tanks. Over a 30-d period following inoculation, the mortality rate was higher among shrimps injected with 12 h gill extracts than in those injected with 24 h gill extracts. Taken together, these data suggest that cannibalism of moribund shrimps presents a far greater potential to transmit the yellow head disease than does water exposure alone. Removing moribund shrimps as soon as morbidity becomes evident could represent an efficient measure to reduce YHV transmission and disease outbreaks. (C) 2014 Elsevier B.V. All rights reserved.	[Hamano, K.; Miyoshi, T.] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Res Ctr Marine Invertebrates, Onomichi, Hiroshima 7220061, Japan; [Aue-umneoy, D.; Tsutsui, I.] King Mongkuts Inst Technol Ladkrabang, Fac Agr Technol, Bangkok 10520, Thailand; [Srisapoome, P.] Kasetsart Univ, Fac Fisheries, Bangkok 10900, Thailand; [Maeno, Y.; Tsutsui, I.] Japan Int Res Ctr Agr Sci, Div Fisheries, Tsukuba, Ibaraki 3058686, Japan	Tsutsui, I (reprint author), Japan Int Res Ctr Agr Sci, Div Fisheries, 1-1 Owashi, Tsukuba, Ibaraki 3058686, Japan.	cong@affrc.go.jp			JSPS	This research was undertaken as part of a project titled "Development of Aquaculture Technologies for Suitable and Equitable Production of Aquatic Products in Tropical Coastal Areas" and was partly supported by aid grants from JSPS. We wish to thank Ms Pannee Panyawattanaporn at the National Research Council of Thailand (NRCT) for her constructive advice and staff at the Samutsongkhram Fisheries Station, Kasetsart University.	Lightner DV, 1998, J AQUAT ANIM HEALTH, V10, P271, DOI 10.1577/1548-8667(1998)010<0271:EIOWHP>2.0.CO;2; Stentiford GD, 2009, AQUACULTURE, V291, P1, DOI 10.1016/j.aquaculture.2009.02.042; CHANTANACHOOKIN C, 1993, DIS AQUAT ORGAN, V17, P145, DOI 10.3354/dao017145; BOONYARATPALIN S, 1993, FISH PATHOL, V28, P103; Small HJ, 2011, J INVERTEBR PATHOL, V106, P153, DOI 10.1016/j.jip.2010.09.016; Senapin S, 2010, J FISH DIS, V33, P421, DOI 10.1111/j.1365-2761.2009.01135.x; Nunan LM, 1998, AQUACULTURE, V160, P19, DOI 10.1016/S0044-8486(97)00222-6; Flegel TW, 1997, WORLD J MICROB BIOT, V13, P433, DOI 10.1023/A:1018580301578; Longyant S, 2006, AQUACULTURE, V257, P83, DOI 10.1016/j.aquaculture.2005.07.043; Walker PJ, 2009, REV AQUACULT, V1, P125, DOI 10.1111/j.1753-5131.2009.01007.x; Longyant S, 2005, DIS AQUAT ORGAN, V64, P5, DOI 10.3354/dao064005; Aranguren LF, 2012, DIS AQUAT ORGAN, V98, P185, DOI 10.3354/dao02448; Castro-Longoria R, 2008, J FISH DIS, V31, P953, DOI 10.1111/j.1365-2761.2008.00978.x; de la Rosa-Velez J, 2006, J FISH DIS, V29, P717, DOI 10.1111/j.1365-2761.2006.00767.x; Durand SV, 2000, J AQUAT ANIM HEALTH, V12, P128, DOI 10.1577/1548-8667(200006)012<0128:FCSPAF>2.0.CO;2; Esparza-Leal HM, 2009, AQUACULTURE, V292, P16, DOI 10.1016/j.aquaculture.2009.03.021; FAO, 2010, FISH STAT SUMM; Flegel T.W., 1995, DIS ASIAN AQUACULTUR, P65; Flegel TW, 1995, SWIMMING THROUGH TROUBLED WATER, P76; Hasson KW, 2006, DIS AQUAT ORGAN, V71, P91, DOI 10.3354/dao071091; Kasai C, 2005, FISHERIES SCI, V71, P791, DOI 10.1111/j.1444-2906.2005.01029.x; LU Y, 1994, J FISH DIS, V17, P649, DOI 10.1111/j.1365-2761.1994.tb00263.x; Ma HW, 2008, AQUACULTURE, V278, P10, DOI 10.1016/j.aquaculture.2008.03.028; Ma HW, 2009, J INVERTEBR PATHOL, V101, P112, DOI 10.1016/j.jip.2009.04.002; McColl K, 2004, AUST VET J, V82, P69, DOI 10.1111/j.1751-0813.2004.tb14647.x; Navarro-Nava F, 2011, J FISH DIS, V34, P327, DOI 10.1111/j.1365-2761.2011.01236.x; Walker P.J., 2008, ENCY VIROLOGY, P476; Wu JL, 2002, FISH SHELLFISH IMMUN, V13, P391, DOI 10.1006/fsim.2002.0414; Wyban J., 2007, GLOBAL AQUACULTU MAY	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0044-8486	1873-5622		AQUACULTURE	Aquaculture	FEB 1	2015	437						161	166		10.1016/j.aquaculture.2014.11.038		6	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CA2LN	WOS:000348740100020		
J	Iwai, T; Takahashi, M; Ido, A; Miura, C; Miura, T				Iwai, Toshiharu; Takahashi, Masaharu; Ido, Atsushi; Miura, Chiemi; Miura, Takeshi			Effect of gender on Akoya pearl quality	AQUACULTURE			English	Article						Pearl oyster culture; Pinctada fucata; Gonad; Sex; Vitellogenesis	OYSTER PINCTADA-FUCATA; GENOME; MANTLE; GENES; COLOR	During the cultivation of pearls, a mantle piece and pearl nucleus are transplanted into a recipient Akoya pearl oyster (Pinctada fucata). The gonad has been the area of transplantation since pearl culture techniques were originally developed. Transplantation into gonads without germ cells is vital for the production of high-quality pearls. Almost all pearl cultivators thus perform forced elimination of the germ cells from the gonads before transplantation. However, little attention has been paid to the sex of the pearl oyster, even though the gonad state is vital for the production of high-quality pearls. In our present study, we investigated the relationship between the sex of the recipient Akoya pearl oyster and pearl quality. We found that the rate of production of commercially valuable pearls was higher for male than for female recipient oysters. Furthermore, the nacre in male recipient oysters grew evenly everymonth whereas it was added less uniformly in female recipient oysters. Nacre growth in female pearl oysters was found to be related to ovarian development. These results indicate that differences exist in the pearl formation ability of male and female Akoya pearl oysters. By understanding the relationship between the sex of Akoya pearl oysters and pearl quality, high-quality pearls could be cultivated with better efficiency. (C) 2014 Elsevier B.V. All rights reserved.	[Iwai, Toshiharu; Ido, Atsushi; Miura, Chiemi; Miura, Takeshi] Ehime Univ, South Ehime Fisheries Res Ctr, Ainan, Ehime 7984292, Japan; [Takahashi, Masaharu] Shimonada Fisheries Cooperat, Pearl Oyster Res Lab, Uwajima, Ehime 7983344, Japan	Miura, T (reprint author), 1289-1 Funakoshi, Ainan, Ehime 7984292, Japan.	miutake@agr.ehime-u.ac.jp			Science and technology research promotion program for agriculture, forestry, fisheries and food industry [26019A]	This study was supported by a Grant-in-Aid from the Science and technology research promotion program for agriculture, forestry, fisheries and food industry (26019A).	Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Wada KT, 1996, AQUACULTURE, V142, P25, DOI 10.1016/0044-8486(95)01242-7; Inoue N, 2011, ZOOL SCI, V28, P32, DOI 10.2108/zsj.28.32; Helm D., 1991, MICROBIOLOGY, V137, P69; Inoue N, 2011, MAR BIOTECHNOL, V13, P474, DOI 10.1007/s10126-010-9318-7; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Ju MJ, 2010, OPT EXPRESS, V18, P13468, DOI 10.1364/OE.18.013468; Matsumoto T, 2013, ZOOL SCI, V30, P826, DOI 10.2108/zsj.30.826; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052372; Southgate PC, 2008, PEARL OYSTER, P1; Tateishi S., 1957, B FACULTY FISHERIES, V5, P75; Toyota T, 2013, OPT REV, V20, P50, DOI 10.1007/s10043-013-0009-2; Uemoto H., 1958, B NATL PEARL RES LAB, V4, P287; Wada K., 1999, SCI PEARL OYSTER; Wada Katsuhiko T., 1991, P245; Wang N, 2012, MAR BIOTECHNOL, V14, P177, DOI 10.1007/s10126-011-9400-9; Watabe S, 2013, ZOOL SCI, V30, P781, DOI 10.2108/zsj.30.781	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0044-8486	1873-5622		AQUACULTURE	Aquaculture	FEB 1	2015	437						333	338		10.1016/j.aquaculture.2014.12.028		6	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CA2LN	WOS:000348740100044		
J	Goto, T; Hirazawa, N; Takaishi, Y; Kashiwada, Y				Goto, Tsuyoshi; Hirazawa, Noritaka; Takaishi, Yoshihisa; Kashiwada, Yoshiki			Antiparasitic effect of matrine and oxymatrine (quinolizidine alkaloids) on the ciliate Cryptocaryon irritans in the red sea bream Pagrus major	AQUACULTURE			English	Article						Cryptocaryon irritans; Sophora flavescens; Matrine; Oxymatrine	SOPHORA-FLAVESCENS; CELLS	The antiparasitic effect of matrine and oxymatrine, the main alkaloidal constituents of the roots of Sophora flavescens, on Cryptocaryon irritans in vitro and in vivo was investigated. Matrine and oxymatrine completely stopped all ciliary movements of C. irritans theronts in vitro. In vivo trials were first conducted with uninfected red sea bream, Pagrus major fed a commercial pellet feed modified to contain matrine or oxymatrine (0.1 or 0.5 g . kg(-1)). The doses were determined by HPLC analysis of the water extract of the S. flavescens roots used in our study. After seven days on the experimental test feed, approximately 50,000 hatched theronts were added to each tank, and the fish were maintained on the experimental feed for three additional days. The matrine-treated feed demonstrated potent anti-C. irritans activity, with the number of parasites reduced by 58% in the 0.5 g . kg(-1) of matrine-fed group. The oxymatrine-treated feed also showed weaker anti-C. irritans activity compared tomatrine. Therefore, the main anti-C. irritans activity of thewater extract of S. flavescenswas considered to be due to matrine. In an 80-day oral challenge trial with P. major, the fish in the group treated with matrine (0.5 g . kg(-1) feed) survived throughout the experimental period against the infestations of C. irritans, which contrasts with the 100% mortality seen in the control group. Furthermore, the number of parasites in the group treated with matrine was reduced by 35% as compared to the control group when C. irritans infected fish fed matrine-treated feed (0.5 g . kg(-1)) for 3 days. These results suggested that matrine could be a useful therapeutic agent against the infestations of C. irritans. (C) 2014 Elsevier B.V. All rights reserved.	[Goto, Tsuyoshi; Hirazawa, Noritaka] Nippon Suisan Kaisha Ltd, Tokyo Innovat Ctr, Cent Res Lab, Hachioji, Tokyo 1920906, Japan; [Takaishi, Yoshihisa; Kashiwada, Yoshiki] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan	Goto, T (reprint author), Nippon Suisan Kaisha Ltd, Tokyo Innovat Ctr, Cent Res Lab, 32-3 Nanakuni 1 Chome, Hachioji, Tokyo 1920906, Japan.	tsuyoshi@nissui.co.jp					Partridge GJ, 2014, DIS AQUAT ORGAN, V109, P155, DOI 10.3354/dao02740; Chen F, 2012, PARASITOL RES, V111, P1827, DOI 10.1007/s00436-012-3030-7; Yang YJ, 2012, MOLECULES, V17, P10370, DOI 10.3390/molecules170910370; Kang TH, 2000, J NAT PROD, V63, P680, DOI 10.1021/np990567x; Aoki H., 1997, SUISANZOSHOKU, V45, P131; Balasubramanian R., 2014, AQUACULT RE IN PRESS; Brown E.M, 1951, P ZOOL SOC LOND, V11, P1; CHO CH, 1986, PLANTA MED, P343; CHUANG CY, 1987, J OCUL PHARMACOL, V3, P129, DOI 10.1089/jop.1987.3.129; Goto T, 2015, AQUACULTURE, V435, P173, DOI 10.1016/j.aquaculture.2014.09.007; Hirayama Fusayoshi, 1995, Natural Medicines, V49, P317; Hirazawa N, 2001, AQUACULTURE, V198, P219, DOI 10.1016/S0044-8486(01)00503-8; Hirazawa N., 2013, AQUACULTURE, V404-405, P169; Hirazawa N, 2003, AQUACULTURE, V223, P1, DOI 10.1016/S0044-8486(03)00167-4; Li X.L., 2011, PARASITOL RES, V108, P247; Liu XS, 2006, PLANTA MED, V72, P501, DOI 10.1055/s-2006-931534; Long Yao, 2004, Hepatobiliary Pancreat Dis Int, V3, P69; Matsuoka S., 1995, SUISANZOSHOKU, V43, P535; Ryu Shi Yong, 1995, Archives of Pharmacal Research (Seoul), V18, P41, DOI 10.1007/BF02976506; Shao J, 2014, J APPL MICROBIOL, V117, P618, DOI 10.1111/jam.12555; Takagi S., 1999, SUISANZOSHOKU, V47, P77; Tang W., 1992, CHINESE DRUGS PLANT, P931; YAGI A, 1989, Shoyakugaku Zasshi, V43, P343; Yoshinaga T., 1994, Journal of Aquatic Animal Health, V6, P197, DOI 10.1577/1548-8667(1994)006<0197:LPOCIO>2.3.CO;2; Yoshinaga T., 1998, KAIYO MON, V14, P73	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0044-8486	1873-5622		AQUACULTURE	Aquaculture	FEB 1	2015	437						339	343		10.1016/j.aquaculture.2014.12.026		5	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CA2LN	WOS:000348740100045		
J	Buen-Ursua, SMA; Azuma, T; Arai, K; Coloso, RM				Buen-Ursua, Shelah Mae A.; Azuma, Teruo; Arai, Katsutoshi; Coloso, Relicardo M.			Improved reproductive performance of tiger tail seahorse, Hippocampus comes, by mysid shrimp fed singly or in combination with other natural food	AQUACULTURE INTERNATIONAL			English	Article						Brood size; Endangered species; Parturition frequency; Seed production; Stock enhancement	EMBRYONIC-DEVELOPMENT; KUDA BLEEKER; LIVE FOOD; GROWTH; SURVIVAL; QUALITY; FISH; SEA; ABDOMINALIS; ARTEMIA	The brood size, parturition frequency and parturition occurrence of tiger tail seahorse, Hippocampus comes were evaluated for 180 days using single and combined diets comprising Artemia salina, mysid shrimp Mesopodopsis orientalis and frozen Acetes sp. The daily food intake of seahorse was determined with the following treatments: T1-Artemia; T2-mysid; T3-Acetes; T4-Artemia + mysid; T5-Artemia + Acetes; T6-mysid + Acetes; and T7-Artemia + mysid + Acetes. Percent body weight (% BW) of daily food intake until satiation was similar in Artemia, mysid and Artemia + Acetes (20-22 %), but significantly higher in mysid + Acetes, Artemia + mysid, and Artemia + mysid + Acetes with 25, 31 and 33 %, respectively (p < 0.05). Single diet of frozen Acetes was least consumed at 6 %. Thus, mysid was the preferred food of adult seahorses as a single or combined diet with Artemia and Acetes. Diet treatments with single mysid or combined with Artemia and Acetes have significantly higher brood size (223-292) than the other treatments (107-152) (p < 0.05). Significantly longer parturition interval (60 days) was observed in seahorses fed with Artemia than those fed with mysid or in combination with other natural food (13-26 days), but not significantly different to seahorses fed with Acetes and Artemia + Acetes (42-45 days). Parturition occurrence in seahorse fed with Artemia, Acetes and Artemia + Acetes (2.7-4.3) were the lowest, while Artemia + mysid and Artemia + mysid + Acetes have significantly higher occurrence followed by mysids + Acetes and mysid only (p < 0.05). Thus, the reproductive performance was improved when seahorses were fed with single or combined foods including mysid. Total lipid was positively correlated to brood size and parturition occurrence, while DHA:EPA ratio was negatively correlated to brood size and parturition occurrence.	[Buen-Ursua, Shelah Mae A.; Azuma, Teruo; Coloso, Relicardo M.] Southeast Asian Fisheries Dev Ctr, Aquaculture Dept SEAFDEC AQD, Iloilo 5021, Philippines; [Arai, Katsutoshi] Hokkaido Univ, Grad Sch Fisheries Sci, Minato Ku, Hakodate, Hokkaido 0418611, Japan	Buen-Ursua, SMA (reprint author), Southeast Asian Fisheries Dev Ctr, Aquaculture Dept SEAFDEC AQD, Iloilo 5021, Philippines.	smbuen@seafdec.org.ph			Government of Japan Trust Fund (GOJ-TF) [5029-TRD-Br0710]; Asia-Africa Science Platform (AASP) Program from Japan Society for the Promotion of Science (JSPS); RONPAKU (Dissertation PhD) Program from Japan Society for the Promotion of Science (JSPS) [DOST-11322]	This study was funded by the Government of Japan Trust Fund (GOJ-TF) for Stock Enhancement Program entitled "Resource Enhancement of Internationally Threatened and Over-Exploited Species in Southeast Asia through Stock Release'' (Budget code 5029-TRD-Br0710). This study was also supported in part by Asia-Africa Science Platform (AASP) Program(2011-2013 FY) and RONPAKU (Dissertation PhD) Program (2013-2015 FY, DOST-11322) from Japan Society for the Promotion of Science (JSPS). The authors wish to thank Charlemagne Recente, Rod Salvador Tibubos and Arnel Abaricio in SEAFDEC/AQD for their assistance in the maintenance of seahorses. We also thank Rose Margaret Albacete for the proximate analysis of natural food and Jilla Alcalde Tornalejo for the fatty acid analysis of seahorse.	Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; Payne MF, 2000, AQUACULTURE, V188, P353, DOI 10.1016/S0044-8486(00)00349-5; Otero-Ferrer F, 2012, J WORLD AQUACULT SOC, V43, P174, DOI 10.1111/j.1749-7345.2012.00550.x; Job SD, 2002, AQUACULTURE, V214, P333, DOI 10.1016/S0044-8486(02)00063-7; Woods CMC, 2005, AQUACULT INT, V13, P305, DOI 10.1007/s10499-004-3100-7; Izquierdo MS, 1996, AQUACULT NUTR, V2, P183, DOI 10.1111/j.1365-2095.1996.tb00058.x; Lin Q, 2008, AQUACULTURE, V277, P287, DOI 10.1016/j.aquaculture.2008.02.030; CERDA J, 1994, AQUACULTURE, V128, P345, DOI 10.1016/0044-8486(94)90322-0; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; Kendrick AJ, 2005, ENVIRON BIOL FISH, V72, P415, DOI 10.1007/s10641-004-2597-y; Olivotto I, 2008, AQUACULTURE, V283, P92, DOI 10.1016/j.aquaculture.2008.06.018; Murugan A, 2009, AQUACULTURE, V290, P87, DOI 10.1016/j.aquaculture.2009.01.033; Woods CMC, 2003, AQUAC RES, V34, P757, DOI 10.1046/j.1365-2109.2003.00882.x; Koldewey HJ, 2010, AQUACULTURE, V302, P131, DOI 10.1016/j.aquaculture.2009.11.010; Kitsos MS, 2008, J FISH BIOL, V72, P1259, DOI 10.1111/j.1095-8649.2007.01789.x; Azuma T, 2012, SE ASIAN STATE FISHE, P46; Buen-Ursua SMA, 2011, ISR J AQUACULT-BAMID, V63, P1; DURAY M, 1994, PHILIPP SCI, V31, P42; Dzyuba B, 2006, J EXP BIOL, V209, P3055, DOI 10.1242/jeb.02336; Eusebio PS, 2010, AQUACULTURE, V306, P289, DOI 10.1016/j.aquaculture.2010.05.004; FERNANDEZPALACIOS H, 1995, AQUACULTURE, V132, P325, DOI 10.1016/0044-8486(94)00345-O; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia LMB, 2010, ISR J AQUACULT-BAMID, V62, P122; Hamre K, 2005, AQUACULTURE, V250, P555, DOI 10.1016/j.aquaculture.2005.01.016; Helrich K., 1995, OFFICIAL METHODS ANA; HOSSAIN MA, 1989, NIPPON SUISAN GAKK, V55, P87; Job S, 2006, J WORLD AQUACULT SOC, V37, P322, DOI 10.1111/j.1749-7345.2006.00044.x; Lin Q, 2007, AQUACULTURE, V262, P481, DOI 10.1016/j.aquaculture.2006.11.011; Lin Q, 2006, AQUACULTURE, V254, P701, DOI 10.1016/j.aquaculture.2005.11.005; Lourie SA, 2004, GUIDE IDENTIFICATION; Palma J, 2012, J WORLD AQUACULT SOC, V43, P802, DOI 10.1111/j.1749-7345.2012.00611.x; Palma J, 2014, FISH PHYSIOL BIOCHEM, V40, P739, DOI 10.1007/s10695-013-9881-8; Storero LP, 2009, J WORLD AQUACULT SOC, V40, P394, DOI 10.1111/j.1749-7345.2009.00259.x; Teixeira R.L., 2001, Revista Brasileira de Biologia, V61, P79, DOI 10.1590/S0034-71082001000100011; Vincent Amanda C.J., 2006, P71; Vincent A.C.J., 1996, INT TRADE SEAHORSES, P163; Vite-Garcia N, 2014, LAT AM J AQUAT RES, V42, P150, DOI 10.3856/vol42-issue1-fulltext-12; WATANABE T, 1983, AQUACULTURE, V34, P115, DOI 10.1016/0044-8486(83)90296-X; WATANABE T, 1984, Nippon Suisan Gakkaishi, V50, P1023; Willadino L, 2012, AQUACULTURE, V360, P10, DOI 10.1016/j.aquaculture.2012.06.025; Woods CMC, 2002, NEW ZEAL J MAR FRESH, V36, P655	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-6120	1573-143X		AQUACULT INT	Aquac. Int.	FEB	2015	23	1					29	43		10.1007/s10499-014-9795-1		15	Fisheries	Fisheries	AZ9MF	WOS:000348538200003		
J	Dan, S; Hamasaki, K				Dan, Shigeki; Hamasaki, Katsuyuki			Evaluation of the effects of probiotics in controlling bacterial necrosis symptoms in larvae of the mud crab Scylla serrata during mass seed production	AQUACULTURE INTERNATIONAL			English	Article						Bacterial disease; Biocontrol; Commercial-scale seed production; Extracellular factors; Mass mortality; Mud crab; Scylla serrata	PORTUNUS-TRITUBERCULATUS; TENACIBACULUM-MARITIMUM; BRACHIONUS-PLICATILIS; FEEDING SCHEDULE; FISH LARVAE; MARINE FISH; AQUACULTURE; SURVIVAL; DENSITY; LARVICULTURE	We aimed to evaluate the practicability of probiotics in controlling larval necrosis symptoms and mass mortality occurred during seed production of the mud crab Scylla serrata. We targeted a bacterium in the family Flavobacteriaceae that causes necrosis symptoms of mud crab larvae. Five candidate probiotic bacterial strains, which showed inhibitory effects against the causative bacterium but were innocuous to larvae, were screened from the seed production environment. Sterile culture medium supernatants of the candidate strains inhibited the causative bacterium through the secretion of extracellular factors. These inhibitory effects were largely reduced when the strains were inoculated into sea water, suggesting medium-dependent production of inhibitory factors. The strain that exhibited the highest inhibitory effect on larval necrosis in 7-day larval rearing experiments was selected as a probiotic strain. In large-scale larval rearing experiments, the probiotic treatment significantly suppressed larval necrosis symptoms and improved larval survival in the early rearing period until the fourth zoeal stage. However, the effect disappeared after the fifth (last) zoeal stage, corresponding to a decrease in inoculated probiotic bacterial counts in the larval rearing water. Almost all larvae had died by the first crab stage. The effectiveness of probiotics developed in vitro has not yet proved practical in commercial-scale seed production. The continuous proliferation of probiotic bacteria and extracellular production as inhibitory factors in larval rearing water are the key factors in developing probiotics for commercial-scale seed production.	[Dan, Shigeki] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Tamano Lab, Tamano, Okayama 7060002, Japan; [Hamasaki, Katsuyuki] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Konan, Tokyo 1088477, Japan	Hamasaki, K (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Konan, Tokyo 1088477, Japan.	hamak@kaiyodai.ac.jp	HAMASAKI, Katsuyuki/O-1946-2014				Wang GZ, 2005, AQUACULT INT, V13, P459, DOI 10.1007/s10499-005-1887-5; Irianto A, 2002, J FISH DIS, V25, P633, DOI 10.1046/j.1365-2761.2002.00422.x; Baylon JC, 2009, AQUACULTURE, V288, P190, DOI 10.1016/j.aquaculture.2008.11.028; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Olafsen JA, 2001, AQUACULTURE, V200, P223, DOI 10.1016/S0044-8486(01)00702-5; Dan S, 2011, AQUACULT INT, V19, P323, DOI 10.1007/s10499-010-9374-z; Suprayudi MA, 2004, AQUACULTURE, V231, P403, DOI 10.1016/S0044-8486(03)00542-8; Maeda M, 1997, HYDROBIOLOGIA, V358, P285, DOI 10.1023/A:1003126129709; Suzuki M, 2001, INT J SYST EVOL MICR, V51, P1639; Alderman DJ, 1998, INT J FOOD SCI TECH, V33, P139, DOI 10.1046/j.1365-2621.1998.3320139.x; Villamil L, 2010, AQUACULTURE, V307, P83, DOI 10.1016/j.aquaculture.2010.07.004; Huys L, 2001, AQUACULTURE, V193, P25, DOI 10.1016/S0044-8486(00)00474-9; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0; Verdonck L, 1997, AQUACULTURE, V149, P203, DOI 10.1016/S0044-8486(96)01451-2; Hamasaki K, 2011, AQUACULT INT, V19, P217, DOI 10.1007/s10499-010-9387-7; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Gomez-Gil B, 2000, AQUACULTURE, V191, P259, DOI 10.1016/S0044-8486(00)00431-2; Kogane T, 2007, FISHERIES SCI, V73, P851, DOI 10.1111/j.1444-2906.2007.01406.x; Hamasaki K, 2003, AQUACULTURE, V219, P561, DOI 10.1016/S0044-8486(02)00662-2; PYBUS V, 1994, J FISH DIS, V17, P311, DOI 10.1111/j.1365-2761.1994.tb00227.x; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Hamasaki K, 2002, FISHERIES SCI, V68, P1226, DOI 10.1046/j.1444-2906.2002.00559.x; BRICK RW, 1974, AQUACULTURE, V3, P231, DOI 10.1016/0044-8486(74)90074-X; Huys G, 2007, RES MICROBIOL, V158, P228, DOI 10.1016/j.resmic.2006.12.011; NICOLAS JL, 1989, AQUACULTURE, V83, P237, DOI 10.1016/0044-8486(89)90036-7; NOGAMI K, 1992, CAN J FISH AQUAT SCI, V49, P2373; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Lebata MJHL, 2009, MAR FRESHWATER RES, V60, P58, DOI 10.1071/MF08155; Kesarcodi-Watson A, 2012, AQUACULTURE, V344, P29, DOI 10.1016/j.aquaculture.2012.02.029; Luis-Villasenor IE, 2011, AQUACULTURE, V321, P136, DOI 10.1016/j.aquaculture.2011.08.036; Nakase G, 2007, FISHERIES SCI, V73, P784, DOI 10.1111/j.1444-2906.2007.01397.x; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Davis JA, 2005, AQUACULT INT, V13, P187, DOI 10.1007/s10499-004-1496-8; Suprayudi MA, 2002, FISHERIES SCI, V68, P1295, DOI 10.1046/j.1444-2906.2002.00567.x; VANDENBERGH PA, 1993, FEMS MICROBIOL REV, V12, P221, DOI 10.1016/0168-6445(93)90065-H; Nogami K, 1997, HYDROBIOLOGIA, V358, P291, DOI 10.1023/A:1003149306511; Schmidt AS, 2000, APPL ENVIRON MICROB, V66, P4908, DOI 10.1128/AEM.66.11.4908-4915.2000; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Atlas R. M., 1997, MICROBIAL ECOLOGY FU; Avendano-Herrera R, 2006, DIS AQUAT ORGAN, V71, P255, DOI 10.3354/dao071255; Barrow G. I., 1993, COWAN STEELS MANUAL; Bates D., 2012, LME4 LINEAR MIXED EF; D'Alvise PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043996; Debach P., 1991, BIOL CONTROL NATURAL; Everitt BS, 2005, R S PLUS COMPANION M; Everitt BS, 2009, HDB STAT ANAL USING; Fox J, 2011, R COMPANION APPL REG; Keenan Clive P., 1999, ACIAR Proceedings, V78, P48; Keenan CP, 1999, ACIAR P, P9; Kiyota K, 1997, STOCK ENHANCEMENT SE, V3, P105; Krieg NR, 1984, BERGEYS MANUAL SYSTE, V1; LeVay L, 2008, REV FISH SCI, V16, P78; Mayr-Harting A, 1972, METHODS MICROBIOLO A, V7, P315, DOI 10.1016/S0580-9517(08)70618-4; Muroga K, 2001, AQUACULTURE, V202, P23, DOI 10.1016/S0044-8486(01)00597-X; Nelder J., 1989, GEN LINEAR MODELS; Nghia TT, 2007, AQUAC RES, V38, P1539, DOI 10.1111/j.1365-2109.2007.01814.x; Preetha R, 2006, J APPL MICROBIOL, V102, P1043; R Development Core Team, 2013, R LANG ENV STAT COMP; Ruscoe IM, 2004, AQUACULTURE, V231, P517, DOI 10.1016/j.aquaculture.2003.11.021; Starliper CE, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P606, DOI 10.1079/9781845935542.0606; Suprayudi MA, 2002, AQUACULT SCI, V50, P205; Tomoda T, 2011, FISHERIES SCI, V77, P1015, DOI 10.1007/s12562-011-0412-1; WILLIAMS ST, 1986, MICROBIAL ECOL, V12, P43, DOI 10.1007/BF02153221; Yoshimura K, 1997, HYDROBIOLOGIA, V358, P139, DOI 10.1023/A:1003169414996; Zuur A., 2009, MIXED EFFECTS MODELS	65	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-6120	1573-143X		AQUACULT INT	Aquac. Int.	FEB	2015	23	1					277	296		10.1007/s10499-014-9815-1		20	Fisheries	Fisheries	AZ9MF	WOS:000348538200022		
J	Chaweepack, T; Chaweepack, S; Muenthaisong, B; Ruangpan, L; Nagata, K; Kamei, K				Chaweepack, Tidaporn; Chaweepack, Surachart; Muenthaisong, Boonyee; Ruangpan, Lila; Nagata, Kei; Kamei, Kaeko			Effect of galangal (Alpinia galanga Linn.) extract on the expression of immune-related genes and Vibrio harveyi resistance in Pacific white shrimp (Litopenaeus vannamei)	AQUACULTURE INTERNATIONAL			English	Article						Galangal (Alpinia galanga Linn.); Trans-p-coumaryl diacetate; Litopenaeus vannamei; Immunity; Vibrio	BLACK TIGER SHRIMP; PENAEUS-MONODON; PACIFASTACUS-LENIUSCULUS; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL ACTIVITY; DISEASE RESISTANCE; INFECTION; ALGINOLYTICUS; HEMOCYTES; LYSOZYME	Some plant and herb extracts reportedly possess antimicrobial activities and also have the ability to enhance the nonspecific immune system of shrimp, thereby promoting disease resistance. In this study, a natural herb, galangal (Alpinia galanga Linn.), was used to prevent infectious disease in cultured shrimp, and the effects of galangal-ethanol extract on the expression of the immune-related genes in the shrimp were analyzed via a reverse-transcription polymerase chain reaction of mRNA in circulating hemocytes. Following the intramuscular injection of either galangal extract or trans-p-coumaryl diacetate that had been isolated from galangal rhizome, Pacific white shrimp (Litopenaeus vannamei) showed significant increases in the relative expression ratio of the six immune-related genes compared with a control group. Furthermore, following the oral administration of galangal extract, similar inducible effects of the expression of immune-related genes in the Pacific white shrimp were obtained, which led to an enhanced survival rate from Vibrio harveyi infection. Thus, this study revealed that both galangal extract and trans-p-coumaryl diacetate stimulated the immune system response, thereby promoting resistance to V. harveyi infection in Pacific white shrimp.	[Chaweepack, Tidaporn; Chaweepack, Surachart; Muenthaisong, Boonyee; Ruangpan, Lila] Chanthaburi Coastal Fisheries Res & Dev Ctr, Muang 22000, Chanthaburi, Thailand; [Nagata, Kei; Kamei, Kaeko] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Matsugasaki, Kyoto 6068585, Japan	Chaweepack, T (reprint author), Chanthaburi Coastal Fisheries Res & Dev Ctr, Mu 9, Muang 22000, Chanthaburi, Thailand.	tidaporn2513@gmail.com			Department of Fisheries, Agriculture Research Development Agency (ARDA); Ministry of Agriculture and Cooperatives, Thailand; Kyoto Institute of Technology (KIT), Japan	This research was supported by Department of Fisheries, Agriculture Research Development Agency (ARDA), Ministry of Agriculture and Cooperatives, Thailand, and Kyoto Institute of Technology (KIT), Japan.	Neves CA, 2000, DIS AQUAT ORGAN, V39, P155, DOI 10.3354/dao039155; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; Burge EJ, 2007, FISH SHELLFISH IMMUN, V22, P327, DOI 10.1016/j.fsi.2006.06.004; Tang KFJ, 2007, DIS AQUAT ORGAN, V74, P165; Hikima S, 2003, GENE, V316, P187, DOI 10.1016/S0378-1119(03)00761-3; Holmblad T, 1999, AQUACULTURE, V172, P111, DOI 10.1016/S0044-8486(98)00446-3; Nunan LM, 2011, J VIROL METHODS, V171, P318, DOI 10.1016/j.jviromet.2010.11.015; Ponprateep S, 2009, AQUACULTURE, V289, P219, DOI 10.1016/j.aquaculture.2009.01.026; Lo CF, 1997, DIS AQUAT ORGAN, V30, P53, DOI 10.3354/dao030053; Mayachiew P, 2008, LWT-FOOD SCI TECHNOL, V41, P1153, DOI 10.1016/j.lwt.2007.07.019; Wang YC, 2007, FISH SHELLFISH IMMUN, V23, P1161, DOI 10.1016/j.fsi.2007.04.004; Chang YP, 2012, FISH SHELLFISH IMMUN, V32, P284, DOI 10.1016/j.fsi.2011.11.017; Vargas-Albores F, 2004, COMP BIOCHEM PHYS B, V138, P415, DOI 10.1016/j.cbpc.2004.05.007; Vandenberghe J, 1999, APPL ENVIRON MICROB, V65, P2592; RUANGPAN L, 1991, J FISH DIS, V14, P383, DOI 10.1111/j.1365-2761.1991.tb00836.x; Harikrishnan R, 2011, AQUACULTURE, V317, P1, DOI 10.1016/j.aquaculture.2011.03.039; Shockey JE, 2009, DEV COMP IMMUNOL, V33, P668, DOI 10.1016/j.dci.2008.11.010; Citarasu T, 2006, FISH SHELLFISH IMMUN, V21, P372, DOI 10.1016/j.fsi.2006.01.002; Fagutao FE, 2012, FISH SHELLFISH IMMUN, V32, P711, DOI 10.1016/j.fsi.2012.01.018; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Destoumieux D, 2000, J CELL SCI, V113, P461; de-la-Re-Vega E, 2006, FISH SHELLFISH IMMUN, V20, P405, DOI 10.1016/j.fsi.2005.06.005; Sung HH, 2001, AQUACULTURE, V192, P101, DOI 10.1016/S0044-8486(00)00458-0; Bendjeddou D, 2003, J ETHNOPHARMACOL, V88, P155, DOI 10.1016/S0378-8741(03)00226-5; Cheng W, 2005, FISH SHELLFISH IMMUN, V19, P375, DOI 10.1016/j.fsi.2005.03.002; Chudiwal A.K., 2010, INDIAN J NATURAL PRO, V2, P143; Colwell RR, 1984, VIBRIOS ENV; Cowley JA, 2004, J VIROL METHODS, V117, P49, DOI 10.1016/j.jviromet.2003.11.018; de Lorgeril J, 2005, PHYSIOL GENOMICS, V21, P174, DOI 10.1152/physiolgenomics.00281.2004; DEPOOTER HL, 1985, PHYTOCHEMISTRY, V24, P93, DOI 10.1016/S0031-9422(00)80814-6; Harikrishnan R, 2011, AQUACULTURE, V318, P67, DOI 10.1016/j.aquaculture.2011.05.024; Hsieh TJ, 2008, FISH SHELLFISH IMMUN, V25, P581, DOI 10.1016/j.fsi.2008.07.014; Jiravanichpaisal P, 2007, DEV COMP IMMUNOL, V31, P441, DOI 10.1016/j.dci.2006.08.002; Karunasagar ID, 2004, MARINE MICROBIOLOGY, P121; Lee SW, 2009, FRONT AGR CHINA, V3, P446; Lightner DV, 1993, HDB MARICULTURE CRUS, P455; Liu CH, 2006, FISH SHELLFISH IMMUN, V21, P442, DOI 10.1016/j.fsi.2006.02.003; Maia WJ, 2010, FISH SHELLFISH IMMUN, V28, P727; Min HJ, 2009, INT IMMUNOPHARMACOL, V9, P448, DOI 10.1016/j.intimp.2009.01.008; Montero AB, 1999, J FISH DIS, V22, P377, DOI 10.1046/j.1365-2761.1999.00189.x; Navarro SA, 2009, AQUACULTURE, V293, P290, DOI 10.1016/j.aquaculture.2009.05.003; Oonmetta-aree J, 2006, FOOD SCI TECHNOL, V39, P959; Rao K, 2010, APPL BIOCHEM BIOTECH, V162, P871, DOI 10.1007/s12010-009-8900-9; Ruangpan L, 1998, ADV SHRIMP BIOTECHNO, P205; SODERHALL K, 1984, BIOCHIM BIOPHYS ACTA, V797, P99, DOI 10.1016/0304-4165(84)90387-8; Somboonwiwat K, 2006, BIOCH MOL BIOL, V39, P26; Turker A, 2002, BIODIVERS ECOSYST, V34, P105; Yeh RY, 2009, FISH SHELLFISH IMMUN, V27, P26, DOI 10.1016/j.fsi.2008.11.008; Yu ES, 2009, BRIT J PHARMACOL, V156, P1107, DOI 10.1111/j.1476-5381.2009.00114.x	50	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-6120	1573-143X		AQUACULT INT	Aquac. Int.	FEB	2015	23	1					385	399		10.1007/s10499-014-9822-2		15	Fisheries	Fisheries	AZ9MF	WOS:000348538200029		
J	Abe, K; Giga, Y; Schade, K; Suzuki, T				Abe, Ken; Giga, Yoshikazu; Schade, Katharina; Suzuki, Takuya			On the Stokes semigroup in some non-Helmholtz domains	ARCHIV DER MATHEMATIK			English	Article						Sector-like domain; Helmholtz decomposition; Neumann problem; Weighted estimate	INFINITE-LAYER; OPERATOR; SPACES; ANALYTICITY	This paper shows that the L (p) -Helmholtz decomposition is not necessary to establish the analyticity of the Stokes semigroup in C (0,sigma) , the L (a)-closure of the space of all compactly supported smooth solenoidal vector fields. In fact, in a sector-like domain for which the L (p) -Helmholtz decomposition does not hold, the analyticity of the Stokes semigroup in C (0,sigma) is proved.	[Abe, Ken] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Giga, Yoshikazu; Suzuki, Takuya] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan; [Schade, Katharina] Tech Univ Darmstadt, Fachbereich Math, D-64298 Darmstadt, Germany	Abe, K (reprint author), Nagoya Univ, Grad Sch Math, Chikusa Ku, Furocho, Nagoya, Aichi 4648602, Japan.	abe.ken@math.nagoya-u.ac.jp; labgiga@ms.u-tokyo.ac.jp; schade@mathematik.tu-darmstadt.de; tsuzuki@ms.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); German Research Foundation through Japanese-German Graduate Externship; IRTG [1529]; JSPS [26220702, 23244015, 25610025]	This work was partly supported by the Japan Society for the Promotion of Science (JSPS) and the German Research Foundation through Japanese-German Graduate Externship and IRTG 1529. The work of Ken Abe is partly supported by JSPS as JSPS fellow. The work of Yoshikazu Giga is partly supported by JSPS through the Grants Kiban S (26220702), Kiban A (23244015) and Houga (25610025).	ABE K., STOKES RESO IN PRESS; ABE K., STOKES RESOLVE UNPUB; Abe T., 2003, J MATH FLUID MECH, V5, P245; Abels H, 2005, DIFFER INTEGRAL EQU, V18, P1081; Geissert M, 2012, J REINE ANGEW MATH, V669, P75, DOI 10.1515/CRELLE.2011.150; GIGA Y, 1981, MATH Z, V178, P297, DOI 10.1007/BF01214869; Abe T, 2003, J MATH SOC JPN, V55, P469, DOI 10.2969/jmsj/1191419127; Abe K, 2014, J EVOL EQU, V14, P1, DOI 10.1007/s00028-013-0197-z; Abe K, 2013, ACTA MATH-DJURSHOLM, V211, P1, DOI 10.1007/s11511-013-0098-6; Evans L. C., 2010, PARTIAL DIFFERENTIAL; Farwig R, 2008, J MATH FLUID MECH, V10, P352, DOI 10.1007/s00021-006-0235-5; Galdi GP, 2011, SPRINGER MONOGR MATH, P1, DOI 10.1007/978-0-387-09620-9; GIGA Y., 2006, MONOGRAPHS MATH, V99; Lions JL, 1962, ANN SCUOLA NORM SUP, V16, P1; MASLENNIKOVA V. N., 1986, REND SEM MAT FIS, V56, P125, DOI 10.1007/BF02925141; MERKER J., CALC VAR PD IN PRESS; Protter M. H., 1967, MAXIMUM PRINCIPLES D; Solonnikov V. A., 1977, J SOVIET MATH, V38, p[153, 467], DOI 10.1007/BF01084616; VON BELOW L., 2014, THESIS TU DARMSTADT	19	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0003-889X	1420-8938		ARCH MATH	Arch. Math.	FEB	2015	104	2					177	187		10.1007/s00013-015-0729-6		11	Mathematics	Mathematics	CA9GL	WOS:000349229800008		
J	Momosaki, R; Yasunaga, H; Matsui, H; Horiguchi, H; Fushimi, K; Abo, M				Momosaki, Ryo; Yasunaga, Hideo; Matsui, Hiroki; Horiguchi, Hiromasa; Fushimi, Kiyohide; Abo, Masahiro			Effect of Early Rehabilitation by Physical Therapists on In-hospital Mortality After Aspiration Pneumonia in the Elderly	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Hospital mortality; Pneumonia; aspiration; Rehabilitation	RANDOMIZED CONTROLLED-TRIALS; ISCHEMIC-STROKE; METAANALYSIS; VARIABLES; OUTCOMES; DISEASE; COHORT; JAPAN; RISK; UNIT	Objective: To clarify the effect of early rehabilitation by physical therapists on in-hospital mortality among elderly patients with aspiration pneumonia. Design: A retrospective cohort study. Setting: A total of 1161 acute-care hospitals across Japan. Participants: Consecutive patients (age, 70-100y) (N=68,584) from July 2010 to March 2012 in the Combination inpatient database with aspiration pneumonia on admission who underwent early physical (n=16,835) and who did not undergo rehabilitation administered by physical therapists (n=51,749). Interventions: Early rehabilitation was defined as physical rehabilitation administered by a physical therapist, initiated within 3 days of admission, and undertaken for at least 7 days. Main Outcome Measure: Thirty-day in-hospital mortality. Results: The 30-day in-hospital mortality rates were 5.1% and 7.1% in the early rehabilitation group and the control group, respectively. The multivariable logistic regression model showed that the early rehabilitation group had a significantly lower in-hospital mortality rate (odds ratio, .71; 95% confidence interval [CI], .64-.79; P<.001). Among patients without severe pneumonia, we found no significant difference in mortality rates between patients who underwent early rehabilitation and those who did not undergo rehabilitation by physical therapists. The instrumental variable analysis confirmed that early rehabilitation was associated with a reduced risk for in-hospital mortality (risk difference, -1.9%; 95% CI, -2.3% to -1.5%; P<.001; number needed to treat, 53 [95% CI, 43-67]). Conclusions: The data suggest that early rehabilitation by physical therapists was associated with a reduction in 30-day in-hospital mortality rates in elderly patients with severe aspiration pneumonia. (C) 2015 by the American Congress of Rehabilitation Medicine	[Momosaki, Ryo; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo 1058461, Japan; [Momosaki, Ryo; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Sch Med, Dept Hlth Policy & Informat, Tokyo 113, Japan	Momosaki, R (reprint author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	momosakiryo@gmail.com		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H25-Policy-010]	Supported by a Grant-in-aid from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant no. H25-Policy-010).	Abizanda P, 2011, MATURITAS, V69, P273, DOI 10.1016/j.maturitas.2011.04.001; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Fox MT, 2013, J AM GERIATR SOC, V61, P939, DOI 10.1111/jgs.12282; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; Rassen JA, 2009, AM J EPIDEMIOL, V169, P273, DOI 10.1093/aje/kwn299; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Saposnik G, 2008, STROKE, V39, P2318, DOI 10.1161/STROKEAHA.107.510362; Shindo Y, 2009, CHEST, V135, P633, DOI 10.1378/chest.08-1357; Bachmann S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1718; Bateman BT, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5416; Chang CY, 2013, STROKE, V44, P1182, DOI 10.1161/STROKEAHA.111.000663; Matsuda S, 2008, EUROHEALTH, V14, P27; Matsui H, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-213; ONEIL MB, 1992, PHYS THER, V72, P596; Saltvedt I, 2002, J AM GERIATR SOC, V50, P792, DOI 10.1046/j.1532-5415.2002.50202.x; ZuWallack RL, 2012, COPD, V9, P637, DOI 10.3109/15412555.2012.710668	20	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2015	96	2					205	209		10.1016/j.apmr.2014.09.014		5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CA2QF	WOS:000348751800004		
J	Kono, M; Yasuda, S; Stevens, RL; Koide, H; Kurita, T; Shimizu, Y; Kanetsuka, Y; Oku, K; Bohgaki, T; Amengual, O; Horita, T; Shimizu, T; Majima, T; Koike, T; Atsumi, T				Kono, Michihito; Yasuda, Shinsuke; Stevens, Richard L.; Koide, Hideyuki; Kurita, Takashi; Shimizu, Yuka; Kanetsuka, Yusaku; Oku, Kenji; Bohgaki, Toshiyuki; Amengual, Olga; Horita, Tetsuya; Shimizu, Tomohiro; Majima, Tokifumi; Koike, Takao; Atsumi, Tatsuya			Ras Guanine Nucleotide-Releasing Protein 4 Is Aberrantly Expressed in the Fibroblast-like Synoviocytes of Patients With Rheumatoid Arthritis and Controls Their Proliferation	ARTHRITIS & RHEUMATOLOGY			English	Article							COLLAGEN-INDUCED ARTHRITIS; DIACYLGLYCEROL-BINDING MOTIFS; SYNOVIAL MAST-CELLS; NF-KAPPA-B; INFLAMMATORY ARTHRITIS; SIGNALING PROTEIN; RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; RASGRP4; DISEASE	Objective. Ras guanine nucleotide-releasing protein 4 (RasGRP-4) is a calcium-regulated guanine nucleotide exchange factor and diacylglycerol/phorbol ester receptor not normally expressed in fibroblasts. While RasGRP-4-null mice are resistant to arthritis induced by anti-glucose-6-phosphate isomerase autoantibodies, the relevance of these findings to humans is unknown. We undertook this study to evaluate the importance of RasGRP-4 in the pathogenesis of human and rat arthritis. Methods. Synovial tissue from patients with rheumatoid arthritis (RA) and osteoarthritis (OA) were evaluated immunohistochemically for the presence of RasGRP-4 protein. Fibroblast-like synoviocytes (FLS) were isolated from synovial samples, and expression of RasGRP-4 was evaluated by real-time quantitative reverse transcription-polymerase chain reaction analyses. The proliferation potency of FLS was evaluated by exposing the cells to a RasGRP-4-specific small interfering RNA (siRNA). Finally, the ability of RasGRP-4-specific siRNAs to hinder type II collagen-induced arthritis in rats was evaluated to confirm the importance of the signaling protein in the disease. Results. Unexpectedly, RasGRP-4 protein was detected in the synovial hyperplastic lining, where proliferating FLS preferentially reside. FLS isolated from tissues obtained from a subpopulation of RA patients expressed much more RasGRP-4 than did FLS from examined OA patients. Moreover, the level of RasGRP-4 transcript was correlated with the FLS proliferation rate. The ability of cultured FLS to divide was diminished when they were treated with RasGRP-4-specific siRNAs. The intraarticular injection of RasGRP-4-specific siRNAs also dampened experimental arthritis in rats. Conclusion. RasGRP-4 is aberrantly expressed in FLS and helps regulate their growth. This intracellular signaling protein is therefore a candidate target for dampening proliferative synovitis and joint destruction.	[Kono, Michihito; Yasuda, Shinsuke; Koide, Hideyuki; Kurita, Takashi; Shimizu, Yuka; Kanetsuka, Yusaku; Oku, Kenji; Bohgaki, Toshiyuki; Amengual, Olga; Horita, Tetsuya; Shimizu, Tomohiro; Majima, Tokifumi; Koike, Takao; Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Stevens, Richard L.] Harvard Univ, Sch Med, Boston, MA USA	Yasuda, S (reprint author), Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	syasuda@med.hokudai.ac.jp			Japanese Ministry of Health, Labor, and Welfare; Japanese Ministry of Education, Culture, Sports, Science, and Technology; NIH [AI-059746]	Supported by the Japanese Ministry of Health, Labor, and Welfare, the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and the NIH (grant AI-059746).	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Pine PR, 2007, CLIN IMMUNOL, V124, P244, DOI 10.1016/j.clim.2007.03.543; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Paunovic V, 2013, DRUGS, V73, P101, DOI 10.1007/s40265-013-0014-6; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Fukae J, 2005, ARTHRITIS RHEUM, V52, P2697, DOI 10.1002/art.21258; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; Shin K, 2009, J IMMUNOL, V182, P647; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Izquierdo E, 2011, ARTHRITIS RHEUM-US, V63, P2575, DOI 10.1002/art.30433; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; VANDENBROEK MF, 1988, J RHEUMATOL, V15, P544; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Barchowsky A, 2000, CYTOKINE, V12, P1469, DOI 10.1006/cyto.2000.0743; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Earp JC, 2008, J PHARMACOL EXP THER, V326, P532, DOI 10.1124/jpet.108.137372; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Gotis-Graham I, 1998, ANN RHEUM DIS, V57, P664, DOI 10.1136/ard.57.11.664; GRUBER B, 1986, ARTHRITIS RHEUM, V29, P944, DOI 10.1002/art.1780290802; HASCALL VC, 1969, J BIOL CHEM, V244, P2384; Hashimoto T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3470; Kojima F, 2011, INFLAMM REGEN, V31, P157; Li JY, 1999, NAT GENET, V23, P348; Li LX, 2002, MOL IMMUNOL, V38, P1283, DOI 10.1016/S0161-5890(02)00076-7; Li LX, 2003, J IMMUNOL, V171, P390; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nah SS, 2010, RHEUMATOL INT, V30, P443, DOI 10.1007/s00296-009-0976-6; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Siebuhr AS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-195; Suire S, 2012, EMBO J, V31, P3118, DOI 10.1038/emboj.2012.167; Tognon CE, 1998, MOL CELL BIOL, V18, P6995; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	FEB	2015	67	2					396	407		10.1002/art.38924		12	Rheumatology	Rheumatology	CA9CR	WOS:000349218500011		
J	Shirai, Y; Okazaki, Y; Inoue, Y; Tamura, Y; Yasuoka, H; Takeuchi, T; Kuwana, M				Shirai, Yuichiro; Okazaki, Yuka; Inoue, Yumiko; Tamura, Yuichi; Yasuoka, Hidekata; Takeuchi, Tsutomu; Kuwana, Masataka			Elevated Levels of Pentraxin 3 in Systemic Sclerosis	ARTHRITIS & RHEUMATOLOGY			English	Article							FIBROBLAST-GROWTH-FACTOR; PULMONARY ARTERIAL-HYPERTENSION; ENDOTHELIAL PROGENITOR CELLS; DIGITAL ULCERS; ANGIOGENESIS; SCLERODERMA; PTX3; ASSOCIATIONS; VASCULOPATHY; FACTOR-2	Objective. To clarify the role of pentraxin 3 (PTX3), a multifunctional pattern recognition protein that can suppress fibroblast growth factor 2 (FGF-2), in systemic sclerosis (SSc)-related vasculopathy. Methods. We assessed 171 SSc patients and 19 age- and sex-matched healthy control subjects. Circulating PTX3 and FGF-2 levels were measured by enzyme immunoassay, and CD34+CD133+CD309+ endothelial progenitor cells (EPCs) were counted by flow cytometry. Correlations between PTX3 and FGF-2 and the presence or future development of vascular manifestations, including digital ulcers and pulmonary arterial hypertension (PAH), were identified by univariate and multivariate analysis. The effect of PTX3 on EPC differentiation was evaluated in proangiogenic cultures of mouse bone marrow cells in combination with colony formation assay. Results. Circulating PTX3 and FGF-2 levels were significantly higher in SSc patients than in healthy control subjects. PTX3 was elevated in SSc patients who had digital ulcers or PAH, while FGF-2 was reduced in SSc patients with PAH. Multivariate analysis identified elevated PTX3 as an independent parameter associated with the presence of digital ulcers and PAH, and PTX3 levels were a useful predictor of future occurrences of digital ulcers. Reduced FGF-2 was independently associated with the presence of PAH. EPC counts were significantly lower in patients with digital ulcers or PAH and correlated negatively with circulating PTX3 concentrations. Finally, PTX3 inhibited EPC differentiation in vitro. Conclusion. In SSc patients, exposure to high concentrations of PTX3 may suppress EPC-mediated vasculogenesis and promote vascular manifestations such as digital ulcers and PAH.	[Shirai, Yuichiro; Okazaki, Yuka; Inoue, Yumiko; Tamura, Yuichi; Yasuoka, Hidekata; Takeuchi, Tsutomu; Kuwana, Masataka] Keio Univ, Sch Med, Tokyo, Japan; [Okazaki, Yuka; Kuwana, Masataka] Nippon Med Sch, Grad Sch Med, Tokyo 1138603, Japan	Kuwana, M (reprint author), Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	kuwanam@nms.ac.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Japanese Ministry of Health, Labor, and Welfare	Supported by the Japanese Ministry of Health, Labor, and Welfare (Research on Intractable Diseases grant).	JACKSON CL, 1993, AM J PATHOL, V143, P1024; Tiev KP, 2009, J RHEUMATOL, V36, P1470, DOI 10.3899/jrheum.081044; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Overbeek MJ, 2009, EUR RESPIR J, V34, P371, DOI 10.1183/09031936.00106008; Khimdas S, 2011, ARTHRIT CARE RES, V63, P142, DOI 10.1002/acr.20336; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Wedgwood S, 2007, PEDIATR RES, V61, P32, DOI 10.1203/01.pdr.0000250013.77008.28; Kuwana M, 2014, ARTHRITIS RHEUMATOL, V66, P1300, DOI 10.1002/art.38326; Avouac J, 2012, ANN RHEUM DIS, V71, P394, DOI 10.1136/annrheumdis-2011-200143; Taraboletti G, 1997, CELL GROWTH DIFFER, V8, P471; KUWANA M, 1994, ARTHRITIS RHEUM, V37, P75, DOI 10.1002/art.1780370111; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Hummers LK, 2009, J RHEUMATOL, V36, P576, DOI 10.3899/jrheum.080516; Luchetti MM, 2004, CLIN EXP RHEUMATOL, V22, pS66; ARCOT SS, 1995, GROWTH FACTORS, V12, P121, DOI 10.3109/08977199509028958; Fischer A, 2012, ARTHRIT CARE RES, V64, P303, DOI 10.1002/acr.20693; Cieslik P, 2012, AUTOIMMUNITY, V45, P119, DOI 10.3109/08916934.2011.611549; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Kuwana M, 2004, LANCET, V364, P603, DOI 10.1016/S0140-6736(04)16853-0; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Benisty JI, 2004, CHEST, V126, P1255, DOI 10.1378/chest.126.4.1255; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Rabquer BJ, 2012, CURR RHEUMATOL REP, V14, P56, DOI 10.1007/s11926-011-0219-1; Giusti B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2002; Iwata Y, 2009, J RHEUMATOL, V36, P976, DOI 10.3899/jrheum.080343; Kadono T, 1996, J AM ACAD DERMATOL, V35, P392, DOI 10.1016/S0190-9622(96)90603-9; Kaji K, 2014, ARTHRIT CARE RES, V66, P575, DOI 10.1002/acr.22163; Kuwana M, 2012, ANN RHEUM DIS, V71, P617, DOI 10.1136/annrheumdis-2011-200713; Margheri F, 2010, ARTHRITIS RHEUM-US, V62, P2488, DOI 10.1002/art.27522; Medsger Jr TA, 1989, ARTHRITIS ALLIED CON, P1118; Nevskaya T, 2008, CLIN EXP RHEUMATOL, V26, P421; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Sekiguchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028639; Silver RM, 2005, ARTHRITIS ALLIED CON, P1633; Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Tamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045834; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098	41	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	FEB	2015	67	2					498	507		10.1002/art.38953		10	Rheumatology	Rheumatology	CA9CR	WOS:000349218500022		
J	Taniguchi, T; Asano, Y; Akamata, K; Noda, S; Takahashi, T; Ichimura, Y; Toyama, T; Trojanowska, M; Sato, S				Taniguchi, Takashi; Asano, Yoshihide; Akamata, Kaname; Noda, Shinji; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Trojanowska, Maria; Sato, Shinichi			Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin-Treated Fli-1-Haploinsufficient Mice	ARTHRITIS & RHEUMATOLOGY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR FLI1; PROTEIN-ASSOCIATED FACTOR; SCLERODERMA FIBROBLASTS; INCREASED EXPRESSION; DERMAL FIBROBLASTS; ANIMAL-MODEL; COLLAGEN FIBRILLOGENESIS; INTEGRIN ALPHA-V-BETA-5; MESENCHYMAL TRANSITION	Objective. Fli-1, a potential predisposing factor for systemic sclerosis (SSc), is constitutively down-regulated in the lesional skin of patients with SSc by an epigenetic mechanism. To investigate the impact of Fli-1 deficiency on the induction of an SSc phenotype in various cell types, we generated bleomycin-induced skin fibrosis in Fli-1(+/-) mice and investigated the molecular mechanisms underlying its phenotypic alterations. Methods. Messenger RNA (mRNA) levels and protein expression of target molecules were examined by quantitative reverse transcription-polymerase chain reaction and immunostaining. Transforming growth factor beta (TGF beta) bioassay was used to evaluate the activation of latent TGF beta. The binding of Fli-1 to the target gene promoters was assessed with chromatin immuno-precipitation. Results. Bleomycin induced more severe dermal fibrosis in Fli-1(+/-) mice than in wild-type mice. Fli-1 haploinsufficiency activated dermal fibroblasts via the up-regulation of alpha v beta 3 and alpha v beta 5 integrins and activation of latent TGF beta. Dermal fibrosis in Fli-1(+/-) mice was also attributable to endothelial-to-mesenchymal transition, which is directly induced by Fli-1 deficiency and amplified by bleomycin. Th2/Th17-skewed inflammation and increased infiltration of mast cells and macrophages were seen, partly due to the altered expression of cell adhesion molecules in endothelial cells as well as the induction of the skin chemokines. Fli-1(+/-) mouse macrophages preferentially differentiated into an M2 phenotype upon stimulation with interleukin-4 (IL-4) or IL-13. Conclusion. Our findings provide strong evidence for the fundamental role of Fli-1 deficiency in inducing SSc-like phenotypic alterations in dermal fibroblasts, endothelial cells, and macrophages in a manner consistent with human disease.	[Taniguchi, Takashi; Asano, Yoshihide; Akamata, Kaname; Noda, Shinji; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Tokyo 1138655, Japan; [Trojanowska, Maria] Boston Univ, Sch Med, Boston, MA 02118 USA	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Japan Intractable Diseases Research Foundation; Japanese Society for Investigative Dermatology (JSID Fellowship Shiseido Award); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Foundation; NIH [AR042334]; Rohto Dermatology Prize	Supported by the Ministry of Health, Labor, and Welfare of Japan (Research on Intractable Diseases grant), the Japan Intractable Diseases Research Foundation, a Rohto Dermatology Prize, the Japanese Society for Investigative Dermatology (JSID Fellowship Shiseido Award), the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Japan Foundation for Applied Enzymology. Dr. Trojanowska's work was supported by NIH grant AR042334.	Chrobak I, 2013, J CELL PHYSIOL, V228, P1774, DOI 10.1002/jcp.24337; Noda S, 2013, RHEUMATOLOGY, V52, P790, DOI 10.1093/rheumatology/kes379; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Han YJ, 2013, AM J PHYSIOL-RENAL, V304, pF1043, DOI 10.1152/ajprenal.00389.2012; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Mathai SK, 2010, LAB INVEST, V90, P812, DOI 10.1038/labinvest.2010.73; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Yamamoto T, 1999, J RHEUMATOL, V26, P2628; Asano Y, 2009, MOL CELL BIOL, V29, P425, DOI 10.1128/MCB.01278-08; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Takagawa S, 2003, J INVEST DERMATOL, V121, P41, DOI 10.1046/j.1523-1747.2003.12308.x; Asano Y, 2005, J IMMUNOL, V175, P7708; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Yoshizaki A, 2008, AM J PATHOL, V172, P1650, DOI 10.2353/ajpath.2008.071049; Hugle T, 2011, ARTHRITIS RHEUM-US, V63, P795, DOI 10.1002/art.30190; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Yoshizaki A, 2010, J IMMUNOL, V185, P2502, DOI 10.4049/jimmunol.0901778; Hashimoto N, 2010, AM J RESP CELL MOL, V43, P161, DOI 10.1165/rcmb.2009-0031OC; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Asano Y, 2007, J BIOL CHEM, V282, P34672, DOI 10.1074/jbc.M703907200; Asano Y, 2004, AM J PATHOL, V164, P1275, DOI 10.1016/S0002-9440(10)63215-4; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Liu SX, 2013, ARTHRITIS RHEUM-US, V65, P2940, DOI 10.1002/art.38121; Wang J, 2013, INT J MOL SCI, V14, P10369, DOI 10.3390/ijms140510369; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Asano Y, 2005, ARTHRITIS RHEUM, V52, P2897, DOI 10.1002/art.21246; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Wang YQ, 2006, ARTHRITIS RHEUM, V54, P2271, DOI 10.1002/art.21948; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Asano Y, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0382-7; Bujor AM, 2012, INT J MOL MED, V30, P1473, DOI 10.3892/ijmm.2012.1150; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; Hamilton RF, 2004, AM J PHYSIOL-LUNG C, V286, pL1202, DOI 10.1152/ajplung.00351.2003; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Hussein MR, 2005, J CLIN PATHOL, V58, P178, DOI 10.1136/jcp.2004.019224; Markiewicz M, 2007, J DERMATOL SCI, V47, P217, DOI 10.1016/j.jdermsci.2007.05.008; Nakerakanti SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021911; Noda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032272; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Zeini M, 2006, J IMMUNOL, V177, P3327	48	8	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	FEB	2015	67	2					517	526		10.1002/art.38948		10	Rheumatology	Rheumatology	CA9CR	WOS:000349218500024		
J	Watanabe, K; Yasuda, S; Noguchi, A; Horita, T; Atsumi, T				Watanabe, Kanako; Yasuda, Shinsuke; Noguchi, Atsushi; Horita, Tetsuya; Atsumi, Tatsuya			Clinical Images: Coronary and mesenteric involvement in polyarteritis nodosa	ARTHRITIS & RHEUMATOLOGY			English	Editorial Material									[Watanabe, Kanako; Yasuda, Shinsuke; Noguchi, Atsushi; Horita, Tetsuya; Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Watanabe, K (reprint author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	FEB	2015	67	2					583	583		10.1002/art.38954		1	Rheumatology	Rheumatology	CA9CR	WOS:000349218500033		
J	Kumakura, S				Kumakura, Shunichi			Validity in the diagnosis of reactive hemophagocytic syndrome: comment on the article by Fardet et al	ARTHRITIS & RHEUMATOLOGY			English	Letter									Shimane Univ, Izumo, Shimane, Japan	Kumakura, S (reprint author), Shimane Univ, Izumo, Shimane, Japan.						Fardet L, 2014, ARTHRITIS RHEUMATOL, V66, P2613, DOI 10.1002/art.38690; Kumakura S, 2014, ARTHRITIS RHEUMATOL, V66, P2297, DOI 10.1002/art.38672; Kumakura S, 2002, CLIN EXP RHEUMATOL, V20, P411; Kumakura S, 1997, J RHEUMATOL, V24, P1645; Lehmberg K, 2013, BRIT J HAEMATOL, V160, P275, DOI 10.1111/bjh.12138	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	FEB	2015	67	2					587	588		10.1002/art.38935		3	Rheumatology	Rheumatology	CA9CR	WOS:000349218500039		
J	Yamakado, K				Yamakado, Kotaro			Quantification of the Learning Curve for Arthroscopic Suprascapular Nerve Decompression: An Evaluation of 300 Cases	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							NOTCH; ENTRAPMENT; RELEASE; SUPRASPINATUS	Purpose: This study aimed to quantify the learning curve for arthroscopic suprascapular nerve decompression (SSND) using the log-linear model. Methods: Three hundred consecutive patients underwent arthroscopic SSND by release of the transverse scapular ligament at the suprascapular notch by a single surgeon. Cases with a bony suprascapular nerve foramen were excluded. The arthroscopic SSND time was defined as the time from the beginning of shaving the soft tissue medial to the acromioclavicular joint until the completion of the transverse scapular ligament release. Regression analysis was applied to predict the time required for SSND on the basis of the cumulative case volume after logarithmic transformation of both statistics. Results: The mean SSND time decreased from the first 50 cases (mean, 29.5 minutes) to the last 50 cases (mean, 6.2 minutes). The estimated SSND times of the first and last 50 cases were 25.1 minutes and 5.5 minutes, respectively. A significant linear correlation was observed between the SSND time and the cumulative volume of cases after logarithmic transformation (r(2) = 0.481, P < .01), and the best-fit linear equation was calculated as log y = -0.52 log x + 4.6, where y represents the estimated SSND time and x represents the cumulative volume of cases, resulting in an estimated learning rate of 69.7% (which equals 2(-0.52)). Conclusions: This study presents the overall time reduction in arthroscopic SSND in support of a learning-curve effect. Furthermore, this study quantifies the learning rate, estimated as approximately 70%, indicating that the time required for arthroscopic SSND can decrease by up to 30% when the cumulative volume of cases doubles.	Fukui Gen Hosp, Dept Orthopaed, Fukui 9108561, Japan	Yamakado, K (reprint author), Fukui Gen Hosp, Dept Orthopaed, 58-16-1 Egami, Fukui 9108561, Japan.	yamakadok@gmail.com					Moen TC, 2012, J SHOULDER ELB SURG, V21, P835, DOI 10.1016/j.jse.2011.11.033; Ghodadra N, 2009, ARTHROSCOPY, V25, P439, DOI 10.1016/j.arthro.2008.10.024; Shah AA, 2011, J SHOULDER ELB SURG, V20, P975, DOI 10.1016/j.jse.2010.10.032; Barwood SA, 2007, ARTHROSCOPY, V23, P221, DOI 10.1016/j.arthro.2006.11.011; WARNER JJP, 1992, J BONE JOINT SURG AM, V74A, P36; Lafosse L, 2007, ARTHROSCOPY, V23, P34, DOI 10.1016/j.arthro.2006.10.003; Bhatia DN, 2006, ARTHROSCOPY, V22, P1009, DOI 10.1016/j.arthro.2006.05.012; Barber FA, 2008, ARTHROSCOPY, V24, p[236, e1, e4]; Cummins CA, 2000, J BONE JOINT SURG AM, V82A, P415; Greiner A, 2003, J SHOULDER ELB SURG, V12, P256, DOI 10.1067/mse:2003.32; HIRSHLEIFER J, 1962, J BUS, V35, P235, DOI 10.1086/294508; Hirshmann WB, 1964, CHEM ENG, V71, P95; Jaber MY, 2011, IND INNOVATION SERIE; Jobe C M, 1996, J Shoulder Elbow Surg, V5, P206, DOI 10.1016/S1058-2746(05)80007-2; Kim SH, 2009, KNEE SURG SPORT TR A, V17, P1504, DOI 10.1007/s00167-009-0858-1; Lafosse L, 2011, J SHOULDER ELB SURG, V20, pS9, DOI 10.1016/j.jse.2010.12.003; Oizumi N, 2010, KATAKANSETSU SHOULDE, V34, P867; Post M, 1999, CLIN ORTHOP RELAT R, P92; Reineck John R, 2009, J Shoulder Elbow Surg, V18, pe1, DOI 10.1016/j.jse.2008.08.007; Romeo Anthony A, 2010, J Shoulder Elbow Surg, V19, P118, DOI 10.1016/j.jse.2010.01.006; Safran MR, 2004, AM J SPORT MED, V32, P803, DOI 10.1177/0363546504264582; Wright T. P., 1936, J AERONAUT SCI, V3, P122; Yamakado K., 2013, OA SPORTS MED, V1, P15; Yelle L. E., 1979, Decision Sciences, V10, DOI 10.1111/j.1540-5915.1979.tb00026.x	24	4	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	FEB	2015	31	2					191	196		10.1016/j.arthro.2014.08.029		6	Orthopedics; Surgery	Orthopedics; Surgery	AZ9BN	WOS:000348506300007		
J	Sakurai, K				Sakurai, Kaori			Photoaffinity Probes for Identification of Carbohydrate-Binding Proteins	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Review						carbohydrate-binding proteins; carbohydrates; photoaffinity labeling; photoaffinity probes; photocrosslinking	PHOTO-CROSS-LINKING; SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; MOLECULAR-PROBE; SIGNAL-TRANSDUCTION; CHEMISTRY; TARGET; BENZOPHENONE; INHIBITORS; RECEPTOR	Carbohydrate-protein interactions mediate cellular signals, which are crucial in a diverse array of biological and pathological processes. Despite their importance, many carbohydrate-protein interactions remain unknown due to inherent difficulties in studying them. With the aim to provide the first step in elucidating the biological roles of carbohydrates, photoaffinity labeling has been used as a promising chemical strategy for the detection and identification of carbohydrate-binding proteins in their native environment. Recent efforts in the design of carbohydrate-based photoaffinity probes include the use of selective photoreactive groups, development of biotinylated photoreactive groups and linkers, multivalent carbohydrate ligands, affinity-based protein profiling probes, and photoreactive monosaccharide precursors for metabolic glycan labeling. These methods offer new tools to address challenges associated in capturing the often elusive carbohydrate-protein interactions.	Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan	Sakurai, K (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	sakuraik@cc.tuat.ac.jp	Sakurai, Kaori/F-6238-2013		Human Frontier Science Foundation (Young Investigator Grant); Women's Future Development Organization at TUAT	I thank the Human Frontier Science Foundation (Young Investigator Grant) and the Women's Future Development Organization at TUAT for the financial support.	Hatanaka Y, 2000, J ORG CHEM, V65, P5639, DOI 10.1021/jo000414a; Tomohiro T, 2005, CHEM REC, V5, P385, DOI 10.1002/tcr.20058; Li ZQ, 2014, J AM CHEM SOC, V136, P9990, DOI 10.1021/ja502780z; RICE KG, 1990, J BIOL CHEM, V265, P18429; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; Dubinsky L, 2012, BIOORGAN MED CHEM, V20, P554, DOI 10.1016/j.bmc.2011.06.066; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Yu SH, 2012, P NATL ACAD SCI USA, V109, P4834, DOI 10.1073/pnas.1114356109; Willems LI, 2014, CHEM-EUR J, V20, P10864, DOI 10.1002/chem.201404014; Liebler DC, 2013, BIOCHEMISTRY-US, V52, P3797, DOI 10.1021/bi400110b; Kawamura A, 2012, METHODS MOL BIOL, V803, P65, DOI 10.1007/978-1-61779-364-6_6; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Bond MR, 2011, BIOCONJUGATE CHEM, V22, P1811, DOI 10.1021/bc2002117; Li YM, 2000, NATURE, V405, P689; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; Kiessling LL, 2013, CHEM SOC REV, V42, P4476, DOI 10.1039/c3cs60097a; van Scherpenzeel M, 2010, BIOORGAN MED CHEM, V18, P267, DOI 10.1016/j.bmc.2009.10.060; Sadakane Y, 2006, ANAL SCI, V22, P209, DOI 10.2116/analsci.22.209; Lauc G, 2000, GLYCOBIOLOGY, V10, P357, DOI 10.1093/glycob/10.4.357; Dube DH, 2003, CURR OPIN CHEM BIOL, V7, P616, DOI 10.1016/j.cbpa.2003.08.006; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Angel TE, 2012, CHEM SOC REV, V41, P3912, DOI 10.1039/c2cs15331a; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287; Hosoya T, 2004, ORG BIOMOL CHEM, V2, P637, DOI 10.1039/b316221d; Tanaka Y, 2008, J AM CHEM SOC, V130, P3278, DOI 10.1021/ja7109772; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; FLEMING SA, 1995, TETRAHEDRON, V51, P12479; Ramya TNC, 2010, MOL CELL PROTEOMICS, V9, P1339, DOI 10.1074/mcp.M900461-MCP200; Himo F, 2005, J AM CHEM SOC, V127, P210, DOI 10.1021/ja0471525; van Berkel SS, 2011, ANGEW CHEM INT EDIT, V50, P8806, DOI 10.1002/anie.201008102; Blencowe A, 2005, SOFT MATTER, V1, P178, DOI 10.1039/b501989c; Yu SH, 2012, J CARBOHYD CHEM, V31, P325, DOI 10.1080/07328303.2012.676118; Kawamura A, 2008, BIOORGAN MED CHEM, V16, P8824, DOI 10.1016/j.bmc.2008.08.077; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Sakurai K, 2014, CHEMBIOCHEM, V15, P1399, DOI 10.1002/cbic.201402051; Wibowo A, 2014, J AM CHEM SOC, V136, P9528, DOI 10.1021/ja502482a; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Fonovic M, 2008, EXPERT REV PROTEOMIC, V5, P721, DOI 10.1586/14789450.5.5.721; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Khan AA, 2013, ORG BIOMOL CHEM, V11, P881, DOI 10.1039/c2ob27257a; Gandy MN, 2011, CHEM COMMUN, V47, P5037, DOI 10.1039/c1cc10308c; Nakamura Y, 2011, ORG BIOMOL CHEM, V9, P83, DOI 10.1039/c0ob00843e; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Bailey H., 1983, LAB TECHNIQUES BIOCH, V12; Ballell L, 2005, CHEMBIOCHEM, V6, P291, DOI 10.1002/cbic.200400209; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dorman G., 2000, TOP CURR CHEM, V211, P171; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Feng Y., 2013, J AM CHEM SOC, V135, P9244; Fliegmann J, 2013, ACS CHEM BIOL, V8, P1900, DOI 10.1021/cb400369u; Geurink P. P., 2011, TOP CURR CHEM, V324, P85; GILBERT BA, 1995, J AM CHEM SOC, V117, P8061, DOI 10.1021/ja00136a002; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Hagenstein M. C., 2003, ANGEW CHEM, V115, P5793, DOI 10.1002/ange.200352084; Hagenstein MC, 2003, ANGEW CHEM INT EDIT, V42, P5635, DOI 10.1002/anie.200352084; Hans S., 2005, NAT CHEM BIOL, V1, P93; Hashimoto M., 2008, J ORG CHEM, P2513; Hatanaka Y, 1996, CARBOHYD RES, V294, P95; HUGHES AB, 1994, NAT PROD REP, V11, P135, DOI 10.1039/np9941100135; Kiessling L. L., 2006, ANGEW CHEM, V118, P2408, DOI DOI 10.1002/ANGE.200502794; KNOWLES JR, 1972, ACCOUNTS CHEM RES, V5, P155, DOI 10.1021/ar50052a006; Kotzyba-Hibert F., 1995, ANGEW CHEM, V107, P1391, DOI DOI 10.1002/ANGE.19951071204; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Lapinsky DJ, 2012, BIOORGAN MED CHEM, V20, P6237, DOI 10.1016/j.bmc.2012.09.010; Lee MR, 2005, ORG LETT, V7, P5477, DOI 10.1021/ol0523188; LEE RT, 1986, BIOCHEMISTRY-US, V25, P6835, DOI 10.1021/bi00370a016; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001; Li Z., 2013, ANGEW CHEM, V125, P8713; Li Z., 2013, ANGEW CHEM INT EDIT, V52, P14060; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Nakamura Y, 2006, TETRAHEDRON, V62, P8805, DOI 10.1016/j.tet.2006.06.092; Nakamura Y., 2008, ANGEW CHEM, V120, P7399, DOI 10.1002/ange.200801820; Nakamura Y, 2008, ANGEW CHEM INT EDIT, V47, P7289, DOI 10.1002/anie.200801820; Rizk MS, 2006, BIOCHEMISTRY-US, V45, P543, DOI 10.1021/bi0516632; Sakurai K, 2013, CHEMBIOCHEM, V14, P421, DOI 10.1002/cbic.201200758; Sletten E. M., 2009, ANGEW CHEM, V121, P7108, DOI DOI 10.1002/ANGE.200900942; Stocker BL, 2013, CHEMBIOCHEM, V14, P1164, DOI 10.1002/cbic.201300064; Stocker BL, 2014, CARBOHYD RES, V389, P3, DOI 10.1016/j.carres.2013.08.030; Tamura S, 2013, BIOORG MED CHEM LETT, V23, P188, DOI 10.1016/j.bmcl.2012.10.124; Timmer MSM, 2007, CURR OPIN CHEM BIOL, V11, P59, DOI 10.1016/j.cbpa.2006.11.040; Ueda M, 2012, BIOORGAN MED CHEM, V20, P5832, DOI 10.1016/j.bmc.2012.08.003; Ueda M, 2011, CHEM-ASIAN J, V6, P3286, DOI 10.1002/asia.201100392; van Berkel SS, 2011, ANGEW CHEM, V123, P8968; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wiegand M, 2006, EUR J ORG CHEM, P4841, DOI 10.1002/ejoc.200600449; Xia Y, 2013, CHEM REV, V113, P7880, DOI 10.1021/cr300419p	94	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	FEB	2015	4	2					116	126		10.1002/ajoc.201402209		11	Chemistry, Organic	Chemistry	CA8DX	WOS:000349147900003		
J	Shimizu, M; Yato, A; Kawamura, T				Shimizu, Makoto; Yato, Atsuhiro; Kawamura, Takato			Nucleophilic Addition Reaction to the Iminium Salts Generated from Pipecolic Acid Derivatives and Application to the Synthesis of Bicyclic Compounds	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						(+/-)-S22178; 5-HT1A agonists; iminium salts; pipecolic acid; ring-closing metathesis; umpolung	ALPHA-AMINO ESTERS; ASYMMETRIC-SYNTHESIS; MANNICH REACTION; CHIRAL CENTERS; PEPTIDES; CONFORMATIONS; METATHESIS; PROGENITORS	Nucleophilic addition of Grignard reagents to the iminium salts generated by the oxidation of cyclic amino ketene silyl acetals derived from pipecolic acid gave alpha-quaternary amino ester derivatives. Bicyclic compounds were prepared from N-allylated and homoallylated derivatives with vinylaion, allylation, or homoallylation followed by ring-closing metathesis. Application of this method to the synthesis of (+/-)-S22178, a potent 5-HT1A agonist, was also described.	[Shimizu, Makoto; Yato, Atsuhiro; Kawamura, Takato] Mie Univ, Grad Sch Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan	Shimizu, M (reprint author), Mie Univ, Grad Sch Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan.	mshimizu@chem.mie-u.ac.jp			JSPS; MEXT	This work was supported by Grants-in-Aid for Scientific Research (B) and on Innovative Areas "Organic Synthesis Based on Reaction Integration. Development of New Methods and Creation of New Substances" from JSPS and MEXT.	Andrei M, 2004, TETRAHEDRON-ASYMMETR, V15, P1359, DOI 10.1016/j.tetasy.2004.03.018; Shen HC, 2009, TETRAHEDRON, V65, P3931, DOI 10.1016/j.tet.2009.02.002; Shimizu M, 2011, CHEM LETT, V40, P351, DOI 10.1246/cl.2011.351; Hata S, 2011, J ORG CHEM, V76, P9670, DOI 10.1021/jo201692x; Fustero S, 2012, CHEM-EUR J, V18, P3753, DOI 10.1002/chem.201102351; Karle IL, 1997, J AM CHEM SOC, V119, P12048, DOI 10.1021/ja970596z; Juli C, 2011, J MED CHEM, V54, P277, DOI 10.1021/jm101156y; Kuwabe S, 2001, J AM CHEM SOC, V123, P12202, DOI 10.1021/ja012046d; Chatterjee AK, 2003, J AM CHEM SOC, V125, P11360, DOI 10.1021/ja0214882; Curto JM, 2014, J ORG CHEM, V79, P5359, DOI 10.1021/jo500707t; Shimizu M, 2009, CHEM LETT, V38, P732, DOI 10.1246/cl.2009.732; BURGESS AW, 1994, P NATL ACAD SCI USA, V91, P2649, DOI 10.1073/pnas.91.7.2649; Comoy C, 1996, J MED CHEM, V39, P4285, DOI 10.1021/jm950861w; Kadouri-Puchot C, 2005, AMINO ACIDS, V29, P101, DOI 10.1007/s00726-005-0193-x; Le Corre L, 2005, TETRAHEDRON LETT, V46, P7495, DOI 10.1016/j.tetlet.2005.09.008; Lenda F, 2005, EUR J ORG CHEM, P326, DOI 10.1002/ejoc.200400328; Lim SH, 2001, J ORG CHEM, V66, P9056, DOI 10.1021/jo0108865; Mizota I, 2013, ORG LETT, V15, P4206, DOI 10.1021/ol401934x; Nishi T, 2012, PURE APPL CHEM, V84, P2609, DOI 10.1351/PAC-CON-12-01-03; Niwa Y, 2003, J AM CHEM SOC, V125, P3720, DOI 10.1021/ja029639o; Park KH, 2002, TETRAHEDRON, V58, P8629, DOI 10.1016/S0040-4020(02)00989-4; PAUL PKC, 1986, J AM CHEM SOC, V108, P6363, DOI 10.1021/ja00280a038; Pave G, 2003, J ORG CHEM, V68, P1401, DOI 10.1021/jo026228h; SAARI WS, 1978, J MED CHEM, V21, P746, DOI 10.1021/jm00206a006; SAARI WS, 1984, J MED CHEM, V27, P713, DOI 10.1021/jm00372a002; Shimizu M, 2006, PURE APPL CHEM, V78, P1867, DOI 10.1351/pac200678101867; Shimizu M, 2013, ASIAN J ORG CHEM, V2, P208, DOI 10.1002/ajoc.201300010; Shimizu M, 2005, J AM CHEM SOC, V127, P3296, DOI 10.1021/ja042330f; Shimizu M, 2013, ASIAN J ORG CHEM, V2, P130, DOI 10.1002/ajoc.201200174; Shimizu M, 2009, CHEM COMMUN, P874, DOI 10.1039/b814930e; Tanaka M, 2004, ANGEW CHEM INT EDIT, V43, P5360, DOI 10.1002/anie.200460420; Tanaka M., 2004, ANGEW CHEM, V116, P5474, DOI 10.1002/ange.200460420; Tanaka M, 2005, J AM CHEM SOC, V127, P11570, DOI 10.1021/ja053842c; Tjen KCMF, 2000, CHEM COMMUN, P699, DOI 10.1039/b001253j; Westerhoff O, 2001, J CHEM SOC PERK T 1, P508, DOI 10.1039/b009112j	35	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	FEB	2015	4	2					128	131		10.1002/ajoc.201402270		4	Chemistry, Organic	Chemistry	CA8DX	WOS:000349147900004		
J	Aoki, W; Suda, T; Beers, TC; Honda, S				Aoki, Wako; Suda, Takuma; Beers, Timothy C.; Honda, Satoshi			HIGH-RESOLUTION SPECTROSCOPY OF EXTREMELY METAL-POOR STARS FROM SDSS/SEGUE. II. BINARY FRACTION	ASTRONOMICAL JOURNAL			English	Article						binaries: general; Galaxy: halo; stars: abundances; stars: Population II	PROPER-MOTION STARS; INITIAL MASS FUNCTION; GIANT BRANCH STARS; 1ST STARS; CHEMICAL-COMPOSITIONS; HAMBURG/ESO SURVEY; ORBITAL SOLUTIONS; CARBON; ABUNDANCES; SAMPLE	The fraction of binary systems in various stellar populations of the Galaxy and the distribution of their orbital parameters are important but not well-determined factors in studies of star formation, stellar evolution, and Galactic chemical evolution. While observational studies have been carried out for a large sample of nearby stars, including some metal-poor Population II stars, almost no constraints on the binary nature for extremely metal-poor (EMP; [Fe/H] < -3.0) stars have yet been obtained. Here we investigate the fraction of double-lined spectroscopic binaries and carbon-enhanced metal-poor (CEMP) stars, many of which could have formed as pairs of low-mass and intermediate-mass stars, to estimate the lower limit of the fraction of binary systems having short periods. The estimate is based on a sample of very metal-poor stars selected from the Sloan Digital Sky Survey and observed at high spectral resolution in a previous study by Aoki et al. That survey reported 3 double-lined spectroscopic binaries and 11 CEMP stars, which we consider along with a sample of EMP stars from the literature compiled in the SAGA database. We have conducted measurements of the velocity components for stacked absorption features of different spectral lines for each double-lined spectroscopic binary. Our estimate indicates that the fraction of binary stars having orbital periods shorter than 1000 days is at least 10%, and possibly as high as 20% if the majority of CEMP stars are formed in such short-period binaries. This result suggests that the period distribution of EMP binary systems is biased toward short periods, unless the binary fraction of low-mass EMP stars is significantly higher than that of other nearby stars.	[Aoki, Wako; Suda, Takuma] Natl Astron Observ, Mitaka, Tokyo 1818588, Japan; [Aoki, Wako] Grad Univ Adv Studies, SOKENDAI, Sch Phys Sci, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Suda, Takuma] Univ Tokyo, Res Ctr Early Univ, Bunkyo Ku, Tokyo 1130033, Japan; [Beers, Timothy C.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46656 USA; [Beers, Timothy C.] Univ Notre Dame, JINA Ctr Evolut Elements, Notre Dame, IN 46656 USA; [Honda, Satoshi] Univ Hyogo, Ctr Astron, Sayo, Hyogo 6795313, Japan	Aoki, W (reprint author), Natl Astron Observ, Mitaka, Tokyo 1818588, Japan.	aoki.wako@nao.ac.jp; takuma.suda@nao.ac.jp; tbeers@nd.edu; honda@nhao.jp			JSPS [S: 23224004, B: 26400231]; Physics Frontiers Center/Joint Institute for Nuclear Astrophysics (JINA) [PHY 08-22648]; Physics Frontier Center/JINA Center for the Evolution of the Elements (JINA-CEE) - US National Science Foundation [PHY 14-30152]	This work is based on data collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. The data obtained with Subaru/HDS are available on the Subaru Mitaka Okayama Kiso Archive system (SMOKA: http://smoka.nao.ac.jp). W.A. and T.S. are supported by the JSPS Grant-in-Aid for Scientific Research (S: 23224004). S.H. is supported by the JSPS Grant-in-Aid for Young Scientists (B: 26400231). T.C.B. acknowledges partial support from grant PHY 08-22648: Physics Frontiers Center/Joint Institute for Nuclear Astrophysics (JINA), and PHY 14-30152; Physics Frontier Center/JINA Center for the Evolution of the Elements (JINA-CEE), awarded by the US National Science Foundation.	Ade P. A. R., 2014, ASTRON ASTROPHYS, V571, pAA1; Lai DK, 2008, ASTROPHYS J, V681, P1524, DOI 10.1086/588811; Keller SC, 2014, NATURE, V506, P463, DOI 10.1038/nature12990; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; Latham DW, 2002, ASTRON J, V124, P1144, DOI 10.1086/341384; Yanny B, 2009, ASTRON J, V137, P4377, DOI 10.1088/0004-6256/137/5/4377; DUQUENNOY A, 1991, ASTRON ASTROPHYS, V248, P485; Nakamura F, 2002, ASTROPHYS J, V569, P549, DOI 10.1086/339392; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Cohen JG, 2006, ASTRON J, V132, P137, DOI 10.1086/504597; Suda T, 2004, ASTROPHYS J, V611, P476, DOI 10.1086/422135; Kim YC, 2002, ASTROPHYS J SUPPL S, V143, P499, DOI 10.1086/343041; Sivarani T, 2006, ASTRON ASTROPHYS, V459, P125, DOI 10.1051/0004-6361:20065440; Aoki W, 2007, ASTROPHYS J, V655, P492, DOI 10.1086/509817; Starkenburg E, 2014, MON NOT R ASTRON SOC, V441, P1217, DOI 10.1093/mnras/stu623; Komiya Y, 2007, ASTROPHYS J, V658, P367, DOI 10.1086/510826; Suda T, 2008, PUBL ASTRON SOC JPN, V60, P1159; Jorissen A, 1998, ASTRON ASTROPHYS, V332, P877; Aoki W, 2008, ASTROPHYS J, V678, P1351, DOI 10.1086/533517; Aoki W, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/1/L6; Aoki W, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/13; Behara NT, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913213; CARNEY BW, 1994, ASTRON J, V107, P2240, DOI 10.1086/117035; Depagne E, 2000, ASTRON ASTROPHYS, V364, pL6; Frebel A., 2013, PLANETS STARS STELLA, V5, P55; Goldberg D, 2002, ASTRON J, V124, P1132, DOI 10.1086/341385; Hernandez J I Gonzalez, 2008, Astronomy & Astrophysics, V480, DOI 10.1051/0004-6361:20078847; Hansen T, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/162; Hirano S, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/60; Lugaro M, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/2; Machida MN, 2008, ASTROPHYS J LETT, V682, pL1, DOI 10.1086/590109; Norris JE, 2013, ASTROPHYS J, V762, DOI [10.1088/0004-637X/762/1/28, 10.1088/0004-637X/762/1]; Norris JE, 2000, ASTROPHYS J, V540, P456, DOI 10.1086/309320; Rastegaev DA, 2010, ASTRON J, V140, P2013, DOI 10.1088/0004-6256/140/6/2013; Sbordone L, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913282; Spite M, 2000, ASTRON ASTROPHYS, V360, P1077; Susa H, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/32; TRIMBLE V, 1990, MON NOT R ASTRON SOC, V242, P79	39	4	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	FEB	2015	149	2							39	10.1088/0004-6256/149/2/39		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CB1BA	WOS:000349360200004		
J	De Los Reyes, MA; Ly, C; Lee, JC; Salim, S; Peeples, MS; Momcheva, I; Feddersen, J; Dale, DA; Ouchi, M; Ono, Y; Finn, R				De Los Reyes, Mithi A.; Ly, Chun; Lee, Janice C.; Salim, Samir; Peeples, Molly S.; Momcheva, Ivelina; Feddersen, Jesse; Dale, Daniel A.; Ouchi, Masami; Ono, Yoshiaki; Finn, Rose			THE RELATIONSHIP BETWEEN STELLAR MASS, GAS METALLICITY, AND STAR FORMATION RATE FOR H-alpha-SELECTED GALAXIES AT z approximate to 0.8 FROM THE NEWH alpha SURVEY	ASTRONOMICAL JOURNAL			English	Article						galaxies: abundances; galaxies: evolution; galaxies: fundamental parameters; galaxies: ISM; galaxies: starburst	EMISSION-LINE GALAXIES; DIGITAL SKY SURVEY; SUBARU DEEP FIELD; DISTRIBUTED ELECTRON ENERGIES; ACTIVE GALACTIC NUCLEI; HIGH-REDSHIFT GALAXIES; LYMAN-BREAK GALAXIES; FORMING GALAXIES; LUMINOSITY FUNCTION; POPULATION SYNTHESIS	Using a sample of 299 H alpha-selected galaxies at z approximate to 0.8, we study the relationship between galaxy stellar mass, gasphase metallicity, and star formation rate (SFR), and compare to previous results. We use deep optical spectra obtained with the IMACS spectrograph at the Magellan telescope to measure strong oxygen lines. We combine these spectra and metallicities with (1) rest-frame UV-to-optical imaging, which allows us to determine stellar masses and dust attenuation corrections, and (2) H alpha narrowband imaging, which provides a robust measurement of the instantaneous SFR. Our sample spans stellar masses of similar to 10(9)-6 x 10(11) M-circle dot, SFRs of 0.4-270 M-circle dot yr(-1), and metal abundances of 12 + log (O/H) approximate to 8.3-9.1 (approximate to 0.4-2.6 M-circle dot). The correlations that we find between the H-alpha-based SFR and stellar mass (i.e., the star-forming "main sequence") and between the stellar mass and metallicity are both consistent with previous z similar to 1 studies of star-forming galaxies. We then study the relationship between the three properties using various plane-fitting techniques and a curve-fitting projection. In all cases, we exclude strong dependence of the M*-Z relation on SFR, but are unable to distinguish between moderate and no dependence. Our results are consistent with previous mass-metallicity-SFR studies. We check whether data set limitations may obscure a strong dependence on the SFR by using mock samples drawn from the Sloan Digital Sky Survey. These experiments reveal that the adopted signal-to-noise ratio cuts may have a significant effect on the measured dependence. Further work is needed to investigate these results, and to test whether a "fundamental metallicity relation"or a "fundamental plane"describes star-forming galaxies across cosmic time.	[De Los Reyes, Mithi A.] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [De Los Reyes, Mithi A.; Ly, Chun; Lee, Janice C.; Peeples, Molly S.; Feddersen, Jesse] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Ly, Chun] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Salim, Samir] Indiana Univ, Dept Astron, Bloomington, IN 47405 USA; [Momcheva, Ivelina; Feddersen, Jesse] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Dale, Daniel A.] Univ Wyoming, Dept Phys & Astron, Laramie, WY 82071 USA; [Ouchi, Masami; Ono, Yoshiaki] Univ Tokyo, TODIAS, Inst Phys & Math Universe, Tokyo 1138654, Japan; [Finn, Rose] Siena Coll, Phys Dept Phys & Astron, Loudonville, NY USA	De Los Reyes, MA (reprint author), N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA.	madelosr@ncsu.edu		Feddersen, Jesse/0000-0003-3810-3323	project of CFHT at the CFHT; project of CEA/DAPNIA at the CFHT; GALEX Guest Investigator program under NASA [NNG09EG72I, NNX10AF04G]	This work is based on observations obtained with Mega-Prime/MegaCam, a joint project of CFHT and CEA/DAPNIA, at the CFHT, which is operated by the National Research Council of Canada, the Institut National des Sciences de l'Univers of the Centre National de la Recherche Scientifique of France, and the University of Hawaii. We thank Sebastien Foucaud for facilitating access to publicly available CFHT u-band data in the SXDS field, Victor Villar for providing data from his paper, and Robert Yates for providing their best-fit projection for their local fundamental metallicity relation. We also thank Brett A. Andrews for his insightful comments and discussion. Our work is based in part on observations made with the NASA's GALEX mission. We acknowledge support for this work from the GALEX Guest Investigator program under NASA grants NNG09EG72I and NNX10AF04G.	Amorin RO, 2010, ASTROPHYS J LETT, V715, pL128, DOI 10.1088/2041-8205/715/2/L128; Andrews BH, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/140; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Morrissey P, 2007, ASTROPHYS J SUPPL S, V173, P682, DOI 10.1086/520512; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Caffau E, 2011, SOL PHYS, V268, P255, DOI 10.1007/s11207-010-9541-4; da Cunha E, 2008, MON NOT R ASTRON SOC, V388, P1595, DOI 10.1111/j.1365-2966.2008.13535.x; Boulade O, 2003, P SOC PHOTO-OPT INS, V4841, P72, DOI 10.1117/12.459890; Pettini M, 2004, MON NOT R ASTRON SOC, V348, pL59, DOI 10.1111/j.1365-2966.2004.07591.x; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; PAGEL BEJ, 1979, MON NOT R ASTRON SOC, V189, P95; Villar V, 2008, ASTROPHYS J, V677, P169, DOI 10.1086/528942; Dutton AA, 2010, MON NOT R ASTRON SOC, V405, P1690, DOI 10.1111/j.1365-2966.2010.16620.x; Forbes JC, 2014, MON NOT R ASTRON SOC, V438, P1552, DOI 10.1093/mnras/stt2294; Kobulnicky HA, 2004, ASTROPHYS J, V617, P240, DOI 10.1086/425299; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Autry R, 2003, P SOC PHOTO-OPT INS, V4841, P525, DOI 10.1117/12.460419; Richard J, 2011, MON NOT R ASTRON SOC, V413, P643, DOI 10.1111/j.1365-2966.2010.18161.x; CALZETTI D, 1994, ASTROPHYS J, V429, P582, DOI 10.1086/174346; Elbaz D, 2007, ASTRON ASTROPHYS, V468, P33, DOI 10.1051/0004-6361:20077525; Dave R, 2011, MON NOT R ASTRON SOC, V416, P1354, DOI 10.1111/j.1365-2966.2011.19132.x; Kewley LJ, 2008, ASTROPHYS J, V681, P1183, DOI 10.1086/587500; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; Cresci G, 2012, MON NOT R ASTRON SOC, V421, P262, DOI 10.1111/j.1365-2966.2011.20299.x; Fujita SS, 2003, ASTROPHYS J, V586, pL115, DOI 10.1086/374859; Yates RM, 2012, MON NOT R ASTRON SOC, V422, P215, DOI 10.1111/j.1365-2966.2012.20595.x; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Cowie LL, 2008, ASTROPHYS J, V686, P72, DOI 10.1086/591176; Kong X, 2004, MON NOT R ASTRON SOC, V349, P769, DOI 10.1111/j.1365-2966.2004.07556.x; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; ZARITSKY D, 1994, ASTROPHYS J, V420, P87, DOI 10.1086/173544; Mannucci F, 2011, MON NOT R ASTRON SOC, V414, P1263, DOI 10.1111/j.1365-2966.2011.18459.x; Erb DK, 2006, ASTROPHYS J, V644, P813, DOI 10.1086/503623; Gonzalez V, 2010, ASTROPHYS J, V713, P115, DOI 10.1088/0004-637X/713/1/115; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Kakazu Y, 2007, ASTROPHYS J, V668, P853, DOI 10.1086/521333; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Taylor EN, 2011, MON NOT R ASTRON SOC, V418, P1587, DOI 10.1111/j.1365-2966.2011.19536.x; Peeples MS, 2011, MON NOT R ASTRON SOC, V417, P2962, DOI 10.1111/j.1365-2966.2011.19456.x; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Salim S, 2009, ASTROPHYS J, V700, P161, DOI 10.1088/0004-637X/700/1/161; Tremaine S, 2002, ASTROPHYS J, V574, P740, DOI 10.1086/341002; Nagao T, 2006, ASTRON ASTROPHYS, V459, P85, DOI 10.1051/0004-6361:20065216; Kennicutt RC, 2008, ASTROPHYS J SUPPL S, V178, P247, DOI 10.1086/590058; Lee JC, 2012, PUBL ASTRON SOC PAC, V124, P782, DOI 10.1086/666528; Salim S, 2007, ASTROPHYS J SUPPL S, V173, P267, DOI 10.1086/519218; Martin DC, 2005, ASTROPHYS J, V619, pL1, DOI 10.1086/426387; Reddy NA, 2008, ASTROPHYS J SUPPL S, V175, P48, DOI 10.1086/521105; Charlot S, 2000, ASTROPHYS J, V539, P718, DOI 10.1086/309250; Ellison SL, 2008, ASTROPHYS J LETT, V672, pL107, DOI 10.1086/527296; Mannucci F, 2010, MON NOT R ASTRON SOC, V408, P2115, DOI 10.1111/j.1365-2966.2010.17291.x; Conroy C, 2009, ASTROPHYS J, V699, P486, DOI 10.1088/0004-637X/699/1/486; Belli S, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/141; Berg DA, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/98; Brown WR, 2008, ASTRON J, V135, P92, DOI 10.1088/0004-6256/135/1/92; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Davis M, 2003, P SOC PHOTO-OPT INS, V4834, P161, DOI 10.1117/12.457897; Dopita MA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/10; Dressler A, 2006, P SOC PHOTO-OPT INS, V6269, pF2690, DOI 10.1117/12.670573; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Furusawa H, 2008, ASTROPHYS J SUPPL S, V176, P1, DOI 10.1086/527321; HECKMAN TM, 1980, ASTRON ASTROPHYS, V87, P152; Henry A, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/148; Henry A, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L27; Hu Esther M, 2009, Astrophysical Journal, V698, DOI 10.1088/0004-637X/698/2/2014; Hughes TM, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201218822; Hunt L, 2012, MON NOT R ASTRON SOC, V427, P906, DOI 10.1111/j.1365-2966.2012.21761.x; Juneau S, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/104; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Lamareille F, 2009, ASTRON ASTROPHYS, V495, P53, DOI 10.1051/0004-6361:200810397; Lara-Lopez MA, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/178; Lara-Lopez MA, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201014803; Lee JC, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/6; Lilly SJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/119; Ly C, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/122; Ly C, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L16; Ly C, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/91; Ly C, 2007, ASTROPHYS J, V657, P738, DOI 10.1086/510828; Ly C, 2009, ASTROPHYS J, V697, P1410, DOI 10.1088/0004-637X/697/2/1410; Ly C, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/109; MADAU P, 1995, ASTROPHYS J, V441, P18, DOI 10.1086/175332; Mannucci F, 2009, MON NOT R ASTRON SOC, V398, P1915, DOI 10.1111/j.1365-2966.2009.15185.x; Maraston C, 2005, MON NOT R ASTRON SOC, V362, P799, DOI 10.1111/j.1365-2966.2005.09270.x; Markwardt CB, 2009, ASTR SOC P, V411, P251; Masters D, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/153; MCGAUGH SS, 1991, ASTROPHYS J, V380, P140, DOI 10.1086/170569; Momcheva IG, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/2/47; Moustakas J., 2011, APJ UNPUB; Nicholls DC, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/148; Nicholls DC, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/21; ODONNELL JE, 1994, ASTROPHYS J, V422, P158, DOI 10.1086/173713; OKE JB, 1974, ASTROPHYS J SUPPL S, V27, P21, DOI 10.1086/190287; Peeples MS, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/54; Peeples MS, 2008, ASTROPHYS J, V685, P904, DOI 10.1086/591492; Perez-Montero E, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220070; Persson SE, 2008, P SOC PHOTO-OPT INS, V7014, pV142, DOI 10.1117/12.790015; Probst R. G., 2008, P SOC PHOTO-OPT INS, V7014, P70142; Rodrigues M, 2008, ASTRON ASTROPHYS, V492, P371, DOI 10.1051/0004-6361:200810435; Salim S, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/134; Sanchez SF, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201220669; Savaglio S, 2005, ASTROPHYS J, V635, P260, DOI 10.1086/497331; Shioya Y, 2008, ASTROPHYS J SUPPL S, V175, P128, DOI 10.1086/523703; Sobral D, 2009, MON NOT R ASTRON SOC, V398, P75, DOI 10.1111/j.1365-2966.2009.15129.x; Stott JP, 2013, MON NOT R ASTRON SOC, V436, P1130, DOI 10.1093/mnras/stt1641; Torrey P, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/108; Vibert D, 2009, PROC SPIE, V7246, DOI 10.1117/12.810228; Villar V, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/47; Whitaker KE, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L29; Whitaker KE, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/104; Xia LF, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/1/28; Yabe K, 2012, PUBL ASTRON SOC JPN, V64; Yabe K, 2014, MON NOT R ASTRON SOC, V437, P3647, DOI 10.1093/mnras/stt2185; Zahid HJ, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/75; Zahid HJ, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/137; Zahid HJ, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/2/L19	119	5	5	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	FEB	2015	149	2							79	10.1088/0004-6256/149/2/79		23	Astronomy & Astrophysics	Astronomy & Astrophysics	CB1BA	WOS:000349360200044		
J	Drory, N; MacDonald, N; Bershady, MA; Bundy, K; Gunn, J; Law, DR; Smith, M; Stoll, R; Tremonti, CA; Wake, DA; Yan, R; Weijmans, AM; Byler, N; Cherinka, B; Cope, F; Eigenbrot, A; Harding, P; Holder, D; Huehnerhoff, J; Jaehnig, K; Jansen, TC; Klaene, M; Paat, AM; Percival, J; Sayres, C				Drory, N.; MacDonald, N.; Bershady, M. A.; Bundy, K.; Gunn, J.; Law, D. R.; Smith, M.; Stoll, R.; Tremonti, C. A.; Wake, D. A.; Yan, R.; Weijmans, A. M.; Byler, N.; Cherinka, B.; Cope, F.; Eigenbrot, A.; Harding, P.; Holder, D.; Huehnerhoff, J.; Jaehnig, K.; Jansen, T. C.; Klaene, M.; Paat, A. M.; Percival, J.; Sayres, C.			THE MaNGA INTEGRAL FIELD UNIT FIBER FEED SYSTEM FOR THE SLOAN 2.5 m TELESCOPE	ASTRONOMICAL JOURNAL			English	Article						galaxies: general; instrumentation: spectrographs; surveys; techniques: imaging spectroscopy	DIGITAL SKY SURVEY; BENCH SPECTROGRAPH; SPECTROSCOPY; SPARSEPAK	We describe the design, manufacture, and performance of bare-fiber integral field units (IFUs) for the SDSS-IV survey Mapping Nearby Galaxies at Apache Point Observatory (MaNGA) on the the Sloan 2.5 m telescope at Apache Point Observatory. MaNGA is a luminosity-selected integral-field spectroscopic survey of 10(4) local galaxies covering 360-1030 nm at R similar to 2200. The IFUs have hexagonal dense packing of fibers with packing regularity of 3 mu m (rms), and throughput of 96 +/- 0.5% from 350 nm to 1 mu m in the lab. Their sizes range from 19 to 127 fibers (3-7 hexagonal layers) using Polymicro FBP 120: 132: 150 mu m core: clad: buffer fibers to reach a fill fraction of 56%. High throughput (and low focal-ratio degradation (FRD)) is achieved by maintaining the fiber cladding and buffer intact, ensuring excellent surface polish, and applying a multi-layer anti-reflection (AR) coating of the input and output surfaces. In operations on-sky, the IFUs show only an additional 2.3% FRD-related variability in throughput despite repeated mechanical stressing during plate plugging (however other losses are present). The IFUs achieve on-sky throughput 5% above the single-fiber feeds used in SDSS-III/BOSS, attributable to equivalent performance compared to single fibers and additional gains from the AR coating. The manufacturing process is geared toward mass-production of high-multiplex systems. The low-stress process involves a precision ferrule with a hexagonal inner shape designed to lead inserted fibers to settle in a dense hexagonal pattern. The ferrule ID is tapered at progressively shallower angles toward its tip and the final 2 mm are straight and only a few microns larger than necessary to hold the desired number of fibers. Our IFU manufacturing process scales easily to accommodate other fiber sizes and can produce IFUs with substantially larger fiber counts. To assure quality, automated testing in a simple and inexpensive system enables complete characterization of throughput and fiber metrology. Future applications include larger IFUs, higher fill factors with stripped buffer, decladding, and lenslet coupling.	[Drory, N.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [MacDonald, N.; Byler, N.; Jansen, T. C.; Paat, A. M.; Sayres, C.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Bershady, M. A.; Smith, M.; Tremonti, C. A.; Wake, D. A.; Eigenbrot, A.; Jaehnig, K.; Percival, J.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Bundy, K.] Univ Tokyo, Kavli Inst Phys & Math Universe, Todai Inst Adv Study, Kavli IPMU,WPI, Kashiwa, Chiba 2778583, Japan; [Gunn, J.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Law, D. R.; Cherinka, B.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Stoll, R.] C Technol Inc, Bridgewater, NJ 08807 USA; [Yan, R.] Univ Kentucky, Dept Phys & Astron, Lexington, KY 40506 USA; [Cope, F.; Holder, D.; Huehnerhoff, J.; Klaene, M.] Apache Point Observ, Sunspot, NM 88349 USA; [Harding, P.] Case Western Reserve Univ, Dept Astron, Cleveland, OH 44106 USA; [Wake, D. A.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Weijmans, A. M.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	Drory, N (reprint author), Univ Texas Austin, McDonald Observ, 1 Univ Stn, Austin, TX 78712 USA.	drory@astro.as.utexas.edu			CONACyT [167332, 180125]; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Leverhulme Foundation; Alfred P. Sloan Foundation; Center for High-Performance Computing at the University of Utah; SDSS Collaboration including the Carnegie Institution for Science; Carnegie Mellon University; Chilean Participation Group; Harvard-Smithsonian Center for Astrophysics; Instituto de Astrofisica de Canarias; Johns Hopkins University; Kavli Institute for the Physics and Mathematics of the Universe (IPMU)/University of Tokyo; Lawrence Berkeley National Laboratory; Leibniz Institut fur Astrophysik Potsdam (AIP); Max-Planck-Institut fur Astrophysik (MPA Garching); Max-Planck-Institut fur Extraterrestrische Physik (MPE); Max-Planck-Institut fur Astronomie (MPIA Heidelberg); National Astronomical Observatory of China; New Mexico State University; New York University; Ohio State University; Pennsylvania State University; Shanghai Astronomical Observatory; United Kingdom Participation Group; Universidad Nacional Autonoma de Mexico; University of Arizona; University of Colorado Boulder; University of Portsmouth; University of Utah; University of Washington; University of Wisconsin; Vanderbilt University; Yale University	N.D. acknowledges support through CONACyT grants 167332 and 180125, and the hospitality of the Max-Planck Institute for Extraterrestrial Physics during the writing of this manuscript. K.B. was supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. M.A.B. acknowledges the hospitality of the Institute for Cosmology and Gravitation (Portsmouth University), and support from the Leverhulme Foundation. We are grateful to J. Gonzalez, J. Bland Hawthorne, G. J. Hill, S. Sanchez, F. Hearty, R. Sharples, M. Blanton, C. Rockosi, M. Roth, and A. Pecontal for advice, reviews, and helpful discussions of all topics surrounding fibers, IFUs, and SDSS. We are grateful to J. Etherington, K. Masters, R. McDermid, O. Steele, K. Thanjavur, D. Thomas, D. Wilkinson, T. Xiao, and K. Zhang for analysis of and insights from data collected with prototype IFUs. Funding for the Sloan Digital Sky Survey IV has been provided by the Alfred P. Sloan Foundation and the Participating Institutions. SDSS-IV acknowledges support and resources from the Center for High-Performance Computing at the University of Utah. The SDSS web site is www.sdss.org. SDSS-IV is managed by the Astrophysical Research Consortium for the Participating Institutions of the SDSS Collaboration including the Carnegie Institution for Science, Carnegie Mellon University, the Chilean Participation Group, Harvard-Smithsonian Center for Astrophysics, Instituto de Astrofisica de Canarias, The Johns Hopkins University, Kavli Institute for the Physics and Mathematics of the Universe (IPMU)/University of Tokyo, Lawrence Berkeley National Laboratory, Leibniz Institut fur Astrophysik Potsdam (AIP), Max-Planck-Institut fur Astrophysik (MPA Garching), Max-Planck-Institut fur Extraterrestrische Physik (MPE), Max-Planck-Institut fur Astronomie (MPIA Heidelberg), National Astronomical Observatory of China, New Mexico State University, New York University, The Ohio State University, Pennsylvania State University, Shanghai Astronomical Observatory, United Kingdom Participation Group, Universidad Nacional Autonoma de Mexico, University of Arizona, University of Colorado Boulder, University of Portsmouth, University of Utah, University of Washington, University of Wisconsin, Vanderbilt University, and Yale University.	Kelz A, 2006, PUBL ASTRON SOC PAC, V118, P129, DOI 10.1086/497455; Croom SM, 2012, MON NOT R ASTRON SOC, V421, P872, DOI 10.1111/j.1365-2966.2011.20365.x; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Gunn JE, 2006, ASTRON J, V131, P2332, DOI 10.1086/500975; Fabricant D, 2005, PUBL ASTRON SOC PAC, V117, P1411, DOI 10.1086/497385; ARRIBAS S, 1991, ASTROPHYS J, V369, P260, DOI 10.1086/169757; Barden SC, 1998, P SOC PHOTO-OPT INS, V3355, P892, DOI 10.1117/12.316744; Bershady MA, 2004, PUBL ASTRON SOC PAC, V116, P565, DOI 10.1086/421057; Bershady MA, 2005, ASTROPHYS J SUPPL S, V156, P311, DOI 10.1086/426479; Bland-Hawthorn J., 2010, P SOC PHOTO-OPT INS, V7735, P41; Bryant JJ, 2014, MON NOT R ASTRON SOC, V438, P869, DOI 10.1093/mnras/stt2254; Bundy K, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/7; Crause L., 2008, P SOC PHOTO-OPT INS, V7014, P6; Eigenbrot A. D., 2012, P SOC PHOTO-OPT INS, V8446, P5; Fabricius M. H., 2008, P SOC PHOTO-OPT INS, V7014, P73; Hill G. J., 2008, P SOC PHOTO-OPT INS, V7014, P70; Murphy J. D., 2008, P SOC PHOTO-OPT INS, V7018, P2; Smee SA, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/32; WYNNE CG, 1993, MON NOT R ASTRON SOC, V260, P307	19	6	6	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	FEB	2015	149	2							77	10.1088/0004-6256/149/2/77		24	Astronomy & Astrophysics	Astronomy & Astrophysics	CB1BA	WOS:000349360200042		
J	Kasuga, T; Usui, F; Shirahata, M; Kuroda, D; Ootsubo, T; Okamura, N; Hasegawa, S				Kasuga, Toshihiro; Usui, Fumihiko; Shirahata, Mai; Kuroda, Daisuke; Ootsubo, Takafumi; Okamura, Natsuko; Hasegawa, Sunao			NEAR-INFRARED SPECTRA OF HIGH-ALBEDO OUTER MAIN-BELT ASTEROIDS	ASTRONOMICAL JOURNAL			English	Article						infrared: planetary systems; minor planets, asteroids: general	JOVIAN TROJAN ASTEROIDS; B-TYPE ASTEROIDS; SPECTROSCOPIC SURVEY; WATER-ICE; SURFACE-COMPOSITION; SUBARU TELESCOPE; COMETARY NUCLEI; 596 SCHEILA; BIDIRECTIONAL REFLECTANCE; THERMAL METAMORPHISM	Most outer main-belt asteroids have low albedos because of their carbonaceouslike bodies. However, infrared satellite surveys have revealed that some asteroids have high albedos, which may suggest the presence of unusual surface minerals for those primitive objects. We present new near-infrared (1.1-2.5 mu m) spectra of four outer main-belt asteroids with albedos >= 0.1. The C-complex asteroids (555) Norma and (2542) Calpurnia are featureless and have (50%-60%) amorphous Mg pyroxenes that might explain the high albedos. Asteroids (701) Oriola (which is a C-complex asteroid) and (2670) Chuvashia (a D/T-type or M-type asteroid) show possible broad absorption bands (1.5-2.1 mu m). The feature can be reproduced by either Mg-rich amorphous pyroxene (with 50%-60% and 80%-95% Mg, respectively) or orthopyroxene (crystalline silicate), which might be responsible for the high albedos. No absorption features of water ice (near 1.5 and 2.0 mu m) are detected in the objects. We discuss the origin of high albedo components in the outer main-belt asteroids and their physical relations to comets.	[Kasuga, Toshihiro; Shirahata, Mai] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Usui, Fumihiko] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Shirahata, Mai; Hasegawa, Sunao] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Kuroda, Daisuke] Natl Astron Observ Japan, Okayama Astrophys Observ, Asakuchi, Okayama 7190232, Japan; [Ootsubo, Takafumi] Univ Tokyo, Grad Sch Arts & Sci, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan; [Okamura, Natsuko] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan	Kasuga, T (reprint author), Natl Inst Nat Sci, Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	toshi.kasuga@nao.ac.jp			NAOJ Overseas Visit Program; Optical & Near-Infrared Astronomy Inter-University Cooperation Program; MEXT of Japan; JSPS KAKENHI Grant [25400220]; Space Plasma Laboratory, ISAS/JAXA; National Science Foundation [0506716]; NASA [NAG5-12355]	Toshi Kasuga acknowledges Prof. Kathrin Altwegg for her encouragement of this work at the University of Bern. We thank Hideyo Kawakita, Tomoko Arai, Keiko Nakamura-Messenger, and David Jewitt for discussions. T. K. is financially supported by the NAOJ Overseas Visit Program for Young Researchers. D. K. is supported by the Optical & Near-Infrared Astronomy Inter-University Cooperation Program, the MEXT of Japan. T. O. is supported in part by JSPS KAKENHI Grant Number 25400220. S. H. is supported by the Space Plasma Laboratory, ISAS/JAXA. Taxonomic type results presented in this work were determined, in whole or in part, using the Bus-DeMeo Taxonomy Classification Web tool by Stephen M. Slivan, developed at MIT with the support of National Science Foundation Grant 0506716 and NASA Grant NAG5-12355. The data herein were obtained at the NAOJ Subaru Telescope with assistance from Miki Ishii and Michael Lemmen. We appreciate the informative comments from the anonymous reviewer.	Wooden DH, 2008, SPACE SCI REV, V138, P75, DOI 10.1007/s11214-008-9424-2; JONES TD, 1990, ICARUS, V88, P172, DOI 10.1016/0019-1035(90)90184-B; Vernazza P, 2005, ASTRON ASTROPHYS, V436, P1113, DOI 10.1051/0004-6361:20042506; Bus SJ, 2002, ICARUS, V158, P106, DOI 10.1006/icar.2002.6857; HIROI T, 1993, SCIENCE, V261, P1016, DOI 10.1126/science.261.5124.1016; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Ryan EL, 2010, ASTRON J, V140, P933, DOI 10.1088/0004-6256/140/4/933; GAFFEY MJ, 1993, METEORITICS, V28, P161; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Lamy P, 2009, ICARUS, V201, P674, DOI 10.1016/j.icarus.2009.01.030; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; AHEARN MF, 1992, ICARUS, V98, P54, DOI 10.1016/0019-1035(92)90206-M; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Ootsubo T, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/15; de Leon J, 2012, ICARUS, V218, P196, DOI 10.1016/j.icarus.2011.11.024; DeMeo FE, 2013, ICARUS, V226, P723, DOI 10.1016/j.icarus.2013.06.027; Usui F, 2011, PUBL ASTRON SOC JPN, V63, P1117; Fernandez YR, 2005, ASTRON J, V130, P308, DOI 10.1086/430802; Demeo F, 2008, ICARUS, V194, P436, DOI 10.1016/j.icarus.2007.10.011; Demeo FE, 2009, ICARUS, V202, P160, DOI 10.1016/j.icarus.2009.02.005; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; Dotto E, 2006, ICARUS, V183, P420, DOI 10.1016/j.icarus.2006.02.012; DORSCHNER J, 1995, ASTRON ASTROPHYS, V300, P503; Kasuga T, 2005, ASTRON ASTROPHYS, V438, pL17, DOI 10.1051/0004-6361:200500142; Tedesco EF, 2002, ASTRON J, V123, P1056, DOI 10.1086/338320; Szabo GM, 2007, MON NOT R ASTRON SOC, V377, P1393, DOI 10.1111/j.1365-2966.2007.11687.x; Hiroi T, 1996, METORIT PLANET SCI, V31, P321; Jessberger EK, 1999, SPACE SCI REV, V90, P91, DOI 10.1023/A:1005233727874; VILAS F, 1989, SCIENCE, V246, P790, DOI 10.1126/science.246.4931.790; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; ROULEAU F, 1991, ASTROPHYS J, V377, P526, DOI 10.1086/170382; Berger EL, 2011, GEOCHIM COSMOCHIM AC, V75, P3501, DOI 10.1016/j.gca.2011.03.026; Tokunaga AT, 1998, P SOC PHOTO-OPT INS, V3354, P512, DOI 10.1117/12.317277; POLLACK JB, 1994, ASTROPHYS J, V421, P615, DOI 10.1086/173677; Yang B, 2007, ASTRON J, V134, P223, DOI 10.1086/518368; Kuppers M, 2014, NATURE, V505, P525, DOI 10.1038/nature12918; Prialnik D, 2008, SPACE SCI REV, V138, P147, DOI 10.1007/s11214-007-9301-4; Lazzaro D, 2004, ICARUS, V172, P179, DOI 10.1016/j.icarus.2004.06.006; Zolensky M, 2008, METEORIT PLANET SCI, V43, P261; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; Hanner MS, 1999, SPACE SCI REV, V90, P99, DOI 10.1023/A:1005285711945; Bus SJ, 2002, ICARUS, V158, P146, DOI 10.1006/icar.2002.6856; Takir D, 2012, ICARUS, V219, P641, DOI 10.1016/j.icarus.2012.02.022; Lucey PG, 2008, ICARUS, V197, P348, DOI 10.1016/j.icarus.2008.05.008; Miles R, 2012, ICARUS, V219, P567, DOI 10.1016/j.icarus.2012.03.036; Kelley MS, 2009, PLANET SPACE SCI, V57, P1133, DOI 10.1016/j.pss.2008.11.017; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842; Bell J.F., 1989, ASTEROIDS, VII, P921; Bendjoya P, 2004, ICARUS, V168, P374, DOI 10.1016/j.icarus.2003.12.004; Binzel R. P., 1989, ASTEROIDS, VII, P1139; BISHOP JL, 1995, J GEOPHYS RES-PLANET, V100, P5369, DOI 10.1029/94JE03331; Bodewits D, 2014, ICARUS, V229, P190, DOI 10.1016/j.icarus.2013.11.003; Bodewits D, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L3; Bowell E., 1979, ASTEROIDS, P1108; Brearley A. J., 2006, METEORITES EARLY SOL, P584; Bus S. J., 1999, THESIS MIT; Carruba V, 2013, MON NOT R ASTRON SOC, V431, P3557, DOI 10.1093/mnras/stt437; CLARK RN, 1984, J GEOPHYS RES, V89, P6341, DOI 10.1029/JB089iB07p06341; Cruikshank DP, 2001, ICARUS, V153, P348, DOI 10.1006/icar.2001.6703; Emery JP, 2003, ICARUS, V164, P104, DOI 10.1016/S0019-1035(03)00143-X; Emery JP, 2004, ICARUS, V170, P131, DOI 10.1016/j.icarus.2004.02.004; Fornasier S, 2010, ICARUS, V210, P655, DOI 10.1016/j.icarus.2010.07.001; GAFFEY MJ, 1978, SPACE SCI REV, V21, P555; Hapke B., 2012, THEORY REFLECTANCE E; HAPKE B, 1981, J GEOPHYS RES, V86, P3039, DOI 10.1029/JB086iB04p03039; Hapke B, 1993, THEORY REFLECTANCE E; Hasegawa S., 2003, GEOPHYS RES LETT, V30, P2; Hasselmann P.H., 2012, SDSS BASED ASTEROID; Hayano Y., 2010, P SOC PHOTO-OPT INS, V7736, P21; Ishigaki T, 2004, PUBL ASTRON SOC JPN, V56, P723; Ishiguro M, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L11; Jewitt D, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L4; Jewitt D., 2004, COMETS, VII, P659; Jewitt D., 2007, PROTOSTARS PLANETS, VV, P863; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Jewitt DC, 2002, ASTRON J, V123, P1039, DOI 10.1086/338692; Kamei A, 2002, ICARUS, V156, P551, DOI 10.1006/icar.2002.6818; Kasuga T, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/1/1; Kasuga T, 2005, ASTRON ASTROPHYS, V435, P341, DOI 10.1051/0004-6361:20041428; Kasuga T, 2010, ASTRON J, V140, P1806, DOI 10.1088/0004-6256/140/6/1806; Lamy P. L., 2004, COMETS, VII, P223; Licandro J, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015339; Masiero JR, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/68; Masiero JR, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/1/L8; Masiero JR, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/121; McCord T. B., 2012, NATUR, V490, P83; McKinnon W. B., 2008, SOLAR SYSTEM NEPTUNE, P213; McSween Jr H. Y., 2002, ASTEROIDS, P559; Merk P., 2006, ICAR, V183, P283; Minowa Y., 2010, P SOC PHOTO-OPT INS, V7736, P122; Mothe'-Diniz T., 2012, MOTHE DINIZ ASTEROID; Nakamura-Messenger K, 2011, METEORIT PLANET SCI, V46, P843, DOI 10.1111/j.1945-5100.2011.01197.x; Nesvorny D., 2012, NESVORNY HCM ASTEROI, P189; Novakovic B., 2011, THESIS U BELGRADE; Ohtani H, 1998, P SOC PHOTO-OPT INS, V3355, P750, DOI 10.1117/12.316842; Prialnik D, 1999, SPACE SCI REV, V90, P169, DOI 10.1023/A:1005202215579; RIETMEIJER FJM, 1985, NATURE, V313, P293, DOI 10.1038/313293a0; Rivkin A. S., 2012, EPSC2012359; Rivkin A. S., 2012, AGU; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; ROUSH TL, 1994, ICARUS, V108, P243, DOI 10.1006/icar.1994.1059; Terada H, 2004, P SOC PHOTO-OPT INS, V5492, P1542, DOI 10.1117/12.552516; Tholen D.J., 1984, THESIS ARIZONA U TUC; Usui F, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/56; Weisberg M.K., 2006, METEORITES EARLY SOL, VII, P19; YAMAMOTO T, 1985, ASTRON ASTROPHYS, V142, P31; Yang B, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/95; Yang B, 2010, ASTRON J, V140, P692, DOI 10.1088/0004-6256/140/3/692; Yang B, 2013, ICARUS, V223, P359, DOI 10.1016/j.icarus.2012.11.025	110	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	FEB	2015	149	2							37	10.1088/0004-6256/149/2/37		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CB1BA	WOS:000349360200002		
J	Meixner, M; Panuzzo, P; Roman-Duval, J; Engelbracht, C; Babler, B; Seale, J; Hony, S; Montiel, E; Sauvage, M; Gordon, K; Misselt, K; Okumura, K; Chanial, P; Beck, T; Bernard, JP; Bolatto, A; Bot, C; Boyer, ML; Carlson, LR; Clayton, GC; Chen, CHR; Cormier, D; Fukui, Y; Galametz, M; Galliano, F; Hora, JL; Hughes, A; Indebetouw, R; Israel, FP; Kawamura, A; Kemper, F; Kim, S; Kwon, E; Lebouteiller, V; Li, A; Long, KS; Madden, SC; Matsuura, M; Muller, E; Oliveira, JM; Onishi, T; Otsuka, M; Paradis, D; Poglitsch, A; Reach, WT; Robitaille, TP; Rubio, M; Sargent, B; Sewilo, M; Skibba, R; Smith, LJ; Srinivasan, S; Tielens, AGGM; van Loon, JT; Whitney, B				Meixner, M.; Panuzzo, P.; Roman-Duval, J.; Engelbracht, C.; Babler, B.; Seale, J.; Hony, S.; Montiel, E.; Sauvage, M.; Gordon, K.; Misselt, K.; Okumura, K.; Chanial, P.; Beck, T.; Bernard, J. -P.; Bolatto, A.; Bot, C.; Boyer, M. L.; Carlson, L. R.; Clayton, G. C.; Chen, C. -H. R.; Cormier, D.; Fukui, Y.; Galametz, M.; Galliano, F.; Hora, J. L.; Hughes, A.; Indebetouw, R.; Israel, F. P.; Kawamura, A.; Kemper, F.; Kim, S.; Kwon, E.; Lebouteiller, V.; Li, A.; Long, K. S.; Madden, S. C.; Matsuura, M.; Muller, E.; Oliveira, J. M.; Onishi, T.; Otsuka, M.; Paradis, D.; Poglitsch, A.; Reach, W. T.; Robitaille, T. P.; Rubio, M.; Sargent, B.; Sewilo, M.; Skibba, R.; Smith, L. J.; Srinivasan, S.; Tielens, A. G. G. M.; van Loon, J. Th.; Whitney, B.			THE HERSCHEL INVENTORY OF THE AGENTS OF GALAXY EVOLUTION (HERITAGE) IN THE MAGELLANIC CLOUDS, A HERSCHEL OPEN TIME KEY PROGRAM (vol 146, 62, 2013)	ASTRONOMICAL JOURNAL			English	Correction							EXCESS EMISSION; SUBMILLIMETER; DUST; ORIGIN; GAS		[Meixner, M.; Roman-Duval, J.; Seale, J.; Gordon, K.; Beck, T.; Boyer, M. L.; Long, K. S.; Sargent, B.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Meixner, M.; Sewilo, M.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Panuzzo, P.; Hony, S.; Sauvage, M.; Okumura, K.; Chanial, P.; Cormier, D.; Galliano, F.; Lebouteiller, V.; Madden, S. C.] CEA, Lab AIM, Irfu, SAp, F-91191 Gif Sur Yvette, France; [Panuzzo, P.] CNRS, Observ Paris, Lab GEPI, F-92195 Meudon, France; [Engelbracht, C.; Montiel, E.; Misselt, K.; Skibba, R.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Engelbracht, C.] Raytheon Co, Tucson, AZ 85756 USA; [Babler, B.; Whitney, B.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Montiel, E.; Clayton, G. C.] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; [Bernard, J. -P.; Paradis, D.] CNRS, IRAP, F-31028 Toulouse 4, France; [Bernard, J. -P.; Paradis, D.] Univ Toulouse, UPS OMP, IRAP, F-31028 Toulouse 4, France; [Bolatto, A.] Univ Maryland, Dept Astron, Lab Millimeter Wave Astron, College Pk, MD 20742 USA; [Bot, C.] Univ Strasbourg, Observ Astron Strasbourg, F-67000 Strasbourg, France; [Bot, C.] CNRS, Observ Astron Strasbourg, UMR7550, F-67000 Strasbourg, France; [Boyer, M. L.] NASA, Goddard Space Flight Ctr, Observat Cosmol Lab, Greenbelt, MD 20771 USA; [Boyer, M. L.] Oak Ridge Associated Univ, Oak Ridge, TN 37831 USA; [Chen, C. -H. R.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Fukui, Y.] Nagoya Univ, Dept Astrophys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hora, J. L.] Harvard Univ, Ctr Astrophys, Cambridge, MA 02138 USA; [Hughes, A.; Robitaille, T. P.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Indebetouw, R.] Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; [Indebetouw, R.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Kawamura, A.; Muller, E.] Natl Astron Observ Japan, Tokyo 1818588, Japan; [Kemper, F.; Otsuka, M.; Srinivasan, S.] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Kim, S.] Sejong Univ, Dept Astron & Space Sci, Seoul 143747, South Korea; [Li, A.] Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA; [Matsuura, M.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Oliveira, J. M.; van Loon, J. Th.] Keele Univ, Lennard Jones Labs, Sch Phys & Geog Sci, Keele ST5 5BG, Staffs, England; [Onishi, T.] Osaka Prefecture Univ, Dept Phys Sci, Sakai, Osaka 5998531, Japan; [Poglitsch, A.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Reach, W. T.] Univ Space Res Assoc, Stratospher Observ Infrared Astron, Moffett Field, CA 94035 USA; [Rubio, M.] Univ Chile, Dept Astron, Santiago, Chile; [Sargent, B.] Rochester Inst Technol, Ctr Imaging Sci, Rochester, NY 14623 USA; [Sargent, B.] Rochester Inst Technol, Lab Multiwavelength Astrophys, Rochester, NY 14623 USA; [Smith, L. J.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Smith, L. J.] European Space Agcy, Baltimore, MD 21218 USA; [Srinivasan, S.] UPMC, CNRS, UMR7095, Inst Astrophys, F-75014 Paris, France	Meixner, M (reprint author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	meixner@stsci.edu	Kemper, Francisca/D-8688-2011	Kemper, Francisca/0000-0003-2743-8240			Gordon KD, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/85; Gordon KD, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/102; Israel FP, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/201014073; Meixner M, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/3/62; Ade PAR, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201116473; Roman-Duval J, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/86	6	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	FEB	2015	149	2							88	10.1088/0004-6256/149/2/88		2	Astronomy & Astrophysics	Astronomy & Astrophysics	CB1BA	WOS:000349360200053		
J	Sun, XH; Rudnick, L; Akahori, T; Anderson, CS; Bell, MR; Bray, JD; Farnes, JS; Ideguchi, S; Kumazaki, K; O'Brien, T; O'Sullivan, SP; Scaife, AMM; Stepanov, R; Stil, J; Takahashi, K; van Weeren, RJ; Wolleben, M				Sun, X. H.; Rudnick, L.; Akahori, Takuya; Anderson, C. S.; Bell, M. R.; Bray, J. D.; Farnes, J. S.; Ideguchi, S.; Kumazaki, K.; O'Brien, T.; O'Sullivan, S. P.; Scaife, A. M. M.; Stepanov, R.; Stil, J.; Takahashi, K.; van Weeren, R. J.; Wolleben, M.			COMPARISON OF ALGORITHMS FOR DETERMINATION OF ROTATION MEASURE AND FARADAY STRUCTURE. I. 1100-1400MHZ	ASTRONOMICAL JOURNAL			English	Article						ISM: magnetic fields; magnetic fields; polarization; radio continuum: general; techniques: polarimetric	INTERGALACTIC MAGNETIC-FIELD; EXTRAGALACTIC RADIO-SOURCES; LARGE-MAGELLANIC-CLOUD; SIMILAR-TO 1; POLARIZED EMISSION; 350 MHZ; DEPOLARIZATION; GALAXIES; POLARIMETRY; TOMOGRAPHY	Faraday rotation measures (RMs) and more general Faraday structures are key parameters for studying cosmic magnetism and are also sensitive probes of faint ionized thermal gas. A definition of which derived quantities are required for various scientific studies is needed, as well as addressing the challenges in determining Faraday structures. A wide variety of algorithms has been proposed to reconstruct these structures. In preparation for the Polarization Sky Survey of the Universe ' s Magnetism (POSSUM) to be conducted with the Australian Square Kilometre Array Pathfinder and the ongoing Galactic Arecibo L-band Feeds Array Continuum Transit Survey (GALFACTS), we run a Faraday structure determination data challenge to benchmark the currently available algorithms, including Faraday synthesis (previously called RM synthesis in the literature), wavelet, compressive sampling, and QU-fitting. The input models include sources with one Faraday thin component, two Faraday thin components, and one Faraday thick component. The frequency set is similar to POSSUM/GALFACTS with a 300 MHz bandwidth from 1.1 to 1.4 GHz. We define three figures of merit motivated by the underlying science: (1) an average RM weighted by polarized intensity, RMwtd, (2) the separation Df of two Faraday components, and (3) the reduced chi-squared c r 2. Based on the current test data with a signal-to-noise ratio of about 32, we find the following. (1) When only one Faraday thin component is present, most methods perform as expected, with occasional failures where two components are incorrectly found. (2) For two Faraday thin components, QU-fitting routines perform the best, with errors close to the theoretical ones for RMwtd but with significantly higher errors for Df. All other methods, including standard Faraday synthesis, frequently identify only one component when Df is below or near the width of the Faraday point-spread function. (3) No methods as currently implemented work well for Faraday thick components due to the narrow bandwidth. (4) There exist combinations of two Faraday components that produce a large range of acceptable fits and hence large uncertainties in the derived single RMs; in these cases, different RMs lead to the same Q, U behavior, so no method can recover a unique input model. Further exploration of all these issues is required before upcoming surveys will be able to provide reliable results on Faraday structures.	[Sun, X. H.; Akahori, Takuya; Anderson, C. S.; Farnes, J. S.; O'Sullivan, S. P.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Rudnick, L.; O'Brien, T.] Univ Minnesota, Sch Phys & Astron, Minnesota Inst Astrophys, Minneapolis, MN 55455 USA; [Bell, M. R.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Bray, J. D.; Scaife, A. M. M.] Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England; [Ideguchi, S.; Kumazaki, K.] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Stepanov, R.] Inst Continuous Media Mech, Perm 614061, Russia; [Stepanov, R.] Perm Natl Res Polytech Univ, Perm 614990, Russia; [Stil, J.; Wolleben, M.] Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada; [Takahashi, K.] Kumamoto Univ, Kumamoto 8608555, Japan; [van Weeren, R. J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Sun, XH (reprint author), Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia.	x.sun@physics.usyd.edu.au; larry@umn.edu	Stepanov, Rodion/D-2221-2009	Stepanov, Rodion/0000-0001-8098-0720			Akahori T, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu033; Akahori T, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/150; Akahori T, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/134; Andrecut M, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/2/33; O'Sullivan SP, 2012, MON NOT R ASTRON SOC, V421, P3300, DOI 10.1111/j.1365-2966.2012.20554.x; Feroz F, 2008, MON NOT R ASTRON SOC, V384, P449, DOI 10.1111/j.1365-2966.2007.12353.x; Han JL, 1997, ASTRON ASTROPHYS, V322, P98; Taylor AR, 2009, ASTROPHYS J, V702, P1230, DOI 10.1088/0004-637X/702/2/1230; Fletcher A, 2011, MON NOT R ASTRON SOC, V412, P2396, DOI 10.1111/j.1365-2966.2010.18065.x; Gaensler BM, 2005, SCIENCE, V307, P1610, DOI 10.1126/science.1108832; Haverkorn M, 2003, ASTRON ASTROPHYS, V404, P233, DOI 10.1051/0004-6361:20030530; Minter AH, 1996, ASTROPHYS J, V458, P194, DOI 10.1086/176803; Feroz F, 2009, MON NOT R ASTRON SOC, V398, P1601, DOI 10.1111/j.1365-2966.2009.14548.x; Wolleben M, 2010, ASTRON J, V139, P1681, DOI 10.1088/0004-6256/139/4/1681; Schnitzeler DHFM, 2009, ASTRON ASTROPHYS, V494, P611, DOI 10.1051/0004-6361:20078912; Wolleben M, 2010, ASTROPHYS J LETT, V724, pL48, DOI 10.1088/2041-8205/724/1/L48; Bonafede A, 2013, MON NOT R ASTRON SOC, V433, P3208, DOI 10.1093/mnras/stt960; Akahori T, 2010, ASTROPHYS J, V723, P476, DOI 10.1088/0004-637X/723/1/476; Sokoloff DD, 1998, MON NOT R ASTRON SOC, V299, P189, DOI 10.1046/j.1365-8711.1998.01782.x; Sun XH, 2010, RES ASTRON ASTROPHYS, V10, P1287, DOI 10.1088/1674-4527/10/12/009; Brentjens MA, 2005, ASTRON ASTROPHYS, V441, P1217, DOI 10.1051/0004-6361:20052990; Scaife AMM, 2012, MON NOT R ASTRON SOC, V423, pL30, DOI 10.1111/j.1745-3933.2012.01251.x; Taylor AR, 2010, ASTR SOC P, V438, P402; Mao SA, 2010, ASTROPHYS J, V714, P1170, DOI 10.1088/0004-637X/714/2/1170; Condon JJ, 1998, ASTRON J, V115, P1693, DOI 10.1086/300337; Beck R, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219094; Bell MR, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118672; Bell MR, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220771; Bernet ML, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/2/L28; Brandenburg A, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/91; Braun R, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913375; BURN BJ, 1966, MON NOT R ASTRON SOC, V133, P67; Farnes JS, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/1/15; Farnsworth D, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/6/191; Frick P, 2011, MON NOT R ASTRON SOC, V414, P2540, DOI 10.1111/j.1365-2966.2011.18571.x; Frick P, 2010, MON NOT R ASTRON SOC, V401, pL24, DOI 10.1111/j.1745-3933.2009.00778.x; Gaensler B. M., 2010, BAAS, V215; Gaensler BM, 2004, NEW ASTRON REV, V48, P1003, DOI 10.1016/j.newar.2004.09.003; George SJ, 2012, PUBL ASTRON SOC AUST, V29, P214, DOI 10.1071/AS11027; Giessubel R, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201321765; Han JL, 1998, ASTRON ASTROPHYS, V335, P1117; Harvey-Smith L, 2010, ASTROPHYS J, V712, P1157, DOI 10.1088/0004-637X/712/2/1157; Harvey-Smith L, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/83; Heald G, 2009, IAU S, V259, P591; Hill AS, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/55; Hogbom J. A., 1974, Astronomy and Astrophysics Supplement Series, V15; Horellou C, 2014, MON NOT R ASTRON SOC, V441, P2049, DOI 10.1093/mnras/stu701; Ideguchi S, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/pst007; Jansson R, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/14; Kothes R., 2009, IAU S, V259, P75, DOI DOI 10.1017/S1743921309030087; Kumazaki K, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu030; Law CJ, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/57; Li F, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201015890; Mao SA, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/25; O'Sullivan SP, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/162; Pshirkov MS, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/192; Rudnick L, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/45; Schnitzeler DHFM, 2010, MON NOT R ASTRON SOC, V409, pL99, DOI 10.1111/j.1745-3933.2010.00957.x; Sun XH, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117679; Sun XH, 2009, ASTRON ASTROPHYS, V507, P1087, DOI 10.1051/0004-6361/200912539; Van Eck C L, 2011, Astrophysical Journal, V728, DOI 10.1088/0004-637X/728/2/97	61	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	FEB	2015	149	2							60	10.1088/0004-6256/149/2/60		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CB1BA	WOS:000349360200025		
J	Yagi, M; Gu, LY; Koyama, Y; Nakata, F; Kodama, T; Hattori, T; Yoshida, M				Yagi, Masafumi; Gu, Liyi; Koyama, Yusei; Nakata, Fumiaki; Kodama, Tadayuki; Hattori, Takashi; Yoshida, Michitoshi			DISCOVERY OF NINE EXTENDED IONIZED GAS CLOUDS IN A z=0.4 CLUSTER	ASTRONOMICAL JOURNAL			English	Article						galaxies: clusters: individual (Abell 851, CL0024+17); galaxies: clusters: intracluster medium; galaxies: evolution; intergalactic medium	DIGITAL SKY SURVEY; STAR-FORMATION; COMA CLUSTER; SPECTROSCOPIC SURVEY; DISTANT CLUSTERS; VIRGO CLUSTER; DATA RELEASE; SUPRIME-CAM; ABELL 851; GALAXIES	From deep H alpha imaging data of Suprime-Cam/Subaru, we discovered nine extended ionized gas clouds (EIG) around galaxies in the Abell 851 cluster (A851) at z = 0.4. We surveyed a 30 x 25 arcmin region, and the EIGs were found only near the cluster center (<2.3 arcmin similar to 750 kpc). The parent galaxies of the EIGs are star-forming or post-starburst galaxies, all of which are spectroscopically confirmed members of the cluster. Four out of the nine parent galaxies show distortion of stellar distribution in the disk, which can be a sign of recent interaction, and the interaction may have made the EIGs. On the other hand, six parent galaxies (one overlaps those exhibiting distortion) show Ha emission without stars, which implies ram pressure stripping. The spectrum of the brightest parent galaxy shows a post-starburst signature and resembles the Ha stripped galaxies found in the Coma cluster. Meanwhile, two brightest parent galaxies in A851 are more massive than the EIG parent galaxies in the Coma cluster. This is consistent with a "downsizing" of star-forming galaxies, though it is still within the statistical variance. We also analyzed Suprime-Cam data of another z = 0.39 cluster, CL0024+17, but found no EIGs. The key difference between A851 and CL0024+17 would be the existence of a subcluster colliding with the main body of A851, in which six or seven out of the nine parent galaxies in A851 exist, and the fraction of EIGs in the subcluster is significantly higher than the main subcluster of A851 and CL0024+17.	[Yagi, Masafumi; Koyama, Yusei; Kodama, Tadayuki] Natl Astron Observ Japan, Opt & Infrared Astron Div, Mitaka, Tokyo 1818588, Japan; [Gu, Liyi] Univ Tokyo, Sch Sci, Res Ctr Early Univ, Bunkyo Ku, Tokyo 1130011, Japan; [Gu, Liyi] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130011, Japan; [Koyama, Yusei] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Nakata, Fumiaki; Hattori, Takashi] Subaru Telescope, Hilo, HI 96720 USA; [Yoshida, Michitoshi] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Higashihiroshima, Hiroshima 7398526, Japan	Yagi, M (reprint author), Natl Astron Observ Japan, Opt & Infrared Astron Div, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	YAGI.Masafumi@nao.ac.jp					Ahn CP, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/21; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Dressler A, 1999, ASTROPHYS J SUPPL S, V122, P51, DOI 10.1086/313213; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Oosterloo T, 2005, ASTRON ASTROPHYS, V437, pL19, DOI [10.1051/0004-6361:200500127, 10.1081/0004-6361:200500127]; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Poggianti BM, 1999, ASTROPHYS J, V518, P576, DOI 10.1086/307322; Stern D, 2005, ASTROPHYS J, V631, P163, DOI 10.1086/432523; Koyama Y, 2013, MON NOT R ASTRON SOC, V434, P423, DOI 10.1093/mnras/stt1035; Smith RJ, 2010, MON NOT R ASTRON SOC, V408, P1417, DOI 10.1111/j.1365-2966.2010.17253.x; Sun M, 2010, ASTROPHYS J, V708, P946, DOI 10.1088/0004-637X/708/2/946; Yoshida M, 2002, ASTROPHYS J, V567, P118, DOI 10.1086/338353; Kodama T, 2004, MON NOT R ASTRON SOC, V354, P1103, DOI 10.1111/j.1365-2966.2004.08271.x; GUNN JE, 1972, ASTROPHYS J, V176, P1, DOI 10.1086/151605; BUTCHER H, 1984, ASTROPHYS J, V285, P426, DOI 10.1086/162519; Umetsu K, 2010, ASTROPHYS J, V714, P1470, DOI 10.1088/0004-637X/714/2/1470; Oemler A, 2009, ASTROPHYS J, V693, P152, DOI 10.1088/0004-637X/693/1/152; Kashikawa N, 2002, PUBL ASTRON SOC JPN, V54, P819; Cortese L, 2007, MON NOT R ASTRON SOC, V376, P157, DOI 10.1111/j.1365-2966.2006.11369.x; Wen ZL, 2013, MON NOT R ASTRON SOC, V436, P275, DOI 10.1093/mnras/stt1581; Poggianti BM, 2004, ASTROPHYS J, V601, P197, DOI 10.1086/380195; Sun M, 2007, ASTROPHYS J, V671, P190, DOI 10.1086/522690; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Kodama T, 2001, ASTROPHYS J, V562, pL9, DOI 10.1086/338100; Cortese L, 2006, ASTRON ASTROPHYS, V453, P847, DOI 10.1051/0004-6361:20064873; Yagi M, 2007, ASTROPHYS J, V660, P1209, DOI 10.1086/512359; Dressler A, 2009, ASTROPHYS J, V693, P140, DOI 10.1088/0004-637X/693/1/140; Gavazzi G, 2001, ASTROPHYS J, V563, pL23, DOI 10.1086/338389; Kenney JDP, 2008, ASTROPHYS J LETT, V687, pL69, DOI 10.1086/593300; Baba H, 2002, ASTR SOC P, V281, P298; Moran SM, 2007, ASTROPHYS J, V671, P1503, DOI 10.1086/522303; BINGGELI B, 1988, ANNU REV ASTRON ASTR, V26, P509; Arrigoni Battaia F., 2012, ASTRON ASTROPHYS, V543, pA112; Czoske O, 2002, ASTRON ASTROPHYS, V386, P31, DOI 10.1051/0004-6361:20020230; Fossati M, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219933; Furusawa H, 2000, ASTROPHYS J, V534, P624, DOI 10.1086/308794; Gu LY, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/2/L36; Hayashino T., 2003, PUBL NATL ASTRON OBS, V7, P33; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Jansen RA, 2000, ASTROPHYS J SUPPL S, V126, P331, DOI 10.1086/313308; Kenney JDP, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/119; Kewley LJ, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/1/L10; Kodama T, 1997, ASTRON ASTROPHYS, V320, P41; Kong X, 2002, ASTRON ASTROPHYS, V396, P503, DOI 10.1051/0004-6361:20021452; Koyama Y, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/66; Matsubayashi K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/29; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Steinhauser D, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201118311; Swinbank AM, 2012, MON NOT R ASTRON SOC, V420, P672, DOI 10.1111/j.1365-2966.2011.20082.x; TOOMRE A, 1972, ASTROPHYS J, V178, P623, DOI 10.1086/151823; Vollmer B, 2003, ASTRON ASTROPHYS, V398, P525, DOI 10.1051/0004-6361:20021729; Yagi M, 2010, ASTRON J, V140, P1814, DOI 10.1088/0004-6256/140/6/1814; Yagi M, 2013, PUBL ASTRON SOC JPN, V65; Yagi M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/91; Yoshida M, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/43; Yoshida M, 2008, ASTROPHYS J, V688, P918, DOI 10.1086/592430	57	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	FEB	2015	149	2							36	10.1088/0004-6256/149/2/36		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CB1BA	WOS:000349360200001		
J	Zhao, GY; Chen, YJ; Shen, ZQ; Sudou, H; Iguchi, S				Zhao, Guang-Yao; Chen, Yong-Jun; Shen, Zhi-Qiang; Sudou, Hiroshi; Iguchi, Satoru			MULTI-EPOCH MULTI-FREQUENCY VLBI STUDY OF THE PARSEC-SCALE JET IN THE BLAZAR 3C 66A	ASTRONOMICAL JOURNAL			English	Article						galaxies: individual (3C 66A); galaxies: jets; radio continuum: galaxies	ACTIVE GALACTIC NUCLEI; COMPACT RADIO-SOURCES; BL LACERTAE OBJECTS; RAY BRIGHT BLAZARS; BASE-LINE ARRAY; SUPERLUMINAL MOTION; HIGH-FREQUENCY; KINEMATICS; FERMI; QUASARS	We present observational results of the gamma-ray blazar 3C 66A at 2.3, 8.4, and 22 GHz at four epochs during 2004-2005 with the VLBA. The resulting images show an overall core-jet structure extending roughly to the south, with two intermediate breaks occurring in the region near the core. By model-fitting to the visibility data, the northmost component, which is also the brightest, is identified as the core according to its relatively flat spectrum and its compactness. Combining our results with previous results to investigate the proper motions of the jet components, we found the kinematics of 3C 66A to be quite complicated, with components of inward and outward, subluminal and superluminal motions all detected in the radio structure. The superluminal motions indicate strong Doppler boosting exists in the jet. The apparent inward motions of the innermost components last for at least 10 years and could not be caused by newborn components. A possible reason could be non-stationarity of the core due to opacity change.	[Zhao, Guang-Yao; Chen, Yong-Jun; Shen, Zhi-Qiang] Chinese Acad Sci, Shanghai Astron Observ, Key Lab Res Galaxies & Cosmol, Shanghai 200030, Peoples R China; [Zhao, Guang-Yao] Korea Astron & Space Sci Inst, Taejon 305348, South Korea; [Chen, Yong-Jun; Shen, Zhi-Qiang] Chinese Acad Sci, Key Lab Radio Astron, Beijing 100864, Peoples R China; [Sudou, Hiroshi] Gifu Univ, Fac Engn, Gifu 5011193, Japan; [Iguchi, Satoru] Natl Astron Observ Japan, Tokyo 1818588, Japan	Zhao, GY (reprint author), Chinese Acad Sci, Shanghai Astron Observ, Key Lab Res Galaxies & Cosmol, Shanghai 200030, Peoples R China.	gyzhao@kasi.re.kr			National Basic Research Program of China (973 program) [2012CB821806]; National Natural Science Foundation of China [10625314, 11121062, 11273042]; CAS/SAFEA International Partnership Program for Creative Research Teams; Strategic Priority Research Program on Space Science; Chinese Academy of Sciences [XDA04060700]; Science and Technology Commission of Shanghai Municipality [12ZR1436100]	This work is partly supported by National Basic Research Program of China (973 program) No. 2012CB821806, the National Natural Science Foundation of China (grants 10625314, 11121062, and 11273042), the CAS/SAFEA International Partnership Program for Creative Research Teams, the Strategic Priority Research Program on Space Science, the Chinese Academy of Sciences (grant No. XDA04060700), and the Science and Technology Commission of Shanghai Municipality (grant No. 12ZR1436100).	Abdo AA, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/1/43; Abdo AA, 2010, ASTROPHYS J, V716, P30, DOI 10.1088/0004-637X/716/1/30; Acciari VA, 2009, ASTROPHYS J LETT, V693, pL104, DOI 10.1088/0004-637X/693/2/L104; Aliu E, 2009, ASTROPHYS J LETT, V692, pL29, DOI 10.1088/0004-637X/692/1/L29; Alberdi A, 2000, ASTRON ASTROPHYS, V361, P529; Sudou H, 2003, SCIENCE, V300, P1263, DOI 10.1126/science.1082817; Kellermann KI, 2004, ASTROPHYS J, V609, P539, DOI 10.1086/421289; Shaw MS, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/5/127; Lee SS, 2008, ASTRON J, V136, P159, DOI 10.1088/0004-6256/136/1/159; Jorstad SG, 2005, ASTRON J, V130, P1418, DOI 10.1086/444593; Jorstad SG, 2001, ASTROPHYS J SUPPL S, V134, P181, DOI 10.1086/320858; Lister ML, 2009, ASTRON J, V138, P1874, DOI 10.1088/0004-6256/138/6/1874; Bartel N, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/1/3; Bottcher M, 2005, ASTROPHYS J, V631, P169, DOI 10.1086/432609; Bramel DA, 2005, ASTROPHYS J, V629, P108, DOI 10.1086/431294; Britzen S, 2008, ASTRON ASTROPHYS, V484, P119, DOI 10.1051/0004-6361:20077717; Cai HB, 2007, ASTRON ASTROPHYS, V468, P963, DOI 10.1051/0004-6361:20077155; Furniss A, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/35; Karouzos M, 2012, ASTRON NACHR, V333, P417, DOI 10.1002/asna.201211685; Lister ML, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/5/120; Lu RS, 2011, MON NOT R ASTRON SOC, V418, P2260, DOI 10.1111/j.1365-2966.2011.19537.x; Marscher AP, 2002, ASTROPHYS J, V577, P85, DOI 10.1086/342138; Miller J. S., 1978, PITTSBURGH C BL LAC, P176; Niinuma K, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/84; Price R., 1993, APJS, V86, P364; Pushkarev AB, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219173; Sawada-Satoh S, 2013, EPJ WEB CONF, V61, DOI 10.1051/epjconf/20136108007; SCHWAB FR, 1983, ASTRON J, V88, P688, DOI 10.1086/113360; Shen ZQ, 1997, ASTRON J, V114, P1999, DOI 10.1086/118621; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Stadnik M, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/151; Taylor GB, 1996, ASTROPHYS J SUPPL S, V107, P37, DOI 10.1086/192354; Tosti G., 2008, ASTRONOMERS TELEGRAM, V1759, P1; WILLS BJ, 1974, ASTROPHYS J, V190, pL97, DOI 10.1086/181514; Yang JP, 2010, PUBL ASTRON SOC JPN, V62, pL23; Zhao GY, 2011, J ASTROPHYS ASTRON, V32, P61, DOI 10.1007/s12036-011-9019-2; Zhao G.-Y., 2013, IAU S, V290, P367	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	FEB	2015	149	2							46	10.1088/0004-6256/149/2/46		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CB1BA	WOS:000349360200011		
J	Abdo, AA; Ackermann, M; Ajello, M; Allafort, A; Amin, MA; Baldini, L; Barbiellini, G; Bastieri, D; Bechtol, K; Bellazzini, R; Blandford, RD; Bonamente, E; Borgland, AW; Bregeon, J; Brigida, M; Buehler, R; Bulmash, D; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Cavazzuti, E; Cecchi, C; Charles, E; Cheung, CC; Chiang, J; Chiaro, G; Ciprini, S; Claus, R; Cohen-Tanugi, J; Conrad, J; Corbet, RHD; Cutini, S; D'Ammando, F; de Angelis, A; de Palma, F; Dermer, CD; Drell, PS; Drlica-Wagner, A; Favuzzi, C; Finke, J; Focke, WB; Fukazawa, Y; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Giglietto, N; Giordano, F; Giroletti, M; Glanzman, T; Grenier, IA; Grove, JE; Guiriec, S; Hadasch, D; Hayashida, M; Hays, E; Hughes, RE; Inoue, Y; Jackson, MS; Jogler, T; Johannesson, G; Johnson, AS; Kamae, T; Knodlseder, J; Kuss, M; Lande, J; Larsson, S; Latronico, L; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Madejski, GM; Mazziotta, MN; Mehault, J; Michelson, PF; Mizuno, T; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nemmen, R; Nuss, E; Ohno, M; Ohsugi, T; Paneque, D; Perkins, JS; Pesce-Rollins, M; Piron, F; Pivato, G; Porter, TA; Raino, S; Rando, R; Razzano, M; Reimer, A; Reimer, O; Reyes, LC; Ritz, S; Romoli, C; Roth, M; Parkinson, PMS; Sgro, C; Siskind, EJ; Spandre, G; Spinelli, P; Takahashi, H; Takeuchi, Y; Tanaka, T; Thayer, JG; Thayer, JB; Thompson, DJ; Tibaldo, L; Tinivella, M; Torres, DF; Tosti, G; Troja, E; Tronconi, V; Usher, TL; Vandenbroucke, J; Vasileiou, V; Vianello, G; Vitale, V; Waite, AP; Werner, M; Winer, BL; Wood, KS				Abdo, A. A.; Ackermann, M.; Ajello, M.; Allafort, A.; Amin, M. A.; Baldini, L.; Barbiellini, G.; Bastieri, D.; Bechtol, K.; Bellazzini, R.; Blandford, R. D.; Bonamente, E.; Borgland, A. W.; Bregeon, J.; Brigida, M.; Buehler, R.; Bulmash, D.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Cavazzuti, E.; Cecchi, C.; Charles, E.; Cheung, C. C.; Chiang, J.; Chiaro, G.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Conrad, J.; Corbet, R. H. D.; Cutini, S.; D'Ammando, F.; de Angelis, A.; de Palma, F.; Dermer, C. D.; Drell, P. S.; Drlica-Wagner, A.; Favuzzi, C.; Finke, J.; Focke, W. B.; Fukazawa, Y.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Giglietto, N.; Giordano, F.; Giroletti, M.; Glanzman, T.; Grenier, I. A.; Grove, J. E.; Guiriec, S.; Hadasch, D.; Hayashida, M.; Hays, E.; Hughes, R. E.; Inoue, Y.; Jackson, M. S.; Jogler, T.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Knoedlseder, J.; Kuss, M.; Lande, J.; Larsson, S.; Latronico, L.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Madejski, G. M.; Mazziotta, M. N.; Mehault, J.; Michelson, P. F.; Mizuno, T.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nemmen, R.; Nuss, E.; Ohno, M.; Ohsugi, T.; Paneque, D.; Perkins, J. S.; Pesce-Rollins, M.; Piron, F.; Pivato, G.; Porter, T. A.; Raino, S.; Rando, R.; Razzano, M.; Reimer, A.; Reimer, O.; Reyes, L. C.; Ritz, S.; Romoli, C.; Roth, M.; Parkinson, P. M. Saz; Sgro, C.; Siskind, E. J.; Spandre, G.; Spinelli, P.; Takahashi, H.; Takeuchi, Y.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Thompson, D. J.; Tibaldo, L.; Tinivella, M.; Torres, D. F.; Tosti, G.; Troja, E.; Tronconi, V.; Usher, T. L.; Vandenbroucke, J.; Vasileiou, V.; Vianello, G.; Vitale, V.; Waite, A. P.; Werner, M.; Winer, B. L.; Wood, K. S.			GAMMA-RAY FLARING ACTIVITY FROM THE GRAVITATIONALLY LENSED BLAZAR PKS 1830-211 OBSERVED BY Fermi LAT	ASTROPHYSICAL JOURNAL			English	Article						gamma rays: galaxies; gamma rays: general; gravitational lensing: strong; quasars: individual (PKS 1830-211); radiation mechanisms: non-thermal; X-rays: individual (PKS 1830-211)	LARGE-AREA TELESCOPE; EINSTEIN RING PKS-1830-211; MOLECULAR ABSORPTION-LINES; RADIO-SOURCE PKS1830-211; X-RAY; TIME-DELAY; GALACTIC NUCLEI; SOURCE CATALOG; LIGHT CURVES; 3C 454.3	The Large Area Telescope ( LAT) on board the FermiGamma- ray Space Telescope routinely detects the MeV- peaked flat- spectrum radio quasar PKS 1830- 211 ( z = 2.507). Its apparent isotropic. - ray luminosity ( E > 100 MeV), averaged over 3 years of observations and peaking on 2010 October 14/ 15 at 2.9 x 1050 erg s- 1, makes it among the brightest high- redshift Fermi blazars. No published model with a single lens can account for all of the observed characteristics of this complex system. Based on radio observations, one expects time- delayed variability to follow about 25 days after a primary flare, with flux about a factor of 1.5 less. Two large. - ray flares of PKS 1830- 211 have been detected by the LAT in the considered period, and no substantial evidence for such a delayed activity was found. This allows us to place a lower limit of about 6 on the. - ray flux ratio between the two lensed images. Swift XRT observations from a dedicated Target of Opportunity program indicate a hard spectrum with no significant correlation of X- ray flux with the. - ray variability. The spectral energy distribution can be modeled with inverse Compton scattering of thermal photons from the dusty torus. The implications of the LAT data in terms of variability, the lack of evident delayed flare events, and different radio and. - ray flux ratios are discussed. Microlensing effects, absorption, size and location of the emitting regions, the complex mass distribution of the system, an energy- dependent inner structure of the source, and flux suppression by the lens galaxy for one image path may be considered as hypotheses for understanding our results.	[Abdo, A. A.] George Mason Univ, Coll Sci, Ctr Earth Observing & Space Res, Fairfax, VA 22030 USA; [Ackermann, M.; Buehler, R.] DESY, D-15738 Zeuthen, Germany; [Ajello, M.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Allafort, A.; Bechtol, K.; Blandford, R. D.; Borgland, A. W.; Caliandro, G. A.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Drell, P. S.; Focke, W. B.; Glanzman, T.; Inoue, Y.; Jogler, T.; Johnson, A. S.; Kamae, T.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Thayer, J. G.; Thayer, J. B.; Tibaldo, L.; Usher, T. L.; Vandenbroucke, J.; Waite, A. P.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Allafort, A.; Bechtol, K.; Blandford, R. D.; Borgland, A. W.; Caliandro, G. A.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Drell, P. S.; Focke, W. B.; Glanzman, T.; Inoue, Y.; Jogler, T.; Johnson, A. S.; Kamae, T.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Thayer, J. G.; Thayer, J. B.; Tibaldo, L.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Amin, M. A.] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HA, England; [Amin, M. A.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Amin, M. A.; Bulmash, D.] MIT, Dept Phys, Cambridge, MA 02138 USA; [Baldini, L.; Bellazzini, R.; Kuss, M.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.; Tinivella, M.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Buson, S.; Rando, R.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Chiaro, G.; Pivato, G.; Rando, R.; Romoli, C.; Tronconi, V.] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Bonamente, E.; Cecchi, C.; Lubrano, P.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Lubrano, P.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Bregeon, J.; Cohen-Tanugi, J.; Nuss, E.; Piron, F.; Vasileiou, V.] Univ Montpellier 2, Lab Univers & Particules Montpellier, CNRS, IN2P3, Montpellier, France; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bulmash, D.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Caliandro, G. A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Cavazzuti, E.; Ciprini, S.; Cutini, S.; Gasparrini, D.] Agenzia Spaziale Italiana, Sci Data Ctr, I-00133 Rome, Italy; [Cheung, C. C.; Dermer, C. D.; Finke, J.; Grove, J. E.; Lovellette, M. N.; Wood, K. S.] Naval Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ciprini, S.; Cutini, S.; Gasparrini, D.] Ist Nazl Astrofis, Osservatorio Astron Roma, I-00040 Rome, Italy; [Conrad, J.; Larsson, S.] Stockholm Univ, AlbaNova, Dept Phys, SE-10691 Stockholm, Sweden; [Conrad, J.; Jackson, M. S.; Larsson, S.] AlbaNova, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Conrad, J.] Royal Swedish Acad Sci, SE-10405 Stockholm, Sweden; [Corbet, R. H. D.; Nemmen, R.] Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Corbet, R. H. D.; Nemmen, R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Corbet, R. H. D.; Nemmen, R.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Corbet, R. H. D.; Nemmen, R.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [D'Ammando, F.; Giroletti, M.] INAF, Ist Radioastron, I-40129 Bologna, Italy; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy; [Drlica-Wagner, A.] Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA; [Fukazawa, Y.; Ohno, M.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Gehrels, N.; Guiriec, S.; Hays, E.; Nemmen, R.; Perkins, J. S.; Thompson, D. J.; Troja, E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Grenier, I. A.] Univ Paris Diderot, Lab AIM, CEA IRFU CNRS, Serv Astrophys,CEA Saclay, F-91191 Gif Sur Yvette, France; [Hadasch, D.; Reimer, A.; Reimer, O.; Werner, M.] Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Hadasch, D.; Reimer, A.; Reimer, O.; Werner, M.] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Hayashida, M.] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan; [Hughes, R. E.; Winer, B. L.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Dept Phys, Columbus, OH 43210 USA; [Jackson, M. S.] KTH Royal Inst Technol, AlbaNova, Dept Phys, SE-10691 Stockholm, Sweden; [Johannesson, G.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Knoedlseder, J.] CNRS, IRAP, F-31028 Toulouse 4, France; [Knoedlseder, J.] Univ Toulouse, GAHEC, UPS OMP, IRAP, Toulouse, France; [Larsson, S.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Latronico, L.] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [Lott, B.; Mehault, J.] Univ Bordeaux 1, Ctr Etud Nucl Bordeaux Gradignan, CNRS, IN2P3, F-33175 Gradignan, France; [Mizuno, T.; Ohsugi, T.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Higashihiroshima, Hiroshima 7398526, Japan; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Murgia, S.] Univ Calif Irvine, Dept Phys & Astron, Ctr Cosmol, Irvine, CA 92697 USA; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Reyes, L. C.] Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93401 USA; [Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Parkinson, P. M. Saz] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Takeuchi, Y.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Tanaka, T.] Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan; [Torres, D. F.] Inst Ciencies Espai IEEE CSIC, E-08193 Barcelona, Spain; [Torres, D. F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Troja, E.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Troja, E.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy	Ciprini, S (reprint author), Agenzia Spaziale Italiana, Sci Data Ctr, I-00133 Rome, Italy.	sara.buson@pd.infn.it; stefano.ciprini@asdc.asi.it; dammando@ira.inaf.it; justin.finke@nrl.navy.mil	Loparco, Francesco/O-8847-2015; Mazziotta, Mario /O-8867-2015; Gargano, Fabio/O-8934-2015; Torres, Diego/F-3009-2015; Nemmen, Rodrigo/O-6841-2014; Morselli, Aldo/G-6769-2011; Reimer, Olaf/A-3117-2013; Johannesson, Gudlaugur/O-8741-2015	Gasparrini, Dario/0000-0002-5064-9495; Giroletti, Marcello/0000-0002-8657-8852; Caraveo, Patrizia/0000-0003-2478-8018; Loparco, Francesco/0000-0002-1173-5673; Mazziotta, Mario /0000-0001-9325-4672; Gargano, Fabio/0000-0002-5055-6395; Bastieri, Denis/0000-0002-6954-8862; Torres, Diego/0000-0002-1522-9065; Morselli, Aldo/0000-0002-7704-9553; SPINELLI, Paolo/0000-0001-6688-8864; Johannesson, Gudlaugur/0000-0003-1458-7036			Abdo AA, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L26; Ackermann M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/171; Ackermann M, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/4; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Aller MC, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/19; Blackburne JA, 2006, ASTROPHYS J, V640, P569, DOI 10.1086/500172; Gregg MD, 2002, ASTROPHYS J, V564, P133, DOI 10.1086/324145; WISOTZKI L, 1993, ASTRON ASTROPHYS, V278, pL15; Raiteri CM, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117026; Dermer CD, 2009, ASTROPHYS J, V692, P32, DOI 10.1088/0004-637X/692/1/32; Bisnovatyi-Kogan GS, 2010, MON NOT R ASTRON SOC, V404, P1790, DOI 10.1111/j.1365-2966.2010.16290.x; Jin C, 2003, MON NOT R ASTRON SOC, V340, P1309, DOI 10.1046/j.1365-8711.2003.06390.x; Lidman C, 1999, ASTROPHYS J, V514, pL57, DOI 10.1086/311949; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; De Rosa A, 2005, ASTRON ASTROPHYS, V438, P121, DOI [10.1051/0004-6361:20052710, 10.1051/000-6361:20052710]; Combi JA, 1998, ASTRON ASTROPHYS SUP, V128, P423, DOI 10.1051/aas:1998153; Mattox JR, 1997, ASTROPHYS J, V481, P95, DOI 10.1086/304039; NAIR S, 1993, ASTROPHYS J, V407, P46, DOI 10.1086/172491; Sluse D, 2007, ASTRON ASTROPHYS, V468, P885, DOI 10.1051/0004-6361:20066821; Wiklind T, 2001, ASTR SOC P, V237, P155; Muller S, 2008, ASTRON ASTROPHYS, V491, P739, DOI 10.1051/0004-6361:200810392; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; Barnacka A, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016175; Abdo AA, 2010, ASTROPHYS J, V722, P520, DOI 10.1088/0004-637X/722/1/520; Pooley D, 2006, ASTROPHYS J, V648, P67, DOI 10.1086/505860; Lovell JEJ, 1998, ASTROPHYS J, V508, pL51, DOI 10.1086/311723; Witt HJ, 2000, ASTROPHYS J, V544, P98, DOI 10.1086/317201; JAUNCEY DL, 1991, NATURE, V352, P132, DOI 10.1038/352132a0; Winn JN, 2002, ASTROPHYS J, V575, P103, DOI 10.1086/341265; Mattox JR, 1997, ASTROPHYS J, V476, P692, DOI 10.1086/303639; Wiklind T, 1998, ASTROPHYS J, V500, P129, DOI 10.1086/305701; Marscher AP, 2010, ASTROPHYS J LETT, V710, pL126, DOI 10.1088/2041-8205/710/2/L126; Sikora M, 2009, ASTROPHYS J, V704, P38, DOI 10.1088/0004-637X/704/1/38; Abdo AA, 2010, ASTROPHYS J SUPPL S, V188, P405, DOI 10.1088/0067-0049/188/2/405; Courbin F, 2002, ASTROPHYS J, V575, P95, DOI 10.1086/341261; Cheung CC, 2014, ASTROPHYS J LETT, V782, DOI 10.1088/2041-8205/782/2/L14; VANOMMEN TD, 1995, ASTROPHYS J, V444, P561, DOI 10.1086/175630; Ackermann M, 2010, ASTROPHYS J, V721, P1383, DOI 10.1088/0004-637X/721/2/1383; Wiklind T, 1996, NATURE, V379, P139, DOI 10.1038/379139a0; Dobler G, 2006, MON NOT R ASTRON SOC, V365, P1243, DOI 10.1111/j.1365-2966.2005.09809.x; Giommi P, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201117825; Lovell JEJ, 1996, ASTROPHYS J, V472, pL5, DOI 10.1086/310353; Bagdonaite J, 2013, SCIENCE, V339, P46, DOI 10.1126/science.1224898; Gehrels N, 2004, ASTROPHYS J, V611, P1005, DOI 10.1086/422091; Ghisellini G, 2008, MON NOT R ASTRON SOC, V387, P1669, DOI 10.1111/j.1365-2966.2008.13360.x; Barnacka A, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/139; Blackburne JA, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/34; BLANDFORD RD, 1992, ANNU REV ASTRON ASTR, V30, P311; Celotti A, 2008, MON NOT R ASTRON SOC, V385, P283, DOI 10.1111/j.1365-2966.2007.12758.x; Chartas G, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/137; Chen B, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/2/L34; Chen B, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/24; Ciprini S., 2010, ATEL, V2943, P1; Ciprini S., 2012, ATEL, V4158, P1; Collmar W., 2006, ASP C SER, V350, P120; Corbet R., 2013, 4 FERM S P ECONF; Courbin F, 1998, ASTROPHYS J, V499, pL119, DOI 10.1086/311376; Cruz A., 2013, P 33 ICRC; Dai X, 2008, ASTRON J, V135, P333, DOI 10.1088/0004-6256/135/1/333; Donnarumma I, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/2/L30; Einstein A, 1936, Science, V84, P506, DOI 10.1126/science.84.2188.506; ELLIOT JL, 1974, ASTROPHYS J, V192, pL3, DOI 10.1086/181575; Fluke CJ, 1999, MON NOT R ASTRON SOC, V302, P68, DOI 10.1046/j.1365-8711.1999.02109.x; Foschini L, 2006, ASTRON ASTROPHYS, V453, P829, DOI 10.1051/0004-6361:20064921; Frye BL, 1999, ASTR SOC P, V156, P240; GRIEGER B, 1991, ASTRON ASTROPHYS, V252, P508; Hadasch D, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/54; Hayashida M, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/114; Jovanovic P, 2008, MON NOT R ASTRON SOC, V386, P397, DOI 10.1111/j.1365-2966.2008.13036.x; KOCHANEK CS, 1992, ASTROPHYS J, V401, P461, DOI 10.1086/172078; Lehar J, 2000, ASTROPHYS J, V536, P584, DOI 10.1086/308963; Liang EW, 2003, MON NOT R ASTRON SOC, V340, P632, DOI 10.1046/j.1365-8711.2003.06327.x; Marscher A. P., 2012, P FERM JANSK C; Marti-Vidal I, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322131; Mathur S, 1997, ASTROPHYS J, V484, P140, DOI 10.1086/304327; Mattox JR, 1996, ASTROPHYS J, V461, P396, DOI 10.1086/177068; Mosquera AM, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/96; Muller S, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117096; Nenkova M, 2008, ASTROPHYS J, V685, P160, DOI 10.1086/590483; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; Oshima T, 2001, ASTROPHYS J, V551, P929, DOI 10.1086/320246; PACZYNSKI B, 1986, ASTROPHYS J, V304, P1, DOI 10.1086/164140; Perna R, 2009, MON NOT R ASTRON SOC, V397, P1084, DOI 10.1111/j.1365-2966.2009.15041.x; RAO AP, 1988, MON NOT R ASTRON SOC, V231, P229; Schneider P., 1992, GRAVITATIONAL LENSES; Sikora M, 2001, ASTROPHYS J, V554, P1, DOI 10.1086/321329; Sluse D, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220843; Sokolov A, 2005, ASTROPHYS J, V629, P52, DOI 10.1086/431321; Striani E., 2009, ATEL, V2242, P1; Tanaka YT, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/1/L18; Torres DF, 2003, MON NOT R ASTRON SOC, V339, P335, DOI 10.1046/j.1365-8711.2003.06219.x; Wambsganss J, 2001, PUBL ASTRON SOC AUST, V18, P207, DOI 10.1071/AS01016; Yonehara A, 1998, ASTROPHYS J, V501, pL41, DOI 10.1086/311431; Zhang S, 2008, ASTROPHYS J, V683, P400, DOI 10.1086/589498; Zimmer F, 2011, MON NOT R ASTRON SOC, V413, P1099, DOI 10.1111/j.1365-2966.2011.18196.x	95	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							143	10.1088/0004-637X/799/2/143		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900030		
J	Aota, T; Inoue, T; Aikawa, Y				Aota, Takuhiro; Inoue, Tsuyoshi; Aikawa, Yuri			EVAPORATION OF GRAIN-SURFACE SPECIES BY SHOCK WAVES IN A PROTOPLANETARY DISK	ASTROPHYSICAL JOURNAL			English	Article						ISM: clouds; ISM: molecules; protoplanetary disks; shock waves	CARBON-CHAIN-CHEMISTRY; HOT MOLECULAR CORES; INTERSTELLAR-MOLECULES; CHEMICAL-COMPOSITION; KEPLERIAN DISK; SOLAR NEBULA; DUST GRAINS; PROTOSTAR; L1527; EVOLUTION	Recent Atacama Large Millimeter/submillimeter Array observations of young protostellar objects detected warm SO emission, which could be associated with a forming protostellar disk. In order to investigate if such warm gas can be produced by accretion shock onto the forming disk, we calculate the sputtering and thermal desorption of various grain-surface species in one-dimensional shock waves. We find that thermal desorption is much more efficient than the sputtering in the post-shock region. While H2O can be thermally desorbed, if the accretion velocity is larger than 8 kms(-1) with the pre-shock gas number density of 10(9) cm(-3), SO is desorbed if the accretion velocity greater than or similar to 2 km s(-1) and greater than or similar to 4 km s(-1), with the pre-shock density of 10(9) cm(-3) and 10(8) cm(-3), respectively. We also find that the column density of hydrogen nuclei in warm post-shock gas is N-warm similar to 10(21) cm(-2).	[Aota, Takuhiro; Aikawa, Yuri] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan; [Inoue, Tsuyoshi] Natl Astron Observ Japan, Div Theoret Astron, Mitaka, Tokyo 1810015, Japan	Aota, T (reprint author), Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan.				Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23740154, 23540266, 23103004]	We thank Nami Sakai, Satoshi Yamamoto, Nagayoshi Ohashi, and Hitoshi Miura for stimulating discussions. Numerical computations were in part carried out on the XC30 system at the Center for Computational Astrophysics (CfCA) of the National Astronomical Observatory of Japan. This work is supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, Nos. 23740154 (T.I.), 23540266, and 23103004 (Y.A.).	Aikawa Y, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/40; Sakai N, 2009, ASTROPHYS J, V697, P769, DOI 10.1088/0004-637X/697/1/769; Sakai N, 2010, ASTROPHYS J, V722, P1633, DOI 10.1088/0004-637X/722/2/1633; Draine BT, 1995, ASTROPHYS SPACE SCI, V233, P111, DOI 10.1007/BF00627339; Sakai N, 2013, CHEM REV, V113, P8981, DOI 10.1021/cr4001308; Sakai N, 2008, ASTROPHYS J, V672, P371, DOI 10.1086/523635; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Jorgensen JK, 2007, ASTROPHYS J, V659, P479, DOI 10.1086/512230; HASEGAWA TI, 1993, MON NOT R ASTRON SOC, V263, P589; Sakai N, 2014, NATURE, V507, P78, DOI 10.1038/nature13000; Inoue T, 2008, ASTROPHYS J, V687, P303, DOI 10.1086/590528; Tobin JJ, 2012, NATURE, V492, P83, DOI 10.1038/nature11610; Garrod RT, 2006, ASTRON ASTROPHYS, V457, P927, DOI 10.1051/0004-6361:20065560; Aikawa Y, 2008, ASTROPHYS J, V674, P984, DOI 10.1086/524096; VANLEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; Visser R, 2009, ASTRON ASTROPHYS, V495, P881, DOI 10.1051/0004-6361/200810846; DRAINE BT, 1979, ASTROPHYS J, V231, P77, DOI 10.1086/157165; Jimenez-Serra I, 2008, ASTRON ASTROPHYS, V482, P549, DOI 10.1051/0004-6361:20078054; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; LUNINE JI, 1991, ICARUS, V94, P333, DOI 10.1016/0019-1035(91)90232-I; BARLOW MJ, 1978, MON NOT R ASTRON SOC, V183, P367; Caselli P, 2012, ASTRON ASTROPHYS REV, V20, DOI 10.1007/s00159-012-0056-x; Furuya K, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/11; Hartmann L., 1998, ACCRETION PROCESSES; Hincelin U, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/44; HOOD LL, 1991, ICARUS, V93, P259, DOI 10.1016/0019-1035(91)90211-B; Landau LD, 1987, FLUID MECH; NEUFELD DA, 1994, ASTROPHYS J, V428, P170, DOI 10.1086/174230; Nomura H, 2004, ASTRON ASTROPHYS, V414, P409, DOI 10.1051/0004-6361:20031646; Ohashi N, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/131; Pineda J. E., 2012, ASTRON ASTROPHYS, V544, P7; Rodgers SD, 2003, ASTROPHYS J, V585, P355, DOI 10.1086/345497; Takakuwa S, 2007, ASTROPHYS J, V662, P431, DOI 10.1086/513589; Tielens AGGM, 2005, PHYSICS AND CHEMISTRY OF THE INTERSTELLAR MEDIUM, P1, DOI 10.1017/CBO9780511819056; Tobin JJ, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/48; Tsukamoto Y, 2013, MON NOT R ASTRON SOC, V436, P1667, DOI 10.1093/mnras/stt1684; Visser R., 2011, ASTRON ASTROPHYS, V534, P132; Wakelam V., 2011, ASTRON ASTROPHYS, V529, P112; Yen HW, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/1; Zapata L. A., 2013, APJ, V764, P14	41	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							141	10.1088/0004-637X/799/2/141		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900028		
J	Braga, VF; Dall'Ora, M; Bono, G; Stetson, PB; Ferraro, I; Iannicola, G; Marengo, M; Neeley, J; Persson, SE; Buonanno, R; Coppola, G; Freedman, W; Madore, BF; Marconi, M; Matsunaga, N; Monson, A; Rich, J; Scowcroft, V; Seibert, M				Braga, V. F.; Dall'Ora, M.; Bono, G.; Stetson, P. B.; Ferraro, I.; Iannicola, G.; Marengo, M.; Neeley, J.; Persson, S. E.; Buonanno, R.; Coppola, G.; Freedman, W.; Madore, B. F.; Marconi, M.; Matsunaga, N.; Monson, A.; Rich, J.; Scowcroft, V.; Seibert, M.			ON THE DISTANCE OF THE GLOBULAR CLUSTER M4 (NGC 6121) USING RR LYRAE STARS. I. OPTICAL AND NEAR-INFRARED PERIOD-LUMINOSITY AND PERIOD-WESENHEIT RELATIONS	ASTROPHYSICAL JOURNAL			English	Article						globular clusters: individual (M4); stars: distances; stars: horizontal-branch stars: variables: RR Lyrae	HUBBLE-SPACE-TELESCOPE; BAADE-WESSELINK METHOD; STELLAR EVOLUTION DATABASE; AGE-METALLICITY RELATION; DWARF COOLING SEQUENCE; OUTER GALACTIC HALO; METAL-POOR STARS; WHITE-DWARF; ABSOLUTE MAGNITUDES; OMEGA-CENTAURI	We present new distance determinations to the nearby globular M4 (NGC 6121) based on accurate optical and near-infrared (NIR) mean magnitudes for fundamental (FU) and first overtone (FO) RR Lyrae variables (RRLs), and new empirical optical and NIR period-luminosity (PL) and period-Wesenheit (PW) relations. We have found that optical-NIR and NIR PL and PW relations are affected by smaller standard deviations than optical relations. The difference is the consequence of a steady decrease in the intrinsic spread of cluster RRL apparent magnitudes at fixed period as longer wavelengths are considered. The weighted mean visual apparent magnitude of 44 cluster RRLs is < V > = 13.329 +/- 0.001 (standard error of the mean) +/- 0.177 (weighted standard deviation) mag. Distances were estimated using RR Lyr itself to fix the zero-point of the empirical PL and PW relations. Using the entire sample (FU+FO) we found weighted mean true distance moduli of 11.35 +/- 0.03 +/- 0.05 mag and 11.32 +/- 0.02 +/- 0.07 mag. Distances were also evaluated using predicted metallicity dependent PLZ and PWZ relations. We found weighted mean true distance moduli of 11.283 +/- 0.010 +/- 0.018 mag (NIR PLZ) and 11.272 +/- 0.005 +/- 0.019 mag (optical-NIR and NIR PWZ). The above weighted mean true distance moduli agree within 1 sigma. The same result is found from distances based on PWZ relations in which the color index is independent of the adopted magnitude (11.272 +/- 0.004 +/- 0.013 mag). These distances agree quite well with the geometric distance provided by Kaluzny et al. based on three eclipsing binaries. The available evidence indicates that this approach can provide distances to globulars hosting RRLs with a precision better than 2%-3%.	[Braga, V. F.; Bono, G.; Buonanno, R.] Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; [Braga, V. F.; Bono, G.; Ferraro, I.; Iannicola, G.] INAF Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy; [Dall'Ora, M.; Coppola, G.; Marconi, M.] INAF Osservatorio Astron Capodimonte, I-80131 Naples, Italy; [Stetson, P. B.] Dominion Astrophys Observ, NRC Herzberg, Victoria, BC V9E 2E7, Canada; [Marengo, M.; Neeley, J.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Persson, S. E.; Freedman, W.; Madore, B. F.; Monson, A.; Rich, J.; Scowcroft, V.; Seibert, M.] Carnegie Observ, Pasadena, CA 91101 USA; [Buonanno, R.] INAF Osservatorio Astron Teramo, I-64100 Loc Collurania, Teramo, Italy; [Matsunaga, N.] Univ Tokyo, Sch Sci, Inst Astron, Kiso Observ, Kiso, Nagano 970101 3, Japan	Braga, VF (reprint author), Univ Roma Tor Vergata, Dept Phys, Via Ric Sci 1, I-00133 Rome, Italy.			Rich, Jeffrey/0000-0002-5807-5078; Dall'Ora, Massimo/0000-0001-8209-0449; Ferraro, Ivan/0000-0001-8514-7957; Iannicola, Giacinto/0000-0001-9816-5484; Marconi, Marcella/0000-0002-1330-2927; BUONANNO, Roberto/0000-0002-8255-815X	PRIN-INAF "Tracing the formation and evolution of the Galactic halowith VST"; PRIN-MIUR "Chemical and dynamical evolution of the Milky Way and Local Group galaxies" [2010LY5N2T]; National Aeronautics and Space Administration; National Science Foundation	It is a pleasure to thank the organizers of the MIAPP-Munich Institute for Astro and Particle Physics-workshop on The Extragalactic Distance Scale. During the workshop several authors have had the opportunity to present the preliminary results of this investigation and to discuss pros and cons of the RR Lyrae distance scale in a very fruitful and pleasant environment. In addition we warmly thank R. P. Kudritzski for many useful discussions and insights concerning stellar atmospheres and non-LTE effects in giant stars. We also would like to thank an anonymous referee for several suggestions concerning the content and the cut of an early version of the current manuscript. This work was partially supported by PRIN-INAF 2011 "Tracing the formation and evolution of the Galactic halowith VST" (P.I.: M. Marconi) and by PRIN-MIUR (2010LY5N2T) "Chemical and dynamical evolution of the Milky Way and Local Group galaxies" (P.I.: F. Matteucci). One of us (G. B.) thanks The Carnegie Observatories visitor programme for support as science visitor. This publication makes use of data products from the Two Micron All Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the National Aeronautics and Space Administration and the National Science Foundation.	Bono G, 2001, MON NOT R ASTRON SOC, V326, P1183, DOI 10.1046/j.1365-8711.2001.04655.x; Gratton RG, 2003, ASTRON ASTROPHYS, V408, P529, DOI 10.1051/0004-6361:20031003; De Angeli F, 2005, ASTRON J, V130, P116, DOI 10.1086/430723; Dotter A, 2007, ASTRON J, V134, P376, DOI 10.1086/517915; Pietrinferni A, 2004, ASTROPHYS J, V612, P168, DOI 10.1086/422498; Thompson IB, 2010, ASTRON J, V139, P329, DOI 10.1088/0004-6256/139/2/329; Stetson PB, 2014, PUBL ASTRON SOC PAC, V126, P521; Fiorentino G, 2013, MON NOT R ASTRON SOC, V434, P2866, DOI 10.1093/mnras/stt1193; Preston GW, 2013, EAS PUBLICATIONS, V63, P35, DOI 10.1051/eas/1363004; Del Principe M, 2006, ASTROPHYS J, V652, P362, DOI 10.1086/508136; Caputo F, 2000, MON NOT R ASTRON SOC, V316, P819, DOI 10.1046/j.1365-8711.2000.03591.x; LONGMORE AJ, 1986, MON NOT R ASTRON SOC, V220, P279; Casetti-Dinescu DI, 2007, ASTRON J, V134, P195, DOI 10.1086/518507; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Bono G, 2010, ASTROPHYS J, V715, P277, DOI 10.1088/0004-637X/715/1/277; Cassisi S, 2007, ASTROPHYS J, V661, P1094, DOI 10.1086/516819; Carretta E, 2009, ASTRON ASTROPHYS, V508, P695, DOI 10.1051/0004-6361/200913003; COX AN, 1983, ASTROPHYS J, V266, P94, DOI 10.1086/160762; Catelan M, 2004, ASTROPHYS J SUPPL S, V154, P633, DOI 10.1086/422916; Leaman R, 2013, MON NOT R ASTRON SOC, V436, P122, DOI 10.1093/mnras/stt1540; Pietrinferni A, 2006, ASTROPHYS J, V642, P797, DOI 10.1086/501344; CARNEY BW, 1992, ASTROPHYS J, V386, P663, DOI 10.1086/171047; Matsunaga N, 2009, MON NOT R ASTRON SOC, V397, P933, DOI 10.1111/j.1365-2966.2009.14992.x; Sollima A, 2008, MON NOT R ASTRON SOC, V384, P1583, DOI 10.1111/j.1365-2966.2007.12804.x; Cassisi S, 2004, ASTRON ASTROPHYS, V426, P641, DOI 10.1051/0004-6361:20041048; Ferraro FR, 1999, ASTRON J, V118, P1738, DOI 10.1086/301029; Bono G, 2010, ASTROPHYS J LETT, V708, pL74, DOI 10.1088/2041-8205/708/2/L74; Capuzzo-Dolcetta R, 2008, ASTROPHYS J, V681, P1136, DOI 10.1086/588017; Gilliland RL, 1998, ASTROPHYS J, V507, P818, DOI 10.1086/306363; BONO G, 1994, ASTROPHYS J SUPPL S, V93, P233, DOI 10.1086/192054; Cohen RE, 2012, MON NOT R ASTRON SOC, V419, P342, DOI 10.1111/j.1365-2966.2011.19697.x; Andrievsky SM, 2010, PUBL ASTRON SOC PAC, V122, P877; Gratton R, 2004, ANNU REV ASTRON ASTR, V42, P385, DOI 10.1146/annurev.astro.42.053102.133945; Kouwenhoven MBN, 2010, MON NOT R ASTRON SOC, V404, P1835, DOI 10.1111/j.1365-2966.2010.16399.x; Marino AF, 2008, ASTRON ASTROPHYS, V490, P625, DOI 10.1051/0004-6361:200810389; Sollima A, 2006, MON NOT R ASTRON SOC, V372, P1675, DOI 10.1111/j.1365-2966.2006.10962.x; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; PETERSON RC, 1995, ASTROPHYS J, V453, P214, DOI 10.1086/176381; Bono G, 2008, ASTROPHYS J, V684, P102, DOI 10.1086/589965; Sarajedini A, 2007, ASTRON J, V133, P1658, DOI 10.1086/511979; Bono G, 2003, MON NOT R ASTRON SOC, V344, P1097, DOI 10.1046/j.1365-8711.2003.06878.x; Kraft RP, 2003, PUBL ASTRON SOC PAC, V115, P143, DOI 10.1086/345914; Zoccali M, 2003, ASTRON ASTROPHYS, V399, P931, DOI 10.1051/0004-6361:20021604; Bedin LR, 2009, ASTROPHYS J, V697, P965, DOI 10.1088/0004-637X/697/2/965; Zoccali M, 2000, ASTROPHYS J, V530, P418, DOI 10.1086/308359; Del Principe M, 2005, ASTRON J, V129, P2714, DOI 10.1086/430148; ZINN R, 1984, ASTROPHYS J SUPPL S, V55, P45, DOI 10.1086/190947; Castelli F, 1997, ASTRON ASTROPHYS, V318, P841; Zoccali M, 2001, ASTROPHYS J, V553, P733, DOI 10.1086/320980; Denissenkov PA, 2003, ASTROPHYS J, V593, P509, DOI 10.1086/376410; Benko JM, 2006, MON NOT R ASTRON SOC, V372, P1657, DOI 10.1111/j.1365-2966.2006.10953.x; Asplund M, 2005, ASTR SOC P, V336, P25; Benedict GF, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/6/187; Benedict GF, 2002, ASTRON J, V123, P473, DOI 10.1086/338087; Bond H. E., 2013, ASTROPHYS J, V765, P12; Bono G, 2003, LECT NOTES PHYS, V635, P85; Bono G., 2002, MNRAS, V332, P78; Bono G, 2008, ASTROPHYS J LETT, V686, pL87, DOI 10.1086/593013; Bono G., 2011, CARNEGIE OBS ASTROPH, V5, P1; Bono G., 1994, APJ, V432, P51; Buonanno R, 1998, ASTRON ASTROPHYS, V333, P505; BUONANNO R, 1989, ASTRON ASTROPHYS, V216, P80; Casetti-Dinescu DI, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/33; Castelli F, 1997, ASTRON ASTROPHYS, V324, P432; CLEMENTINI G, 1994, MON NOT R ASTRON SOC, V267, P83; Coppola G, 2011, MON NOT R ASTRON SOC, V416, P1056, DOI 10.1111/j.1365-2966.2011.19102.x; Dall'Ora M, 2004, ASTROPHYS J, V610, P269, DOI 10.1086/421513; Di Cecco A, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/4/103; Di Criscienzo M, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/81; DIXON RI, 1993, MON NOT R ASTRON SOC, V265, P395; Dotter A, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/74; Feast M., 2002, MNRAS, V329, P7; Hansen BMS, 2004, ASTROPHYS J SUPPL S, V155, P551, DOI 10.1086/424832; Harris WE, 1996, ASTRON J, V112, P1487, DOI 10.1086/118116; Hendricks B, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/1/25; IBEN I, 1971, ASTRON ASTROPHYS, V14, P293; Inno L, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/84; Johnson CI, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/157; Jones RV, 1996, PUBL ASTRON SOC PAC, V108, P877, DOI 10.1086/133809; JONES RV, 1988, ASTROPHYS J, V332, P206, DOI 10.1086/166647; Kaluzny J, 2009, ACTA ASTRONOM, V59, P273; Kaluzny J, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/2/43; Klein CR, 2014, MON NOT R ASTRON SOC, V440, pL96, DOI 10.1093/mnrasl/slu031; Kolenberg K., 2010, ASTRON ASTROPHYS, V519, P64; Kolenberg K, 2006, ASTRON ASTROPHYS, V459, P577, DOI 10.1051/0004-6361:20054415; Kudritzki R. P., 1979, LIACO, V22, P295; Lardo C, 2013, MON NOT R ASTRON SOC, V433, P1941, DOI 10.1093/mnras/stt854; Layden AC, 2005, ASTROPHYS J, V632, P266, DOI 10.1086/444407; LIU TX, 1990, ASTROPHYS J, V360, P561, DOI 10.1086/169145; Liu TX, 1990, ASTROPHYS J, V354, P273, DOI 10.1086/168688; LONGMORE AJ, 1990, MON NOT R ASTRON SOC, V247, P684; Madore BF, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/135; MADORE BF, 1982, ASTROPHYS J, V253, P575, DOI 10.1086/159659; Majaess D., 2012, APJ, V752, P10; Majaess D, 2012, PUBL ASTRON SOC PAC, V124, P1035, DOI 10.1086/668292; Malavolta L, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/2/25; Marconi M, 2005, ASTROPHYS J, V623, pL133, DOI 10.1086/430273; Marconi M, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/111; Marin-Franch A, 2009, ASTROPHYS J, V694, P1498, DOI 10.1088/0004-637X/694/2/1498; McNamara DH, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/110; Milone AP, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/120; Nardetto N., 2013, ASTRON ASTROPHYS, V534, P16; Perryman M. A. C., 1997, ASTRON ASTROPHYS, V323, P49; Peterson R. C., 1996, APJ, V465, P47; Pietrinferni A., 2013, ASTRON ASTROPHYS, V558, P46; Pietrzynski G, 2006, ASTRON J, V132, P2556, DOI 10.1086/508927; Poleski R, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/76; Pulone L, 1992, MEM SOC ASTRON ITAL, V63, P485; Richer HB, 2004, ASTRON J, V127, P2904, DOI 10.1086/383294; Richer HB, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/104; Richer HB, 1997, ASTROPHYS J, V484, P741, DOI 10.1086/304379; Riess AG, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/119; Roederer IU, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/37; ROOD RT, 1973, ASTROPHYS J, V184, P815, DOI 10.1086/152373; Salaris M., 2013, IAU S, V289, P145; Salaris M, 2004, ASTRON ASTROPHYS, V420, P911, DOI 10.1051/0004-6361:20035607; Salaris M, 2012, ASTROPHYS SPACE SCI, V341, P65, DOI 10.1007/s10509-011-0927-z; Spite M., 2012, MEM SOC ASTRON ITA S, V22, P9; Stetson PB, 2005, PUBL ASTRON SOC PAC, V117, P563, DOI 10.1086/430281; Stetson PB, 2000, PUBL ASTRON SOC PAC, V112, P925, DOI 10.1086/316595; Stetson PB, 1999, ASTRON J, V117, P247, DOI 10.1086/300670; Szeidl B., 1997, COMMUN KONKOLY OBS, V99, P1; Troisi F, 2011, PUBL ASTRON SOC PAC, V123, P879, DOI 10.1086/661534; Valenti E, 2011, MON NOT R ASTRON SOC, V414, P2690, DOI 10.1111/j.1365-2966.2011.18580.x; van Altena W. F., 1995, GEN CATALOGUE TRIGON; van den Bergh S., 1975, STARS STELLAR SYSTEM, V9, P509; VandenBerg DA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/134; VandenBerg DA, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/15; Vieira K, 2007, ASTRON J, V134, P1432, DOI 10.1086/520813; ZINN R, 1980, ASTROPHYS J SUPPL S, V42, P19, DOI 10.1086/190643	130	4	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							165	10.1088/0004-637X/799/2/165		21	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900052		
J	Freeman, M; Philpott, LC; Abe, F; Albrow, MD; Bennett, DP; Bond, IA; Botzler, CS; Bray, JC; Cherrie, JM; Christie, GW; Dionnet, Z; Gould, A; Han, C; Heyrovsky, D; McCormick, JM; Moorhouse, DM; Muraki, Y; Natusch, T; Rattenbury, NJ; Skowron, J; Sumi, T; Suzuki, D; Tan, TG; Tristram, PJ; Yock, PCM				Freeman, M.; Philpott, L. C.; Abe, F.; Albrow, M. D.; Bennett, D. P.; Bond, I. A.; Botzler, C. S.; Bray, J. C.; Cherrie, J. M.; Christie, G. W.; Dionnet, Z.; Gould, A.; Han, C.; Heyrovsky, D.; McCormick, J. M.; Moorhouse, D. M.; Muraki, Y.; Natusch, T.; Rattenbury, N. J.; Skowron, J.; Sumi, T.; Suzuki, D.; Tan, T. -G.; Tristram, P. J.; Yock, P. C. M.			CAN THE MASSES OF ISOLATED PLANETARY-MASS GRAVITATIONAL LENSES BE MEASURED BY TERRESTRIAL PARALLAX?	ASTROPHYSICAL JOURNAL			English	Article						gravitational lensing: micro; planets and satellites: detection; planets and satellites: general	FREE-FLOATING PLANET; GALACTIC BULGE; BROWN DWARF; MICROLENSING OBSERVATIONS; CHEMICAL EVOLUTION; IMAGING SURVEY; GIANT PLANETS; EARTH-MASS; STARS; SYSTEMS	Recently Sumi et al. reported evidence for a large population of planetary-mass objects ( PMOs) that are either unbound or orbit host stars in orbits >= 10 AU. Their result was deduced from the statistical distribution of durations of gravitational microlensing events observed by the MOA collaboration during 2006 and 2007. Here we study the feasibility of measuring the mass of an individual PMO through microlensing by examining a particular event, MOA-2011-BLG-274. This event was unusual as the duration was short, the magnification high, the source-size effect large, and the angular Einstein radius small. Also, it was intensively monitored from widely separated locations under clear skies at low air masses. Choi et al. concluded that the lens of the event may have been a PMO but they did not attempt a measurement of its mass. We report here a re-analysis of the event using re-reduced data. We confirm the results of Choi et al. and attempt a measurement of the mass and distance of the lens using the terrestrial parallax effect. Evidence for terrestrial parallax is found at a 3 sigma level of confidence. The best fit to the data yields the mass and distance of the lens as 0.80 +/- 0.30 M-J and 0.80 +/- 0.25 kpc respectively. We exclude a host star to the lens out to a separation similar to 40 AU. Drawing on our analysis of MOA-2011-BLG-274 we propose observational strategies for future microlensing surveys to yield sharper results on PMOs including those down to super-Earth mass.	[Freeman, M.; Botzler, C. S.; Bray, J. C.; Cherrie, J. M.; Rattenbury, N. J.; Yock, P. C. M.] Univ Auckland, Dept Phys, Auckland 1142, New Zealand; [Philpott, L. C.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada; [Abe, F.; Muraki, Y.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Albrow, M. D.] Univ Canterbury, Dept Phys & Astron, Christchurch 8020, New Zealand; [Bennett, D. P.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Bond, I. A.] Massey Univ, Inst Informat & Math Sci, Auckland 1330, New Zealand; [Christie, G. W.; Natusch, T.] Auckland Observ, Auckland 1345, New Zealand; [Dionnet, Z.] Univ Orsay, F-91400 Orsay, France; [Gould, A.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Han, C.] Chungbuk Natl Univ, Dept Phys, Chongju 371763, South Korea; [Heyrovsky, D.] Charles Univ Prague, Fac Math & Phys, Inst Theoret Phys, CR-18000 Prague, Czech Republic; [McCormick, J. M.] Farm Cove Observ, Auckland 2012, New Zealand; [Moorhouse, D. M.] Kumeu Observ, Kumeu, New Zealand; [Skowron, J.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Sumi, T.; Suzuki, D.] Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Tan, T. -G.] Perth Exoplanet Survey Telescope, Perth, WA, Australia; [Tristram, P. J.] Mt John Univ Observ, Tekapo 8770, New Zealand	Freeman, M (reprint author), Univ Auckland, Dept Phys, Private Bag 92019, Auckland 1142, New Zealand.	mfre070@aucklanduni.ac.nz	Skowron, Jan/M-5186-2014	Skowron, Jan/0000-0002-2335-1730	Marsden Fund of New Zealand; JSPS [22403003, 23340064, 23654082]; Fondation deCooperation Scientifique Paris-Saclay; NSF [AST 1103471]; NASA [NNX12AB99G]; Czech Science Foundation [GACR P209/10/1318]; Creative Research Initiative Program of National Research Foundation of Korea [2009-0081561]; (FP7)/ERC European Research Council under the European Community's Seventh Framework Programme [246678]; Royal Society of New Zealand Rutherford Discovery Fellowship	I.B. and P.Y. acknowledge support by the Marsden Fund of New Zealand, F.A. and Y.M. by JSPS grants 22403003, 23340064, and 23654082, Z.D. by the Fondation deCooperation Scientifique Paris-Saclay, A.G. by NSF grant AST 1103471 and NASA grant NNX12AB99G, D.H. by a Czech Science Foundation grant GACR P209/10/1318, C.H. by the Creative Research Initiative Program (2009-0081561) of National Research Foundation of Korea, J.S. by (FP7/2007-2013)/ERC grant agreement No. 246678 awarded by the European Research Council under the European Community's Seventh Framework Programme to the OGLE project and N.R. by a Royal Society of New Zealand Rutherford Discovery Fellowship.	Abe F, 2013, MON NOT R ASTRON SOC, V431, P2975, DOI 10.1093/mnras/stt318; Albrow M., 2009, MNRAS, V397, P2009; CHANG K, 1979, NATURE, V282, P561, DOI 10.1038/282561a0; Alard C, 1998, ASTROPHYS J, V503, P325, DOI 10.1086/305984; Girardi L, 2002, ASTRON ASTROPHYS, V391, P195, DOI 10.1051/0004-6361:20020612; HARDY SJ, 1995, MON NOT R ASTRON SOC, V276, pL79; Cassan A, 2012, NATURE, V481, P167, DOI 10.1038/nature10684; Gould A, 2009, ASTROPHYS J LETT, V698, pL147, DOI 10.1088/0004-637X/698/2/L147; SCHECHTER PL, 1993, PUBL ASTRON SOC PAC, V105, P1342, DOI 10.1086/133316; Cao L, 2013, MON NOT R ASTRON SOC, V434, P595, DOI 10.1093/mnras/stt1045; Kervella P, 2008, ASTRON ASTROPHYS, V491, P855, DOI 10.1051/0004-6361:200810317; Alcock C, 1997, ASTROPHYS J, V491, P436, DOI 10.1086/304974; Malmberg D, 2011, MON NOT R ASTRON SOC, V411, P859, DOI 10.1111/j.1365-2966.2010.17730.x; Bessell MS, 1998, ASTRON ASTROPHYS, V333, P231; Bond IA, 2001, MON NOT R ASTRON SOC, V327, P868, DOI 10.1046/j.1365-8711.2001.04776.x; Marsh KA, 2010, ASTROPHYS J, V719, P550, DOI 10.1088/0004-637X/719/1/550; Burgess ASM, 2009, ASTRON ASTROPHYS, V508, P823, DOI 10.1051/0004-6361/200912444; ALCOCK C, 1995, ASTROPHYS J, V454, pL125, DOI 10.1086/309783; Kaib NA, 2013, NATURE, V493, P381, DOI 10.1038/nature11780; Barrado, 2001, ASTRON ASTROPHYS, V377, pL9; Beichman C, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/101; Bennett DP, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/155; Bensby T, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220678; Bensby T, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117059; Choi JY, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/41; Delorme P, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219984; Dominik M, 1999, ASTRON ASTROPHYS, V349, P108; Gahm GF, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321547; Gould A, 1997, ASTROPHYS J, V480, P188, DOI 10.1086/303942; GOULD A, 1994, ASTROPHYS J, V421, pL71, DOI 10.1086/187190; GOULD A, 1992, ASTROPHYS J, V392, P442, DOI 10.1086/171443; Gould A, 2004, ASTROPHYS J, V606, P319, DOI 10.1086/382782; Gould A, 2000, ASTROPHYS J, V542, P785, DOI 10.1086/317037; Gould A, 2010, ASTROPHYS J, V710, P1800, DOI 10.1088/0004-637X/710/2/1800; Gould A, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/107; Guillochon J, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/74; Haisch KE, 2010, ASTROPHYS J LETT, V719, pL90, DOI 10.1088/2041-8205/719/1/L90; Henderson CB, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/52; Heyrovsky D, 2007, ASTROPHYS J, V656, P483, DOI 10.1086/509566; Liebes Jr S., 1964, PHYS REV B, V133, P835, DOI DOI 10.1103/PHYSREV.133.B835; Liu MC, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/2/L20; Luhman KL, 2014, ASTROPHYS J LETT, V786, DOI 10.1088/2041-8205/786/2/L18; Paczynski B, 1996, ANNU REV ASTRON ASTR, V34, P419, DOI 10.1146/annurev.astro.34.1.419; Ramirez KP, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/30; Quanz SP, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118320; Scholz A, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/6; Sumi T, 2011, NATURE, V473, P349, DOI 10.1038/nature10092; Sumi T, 2003, ASTROPHYS J, V591, P204, DOI 10.1086/375212; Udalski A, 2003, ACTA ASTRONOM, V53, P291; Veras D, 2012, MON NOT R ASTRON SOC, V421, pL117, DOI 10.1111/j.1745-3933.2012.01218.x; Wozniak P. R., 2000, ACA, V421, P50	51	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							181	10.1088/0004-637X/799/2/181		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900068		
J	Fukugita, M; Menard, B				Fukugita, Masataka; Menard, Brice			THE NATURE OF DAMPED LYMAN-alpha AND Mg II ABSORBERS EXPLORED THROUGH THEIR DUST CONTENTS	ASTROPHYSICAL JOURNAL			English	Article						dust, extinction; galaxies: halos; quasars: absorption lines	DIGITAL-SKY-SURVEY; STAR-FORMING GALAXIES; 9TH DATA RELEASE; NEUTRAL GAS; H-I; SYSTEMS; EXTINCTION; SPECTRA; DENSITY; MASS	We estimate the abundance of dust in damped Lyman-alpha absorbers (DLAs) by statistically measuring the excess reddening they induce on their background quasars. We detect systematic reddening behind DLAs consistent with the SMC-type reddening curve and inconsistent with the Milky Way type. We find that the derived dust-to-gas ratio is, on average, inversely proportional to the column density of neutral hydrogen, implying that the amount of dust is constant, regardless of the column density of hydrogen. It means that the average metallicity is inversely proportional to the column density of hydrogen, unless the average dust-to-metal ratio varies with the hydrogen column density. This indicates that the prime origin of metals seen in DLAs is not by in situ star formation, with which Z similar to N-HI(0.4) is expected from the empirical star formation law, contrary to our observation. We interpret the metals observed in absorbers to be deposited dominantly from nearby galaxies by galactic winds ubiquitous in intergalactic space. When extrapolating the relation between dust-to-gas ratio and H I column density to lower column density, we find a value that is consistent with what is observed for Mg II absorbers.	[Fukugita, Masataka; Menard, Brice] Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan; [Fukugita, Masataka] Inst Adv Study, Princeton, NJ 08540 USA; [Menard, Brice] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Fukugita, M (reprint author), Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan.				W.M. Keck Foundation; Ambrose Monell Foundation at the Institute for Advanced Study; Ministry of Education [23540288]; NSF [AST-1109665]	M.F. thanks the W.M. Keck Foundation (2013) and Ambrose Monell Foundation (2014) at the Institute for Advanced Study, and received in Tokyo a Grant-in-Aid (No. 23540288) from the Ministry of Education. B.M. is supported by NSF Grant AST-1109665. He also acknowledges the hospitality of the Institute for Advanced Study.	Ahn CP, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/21; Prochaska JX, 2014, MON NOT R ASTRON SOC, V438, P476, DOI 10.1093/mnras/stt2218; Zwaan MA, 2003, ASTRON J, V125, P2842, DOI 10.1086/374944; Prochaska JX, 2003, ASTROPHYS J, V595, pL9, DOI 10.1086/378945; Heckman TM, 2000, ASTROPHYS J SUPPL S, V129, P493, DOI 10.1086/313421; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Boisse P, 1998, ASTRON ASTROPHYS, V333, P841; Prochaska JX, 2005, ASTROPHYS J, V635, P123, DOI 10.1086/497287; York DG, 2006, MON NOT R ASTRON SOC, V367, P945, DOI 10.1111/j.1365-2966.2005.10018.x; Menard B, 2010, MON NOT R ASTRON SOC, V405, P1025, DOI 10.1111/j.1365-2966.2010.16486.x; Rao SM, 2003, ASTROPHYS J, V595, P94, DOI 10.1086/377331; BOHLIN RC, 1978, ASTROPHYS J, V224, P132, DOI 10.1086/156357; Fumagalli M, 2011, SCIENCE, V334, P1245, DOI 10.1126/science.1213581; Menard B, 2008, MON NOT R ASTRON SOC, V385, P1053, DOI 10.1111/j.l365-2966.2008.12909.x; LeBrun V, 1997, ASTRON ASTROPHYS, V321, P733; Khare P, 2007, ASTRON ASTROPHYS, V464, P487, DOI 10.1051/0004-6361:20066186; Krumholz MR, 2009, ASTROPHYS J LETT, V701, pL12, DOI 10.1088/0004-637X/701/1/L12; Vladilo G, 2008, ASTRON ASTROPHYS, V478, P701, DOI 10.1051/0004-6361:20078480; Fukugita M, 2004, ASTROPHYS J, V616, P643, DOI 10.1086/425155; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610; Meiring JD, 2009, MON NOT R ASTRON SOC, V397, P2037, DOI 10.1111/j.1365-2966.2009.15064.x; Nestor DB, 2005, ASTROPHYS J, V628, P637, DOI 10.1086/427547; Weiner BJ, 2009, ASTROPHYS J, V692, P187, DOI 10.1088/0004-637X/692/1/187; Prochaska JX, 2009, ASTROPHYS J, V696, P1543, DOI 10.1088/0004-637X/696/2/1543; Menard B, 2009, MON NOT R ASTRON SOC, V393, P808, DOI 10.1111/j.1365-2966.2009.14225.x; De Cia A, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201321834; FALL SM, 1989, ASTROPHYS J, V341, pL5, DOI 10.1086/185444; Frank S, 2010, MON NOT R ASTRON SOC, V406, P2235, DOI 10.1111/j.1365-2966.2010.16848.x; Fukugita M., 2011, ARXIV11034191; Kennicutt RC, 1998, ASTROPHYS J, V498, P541; Khare P., 2011, ARXIV11094225; Masaki S, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/38; Menard B, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/116; Murphy MT, 2004, MON NOT R ASTRON SOC, V354, pL31, DOI 10.1111/j.1365-2966.2004.08374.x; Neeleman M, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/54; Noterdaeme P, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201220259; Noterdaeme P, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201322809; Paris I, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220142; PEI YCC, 1991, ASTROPHYS J, V378, P6, DOI 10.1086/170401; Peroux C, 2003, MON NOT R ASTRON SOC, V345, P480, DOI 10.1046/j.1365-8711.2003.06952.x; Pieri MM, 2014, MON NOT R ASTRON SOC, V441, P1718, DOI 10.1093/mnras/stu577; Rafelski M., 2012, APJ, V755, P8; Rafelski M, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/48; SCHMIDT M, 1959, ASTROPHYS J, V129, P243, DOI 10.1086/146614; Wyder TK, 2009, ASTROPHYS J, V696, P1834, DOI 10.1088/0004-637X/696/2/1834; Zhu GT, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/130	46	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							195	10.1088/0004-637X/799/2/195		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900082		
J	Homma, H; Murayama, T; Kobayashi, MAR; Taniguchi, Y				Homma, Hidetomo; Murayama, Takashi; Kobayashi, Masakazu A. R.; Taniguchi, Yoshiaki			A NEW CHEMICAL EVOLUTION MODEL FOR DWARF SPHEROIDAL GALAXIES BASED ON OBSERVED LONG STAR FORMATION HISTORIES	ASTROPHYSICAL JOURNAL			English	Article						galaxies: abundances; galaxies: dwarf; galaxies: evolution; Local Group	MULTIELEMENT ABUNDANCE MEASUREMENTS; DELAY-TIME DISTRIBUTION; INITIAL MASS FUNCTION; MILKY-WAY; IA SUPERNOVAE; URSA-MINOR; STELLAR POPULATIONS; LOCAL GROUP; METALLICITY DISTRIBUTION; IRREGULAR GALAXIES	We present a new chemical evolution model for dwarf spheroidal galaxies (dSphs) in the local universe. Our main aim is to explain both their observed star formation histories and metallicity distribution functions simultaneously. Applying our new model for the four local dSphs, that is, Fornax, Sculptor, Leo II, and Sextans, we find that our new model reproduces the observed chemical properties of the dSphs consistently. Our results show that the dSphs have evolved with both a low star formation efficiency and a large gas outflow efficiency compared with the Milky Way, as suggested by previous works. Comparing the observed [alpha/Fe]-[Fe/H] relation of the dSphs with the model predictions, we find that our model favors a longer onset time of Type Ia supernovae (i. e., 0.5 Gyr) than that suggested in previous studies (i.e., 0.1 Gyr). We discuss the origin of this discrepancy in detail.	[Homma, Hidetomo; Murayama, Takashi] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kobayashi, Masakazu A. R.; Taniguchi, Yoshiaki] Ehime Univ, Res Ctr Space & Cosm Evolut, Matsuyama, Ehime 7908577, Japan	Homma, H (reprint author), Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan.	hide@astr.tohoku.ac.jp			Japan Society for the Promotion of Science [23244031]	We are grateful to M. Chiba, K. Hayashi, D. Toyouchi, T. Otsuka, and T. Obata for insightful discussions and comments. We thank the referee for useful comments and suggestions. This work was financially supported in part by the Japan Society for the Promotion of Science (No. 23244031 (Y.T.)).	Aden D, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201014963; Calura F, 2009, MON NOT R ASTRON SOC, V400, P1347, DOI 10.1111/j.1365-2966.2009.15440.x; KROUPA P, 1993, MON NOT R ASTRON SOC, V262, P545; Nomoto K, 2006, NUCL PHYS A, V777, P424, DOI 10.1016/j.nuclphysa.2006.05.008; Cohen JG, 2010, ASTROPHYS J, V719, P931, DOI 10.1088/0004-637X/719/1/931; Marcolini A, 2006, MON NOT R ASTRON SOC, V371, P643, DOI 10.1111/j.1365-2966.2006.10671.x; Bell EF, 2001, ASTROPHYS J, V550, P212, DOI 10.1086/319728; van Eymeren J, 2009, ASTRON ASTROPHYS, V505, P105, DOI 10.1051/0004-6361/200911766; Iwamoto K, 1999, ASTROPHYS J SUPPL S, V125, P439, DOI 10.1086/313278; van Eymeren J, 2009, ASTRON ASTROPHYS, V493, P511, DOI 10.1051/0004-6361:200809585; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Lee MG, 2009, ASTROPHYS J, V703, P692, DOI 10.1088/0004-637X/703/1/692; Shetrone M, 2003, ASTRON J, V125, P684, DOI 10.1086/345966; Maoz D, 2012, PUBL ASTRON SOC AUST, V29, P447, DOI 10.1071/AS11052; Cohen JG, 2009, ASTROPHYS J, V701, P1053, DOI 10.1088/0004-637X/701/2/1053; Maoz D, 2010, ASTROPHYS J, V722, P1879, DOI 10.1088/0004-637X/722/2/1879; Shetrone MD, 2001, ASTROPHYS J, V548, P592, DOI 10.1086/319022; Fenner Y, 2006, ASTROPHYS J, V646, P184, DOI 10.1086/504893; COLE S, 1994, MON NOT R ASTRON SOC, V271, P781; Kobayashi C, 1998, ASTROPHYS J, V503, pL155, DOI 10.1086/311556; KAUFFMANN G, 1993, MON NOT R ASTRON SOC, V264, P201; Kirby EN, 2010, ASTROPHYS J SUPPL S, V191, P352, DOI 10.1088/0067-0049/191/2/352; Hunter DA, 2004, ASTRON J, V128, P2170, DOI 10.1086/424615; Heckman TM, 2001, ASTROPHYS J, V554, P1021, DOI 10.1086/321422; Saviane I, 2000, ASTRON ASTROPHYS, V355, P56; Carrera R, 2002, ASTRON J, V123, P3199, DOI 10.1086/340702; Hunter DA, 2006, ASTROPHYS J SUPPL S, V162, P49, DOI 10.1086/498096; Geisler D, 2005, ASTRON J, V129, P1428, DOI 10.1086/427540; PADOVANI P, 1993, ASTROPHYS J, V416, P26, DOI 10.1086/173212; Martin CL, 2002, ASTROPHYS J, V574, P663, DOI 10.1086/341092; Aoki W, 2009, ASTRON ASTROPHYS, V502, P569, DOI 10.1051/0004-6361/200911959; Kennicutt RC, 2008, ASTROPHYS J SUPPL S, V178, P247, DOI 10.1086/590058; Tolstoy E, 2009, ANNU REV ASTRON ASTR, V47, P371, DOI 10.1146/annurev-astro-082708-101650; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; SNEDEN C, 1992, ASTRON J, V104, P2121, DOI 10.1086/116388; Weidner C, 2013, MON NOT R ASTRON SOC, V436, P3309, DOI 10.1093/mnras/stt1806; Hernandez X, 2000, MON NOT R ASTRON SOC, V317, P831, DOI 10.1046/j.1365-8711.2000.03809.x; Battaglia G, 2006, ASTRON ASTROPHYS, V459, P423, DOI 10.1051/0004-6361:20065720; Bosler TL, 2007, MON NOT R ASTRON SOC, V378, P318, DOI 10.1111/j.1365-2966.2007.11792.x; Carigi L, 2002, MON NOT R ASTRON SOC, V334, P117, DOI 10.1046/j.1365-8711.2002.05491.x; Cescutti G, 2008, ASTRON ASTROPHYS, V491, P401, DOI 10.1051/0004-6361:200810537; Combes F., 2013, ASTRON ASTROPHYS, V550, P41; Cooper MC, 2009, ASTROPHYS J, V704, P687, DOI 10.1088/0004-637X/704/1/687; de Boer TJL, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219547; de Boer TJL, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118378; Dolphin A. E., 2005, ARXIVASTROPH0506430; Dolphin AE, 2002, MON NOT R ASTRON SOC, V332, P91, DOI 10.1046/j.1365-8711.2002.05271.x; Ikuta C, 2002, ASTRON ASTROPHYS, V391, P55, DOI 10.1051/0004-6361:20020609; Joung MR, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/137; Karakas AI, 2010, MON NOT R ASTRON SOC, V403, P1413, DOI 10.1111/j.1365-2966.2009.16198.x; Kennicutt RC, 1998, ASTROPHYS J, V498, P541; Kirby EN, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L25; Kirby EN, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/79; Kistler MD, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/88; Kobayashi C, 2009, ASTROPHYS J, V707, P1466, DOI 10.1088/0004-637X/707/2/1466; Kodama T., 1997, THESIS U TOKYO; KORMENDY J, 1985, ASTROPHYS J, V295, P73, DOI 10.1086/163350; Lanfranchi G. A., 2010, ASTRON ASTROPHYS, V512, P85; Lanfranchi GA, 2003, MON NOT R ASTRON SOC, V345, P71, DOI 10.1046/j.1365-8711.2003.06919.x; Lanfranchi GA, 2004, MON NOT R ASTRON SOC, V351, P1338, DOI 10.1111/j.1365-2966.2004.07877.x; Lanfranchi GA, 2006, MON NOT R ASTRON SOC, V365, P477, DOI 10.1111/j.1365-2966.2005.09700.x; Lanfranchi GA, 2008, ASTRON ASTROPHYS, V481, P635, DOI 10.1051/0004-6361:20078696; Lanfranchi GA, 2006, ASTRON ASTROPHYS, V453, P67, DOI 10.1051/0004-6361:20054627; Lanfranchi GA, 2007, ASTRON ASTROPHYS, V468, P927, DOI 10.1051/0004-6361:20066576; Letarte B., 2010, ASTRON ASTROPHYS, V523, P17; Li HJ, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/12; McCall ML, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117669; McConnachie AW, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/1/4; Meng XC, 2011, PUBL ASTRON SOC JPN, V63, pL31; Mighell KJ, 1996, ASTRON J, V111, P777, DOI 10.1086/117823; Mo H., 2010, GALAXY FORMATION EVO; Peeples MS, 2008, ASTROPHYS J, V685, P904, DOI 10.1086/591492; Revaz Y., 2012, ASTRON ASTROPHYS, V538, P82; Rizzi L., 2003, ASTROPHYS J LETT, V589, P85; Robertson B, 2005, ASTROPHYS J, V632, P872, DOI 10.1086/452619; Romano D, 2013, MON NOT R ASTRON SOC, V434, P471, DOI 10.1093/mnras/stt1033; Sadakane K, 2004, PUBL ASTRON SOC JPN, V56, P1041; Sanchez-Salcedo FJ, 2007, ASTROPHYS J, V667, P878, DOI 10.1086/521213; SCHMIDT M, 1959, ASTROPHYS J, V129, P243, DOI 10.1086/146614; Starkenburg E., 2013, ASTRON ASTROPHYS, V549, P88; Tafelmeyer M., 2010, ASTRON ASTROPHYS, V524, P58; TIMMES FX, 1995, ASTROPHYS J SUPPL S, V98, P617, DOI 10.1086/192172; Tsujimoto T, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/113; Tumlinson J, 2006, ASTROPHYS J, V641, P1, DOI 10.1086/500383; van Eymeren J, 2010, MON NOT R ASTRON SOC, V407, P113, DOI 10.1111/j.1365-2966.2010.16923.x; Weisz DR, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/5; Zahid HJ, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/120	87	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							230	10.1088/0004-637X/799/2/230		18	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900117		
J	Kaithakkal, AJ; Suematsu, Y; Kubo, M; Iida, Y; Shiota, D; Tsuneta, S				Kaithakkal, Anjali John; Suematsu, Y.; Kubo, M.; Iida, Y.; Shiota, D.; Tsuneta, S.			PHOTOSPHERIC FLOW FIELD RELATED TO THE EVOLUTION OF THE SUN'S POLAR MAGNETIC PATCHES OBSERVED BY HINODE SOLAR OPTICAL TELESCOPE	ASTROPHYSICAL JOURNAL			English	Article						Sun: granulation; Sun: magnetic fields; Sun: photosphere	CHROMOSPHERIC NETWORK; VELOCITY-FIELDS; QUIET SUN; PORES; FEATURES; MISSION; REGION; MOTION; SIZES	We investigated the role of photospheric plasma motions in the formation and evolution of polar magnetic patches using time-sequence observations with high spatial resolution. The observations were obtained with the spectropolarimeter on board the Hinode satellite. From the statistical analysis using 75 magnetic patches, we found that they are surrounded by strong converging, supergranulation associated flows during their apparent lifetime and that the converging flow around the patch boundary is better observed in the Doppler velocity profile in the deeper photosphere. Based on our analysis, we suggest that the like-polarity magnetic fragments in the polar region are advected and clustered by photospheric converging flows, thereby resulting in the formation of polar magnetic patches. Our observations show that, in addition to direct cancellation, magnetic patches decay by fragmentation followed by unipolar disappearance or unipolar disappearance without fragmentation. It is possible that the magnetic patches of existing polarity fragment or diffuse away into smaller elements and eventually cancel out with opposite polarity fragments that reach the polar region around the solar cycle maximum. This could be one of the possible mechanisms by which the existing polarity decays during the reversal of the polar magnetic field.	[Kaithakkal, Anjali John; Suematsu, Y.; Kubo, M.] Grad Univ Adv Studies SOKENDAI, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Kaithakkal, Anjali John; Suematsu, Y.; Kubo, M.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Iida, Y.; Tsuneta, S.] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Shiota, D.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan	Kaithakkal, AJ (reprint author), Grad Univ Adv Studies SOKENDAI, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan.	anjali.johnk@nao.ac.jp		Kaithakkal, Anjali/0000-0002-2527-1558	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; GUAS (SOKENDAI)	Helpful discussions with Drs. D. Orozco Suarez, Robert Cameron, Yukio Katsukawa, and Toshifumi Shimizu are gratefully acknowledged. A.J.K. thanks the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan for financial support through its doctoral fellowship program for foreign students and the GUAS (SOKENDAI) for an associate researcher's grant. Hinode is a Japanese mission developed and launched by ISAS/JAXA, with NAOJ as domestic partner and NASA and STFC (UK) as international partners. It is operated by these agencies in cooperation with ESA and NSC (Norway).	PARKER EN, 1978, ASTROPHYS J, V221, P368, DOI 10.1086/156035; Srikanth R, 2000, ASTROPHYS J, V534, P1008, DOI 10.1086/308777; WANG HM, 1992, SOL PHYS, V140, P41, DOI 10.1007/BF00148428; Lamb DA, 2010, ASTROPHYS J, V720, P1405, DOI 10.1088/0004-637X/720/2/1405; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Keil SL, 1999, ASTROPHYS J, V510, P422, DOI 10.1086/306549; SPRUIT HC, 1979, SOL PHYS, V61, P363, DOI 10.1007/BF00150420; Sobotka M, 1999, ASTROPHYS J, V511, P436, DOI 10.1086/306671; NOVEMBER LJ, 1988, ASTROPHYS J, V333, P427, DOI 10.1086/166758; Hathaway DH, 2002, SOL PHYS, V205, P25, DOI 10.1023/A:1013881213279; Ito H, 2010, ASTROPHYS J, V719, P131, DOI 10.1088/0004-637X/719/1/131; Suarez DO, 2007, ASTRON ASTROPHYS, V462, P1137, DOI 10.1051/0004-6361:20066201; SIMON GW, 1964, ASTROPHYS J, V140, P1120, DOI 10.1086/148010; Berger TE, 1998, ASTROPHYS J, V495, P973, DOI 10.1086/305309; DeRosa ML, 2004, ASTROPHYS J, V616, P1242, DOI 10.1086/424920; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Tsuneta S, 2008, ASTROPHYS J, V688, P1374, DOI 10.1086/592226; Lites BW, 2013, SOL PHYS, V283, P579, DOI 10.1007/s11207-012-0206-3; Ichimoto K, 2008, SOL PHYS, V249, P233, DOI 10.1007/s11207-008-9169-9; PIERCE AK, 1977, SOL PHYS, V52, P179, DOI 10.1007/BF00935800; YI Z, 1993, SOL PHYS, V144, P1, DOI 10.1007/BF00667978; Shimizu T, 2008, SOL PHYS, V249, P221, DOI 10.1007/s11207-007-9053-z; Benevolenskaya EE, 2007, ASTRON NACHR, V328, P1016, DOI 10.1002/asna.200710866; Berrilli F, 1999, ASTRON ASTROPHYS, V344, P965; Hagenaar HJ, 1997, ASTROPHYS J, V481, P988, DOI 10.1086/304066; Iida Y, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/149; Kaithakkal AJ, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/122; Lamb DA, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/127; Liu Y, 2009, SOL PHYS, V260, P289, DOI 10.1007/s11207-009-9450-6; Narayan G, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016016; Suarez DO, 2007, PUBL ASTRON SOC JPN, V59, pS837; Lin HS, 1999, ASTROPHYS J, V514, P448, DOI 10.1086/306925; Sankarasubramanian K, 2003, ASTROPHYS J, V598, P689, DOI 10.1086/378883; Shine RA, 2000, SOL PHYS, V193, P313, DOI 10.1023/A:1005207625696; Shiota D, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/157; Suematsu Y, 2008, SOL PHYS, V249, P197, DOI 10.1007/s11207-008-9129-4	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							139	10.1088/0004-637X/799/2/139		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900026		
J	Kashiwagi, T; Suto, Y; Taruya, A; Kayo, I; Nishimichi, T; Yahata, K				Kashiwagi, Toshiya; Suto, Yasushi; Taruya, Atsushi; Kayo, Issha; Nishimichi, Takahiro; Yahata, Kazuhiro			MODELING THE ANOMALY OF SURFACE NUMBER DENSITIES OF GALAXIES ON THE GALACTIC EXTINCTION MAP DUE TO THEIR FIR EMISSION CONTAMINATION	ASTROPHYSICAL JOURNAL			English	Article						dust, extinction; galaxies: ISM; local interstellar matter; infrared: ISM	DIGITAL SKY SURVEY; DATA RELEASE; LUMINOSITY FUNCTION; SPATIAL VARIATIONS; INFRARED-EMISSION; COUNTS; CALIBRATION; TELESCOPE; CATALOG; MONITOR	The most widely used Galactic extinction map is constructed assuming that the observed far-infrared (FIR) fluxes come entirely from Galactic dust. According to the earlier suggestion by Yahata et al., we consider how FIR emission of galaxies affects the SFD map. We first compute the surface number density of Sloan Digital Sky Survey (SDSS) DR7 galaxies as a function of the r-band extinction, A(r,SFD). We confirm that the surface densities of those galaxies positively correlate with A(r,SFD) for A(r,SFD) < 0.1, as first discovered by Yahata et al. for SDSS DR4 galaxies. Next we construct an analytical model to compute the surface density of galaxies, taking into account the contamination of their FIR emission. We adopt a log-normal probability distribution for the ratio of 100 mu m and r-band luminosities of each galaxy, y equivalent to (nu L)(100 mu m)/(nu L)(r). Then we search for the mean and rms values of y that fit the observed anomaly, using the analytical model. The required values to reproduce the anomaly are roughly consistent with those measured from the stacking analysis of SDSS galaxies. Due to the limitation of our statistical modeling, we are not yet able to remove the FIR contamination of galaxies from the extinction map. Nevertheless, the agreement with the model prediction suggests that the FIR emission of galaxies is mainly responsible for the observed anomaly. Whereas the corresponding systematic error in the Galactic extinction map is 0.1-1 mmag, it is directly correlated with galaxy clustering and thus needs to be carefully examined in precision cosmology.	[Kashiwagi, Toshiya; Suto, Yasushi; Taruya, Atsushi; Yahata, Kazuhiro] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Suto, Yasushi; Taruya, Atsushi] Univ Tokyo, Sch Sci, Res Ctr Early Universe, Tokyo 1130033, Japan; [Suto, Yasushi] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Taruya, Atsushi; Nishimichi, Takahiro] Univ Tokyo, Inst Phys & Math Universe, Kashiwa, Chiba 2778568, Japan; [Kayo, Issha] Toho Univ, Dept Phys, Funabashi, Chiba 2748510, Japan; [Kayo, Issha] Tokyo Univ Technol, Dept Liberal Arts, Ota Ku, Tokyo 1448650, Japan	Kashiwagi, T (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.	kashiwagi@utap.phys.s.u-tokyo.ac.jp			Global COE Program, "the Physical Sciences Frontier," MEXT, Japan; Global Collaborative Research Fund " Worldwide Investigation of Other Worlds" grant; Global Scholars Program of Princeton University; JSPS [24340035, 24540257]; Alfred P. Sloan Foundation; National Science Foundation; U.S. Department of Energy; National Aeronautics and Space Administration; Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England	T.K. is supported by a Global COE Program, "the Physical Sciences Frontier," MEXT, Japan. T. N. is supported by a Grant-in-Aid for the JSPS fellows. Y. S. gratefully acknowledges the support from the Global Collaborative Research Fund " Worldwide Investigation of Other Worlds" grant, the Global Scholars Program of Princeton University, and the Grant-in-Aid for Scientific Research by JSPS (24340035). A. T. acknowledges the support from the Grant-in-Aid for Scientific Research by JSPS (24540257).; Funding for the SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, the U.S. Department of Energy, the National Aeronautics and Space Administration, the Japanese Monbukagakusho, the Max Planck Society, and the Higher Education Funding Council for England. The SDSS Web site is http://www.sdss.org/. The SDSS is managed by the Astrophysical Research Consortium for the Participating Institutions. The Participating Institutions are the American Museum of Natural History, Astrophysical Institute Potsdam, University of Basel, University of Cambridge, Case Western Reserve University, University of Chicago, Drexel University, Fermilab, the Institute for Advanced Study, the Japan Participation Group, Johns Hopkins University, the Joint Institute for Nuclear Astrophysics, the Kavli Institute for Particle Astrophysics and Cosmology, the Korean Scientist Group, the Chinese Academy of Sciences (LAMOST), Los Alamos National Laboratory, the Max-Planck-Institute for Astronomy (MPIA), the Max-Planck-Institute for Astrophysics (MPA), New Mexico State University, Ohio State University, University of Pittsburgh, University of Portsmouth, Princeton University, the United States Naval Observatory, and the University of Washington.	BURSTEIN D, 1982, ASTRON J, V87, P1165, DOI 10.1086/113199; Adelman-McCarthy JK, 2006, ASTROPHYS J SUPPL S, V162, P38, DOI 10.1086/497917; Hogg DW, 2001, ASTRON J, V122, P2129, DOI 10.1086/323103; Tucker DL, 2006, ASTRON NACHR, V327, P821, DOI 10.1002/asna.200610655; Stoughton C, 2002, ASTRON J, V123, P485, DOI 10.1086/324741; Smith JA, 2002, ASTRON J, V123, P2121, DOI 10.1086/339311; Padmanabhan N, 2008, ASTROPHYS J, V674, P1217, DOI 10.1086/524677; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; Ivezic Z, 2004, ASTRON NACHR, V325, P583, DOI 10.1002/asna.200410285; Arce HG, 1999, ASTROPHYS J, V512, pL135, DOI 10.1086/311885; Saunders W, 2000, MON NOT R ASTRON SOC, V317, P55, DOI 10.1046/j.1365-8711.2000.03528.x; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Schlafly EF, 2010, ASTROPHYS J, V725, P1175, DOI 10.1088/0004-637X/725/1/1175; Chilingarian IV, 2010, MON NOT R ASTRON SOC, V405, P1409, DOI 10.1111/j.1365-2966.2010.16506.x; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Blanton MR, 2005, ASTROPHYS J, V631, P208, DOI 10.1086/431416; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Nishimichi T, 2009, PUBL ASTRON SOC JPN, V61, P321; Yasuda N, 2001, ASTRON J, V122, P1104, DOI 10.1086/322093; Peek JEG, 2010, ASTROPHYS J, V719, P415, DOI 10.1088/0004-637X/719/1/415; Cambresy L, 2001, ASTRON ASTROPHYS, V375, P999, DOI 10.1051/0004-6361:20010930; Abazajian K, 2003, ASTRON J, V126, P2081, DOI 10.1086/378165; Gunn JE, 1998, ASTRON J, V116, P3040, DOI 10.1086/300645; Arce HG, 1999, ASTROPHYS J, V517, P264, DOI 10.1086/307168; Pier JR, 2003, ASTRON J, V125, P1559, DOI 10.1086/346138; Scranton R, 2002, ASTROPHYS J, V579, P48, DOI 10.1086/342786; Gunn JE, 2006, ASTRON J, V131, P2332, DOI 10.1086/500975; Rowles J, 2009, MON NOT R ASTRON SOC, V395, P1640, DOI 10.1111/j.1365-2966.2009.14655.x; Yahata K, 2007, PUBL ASTRON SOC JPN, V59, P205; BURSTEIN D, 1978, ASTROPHYS J, V225, P40, DOI 10.1086/156466; Cambresy L, 2005, ASTRON ASTROPHYS, V435, P131, DOI 10.1051/0004-6361:20041767; Chen B, 1999, ASTRON ASTROPHYS, V352, P459; Dobashi K., 2005, PASJ, V57, P1; Fitzpatrick EL, 1999, PUBL ASTRON SOC PAC, V111, P63, DOI 10.1086/316293; Fukugita M, 2004, ASTRON J, V127, P3155, DOI 10.1086/420800; Kashiwagi T, 2013, PUBL ASTRON SOC JPN, V65; Murakami H., 2007, PASJ, V59, P369; ODONNELL JE, 1994, ASTROPHYS J, V422, P158, DOI 10.1086/173713; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Serjeant S, 2005, MON NOT R ASTRON SOC, V356, P192, DOI 10.1111/j.1365-2966.2004.08440.x; Takeuchi TT, 2003, ASTROPHYS J, V587, pL89, DOI 10.1086/375181; Yahata K., 2007, THESIS U TOKYO; Yasuda N, 2007, ASTRON J, V134, P698, DOI 10.1086/519836	44	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							132	10.1088/0004-637X/799/2/132		18	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900019		
J	Kulier, A; Ostriker, JP; Natarajan, P; Lackner, CN; Cen, R				Kulier, Andrea; Ostriker, Jeremiah P.; Natarajan, Priyamvada; Lackner, Claire N.; Cen, Renyue			UNDERSTANDING BLACK HOLE MASS ASSEMBLY VIA ACCRETION AND MERGERS AT LATE TIMES IN COSMOLOGICAL SIMULATIONS	ASTROPHYSICAL JOURNAL			English	Article						black hole physics; galaxies: nuclei; quasars: general	ACTIVE GALACTIC NUCLEI; EARLY-TYPE GALAXIES; DARK-MATTER HALOES; DIGITAL SKY SURVEY; STAR-FORMING GALAXIES; FREQUENCY GRAVITATIONAL-RADIATION; BRIGHTEST CLUSTER GALAXIES; NEAR-INFRARED LUMINOSITY; PULSAR TIMING ARRAYS; SIMILAR-TO 2	Accretion is thought to primarily contribute to the mass accumulation history of supermassive black holes (SMBHs) throughout cosmic time. While this may be true at high redshifts, at lower redshifts and for the most massive black holes (BHs) mergers themselves might add significantly to the mass budget. We explore this in two disparate environments-a massive cluster and a void region. We evolve SMBHs from 4 > z > 0 using merger trees derived from hydrodynamical cosmological simulations of these two regions, scaled to the observed value of the stellar mass fraction to account for overcooling. Mass gains from gas accretion proportional to bulge growth and BH-BH mergers are tracked, as are BHs that remain "orbiting" due to insufficient dynamical friction in a merger remnant, as well as those that are ejected due to gravitational recoil. We find that gas accretion remains the dominant source of mass accumulation in almost all SMBHs; mergers contribute 2.5% +/- 0.1% for all SMBHs in the cluster and 1.0% +/- 0.1% in the void since z = 4. However, mergers are significant for massive SMBHs. The fraction of mass accumulated from mergers for central BHs generally increases for larger values of the host bulge mass: in the void, the fraction is 2% at M-*,(bul) = 10(10) M-circle dot, increasing to 4% at M-*,(bul) greater than or similar to 10(11)M(circle dot), and in the cluster it is 4% at M-*, (bul) = 10(10) M-circle dot and 23% at 10(12) M-circle dot . We also find that the total mass in orbiting SMBHs is negligible in the void, but significant in the cluster, in which a potentially detectable 40% of SMBHs and approximate to 8% of the total SMBH mass (where the total includes central, orbiting, and ejected SMBHs) is found orbiting at z = 0. The existence of orbiting and ejected SMBHs requires modification of the Soltan argument. We estimate this correction to the integrated accreted mass density of SMBHs to be in the range 6%-21%, with a mean value of 11% +/- 3%. Quantifying the growth due to mergers at these late times, we calculate the total energy output and strain from gravitational waves emitted by merging SMBHs, and obtain a signal potentially detectable by pulsar timing arrays.	[Kulier, Andrea; Ostriker, Jeremiah P.; Lackner, Claire N.; Cen, Renyue] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Ostriker, Jeremiah P.] Columbia Univ, Dept Astron, New York, NY 10027 USA; [Natarajan, Priyamvada] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Lackner, Claire N.] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Univ WPI, Kashiwa, Chiba, Japan	Kulier, A (reprint author), Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA.	akulier@princeton.edu			NASA [NNX11AI23G]; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; National Science Foundation Graduate Research Fellowship [DGE-1148900]; NASA-NSFTCAN [1332858]	Computing resources were in part provided by the NASA High-End Computing (HEC) Program through the NASA Advanced Supercomputing (NAS) Division at Ames Research Center. This work is supported in part by grant NASA NNX11AI23G. This work was also supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. A.K. is supported by the National Science Foundation Graduate Research Fellowship, Grant No. DGE-1148900. P.N. acknowledges support from a NASA-NSFTCAN award number 1332858.	Malbon RK, 2007, MON NOT R ASTRON SOC, V382, P1394, DOI 10.1111/j.1365-2966.2007.12317.x; Hilz M, 2012, MON NOT R ASTRON SOC, V425, P3119, DOI 10.1111/j.1365-2966.2012.21541.x; Choi E, 2014, MON NOT R ASTRON SOC, V442, P440, DOI 10.1093/mnras/stu874; Campanelli M, 2007, ASTROPHYS J, V659, pL5, DOI 10.1086/516712; Kocsis B, 2011, MON NOT R ASTRON SOC, V411, P1467, DOI 10.1111/j.1365-2966.2010.17782.x; Booth CM, 2011, MON NOT R ASTRON SOC, V413, P1158, DOI 10.1111/j.1365-2966.2011.18203.x; Dubois Y, 2014, MON NOT R ASTRON SOC, V440, P1590, DOI 10.1093/mnras/stu373; Volonteri M, 2005, ASTROPHYS J, V620, P69, DOI 10.1086/426858; CEN RY, 1995, ASTROPHYS J, V451, P436, DOI 10.1086/176232; Marconi A, 2004, MON NOT R ASTRON SOC, V351, P169, DOI 10.1111/j.1365-2966.2004.07765.x; Sesana A, 2012, ADV ASTRON, DOI 10.1155/2012/805402; Haardt F, 1996, ASTROPHYS J, V461, P20, DOI 10.1086/177035; Sijacki D, 2009, MON NOT R ASTRON SOC, V400, P100, DOI 10.1111/j.1365-2966.2009.15452.x; Ferrarese L, 2006, ASTROPHYS J, V644, pL21, DOI 10.1086/505388; Shankar F, 2013, MON NOT R ASTRON SOC, V428, P421, DOI 10.1093/mnras/sts026; Maiolino R, 2012, MON NOT R ASTRON SOC, V425, pL66, DOI 10.1111/j.1745-3933.2012.01303.x; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Diemand J, 2008, NATURE, V454, P735, DOI 10.1038/nature07153; Lackner CN, 2012, MON NOT R ASTRON SOC, V425, P641, DOI 10.1111/j.1365-2966.2012.21525.x; Bernardi M, 2013, MON NOT R ASTRON SOC, V436, P697, DOI 10.1093/mnras/stt1607; Sesana A, 2004, ASTROPHYS J, V611, P623, DOI 10.1086/422185; Merloni A, 2010, ASTROPHYS J, V708, P137, DOI 10.1088/0004-637X/708/1/137; Kormendy J, 2011, NATURE, V469, P374, DOI 10.1038/nature09694; FITCHETT MJ, 1984, MON NOT R ASTRON SOC, V211, P933; PERES A, 1962, PHYS REV, V128, P2471, DOI 10.1103/PhysRev.128.2471; Cirasuolo M, 2005, ASTROPHYS J, V629, P816, DOI 10.1086/431575; RAJAGOPAL M, 1995, ASTROPHYS J, V446, P543, DOI 10.1086/175813; Sesana A, 2013, MON NOT R ASTRON SOC, V433, pL1, DOI 10.1093/mnrasl/slt034; Forte JC, 2012, MON NOT R ASTRON SOC, V421, P635, DOI 10.1111/j.1365-2966.2011.20341.x; Sani E, 2011, MON NOT R ASTRON SOC, V413, P1479, DOI 10.1111/j.1365-2966.2011.18229.x; Kawakatu N, 2002, MON NOT R ASTRON SOC, V329, P572, DOI 10.1046/j.1365-8711.2002.05037.x; Bogdanovic T, 2007, ASTROPHYS J, V661, pL147, DOI 10.1086/518769; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Greene JE, 2010, ASTROPHYS J, V709, P937, DOI 10.1088/0004-637X/709/2/937; Jaffe AH, 2003, ASTROPHYS J, V583, P616, DOI 10.1086/345443; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Wyithe JSB, 2003, ASTROPHYS J, V590, P691, DOI 10.1086/375187; Dubois Y, 2013, MON NOT R ASTRON SOC, V433, P3297, DOI 10.1093/mnras/stt997; Oser L, 2010, ASTROPHYS J, V725, P2312, DOI 10.1088/0004-637X/725/2/2312; Dotti M, 2010, MON NOT R ASTRON SOC, V402, P682, DOI 10.1111/j.1365-2966.2009.15922.x; Behroozi PS, 2010, ASTROPHYS J, V717, P379, DOI 10.1088/0004-637X/717/1/379; Sesana A, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224014; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Gilli R, 2007, ASTRON ASTROPHYS, V463, P79, DOI 10.1051/0004-6361:20066334; Lapi A, 2006, ASTROPHYS J, V650, P42, DOI 10.1086/507122; Di Matteo T, 2008, ASTROPHYS J, V676, P33, DOI 10.1086/524921; Granato GL, 2004, ASTROPHYS J, V600, P580, DOI 10.1086/379875; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Koppitz M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.041102; Marconi A, 2003, ASTROPHYS J, V589, pL21, DOI 10.1086/375804; Dubois Y, 2012, MON NOT R ASTRON SOC, V420, P2662, DOI 10.1111/j.1365-2966.2011.20236.x; Beifiori A, 2012, MON NOT R ASTRON SOC, V419, P2497, DOI 10.1111/j.1365-2966.2011.19903.x; Kormendy J, 2011, NATURE, V469, P377, DOI 10.1038/nature09695; Hopkins PF, 2007, ASTROPHYS J, V654, P731, DOI 10.1086/509629; Ostriker JP, 2010, ASTROPHYS J, V722, P642, DOI 10.1088/0004-637X/722/1/642; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; Pratt GW, 2009, ASTRON ASTROPHYS, V498, P361, DOI 10.1051/0004-6361/200810994; Guo Q, 2013, MON NOT R ASTRON SOC, V428, P1351, DOI 10.1093/mnras/sts115; CEN RY, 1992, ASTROPHYS J, V399, pL113, DOI 10.1086/186620; Komossa S, 2008, ASTROPHYS J LETT, V683, pL21, DOI 10.1086/591420; Hirschmann M, 2010, MON NOT R ASTRON SOC, V407, P1016, DOI 10.1111/j.1365-2966.2010.17006.x; Tremaine S, 2002, ASTROPHYS J, V574, P740, DOI 10.1086/341002; Kawakatu N, 2003, ASTROPHYS J, V583, P85, DOI 10.1086/345085; Woo JH, 2008, ASTROPHYS J, V681, P925, DOI 10.1086/588804; Merloni A, 2008, MON NOT R ASTRON SOC, V388, P1011, DOI [10.1111/j.1365-2966.2008.13472.x, 10.1111/j.1365-2966.2009.13472.x]; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Enoki M, 2004, ASTROPHYS J, V615, P19, DOI 10.1086/424475; Milosavljevic M, 2003, AIP CONF PROC, V686, P201; Moster BP, 2013, MON NOT R ASTRON SOC, V428, P3121, DOI 10.1093/mnras/sts261; Booth CM, 2010, MON NOT R ASTRON SOC, V405, pL1, DOI 10.1111/j.1745-3933.2010.00832.x; Somerville RS, 2012, MON NOT R ASTRON SOC, V423, P1992, DOI 10.1111/j.1365-2966.2012.20490.x; Cen RY, 2005, ASTROPHYS J, V635, P86, DOI 10.1086/497353; Merloni A, 2004, MON NOT R ASTRON SOC, V354, pL37, DOI 10.1111/j.1365-2966.2004.08382.x; Schulze A, 2014, MON NOT R ASTRON SOC, V438, P3422, DOI 10.1093/mnras/stt2457; Campanelli M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.231102; Lousto CO, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.231102; van Haasteren R, 2011, MON NOT R ASTRON SOC, V414, P3117, DOI 10.1111/j.1365-2966.2011.18613.x; Treister E, 2009, ASTROPHYS J, V696, P110, DOI 10.1088/0004-637X/696/1/110; Sesana A, 2009, MON NOT R ASTRON SOC, V394, P2255, DOI 10.1111/j.1365-2966.2009.14499.x; Van Der Wel A, 2008, ASTROPHYS J, V688, P48, DOI 10.1086/592267; Hopkins PF, 2010, ASTROPHYS J, V715, P202, DOI 10.1088/0004-637X/715/1/202; Brusa M, 2009, ASTRON ASTROPHYS, V507, P1277, DOI 10.1051/0004-6361/200912261; Eisenstein DJ, 1999, ASTROPHYS J, V511, P5, DOI 10.1086/306640; van Meter JR, 2010, ASTROPHYS J, V719, P1427, DOI 10.1088/0004-637X/719/2/1427; Lin YT, 2010, ASTROPHYS J, V715, P1486, DOI 10.1088/0004-637X/715/2/1486; Guo Q, 2010, MON NOT R ASTRON SOC, V404, P1111, DOI 10.1111/j.1365-2966.2010.16341.x; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Shankar F, 2009, ASTROPHYS J, V690, P20, DOI 10.1088/0004-637X/690/1/20; Avila-Reese V, 2014, MON NOT R ASTRON SOC, V441, P417, DOI 10.1093/mnras/stu382; Baker JG, 2008, ASTROPHYS J LETT, V682, pL29, DOI 10.1086/590927; Barausse E, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/63; Barausse E, 2012, MON NOT R ASTRON SOC, V423, P2533, DOI 10.1111/j.1365-2966.2012.21057.x; BEKENSTE.JD, 1973, ASTROPHYS J, V183, P657, DOI 10.1086/152255; Belli S, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/117; Bennert VN, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/107; Bernardi M, 2011, MON NOT R ASTRON SOC, V412, P684, DOI 10.1111/j.1365-2966.2010.17984.x; Bernardi M, 2011, MON NOT R ASTRON SOC, V412, pL6, DOI 10.1111/j.1745-3933.2010.00982.x; Bezanson R, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/2/L21; Binney J., 1987, GALACTIC DYNAMICS; Bolzonella M, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/200912801; Bournaud F, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/81; Bryan GL, 1999, COMPUT SCI ENG, V1, P46, DOI 10.1109/5992.753046; Cen RY, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/121; Cen RY, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/17; Cen RY, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/139; Cen R, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/99; Cen RY, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L33; Chen CTJ, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/3; Cibinel A, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/72; Ciotti L, 1997, ASTROPHYS J, V487, pL105, DOI 10.1086/310902; Cisternas M, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/1/L11; Di Matteo T, 2003, ASTROPHYS J, V593, P56, DOI 10.1086/376501; Dotti M, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/68; Fan L, 2008, ASTROPHYS J LETT, V689, pL101, DOI 10.1086/595784; Ferrarese L, 2002, ASTROPHYS J, V578, P90, DOI 10.1086/342308; Gadotti DA, 2009, MON NOT R ASTRON SOC, V393, P1531, DOI 10.1111/j.1365-2966.2008.14257.x; Gaskell C. M., 2009, ARXIV09080328; Gebhardt K, 2009, ASTROPHYS J, V700, P1690, DOI 10.1088/0004-637X/700/2/1690; Gnedin OY, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/71; Granato GL, 2006, MON NOT R ASTRON SOC, V368, pL72, DOI 10.1111/j.1745-3933.2006.00160.x; Greene JE, 2010, ASTROPHYS J, V721, P26, DOI 10.1088/0004-637X/721/1/26; Haehnelt MG, 2000, MON NOT R ASTRON SOC, V318, pL35, DOI 10.1046/j.1365-8711.2000.03989.x; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; HAUSMAN MA, 1978, ASTROPHYS J, V224, P320, DOI 10.1086/156380; Heckman TM, 2004, ASTROPHYS J, V613, P109, DOI 10.1086/422872; Herrmann F, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.084032; Hickox RC, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/9; Hopkins PF, 2009, MON NOT R ASTRON SOC, V398, P303, DOI 10.1111/j.1365-2966.2009.15132.x; Islam RR, 2004, MON NOT R ASTRON SOC, V354, P443, DOI 10.1111/j.1365-2966.2004.08202.x; Joung MR, 2009, ASTROPHYS J LETT, V692, pL1, DOI 10.1088/0004-637X/692/1/L1; Lang P, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/11; Lasker R, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/70; Leauthaud A, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/95; Li S, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/65; Li YX, 2007, ASTROPHYS J, V663, P61, DOI 10.1086/518398; Lin YT, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/61; Lin YT, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/1/L3; Lippai Z, 2009, ASTROPHYS J, V701, P360, DOI 10.1088/0004-637X/701/1/360; Liu FK, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/18; Lousto CO, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/11/114006; Lousto CO, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.084015; Lousto CO, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.044028; Madau P, 2004, ASTROPHYS J, V606, pL17, DOI 10.1086/421017; MAOZ E, 1993, MON NOT R ASTRON SOC, V263, P75; McConnell NJ, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/184; McLeod KK, 2009, ASTROPHYS J, V704, P415, DOI 10.1088/0004-637X/704/1/415; McLure RJ, 2013, MON NOT R ASTRON SOC, V428, P1088, DOI 10.1093/mnras/sts092; McWilliams S. T., 2012, ARXIV12114590; McWilliams ST, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/156; Mendel JT, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/1/3; Menou K, 2004, ASTROPHYS J, V615, P130, DOI 10.1086/423951; Natarajan P, 2009, MON NOT R ASTRON SOC, V393, P838, DOI 10.1111/j.1365-2966.2008.13864.x; Natarajan P., 2011, ARXIV11054902; Natarajan P., 2004, SUPERMASSIVE BLACK H, V308, P127; Netzer H, 2009, MON NOT R ASTRON SOC, V399, P1907, DOI 10.1111/j.1365-2966.2009.15434.x; Nipoti C, 2009, ASTROPHYS J LETT, V706, pL86, DOI 10.1088/0004-637X/706/1/L86; Oser L, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/63; OShea B. W., 2004, ARXIVASTROPH0403044; Rashkov V, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/187; Ravi V, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/84; Rosario DJ, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219258; Salvaterra R, 2007, MON NOT R ASTRON SOC, V374, P761, DOI 10.1111/j.1365-2966.2006.11195.x; Salviander S, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/80; Schnittman JD, 2007, ASTROPHYS J, V662, pL63, DOI 10.1086/519309; Shankar F, 2009, ASTROPHYS J, V694, P867, DOI 10.1088/0004-637X/694/2/867; Shankar F, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/24/244001; Shen Y, 2009, ASTROPHYS J, V704, P89, DOI 10.1088/0004-637X/704/1/89; Shields GA, 2003, ASTROPHYS J, V583, P124, DOI 10.1086/345348; SOLTAN A, 1982, MON NOT R ASTRON SOC, V200, P115; Treister E, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/130; Umemura M, 2001, ASTROPHYS J, V560, pL29, DOI 10.1086/324063; Volonteri M, 2006, MON NOT R ASTRON SOC, V373, P121, DOI 10.1111/j.1365-2966.2006.10976.x; Volonteri M, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/94; Volonteri M, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/29; Volonteri M, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/50; Volonteri M, 2005, MON NOT R ASTRON SOC, V358, P913, DOI 10.1111/j.1365-2966.2005.08832.x; Yoo J, 2007, ASTROPHYS J, V667, P813, DOI 10.1086/521015; Yu QJ, 2002, MON NOT R ASTRON SOC, V335, P965, DOI 10.1046/j.1365-8711.2002.05532.x; Zhang XX, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/5	181	4	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							178	10.1088/0004-637X/799/2/178		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900065		
J	Lee, KG; Hennawi, JF; Spergel, DN; Weinberg, DH; Hogg, DW; Viel, M; Bolton, JS; Bailey, S; Pieri, MM; Carithers, W; Schlegel, DJ; Lundgren, B; Palanque-Delabrouille, N; Suzuki, N; Schneider, DP; Yeche, C				Lee, Khee-Gan; Hennawi, Joseph F.; Spergel, David N.; Weinberg, David H.; Hogg, David W.; Viel, Matteo; Bolton, James S.; Bailey, Stephen; Pieri, Matthew M.; Carithers, William; Schlegel, David J.; Lundgren, Britt; Palanque-Delabrouille, Nathalie; Suzuki, Nao; Schneider, Donald P.; Yeche, Christophe			IGM CONSTRAINTS FROM THE SDSS-III/BOSS DR9 Ly alpha FOREST TRANSMISSION PROBABILITY DISTRIBUTION FUNCTION	ASTROPHYSICAL JOURNAL			English	Article						intergalactic medium; large-scale structure of universe; methods: data analysis; quasars: absorption lines; quasars: emission lines; techniques: spectroscopic	DIGITAL SKY SURVEY; OSCILLATION SPECTROSCOPIC SURVEY; COLUMN DENSITY DISTRIBUTION; EQUATION-OF-STATE; PRINCIPAL COMPONENT ANALYSIS; DATA RELEASE 9; PHOTOIONIZED INTERGALACTIC MEDIUM; BARYON ACOUSTIC-OSCILLATIONS; COMPOSITE QUASAR SPECTRA; QSO ABSORPTION-SPECTRA	The Ly alpha forest transmission probability distribution function (PDF) is an established probe of the intergalactic medium (IGM) astrophysics, especially the temperature-density relationship of the IGM. We measure the transmission PDF from 3393 Baryon Oscillations Spectroscopic Survey (BOSS) quasars from Sloan Digital Sky Survey Data Release 9, and compare with mock spectra that include careful modeling of the noise, continuum, and astrophysical uncertainties. The BOSS transmission PDFs, measured at < z > = [2.3, 2.6, 3.0], are compared with PDFs created from mock spectra drawn from a suite of hydrodynamical simulations that sample the IGM temperature-density relationship, gamma, and temperature at mean density, T-0, where T (Delta) = T-0 Delta(gamma-1). We find that a significant population of partial Lyman-limit systems (LLSs) with a column-density distribution slope of beta(pLLS)similar to-2 are required to explain the data at the low-transmission end of transmission PDF, while uncertainties in the mean Ly alpha forest transmission affect the high-transmission end. After modeling the LLSs and marginalizing over mean transmission uncertainties, we find that gamma = 1.6 best describes the data over our entire redshift range, although constraints on T-0 are affected by systematic uncertainties. Within our model framework, isothermal or inverted temperature-density relationships (gamma <= 1) are disfavored at a significance of over 4s, although this could be somewhat weakened by cosmological and astrophysical uncertainties that we did not model.	[Lee, Khee-Gan; Hennawi, Joseph F.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Lee, Khee-Gan; Spergel, David N.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Weinberg, David H.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Weinberg, David H.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Hogg, David W.] NYU, Ctr Cosmol & Particle Phys, New York, NY 10003 USA; [Viel, Matteo] Osserv Astron Trieste, INAF, I-34131 Trieste, Italy; [Viel, Matteo] Ist Nazl Fis Nucl, I-34127 Trieste, Italy; [Bolton, James S.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Bailey, Stephen; Carithers, William; Schlegel, David J.] EO Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Pieri, Matthew M.] Univ Portsmouth, Inst Cosmol & Gravitat, Portsmouth PO1 3FX, Hants, England; [Lundgren, Britt] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Palanque-Delabrouille, Nathalie; Yeche, Christophe] CEA, Ctr Saclay, F-91191 Gif Sur Yvette, France; [Suzuki, Nao] Univ Tokyo, Kavli Inst Phys & Math Universe IPMU, Kashiwa, Chiba, Japan; [Schneider, Donald P.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Schneider, Donald P.] Penn State Univ, Inst Gravitat & Cosmos, University Pk, PA 16802 USA	Lee, KG (reprint author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	lee@mpia.de	Hogg, David/B-5580-2014	Hogg, David/0000-0003-2866-9403	Alexander von Humboldt foundation; German Federal Ministry for Education and Research; STFC; ERC [GA-257670]; PRIN-MIUR; Royal Society University; NSF [AST-1202963]; Alfred P. Sloan Foundation; National Science Foundation; U.S. Department of Energy Office of Science	We thank Michael Strauss, J. Xavier Prochaska, Gabor Worseck, and Joop Schaye for useful comments and discussion. We also thank the members of the ENIGMA group (http://www.mpia-hd.mpg.de/ENIGMA/) at the Max Planck Institute for Astronomy (MPIA) for helpful discussions. J.F.H. acknowledges generous support from the Alexander von Humboldt foundation in the context of the Sofja Kovalevskaja Award. The Humboldt foundation is funded by the German Federal Ministry for Education and Research. The hydrodynamic simulations in this work were performed using the COSMOS Supercomputer in Cambridge (UK), which is sponsored by SGI, Intel, HEFCE and the Darwin Supercomputer of the University of Cambridge High Performance Computing Service (http://www.hpc.cam.ac.uk/), provided by Dell Inc. using Strategic Research Infrastructure Funding from the Higher Education Funding Council for England. COSMOS and DARWIN are part of the DIRAC high performance computing facility funded by STFC. M. V. is supported by the FP7 ERC grant "cosmoIGM" GA-257670, PRIN-MIUR and INFN/PD51 grants. J.S.B. acknowledges the support of a Royal Society University Research Fellowship. B.L. acknowledges support from the NSF Astronomy and Astrophsics Fellowship grant AST-1202963.; Funding for SDSS-III has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, and the U.S. Department of Energy Office of Science. The SDSS-III Web site is http://www.sdss3.org/.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Ahn CP, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/17; Ahn CP, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/21; Almgren AS, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/39; Altay G, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/2/L37; Bolton JS, 2014, MON NOT R ASTRON SOC, V438, P2499, DOI 10.1093/mnras/stt2374; Lewis A, 2000, ASTROPHYS J, V538, P473, DOI 10.1086/309179; Rollinde E, 2013, MON NOT R ASTRON SOC, V428, P540, DOI 10.1093/mnras/sts057; McDonald P, 2005, ASTROPHYS J, V635, P761, DOI 10.1086/497563; Abazajian K, 2005, ASTRON J, V129, P1755, DOI 10.1086/427544; Stoughton C, 2002, ASTRON J, V123, P485, DOI 10.1086/324741; Altay G, 2013, MON NOT R ASTRON SOC, V436, P2689, DOI 10.1093/mnras/stt1765; Rahmati A, 2013, MON NOT R ASTRON SOC, V430, P2427, DOI 10.1093/mnras/stt066; Becker GD, 2013, MON NOT R ASTRON SOC, V430, P2067, DOI 10.1093/mnras/stt031; Springel V, 2005, MON NOT R ASTRON SOC, V361, P776, DOI 10.1111/j.1365-2966.2005.09238.x; McDonald P, 2005, MON NOT R ASTRON SOC, V360, P1471, DOI 10.1111/j.1365-2966.2005.09141.x; LYNDS R, 1971, ASTROPHYS J, V164, pL73, DOI 10.1086/180695; Bolton JS, 2009, MON NOT R ASTRON SOC, V395, P736, DOI 10.1111/j.1365-2966.2009.14597.x; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Prochaska JX, 1997, ASTROPHYS J, V487, P73, DOI 10.1086/304591; Telfer RC, 2002, ASTROPHYS J, V565, P773, DOI 10.1086/324689; McQuinn M, 2011, MON NOT R ASTRON SOC, V415, P2257, DOI 10.1111/j.1365-2966.2011.18855.x; Dave R, 1999, ASTROPHYS J, V511, P521, DOI 10.1086/306722; Hui L, 2003, ASTROPHYS J, V596, P9, DOI 10.1086/377229; Hui L, 1997, MON NOT R ASTRON SOC, V292, P27; Viel M, 2013, MON NOT R ASTRON SOC, V429, P1734, DOI 10.1093/mnras/sts465; Viel M, 2009, MON NOT R ASTRON SOC, V399, pL39, DOI 10.1111/j.1745-3933.2009.00720.x; Schaye J, 2000, MON NOT R ASTRON SOC, V318, P817, DOI 10.1046/j.1365-8711.2000.03815.x; Dall'Aglio A, 2008, ASTRON ASTROPHYS, V491, P465, DOI 10.1051/0004-6361:200810724; Ricotti M, 2000, ASTROPHYS J, V534, P41, DOI 10.1086/308733; Viel M, 2006, MON NOT R ASTRON SOC, V365, P231, DOI 10.1111/j.1365-2966.2005.09703.x; Prochaska JX, 2005, ASTROPHYS J, V635, P123, DOI 10.1086/497287; McDonald P, 2000, ASTROPHYS J, V543, P1, DOI 10.1086/317079; Anderson L, 2014, MON NOT R ASTRON SOC, V441, P24, DOI 10.1093/mnras/stu523; Shull JM, 2010, ASTROPHYS J, V722, P1312, DOI 10.1088/0004-637X/722/2/1312; Meiksin A, 2012, MON NOT R ASTRON SOC, V423, P7, DOI 10.1111/j.1365-2966.2011.20380.x; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Viel M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.043502; Kim TS, 2007, MON NOT R ASTRON SOC, V382, P1657, DOI 10.1111/j.1365-2966.2007.12406.x; Lundgren BF, 2009, ASTROPHYS J, V698, P819, DOI 10.1088/0004-637X/698/1/819; Bolton JS, 2008, MON NOT R ASTRON SOC, V386, P1131, DOI 10.1111/j.1365-2966.2008.13114.x; Furlanetto SR, 2008, ASTROPHYS J, V682, P14, DOI 10.1086/589613; Penton SV, 2000, ASTROPHYS J, V544, P150, DOI 10.1086/317179; Croft RAC, 1998, ASTROPHYS J, V495, P44, DOI 10.1086/305289; Suzuki N, 2005, ASTROPHYS J, V618, P592, DOI 10.1086/426062; Seljak U, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.103515; CEN RY, 1994, ASTROPHYS J, V437, pL9, DOI 10.1086/187670; Faucher-Giguere CA, 2008, ASTROPHYS J, V681, P831, DOI 10.1086/588648; Bolton AS, 2010, PUBL ASTRON SOC PAC, V122, P248; Theuns T, 2002, ASTROPHYS J, V567, pL103, DOI 10.1086/339998; Zhu GT, 2014, MON NOT R ASTRON SOC, V439, P3139, DOI 10.1093/mnras/stu186; McDonald P, 2001, ASTROPHYS J, V562, P52, DOI 10.1086/323426; Garzilli A, 2012, MON NOT R ASTRON SOC, V424, P1723, DOI 10.1111/j.1365-2966.2012.21223.x; Gnedin NY, 1998, MON NOT R ASTRON SOC, V296, P44, DOI 10.1046/j.1365-8711.1998.01249.x; Compostella M, 2013, MON NOT R ASTRON SOC, V435, P3169, DOI 10.1093/mnras/stt1510; PETITJEAN P, 1993, MON NOT R ASTRON SOC, V262, P499; McQuinn M, 2009, ASTROPHYS J, V694, P842, DOI 10.1088/0004-637X/694/2/842; Schneider DP, 2010, ASTRON J, V139, P2360, DOI 10.1088/0004-6256/139/6/2360; McDonald P, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.063009; Puchwein E, 2012, MON NOT R ASTRON SOC, V423, P149, DOI 10.1111/j.1365-2966.2012.20738.x; Viel M, 2004, MON NOT R ASTRON SOC, V354, P684, DOI 10.1111/j.1365-2966.2004.08224.x; Calura F, 2012, MON NOT R ASTRON SOC, V422, P3019, DOI 10.1111/j.1365-2966.2012.20811.x; Becker GD, 2011, MON NOT R ASTRON SOC, V410, P1096, DOI 10.1111/j.1365-2966.2010.17507.x; Theuns T, 1998, MON NOT R ASTRON SOC, V301, P478, DOI 10.1046/j.1365-8711.1998.02040.x; Schaye J, 2003, ASTROPHYS J, V596, P768, DOI 10.1086/378044; Gunn JE, 2006, ASTRON J, V131, P2332, DOI 10.1086/500975; Prochaska JX, 2010, ASTROPHYS J, V718, P392, DOI 10.1088/0004-637X/718/1/392; Bernardi M, 2003, ASTRON J, V125, P32, DOI 10.1086/344945; Bird S, 2013, MON NOT R ASTRON SOC, V429, P3341, DOI 10.1093/mnras/sts590; Bolton AS, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/144; Borde A, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/07/005; Bovy J, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/141; Broderick AE, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/22; Busca NG, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220724; Chang PL, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/23; Cooksey KL, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/37; Dawson KS, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/10; Desjacques V, 2007, MON NOT R ASTRON SOC, V374, P206, DOI 10.1111/j.1365-2966.2006.11134.x; Draine BT, 2011, PR S ASTROP, P1; Eisenstein DJ, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/3/72; Font-Ribera A, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/07/028; Font-Ribera A, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/01/001; Gleser L, 2005, MON NOT R ASTRON SOC, V361, P1399, DOI 10.1111/j.1365-2966.2005.09276.x; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; Hui L, 1997, ASTROPHYS J, V486, P599, DOI 10.1086/304539; Janknecht E, 2006, ASTRON ASTROPHYS, V458, P427, DOI 10.1051/0004-6361:20065372; JENKINS EB, 1991, ASTROPHYS J, V376, P33, DOI 10.1086/170252; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Lee KG, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/21; Lee KG, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/2/51; Lee KG, 2014, ASTROPHYS J LETT, V795, DOI 10.1088/2041-8205/795/1/L12; Lee KG, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/136; Lee KG, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/49; Lee KG, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/3/69; Lidz A, 2010, ASTROPHYS J, V718, P199, DOI 10.1088/0004-637X/718/1/199; Lukic Z, 2015, MON NOT R ASTRON SOC, V446, P3697, DOI 10.1093/mnras/stu2377; McDonald P, 2006, ASTROPHYS J SUPPL S, V163, P80, DOI 10.1086/444361; McQuinn M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/82; Meiksin AA, 2009, REV MOD PHYS, V81, P1405, DOI 10.1103/RevModPhys.81.1405; MIRALDAESCUDE J, 1994, MON NOT R ASTRON SOC, V266, P343; MiraldaEscude J, 1996, ASTROPHYS J, V471, P582; Noterdaeme P, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201220259; OShea B. W., 2004, ARXIVASTROPH0403044; Palanque-Delabrouille N, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322130; Paris I, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201016233; Paris I, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220142; Pieri MM, 2014, MON NOT R ASTRON SOC, V441, P1718, DOI 10.1093/mnras/stu577; Pieri MM, 2010, ASTROPHYS J LETT, V724, pL69, DOI 10.1088/2041-8205/724/1/L69; RAUCH M, 1992, ASTROPHYS J, V390, P387, DOI 10.1086/171290; Rauch M, 1998, ANNU REV ASTRON ASTR, V36, P267, DOI 10.1146/annurev.astro.36.1.267; Ribaudo J, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/42; Rorai A, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/81; Ross NP, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/1/3; Rudie GC, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/146; Rudie GC, 2012, ASTROPHYS J LETT, V757, DOI 10.1088/2041-8205/757/2/L30; Schaye J, 1999, MON NOT R ASTRON SOC, V310, P57, DOI 10.1046/j.1365-8711.1999.02956.x; SCHMIDT M, 1965, ASTROPHYS J, V141, P1295, DOI 10.1086/148217; Sironi L, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/49; Slosar A, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/04/026; Slosar A, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/09/001; Smee SA, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/32; Suzuki N, 2006, ASTROPHYS J SUPPL S, V163, P110, DOI 10.1086/499272; Tytler D, 2004, ASTROPHYS J, V617, P1, DOI 10.1086/425226; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Worseck G, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/23; Worseck G, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L24	127	6	6	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							196	10.1088/0004-637X/799/2/196		32	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900083		
J	Nishizuka, N; Karlicky, M; Janvier, M; Barta, M				Nishizuka, N.; Karlicky, M.; Janvier, M.; Barta, M.			PARTICLE ACCELERATION IN PLASMOID EJECTIONS DERIVED FROM RADIO DRIFTING PULSATING STRUCTURES	ASTROPHYSICAL JOURNAL			English	Article						acceleration of particles; magnetic reconnection; Sun: flares; Sun: particle emission; Sun: radio radiation; Sun: X-rays, gamma rays	CORONAL MASS EJECTIONS; SOLAR-FLARE; X-RAY; CURRENT SHEET; MAGNETIC RECONNECTION; ELECTRON ACCELERATION; SOHO EIT; BURSTS; LOOP; HOT	We report observations of slowly drifting pulsating structures (DPSs) in the 0.8-4.5 GHz frequency range of the RT4 and RT5 radio spectrographs at Ondrejov Observatory, between 2002 and 2012. We found 106 events of DPSs, which we classified into four cases: (I) single events with a constant frequency drift (12 events), (II) multiple events occurring in the same flare with constant frequency drifts (11 events), (III) single or multiple events with increasing or decreasing frequency drift rates (52 events), and (IV) complex events containing multiple events occurring at the same time in a different frequency range (31 events). Many DPSs are associated with hard X-ray (HXR) bursts (15-25 keV) and soft X-ray (SXR) gradient peaks, as they typically occurred at the beginning of HXR peaks. This indicates that DPS events are related to the processes of fast energy release and particle acceleration. Furthermore, interpreting DPSs as signatures of plasmoids, we measured their ejection velocity, their width, and their height from the DPS spectra, from which we also estimated the reconnection rate and the plasma beta. In this interpretation, constant frequency drift indicates a constant velocity of a plasmoid, and an increasing/decreasing frequency drift indicates a deceleration/acceleration of a plasmoid ejection. The reconnection rate shows a good positive correlation with the plasmoid velocity. Finally we confirmed that some DPS events show plasmoid counterparts in Solar Dynamics Observatory/Atmospheric Imaging Assembly images.	[Nishizuka, N.] Natl Inst Informat & Commun Technol, Tokyo 1848795, Japan; [Karlicky, M.; Barta, M.] Acad Sci Czech Republic, Inst Astron, CS-25165 Ondrejov, Czech Republic; [Janvier, M.] Univ Dundee, Dept Math, Dundee DD1 4HN, Scotland	Nishizuka, N (reprint author), Natl Inst Informat & Commun Technol, 4-2-1 Nukui Kitamachi, Tokyo 1848795, Japan.	nishizuka.naoto@nict.go.jp	Barta, Miroslav/C-7069-2012; Karlicky, Marian/G-9023-2014		JSPS KAKENHI grant [24740132]; JSPS [22001];  [P209/12/0103]	We acknowledge the anonymous referee for useful comments and suggestions. This work was supported in part by JSPS KAKENHI grant Number 24740132 and in part by the JSPS Core-to-Core Program 22001. M.K. and M.B. acknowledge the support by grant P209/12/0103 (GA CR).	ALVAREZ H, 1973, SOL PHYS, V30, P175, DOI 10.1007/BF00156186; Kliem B, 2000, ASTRON ASTROPHYS, V360, P715; Barta M, 2008, SOL PHYS, V253, P173, DOI 10.1007/s11207-008-9217-5; Asai A, 2004, ASTROPHYS J, V611, P557, DOI 10.1086/422159; Lin RP, 2002, SOL PHYS, V210, P3, DOI 10.1023/A:1022428818870; Tsuneta S, 1997, ASTROPHYS J, V478, P787, DOI 10.1086/303812; Savage SL, 2010, ASTROPHYS J, V722, P329, DOI 10.1088/0004-637X/722/1/329; Kolomanski S, 2007, ASTRON ASTROPHYS, V475, P685, DOI 10.1051/0004-6361:20078356; DULK GA, 1978, SOL PHYS, V57, P279, DOI 10.1007/BF00160102; Narukage N, 2006, ASTROPHYS J, V637, P1122, DOI 10.1086/498492; Nishizuka N, 2010, ASTROPHYS J, V711, P1062, DOI 10.1088/0004-637X/711/2/1062; Milligan RO, 2010, ASTROPHYS J, V713, P1292, DOI 10.1088/0004-637X/713/2/1292; DULK GA, 1987, ASTRON ASTROPHYS, V173, P366; Nishizuka N, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.051101; Ono Y, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3662434; Lin J, 2000, J GEOPHYS RES-SPACE, V105, P2375, DOI 10.1029/1999JA900477; SHIBATA K, 1995, ASTROPHYS J, V451, pL83, DOI 10.1086/309688; Benz AO, 2005, SOL PHYS, V226, P121, DOI 10.1007/s11207-005-5254-5; Sui LH, 2003, ASTROPHYS J, V596, pL251, DOI 10.1086/379343; Tanaka KG, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3491123; Yokoyama T, 2001, ASTROPHYS J, V546, pL69, DOI 10.1086/318053; Oka M, 2010, ASTROPHYS J, V714, P915, DOI 10.1088/0004-637X/714/1/915; Temmer M, 2008, ASTROPHYS J LETT, V673, pL95, DOI 10.1086/527414; Karlicky M, 2004, ASTRON ASTROPHYS, V419, P365, DOI 10.1051/0004-6361:20035817; Ohyama M, 1997, PUBL ASTRON SOC JPN, V49, P249; Shibata K, 2001, EARTH PLANETS SPACE, V53, P473; Zhang J, 2001, ASTROPHYS J, V559, P452, DOI 10.1086/322405; Drake JF, 2006, NATURE, V443, P553, DOI 10.1038/nature05116; Krucker S, 2010, ASTROPHYS J, V714, P1108, DOI 10.1088/0004-637X/714/2/1108; Hudson HS, 2001, ASTROPHYS J, V561, pL211, DOI 10.1086/324760; Isobe H, 2002, ASTROPHYS J, V566, P528, DOI 10.1086/324777; Hoshino M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.135003; Aschwanden MJ, 1999, ASTROPHYS J, V515, P842, DOI 10.1086/307036; Aschwanden MJ, 1997, ASTROPHYS J, V480, P825, DOI 10.1086/303995; Liu R, 2010, ASTROPHYS J LETT, V723, pL28, DOI 10.1088/2041-8205/723/1/L28; Aschwanden M. J., 2004, PHYS SOLAR CORONA; Aschwanden MJ, 2002, SPACE SCI REV, V101, P1, DOI 10.1023/A:1019712124366; Bain HM, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/44; Barta M., 2012, APSSP, P43; Barta M, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/24; Farnik F, 2001, SOL PHYS, V201, P357, DOI 10.1023/A:1017533125731; Glesener L., 2013, APJ, P779; Hayashi Y., 2012, IJTFM, V132, P239; JIRICKA K, 1993, SOL PHYS, V147, P203, DOI 10.1007/BF00675495; Karlicky M, 2004, ASTRON ASTROPHYS, V417, P325, DOI 10.1051/0004-6361:20034249; Karlicky M, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/107; Karlicky M, 2002, ASTRON ASTROPHYS, V395, P677, DOI 10.1051/0004-6361:20021310; Khan JI, 2002, ASTRON ASTROPHYS, V388, P363, DOI 10.1051/0004-6361:20020385; Kumar P, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201220999; Kundu MR, 2001, ASTROPHYS J, V559, P443, DOI 10.1086/322301; Liu W, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/168; NEUPERT WM, 1968, ASTROPHYS J, V153, pL59, DOI 10.1086/180220; Nishida K, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/2/L39; Reeves KK, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L52; Reid HAS, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016181; Webb DF, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009923; Shimizu T, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3095562; Takasao S, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/1/L6; Tan BL, 2008, SOL PHYS, V253, P117, DOI 10.1007/s11207-008-9235-3; Tan BL, 2007, ASTROPHYS J, V671, P964, DOI 10.1086/522327; Tan CM, 2008, ADV SPACE RES, V41, P969, DOI 10.1016/j.asr.2007.04.085; Wang R, 2012, SOL PHYS, V278, P411, DOI 10.1007/s11207-012-9937-4; WILD JP, 1954, NATURE, V173, P532, DOI 10.1038/173532a0	63	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							126	10.1088/0004-637X/799/2/126		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900013		
J	Sano, H; Fukuda, T; Yoshiike, S; Sato, J; Horachi, H; Kuwahara, T; Torii, K; Hayakawa, T; Tanaka, T; Matsumoto, H; Inoue, T; Yamazaki, R; Inutsuka, S; Kawamura, A; Yamamoto, H; Okuda, T; Tachihara, K; Mizuno, N; Onishi, T; Mizuno, A; Acero, F; Fukui, Y				Sano, H.; Fukuda, T.; Yoshiike, S.; Sato, J.; Horachi, H.; Kuwahara, T.; Torii, K.; Hayakawa, T.; Tanaka, T.; Matsumoto, H.; Inoue, T.; Yamazaki, R.; Inutsuka, S.; Kawamura, A.; Yamamoto, H.; Okuda, T.; Tachihara, K.; Mizuno, N.; Onishi, T.; Mizuno, A.; Acero, F.; Fukui, Y.			A DETAILED STUDY OF NON-THERMAL X-RAY PROPERTIES AND INTERSTELLAR GAS TOWARD THE gamma-RAY SUPERNOVA REMNANT RX J1713.7-3946	ASTROPHYSICAL JOURNAL			English	Article						cosmic rays; ISM: clouds; ISM: individual objects (RX J1713.7-3946); ISM: supernova remnants; X-rays: ISM	MAGNETIC-FIELD AMPLIFICATION; SHELL-TYPE MORPHOLOGY; PARTICLE-ACCELERATION; SHOCK-WAVES; COSMIC-RAYS; XMM-NEWTON; H I; SNR; TEV; EMISSION	We have carried out a spectral analysis of the Suzaku X-ray data in the 0.4-12 keV range toward the shell-type very high-energy gamma-ray supernova remnant (SNR) RX J1713.7-3946. The aims of this analysis are to estimate detailed X-rays spectral properties at a high angular resolution up to 2 arcmin and to compare them with the interstellar gas. The X-ray spectrum is non-thermal and used to calculate absorbing column density, photon index, and absorption-corrected X-ray flux. The photon index varies significantly from 2.1 to 2.9. It is shown that the X-ray intensity is well correlated with the photon index, especially in the west region, with a correlation coefficient of 0.81. The X-ray intensity tends to increase with the averaged interstellar gas density while the dispersion is relatively large. The hardest spectra, with photon indexes of less than 2.4, are found outside of the central 10 arcmin of the SNR, from the north to the southeast (similar to 430 arcmin2) and from the southwest to the northwest (similar to 150 arcmin2). The former region shows low interstellar gas density, while the latter shows high interstellar gas density. We present a discussion of possible scenarios that explain the distribution of the photon index and its relationship with the interstellar gas.	[Sano, H.; Fukuda, T.; Yoshiike, S.; Sato, J.; Horachi, H.; Kuwahara, T.; Torii, K.; Hayakawa, T.; Matsumoto, H.; Inutsuka, S.; Yamamoto, H.; Tachihara, K.; Fukui, Y.] Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tanaka, T.] Kyoto Univ, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan; [Inoue, T.; Kawamura, A.; Okuda, T.; Mizuno, N.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Yamazaki, R.] Aoyama Gakuin Univ, Dept Math & Phys, Chuou Ku, Sagamihara, Kanagawa 2525258, Japan; [Onishi, T.] Osaka Prefecture Univ, Dept Astrophys, Grad Sch Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Mizuno, A.] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Acero, F.] Univ Montpellier 2, CNRS, LUPM, F-34095 Montpellier 5, France	Sano, H (reprint author), Nagoya Univ, Dept Phys, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	sano@a.phys.nagoya-u.ac.jp	XRAY, SUZAKU/A-1808-2009		Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [24.10082, 23403001, 22244014, 23740154, 22740119, 24224005]; Young Research Overseas Visits Program for Vitalizing Brain Circulation [R2211]; Japan Society for the Promotion of Science (JSPS) [R29]; Mitsubishi Foundation; MEXT	NANTEN2 is an international collaboration of 10 universities: Nagoya University, Osaka Prefecture University, University of Cologne, University of Bonn, Seoul National University, University of Chile, University of New South Wales, Macquarie University, University of Sydney, and University of ETH Zurich. This work was financially supported by a grant-in-aid for Scientific Research (KAKENHI, Nos. 24.10082, 23403001, 22244014, 23740154 (T.I.), 22740119, and 24224005) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This work was also financially supported by the Young Research Overseas Visits Program for Vitalizing Brain Circulation (R2211) and the Institutional Program for Young Researcher Overseas Visits (R29) by Japan Society for the Promotion of Science (JSPS) and by the Mitsubishi Foundation and by the grant-in-aid for Nagoya University Global COE Program, "Quest for Fundamental Principles in the Universe: From Particles to the Solar System and the Cosmos", from MEXT. This research made use of data obtained from Data ARchives and Transmission System (DARTS), provided by the Center for Science-satellite Operation, and the Data Archive (C-SODA) at ISAS/JAXA.	Abdo AA, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/28; Abramowski A, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201016425; Aharonian F, 2006, ASTRON ASTROPHYS, V449, P223, DOI 10.1051/0004-6361:20054279; Aharonian F, 2007, ASTRON ASTROPHYS, V464, P235, DOI 10.1051/0004-6361:20066381; Moriguchi Y, 2005, ASTROPHYS J, V631, P947, DOI 10.1086/432653; Koyama K, 1997, PUBL ASTRON SOC JPN, V49, pL7; Inoue T, 2009, ASTROPHYS J, V695, P825, DOI 10.1088/0004-637X/695/2/825; Uchiyama Y, 2007, NATURE, V449, P576, DOI 10.1038/nature06210; Hiraga JS, 2005, ASTRON ASTROPHYS, V431, P953, DOI 10.1051/0004-6361:20047015; Tanaka T, 2008, ASTROPHYS J, V685, P988, DOI 10.1086/591020; Fukui Y, 2003, PUBL ASTRON SOC JPN, V55, pL61; Zirakashvili VN, 2010, ASTROPHYS J, V708, P965, DOI 10.1088/0004-637X/708/2/965; Aharonian FA, 2004, NATURE, V432, P75, DOI 10.1038/nature02960; Aharonian F, 2007, ASTROPHYS J, V661, P236, DOI 10.1086/512603; Aharonian F, 2006, ASTROPHYS J, V636, P777, DOI 10.1086/498013; Sano H, 2010, ASTROPHYS J, V724, P59, DOI 10.1088/0004-637X/724/1/59; Lucek SG, 2000, MON NOT R ASTRON SOC, V314, P65, DOI 10.1046/j.1365-8711.2000.03363.x; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Aharonian FA, 2005, ASTRON ASTROPHYS, V437, pL7, DOI 10.1051/0004-6361:200500130; Uchiyama Y, 2003, ASTRON ASTROPHYS, V400, P567, DOI 10.1051/0004-6361:20021824; Acero F, 2009, ASTRON ASTROPHYS, V505, P157, DOI 10.1051/0004-6361/200811556; Gabici S, 2014, MON NOT R ASTRON SOC, V445, pL70, DOI 10.1093/mnrasl/slu132; DICKEY JM, 1990, ANNU REV ASTRON ASTR, V28, P215; Cassam-Chenai G, 2004, ASTRON ASTROPHYS, V427, P199, DOI 10.1051/0004-6361:20041154; Zirakashvili VN, 2007, ASTRON ASTROPHYS, V465, P695, DOI 10.1051/0004-6361:20066494; Hoshino M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.135003; Dobashi K., 2005, PASJ, V57, P1; Ellison DC, 2001, SPACE SCI REV, V99, P305, DOI 10.1023/A:1013865619908; Ellison DC, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/39; Enomoto R, 2002, NATURE, V416, P823, DOI 10.1038/416823a; Fermi E., 1949, Physical Review, V75, DOI 10.1103/PhysRev.75.1169; Fukui Y, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/82; Fukui Y., 2013, ASTROPHYSICS SPACE S, V34, P249; Giacalone J, 2007, ASTROPHYS J, V663, pL41, DOI 10.1086/519994; GORENSTE.P, 1974, ASTROPHYS J, V192, P661, DOI 10.1086/153103; Inoue T, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/71; Ishisaki Y., 2007, PASJ, V59, P113; JENKINS EB, 1974, ASTROPHYS J, V187, P243, DOI 10.1086/152620; Kishishita T, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220525; McClure-Griffiths NM, 2005, ASTROPHYS J SUPPL S, V158, P178, DOI 10.1086/430114; Pfeffermann E., 1996, P RONTG UN, P267; Sano H, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/59; Takahashi T., 2008, PASJ, V60, P131; Taylor J.R., 1982, INTRO ERROR ANAL; WALLERST.G, 1971, ASTROPHYS J, V170, P289, DOI 10.1086/151214; Yamazaki R, 2014, RES ASTRON ASTROPHYS, V14, P165, DOI 10.1088/1674-4527/14/2/005	46	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							175	10.1088/0004-637X/799/2/175		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900062		
J	Shirasaki, M				Shirasaki, Masato			WEAK GRAVITATIONAL LENSING AS A PROBE OF PHYSICAL PROPERTIES OF SUBSTRUCTURES IN DARK MATTER HALOS	ASTROPHYSICAL JOURNAL			English	Article						gravitational lensing: weak	DIGITAL SKY SURVEY; GALAXY CLUSTERS; STATISTICAL PROPERTIES; DENSITY PROFILE; MASS FUNCTION; STELLAR MASS; EVOLUTION; SIMULATIONS; CONSTRAINTS; COSMOLOGY	We propose a novel method to select satellite galaxies in outer regions of galaxy groups or clusters using weak gravitational lensing. The method is based on the theoretical expectation that the tangential shear pattern around satellite galaxies would appear with negative values at an offset distance from the center of the main halo. We can thus locate the satellite galaxies statistically with an offset distance of several lensing smoothing scales by using the standard reconstruction of surface mass density maps from weak lensing observation. We test the idea using high-resolution cosmological simulations. We show that subhalos separated from the center of the host halo are successfully located even without assuming the position of the center. For a number of such subhalos, the characteristic mass and offset length can be also estimated on a statistical basis. We perform a Fisher analysis to show how well upcoming weak lensing surveys can constrain the mass density profile of satellite galaxies. In the case of the Large Synoptic Survey Telescope with a sky coverage of 20,000 deg(2), the mass of the member galaxies in the outer region of galaxy clusters can be constrained with an accuracy of similar to 0.1 dex for galaxy clusters with mass 1014 h(-1) M-circle dot at z = 0.15. Finally we explore the detectability of tidal stripping features for subhalos having a wide range of masses of 10(11)-10(13) h(-1) M-circle dot.	Univ Tokyo, Dept Phys, Tokyo 1130033, Japan	Shirasaki, M (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.	masato.shirasaki@utap.phys.s.u-tokyo.ac.jp			Research Fellowships of the Japan Society for the Promotion of Science (JSPS); "Interdisciplinary Computational Science Program" in the Center for Computational Sciences, University Tsukuba	The author would like to thank Naoki Yoshida for helpful discussions and comments on the manuscript. We appreciate the helpful comments of the referee. The author is supported by Research Fellowships of the Japan Society for the Promotion of Science (JSPS) for Young Scientists. Numerical calculations for the present work have been in part carried out under the "Interdisciplinary Computational Science Program" in the Center for Computational Sciences, University Tsukuba, and also on the general-purpose PC farm at the Center for Computational Astrophysics, CfCA, of the National Astronomical Observatory of Japan.	Hu W, 2003, ASTROPHYS J, V584, P702, DOI 10.1086/345846; Oguri M, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.023008; Crocce M, 2006, MON NOT R ASTRON SOC, V373, P369, DOI 10.1111/j.1365-2966.2006.11040.x; Li R, 2014, MON NOT R ASTRON SOC, V438, P2864, DOI 10.1093/mnras/stt2395; Lewis A, 2000, ASTROPHYS J, V538, P473, DOI 10.1086/309179; Duffy AR, 2008, MON NOT R ASTRON SOC, V390, pL64, DOI 10.1111/j.1745-3933.2008.00537.x; Hayashi E, 2003, ASTROPHYS J, V584, P541, DOI 10.1086/345788; Shirasaki M, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/43; Hennawi JF, 2005, ASTROPHYS J, V624, P59, DOI 10.1086/428749; Hamana T, 2012, MON NOT R ASTRON SOC, V425, P2287, DOI 10.1111/j.1365-2966.2012.21582.x; Velander M, 2014, MON NOT R ASTRON SOC, V437, P2111, DOI 10.1093/mnras/stt2013; Broadhurst T, 2005, ASTROPHYS J, V619, pL143, DOI 10.1086/428122; Bullock JS, 2001, MON NOT R ASTRON SOC, V321, P559, DOI 10.1046/j.1365-8711.2001.04068.x; Springel V, 2001, MON NOT R ASTRON SOC, V328, P726, DOI 10.1046/j.1365-8711.2001.04912.x; Yang XH, 2006, MON NOT R ASTRON SOC, V373, P1159, DOI 10.1111/j.1365-2966.2006.11091.x; Tegmark M, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.123507; Menard B, 2010, MON NOT R ASTRON SOC, V405, P1025, DOI 10.1111/j.1365-2966.2010.16486.x; Tinker JL, 2010, ASTROPHYS J, V724, P878, DOI 10.1088/0004-637X/724/2/878; Brainerd TG, 1996, ASTROPHYS J, V466, P623, DOI 10.1086/177537; Tinker J, 2008, ASTROPHYS J, V688, P709, DOI 10.1086/591439; Yang XH, 2007, ASTROPHYS J, V671, P153, DOI 10.1086/522027; Oguri M, 2012, MON NOT R ASTRON SOC, V420, P3213, DOI 10.1111/j.1365-2966.2011.20248.x; Nishimichi T, 2009, PUBL ASTRON SOC JPN, V61, P321; Mandelbaum R, 2006, MON NOT R ASTRON SOC, V372, P758, DOI 10.1111/j.1365-2966.2006.10906.x; Reyes R, 2008, MON NOT R ASTRON SOC, V390, P1157, DOI 10.1111/j.1365-2966.2008.13818.x; Hudson MJ, 1998, ASTROPHYS J, V503, P531, DOI 10.1086/306026; Sato M, 2009, ASTROPHYS J, V701, P945, DOI 10.1088/0004-637X/701/2/945; Hoekstra H, 2004, ASTROPHYS J, V606, P67, DOI 10.1086/382726; Erben T, 2013, MON NOT R ASTRON SOC, V433, P2545, DOI 10.1093/mnras/stt928; Maturi M, 2005, ASTRON ASTROPHYS, V442, P851, DOI 10.1051/0004-6361:20042600; Hamana T, 2004, MON NOT R ASTRON SOC, V350, P893, DOI 10.1111/j.1365-2966.2004.07691.x; Reyes R, 2012, MON NOT R ASTRON SOC, V425, P2610, DOI 10.1111/j.1365-2966.2012.21472.x; White M, 2000, ASTROPHYS J, V537, P1, DOI 10.1086/309009; Hilbert S, 2010, MON NOT R ASTRON SOC, V404, P486, DOI 10.1111/j.1365-2966.2010.16310.x; Dutton AA, 2010, MON NOT R ASTRON SOC, V407, P2, DOI 10.1111/j.1365-2966.2010.16911.x; Yang XH, 2005, MON NOT R ASTRON SOC, V356, P1293, DOI 10.1111/j.1365-2966.2005.08560.x; Oguri M, 2011, MON NOT R ASTRON SOC, V414, P1851, DOI 10.1111/j.1365-2966.2011.18481.x; Mandelbaum R, 2006, MON NOT R ASTRON SOC, V368, P715, DOI 10.1111/j.1365-2966.2006.10156.x; Gao L, 2004, MON NOT R ASTRON SOC, V355, P819, DOI 10.1111/j.1365-2966.2004.08360.x; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Baltz EA, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/01/015; Covone G, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/2/L25; Du W, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/57; Gillis BR, 2013, MON NOT R ASTRON SOC, V431, P1439, DOI 10.1093/mnras/stt274; Guzik J, 2002, MON NOT R ASTRON SOC, V335, P311, DOI 10.1046/j.1365-8711.2002.05591.x; Hamana T, 2001, MON NOT R ASTRON SOC, V327, P169, DOI 10.1046/j.1365-8711.2001.04685.x; Hamana T, 2009, PUBL ASTRON SOC JPN, V61, P833; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Johnston D. E., 2007, ARXIV07091159; Kneib JP, 2011, ASTRON ASTROPHYS REV, V19, P1, DOI 10.1007/s00159-011-0047-3; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Leauthaud A, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/159; Li R, 2013, MON NOT R ASTRON SOC, V430, P3359, DOI 10.1093/mnras/stt133; Okabe N, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/90; Okabe N, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/2/L35; Reid BA, 2010, MON NOT R ASTRON SOC, V404, P60, DOI 10.1111/j.1365-2966.2010.16276.x; Seljak U, 2002, MON NOT R ASTRON SOC, V334, P797, DOI 10.1046/j.1365-8711.2002.05492.x; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Tormen G, 1998, MON NOT R ASTRON SOC, V299, P728, DOI 10.1046/j.1365-8711.1998.01775.x; Valageas P, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015685	60	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							188	10.1088/0004-637X/799/2/188		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900075		
J	Slane, P; Lee, SH; Ellison, DC; Patnaude, DJ; Hughes, JP; Eriksen, KA; Castro, D; Nagataki, S				Slane, P.; Lee, S. -H.; Ellison, D. C.; Patnaude, D. J.; Hughes, J. P.; Eriksen, K. A.; Castro, D.; Nagataki, S.			A CR-HYDRO-NEI MODEL OF THE STRUCTURE AND BROADBAND EMISSION FROM TYCHO'S SUPERNOVA REMNANT (vol 33, 783, 2014)	ASTROPHYSICAL JOURNAL			English	Correction									[Slane, P.; Patnaude, D. J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Lee, S. -H.; Nagataki, S.] RIKEN, Astrophys Big Bang Lab, Wako, Saitama 3510198, Japan; [Ellison, D. C.] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Hughes, J. P.; Eriksen, K. A.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Eriksen, K. A.] Los Alamos Natl Lab, XTD IDA, Los Alamos, NM 87545 USA; [Castro, D.] MIT, Kavli Ctr Astrophys & Space Res, Cambridge, MA 02139 USA	Slane, P (reprint author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	slane@cfa.harvard.edu; shiu-hang.lee@riken.jp; don_ellison@ncsu.edu; dpatnaude@cfa.harvard.edu; jph@physics.rutgers.edu; castro@mit.edu; shigehiro.nagataki@riken.jp					Katsuda S, 2010, ASTROPHYS J, V709, P1387, DOI 10.1088/0004-637X/709/2/1387; SLANE P, 2014, APJ, V33	2	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							238	10.1088/0004-637X/799/2/238		3	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900124		
J	Tazaki, R; Nomura, H				Tazaki, Ryo; Nomura, Hideko			OUTWARD MOTION OF POROUS DUST AGGREGATES BY STELLAR RADIATION PRESSURE IN PROTOPLANETARY DISKS	ASTROPHYSICAL JOURNAL			English	Article						comets: general; protoplanetary disks; radiation: dynamics; solid state: refractory	DISCRETE-DIPOLE APPROXIMATION; COMET 73P/SCHWASSMANN-WACHMANN 3; DIFFUSE INTERSTELLAR-MEDIUM; ACCRETION DISKS; CRYSTALLINE SILICATES; INTERPLANETARY DUST; LIGHT-SCATTERING; SOLAR NEBULA; SPITZER VIEW; PARTICLES	We study the dust motion at the surface layer of protoplanetary disks. Dust grains in the surface layer migrate outward owing to angular momentum transport via gas-drag force induced by the stellar radiation pressure. In this study we calculate the mass flux of the outward motion of compact grains and porous dust aggregates by the radiation pressure. The radiation pressure force for porous dust aggregates is calculated using the T-Matrix Method for the Clusters of Spheres. First, we confirm that porous dust aggregates are forced by strong radiation pressure even if they grow to be larger aggregates, in contrast to homogeneous and spherical compact grains, for which radiation pressure efficiency becomes lower when their sizes increase. In addition, we find that the outward mass flux of porous dust aggregates with monomer size of 0.1 mu m is larger than that of compact grains by an order of magnitude at the disk radius of 1 AU, when their sizes are several microns. This implies that large compact grains like calcium-aluminum-rich inclusions are hardly transported to the outer region by stellar radiation pressure, whereas porous dust aggregates like chondritic-porous interplanetary dust particles are efficiently transported to the comet formation region. Crystalline silicates are possibly transported in porous dust aggregates by stellar radiation pressure from the inner hot region to the outer cold cometary region in the protosolar nebula.	[Tazaki, Ryo] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Nomura, Hideko] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan	Tazaki, R (reprint author), Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	rtazaki@kusastro.kyoto-u.ac.jp			 [23103005];  [25400229]	R.T. thanks Yasuhiko Okada for technical advice about the T-Matrix Method. R.T. also acknowledges useful discussions with Hiroshi Kimura and Junya Matsuno. The numerical calculations were carried out on SR16000 at YITP at Kyoto University. This work is supported by Grants-in-Aid for Scientific Research, 23103005 and 25400229.	Hughes ALH, 2010, ASTROPHYS J, V719, P1633, DOI 10.1088/0004-637X/719/2/1633; CUZZI JN, 1993, ICARUS, V106, P102, DOI 10.1006/icar.1993.1161; Ciesla FJ, 2007, SCIENCE, V318, P613, DOI 10.1126/science.1147273; MIYAKE K, 1993, ICARUS, V106, P20, DOI 10.1006/icar.1993.1156; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Juhasz A, 2010, ASTROPHYS J, V721, P431, DOI 10.1088/0004-637X/721/1/431; Harker DE, 2002, ASTROPHYS J, V565, pL109, DOI 10.1086/339363; Harker DE, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/1/26; Brownlee D, 2014, ANNU REV EARTH PL SC, V42, P179, DOI 10.1146/annurev-earth-050212-124203; Wooden DH, 2004, ASTROPHYS J, V612, pL77, DOI 10.1086/424593; Kolokolova L, 2007, ASTRON ASTROPHYS, V463, P1189, DOI 10.1051/0004-6361:20065069; Ootsubo T, 2007, PLANET SPACE SCI, V55, P1044, DOI 10.1016/j.pss.2006.11.012; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Bouwman J, 2008, ASTROPHYS J, V683, P479, DOI 10.1086/587793; BRADLEY JP, 1983, NATURE, V301, P473, DOI 10.1038/301473a0; Hernandez J, 2008, ASTROPHYS J, V686, P1195, DOI 10.1086/591224; Riaz B, 2012, MON NOT R ASTRON SOC, V420, P2603, DOI 10.1111/j.1365-2966.2011.20233.x; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183; Olofsson J, 2009, ASTRON ASTROPHYS, V507, P327, DOI 10.1051/0004-6361/200912062; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; DRAINE BT, 1994, J OPT SOC AM A, V11, P1491, DOI 10.1364/JOSAA.11.001491; Mishchenko MI, 1996, J QUANT SPECTROSC RA, V55, P535, DOI 10.1016/0022-4073(96)00002-7; DRAINE BT, 1993, ASTROPHYS J, V405, P685, DOI 10.1086/172396; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; Kemper F, 2005, ASTROPHYS J, V633, P534, DOI 10.1086/447764; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; Keller LP, 2011, GEOCHIM COSMOCHIM AC, V75, P5336, DOI 10.1016/j.gca.2011.06.040; Ciesla FJ, 2009, ICARUS, V200, P655, DOI 10.1016/j.icarus.2008.12.009; Takeuchi T, 2002, ASTROPHYS J, V581, P1344, DOI 10.1086/344437; PURCELL EM, 1973, ASTROPHYS J, V186, P705, DOI 10.1086/152538; Keller C, 2004, ASTRON ASTROPHYS, V415, P1177, DOI 10.1051/0004-6361:20034629; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Ishii HA, 2008, SCIENCE, V319, P447, DOI 10.1126/science.1150683; Dullemond CP, 2004, ASTRON ASTROPHYS, V421, P1075, DOI 10.1051/0004-6361:20040284; Takeuchi T, 2001, ASTROPHYS J, V557, P990, DOI 10.1086/322252; MUKAI T, 1992, ASTRON ASTROPHYS, V262, P315; Li AG, 2001, ASTROPHYS J, V554, P778, DOI 10.1086/323147; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Abraham P, 2009, NATURE, V459, P224, DOI 10.1038/nature08004; Bohren C. F., 1983, ABSORPTION SCATTERIN; Chiang E., 2007, PROTOSTARS PLANETS, VV, P895; Chylek P., 2000, EFFECTIVE MEDIUM APR; Cuzzi JN, 2003, ICARUS, V166, P385, DOI 10.1016/j.icarus.2003.08.016; DRAINE BT, 1988, ASTROPHYS J, V333, P848, DOI 10.1086/166795; Fromang S, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201016068; Gail HP, 2004, ASTRON ASTROPHYS, V413, P571, DOI 10.1051/0004-6361:20031554; Gail HP, 2010, LECT NOTES PHYS, V815, P61, DOI 10.1007/978-3-642-13259-9_2; Gail HP, 2001, ASTRON ASTROPHYS, V378, P192, DOI 10.1051/0004-6361:20011130; Hayashi C., 1985, PROTOSTARS PLANETS, VII, P1100; Juhasz A, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/118; Kataoka A, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201323199; Kimura H, 2002, ICARUS, V157, P349, DOI 10.1006/icar.2002.6849; Kohler M, 2007, ADV SPACE RES, V40, P266, DOI 10.1016/j.asr.2007.05.044; Matsuno J., 2014, LUN PLAN SCI C HOUST, V45, P1335; Messenger S., 2013, LIFE CYCLE DUST UNIV; Mishchenko MI, 2000, LIGHT SCATTERING NON; Murata K, 2009, ASTROPHYS J, V697, P836, DOI 10.1088/0004-637X/697/1/836; Nagasawa M, 2014, ASTROPHYS J LETT, V794, DOI 10.1088/2041-8205/794/1/L7; Okada Y, 2008, J QUANT SPECTROSC RA, V109, P1719, DOI 10.1016/j.jqsrt.2008.01.002; Okamoto H, 1998, EARTH PLANETS SPACE, V50, P577; Okuzumi S, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/106; Sitko ML, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/3/80; Takeuchi T, 2003, ASTROPHYS J, V593, P524, DOI 10.1086/376496; Urpin V. A., 1984, Soviet Astronomy, V28; Vinkovic D, 2009, NATURE, V459, P227, DOI 10.1038/nature08032; Vorobyov EI, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/2/L45; Watson DM, 2009, ASTROPHYS J SUPPL S, V180, P84, DOI 10.1088/0067-0049/180/1/84; Woodward CE, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/6/181	69	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	FEB 1	2015	799	2							119	10.1088/0004-637X/799/2/119		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CA3QH	WOS:000348820900006		
J	Hashimoto, K; Sasaki, T				Hashimoto, Kenji; Sasaki, Tsuyoshi			Old drug tipepidine as new hope for children with ADHD	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY			English	Article							METAANALYSIS; DISORDER		[Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan; [Sasaki, Tsuyoshi] Chiba Univ Hosp, Dept Child Psychiat, Chiba, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp			AbbVie; Dainippon Sumitomo; Otsuka; Taisho; Astellas; Eli Lilly; Janssen; Mochida; Shionogi; Yoshitomi	Dr Hashimoto has served as a scientific consultant to Astellas, Dainippon Sumitomo, and Taisho, and he has also received research support from AbbVie, Dainippon Sumitomo, Otsuka, and Taisho. Dr Sasaki has received research support or speakers' honoraria from Astellas, Dainippon Sumitomo, Eli Lilly, Janssen, Mochida, Otsuka, Shionogi, Taisho and Yoshitomi.	Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Bangs ME, 2008, J AM ACAD CHILD PSY, V47, P209, DOI 10.1097/chi.0b013e31815d88b2; Hirota T, 2014, J AM ACAD CHILD PSY, V53, P153, DOI 10.1016/j.jaac.2013.11.009; Kawaura K, 2010, YAKUGAKU ZASSHI, V130, P699; Sasaki T, 2014, NEUROPSYCH DIS TREAT, V10, P147, DOI 10.2147/NDT.S58480	5	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0004-8674	1440-1614		AUST NZ J PSYCHIAT	Aust. N. Z. J. Psych.	FEB	2015	49	2					181	182		10.1177/0004867414553952		2	Psychiatry	Psychiatry	CA1AS	WOS:000348645600012		
J	Cazares-Ordonez, V; Gonzalez-Duarte, RJ; Diaz, L; Ishizawa, M; Uno, S; Ortiz, V; Ordonez-Sanchez, ML; Makishima, M; Larrea, F; Avila, E				Cazares-Ordonez, V.; Gonzalez-Duarte, R. J.; Diaz, L.; Ishizawa, M.; Uno, S.; Ortiz, V.; Ordonez-Sanchez, M. L.; Makishima, M.; Larrea, F.; Avila, E.			A cis-acting element in the promoter of human ether a go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells	BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE			English	Article						1,25-dihydroxyvitamin D-3; cervical cancer; hEAG K+ channel; VDIR; WSTF	VITAMIN-D-RECEPTOR; TRANSCRIPTION FACTOR; EXPRESSION; TRANSREPRESSION; MECHANISMS; MARKERS; WSTF	The human ether a go-go 1 potassium channel (hEAG1) is required for cell cycle progression and proliferation of cancer cells. Inhibitors of hEAG1 activity and expression represent potential therapeutic drugs in cancer. Previously, we have shown that hEAG1 expression is downregulated by calcitriol in a variety of cancer cells. Herein, we provided evidence on the regulatory mechanism involved in such repressive effect in cells derived from human cervical cancer. Our results indicate that repression by calcitriol occurs at the transcriptional level and involves a functional negative vitamin Dresponse element (nVDRE) E-box type in the hEAG1 promoter. The described mechanism in this work implies that a protein complex formed by the vitamin D receptor-interacting repressor, the vitamin D receptor, the retinoid X receptor, and the Williams syndrome transcription factor interact with the nVDRE in the hEAG1 promoter in the absence of ligand. Interestingly, all of these transcription factors except the vitamin D receptor-interacting repressor are displaced from hEAG1 promoter in the presence of calcitriol. Our results provide novel mechanistic insights into calcitriol mode of action in repressing hEAG1 gene expression.	[Cazares-Ordonez, V.; Gonzalez-Duarte, R. J.; Diaz, L.; Larrea, F.; Avila, E.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Reprod Biol, Mexico City 14000, DF, Mexico; [Cazares-Ordonez, V.; Gonzalez-Duarte, R. J.] Univ Nacl Autonoma Mexico, Sch Med, Mexico City 04510, DF, Mexico; [Ishizawa, M.; Uno, S.; Makishima, M.] Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem,Itabashi Ku, Tokyo, Japan; [Ortiz, V.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Physiol Nutr, Mexico City 14000, DF, Mexico; [Ordonez-Sanchez, M. L.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Genom Med, Mexico City 14000, DF, Mexico	Avila, E (reprint author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Reprod Biol, Vasco de Quiroga 15,Col Secc 16, Mexico City 14000, DF, Mexico.	euclides.avilac@quetzal.innsz.mx			Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [106422, 153862]; Programa de Movilidad Internacional de Estudiantes of the Direccion General de Estudios de Posgrado (DGEP-UNAM); CONACyT [207284]	We acknowledge with thanks to Hoffmann-La Roche Ltd (Basel, Switzerland) for their calcitriol donation. This work was supported by grant Nos. 106422 and 153862 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico). This article is part of the doctoral thesis of VCO who is a Ph.D. student from Programa de Doctorado en Ciencias Biomedicas at School of Medicine, Universidad Nacional Autonoma de Mexico (UNAM, Mexico) under the fellowship 207284 from CONACyT. This work was also supported by the Programa de Apoyo a los Estudios de Posgrado (PAEP-UNAM) and the Programa de Movilidad Internacional de Estudiantes of the Direccion General de Estudios de Posgrado (DGEP-UNAM).	Adams C., 2007, PROTEIN INTERACTIONS, P417, DOI 10.1007/978-0-387-35966-3_14; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Endo-Umeda K, 2012, MOL PHARMACOL, V81, P800, DOI 10.1124/mol.111.077206; Ortiz CS, 2011, ONCOL REP, V26, P1377, DOI 10.3892/or.2011.1441; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Garcia-Becerra R, 2010, EXP CELL RES, V316, P433, DOI 10.1016/j.yexcr.2009.11.008; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Matsunawa M, 2012, DRUG METAB DISPOS, V40, P2059, DOI 10.1124/dmd.112.046839; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Diaz L, 2009, CANCER RES, V69, P3300, DOI 10.1158/0008-5472.CAN-08-2036; Friedrich M, 2003, RECENT RES CANCER, V164, P239; Avila E, 2010, ANTICANCER RES, V30, P2667; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Barnett C, 2011, BIOCHEM CELL BIOL, V89, P12, DOI 10.1139/O10-114; Garcia-Quiroz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045063; Kato S, 2007, CURR OPIN NEPHROL HY, V16, P297, DOI 10.1097/MNH.0b013e3281c55f16; Kim M, 2007, MOL ENDOCRINOL, V21, P334, DOI 10.1210/me.2006-0231; Lin HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020362; Lundqvist J, 2012, BBA-GEN SUBJECTS, V1820, P1553, DOI 10.1016/j.bbagen.2012.04.017; Lundqvist J, 2013, BBA-MOL CELL RES, V1833, P40, DOI 10.1016/j.bbamcr.2012.10.012; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Pike JW, 2014, J STEROID BIOCHEM, V144, P5, DOI 10.1016/j.jsbmb.2013.11.004; Pike JW, 2011, MOL CELL ENDOCRINOL, V347, P3, DOI 10.1016/j.mce.2011.05.012	24	2	2	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0829-8211	1208-6002		BIOCHEM CELL BIOL	Biochem. Cell Biol.	FEB	2015	93	1					94	101		10.1139/bcb-2014-0073		8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CA6KQ	WOS:000349022600011		
J	Murashima, A; Kishigami, S; Thomson, A; Yamada, G				Murashima, Aki; Kishigami, Satoshi; Thomson, Axel; Yamada, Gen			Androgens and mammalian male reproductive tract development	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						androgen receptor; growth factor; knockout mouse; external genitalia; epididymis; prostate	WOLFFIAN DUCT DEVELOPMENT; PROSTATE EPITHELIAL DEVELOPMENT; EXTERNAL GENITALIA DEVELOPMENT; ALTERED GENE-EXPRESSION; RAT VENTRAL PROSTATE; MICE LACKING; BRANCHING MORPHOGENESIS; TESTICULAR FEMINIZATION; NUCLEAR RECEPTORS; SMOOTH-MUSCLE	One of the main functions of androgen is in the sexually dimorphic development of the male reproductive tissues. During embryogenesis, androgen determines the morphogenesis of male specific organs, such as the epididymis, seminal vesicle, prostate and penis. Despite the critical function of androgens in masculinization, the downstream molecular mechanisms of androgen signaling are poorly understood. Tissue recombination experiments and tissue specific androgen receptor (AR) knockout mouse studies have revealed epithelial or mesenchymal specific androgen-AR signaling functions. These findings also indicate that epithelial-mesenchymal interactions are a key feature of AR specific activity, and paracrine growth factor action may mediate some of the effects of androgens. This review focuses on mouse models showing the interactions of androgen and growth factor pathways that promote the sexual differentiation of reproductive organs. Recent studies investigating context dependent AR target genes are also discussed. This article is part of a Special Issue entitled: Nuclear receptors in animal development. (C) 2014 Elsevier B.V. All rights reserved.	[Murashima, Aki; Yamada, Gen] Wakayama Med Univ, Dept Dev Genet, Inst Adv Med, Wakayama 6418509, Japan; [Kishigami, Satoshi] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan; [Thomson, Axel] McGill Univ, Ctr Hlth, Dept Urol, Montreal, PQ H3A1A4, Canada	Yamada, G (reprint author), Wakayama Med Univ, Dept Dev Genet, Inst Adv Med, Kimiidera 811-1, Wakayama 6418509, Japan.	genyama77@yahoo.co.jp			 [25860771];  [22132006]	We thank Drs. Robert Kypta, Blanche Capel, Denis Duboule, Gail Prins, Richard Behringer, Barry Hinton and Hiort Olaf for their supports. We also express our appreciation to Drs. Daisuke Matsumaru, Yukiko Ogino, Shinichi Miyagawa Ryuma Haraguchi, Kentaro Suzuki, Akiko Omori and Lerrie anne Ipulan for their assistances. We thank Tomiko I. Iba for technical helps. This work is supported by Grant-in-Aid for Young Scientists B (25860771), for Scientific Research on Innovative Areas: Molecular mechanisms for establishment of sex differences (22132006).	SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Ross AJ, 2005, TRENDS ENDOCRIN MET, V16, P19, DOI 10.1016/j.tem.2004.11.004; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Choo D, 2006, DEV BIOL, V289, P308, DOI 10.1016/j.ydbio.2005.10.007; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Lee SO, 2012, J ENDOCRINOL, V213, P173, DOI 10.1530/JOE-11-0474; Ma WB, 2013, J BIOL CHEM, V288, P29369, DOI 10.1074/jbc.M113.454066; Imai Y, 2013, PHYSIOL REV, V93, P481, DOI 10.1152/physrev.00008.2012; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Simanainen U, 2007, ENDOCRINOLOGY, V148, P2264, DOI 10.1210/en.2006-1223; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573; Miyagawa S, 2009, MOL ENDOCRINOL, V23, P871, DOI 10.1210/me.2008-0478; Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248; DESLYPERE JP, 1992, MOL CELL ENDOCRINOL, V88, P15, DOI 10.1016/0303-7207(92)90004-P; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Gupta A, 2006, ENVIRON HEALTH PERSP, V114, P1649, DOI 10.1289/ehp.8957; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Petiot A, 2005, DEVELOPMENT, V132, P2441, DOI 10.1242/dev.01778; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Febbo PG, 2005, J UROLOGY, V173, P1772, DOI 10.1097/01.ju.0000155845.44729.ba; CUNHA GR, 1992, J ANDROL, V13, P465; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Yu SQ, 2012, PROSTATE, V72, P437, DOI 10.1002/pros.21445; Pu YB, 2007, ENDOCRINOLOGY, V148, P1697, DOI 10.1210/en.2006-1113; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; Gupta C, 1996, ENDOCRINOLOGY, V137, P905, DOI 10.1210/en.137.3.905; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; Pihlajamaa P, 2014, EMBO J, V33, P312, DOI 10.1002/embj.201385895; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Suzuki K, 2003, DEVELOPMENT, V130, P6209, DOI 10.1242/dev.00846; Murashima A, 2011, ENDOCRINOLOGY, V152, P1640, DOI 10.1210/en.2010-1121; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Nishida Hisayo, 2008, Congenital Anomalies, V48, P63, DOI 10.1111/j.1741-4520.2008.00180.x; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Sissung TM, 2006, MOL CANCER RES, V4, P135, DOI 10.1158/1541-7786.MCR-05-0101; Escriva H, 2000, BIOESSAYS, V22, P717; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj/onc/1205352; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Renfree MB, 2009, DEV BIOL, V334, P429, DOI 10.1016/j.ydbio.2009.07.040; Beleza-Meireles A, 2007, EUR J HUM GENET, V15, P405, DOI 10.1038/sj.ejhg.5201777; Berry PA, 2008, MOL CELL ENDOCRINOL, V288, P30, DOI 10.1016/j.mce.2008.02.024; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Bowman CJ, 2005, TOXICOL SCI, V86, P161, DOI 10.1093/toxsci/kfi172; Chang CS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109132; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Ching ST, 2014, DEV BIOL, V386, P1, DOI 10.1016/j.ydbio.2013.12.014; COOKE PS, 1991, ENDOCRINOLOGY, V128, P2867; CUNHA GR, 1994, CANCER, V74, P1030, DOI 10.1002/1097-0142(19940801)74:3+<1030::AID-CNCR2820741510>3.0.CO;2-Q; CUNHA GR, 1991, ENDOCRINOLOGY, V128, P3293; CUNHA GR, 1991, DEVELOPMENT, V111, P145; Donjacour AA, 2003, DEV BIOL, V261, P39, DOI 10.1016/S0012-1606(03)00250-1; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; Gupta C, 1996, ENDOCRINOLOGY, V137, P705, DOI 10.1210/en.137.2.705; GUPTA C, 1991, DEV BIOL, V146, P106, DOI 10.1016/0012-1606(91)90451-8; Gupta C, 1996, MOL CELL ENDOCRINOL, V123, P89, DOI 10.1016/0303-7207(96)03899-3; Hannema SE, 2007, HORM RES, V67, P142, DOI 10.1159/000096644; Hannema SE, 2006, HORM RES, V65, P200, DOI 10.1159/000092408; Huang LW, 2005, DEV BIOL, V278, P396, DOI 10.1016/j.ydbio.2004.11.020; IMPERATOMCGINLEY J, 1979, NEW ENGL J MED, V300, P1233, DOI 10.1056/NEJM197905313002201; Ipulan L.A., 2014, SEX DEV; Ipulan L.A, 2014, ENDOCRINOLOGY; Jiang F, 2003, ENDOCRINOLOGY, V144, P1257, DOI 10.1210/en.2002-220718; JOST A, 1947, ARCH ANAT MICROSC MO, V36, P151; KALLOO NB, 1993, J CLIN ENDOCR METAB, V77, P692, DOI 10.1210/jc.77.3.692; Kim KS, 2002, CELL TISSUE RES, V307, P145, DOI 10.1007/s004410100464; Krutskikh A, 2011, ENDOCRINOLOGY, V152, P689, DOI 10.1210/en.2010-0768; Kurzrock EA, 1999, CELLS TISSUES ORGANS, V164, P125, DOI 10.1159/000016650; Lai KP, 2012, MOL ENDOCRINOL, V26, P52, DOI 10.1210/me.2011-1189; Li J, 2006, BJU INT, V98, P880, DOI 10.1111/j.1464-410X.2006.06435.x; Li J, 2009, MATURITAS, V63, P142, DOI 10.1016/j.maturitas.2009.03.008; Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231; Lorenzo AJ, 2003, J UROLOGY, V170, P1618, DOI 10.1097/01.ju.0000087423.89813.64; MORRIS JM, 1953, AM J OBSTET GYNECOL, V65, P1192; MURAKAMI R, 1986, J EMBRYOL EXP MORPH, V92, P133; Niu YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020202; Omori A., 2014, ENDOCRINOLOGY; Orr B, 2011, PROSTATE, V71, P305, DOI 10.1002/pros.21244; Satoh Y, 2004, ANAT EMBRYOL, V208, P479, DOI 10.1007/s00429-004-0419-9; Simanainen U, 2008, ENDOCRINOLOGY, V149, P3330, DOI 10.1210/en.2007-1805; Sugimura Y, 1996, INT J DEV BIOL, V40, P941; Susumu O., 1979, MAJOR SEX DETERMININ, P140; TAKEDA H, 1991, J ENDOCRINOL, V129, P83, DOI 10.1677/joe.0.1290083; Thomson AA, 2001, REPRODUCTION, V121, P187; Tomaszewski J, 2007, P NATL ACAD SCI USA, V104, P11322, DOI 10.1073/pnas.0703445104; Tong SYC, 1996, J UROLOGY, V155, P2057, DOI 10.1016/S0022-5347(01)66107-X; Turner KJ, 2003, TOXICOL SCI, V74, P114, DOI 10.1093/toxsci/kfg096; Welsh M, 2010, ENDOCRINOLOGY, V151, P3374, DOI 10.1210/en.2009-1339; Welsh M, 2011, ENDOCRINOLOGY, V152, P3541, DOI 10.1210/en.2011-0282; YARBROUGH WG, 1990, J BIOL CHEM, V265, P8893; Yu SQ, 2011, PROSTATE, V71, P517, DOI 10.1002/pros.21264; Zhou XC, 2010, J ANDROL, V31, P235, DOI 10.2164/jandrol.109.009266	108	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	FEB	2015	1849	2			SI		163	170		10.1016/j.bbagrm.2014.05.020		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CA9VK	WOS:000349272700010		
J	Inukai, T; Nagi, M; Morita, A; Tanabe, K; Aoyama, T; Miyazaki, Y; Bard, M; Nakayama, H				Inukai, Tatsuya; Nagi, Minoru; Morita, Aldhiro; Tanabe, Koichi; Aoyama, Toshihiro; Miyazaki, Yoshitsugu; Bard, Martin; Nakayama, Hironobu			The mannoprotein TIR3 (CAGL0C03872g) is required for sterol uptake in Candida glabrata	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article						Sterol uptake; Mannoprotein; DAN/TIR; Candida glabrata; UPC2	SACCHAROMYCES-CEREVISIAE; CELL-WALL; GENE-EXPRESSION; YEAST; EPIDEMIOLOGY; MECHANISMS; PROTEIN; TRANSCRIPTOME; BIOSYNTHESIS; SURVEILLANCE	Sterol uptake in the pathogenic fungus, Candida glabrata, occurs via the sterol transporter, CgAus1p. Azole inhibition of sterol biosynthesis can under certain circumstances be reversed by adding exogenously sterol. Here we demonstrate that the CgTIR3 (CAGL0C03872g) gene product is also required for sterol uptake, since Cgtir3 Delta strains fail to take up sterol both aerobically and under hypoxic conditions. Western analysis using an HA-tagged TIR3 strain showed that CgTir3p localizes to the cell wall, and its expression is induced by serum. Semiquantitative reverse transcriptase-PCR also showed that two transcription regulatory genes, CgUPC2A and CgUPC2B, control CgTIR3 as well as CgAUS1 gene expression. Interestingly, complementation studies using Cgtir3 Delta showed that ScDAN1, a mannoprotein required for sterol uptake in Saccharomyces cerevisiae, could not complement the C. glabrata TIR3 function. Furthermore, sterol analyses, in which both the CgAUS1 and CgTIR3 genes were constitutively expressed, resulted in aerobic sterol uptake although the amount of uptake was considerably less than that of cells cultured aerobically with serum. These results suggest that additional factors other than CgAUS1 and CgTIR3 are required for sterol uptake in C. glabrata. (C) 2014 Elsevier B.V. All rights reserved.	[Inukai, Tatsuya; Morita, Aldhiro; Nakayama, Hironobu] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [Inukai, Tatsuya; Nagi, Minoru; Tanabe, Koichi; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Inukai, Tatsuya] Univ Tokyo, Grad Sch Med, Div Pathol Immunol & Microbiol, Tokyo 1138654, Japan; [Aoyama, Toshihiro] Suzuka Natl Coll Technol, Dept Electron & Informat Engn, Suzuka, Mie, Japan; [Bard, Martin] Indiana Univ, Purdue Univ, Dept Biol, Indianapolis, IN USA	Nakayama, H (reprint author), Suzuka Univ Med Sci, Fac Pharmaceut Sci, 3500-3 Minami Tamagaki, Suzuka, Mie 5138670, Japan.	nakayamh@suzuka-u.ac.jp		Aoyama, Toshihiro/0000-0001-7150-3180	JSPS KAKENHI Grant [26860296, 26460541, 2459054]	We thank Drs. Keigo Ueno and Hiroji Chibana for providing the strain KUE200 and the plasmids pZeoi_comp606, p906HIS and p916TRP and Misato Nara, Shohei Shimizu, Makoto Okano, and Marina Ito for their technical assistance. The authors declare that they have no conflict of interest. This work was supported by JSPS KAKENHI Grant Numbers 26860296 (M. N.), 26460541 (K. T.), and 2459054 (H. N.).	Abe F, 2007, FEBS LETT, V581, P4993, DOI 10.1016/j.febslet.2007.09.039; Abramova N, 2001, J BACTERIOL, V183, P2881, DOI 10.1128/JB.183.9.2881-2887.2001; Alimardani P., 2004, BIOCHEM J, V381; Nagi M, 2011, GENES CELLS, V16, P80, DOI 10.1111/j.1365-2443.2010.01470.x; Crowley JH, 1998, J BACTERIOL, V180, P4177; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Hanaoka N, 2008, EUKARYOT CELL, V7, P1640, DOI 10.1128/EC.00129-08; LEWIS TA, 1987, BIOCHIM BIOPHYS ACTA, V921, P205, DOI 10.1016/0005-2760(87)90020-8; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Pfaller MA, 2010, DIAGN MICR INFEC DIS, V67, P162, DOI 10.1016/j.diagmicrobio.2010.01.002; Schneiter R, 2007, BIOCHIMIE, V89, P255, DOI 10.1016/j.biochi.2006.07.022; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; ANDREASEN AA, 1953, J CELL COMPAR PHYSL, V41, P23, DOI 10.1002/jcp.1030410103; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Jacquier N, 2012, J STEROID BIOCHEM, V129, P70, DOI 10.1016/j.jsbmb.2010.11.014; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; ANDREASEN AA, 1954, J CELL COMPAR PHYSL, V43, P271, DOI 10.1002/jcp.1030430303; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80; Bard M, 2005, DIAGN MICR INFEC DIS, V52, P285, DOI 10.1016/j.diagmicrobio.2005.03.001; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Abramova NE, 2001, GENETICS, V157, P1169; Pfaller MA, 2011, DIAGN MICR INFEC DIS, V69, P45, DOI 10.1016/j.diagmicrobio.2010.08.013; BARD M, 1974, BIOCHEM BIOPH RES CO, V56, P324, DOI 10.1016/0006-291X(74)90845-6; Cohen BD, 2001, NUCLEIC ACIDS RES, V29, P799, DOI 10.1093/nar/29.3.799; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Lai LC, 2005, MOL CELL BIOL, V25, P4075, DOI 10.1128/MCB.25.10.4075-4091.2005; LEWIS TL, 1988, YEAST, V4, P93, DOI 10.1002/yea.320040203; LORENZ RT, 1987, J BACTERIOL, V169, P3707; Nagahashi S, 1997, MOL GEN GENET, V255, P372; Nagi M, 2013, MOL MICROBIOL, V88, P371, DOI 10.1111/mmi.12189; Nakayama H, 1998, MICROBIOL-UK, V144, P2407; Nakayama H, 2000, ANTIMICROB AGENTS CH, V44, P2411, DOI 10.1128/AAC.44.9.2411-2418.2000; Nakayama H, 2007, J ANTIMICROB CHEMOTH, V60, P1264, DOI 10.1093/jac/dkm321; Pfaller MA, 1998, J CLIN MICROBIOL, V36, P2609; Raychaudhuri S, 2006, BIOCHEM SOC T, V34, P359; Ross SJ, 2000, MOL BIOL CELL, V11, P2631; Tai SL, 2005, J BIOL CHEM, V280, P437, DOI 10.1074/jbc.M410573200; Ueno K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024759; Zavrel M., 2013, EUKARYOT CELL, V12, P25	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	FEB	2015	1851	2					141	151		10.1016/j.bbalip.2014.11.002		11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CA5QT	WOS:000348963600004		
J	Hashimoto, M; Katakura, M; Tanabe, Y; Al Mamun, A; Inoue, T; Hossain, S; Arita, M; Shido, O				Hashimoto, Michio; Katakura, Masanori; Tanabe, Yoko; Al Mamun, Abdullah; Inoue, Takayuki; Hossain, Shandat; Arita, Makoto; Shido, Osamu			n-3 fatty acids effectively improve the reference memory-related learning ability associated with increased brain docosahexaenoic acid-derived docosanoids in aged rats	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article						Brain; PUFA-derived mediators; Memory; Aging; EPA and DHA	EICOSAPENTAENOIC ACID; DIETARY SUPPLEMENTATION; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; NEUROINFLAMMATION; CONSUMPTION; IMPAIRMENT; MECHANISMS; MEDIATORS; INJURY	We investigated whether a highly purified eicosapentaenoic acid (EPA) and a concentrated n-3 fatty acid formulation (prescription TAK-085) containing EPA and docosahexaenoic acid (DHA) ethyl ester could improve the learning ability of aged rats and whether this specific outcome had any relation with the brain levels of EPA-derived eicosanoids and DHA-derived docosanoids. The rats were tested for reference memory errors (RMEs) and working memory errors (WMEs) in an eight-arm radial maze. Fatty acid comipositions were analyzed by GC, whereas brain eicosanoid/docosanoids were measured by LC-ESI-MS-MS-based analysis. The levels of lipid peroxides (LPOs) were measured by thiobarbituric acid reactive substances. The administration of TAK085 at 300 mg.kg(-1) day(-1) for 17 weeks reduced the number of RMEs in aged rats compared with that in the control rats. Both TAK-085 and EPA administration increased plasma EPA and DHA levels in aged rats, with concurrent increases in DHA and decreases in arachidonic acid in the corticohippocampal brain tissues. TAK085 administration significantly increased the formation of EPA-derived 5-HETE and DHA-derived 7-, 10-, and 17-HDoHE, PD1, RvD1, and RvD2. ARA-derived PGE(2), PGD(2), and PGF(2 alpha) significantly decreased in TAK-085-treated rats. DHA-derived mediators demonstrated a significantly negative correlation with the number of RMEs, whereas EPA-derived mediators did not exhibit any relationship. Furthermore, compared with the control rats, the levels of LPO in the plasma, cerebral cortex, and hippocampus were significantly reduced in TAK-085-treated rats. The findings of the present study suggest that long-term EPA + DHA administration may be a possible preventative strategy against age-related cognitive decline. (C) 2014 Published by Elsevier B.V.	[Hashimoto, Michio; Katakura, Masanori; Tanabe, Yoko; Al Mamun, Abdullah; Inoue, Takayuki; Hossain, Shandat; Shido, Osamu] Shimane Univ, Fac Med, Dept Environm Physiol, Izumo, Shimane 5938501, Japan; [Hossain, Shandat] Jahangimagar Univ, Dept Biochem & Mol Biol, Dhaka, Bangladesh; [Arita, Makoto] RIKEN, Ctr Integrat Med Sci IMS, Lab Metabol, Yokohama, Kanagawa 2300045, Japan	Hashimoto, M (reprint author), Enyacho 89-1, Izumo, Shimane 6938501, Japan.	michio1@med.shimane-u.ac.jp			Ministry of Education Culture, Sports, Science and Technology, Japan [23500955]; Takeda Pharmaceutical Company	This work was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education Culture, Sports, Science and Technology, Japan (23500955, M.H.) and a research grant from Takeda Pharmaceutical Company.	Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Hashimoto M, 2011, J PHARMACOL SCI, V116, P150, DOI 10.1254/jphs.10R33FM; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Hashimoto M, 2009, J NUTR BIOCHEM, V20, P965, DOI 10.1016/j.jnutbio.2008.08.009; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Hashimoto M, 2005, J NUTR, V135, P549; Gamoh S, 1999, NEUROSCIENCE, V93, P237, DOI 10.1016/S0306-4522(99)00107-4; Chen CT, 2013, J LIPID RES, V54, P2410, DOI 10.1194/jlr.M038505; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Green P, 1998, J NEUROSCI RES, V52, P129, DOI 10.1002/(SICI)1097-4547(19980415)52:2<129::AID-JNR1>3.0.CO;2-C; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Delion S, 1997, J LIPID RES, V38, P680; Hashimoto M., 2012, J AGING RES CLIN PRA, V1, P193; Hashimoto M, 1998, J VASC RES, V35, P55, DOI 10.1159/000025565; Hossain MS, 1999, J NEUROCHEM, V72, P1133, DOI 10.1046/j.1471-4159.1999.0721133.x; Ishiguro J., 1987, DRUG METAB DISPOS, V2, P683; Itakura H, 2012, J ATHEROSCLER THROMB, V19, P673; Kawashima A, 2010, J NUTR BIOCHEM, V21, P268, DOI 10.1016/j.jnutbio.2008.12.015; Kelley DS, 1999, LIPIDS, V34, P317, DOI 10.1007/s11745-999-0369-5; Kelly L., 2011, NEUROBIOL AGING, V32; YAMAZAKI K, 1992, BIOCHIM BIOPHYS ACTA, V1128, P35, DOI 10.1016/0005-2760(92)90254-S	31	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	FEB	2015	1851	2					203	209		10.1016/j.bbalip.2014.10.009		7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CA5QT	WOS:000348963600010		
J	Maeda, K				Maeda, Kazuya			Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Review						organic anion transporting polypeptide; hepatocyte; genetic polymorphism; drug-drug interaction	POSITRON-EMISSION-TOMOGRAPHY; MEDIATED HEPATIC-UPTAKE; GENETIC POLYMORPHISMS; HEPATOBILIARY TRANSPORT; TRANSPLANT RECIPIENTS; CYCLOSPORINE-A; SLCO1B1 POLYMORPHISMS; C SLC21A6; HUMANS; PRAVASTATIN	Nobody doubts the importance of organic anion transporting polypeptide (OATP)1B1 and 1B3 in the clinical pharmacokinetics of substrate drugs. Based on the theory of pharmacokinetics, even if a drug is eliminated from the body by extensive metabolism, the rate-determining process of the hepatic intrinsic clearance of OATP substrates is often hepatic uptake. Because of their broad substrate specificities, once the functions of OATP1B1 or OATP1B3 are altered by several kinds of special occasions such as drug drug interactions (DDI) and genetic polymorphisms of transporter genes, the hepatic clearance of many kinds of structurally-unrelated drugs is expected to be changed. In some cases, these alterations of pharmacokinetics lead to modified pharmacological effects and adverse reactions such as statin-induced myotoxicity and the glucose-lowering effect of anti-diabetes drugs. Thus, appropriate methods with which to quantitatively predict the changes in plasma and tissue concentrations of drugs are needed in the process of drug development. As for DDI, a static model that takes into consideration of the theoretically-maximum unbound inhibitor concentration is often used for the sensitive detection of possible DDI risks and this method has been adopted in several regulatory guidance/guidelines on DDI. Regarding genetic polymorphisms, the effects of SLCO1B1 c.388A>G and c.521T>C on the pharmacokinetics of substrate drugs have been extensively investigated. Even though there are some discrepancies, c.521T>C generally decreased hepatic uptake activity, while c.388A>G tended to slightly increase it. This article briefly summarizes the current status of research on hepatic OATP1B1 and OATP1B3 and the clinical significance of their functions.	Univ Tokyo, Lab Mol Pharmacokinet, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Maeda, K (reprint author), Univ Tokyo, Lab Mol Pharmacokinet, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kmaeda@mol.f.u-tokyo.ac.jp			Japan Society for the Promotion of Science	I would like to thank my former supervisor, Dr. Yuichi Sugiyama (Sugiyama Laboratory, RIKEN Innovation Center, RIKEN) and my current supervisor, Prof Hiroyuki Kusuhara (Lab. of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo) for their great guidance and suggestions. I also wish to express my sincere thanks to all of my colleagues and collaborators for their kind support of my research. This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Link E, 2008, NEW ENGL J MED, V359, P789; Ito K, 1998, PHARMACOL REV, V50, P387; Gong IY, 2013, DRUG METAB PHARMACOK, V28, P4, DOI 10.2133/dmpk.DMPK-12-RV-099; Nishizato Y, 2003, CLIN PHARMACOL THER, V73, P554, DOI 10.1016/S0009-9236(03)00060-2; Noe J, 2007, DRUG METAB DISPOS, V35, P1308, DOI 10.1124/dmd.106.012930; Amundsen R, 2010, DRUG METAB DISPOS, V38, P1499, DOI 10.1124/dmd.110.032268; Niemi M, 2005, CLIN PHARMACOL THER, V77, P468, DOI 10.1016/j.cplt.2005.01.018; Ishiguro N, 2006, DRUG METAB DISPOS, V34, P1109, DOI 10.1124/dmd.105.009175; Lee HK, 2013, PHARMACOGENOMICS, V14, P1283, DOI 10.2217/pgs.13.115; Iwatsubo T, 1997, PHARMACOL THERAPEUT, V73, P147, DOI 10.1016/S0163-7258(96)00184-2; Watanabe T, 2009, J PHARMACOL EXP THER, V328, P652, DOI 10.1124/jpet.108.146647; Chiba M, 2009, AAPS J, V11, P262, DOI 10.1208/s12248-009-9103-6; Igel M, 2006, CLIN PHARMACOL THER, V79, P419, DOI 10.1016/j.clpt.2006.01.010; Hirano M, 2006, DRUG METAB DISPOS, V34, P1229, DOI 10.1124/dmd.106.009290; Donnelly LA, 2011, CLIN PHARMACOL THER, V89, P210, DOI 10.1038/clpt.2010.255; Yamashiro W, 2006, DRUG METAB DISPOS, V34, P1247, DOI 10.1124/dmd.105.008938; Shitara Y, 2003, J PHARMACOL EXP THER, V304, P610, DOI 10.1124/jpet.102.041921; Muck W, 1999, CLIN PHARMACOL THER, V65, P251, DOI 10.1016/S0009-9236(99)70104-9; Hedman M, 2006, BRIT J CLIN PHARMACO, V61, P706, DOI 10.1111/j.1365-2125.2006.02643x; Maeda K, 2011, CLIN PHARMACOL THER, V90, P575, DOI 10.1038/clpt.2011.142; Watanabe T, 2010, DRUG METAB DISPOS, V38, P215, DOI 10.1124/dmd.109.030254; van de Steeg E, 2012, J CLIN INVEST, V122, P519, DOI 10.1172/JCI59526; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; Martin NG, 2012, BRIT J CLIN PHARMACO, V73, P303, DOI 10.1111/j.1365-2125.2011.04090.x; Watanabe T, 2011, DRUG METAB DISPOS, V39, P1031, DOI 10.1124/dmd.110.036129; Mwinyi J, 2004, CLIN PHARMACOL THER, V75, P415, DOI 10.1016/j.clpt.2003.12.016; Yoshida K, 2012, CLIN PHARMACOL THER, V91, P1053, DOI 10.1038/clpt.2011.351; Maeda K, 2006, CLIN PHARMACOL THER, V79, P427, DOI 10.1016/j.clpt.2006.01.011; Shitara Y, 2006, EUR J PHARM SCI, V27, P425, DOI 10.1016/j.ejps.2005.12.003; Kiyotani K, 2008, CANCER SCI, V99, P967, DOI 10.1111/j.1349-7006.2008.00765.x; Miura M, 2007, EUR J CLIN PHARMACOL, V63, P1161, DOI 10.1007/s00228-007-0380-7; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; He JK, 2014, MOL PHARMACEUT, V11, P2745, DOI 10.1021/mp500027c; Maeda K, 2008, DRUG METAB PHARMACOK, V23, P223, DOI 10.2133/dmpk.23.223; Yoshida K, 2013, ANNU REV PHARMACOL, V53, P581, DOI 10.1146/annurev-pharmtox-011112-140309; Iwai M, 2004, PHARMACOGENETICS, V14, P749, DOI 10.1097/00008571-200411000-00006; Han JY, 2008, LUNG CANCER, V59, P69, DOI 10.1016/j.lungcan.2007.07.019; Shitara Y, 2004, J PHARMACOL EXP THER, V311, P228, DOI 10.1124/jpet.104.068536; Watanabe T, 2009, DRUG METAB DISPOS, V37, P1471, DOI 10.1124/dmd.108.026062; Shitara Y, 2013, BIOPHARM DRUG DISPOS, V34, P45, DOI 10.1002/bdd.1823; Shitara Y, 2009, DRUG METAB DISPOS, V37, P1172, DOI 10.1124/dmd.108.025544; He JK, 2011, EUR J CLIN PHARMACOL, V67, P701, DOI 10.1007/s00228-011-0994-7; Shabana MF, 2013, MOL DIAGN THER, V17, P299, DOI 10.1007/s40291-013-0038-3; Briz O, 2003, BIOCHEM J, V371, P897, DOI 10.1042/BJ20030034; Ogilvie BW, 2006, DRUG METAB DISPOS, V34, P191, DOI 10.1124/dmd.105.007633; Voora D, 2009, J AM COLL CARDIOL, V54, P1609, DOI 10.1016/j.jacc.2009.04.053; Hagenbuch B, 2013, MOL ASPECTS MED, V34, P396, DOI 10.1016/j.mam.2012.10.009; Matsushima S, 2008, DRUG METAB DISPOS, V36, P663, DOI 10.1124/dmd.107.017814; Floyd JS, 2012, CLIN PHARMACOL THER, V91, P896, DOI 10.1038/clpt.2011.295; Hirano M, 2004, J PHARMACOL EXP THER, V311, P139, DOI 10.1124/jpet.104.068056; Yamada A, 2011, PHARMACOGENET GENOM, V21, P523, DOI 10.1097/FPC.0b013e3283482502; Shingaki T, 2013, J PHARMACOL EXP THER, V347, P193, DOI 10.1124/jpet.113.206425; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; Fu Q, 2013, EUR J CLIN PHARMACOL, V69, P1269, DOI 10.1007/s00228-012-1453-9; Generaux GT, 2011, XENOBIOTICA, V41, P639, DOI 10.3109/00498254.2011.562566; Cheng Y, 2013, EUR J CLIN PHARMACOL, V69, P407, DOI 10.1007/s00228-012-1364-9; Chew SC, 2012, BRIT J CLIN PHARMACO, V73, P606, DOI 10.1111/j.1365-2125.2011.04123.x; Crespi C L, 1997, Adv Pharmacol, V43, P171, DOI 10.1016/S1054-3589(08)60205-7; European Medicines Agency (EMA), 2012, GUID INV DRUG INT FI; FDA, 2012, DRUG INT STUD STUD D; Ito K, 2002, AAPS PHARMSCI, V4, P53, DOI 10.1208/ps040425; Kalliokoski A, 2008, PHARMACOGENET GENOM, V18, P937, DOI 10.1097/FPC.0b013e32830d733e; Kalliokoski A, 2008, J CLIN PHARMACOL, V48, P311, DOI 10.1177/0091270007311569; Maeda K, 2012, ENCY DRUG METABOLISM, V3, P1; Maeda K, 2007, VITRO VIVO SCALE DRU, P557; Maeda K, 2013, PREDICTION HEPATIC T, P121; Nies AT, 2013, GENOME MED, V5, DOI 10.1186/gm405; Pharmaceuticals and Medical Devices Agency (PMDA), 2014, DRUG INT GUID DRUG D; Tachibana T, 2009, XENOBIOTICA, V39, P430, DOI 10.1080/00498250902846252; Takashima T, 2010, J PHARMACOL EXP THER, V335, P314, DOI 10.1124/jpet.110.170092; Takashima T, 2012, J NUCL MED, V53, P741, DOI 10.2967/jnumed.111.098681; Tomalik-Scharte D, 2011, DRUG METAB DISPOS, V39, P927, DOI 10.1124/dmd.110.036921; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; Vormfelde SV, 2008, CLIN PHARMACOL THER, V83, P815, DOI 10.1038/sj.clpt.6100404; Yamada A, 2014, CPT Pharmacometrics Syst Pharmacol, V3, pe126, DOI 10.1038/psp.2014.23; Yoshida K, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S3-S3	76	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					155	168				14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200001		
J	Kitamura, M; Nishino, T; Obata, Y; Oka, S; Abe, S; Muta, K; Ozono, Y; Koji, T; Kohno, S				Kitamura, Mineaki; Nishino, Tomoya; Obata, Yoko; Oka, Satoru; Abe, Shinichi; Muta, Kumiko; Ozono, Yoshiyuki; Koji, Takehiko; Kohno, Shigeru			The Kampo Medicine Daikenchuto Inhibits Peritoneal Fibrosis in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Daikenchuto; heat-shock protein 47; inflammation; peritoneal dialysis; peritoneal fibrosis	DAI-KENCHU-TO; HERBAL MEDICINE; RAT MODEL; EXPRESSION; SCLEROSIS; PROTEIN; HEAT-SHOCK-PROTEIN-47; OBSTRUCTION; DYSFUNCTION; SUPPRESSES	Long-term peritoneal dialysis therapy causes inflammation and histological changes in the peritoneal membrane. Inflammation generally activates fibroblasts and results in fibroblast-myofibroblast differentiation. Heat-shock protein 47 (HSP 47), a collagen-specific molecular chaperone, is localized in myofibroblasts and is involved in the progression of peritoneal fibrosis. Daikenchuto (DKT), a Kampo medicine, is used to prevent postoperative colon adhesion. It inhibits inflammation and HSP 47 expression in the gastrointestinal tract. We examined the effect of DKT on chlorhexidine gluconate (CG)-induced peritoneal fibrosis in mice injected with 0.1% CG dissolved in 15% ethanol. DKT was dissolved in the drinking water. Histological changes were assessed using Masson trichrome staining. Cells expressing alpha-smooth muscle actin (alpha-SMA), HSP 47, phospho-Smad 2/3, F4/80, and monocyte chemotactic protein-1 were examined immunohistochemically. Compared with the control group, the peritoneal tissues of the CG group were markedly thickened, and the number of cells expressing alpha-SMA, HSP 47, phospho-Smad 2/3, F4/80, and monocyte chemotactic protein-1 was significantly increased. However, these changes were inhibited in the DKT-treated group. These results indicate that DKT can prevent peritoneal fibrosis by inhibiting inflammation and HSP 47 expression.	[Kitamura, Mineaki; Nishino, Tomoya; Obata, Yoko; Oka, Satoru; Abe, Shinichi; Muta, Kumiko; Kohno, Shigeru] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan; [Obata, Yoko] Nagasaki Univ Hosp, Med Educ Dev Ctr, Nagasaki 8528501, Japan; [Ozono, Yoshiyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gen Med, Nagasaki 8528501, Japan; [Koji, Takehiko] Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Dept Histol & Cell Biol, Nagasaki 8528523, Japan	Nishino, T (reprint author), Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan.	tnishino@nagasaki-u.ac.jp					Akiho H, 2011, DIGESTION, V83, P173, DOI 10.1159/000321798; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Mochiki E, 2010, SURG TODAY, V40, P1105, DOI 10.1007/s00595-010-4388-8; Munekage M, 2011, DRUG METAB DISPOS, V39, P1784, DOI 10.1124/dmd.111.040097; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; Mishima Y, 2003, PERITON DIALYSIS INT, V23, P14; Kono T, 2011, J GASTROENTEROL, V46, P1187, DOI 10.1007/s00535-011-0438-2; Shioshita K, 2000, KIDNEY INT, V57, P619, DOI 10.1046/j.1523-1755.2000.00883.x; GANDHI VC, 1980, ARCH INTERN MED, V140, P1201, DOI 10.1001/archinte.140.9.1201; Nishino T, 2003, KIDNEY INT, V64, P887, DOI 10.1046/j.1523-1755.2003.00169.x; Isa Y, 2008, BIOCHEM BIOPH RES CO, V373, P429, DOI 10.1016/j.bbrc.2008.06.046; Murata P, 2002, LIFE SCI, V70, P2061, DOI 10.1016/S0024-3205(01)01552-1; Nievergelt A, 2011, J IMMUNOL, V187, P4140, DOI 10.4049/jimmunol.1100880; Kono T, 2010, J CROHNS COLITIS, V4, P161, DOI 10.1016/j.crohns.2009.09.006; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Williams JD, 2002, J AM SOC NEPHROL, V13, P470; De Vriese AS, 2006, NEPHROL DIAL TRANSPL, V21, P2549, DOI 10.1093/ndt/gfl271; Braun N, 2011, PERITON DIALYSIS INT, V31, P291, DOI 10.3747/pdi.2010.00118; Hoff CM, 2005, PERITON DIALYSIS INT, V25, pS57; Inoue K, 2011, BIOL PHARM BULL, V34, P1659, DOI 10.1248/bpb.34.1659; Kitamura M, 2012, CHEM-BIOL INTERACT, V195, P95, DOI 10.1016/j.cbi.2011.11.002; Lo WK, 2009, PERITON DIALYSIS INT, V29, pS211; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Narita M, 2009, J GASTROEN HEPATOL, V24, P1051, DOI 10.1111/j.1440-1746.2009.05795.x; Razzaque MS, 2005, CONTRIB NEPHROL, V148, P57; Razzaque MS, 1999, HISTOL HISTOPATHOL, V14, P1199; Takagi A, 2010, INT SURG, V95, P350; Tokita Y., 2007, Inflammopharmacology, V15, P65, DOI 10.1007/s10787-006-1552-2; Tokita Y, 2007, J PHARMACOL SCI, V104, P303, DOI 10.1254/jphs.FP0070831; Tokita Y, 2011, J PHARMACOL SCI, V115, P75, DOI 10.1254/jphs.10226FP	30	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					193	200				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200005		
J	Matsumoto, K; Shigemi, A; Ikawa, K; Kanazawa, N; Fujisaki, Y; Morikawa, N; Takeda, Y				Matsumoto, Kazuaki; Shigemi, Akari; Ikawa, Kazuro; Kanazawa, Naoko; Fujisaki, Yuko; Morikawa, Norifumi; Takeda, Yasuo			Risk Factors for Ganciclovir-Induced Thrombocytopenia and Leukopenia	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						ganciclovir; thrombocytopenia; leukopenia	STEM-CELL TRANSPLANTATION; ALLOGENEIC MARROW TRANSPLANT; PREVENT CYTOMEGALOVIRUS DISEASE; ORAL GANCICLOVIR; PREEMPTIVE THERAPY; CMV ANTIGENEMIA; RENAL-FUNCTION; RECIPIENTS; PHARMACOKINETICS; NEUTROPENIA	Ganciclovir is a nucleoside guanosine analogue that exhibits therapeutic activity against human cytomegalovirus infection, and is primarily excreted via glomerular filtration and active tubular secretion. The adverse effects induced by ganciclovir therapy are generally of a hematological nature and include thrombocytopenia and leukopenia. Low marrow cellularity and elevated serum creatinine have been identified as risk factors for ganciclovir-induced neutropenia. However, the risk factors for thrombocytopenia have yet to be determined. Therefore, this study investigated patients administered ganciclovir to determine the risk factors for thrombocytopenia and leukopenia. Thrombocytopenia occurred in 41 of these patients (30.6%). Multivariate logistic regression analysis identified three independent risk factors for thrombocytopenia: cancer chemotherapy (odds ratio (OR)=3.1), creatinine clearance (<20 mL/min) (OR=12.8), and the ganciclovir dose (>= 12mg/kg/d) (OR=15.1). Leukopenia occurred in 36 patients (28.6%), and white blood cell count (<6000cells/mm(3)) (OR=3.7) and the ganciclovir dose (>= 12mg/kg/d) (OR=7.8) were identified as risk factors. These results demonstrated that several factors influenced the occurrence of ganciclovir-induced thrombocytopenia and leukopenia, and suggest that special attention should be paid to patients receiving cancer chemotherapy with a low creatinine clearance (<20 mL/min) and high dose (>= 12mg/kg/d) in order to avoid ganciclovir-induced thrombocytopenia.	[Matsumoto, Kazuaki; Shigemi, Akari; Kanazawa, Naoko; Fujisaki, Yuko; Takeda, Yasuo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 8908520, Japan; [Ikawa, Kazuro; Morikawa, Norifumi] Hiroshima Univ, Dept Clin Pharmacotherapy, Minami Ku, Hiroshima 7348551, Japan	Takeda, Y (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	takeda@m.kufm.kagoshima-u.ac.jp			Japan Society for the Promotion of Science [25928013]	Financial support for this study was provided by the Japan Society for the Promotion of Science (#25928013).	Venton G, 2014, CLIN MICROBIOL INFEC, V20, P160, DOI 10.1111/1469-0691.12222; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; McGavin JK, 2001, DRUGS, V61, P1153, DOI 10.2165/00003495-200161080-00016; Salzberger B, 1997, BLOOD, V90, P2502; Gane E, 1997, LANCET, V350, P1729, DOI 10.1016/S0140-6736(97)05535-9; GOODRICH JM, 1993, ANN INTERN MED, V118, P173; Asano-Mori Y, 2006, J ANTIMICROB CHEMOTH, V57, P1004, DOI 10.1093/jac/dk1089; Boeckh M, 1999, BLOOD, V93, P1781; Boeckh M, 1998, Biol Blood Marrow Transplant, V4, P13; Kanda Y, 2001, BONE MARROW TRANSPL, V27, P437, DOI 10.1038/sj.bmt.1702805; MERIGAN TC, 1992, NEW ENGL J MED, V326, P1182, DOI 10.1056/NEJM199204303261803; Moretti S, 1998, BONE MARROW TRANSPL, V22, P175, DOI 10.1038/sj.bmt.1701302; Perrottet N, 2009, ANTIMICROB AGENTS CH, V53, P3017, DOI 10.1128/AAC.00836-08; Pescovitz MD, 1998, TRANSPLANTATION, V66, P1104, DOI 10.1097/00007890-199810270-00023; SOMMADOSSI JP, 1988, REV INFECT DIS, V10, pS507; Tomonari A, 2004, ANN HEMATOL, V83, P573, DOI 10.1007/s00277-004-0887-2; Wiltshire H, 2005, TRANSPLANTATION, V79, P1477, DOI 10.1097/01.TP.0000164512.99703.AD	17	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					235	238				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200010		
J	Kobayashi, T; Suzuki, M; Morikawa, M; Kino, K; Tanuma, S; Miyazawa, H				Kobayashi, Takanobu; Suzuki, Masayo; Morikawa, Masayuki; Kino, Katsuhito; Tanuma, Sei-ichi; Miyazawa, Hiroshi			Transcriptional Regulation of Tal2 Gene by All-trans Retinoic Acid (atRA) in P19 Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Tal2 gene; retinoic acid receptor alpha (RAR alpha); TATA-box binding protein (TBP); retinoic acid response element (RARE); TATA-box	EMBRYONAL CARCINOMA-CELLS; II CORE PROMOTER; RESPONSE ELEMENTS; NERVOUS-SYSTEM; TARGET GENES; MOUSE-BRAIN; RECEPTORS; EXPRESSION; DIFFERENTIATION; ONCOGENE	TAL2 is a transcription factor required in the normal development of mouse brain. In a previous study, we demonstrated that the expression of Tal2 gene is induced by the complex of all-trans retinoic acid (atRA) and retinoic acid receptor alpha (RAR alpha) in mouse embryonal carcinoma P19 cells. atRA is also known to be important in inducing P19 cells to differentiate into the neural lineage. Therefore, we believe that the function of TAL2 in neural differentiation may be clarified by utilizing P19 cells. As the atRA-RAR alpha complex induced the expression of Tal2, we focused on the regulatory region that is involved in its transcription. The atRA-RAR alpha complex occupies a characteristic retinoic acid response element (RARE) located in the promoter of target genes. Therefore, we searched for RARE on the mouse Tal2 and found that a RARE-like element was located in the intron. We also found that a TATA-box-like element was located in the 5'-region of Tal2. Involvement between transcriptional activity and the TATA-box-like element was confirmed in the luciferase assay, and TATA-box binding protein was bound to this element upstream of Tal2 in P19 cells. atRA signaling activated the transcription through the RARE-like element, and RAR alpha was bound to this element on Tal2 in P19 cells. In addition, the interaction between these elements on Tal2 was shown in the chromatin immunoprecipitation assay. These results suggest that the transcription of Tal2 is coordinately mediated by two distal regulatory elements.	[Kobayashi, Takanobu; Suzuki, Masayo; Morikawa, Masayuki; Kino, Katsuhito; Miyazawa, Hiroshi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan; [Tanuma, Sei-ichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 2788510, Japan	Miyazawa, H (reprint author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, 1314-1 Shido, Sanuki, Kagawa 7692193, Japan.	miyazawah@kph.bunri-u.ac.jp			Tokushima Bunri University, Japan	We would like to thank Yusuke Nakahira, Nana Okamoto, and Hiroaki Mori for technical support. This research was supported by a research grant from Tokushima Bunri University, Japan.	Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; DANG CV, 1991, MOL CELL BIOL, V11, P954; NIWA H, 1991, GENE, V108, P193; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271; [Anonymous], GENE; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Chambon P, 1996, FASEB J, V10, P940; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; FEARON ER, 1992, P NATL ACAD SCI USA, V89, P7958, DOI 10.1073/pnas.89.17.7958; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.RI00015-JLR200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Bucher K, 2000, DEV BIOL, V227, P533, DOI 10.1006/dbio.2000.9920; Chen YL, 2011, J CELL BIOCHEM, V112, P2865, DOI 10.1002/jcb.23200; Cotnoir-White D, 2011, MOL CELL ENDOCRINOL, V334, P76, DOI 10.1016/j.mce.2010.10.021; Gaunt SJ, 2011, INT J DEV BIOL, V55, P93, DOI 10.1387/ijdb.103252sg; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kobayashi T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04935; Komori R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061938; Lalevee S, 2011, J BIOL CHEM, V286, P33322, DOI 10.1074/jbc.M111.263681; LIPKIN SM, 1992, P NATL ACAD SCI USA, V89, P1209, DOI 10.1073/pnas.89.4.1209; Lipkin SM, 1996, J VIROL, V70, P7182; Lu JF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-57; MADEN M, 1992, BIOESSAYS, V14, P431, DOI 10.1002/bies.950140702; Mori S, 1999, MOL BRAIN RES, V64, P199, DOI 10.1016/S0169-328X(98)00323-4; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; XIA Y, 1994, ONCOGENE, V9, P1437; XIA Y, 1991, P NATL ACAD SCI USA, V88, P11416, DOI 10.1073/pnas.88.24.11416	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					248	256				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200012		
J	Zakoji, N; Akanuma, S; Tachikawa, M; Hosoya, K				Zakoji, Nobuyuki; Akanuma, Shin-ichi; Tachikawa, Masanori; Hosoya, Ken-ichi			Involvement of Cationic Amino Acid Transporter 1 in L-Arginine Transport in Rat Retinal Pericytes	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						L-arginine; cationic amino acid transporter (CAT); CAT1; retinal pericyte; TR-rPCT	NITRIC-OXIDE SYNTHASE; CEREBRAL CAPILLARIES; GLIAL-CELLS; RELAXATION; ENDOTHELIN-1; INHIBITORS; COVERAGE; EXCHANGE; RECEPTOR; FAMILY	Nitric oxide (NO), a known relaxant, is produced in cells from L-arginine (L-Arg). Because the relaxation of retinal pericytes alters the microcirculatory hemodynamics, it is important to understand the manner of NO production in retinal pericytes. The purpose of this study was to clarify the molecular mechanism(s) of uptake of L-Arg in retinal pericytes using a conditionally immortalized rat retinal pericyte cell line (TR-rPCT1 cells) which expresses the mRNAs of endothelial NO synthase and inducible NO synthase. L-Arg uptake by TR-rPCT1 cells exhibited Na+-independence and concentration-dependence with a K-m of 28.9 mu M. This process was strongly inhibited by substrates of cationic amino acid transporters (CAT), such as L-ornithine and L-lysine. In contrast, L-valine, L-leucine, and L-glutamine, which are substrates of cation/neutral amino acid transport systems, such as system y(+)L, system B-0,B-+, and system b(0,+), did not strongly inhibit L-Arg uptake by TR-rPCT1 cells. In addition, the expression of mRNA and protein of CAT1 in TR-rPCT1 cells was observed by reverse transcription-polymerase chain reaction and immunoblot analyses. Taking these results into consideration, it appears that CAT1 is involved in L-Arg uptake by retinal pericytes and this is expected to play an important role in the relaxation of retinal pericytes, thereby modulating the microcirculatory hemodynamics in the retina.	[Zakoji, Nobuyuki; Akanuma, Shin-ichi; Tachikawa, Masanori; Hosoya, Ken-ichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, Toyama 9300194, Japan	Hosoya, K (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, Toyama 9300194, Japan.	hosoyak@pha.u-toyama.ac.jp			Japan Society for the Promotion of Sciences (JSPS)	This study was supported, in part, by a Grain-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Sciences (JSPS).	Adachi T, 2010, REDOX REP, V15, P250, DOI 10.1179/135100010X12826446921662; FRANK RN, 1990, INVEST OPHTH VIS SCI, V31, P999; CLOSS EI, 1993, J BIOL CHEM, V268, P20796; Kurz S, 1997, J CLIN INVEST, V99, P369, DOI 10.1172/JCI119166; WANG H, 1991, NATURE, V352, P729, DOI 10.1038/352729a0; Matsugi T, 1997, INVEST OPHTH VIS SCI, V38, P652; SCHMIDLIN A, 1994, GLIA, V11, P262, DOI 10.1002/glia.440110307; CRONE C, 1963, ACTA PHYSIOL SCAND, V58, P292, DOI 10.1111/j.1748-1716.1963.tb02652.x; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; Deves R, 1998, PHYSIOL REV, V78, P487; [Anonymous], 2004, J NUTR S; HAEFLIGER IO, 1994, INVEST OPHTH VIS SCI, V35, P991; FRANK RN, 1987, INVEST OPHTH VIS SCI, V28, P1086; Hosoya K, 2001, EXP EYE RES, V72, P163, DOI 10.1006/exer.2000.0941; Bertram KM, 2008, EYE, V22, P582, DOI 10.1038/sj.eye.6702993; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Broer A, 2000, BIOCHEM J, V349, P787; Gilles W, 2005, BBA-BIOMEMBRANES, V1668, P234, DOI 10.1016/j.bbmamem.2004.12.011; CHAKRAVARTHY U, 1992, MICROVASC RES, V43, P241, DOI 10.1016/0026-2862(92)90022-H; Chillaron J, 1996, J BIOL CHEM, V271, P17761; Forray MI, 1995, BIOCHEM PHARMACOL, V50, P1963, DOI 10.1016/0006-2952(95)02090-X; Hosoya K, 2010, NEUROCHEM INT, V57, P262, DOI 10.1016/j.neuint.2010.06.004; Hosoya Ken-ichi, 2012, Adv Exp Med Biol, V763, P85; Kondo T, 2003, CELL STRUCT FUNCT, V28, P145; Martin AR, 2000, MICROVASC RES, V59, P131, DOI 10.1006/mvre.1999.2208; Matsugi T, 1997, INVEST OPHTH VIS SCI, V38, P2695; SCHMIDT K, 1995, J NEUROCHEM, V64, P1469; Tomi M, 2009, J NEUROCHEM, V111, P716, DOI 10.1111/j.1471-4159.2009.06367.x; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	29	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					257	262				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200013		
J	Tomimoto, D; Okuma, C; Ishii, Y; Akiyama, Y; Ohta, T; Kakutani, M; Ohkuma, Y; Ogawa, N				Tomimoto, Daisuke; Okuma, Chihiro; Ishii, Yukihito; Akiyama, Yoshiyuki; Ohta, Takeshi; Kakutani, Makoto; Ohkuma, Yoshiaki; Ogawa, Nobuya			Pharmacological Characterization of [trans-5 '-(4-Amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-y1)-2 ',3 '-dihydrospiro(cyclohexane-1,1 '-inden)-4-yl]acetic Acid Monobenzenesulfonate (JTT-553), a Novel Acyl CoA:Diacylglycerol Transferase (DGAT) 1 Inhibitor	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						obesity; triacylglycerol; acyl CoA:diacylglycerol acyltransferase (DGAT) 1	DIACYLGLYCEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; GLUCOSE DISPOSAL; FAT DIGESTION; MICE; COENZYME; ENZYMES; OBESITY; EXPRESSION	Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 is an enzyme that catalyzes the final step in triglyceride (TG) synthesis. This enzyme is considered to be a potential therapeutic target for obesity and diabetes. Here, results of an investigation of the pharmacological effects of JTT-553 [trans-5'-(4-amino-7,7-dimethy1-2trifluoromethy1-7H-pyrimido[4,5-b] [1,4] oxazin- 6 -yl)-2',3 dihydrospiro (cyclohexane-1,1'-inden)- 4 -yl] acetic acid monobenzenesulfonate, a novel DGAT1 inhibitor, are reported. To measure the inhibitory activity of JTT-553 against DGAT1, TG synthesis using [14C1-labeled oleoyl-CoA was evaluated. Similarly, the inhibitory activity of JTT-553 against DGAT2, an isozyme of DGAT1, and acyl-CoA cholesterol acyltransferase (ACAT) 1, which is highly homologous to DGAT1, were evaluated. JTT-553 selectively inhibited human DGAT1 and showed comparable inhibitory effects on the activity of human, rat, and mouse DGAT. In vivo, JTT-553 suppressed plasma TG and chylomicron TG levels after olive oil loading in Sprague-Dawley (SD) rats. JTT-553 also inhibited TG synthesis in epididymal fat after [C-14] oleic acid injection in C57BL/6J mice. Food intake was evaluated in SD rats fed 3.1%, 13%, or 35% (w/w) fat diets. In rats fed the 35% fat diet, JTT-553 reduced food intake. This reduction of food intake was observed 2h after feeding, lasted for 24h, and correlated with dietary fat content. Furthermore, JTT-553 reduced daily food intake and body weight gain in diet-induced obese rats after 4-week repeated administration. JTT-553 exerted multiple effects on intestinal fat absorption, adipose fat synthesis, and food intake, and consequently induced body weight reduction. Therefore, JTT-553 is expected to be an effective novel therapeutic agent for the treatment of obesity.	[Tomimoto, Daisuke; Okuma, Chihiro; Ishii, Yukihito; Akiyama, Yoshiyuki; Ohta, Takeshi; Kakutani, Makoto; Ogawa, Nobuya] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5691125, Japan; [Ohkuma, Yoshiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, Toyama 9300194, Japan	Tomimoto, D (reprint author), Japan Tobacco Inc, Cent Pharmaceut Res Inst, 1-1 Murasaki Cho, Takatsuki, Osaka 5691125, Japan.	daisuke.tomimoto@jt.com					O'Donovan D, 2003, BRIT J NUTR, V90, P849, DOI 10.1079/BJN2003971; Feinle C, 2001, GASTROENTEROLOGY, V120, P1100, DOI 10.1053/gast.2001.23232; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Smith SJ, 2000, NAT GENET, V25, P87; Ludwig EH, 2002, CLIN GENET, V62, P68, DOI 10.1034/j.1399-0004.2002.620109.x; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Fox BM, 2014, J MED CHEM, V57, P3464, DOI 10.1021/jm500135c; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Fox BM, 2010, BIOORG MED CHEM LETT, V20, P6030, DOI 10.1016/j.bmcl.2010.08.066; Feinle C, 2003, AM J PHYSIOL-GASTR L, V284, pG798, DOI 10.1152/ajpgi.00512.2002; Lau D, 2006, CAN MED ASSOC J, V2007, pS1, DOI DOI 10.1503/CMAJ.061409; WARNER GJ, 1995, J BIOL CHEM, V270, P5772; WOLFGANG GHI, 1995, FUND APPL TOXICOL, V26, P272, DOI 10.1006/faat.1995.1098	25	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					263	269				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200014		
J	Togami, K; Miyao, A; Miyakoshi, K; Kanehira, Y; Tada, H; Chono, S				Togami, Kohei; Miyao, Aki; Miyakoshi, Kei; Kanehira, Yukimune; Tada, Hitoshi; Chono, Sumio			Efficient Delivery to Human Lung Fibroblasts (WI-38) of Pirfenidone Incorporated into Liposomes Modified with Truncated Basic Fibroblast Growth Factor and Its Inhibitory Effect on Collagen Synthesis in Idiopathic Pulmonary Fibrosis	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						liposome; lung fibroblast (WI-38); truncated basic fibroblast growth factor; idiopathic pulmonary fibrosis; pirfenidone	FACTOR-BINDING PEPTIDE; CELLS; EXPRESSION; MICE	In the present in vitro study, we assessed the delivery of pirfenidone incorporated into liposomes modified with truncated basic fibroblast growth factor (tbFGF) to lung fibroblasts and investigated the anti-fibrotic effect of the drug. The tbFGF peptide, KRTGQYKLC, was used to modify the surface of liposomes (tbFGF-liposomes). We used the thin-layer evaporation method, followed by sonication, to prepare tbFGF-liposomes containing pirfenidone. The cellular accumulation of tbFGF-liposomes was 1.7-fold greater than that of non-modified liposomes in WI-38 cells used as a model of lung fibroblasts. Confocal laser scanning microscopy showed that tbFGF-liposomes were widely localized in WI-38 cells. The inhibitory effects of pirfenidone incorporated into tbFGF-liposomes on transforming growth factor-beta 1 (TGF-beta 1)-induced collagen synthesis in WI-38 cells were evaluated by measuring the level of intracellular hydroxyproline, a major component of the protein collagen. Pirfenidone incorporated into tbFGF-liposomes at concentrations of 10, 30, and 100 mu M significantly decreased the TGF-beta 1-induced hydroxyproline content in WI-38 cells. The anti-fibrotic effect of pirfenidone incorporated into tbFGF-liposomes was enhanced compared with that of pirfenidone solution. These results indicate that tbFGF-liposomes are a useful drug delivery system of anti-fibrotic drugs to lung fibroblasts for the treatment of idiopathic pulmonary fibrosis.	[Togami, Kohei; Miyao, Aki; Miyakoshi, Kei; Kanehira, Yukimune; Tada, Hitoshi; Chono, Sumio] Hokkaido Pharmaceut Univ, Sch Pharm, Div Pharmaceut, Otaru, Hokkaido 0470264, Japan	Togami, K (reprint author), Hokkaido Pharmaceut Univ, Sch Pharm, Div Pharmaceut, 7-1 Katsuraoka Cho, Otaru, Hokkaido 0470264, Japan.	k-togami@hokuyakudai.ac.jp			Japan Society for the Promotion of Science [24790167, 25870654]; Akiyama Life Science Foundation (Sapporo, Japan)	This work was supported by Grants-in-Aid (No. 24790167 and 25870654) for Young Scientists (B) provided by the Japan Society for the Promotion of Science and in part by a Grant-in-Aid (2013) provided by The Akiyama Life Science Foundation (Sapporo, Japan).	Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Adamali HI, 2012, DRUG DES DEV THER, V6, P261, DOI 10.2147/DDDT.S29928; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Nakayama S, 2008, LIFE SCI, V82, P210, DOI 10.1016/j.lfs.2007.11.003; Grattendick KJ, 2008, INT IMMUNOPHARMACOL, V8, P679, DOI 10.1016/j.intimp.2008.01.013; Peng ZZ, 2009, NEPHROLOGY, V14, P565, DOI 10.1111/j.1440-1797.2009.01129.x; Terada T, 2006, J DRUG TARGET, V14, P536, DOI 10.1080/10611860600849498; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Terada T, 2007, J CONTROL RELEASE, V119, P262, DOI 10.1016/j.jconrel.2007.01.018; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061; Yara S, 2001, CLIN EXP IMMUNOL, V124, P77, DOI 10.1046/j.1365-2249.2001.01493.x; BANGHAM AD, 1965, J MOL BIOL, V13, P238; Barrios R, 1997, AM J PHYSIOL-LUNG C, V273, pL451; Belkin A, 2013, CURR OPIN PULM MED, V19, P474, DOI 10.1097/MCP.0b013e328363f479; Chono S, 2011, DRUG DEV IND PHARM, V37, P367, DOI 10.3109/03639045.2010.513389; FUNATO K, 1992, BIOCHIM BIOPHYS ACTA, V1103, P198, DOI 10.1016/0005-2736(92)90087-3; Gong LK, 2005, J ETHNOPHARMACOL, V96, P537, DOI 10.1016/j.jep.2004.09.046; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Li YJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-16; Mott NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010143; SCHMITZ S, 1992, CANCER RES, V52, P6638; Togami K, 2013, BIOL PHARM BULL, V36, P1525	24	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					270	276				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200015		
J	Katane, M; Kawata, T; Nakayama, K; Saitoh, Y; Kaneko, Y; Matsuda, S; Saitoh, Y; Miyamoto, T; Sekine, M; Homma, H				Katane, Masumi; Kawata, Tomonori; Nakayama, Kazuki; Saitoh, Yuki; Kaneko, Yuusuke; Matsuda, Satsuki; Saitoh, Yasuaki; Miyamoto, Tetsuya; Sekine, Masae; Homma, Hiroshi			Characterization of the Enzymatic and Structural Properties of Human D-Aspartate Oxidase and Comparison with Those of the Rat and Mouse Enzymes	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						D-aspartate oxidase (DDO); flavoprotein; D-aspartate (D-Asp); D-amino acid; species difference; experimental animal	AMINO-ACID OXIDASE; D-SERINE; FUNCTIONAL-CHARACTERIZATION; CAENORHABDITIS-ELEGANS; SWISS-MODEL; SCHIZOPHRENIA; RECEPTOR; BRAIN; MAMMALS; KIDNEY	D-Aspartate (D-Asp), a free D-amino acid found in mammals, plays crucial roles in the neuroendocrine, endocrine, and central nervous systems. Recent studies have implicated D-Asp in the pathophysiology of infertility and N-methyl-D-Asp receptor-related diseases. D-Asp oxidase (DDO), a degradative enzyme that is stereospecific for acidic D-amino acids, is the sole catabolic enzyme acting on D-Asp in mammals. Human DDO is considered an attractive therapeutic target, and DDO inhibitors may be potential lead compounds for the development of new drugs against the aforementioned diseases. However, human DDO has not been characterized in detail and, although preclinical studies using experimental rodents are prerequisites for evaluating the in vivo effects of potential inhibitors, the existence of species-specific differences in the properties of human and rodent DDOs is still unclear. Here, the enzymatic activity and characteristics of purified recombinant human DDO were analyzed in detail. The kinetic and inhibitor-binding properties of this enzyme were also compared with those of purified recombinant rat and mouse DDOs. In addition, structural models of human, rat, and mouse DDOs were generated and compared. It was found that the differences among these DDO proteins occur in regions that appear involved in migration of the substrate/product in and out of the active site. In summary, detailed characterization of human DDO was performed and provides useful insights into the use of rats and mice as experimental models for evaluating the in vivo effects of DDO inhibitors.	[Katane, Masumi; Kawata, Tomonori; Nakayama, Kazuki; Saitoh, Yuki; Kaneko, Yuusuke; Matsuda, Satsuki; Saitoh, Yasuaki; Miyamoto, Tetsuya; Sekine, Masae; Homma, Hiroshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Lab Biomol Sci, Minato Ku, Tokyo 1088641, Japan	Homma, H (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Lab Biomol Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	hommah@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21590090]; Kitasato University Research Grant for Young Researchers	This work was supported in part by a Grant-in-Aid for Scientific Research (21590090) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Kitasato University Research Grant for Young Researchers (to M.K.).	Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; Weil ZM, 2006, BEHAV BRAIN RES, V171, P295, DOI 10.1016/j.bbr.2006.04.008; Errico F, 2008, J NEUROSCI, V28, P10404, DOI 10.1523/JNEUROSCI.1618-08.2008; DANIELLO A, 1993, COMP BIOCHEM PHYS B, V105, P731, DOI 10.1016/0305-0491(93)90113-J; OLVERMAN HJ, 1988, NEUROSCIENCE, V26, P17, DOI 10.1016/0306-4522(88)90124-8; Ota N, 2012, AMINO ACIDS, V43, P1873, DOI 10.1007/s00726-012-1364-1; Sasabe J, 2012, P NATL ACAD SCI USA, V109, P627, DOI 10.1073/pnas.1114639109; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Katane M, 2011, AMINO ACIDS, V40, P467, DOI 10.1007/s00726-010-0658-4; Errico F, 2013, J PSYCHIATR RES, V47, P1432, DOI 10.1016/j.jpsychires.2013.06.013; Katane M, 2010, CHEM BIODIVERS, V7, P1435, DOI 10.1002/cbdv.200900250; DIXON M, 1967, BIOCHIM BIOPHYS ACTA, V146, P54, DOI 10.1016/0005-2744(67)90073-3; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Ohide H, 2011, J CHROMATOGR B, V879, P3162, DOI 10.1016/j.jchromb.2011.06.028; Errico F, 2012, AMINO ACIDS, V43, P1861, DOI 10.1007/s00726-012-1356-1; Katane M, 2013, J MED CHEM, V56, P1894, DOI 10.1021/jm3017865; Nishikawa T, 2011, J CHROMATOGR B, V879, P3169, DOI 10.1016/j.jchromb.2011.08.030; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; STILL JL, 1949, J BIOL CHEM, V179, P831; D'Aniello G, 2005, FERTIL STERIL, V84, P1444, DOI 10.1016/j.fertnstert.2005.05.019; DEMARCO C, 1967, ENZYMOLOGIA, V33, P325; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Katane M, 2010, CHEM BIODIVERS, V7, P1424, DOI 10.1002/cbdv.200900294; Katane M, 2007, AMINO ACIDS, V32, P69, DOI 10.1007/s00726-006-0350-x; Setoyama C, 1997, J BIOCHEM-TOKYO, V121, P798; Katane M, 2007, FEBS J, V274, P137, DOI 10.1111/j.1742-4658.2006.05571.x; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Di Fiore MM, 2014, AMINO ACIDS, V46, P1805, DOI 10.1007/s00726-014-1759-2; Negri A, 1999, BBA-PROTEIN STRUCT M, V1431, P212, DOI 10.1016/S0167-4838(99)00027-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Yamada K, 2005, BIOL PSYCHIAT, V57, P1493, DOI 10.1016/j.biopsych.2005.03.018; Katane M, 2011, J CHROMATOGR B, V879, P3108, DOI 10.1016/j.jchromb.2011.03.062; Katane M, 2010, BIOCHIMIE, V92, P1371, DOI 10.1016/j.biochi.2010.06.021; D'Aniello G, 2007, HUM REPROD, V22, P3178, DOI 10.1093/humrep/dem328; Katane M, 2008, AMINO ACIDS, V35, P75, DOI 10.1007/s00726-007-0627-8; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P767, DOI 10.1016/j.pnpbp.2005.04.023; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; FAGG GE, 1984, P NATL ACAD SCI-BIOL, V81, P6876, DOI 10.1073/pnas.81.21.6876; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1620; LOCKRIDG.O, 1972, J BIOL CHEM, V247, P8097; Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2; Takahashi S, 2009, J MOL CATAL B-ENZYM, V61, P235, DOI 10.1016/j.molcatb.2009.07.011; Worthington CS, 1972, WORTHINGTON ENZYME M, P43; Yamamoto A, 2007, J BIOCHEM, V141, P363, DOI 10.1093/jb/mvm041; YANO S., 2012, ADV BIOSCI BIOTECHNO, V3, P7	50	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					298	305				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200019		
J	Ishii, Y; Imamoto, Y; Yamamoto, R; Tsukahara, M; Wakamatsu, K				Ishii, Yoichi; Imamoto, Yasufumi; Yamamoto, Rie; Tsukahara, Masayoshi; Wakamatsu, Kaori			Comparison of Antibody Molecules Produced from Two Cell Lines with Contrasting Productivities and Aggregate Contents	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						antibody aggregate; light chain production; cell line; antibody fragment; covalent aggregate; non-covalent aggregate	HAMSTER OVARY CELLS; PROTEIN AGGREGATION; MONOCLONAL-ANTIBODIES; CHO-CELLS; RECOMBINANT ANTIBODY; FRAGMENTATION; MECHANISMS; STABILITY; HETEROGENEITY; EXPRESSION	Cell culture processes that produce therapeutic antibodies with high productivity (titer) and low aggregate content reduce the risk of adverse effects and expense to patients. To elucidate the mechanism of aggregate formation, we compared trastuzumab samples produced from two contrasting cell lines: cell line A, which exhibits high titer and low aggregate content, and cell line B, which exhibits low titer and high aggregate content. Cell line B produced significantly fewer (approximately 1/3) antibodies compared with cell line A and contained higher (approximately 3-fold) percentages of aggregates. The aggregates of antibodies found in the protein A-purified samples of cell line B were associated mostly with noncovalent interactions. Cell line B exhibited a low content of monomers/dimers of light chains in the medium and within cells. Because light chains are essential for the correct folding of heavy chains and secretion of mature antibodies, the characteristics of cell line B may be attributed to low levels of light chain production. In addition, protein A-purified antibodies from cell line B (but not those from cell line A) contained fragments that are expected to expose the hydrophobic C(H)3 domain, which may serve as nuclei for aggregation.	[Ishii, Yoichi; Imamoto, Yasufumi; Yamamoto, Rie] Kyowa Hakko Kirin Co Ltd, Bioproc Res & Dev Labs, Takasaki, Gunma 3700013, Japan; [Tsukahara, Masayoshi] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo 1008185, Japan; [Ishii, Yoichi; Wakamatsu, Kaori] Gunma Univ, Grad Sch Engn, Kiryu, Gunma 3768515, Japan	Ishii, Y (reprint author), Kyowa Hakko Kirin Co Ltd, Bioproc Res & Dev Labs, 100-1 Hagiwara Machi, Takasaki, Gunma 3700013, Japan.	yoichi.ishii@kyowa-kirin.co.jp					Andya JD, 2003, AAPS PHARMSCI, V5, P21, DOI DOI 10.1208/PS050210; Rozhkova A, 2009, J CHROMATOGR A, V1216, P5989, DOI 10.1016/j.chroma.2009.06.045; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025; Strutzenberger K, 1999, J BIOTECHNOL, V69, P215, DOI 10.1016/S0168-1656(99)00044-9; Chi EY, 2003, PHARMACEUT RES, V20, P1325, DOI 10.1023/A:1025771421906; Lee CJ, 2009, BIOTECHNOL BIOENG, V102, P1107, DOI 10.1002/bit.22126; Jiang Z, 2006, BIOTECHNOL PROGR, V22, P313, DOI 10.1021/bp0501524; Cordoba AJ, 2005, J CHROMATOGR B, V818, P115, DOI 10.1016/j.jchromb.2004.12.033; Takuma S, 2007, BIOTECHNOL BIOENG, V97, P1479, DOI 10.1002/bit.21376; Brinda KV, 2002, PROTEIN ENG, V15, P265, DOI 10.1093/protein/15.4.265; Elvin JG, 2013, INT J PHARMACEUT, V440, P83, DOI 10.1016/j.ijpharm.2011.12.039; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Ishii Y, 2014, J BIOSCI BIOENG, V118, P223, DOI 10.1016/j.jbiosc.2014.01.013; Gadgil HS, 2006, J AM SOC MASS SPECTR, V17, P867, DOI 10.1016/j.jasms.2006.02.023; Rispens T, 2008, ANAL BIOCHEM, V380, P303, DOI [10.1016/j.ab.2008.06.001, 10.1016/j.ah.2008.06.001]; Dinnis DM, 2005, BIOTECHNOL BIOENG, V91, P180, DOI 10.1002/bit.20499; Vlasak J, 2008, CURR PHARM BIOTECHNO, V9, P468, DOI 10.2174/138920108786786402; Harris RJ, 2005, DEV BIOLOGICALS, V122, P117; Dick LW, 2008, BIOTECHNOL BIOENG, V100, P1132, DOI 10.1002/bit.21855; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Cromwell MEM, 2006, AAPS J, V8, pE572, DOI 10.1208/aapsj080366; Ho SCL, 2013, J BIOTECHNOL, V165, P157, DOI 10.1016/j.jbiotec.2013.03.019; Wang W, 2012, INT J PHARMACEUT, V431, P1, DOI 10.1016/j.ijpharm.2012.04.040; Gomez N, 2012, BIOTECHNOL BIOENG, V109, P125, DOI 10.1002/bit.23288; Berkowitz SA, 2012, NAT REV DRUG DISCOV, V11, P527, DOI 10.1038/nrd3746; Bhoskar P, 2013, BIOTECHNOL PROGR, V29, P1131, DOI 10.1002/btpr.1767; Carpenter John, 2010, Biologicals, V38, P602, DOI 10.1016/j.biologicals.2010.07.002; Cordoba-Rodriguez RV, 2008, BIOPHARM INT, V21, P44; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; Davies SL, 2009, CELL ENG, V6, P153, DOI 10.1007/978-90-481-2245-5_8; DIAZ MAAA, 2011, PHILIPP SCI LETT, V4, P48; Goswami S, 2013, ANTIBODIES, V2, P452; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Kameoka D, 2011, APPL BIOCHEM BIOTECH, V164, P642, DOI 10.1007/s12010-011-9164-8; Pace C. N., 1997, DETERMINE MOLAR ABSO, P253; Pan H, 2009, ANAL BIOCHEM, V388, P273, DOI 10.1016/j.ab.2009.02.037; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P348; Seshadri S, 2009, CURR PROTEIN PEPT SC, V10, P456; Tovey Michael G, 2011, Expert Rev Clin Pharmacol, V4, P623, DOI 10.1586/ecp.11.39; Vlasak J, 2011, MABS-AUSTIN, V3, P253, DOI 10.4161/mabs.3.3.15608; Wang W, 2005, INT J PHARM, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014	43	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					306	316				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200020		
J	Matsui, K; Tofukuji, S; Ikeda, R				Matsui, Katsuhiko; Tofukuji, Soichi; Ikeda, Reiko			CCL17 Production by Mouse Langerhans Cells Stimulated with Staphylococcus aureus Cell Wall Components	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Staphylococcus aureus; cell wall component; Langerhans cell (LC); CCL17; interleukin (IL)-4	HUMAN GINGIVAL FIBROBLASTS; TOLL-LIKE RECEPTORS; ATOPIC-DERMATITIS; CHEMOKINE EXPRESSION; COLONIZATION; SKIN; INFLAMMATION; INFECTION	Patients with atopic dermatitis (AD) show increased numbers of Th2 cells in their acute skin lesions and superficial skin colonization by Staphylococcus aureus. The purpose of this study was to clarify the effect of S. aureus cell wall components on Th2 chemokine production by murine Langerhans cells (LCs). Murine LCs were stimulated with peptidoglycan (PEG) and/or muramyldipeptide (MDP) for 24 or 48h, and Th1 and Th2 chemokine production was investigated by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). PEG-stimulation of LCs induced production of the Th2 chemokine CCL17 and this was enhanced in the presence of interleukin (IL)-4. A low-molecular weight PEG fragment, MDP, did not induce CCL17 production by LCs. However, when LCs were stimulated with PEG in combination with MDP, PEG-induced CCL17 production was synergistically enhanced by MDP. Furthermore, PEG- and MDP-induced CCL17 production was enhanced to a greater extent in the presence of IL-4. These results suggest that S. aureus colonization in AD patients may enhance the Th2-prone immune response through upregulation of CCL17 production by LCs, which would occur as a result of simultaneous stimulation with PEG and MDP from S. aureus in a Th2 environment.	[Matsui, Katsuhiko; Tofukuji, Soichi; Ikeda, Reiko] Meiji Pharmaceut Univ, Dept Microbial Sci & Host Def, Tokyo 2048588, Japan	Matsui, K (reprint author), Meiji Pharmaceut Univ, Dept Microbial Sci & Host Def, 2-522-1 Noshio, Tokyo 2048588, Japan.	kmatsui@my-pharm.ac.jp					Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Uehori J, 2005, J IMMUNOL, V174, P7096; Lacroix-Lamande S, 2002, INFECT IMMUN, V70, P2090, DOI 10.1128/IAI.70.4.2090-2099.2002; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Zollner TM, 2000, CLIN EXP ALLERGY, V30, P994; Hosokawa Y, 2008, J PERIODONTAL RES, V43, P471, DOI 10.1111/j.1600-0765.2007.01080.x; Guzik TJ, 2005, CLIN EXP ALLERGY, V35, P448, DOI 10.1111/j.1365-2222.2005.02210.x; Hosokawa I, 2010, J PERIODONTAL RES, V45, P193, DOI 10.1111/j.1600-0765.2009.01217.x; Jappe U, 1998, J INVEST DERMATOL, V110, P844; Matsui K, 2000, MICROBIOL IMMUNOL, V44, P945; Matsui K, 2000, J INTERF CYTOK RES, V20, P321, DOI 10.1089/107999000312469; Matsui K, 2011, J INVEST ALLERG CLIN, V21, P354; Park MK, 2001, INFECT IMMUN, V69, P6755, DOI 10.1128/IAI.69.11.6755-6768.2001; Taskapan MO, 2000, ANN ALLERG ASTHMA IM, V84, P3, DOI 10.1016/S1081-1206(10)62731-7	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					317	320				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200021		
J	Aoki, Y; Nakahara, T; Asano, D; Ushikubo, H; Mori, A; Sakamoto, K; Ishii, K				Aoki, Yuto; Nakahara, Tsutomu; Asano, Daiki; Ushikubo, Hiroko; Mori, Asami; Sakamoto, Kenji; Ishii, Kunio			Preventive Effects of Rapamycin on Inflammation and Capillary Degeneration in a Rat Model of NMDA-Induced Retinal Injury	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						endothelial cell; excitotoxicity; leukocyte; mammalian target of rapamycin; microglia	REPERFUSION INJURY; AXON REGENERATION; ISCHEMIA; AUTOPHAGY; MICROGLIA/MACROPHAGES; NEUROPROTECTION; SIMILARITIES; MECHANISM; PATHWAY; MK-801	Inhibitors of the mammalian target of rapamycin (mTOR) have been shown to protect against neuronal injury, but the mechanisms underlying this effect are not fully understood. The present study aimed to examine the effects of rapamycin, an inhibitor of the mTOR pathway, on inflammation and capillary degeneration in a rat model of N-methyl-D-aspartate (NMDA)-induced retinal neurotoxicity. Inflammation and capillary degeneration were evaluated by counting the numbers of CD45-positive leukocytes and Iba1-positive microglia, and by measuring the length of empty basement membrane sleeves, respectively. Marked increases in the numbers of leukocytes and microglia were observed 1 d after intravitreal injection of NMDA (200 nmol), and significant capillary degeneration was observed after 7d. These NMDA-induced changes were significantly reduced by the simultaneous injection of rapamycin (20 nmol) with NMDA. These results suggest that rapamycin has preventive effects on inflammation and capillary degeneration during retinal injury.	[Aoki, Yuto; Nakahara, Tsutomu; Asano, Daiki; Ushikubo, Hiroko; Mori, Asami; Sakamoto, Kenji; Ishii, Kunio] Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, Tokyo 1088641, Japan	Nakahara, T (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	nakaharat@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23590112, 26460103]	This study was supported in part by Grants-in-Aid for Scientific Research (C) (Nos. 23590112, 26460103, T.N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Al-Gayyar MMH, 2011, BRIT J PHARMACOL, V164, P170, DOI 10.1111/j.1476-5381.2011.01336.x; Al-Gayyar MMH, 2010, AM J PATHOL, V177, P1187, DOI 10.2353/ajpath.2010.091289; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ichikawa A, 2014, J NEUROSCI RES, V92, P692, DOI 10.1002/jnr.23358; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.1146.x; SZABO ME, 1991, INVEST OPHTH VIS SCI, V32, P1471; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Leibinger M, 2012, NEUROBIOL DIS, V46, P314, DOI 10.1016/j.nbd.2012.01.004; Ueda K, 2013, EUR J PHARMACOL, V699, P188, DOI 10.1016/j.ejphar.2012.11.054; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Naruoka T, 2013, EUR J PHARMACOL, V718, P138, DOI 10.1016/j.ejphar.2013.08.041; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Hernandez C, 2012, CURR DIABETES REP, V12, P329, DOI 10.1007/s11892-012-0284-5; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Russo R, 2013, CURR OPIN PHARMACOL, V13, P72, DOI 10.1016/j.coph.2012.09.004; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Tsujikawa A, 1999, INVEST OPHTH VIS SCI, V40, P1183; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Tsuda Y, 2012, BIOL PHARM BULL, V35, P2209; Solberg Y, 1997, INVEST OPHTH VIS SCI, V38, P1380; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Lam TT, 1997, J OCUL PHARMACOL TH, V13, P129, DOI 10.1089/jop.1997.13.129; Chang ML, 2006, NEUROSCI RES, V54, P202, DOI 10.1016/j.neures.2005.11.010; HANGAI M, 1995, INVEST OPHTH VIS SCI, V36, P571; Ueda K, 2010, NEUROSCI LETT, V485, P55, DOI 10.1016/j.neulet.2010.08.061	29	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					321	324				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200022		
J	Takagaki, A; Nanjo, F				Takagaki, Akiko; Nanjo, Fumio			Biotransformation of (-)-Epigallocatechin and (-)-Gallocatechin by Intestinal Bacteria Involved in Isoflavone Metabolism	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						epigallocatechin; gallocatechin; isoilavone-metabolizing bacterium; degradation; dehydroxylation; metabolite	GEN-NOV.; RAT; GALLATE; DEHYDROXYLATION; (-)-EPICATECHIN; IDENTIFICATION; EGGERTHELLA; CATECHINS; DAIDZEIN; EQUOL	Four isoflavone-metabolizing bacteria were tested for their abilities to degrade (-)-epigallocatechin (EGC) and its isomer (-)-gallocatechin (GC). Biotransformation of both EGC and GC was observed with Adlercreutzia equohlaciens JCM 14793, Asaccharobacter celatus JCM 14811, and Slackia equohfaciens JCM 16059, but not Slackia isoflavoniconvertens JCM 16137. With respect to the degradation of EGC, strain JCM 14793 only catalyzed 4'-dehydroxylation to produce 4'-dehydroxylated EGC (7). Strain JCM 14811 mainly produced 7, along with a slight formation of the C ring-cleaving product 1-(3,4,5-trihydroxypheny1)-3-(2,4,6trihydroxyphenyl)propan-2-ol (1). Strain JCM 16059 catalyzed only C ring cleavage to form 1. Interestingly, the presence of hydrogen promoted the bioconversion of EGC by these bacteria. In addition, strain JCM 14811 revealed the ability to catalyze 4'-dehydroxylation of 1 to yield 1-(3,5-dihydroxypheny1)-3-(2,4,6-trihydroxyphenyl)propan-2-ol (2) in the presence of hydrogen. In the case of GC, strain JCM 14793 mainly produced C ring-cleaving product (1) with only a very small amount of 4'-dehydroxylated GC (8), while Strain JCM 14811 only catalyzed 4'-dehydroxylation to form 8. Strain JCM 16059 formed 1. The bioconversion of GC by the three strains was stimulated by hydrogen. Strain JCM 14793 showed the ability to convert 1 into 2 in the presence of hydrogen as did strain JCM 14811. Furthermore, strains JCM 14793 and JCM 14811 were found to have the ability to catalyze p-dehydroxylation of the pyrogallol moiety in the EGC metabolites 4-hydroxy-5-(3,4,5-trihydroxyphenyl)valeric acid (3) and 5-(3,4,5-trihydroxyphenyI)-y-valerolactone (4), and this ability was enhanced by the presence of hydrogen.	[Takagaki, Akiko; Nanjo, Fumio] Mitsui Norin Co Ltd, Food Res Labs, Fujieda, Shizuoka 4260133, Japan	Nanjo, F (reprint author), Mitsui Norin Co Ltd, Food Res Labs, 223-1 Miyabara, Fujieda, Shizuoka 4260133, Japan.	fnanjo@mitsui-norin.co.jp					Kohri T, 2003, J AGR FOOD CHEM, V51, P5561, DOI 10.1021/jf034450x; Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837; Meselhy MR, 1997, CHEM PHARM BULL, V45, P888; Minamida K, 2008, INT J SYST EVOL MICR, V58, P1238, DOI 10.1099/ijs.0.64894-0; Minamida K, 2006, J BIOSCI BIOENG, V102, P247, DOI 10.1263/jbb.102.247; Takagaki A, 2010, J AGR FOOD CHEM, V58, P1313, DOI 10.1021/jf903375s; Jin JS, 2010, INT J SYST EVOL MICR, V60, P1721, DOI [10.1099/ijs.0.016774-0, 10.1099/ijs.0.0167747-0]; Maruo T, 2008, INT J SYST EVOL MICR, V58, P1221, DOI [10.1099/ijs.0.65404-0, 10.1099/jjs.0.65404-0]; Matthies A, 2009, APPL ENVIRON MICROB, V75, P1740, DOI 10.1128/AEM.01795-08; Wang LQ, 2001, CHEM PHARM BULL, V49, P1640, DOI 10.1248/cpb.49.1640; Kohri T, 2001, J AGR FOOD CHEM, V49, P4102, DOI 10.1021/jf001491+; Jin JS, 2008, BIOL PHARM BULL, V31, P1621, DOI 10.1248/bpb.31.1621; Hara Y, 2001, GREEN TEA HLTH BENEF; Ito K, 2008, 128 ANN M PHARM SOC, P87; Jin JS, 2012, BIOL PHARM BULL, V35, P2252; Takagaki A, 2014, ARCH MICROBIOL, V196, P681, DOI 10.1007/s00203-014-1006-y	16	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					325	330				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200023		
J	Chen, SJ; Aikawa, C; Matsui, T				Chen, Si Jing; Aikawa, Chiwa; Matsui, Toshiro			Quantitative Analysis of Methylglyoxal, Glyoxal and Free Advanced Glycation End-Products in the Plasma of Wistar Rats during the Oral Glucose Tolerance Test	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						advanced glycation end-product; methylglyoxal; glyoxal; oral glucose tolerance test	TANDEM MASS-SPECTROMETRY; SERUM-LEVELS; 3-DEOXYGLUCOSONE; RETINOPATHY; PROTEINS	The purpose of this study was to gain insight into the production behavior of free adducts of advanced glycation end-products (AGEs) in Wistar rats under acute hyperglycemic conditions. Five AGE-free adducts as well as their precursors (i.e., highly reactive carbonyl intermediates of methylglyoxal and glyoxal) in rat plasma were quantitatively determined at greater than nanomolar levels using the liquid chromatography/tandem mass spectrometry method coupled with 2,4,6-trinitrobenzene sulfonate and 2,3-diaminonaphthalene derivatization techniques. An oral glucose (2 g/kg dose) tolerance test to 10-week-old Wistar rats provided evidence that the plasma levels of diabetes-related metabolites did not change acutely within 120 mm, irrespective of increasing blood glucose levels.	[Chen, Si Jing; Aikawa, Chiwa; Matsui, Toshiro] Kyushu Univ, Grad Sch, Fac Agr, Div Biosci & Bioenvironm Sci, Fukuoka 8128581, Japan	Matsui, T (reprint author), Kyushu Univ, Grad Sch, Fac Agr, Div Biosci & Bioenvironm Sci, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tmatsui@agr.kyushu-u.ac.jp			Fukuoka Prefectural Support Fund for Creating New Products or New Technology (Development stage); China Scholarship Council [201206350185]	This study was in part supported by a Fukuoka Prefectural Support Fund for Creating New Products or New Technology (Development stage) to TM. SJ Chen thanks the support of China Scholarship Council (No. 201206350185).	Lu JX, 2011, CLIN BIOCHEM, V44, P307, DOI 10.1016/j.clinbiochem.2010.11.004; Hashimoto C, 2013, ANAL CHEM, V85, P4289, DOI 10.1021/ac400294q; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; Ahmed N, 2005, DIABETES CARE, V28, P2465, DOI 10.2337/diacare.28.10.2465; YAMADA H, 1994, J BIOL CHEM, V269, P20275; Zhu WF, 2012, BLOOD, V119, P6136, DOI 10.1182/blood-2011-10-387506; Rabbani N, 2007, KIDNEY INT, V72, P1113, DOI 10.1038/sj.ki.5002513; Wang XX, 2004, KIDNEY INT, V66, P2315, DOI 10.1111/j.1523-1755.2004.66034.x; Fosmark DS, 2006, METABOLISM, V55, P232, DOI 10.1016/j.metabol.2005.08.017; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Boehm BO, 2004, DIABETOLOGIA, V47, P1376, DOI 10.1007/s00125-004-1455-y	12	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2015	38	2					336	339				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RW	WOS:000348690200025		
J	Khan, KN; Kitajima, M; Hiraki, K; Fujishita, A; Nakashima, M; Masuzaki, H				Khan, Khaleque Newaz; Kitajima, Michio; Hiraki, Koichi; Fujishita, Akira; Nakashima, Masahiro; Masuzaki, Hideaki			Involvement of Hepatocyte Growth Factor-Induced Epithelial-Mesenchymal Transition in Human Adenomyosis	BIOLOGY OF REPRODUCTION			English	Article						adenomyosis; basalis endometrium; EMT; estrogen; HGF	E-CADHERIN EXPRESSION; HUMAN HEAT-SHOCK-PROTEIN-70; ENDOMETRIOSIS; CELLS; WOMEN; ESTROGEN; RECEPTOR; MACROPHAGES; SNAIL; CONTRIBUTES	Adenomyosis is commonly believed to arise from the basalis endometrium. As an estromedin growth factor, hepatocyte growth factor (HGF) exhibits multiple functions in endometriosis, a disease commonly believed to arise from the functionalis endometrium. Here, we investigated the role of HGF in the occurrence of epithelial-mesenchymal transition (EMT) in adenomyosis. Full-thickness-biopsy specimens from endometrium to myometrium were collected after hysterectomy from women with and without adenomyosis. The relationship between HGF and E-cadherin (epithelial cell marker) and N-cadherin (mesenchymal cell markers) was examined at the gene and protein levels using endometrial epithelial cells (EECs) in culture and tissues by quantitative RT-PCR and immunohistochemistry. The gene and protein expressions of two transcriptional repressors of E-cadherin, SLUG and SNAIL, were examined using Ishikawa cells and in response to HGF and estrogen (E-2). HGF down-regulated E-cadherin and up-regulated N-cadherin mRNA expression in EECs, and an inverse relationship in protein expression between HGF and E-cadherin was observed in basalis endometria derived from women with diffuse and focal adenomyosis. HGF induced morphological changes of EECs from a cobblestone-like appearance to spindle-shaped cells and promoted migration of EECs. Ishikawa cells exhibited up-regulation of SLUG/SNAIL gene expression in response to both HGF and E-2 with an additive effect between them. HGF- and E-2 promoted SLUG/SNAIL gene expression was significantly abrogated after pretreatment of cells with anti-HGF antibody or ICI 182720, an estrogen receptor antagonist. HGF may be involved in gland invagination deep into the myometrium by inducing EMT at the endo-myometrial junction in women with adenomyosis.	[Khan, Khaleque Newaz; Kitajima, Michio; Hiraki, Koichi; Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 8528501, Japan; [Fujishita, Akira] Saiseikai Nagasaki Hosp, Nagasaki, Japan; [Nakashima, Masahiro] Nagasaki Univ, Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki 8528501, Japan	Khan, KN (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	nemokhan@nagasaki-u.ac.jp			Japan Society of the Promotion of Science [21592101, 24592474]	This work was supported in part by grants-in-aid for Scientific Research (grants 21592101 and 24592474) from the Japan Society of the Promotion of Science (to K.N.K.). This article was partly presented at the seminar session of 12th World Congress on Endometriosis that was held in Sao Paulo, Brazil, from 30 April to 3 May 2014.	Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; OSTEEN KG, 1989, FERTIL STERIL, V52, P965; Zeitvogel A, 2001, AM J PATHOL, V159, P1839, DOI 10.1016/S0002-9440(10)63030-1; Khan KN, 2005, HUM REPROD, V20, P2004, DOI 10.1093/humrep/deh897; Wang PH, 2009, J OBSTET GYNAECOL RE, V35, P495, DOI 10.1111/j.1447-0756.2008.00951.x; Chen YJ, 2010, J PATHOL, V222, P261, DOI 10.1002/path.2761; Khan KN, 2008, HUM REPROD, V23, P2210, DOI 10.1093/humrep/den195; Oh SJ, 2013, J PATHOL, V231, P210, DOI 10.1002/path.4224; Bergeron C, 2006, BEST PRACT RES CL OB, V20, P511, DOI 10.1016/j.bpobgyn.2006.01.016; Fujishita A, 1997, FERTIL STERIL, V67, P856, DOI 10.1016/S0015-0282(97)81397-0; Ota H, 1998, HUM REPROD UPDATE, V4, P360, DOI 10.1093/humupd/4.4.360; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Ferenczy A, 1998, HUM REPROD UPDATE, V4, P312, DOI 10.1093/humupd/4.4.312; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Gaetje R, 1997, AM J PATHOL, V150, P461; Imamura T, 2014, EUR J OBSTET GYN R B, V180, P16, DOI 10.1016/j.ejogrb.2014.06.002; Khan KN, 2005, HUM REPROD, V20, P49, DOI 10.1093/humrep/deh525; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Castelbaum AJ, 1997, J CLIN ENDOCR METAB, V82, P136, DOI 10.1210/jc.82.1.136; Dejina E, 1985, J CLIN INVEST, V75, P11; Hay E. D., 1968, EPITHELIAL MESENCHYM, P31; Hendrickson MR, 1997, HISTOLOGY PATHOLOGIS, P894; Hiscox S., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P500; Khan KN, 2008, WES E J          JUL, P13; Khan KN, 2005, HUM REPROD, V20, P2715, DOI 10.1093/humrep/dei156; Khan KN, 2003, FERTIL STERIL, V79, P173, DOI 10.1016/S0015-0282(02)04535-1; Li XL, 2014, J OBSTET GYNAECOL RE, V40, P485, DOI 10.1111/jog.12211; Miura S, 2006, HUM REPROD, V21, P2545, DOI 10.1093/humrep/del205; Montserrat N, 2012, HUM PATHOL, V43, P632, DOI 10.1016/j.humpath.2011.06.021; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Ridley JH, 1968, OBSTET GYNECOL SURV, V23, P1, DOI 10.1097/00006254-196801000-00001; Setoguchi T., 1979, TXB PRACTICAL HISTOL, P218	35	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	FEB 1	2015	92	2							35	10.1095/biolreprod.114.124891		11	Reproductive Biology	Reproductive Biology	CB1YC	WOS:000349422900007		
J	Mulvaney, JF; Amemiya, Y; Freeman, SD; Ladher, RK; Dabdoub, A				Mulvaney, Joanna F.; Amemiya, Yutaka; Freeman, Stephen D.; Ladher, Raj K.; Dabdoub, Alain			Molecular cloning and functional characterisation of chicken Atonal homologue 1: A comparison with human Atoh1	BIOLOGY OF THE CELL			English	Article						cAtoh1; Cochlea; Development; Notch; Regeneration	HAIR-CELL-DIFFERENTIATION; INNER-EAR DEVELOPMENT; MAMMALIAN COCHLEA; IN-VIVO; MATH1 EXPRESSION; GENE-EXPRESSION; GC-CONTENT; PROGENITOR CELLS; REGENERATION; REVEALS	Background informationThe vertebrate basic helix-loop-helix transcription factor Atoh1 is essential for maturation and survival of mechanosensory hair cells of the inner ear, neurogenesis, differentiation of the intestine, homeostasis of the colon and is implicated in cancer progression. Given that mutations in Atoh1 are detected in malignant tumours, study of functionally different Atoh1 alleles and homologues might yield useful avenues for investigation. The predicted sequence of chicken Atoh1 (cAtoh1) has large regions of dissimilarity to that of mammalian Atoh1 homologues. We hypothesise that cAtoh1 might have intrinsic functional differences to mammalian Atoh1. ResultsIn this study, we cloned and sequenced the full open reading frame of cAtoh1. In overexpression experiments, we show that this sequence is sufficient to generate a cAtoh1 protein capable of inducing hair cell markers when expressed in nonsensory regions of the developing inner ear, and that morpholino-mediated knock-down using a section of the sequence 5 to the start codon inhibits differentiation of hair cells in the chicken basilar papilla. Furthermore, we compare the behaviour of cAtoh1 and human Atoh1 (hAtoh1) in embryonic mouse cochlear explants, showing that cAtoh1 is a potent inducer of hair cell differentiation and that it can overcome Sox2-mediated repression of hair cell differentiation more effectively than hAtoh1. ConclusionscAtoh1 is both necessary and sufficient for avian mechanosensory hair cell differentiation. The non-conserved regions of the cAtoh1 coding region have functional consequences on its behaviour.	[Mulvaney, Joanna F.; Amemiya, Yutaka; Dabdoub, Alain] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Freeman, Stephen D.; Ladher, Raj K.] RIKEN Ctr Dev Biol, Lab Sensory Dev, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Dabdoub, Alain] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Dabdoub, Alain] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Mulvaney, JF (reprint author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	jfm30@sri.utoronto.ca			Hearing Foundation of Canada; Sunnybrook Hearing Regeneration Initiative; JSPS; RIKEN CDB	This work was supported by a medical research grant from The Hearing Foundation of Canada and the Sunnybrook Hearing Regeneration Initiative. This work was partially supported by JSPS fellowship (http://www.jsps.jp) to SF and a RIKEN CDB intramural grant.	Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Driver EC, 2013, DEV BIOL, V376, P86, DOI 10.1016/j.ydbio.2013.01.005; Mulvaney JF, 2013, DEV DYNAM, V242, P179, DOI 10.1002/dvdy.23908; Zheng JL, 2000, NAT NEUROSCI, V3, P580; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Helms AW, 1998, DEVELOPMENT, V125, P919; Masuda M, 2011, NEUROSCIENCE, V197, P48, DOI 10.1016/j.neuroscience.2011.09.033; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Jacques BE, 2014, DEV NEUROBIOL, V74, P438, DOI 10.1002/dneu.22134; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Stone JS, 2003, J COMP NEUROL, V460, P487, DOI 10.1002/cne.10662; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Saba R, 2005, DEVELOPMENT, V132, P2147, DOI 10.1242/dev.01781; Ebert PJ, 2003, DEVELOPMENT, V130, P1949, DOI 10.1242/dev.00419; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Chonko KT, 2013, DEV BIOL, V381, P401, DOI 10.1016/j.ydbio.2013.06.022; Lai HC, 2011, J NEUROSCI, V31, P10859, DOI 10.1523/JNEUROSCI.0445-11.2011; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Ahmed M, 2012, DEV CELL, V22, P377, DOI 10.1016/j.devcel.2011.12.006; Yang JM, 2013, NEUROSCI LETT, V549, P7, DOI 10.1016/j.neulet.2013.04.053; Lanford PJ, 1999, NAT GENET, V21, P289; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Chen P, 2002, DEVELOPMENT, V129, P2495; BARTOLAMI S, 1991, J COMP NEUROL, V314, P777, DOI 10.1002/cne.903140410; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; Neves J, 2013, HEARING RES, V297, P20, DOI 10.1016/j.heares.2012.11.003; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Goodyear RJ, 2010, JARO-J ASSOC RES OTO, V11, P573, DOI 10.1007/s10162-010-0231-6; Galtier N, 2001, GENETICS, V159, P907; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Groves AK, 2013, ANNU REV NEUROSCI, V36, P361, DOI 10.1146/annurev-neuro-062012-170309; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; GOODYEAR R, 1995, J COMP NEUROL, V351, P81, DOI 10.1002/cne.903510108; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Park C, 2013, P NATL ACAD SCI USA, V110, pE678, DOI 10.1073/pnas.1218066110; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; BenArie N, 1997, NATURE, V390, P169; Puligilla C, 2009, CURR OPIN GENET DEV, V19, P368, DOI 10.1016/j.gde.2009.06.004; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Cafaro J, 2007, DEV DYNAM, V236, P156, DOI 10.1002/dvdy.21023; Mulvaney J, 2012, JARO-J ASSOC RES OTO, V13, P281, DOI 10.1007/s10162-012-0317-4; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Freeman SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046387; Frenkel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032076; Kano Y, 2013, BIOCHEM BIOPH RES CO, V432, P175, DOI 10.1016/j.bbrc.2013.01.034; Kazanjian A, 2011, CURR COLORECTAL CANC, V7, P121; Kirjavainen A, 2008, DEV BIOL, V322, P33, DOI 10.1016/j.ydbio.2008.07.004; Lanford Pamela J., 2000, JARO Journal of the Association for Research in Otolaryngology, V1, P161, DOI 10.1007/s101620010023; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; Lewis RM, 2012, HEARING RES, V289, P74, DOI 10.1016/j.heares.2012.04.008; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; NEVES JTD, 2012, PERSPECT CIENC INF, V17, P1; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Rao YS, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-9; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Sheykholeslami K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079791; Stone JS, 2004, DEV DYNAM, V230, P597, DOI 10.1002/dvdy.20087; Yu L., 2011, GENESIS, V50, P393	68	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0248-4900	1768-322X		BIOL CELL	Biol. Cell	FEB	2015	107	2					41	+		10.1111/boc.201400078		20	Cell Biology	Cell Biology	CA5DD	WOS:000348927400001		
J	Azuma, K; Nishihara, M; Shimizu, H; Itoh, Y; Takashima, O; Osaki, T; Itoh, N; Imagawa, T; Murahata, Y; Tsuka, T; Izawa, H; Ifuku, S; Minami, S; Saimoto, H; Okamoto, Y; Morimoto, M				Azuma, Kazuo; Nishihara, Masahiro; Shimizu, Haruki; Itoh, Yoshiki; Takashima, Osamu; Osaki, Tomohiro; Itoh, Norihiko; Imagawa, Tomohiro; Murahata, Yusuke; Tsuka, Takeshi; Izawa, Hironori; Ifuku, Shinsuke; Minami, Saburo; Saimoto, Hiroyuki; Okamoto, Yoshiharu; Morimoto, Minoru			Biological adhesive based on carboxymethyl chitin derivatives and chitin nanofibers	BIOMATERIALS			English	Article						Chitin; 2-Hydroxy-3-methacryloyloxypropylated carboxymethyl chitin; Adhesion; Chitin nanofiber	PHOTOCROSSLINKABLE CHITOSAN; IN-VITRO; FIBROBLASTS; PROLIFERATION; BIOADHESIVES; TOXICITY; SEALANTS; GELATIN; SURFACE	Novel biological adhesives made from chitin derivatives were prepared and evaluated for their adhesive properties and biocompatibility. Chitin derivatives with acrylic groups, such as 2-hydroxy-3-methacryloyloxypropylated carboxymethyl chitin (HMA-CM-chitin), were synthesized and cured by the addition of an aqueous hydrogen peroxide solution as a radical initiator. The adhesive strength of HMA-CM-chitin increased when it was blended with chitin nanofibers (CNFs) or surface-deacetylated chitin nanofibers (S-DACNFs). HMA-CM-chitin/CNFs or HMA-CM-chitin/S-DACNFs have almost equal adhesive strength compared to that of a commercial cyanoacrylate adhesive. Moreover, quick adhesion and induction of inflammatory cells migration were observed in HMA-CM-chitin/CNF and HMA-CM-chitin/S-DACNF. These findings indicate that the composites prepared in this study are promising materials as new biological adhesives. (C) 2014 Elsevier Ltd. All rights reserved.	[Azuma, Kazuo; Nishihara, Masahiro; Osaki, Tomohiro; Itoh, Norihiko; Imagawa, Tomohiro; Murahata, Yusuke; Tsuka, Takeshi; Minami, Saburo; Okamoto, Yoshiharu] Tottori Univ, Dept Vet Clin Med, Tottori 6808533, Japan; [Shimizu, Haruki; Itoh, Yoshiki; Izawa, Hironori; Ifuku, Shinsuke; Saimoto, Hiroyuki] Tottori Univ, Grad Sch Engn, Tottori 6808533, Japan; [Takashima, Osamu] Tottori Prefectural Police HQ, Sci Crime Lab, Tottori 6800911, Japan; [Morimoto, Minoru] Tottori Univ, Res Ctr Biosci & Technol, Div Instrumental Anal, Tottori 6808550, Japan	Azuma, K (reprint author), Tottori Univ, Dept Vet Clin Med, Tottori 6808533, Japan.	kazu-azuma@muses.tottori-u.ac.jp; morimoto@chem.tottori-u.ac.jp	Izawa, Hironori/M-7037-2014	Izawa, Hironori/0000-0002-8715-8462	Tottori prefectural-financed aid project for beauty & healthy products;  [22550197];  [25410227]	This research was supported in part by Grant-in-Aid for Scientific Research (C) (Grant No.22550197 and 25410227) and Tottori prefectural-financed aid project for beauty & healthy products.	Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005; Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3; Elvin CM, 2010, BIOMATERIALS, V31, P8323, DOI 10.1016/j.biomaterials.2010.07.032; Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0; Ono K, 2000, J BIOMED MATER RES, V49, P289; Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d; Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6; Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4; Muzzarelli RAA, 2011, TOP GEOBIOL, V34, P1, DOI 10.1007/978-90-481-9684-5_1; Ifuku S, 2011, GREEN CHEM, V13, P1708, DOI 10.1039/c1gc15321h; Azuma K, 2014, J BIOMED NANOTECHNOL, V10, P2891, DOI 10.1166/jbn.2014.1882; Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7; Wheat JC, 2009, UROL CLIN N AM, V36, P265, DOI 10.1016/j.ucl.2009.02.002; Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x; Mehdizadeh M, 2013, MACROMOL BIOSCI, V13, P271, DOI 10.1002/mabi.201200332; TSENG YC, 1990, J BIOMED MATER RES, V24, P1355, DOI 10.1002/jbm.820241007; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; Leggat PA, 2004, IND HEALTH, V42, P207, DOI 10.2486/indhealth.42.207; Ifuku S, 2013, CARBOHYD POLYM, V98, P1198, DOI 10.1016/j.carbpol.2013.07.033; PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0; Lih E, 2012, ACTA BIOMATER, V8, P3261, DOI 10.1016/j.actbio.2012.05.001; Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x; Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2; Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001; BRAUNWAL.NS, 1966, SURGERY, V59, P1024; Diegelmann Robert F., 1996, Wound Repair and Regeneration, V4, P48, DOI 10.1046/j.1524-475X.1996.40109.x; Ifuku S, 2010, BIOMACROMOLECULES, V11, P1326, DOI 10.1021/bm100109a; Juan GM, 1999, NEUROL MED-CHIR, V39, P908, DOI 10.2176/nmc.39.908; NISHIMURA S, 1985, INT J BIOL MACROMOL, V7, P100, DOI 10.1016/0141-8130(85)90038-8; Okamoto Y, 1995, J VET MED SCI, V57; Ono K, 2002, TRENDS GLYCOSCI GLYC, V14, P331; Renbutsu E, 2005, BIOMACROMOLECULES, V6, P2385, DOI 10.1021/1bm0500796; Ryan BM, 2004, GASTROENTEROLOGY, V126, P1175, DOI 10.1053/j.gastro.2004.01.058; SMITH TW, 1985, J NEUROSURG, V62, P108, DOI 10.3171/jns.1985.62.1.0108; Spotnitz William D, 2005, J Long Term Eff Med Implants, V15, P245, DOI 10.1615/JLongTermEffMedImplants.v15.i3.20; Valbonesi M, 2006, BEST PRACT RES CL HA, V19, P191, DOI 10.1016/j.beha.2005.01.009	36	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	FEB	2015	42						20	29		10.1016/j.biomaterials.2014.11.043		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA4OH	WOS:000348883700003		
J	Yamamoto, K; Hama, T; Yamato, M; Uchimizu, H; Sugiyama, H; Takagi, R; Yaguchi, Y; Okano, T; Kojima, H				Yamamoto, Kazuhisa; Hama, Takanori; Yamato, Masayuki; Uchimizu, Hirotaka; Sugiyama, Hiroaki; Takagi, Ryo; Yaguchi, Yuichiro; Okano, Teruo; Kojima, Hiromi			The effect of transplantation of nasal mucosal epithelial cell sheets after middle ear surgery in a rabbit model	BIOMATERIALS			English	Article						Mucosal regeneration; Cell sheet; Middle ear surgery; Cholesteatoma; Temperature-responsive culture dish; Nasal mucosal epithelium	GAS-EXCHANGE FUNCTION; GENERAL-ANESTHESIA; TOTAL PRESSURE; RECONSTRUCTION; CHOLESTEATOMA; PREVENTION; PREDICTION	Postoperative regeneration of the middle ear mucosa and pneumatization of the middle ear cavity are of great importance after middle ear surgery. This study developed a new method to transplant autologous nasal mucosal epithelial cell sheets into the damaged middle ear cavity. The aim of this study was to evaluate postoperative healing after the transplantation of the cell sheets. Rabbit nasal mucosal epithelial cell sheets were fabricated on a temperature-responsive culture dish, and transplanted into the damaged middle ear of rabbit, which was surgically created. The healing of middle ears was evaluated by histology and X-ray computed tomography after transplantation. Functional evaluation was performed by measuring the maximum middle ear total pressure reflecting a trans-mucosal gas exchange function. Two control groups were used: the normal control group and the mucosa-eliminated control group. Transplantation of cell sheets suppressed the bone hyperplasia and the narrowing of pneumatic space in the middle ear cavity compared with the mucosa-eliminated control group. The mucosal gas exchange function was also better in the cell sheet-transplanted group. Nasal mucosal epithelial cell sheet was confirmed to be useful as an effective graft material after middle ear surgery and hopefully become a novel therapy in the future. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamamoto, Kazuhisa; Hama, Takanori; Uchimizu, Hirotaka; Yaguchi, Yuichiro; Kojima, Hiromi] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo 1058461, Japan; [Yamamoto, Kazuhisa; Yamato, Masayuki; Sugiyama, Hiroaki; Takagi, Ryo; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	Yamamoto, K (reprint author), Jikei Univ, Sch Med, Dept Otorhinolaryngol, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	kazu1109@jikei.ac.jp			Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds; Global COE program; Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This study was supported in part by Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology 'Cell Sheet Tissue Engineering Center (CSTEC)' and the Global COE program, the Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; LUNTZ M, 1995, LARYNGOSCOPE, V105, P510, DOI 10.1288/00005537-199505000-00012; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Ars B, 1997, ACTA OTO-LARYNGOL, V117, P704, DOI 10.3109/00016489709113463; Black B, 2011, OTOL NEUROTOL, V32, P992, DOI 10.1097/MAO.0b013e3182255874; Hamada Y, 2002, INT J PEDIATR OTORHI, V64, P41, DOI 10.1016/S0165-5876(02)00040-X; HENTZER E, 1984, ACTA OTO-LARYNGOL, P19; Ikarashi F, 1996, ANN OTO RHINOL LARYN, V105, P784; Ikarashi F, 1999, ARCH OTOLARYNGOL, V125, P975; McGhee MA, 1999, AM J OTOL, V20, P712; Michael G, 1995, ACTA OTO-LARYNGOL, V115, P522; NG M, 1992, LARYNGOSCOPE, V102, P1097, DOI 10.1288/00005537-199210000-00002; ONEILL G, 1985, ACTA OTO-LARYNGOL, V100, P51, DOI 10.3109/00016488509108587; RICHARDS SH, 1982, J LARYNGOL OTOL, V96, P883, DOI 10.1017/S0022215100093245; SADE J, 1995, ANN OTO RHINOL LARYN, V104, P369; Suzuki J, 1987, Adv Otorhinolaryngol, V37, P178; Takahashi H, 1997, LARYNGOSCOPE, V107, P1117, DOI 10.1097/00005537-199708000-00020; Uchimizu H, 2007, ACTA OTO-LARYNGOL, V127, P1031, DOI 10.1080/00016480701200228; Uchimizu H, 2005, INT J PEDIATR OTORHI, V69, P1659, DOI 10.1016/j.ijporl.2005.03.048; VARTIAINEN E, 1993, AM J OTOLARYNG, V14, P49, DOI 10.1016/0196-0709(93)90010-5; Wada K, 2006, ACTA OTO-LARYNGOL, V126, P801, DOI 10.1080/00016480500507385; Yaguchi Y, 2007, ACTA OTO-LARYNGOL, V127, P1038, DOI 10.1080/00016480701200285; Yamamoto Y, 1999, ACTA OTO-LARYNGOL, V119, P72; Yamato M, 2000, TISSUE ENG, V7, P1473; Yamato M, 2007, INFLAMM REGEN, V27, P156, DOI 10.2492/inflammregen.27.156	28	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	FEB	2015	42						87	93		10.1016/j.biomaterials.2014.11.037		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA4OH	WOS:000348883700009		
J	Ueki, A; Kidoaki, S				Ueki, Ayaka; Kidoaki, Satoru			Manipulation of cell mechanotaxis by designing curvature of the elasticity boundary on hydrogel matrix	BIOMATERIALS			English	Article						Curvature effect; Mechanotaxis; Durotaxis; Microelasticity patterning; Elasticity boundary	MECHANICAL-PROPERTIES; FORCE MICROSCOPY; TRACTION FIELDS; SUBSTRATE; MIGRATION; MOTILITY; MORPHOGENESIS; MOVEMENT; PHOTOPOLYMERIZATION; ORIENTATION	Directional cell migration induced by the stiffness gradient of cell culture substrates is known as a subset of the mechanical-cue-induced taxis, so-called mechanotaxis, typically durotaxis toward hard region. To establish the general conditions of biomaterials to manipulate the mechanotaxis, the effect of the shape of the elasticity transition boundary between hard and soft regions of a substrate on mechanotaxis should be systematically determined as well as the conditions of elasticity gradient strength. Here, as a simplified factor of expressing variations in the shape of the elasticity boundary in living tissues, we focus on the curvature of the elasticity boundary. Mask-free photolithographic microelasticity patterning of photocurable gelatin gel was employed to systematically prepare elasticity boundaries with various curvatures, and the efficiency of mechanotaxis of fibroblast cells around each curved boundary was examined. Highly efficient usual durotaxis was induced on a convex boundary with 100 gm in radius and on a concave boundary with 750 mu m in radius of curvature. Interestingly, biased migration toward soft regions of the gel, i.e., inverse durotaxis, was first observed for concave boundaries with 50 mu m or 100 mu m in radius of curvature, which was named as "negative mechanotaxis". The curvature of the elasticity boundary was found to markedly affect the efficiency of induction and the direction of mechanotaxis. The mechanism responsible for this phenomenon and the implication for the curvature effect in in vivo systems are discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Ueki, Ayaka] Kyushu Univ, Inst Mat Chem & Engn, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Kidoaki, Satoru] Kyushu Univ, Inst Mat Chem & Engn, Lab Biomed & Biophys Chem, Nishi Ku, Fukuoka 8190395, Japan	Kidoaki, S (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Lab Biomed & Biophys Chem, Nishi Ku, CE11-115,744 Motooka, Fukuoka 8190395, Japan.	kidoaki@ms.ifoc.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24300173, 24120007]	The authors thank Prof. Takehisa Matsuda of the Kanazawa Institute of Technology (Japan) for assistance with the synthesis of styrenated gelatins. We also thank Prof. Testuo Yamaguchi of Kyushu University for his insightful discussions. This work was supported by a Grant-in-Aid for Scientific Research (24300173, 24120007), a Management Expenses Grants for National Universities Corporations (Nano-Macro Materials, Devices and System Research Alliance) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Lo CM, 2000, BIOPHYS J, V79, P144; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; McLennan R, 2012, DEVELOPMENT, V139, P2935, DOI 10.1242/dev.081471; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; James J, 2008, CELL MOTIL CYTOSKEL, V65, P841, DOI 10.1002/cm.20305; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595; Legant WR, 2013, P NATL ACAD SCI USA, V110, P881, DOI 10.1073/pnas.1207997110; Dembo M, 1999, BIOPHYS J, V76, P2307; Wu HW, 1998, SCANNING, V20, P389; RADMACHER M, 1995, BIOPHYS J, V69, P264; Itoga K, 2004, BIOMATERIALS, V25, P2047, DOI 10.1016/j.biomaterials.2003.08.052; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Berstein LR, 1994, CURR OPIN ONCOL, V6, P106; Boresi A, 1993, ADV MECH MAT; Brown RH, 2003, EUR RESPIR J, V22, P57, DOI 10.1183/09031936.03.00090403; del Alamo JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069850; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Hertz H., 1881, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRIL.1882.92.156>; INGBER DE, 1994, INT REV CYTOL, V150, P173; Jose VG, 2005, NATURE, V434, P777; Kawano T, 2011, BIOMATERIALS, V32, P2725, DOI 10.1016/j.biomaterials.2011.01.009; Kawano T, 2013, BIOMATERIALS, V34, P7563, DOI 10.1016/j.biomaterials.2013.06.011; Kidoaki Satoru, 2008, J Biotechnol, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015; Kuboki T, 2014, LANGMUIR, V30, P6187, DOI 10.1021/la501058j; LANGILLE BL, 1981, CIRC RES, V48, P481; Noble PB, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-9; PARENTE L, 1979, AGENTS ACTIONS, V9, P190, DOI 10.1007/BF02024733; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; TRINKAUS JP, 1985, J NEUROSCI RES, V13, P1, DOI 10.1002/jnr.490130102; Van ES, 1999, CELL MOL LIFE SCI, V55, P1341; Xu JM, 2011, BIOCHEM BIOPH RES CO, V415, P591, DOI 10.1016/j.bbrc.2011.10.111	48	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	FEB	2015	41						45	52		10.1016/j.biomaterials.2014.11.030		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA6XY	WOS:000349062100005		
J	Pall-Gergely, B				Pall-Gergely, Barna			On the Confusion of Quality with Impact: A Note on Pyke's M-Index	BIOSCIENCE			English	Letter							TAXONOMY; IMPEDIMENT		[Pall-Gergely, Barna] Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan	Pall-Gergely, B (reprint author), Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan.	pallgergely2@gmail.corn					Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285; de Carvalho MR, 2005, SCIENCE, V307, P353; Krell FT, 2002, NATURE, V415, P957, DOI 10.1038/415957a; DESCHKA G, 1986, Acta Entomologica Jugoslavica, V22, P11; Ebach MC, 2011, CLADISTICS, V27, P1; Kohler F, 1997, BEITRAGE KAFERFAUNA, V36, P351; Krell FT, 2000, NATURE, V405, P507, DOI 10.1038/35014664; Maupas E., 1899, ARCH ZOOL EXP GEN, V7, P563; Pyke GH, 2014, BIOSCIENCE, V64, P961, DOI 10.1093/biosci/biu154; Sefrova Hana, 2001, Entomologische Zeitschrift, V111, P194; Valdecasas AG, 2000, NATURE, V403, P698, DOI 10.1038/35001751; Venu P, 2011, CURR SCI INDIA, V101, P1397; Wagele H, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-25	13	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-3568	1525-3244		BIOSCIENCE	Bioscience	FEB	2015	65	2					117	117		10.1093/biosci/biu207		1	Biology	Life Sciences & Biomedicine - Other Topics	CA5UP	WOS:000348973600002		
J	Ishimaru, Y				Ishimaru, Yoshiro			Molecular mechanisms underlying the reception and transmission of sour taste information	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Review						taste receptor; sour taste	TRANSIENT RECEPTOR; FOLIATE PAPILLAE; NEURAL PATHWAYS; SOLITARY TRACT; CELLS; MOUSE; BUDS; PKD1L3; ACID; GENE	Taste enables organisms to determine the properties of ingested substances by conveying information regarding the five basic taste modalities: sweet, salty, sour, bitter, and umami. The sweet, salty, and umami taste modalities convey the carbohydrate, electrolyte, and glutamate content of food, indicating its desirability and stimulating appetitive responses. The sour and bitter modalities convey the acidity of food and the presence of potential toxins, respectively, stimulating aversive responses to such tastes. In recent years, the receptors mediating sweet, bitter, and umami tastes have been identified as members of the T1R and T2R G-protein-coupled receptor families; however, the molecular mechanisms underlying sour taste detection have yet to be clearly elucidated. This review covers the molecular mechanisms proposed to mediate the detection and transmission of sour stimuli, focusing on polycystic kidney disease 1-like 3 (Pkd1l3), Pkd2l1, and carbonic anhydrase 4 (Car4).	Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138654, Japan	Ishimaru, Y (reprint author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138654, Japan.	ayishi@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25292068, 26660108]	This work was supported in part by a Grant-in-Aid for Scientific Research (B) [25292068] and a Grant-in-Aid for Challenging Exploratory Research [26660108] to Y.I. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; SPECTOR AC, 1995, BEHAV NEUROSCI, V109, P939, DOI 10.1037/0735-7044.109.5.939; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Kawaguchi H, 2010, J BIOL CHEM, V285, P17277, DOI 10.1074/jbc.C110.132944; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; TRAVERS SP, 1995, J NEUROPHYSIOL, V73, P2144; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Yoshihara Y, 2002, NEUROSCI RES, V44, P133, DOI 10.1016/S0168-0102(02)00130-X; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Chang RB, 2010, P NATL ACAD SCI USA, V107, P22320, DOI 10.1073/pnas.1013664107; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Pan Zan, 2011, Human Genomics, V5, P108; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Baeyens F, 1996, APPETITE, V27, P235, DOI 10.1006/appe.1996.0049; Damak S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-96; Delmas P, 2004, BIOCHEM BIOPH RES CO, V322, P1374, DOI 10.1016/j.bbrc.2004.08.044; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang YJ, 2005, CHEM SENSES, V30, pI39, DOI 10.1093/chemse/bjh102; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Ishimaru Y, 2009, ODONTOLOGY, V97, P1, DOI 10.1007/s10266-008-0095-y; Ishimaru Y, 2009, J DENT RES, V88, P212, DOI 10.1177/0022034508330212; Medler KF, 2003, J NEUROSCI, V23, P2608; NAKAMURA K, 1995, AM J PHYSIOL-REG I, V269, pR647; Ohmoto M, 2010, BIOCHEM BIOPH RES CO, V400, P734, DOI 10.1016/j.bbrc.2010.08.139; Richter TA, 2003, J PHYSIOL-LONDON, V547, P475, DOI 10.1113/jphysiol.2002.033811; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Saper CB, 2000, PROG BRAIN RES, V126, P39; SCALERA G, 1995, BEHAV NEUROSCI, V109, P997, DOI 10.1037/0735-7044.109.5.997; Yamamoto K, 2011, J NEUROCHEM, V119, P497, DOI 10.1111/j.1471-4159.2011.07443.x; YAMAMOTO T, 1975, CHEM SENS FLAV, V1, P241, DOI 10.1093/chemse/1.3.241; Yang RB, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-51	44	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					171	176		10.1080/09168451.2014.975187		6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900001		
J	Fujino, T; Kuroda, M; Matsuo, Y; Kubo, S; Tamura, C; Sakamoto, N; Mimaki, Y; Hayakawa, M				Fujino, Tomofumi; Kuroda, Minpei; Matsuo, Yukiko; Kubo, Satoshi; Tamura, Chikako; Sakamoto, Nami; Mimaki, Yoshihiro; Hayakawa, Makio			Cardenolide glycosides from the seeds of Digitalis purpurea exhibit carcinoma-specific cytotoxicity toward renal adenocarcinoma and hepatocellular carcinoma cells	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						carcinoma-specific cytotoxicity; CDK inhibitor; adenocarcinoma; cardenolide glycoside; hepatocellular carcinoma	TRANSCRIPTION FACTOR; GENE-EXPRESSION; CYCLE ARREST; ACTIVATION; PROMOTER; RECEPTOR; GROWTH; PROLIFERATION; BCL-2; P53	Four cardenolide glycosides, glucodigifucoside (2), 3 '-O-acetylglucoevatromonoside (9), digitoxigenin 3-O-beta-D-glucopyranosyl-(1 -> 4)-beta-D-glucopyranosyl-(1 -> 4)-3-O-acetyl-beta-D-digitoxopyranoside (11), and purpureaglycoside A (12), isolated from the seeds of Digitalis purpurea, exhibited potent cytotoxicity against human renal adenocarcinoma cell line ACHN. These compounds exhibited significantly lower IC50 values against ACHN than that against normal human renal proximal tubule-derived cell line HK-2. In particular, 2 exhibited the most potent and carcinoma-specific cytotoxicity, with a sixfold lower IC50 value against ACHN than that against HK-2. Measurement of cyclin-dependent kinase inhibitor levels revealed that upregulation of p21/Cip1 expression was involved in the carcinoma-specific cytotoxicity of 2. Further, compound 2 also exhibited the carcinoma-specific cytotoxicity toward hepatocellular carcinoma cell line.	[Fujino, Tomofumi; Tamura, Chikako; Sakamoto, Nami; Hayakawa, Makio] Tokyo Univ Pharm & Life Sci, Dept Hyg & Hlth Sci, Sch Pharm, Tokyo, Japan; [Kuroda, Minpei; Matsuo, Yukiko; Kubo, Satoshi; Mimaki, Yoshihiro] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Med Pharmacognosy, Tokyo, Japan	Fujino, T (reprint author), Tokyo Univ Pharm & Life Sci, Dept Hyg & Hlth Sci, Sch Pharm, Tokyo, Japan.	tfujino@ps.toyaku.ac.jp			Japan Private School Promotion Foundation	This work was supported in part by a grant from the Japan Private School Promotion Foundation.	Zhang DM, 2012, EUR J PHARMACOL, V692, P19, DOI 10.1016/j.ejphar.2012.06.045; Kuroda M, 2013, BIOSCI BIOTECH BIOCH, V77, P1186, DOI 10.1271/bbb.120922; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Lu D, 2014, ONCOGENE, V33, P1101, DOI 10.1038/onc.2013.69; Xu ZW, 2011, J STEROID BIOCHEM, V125, P181, DOI 10.1016/j.jsbmb.2010.12.016; Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/Jj.yexer.2004.08.014; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Einbond Linda Saxe, 2010, J Carcinog, V9, P10, DOI 10.4103/1477-3163.72578; Fujino T, 2012, J BIOCHEM, V152, P577, DOI 10.1093/jb/mvs101; Hiyoshi H, 2012, BRIT J CANCER, V106, P1807, DOI 10.1038/bjc.2012.159; Pietrzak M, 2008, BIOL CHEM, V389, P383, DOI 10.1515/BC.2008.039; Sugars KL, 2001, NUCLEIC ACIDS RES, V29, P4530, DOI 10.1093/nar/29.22.4530	15	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					177	184		10.1080/09168451.2014.975183		8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900002		
J	Yamane, T; Nakagami, G; Yoshino, S; Shimura, M; Kitamura, A; Kobayashi-Hattori, K; Oishi, Y; Nishijima, Y; Minematsu, T; Sanada, H				Yamane, Takumi; Nakagami, Gojiro; Yoshino, Sawako; Shimura, Mari; Kitamura, Aya; Kobayashi-Hattori, Kazuo; Oishi, Yuichi; Nishijima, Yoshimi; Minematsu, Takeo; Sanada, Hiromi			Hydrocellular foam dressings promote wound healing associated with decrease in inflammation in rat periwound skin and granulation tissue, compared with hydrocolloid dressings	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						wound healing; hydrocellular foam dressing; inflammation; interleukin; granulation tissue	REPAIR	The effects of modern dressings on inflammation, which represent the earliest phase of wound healing, are poorly understood. We investigated the effects of modern hydrocellular foam dressings (HCFs) on wound healing and on the gene expression levels of the inflammatory markers-interleukin (IL)-1 beta, IL-6, and IL-10-in rat periwound skin and granulation tissue by quantitative reverse transcription-polymerase chain reaction. HCF absorbed significantly higher volume of water than hydrocolloid dressing (HCD) and increased the contraction of wounds. Polymorphonuclear neutrophils were massively infiltrated to the wound edge and boarded between granulation and dermis in the HCD group. IL-1 beta, IL-6, and IL-10 mRNA levels were significantly decreased in the periwound skin around the wounds and granulation tissue covered with HCF. These findings suggest that HCF may promote wound healing along with decrease in inflammation by reducing gene expression levels of IL-1 beta, IL-6, and IL-10.	[Yamane, Takumi; Yoshino, Sawako; Shimura, Mari; Oishi, Yuichi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Tokyo, Japan; [Nakagami, Gojiro; Kitamura, Aya; Nishijima, Yoshimi; Minematsu, Takeo; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan; [Kobayashi-Hattori, Kazuo] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan	Sanada, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan.	hsanada-tky@umin.ac.jp					Kunugiza Y, 2010, J WOUND CARE, V19, P10; Cooney R, 1997, J TRAUMA, V42, P415, DOI 10.1097/00005373-199703000-00008; Sato Y, 2000, INT J LEGAL MED, V113, P140, DOI 10.1007/s004140050285; SIMPSON DM, 1972, J CLIN INVEST, V51, P2009, DOI 10.1172/JCI107007; Sato Y, 1999, BIOCHEM BIOPH RES CO, V265, P194, DOI 10.1006/bbrc.1999.1455; HINMAN CD, 1963, NATURE, V200, P377, DOI 10.1038/200377a0; Banks V, 1997, J Wound Care, V6, P266; Bello YM, 2000, JAMA-J AM MED ASSOC, V283, P716, DOI 10.1001/jama.283.6.716; GARNER WL, 1993, J INVEST DERMATOL, V101, P875, DOI 10.1111/1523-1747.ep12371710; Heyneman A, 2008, J CLIN NURS, V17, P1164, DOI 10.1111/j.1365-2702.2007.02218.x; Kondo S, 2012, J BIOMAT SCI-POLYM E, V23, P629, DOI 10.1163/092050611X555687; ROSS R, 1968, J CELL BIOL, V39, P152, DOI 10.1083/jcb.39.1.152; SALISBURY RE, 1979, ARCH SURG-CHICAGO, V114, P1188	13	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					185	189		10.1080/09168451.2014.968088		5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900003		
J	Tone, J; Yamanaka, A; Manabe, K; Murao, N; Kawano-Kawada, M; Sekito, T; Kakinuma, Y				Tone, Junichi; Yamanaka, Atsushi; Manabe, Kunio; Murao, Nami; Kawano-Kawada, Miyuki; Sekito, Takayuki; Kakinuma, Yoshimi			A vacuolar membrane protein Avt7p is involved in transport of amino acid and spore formation in Saccharomyces cerevisiae	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						extrusion; vacuole; starvation; spore; amino acid	ACTIVE-TRANSPORT; GENE DISRUPTION; YEAST; EXPRESSION; VESICLES; FAMILY; POOLS; CELLS	Active transport systems for various amino acids operate in the vacuolar membrane of Saccharomyces cerevisiae. The gene families for vacuolar amino acid transporters were identified by reverse genetics experiments. In the AVT transporter family, Avt1p works for active uptake of amino acid into vacuole, and Avt3p, Avt4p, and Avt6p for active extrusion of amino acid from vacuole to cytosol. Here, we found green fluorescent protein-tagged Avt7p, an unidentified member of the AVT family, localized to the vacuolar membrane of S. cerevisiae. Disruption of the AVT7 gene enhanced both vacuolar contents of several amino acids and uptake activities of glutamine and proline by vacuolar membrane vesicles. Efficiency of spore formation was impaired by the disruption of the AVT7 gene, suggesting the physiological importance of Avt7p-dependent efflux of amino acid from vacuoles under nutrient-poor condition.	[Tone, Junichi; Yamanaka, Atsushi; Manabe, Kunio; Murao, Nami; Kawano-Kawada, Miyuki; Sekito, Takayuki; Kakinuma, Yoshimi] Ehime Univ, Fac Agr, Lab Mol Physiol & Genet, Matsuyama, Ehime 790, Japan; [Kawano-Kawada, Miyuki; Kakinuma, Yoshimi] Ehime Univ, Integrated Ctr Sci INCS, Matsuyama, Ehime, Japan	Kakinuma, Y (reprint author), Ehime Univ, Fac Agr, Lab Mol Physiol & Genet, Matsuyama, Ehime 790, Japan.	ykaki@agr.ehime-u.ac.jp			Public Foundation of Elizabeth Arnold-Fuji; Noda Institute for Scientific Research	This work was supported in part by a grant-in-aid from the Public Foundation of Elizabeth Arnold-Fuji (to M.K-K.) and from the Noda Institute for Scientific Research (to Y.K. and T.S.).	Gasch AP, 2000, MOL BIOL CELL, V11, P4241; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; OHSUMI Y, 1988, J BACTERIOL, V170, P2676; KITAMOTO K, 1988, J BACTERIOL, V170, P2683; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; WIEMKEN A, 1974, ARCH MICROBIOL, V101, P45, DOI 10.1007/BF00455924; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; Chahomchuen T, 2009, J GEN APPL MICROBIOL, V55, P409; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Chardwiriyapreecha S, 2010, FEBS LETT, V584, P2339, DOI 10.1016/j.febslet.2010.04.012; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; SATO T, 1984, J BIOL CHEM, V259, P1505; Sekito T, 2014, BIOSCI BIOTECH BIOCH, V78, P269	19	3	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					190	195		10.1080/09168451.2014.963501		6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900004		
J	Kawaguchi, Y; Yoneda, K; Torikata, T; Araki, T				Kawaguchi, Yuya; Yoneda, Kazunari; Torikata, Takao; Araki, Tomohiro			Asp48 function in the hydrogen-bonding network involving Asp52 of hen egg-white lysozyme	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						enzymatic activity; lysozyme; crystallization; substrate binding; hydrogen-bonding network	ENZYME-SUBSTRATE COMPLEXES; SITE-DIRECTED MUTAGENESIS; CATALYZED REACTION; PROTEIN STABILITY; CHICKEN LYSOZYME; SUBSITE-F; BINDING; RESIDUES; CHITOOLIGOSACCHARIDES; MECHANISM	To characterize the hydrogen-bonding network in lysozyme, we focused on the residue of Asp48 located at the active site in hen egg-white lysozyme. We constructed a mutant lysozyme (D48A) and analyzed using (GlcNAc)(3) and chitin-affinity chromatography. The substrate binding of subsites D-F in D48A and the activity against (GlcNAc)(5) were decreased. The parameters of substrate binding and rate constants obtained from computer simulations confirmed these changes. In the crystal structure, (GlcNAc)(4) was located at the same position as wildtype. However, the side chains of Arg45 and Thr47 at subsites E-F were moved by the replacement. Further, the loss of the hydrogen bond between Asp48 and Ser50 changed the hydrogen-bonding network, and this resulted in an alteration of the side chain of Asn59. This result suggests that the hydrogen-bonding network plays a crucial in the function of Asp52 and of transglycosylation at subsites E-F.	[Kawaguchi, Yuya; Yoneda, Kazunari; Torikata, Takao; Araki, Tomohiro] Tokai Univ, Dept Biosci, Sch Agr, Kumamoto, Japan	Araki, T (reprint author), Tokai Univ, Dept Biosci, Sch Agr, Kumamoto, Japan.	araki@agri.u-tokai.ac.jp					ABE Y, 1995, J BIOCHEM-TOKYO, V118, P946; McRee DE, 2004, ACTA CRYSTALLOGR D, V60, P2276, DOI 10.1107/S0907444904025491; BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P378, DOI 10.1098/rspb.1967.0035; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; PACE CN, 1995, PROTEIN SCI, V4, P2411; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; PHILLIPS DC, 1966, SCI AM, V215, P78; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; RUPLEY JA, 1964, BIOCHIM BIOPHYS ACTA, V83, P245, DOI 10.1016/0926-6526(64)90001-1; Goto T, 2007, J BIOL CHEM, V282, P27459, DOI 10.1074/jbc.M704555200; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; FUKAMIZO T, 1983, J BIOCHEM-TOKYO, V94, P115; FUKAMIZO T, 1986, ARCH BIOCHEM BIOPHYS, V250, P312, DOI 10.1016/0003-9861(86)90732-0; Hashimoto Y, 1996, J BIOCHEM-TOKYO, V119, P145; INOUE M, 1992, BIOCHEMISTRY-US, V31, P10322, DOI 10.1021/bi00157a021; INOUE M, 1992, BIOCHEMISTRY-US, V31, P5545, DOI 10.1021/bi00139a017; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kawaguchi Y, 2012, CHITIN CHITOSAN RES, V18, P242; Kawamura S, 2013, BIOSCI BIOTECH BIOCH, V77, P560, DOI 10.1271/bbb.120811; Kawamura S, 2002, J BIOCHEM, V131, P663; Kawamura S, 2008, BIOSCI BIOTECH BIOCH, V72, P823, DOI 10.1271/bbb.70694; KOSHLAND DE, 1968, ANNU REV BIOCHEM, V37, P359, DOI 10.1146/annurev.bi.37.070168.002043; KUHARA S, 1982, J BIOCHEM-TOKYO, V92, P121; KUROKI R, 1986, J BIOL CHEM, V261, P3571; Kuwano Y, 2013, ACTA CRYSTALLOGR F, V69, P1202, DOI 10.1107/S1744309113028170; MAENAKA K, 1995, J MOL BIOL, V247, P281, DOI 10.1006/jmbi.1994.0139; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; MASAKI A, 1981, J BIOCHEM-TOKYO, V90, P527; MASAKI A, 1981, J BIOCHEM-TOKYO, V90, P1167; Matsumura I, 1996, BIOCHEMISTRY-US, V35, P1890, DOI 10.1021/bi951672i; Ose T, 2009, J BIOCHEM, V146, P651, DOI 10.1093/jb/mvp110; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; PINCUS MR, 1976, BIOPOLYMERS, V15, P2485, DOI 10.1002/bip.1976.360151212; PINCUS MR, 1977, P NATL ACAD SCI USA, V74, P2629, DOI 10.1073/pnas.74.7.2629; POLLOCK JJ, 1970, BIOCHEMISTRY-US, V9, P3913, DOI 10.1021/bi00822a009; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SMITHGILL SJ, 1984, BIOCHEMISTRY-US, V23, P993, DOI 10.1021/bi00300a030; TESHIMA K, 1980, J BIOCHEM-TOKYO, V87, P1015; UEDA T, 1994, J MOL BIOL, V235, P1312, DOI 10.1006/jmbi.1994.1084; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; YAMADA H, 1981, CARBOHYD RES, V92, P160, DOI 10.1016/S0008-6215(00)85993-5	44	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					196	204		10.1080/09168451.2014.963502		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900005		
J	Takahashi, S; Abe, E; Nakayama, K; Satoh, H				Takahashi, Shigekazu; Abe, Eriko; Nakayama, Katsumi; Satoh, Hiroyuki			Identification of genes encoding photoconvertible (Class I) water-soluble chlorophyll-binding proteins from Chenopodium ficifolium	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						Chenopodium ficifolium; chlorophyll; water-soluble chlorophyll-binding protein; Class I WSCP; DUF538	ENERGY-LEVEL STRUCTURE; MOLECULAR-CLONING; INTRACELLULAR-LOCALIZATION; FUNCTIONAL EXPRESSION; ALBUM; PIGMENT; CAULIFLOWER; BRASSICA; COMPLEX; WSCP	Photoconvertible water-soluble chlorophyll-binding proteins, called Class I WSCPs, have been detected in Chenopodiaceae, Amaranthaceae and Polygonaceae plant species. To date, Chenopodium album WSCP (CaWSCP) is the only cloned gene encoding a Class I WSCP. In this study, we identified two cDNAs encoding Chenopodium ficifolium Class I WSCPs, CfWSCP1, and CfWSCP2. Sequence analyses revealed that the open reading frames of CfWSCP1 and CfWSCP2 were 585 and 588bp, respectively. Furthermore, both CfWSCPs contain cystein2 and cystein30, which are essential for the chlorophyll-binding ability of CaWSCP. Recombinant CfWSCP1 and CfWSCP2, expressed in Escherichia coli as hexa-histidine fusion proteins (CfWSCP1-His and CfWSCP2-His), formed inclusion bodies; however, we were able to solubilize these using a buffer containing 8M urea and then refold them by dialysis. The refolded CfWSCP1-His and CfWSCP2-His could bind chlorophylls and exhibited photoconvertibility, confirming that the cloned CfWSCPs are further examples of Class I WSCPs.	[Takahashi, Shigekazu; Abe, Eriko; Nakayama, Katsumi; Satoh, Hiroyuki] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan	Satoh, H (reprint author), Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan.	hsatoh@biomol.sci.toho-u.ac.jp			Hamaguchi Foundation for the Advancement of Biochemistry [H25]	This study was supported by a grant from the Hamaguchi Foundation for the Advancement of Biochemistry [grant number H25] to S.T.	Takahashi S, 2012, PLANT CELL PHYSIOL, V53, P879, DOI 10.1093/pcp/pcs031; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Pieper J, 2011, J PHYS CHEM B, V115, P4042, DOI 10.1021/jp111455g; Renger T, 2007, J PHYS CHEM B, V111, P10487, DOI 10.1021/jp0717241; Takahashi S, 2013, J PLANT PHYSIOL, V170, P406, DOI 10.1016/j.jplph.2012.10.007; Renger T, 2009, J PHYS CHEM B, V113, P9948, DOI 10.1021/jp901886w; Theiss C, 2007, J PHYS CHEM B, V111, P13325, DOI 10.1021/jp0723968; Pieper J, 2011, J PHYS CHEM B, V115, P4053, DOI 10.1021/jp111457t; Schmidt K, 2003, BIOCHEMISTRY-US, V42, P7427, DOI 10.1021/bi034207r; Hughes JL, 2006, J AM CHEM SOC, V128, P3649, DOI 10.1021/ja056676b; Satoh H, 2001, PLANT CELL PHYSIOL, V42, P906, DOI 10.1093/pcp/pce117; Bektas I, 2012, PLANTA, V236, P251, DOI 10.1007/s00425-012-1609-y; GOEDHEER JC, 1977, ACTA BOT NEERL, V26, P289; Hagar W. G., 1974, CARNEGIE I WASH YB, V73, P706; HAGAR WG, 1979, PLANT PHYSIOL, V63, P1182, DOI 10.1104/pp.63.6.1182; Hirabayashi H, 2006, J PHOTOCH PHOTOBIO A, V183, P121, DOI 10.1016/j.jphotochem.2006.03.003; Murata T., 1968, COMP BIOCH BIOPHYSIC, P222; Noguchi T, 1999, PLANT CELL PHYSIOL, V40, P305; Ohtsuki T, 2007, ACTA CRYSTALLOGR F, V63, P740, DOI 10.1107/S1744309107035658; OKU T, 1972, PLANT CELL PHYSIOL, V13, P773; OKU T, 1975, PLANT CELL PHYSIOL, V16, P1009; OKU T, 1972, PLANT CELL PHYSIOL, V13, P183; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Satoh H, 2002, J PLANT PHYSIOL, V159, P325, DOI 10.1078/0176-1617-00704; Satoh H, 1998, J BIOL CHEM, V273, P30568, DOI 10.1074/jbc.273.46.30568; Schmitt FJ, 2008, J PHYS CHEM B, V112, P13951, DOI 10.1021/jp8024057; Takahashi S, 2013, PLANTA, V238, P1065, DOI 10.1007/s00425-013-1952-7; Takahashi S, 2014, PROTEIN J, V33, P75, DOI 10.1007/s10930-013-9539-5; Takahashi S, 2014, BIOSCI BIOTECH BIOCH, V78, P1825, DOI 10.1080/09168451.2014.940274; Takahashi S, 2013, BRASSICACEAE CHARACT, P111; Takahashi S, 2013, J PLANT PHYSIOL, V170, P1549, DOI 10.1016/j.jplph.2013.06.001; Takahashi S, 2014, PROTEIN J, V33, P337, DOI 10.1007/s10930-014-9565-y; Takamiya A., 1973, CARNEGIE I WASH YB, V72, P330; Takamiya A., 1968, COMP BIOCH BIOPHYSIC, P229; TERPSTRA W, 1966, BIOCHIM BIOPHYS ACTA, V120, P317, DOI 10.1016/0926-6585(66)90298-6; YAKUSHIJI E, 1963, BIOCHIM BIOPHYS ACTA, V75, P293, DOI 10.1016/0006-3002(63)90615-2	36	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					205	210		10.1080/09168451.2014.972326		6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900006		
